PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alnaas, AA; Watson-Siriboe, A; Tran, S; Negussie, M; Henderson, JA; Osterberg, JR; Chon, NL; Harrott, BM; Oviedo, J; Lyakhova, T; Michel, C; Reisdorph, N; Reisdorph, R; Shearn, CT; Lin, H; Knight, JD				Alnaas, Aml A.; Watson-Siriboe, Abena; Tran, Sherleen; Negussie, Mikias; Henderson, Jack A.; Osterberg, J. Ryan; Chon, Nara L.; Harrott, Beckston M.; Oviedo, Julianna; Lyakhova, Tatyana; Michel, Cole; Reisdorph, Nichole; Reisdorph, Richard; Shearn, Colin T.; Lin, Hai; Knight, Jefferson D.			Multivalent lipid targeting by the calcium-independent C2A domain of synaptotagmin-like protein 4/granuphilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PLASMA-MEMBRANE; INSULIN GRANULES; GRANUPHILIN; BINDING; EXOCYTOSIS; SIMULATIONS; PARAMETERS; INSIGHTS	Synaptotagmin-like protein 4 (Slp-4), also known as granuphilin, is a Rab effector responsible for docking secretory vesicles to the plasma membrane before exocytosis. Slp-4 binds vesicular Rab proteins via an N-terminal Slp homology domain, interacts with plasma membrane SNARE complex proteins via a central linker region, and contains tandem C-terminal C2 domains (C2A and C2B) with affinity for phosphatidylinositol(4,5)-bisphosphate (PIP2). The Slp-4 C2A domain binds with low nanomolar apparent affinity to PIP2 in lipid vesicles that also contain background anionic lipids such as phosphatidylserine but much weaker when either the background anionic lipids or PIP2 is removed. Through computational and experimental approaches, we show that this high-affinity membrane binding arises from concerted interaction at multiple sites on the C2A domain. In addition to a conserved PIP2-selective lysine cluster, a larger cationic surface surrounding the cluster contributes substantially to the affinity for physiologically relevant lipid compositions. Although the K398A mutation in the lysine cluster blocks PIP2 binding, this mutated protein domain retains the ability to bind physiological membranes in both a liposome-binding assay and MIN6 cells. Molecular dynamics simulations indicate several conformationally flexible loops that contribute to the nonspecific cationic surface. We also identify and characterize a covalently modified variant that arises through reactivity of the PIP2-binding lysine cluster with endogenous bacterial compounds and binds weakly to membranes. Overall, multivalent lipid binding by the Slp-4 C2A domain provides selective recognition and high-affinity docking of large dense core secretory vesicles to the plasma membrane.	[Alnaas, Aml A.; Watson-Siriboe, Abena; Tran, Sherleen; Negussie, Mikias; Henderson, Jack A.; Osterberg, J. Ryan; Chon, Nara L.; Harrott, Beckston M.; Oviedo, Julianna; Lyakhova, Tatyana; Lin, Hai; Knight, Jefferson D.] Univ Colorado, Dept Chem, Denver, CO 80202 USA; [Michel, Cole; Reisdorph, Nichole; Reisdorph, Richard] Univ Colorado, Dept Pharmaceut Sci, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Shearn, Colin T.] Univ Colorado, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Sch Med, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Lin, H; Knight, JD (corresponding author), Univ Colorado, Dept Chem, Denver, CO 80202 USA.	Hai.Lin@ucdenver.edu; Jefferson.Knight@ucdenver.edu		Negussie, Mikias/0000-0001-6060-6926; Lin, Hai/0000-0002-3525-9122	NIH [R15GM102866]; Camille and Henry Dreyfus Foundation [TH-14-028, TH-18-061]; University of Colorado Denver Undergraduate Research Opportunity Program; University of Colorado Denver LABCOATS program [NIH 5R25GM083333]; NSF [CHE-140070, ACI-1548562]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camille and Henry Dreyfus Foundation; University of Colorado Denver Undergraduate Research Opportunity Program; University of Colorado Denver LABCOATS program; NSF(National Science Foundation (NSF))	This work was funded by the NIH grant R15GM102866. The authors acknowledge support from the Camille and Henry Dreyfus Foundation (TH-14-028 to H. L. and TH-18-061 to J. D. K.) and the University of Colorado Denver Undergraduate Research Opportunity Program (to S. T., J. A. H., and T. L.). T. L. was supported by a fellowship through the University of Colorado Denver LABCOATS program (NIH 5R25GM083333 to Prof Sonia Flores). This work used XSEDE under grant CHE-140070, supported by NSF grant ACI-1548562. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2007, FORCE FIELD MANUAL S, P1; Aon JC, 2008, APPL ENVIRON MICROB, V74, P950, DOI 10.1128/AEM.01790-07; Brandt DS, 2012, BIOCHEMISTRY-US, V51, P7654, DOI 10.1021/bi3007115; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chon NL, 2015, BIOCHEMISTRY-US, V54, P5696, DOI 10.1021/acs.biochem.5b00422; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; Fukuda M, 2003, J BIOL CHEM, V278, P15390, DOI 10.1074/jbc.M213090200; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Gaylord N. G., 1962, J POLYM SCI, V62, pS24; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P1953, DOI 10.1021/jp0750708; HALL D, 1984, J COMPUT CHEM, V5, P441, DOI 10.1002/jcc.540050504; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurkiewicz P, 2012, BBA-BIOMEMBRANES, V1818, P609, DOI 10.1016/j.bbamem.2011.11.033; Kalli AC, 2014, BIOCHEMISTRY-US, V53, P1724, DOI 10.1021/bi5000299; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lai CL, 2010, J MOL BIOL, V402, P301, DOI 10.1016/j.jmb.2010.07.037; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lyakhova TA, 2014, CHEM PHYS LIPIDS, V182, P29, DOI 10.1016/j.chemphyslip.2013.10.009; MacDougall DD, 2018, J GEN PHYSIOL, V150, P783, DOI 10.1085/jgp.201711944; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martos-Maldonado MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05695-3; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Miyamoto K, 2017, PROTEIN SCI, V26, P2451, DOI 10.1002/pro.3301; Mizuno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep23909; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Osna NA, 2016, WORLD J GASTROENTERO, V22, P6192, DOI 10.3748/wjg.v22.i27.6192; Pant S, 2020, J COMPUT CHEM, V41, P489, DOI 10.1002/jcc.26109; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Posner MG, 2018, J BIOL CHEM, V293, P9335, DOI 10.1074/jbc.RA118.002279; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; Reisdorph N, 2018, J CHROMATOGR B, V1084, P132, DOI 10.1016/j.jchromb.2018.03.031; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; SEELIG J, 1978, BIOCHEMISTRY-US, V17, P3310, DOI 10.1021/bi00609a021; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Torii S, 2004, J BIOL CHEM, V279, P22532, DOI 10.1074/jbc.M400600200; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; Tran HT, 2019, BIOPHYS J, V116, P1025, DOI 10.1016/j.bpj.2019.01.035; Tsuboi T, 2006, MOL BIOL CELL, V17, P2101, DOI 10.1091/mbc.E05-11-1047; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Venable RM, 2013, J PHYS CHEM B, V117, P10183, DOI 10.1021/jp401512z; Wan CJ, 2015, CHEM PHYS LIPIDS, V186, P61, DOI 10.1016/j.chemphyslip.2015.01.003; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yamaoka M, 2015, WORLD J DIABETES, V6, P508, DOI 10.4239/wjd.v6.i3.508; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Yu M, 2007, MOL BIOL CELL, V18, P688, DOI 10.1091/mbc.E06-10-0914; Zhou A, 2013, BIOCHEMISTRY-US, V52, P3446, DOI 10.1021/bi400230u	70	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100159	10.1074/jbc.RA120.014618	http://dx.doi.org/10.1074/jbc.RA120.014618			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33277360	gold, Green Published			2022-12-26	WOS:000672866400137
J	Vemula, V; Huber, T; Usaj, M; Bugyi, B; Mansson, A				Vemula, Venukumar; Huber, Tamas; Usaj, Marko; Bugyi, Beata; Mansson, Alf			Myosin and gelsolin cooperate in actin filament severing and actomyosin motor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LABELED F-ACTIN; IN-VITRO; SLIDING MOVEMENT; FUNCTIONAL INTERACTIONS; ROTATIONAL-DYNAMICS; STRUCTURAL DYNAMICS; DEPENDENT BINDING; TERMINAL HALF; STEP-SIZE; FLEXIBILITY	Actin is a major intracellular protein with key functions in cellular motility, signaling, and structural rearrangements. Its dynamic behavior, such as polymerization and depolymerization of actin filaments in response to intracellular and extracellular cues, is regulated by an abundance of actin binding proteins. Out of these, gelsolin is one of the most potent for filament severing. However, myosin motor activity also fragments actin filaments through motor-induced forces, suggesting that these two proteins could cooperate to regulate filament dynamics and motility. To test this idea, we used an in vitro motility assay, where actin filaments are propelled by surface-adsorbed heavy meromyosin (HMM) motor fragments. This allows studies of both motility and filament dynamics using isolated proteins. Gelsolin, at both nanomolar and micromolar Ca2+ concentration, appreciably enhanced actin filament severing caused by HMM-induced forces at 1 mM MgATP, an effect that was increased at higher HMM motor density. This finding is consistent with cooperativity between actin filament severing by myosin-induced forces and by gelsolin. We also observed reduced sliding velocity of the HMM-propelled filaments in the presence of gelsolin, providing further support of myosin-gelsolin cooperativity. Total internal reflection fluorescence microscopy-based single molecule studies corroborated that the velocity reduction was a direct effect of gelsolin binding to the filament and revealed different filament severing pattern of stationary and HMM propelled filaments. Overall, the results corroborate cooperative effects between gelsolin-induced alterations in the actin filaments and changes due to myosin motor activity leading to enhanced F-actin severing of possible physiological relevance.	[Vemula, Venukumar; Usaj, Marko; Mansson, Alf] Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden; [Huber, Tamas; Bugyi, Beata] Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary	Linnaeus University; University of Pecs	Mansson, A (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden.; Bugyi, B (corresponding author), Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary.	beata.bugyi@aok.pte.hu; alf.mansson@lnu.se	Mansson, Alf/ABC-6271-2021	Mansson, Alf/0000-0002-5889-7792; Bugyi, Beata/0000-0003-4181-3633	EU Horizon 2020 Research and Innovation Framework Programme of the European Union [732482]; Swedish Research Council [2015-05290, 2019-03456]; Faculty of Health and Life Sciences at The Linnaeus University, Sweden;  [GINOP-2.3.2-15-2016-00049];  [EFOP-3.6.2-16-2017-00006];  [PTE AOK-KA-2019-50]	EU Horizon 2020 Research and Innovation Framework Programme of the European Union; Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Health and Life Sciences at The Linnaeus University, Sweden; ; ; 	TThis work was funded by EU Horizon 2020 Research and Innovation Framework Programme of the European Union (grant agreement 732482) (Future and Emerging Technologies; Bio4comp), The Swedish Research Council (grant numbers 2015-05290 and 2019-03456), and The Faculty of Health and Life Sciences at The Linnaeus University, Sweden. We also acknowledge support by the GINOP-2.3.2-15-2016-00049 and EFOP-3.6.2-16-2017-00006 grants, as well as by PTE AOK-KA-2019-50 (to T. H.).	Agarwal P, 2019, TRENDS CELL BIOL, V29, P150, DOI 10.1016/j.tcb.2018.09.006; Aksnes Henriette, 2018, Commun Integr Biol, V11, pe1526572, DOI 10.1080/19420889.2018.1526572; ALLEN PG, 1994, J BIOL CHEM, V269, P32916; Arora PD, 2013, MOL BIOL CELL, V24, P734, DOI 10.1091/mbc.E12-10-0754; Arora PD, 2011, J BIOL CHEM, V286, P34184, DOI 10.1074/jbc.M111.247783; Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Badmalia MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04975-0; Ballestrem C, 1998, J CELL SCI, V111, P1649; BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; Bearer EL, 2000, CELL MOTIL CYTOSKEL, V47, P351, DOI 10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8; Bengtsson E, 2016, BIOPHYS J, V111, P1465, DOI 10.1016/j.bpj.2016.08.025; Benoit MPMH, 2018, METHODS MOL BIOL, V1665, P199, DOI 10.1007/978-1-4939-7271-5_11; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Carlier MF, 2017, NAT REV MOL CELL BIO, V18, P389, DOI 10.1038/nrm.2016.172; Cooper GM, 2000, CELL MOL APPROACH; COOPER JA, 1991, ANNU REV PHYSIOL, V53, P585, DOI 10.1146/annurev.ph.53.030191.003101; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; DREWES G, 1993, EUR J BIOCHEM, V212, P247, DOI 10.1111/j.1432-1033.1993.tb17656.x; EGELMAN EH, 1995, J STRUCT BIOL, V115, P159, DOI 10.1006/jsbi.1995.1040; Egelman EH, 2001, NAT STRUCT BIOL, V8, P735, DOI 10.1038/nsb0901-735; Feldt J, 2019, EXPERT REV MOL MED, V20, DOI 10.1017/erm.2018.7; Fujita H, 1997, EUR J BIOCHEM, V248, P834, DOI 10.1111/j.1432-1033.1997.00834.x; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Ghoshdastider U, 2013, CYTOSKELETON, V70, P775, DOI 10.1002/cm.21149; Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hild G, 1998, BIOPHYS J, V75, P3015, DOI 10.1016/S0006-3495(98)77742-2; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Howard J., 2001, MECH MOTOR PROTEINS; Jegou A, 2020, SEMIN CELL DEV BIOL, V102, P65, DOI 10.1016/j.semcdb.2019.10.018; Khaitlina S, 2002, FEBS LETT, V521, P14, DOI 10.1016/S0014-5793(02)02657-1; Kinosian HJ, 1998, BIOPHYS J, V75, P3101, DOI 10.1016/S0006-3495(98)77751-3; Kis-Bicskei N, 2018, BIOPHYS J, V114, P777, DOI 10.1016/j.bpj.2017.11.3812; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Kolodney MS, 1999, J PHYSIOL-LONDON, V515, P87, DOI 10.1111/j.1469-7793.1999.087ad.x; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Lagarrigue E, 2003, EUR J BIOCHEM, V270, P4105, DOI 10.1046/j.1432-1033.2003.03803.x; Lard M, 2015, IEEE T NANOBIOSCI, V14, P289, DOI 10.1109/TNB.2015.2412036; Li J, 2017, SOFT MATTER, V13, P3213, DOI 10.1039/c6sm02703b; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; Mansson A., 2020, OPTIMIZED SINGLE MOL, DOI [10.1101/2020.01.16.908947, DOI 10.1101/2020.01.16.908947]; Mansson A, 2016, J MUSCLE RES CELL M, V37, P181, DOI 10.1007/s10974-016-9458-0; Mansson A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/245154; Mansson A, 2012, J MUSCLE RES CELL M, V33, P219, DOI 10.1007/s10974-012-9298-5; Matsuda K., 2018, MYOSIN DRIVEN FRAGME, DOI [10.1101/332684, DOI 10.1101/332684]; Melton AC, 2006, AM J PHYSIOL-GASTR L, V290, pG7, DOI 10.1152/ajpgi.00337.2005; Merino F, 2018, NAT STRUCT MOL BIOL, V25, P531, DOI 10.1038/s41594-018-0074-0; MIKI M, 1982, BIOPHYS CHEM, V16, P165, DOI 10.1016/0301-4622(82)85019-9; MOSSAKOWSKA M, 1988, EUR J BIOCHEM, V175, P557, DOI 10.1111/j.1432-1033.1988.tb14228.x; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Nyitrai M, 1999, J BIOL CHEM, V274, P12996, DOI 10.1074/jbc.274.19.12996; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PATE E, 1993, P NATL ACAD SCI USA, V90, P2451, DOI 10.1073/pnas.90.6.2451; Patel VB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07812-8; PATKOWSKI A, 1990, BIOPOLYMERS, V30, P219, DOI 10.1002/bip.360300123; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; Prochniewicz E, 1997, BIOCHEMISTRY-US, V36, P12845, DOI 10.1021/bi971201r; PROCHNIEWICZ E, 1993, BIOPHYS J, V65, P113, DOI 10.1016/S0006-3495(93)81057-9; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Rahman MA, 2018, BIOPHYS J, V115, P386, DOI 10.1016/j.bpj.2018.05.037; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Sundberg M, 2003, ANAL BIOCHEM, V323, P127, DOI 10.1016/j.ab.2003.07.022; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Szatmari D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201826; ten Siethoff L, 2014, NANO LETT, V14, P737, DOI 10.1021/nl404032k; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; VERKHOVSKY AB, 1984, BIOCHEM BIOPH RES CO, V123, P596, DOI 10.1016/0006-291X(84)90271-7; Vogel SK, 2013, ELIFE, V2, DOI 10.7554/eLife.00116; von der Ecken J, 2016, NATURE, V534, P724, DOI 10.1038/nature18295; Walcott S, 2012, BIOPHYS J, V103, P501, DOI 10.1016/j.bpj.2012.06.031; WEGNER A, 1982, NATURE, V296, P266, DOI 10.1038/296266a0; Wilson C, 2016, CYTOSKELETON, V73, P577, DOI 10.1002/cm.21315; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670	99	4	4	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100181	10.1074/jbc.RA120.015863	http://dx.doi.org/10.1074/jbc.RA120.015863			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303625	Green Published, gold			2022-12-26	WOS:000672866400159
J	Markos, JR; Schaepe, KS; Teaford, HR; Rule, AD; Kashani, KB; Lieske, JC; Barreto, EF				Markos, James Roland; Schaepe, Karen S.; Teaford, Hilary R.; Rule, Andrew D.; Kashani, Kianoush B.; Lieske, John C.; Barreto, Erin F.			Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; MARKER; LIMITATIONS; BIOMARKERS; RELEVANCE; GFR	Introduction Serum creatinine (SCr) testing has been the mainstay of kidney function assessment for decades despite known limitations. Cystatin C (CysC) is an alternative biomarker that is generally less affected than SCr by pertinent non-renal factors in hospitalized patients, such as muscle mass. Despite its potential advantages, the adoption of CysC for inpatient care is not widespread. At one hospital with CysC testing, we demonstrated a significant rise in non-protocolized use over the last decade. This study uses qualitative methods to provide the first report of how clinicians understand, approach, and apply CysC testing in inpatient care. Methods Fifteen clinicians from various disciplines were interviewed about their experience with inpatient CysC testing. The semi-structured interviews were audio-recorded, transcribed verbatim, and analyzed thematically using a phenomenological approach. Results Knowledge and confidence with CysC varied greatly. Clinicians reported first learning about the test from colleagues on consulting services or multidisciplinary teams. The majority believed CysC to provide a more accurate measure of kidney function than SCr. Common scenarios for CysC ordering included medication dosing, evaluation of acute kidney injury, and a thorough evaluation of kidney function in patients with risk factors for an altered SCr. Facilitators for ordering CysC included the availability of rapid results turnaround and the automated calculation of glomerular filtration rate based on the biomarker. Barriers to use included a lack of education about CysC, and the absence of an institutional protocol for use. Discussion Clinicians at our site decided independent of institutional guidance whether and when CysC added value to patient care. While the majority of study participants indicated advantages to rapid turnaround CysC testing, its use depended not just on the features of the specific case but on clinician familiarity and personal preference. Findings from this research can guide the implementation and expansion of CysC testing.	[Markos, James Roland] Mayo Clin, Alix Sch Med, Rochester, MN USA; [Schaepe, Karen S.; Barreto, Erin F.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Teaford, Hilary R.] Cedars Sinai Med Ctr, Dept Pharm, Los Angeles, CA 90048 USA; [Rule, Andrew D.; Kashani, Kianoush B.; Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Rule, Andrew D.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Kashani, Kianoush B.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Barreto, Erin F.] Mayo Clin, Dept Pharm, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Cedars Sinai Medical Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Barreto, EF (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.; Barreto, EF (corresponding author), Mayo Clin, Dept Pharm, Rochester, MN 55905 USA.	Barreto.Erin@mayo.edu		Markos, James/0000-0001-7042-0674; Lieske, John/0000-0002-0202-5944; Kashani, Kianoush/0000-0003-2184-3683	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23AI143882]	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number K23AI143882 (PI; Dr. Erin Barreto). The funding sources had no role in study design; data collection, analysis, or interpretation; writing the report; or the decision to submit the report for publication. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funder provided support in the form of salaries for authors [KSS, EFB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. https://www.mayo.edu/research/centersprograms/robert-d-patricia-e-kern-center-science-health-care-delivery/about https://www.niaid.nih.gov/	Al Musaimi O, 2019, MED FAM-SEMERGEN, V45, P44, DOI 10.1016/j.semerg.2018.07.005; Alge JL, 2015, CLIN J AM SOC NEPHRO, V10, P147, DOI 10.2215/CJN.12191213; Anderson TS, 2020, JAMA INTERN MED, V180, P984, DOI 10.1001/jamainternmed.2020.1588; Barreto EF, 2019, MAYO CLIN PROC, V94, P500, DOI 10.1016/j.mayocp.2018.08.002; Barreto EF, 2018, PHARMACOTHERAPY, V38, P794, DOI 10.1002/phar.2149; Chau Katrina, 2014, Can J Kidney Health Dis, V1, P19, DOI 10.1186/s40697-014-0019-4; Colaizzi P. F., 1978, EXISTENTIAL PHENOMEN; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-9; Digvijay K, 2019, BLOOD PURIFICAT, V47, P113, DOI 10.1159/000493724; Ebert N, 2020, CURR OPIN NEPHROL HY, V29, P591, DOI 10.1097/MNH.0000000000000638; Ferguson TW, 2015, CURR OPIN NEPHROL HY, V24, P295, DOI 10.1097/MNH.0000000000000115; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Filler G, 2016, CURR OPIN PEDIATR, V28, P173, DOI 10.1097/MOP.0000000000000318; Frazee E, 2017, AM J KIDNEY DIS, V69, P658, DOI 10.1053/j.ajkd.2016.11.016; Frazee Erin N, 2016, J Pharm Pract, V29, P125, DOI 10.1177/0897190014549841; Frazee EN, 2014, CRIT CARE, V18, DOI 10.1186/cc13899; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gharaibeh KA, 2018, KIDNEY INT REP, V3, P337, DOI 10.1016/j.ekir.2017.10.012; Giorgi A., 2006, HUMANIST PSYCHOL, V34, P305, DOI [DOI 10.1207/S15473333THP3404_2, 10.1207/s15473333thp3404_2]; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Hudson JQ, 2018, ADV CHRONIC KIDNEY D, V25, P14, DOI 10.1053/j.ackd.2017.10.003; Inker LA, 2016, AM J KIDNEY DIS, V67, P40, DOI 10.1053/j.ajkd.2015.07.025; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kane-Gill SL, 2017, DRUG SAFETY, V40, P1049, DOI 10.1007/s40264-017-0565-7; Kashani K, 2020, EUR J INTERN MED, V72, P9, DOI 10.1016/j.ejim.2019.10.025; Levey AS, 2014, CLIN CHEM, V60, P916, DOI 10.1373/clinchem.2014.225383; Liu KD, 2011, CRIT CARE MED, V39, P2665, DOI 10.1097/CCM.0b013e318228234b; Meersch M, 2017, INTENS CARE MED, V43, P1551, DOI 10.1007/s00134-016-4670-3; Mussap M, 2002, KIDNEY INT, V61, P1453, DOI 10.1046/j.1523-1755.2002.00253.x; Rule AD, 2006, MAYO CLIN PROC, V81, P1427, DOI 10.4065/81.11.1427; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Stabuc B, 2000, CLIN CHEM, V46, P193; Teaford HR, 2020, MAYO CLIN PROC, V95, P1649, DOI 10.1016/j.mayocp.2020.03.030; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Woo KS, 2014, DIABETES METAB J, V38, P278, DOI 10.4093/dmj.2014.38.4.278	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243618	10.1371/journal.pone.0243618	http://dx.doi.org/10.1371/journal.pone.0243618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306741	Green Published, gold			2022-12-26	WOS:000600144200012
J	Rao, S; Linke, L; Doster, E; Hyatt, D; Burgess, BA; Magnuson, R; Pabilonia, KL; Morley, PS				Rao, Sangeeta; Linke, Lyndsey; Doster, Enrique; Hyatt, Doreene; Burgess, Brandy A.; Magnuson, Roberta; Pabilonia, Kristy L.; Morley, Paul S.			Genomic diversity of class I integrons from antimicrobial resistant strains of Salmonella Typhimurium isolated from livestock, poultry and humans	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; GENE CASSETTES; ESCHERICHIA-COLI; IDENTIFICATION; ORGANIZATION; INTEGRASES; INFECTIONS; ACCURACY; SEROVARS; SITE	Introduction Multidrug resistance (MDR) is a serious issue prevalent in various agriculture-related foodborne pathogens including Salmonella enterica (S. enterica) Typhimurium. Class I integrons have been detected in Salmonella spp. strains isolated from food producing animals and humans and likely play a critical role in transmitting antimicrobial resistance within and between livestock and human populations. Objective The main objective of our study was to characterize class I integron presence to identify possible integron diversity among and between antimicrobial resistant Salmonella Typhimurium isolates from various host species, including humans, cattle, swine, and poultry. Methods An association between integron presence with multidrug resistance was evaluated. One hundred and eighty-three S. Typhimurium isolates were tested for antimicrobial resistance (AMR). Class I integrons were detected and sequenced. Similarity of AMR patterns between host species was also studied within each integron type. Results One hundred seventy-four (95.1%) of 183 S.Typhimurium isolates were resistant to at least one antimicrobial and 82 (44.8%) were resistant to 5 or more antimicrobials. The majority of isolates resistant to at least one antimicrobial was from humans (45.9%), followed by swine (19.1%) and then bovine (16.9%) isolates; poultry showed the lowest number (13.1%) of resistant isolates. Our study has demonstrated high occurrence of class I integrons in S. Typhimurium across different host species. Only one integron size was detected in poultry isolates. There was a significant association between integron presence of any size and specific multidrug resistance pattern among the isolates from human, bovine and swine. Conclusions Our study has demonstrated a high occurrence of class I integrons of different sizes in Salmonella Typhimurium across various host species and their association with multidrug resistance. This demonstration indicates that multidrug resistant Salmonella Typhimurium is of significant public health occurrence and reflects on the importance of judicious use of antimicrobials among livestock and poultry.	[Rao, Sangeeta; Linke, Lyndsey; Magnuson, Roberta; Pabilonia, Kristy L.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Doster, Enrique] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, Minneapolis, MN USA; [Doster, Enrique; Morley, Paul S.] Texas A&M Univ, Vet Educ Res & Outreach Program, College Stn, TX USA; [Doster, Enrique; Morley, Paul S.] West Texas A&M Univ, Vet Educ Res & Outreach Program, College Stn, TX USA; [Hyatt, Doreene] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO USA; [Burgess, Brandy A.] Univ Georgia, Coll Vet Med, Athens, GA USA	Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Colorado State University; University System of Georgia; University of Georgia	Rao, S (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.	Sangeeta.Rao@Colostate.edu	; Morley, Paul/C-9960-2009	Rao, Sangeeta/0000-0002-9234-0082; Linke, Lyndsey/0000-0002-9423-2456; Morley, Paul/0000-0001-8138-2714	Gates Grand Challenges One Health and United States Department of Agriculture - Animal Health and Disease	Gates Grand Challenges One Health and United States Department of Agriculture - Animal Health and Disease	The funding support was provided by Gates Grand Challenges One Health and United States Department of Agriculture - Animal Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2014, INT J FOOD MICROBIOL, V189, P39, DOI 10.1016/j.ijfoodmicro.2014.07.031; [Anonymous], 1995, CHINESE J EXP SURG, V12, P131; Barlow RS, 2009, J APPL MICROBIOL, V107, P540, DOI 10.1111/j.1365-2672.2009.04240.x; Bennett PM, 1999, J ANTIMICROB CHEMOTH, V43, P1, DOI 10.1093/jac/43.1.1; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Centers for Disease Control and Prevention, 2016, SURVEILLANCE; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI WAYN PA; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Diaz-Mejia JJ, 2008, MICROBIOL-SGM, V154, P94, DOI 10.1099/mic.0.2007/008649-0; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; Ebner P, 2004, J ANTIMICROB CHEMOTH, V53, P1004, DOI 10.1093/jac/dkh192; El-Najjar NG, 2010, LETT APPL MICROBIOL, V51, P456, DOI 10.1111/j.1472-765X.2010.02926.x; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; Gebreyes WA, 2004, J ANTIMICROB CHEMOTH, V53, P997, DOI 10.1093/jac/dkh247; Gruenberg W., 2019, OVERVIEW SALMONELLOS; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Hall RM, 2012, ANN NY ACAD SCI, V1267, P71, DOI 10.1111/j.1749-6632.2012.06588.x; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hsu YM, 2013, COMP IMMUNOL MICROB, V36, P9, DOI 10.1016/j.cimid.2012.08.004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khemtong S, 2008, MICROB DRUG RESIST, V14, P65, DOI 10.1089/mdr.2008.0807; Krauland MG, 2009, EMERG INFECT DIS, V15, P388, DOI 10.3201/eid1503.081131; Lakin SM, 2017, NUCLEIC ACIDS RES, V45, pD574, DOI 10.1093/nar/gkw1009; Lee KM, 2015, FOOD CONTROL, V47, P264, DOI 10.1016/j.foodcont.2014.07.011; Lopes GV, 2016, VET MICROBIOL, V194, P84, DOI 10.1016/j.vetmic.2016.04.020; Lucey B, 2000, EMERG INFECT DIS, V6, P50; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Malorny B, 2003, APPL ENVIRON MICROB, V69, P290, DOI 10.1128/AEM.69.1.290-296.2003; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; NDRC: Natural Resources Defense Council, 2018, ANT CONS US PORK BEE; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Rao S, 2008, J CLIN MICROBIOL, V46, P916, DOI 10.1128/JCM.01597-07; Roe MT, 2003, POULTRY SCI, V82, P622, DOI 10.1093/ps/82.4.622; Sneath PHA., 1973, NUMERICAL TAXONOMY, P230, DOI DOI 10.1111/J.1523-1739.2007.00775.X; Threlfall EJ, 2002, FEMS MICROBIOL REV, V26, P141, DOI 10.1016/S0168-6445(02)00092-X; Wannaprasat W, 2011, INT J ANTIMICROB AG, V37, P457, DOI 10.1016/j.ijantimicag.2010.12.001; Zhao S, 2005, FOODBORNE PATHOG DIS, V2, P169, DOI 10.1089/fpd.2005.2.169	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243477	10.1371/journal.pone.0243477	http://dx.doi.org/10.1371/journal.pone.0243477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306723	Green Published, gold			2022-12-26	WOS:000600144200018
J	Callaghan, PJ; Rybakovsky, E; Ferrick, B; Thomas, S; Mullin, JM				Callaghan, Patrick J.; Rybakovsky, Elizabeth; Ferrick, Bryan; Thomas, Sunil; Mullin, James M.			Retinoic acid improves baseline barrier function and attenuates TNF-alpha-induced barrier leak in human bronchial epithelial cell culture model, 16HBE 14o-	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TIGHT JUNCTIONS; PHORBOL ESTER; KINASE; EXPRESSION; OCCLUDIN; PHOSPHORYLATION; ACTIVATION; TISSUE	Retinoic acid (RA) has been shown to improve epithelial and endothelial barrier function and development and even suppress damage inflicted by inflammation on these barriers through regulating immune cell activity. This paper thus sought to determine whether RA could improve baseline barrier function and attenuate TNF-alpha-induced barrier leak in the human bronchial epithelial cell culture model, 16HBE14o- (16HBE). We show for the first time that RA increases baseline barrier function of these cell layers indicated by an 89% increase in transepithelial electrical resistance (TER) and 22% decrease in C-14-mannitol flux. A simultaneous, RA-induced 70% increase in claudin-4 attests to RA affecting the tight junctional (TJ) complex itself. RA was also effective in alleviating TNF-alpha-induced 16HBE barrier leak, attenuating 60% of the TNF-alpha-induced leak to C-14-mannitol and 80% of the leak to C-14-inulin. Interleukin-6-induced barrier leak was also reduced by RA. Treatment of 16HBE cell layers with TNF-alpha resulted in dramatic decrease in immunostaining for occludin and claudin-4, as well as a downward "band-shift" in occludin Western immunoblots. The presence of RA partially reversed TNF-alpha's effects on these select TJ proteins. Lastly, RA completely abrogated the TNF-alpha-induced increase in ERK-1,2 phosphorylation without significantly decreasing the TNF-driven increase in total ERK-1,2. This study suggests RA could be effective as a prophylactic agent in minimizing airway barrier leak and as a therapeutic in preventing leak triggered by inflammatory cascades. Given the growing literature suggesting a "cytokine storm" may be related to COVID-19 morbidity, RA may be a useful adjuvant for use with anti-viral therapies.	[Callaghan, Patrick J.; Rybakovsky, Elizabeth; Thomas, Sunil; Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Ferrick, Bryan] Drexel Univ, Dept Biomed Engn, Philadelphia, PA 19104 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Drexel University	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA 19096 USA.	mullinj@mlhs.org		Thomas, Sunil/0000-0003-4780-8851	NIH [1R21AI139392-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grant 1R21AI139392-01 (PI: JMM).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; [Anonymous], 2020, LANCET PLANET HEALTH, V4, pE168, DOI 10.1016/S2542-5196(20)30110-8; Antharavally BS, 2004, ANAL BIOCHEM, V329, P276, DOI 10.1016/j.ab.2004.02.049; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Barbin G, 2001, NEUROCHEM RES, V26, P107, DOI 10.1023/A:1011086426652; BUCKLE FG, 1975, J ALLERGY CLIN IMMUN, V55, P213, DOI 10.1016/0091-6749(75)90139-6; Chau Vinh Q, 2020, JACC Case Rep, V2, P1315, DOI 10.1016/j.jaccas.2020.04.001; Clarke H, 2000, J CELL SCI, V113, P3187; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; DiGuilio Katherine M, 2016, World J Gastrointest Pathophysiol, V7, P223, DOI 10.4291/wjgp.v7.i2.223; Elshal M, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105808; Feng WQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123520; Forbes B, 2003, INT J PHARM, V257, P161, DOI 10.1016/S0378-5173(03)00129-7; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; He WQ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030993; Hufnagl K, 2018, ALLERGO J, V27, P21, DOI 10.1007/s40629-018-0054-2; Japanese Gastric Cancer Association, 2001, Gastric Cancer, V4, P1; Karkeni E, 2017, J NUTR BIOCHEM, V42, P101, DOI 10.1016/j.jnutbio.2017.01.004; Koh Y, 1996, INFLAMMATION, V20, P461, DOI 10.1007/BF01487039; Lasalvia M, 2016, EXP CELL RES, V348, P46, DOI 10.1016/j.yexcr.2016.08.025; Lei Y, 2020, CHINESE J CONT PEDIA, V22, P171, DOI [10.7499/j.issn.1008-8830.2020.02.016, DOI 10.7499/J.ISSN.1008-8830.2020.02.016]; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Mullin JM, 2005, MOL BIOL CELL, V16, P5538, DOI 10.1091/mbc.E05-04-0294; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Mullin JM, 1996, EXP CELL RES, V227, P12, DOI 10.1006/excr.1996.0244; Mullin JM, 1997, J CELL PHYSIOL, V171, P226, DOI 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B; Ni YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170346; Omarjee L, 2020, CLIN IMMUNOL, V216, DOI 10.1016/j.clim.2020.108464; Paces J, 2020, PHYSIOL RES, V69, P379, DOI 10.33549/physiolres.934492; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Pollock LM, 2018, FASEB J, V32, P5674, DOI 10.1096/fj.201701469R; Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446; Reiter Russel J, 2020, Med Drug Discov, V6, P100044, DOI 10.1016/j.medidd.2020.100044; Ruscitti P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102562; Rybakovsky E, 2017, J AGR FOOD CHEM, V65, P10950, DOI 10.1021/acs.jafc.7b04203; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Sangiorgi C, 2017, INT J IMMUNOPATH PH, V30, P333, DOI 10.1177/0394632017734479; Schlingmann B, 2015, SEMIN CELL DEV BIOL, V42, P47, DOI 10.1016/j.semcdb.2015.04.009; Schmitz H, 1999, J CELL SCI, V112, P137; Sekiyama A, 2012, INT IMMUNOPHARMACOL, V12, P350, DOI 10.1016/j.intimp.2011.12.006; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Sierra-Mondragon E, 2018, J NUTR BIOCHEM, V60, P47, DOI 10.1016/j.jnutbio.2018.06.002; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Soler AP, 1999, EUR J CELL BIOL, V78, P56, DOI 10.1016/S0171-9335(99)80007-7; Soler AP, 1996, AM J PHYSIOL-RENAL, V270, pF869, DOI 10.1152/ajprenal.1996.270.5.F869; Sweerus K, 2017, J ALLERGY CLIN IMMUN, V139, P72, DOI 10.1016/j.jaci.2016.02.035; Wittekindt OH, 2017, PFLUG ARCH EUR J PHY, V469, P135, DOI 10.1007/s00424-016-1917-3; Wu JH, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-28; Xie Xue-Jian, 2016, Sichuan Da Xue Xue Bao Yi Xue Ban, V47, P479; Yamada S, 2019, J PHARMACOL SCI, V140, P337, DOI 10.1016/j.jphs.2019.06.012; [曾香 Zeng Xiang], 2017, [南方医科大学学报, Journal of Southern Medical University], V37, P172	54	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242536	10.1371/journal.pone.0242536	http://dx.doi.org/10.1371/journal.pone.0242536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301441	Green Published, gold			2022-12-26	WOS:000600143100012
J	Miller, DJ; Capodilupo, JV; Lastella, M; Sargent, C; Roach, GD; Lee, VH; Capodilupo, ER				Miller, Dean J.; Capodilupo, John, V; Lastella, Michele; Sargent, Charli; Roach, Gregory D.; Lee, Victoria H.; Capodilupo, Emily R.			Analyzing changes in respiratory rate to predict the risk of COVID-19 infection	PLOS ONE			English	Article								COVID-19, the disease caused by the SARS-CoV-2 virus, can cause shortness of breath, lung damage, and impaired respiratory function. Containing the virus has proven difficult, in large part due to its high transmissibility during the pre-symptomatic incubation. The study's aim was to determine if changes in respiratory rate could serve as a leading indicator of SARS-CoV-2 infections. A total of 271 individuals (age = 37.3 +/- 9.5, 190 male, 81 female) who experienced symptoms consistent with COVID-19 were included- 81 tested positive for SARS-CoV-2 and 190 tested negative; these 271 individuals collectively contributed 2672 samples (days) of data (1856 healthy days, 231 while infected with COVID-19 and 585 while negative for COVID-19 but experiencing symptoms). To train a novel algorithm, individuals were segmented as follows; (1) a training dataset of individuals who tested positive for COVID-19 (n = 57 people, 537 samples); (2) a validation dataset of individuals who tested positive for COVID-19 (n = 24 people, 320 samples); (3) a validation dataset of individuals who tested negative for COVID-19 (n = 190 people, 1815 samples). All data was extracted from the WHOOP system, which uses data from a wrist-worn strap to produce validated estimates of respiratory rate and other physiological measures. Using the training dataset, a model was developed to estimate the probability of SARS-CoV-2 infection based on changes in respiratory rate during night-time sleep. The model's ability to identify COVID-positive individuals not used in training and robustness against COVID-negative individuals with similar symptoms were examined for a critical six-day period spanning the onset of symptoms. The model identified 20% of COVID-19 positive individuals in the validation dataset in the two days prior to symptom onset, and 80% of COVID-19 positive cases by the third day of symptoms.	[Miller, Dean J.; Lastella, Michele; Sargent, Charli; Roach, Gregory D.] Cent Queensland Univ, Appleton Inst Behav Sci, Adelaide, SA, Australia; [Capodilupo, John, V; Lee, Victoria H.; Capodilupo, Emily R.] Whoop Inc, Data Sci & Res, Boston, MA USA	Central Queensland University	Miller, DJ (corresponding author), Cent Queensland Univ, Appleton Inst Behav Sci, Adelaide, SA, Australia.	d.j.miller@cqu.edu.au		Capodilupo, Emily/0000-0003-4203-5693; Lastella, Michele/0000-0003-1793-3811; Miller, Dr Dean J./0000-0003-3869-4346	ERC	ERC(European Research Council (ERC)European Commission)	There was no specific funding provided for this project. However, ERC, JVC and VHL are employees of Whoop Inc. In addition, Whoop Inc is sponsoring the employment of DJM's position at CQUniversity. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berryhill S, 2020, J CLIN SLEEP MED, V16, P775, DOI 10.5664/jcsm.8356; Ebell MH, 2007, AM FAM PHYSICIAN, V76, P560; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; World-Health-Organization, 2021, WORLD HLTH ORG	11	57	57	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243693	10.1371/journal.pone.0243693	http://dx.doi.org/10.1371/journal.pone.0243693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301493	gold, Green Published, Green Submitted			2022-12-26	WOS:000600143100081
J	Jin, X; Marshall, JS				Jin, Xing; Marshall, Jeffrey S.			Mechanics of biofilms formed of bacteria with fimbriae appendages	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; IV PILI; MODEL; GROWTH; ADHESION; COEFFICIENT; PARTICLES; CONTINUUM; CONTACT; SYSTEMS	Gram-negative bacteria, as well as some Gram-positive bacteria, possess hair-like appendages known as fimbriae, which play an important role in adhesion of the bacteria to surfaces or to other bacteria. Unlike the sex pili or flagellum, the fimbriae are quite numerous, with of order 1000 fimbriae appendages per bacterial cell. In this paper, a recently developed hybrid model for bacterial biofilms is used to examine the role of fimbriae tension force on the mechanics of bacterial biofilms. Each bacterial cell is represented in this model by a spherocylindrical particle, which interact with each other through collision, adhesion, lubrication force, and fimbrial force. The bacterial cells absorb water and nutrients and produce extracellular polymeric substance (EPS). The flow of water and EPS, and nutrient diffusion within these substances, is computed using a continuum model that accounts for important effects such as osmotic pressure gradient, drag force on the bacterial cells, and viscous shear. The fimbrial force is modeled using an outer spherocylinder capsule around each cell, which can transmit tensile forces to neighboring cells with which the fimbriae capsule collides. We find that the biofilm structure during the growth process is dominated by a balance between outward drag force on the cells due to the EPS flow away from the bacterial colony and the inward tensile fimbrial force acting on chains of cells connected by adhesive fimbriae appendages. The fimbrial force also introduces a large rotational motion of the cells and disrupts cell alignment caused by viscous torque imposed by the EPS flow. The current paper characterizes the competing effects of EPS drag and fimbrial force using a series of computations with different values of the ratio of EPS to bacterial cell production rate and different numbers of fimbriae per cell.	[Jin, Xing; Marshall, Jeffrey S.] Univ Vermont, Dept Mech Engn, Burlington, VT 05405 USA	University of Vermont	Marshall, JS (corresponding author), Univ Vermont, Dept Mech Engn, Burlington, VT 05405 USA.	jmarsha1@uvm.edu			National Aeronautics and Space Administration (NASA) [NNX16AQ96A]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	This work was supported by the National Aeronautics and Space Administration (NASA) under cooperative agreement number NNX16AQ96A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemel RD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23524-x; Alpkvist E, 2007, WATER SCI TECHNOL, V55, P265, DOI 10.2166/wst.2007.267; Alpkvist E, 2006, BIOTECHNOL BIOENG, V94, P961, DOI 10.1002/bit.20917; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Bak G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15287; Berne C, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0018-2015; Beroz F, 2018, NAT PHYS, V14, P954, DOI 10.1038/s41567-018-0170-4; Chen FJ, 2011, J BACTERIOL, V193, P1718, DOI 10.1128/JB.01395-10; Chesnutt JKW, 2010, ANN BIOMED ENG, V38, P714, DOI 10.1007/s10439-009-9871-2; Chesnutt JKW, 2009, COMPUT FLUIDS, V38, P1782, DOI 10.1016/j.compfluid.2009.04.002; CHHABRA RP, 1980, J NON-NEWTON FLUID, V6, P187, DOI 10.1016/0377-0257(80)80002-4; Cogan NG, 2004, MATH MED BIOL, V21, P147, DOI 10.1093/imammb/21.2.147; Cohen N, 2019, COLLOID SURFACE B, V182, DOI 10.1016/j.colsurfb.2019.110361; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Dillon RH, 2011, DISCRETE CONT DYN-B, V15, P343, DOI 10.3934/dcdsb.2011.15.343; Drescher K, 2016, P NATL ACAD SCI USA, V113, pE2066, DOI 10.1073/pnas.1601702113; Flemming HC, 2009, SPRINGER SER BIOFILM, V4, P3, DOI 10.1007/7142_2008_13; FLORY PJ, 1951, ANNU REV PHYS CHEM, V2, P383, DOI 10.1146/annurev.pc.02.100151.002123; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; GALLILY I, 1979, J COLLOID INTERF SCI, V68, P338, DOI 10.1016/0021-9797(79)90287-X; Ghosh P, 2015, P NATL ACAD SCI USA, V112, pE2166, DOI 10.1073/pnas.1504948112; Giaouris E, 2014, MEAT SCI, V97, P298, DOI 10.1016/j.meatsci.2013.05.023; Gonzo EE, 2018, NPJ BIOFILMS MICROBI, V4, DOI 10.1038/s41522-017-0045-y; Hackbusch W., 1985, MULTIGRID METHODS AP; Hancock V, 2011, INT J MED MICROBIOL, V301, P570, DOI 10.1016/j.ijmm.2011.04.018; Happel J, 1973, LOW REYNOLDS NUMBER, DOI [10.1126/science.182.4110.336, DOI 10.1126/SCIENCE.182.4110.336]; Horn H, 2001, WATER SCI TECHNOL, V43, P121, DOI 10.2166/wst.2001.0355; Horn H, 2014, ADV BIOCHEM ENG BIOT, V146, P53, DOI 10.1007/10_2014_275; Huggins ML, 1941, J CHEM PHYS, V9, P440, DOI 10.1063/1.1750930; Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078; Jin X, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0021126; Jin X, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00701-6; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kapur V, 1996, IND ENG CHEM RES, V35, P3179, DOI 10.1021/ie960015z; Klapper I, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031902; Klapper I, 2010, SIAM REV, V52, P221, DOI 10.1137/080739720; Kommedal R, 2001, WATER SCI TECHNOL, V43, P129, DOI 10.2166/wst.2001.0357; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kumar R, 2018, AICHE J, V64, P1986, DOI 10.1002/aic.16082; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; Lear G, 2016, BIOFILMS IN BIOREMEDIATION: CURRENT RESEARCH AND EMERGING TECHNOLOGIES, P105; Legner M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00916; Lewandowski Z, 2011, TREATISE ON WATER SCIENCE, VOL 4: WATER-QUALITY ENGINEERING, P529; Li SQ, 2011, PROG ENERG COMBUST, V37, P633, DOI 10.1016/j.pecs.2011.02.001; Marshall JS, 2013, INT J MULTIPHAS FLOW, V56, P4, DOI 10.1016/j.ijmultiphaseflow.2013.05.009; Marshall JS, 2009, J COMPUT PHYS, V228, P1541, DOI 10.1016/j.jcp.2008.10.035; Marshall J.S., 2014, ADHESIVE PARTICLE FL; Mattei MR, 2018, J MATH BIOL, V76, P945, DOI 10.1007/s00285-017-1165-y; Mazza MG, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/20/203001; McLay RB, 2018, LANGMUIR, V34, P1133, DOI 10.1021/acs.langmuir.7b02447; Melaugh G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149683; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Nadell CD, 2016, NAT REV MICROBIOL, V14, P589, DOI 10.1038/nrmicro.2016.84; Napov A, 2011, NUMER MATH, V118, P457, DOI 10.1007/s00211-011-0362-7; Ni BJ, 2012, CRIT REV ENV SCI TEC, V42, P187, DOI 10.1080/10643389.2010.507696; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Picioreanu C, 1998, BIOTECHNOL BIOENG, V57, P718, DOI 10.1002/(SICI)1097-0290(19980320)57:6<718::AID-BIT9>3.0.CO;2-O; Piepenbrink KH, 2016, BIOCHEM SOC T, V44, P1659, DOI 10.1042/BST20160221; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443; Schroll C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-179; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102; Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001; Srivastava S, 2016, BIOTECHNOL LETT, V38, P1, DOI 10.1007/s10529-015-1960-8; Storck T, 2014, BIOPHYS J, V106, P2037, DOI 10.1016/j.bpj.2014.03.015; TOKITA M, 1993, ADV POLYM SCI, V110, P27; TOKITA M, 1991, J CHEM PHYS, V95, P4613, DOI 10.1063/1.461729; Van Lent J, 2006, THESIS; VANKA SP, 1986, J COMPUT PHYS, V65, P138, DOI 10.1016/0021-9991(86)90008-2; Vo GD, 2010, WATER SCI TECHNOL, V61, P3033, DOI 10.2166/wst.2010.213; von der Schulenburg DAG, 2009, AICHE J, V55, P494, DOI 10.1002/aic.11674; Wang HB, 2017, LANGMUIR, V33, P100, DOI 10.1021/acs.langmuir.6b03764; Wang LY, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02343-17; Warren MR, 2019, ELIFE, V8, DOI 10.7554/eLife.41093; Yan J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00401-1; Yan J, 2016, P NATL ACAD SCI USA, V113, pE5337, DOI 10.1073/pnas.1611494113; Zuberi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01552	83	6	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243280	10.1371/journal.pone.0243280	http://dx.doi.org/10.1371/journal.pone.0243280			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290393	Green Published, gold			2022-12-26	WOS:000598620100018
J	Kibret, S; Teshome, D; Fenta, E; Hunie, M; Tamire, T				Kibret, Simegnew; Teshome, Diriba; Fenta, Efrem; Hunie, Metages; Tamire, Tadese			Prevalence of anxiety towards COVID-19 and its associated factors among healthcare workers in a Hospital of Ethiopia	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; SARS; EMERGENCY; OUTBREAK	Background The World Health Organization declared the outbreak of COVID-19 as a pandemic on 11 March 2020. Healthcare workers are directly involved in the prevention, diagnosis, treatment, and care of patients with COVID-19.This study aims to assess the prevalence of anxiety and its associated factors towards the COVID-19 outbreak among healthcare workers in a Hospital of Ethiopia. Methods A Hospital-based survey study was conducted on a total of 305 Healthcare workers in a Hospital of Ethiopia. Bivariable and multivariable logistic regression were used to analyze data between independent variables with anxiety. Variables with a p-value of <0.2 were transformed into multivariate analysis. Crude and adjusted odds ratios with 95% CI, p-values of Results The prevalence of CVID-19 anxiety was 63%. In multivariate logistic regression, age of 30-39 (AOR, 3.05; 95% CI, (1.70, 5.47) and age of >= 40 (AOR, 11.32; 95% CI (3.37, 37.98), being married (AOR, 3.56; 95% CI, (2.30, 6.38), having chronic illness (AOR, 3.43; 95% CI, (1.59,7.43), having suspected COVID-19 family members (AOR, 5.20; 95% CI, (2.11, 12.78), and not having an access to PPEs (AOR, 2.55; 95% CI, (1.43, 4.56) were statistically significantly associated with anxiety. Conclusion Being married, having a chronic illness, having suspected COVID-19 family members, not having access to PPEs, and age greater than or equal to 30 years were identified as risk factors for anxiety of Healthcare Workers towards COVID-19.	[Kibret, Simegnew; Teshome, Diriba; Fenta, Efrem; Hunie, Metages; Tamire, Tadese] Debre Tabor Univ, Debre Tabor Coll Hlth Sci, Dept Anesthesia, Debre Tabor, Ethiopia		Kibret, S (corresponding author), Debre Tabor Univ, Debre Tabor Coll Hlth Sci, Dept Anesthesia, Debre Tabor, Ethiopia.	k.simegnew@yahoo.com	Teshome, Diriba/AAX-7540-2020	Teshome, Diriba/0000-0001-5449-5262; Fenta, Efrem/0000-0001-9709-8718				[Anonymous], 2020, ACCESS JUSTICE E EUR; Barua S, SSRN ELECT J; Cao JL, 2020, INTENS CARE MED, V46, P851, DOI 10.1007/s00134-020-05987-7; Cevik M, 2020, CLIN MICROBIOLOGY IN; Chen MIC, 2010, EMERG INFECT DIS, V16, P1554, DOI 10.3201/eid1610.100516; Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P743, DOI 10.1007/s10654-020-00660-1; Devnani M, 2012, PREHOSP DISASTER MED, V27, P551, DOI 10.1017/S1049023X12001331; Donovan DM, COVID 19 IS EMERGING, V2020, P1; Imai H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-672; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Liang C, 2020, INFECT DIS-NOR, V52, P517, DOI [10.1080/23744235.2020.1755447, 10.1145/3436209.3436383]; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; Meredith GR, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02942; Shiao JSC, 2007, NURS ETHICS, V14, P5, DOI 10.1177/0969733007071350; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; Tolksdorf K, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.11.2000258; WANG CY, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17051729, DOI 10.3390/IJERPH17051729]; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; World Health Organization (WHO), 2020, TIM WHOS COVID 19 RE, DOI DOI 10.1093/CID/CIAA344; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Yuan, 2020, PSYCHOL IMPACT CORON, DOI DOI 10.1101/2020.03.03.20030874; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou XY, 2020, TELEMED E-HEALTH, V26, P377, DOI 10.1089/tmj.2020.0068	29	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243022	10.1371/journal.pone.0243022	http://dx.doi.org/10.1371/journal.pone.0243022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290427	gold, Green Published			2022-12-26	WOS:000598620100009
J	Barbosa, AMP; Enriquez, EMA; Rodrigues, MRK; Prudencio, CB; Atallah, AN; Reyes, DRA; Hallur, RLS; Nunes, SK; Pinheiro, FA; Sartorao, CI; Andrade, GLP; Berghmans, B; de Bie, R; Lima, SAM; Rudge, MVC				Barbosa, Angelica Mercia Pascon; Enriquez, Eusebio Mario Amador; Rodrigues, Meline Rossetto Kron; Prudencio, Caroline Baldini; Atallah, Alvaro Nagib; Reyes, David Rafael Abreu; Hallur, Raghavendra Lakshmana Shetty; Nunes, Sthefanie Kenickel; Pinheiro, Fabiane Affonso; Sartorao Filho, Carlos Isaias; Andrade, Gabriela Lopes Piemonte; Berghmans, Bary; Bie, Rob de; Lima, Silvana Andrea Molina; Rudge, Marilza Vieira Cunha		Diamater Study Grp	Effectiveness of the pelvic floor muscle training on muscular dysfunction and pregnancy specific urinary incontinence in pregnant women with gestational diabetes mellitus: A systematic review protocol	PLOS ONE			English	Review								Background There is ample evidence that gestational diabetes mellitus has a direct influence on urinary incontinence and pelvic floor muscles. There are no standardized pelvic floor muscle exercise programs in the literature for the physiotherapy and differ in the type of exercise, intensity, type and duration of application, and the frequency and duration of treatment sessions. The aim of this systematic review will be to investigate that Pelvic Floor Muscle Training can prevent and/or decrease the pregnancy specific urinary incontinence in women with gestational diabetes mellitus or gestational hyperglycemia. Methods We will perform a systematic review according to the Cochrane methodology of Randomized Controlled Trials. An overall search strategy will be developed and adapted for Embase, MEDLINE, LILACS, and CENTRAL databases, with the date of consultation until June 2020. The MeSH terms used will be "Pregnancy", "Hyperglycemia", "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Type 1", "Pregnancy in Diabetics", "Diabetes, Gestational", "Urinary Incontinence", "Pelvic Floor Muscle Strength". Primary outcomes: improvement or cure of pregnancy specific urinary incontinence (which can be assessed by questionnaires, and tools such as tampon test, voiding diary, urodynamic study). Secondary outcomes: improvement of pelvic floor muscle strength (pelvic floor functional assessment, perineometer, electromyography, functional ultrasonography), improved quality of life (questionnaires), presence or absence of postpartum Urinary Incontinence and adverse effects. Quality assessment by Cochrane instrument. Metanalysis if plausible, will be performed by the software Review Manager 5.3. Discussion The present study will be the first to analyze the effectiveness of pelvic floor exercises in pregnant women with Gestational Diabetes Mellitus or Hyperglycemia, who suffer from pregnancy specific urinary incontinence. Randomized Controlled Trials design will be chosen because they present the highest level of evidence. It is expected to obtain robust and conclusive evidence to support clinical practice, in addition to promoting studies on the theme and contributing to new studies.	[Barbosa, Angelica Mercia Pascon] Sao Paulo State Univ UNESP, Sch Philosophy & Sci, Dept Physiotherapy & Occupat Therapy, Marilia, SP, Brazil; [Enriquez, Eusebio Mario Amador; Prudencio, Caroline Baldini; Reyes, David Rafael Abreu; Hallur, Raghavendra Lakshmana Shetty; Nunes, Sthefanie Kenickel; Pinheiro, Fabiane Affonso; Sartorao Filho, Carlos Isaias; Rudge, Marilza Vieira Cunha] Sao Paulo State Univ UNESP, Botucatu Med Sch FMB, Dept Gynecol & Obstet, Botucatu, SP, Brazil; [Rodrigues, Meline Rossetto Kron] Guarulhos Univ UNG, Stricto Sensu Grad Program Nursing UNIVERITAS, Guarulhos, SP, Brazil; [Atallah, Alvaro Nagib] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Discipline Evidence Based Med, Sao Paulo, Brazil; [Andrade, Gabriela Lopes Piemonte] Univ Oeste Paulista UNOESTE, Dept Physiotherapy, Presidente Prudente, SP, Brazil; [Berghmans, Bary; Bie, Rob de] Maastricht Univ, Med Ctr, Pelv Care Ctr Maastricht, Maastricht, Netherlands; [Lima, Silvana Andrea Molina] Sao Paulo State Univ UNESP, Botucatu Med Sch FMB, Dept Nursing, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Guarulhos; Universidade Federal de Sao Paulo (UNIFESP); Universidade do Oeste Paulista; Maastricht University; Universidade Estadual Paulista	Barbosa, AMP (corresponding author), Sao Paulo State Univ UNESP, Sch Philosophy & Sci, Dept Physiotherapy & Occupat Therapy, Marilia, SP, Brazil.	angelicapascon@gmail.com	Barker, Maegan/ABD-6702-2021; DE OLIVEIRA, RAFAEL GUILEN/AAS-6494-2020; Baldini Prudencio, Caroline/A-7915-2016; de Aquino Nava, Guilherme GTA Thomaz/C-3653-2015; Carvalho, Carolina Neiva Frota de/GXI-0411-2022; Sartorao-Filho, Carlos izaias/AAQ-3078-2021	DE OLIVEIRA, RAFAEL GUILEN/0000-0002-1700-5890; Baldini Prudencio, Caroline/0000-0002-2070-3606; de Aquino Nava, Guilherme GTA Thomaz/0000-0003-3607-2375; Affonso Pinheiro, Fabiane/0000-0002-2223-7522; Amador Enriquez, Eusebio Mario/0000-0002-3288-9014; HALLUR, RAGHAVENDRA/0000-0003-4300-109X; Rossignoli, Patricia/0000-0001-6946-1145	Sao Paulo Research Foundation-FAPESP, government agency in Sao Paulo, Brazil [FAPESP 2018/17534-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2016/01743-5]	Sao Paulo Research Foundation-FAPESP, government agency in Sao Paulo, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This ongoing (2018-2020) project (FAPESP 2018/17534-1) is funded by the Sao Paulo Research Foundation-FAPESP, government agency located in Sao Paulo, Brazil. Linked with the thematic project Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP 2016/01743-5. The funders had not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; [Anonymous], 2014, REV MAN REVMAN COMP; Rudge MVC, 2011, REV BRAS GINECOL OBS, V33, P207, DOI 10.1590/S0100-72032011000500001; Davenport MH, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2018-099780; Dumoulin C, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub4; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JP., 2019, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Barbosa AMP, 2011, CLINICS, V66, P1341, DOI 10.1590/S1807-59322011000800006; Perales M, 2016, EARLY HUM DEV, V94, P43, DOI 10.1016/j.earlhumdev.2016.01.004; Santos Paula Clara, 2006, Acta Med Port, V19, P349; Stafne SN, 2012, BJOG-INT J OBSTET GY, V119, P1270, DOI 10.1111/j.1471-0528.2012.03426.x; Van Kampen M, 2015, INT UROGYNECOL J, V26, P1575, DOI 10.1007/s00192-015-2684-y; Woodley Stephanie J, 2020, Cochrane Database Syst Rev, V5, pCD007471, DOI 10.1002/14651858.CD007471.pub4	15	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0241962	10.1371/journal.pone.0241962	http://dx.doi.org/10.1371/journal.pone.0241962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284811	gold, Green Published			2022-12-26	WOS:000597930500010
J	Baumann-Vogel, H; Hor, H; Poryazova, R; Valko, P; Werth, E; Baumann, CR				Baumann-Vogel, Heide; Hor, Hyun; Poryazova, Rositsa; Valko, Philipp; Werth, Esther; Baumann, Christian R.			REM sleep behavior in Parkinson disease: Frequent, particularly with higher age	PLOS ONE			English	Article							DISORDER; DIAGNOSIS; CRITERIA; MOTOR; SIDE; MEN	This retrospective single-center polysomnography-based study was designed to assess the frequency of REM sleep behavior disorder (RBD) in consecutive patients with Parkinsonism, including Parkinson disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. We observed RBD in 77% of 540 Parkinson patients, with rising frequency at higher age and regardless of sex, in >89% of 89 patients with dementia with Lewy bodies or multiple system atrophy, and in <15% of 42 patients with progressive supranuclear palsy or corticobasal degeneration. Thus, the prevalence of RBD in sporadic Parkinson disease might be higher than previously assumed, particularly in elderly patients.	[Baumann-Vogel, Heide; Hor, Hyun; Poryazova, Rositsa; Valko, Philipp; Werth, Esther; Baumann, Christian R.] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Baumann-Vogel, Heide; Hor, Hyun; Poryazova, Rositsa; Valko, Philipp; Werth, Esther] Univ Zurich, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich	Baumann, CR (corresponding author), Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland.	christian.baumann@usz.ch	Werth, E/AAN-7955-2021	Werth, Esther/0000-0002-5099-3122; Baumann, Christian/0000-0003-3417-1978				Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Bajaj N, 2013, J NEUROL NEUROSUR PS, V84, P1288, DOI 10.1136/jnnp-2012-304436; Barone DA, 2018, CLIN NEUROPHYSIOL, V129, P1551, DOI 10.1016/j.clinph.2018.05.003; Baumann CR, 2014, MOVEMENT DISORD, V29, P207, DOI 10.1002/mds.25650; Baumann-Vogel H, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx033; Bjornara KA, 2013, PARKINSONISM RELAT D, V19, P120, DOI 10.1016/j.parkreldis.2012.05.027; Borghammer P, 2019, J PARKINSON DIS, V9, pS281, DOI 10.3233/JPD-191721; Fereshtehnejad SM, 2015, JAMA NEUROL, V72, P863, DOI 10.1001/jamaneurol.2015.0703; Frauscher B, 2012, SLEEP, V35, P835, DOI 10.5665/sleep.1886; Gilman S, 2008, NEUROLOGY, V70, pA229, DOI 10.1212/01.wnl.0000324625.00404.15; Gjerstad MD, 2008, J NEUROL NEUROSUR PS, V79, P387, DOI 10.1136/jnnp.2007.116830; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P853, DOI 10.1002/mds.26987; Iber C, 2007, AASM MANUAL SCORING; Iranzo A, 2006, LANCET NEUROL, V5, P572, DOI 10.1016/S1474-4422(06)70476-8; McCarter SJ, 2014, ANN CLIN TRANSL NEUR, V1, P733, DOI 10.1002/acn3.93; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Montplaisir J, 2010, MOVEMENT DISORD, V25, P2044, DOI 10.1002/mds.23257; Neikrug AB, 2013, J CLIN SLEEP MED, V9, P1119, DOI 10.5664/jcsm.3148; Pagano G, 2018, NEUROLOGY, V91, pE894, DOI 10.1212/WNL.0000000000006134; Pilotto A, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0566-9; Postuma RB, 2008, J NEUROL NEUROSUR PS, V79, P1117, DOI 10.1136/jnnp.2008.149195; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Postuma RB, 2015, ANN NEUROL, V77, P830, DOI 10.1002/ana.24385; Postuma RB, 2013, SLEEP, V36, P1579, DOI 10.5665/sleep.3102; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Romenets Silvia Rios, 2012, Mov Disord, V27, P996, DOI 10.1002/mds.25086; Saunders-Pullman R, 2015, MOVEMENT DISORD, V30, P1834, DOI 10.1002/mds.26413; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; SCHENCK CH, 1986, SLEEP, V9, P293, DOI 10.1093/sleep/9.2.293; Sixel-Doring F, 2012, SLEEP MED, V13, P1178, DOI 10.1016/j.sleep.2012.06.009; Sobreira-Neto MA, 2017, EUR NEUROL, V78, P330, DOI 10.1159/000481939; Vendette M, 2007, NEUROLOGY, V69, P1843, DOI 10.1212/01.wnl.0000278114.14096.74; Videnovic A, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0838-2; Zhang J, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0795-4	34	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243454	10.1371/journal.pone.0243454	http://dx.doi.org/10.1371/journal.pone.0243454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284860	gold, Green Published			2022-12-26	WOS:000597930500046
J	Razzak, JA; Bhatti, JA; Tahir, MR; Pasha-Razzak, O				Razzak, Junaid A.; Bhatti, Junaid A.; Tahir, Muhammad Ramzan; Pasha-Razzak, Omrana			Initial estimates of COVID-19 infections in hospital workers in the United States during the first wave of pandemic	PLOS ONE			English	Article								Objective We estimated the number of hospital workers in the United States (US) that might be infected or die during the COVID-19 pandemic based on the data in the early phases of the pandemic. Methods We calculated infection and death rates amongst US hospital workers per 100 COVID-19-related deaths in the general population based on observed numbers in Hubei, China, and Italy. We used Monte Carlo simulations to compute point estimates with 95% confidence intervals for hospital worker (HW) infections in the US based on each of these two scenarios. We also assessed the impact of restricting hospital workers aged >= 60 years from performing patient care activities on these estimates. Results We estimated that about 53,000 hospital workers in the US could get infected, and 1579 could die due to COVID19. The availability of PPE for high-risk workers alone could reduce this number to about 28,000 infections and 850 deaths. Restricting high-risk hospital workers such as those aged >= 60 years from direct patient care could reduce counts to 2,000 healthcare worker infections and 60 deaths. Conclusion We estimate that US hospital workers will bear a significant burden of illness due to COVID-19. Making PPE available to all hospital workers and reducing the exposure of hospital workers above the age of 60 could mitigate these risks.	[Razzak, Junaid A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Bhatti, Junaid A.] Manulife Canada, Toronto, ON, Canada; [Tahir, Muhammad Ramzan] Apotex Inc, Toronto, ON, Canada; [Pasha-Razzak, Omrana] Penn State Coll Med, Hershey, PA USA	Johns Hopkins University; Apotex; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Razzak, JA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	junaid.razzak@jhu.edu		Pasha, Omrana/0000-0003-4046-3918; Razzak, Junaid/0000-0003-0735-9094	Fogarty International Centre of the National Institute of Health; ELRHA UK	Fogarty International Centre of the National Institute of Health; ELRHA UK	The Fogarty International Centre of the National Institute of Health and ELRHA UK provided grant support to JAR. Manulife Canada (Financial Institution) provided support in the form of salary for JAB, and APOTEX (Generic Pharmaceutical manufacturing company) provided support in the form of salary for MRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	American College of Emergency Physicians (ACEP), 2020, COVID 19 PERS PROT E; American Hospital Association, 2020, FAST FACTS US HOSP; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; Barranco Rosario, 2020, Med Leg J, V88, P65, DOI 10.1177/0025817220923694; Buerhaus PI, 2020, JAMA-J AM MED ASSOC, V323, P1777, DOI 10.1001/jama.2020.4978; Centers for Disease Control and Prevention (CDC), 2020, INT INF PREV CONTR; COVID-19 National Emergency Response Center Epidemiology & Case Management Team Korea Centers for Disease Control & Prevention, 2020, Osong Public Health Res Perspect, V11, P60, DOI 10.24171/j.phrp.2020.11.1.09; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; DXY, 2020, COVID 19 GLOB PAND R; Florida Department of Health, 2020, COR SUMM PERS BEING; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Istituto Superiore di Sanita, 2020, INT SURV COVID 19 IT; Juraschek SP, 2019, AM J MED QUAL, V34, P473, DOI 10.1177/1062860619873217; Khot Wasim Yunus, 2020, J Assoc Physicians India, V68, P67; Liu R, 2020, CLIN CHIM ACTA, V505, P172, DOI 10.1016/j.cca.2020.03.009; Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344; Massachusetts Department of Public Health, 2020, COR DIS 2019 COVID 1; New York City Department of Health, 2020, COR DIS 2019 COVID 1; Odone A, 2020, LANCET PUBLIC HEALTH, V5, pE310, DOI 10.1016/S2468-2667(20)30099-2; Ran L, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa287, DOI 10.1093/CID/CIAA28732179890]; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; RIMMER A, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1055; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Skinner L, 2019, NEW ENGL J MED, V381, P299, DOI 10.1056/NEJMp1900808; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Sun Y, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa322, DOI 10.1093/CID/CIAA32232211755]; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; WHO, 2020, 61 WHO; World Health Organization (WHO), 2020, CLIN MANAGEMENT SEVE; Wu JT, 2020, CHINA NATURE MED, DOI [10.1038/s41591-020-0822-7, DOI 10.1038/S41591-020-0822-732284616]; Zastrow M, 2020, NATURE, DOI [10.1038/d41586-020-00740-y, DOI 10.1038/D41586-020-00740-Y32203363]; Zhang XM, 2020, HUM RESOUR HEALTH, V18, DOI 10.1186/s12960-020-0448-3; 2020, MMWR MORBID MORTAL W, V69, P343	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0242589	10.1371/journal.pone.0242589	http://dx.doi.org/10.1371/journal.pone.0242589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275599	Green Published, gold			2022-12-26	WOS:000597150200031
J	Esquivel, JF; Medrano, EG				Esquivel, Jesus F.; Medrano, Enrique G.			Retention of Pantoea agglomerans Sc1R across stadia of the southern green stink bug, Nezara viridula (L.) (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							SPOT DISEASE ORGANISM; STYLET PENETRATION; VERTICAL TRANSMISSION; BACTERIAL; EREMOTHECIUM; ASSOCIATION; PATHOGEN; SOYBEANS; INSECT; SEED	Southern green stink bug [Nezara viridula (L.)] adults and other pentatomid pests can transmit pathogens (e.g., the bacterium Pantoea agglomerans) that cause disease in cotton (Gossypium hirsutum L.) and other high-value cash crops worldwide. First instars of N. viridula were recently shown to ingest P. agglomerans strain Sc1R with rifampicin-resistance, and to retain the pathogen to the 2(nd) instar. The objective of this study was to determine the acquisition of P. agglomerans Sc1R by early instars of N. viridula and determine persistence of P. agglomerans Sc1R across subsequent stadia. In three trials, early instars (1(st) and 2(nd)) were exposed to P. agglomerans Sc1R and subsequently maintained to adulthood; cohorts were sampled at 3(rd) and 5(th) instars, as well as adults. In every trial, P. agglomerans Sc1R was detected in all stadia, including adults, but significantly higher frequencies of infection than expected were observed at the initial stage of infection (either 1(st) or 2(nd) instar). Higher densities of P. agglomerans Sc1R were detected in 1(st) and 2(nd) instars, and lower densities were observed in subsequent stadia. Densities of innate microbiota were generally lower when the initial stage of exposure was at 1(st) instar than when the initial stage of exposure was at the 2(nd) instar. Overall, half of the adults possessed P. agglomerans Sc1R. These findings demonstrated that N. viridula nymphs can acquire P. agglomerans Sc1R and retain the pathogen to adulthood. Potential avenues of research to further elucidate the implications of nymphs harboring pathogens to adulthood are discussed.	[Esquivel, Jesus F.; Medrano, Enrique G.] ARS, Insect Control & Cotton Dis Res Unit, Plains Area, USDA, College Stn, TX 77845 USA	United States Department of Agriculture (USDA)	Esquivel, JF (corresponding author), ARS, Insect Control & Cotton Dis Res Unit, Plains Area, USDA, College Stn, TX 77845 USA.	Jesus.Esquivel@usda.gov						[Anonymous], 2012, VERS 9; Canton PE, 2019, J INSECT PHYSIOL, V119, DOI 10.1016/j.jinsphys.2019.103965; Chapman R. F., 1969, INSECTS STRUCTURE FU; CLARKE RG, 1970, J ECON ENTOMOL, V63, P200, DOI 10.1093/jee/63.1.200; CLARKE RG, 1970, J ECON ENTOMOL, V63, P355, DOI 10.1093/jee/63.2.355; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Deep Antariksh, 2011, J Lab Physicians, V3, P4, DOI 10.4103/0974-2727.78553; Esquivel JF, 2015, ENVIRON ENTOMOL, V44, P619, DOI 10.1093/ee/nvv027; Esquivel JF, 2014, ENVIRON ENTOMOL, V43, P110, DOI 10.1603/EN13051; Esquivel JF, 2012, ENTOMOL EXP APPL, V142, P114, DOI 10.1111/j.1570-7458.2011.01205.x; Esquivel JF, 2011, ENTOMOL EXP APPL, V140, P163, DOI 10.1111/j.1570-7458.2011.01148.x; Esquivel J.F., 2018, INVASIVE STINK BUGS; Esquivel JF, 2019, SOUTHWEST ENTOMOL, V44, P853, DOI 10.3958/059.044.0414; Esquivel JF, 2019, CROP SCI, V59, P1211, DOI 10.2135/cropsci2018.08.0528; Hirose E, 2006, ANN ENTOMOL SOC AM, V99, P91, DOI 10.1603/0013-8746(2006)099[0091:BITGOS]2.0.CO;2; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; KURTZMAN CP, 1995, J IND MICROBIOL, V14, P523, DOI 10.1007/BF01573968; MALOUF N. S. R., 1933, BULL SOC ROY ENT EGYPTE, V17, P96; Medrano EG, 2007, J APPL MICROBIOL, V103, P436, DOI 10.1111/j.1365-2672.2006.03262.x; Medrano EG, 2007, J APPL MICROBIOL, V102, P134, DOI 10.1111/j.1365-2672.2006.03055.x; Medrano EG, 2011, PHYTOPATHOLOGY, V101, pS119; Medrano EG, 2009, CURR MICROBIOL, V59, P405, DOI 10.1007/s00284-009-9452-5; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Schmid-Hempel P, 2007, PLOS PATHOG, V3, P1372, DOI 10.1371/journal.ppat.0030147; Tada A, 2011, APPL ENTOMOL ZOOL, V46, P483, DOI 10.1007/s13355-011-0066-6	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242988	10.1371/journal.pone.0242988	http://dx.doi.org/10.1371/journal.pone.0242988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270731	gold, Green Published			2022-12-26	WOS:000597149100034
J	Isabirye, A; Mbonye, MK; Kwagala, B				Isabirye, Alone; Mbonye, Martin Kayitale; Kwagala, Betty			Predictors of cervical cancer screening uptake in two districts of Central Uganda	PLOS ONE			English	Article							VISUAL INSPECTION; ACCEPTABILITY; VACCINATION; ATTITUDES; KNOWLEDGE	Uganda's cervical cancer age standardized incidence rate is four times the global estimate. Although Uganda's ministry of health recommends screening for women aged 25-49 years, the screening remains low even in the most developed region (Central Uganda) of the country. This study examined the demographic, social, and economic predictors of cervical cancer screening in Central Uganda with the aim of informing targeted interventions to improve screening. The cross-sectional survey was conducted in Wakiso and Nakasongola districts in Central Uganda. A total of 845 women age 25-49 years participated in the study. Data were analyzed at bivariate and multivariate levels to examine the predictors of CC (cervical cancer) screening. Only 1 in 5 women (20.6%) had ever screened for cervical cancer. Our multivariate logistic regression model indicated that wealth index, source of information, and knowledge about CC and CC screening were significantly associated with cervical cancer screening. The odds of cervical cancer screening were higher among rich women compared with poor women [AOR = 1.93 (95%CI: 1.06-3.42), p = 0.031)], receiving information from health providers compared with radios [AOR = 4.14 (95%CI: 2.65-6.48), p<0.001, and being more knowledgeable compared with being less knowledgeable about CC and CC screening [AOR = 2.46 (95%CI: 1.49-3.37), p<0.001)]. Overall cervical cancer screening uptake in central Uganda was found to be low. The findings of the study indicate that women from a wealthy background, who had been sensitized by health workers and with high knowledge about CC and CC screening had higher odds of having ever screened compared with their counterparts. Efforts to increase uptake of screening must address disparities in access to resources and knowledge.	[Isabirye, Alone; Mbonye, Martin Kayitale; Kwagala, Betty] Makerere Univ, Coll Business & Management Sci, Sch Stat & Planning, Dept Populat Studies, Kampala, Uganda; [Isabirye, Alone] Kyambogo Univ, Fac Arts & Social Sci, Dept Sociol & Social Adm, Kampala, Uganda	Makerere University	Isabirye, A (corresponding author), Makerere Univ, Coll Business & Management Sci, Sch Stat & Planning, Dept Populat Studies, Kampala, Uganda.; Isabirye, A (corresponding author), Kyambogo Univ, Fac Arts & Social Sci, Dept Sociol & Social Adm, Kampala, Uganda.	aloneisab@gmail.com	Alone, Isabirye/GNO-9546-2022	Alone, Isabirye/0000-0003-3871-7632	Germany Academic Exchange Service (DAAD) [57299305]	Germany Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was funded by the Germany Academic Exchange Service (DAAD) (https://www.daad.de) funding program in-country/in-region scholarship program Uganda 2016 under grant number 57299305 and awarded to IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun OA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-814; Akinyemiju TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048834; Alfaro, 2015, FACTORS AFFECTING AT, P1; Ali-Risasi C, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-30; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; [Anonymous], 2017, J MANAG CARE SPEC PH, V23, ps6; Audet CM, 2012, HEALTH EDUC RES, V27, P544, DOI 10.1093/her/cys008; Black E, 2019, INT J QUAL METH, V18; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L, 2016, 20160226 ICO HPV INF; Craciun C, 2012, VACCINE, V30, P6789, DOI 10.1016/j.vaccine.2012.09.016; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kish L, 1965, SURVEY SAMPLING; Li M, 2017, PAPILLOMAVIRUS RES, V4, P17, DOI 10.1016/j.pvr.2017.06.004; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Medici AC, 2011, DIR DEV, P135; Mukama T, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0365-3; Munoz N, 2013, NEW ENGL J MED, P1; Mupepi SC, 2011, J WOMENS HEALTH, V20, P943, DOI 10.1089/jwh.2010.2062; Mvundura M, 2014, INT J GYNECOL OBSTET, V126, P151, DOI 10.1016/j.ijgo.2014.02.012; Mwaka D, 2015, AWARENESS CERVICAL C, P854; Nakisige C, 2017, GYNECOL ONCOL REP, V20, P37, DOI 10.1016/j.gore.2017.01.009; Ndejjo R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149696; Nwobodo H, 2016, J PUBLIC HEALTH AFR; PATH, 2009, SHAP START INTR HPV; PATH, 2013, CERV CANC SCREEN TRE, P1; StataCorp, 2019, STAT REL 16 STAT SOF; Tiruneh FN, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0469-9; Twinomujuni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128498; UBOS, 2017, NAT POP HOUS CENS 20, V37, P1; UBOS, 2017, REP NAT POP HOUS CEN, P121; UBOS and IFC, 2018, UG DEM HLTH SURV 201, P1; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Ugandan Ministry of Health, 2010, BOOK STRAT PLAN CERV; Wabinga HR, 2012, KAMPALA CANC REGISTR; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID WHO GUID SC, V60; 2015, E ASIA FORUM Q, V7, P1	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243281	10.1371/journal.pone.0243281	http://dx.doi.org/10.1371/journal.pone.0243281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270792	Green Published, gold			2022-12-26	WOS:000597149100135
J	Sallam, M; Dababseh, D; Yaseen, A; Al-Haidar, A; Taim, D; Eid, H; Ababneh, NA; Bakri, FG; Mahafzah, A				Sallam, Malik; Dababseh, Deema; Yaseen, Alaa; Al-Haidar, Ayat; Taim, Duaa; Eid, Huda; Ababneh, Nidaa A.; Bakri, Faris G.; Mahafzah, Azmi			COVID-19 misinformation: Mere harmless delusions or much more? A knowledge and attitude cross-sectional study among the general public residing in Jordan	PLOS ONE			English	Article							CONSPIRACY THEORIES; SOCIAL MEDIA; ANXIETY; HEALTH; RESIDENTS; CRISIS; IMPACT	Since the emergence of the recent coronavirus disease 2019 (COVID-19) and its spread as a pandemic, media was teeming with misinformation that led to psychologic, social and economic consequences among the global public. Probing knowledge and anxiety regarding this novel infectious disease is necessary to identify gaps in knowledge and sources of misinformation which can help public health efforts to design and implement more focused interventional measures. The aim of this study was to evaluate the knowledge, attitude and effects of misinformation about COVID-19 on anxiety level among the general public residing in Jordan. This cross-sectional study was conducted using an online-based questionnaire that took place in April 2020, which targeted people residing in Jordan, aged 18 and above. The questionnaire included items on the following: demographic characteristics of the participants, knowledge about COVID-19, anxiety level and misconceptions regarding the origin of the pandemic. The total number of participants included in final analysis was 3150. The study population was predominantly females (76.0%), with mean age of 31 years. The overall knowledge of COVID-19 was satisfactory. Older age, males, lower monthly income and educational levels, smoking and history of chronic disease were associated with perceiving COVID-19 as a very dangerous disease. Variables that were associated with a higher anxiety level during the pandemic included: lower monthly income and educational level, residence outside the capital (Amman) and history of smoking. Misinformation about the origin of the pandemic (being part of a conspiracy, biologic warfare and the 5G networks role) was also associated with higher anxiety levels. Social media platforms, TV and news releases were the most common sources of information about the pandemic. The study showed the potential harmful effects of misinformation on the general public and emphasized the need to meticulously deliver timely and accurate information about the pandemic to lessen the health, social and psychological impact of the disease.	[Sallam, Malik; Yaseen, Alaa; Mahafzah, Azmi] Univ Jordan, Sch Med, Dept Pathol Microbiol & Forens Med, Amman, Jordan; [Sallam, Malik; Mahafzah, Azmi] Jordan Univ Hosp, Dept Clin Labs & Forens Med, Amman, Jordan; [Sallam, Malik] Lund Univ, Fac Med, Dept Translat Med, Malmo, Sweden; [Dababseh, Deema; Al-Haidar, Ayat; Taim, Duaa; Eid, Huda] Univ Jordan, Sch Dent, Amman, Jordan; [Ababneh, Nidaa A.] Univ Jordan, Cell Therapy Ctr CTC, Amman, Jordan; [Bakri, Faris G.] Univ Jordan, Sch Med, Dept Internal Med, Amman, Jordan; [Bakri, Faris G.] Jordan Univ Hosp, Dept Internal Med, Amman, Jordan; [Bakri, Faris G.] Univ Jordan, Infect Dis & Vaccine Ctr, Amman, Jordan	University of Jordan; University of Jordan; Lund University; University of Jordan; University of Jordan; University of Jordan; University of Jordan; University of Jordan	Sallam, M (corresponding author), Univ Jordan, Sch Med, Dept Pathol Microbiol & Forens Med, Amman, Jordan.; Sallam, M (corresponding author), Jordan Univ Hosp, Dept Clin Labs & Forens Med, Amman, Jordan.; Sallam, M (corresponding author), Lund Univ, Fac Med, Dept Translat Med, Malmo, Sweden.	malik.sallam@ju.edu.jo	Eid, Huda/ABD-9884-2021; Sallam, Malik/O-5021-2014; Bakri, Faris/M-7862-2016	Sallam, Malik/0000-0002-0165-9670; Bakri, Faris/0000-0001-5447-5245; Dababseh, Deema/0000-0001-7678-302X				Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556; Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; [Anonymous], 2020, LANCET, V396, P291, DOI 10.1016/S0140-6736(20)31678-0; [Anonymous], 2020, J MED INTERNET RES, DOI DOI 10.2196/19659; [Anonymous], 2020, NOV COR 2019 NCOV SI; Apisarnthanarak A, 2021, INFECT CONT HOSP EP, V42, P1288, DOI 10.1017/ice.2020.1240; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bahrami F, 2011, IRAN J PSYCHIATRY BE, V5, P83; Baines D., 2020, DISCUSSION PAPERS, V20; Benvenuto D, 2020, PATHOG GLOB HEALTH, V114, P64, DOI 10.1080/20477724.2020.1725339; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; CheckMarket, 2020, CALC SAMPL SIZ MARG; Chen X, 2020, JMIR PUBLIC HLTH SUR, V6, P275, DOI 10.2196/20737; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Constantinou M., 2020, SCI FAILS CONVINCE E, P1, DOI [10.21203/rs.3.rs-33972/v1, DOI 10.21203/RS.3.RS-33972/V1]; Alves RRD, 2010, CIENC SAUDE COLETIVA, V15, P2105, DOI 10.1590/S1413-81232010000400024; Donner NC, 2013, PFLUG ARCH EUR J PHY, V465, P601, DOI 10.1007/s00424-013-1271-7; Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912; Georgiou N, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110201; Gu ZY, 2018, NATL SCI REV, V5, P8, DOI 10.1093/nsr/nwx098; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; He F, 2020, CLIN RHEUMATOL, V39, P2803, DOI 10.1007/s10067-020-05230-0; Hezima A, 2020, E MEDITERR HEALTH J, V26, P646, DOI 10.26719/emhj.20.076; Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Jakub Srol, 2020, PREPRINT; Jansen KL, 2010, MENT HEALTH RELIG CU, V13, P267, DOI 10.1080/13674670903352837; Jolley D, 2013, PSYCHOLOGIST, V26, P60; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kampf G, 2020, J HOSP INFECT, V105, P587, DOI [10.1016/j.jhin.2020.01.022, 10.1016/j.jhin.2020.06.001]; Kumar S., 2018, ARXIV180408559; Lau LL, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011007; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Llewellyn S, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1160; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Madan M, 2020, CLIN RHEUMATOL, V39, P3189, DOI 10.1007/s10067-020-05427-3; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Mian A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01556-3; Moghanibashi-Mansourieh A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102076; Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Ota Miyo, 2020, Nat Rev Immunol, V20, P351, DOI 10.1038/s41577-020-0316-3; Patanavanich R, 2020, NICOTINE TOB RES, V22, P1653, DOI 10.1093/ntr/ntaa082; Patsali ME, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113298; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Safara M, 2008, DELHI PSYCHIAT J, V11, P177; Sallam M., 2020, PREPRINT, DOI [10.13140/RG.2.2.26744.39687, DOI 10.13140/RG.2.2.26744.39687]; Sallam M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144915; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275; Trethewey SP, 2020, POSTGRAD MED J, V96, P4, DOI 10.1136/postgradmedj-2019-137201; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; van Prooijen JW, 2017, MEM STUD, V10, P323, DOI 10.1177/1750698017701615; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Waszak PM, 2018, HEALTH POLICY TECHN, V7, P115, DOI 10.1016/j.hlpt.2018.03.002; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Worldometer, 2020, COR CAS JORD; Worldometer, 2020, JORD POP; Yang J., 2020, INT J INFECT DIS, V94, P91, DOI [10.1016/j.ijid.2020.03.017, DOI 10.1016/J.IJID.2020.03.017]; Zhang DX, 2020, J HOSP INFECT, V105, P577, DOI 10.1016/j.jhin.2020.05.001; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou M, 2020, FRONT MED-PRC, V14, P126, DOI 10.1007/s11684-020-0767-8	77	53	53	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243264	10.1371/journal.pone.0243264	http://dx.doi.org/10.1371/journal.pone.0243264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270783	Green Published, Green Submitted, gold			2022-12-26	WOS:000597149100020
J	Tsuji, S; Takahashi, A; Higuchi, A; Yamanaka, A; Amano, T; Kimura, F; Seko-Nitta, A; Murakami, T				Tsuji, Shunichiro; Takahashi, Akimasa; Higuchi, Asuka; Yamanaka, Akiyoshi; Amano, Tsukuru; Kimura, Fuminori; Seko-Nitta, Ayumi; Murakami, Takashi			Pregnancy outcomes after hysteroscopic surgery in women with cesarean scar syndrome	PLOS ONE			English	Article							SECTION SCAR; INDUCED ISTHMOCELE; MANAGEMENT; PREVALENCE; PATHOLOGY; DEFECTS; REPAIR; JAPAN	Cesarean scar defect often causes postmenstrual abnormal uterine bleeding, dysmenorrhea, chronic pelvic pain, and infertility, which are collectively known as cesarean scar syndrome (CSS). Several studies have reported that hysteroscopic surgery can restore fertility in women with CSS. The study aimed to identify factors that influence subsequent pregnancy following hysteroscopic surgery. Therefore, we studied 38 women with secondary infertility due to CSS who underwent hysteroscopic surgery at Shiga University of Medical Hospital between July 2014 and July 2019. Our hysteroscopic procedure included inferior edge resection and superficial cauterization of the cesarean scar defect under laparoscopic guidance. Patients were followed up for 3 to 40 months after surgery. Surgery was successful in all cases and no complications were observed. Twenty-seven patients (71%) became pregnant (pregnant group), while 11 (29%) did not (non-pregnant group). Baseline characteristics of age, body mass index, gravidity, parity, previous cesarean section, presence of endometriosis, retroflex uterus, and preoperative residual myometrial thickness were not significantly different between the groups. However, the median residual myometrium thickness was significantly higher after surgery than before surgery in the pregnant group (1.9 [1.1-3.6] vs 4.9 [3.4-6.6] mm, P<0.0001), whereas this difference was not significant in the non-pregnant group. Of those who became pregnant, 85% conceived within 2 years of surgery. Although three pregnancies resulted in abortion and one is ongoing at the time of writing, 23 pregnancies resulted in healthy babies at 35-38 gestational weeks by scheduled cesarean sections with no obstetrical complications due to hysteroscopic surgery. The average birth weight was 3,076 g. Our findings support that hysteroscopic surgery is a safe and effective treatment for secondary infertility due to CSS. The thickness of the residual myometrium may be a key factor that influences subsequent pregnancy in women with CSS.	[Tsuji, Shunichiro; Takahashi, Akimasa; Higuchi, Asuka; Yamanaka, Akiyoshi; Amano, Tsukuru; Kimura, Fuminori; Murakami, Takashi] Shiga Univ Med Sci, Dept Obstet & Gynecol, Seta Tsukinowa Cho, Otsu, Shiga, Japan; [Seko-Nitta, Ayumi] Shiga Univ Med Sci, Dept Radiol, Seta Tsukinowa Cho, Otsu, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Tsuji, S (corresponding author), Shiga Univ Med Sci, Dept Obstet & Gynecol, Seta Tsukinowa Cho, Otsu, Shiga, Japan.	tsuji002@belle.shiga-med.ac.jp	shunichiro, tsuji/L-2420-2019; Kimura, Fuminori/AAZ-7380-2020; Takahashi, Akimasa/AAD-4753-2019	shunichiro, tsuji/0000-0003-3945-6817; Takahashi, Akimasa/0000-0001-5698-553X	 [20K09616]		This study was supported by the Grants-in-Aid for Scientific Research (KAKENHI; 20K09616). The grant provided financial support for preparation of the article, such as English language editing services and Open Access Publication Fee. https://www.jsps.go.jp/english/index.html.	Abacjew-Chmylko A, 2017, ADV MED SCI-POLAND, V62, P230, DOI 10.1016/j.advms.2017.01.004; Agarwal SK, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.12.039; Ahimbisibwe A, 2019, J OBSTET GYNAECOL CA, V41, P1144, DOI 10.1016/j.jogc.2018.11.002; Bhagavath B, 2018, FERTIL STERIL, V110, P417, DOI 10.1016/j.fertnstert.2018.06.035; Chang Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.038; Donnez O, 2020, FERTIL STERIL, V113, P704, DOI 10.1016/j.fertnstert.2020.01.037; Donnez O, 2017, FERTIL STERIL, V107, P289, DOI 10.1016/j.fertnstert.2016.09.033; Fabres C, 2005, J MINIM INVAS GYN L, V12, P25, DOI 10.1016/j.jmig.2004.12.023; Fernandez, 1996, J Am Assoc Gynecol Laparosc, V3, pS13; Florio P, 2012, CURR OPIN OBSTET GYN, V24, P180, DOI 10.1097/GCO.0b013e3283521202; Franchi M, 2019, EUR J OBSTET GYN R B, V236, P26, DOI 10.1016/j.ejogrb.2019.02.023; Giampietro G, 2018, J MINIM INVAS GYN, V25, P1111, DOI 10.1016/j.jmig.2018.04.007; Gubbini G, 2008, J MINIM INVAS GYN, V15, P172, DOI 10.1016/j.jmig.2007.10.004; Gubbini G, 2011, J MINIM INVAS GYN, V18, P234, DOI 10.1016/j.jmig.2010.10.011; Kremer TG, 2019, REV ASSOC MED BRAS, V65, P714, DOI 10.1590/1806-9282.65.5.714; Lagana AS, 2018, J MINIM INVAS GYN, V25, P558, DOI 10.1016/j.jmig.2018.01.018; Li CD, 2014, J PERINAT MED, V42, P363, DOI 10.1515/jpm-2013-0081; Maeda E, 2018, J OBSTET GYNAECOL RE, V44, P208, DOI 10.1111/jog.13518; MORRIS H, 1995, INT J GYNECOL PATHOL, V14, P16, DOI 10.1097/00004347-199501000-00004; Tanimura S, 2017, J MINIM INVAS GYN, V24, P340, DOI 10.1016/j.jmig.2016.06.014; Tanimura S, 2015, J OBSTET GYNAECOL RE, V41, P1363, DOI 10.1111/jog.12738; Tsuji S, 2018, J OBSTET GYNAECOL RE, V44, P43, DOI 10.1111/jog.13464; Tsuji S, 2015, J OBSTET GYNAECOL RE, V41, P1305, DOI 10.1111/jog.12750; van der Voet LF, 2014, BJOG-INT J OBSTET GY, V121, P236, DOI 10.1111/1471-0528.12542; Zondervan KT, 2020, NEW ENGL J MED, V382, P1244, DOI 10.1056/NEJMra1810764	25	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243421	10.1371/journal.pone.0243421	http://dx.doi.org/10.1371/journal.pone.0243421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270754	Green Published, gold			2022-12-26	WOS:000597149100001
J	Yim, Y; Jung, SC; Kim, JY; Kim, SO; Kim, BJ; Lee, DH; Park, W; Park, JC; Ahn, JS				Yim, Younghee; Jung, Seung Chai; Kim, Jung Youn; Kim, Seon-Ok; Kim, Byung Jun; Lee, Deok Hee; Park, Wonhyoung; Park, Jung Cheol; Ahn, Jae Sung			Added diagnostic values of three-dimensional high-resolution proton density-weighted magnetic resonance imaging for unruptured intracranial aneurysms in the circle-of-Willis: Comparison with time-of-flight magnetic resonance angiography	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; CEREBRAL-ANGIOGRAPHY; ARTERY; MRI; DIFFERENTIATION; COMPLICATIONS; PREVALENCE; QUALITY	Background Advanced imaging methods can enhance the identification of aneurysms of the infundibula, which can reduce unnecessary follow-ups or further work-up, fear, and anxiety in patients. Purpose This study aimed to evaluate the added diagnostic value of three-dimensional proton density-weighted vessel wall magnetic resonance imaging (3D-PD MRI) in identifying aneurysms from index lesions refer to vascular bulging lesions without vessels arising from the apex, observed using volume-rendered TOF-MRA in the circle-of-Willis compared with time-of-flight magnetic resonance angiography (TOF-MRA). Study type Retrospective. Population A total of 299 patients who underwent 3D-PD MRI, digital subtraction angiography (DSA), and TOF-MRA between January 2012 and December 2016 were retrospectively enrolled in this study. Field strength/sequence 3 Tesla, 3D-PD MRI. Assessment Three neuroradiologists independently evaluated TOF-MRA and 3D-PD MRI combined with TOF-MRA for the determination of intracranial aneurysms in patients with index lesions within the circle of Willis. Final diagnoses were made by another neuroradiologist and neurointerventionist in consensus using DSA as the reference standard. The diagnostic performance and proportions of undetermined lesions on TOF-MRA and 3D-PD MRI with TOF-MRA were assessed based on the final diagnoses. Statistical tests The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for the diagnosis of unruptured intracranial aneurysms were calculated for each imaging modality. Results Of 452 lesions identified on volume-rendered TOF-MRA images, 173 (38%) aneurysms and 276 (61%) infundibula were finally diagnosed on DSA. 3D-PD MRI with TOF-MRA showed superior diagnostic performance (p = .001; accuracy, 85.5% versus 95.4%), superior area under the receiver operating characteristic curve over TOF-MRA (p = .001; 0.837 versus 0.947), and a lower proportion of undetermined lesions than TOF-MRA (p = .001; 25.1% versus 2.3%). Data conclusion For unruptured intracranial aneurysms in the circle of Willis, 3D-PD MRI can complement TOF-MRA to improve diagnostic performance and lower the proportion of undetermined lesions.	[Yim, Younghee] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Jung, Seung Chai; Lee, Deok Hee] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea; [Jung, Seung Chai; Lee, Deok Hee] Univ Ulsan, Asan Med Ctr, Res Inst Radiol, Coll Med, Seoul, South Korea; [Kim, Jung Youn] Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Kim, Seon-Ok] Univ Ulsan, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Coll Med, Seoul, South Korea; [Kim, Byung Jun] Korea Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Wonhyoung; Park, Jung Cheol; Ahn, Jae Sung] Univ Ulsan, Asan Med Ctr, Dept Neurosurg, Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center	Jung, SC (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.; Jung, SC (corresponding author), Univ Ulsan, Asan Med Ctr, Res Inst Radiol, Coll Med, Seoul, South Korea.	dynamics79@gmail.com	Kim, Byungjun/GRX-3560-2022	Kim, Byungjun/0000-0001-9462-5885; Kim, Seonok/0000-0001-9010-5460	National Research Foundation of Korea (NRF) - Korea government [2019R1A2C1089939]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2019R1A2C1089939).	Alexander MD, 2016, J NEUROL NEUROSUR PS, V87, P589, DOI 10.1136/jnnp-2015-312020; Bossuyt PM, 2015, RADIOLOGY, V277, P826, DOI 10.1148/radiol.2015151516; Cooke DL, 2014, INTERV NEURORADIOL, V20, P261, DOI 10.15274/NRJ-2014-10027; Demerath T, 2020, NEURORADIOLOGY, V62, P753, DOI 10.1007/s00234-020-02395-y; Gibbs GF, 2004, AM J NEURORADIOL, V25, P84; Hui FK, 2015, J NEUROINTERV SURG, V7, P509, DOI 10.1136/neurintsurg-2014-011142; Jeon TY, 2011, KOREAN J RADIOL, V12, P547, DOI 10.3348/kjr.2011.12.5.547; Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536; Kim S, 2020, J NEUROINTERV SURG, V12, P315, DOI 10.1136/neurintsurg-2019-015149; Kim YS, 2012, ATHEROSCLEROSIS, V224, P411, DOI 10.1016/j.atherosclerosis.2012.07.037; Koktzoglou I, 2020, MAGN RESON MED, V84, P3316, DOI 10.1002/mrm.28339; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JN, 2016, AM J NEURORADIOL, V37, P2245, DOI 10.3174/ajnr.A4950; Lee SH, 2017, EUR NEUROL, V78, P229, DOI 10.1159/000479556; Liu Q, 2013, INT J CARDIOVAS IMAG, V29, P1491, DOI 10.1007/s10554-013-0237-3; Mandell DM, 2017, AM J NEURORADIOL, V38, P218, DOI 10.3174/ajnr.A4893; Meixner CR, 2019, MAGN RESON IMAGING, V63, P193, DOI 10.1016/j.mri.2019.08.014; Park JE, 2017, EUR RADIOL, V27, P4737, DOI 10.1007/s00330-017-4860-6; Pereira Benedito Jamilson Araujo, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-200115; Sailer AMH, 2014, STROKE, V45, P119, DOI 10.1161/STROKEAHA.113.003133; Satoh T, 2006, AM J NEURORADIOL, V27, P306; Shi WY, 2011, SURG RADIOL ANAT, V33, P75, DOI 10.1007/s00276-010-0728-z; Suh CH, 2019, KOREAN J RADIOL, V20, DOI 10.3348/kjr.2018.0424; Sun LJ, 2017, J NEUROINTERV SURG, V9, P591, DOI 10.1136/neurintsurg-2016-012425; Sun ZK, 2011, J CLIN NEUROSCI, V18, P504, DOI 10.1016/j.jocn.2010.07.128; van der Schaaf IC, 2002, STROKE, V33, P440, DOI 10.1161/hs0202.102335; van Rooij SBT, 2015, AM J NEURORADIOL, V36, P1167, DOI 10.3174/ajnr.A4236; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wermer MJH, 2017, MAGN RESON IMAGING, V37, P16, DOI 10.1016/j.mri.2016.11.006; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071; Yang ZL, 2017, RADIOLOGY, V285, P941, DOI 10.1148/radiol.2017162290; Yoon Seon Jin, 2015, J Cerebrovasc Endovasc Neurosurg, V17, P180, DOI 10.7461/jcen.2015.17.3.180; Zhang X, 2020, EUR RADIOL, V30, P3059, DOI 10.1007/s00330-020-06682-3	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243235	10.1371/journal.pone.0243235	http://dx.doi.org/10.1371/journal.pone.0243235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270756	gold, Green Published			2022-12-26	WOS:000597149100108
J	Kythreoti, G; Sdralia, N; Tsitoura, P; Papachristos, DP; Michaelakis, A; Karras, V; Ruel, DM; Yakir, E; Bohbot, JD; Schulz, S; Iatrou, K				Kythreoti, Georgia; Sdralia, Nadia; Tsitoura, Panagiota; Papachristos, Dimitrios P.; Michaelakis, Antonios; Karras, Vasileios; Ruel, David M.; Yakir, Esther; Bohbot, Jonathan D.; Schulz, Stefan; Iatrou, Kostas			Volatile allosteric antagonists of mosquito odorant receptors inhibit human-host attraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA VECTOR MOSQUITO; BINDING-PROTEINS; ANOPHELES-GAMBIAE; SOCIAL-BEHAVIOR; IDENTIFICATION; EXPRESSION; REPELLENTS; DIPTERA; SYSTEM; GENES	Odorant-dependent behaviors in insects are triggered by the binding of odorant ligands to the variable subunits of heteromeric olfactory receptors. Previous studies have shown, however, that specific odor binding to ORco, the common subunit of odorant receptor heteromers, may allosterically alter olfactory receptor function and profoundly affect subsequent behavioral responses. Using an insect cell-based screening platform, we identified and characterized several antagonists of the odorant receptor coreceptor of the African malaria vector Anopheles gambiae (AgamORco) in a small collection of natural volatile organic compounds. Because some of the identified antagonists were previously shown to strongly repel Anopheles and Culex mosquitoes, we examined the bioactivities of the identified antagonists against Aedes, the third major genus of the Culicidae family. The tested antagonists inhibited the function of Ae. aegypti ORco ex vivo and repelled adult Asian tiger mosquitoes (Ae. albopictus). Binary mixtures of specific antagonists elicited higher repellency than single antagonists, and binding competition assays suggested that this enhanced repellence is due to antagonist interaction with distinct ORco sites. Our results also suggest that the enhanced mosquito repellency by antagonist mixtures is due to additive rather than synergistic effects of the specific antagonist combinations on ORco function. Taken together, these findings provide novel insights concerning the molecular aspects of odorant receptor function. Moreover, our results demonstrate that a simple screening assay may be used for the identification of allosteric modifiers of olfactory-driven behaviors capable of providing enhanced personal protection against multiple mosquito-borne infectious diseases.	[Kythreoti, Georgia; Sdralia, Nadia; Tsitoura, Panagiota; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Aghia Paraskevi, Greece; [Papachristos, Dimitrios P.; Michaelakis, Antonios; Karras, Vasileios] Benaki Phytopathol Inst, Entomol & Agr Zool, Kifisia, Greece; [Ruel, David M.; Yakir, Esther; Bohbot, Jonathan D.] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Entomol, Rehovot, Israel; [Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany	National Centre of Scientific Research "Demokritos"; Hebrew University of Jerusalem; Braunschweig University of Technology	Iatrou, K (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Aghia Paraskevi, Greece.	iatrou@bio.demokritos.gr	Papachristos, Dimitrios/AHC-0813-2022; Bohbot, Jonathan/A-6233-2014	Ruel, David/0000-0003-2148-1512; Schulz, Stefan/0000-0002-4810-324X; Bohbot, Jonathan/0000-0001-5204-6340	European Cooperation in Science and Technology (COST) Action [CA18133]; OPENSCREEN-GR ("An Open-Access Research Infrastructure of Chemical Biology and Target-Based Screening Technologies for Human and Animal Health, Agriculture and the Environment") - Operational Program "Competitiveness, Entrepreneurship and Innovation" (NSRF [MIS 5002691]; European Union (European Regional Development Fund); Israel Science Foundation [1990/16]; project LIFE CONOPS of the program LIFE + Environment Policy and Governance - European Commission [LIFE12 ENV/GR/000466]	European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); OPENSCREEN-GR ("An Open-Access Research Infrastructure of Chemical Biology and Target-Based Screening Technologies for Human and Animal Health, Agriculture and the Environment") - Operational Program "Competitiveness, Entrepreneurship and Innovation" (NSRF; European Union (European Regional Development Fund)(European Commission); Israel Science Foundation(Israel Science Foundation); project LIFE CONOPS of the program LIFE + Environment Policy and Governance - European Commission	This research was funded by the European Cooperation in Science and Technology (COST) Action CA18133 "European Research Network on Signal Transduction (ERNEST)." The research was also supported in part by OPENSCREEN-GR ("An Open-Access Research Infrastructure of Chemical Biology and Target-Based Screening Technologies for Human and Animal Health, Agriculture and the Environment" (MIS 5002691), a project implemented under the Action "Reinforcement of the Research and Innovation Infrastructure," funded by the Operational Program "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and cofinanced by Greece and the European Union (European Regional Development Fund); the project LIFE CONOPS (LIFE12 ENV/GR/000466) of the program LIFE + Environment Policy and Governance funded by the European Commission; and the Israel Science Foundation (grant no. 1990/16).	Afify A, 2019, CURR BIOL, V29, P3669, DOI 10.1016/j.cub.2019.09.007; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Butterwick JA, 2018, NATURE, V560, P447, DOI 10.1038/s41586-018-0420-8; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; CHRISTOPHERS SR, 1947, J HYG-CAMBRIDGE, V45, P176, DOI 10.1017/S0022172400013863; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dekel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37330; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Evergetis E, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00204; Farrell PJ, 1998, BIOTECHNOL BIOENG, V60, P656, DOI 10.1002/(SICI)1097-0290(19981220)60:6<656::AID-BIT2>3.0.CO;2-9; Franco TA, 2016, INSECT BIOCHEM MOLEC, V69, P82, DOI 10.1016/j.ibmb.2015.02.012; Giatropoulos A, 2012, PARASITOL RES, V111, P2253, DOI 10.1007/s00436-012-3074-8; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; Gunathilaka N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3196924; Hall S. A., 1945, U.S. Patent, Patent No. [2,390,249A, 2390249]; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hazra A, 2016, INDIAN J DERMATOL, V61, P251, DOI 10.4103/0019-5154.182416; Iatrou K., 2015, USA Patent, Patent No. [US 9,615,585 B2, 9615585]; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Justice RW, 2003, BIOESSAYS, V25, P1011, DOI 10.1002/bies.10331; Kepchia D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40640-4; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Krober T, 2018, INSECT BIOCHEM MOLEC, V96, P36, DOI 10.1016/j.ibmb.2018.03.008; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Liu Q, 2017, INSECT BIOCHEM MOLEC, V86, P58, DOI 10.1016/j.ibmb.2017.05.007; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Soffan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162203; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Trible W, 2017, CELL, V170, P727, DOI 10.1016/j.cell.2017.07.001; Tsitoura P, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00275; Tsitoura P, 2015, J BIOL CHEM, V290, P7961, DOI 10.1074/jbc.M114.632299; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Venthur H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01163; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2019, ISCIENCE, V19, P25, DOI 10.1016/j.isci.2019.07.008; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yan H, 2017, CELL, V170, P736, DOI 10.1016/j.cell.2017.06.051; Zhang RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23136; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	64	4	4	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100172	10.1074/jbc.RA120.016557	http://dx.doi.org/10.1074/jbc.RA120.016557			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33298524	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400150
J	Oliveira, IA; Allonso, D; Fernandes, TVA; Lucena, DMS; Ventura, GT; Dias, WB; Mohana-Borges, RS; Pascutti, PG; Todeschini, AR				Oliveira, Isadora A.; Allonso, Diego; Fernandes, Tacio V. A.; Lucena, Daniela M. S.; Ventura, Gustavo T.; Dias, Wagner Barbosa; Mohana-Borges, Ronaldo S.; Pascutti, Pedro G.; Todeschini, Adriane R.			Enzymatic and structural properties of human glutamine:fructose-6-phosphate amidotransferase 2 (hGFAT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; HUMAN GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; GLUCOSAMINE-6-PHOSPHATE SYNTHASE; HEXOSAMINE BIOSYNTHESIS; GLUCOSAMINE SYNTHETASE; MESSENGER-RNA; GLUTAMINE; GFAT1	Glycoconjugates play a central role in several cellular processes, and alteration in their composition is associated with numerous human pathologies. Substrates for cellular glycosylation are synthesized in the hexosamine biosynthetic pathway, which is controlled by the glutamine:fructose-6-phosphate amidotransfera-se (GFAT). Human isoform 2 GFAT (hGFAT2) has been implicated in diabetes and cancer; however, there is no information about structural and enzymatic properties of this enzyme. Here, we report a successful expression and purification of a catalytically active recombinant hGFAT2 (rhGFAT2) in Escherichia coli cells fused or not to a HisTag at the C-terminal end. Our enzyme kinetics data suggest that hGFAT2 does not follow the expected ordered bi-bi mechanism, and performs the glucosamine-6-phosphate synthesis much more slowly than previously reported for other GFATs. In addition, hGFAT2 is able to isomerize fructose-6-phosphate into glucose-6-phosphate even in the presence of equimolar amounts of glutamine, which results in unproductive glutamine hydrolysis. Structural analysis of a three-dimensional model of rhGFAT2, corroborated by circular dichroism data, indicated the presence of a partially structured loop in the glutaminase domain, whose sequence is present in eukaryotic enzymes but absent in the E. coli homolog. Molecular dynamics simulations suggest that this loop is the most flexible portion of the protein and plays a key role on conformational states of hGFAT2. Thus, our study provides the first comprehensive set of data on the structure, kinetics, and mechanics of hGFAT2, which will certainly contribute to further studies on the (patho)physiology of hGFAT2.	[Oliveira, Isadora A.; Allonso, Diego; Lucena, Daniela M. S.; Ventura, Gustavo T.; Dias, Wagner Barbosa; Todeschini, Adriane R.] Univ Fed Rio de Janeiro UFRJ, Inst Biofis Carlos Chagas Filho IBCCF, Lab Glicobiol Estrutural & Func, Rio De Janeiro, RJ, Brazil; [Allonso, Diego] Univ Fed Rio de Janeiro, Dept Biotecnol Farmaceut, Fac Farm, Rio de Janeiro, RJ, Brazil; [Fernandes, Tacio V. A.; Pascutti, Pedro G.] Univ Fed Rio de Janeiro, Lab Modelagem & Dinam Mol, IBCCF, Rio de Janeiro, RJ, Brazil; [Fernandes, Tacio V. A.] Inst Nacl Metrol Qualidade & Tecnol INMETRO, Lab Macromol, Diretoria Metrol Aplicada Ciencias Vida, Duque De Caxias, RJ, Brazil; [Mohana-Borges, Ronaldo S.] Univ Fed Rio de Janeiro, Lab Genom Estrutural, IBCCF, Rio de Janeiro, RJ, Brazil; [Oliveira, Isadora A.] Univ Fed Rio de Janeiro, Ctr Espectrometria Massas Biomol CEMBIO, IBCCF, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Oliveira, IA; Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro UFRJ, Inst Biofis Carlos Chagas Filho IBCCF, Lab Glicobiol Estrutural & Func, Rio De Janeiro, RJ, Brazil.; Oliveira, IA (corresponding author), Univ Fed Rio de Janeiro, Ctr Espectrometria Massas Biomol CEMBIO, IBCCF, Rio de Janeiro, Brazil.	isadora@biof.ufrj.br; adrianet@biof.ufrj.br	Allonso, Diego/Y-3446-2018	Allonso, Diego/0000-0002-1410-480X; Mohana Borges, Ronaldo/0000-0002-1796-475X; Oliveira, Isadora/0000-0003-0269-1450; Ventura, Gustavo/0000-0003-3707-0611; AMORIM FERNANDES, TACIO VINICIO/0000-0001-5881-9519; Todeschini, Adriane/0000-0002-6049-2751	National Council for Scientific and Technological Development (CNPq) [407436/2018-9, 302088/2017-2]; Carlos Chagas Filho Foundation for Supporting Research in the State of Rio de Janeiro (FAPERJ) [E-26/202.644/2019, E-26/010.002423/2019]; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; Programa Nacional de Apoio ao Desenvolvimento da Metrologia, Qualidade e Tecnologia (PRONAMETRO) from the Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Supporting Research in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Nacional de Apoio ao Desenvolvimento da Metrologia, Qualidade e Tecnologia (PRONAMETRO) from the Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	This work was supported by the National Council for Scientific and Technological Development (CNPq; 407436/2018-9, 302088/2017-2), Carlos Chagas Filho Foundation for Supporting Research in the State of Rio de Janeiro (FAPERJ; E-26/202.644/2019, E-26/010.002423/2019), and Coordination for the Improvement of Higher Education Personnel (CAPES)-Finance Code 001. This study was also supported by Programa Nacional de Apoio ao Desenvolvimento da Metrologia, Qualidade e Tecnologia (PRONAMETRO) from the Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; BADET B, 1988, BIOCHEMISTRY-US, V27, P2282, DOI 10.1021/bi00407a006; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Case DA, 2012, AMBER 12; Chang Q, 2000, J BIOL CHEM, V275, P21981, DOI 10.1074/jbc.M001049200; Dai WW, 2018, BBA-MOL BASIS DIS, V1864, P3568, DOI 10.1016/j.bbadis.2018.09.006; de Queiroz RM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00116; DeHaven JE, 2001, DIABETES, V50, P2419, DOI 10.2337/diabetes.50.11.2419; Dong TY, 2016, TUMOR BIOL, V37, P8159, DOI 10.1007/s13277-015-4729-8; Durand P, 2008, ARCH BIOCHEM BIOPHYS, V474, P302, DOI 10.1016/j.abb.2008.01.026; Eguchi S, 2009, GENES CELLS, V14, P179, DOI 10.1111/j.1365-2443.2008.01260.x; Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Floquet N, 2007, FEBS LETT, V581, P2981, DOI 10.1016/j.febslet.2007.05.068; Floquet N, 2009, J MOL BIOL, V385, P653, DOI 10.1016/j.jmb.2008.10.032; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Gabriel I, 2004, FEMS MICROBIOL LETT, V235, P73, DOI [10.1016/j.femsle.2004.04.013, 10.1111/j.1574-6968.2004.tb09569.x]; GHOSH S, 1960, J BIOL CHEM, V235, P1265; Graack HR, 2001, BIOCHEM J, V360, P401, DOI 10.1042/0264-6021:3600401; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Handa K, 2012, GLYCOCONJUGATE J, V29, P627, DOI 10.1007/s10719-012-9380-7; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hu Y, 2004, J BIOL CHEM, V279, P29988, DOI 10.1074/jbc.M401547200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huynh QK, 2000, ARCH BIOCHEM BIOPHYS, V379, P307, DOI 10.1006/abbi.2000.1895; Isupov MN, 1996, STRUCTURE, V4, P801, DOI 10.1016/S0969-2126(96)00087-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Leriche C, 1996, J AM CHEM SOC, V118, P1797, DOI 10.1021/ja953614q; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li LL, 2017, ONCOTARGET, V8, P19205, DOI 10.18632/oncotarget.15164; Liu B, 2019, CELL MOL NEUROBIOL, V39, P415, DOI 10.1007/s10571-019-00659-7; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Moloughney JG, 2016, MOL CELL, V63, P811, DOI 10.1016/j.molcel.2016.07.015; Mouilleron S, 2006, J BIOL CHEM, V281, P4404, DOI 10.1074/jbc.M511689200; Mouilleron S, 2012, J BIOL CHEM, V287, P34533, DOI 10.1074/jbc.M112.380378; Mouilleron S, 2011, ARCH BIOCHEM BIOPHYS, V505, P1, DOI 10.1016/j.abb.2010.08.008; Nakaishi Y, 2009, FEBS LETT, V583, P163, DOI 10.1016/j.febslet.2008.11.041; Niimi M, 2001, J HUM GENET, V46, P566, DOI 10.1007/s100380170022; Oki T, 1999, GENOMICS, V57, P227, DOI 10.1006/geno.1999.5785; Olchowy J, 2007, BIOCHEM J, V404, P121, DOI 10.1042/BJ20061502; Qian YM, 2011, BIOORG MED CHEM LETT, V21, P6264, DOI 10.1016/j.bmcl.2011.09.009; Ren SC, 2016, MOL CELL PROTEOMICS, V15, P154, DOI 10.1074/mcp.M115.052381; Richez C, 2007, PROTEIN EXPRES PURIF, V54, P45, DOI 10.1016/j.pep.2007.01.015; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruegenberg S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14524-5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Srinivasan V, 2007, CLIN BIOCHEM, V40, P952, DOI 10.1016/j.clinbiochem.2007.05.002; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Vasconcelos-dos-Santos A., 2015, FRONT ONCOL, V5, P23; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017082; Ye F, 2004, J BIOCHEM BIOPH METH, V59, P201, DOI 10.1016/j.jbbm.2003.02.001; Zhang HL, 2004, J CLIN ENDOCR METAB, V89, P748, DOI 10.1210/jc.2003-031286; Zhou JX, 1998, DIABETES, V47, P1836, DOI 10.2337/diabetes.47.12.1836; Zibrova D, 2017, BIOCHEM J, V474, P983, DOI 10.1042/BCJ20160980	68	6	6	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100180	10.1074/jbc.RA120.015189	http://dx.doi.org/10.1074/jbc.RA120.015189			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303629	gold, Green Published			2022-12-26	WOS:000672866400158
J	Ali, AS; Langer, SW; Federspiel, B; Hjortland, GO; Gronbaek, H; Ladekarl, M; Welin, S; Vestermark, LW; Arola, J; Osterlund, P; Knigge, U; Sorbye, H; Micke, P; Grimelius, L; Gronberg, M; Janson, ET				Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav; Gronbaek, Henning; Ladekarl, Morten; Welin, Staffan; Vestermark, Lene Weber; Arola, Johanna; Osterlund, Pia; Knigge, Ulrich; Sorbye, Halfdan; Micke, Patrick; Grimelius, Lars; Gronberg, Malin; Janson, Eva Tiensuu			PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3	PLOS ONE			English	Article							CONSENSUS GUIDELINES; CELL CARCINOMA; CANCER; TUMORS; STIMULATION; DIAGNOSIS; SYSTEM; NSCLC	Gastroenteropancreatic neuroendocrine neoplasms grade 3 (GEP-NENs G3) are rare tumors. These highly aggressive neoplasms are traditionally treated with platinum-based chemotherapy in combination with etoposide. Immune checkpoint proteins such as programmed cell death ligand (PD-L1) may have a role in different cancers allowing them escape the immune system and hence, progress. We aimed to investigate the immunohistochemical expression of PD-L1 in GEP-NEN G3 and evaluate its correlation to clinical parameters. In a cohort of 136 patients, 14 (10%) expressed PD-L1 immunoreactivity; four (3%) patients in the tumor cells and 10 (7%) had immunoreactive immune cells. PD-L1 expression did not correlate to clinical parameters, progression-free survival or overall survival. We conclude that PD-L1 expression is present only in a subset of GEP-NEN G3 patients. Further studies are needed to fully understand the role of PD-L1 in patients with GEP-NEN G3, including the future possibility for treatment with immune checkpoint inhibitors.	[Ali, Abir Salwa; Welin, Staffan; Gronberg, Malin; Janson, Eva Tiensuu] Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden; [Langer, Seppo W.] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark; [Federspiel, Birgitte] Copenhagen Univ Hosp, Dept Pathol, Rigshosp, Copenhagen, Denmark; [Hjortland, Geir Olav] Univ Oslo, Dept Oncol, Oslo, Norway; [Gronbaek, Henning] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark; [Ladekarl, Morten] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Ladekarl, Morten] Aalborg Univ Hosp, Dept Oncol, Clin Canc Res Ctr, Aalborg, Denmark; [Vestermark, Lene Weber] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Arola, Johanna] Univ Helsinki, Pathol, HUSLAB, Helsinki, Finland; [Arola, Johanna] Helsinki Univ Hosp, Helsinki, Finland; [Osterlund, Pia] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Osterlund, Pia] Univ Helsinki, Helsinki, Finland; [Osterlund, Pia] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Osterlund, Pia] Tampere Univ, Tampere, Finland; [Knigge, Ulrich] Copenhagen Univ Hosp, Dept Surg & Endocrinol PE C, Rigshosp, Copenhagen, Denmark; [Sorbye, Halfdan] Univ Bergen, Haukeland Univ Hosp, Dept Oncol, Bergen, Norway; [Sorbye, Halfdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Micke, Patrick; Grimelius, Lars] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oslo; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Rigshospitalet; University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Bergen; Uppsala University	Gronberg, M (corresponding author), Uppsala Univ, Sect Endocrine Oncol, Dept Med Sci, Uppsala, Sweden.	malin.gronberg@medsci.uu.se	Gronbaek, Henning/AAJ-3202-2020; Grönberg, Malin/A-9331-2010	Gronbaek, Henning/0000-0001-8998-7910; Osterlund, Pia/0000-0002-7124-3515; Ladekarl, Morten/0000-0002-0182-1228; /0000-0001-9732-9192	Swedish Cancer Society [ETJ CAN 18 0576]; Lions Foundation for Cancer Research at the Uppsala University Hospital; Selander foundation; foundation for International Studies at the Faculty of Health Science, University of Copenhagen	Swedish Cancer Society(Swedish Cancer Society); Lions Foundation for Cancer Research at the Uppsala University Hospital; Selander foundation; foundation for International Studies at the Faculty of Health Science, University of Copenhagen	This work was supported by the Swedish Cancer Society (ETJ CAN 18 0576, www.cancerfonden.se), the Lions Foundation for Cancer Research at the Uppsala University Hospital (ETJ), the Selander foundation (ETJ) and the foundation for International Studies at the Faculty of Health Science, University of Copenhagen (UK).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; [Anonymous], 2010, J AM COLL CARDIOL, V56, pe50; [Anonymous], 2019, CIRCULATION, V2019; Bosch F, 2019, ENDOCR-RELAT CANCER, V26, P293, DOI 10.1530/ERC-18-0494; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brennan SM, 2010, CANCER-AM CANCER SOC, V116, P888, DOI 10.1002/cncr.24858; Brenner B, 2004, BRIT J CANCER, V90, P1720, DOI 10.1038/sj.bjc.6601758; Cavalcanti E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.401; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Ferrata M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00343; Garcia-Carbonero R, 2016, NEUROENDOCRINOLOGY, V103, P186, DOI 10.1159/000443172; Haugvik SP, 2016, ANN SURG ONCOL, V23, P1721, DOI 10.1245/s10434-015-5013-2; Hutarew G, 2016, MEMO-MAG EUR MED ONC, V9, P201, DOI 10.1007/s12254-016-0292-2; Ilett EE, 2015, DIAGNOSTICS, V5, P119, DOI 10.3390/diagnostics5020119; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Jernman J, 2012, NEUROENDOCRINOLOGY, V95, P317, DOI 10.1159/000333035; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kim ST, 2016, J CANCER, V7, P484, DOI 10.7150/jca.13711; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kulangara K, 2019, ARCH PATHOL LAB MED, V143, P330, DOI 10.5858/arpa.2018-0043-OA; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Li AFY, 2010, J SURG ONCOL, V102, P497, DOI 10.1002/jso.21629; Luo M, 2016, ONCOTARGET, V7, P29794, DOI 10.18632/oncotarget.7631; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Oberg KE, 2010, ANN ONCOL, V21, P72, DOI 10.1093/annonc/mdq290; Passiglia F, 2016, ONCOTARGET, V7, P19738, DOI 10.18632/oncotarget.7582; Sahu A, 2019, J ONCOL, V2019, DOI 10.1155/2019/9032753; Sampedro-Nunez M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36129-1; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Sorbye H, 2018, ENDOCRIN METAB CLIN, V47, P683, DOI 10.1016/j.ecl.2018.05.001; Sorbye H, 2014, CANCER-AM CANCER SOC, V120, P2814, DOI 10.1002/cncr.28721; Strosberg JR, 2010, PANCREAS, V39, P799, DOI 10.1097/MPA.0b013e3181ebb56f; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Webb ES, 2018, J BIOMED RES, V32, P317, DOI 10.7555/JBR.31.20160168; Zhang J, 2015, THORAC CANCER, V6, P534, DOI 10.1111/1759-7714.12247	36	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243900	10.1371/journal.pone.0243900	http://dx.doi.org/10.1371/journal.pone.0243900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315908	Green Published, gold			2022-12-26	WOS:000600186100029
J	Hyde, MK; Masser, BM				Hyde, Melissa K.; Masser, Barbara M.			Determinants of community members' willingness to donate stool for faecal microbiota transplantation	PLOS ONE			English	Article							PATTERNS; SCALE	Universal stool banks rely on, but face difficulties recruiting, community volunteers to donate stool for faecal microbiota transplantation (FMT) to effectively treat recurrent Clostridioides difficile. This study sought to identify determinants of community members' willingness to donate stool to guide donor recruitment. 397 Australian residents (52% male, 47% 21-30 years, 63% university educated) completed a survey to gauge willingness to donate stool, bowel habits, information needs, attitudes, barriers, and motives for donation. Most reported regular bowel movements (BMs; 90%), morning BMs (63%), BMs <= 5 minutes duration (67%), and some discomfort doing BMs in public restrooms (69%). Less than half were willing to donate stool in-centre (45% willing) or at home (48%). Important information needs identified by >80% were convenience and travel requirements associated with donation. Main barriers were logistics, capabilities to donate, disgust (e.g., donation process), and discomfort (e.g., privacy). The main motivator was altruism, with compensation secondary. Linear regression models identified less discomfort doing BMs in public restrooms (beta = -0.15), understanding benefits to patients (beta = 0.15), placing less importance on understanding the donation process (beta = -0.13), and positive attitudes (beta = 0.56) as determinants of willingness to donate in-centre. Understanding benefits to self (beta = 0.11) and patients (beta = 0.24), placing less importance on understanding the donation purpose (beta = -0.19), and positive attitudes (beta = 0.50) determined willingness to donate at home. Stool banks should consider donor's bowel habits, comfort donating in-centre, and information needs early in recruitment; and implement flexible logistics for potential donors who face time constraints and limited access to stool banks.	[Hyde, Melissa K.; Masser, Barbara M.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Masser, Barbara M.] Australian Red Cross Lifeblood, Clin Serv & Res, Sydney, NSW, Australia	University of Queensland	Hyde, MK (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	m.hyde@uq.edu.au	Hyde, Melissa/H-6785-2012	Hyde, Melissa/0000-0001-9616-2028	University of Queensland Vice-Chancellor's Strategic Funds; University of Queensland School of Psychology	University of Queensland Vice-Chancellor's Strategic Funds; University of Queensland School of Psychology	The authors received funding from The University of Queensland Vice-Chancellor's Strategic Funds (BM) and internal funds granted by The University of Queensland School of Psychology (MH) to collect data using a paid participant panel and to employ a research assistant to assist with data collection and coding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.	Allegretti JR, 2019, LANCET, V394, P420, DOI 10.1016/S0140-6736(19)31266-8; American College of Physicians, 2019, CLOSTR DIFF INF; American Gut Health Check Survey, 2018, AM GUT HLTH CHECK SU; [Anonymous], 2019, BRAIN STIMUL MAR; Arnetz J, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4724-z; Australian Government Department of Health. Therapeutic Goods Administration, 2019, DRAFT STAND FAEC MIC; Australian Government Department of Health. Therapeutic Goods Administration, 2020, THER GOODS STAND FAE; Australian Red Cross Lifeblood, 2019, WA HOST LIF CHANG CL; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burns LJ, 2015, GASTROENTEROLOGY, V148, pS96, DOI 10.1016/S0016-5085(15)30331-0; Cammarota G, 2019, GUT, V68, P2111, DOI 10.1136/gutjnl-2019-319548; Centre for Digestive Diseases, 2016, FAEC MICR TRANSPL; Costello SP, 2017, ALIMENT PHARM THER, V46, P213, DOI 10.1111/apt.14173; Costello SP, 2019, INTERN MED J, V49, P148, DOI 10.1111/imj.14212; Edelstein C, 2016, CAN MED ASSOC J, V188, pE431, DOI 10.1503/cmaj.150672; EVERHART JE, 1989, DIGEST DIS SCI, V34, P1153, DOI 10.1007/BF01537261; Harari D, 1996, ARCH INTERN MED, V156, P315, DOI 10.1001/archinte.156.3.315; Hota Susy S, 2019, J Assoc Med Microbiol Infect Dis Can, V4, P218, DOI 10.3138/jammi.2019-0003; HYDE MK, 2020, TRANSFUSION 1001, DOI DOI 10.1111/TRF.16109; Jones CW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013649; Jorgensen SMD, 2018, GUT MICROBES, V9, P540, DOI 10.1080/19490976.2018.1458179; Kassam Z, 2019, GASTROENTEROLOGY, V156, pS100; Knowles SR, 2016, COGN BEHAV THERAPY, V45, P324, DOI 10.1080/16506073.2016.1178800; Konig J, 2017, ALIMENT PHARM THER, V45, P222, DOI 10.1111/apt.13868; Krishnan S, 2020, ABC NEWS; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Ling K, 2018, AM J GASTROENTEROL, V113, pS1590; McSweeney B, 2020, GUT MICROBES, V11, P51, DOI 10.1080/19490976.2019.1611153; Merlo G, 2016, J GASTROEN HEPATOL, V31, P1927, DOI 10.1111/jgh.13402; NHS University of Southampton, 2017, PAT INF FACTSH CLOST; Open Biome, 2019, FMT; Paramsothy S, 2015, INFLAMM BOWEL DIS, V21, P1600, DOI 10.1097/MIB.0000000000000405; RAYBARDHAN S, 2017, JAMMI OFFICIAL J ASS, V2, P9, DOI DOI 10.3138/JAMMI.2.1.002; RENDTORFF RC, 1967, DIS COLON RECTUM, V10, P222, DOI 10.1007/BF02617184; Rode AA, 2019, EUR J CLIN MICROBIOL, V38, P1837, DOI 10.1007/s10096-019-03615-x; Sanjoaquin MA, 2004, PUBLIC HEALTH NUTR, V7, P77, DOI 10.1079/PHN2003522; Shi Q, 2020, CHINESE MED J-PEKING, V133, P2330, DOI 10.1097/CM9.0000000000000954; Tariq R, 2018, J CLIN GASTROENTEROL, V52, P146, DOI 10.1097/MCG.0000000000000768; Terveer EM, 2020, UNITED EUR GASTROENT, V8, P1236, DOI 10.1177/2050640620957765; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Turse EP, 2019, CURR OPIN PHARMACOL, V49, P24, DOI 10.1016/j.coph.2019.04.009; US Department of Health and Human Services Centers for Disease Control and Prevention, 2019, CLOSTR DIFF C DIFF; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wu X, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819869144; ZUCKERMAN MJ, 1995, DIGEST DIS SCI, V40, P1763, DOI 10.1007/BF02212699	45	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243751	10.1371/journal.pone.0243751	http://dx.doi.org/10.1371/journal.pone.0243751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301497	gold, Green Published			2022-12-26	WOS:000600143100020
J	Liao, LH; Pearlstein, DJ; Wu, WY; Kelley, AG; Montag, WM; Hsieh, EM; Berenbaum, MR				Liao, Ling-Hsiu; Pearlstein, Daniel J.; Wu, Wen-Yen; Kelley, Allison G.; Montag, William M.; Hsieh, Edward M.; Berenbaum, May R.			Increase in longevity and amelioration of pesticide toxicity by natural levels of dietary phytochemicals in the honey bee, Apis mellifera	PLOS ONE			English	Article							P-COUMARIC ACID; SOLID-PHASE EXTRACTION; PHENOLIC-COMPOUNDS; LIQUID-CHROMATOGRAPHY; FUNCTIONAL-CHARACTERIZATION; ANTIOXIDANT PROPERTIES; QUANTITATIVE-ANALYSIS; CHEMICAL-COMPOSITION; PLANT-RESISTANCE; BOTANICAL ORIGIN	For the past decade, migratory beekeepers who provide honey bees for pollination services have experienced substantial colony losses on a recurring basis that have been attributed in part to exposure to insecticides, fungicides, or their combinations applied to crops. The phytochemicals p-coumaric acid and quercetin, which occur naturally in a wide variety of bee foods, including beebread and many types of honey, can enhance adult bee longevity and reduce the toxicity of certain pesticides. How variation in concentrations of natural dietary constituents affects interactions with xenobiotics, including synthetic pesticides, encountered in agroecosystems remains an open question. We tested the effects of these two phytochemicals at a range of natural concentrations on impacts of consuming propiconazole and chlorantraniliprole, a triazole fungicide and an insecticide frequently applied as a tank mix to almond trees during bloom in California's Central Valley. Propiconazole, even at low field concentrations, significantly reduced survival and longevity when consumed by adult bees in a sugar-based diet. The effects of propiconazole in combination with chlorantraniliprole enhanced mortality risk. The detrimental effects of the two pesticides were for the most part reduced when either or both of the phytochemicals were present in the diet. These findings suggest that honey bees may depend on non-nutritive but physiologically active phytochemical components of their natural foods for ameliorating xenobiotic stress, although only over a certain range of concentrations; particularly at the high end of the natural range, certain combinations can incur additive toxicity. Thus, efforts to develop nectar or pollen substitutes with phytochemicals to boost insecticide tolerance or immunity or to evaluate toxicity of pesticides to pollinators should take concentration-dependent effects of phytochemicals into consideration.	[Liao, Ling-Hsiu; Pearlstein, Daniel J.; Wu, Wen-Yen; Kelley, Allison G.; Montag, William M.; Hsieh, Edward M.; Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Kelley, Allison G.] Parkland Coll, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Liao, LH (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	liao19@illinois.edu	Liao, LH/AAB-1547-2019	Liao, LH/0000-0003-1776-9564	Almond Board of California [16.POLL17.Berenbaum, 18.POLL19.Berenbaum]; National Honey Board, USDA AFRI [USDA AFRI AG 2017-67013-26533]; Phenotypic Plasticity Research Experience for Community College Student Program [NSF REU 1559908/1559929]	Almond Board of California; National Honey Board, USDA AFRI; Phenotypic Plasticity Research Experience for Community College Student Program	This research was funded by the Almond Board of California (16.POLL17.Berenbaum and 18.POLL19.Berenbaum), the National Honey Board, USDA AFRI (USDA AFRI AG 2017-67013-26533 to MRB) and Phenotypic Plasticity Research Experience for Community College Student Program (NSF REU 1559908/1559929).	Adaskaveg J., 2017, FUNGICIDES BACTERICI; Adaskaveg JE, 2019, UC IPM PEST MANAGEME; Ahn MR, 2004, J AGR FOOD CHEM, V52, P7286, DOI 10.1021/jf048726s; Akdemir FNE, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020018; Aliyazicioglu R, 2013, INT J FOOD PROP, V16, P277, DOI 10.1080/10942912.2010.551312; Alvarez-Suarez JM, 2010, J AGR FOOD CHEM, V58, P9817, DOI 10.1021/jf1018164; Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044; [Anonymous], 2014, Obesity (Silver Spring), V22 Suppl 2, pS40, DOI 10.1002/oby.20822; Barbaric M, 2011, J ETHNOPHARMACOL, V135, P772, DOI 10.1016/j.jep.2011.04.015; Berenbaum MR, 2019, TOXICOL PATHOL, V47, P1076, DOI 10.1177/0192623319877154; Bernklau E, 2019, INSECTS, V10, DOI 10.3390/insects10010014; Bertelli D, 2012, PHYTOCHEM ANALYSIS, V23, P260, DOI 10.1002/pca.1352; Blokker P, 2006, PLANT ECOL, V182, P197, DOI 10.1007/s11258-005-9026-y; Bonvehi JS, 2001, J AGR FOOD CHEM, V49, P1848, DOI 10.1021/jf0012300; Campillo N, 2015, TALANTA, V131, P185, DOI 10.1016/j.talanta.2014.07.083; Cheng N, 2013, FOOD CHEM TOXICOL, V55, P234, DOI 10.1016/j.fct.2012.11.022; Christen V, 2017, ENVIRON POLLUT, V226, P48, DOI 10.1016/j.envpol.2017.04.003; Consonni R, 2019, FOOD CONTROL, V98, P133, DOI 10.1016/j.foodcont.2018.11.007; COX DR, 1972, J R STAT SOC B, V34, P187; Databank HS, 2006, PROP CASRN 60207 90; Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057; de Sousa JPB, 2007, J SEP SCI, V30, P2656, DOI 10.1002/jssc.200700228; Dimitrova B, 2007, PHYTOCHEM ANALYSIS, V18, P24, DOI 10.1002/pca.948; Dinter A, 2009, 10 INT S ICP BEE PRO; E. I. du Pont de Nemours and Company, 2017, ALT PROD LAB; Ekinci-Akdemir FN, 2017, J ANIM PLANT SCI-PAK, V27, P1560; Erdogan S, 2011, FOOD CHEM TOXICOL, V49, P1592, DOI 10.1016/j.fct.2011.04.006; Escriche I, 2014, FOOD CHEM, V142, P135, DOI 10.1016/j.foodchem.2013.07.033; Escriche I, 2011, FOOD RES INT, V44, P1504, DOI 10.1016/j.foodres.2011.03.049; Fanali C, 2013, J CHROMATOGR A, V1313, P270, DOI 10.1016/j.chroma.2013.06.055; Fernandes-Silva CC, 2013, QUIM NOVA, V36, P237, DOI 10.1590/S0100-40422013000200006; FERRERES F, 1993, J SCI FOOD AGR, V61, P121, DOI 10.1002/jsfa.2740610119; FEWTRELL CMS, 1977, NATURE, V265, P635, DOI 10.1038/265635a0; Fiorani M, 2006, J AGR FOOD CHEM, V54, P8328, DOI 10.1021/jf061602q; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Franeta F, 2018, ARCH BIOL SCI, V70, P765, DOI 10.2298/ABS180701042F; Freire KRL, 2012, MOLECULES, V17, P1652, DOI 10.3390/molecules17021652; Gambacorta E, 2014, INT J FOOD SCI TECH, V49, P2260, DOI 10.1111/ijfs.12541; Goodrich BK, 2019, FOOD POLICY, V83, P150, DOI 10.1016/j.foodpol.2018.12.008; Guffa B, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700061; Habib HM, 2014, FOOD CHEM, V153, P28, DOI 10.1016/j.foodchem.2013.12.044; Hamdy AA, 2009, J EGYPT PUBLIC HEAL, V84, P245; Han WS, 2019, ECOTOXICOLOGY, V28, P399, DOI 10.1007/s10646-019-02030-4; Haroun M. I., 2012, Journal of Food Technology, V10, P39, DOI 10.3923/jftech.2012.39.45; Hu Z, 2014, B ENTOMOL RES, V104, P716, DOI 10.1017/S0007485314000510; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jasprica I, 2004, JPC-J PLANAR CHROMAT, V17, P95, DOI 10.1556/JPC.17.2004.2.3; Johnson RM, 2018, INSECT SOC, V65, P445, DOI 10.1007/s00040-018-0631-x; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kadala A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39193-3; Kao YT, 2011, J FOOD DRUG ANAL, V19, P470; Karabagias IK, 2014, FOOD ANAL METHOD, V7, P2113, DOI 10.1007/s12161-014-9851-5; Keckes S, 2013, FOOD CHEM, V138, P32, DOI 10.1016/j.foodchem.2012.10.025; Kumazawa S, 2013, PHYTOCHEM ANALYSIS, V24, P608, DOI 10.1002/pca.2439; Kumazawa S, 2010, NAT PROD RES, V24, P804, DOI 10.1080/14786410802615270; Kurtagi H, 2015, J ENV SCI ENG A, V4, P615, DOI [10.17265/2162-5298/2015.12.001, DOI 10.17265/2162-5298/2015.12.001]; Lee EH, 2002, BIOPHYS J, V82, P1266, DOI 10.1016/S0006-3495(02)75483-0; Li FS, 2019, NAT PLANTS, V5, P41, DOI 10.1038/s41477-018-0330-7; Liao LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15066-5; Liao LH, 2017, INSECTS, V8, DOI 10.3390/insects8010022; Liu HM, 2015, ANAL METHODS-UK, V7, P3486, DOI 10.1039/c5ay00271k; Lu YH, 2017, J ECON ENTOMOL, V110, P1803, DOI 10.1093/jee/tox117; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Mao WF, 2017, P NATL ACAD SCI USA, V114, P2538, DOI 10.1073/pnas.1614864114; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Medana C, 2008, PHYTOCHEM ANALYSIS, V19, P32, DOI 10.1002/pca.1010; Medic-Saric M, 2004, JPC-J PLANAR CHROMAT, V17, P459, DOI 10.1556/JPC.17.2004.6.12; Michalkiewicz A, 2008, J CHROMATOGR A, V1187, P18, DOI 10.1016/j.chroma.2008.02.001; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nierop KGJ, 2019, PHYTOCHEMISTRY, V162, P207, DOI 10.1016/j.phytochem.2019.03.023; Ontiveros M, 2019, BIOCHEM PHARMACOL, V166, P1, DOI 10.1016/j.bcp.2019.05.004; Palmer-Young EC, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1335; Papotti G, 2012, J AGR FOOD CHEM, V60, P2852, DOI 10.1021/jf205179d; Park YK, 1998, CURR MICROBIOL, V36, P24, DOI 10.1007/s002849900274; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Pei KH, 2016, J SCI FOOD AGR, V96, P2952, DOI 10.1002/jsfa.7578; Pellati F, 2011, J PHARMACEUT BIOMED, V55, P934, DOI 10.1016/j.jpba.2011.03.024; Petrus K, 2011, ANAL BIOANAL CHEM, V400, P2555, DOI 10.1007/s00216-010-4614-7; Ryan KG, 2002, PHYTOCHEMISTRY, V59, P23, DOI 10.1016/S0031-9422(01)00404-6; Saric A, 2009, FOOD CHEM TOXICOL, V47, P547, DOI 10.1016/j.fct.2008.12.007; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Sgolastra F, 2017, PEST MANAG SCI, V73, P1236, DOI 10.1002/ps.4449; SHOSHAN V, 1980, P NATL ACAD SCI-BIOL, V77, P4435, DOI 10.1073/pnas.77.8.4435; de Funari CS, 2007, J ETHNOPHARMACOL, V111, P206, DOI 10.1016/j.jep.2006.11.032; SOLER C, 1995, APIDOLOGIE, V26, P53, DOI 10.1051/apido:19950107; Sulaiman GM, 2011, FOOD CHEM TOXICOL, V49, P2415, DOI 10.1016/j.fct.2011.06.060; Sun YM, 2014, J CHROMATOGR B, V962, P59, DOI 10.1016/j.jchromb.2014.05.027; TARONE RE, 1977, BIOMETRIKA, V64, P156, DOI 10.1093/biomet/64.1.156; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Tomas-Barberan FA, 2001, J SCI FOOD AGR, V81, P485, DOI 10.1002/jsfa.836; Trautvetter S, 2009, APIDOLOGIE, V40, P140, DOI 10.1051/apido/2008072; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Ulusoy E, 2014, J FOOD BIOCHEM, V38, P73, DOI 10.1111/jfbc.12027; Wade A, 2019, INSECTS, V10, DOI 10.3390/insects10010020; WEHLING K, 1989, PLANTA, V179, P376, DOI 10.1007/BF00391083; Winston M., 1987, The biology of the honey bee.; Wong MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206625; Yao LH, 2004, J AGR FOOD CHEM, V52, P210, DOI 10.1021/jf034990u; Yao LH, 2003, FOOD CHEM, V81, P159, DOI 10.1016/S0308-8146(02)00388-6; YLSTRA B, 1992, PLANT PHYSIOL, V100, P902, DOI 10.1104/pp.100.2.902	104	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243364	10.1371/journal.pone.0243364	http://dx.doi.org/10.1371/journal.pone.0243364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296402	Green Published, gold			2022-12-26	WOS:000598626100050
J	Stens, NA; Hisdal, J; Bakke, EF; Kaur, N; Sharma, A; Stranden, E; Thijssen, DHJ; Hoiseth, LO				Stens, Niels A.; Hisdal, Jonny; Bakke, Espen F.; Kaur, Narinder; Sharma, Archana; Stranden, Einar; Thijssen, Dick H. J.; Hoiseth, Lars Oivind			Factors mediating the pressor response to isometric muscle contraction: An experimental study in healthy volunteers during lower body negative pressure	PLOS ONE			English	Article							ARTERIAL-BLOOD PRESSURE; STATIC EXERCISE; CARDIAC-OUTPUT; STROKE VOLUME; CARDIOPULMONARY BAROREFLEXES; CARDIOVASCULAR-RESPONSES; SYMPATHETIC RESPONSES; CIRCULATORY RESPONSES; HEMODYNAMIC-RESPONSES; HANDGRIP EXERCISE	Whilst both cardiac output (CO) and total peripheral resistance (TPR) determine mean arterial blood pressure (MAP), their relative importance in the pressor response to isometric exercise remains unclear. This study aimed to elucidate the relative importance of these two different factors by examining pressor responses during cardiopulmonary unloading leading to step-wise reductions in CO. Hemodynamics were investigated in 11 healthy individuals before, during and after two-minute isometric exercise during lower body negative pressure (LBNP; -20mmHg and -40mmHg). The blood pressure response to isometric exercise was similar during normal and reduced preload, despite a step-wise reduction in CO during LBNP (-20mmHg and -40mmHg). During -20mmHg LBNP, the decreased stroke volume, and consequently CO, was counteracted by an increased TPR, while heart rate (HR) was unaffected. HR was increased during -40 mmHg LBNP, although insufficient to maintain CO; the drop in CO was perfectly compensated by an increased TPR to maintain MAP. Likewise, transient application of LBNP (-20mmHg and -40mmHg) resulted in a short transient drop in MAP, caused by a decrease in CO, which was compensated by an increase in TPR. This study suggests that, in case of reductions of CO, changes in TPR are primarily responsible for maintaining the pressor response during isometric exercise. This highlights the relative importance of TPR compared to CO in mediating the pressor response during isometric exercise.	[Stens, Niels A.; Thijssen, Dick H. J.] Radboud Univ Nijmegen Med Ctr, Res Inst Hlth Sci, Dept Physiol, Nijmegen, Netherlands; [Stens, Niels A.; Hisdal, Jonny; Kaur, Narinder; Stranden, Einar] Oslo Univ Hosp, Dept Vasc Surg, Div Cardiovasc & Pulm Dis, Sect Vasc Invest, Oslo, Norway; [Hisdal, Jonny] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Bakke, Espen F.] Norwegian Armed Forces Med Serv, Inst Aviat Med, Oslo, Norway; [Kaur, Narinder] Dermatol Ctr Telemark, Porsgrunn, Norway; [Sharma, Archana] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Sharma, Archana; Hoiseth, Lars Oivind] Oslo Univ Hosp, Dept Anesthesiol, Oslo, Norway; [Thijssen, Dick H. J.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England	Radboud University Nijmegen; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Liverpool John Moores University	Hoiseth, LO (corresponding author), Oslo Univ Hosp, Dept Anesthesiol, Oslo, Norway.	Lars.Oivind.Hoiseth@hotmail.com	Stens, Niels/AAX-5355-2021	Stens, Niels/0000-0001-7487-151X; Hoiseth, Lars Oivind/0000-0003-0669-8297				Alam M, 1937, J PHYSIOL-LONDON, V89, P372, DOI 10.1113/jphysiol.1937.sp003485; ARROWOOD JA, 1993, J APPL PHYSIOL, V74, P2559, DOI 10.1152/jappl.1993.74.5.2559; Augustyniak RA, 2001, AM J PHYSIOL-HEART C, V280, pH1645, DOI 10.1152/ajpheart.2001.280.4.H1645; BERGENWALD L, 1981, J PHYSIOL-LONDON, V318, P445; Berger A, 2016, J AM SOC HYPERTENS, V10, P527, DOI 10.1016/j.jash.2016.04.003; Binder K, 2013, EUR J APPL PHYSIOL, V113, P183, DOI 10.1007/s00421-012-2428-3; BROWN E, 1966, J PHYSIOL-LONDON, V183, P607, DOI 10.1113/jphysiol.1966.sp007887; CHANEY RH, 1988, AM J CARDIOL, V62, P1058, DOI 10.1016/0002-9149(88)90548-6; CHANG CM, 1994, AVIAT SPACE ENVIR MD, V65, P615; Chirinos JA, 2010, AM J PHYSIOL-HEART C, V298, pH320, DOI 10.1152/ajpheart.00334.2009; Conviser JM, 2017, J SCI MED SPORT, V20, P196, DOI 10.1016/j.jsams.2016.01.003; Elstad M, 2009, ACTA PHYSIOL, V195, P289, DOI 10.1111/j.1748-1716.2008.01887.x; ERIKSEN M, 1990, J PHYSIOL-LONDON, V426, P423, DOI 10.1113/jphysiol.1990.sp018147; ERIKSEN M, 1990, MED BIOL ENG COMPUT, V28, P555, DOI 10.1007/BF02442607; Franklin Barry A, 2003, J Cardiovasc Nurs, V18, P116; FREY MAB, 1988, J APPL PHYSIOL, V65, P1752, DOI 10.1152/jappl.1988.65.4.1752; FREY MAB, 1986, AVIAT SPACE ENVIR MD, V57, P531; Goswami N, 2019, PHYSIOL REV, V99, P807, DOI 10.1152/physrev.00006.2018; Grotle AK, 2020, AUTON NEUROSCI-BASIC, V228, DOI 10.1016/j.autneu.2020.102698; GUZ A, 1987, J PHYSIOL-LONDON, V393, P499, DOI 10.1113/jphysiol.1987.sp016836; Hammond RL, 2000, AM J PHYSIOL-HEART C, V278, pH818, DOI 10.1152/ajpheart.2000.278.3.H818; Hatzaras I, 2007, CARDIOLOGY, V107, P103, DOI 10.1159/000094530; Hisdal J, 2004, EUR J APPL PHYSIOL, V91, P336, DOI 10.1007/s00421-003-0982-4; Hisdal J, 2003, AVIAT SPACE ENVIR MD, V74, P874; Hisdal J, 2001, AM J PHYSIOL-REG I, V281, pR213, DOI 10.1152/ajpregu.2001.281.1.R213; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IELLAMO F, 1993, EUR J APPL PHYSIOL, V66, P381, DOI 10.1007/BF00599609; IMHOLZ BPM, 1990, CARDIOVASC RES, V24, P214, DOI 10.1093/cvr/24.3.214; Incognito AV, 2018, AM J PHYSIOL-REG I, V314, pR114, DOI 10.1152/ajpregu.00266.2017; Kiviniemi AM, 2012, ACTA PHYSIOL, V206, P51, DOI 10.1111/j.1748-1716.2012.02447.x; Laszlo Z, 1998, AVIAT SPACE ENVIR MD, V69, P32; LEVENHAGEN DK, 1994, AM J PHYSIOL, V267, pH593, DOI 10.1152/ajpheart.1994.267.2.H593; LEWIS SF, 1983, CLIN SCI, V64, P593, DOI 10.1042/cs0640593; LIND AR, 1964, CLIN SCI, V27, P229; LIND AR, 1967, J PHYSIOL-LONDON, V192, P595, DOI 10.1113/jphysiol.1967.sp008319; Lindhard J, 1920, SKAND ARCH PHYSIOL, V40, P196, DOI 10.1111/j.1748-1716.1920.tb01419.x; MARTIN CE, 1974, J CLIN INVEST, V54, P104, DOI 10.1172/JCI107731; MITCHELL JH, 1974, ANNU REV MED, V25, P369, DOI 10.1146/annurev.me.25.020174.002101; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Mortensen KH, 2016, EUR RADIOL, V26, P1009, DOI 10.1007/s00330-015-3920-z; Mueller PJ, 2018, COMPR PHYSIOL, V8, P103, DOI 10.1002/cphy.c160040; PARATI G, 1989, HYPERTENSION, V13, P647, DOI 10.1161/01.HYP.13.6.647; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; R Development Core Team, 2020, LANG ENV STAT COMP; Reed AS, 2000, J PHYSIOL-LONDON, V525, P253, DOI 10.1111/j.1469-7793.2000.t01-1-00253.x; RStudio Team, 2020, RSTUDIO INTEGRATED D; SAGIV M, 1991, INT J SPORTS MED, V12, P41, DOI 10.1055/s-2007-1024653; Samora M, 2019, J APPL PHYSIOL, V127, P408, DOI 10.1152/japplphysiol.00270.2019; SANDERS JS, 1988, J AM COLL CARDIOL, V12, P1241, DOI 10.1016/0735-1097(88)92607-1; SCHERRER U, 1988, CIRCULATION, V78, P49, DOI 10.1161/01.CIR.78.1.49; SEALS DR, 1988, J APPL PHYSIOL, V64, P2197, DOI 10.1152/jappl.1988.64.5.2197; Sheriff DD, 1998, AM J PHYSIOL-HEART C, V275, pH767, DOI 10.1152/ajpheart.1998.275.3.H767; Shoemaker J. K., 1985, J APPL PHYSIOL, V103, P228; Somani YB, 2018, AM J HYPERTENS, V31, P362, DOI 10.1093/ajh/hpx173; STEFADOUROS MA, 1974, CIRCULATION, V49, P1185, DOI 10.1161/01.CIR.49.6.1185; Stewart JM, 2007, AM J PHYSIOL-HEART C, V293, pH1908, DOI 10.1152/ajpheart.00439.2007; Stewart JM, 2007, AM J PHYSIOL-HEART C, V292, pH215, DOI 10.1152/ajpheart.00681.2006; Teixeira AL, 2018, AM J PHYSIOL-HEART C, V314, pH593, DOI 10.1152/ajpheart.00576.2017; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; THORESEN M, 1980, ACTA PHYSIOL SCAND, V109, P333, DOI 10.1111/j.1748-1716.1980.tb06604.x; TOSKA K, 1993, J PHYSIOL-LONDON, V472, P501, DOI 10.1113/jphysiol.1993.sp019958; Toska K, 2010, ACTA PHYSIOL, V200, P211, DOI 10.1111/j.1748-1716.2010.02144.x; Watanabe K, 2014, AM J PHYSIOL-HEART C, V306, pH251, DOI 10.1152/ajpheart.00699.2013; Yamagata T, 2020, CLIN EXP HYPERTENS, V42, P595, DOI 10.1080/10641963.2020.1747482	64	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243627	10.1371/journal.pone.0243627	http://dx.doi.org/10.1371/journal.pone.0243627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296410	Green Published, gold, Green Accepted			2022-12-26	WOS:000598626100030
J	Rivas-Astroza, M; Conejeros, R				Rivas-Astroza, Marcelo; Conejeros, Raul			Metabolic flux configuration determination using information entropy	PLOS ONE			English	Article							THERMODYNAMICALLY INFEASIBLE LOOPS; ESCHERICHIA-COLI; C-13-LABELING EXPERIMENTS; GENE-KNOCKOUT; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; ENZYME-ACTIVITIES; RESPONSES; ACETATE; PREDICTIONS	Constraint-based models use steady-state mass balances to define a solution space of flux configurations, which can be narrowed down by measuring as many fluxes as possible. Due to loops and redundant pathways, this process typically yields multiple alternative solutions. To address this ambiguity, flux sampling can estimate the probability distribution of each flux, or a flux configuration can be singled out by further minimizing the sum of fluxes according to the assumption that cellular metabolism favors states where enzyme-related costs are economized. However, flux sampling is susceptible to artifacts introduced by thermodynamically infeasible cycles and is it not clear if the economy of fluxes assumption (EFA) is universally valid. Here, we formulated a constraint-based approach, MaxEnt, based on the principle of maximum entropy, which in this context states that if more than one flux configuration is consistent with a set of experimentally measured fluxes, then the one with the minimum amount of unwarranted assumptions corresponds to the best estimation of the non-observed fluxes. We compared MaxEnt predictions to Escherichia coli and Saccharomyces cerevisiae publicly available flux data. We found that the mean square error (MSE) between experimental and predicted fluxes by MaxEnt and EFA-based methods are three orders of magnitude lower than the median of 1,350,000 MSE values obtained using flux sampling. However, only MaxEnt and flux sampling correctly predicted flux through E. coli's glyoxylate cycle, whereas EFA-based methods, in general, predict no flux cycles. We also tested MaxEnt predictions at increasing levels of overflow metabolism. We found that MaxEnt accuracy is not affected by overflow metabolism levels, whereas the EFA-based methods show a decreasing performance. These results suggest that MaxEnt is less sensitive than flux sampling to artifacts introduced by thermodynamically infeasible cycles and that its predictions are less susceptible to overfitting than EFA-based methods.	[Rivas-Astroza, Marcelo; Conejeros, Raul] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Rivas-Astroza, Marcelo] Univ Tecnol Metropolitana, Dept Biotecnol, Nunoa, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad Tecnologica Metropolitana	Rivas-Astroza, M (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.; Rivas-Astroza, M (corresponding author), Univ Tecnol Metropolitana, Dept Biotecnol, Nunoa, Chile.	marcelo.rivas@utem.cl	Conejeros, Raul/ABG-5517-2020	Conejeros, Raul/0000-0002-1273-535X; Rivas-Astroza, Marcelo/0000-0003-1809-3922	Fondo Nacional de Ciencia y Tecnologi' Ciencia y Tecnologi'a (FONDECYT, Chile; http://www.conicyt.cl/fondecyt/), grant number 3170488. [3170488]	Fondo Nacional de Ciencia y Tecnologi' Ciencia y Tecnologi'a (FONDECYT, Chile; http://www.conicyt.cl/fondecyt/), grant number 3170488.	This work was supported by Fondo Nacional de Ciencia y Tecnologi ' a (FONDECYT, Chile; http://www.conicyt.cl/fondecyt/), grant number 3170488.	Ahn S, 2016, J BIOL CHEM, V291, P11928, DOI 10.1074/jbc.M115.708149; Andersson JAE, 2019, MATH PROGRAM COMPUT, V11, P1, DOI 10.1007/s12532-018-0139-4; [Anonymous], 2019, PROG RETIN EYE RES; [Anonymous], 2019, TR2195 3GPP; Basan M, 2015, NATURE, V528, P99, DOI 10.1038/nature15765; Boltzmann L., 2015, ENTROPY, V17, P1971, DOI [10.3390/e17041971, DOI 10.3390/E17041971]; Braakman R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/011001; Carlson R, 2004, BIOTECHNOL BIOENG, V86, P149, DOI 10.1002/bit.20044; Cuevas DA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00907; Davidi D, 2016, P NATL ACAD SCI USA, V113, P3401, DOI 10.1073/pnas.1514240113; de Groot DH, 2020, CELL MOL LIFE SCI, V77, P441, DOI 10.1007/s00018-019-03380-2; De Martino A, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00596; De Martino D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05417-9; De Martino D, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/3/036005; Desouki AA, 2015, BIOINFORMATICS, V31, P2159, DOI 10.1093/bioinformatics/btv096; Ebrahim A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156157; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Farmer WR, 1997, APPL ENVIRON MICROB, V63, P3205, DOI 10.1128/AEM.63.8.3205-3210.1997; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fondi M, 2015, METHODS MOL BIOL, V1231, P233, DOI 10.1007/978-1-4939-1720-4_15; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Gerstl MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08930; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; Hua Q, 2003, J BACTERIOL, V185, P7053, DOI 10.1128/JB.185.24.7053-7067.2003; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Jenatton R, 2011, J MACH LEARN RES, V12, P2777; Jiao Z, 2003, FEMS MICROBIOL LETT, V220, P295, DOI 10.1016/S0378-1097(03)00133-2; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Li M, 2006, J BIOTECHNOL, V122, P254, DOI 10.1016/j.jbiotec.2005.09.016; McGlinn DJ, 2015, GLOBAL ECOL BIOGEOGR, V24, P675, DOI 10.1111/geb.12295; Megchelenbrink W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086587; Meza E, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-127; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Mori M, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0093-4; Mori M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004913; Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; Niebel B, 2019, NAT METAB, V1, P125, DOI 10.1038/s42255-018-0006-7; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Papini M, 2012, APPL MICROBIOL BIOT, V95, P1001, DOI 10.1007/s00253-012-3936-0; Peng LF, 2004, FEMS MICROBIOL LETT, V235, P17, DOI 10.1016/j.femsle.2004.04.003; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Rao CR, 1984, INEQUALITIES STAT PR, V5, P68, DOI DOI 10.1214/LNMS/1215465631; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sambamoorthy G, 2018, BIOINFORMATICS, V34, P981, DOI 10.1093/bioinformatics/bty604; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schellenberger J, 2011, BIOPHYS J, V100, P544, DOI 10.1016/j.bpj.2010.12.3707; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smallbone K, 2009, J THEOR BIOL, V258, P311, DOI 10.1016/j.jtbi.2009.01.027; Sohrab Siavash H., 2014, International Journal of Mechanics, V8, P73; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Tourigny DS, 2020, J MATH BIOL, V80, P2395, DOI 10.1007/s00285-020-01499-6; Toya Y, 2007, J CHROMATOGR A, V1159, P134, DOI 10.1016/j.chroma.2007.04.011; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zhang ZD, 2015, NUCLEIC ACIDS RES, V43, pD549, DOI 10.1093/nar/gku1137; Zhao J, 2004, APPL MICROBIOL BIOT, V64, P91, DOI 10.1007/s00253-003-1458-5; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4; Zhuang K, 2017, MOL SYSTEMS BIOL, V7, P500	79	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243067	10.1371/journal.pone.0243067	http://dx.doi.org/10.1371/journal.pone.0243067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275628	gold, Green Published			2022-12-26	WOS:000597150200014
J	Lin, Q; Luo, MY; Gao, RT; Li, TT; Man, ZX; Cao, YC; Wang, HJ				Lin, Qiang; Luo, Mingyang; Gao, Ruiting; Li, Tongtong; Man, Zhengxing; Cao, Yongchun; Wang, Haijun			Deep learning based automatic segmentation of metastasis hotspots in thorax bone SPECT images	PLOS ONE			English	Article								SPECT imaging has been identified as an effective medical modality for diagnosis, treatment, evaluation and prevention of a range of serious diseases and medical conditions. Bone SPECT scan has the potential to provide more accurate assessment of disease stage and severity. Segmenting hotspot in bone SPECT images plays a crucial role to calculate metrics like tumor uptake and metabolic tumor burden. Deep learning techniques especially the convolutional neural networks have been widely exploited for reliable segmentation of hotspots or lesions, organs and tissues in the traditional structural medical images (i.e., CT and MRI) due to their ability of automatically learning the features from images in an optimal way. In order to segment hotspots in bone SPECT images for automatic assessment of metastasis, in this work, we develop several deep learning based segmentation models. Specifically, each original whole-body bone SPECT image is processed to extract the thorax area, followed by image mirror, translation and rotation operations, which augments the original dataset. We then build segmentation models based on two commonly-used famous deep networks including U-Net and Mask R-CNN by fine-tuning their structures. Experimental evaluation conducted on a group of real-world bone SEPCT images reveals that the built segmentation models are workable on identifying and segmenting hotspots of metastasis in bone SEPCT images, achieving a value of 0.9920, 0.7721, 0.6788 and 0.6103 for PA (accuracy), CPA (precision), Rec (recall) and IoU, respectively. Finally, we conclude that the deep learning technology have the huge potential to identify and segment hotspots in bone SPECT images.	[Lin, Qiang; Li, Tongtong; Man, Zhengxing; Cao, Yongchun] Northwest Minzu Univ, Sch Math & Comp Sci, Lanzhou, Gansu, Peoples R China; [Lin, Qiang; Luo, Mingyang; Gao, Ruiting; Cao, Yongchun] Northwest Minzu Univ, Key Lab Chinas Ethn Languages & Informat Technol, Minist Educ, Lanzhou, Gansu, Peoples R China; [Lin, Qiang; Luo, Mingyang; Gao, Ruiting; Li, Tongtong; Man, Zhengxing; Cao, Yongchun] Northwest Minzu Univ, Key Lab Streaming Comp & Applicat, Lanzhou, Gansu, Peoples R China; [Wang, Haijun] Gansu Prov Hosp, Dept Nucl Med, Lanzhou, Gansu, Peoples R China	Northwest Minzu University; Northwest Minzu University; Northwest Minzu University	Lin, Q (corresponding author), Northwest Minzu Univ, Sch Math & Comp Sci, Lanzhou, Gansu, Peoples R China.; Lin, Q (corresponding author), Northwest Minzu Univ, Key Lab Chinas Ethn Languages & Informat Technol, Minist Educ, Lanzhou, Gansu, Peoples R China.; Lin, Q (corresponding author), Northwest Minzu Univ, Key Lab Streaming Comp & Applicat, Lanzhou, Gansu, Peoples R China.	qiang.lin2010@hotmail.com		Lin, Qiang/0000-0002-3842-2634	National Natural Science Foundation of China [61562075]; Gansu Provincial First-class Discipline Program of Northwest Minzu University [11080305]; Program for Innovative Research Team of SEAC [[2018] 98]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Provincial First-class Discipline Program of Northwest Minzu University; Program for Innovative Research Team of SEAC	This study was funded by the National Natural Science Foundation of China (61562075), the Gansu Provincial First-class Discipline Program of Northwest Minzu University (11080305), and the Program for Innovative Research Team of SEAC ([2018] 98).]	[Anonymous], 2014, J ELECT MAT, V1, P1; Anwar SM, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1088-1; Banks S, 2009, SIGNAL PROCESSING IM; Brigger P, 1999, J NUCL CARDIOL, V6, P286, DOI 10.1016/S1071-3581(99)90041-7; Brox T., 2015, U NET CONVOLUTIONAL, DOI DOI 10.1007/978-3-319-24574-4_28; Cheimariotis G, 2016, P EMBC 2016 16 20, P16; Cheimariotis GA, 2018, ANN NUCL MED, V32, P94, DOI 10.1007/s12149-017-1223-y; Chen C, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00025; Chen J, 2020, ARXIV200110155V4CSCV; Chen J, 2019, SPIE MED IMAGING, DOI 10:1117/12:2506805; Ghosh S, 2019, ACM COMPUT SURV, V52, DOI 10.1145/3329784; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Humphries T, 2009, IEEE NUCL SCI CONF R, P2849, DOI 10.1109/NSSMIC.2009.5401638; Jordan M. I., 1997, ADV PSYCHOL, V121, P471, DOI [10.1016/s0166-4115(97)80111-2, DOI 10.1016/S0166-4115(97)80111-2]; Ker J, 2018, IEEE ACCESS, V6, P9375, DOI 10.1109/ACCESS.2017.2788044; Kiraly A, 2020, NUKLEARMEDIZIN, V59, P172; Lai M, 2015, ARXIV150502000V1CSLG; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu SF, 2019, ENGINEERING-PRC, V5, P261, DOI 10.1016/j.eng.2018.11.020; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Minaee S, 2020, ARXIV200105566V4; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Schreibmann E, 2008, MED PHYS, V35, P2895, DOI 10.1118/1.2962523; Shan HM, 2020, MACH LEARN-SCI TECHN, V1, DOI 10.1088/2632-2153/ab869f; Singh SP, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20185097; Thorwarth R, 2013, MED PHYS, V40, DOI 10.1118/1.4814398; Toennies KD, 2003, PROC SPIE, V5032, P507, DOI 10.1117/12.480172; Vargas-Quintero Lorena, 2019, VipIMAGE 2019. Proceedings of the VII ECCOMAS Thematic Conference on Computational Vision and Medical Image Processing. Lecture Notes in Computational Vision and Biomechanics (LNCVB 34), P127, DOI 10.1007/978-3-030-32040-9_14; Wang TH, 2020, J NUCL CARDIOL, V27, P976, DOI 10.1007/s12350-019-01594-2; Yang R., 2006, POW EL MOT CONTR C 2, V1, P1; Zhou Y, 2019, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-018-0398-z; Zhu Chunmei, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P1050; Zhu Chunmei, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P27	38	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243253	10.1371/journal.pone.0243253	http://dx.doi.org/10.1371/journal.pone.0243253			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270746	gold, Green Published			2022-12-26	WOS:000597149100081
J	Liu, CJ; Huang, TS; Ho, PT; Huang, JC; Hsieh, CT				Liu, Cheng-Ju; Huang, Tien-Shou; Ho, Ping-Tsan; Huang, Jui-Chan; Hsieh, Ching-Tang			Machine learning-based e-commerce platform repurchase customer prediction model	PLOS ONE			English	Article							INTENTION; SATISFACTION	In recent years, China's e-commerce industry has developed at a high speed, and the scale of various industries has continued to expand. Service-oriented enterprises such as e-commerce transactions and information technology came into being. This paper analyzes the shortcomings and challenges of traditional online shopping behavior prediction methods, and proposes an online shopping behavior analysis and prediction system. The paper chooses linear model logistic regression and decision tree based XGBoost model. After optimizing the model, it is found that the nonlinear model can make better use of these features and get better prediction results. In this paper, we first combine the single model, and then use the model fusion algorithm to fuse the prediction results of the single model. The purpose is to avoid the accuracy of the linear model easy to fit and the decision tree model over-fitting. The results show that the model constructed by the article has further improvement than the single model. Finally, through two sets of contrast experiments, it is proved that the algorithm selected in this paper can effectively filter the features, which simplifies the complexity of the model to a certain extent and improves the classification accuracy of machine learning. The XGBoost hybrid model based on p/n samples is simpler than a single model. Machine learning models are not easily over-fitting and therefore more robust.	[Liu, Cheng-Ju; Huang, Tien-Shou] Natl Kaohsiung Univ Sci & Technol, Dept Intelligent Commerce, Kaohsiung, Taiwan; [Ho, Ping-Tsan] Cheng Shiu Univ, Coll Life & Creat, Dept Leisure & Sport Management, Kaohsiung, Taiwan; [Huang, Jui-Chan] Yango Univ, Fuzhou, Peoples R China; [Hsieh, Ching-Tang] Natl Kaohsiung Univ Sci & Technol, Dept Int Business, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; Cheng Shiu University; National Kaohsiung University of Science & Technology	Ho, PT (corresponding author), Cheng Shiu Univ, Coll Life & Creat, Dept Leisure & Sport Management, Kaohsiung, Taiwan.	k0630@csu.edu.tw	Ho, Ping-Tsan/GWD-0757-2022	Ho, Ping-Tsan/0000-0001-6695-9626				[Anonymous], 2017, NABA, V9, P1, DOI DOI 10.3390/rs9101060; Chen CCV, 2017, MANAGE DECIS, V55, P547, DOI 10.1108/MD-06-2016-0380; Elbeltagi I, 2016, INTERNET RES, V26, P288, DOI 10.1108/IntR-10-2014-0244; Fazal-E-Hasan S. M., 2018, J BRAND MANAG, V26, P1; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Kavakiotis I, 2017, COMPUT STRUCT BIOTEC, V15, P104, DOI 10.1016/j.csbj.2016.12.005; Tarofder AK, 2016, INT J QUAL SERV SCI, V8, P516, DOI 10.1108/IJQSS-04-2015-0044; Wang JG, 2016, ENERGY STORAGE MATER, V2, P1, DOI 10.1016/j.ensm.2015.11.001; Yang SQ, 2017, INT J MOB COMMUN, V15, P1, DOI 10.1504/IJMC.2017.10001203	10	7	7	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243105	10.1371/journal.pone.0243105	http://dx.doi.org/10.1371/journal.pone.0243105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270714	Green Published, gold			2022-12-26	WOS:000597149100093
J	Liu, YZ; Yang, MZ; Cui, YY; Yao, YY; Liao, MX; Yuan, H; Gong, GJ; Deng, SP; Zhao, GP				Liu, Yanzhuo; Yang, Maozhu; Cui, Yuanyuan; Yao, Yuanyuan; Liao, Minxue; Yuan, Hao; Gong, Guojin; Deng, Shaoping; Zhao, Gaoping			A novel prevascularized tissue-engineered chamber as a site for allogeneic and xenogeneic islet transplantation to establish a bioartificial pancreas	PLOS ONE			English	Article							T-REGULATORY CELLS; STROMAL CELLS; ALLOGRAFTS; CULTURE	Although sites for clinical or experimental islet transplantation are well established, pancreatic islet survival and function in these locations remain unsatisfactory. A possible factor that might account for this outcome is local hypoxia caused by the limited blood supply. Here, we modified a prevascularized tissue-engineered chamber (TEC) that facilitated the viability and function of the seeded islets in vivo by providing a microvascular network prior to transplantation. TECs were created, filled with Growth Factor-Matrigel((TM)) (Matrigel((TM))) and then implanted into the groins of mice with streptozotocin-induced diabetes. The degree of microvascularization in each TECs was analyzed by histology, real-time PCR, and Western blotting. Three hundred syngeneic islets were seeded into each chamber on days 0, 14, and 28 post-chamber implantation, and 300, 200, or 100 syngeneic islets were seeded into additional chambers on day 28 post-implantation, respectively. Furthermore, allogeneic or xenogeneic islet transplantation is a potential solution for organ shortage. The feasibility of TECs as transplantation sites for islet allografts or xenografts and treatment with anti-CD45RB and/or anti-CD40L (MR-1) was therefore explored. A highly developed microvascularized network was established in each TEC on day 28 post-implantation. Normalization of blood glucose levels in diabetic mice was negatively correlated with the duration of prevascularization and the number of seeded syngeneic islets. Combined treatment with anti-CD45RB and MR-1 resulted in long-term survival of the grafts following allotransplantation (5/5, 100%) and xenotransplantation (16/20, 80%). Flow cytometry demonstrated that the frequency of CD4(+)Foxp3-Treg and CD4(+)IL-4(+)-Th2 cells increased significantly after tolerogenic xenograft transplantation, while the number of CD4+IFN-gamma-Th1 cells decreased. These findings demonstrate that highly developed microvascularized constructs can facilitate the survival of transplanted islets in a TECs, implying its potential application as artificial pancreas in the future.	[Liu, Yanzhuo; Cui, Yuanyuan; Yao, Yuanyuan; Liao, Minxue; Yuan, Hao; Zhao, Gaoping] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Sch Med, Dept Gastrointestinal, Chengdu, Sichuan, Peoples R China; [Yang, Maozhu; Deng, Shaoping; Zhao, Gaoping] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Organ Transplantat Translat Med Key Lab Sichuan P, Chengdu, Sichuan, Peoples R China; [Gong, Guojin] Xi Chang Peoples Hosp, Dept Gastrointestinal Surg, Xi Chang, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital	Zhao, GP (corresponding author), Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Sch Med, Dept Gastrointestinal, Chengdu, Sichuan, Peoples R China.; Zhao, GP (corresponding author), Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Organ Transplantat Translat Med Key Lab Sichuan P, Chengdu, Sichuan, Peoples R China.	gzhao@uestc.edu.cn	yao, yao/HHZ-7438-2022	Zhao, Gao-ping/0000-0001-5899-9230	National Natural Science Foundation of China [81172832, 81771723]; Sichuan Youth Science and Technology Foundation [2013JQ0020]; Special Program for Sichuan Youth Science and Technology Innovation [2014TD0010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Youth Science and Technology Foundation; Special Program for Sichuan Youth Science and Technology Innovation	This study was supported by grants from the National Natural Science Foundation of China (nos. 81172832 and 81771723), Sichuan Youth Science and Technology Foundation (no. 2013JQ0020), and Special Program for Sichuan Youth Science and Technology Innovation (no. 2014TD0010).	Afrashtehfar KI, 2018, J PROSTHET DENT, V120, P313, DOI 10.1016/j.prosdent.2017.11.005; Arifin DR, 2016, XENOTRANSPLANTATION, V23, P211, DOI 10.1111/xen.12235; Bertuzzi F, 2018, EUR REV MED PHARMACO, V22, P1731, DOI 10.26355/eurrev_201803_14588; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9; Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chen XJ, 2007, TRANSPLANTATION, V84, P122, DOI 10.1097/01.tp.0000266909.58117.e3; COVID-19 National Emergency Response Center Epidemiology & Case Management Team Korea Centers for Disease Control & Prevention, 2020, Osong Public Health Res Perspect, V11, P60, DOI 10.24171/j.phrp.2020.11.1.09; Ehlers MR, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0659-5; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Facklam AL, 2020, ADV MATER, V32, DOI 10.1002/adma.201902005; Fraker CA, 2013, CELL TRANSPLANT, V22, P1723, DOI 10.3727/096368912X657873; Fujita M, 2013, CELL TRANSPLANT, V22, P2335, DOI 10.3727/096368912X662381; Fumimoto Y, 2009, TISSUE ENG PART C-ME, V15, P437, DOI 10.1089/ten.tec.2008.0555; Gao C, 2015, TRANSPLANTATION, V99, P1796, DOI 10.1097/TP.0000000000000735; Gribble FM, 2009, NAT MED, V15, P247, DOI 10.1038/nm0309-247; Hughes AD, 2020, J CLIN INVEST, V130, P287, DOI 10.1172/JCI125773; Hussey AJ, 2009, TISSUE ENG PT A, V15, P3823, DOI [10.1089/ten.tea.2008.0682, 10.1089/ten.TEA.2008.0682]; Ibarra V, 2016, J BIOMED MATER RES A, V104, P1581, DOI 10.1002/jbm.a.35769; Itoh T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170899; Janowska-Wieczorek A, 2002, LEUKEMIA, V16, P1160, DOI 10.1038/sj.leu.2402486; Kasoju N, 2020, BIOMATER SCI-UK, V8, P631, DOI 10.1039/c9bm01280j; Kim J, 2020, NANO LETT, V20, P1517, DOI 10.1021/acs.nanolett.9b03605; Kim J, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1166-x; Kourtzelis I, 2016, THROMB HAEMOSTASIS, V115, P781, DOI 10.1160/TH15-05-0429; Martin BM, 2015, AM J TRANSPLANT, V15, P1241, DOI 10.1111/ajt.13098; MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199; Morini S, 2007, J ANAT, V210, P565, DOI 10.1111/j.1469-7580.2007.00717.x; Muller YD, 2012, CURR OPIN ORGAN TRAN, V17, P155, DOI 10.1097/MOT.0b013e3283508e17; Muller YD, 2009, XENOTRANSPLANTATION, V16, P121, DOI 10.1111/j.1399-3089.2009.00531.x; Papas KK, 2005, TRANSPL P, V37, P3412, DOI 10.1016/j.transproceed.2005.09.086; Pathak S, 2017, FASEB J, V31, P5111, DOI 10.1096/fj.201700490R; Pepper AR, 2016, TRANSPLANTATION, V100, P1474, DOI 10.1097/TP.0000000000001162; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012; Saito Y, 2010, CELL TRANSPLANT, V19, P775, DOI 10.3727/096368910X508889; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SIMEONOVIC CJ, 1986, AUST J EXP BIOL MED, V64, P37, DOI 10.1038/icb.1986.4; Song W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12373-5; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; UNUTMAZ D, 1995, INT IMMUNOL, V7, P1417, DOI 10.1093/intimm/7.9.1417; Veriter S, 2013, CURR DIABETES REP, V13, P745, DOI 10.1007/s11892-013-0412-x; Vlahos AE, 2020, BIOMATERIALS, V232, DOI 10.1016/j.biomaterials.2019.119710; Vlahos AE, 2017, P NATL ACAD SCI USA, V114, P9337, DOI 10.1073/pnas.1619216114; Woodward KB, 2020, AM J TRANSPLANT, V20, P1285, DOI 10.1111/ajt.15747; Wu JJ, 2017, TRANSPLANTATION, V101, P1587, DOI 10.1097/TP.0000000000001482	49	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0234670	10.1371/journal.pone.0234670	http://dx.doi.org/10.1371/journal.pone.0234670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270650	Green Published			2022-12-26	WOS:000597149100025
J	Ylli, A; Wu, YY; Burazeri, G; Pirkle, C; Sentell, T				Ylli, Alban; Wu, Yan Yan; Burazeri, Genc; Pirkle, Catherine; Sentell, Tetine			The lower COVID-19 related mortality and incidence rates in Eastern European countries are associated with delayed start of community circulation	PLOS ONE			English	Article								Background The purpose of this analysis was to assess the variations in COVID-19 related mortality in relation to the time differences in the commencement of virus circulation and containment measures in the European Region. Methods The data for the current analysis (N = 50 countries) were retrieved from the John Hopkins University dataset on the 7(th) of May 2020, with countries as study units. A piecewise regression analysis was conducted with mortality and cumulative incidence rates introduced as dependent variables and time interval (days from the 22(nd) of January to the date when 100 first cases were reported) as the main predictor. The country average life expectancy at birth and outpatient contacts per person per year were statistically adjusted for in the regression model. Results Mortality and incidence were strongly and inversely intercorrelated with days from January 22, respectively -0.83 (p<0.001) and -0.73 (p<0.001). Adjusting for average life expectancy and outpatients contacts per person per year, between days 33 to 50 from the 22(nd) of the January, the average mortality rate decreased by 30.1/million per day (95% CI: 22.7, 37.6, p<0.001). During interval 51 to 73 days, the change in mortality was no longer statistically significant but still showed a decreasing trend. A similar relationship with time interval was found for incidence. Life expectancy and outpatients contacts per person per year were not associated with mortality rate. Conclusion Countries in Europe that had the earliest COVID-19 circulation suffered the worst consequences in terms of health outcomes, specifically mortality. The drastic social isolation measures, quickly undertaken in response to those initial outbreaks appear effective, especially in Eastern European countries, where community circulation started after March 11(th). The study demonstrates that efforts to delay the early spread of the virus may have saved an average 30 deaths daily per one million inhabitants.	[Ylli, Alban; Burazeri, Genc] Univ Med, Fac Med, Dept Publ Hlth, Tirana, Albania; [Ylli, Alban] Inst Publ Hlth, Tirana, Albania; [Wu, Yan Yan; Pirkle, Catherine; Sentell, Tetine] Univ Honolulu Manoa, Off Publ Hlth Studies, Honolulu, HI USA; [Burazeri, Genc] Maastricht Univ, Sch CAPHRI Care & Publ Hlth Res Inst, Dept Int Hlth, Maastricht, Netherlands	Maastricht University	Ylli, A (corresponding author), Univ Med, Fac Med, Dept Publ Hlth, Tirana, Albania.; Ylli, A (corresponding author), Inst Publ Hlth, Tirana, Albania.	albanylli@yahoo.co.uk		ylli, alban/0000-0002-3850-0452				[Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2020, GERMANY VACCINE CAND; Barr J., 2020, SCI AM, P1; Bates D., 2007, NONLINEAR REGRESSION; Berberi Leonard, 2020, CORONAVIRUS CONTROLL; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020; Cornwall W., 2020, SCIENCE, DOI [10.1126/science.abc0192, DOI 10.1126/SCIENCE.ABC0192]; Dawood FS, 2020, LANCET INFECT DIS, V20, P1255, DOI 10.1016/S1473-3099(20)30581-8; Decreto del Presidente del Consiglio dei Ministri, 2020, MIS URG MAT CONT GES; Delanghe JR, 2020, CLIN CHIM ACTA, V505, P192, DOI 10.1016/j.cca.2020.03.031; European Centre for Disease Prevention and Control, EV BACKGR COVID 19; Fang W., 2020, URBAN DENSITY IS NOT; Mazzoli M., 2020, EFFECTS MOBILITY MUL, DOI 10.1101/2020.05.09.20096339; Mereo Florence, 2020, CORONAVIRUS RISQUE I; Miller A., 2020, MEDRXIV, DOI 10.1101/2020.03.24.20042937; Mladovsky P., 2009, HLTH EUROPEAN UNION; Ng YX, 2020, MMWR-MORBID MORTAL W, V69, P307, DOI 10.15585/mmwr.mm6911e1; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178; The World Health Organization (WHO), 2020, DIS OUTBREAK NE 0208; WHO, 2020, COVID 19 CONF CAS DE; WHO Regional Office for Europe, 2020, STRENGTH ADJ PUBL HL; WHO. Scientific Brief, 2020, SCI BRIEF BAC CALM G; Worobey M, 2020, SCIENCE, V370, P564, DOI 10.1126/science.abc8169	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243411	10.1371/journal.pone.0243411	http://dx.doi.org/10.1371/journal.pone.0243411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270782	Green Submitted, Green Published, gold			2022-12-26	WOS:000597149100068
J	Yeshaw, Y; Worku, MG; Tessema, ZT; Teshale, AB; Tesema, GA				Yeshaw, Yigizie; Worku, Misganaw Gebrie; Tessema, Zemenu Tadesse; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn			Zinc utilization and associated factors among under-five children with diarrhea in East Africa: A generalized linear mixed modeling	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; MORTALITY	Introduction Diarrhea is the leading cause of illness and death among under-five children in low and middle income countries. Through the provision of zinc supplements has been shown to reduce the severity and duration of diarrhea, as well as the risk of mortality, the use of zinc for the treatment of diarrhea is still very low in low-income countries. Therefore, this study was conducted to determine the prevalence and associated factors of zinc utilization among under-five children with diarrhea in East Africa. Methods A secondary data analysis of the recent Demographic and Health Surveys (DHS) of East African countries were used to determine the prevalence and associated factors of zinc utilization among under-five children with diarrhea in East Africa. A total weighted samples of 16,875 under-five children with diarrhea were included in the study. A generalized linear mixed model (using Poisson regression with robust error variance) was used. Prevalence Ratios (PR) with their 95% confidence interval (CI) were calculated for those variables included in the final model. Results The overall prevalence of zinc utilization among under-five children with diarrhea in this study was 21.54% (95% CI = 20.92-22.16). Of East African countries, Uganda had the highest prevalence of zinc utilization (40.51%) whereas Comoros had the lowest (0.44%). Maternal primary education (Adjusted Prevalence Ratio(aPR) = 1.29, 95% CI: 1.16-1.44), secondary education (aPR = 1.36, 95% CI = 1.19-1.55) and higher education (aPR = 1.91, 95% CI = 1.52-2.40), high community women education (aPR = 1.12, 95% CI = 1.02-1.24), high wealth index (aPR = 1.12, 95% CI = 1.01-1.24), high community media exposure (aPR = 1.17, 95% CI = 1.06-1.29) were associated with a higher prevalence of zinc utilization. Conclusion The prevalence of zinc utilization among under-five children was found to be low in East Africa. Maternal education, wealth index, community women education, and community media exposure were significantly associated with zinc utilization. Increased mass media exposure, maternal education and wealth index is recommended to improve zinc utilization among under-five children with diarrhea.	[Yeshaw, Yigizie] Univ Gondar, Sch Med, Dept Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yeshaw, Yigizie; Tessema, Zemenu Tadesse; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Sch Med, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Yeshaw, Y (corresponding author), Univ Gondar, Sch Med, Dept Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia.; Yeshaw, Y (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	yigizieyeshaw29@gmail.com	Tadesse, Zemenu/ABG-1690-2021; Yeshaw, Yigizie/L-6336-2019; Teshale, Achamyeleh/HHN-8416-2022	Yeshaw, Yigizie/0000-0003-4587-7925				Ajayi DT, 2019, ARCH BASIC APPL MED, V7, P35; Alam Z, 2019, NAGOYA J MED SCI, V81, P31, DOI 10.18999/nagjms.81.1.31; [Anonymous], 2020, NAT HUM BEHAV, V4, P1, DOI 10.1038/s41562-020-0818-9; [Anonymous], 2019, Cancer Discov, V9, pOF3, DOI 10.1158/2159-8290.CD-NB2018-158; Ayele E, 2020, MEDICINE, V4, P15; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Center IVA, PNEUM DIARRH PROGR R; Control CfD Prevention., GUID EV NUTR STAT GR; El-Khoury M, 2016, GLOB HEALTH-SCI PRAC, V4, P264, DOI 10.9745/GHSP-D-16-00021; Farahat TM., 2020, MENOUFIA MED J, V33, P5; GD G, 2018, NIGER J PAEDIAT, V45, P81; Health IaJHBSoP, PNEUM DIARRH PROGR R, P1; Kotloff KL, 2019, LANCET GLOB HEALTH, V7, pE568, DOI 10.1016/S2214-109X(19)30076-2; Lamberti L, GLOBAL ORS ZINC COVE; Larson CP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000175; Lassi ZS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005978.pub3; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; Mokomane M, 2018, THER ADV INFECT DIS, V5, P29, DOI 10.1177/2049936117744429; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Organization WH, IMPL NEW REC CLIN MA; Prevention CfDCa, 2012, GUID EV NUTR GROWTH; Solomons NW, 2013, ANN NUTR METAB, V62, P8, DOI 10.1159/000348547; Troeger CE, 2020, LANCET INFECT DIS, V20, P37, DOI 10.1016/S1473-3099(19)30401-3; Ugwu J. I., 2019, International Journal of Medicine and Health Development, V24, P63, DOI 10.4103/1110-1067.271082; UNICEF, MON SIT CHILDR WOM 2; UNICEF, 2015, GLOB DAT BAS MULT IN; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Walker CLF, 2009, EUR J CLIN NUTR, V63, P591, DOI 10.1038/ejcn.2008.9; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Wang WJ, 2011, J HEALTH POPUL NUTR, V29, P207, DOI 10.3329/jhpn.v29i3.7868; WHO, 2020, CLIN MAN AC DIARRH 2; WHO, DIARRH DIS 2017; Workie HM, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1321-6	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243245	10.1371/journal.pone.0243245	http://dx.doi.org/10.1371/journal.pone.0243245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264367	gold, Green Published			2022-12-26	WOS:000596569200045
J	Hemkemeyer, SA; Vollmer, V; Schwarz, V; Lohmann, B; Honnert, U; Taha, M; Schnittler, HJ; Bahler, M				Hemkemeyer, Sandra A.; Vollmer, Veith; Schwarz, Vera; Lohmann, Birgit; Honnert, Ulrike; Taha, Muna; Schnittler, Hans-Joachim; Baehler, Martin			Local Myo9b RhoGAP activity regulates cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RHOA ACTIVITY; SPATIOTEMPORAL DYNAMICS; MYOSIN IXB; MIGRATION; ACTIN; FIBROBLASTS; SITES; ATLAS; BACK	To migrate, cells assume a polarized morphology, extending forward with a leading edge with their trailing edge retracting back toward the cell body. Both cell extension and retraction critically depend on the organization and dynamics of the actin cytoskeleton, and the small, monomeric GTPases Rac and Rho are important regulators of actin. Activation of Rac induces actin polymerization and cell extension, whereas activation of Rho enhances acto-myosin II contractility and cell retraction. To coordinate migration, these processes must be carefully regulated. The myosin Myo9b, a Rho GTPase-activating protein (GAP), negatively regulates Rho activity and deletion of Myo9b in leukocytes impairs cell migration through increased Rho activity. However, it is not known whether cell motility is regulated by global or local inhibition of Rho activity by Myo9b. Here, we addressed this question by using Myo9b-deficient macrophage-like cells that expressed different recombinant Myo9b constructs. We found that Myo9b accumulates in lamellipodial extensions generated by Rac-induced actin polymerization as a function of its motor activity. Deletion of Myo9b in HL-60-derived macrophages altered cell morphology and impaired cell migration. Reintroduction of Myo9b or Myo9b motor and GAP mutants revealed that local GAP activity rescues cell morphology and migration. In summary, Rac activation leads to actin polymerization and recruitment of Myo9b, which locally inhibits Rho activity to enhance directional cell migration.	[Hemkemeyer, Sandra A.; Vollmer, Veith; Schwarz, Vera; Lohmann, Birgit; Honnert, Ulrike; Baehler, Martin] Westfalian Wilhelms Univ Munster, Inst Mol Cell Biol, Munster, Germany; [Taha, Muna; Schnittler, Hans-Joachim] Westfalian Wilhelms Univ Munster, Inst Anat & Vasc Biol, Munster, Germany; [Hemkemeyer, Sandra A.] UCL, Inst Ophthalmol, Dept Cell Biol, London, England; [Taha, Muna] Hebron Univ, Coll Pharm & Med Sci, Hebron, Palestine	University of Munster; University of Munster; University of London; University College London	Bahler, M (corresponding author), Westfalian Wilhelms Univ Munster, Inst Mol Cell Biol, Munster, Germany.	baehler@uni-muenster.de		Taha, Muna/0000-0003-2674-6399; Schnittler, Hans-J./0000-0001-6807-3343; Hemkemeyer, Sandra A./0000-0003-1854-9512	Deutsche Forschungsgemeinschaft [BA1354/14-1, SCHN430/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the "Deutsche Forschungsgemeinschaft" grants BA1354/14-1 to M. B. and SCHN430/9-1 to H. S.	BEJSOVEC A, 1990, CELL, V60, P133, DOI 10.1016/0092-8674(90)90723-R; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Cao JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02373-8; Chandhoke SK, 2012, MOL BIOL CELL, V23, P2468, DOI 10.1091/mbc.E11-09-0803; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Chieregatti E, 1998, J CELL SCI, V111, P3597; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Hinde E, 2013, P NATL ACAD SCI USA, V110, P135, DOI 10.1073/pnas.1211882110; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Moalli F, 2018, J EXP MED, V215, P1869, DOI 10.1084/jem.20170896; Muller RT, 1997, MOL BIOL CELL, V8, P2039, DOI 10.1091/mbc.8.10.2039; Paul CD, 2016, ANNU REV BIOMED ENG, V18, P159, DOI 10.1146/annurev-bioeng-071114-040654; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Symons M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-213; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Tschumperlin DJ, 2013, PHYSIOLOGY, V28, P380, DOI 10.1152/physiol.00024.2013; van den Boom F, 2007, MOL BIOL CELL, V18, P1507, DOI 10.1091/mbc.E06-08-0771; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695; Yi FS, 2016, J MOL BIOL, V428, P3043, DOI 10.1016/j.jmb.2016.06.014; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	42	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100136	10.1074/jbc.RA120.013623	http://dx.doi.org/10.1074/jbc.RA120.013623			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268376	gold, Green Published			2022-12-26	WOS:000672866400115
J	Aimagambetova, G; Issanov, A; Terzic, S; Bapayeva, G; Ukybassova, T; Baikoshkarova, S; Aldiyarova, A; Shauyen, F; Terzic, M				Aimagambetova, Gulzhanat; Issanov, Alpamys; Terzic, Sanja; Bapayeva, Gauri; Ukybassova, Talshyn; Baikoshkarova, Saltanat; Aldiyarova, Aidana; Shauyen, Fariza; Terzic, Milan			The effect of psychological distress on IVF outcomes: Reality or speculations?	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; CENTRAL-ASIA; STRESS; WOMEN; FERTILITY; INFERTILITY; DEPRESSION; KAZAKSTAN; OBESITY	Introduction Infertility is a problem that affects millions of people worldwide. The aim of this study was to assess the effect of stress, depression and anxiety on the IVF outcomes in Kazakhstan. Methods The prospective cohort study was performed using questionnaires to assess psychological distress in 304 infertile female in three different cities in Kazakhstan. Results The average age of participants was 33.7 years with infertility duration of 5.9 years. Regarding stress, depression and anxiety we found that more than 80% of all respondents had CES-D score higher than 16, indicating that they are at risk of developing clinical depression. On average, FPI subscales' scores, global stress score and anxiety scale (STAI-S and STAI-T) scores were statistically significantly higher among not pregnant women than pregnant women. Similarly, in simple logistic regression analysis all FPI subscales scores, global stress scale score and anxiety scales' scores were negatively associated with clinical pregnancy. Conclusion Rates of stress, anxiety and depression among IVF patients are higher than in general population. If the level of infertility-related stress is higher, IVF success rate is lower. Findings of our study indicate the need for the specific psychological interventions for all infertility women, to improve IVF success rate.	[Aimagambetova, Gulzhanat] Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan; [Issanov, Alpamys; Terzic, Sanja; Terzic, Milan] Nazarbayev Univ, Sch Med, Dept Med, Nur Sultan, Kazakhstan; [Bapayeva, Gauri; Ukybassova, Talshyn; Aldiyarova, Aidana; Shauyen, Fariza; Terzic, Milan] Univ Med Ctr, Natl Res Ctr Mother & Child Hlth, Clin Acad Dept Womens Hlth, Nur Sultan, Kazakhstan; [Baikoshkarova, Saltanat] IVF Clin Ecomed, Alma Ata, Kazakhstan; [Terzic, Milan] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Nazarbayev University; Nazarbayev University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aimagambetova, G (corresponding author), Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan.	gulzhanat.aimagambetova@nu.edu.kz	Issanov, Alpamys/AAD-2792-2020; Aimagambetova, Gulzhanat/M-2731-2019; Terzic, Sanja/ABH-4367-2020; Terzic, Milan/P-7243-2017	Issanov, Alpamys/0000-0002-8968-2655; Aimagambetova, Gulzhanat/0000-0002-2868-4497; Terzic, Sanja/0000-0002-0034-2559; Shauyen, Fariza/0000-0001-7241-2811; Otarbaev, Marat/0000-0002-4323-9252; Terzic, Milan/0000-0003-3914-5154; Baikoshkarova, Saltanat/0000-0001-9428-489X	Nazarbayev University Social policy grant	Nazarbayev University Social policy grant	The research was supported by the Nazarbayev University Social policy grant awarded for author MT. Ecomed provided support for this study in the form of salary for author SB. The specific roles of these authors are articulated in the `author contributions' section. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2013, J POPUL RES, V30, P197, DOI 10.1007/s12546-013-9112-2; Aketayeva A, 2018, IRAN J PUBLIC HEALTH, V47, P135; Alchinbaev M. K., 2016, Urologiya (Moscow), P75; Amer Soc Reprod Med, 2020, FERTIL STERIL, V113, P533, DOI 10.1016/j.fertnstert.2019.11.025; An Y, 2013, J ASSIST REPROD GEN, V30, P35, DOI 10.1007/s10815-012-9904-x; An Y, 2011, FERTIL STERIL, V96, P404, DOI 10.1016/j.fertnstert.2011.05.092; Anderheim L, 2005, HUM REPROD, V20, P2969, DOI 10.1093/humrep/dei219; [Anonymous], 2019, Obstet Gynecol, V133, pe377, DOI 10.1097/AOG.0000000000003271; Barut MU, 2016, MED SCI MONITOR, V22, P4386, DOI 10.12659/MSM.897620; Bellver J, 2010, FERTIL STERIL, V93, P447, DOI 10.1016/j.fertnstert.2008.12.032; Cox SJ, 2006, FERTIL STERIL, V85, P84, DOI 10.1016/j.fertnstert.2005.07.1287; De Pergola G, 2006, OBESITY, V14, P1954, DOI 10.1038/oby.2006.228; Ebbesen SMS, 2009, HUM REPROD, V24, P2173, DOI 10.1093/humrep/dep185; Gabnai-Nagy E, 2020, GEBURTSH FRAUENHEILK, V80, P200, DOI 10.1055/a-0854-5987; Garcia-Blanco A, 2018, HUM REPROD, V33, P1237, DOI 10.1093/humrep/dey109; Henry SK, 2018, J AFFECT DISORDERS, V234, P270, DOI 10.1016/j.jad.2018.02.071; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Lakatos E, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0410-2; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lokshin V.N., 2018, REP, V1, P37; Mahalingaiah S, 2011, FERTIL STERIL, V95, P2618, DOI 10.1016/j.fertnstert.2011.05.015; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Mandrik O, 2015, CLINICOECONOMIC OUTC, V7, P347, DOI 10.2147/CEOR.S79513; Maroufizadeh S, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4294-0; Matthiesen SMS, 2011, HUM REPROD, V26, P2763, DOI 10.1093/humrep/der246; Michael Anthony E, 2003, Reprod Biomed Online, V7, P683; Newton CR, 1999, FERTIL STERIL, V72, P54, DOI 10.1016/S0015-0282(99)00164-8; Nouri K, 2014, ASIAN J ANDROL, V16, P597, DOI 10.4103/1008-682X.125404; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Pasch LA, 2018, FERTIL STERIL, V110, P1194, DOI 10.1016/j.fertnstert.2018.08.055; Pasch LA, 2017, CURR OPIN PSYCHOL, V13, P131, DOI 10.1016/j.copsyc.2016.07.004; Pasch LA, 2012, FERTIL STERIL, V98, P459, DOI 10.1016/j.fertnstert.2012.05.023; Pike JL, 1997, PSYCHOSOM MED, V59, P447, DOI 10.1097/00006842-199707000-00015; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rooney KL, 2018, DIALOGUES CLIN NEURO, V20, P41; Rossi Brooke V, 2016, Fertil Res Pract, V2, P11, DOI 10.1186/s40738-016-0026-5; Sapolsky RM, 2015, NAT NEUROSCI, V18, P1344, DOI 10.1038/nn.4109; Spielberger CD, 1970, MANUAL STATETRAIT IN; Spoorenberg T, 2017, J BIOSOC SCI, V49, pS62, DOI 10.1017/S0021932017000335; Tabyshalieva A, 1997, ANTHR ARCHEOL EURAS, V36, P45, DOI 10.2753/AAE1061-1959360245; Utepova G, 2019, CLIN EXP OBSTET GYN, V46, P461, DOI 10.12891/ceog4685.2019; Vander Borght M, 2018, CLIN BIOCHEM, V62, P2, DOI 10.1016/j.clinbiochem.2018.03.012	42	18	18	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242024	10.1371/journal.pone.0242024	http://dx.doi.org/10.1371/journal.pone.0242024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315878	gold, Green Published			2022-12-26	WOS:000600186100035
J	Bayoumi, A; Jalil, I; Metwally, M; Adams, LA; Aller, R; Garcia-Monzon, C; Arias-Loste, MT; Miele, L; Petta, S; Craxi, A; Gallego-Duran, R; Fischer, J; Berg, T; Qiao, L; Liddle, C; Bugianesi, E; Romero-Gomez, M; George, J; Eslam, M				Bayoumi, Ali; Jalil, Ismail; Metwally, Mayada; Adams, Leon A.; Aller, Rocio; Garcia-Monzon, Carmelo; Teresa Arias-Loste, Maria; Miele, Luca; Petta, Salvatore; Craxi, Antonio; Gallego-Duran, Rocio; Fischer, Janett; Berg, Thomas; Qiao, Liang; Liddle, Christopher; Bugianesi, Elisabetta; Romero-Gomez, Manuel; George, Jacob; Eslam, Mohammed			Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANT; NAFLD; RISK; PROGRESSION; STEATOSIS; INCREASES; TM6SF2; PNPLA3	Metabolic associated fatty liver disease (MAFLD) is the most prevalent liver disease in Western nations, with high heritability. A recent study of Japanese patients with the disease suggested that TLL1 rs17047200 is associated with fibrosis; whether a similar association is observed in Caucasian patients with MAFLD is unknown. We investigated the association of the TLL1 rs17047200 polymorphism with liver fibrosis in a cohort of Caucasian patients with MAFLD (n = 728). We also investigated whether TLL1 expression is altered during liver injury in humans, in murine models of fibrosis, and in in-vitro. While TLL1 expression is upregulated in the liver of humans with MAFLD and in mice, the rs17047200 variant was not associated with fibrosis or any other histological features, or with hepatic TLL1 expression. In conclusion, the TLL1 rs17047200 variant is not a risk variant for fibrosis in Caucasian patients with MAFLD. However, TLL1 could be involved in the pathogenesis of liver fibrosis.	[Bayoumi, Ali; Jalil, Ismail; Metwally, Mayada; Qiao, Liang; Liddle, Christopher; George, Jacob; Eslam, Mohammed] Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Sydney, NSW, Australia; [Bayoumi, Ali; Jalil, Ismail; Metwally, Mayada; Qiao, Liang; Liddle, Christopher; George, Jacob; Eslam, Mohammed] Univ Sydney, Sydney, NSW, Australia; [Adams, Leon A.] Univ Western Australia, Sir Charles Gairdner Hosp Unit, Med Sch, Nedlands, WA, Australia; [Aller, Rocio] Valladolid Univ, Hosp Clin Univ Valladolid, Sch Med, Gastroenterol Svo, Valladolid, Spain; [Garcia-Monzon, Carmelo] Univ Hosp Santa Cristina, CIBERehd, Inst Invest Sanitaria Princesa, Liver Res Unit, Madrid, Spain; [Teresa Arias-Loste, Maria] Marques de Valdecilla Univ Hosp, Gastroenterol & Hepatol Dept, Santander, Spain; [Miele, Luca] Univ Cattolica Sacro Cuore, Dept Internal Med, Rome, Italy; [Petta, Salvatore; Craxi, Antonio] Univ Palermo, Sect Gastroenterol & Hepatol, PROMISE, Palermo, Italy; [Gallego-Duran, Rocio; Romero-Gomez, Manuel] Virgen del Rocio Univ Hosp, Inst Biomed Seville, Seville, Spain; [Fischer, Janett; Berg, Thomas] Univ Leipzig, Dept Med 2, Div Hepatol, Med Ctr, Leipzig, Germany; [Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Div Gastroenterol, Turin, Italy	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Western Australia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Marques de Valdecilla (HUMV); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Leipzig University; University of Turin	George, J; Eslam, M (corresponding author), Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Sydney, NSW, Australia.; George, J; Eslam, M (corresponding author), Univ Sydney, Sydney, NSW, Australia.	jacob.george@sydney.edu.au; mohammed.eslam@sydney.edu.au	Romero-Gomez, Manuel/L-8030-2014; Miele, Luca/C-2255-2015	Romero-Gomez, Manuel/0000-0001-8494-8947; Miele, Luca/0000-0003-3464-0068; Bayoumi, Ali/0000-0002-4939-1351; Arias-Loste, Maria Teresa/0000-0001-8864-3833; George, Jacob/0000-0002-8421-5476	Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC) [1053206, 1149976, 1107178, 1108422]; Australian Government Research Training Program (RTP) scholarship; Horizon 2020 [634413]	Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program (RTP) scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Horizon 2020	ME and JG are supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC) Program Grants (1053206 and 1149976) and Project grants (1107178 and 1108422). EB is supported by Horizon 2020 under grant 634413 for the project EPoS. AB is supported by an Australian Government Research Training Program (RTP) scholarship.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738; El Sharkawy R, 2018, ALIMENT PHARM THER, V48, P564, DOI 10.1111/apt.14866; Eslam M, 2020, HEPATOL INT, V14, P889, DOI 10.1007/s12072-020-10094-2; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; Eslam M, 2020, NAT REV GASTRO HEPAT, V17, P40, DOI 10.1038/s41575-019-0212-0; Eslam M, 2019, GASTROENTEROLOGY, V157, P590, DOI 10.1053/j.gastro.2019.05.064; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Eslam M, 2016, HEPATOLOGY, V64, P34, DOI 10.1002/hep.28475; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fouad Y, 2020, LIVER INT, V40, P1254, DOI 10.1111/liv.14478; John M, 2017, GASTROENTEROLOGY, V153, P1448, DOI 10.1053/j.gastro.2017.04.056; Karlsen TH, 2015, J HEPATOL, V62, pS6, DOI 10.1016/j.jhep.2015.02.025; Kazankov K, 2016, LIVER INT, V36, P1549, DOI 10.1111/liv.13150; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Loomba R, 2015, GASTROENTEROLOGY, V149, P1784, DOI 10.1053/j.gastro.2015.08.011; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Matsuura K, 2017, GASTROENTEROLOGY, V152, P1383, DOI 10.1053/j.gastro.2017.01.041; Mendez-Sanchez N, 2020, LANCET GASTROENTEROL; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Seko Y, 2018, J GASTROENTEROL, V53, P438, DOI 10.1007/s00535-017-1372-8; Shiha G, 2021, LANCET GASTROENTEROL, V6, P73, DOI 10.1016/S2468-1253(20)30294-6; Shiha G, 2021, LANCET GASTROENTEROL, V6, P57, DOI 10.1016/S2468-1253(20)30213-2; Thabet K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12757; Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034; Yang J, 2019, INT J CANCER, V144, P533, DOI 10.1002/ijc.31910; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zheng Kenneth I, 2020, Chin Med J (Engl), V133, P2271, DOI 10.1097/CM9.0000000000000981	31	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243590	10.1371/journal.pone.0243590	http://dx.doi.org/10.1371/journal.pone.0243590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306709	Green Published, gold			2022-12-26	WOS:000600144200028
J	Al-Mujtaba, M; Sam-Agudu, NA; Torbunde, N; Aliyu, MH; Cornelius, LJ				Al-Mujtaba, Maryam; Sam-Agudu, Nadia A.; Torbunde, Nguavese; Aliyu, Muktar H.; Cornelius, Llewellyn J.			Access to maternal-child health and HIV services for women in North-Central Nigeria: A qualitative exploration of the male partner perspective	PLOS ONE			English	Article							MENTOR MOTHER PROGRAMS; MALE INVOLVEMENT; POSITIVE WOMEN; PREGNANT-WOMEN; RURAL NIGERIA; TRANSMISSION; CARE; PREVENTION; DELIVERY; IMPACT	Background In much of sub-Saharan Africa, male partners play influential roles in women's access to maternal-child healthcare, including prevention of mother-to-child transmission of HIV services. We explored male partner perspectives on women's access to maternal-child healthcare in North-Central Nigeria. Methods Three focus groups were conducted with 30 men, purposefully-selected on the basis of being married, and rural or urban residence. Major themes explored were men's maternal-child health knowledge, gender power dynamics in women's access to healthcare, and peer support for pregnant and postpartum women. Data were manually analyzed using Grounded Theory, which involves constructing theories out of data collected, rather than applying pre-formed theories. Results Mean participant age was 48.3 years, with 36.7% aged <40 years, 46.7% between 41 and 60 years, and 16.6% over 60 years old. Religious affiliation was self-reported; 60% of participants were Muslim and 40% were Christian. There was consensus on the acceptability of maternal-child health services and their importance for optimal maternal-infant outcomes. Citing underlying patriarchal norms, participants acknowledged that men had more influence in family health decision-making than women. However, positive interpersonal couple relationships were thought to facilitate equitable decision-making among couples. Financial constraints, male-unfriendly clinics and poor healthcare worker attitudes were major barriers to women's access and male partner involvement. The provision of psychosocial and maternal peer support from trained women was deemed highly acceptable for both HIV-positive and HIV-negative women. Conclusions Strategic engagement of community leaders, including traditional and religious leaders, is needed to address harmful norms and practices underlying gender inequity in health decision-making. Gender mainstreaming, where the needs and concerns of both men and women are considered, should be applied in maternal-child healthcare education and delivery. Clinic fee reductions or elimination can facilitate service access. Finally, professional organizations can do more to reinforce respectful maternity care among healthcare workers.	[Al-Mujtaba, Maryam; Sam-Agudu, Nadia A.] Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria; [Sam-Agudu, Nadia A.] Univ Maryland, Sch Med, Div Epidemiol & Prevent, Inst Human Virol, Baltimore, MD 21201 USA; [Sam-Agudu, Nadia A.; Torbunde, Nguavese] Inst Human Virol Nigeria, Prevent Care & Treatment Dept, Pediat & Adolescent HIV Unit, Abuja, Nigeria; [Aliyu, Muktar H.] Vanderbilt Univ, Dept Hlth Policy, Med Ctr, Nashville, TN USA; [Aliyu, Muktar H.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Med Ctr, Nashville, TN USA; [Cornelius, Llewellyn J.] Univ Georgia Athens, Sch Social Work, Athens, GA USA; [Cornelius, Llewellyn J.] Univ Georgia Athens, Coll Publ Hlth, Athens, GA USA	University System of Maryland; University of Maryland Baltimore; Vanderbilt University; Vanderbilt University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sam-Agudu, NA (corresponding author), Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria.; Sam-Agudu, NA (corresponding author), Univ Maryland, Sch Med, Div Epidemiol & Prevent, Inst Human Virol, Baltimore, MD 21201 USA.; Sam-Agudu, NA (corresponding author), Inst Human Virol Nigeria, Prevent Care & Treatment Dept, Pediat & Adolescent HIV Unit, Abuja, Nigeria.	nsamagudu@ihvnigeria.org		Adejuyigbe, Ebunoluwa/0000-0002-8671-4965	World Health Organization [WHO RPC 531]	World Health Organization(World Health Organization)	The MoMent Nigeria study was funded by the World Health Organization through award WHO RPC 531 to NASA, for the INtegrating and Scaling up PMTCT through Implementation REsearch (INSPIRE) initiative from Global Affairs Canada. https://www.who.int/hiv/pub/journal_articles/inspire-intro/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborigo RA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-017-1641-9; Adeniran AS, 2015, INT J HEALTH SCI-IJH, V9, P305; Adeyinka DA, 2016, INT J STD AIDS, V27, P1338, DOI 10.1177/0956462416665027; Aguiar C, 2015, MATERN CHILD HLTH J, V19, P2012, DOI 10.1007/s10995-015-1713-2; Al-Mujtaba M., 2016, J AIDS HIV RES, V8, P70, DOI DOI 10.5897/JAHR2015.0353; Al-Mujtaba M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3645415; Aliyu M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1965; Aluisio AR, 2016, JAIDS-J ACQ IMM DEF, V73, P169, DOI 10.1097/QAI.0000000000001038; Anastasi E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0695-9; Andersson N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S7; [Anonymous], 2019, THE ECONOMIST; Atuoye KN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1005-y; August F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125978; Azuh D., 2015, OPEN J SOCIAL SCI, V3, P105, DOI DOI 10.4236/JSS.2015.34013; Belich M, 2017, ANN GLOB HEALTH, V83, P95; Bove R, 2009, SOC SCI MED, V68, P21, DOI 10.1016/j.socscimed.2008.09.045; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Burt RS, 2005, BROKERAGE CLOSURE IN; Cataldo F, 2017, JAIDS-J ACQ IMM DEF, V75, pS224, DOI [10.1097/QAI.0000000000001375, 10.1097/qai.0000000000001375]; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Cornelius LJ, 2018, J EVID-INFORM SOC WO, V15, P38, DOI 10.1080/23761407.2017.1397580; Doctor HV, 2012, REPROD HEALTH MATTER, V20, P104, DOI 10.1016/S0968-8080(12)39615-8; Downe S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0466-y; Dunlap J, 2014, CURR HIV-AIDS REP, V11, P109, DOI 10.1007/s11904-014-0200-5; Eagly A.H., 2012, HDB THEORIES SOCIAL, P458, DOI [10.4135/9781446249222.n49, DOI 10.4135/9781446249222.N49]; Fagbamigbe AF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0527-y; Falnes EF, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-21; Fapohunda BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069569; Fawole AO, 2012, AFR HEALTH SCI, V12, P32; Federal Ministry of Health (FMoH), 2015, NAT HIV SER PREV SEN; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ganle JK, 2016, SOC SCI MED, V166, P195, DOI 10.1016/j.socscimed.2016.08.030; Ganle JK, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0083-y; Gbadamosi SO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211022; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Gibore NS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232939; Hamilton E, 2017, JAIDS-J ACQ IMM DEF, V75, pS27, DOI 10.1097/QAI.0000000000001325; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; HIarlaithe MO, 2014, AIDS BEHAV, V18, pS516, DOI 10.1007/s10461-014-0756-5; Hlongwa M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4124-y; Homer CSE, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1686-4; Iliyasu Zubairu, 2010, Afr J Reprod Health, V14, P21; Joint United Nations Program on HIV/AIDS {UNAIDS}, 2014, GEND MATT OV GEND RE; Kashitala J, 2015, AFR J REPROD HEALTH, V19, P117; Kaye DK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-54; Kenya Ministry of Health, 2012, NAT GUID PMTCT PEER; Koo K, 2013, AIDS EDUC PREV, V25, P14, DOI 10.1521/aeap.2013.25.1.14; Koye DN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-398; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Ladur AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133239; Loeffen MJW, 2017, EUR J GEN PRACT, V23, P27, DOI 10.1080/13814788.2016.1267724; Lowe M, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.255.11378; Lowe M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163653; Manda-Taylor L, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1523-1; Mannava P, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0117-9; McMahon SA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1058-x; Mersha AG, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2139-9; Mkandawire E, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1669-5; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Mugo NS, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-017-2788-9; Muheirwe F, 2019, INT J HEALTH PLAN M, V34, P263, DOI 10.1002/hpm.2627; Mutale W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4187-x; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; National Agency for the Control of AIDS, 2015, GLOB AIDS RESP COUNT; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; Neale J, 2016, ADDICTION, V111, P1096, DOI 10.1111/add.13314; Nesane K, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i2.929; Nkuoh GN, 2010, J MIDWIFERY WOM HEAL, V55, P363, DOI 10.1016/j.jmwh.2010.02.009; Nyondo AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-691; Nyondo-Mipando AL, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2999-8; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; O'Gorman DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-354; Okonofua F, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1730-4; Olakunde BO, 2018, INT J STD AIDS, V29, P404, DOI 10.1177/0956462417739752; Payen D, 2008, CRIT CARE, V12, pR74, DOI 10.1186/cc6916; Peneza AK, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1449724; Remien RH, 2009, JAIDS-J ACQ IMM DEF, V51, pS106, DOI 10.1097/QAI.0b013e3181aafd66; Sam-Agudu N, 2014, 8 INTEREST WORKSH LU; Sam-Agudu NA, 2017, JAIDS-J ACQ IMM DEF, V75, pS173, DOI [10.1097/QAI.0000000000001346, 10.1097/qai.0000000000001346]; Sam-Agudu NA, 2017, JAIDS-J ACQ IMM DEF, V75, pS182, DOI [10.1097/QAI.0000000000001345, 10.1097/qai.0000000000001345]; Sam-Agudu NA, 2014, JAIDS-J ACQ IMM DEF, V67, pS132, DOI 10.1097/QAI.0000000000000331; Shapiro David, 2013, POPULATION RES POLIC, V33, P229; Sifunda S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217467; Singh D, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-68; Singh K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-941; Strategies for Management of Anti-retroviral Therapy/INSIGHT, 2008, AIDS, V22, pF17; Taft AJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-159; Tenkorang EY, 2014, INT HEALTH, V6, P46, DOI 10.1093/inthealth/ihu003; Tilahun M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/763876; Tokhi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191620; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2019, EL METH CHILD TRANSM; UNAIDS, 2019, COUNTR FACT SHEETS N; USAID, 2015, REL REPR BEH SUBS AF, P48; Uzondu CA, 2015, GLOB HEALTH, V3, P97, DOI 10.9745/GHSP-D-14-00117; Vermeulen E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0853-8; Vouking MZ, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.349.5090; Vrazo AC, 2018, TROP MED INT HEALTH, V23, P136, DOI 10.1111/tmi.13014; WHO, 2007, UN UNF IN IN GEND IN; World Health Organization, 2018, WHO RECOMMENDATION R; Yaya S, 2019, INT HEALTH, V11, P551, DOI 10.1093/inthealth/ihz019; Yaya S, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0752-3	103	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243611	10.1371/journal.pone.0243611	http://dx.doi.org/10.1371/journal.pone.0243611			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301478	gold, Green Published			2022-12-26	WOS:000600143100074
J	Araujo, RF; Chambers, JQ; Celes, CHS; Muller-Landau, HC; dos Santos, APF; Emmert, F; Ribeiro, GHPM; Gimenez, BO; Lima, AJN; Campos, MAA; Higuchi, N				Araujo, Raquel Fernandes; Chambers, Jeffrey Q.; Souza Celes, Carlos Henrique; Muller-Landau, Helene C.; Ferreira dos Santos, Ana Paula; Emmert, Fabiano; Ribeiro, Gabriel H. P. M.; Gimenez, Bruno Oliva; Lima, Adriano J. N.; Campos, Moacir A. A.; Higuchi, Niro			Integrating high resolution drone imagery and forest inventory to distinguish canopy and understory trees and quantify their contributions to forest structure and dynamics	PLOS ONE			English	Article							UNMANNED AERIAL VEHICLES; SIZE DISTRIBUTIONS; METABOLIC ECOLOGY; GROWTH; MODEL; AREA; MORTALITY; DOMINANCE; DENSITY; BIOMASS	Tree growth and survival differ strongly between canopy trees (those directly exposed to overhead light), and understory trees. However, the structural complexity of many tropical forests makes it difficult to determine canopy positions. The integration of remote sensing and ground-based data enables this determination and measurements of how canopy and understory trees differ in structure and dynamics. Here we analyzed 2 cm resolution RGB imagery collected by a Remotely Piloted Aircraft System (RPAS), also known as drone, together with two decades of bi-annual tree censuses for 2 ha of old growth forest in the Central Amazon. We delineated all crowns visible in the imagery and linked each crown to a tagged stem through field work. Canopy trees constituted 40% of the 1244 inventoried trees with diameter at breast height (DBH) > 10 cm, and accounted for similar to 70% of aboveground carbon stocks and wood productivity. The probability of being in the canopy increased logistically with tree diameter, passing through 50% at 23.5 cm DBH. Diameter growth was on average twice as large in canopy trees as in understory trees. Growth rates were unrelated to diameter in canopy trees and positively related to diameter in understory trees, consistent with the idea that light availability increases with diameter in the understory but not the canopy. The whole stand size distribution was best fit by a Weibull distribution, whereas the separate size distributions of understory trees or canopy trees > 25 cm DBH were equally well fit by exponential and Weibull distributions, consistent with mechanistic forest models. The identification and field mapping of crowns seen in a high resolution orthomosaic revealed new patterns in the structure and dynamics of trees of canopy vs. understory at this site, demonstrating the value of traditional tree censuses with drone remote sensing.	[Araujo, Raquel Fernandes; Souza Celes, Carlos Henrique; Ferreira dos Santos, Ana Paula; Ribeiro, Gabriel H. P. M.; Gimenez, Bruno Oliva; Lima, Adriano J. N.; Campos, Moacir A. A.; Higuchi, Niro] Inst Nacl de Pesquisas da Amazonia, Lab Manejo Florestal, Manaus, Amazonas, Brazil; [Araujo, Raquel Fernandes; Muller-Landau, Helene C.; Gimenez, Bruno Oliva] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Panama City, Panama; [Chambers, Jeffrey Q.] Univ Calif Berkeley, Geog Dept, Berkeley, CA 94720 USA; [Emmert, Fabiano] Univ Fed Rural Amazonia, Inst Ciencias Agr, Belem, Para, Brazil; [Ribeiro, Gabriel H. P. M.] Univ Fed Mato Grosso, Fac Engn Florestal, Cuiaba, Mato Grosso, Brazil	Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Berkeley; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal de Mato Grosso	Araujo, RF (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Manejo Florestal, Manaus, Amazonas, Brazil.; Araujo, RF (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Panama City, Panama.	araujo.raquelf@gmail.com	Chambers, Jeffrey Q/AAU-7097-2021; Ribeiro, Gabriel Henrique Pires de Mello/H-8948-2019	Ribeiro, Gabriel Henrique Pires de Mello/0000-0002-3343-3043; Muller-Landau, Helene C./0000-0002-3526-9021; Gimenez, Bruno/0000-0001-7336-9448	INCT Amazonian Woods (FAPEAM/CNPq); Next Generation Ecosystem Experiments-Tropics - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Coordination for the Improvement of Higher Education Personnel (CAPES)	INCT Amazonian Woods (FAPEAM/CNPq); Next Generation Ecosystem Experiments-Tropics - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed by the INCT Amazonian Woods (FAPEAM/CNPq) and by the Next Generation Ecosystem Experiments-Tropics, funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research under Contract DE-AC02-05CH11231. Fellowship support for RFA was provided from Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder D, 2000, FOREST ECOL MANAG, V130, P141, DOI 10.1016/S0378-1127(99)00196-6; Bastin JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13156; Bohlman S, 2012, J ECOL, V100, P508, DOI 10.1111/j.1365-2745.2011.01935.x; Bohlman SA, 2015, ECOSYSTEMS, V18, P658, DOI 10.1007/s10021-015-9854-0; BROWN IF, 1995, FOREST ECOL MANAG, V75, P175, DOI 10.1016/0378-1127(94)03512-U; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cano IM, 2019, BIOGEOSCIENCES, V16, P847, DOI 10.5194/bg-16-847-2019; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Farrior CE, 2016, SCIENCE, V351, P155, DOI 10.1126/science.aad0592; Fisher RA, 2018, GLOBAL CHANGE BIOL, V24, P35, DOI 10.1111/gcb.13910; Getzin S, 2014, REMOTE SENS-BASEL, V6, P6988, DOI 10.3390/rs6086988; Goncalves NB, 2020, REMOTE SENS ENVIRON, V237, DOI 10.1016/j.rse.2019.111489; Herwitz SR, 2000, ECOLOGY, V81, P585, DOI 10.1890/0012-9658(2000)081[0585:LTSACA]2.0.CO;2; Higuchi F. G., 2012, Floresta, V42, P599; Higuchi N, 2016, ECOL STUD-ANAL SYNTH, V227, P171, DOI 10.1007/978-3-662-49902-3_9; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Johnson NL, 1994, CONTINUOUS UNIVARIAT, DOI [10.2307/1269751, DOI 10.2307/1269751]; Kabakoff RP, 1996, J TROP ECOL, V12, P779, DOI 10.1017/S0266467400010038; Kattenborn T, 2019, REMOTE SENS ENVIRON, V227, P61, DOI 10.1016/j.rse.2019.03.025; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; Kitajima K, 2005, ANN BOT-LONDON, V95, P535, DOI 10.1093/aob/mci051; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lutz JA, 2018, GLOBAL ECOL BIOGEOGR, V27, P849, DOI 10.1111/geb.12747; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Meakem V, 2018, NEW PHYTOL, V219, P947, DOI 10.1111/nph.14633; Morton DC, 2016, BIOGEOSCIENCES, V13, P2195, DOI 10.5194/bg-13-2195-2016; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Park JY, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11131534; PARRESOL BR, 1995, FOREST ECOL MANAG, V73, P211, DOI 10.1016/0378-1127(94)03486-G; Poorter L, 2005, J ECOL, V93, P256, DOI 10.1111/j.1365-2745.2004.00956.x; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE, V1; Rutishauser E, 2020, GLOBAL CHANGE BIOL, V26, P1485, DOI 10.1111/gcb.14833; Sheil D, 2006, J ECOL, V94, P494, DOI 10.1111/j.1365-2745.2006.01111.x; Shugart HH, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000993; Silva R.P., 2007, ALOMETRIA ESTOQUE DI; Stark SC, 2015, ECOL LETT, V18, P636, DOI 10.1111/ele.12440; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Suomalainen J, 2014, REMOTE SENS-BASEL, V6, P11013, DOI 10.3390/rs61111013; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Zahawi RA, 2015, BIOL CONSERV, V186, P287, DOI 10.1016/j.biocon.2015.03.031	52	5	5	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243079	10.1371/journal.pone.0243079	http://dx.doi.org/10.1371/journal.pone.0243079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301487	Green Published, gold			2022-12-26	WOS:000600143100042
J	von Jeinsen, B; Vasan, RS; McManus, DD; Mitchell, GF; Cheng, SS; Xanthakis, V				von Jeinsen, Beatrice; Vasan, Ramachandran S.; McManus, David D.; Mitchell, Gary F.; Cheng, Susan; Xanthakis, Vanessa			Joint influences of obesity, diabetes, and hypertension on indices of ventricular remodeling: Findings from the community-based Framingham Heart Study	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; HYPERTROPHY; FAILURE; ECHOCARDIOGRAPHY; GEOMETRY; IMPACT; RECOMMENDATIONS; ASSOCIATION; PREVALENCE	Introduction Obesity, hypertension, and diabetes are independently associated with cardiac remodeling and frequently co-cluster. The conjoint and separate influences of these conditions on cardiac remodeling have not been investigated. Materials and methods We evaluated 5,741 Framingham Study participants (mean age 50 years, 55% women) who underwent echocardiographic measurements of left ventricular (LV) mass (LVM), LV ejection fraction (LVEF), global longitudinal strain (GLS), mitral E/e', left atrial end-systolic (peak) dimension (LASD) and emptying fraction (LAEF). We used multivariable generalized linear models to estimate the adjusted-least square means of these measures according to cross-classified categories of body mass index (BMI; normal, overweight and obese), hypertension (yes/no), and diabetes (yes/no). Results We observed statistically significant interactions of BMI category, hypertension, and diabetes with LVM, LVEF, GLS, and LAEF (p for all 3-way interactions <0.01). Overweight and obesity (compared to normal BMI), hypertension, and diabetes status were individually and conjointly associated with higher LVM and worse GLS (p<0.01 for all). We observed an increase of 34% for LVM and of 9% for GLS between individuals with a normal BMI and without hypertension or diabetes compared to obese individuals with hypertension and diabetes. Presence of hypertension was associated with higher LVEF, whereas people with diabetes had lower LVEF. Conclusions Obesity, hypertension, and diabetes interact synergistically to influence cardiac remodeling. These findings may explain the markedly heightened risk of heart failure and cardiovascular disease when these factors co-cluster.	[von Jeinsen, Beatrice; Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ & Natl Heart Lung & Blood Inst Farmin, Framingham, MA 01701 USA; [Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [McManus, David D.] Univ Massachusetts, Med Ctr, Dept Med, Div Cardiovasc Med, Worcester, MA USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [Cheng, Susan] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Xanthakis, Vanessa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA	Boston University; Boston University; Boston University; University of Massachusetts System; University of Massachusetts Worcester; Cardiovascular Engineering; Cedars Sinai Medical Center; Boston University	Xanthakis, V (corresponding author), Boston Univ & Natl Heart Lung & Blood Inst Farmin, Framingham, MA 01701 USA.; Xanthakis, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA.; Xanthakis, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.; Xanthakis, V (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA.	vanessax@bu.edu		Ramachandran, Vasan/0000-0001-7357-5970; Xanthakis, Vanessa/0000-0002-7352-621X; Cheng, Susan/0000-0002-4977-036X	National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC25195, HHSN268201500001I]; German Heart Foundation/German Foundation of Heart Research; Cardiovascular Engineering., Inc;  [R01HL131532];  [R01HL134168];  [2K24-HL04334]	National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Heart Foundation/German Foundation of Heart Research; Cardiovascular Engineering., Inc; ; ; 	This work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contracts N01-HC25195 and HHSN268201500001I) and by grants R01HL131532 (SC), R01HL134168 (SC); and 2K24-HL04334. Beatrice von Jeinsen was supported by the German Heart Foundation/German Foundation of Heart Research. Gary F. Mitchell was supported by Cardiovascular Engineering., Inc; this funder provided support in the form of salary for Gary F. Mitchell and various employees of Cardiovascular Engineering, Inc., who are involved in analysis of hemodynamic data. The aforementioned salary support is derived from the various NIH grants that supported the study. Cardiovascular Engineering, Inc., did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript outside of the work done through these NIH grants. The specific role of this author is articulated in the `author contributions' section. There was no additional external funding received for this study.	Ahmed MI, 2012, JACC-CARDIOVASC IMAG, V5, P273, DOI 10.1016/j.jcmg.2011.11.013; Alpert MA, 2016, J CARDIOPULM REHABIL, V36, P1, DOI 10.1097/HCR.0000000000000147; Alpert MA, 2014, TRANSL RES, V164, P345, DOI 10.1016/j.trsl.2014.04.010; Alpert MA, 2014, PROG CARDIOVASC DIS, V56, P391, DOI 10.1016/j.pcad.2013.09.003; Andersen N H, 2003, Eur J Echocardiogr, V4, P306, DOI 10.1016/S1525-2167(03)00034-9; [Anonymous], 2017, NAT MATER, V16, P1, DOI 10.1038/nmat4841; [Anonymous], 2000, MED PEDIATR ONCOL, V35, P6; Aurigemma GP, 2013, CIRC-CARDIOVASC IMAG, V6, P142, DOI 10.1161/CIRCIMAGING.111.964627; Avelar E, 2007, HYPERTENSION, V49, P34, DOI 10.1161/01.HYP.0000251711.92482.14; Ballo P, 2010, DIABETES RES CLIN PR, V90, P209, DOI 10.1016/j.diabres.2010.08.004; Ballo P, 2010, INT J CARDIOL, V141, P316, DOI 10.1016/j.ijcard.2008.11.129; Cheng S, 2013, J AM SOC ECHOCARDIOG, V26, P1258, DOI 10.1016/j.echo.2013.07.002; Cuspidi C, 2012, J HUM HYPERTENS, V26, P343, DOI 10.1038/jhh.2011.104; Cuspidi C, 2014, J HYPERTENS, V32, P16, DOI 10.1097/HJH.0b013e328364fb58; de Simone G, 2000, CIRCULATION, V101, P152, DOI 10.1161/01.CIR.101.2.152; de Simone G, 2002, J HYPERTENS, V20, P323, DOI 10.1097/00004872-200202000-00024; de Simone G, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0193-x; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diez J, 2010, HYPERTENSION, V55, P1, DOI 10.1161/HYPERTENSIONAHA.109.141887; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Eguchi K, 2005, AM J HYPERTENS, V18, P23, DOI 10.1016/j.amjhyper.2004.08.024; Ernande L, 2017, J AM COLL CARDIOL, V70, P1704, DOI 10.1016/j.jacc.2017.07.792; Holscher ME, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122136; Hu K, 2013, EUR HEART J-CARD IMG, V14, P205, DOI 10.1093/ehjci/jes240; Kaess BM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002693; KANNEL WB, 1972, NEW ENGL J MED, V287, P782; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB, 1987, FRAMINGHAM STUDY EPI, P2703; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kindel TL, 2018, SURG OBES RELAT DIS, V14, P117, DOI 10.1016/j.soard.2017.09.534; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; LAUER MS, 1992, J AM COLL CARDIOL, V19, P130, DOI 10.1016/0735-1097(92)90063-S; Lembo M, 2016, J HYPERTENS, V34, P1201, DOI 10.1097/HJH.0000000000000906; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Lorenzo-Almoros A, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0506-x; Mahajan R, 2015, TRENDS CARDIOVAS MED, V25, P119, DOI 10.1016/j.tcm.2014.09.005; Marwick TH, 2018, J AM COLL CARDIOL, V71, P339, DOI 10.1016/j.jacc.2017.11.019; Messerli Franz H, 2017, JACC Heart Fail, V5, P543, DOI 10.1016/j.jchf.2017.04.012; Milani RV, 2006, AM J CARDIOL, V97, P959, DOI 10.1016/j.amjcard.2005.10.030; Ojji Dike B, 2009, Prev Cardiol, V12, P184, DOI 10.1111/j.1751-7141.2009.00033.x; Oktay AA, 2016, PROG CARDIOVASC DIS, V59, P235, DOI 10.1016/j.pcad.2016.09.001; Park J, 2011, J HYPERTENS, V29, P1765, DOI 10.1097/HJH.0b013e32834a50f3; Quan SF, 1997, SLEEP, V20, P1077; Raman SV, 2010, J AM COLL CARDIOL, V55, P91, DOI 10.1016/j.jacc.2009.07.059; Rider OJ, 2013, INT J CARDIOL, V167, P2989, DOI 10.1016/j.ijcard.2012.08.049; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Santos M, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0428-x; Scheurich JJ, 2017, INT J QUAL STUD EDUC, V30, P904, DOI 10.1080/09518398.2017.1399666; Selvaraj S, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004396; Shah AM, 2012, EUR HEART J, V33, P1716, DOI 10.1093/eurheartj/ehs124; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Sundstroma J, 2004, EUR HEART J, V25, P523, DOI 10.1016/j.ehj.2004.01.008; Suto M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0632-5; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tromba L, 2017, OBES SURG, V27, P1145, DOI 10.1007/s11695-016-2441-4; Tsao CW, 2016, JACC-HEART FAIL, V4, P502, DOI 10.1016/j.jchf.2016.03.003; Varma U, 2018, BBA MOL BASIS DIS; Wang QQ, 2015, J CLIN ULTRASOUND, V43, P502, DOI 10.1002/jcu.22268; Wierzbowska-Drabik K, 2013, ECHOCARDIOGR-J CARD, V30, P904, DOI 10.1111/echo.12164	60	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243199	10.1371/journal.pone.0243199	http://dx.doi.org/10.1371/journal.pone.0243199			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301464	Green Published, gold			2022-12-26	WOS:000600143100040
J	Cunningham, J; Thuijsman, F; Peeters, R; Viossat, Y; Brown, J; Gatenby, R; Stankova, K				Cunningham, Jessica; Thuijsman, Frank; Peeters, Ralf; Viossat, Yannick; Brown, Joel; Gatenby, Robert; Stankova, Katerina			Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer	PLOS ONE			English	Article							INTERMITTENT ANDROGEN SUPPRESSION; GAME-THEORY; MATHEMATICAL-MODEL; CLONAL EVOLUTION; TUMOR-GROWTH; CHEMOTHERAPY; SURVIVAL; DYNAMICS; THERAPY; HETEROGENEITY	In the absence of curative therapies, treatment of metastatic castrate-resistant prostate cancer (mCRPC) using currently available drugs can be improved by integrating evolutionary principles that govern proliferation of resistant subpopulations into current treatment protocols. Here we develop what is coined as an 'evolutionary stable therapy', within the context of the mathematical model that has been used to inform the first adaptive therapy clinical trial of mCRPC. The objective of this therapy is to maintain a stable polymorphic tumor heterogeneity of sensitive and resistant cells to therapy in order to prolong treatment efficacy and progression free survival. Optimal control analysis shows that an increasing dose titration protocol, a very common clinical dosing process, can achieve tumor stabilization for a wide range of potential initial tumor compositions and volumes. Furthermore, larger tumor volumes may counter intuitively be more likely to be stabilized if sensitive cells dominate the tumor composition at time of initial treatment, suggesting a delay of initial treatment could prove beneficial. While it remains uncertain if metastatic disease in humans has the properties that allow it to be truly stabilized, the benefits of a dose titration protocol warrant additional pre-clinical and clinical investigations.	[Cunningham, Jessica; Brown, Joel; Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA; [Cunningham, Jessica; Thuijsman, Frank; Peeters, Ralf; Stankova, Katerina] Maastricht Univ, Dept Data Sci & Knowledge Engn, Maastricht, Netherlands; [Viossat, Yannick] Univ Paris 09, Univ PSL, CEREMADE, Paris, France; [Brown, Joel] Univ Illinois, Dept Biol Sci, Chicago, IL USA; [Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Diagnost Imaging & Intervent Radiol, Tampa, FL USA; [Stankova, Katerina] Delft Univ Technol, Delft Inst Appl Math, Delft, Netherlands	H Lee Moffitt Cancer Center & Research Institute; Maastricht University; UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; H Lee Moffitt Cancer Center & Research Institute; Delft University of Technology	Cunningham, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA.; Cunningham, J (corresponding author), Maastricht Univ, Dept Data Sci & Knowledge Engn, Maastricht, Netherlands.	jessica.cunningham@moffitt.org		Cunningham, Jessica/0000-0001-8704-8848; Stankova, Katerina/0000-0002-4519-0325; Peeters, Ralf/0000-0002-9973-8181	European Union [690817]; Dutch National Foundation (NWO) Visitor's Travel Grant [040.11.712]; James S. McDonnell Foundation grant; Cancer therapy: Perturbing a complex adaptive system; V Foundation grant; NIH/National Cancer Institute (NCI) [R01CA170595]; Application of Evolutionary Principles to Maintain Cancer Control (PQ21); NIH/NCI [U54CA143970-05]; FMJH "Program Gaspard Monge for optimization and operation research and their interactions with data science"; EDF; Thales; Orange; Criteo	European Union(European Commission); Dutch National Foundation (NWO) Visitor's Travel Grant; James S. McDonnell Foundation grant; Cancer therapy: Perturbing a complex adaptive system; V Foundation grant; NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Application of Evolutionary Principles to Maintain Cancer Control (PQ21); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FMJH "Program Gaspard Monge for optimization and operation research and their interactions with data science"; EDF(Electricite de France (EDF)); Thales(Thales Group); Orange; Criteo	This research was supported by the European Union's Horizon 2020 research and innovation program under the Marie SklodowskaCurie grant agreement No 690817, the Dutch National Foundation (NWO) Visitor's Travel Grant number 040.11.712, the James S. McDonnell Foundation grant, Cancer therapy: Perturbing a complex adaptive system, a V Foundation grant, NIH/National Cancer Institute (NCI) R01CA170595, Application of Evolutionary Principles to Maintain Cancer Control (PQ21), and NIH/NCI U54CA143970-05 [Physical Science Oncology Network (PSON)] Cancer as a complex adaptive system. This research benefited from the support of the FMJH "Program Gaspard Monge for optimization and operation research and their interactions with data science"and from the support from EDF, Thales, Orange and Criteo.	[Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Archetti M, 2013, BRIT J CANCER, V109, P1056, DOI 10.1038/bjc.2013.336; Archetti M, 2015, P NATL ACAD SCI USA, V112, P1833, DOI 10.1073/pnas.1414653112; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Bacevic K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01516-1; Bach LA, 2001, EUR J CANCER, V37, P2116, DOI 10.1016/S0959-8049(01)00246-5; Barzman M, 2015, AGRON SUSTAIN DEV, V35, P1199, DOI 10.1007/s13593-015-0327-9; Basanta D, 2012, BRIT J CANCER, V106, P174, DOI 10.1038/bjc.2011.517; Bayer P, 2018, J THEOR BIOL, V455, P191, DOI 10.1016/j.jtbi.2018.07.014; Bekaii-Saab TS, 2018, J CLIN ONCOL, V36, P3932; Carrere C, 2017, J THEOR BIOL, V413, P24, DOI 10.1016/j.jtbi.2016.11.009; Cleveland C, 2012, AIP ADV, V2, DOI 10.1063/1.3699043; Craig M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007278; Cross WCH, 2016, J PATHOL, V240, P126, DOI 10.1002/path.4757; Cunningham JJ, 2018, J THEOR BIOL, V459, P67, DOI 10.1016/j.jtbi.2018.09.022; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dhawan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00791-8; Dingli D, 2009, CANCER GENE THER, V16, P873, DOI 10.1038/cgt.2009.40; Dingli D, 2009, BRIT J CANCER, V101, P1130, DOI 10.1038/sj.bjc.6605288; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Evans JM, 2016, EUR J CANCER CARE, V25, P883, DOI 10.1111/ecc.12408; Fischer A, 2015, P NATL ACAD SCI USA, V112, P1007, DOI 10.1073/pnas.1409403112; Fizazi K, 2019, LANCET ONCOL, V20, P686, DOI 10.1016/S1470-2045(19)30082-8; Fox JJ, 2018, JAMA ONCOL, V4, P217, DOI 10.1001/jamaoncol.2017.3588; Freischel AR, 2020, BIORXIV; Gallaher J, 2014, CLIN EXP METASTAS, V31, P991, DOI 10.1007/s10585-014-9674-1; Gallaher JA, 2018, CANCER RES, V78, P2127, DOI 10.1158/0008-5472.CAN-17-2649; Gatenby RA, 2003, MOL CANCER THER, V2, P919; Gatenby RA, 2019, CANC RES; Gatenby RA, 2019, CANCER RES, V79, P3174, DOI 10.1158/0008-5472.CAN-19-0807; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gerlee P, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0342; Gluzman M, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2454; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grolmusz VK, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01337-1; HANSEN E, 2019, BIORXIV, DOI DOI 10.1101/638924; Hansen E, 2020, EVOL APPL, V13, P1660, DOI 10.1111/eva.12994; Heller G, 2018, J CLIN ONCOL, V36, P572, DOI 10.1200/JCO.2017.75.2998; Hirata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20788-1; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huss M, 2017, NEUROPSYCH DIS TREAT, V13, P1741, DOI 10.2147/NDT.S130444; Ideta AM, 2008, J NONLINEAR SCI, V18, P593, DOI 10.1007/s00332-008-9031-0; Jackson TL, 2004, NEOPLASIA, V6, P697, DOI 10.1593/neo.04259; Jackson TL, 2004, DISCRETE CONT DYN-B, V4, P187; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Jemal A, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx030; Jolly MK, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00050; Kaplan DE, 2017, UP TITRATION SORAFEN; Kaznatcheev A, 2019, NAT ECOL EVOL, V3, P450, DOI 10.1038/s41559-018-0768-z; Kaznatcheev A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0154; Koch H, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00017; Koo KM, 2019, NAT REV UROL, V16, P302, DOI 10.1038/s41585-019-0178-2; Lankau RA, 2011, ANNU REV ECOL EVOL S, V42, P335, DOI 10.1146/annurev-ecolsys-102710-145100; Leung CY, 2017, J THEOR BIOL, V429, P241, DOI 10.1016/j.jtbi.2017.06.037; MARTIN RB, 1992, MATH BIOSCI, V110, P201, DOI 10.1016/0025-5564(92)90038-X; Maynard Smith J., 1982, pi; McAsey M, 2012, COMPUT OPTIM APPL, V53, P207, DOI 10.1007/s10589-011-9454-7; McEvoy JW, 2009, BRIT J CANCER, V101, P2060, DOI 10.1038/sj.bjc.6605444; Mercadante S, 2007, EUR J PAIN, V11, P823, DOI 10.1016/j.ejpain.2007.01.003; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Nakazawa M, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0568-7; Nam A, 2020, BIORXIV; Nanda M, 2017, P NATL ACAD SCI USA, V114, P6046, DOI 10.1073/pnas.1620852114; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nielsen MK, 2012, VET PARASITOL, V185, P32, DOI 10.1016/j.vetpar.2011.10.012; Orlando PA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/065007; Pacheco JM, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0019; Pouchol C, 2018, J MATH PURE APPL, V116, P268, DOI 10.1016/j.matpur.2017.10.007; Rini BI, 2013, LANCET ONCOL, V14, P1233, DOI 10.1016/S1470-2045(13)70464-9; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Roden DM, 1995, PRINCIPLES CLIN PHAR; Sandrock C, 2020, PLOT TERNARY DIAGRAM; Scher HI, 2015, J CLIN ONCOL, V33, P1348, DOI 10.1200/JCO.2014.55.3487; Shimada T, 2008, MATH BIOSCI, V214, P134, DOI 10.1016/j.mbs.2008.03.001; Smalley I, 2019, EBIOMEDICINE, V48, P178, DOI 10.1016/j.ebiom.2019.09.023; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Stankova K, 2019, NAT ECOL EVOL, V3, P336, DOI 10.1038/s41559-018-0785-y; Strauss SY, 2014, OIKOS, V123, P257, DOI 10.1111/j.1600-0706.2013.01093.x; SWAN GW, 1988, IMA J MATH APPL MED, V5, P303; SWAN GW, 1977, B MATH BIOL, V39, P317, DOI 10.1016/S0092-8240(77)80070-0; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; SWAN GW, 1980, INT J SYST SCI, V11, P223, DOI 10.1080/00207728008967009; SWAN GW, 1986, B MATH BIOL, V48, P381, DOI 10.1007/BF02459688; Swierniak A, 2019, MATH BIOSCI ENG, V16, P265, DOI 10.3934/mbe.2019014; Swierniak A, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0156-z; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tao YS, 2010, J NONLINEAR SCI, V20, P219, DOI 10.1007/s00332-009-9056-z; Thomas F, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2007066; Tomlinson IPM, 1997, EUR J CANCER, V33, P1495, DOI 10.1016/S0959-8049(97)00170-6; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Verbel DA, 2002, CLIN CANCER RES, V8, P2576; Vincent TL, 2005, INT GAME THEORY REV, V7, P331, DOI 10.1142/S0219198905000557; Viossat Y, 2020, LOGIC CONTAINING TUM, DOI [10.1101/2020.01.22.915355, DOI 10.1101/2020.01.22.915355]; Wang S, 2016, MATH BIOSCI ENG, V13, P1223, DOI 10.3934/mbe.2016040; West J, 2018, J BIORXIV, DOI [10.1101/476507, DOI 10.1101/476507]; West J, 2018, J THEOR BIOL, V455, P249, DOI 10.1016/j.jtbi.2018.07.028; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964; Yoon N, 2018, B MATH BIOL, V80, P1776, DOI 10.1007/s11538-018-0434-2; You L, 2017, J THEOR BIOL, V435, P78, DOI 10.1016/j.jtbi.2017.08.022; ZHANG JS, 2019, J CLIN ONCOL S, V37; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]	104	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243386	10.1371/journal.pone.0243386	http://dx.doi.org/10.1371/journal.pone.0243386			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290430	Green Published, gold			2022-12-26	WOS:000598620100010
J	Calvez, R; Taylor, A; Calvo-Bado, L; Fraser, D; Fink, CG				Calvez, Ronan; Taylor, Andrew; Calvo-Bado, Leonides; Fraser, Donald; Fink, Colin G.			Molecular detection of SARS-CoV-2 using a reagent-free approach	PLOS ONE			English	Article								Shortage of reagents and consumables required for the extraction and molecular detection of SARS-CoV-2 RNA in respiratory samples has led many laboratories to investigate alternative approaches for sample preparation. Many groups recently presented results using heat processing method of respiratory samples prior to RT-qPCR as an economical method enabling an extremely fast streamlining of the processes at virtually no cost. Here, we present our results using this method and highlight some major pitfalls that diagnostics laboratories should be aware of before proceeding with this methodology. We first investigated various treatments using different temperatures, incubation times and sample volumes to optimise the heat treatment conditions. Although the initial data confirmed results published elsewhere, further investigations revealed unexpected inhibitory properties of some commonly used universal transport media (UTMs) on some commercially available RT-qPCR mixes, leading to a risk of reporting false-negative results. This emphasises the critical importance of a thorough validation process to determine the most suitable reagents to use depending on the sample types to be tested. In conclusion, a heat processing method is effective with very consistent Ct values and a sensitivity of 96.2% when compared to a conventional RNA extraction method. It is also critical to include an internal control to check each sample for potential inhibition.	[Calvez, Ronan; Taylor, Andrew; Calvo-Bado, Leonides; Fraser, Donald; Fink, Colin G.] Univ Warwick, Micropathol Ltd, Sci Pk, Coventry, W Midlands, England	University of Warwick	Calvez, R (corresponding author), Univ Warwick, Micropathol Ltd, Sci Pk, Coventry, W Midlands, England.	r.calvez@micropathology.com		Fraser, Donald/0000-0002-5951-6365				Alcoba-Florez J, 2020, INT J INFECT DIS, V97, P66, DOI 10.1016/j.ijid.2020.05.099; Bruce Emily A, 2020, bioRxiv, DOI 10.1101/2020.03.20.001008; CDC, RES US ONL 2019 NOV; Fomsgaard AS, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.14.2000398; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Levett LJ., 2020, EXTRACTION FREE COVI, P1, DOI 10.1101/2020.04.06.028316; R Core Team, 2021, R LANGUAGE ENV STAT; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243266	10.1371/journal.pone.0243266	http://dx.doi.org/10.1371/journal.pone.0243266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284857	Green Published, Green Submitted, gold			2022-12-26	WOS:000597930500017
J	Li, HF; Liang, XQ; Zhou, BJ; Chen, XP; Hong, YB; Zhou, R; Li, SX; Liu, HY; Lu, Q; Liu, H; Wu, H				Li, Haifen; Liang, Xuanqiang; Zhou, Baojin; Chen, Xiaoping; Hong, Yanbin; Zhou, Ruo; Li, Shaoxiong; Liu, Haiyan; Lu, Qing; Liu, Hao; Wu, Hong			A proteomic analysis of peanut seed at different stages of underground development to understand the changes of seed proteins	PLOS ONE			English	Article							ARA H 1; ARACHIS-HYPOGAEA; METABOLISM; REVEALS; EXPRESSION; ALLERGY; STORAGE; AERIAL; GENES; POD	In order to obtain more valuable insights into the protein dynamics and accumulation of allergens in seeds during underground development, we performed a proteomic study on developing peanut seeds at seven different stages. A total of 264 proteins with altered abundance and contained at least one unique peptide was detected by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF MS). All identified proteins were classified into five functional categories as level 1 and 20 secondary functional categories as level 2. Among them, 88 identified proteins (IPs) were related to carbohydrate/ amino acid/ lipid transport and metabolism, indicating that carbohydrate/amino acid/ lipid metabolism played a key role in the underground development of peanut seeds. Hierarchical cluster analysis showed that all IPs could be classified into eight cluster groups according to the abundance profiles, suggesting that the modulatory patterns of these identified proteins were complicated during seed development. The largest group contained 41 IPs, the expression of which decreased at R 2 and reached a maximum at R3 but gradually decreased from R4. A total of 14 IPs were identified as allergen-like proteins by BLAST with A genome (Arachis duranensis) or B genome (Arachis ipaensis) translated allergen sequences. Abundance profile analysis of 14 identified allergens showed that the expression of all allergen proteins was low or undetectable by 2-DE at the early stages (R1 to R4), and began to accumulate from the R5 stage and gradually increased. Network analysis showed that most of the significant proteins were involved in active metabolic pathways in early development. Real time RT-PCR analysis revealed that transcriptional regulation was approximately consistent with expression at the protein level for 8 selected identified proteins. In addition, some amino acid sequences that may be associated with new allergens were also discussed.	[Li, Haifen; Wu, Hong] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Peoples R China; [Li, Haifen; Liang, Xuanqiang; Chen, Xiaoping; Hong, Yanbin; Li, Shaoxiong; Liu, Haiyan; Lu, Qing; Liu, Hao] Guangdong Acad Agr Sci GAAS, Crops Res Inst, South China Peanut Subctr, Natl Ctr Oilseed Crops Improvement,Guangdong Key, Guangzhou, Peoples R China; [Zhou, Baojin; Zhou, Ruo] Deepxomics Co Ltd, Tech Serv Dept, Shenzhen, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Wu, H (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Peoples R China.	wh@scau.edu.au		Lu, Qing/0000-0001-6287-553X; Zhou, Baojin/0000-0002-8255-3439	National Natural Science Foundation of China [31801401, 31771841]; Open Fund of Guangdong Key Laboratory of Crop Genetic Improvement [2017B030314090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of Guangdong Key Laboratory of Crop Genetic Improvement	This project was supported by the National Natural Science Foundation of China (31801401 and 31771841) to QL and XC, the Open Fund of Guangdong Key Laboratory of Crop Genetic Improvement (2017B030314090) to HL.	Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Aguirre M, 2018, PLANT REPROD, V31, P263, DOI 10.1007/s00497-018-0336-3; Al-Muhsen S, 2003, CAN MED ASSOC J, V168, P1279; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Bourgeois M, 2009, PROTEOMICS, V9, P254, DOI 10.1002/pmic.200700903; Cai BB, 2016, PLANT PHYSIOL BIOCH, V108, P251, DOI 10.1016/j.plaphy.2016.07.019; Chen XP, 2016, PLANT BIOTECHNOL J, V14, P1215, DOI 10.1111/pbi.12487; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Chruszcz M, 2011, J BIOL CHEM, V286, P39318, DOI 10.1074/jbc.M111.270132; Comstock SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157849; Duan EC, 2016, PLANT CELL REP, V35, P1321, DOI 10.1007/s00299-016-1964-4; Gallardo K, 2003, PLANT PHYSIOL, V133, P664, DOI 10.1104/pp.103.025254; Gallardo K, 2007, MOL CELL PROTEOMICS, V6, P2165, DOI 10.1074/mcp.M700171-MCP200; Guo L, 2014, PLANT CELL, V26, P3023, DOI 10.1105/tpc.114.126946; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Hashiguchi A, 2017, METHOD ENZYMOL, V586, P97, DOI 10.1016/bs.mie.2016.09.030; Hernandez-Sebastia C, 2005, J EXP BOT, V56, P1951, DOI 10.1093/jxb/eri191; Kim Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111271; Kottapalli KR, 2008, PLANT SCI, V175, P321, DOI 10.1016/j.plantsci.2008.05.005; Krishnan HB, 2009, PROTEOMICS, V9, P3174, DOI 10.1002/pmic.200800875; Li HF, 2013, J PROTEOMICS, V93, P303, DOI 10.1016/j.jprot.2013.08.006; Liu F, 2015, J EXP BOT, V66, P5663, DOI 10.1093/jxb/erv313; Liu H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041235; Locascio A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00412; Malinova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112468; Moison M, 2018, J EXP BOT, V69, P4379, DOI 10.1093/jxb/ery217; Nautrup-Pedersen G, 2010, J PROTEOME RES, V9, P5715, DOI 10.1021/pr100511u; Palladino C, 2018, MOL IMMUNOL, V100, P58, DOI 10.1016/j.molimm.2018.04.005; Payton P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-265; Petersen A, 2015, J ALLERGY CLIN IMMUN, V136, P1295, DOI 10.1016/j.jaci.2015.04.010; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Savadi S, 2018, PLANT GROWTH REGUL, V84, P401, DOI 10.1007/s10725-017-0355-3; Sebei K, 2013, BIOL RES, V46, P257, DOI 10.4067/S0716-97602013000300006; SHUSHU DD, 1990, CAN J BOT, V68, P965, DOI 10.1139/b90-123; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; SMITH BW, 1950, AM J BOT, V37, P802, DOI 10.2307/2437758; Stein Ofer, 2016, Front Plant Sci, V7, P2047, DOI 10.3389/fpls.2016.02047; TELLMANN G, 2006, BIOCHEMICA MANNHEIM, V4, P16; Toomer OT, 2018, CRIT REV FOOD SCI, V58, P3042, DOI 10.1080/10408398.2017.1339015; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x; Villalta D, 2018, EUR ANN ALLERGY CLIN, V50, P51, DOI 10.23822/EurAnnACI.1764-1489.32; Wang L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3193-1; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061722; Watson BS, 2003, PLANT PHYSIOL, V131, P1104, DOI 10.1104/pp.102.019034; Weigelt K, 2008, PLANT J, V55, P909, DOI 10.1111/j.1365-313X.2008.03560.x; Wilson KA, 2015, PLANT PHYSIOL BIOCH, V96, P301, DOI 10.1016/j.plaphy.2015.08.008; Wood RA, 2013, ALLERGY, V68, P803, DOI 10.1111/all.12158; Zhang EH, 2011, ELECTROPHORESIS, V32, P696, DOI 10.1002/elps.201000557; Zhen Y, 2012, PLANT PHYSIOL BIOCH, V54, P97, DOI 10.1016/j.plaphy.2012.02.009; Zhu W, 2013, J PROTEOMICS, V91, P172, DOI 10.1016/j.jprot.2013.07.002	51	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243132	10.1371/journal.pone.0243132	http://dx.doi.org/10.1371/journal.pone.0243132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284814	gold, Green Published			2022-12-26	WOS:000597930500054
J	Hashimoto, S; Maoka, T; Kawata, T; Mochizuki, T; Koike, T; Shigematsu, T				Hashimoto, Seiji; Maoka, Tomochika; Kawata, Tetsuya; Mochizuki, Toshio; Koike, Takao; Shigematsu, Takashi			Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; SMOOTH-MUSCLE; PIOGLITAZONE; MICE; RESISTANCE; PHOSPHORYLATION; HYPERGLYCEMIA; SENSITIVITY; DISRUPTION	We have reported previously that renal hemodynamic abnormalities exist in the prediabetic stage of type II diabetic rats. At this prediabetic stage these rats have hyperinsulinemia, insulin resistance and metabolic syndrome. It is well known that insulin resistance is frequently associated with renal abnormalities, but the mechanism underlying this association has remained speculative. Although insulin is known to modify renal hemodynamics, little is known about the roles of insulin receptor substrates (IRS1, IRS2) in the renal actions of insulin. To address this issue, the effects of insulin on renal function and renal hemodynamics were investigated in C57BL/6 (WT: wild type), insulin receptor substrate 1- knockout (IRS1-/-), and IRS2-knockout (IRS2-/-) mice. IRS2-/-mice had elevated glucose level as expected. 24-h urine collections and serum creatinine revealed that creatinine clearance did not significantly differ between these groups. Albuminuria was found in IRS1-/-and IRS2-/-groups. We examined the effects on the IRS during the administration of Losartan, which is widely used for diabetic nephropathy. After the administration of Losartan the IRS displayed improved renal hemodynamics. Moreover, the subjects were also given Pioglitazone, which improves insulin resistance. Losartan significantly reduced albuminuria in both groups. Pioglitazone also showed similar results. We assessed the autoregulatory responses of the total renal blood flow (RBF), the superficial (SBF) and the deep renal cortical blood flow (DBF) with stepwise reductions of renal perfusion pressure (RPP), which was induced by a manual clamp on the abdominal aorta. During the clamp induced reductions of the RPP by 10 to 20mm HG, RBF, SBF and the DBF fell significantly more in the IRS1 and IRS2 than in the WT mice. Furthermore micropuncture studies showded that compared to the WT tubuloglomerular feedback (TGF) responses of the stop flow pressure (P-sf) were reduced in both the IRS1 -/- and IRS2 -/-. The results of the IRS1 and IRS2 mice displayed the pressence of hemodynamic abnormalities. Losartan and Pioglitazone have shown the potential to improve these abnormalities. In conclusion the results indicate that IRS plays a major role in the stimulation of renal functions and renal hemodynamics in type type II diabetes.	[Hashimoto, Seiji] Kinan Hosp, Dept Nephrol, Tanabe, Wakayama Prefec, Japan; [Maoka, Tomochika; Koike, Takao] NTT East Japan Sapporo Hosp, Dept Nephrol, Chuou Ku, Sapporo, Hokkaido, Japan; [Kawata, Tetsuya; Mochizuki, Toshio] Hokkaido Univ, Grad Sch Med, Internal Med 2, Kita Ku, Sapporo, Hokkaido, Japan; [Shigematsu, Takashi] Wakayama Med Univ, Dept Nephrol, Wakayama, Wakayama Prefec, Japan; [Mochizuki, Toshio] Tokyo Womens Med Univ, Dept Internal Med 4, Tokyo, Japan	Hokkaido University; Wakayama Medical University; Tokyo Women's Medical University	Hashimoto, S (corresponding author), Kinan Hosp, Dept Nephrol, Tanabe, Wakayama Prefec, Japan.	seijinih@med.hokudai.ac.jp		Hashimoto, Seiji/0000-0002-6404-9503				Ahmad J, 2015, DIABETES METAB SYND, V9, P343, DOI 10.1016/j.dsx.2015.02.008; Andronico G, 2002, KIDNEY INT, V62, P1005, DOI 10.1046/j.1523-1755.2002.00529.x; Asano T, 2007, BIOL PHARM BULL, V30, P1610, DOI 10.1248/bpb.30.1610; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Chan DT, 2017, NEPHROL DIAL TRANSPL, V32, P1274, DOI 10.1093/ndt/gfv326; Clough MH, 2005, J HISTOCHEM CYTOCHEM, V53, P603, DOI 10.1369/jhc.4A6590.2005; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; DEFRONZO RA, 1983, DIABETES, V32, P35, DOI 10.2337/diab.32.1.35; DEFRONZO RA, 1978, P NATL ACAD SCI USA, V75, P5173, DOI 10.1073/pnas.75.10.5173; Dengel DR, 1996, HYPERTENSION, V28, P127, DOI 10.1161/01.HYP.28.1.127; DUBEY RK, 1993, AM J PHYSIOL, V265, pR726, DOI 10.1152/ajpregu.1993.265.4.R726; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Hashimoto S, 2006, AM J PHYSIOL-RENAL, V290, pF888, DOI 10.1152/ajprenal.00381.2005; Hashimoto S, 2004, ACTA PHYSIOL SCAND, V181, P455, DOI 10.1111/j.1365-201X.2004.01318.x; Hashimoto S, 2009, AM J PHYSIOL-RENAL, V296, pF598, DOI 10.1152/ajprenal.00074.2008; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Masakane I, 2015, THER APHER DIAL, V19, P540, DOI 10.1111/1744-9987.12378; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Petrica L, 2011, DIABETES RES CLIN PR, V94, P22, DOI 10.1016/j.diabres.2011.05.032; Pihl L, 2012, AM J PHYSIOL-REG I, V303, pR39, DOI 10.1152/ajpregu.00582.2011; RABKIN R, 1970, NEW ENGL J MED, V282, P182, DOI 10.1056/NEJM197001222820402; Rebholz CM, 2015, AM J NEPHROL, V42, P427, DOI 10.1159/000443746; Sarafidis Pantelis A, 2006, J Cardiometab Syndr, V1, P334, DOI 10.1111/j.1559-4564.2006.05795.x; Sentinelli F, 2006, J ENDOCRINOL, V188, P271, DOI 10.1677/joe.1.06290; Shiuchi T, 2004, HYPERTENSION, V43, P1003, DOI 10.1161/01.HYP.0000125142.41703.64; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; VALLON V, 1995, J AM SOC NEPHROL, V5, P1761; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zafiriou S, 2004, KIDNEY INT, V65, P1647, DOI 10.1111/j.1523-1755.2004.00574.x; ZUBROD CG, 1951, NEW ENGL J MED, V245, P518, DOI 10.1056/NEJM195110042451402	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242332	10.1371/journal.pone.0242332	http://dx.doi.org/10.1371/journal.pone.0242332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270683	Green Published, gold			2022-12-26	WOS:000597149100021
J	Jones, E; Wei, J; Nelson, MD; Bakir, M; Mehta, PK; Shufelt, C; Minissian, M; Sharif, B; Pepine, CJ; Handberg, E; Cook-Wiens, G; Sopko, G; Merz, CNB				Jones, Erika; Wei, Janet; Nelson, Michael D.; Bakir, May; Mehta, Puja K.; Shufelt, Chrisandra; Minissian, Margo; Sharif, Behzad; Pepine, Carl J.; Handberg, Eileen; Cook-Wiens, Galen; Sopko, George; Merz, C. Noel Bairey			N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study	PLOS ONE			English	Article							END-DIASTOLIC PRESSURE; HEART-FAILURE; ARTERY-DISEASE; CARDIOVASCULAR EVENTS; PROGNOSTIC VALUE; NATIONAL-HEART; FLOW RESERVE; BNP; RISK; MORTALITY	Background Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. Methods We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. Results Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 +/- 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). Conclusion Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF.	[Jones, Erika; Wei, Janet; Nelson, Michael D.; Bakir, May; Mehta, Puja K.; Shufelt, Chrisandra; Minissian, Margo; Sharif, Behzad; Merz, C. Noel Bairey] Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Pepine, Carl J.; Handberg, Eileen] Univ Florida, Gainesville, FL USA; [Cook-Wiens, Galen] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Sopko, George] NHLBI, Bldg 10, Bethesda, MD 20892 USA	Cedars Sinai Medical Center; State University System of Florida; University of Florida; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Merz, CNB (corresponding author), Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA.	Noel.BaireyMerz@cshs.org	Nelson, Michael Shawn/GXF-4934-2022	Sharif, Behzad/0000-0002-8945-8178; Pepine, Carl/0000-0002-6011-681X; Shufelt, Chrisandra/0000-0001-6886-9210	National Heart, Lung and Blood Institute (NHLBI) [N01HV68161, N01HV68162, N01HV68163, N01HV68164, U01HL64829, U01HL64914, U01HL64924, K23HL105787, T32HL69751, R01HL090957, R01HL33610, R01HL56921, UM1HL087366, R00HL124323, K23HL125941, K23HL127262]; National Institute on Aging (NIA) [R03AG032631]; National Center for Research Resources (NCRR) [M01RR000425]; National Center for Advancing Translational Sciences (NCATS) [UL1TR000124, UL1TR000064, UL1TR001427]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; Society for Women's Health Research (SWHR), Washington, D.C.; QMED, Inc., Laurence Harbor, NJ; Women's Guild of Cedars-Sinai; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships; Barbra Streisand Women's Cardiovascular Research and Education Program; Linda Joy Pollin Women's Heart Health Program; Erika J. Glazer Women's Heart Research Initiative; Adelson Family Foundation, Cedars-Sinai Medical Center, Los Angeles, CA; Gatorade Trust; PCORnetOne Florida Clinical Research Consortium, University of Florida, Gainesville, FL [CDRN1501-26692]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; Society for Women's Health Research (SWHR), Washington, D.C.; QMED, Inc., Laurence Harbor, NJ; Women's Guild of Cedars-Sinai; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships; Barbra Streisand Women's Cardiovascular Research and Education Program; Linda Joy Pollin Women's Heart Health Program; Erika J. Glazer Women's Heart Research Initiative; Adelson Family Foundation, Cedars-Sinai Medical Center, Los Angeles, CA; Gatorade Trust; PCORnetOne Florida Clinical Research Consortium, University of Florida, Gainesville, FL	This was supported by the National Heart, Lung and Blood Institute (NHLBI) under grant numbers N01HV68161, N01HV68162, N01HV68163, N01HV68164, U01HL64829, U01HL64914, U01HL64924, K23HL105787, T32HL69751, R01HL090957, R01HL33610, R01HL56921, UM1HL087366, R00HL124323, K23HL105787, K23HL125941, T32HL69751, K23HL127262; the National Institute on Aging (NIA) under grant number R03AG032631; the National Center for Research Resources (NCRR) under grant number M01RR000425; the National Center for Advancing Translational Sciences (NCATS) under grant numbers UL1TR000124, UL1TR000064, UL1TR001427. This work was also supported by grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; The Society for Women's Health Research (SWHR), Washington, D.C.; QMED, Inc., Laurence Harbor, NJ; The Women's Guild of Cedars-Sinai, the Edythe L. Broad, the Constance Austin Women's Heart Research Fellowships, the Barbra Streisand Women's Cardiovascular Research and Education Program, the Linda Joy Pollin Women's Heart Health Program, the Erika J. Glazer Women's Heart Research Initiative, and The Adelson Family Foundation, Cedars-Sinai Medical Center, Los Angeles, CA; the Gatorade Trust and the PCORnetOne Florida Clinical Research Consortium CDRN1501-26692Y, University of Florida, Gainesville, FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MJ, 2014, HEART FAIL CLIN, V10, P435, DOI 10.1016/j.hfc.2014.03.001; [Anonymous], 2014, BRAUNWALDS HEART DIS; Bakir M, 2016, INT J CARDIOL, V223, P936, DOI 10.1016/j.ijcard.2016.07.301; Balion CM, 2008, CLIN BIOCHEM, V41, P231, DOI 10.1016/j.clinbiochem.2007.10.005; Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; Booth RA, 2014, HEART FAIL REV, V19, P439, DOI 10.1007/s10741-014-9445-8; Britten MB, 2004, CORONARY ARTERY DIS, V15, P259, DOI 10.1097/01.mca.0000134590.99841.81; Chang AY, 2007, J AM COLL CARDIOL, V49, P109, DOI 10.1016/j.jacc.2006.10.040; D'Souza SP, 2004, PHARMACOL THERAPEUT, V101, P113, DOI 10.1016/j.pharmthera.2003.11.001; Davidson CJ, 1997, CARDIAC CATHETERIZAT, V5th, P177; Elhabyan AK, 2004, CURR MED RES OPIN, V20, P773, DOI 10.1185/030079904125003359; Emdin M, 2007, CLIN CHEM, V53, P1289, DOI 10.1373/clinchem.2006.080234; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Fradley MG, 2011, AM J CARDIOL, V108, P1341, DOI 10.1016/j.amjcard.2011.06.057; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Gremmler Bernhard, 2003, Exp Clin Cardiol, V8, P91; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hirakawa K, 2017, INT J CARDIOL, V228, P881, DOI 10.1016/j.ijcard.2016.11.054; HOLM S, 1979, SCAND J STAT, V6, P65; Horii M, 2013, J CARDIOL, V61, P410, DOI 10.1016/j.jjcc.2013.01.015; Karjalainen AH, 2004, MATURITAS, V47, P201, DOI 10.1016/S0378-5122(03)00279-2; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Lam CSP, 2011, J AM COLL CARDIOL, V58, P618, DOI 10.1016/j.jacc.2011.03.042; Liang HY, 2006, AM J CARDIOL, V97, P866, DOI 10.1016/j.amjcard.2005.09.136; Marz W, 2007, CLIN CHEM, V53, P1075, DOI 10.1373/clinchem.2006.075929; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Mishra RK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000907; Mitchell A, 2015, AM J CARDIOL, V115, P1341, DOI 10.1016/j.amjcard.2015.02.040; Nelson MD, 2018, EUR HEART J, V39, P850, DOI 10.1093/eurheartj/ehx818; Nelson MD, 2014, CIRC-CARDIOVASC IMAG, V7, P510, DOI 10.1161/CIRCIMAGING.114.001714; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Oremus M, 2014, HEART FAIL REV, V19, P471, DOI 10.1007/s10741-014-9439-6; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pepine C, 1989, HIST DEV APPL CARDIA, P3; Pepine CJ, 2014, JACC-CARDIOVASC IMAG, V7, P362, DOI 10.1016/j.jcmg.2013.11.009; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Sanchez OA, 2014, METABOLISM, V63, P475, DOI 10.1016/j.metabol.2013.11.017; Takase H, 2014, EUR J CLIN INVEST, V44, P303, DOI 10.1111/eci.12234; Taqueti VR, 2017, CIRCULATION, V136, P241, DOI 10.1161/CIRCULATIONAHA.117.028569; Taqueti VR, 2015, CIRCULATION, V131, P19, DOI 10.1161/CIRCULATIONAHA.114.011939; Taylor JA, 2006, AM HEART J, V152, P1071, DOI 10.1016/j.ahj.2006.07.010; Tschope C, 2005, EUR HEART J, V26, P2277, DOI 10.1093/eurheartj/ehi406; Uemura T, 2016, HEART VESSELS, V31, P1969, DOI 10.1007/s00380-016-0816-z; von Mering GO, 2004, CIRCULATION, V109, P722, DOI 10.1161/01.CIR.0000115525.92645.16; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233; Wei J, 2012, JACC-CARDIOVASC INTE, V5, P646, DOI 10.1016/j.jcin.2012.01.023	51	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243213	10.1371/journal.pone.0243213	http://dx.doi.org/10.1371/journal.pone.0243213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270715	Green Published, gold			2022-12-26	WOS:000597149100150
J	Manavalan, P; Minja, L; Wanda, L; Hertz, JT; Thielman, NM; Okeke, NL; Mmbaga, BT; Watt, MH				Manavalan, Preeti; Minja, Linda; Wanda, Lisa; Hertz, Julian T.; Thielman, Nathan M.; Okeke, Nwora Lance; Mmbaga, Blandina T.; Watt, Melissa H.			"It's because I think too much": Perspectives and experiences of adults with hypertension engaged in HIV care in northern Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; BURDEN; ASSOCIATION; MEDICATIONS; INTERVIEWS; INFECTION; ADHERENCE	Background Hypertension, a leading risk for cardiovascular mortality, is an important co-morbidity among people living with HIV (PLHIV). In Tanzania, hypertension prevalence among PLHIV approaches 20 to 30%. However, most patients are unaware of their diagnosis and are not receiving treatment. Understanding the barriers to hypertension care is a critical first step in developing interventions to improve cardiovascular outcomes among PLHIV in Tanzania and similar settings. Methods Between September 1(st) and November 26(th), 2018 thirteen semi structured in-depth interviews were conducted with hypertensive patients engaged in HIV care in two HIV clinics located in government health facilities in northern Tanzania. Interviews were audio-recorded, translated into English, transcribed and thematically coded using NVivo. Data analysis was conducted using applied thematic analysis. Results Participants had a median age of 54 (IQR 41-65) years. Of the 13 participants, eight stated they had used antihypertensive medication previously, but only one participant described current use of antihypertensive therapy. All participants were currently using antiretroviral therapy. The data revealed a range of themes including limited hypertension knowledge. Universally, all participants believed that "thinking too much", i.e. stress, was the major contributor to hypertension and that by "reducing thoughts", one may control hypertension. Additional emerging themes included a perceived overlap between hypertension and HIV, delays in hypertension diagnosis and linkage to care, challenges with provider communication and counseling, reluctance towards antihypertensive medication, lack of integration of hypertension and HIV care, and additional structural barriers to hypertension care. Conclusions Participants described multiple, intersecting challenges related to hypertension management. Barriers specific to PLHIV included siloed care, HIV-related stigma, and burden from multiple medical conditions. Multifaceted strategies that seek to address structural barriers, hypertension education, psychosocial stressors and stigma, and that are integrated within HIV care are urgently needed to improve cardiovascular outcomes among PLHIV in sub-Saharan Africa.	[Manavalan, Preeti] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA; [Manavalan, Preeti; Thielman, Nathan M.; Okeke, Nwora Lance] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Manavalan, Preeti; Hertz, Julian T.; Thielman, Nathan M.; Mmbaga, Blandina T.; Watt, Melissa H.] Duke Global Hlth Inst, Durham, NC 27710 USA; [Minja, Linda; Wanda, Lisa; Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Hertz, Julian T.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Mmbaga, Blandina T.] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Watt, Melissa H.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA	State University System of Florida; University of Florida; Duke University; Duke University; Duke University; Utah System of Higher Education; University of Utah	Manavalan, P (corresponding author), Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.; Manavalan, P (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.; Manavalan, P (corresponding author), Duke Global Hlth Inst, Durham, NC 27710 USA.	preeti.manavalan@gmail.com	Mmbaga, Blandina Theophil/AAR-8707-2021	Mmbaga, Blandina Theophil/0000-0002-5550-1916; Manavalan, Preeti/0000-0001-7587-224X	US National Institutes of Health Fogarty International Center [D43TW009337]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [5T32AI007392]; Duke Center for AIDS Research [P30AI064518]	US National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Center for AIDS Research	PM received support for this study from the US National Institutes of Health Fogarty International Center, grant number D43TW009337, [https://www.fic.nih.gov/Grants/Search/Pages/fellows-scholars-D43TW009337.aspx] and from the National Institutes of Health Ruth L. Kirschstein National Research Service Award, grant number 5T32AI007392, [https://www.niaid.nih.gov/grantscontracts/training-grants].MHW received support from the Duke Center for AIDS Research, grant number P30AI064518, [https://cfar.duke.edu/].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, INTERPRETATIVE PHENO; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Birks M, 2008, J RES NURS, V13, P68, DOI 10.1177/1744987107081254; Boima V, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/205716; Brook RD, 2013, HYPERTENSION, V61, P1360, DOI 10.1161/HYP.0b013e318293645f; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chang H, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0934-1; Davidsen AS, 2013, QUAL RES PSYCHOL, V10, P318, DOI 10.1080/14780887.2011.608466; Feinstein MJ, 2019, CIRCULATION, V140, pE98, DOI 10.1161/CIR.0000000000000695; Frank TD, 2019, LANCET HIV, V6, pE831, DOI 10.1016/S2352-3018(19)30196-1; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Geldsetzer P, 2019, LANCET, V394, P652, DOI 10.1016/S0140-6736(19)30955-9; Goverwa Tafadzwa Priscilla, 2014, BMC Res Notes, V7, P703, DOI 10.1186/1756-0500-7-703; Guest G., 2012, APPL THEMATIC ANAL, P79, DOI [10.4135/9781483384436.n4., DOI 10.4135/9781483384436.N4]; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hing M, 2019, HEALTH POLICY PLANN, V34, P36, DOI 10.1093/heapol/czz112; Jones HS, 2020, TROP MED INT HEALTH, V25, P1246, DOI 10.1111/tmi.13473; Kagaruki GB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5639-7; Kaiser BN, 2015, SOC SCI MED, V147, P170, DOI 10.1016/j.socscimed.2015.10.044; Kalichman SC, 2019, INT J STD AIDS, V30, P362, DOI 10.1177/0956462418813047; Kane JC, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1250-8; Koffi J, 2018, Ann Cardiol Angeiol (Paris), V67, P9, DOI 10.1016/j.ancard.2017.04.012; Kwarisiima D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6838-6; Laukamm-Josten U, 2000, AIDS CARE, V12, P27, DOI 10.1080/09540120047440; Leung C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3661-1; Manavalan P, 2020, J CLIN HYPERTENS, V22, P1518, DOI 10.1111/jch.13929; Menna T, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0077-9; Mercer T, 2019, DIABET METAB SYND OB, V12, P2261, DOI 10.2147/DMSO.S207427; Murphy K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0969-y; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142312; Nel A, 2013, AIDS CARE, V25, P948, DOI 10.1080/09540121.2012.748867; Nyaaba GN, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023451; Patel P, 2018, AIDS, V32, pS5, DOI 10.1097/QAD.0000000000001888; Patel P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002523; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Pfaff C, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1151; Rice WS, 2017, JAIDS-J ACQ IMM DEF, V76, P482, DOI [10.1097/qai.0000000000001543, 10.1097/QAI.0000000000001543]; Sando D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25507; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Tapera T, 2019, GLOB HEALTH-SCI PRAC, V7, P575, DOI 10.9745/GHSP-D-19-00210; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; Temu TM, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000570; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; Wagner GJ, 2017, AIDS BEHAV, V21, P1655, DOI 10.1007/s10461-016-1500-0; Weiss JJ, 2016, JAIDS-J ACQ IMM DEF, V73, P403, DOI 10.1097/QAI.0000000000001075; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Xu YN, 2017, J AM SOC HYPERTENS, V11, P530, DOI 10.1016/j.jash.2017.06.004	50	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243059	10.1371/journal.pone.0243059	http://dx.doi.org/10.1371/journal.pone.0243059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270765	gold, Green Published			2022-12-26	WOS:000597149100149
J	Salibe, W; Araujo, TLS; Melo, EG; Coimbra, LBCT; Lapa, MS; Acencio, MMP; Freitas, O; Capelozzi, VL; Teixeira, LR; Fernandes, CJCS; Jatene, FB; Laurindo, FRM; Terra, M				Salibe-Filho, William; Araujo, Thais L. S.; Melo, Everton G.; Coimbra, Luiza B. C. T.; Lapa, Monica S.; Acencio, Milena M. P.; Freitas-Filho, Orival; Capelozzi, Vera Luiza; Teixeira, Lisete Ribeiro; Fernandes, Caio J. C. S.; Jatene, Fabio Biscegli; Laurindo, Francisco R. M.; Terra-Filho, Mario			Shear stress-exposed pulmonary artery endothelial cells fail to upregulate HSP70 in chronic thromboembolic pulmonary hypertension	PLOS ONE			English	Article							ANNEXIN A2 SYSTEM; BLOOD-FLOW; DYSFUNCTION	The pathophysiological mechanisms underlying chronic thromboembolic pulmonary hypertension (CTEPH) are still unclear. Endothelial cell (EC) remodeling is believed to contribute to this pulmonary disease triggered by thrombus and hemodynamic forces disbalance. Recently, we showed that HSP70 levels decrease by proatherogenic shear stress. Molecular chaperones play a major role in proteostasis in neurological, cancer and inflammatory/ infectious diseases. To shed light on microvascular responses in CTEPH, we characterized the expression of molecular chaperones and annexin A2, a component of the fibrinolytic system. There is no animal model that reproduces microvascular changes in CTEPH, and this fact led us to isolated endothelial cells from patients with CTEPH undergoing pulmonary endarterectomy (PEA). We exposed CTEPH-EC and control human pulmonary endothelial cells (HPAEC) to high- (15 dynes/cm(2)) or low- (5 dynes/cm(2)) shear stress. After high-magnitude shear stress HPAEC upregulated heat shock protein 70kDa (HSP70) and the HSP ER paralogs 78 and 94kDa glucose-regulated protein (GRP78 and 94), whereas CTEPH-ECs failed to exhibit this response. At static conditions, both HSP70 and HSP90 families in CTEPH-EC are decreased. Importantly, immunohistochemistry analysis showed that HSP70 expression was downregulated in vivo, and annexin A2 was upregulated. Interestingly, wound healing and angiogenesis assays revealed that HSP70 inhibition with VER-155008 further impaired CTEPH-EC migratory responses. These results implicate HSP70 as a novel master regulator of endothelial dysfunction in type 4 PH. Overall, we first show that global failure of HSP upregulation is a hallmark of CTEPH pathogenesis and propose HSP70 as a potential biomarker of this condition.	[Salibe-Filho, William; Lapa, Monica S.; Acencio, Milena M. P.; Teixeira, Lisete Ribeiro; Fernandes, Caio J. C. S.; Terra-Filho, Mario] Univ Sao Paulo, Heart Inst InCor, Pulm Div, Hosp Clin,Fac Med, Sao Paulo, Brazil; [Araujo, Thais L. S.; Melo, Everton G.; Coimbra, Luiza B. C. T.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Freitas-Filho, Orival; Jatene, Fabio Biscegli] Univ Sao Paulo, Cardiovasc Surg Div, Fac Med, Hosp Clin, Sao Paulo, Brazil; [Capelozzi, Vera Luiza] Univ Sao Paulo, Dept Pathol, Fac Med, Sao Paulo, Brazil; [Laurindo, Francisco R. M.] Univ Sao Paulo, Heart Inst InCor, Vasc Biol Lab, Hosp Clin,Fac Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Salibe, W (corresponding author), Univ Sao Paulo, Heart Inst InCor, Pulm Div, Hosp Clin,Fac Med, Sao Paulo, Brazil.	wsalibe@alumni.usp.br	Araujo, Thaís/V-5974-2019; , Capelozzi/N-1737-2019	Araujo, Thaís/0000-0003-1003-2703; , Capelozzi/0000-0001-9732-5853; Melo, Everton/0000-0003-2401-6106	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [18/13739-8, 19/20435-8, 15/06210-2, 20/11249-3, 19/25503-9]; Centro de Pesquisa, Inovacao e Difusao FAPESP (CEPID "Processos Redox em Biomedicina") [13/07937-8]; Fundacao Zerbini; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro de Pesquisa, Inovacao e Difusao FAPESP (CEPID "Processos Redox em Biomedicina"); Fundacao Zerbini; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) in the form of a research grant awarded to TLSA (18/13739-8) and fellowships awarded to TLSA (19/20435-8, 15/06210-2), LBCTC (20/11249-3) and EGM (19/25503-9), Centro de Pesquisa, Inovacao e Difusao FAPESP (CEPID "Processos Redox em Biomedicina") in the form of a research grant awarded to FRML (13/07937-8), and Fundacao Zerbini and Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior Brasil (CAPES) (Finance Code 001) in the form of funds used for the purchase of materials and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman J, 2016, AM J PHYSIOL-LUNG C, V311, pL453, DOI 10.1152/ajplung.00393.2015; Araujo TLS, 2019, CELL STRESS CHAPERON, V24, P273, DOI 10.1007/s12192-018-00964-y; Araujo TLS, 2017, FREE RADICAL BIO MED, V103, P199, DOI 10.1016/j.freeradbiomed.2016.12.021; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Campanella C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092603; Dromparis P, 2013, CIRCULATION, V127, P115, DOI 10.1161/CIRCULATIONAHA.112.133413; Feaver RE, 2008, ARTERIOSCL THROM VAS, V28, P1534, DOI 10.1161/ATVBAHA.108.167999; Fernandes D.C., 2018, HEMODYNAMIC FORCES E; Firasat S, 2014, EXPERT REV PROTEOMIC, V11, P611, DOI 10.1586/14789450.2014.933673; Flood EC, 2011, VASC PHARMACOL, V54, P59, DOI 10.1016/j.vph.2011.03.003; Campos LCG, 2009, CARDIOVASC RES, V83, P140, DOI 10.1093/cvr/cvp108; Hajjar Katherine A, 2015, Trans Am Clin Climatol Assoc, V126, P144; Happe CM, 2016, VASC PHARMACOL, V83, P17, DOI 10.1016/j.vph.2016.01.004; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11118-y; Jenkins D, 2015, EUR RESPIR REV, V24, P263, DOI 10.1183/16000617.00000815; Joshi S, 2018, NAT REV CANCER, V18, P562, DOI 10.1038/s41568-018-0020-9; Kim N.H., 2019, EUR RESP J, V53; Kim TK, 2016, BIOCHEM BIOPH RES CO, V469, P222, DOI 10.1016/j.bbrc.2015.11.125; Klinger JR, 2013, AM J RESP CRIT CARE, V188, P639, DOI 10.1164/rccm.201304-0686PP; Krause M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/249205; Lang IM, 2016, ANN AM THORAC SOC, V13, pS215, DOI 10.1513/AnnalsATS.201509-620AS; Luo M, 2013, SEMIN THROMB HEMOST, V39, P338, DOI 10.1055/s-0033-1334143; Matthews DT, 2016, PULM CIRC, V6, P145, DOI 10.1086/686011; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Nickel N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-62; Pockley AG, 2009, CELL STRESS CHAPERON, V14, P545, DOI 10.1007/s12192-009-0113-1; Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P45, DOI 10.1016/S0076-6879(08)02003-X; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Sakao S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-109; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sciascia Savino, 2016, Clin Mol Allergy, V14, P6, DOI 10.1186/s12948-016-0043-2; Shiota M, 2010, ARTERIOSCL THROM VAS, V30, P491, DOI 10.1161/ATVBAHA.109.193631; Stasch JP, 2013, HANDB EXP PHARMACOL, V218, P279, DOI 10.1007/978-3-642-38664-0_12; Sun XT, 2016, AM J RESP CELL MOL, V55, P275, DOI 10.1165/rcmb.2015-0185OC; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069320; Tworetzky W, 2000, J AM COLL CARDIOL, V35, P463, DOI 10.1016/S0735-1097(99)00576-8; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Wang JJ, 2016, CARDIOVASC DRUG THER, V30, P587, DOI 10.1007/s10557-016-6702-1; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50	40	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242960	10.1371/journal.pone.0242960	http://dx.doi.org/10.1371/journal.pone.0242960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270690	Green Published, gold			2022-12-26	WOS:000597149100067
J	Shin, WY; Kim, JH				Shin, Woo-young; Kim, Jung-ha			Use of workplace foodservices is associated with reduced meal skipping in Korean adult workers: A nationwide cross-sectional study	PLOS ONE			English	Article							NUTRIENT INTAKE; HEALTH; DIET; FOOD; ADOLESCENTS; FREQUENCY; BEHAVIORS; PATTERNS; BARRIERS; QUALITY	Skipping meals is a poor eating behaviour known to result in poor diet quality and health outcomes. Nevertheless, it has become increasingly common over the past few decades in many countries. This study aimed to examine the potential association between the use of workplace foodservices and skipping meals among Korean adult workers using data from the Korea National Health and Nutrition Examination Survey 2016-2018, a nationwide cross-sectional survey of a representative Korean population. A total of 5,137 workers aged 20-64 years were included. Dietary assessment was conducted using a 24-hour dietary recall. In total, 41.2% participants skipped one meal or more per day. The percentage of workers who skipped meals was 43.1 +/- 1.0% among participants who did not use workplace foodservices compared to 31.8 +/- 1.9% among those who did (P<0.01). Skipping meals was significantly associated with not using workplace foodservices, after adjusting for other confounders including sociodemographic variables, health-related variables, and meal procurement source (odds ratio = 3.4; 95% confidence interval = 2.6-4.4; P<0.01). We found a significant association between using workplace foodservices and reduced skipping meals in Korean adult workers. This study suggests the importance of the provision of workplace foodservices for workers to potentially reduce poor eating behaviours such as skipping meals.	[Shin, Woo-young; Kim, Jung-ha] Chung Ang Univ, Chung Ang Univ Med Ctr, Dept Family Med, Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, JH (corresponding author), Chung Ang Univ, Chung Ang Univ Med Ctr, Dept Family Med, Coll Med, Seoul, South Korea.	girlpower219@cau.ac.kr		, Jung-Ha/0000-0002-7630-9501				[Anonymous], 2008, MEISTER ECKHART JB, V2, P269; Belon AP, 2016, SOC SCI MED, V171, P18, DOI 10.1016/j.socscimed.2016.11.004; Clohessy S, 2019, OBES REV, V20, P1771, DOI 10.1111/obr.12920; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136; Deshmukh-Taskar PR, 2010, J AM COLL NUTR, V29, P407, DOI 10.1080/07315724.2010.10719858; Devine CM, 2009, J NUTR EDUC BEHAV, V41, P365, DOI 10.1016/j.jneb.2009.01.007; ENEOBONG HN, 1993, ECOL FOOD NUTR, V30, P179, DOI 10.1080/03670244.1993.9991335; Escoto KH, 2012, AM J HEALTH BEHAV, V36, P786, DOI 10.5993/AJHB.36.6.6; Ferrer-Cascales R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081781; Finkelstein J., 1989, DINING OUT SOCIOLOGY; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hemio K, 2015, OCCUP ENVIRON MED, V72, P513, DOI 10.1136/oemed-2014-102624; Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Knoche K, 2012, PROMOTING HLTH WORK; Kong JS, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132319; Korea National Health and Nutrition Examination Survey (KNHANES), 2018, DES METH; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Meng HY, 2020, NUTRITION, V77, DOI 10.1016/j.nut.2020.110801; Payne N, 2013, J HEALTH PSYCHOL, V18, P887, DOI 10.1177/1359105312446772; Pendergast FJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0451-1; Pereira M, 2011, J NUTR, V141, P163, DOI 10.3945/jn.109.114405; Pridgeon A, 2013, J HUM NUTR DIET, V26, P85, DOI 10.1111/j.1365-277X.2012.01281.x; Roos E, 2004, PUBLIC HEALTH NUTR, V7, P53, DOI 10.1079/PHN2003511; Rosenrauch S, 2017, PUBLIC HEALTH NUTR, V20, P3266, DOI 10.1017/S136898001700235X; Santos HO, 2022, CRIT REV FOOD SCI, V62, P466, DOI 10.1080/10408398.2020.1819768; Santos HO, 2018, CLIN NUTR ESPEN, V24, P14, DOI 10.1016/j.clnesp.2018.01.002; Shetty P, 2011, NUTR LIFESTYLE OBESI; Smith KJ, 2013, J NUTR, V143, P1774, DOI 10.3945/jn.113.181396; St-Onge MP, 2017, CIRCULATION, V135, pE96, DOI 10.1161/CIR.0000000000000476; Sungha Y, 2018, DIETARY NUTR STATUS; Timlin MT, 2007, NUTR REV, V65, P268, DOI 10.1111/j.1753-4887.2007.tb00304.x; US Department of Health and Human Services, 2008, PHYS ACT GUID AM BE; Wang XL, 2020, NUTRITION, V79-80, DOI 10.1016/j.nut.2020.110974; WHO, 2003, WHO TECH REP SER, V916, P1	36	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243160	10.1371/journal.pone.0243160	http://dx.doi.org/10.1371/journal.pone.0243160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270703	Green Submitted, gold, Green Published			2022-12-26	WOS:000597149100134
J	Beauchamp, RL; Erdin, S; Witt, L; Jordan, JT; Plotkin, SR; Gusella, JF; Ramesh, V				Beauchamp, Roberta L.; Erdin, Serkan; Witt, Luke; Jordan, Justin T.; Plotkin, Scott R.; Gusella, James F.; Ramesh, Vijaya			mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF2 TUMOR-SUPPRESSOR; NEUROFIBROMATOSIS TYPE-2; PHASE-II; THERAPEUTIC TARGET; PLASMA-MEMBRANE; QUALITY-CONTROL; MERLIN; GROWTH; ACTIVATION; EVEROLIMUS	Meningiomas (MNs), arising from the arachnoid/meningeal layer, are nonresponsive to chemotherapies, with similar to 50% showing loss of the Neurofibromatosis 2 (NF2) tumor suppressor gene. Previously, we established NF2 loss activates mechanistic target of rapamycin complex 1 (mTORC1) and mechanistic target of rapamycin complex 2 (mTORC2) signaling, leading to clinical trials for NF2 and MN. Recently our omics studies identified activated ephrin (EPH) receptor and Src family kinases upon NF2 loss. Here, we report increased expression of several ligands in NF2-null human arachnoidal cells (ACs) and the MN cell line Ben-Men-1, particularly neuregulin-1/heregulin (NRG1), and confirm increased NRG1 secretion and activation of V-ERB-B avian erythroblastic leukemia viral oncogene homolog 3 (ERBB3) receptor kinase. Conditioned-medium from NF2-null ACs or exogenous NRG1 stimulated ERBB3, EPHA2, and mTORC1/2 signaling, suggesting pathway crosstalk. NF2-null cells treated with an ERBB3-neutralizing antibody partially downregulated mTOR pathway activation but showed no effect on viability. mTORC1/2 inhibitor treatment decreased NRG1 expression and downregulated ERBB3 while re-activating pAkt T308, suggesting a mechanism independent of NRG1-ERBB3 but likely involving activation of another upstream receptor kinase. Transcriptomics after mTORC1/2 inhibition confirmed decreased ERBB3/ERBB4 while revealing increased expression of insulin-like growth factor receptor 1 (IGF1R). Drug treatment co-targeting mTORC1/2 and IGF1R/insulin receptor attenuated pAkt T308 and showed synergistic effects on viability. Our findings indicate potential autocrine signaling where NF2 loss leads to secretion/activation of NRG1-ERBB3 signaling. mTORC1/2 inhibition downregulates NRG1-ERBB3, while upregulating pAkt T308 through an adaptive response involving IGF1R/insulin receptor and co-targeting these pathways may prove effective for treatment of NF2-deficient MN.	[Beauchamp, Roberta L.; Erdin, Serkan; Witt, Luke; Gusella, James F.; Ramesh, Vijaya] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Jordan, Justin T.; Plotkin, Scott R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Jordan, Justin T.; Plotkin, Scott R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ramesh, V (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.	ramesh@helix.mgh.harvard.edu	Erdin, Serkan/B-4988-2008; Erdin, Serkan/AAE-4288-2019	Erdin, Serkan/0000-0001-6587-2625; Plotkin, Scott/0000-0002-6109-6419; Jordan, Justin/0000-0001-6198-817X	U.S. Army Medical Research Neurofibromatosis Program [W81XWH1810547]; National Institutes of Health [R01 NS113854]; S. Sydney DeYoung Foundation; Children's Tumor Foundation-Synodos for NF2; NF Northeast	U.S. Army Medical Research Neurofibromatosis Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); S. Sydney DeYoung Foundation; Children's Tumor Foundation-Synodos for NF2; NF Northeast	This study was supported by Children's Tumor Foundation-Synodos for NF2, NF Northeast, U.S. Army Medical Research Neurofibromatosis Program W81XWH1810547, National Institutes of Health R01 NS113854, and the S. Sydney DeYoung Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allaway R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197350; Ammoun S, 2010, NEURO-ONCOLOGY, V12, P834, DOI 10.1093/neuonc/noq012; Angus SP, 2018, NEURO-ONCOLOGY, V20, P1185, DOI 10.1093/neuonc/noy046; Appert-Collin A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00283; Apra C, 2018, EXPERT REV NEUROTHER, V18, P241, DOI 10.1080/14737175.2018.1429920; Beauchamp RL, 2015, ONCOTARGET, V6, P16981, DOI 10.18632/oncotarget.4858; Blakeley Jaishri O, 2012, Am J Med Genet A, V158A, P24, DOI 10.1002/ajmg.a.34359; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Capparelli C, 2018, CANCER RES, V78, P5680, DOI 10.1158/0008-5472.CAN-18-1001; Capparelli C, 2015, J BIOL CHEM, V290, P24267, DOI 10.1074/jbc.M115.657270; Capparelli C, 2015, CANCER RES, V75, P3554, DOI 10.1158/0008-5472.CAN-14-2959; Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doherty JK, 2008, OTOL NEUROTOL, V29, P50, DOI 10.1097/mao.0b013e31815d4429; Evans DGR, 2009, GENET MED, V11, P599, DOI 10.1097/GIM.0b013e3181ac9a27; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Giovannini M, 2014, NEURO-ONCOLOGY, V16, P493, DOI 10.1093/neuonc/not242; Goutagny S, 2017, J NEURO-ONCOL, V133, P443, DOI 10.1007/s11060-017-2447-3; Goutagny S, 2015, J NEURO-ONCOL, V122, P313, DOI 10.1007/s11060-014-1710-0; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harford-Wright E, 2017, BRAIN, V140, P2939, DOI 10.1093/brain/awx253; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Ianevski A, 2020, NUCLEIC ACIDS RES, V48, pW488, DOI 10.1093/nar/gkaa216; James MF, 2008, NEUROBIOL DIS, V29, P278, DOI 10.1016/j.nbd.2007.09.002; James MF, 2012, MOL CANCER RES, V10, P649, DOI 10.1158/1541-7786.MCR-11-0425-T; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Karajannis MA, 2012, NEURO-ONCOLOGY, V14, P1163, DOI 10.1093/neuonc/nos146; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Luo Y, 2015, ONCOTARGET, V6, P4286, DOI 10.18632/oncotarget.3006; Malyutina A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006752; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Osorio DS, 2018, J NEURO-ONCOL, V139, P749, DOI 10.1007/s11060-018-2922-5; Puttmann S, 2005, LAB INVEST, V85, P1163, DOI 10.1038/labinvest.3700307; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Roskoski R, 2019, PHARMACOL RES, V139, P395, DOI 10.1016/j.phrs.2018.11.014; Ruggieri M, 2015, SEMIN PEDIATR NEUROL, V22, P240, DOI 10.1016/j.spen.2015.10.008; Sagers JE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60156-6; Schoeberl B, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/npjsba.2016.34; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Stonecypher MS, 2006, J NEUROPATH EXP NEUR, V65, P162, DOI 10.1097/01.jnen.0000199575.93794.2f; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Yang YJ, 2016, CLIN CHIM ACTA, V457, P112, DOI 10.1016/j.cca.2016.04.001; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yoon SO, 2017, MOL CELL, V67, P512, DOI 10.1016/j.molcel.2017.06.033; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	61	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100157	10.1074/jbc.RA120.014960	http://dx.doi.org/10.1074/jbc.RA120.014960			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273014	gold, Green Published			2022-12-26	WOS:000672866400135
J	Peltzer, S; Muller, H; Kostler, U; Schulz-Nieswandt, F; Jessen, F; Albus, C				Peltzer, Samia; Mueller, Hendrik; Koestler, Ursula; Schulz-Nieswandt, Frank; Jessen, Frank; Albus, Christian		CoRe-Net Study Grp	Detection and treatment of mental disorders in patients with coronary heart disease (MenDis-CHD): A cross-sectional study	PLOS ONE			English	Article							HOSPITAL ANXIETY; RISK-FACTOR; HEALTH; SATISFACTION; DEPRESSION; ILLNESS; CARE; METAANALYSIS; MANAGEMENT; SCALE	Mental disorders (MD) are associated with an increased risk of developing coronary heart disease (CHD) and with higher CHD-related morbidity and mortality. There is a strong recommendation to routinely screen CHD patients for MDs, diagnosis, and treatment by recent guidelines. The current study aimed at mapping CHD patients' (1) state of diagnostics and, if necessary, treatment of MDs, (2) trajectories and detection rate in healthcare, and (3) the influence of MDs and its management on quality of life and patient satisfaction. The design was a cross-sectional study in three settings (two hospitals, two rehabilitation clinics, three cardiology practices). CHD patients were screened for MDs with the Hospital Anxiety and Depression Scale (HADS), and, if screened-positive, examined for MDs with the Structured Clinical Interview for DSM-IV (SCID-I). Quality of Life (EQ-5D), Patient Assessment of Care for Chronic Conditions (PACIC), and previous routine diagnostics and treatment for MDs were examined. Descriptive statistics, Chi-squared tests, and ANOVA were used for analyses. Analyses of the data of 364 patients resulted in 33.8% positive HADS-screenings and 28.0% SCID-I diagnoses. The detection rate of correctly pre-diagnosed MDs was 49.0%. Physicians actively approached approximately thirty percent of patients on MDs; however, only 6.6% of patients underwent psychotherapy and 4.1% medication therapy through psychotherapists/psychiatrists. MD patients scored significantly lower on EQ-5D and the PACIC. The state of diagnostic and treatment of comorbid MDs in patients with CHD is insufficient. Patients showed a positive attitude towards addressing MDs and were satisfied with medical treatment, but less with MD-related advice. Physicians in secondary care need more training inadequately addressing mental comorbidity.	[Peltzer, Samia; Albus, Christian] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Psychosomat & Psychotherapy, Cologne, North Rhine Wes, Germany; [Mueller, Hendrik; Jessen, Frank] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Psychiat & Psychotherapy, Cologne, North Rhine Wes, Germany; [Koestler, Ursula; Schulz-Nieswandt, Frank] Univ Cologne, Fac Management Econ & Social Sci, Cologne, North Rhine Wes, Germany; [Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, Bonn, North Rhine Wes, Germany	University of Cologne; University of Cologne; University of Cologne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Peltzer, S (corresponding author), Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Psychosomat & Psychotherapy, Cologne, North Rhine Wes, Germany.	samia.peltzer@uk-koeln.de	Schulz-Nieswandt, Frank/ABG-8401-2021	Schulz-Nieswandt, Frank/0000-0002-9820-417X; Peltzer, Samia/0000-0001-9784-6413	BMBF (Federal Ministry of Research and Education) [01GY1606]	BMBF (Federal Ministry of Research and Education)(Federal Ministry of Education & Research (BMBF))	All authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the BMBF (Federal Ministry of Research and Education [grant number: 01GY1606]. URL: https://www.bmbf.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus C, 2018, UEXKULL PSYCHOSOMATI, P865; Albus C, 2019, CLIN RES CARDIOL, V108, P1175, DOI 10.1007/s00392-019-01488-w; Bishop TF, 2016, HEALTH AFFAIR, V35, P394, DOI 10.1377/hlthaff.2015.1068; Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420; De Hert M, 2018, DIALOGUES CLIN NEURO, V20, P31; Emdin CA, 2016, AM J CARDIOL, V118, P511, DOI 10.1016/j.amjcard.2016.05.041; EuroQol Research Foundation, EQ 5D 3L USER GUIDE; Feinstein Robert E, 2006, Cardiol Rev, V14, P164, DOI 10.1097/01.crd.0000200977.41695.43; Fergusson DM, 2015, PSYCHOL MED, V45, P2427, DOI 10.1017/S0033291715000422; Fortin M, 2018, CAN J PSYCHIAT, V63, P103, DOI 10.1177/0706743717737030; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Graf von Schulenburg J-M, 1998, GESUNDHEITSWISSENSCH, V6, P3, DOI [DOI 10.1007/BF02956350, 10.1007/BF02956350]; Henly SJ, 2011, NURS RES, V60, pS5, DOI 10.1097/NNR.0b013e318216dfd3; IBMCorp, 2013, IBM SPSS STAT WINDOW; Karbach U, 2018, Z EVIDENZ FORTBILD Q, V130, P21, DOI 10.1016/j.zefq.2017.11.005; Karbach U, 2011, DTSCH ARZTEBL INT, V108, P62, DOI 10.3238/arztebl.2011.0061; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; Kuhlmann SL, 2019, PSYCHOTHER PSYCHOSOM, V88, P300, DOI 10.1159/000501502; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lindberg LG, 2019, EUR J PUBLIC HEALTH, V29, P700, DOI 10.1093/eurpub/ckz090; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mykletun A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-35; Pedersen SS, 2017, EUR J PREV CARDIOL, V24, P108, DOI 10.1177/2047487317703827; Peltzer S, 2019, BMC PSYCHOL, V7, DOI 10.1186/s40359-019-0295-y; Petermann F, 2011, Z PSYCHIATR PSYCH PS, V59, P251, DOI 10.1024/1661-4747/a000077; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Pogosova N, 2017, EUR J PREV CARDIOL, V24, P1371, DOI 10.1177/2047487317711334; Priebe S, 2019, WORLD PSYCHIATRY, V18, P30, DOI 10.1002/wps.20586; Prins MA, 2009, J AFFECT DISORDERS, V119, P163, DOI 10.1016/j.jad.2009.03.019; Summerskill WSM, 2002, FAM PRACT, V19, P605, DOI 10.1093/fampra/19.6.605; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Vaccarino V, 2020, EUR HEART J, V41, P1687, DOI 10.1093/eurheartj/ehy913; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; 2018, ADV DIFFERENCE EQU, V104, P1	35	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243800	10.1371/journal.pone.0243800	http://dx.doi.org/10.1371/journal.pone.0243800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315906	gold, Green Published			2022-12-26	WOS:000600186100046
J	Shi, C; Killoran, MP; Hall, MP; Otto, P; Wood, MG; Strauss, E; Encell, LP; Machleidt, T; Wood, KV; Kirkland, TA				Shi, Ce; Killoran, Michael P.; Hall, Mary P.; Otto, Paul; Wood, Monika G.; Strauss, Ethan; Encell, Lance P.; Machleidt, Thomas; Wood, Keith V.; Kirkland, Thomas A.			5,5-Dialkylluciferins are thermal stable substrates for bioluminescence-based detection systems	PLOS ONE			English	Article							FIREFLY LUCIFERASE; ATP; ASSAY; THERMOSTABILITY; DERIVATIVES; SATURATION; DESIGN; PROBES; GREEN; RED	Firefly luciferase-based ATP detection assays are frequently used as a sensitive, cost-efficient method for monitoring hygiene in many industrial settings. Solutions of detection reagent, containing a mixture of a substrate and luciferase enzyme that produces photons in the presence of ATP, are relatively unstable and maintain only a limited shelf life even under refrigerated conditions. It is therefore common for the individual performing a hygiene test to manually prepare fresh reagent at the time of monitoring. To simplify sample processing, a liquid detection reagent with improved thermal stability is needed. The engineered firefly luciferase, Ultra-Glo (TM), fulfills one aspect of this need and has been valuable for hygiene monitoring because of its high resistance to chemical and thermal inactivation. However, solutions containing both Ultra-Glo (TM) luciferase and its substrate luciferin gradually lose the ability to effectively detect ATP over time. We demonstrate here that dehydroluciferin, a prevalent oxidative breakdown product of luciferin, is a potent inhibitor of Ultra-Glo (TM) luciferase and that its formation in the detection reagent is responsible for the decreased ability to detect ATP. We subsequently found that dialkylation at the 5-position of luciferin (e.g., 5,5-dimethylluciferin) prevents degradation to dehydroluciferin and improves substrate thermostability in solution. However, since 5,5-dialkylluciferins are poorly utilized by Ultra-Glo (TM) luciferase as substrates, we used structural optimization of the luciferin dialkyl modification and protein engineering of Ultra-Glo (TM) to develop a luciferase/luciferin pair that shows improved total reagent stability in solution at ambient temperature. The results of our studies outline a novel luciferase/luciferin system that could serve as foundations for the next generation of bioluminescence ATP detection assays with desirable reagent stability.	[Shi, Ce; Kirkland, Thomas A.] Promega Biosci Inc, San Luis Obispo, CA USA; [Killoran, Michael P.; Hall, Mary P.; Otto, Paul; Wood, Monika G.; Strauss, Ethan; Encell, Lance P.; Machleidt, Thomas; Wood, Keith V.] Promega Corp, Madison, WI 53711 USA	Promega Corporation	Killoran, MP (corresponding author), Promega Corp, Madison, WI 53711 USA.	mike.killoran@promega.com			Promega Corporation	Promega Corporation	Funding was provided by Promega Corporation. The funder provided support in the form of salaries and laboratory resources for authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa MJ, 2015, J HOSP INFECT, V90, P59, DOI 10.1016/j.jhin.2015.01.020; [Anonymous], 2010, Prescrire Int, V19, P26; [Anonymous], 2007, WESTMINSTER PAPERS C, V4, P65; Auld DS, 2009, J MED CHEM, V52, P1450, DOI 10.1021/jm8014525; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Baldwin TO, 1996, STRUCTURE, V4, P223, DOI 10.1016/S0969-2126(96)00026-3; Branchini BR, 2002, J AM CHEM SOC, V124, P2112, DOI 10.1021/ja017400m; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Cali JJ, 2006, EXPERT OPIN DRUG MET, V2, P629, DOI 10.1517/17425255.2.4.629; Dostalek P, 2005, CZECH J FOOD SCI, V23, P85, DOI 10.17221/3376-CJFS; Duellman S, 2013, NEW LUMINESCENT ASSA; GRIFFITHS MW, 1993, J DAIRY SCI, V76, P3118, DOI 10.3168/jds.S0022-0302(93)77651-1; Hawronskyj JM, 1997, TRENDS FOOD SCI TECH, V8, P79, DOI 10.1016/S0924-2244(97)01009-1; Koksharov MI, 2011, PROTEIN ENG DES SEL, V24, P835, DOI 10.1093/protein/gzr044; Kumar M, 2007, ASSAY DRUG DEV TECHN, V5, P237, DOI 10.1089/adt.2006.055; Lundin A, 2000, METHOD ENZYMOL, V305, P346; Morciano G, 2017, NAT PROTOC, V12, P1542, DOI 10.1038/nprot.2017.052; Mortazavi M, 2011, PROTEIN ENG DES SEL, V24, P893, DOI 10.1093/protein/gzr051; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Notzel MW, 2000, J ORG CHEM, V65, P3850, DOI 10.1021/jo990170y; O'Brien MA, 2005, J BIOMOL SCREEN, V10, P137, DOI 10.1177/1087057104271865; O'Brien M, 2017, J IMMUNOL METHODS, V447, P1, DOI 10.1016/j.jim.2017.03.004; Park CW, 2014, BIOSENS BIOELECTRON, V52, P379, DOI 10.1016/j.bios.2013.09.015; Pozzo T, 2018, ACS OMEGA, V3, P2628, DOI 10.1021/acsomega.7b02068; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Ramesh CH., 2015, INT J LUMIN APPL, V5, P45; Ribeiro C, 2008, PHOTOCH PHOTOBIO SCI, V7, P1085, DOI 10.1039/b809935a; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Rothweiler U, 2015, EUR J MED CHEM, V94, P140, DOI 10.1016/j.ejmech.2015.02.035; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; STANFIELD CF, 1986, J ORG CHEM, V51, P5153, DOI 10.1021/jo00376a019; Sundlov JA, 2012, BIOCHEMISTRY-US, V51, P6493, DOI 10.1021/bi300934s; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; WHITE EH, 1969, J AM CHEM SOC, V91, P2178, DOI 10.1021/ja01036a093; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343; Working Party on Thrombolysis in the Management of Limb Ischemia, 2003, J VASC INTERV RADIOL, V7, pS337; Zegzouti H, 2009, ASSAY DRUG DEV TECHN, V7, P560, DOI 10.1089/adt.2009.0222; Zhang Y, 2005, J PHARMACOL EXP THER, V313, P1075, DOI 10.1124/jpet.104.082974; Zhou WH, 2006, CHEM COMMUN, P4620, DOI 10.1039/b610682j; Zhou WH, 2006, J AM CHEM SOC, V128, P3122, DOI 10.1021/ja058519o	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243747	10.1371/journal.pone.0243747	http://dx.doi.org/10.1371/journal.pone.0243747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315907	gold, Green Published			2022-12-26	WOS:000600186100059
J	Asfaw, MA; Wegayehu, T; Gezmu, T; Bekele, A; Hailemariam, Z; Gebre, T				Asfaw, Mekuria Asnakew; Wegayehu, Teklu; Gezmu, Tigist; Bekele, Alemayehu; Hailemariam, Zeleke; Gebre, Teshome			Determinants of soil-transmitted helminth infections among pre-school-aged children in Gamo Gofa zone, Southern Ethiopia: A case-control study	PLOS ONE			English	Article								Background Pre-school aged children (PSAC) are highly affected by soil-transmitted helminths (STH), particularly in areas where water, sanitation, and hygiene (WASH) are inadequate. Context-specific evidence on determinants of STH infections in PSAC has not been well established in the study area. This study, therefore, aimed to fill these gaps in Gamo Gofa zone, Southern Ethiopia. Methods A community-based unmatched case-control study, nested in a cross-sectional survey, was conducted in January 2019. Cases and controls were identified based on any STH infection status using the Kato-Katz technique in stool sample examination. Data on social, demographic, economic, behavioral, and WASH related variables were collected from primary caregivers of children using pre-tested questionnaire. Determinants of STH infections were identified using multivariable logistic regression model using SPSS version 25. Results A total of 1206 PSAC (402 cases and 804 controls) participated in this study. Our study showed that the odds of STH infection were lowest among PSAC living in urban areas (AOR = 0.55, 95% CI: 0.39-0.79), among those from households with safe water source (AOR = 0.67, 95% CI: 0.47-0.0.93), and in those PSAC from households with shorter distance from water source (<30 minutes) (AOR = 0.51, 95% CI: 0.39-0.67). On the other hand, the odds of STH infection were highest among PSAC from households that had no functional hand washing facility (AOR = 1.36, 95% CI: 1.04-1.77), in those PSAC from households that had unclean latrine (AOR: 1.82, 95% CI: 1.19-2.78), and among those PSAC under caregivers who had lower score (<= 5) on knowledge related to STH transmission (AOR = 1.85, 95% CI: 1.13-3.01). Conclusions Given efforts required eliminating STH by 2030; the existing preventive chemotherapy intervention should be substantially strengthened with WASH and behavioral interventions. Thus, an urgent call for action is required to integrate context-specific interventions, particularly in rural areas.	[Asfaw, Mekuria Asnakew; Gezmu, Tigist; Bekele, Alemayehu] Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia; [Wegayehu, Teklu] Arba Minch Univ, Coll Nat Sci, Dept Biol, Arba Minch, Ethiopia; [Hailemariam, Zeleke] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Gebre, Teshome] Int Trachoma Initiat, Task Force Global Hlth, Addis Ababa, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Asfaw, MA (corresponding author), Arba Minch Univ, Collaborat Res & Training Ctr NTDs, Arba Minch, Ethiopia.	maksambaramr23@gmail.com	Kassahun, Alemayehu Bekele/ABA-5651-2021	Kassahun, Alemayehu Bekele/0000-0001-8341-4855; Gezmu, Tigist/0000-0001-5937-8452; asfaw, mekuria/0000-0002-5718-0001	Collaborative Research and Training Center, Arba Minch University, Ethiopia	Collaborative Research and Training Center, Arba Minch University, Ethiopia	This study is made possible by the generous support of the Collaborative Research and Training Center, Arba Minch University, Ethiopia.	Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; Alemu A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2864-9; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P145; Asfaw MA, 2020, PREVALENCE INTENSITY, DOI [10.1101/2020.05.14.20102277, DOI 10.1101/2020.05.14.20102277]; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Central Statistical Agency, 2013, POP PROJ ETH 2007 20; Echazu A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004111; Federal Ministry of Health (FMoH) Nigeria, 2016, 2 EDITION ETHIOPIA N; Freeman MC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007201; Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Oberhelman RA, 1998, AM J TROP MED HYG, V58, P470, DOI 10.4269/ajtmh.1998.58.470; Ojja S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3289-0; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Sacolo-Gwebu H, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0561-5; Singer BH, 2007, P NATL ACAD SCI USA, V104, P16038, DOI 10.1073/pnas.0700900104; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Utzinger J, 2010, ADV PARASIT, V72, P1, DOI 10.1016/S0065-308X(10)72001-7; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; WHO, 2015, WAT SAN HYG ACC SUST; WHO, 2020, ENDING NEGLECT ATTAI; WHO, 2006, COORD US ANTH DRUGS; WHO, 2012, EL SOIL TRANSM HELM; World Health Organization, 1994, KAT KATZ TECHN BENCH; World Health Organization, 2017, GUID PREV CHEM CONTR; Worrell CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150744; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243836	10.1371/journal.pone.0243836	http://dx.doi.org/10.1371/journal.pone.0243836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306738	Green Published, gold			2022-12-26	WOS:000600144200045
J	Kitonsa, PJ; Nalutaaya, A; Mukiibi, J; Nakasolya, O; Isooba, D; Kamoga, C; Baik, Y; Robsky, K; Dowdy, DW; Katamba, A; Kendall, EA				Kitonsa, Peter J.; Nalutaaya, Annet; Mukiibi, James; Nakasolya, Olga; Isooba, David; Kamoga, Caleb; Baik, Yeonsoo; Robsky, Katherine; Dowdy, David W.; Katamba, Achilles; Kendall, Emily A.			Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis	PLOS ONE			English	Article							BODY-MASS INDEX	Background When evaluating symptomatic patients for tuberculosis (TB) without access to same-day diagnostic test results, clinicians often make empiric decisions about starting treatment. The number of TB symptoms and/or underweight status could help identify patients at highest risk for a positive result. We sought to evaluate the usefulness of BMI assessment and a count of characteristic TB symptoms for identifying patients at highest risk for TB. Methods We enrolled adult patients receiving pulmonary TB diagnoses and a representative sample with negative TB evaluations at four outpatient health facilities in Kampala, Uganda. We asked patients about symptoms of chronic cough, night sweats, chest pain, fever, hemoptysis, or weight loss; measured height and weight; and collected sputum for mycobacterial culture. We evaluated the diagnostic accuracy (for culture-positive TB) of two simple scoring systems: (a) number of TB symptoms, and (b) number of TB symptoms plus one or more additional points for underweight status (body mass index [BMI] <= 18.5 kg/m(2)). Results We included 121 patients with culture-positive TB and 370 patients with negative culture results (44 of whom had been recommended for TB treatment by evaluating clinicians). Of the six symptoms assessed, the median number of symptoms that patients reported was two (interquartile range [IQR]: 1, 3). The median BMI was 20.9 kg/m(2) (IQR: 18.6, 24.0), and 118 (24%) patients were underweight. Counting the number of symptoms provided an area under the Receiver Operating Characteristic curve (c-statistic) of 0.77 (95% confidence interval, CI: 0.72, 0.81) for identifying culture-positive TB; adding two points for underweight status increased the c-statistic to 0.81 (95%CI: 0.76, 0.85). A cutoff of >= 3 symptoms had sensitivity and specificity of 65% and 74%, whereas a score of >= 4 on the combined score (>= 2 symptoms if underweight, >= 4 symptoms if not underweight) gave higher sensitivity and specificity of 69% and 81% respectively. A sensitivity analysis defining TB by Xpert MTB/RIF status produced similar results. Conclusion A count of patients' TB symptoms may be useful in clinical decision-making about TB diagnosis. Consideration of underweight status adds additional diagnostic value.	[Kitonsa, Peter J.; Nalutaaya, Annet; Mukiibi, James; Nakasolya, Olga; Isooba, David; Kamoga, Caleb; Dowdy, David W.; Katamba, Achilles; Kendall, Emily A.] Makerere Univ, Coll Hlth Sci, Uganda TB Implementat Res Consortium, Kampala, Uganda; [Baik, Yeonsoo; Robsky, Katherine; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Dept Med, Upper Mulago Hill, Kampala, Uganda; [Kendall, Emily A.] Johns Hopkins Univ, Div Infect Dis, Dept Med, Baltimore, MD USA; [Kendall, Emily A.] Johns Hopkins Univ, Ctr TB Res, Dept Med, Baltimore, MD USA	Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Johns Hopkins University; Johns Hopkins University	Kitonsa, PJ (corresponding author), Makerere Univ, Coll Hlth Sci, Uganda TB Implementat Res Consortium, Kampala, Uganda.	kitonsap@gmail.com		Nalutaaya, Annet/0000-0003-3903-303X; Robsky, Katherine/0000-0001-7789-5779; James Kitonsa, Peter/0000-0003-2971-216X	US National Institute of Health [R01HL138728, K08AI127908]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	US National Institute of Health (R01HL138728 to DWD and K08AI127908 to EAK) https://grants.nih.gov/grants/oer.htm NO - The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2012, REGEN MED S3, V7, pS14; Buregyeya E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-586; Casha AR, 2017, J THORAC DIS, V9, pE301, DOI 10.21037/jtd.2017.03.47; Claassens MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172881; Diriba Getu, 2017, BMC Res Notes, V10, P181, DOI 10.1186/s13104-017-2497-9; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hoffmann CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062211; Horne D. J., 2019, Cochrane Database of Systematic Reviews, pCD009593; Joshi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201731; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Lorent N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130179; McCarthy KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207091; Nalugwa T, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4997-x; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Ogbo FA, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0114-9; Prince L, 2016, TROP MED INT HEALTH, V21, P1272, DOI 10.1111/tmi.12763; Semunigus T, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0165-x; Silva DR, 2018, J BRAS PNEUMOL, V44, P145, DOI [10.1590/s1806-37562017000000443, 10.1590/S1806-37562017000000443]; StataCorp, 2013, STAT STAT SOFTW REL; Thomas BE, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001974; WHO, 2020, TUBERCULOSIS; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; Wynne A., 2014, INT J AFRICA NURS SC, V1, P6, DOI [10.1016/j.ijans.2014.05.001, DOI 10.1016/J.IJANS.2014.05.001]; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zhang HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41933	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243542	10.1371/journal.pone.0243542	http://dx.doi.org/10.1371/journal.pone.0243542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306710	gold, Green Published			2022-12-26	WOS:000600144200002
J	Hussain, B; Li, JM; Ma, YB; Tahir, N; Ullah, A				Hussain, Babar; Li, Jumei; Ma, Yibing; Tahir, Nazia; Ullah, Aman			Effects of Fe and Mn cations on Cd uptake by rice plant in hydroponic culture experiment	PLOS ONE			English	Article							ORYZA-SATIVA L.; CADMIUM UPTAKE; IRON PLAQUE; MANGANESE UPTAKE; ACCUMULATION; EXPRESSION; TRANSLOCATION; TRANSPORTER; TOLERANCE; OSNRAMP1	Iron (Fe) and manganese (Mn) are nutritional components of rice, plays an important role in its physiological processes and can minimize absorption of cadmium (Cd) in rice. Fe, Mn, and Cd transporters such as CAL1, OsNRAMP5, OsNRAMP1, OsIRT1, OsHMA3, and OsNAAT1 regulate uptake of Cd in rice. However, the effect of exogenous application of Fe, and Mn on the accumulation of Cd and relative expression (RE) of these transporters in rice has not been investigated. Therefore, a hydroponic culture experiment was conducted to investigate the impact of Fe and Mn on Cd uptake and RE of these transporters in rice. The results showed that the Fe and Mn application significantly decreased Cd in the roots and shoots of rice. Whereas, Cd concentration in the rice significantly increased with increasing Cd concentration in the solution. The addition of manganese in the culture medium can reduce the cadmium content of rice roots by 11.9-82.3% and shoots by 11.6-85.0%, while the addition of iron in the culture medium can reduce the cadmium content of rice roots and shoots by 26-65% and 9-683% respectively. Meanwhile, application of sufficient doses of Fe and Cd in solution culture increased RE of CAL1, OsNRAMP5, OsNRAMP1, OsIRT1, and OsNAAT1 in roots, whereas expression level of OsHMA3 was decreased. Similarly, expression level of CAL1, OsNRAMP5, and OsNRAMP1 significantly increased in roots in high Cd and Mn deficient treatments. This may be concluded that the Cd increases expression of CAL1, OsNRAMP5, OsNRAMP1, OsIRT1, and OsNAAT1 but decreases OsHMA3 expression in rice roots, which resulted in increased Cd uptake in hydroponically grown rice.	[Hussain, Babar; Li, Jumei; Tahir, Nazia; Ullah, Aman] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Ma, Yibing] Macau Univ Sci & Technol, Macao Environm Res Inst, Macau, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Macau University of Science & Technology	Li, JM (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.	lijumei@caas.cn	Hussain, Babar/AGX-9804-2022	Hussain, Babar/0000-0001-9889-4636	Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences; National Key Research and Development Program of China; National Key Research and Development Program of China [2016YFD0800406]; project "Research on Migration/Transformation and Safety Threshold of Heavy Metals in Farmland Systems	Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences; National Key Research and Development Program of China; National Key Research and Development Program of China; project "Research on Migration/Transformation and Safety Threshold of Heavy Metals in Farmland Systems	We are thankful to Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences and National Key Research and Development Program of China for funding and resources. The research was funded by the National Key Research and Development Program of China, under grant no (2016YFD0800406) and project "Research on Migration/Transformation and Safety Threshold of Heavy Metals in Farmland Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari T, 2006, J PLANT NUTR, V29, P1919, DOI 10.1080/01904160600927435; da Silva YJAB, 2014, ENVIRON MONIT ASSESS, V186, P47, DOI 10.1007/s10661-013-3354-5; Bashir A, 2018, ENVIRON SCI POLLUT R, V25, P20691, DOI 10.1007/s11356-018-2042-y; Cai YM, 2020, ENVIRON POLLUT, V260, DOI 10.1016/j.envpol.2020.113941; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Chang JD, 2020, PLANT CELL ENVIRON, V43, P2476, DOI 10.1111/pce.13843; Chen Z, 2017, ENVIRON POLLUT, V231, P549, DOI 10.1016/j.envpol.2017.08.055; Chen Z, 2017, CHEMOSPHERE, V175, P275, DOI 10.1016/j.chemosphere.2017.02.053; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Cohen CK, 1998, PLANT PHYSIOL, V116, P1063, DOI 10.1104/pp.116.3.1063; Cui JH, 2018, SCI TOTAL ENVIRON, V644, P602, DOI 10.1016/j.scitotenv.2018.07.002; Du JN, 2013, MAR POLLUT BULL, V74, P105, DOI 10.1016/j.marpolbul.2013.07.023; Gao L, 2016, RICE, V9, DOI 10.1186/s12284-016-0112-7; Huang QN, 2017, PLANT GROWTH REGUL, V82, P317, DOI 10.1007/s10725-017-0261-8; Huang XC, 2017, CHEMOSPHERE, V174, P585, DOI 10.1016/j.chemosphere.2017.02.012; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2012, PLANT SIGNAL BEHAV, V7, P763, DOI 10.4161/psb.20510; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Kobayashi T, 2010, P JPN ACAD B-PHYS, V86, P900, DOI 10.2183/pjab.86.900; Lee S, 2009, PLANT CELL ENVIRON, V32, P408, DOI 10.1111/j.1365-3040.2009.01935.x; Liu HJ, 2007, ENVIRON EXP BOT, V59, P314, DOI 10.1016/j.envexpbot.2006.04.001; Liu HJ, 2008, SCI TOTAL ENVIRON, V394, P361, DOI 10.1016/j.scitotenv.2008.02.004; Liu HJ, 2017, CHEMOSPHERE, V171, P240, DOI 10.1016/j.chemosphere.2016.12.081; Liu R, 2014, SOIL SEDIMENT CONTAM, V23, P374, DOI 10.1080/15320383.2014.831027; Liu WJ, 2005, PLANT SOIL, V277, P127, DOI 10.1007/s11104-005-6453-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CN, 2019, ENVIRON INT, V126, P619, DOI 10.1016/j.envint.2019.03.004; Luo JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03088-0; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Nocito FF, 2011, PLANT CELL ENVIRON, V34, P994, DOI 10.1111/j.1365-3040.2011.02299.x; Qin Du, 2010, Chinese Journal of Rice Science, V24, P189, DOI 10.3969/j.issn.1001-7216.2010.02.14; Rahman A, 2016, CR BIOL, V339, P462, DOI 10.1016/j.crvi.2016.08.002; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Sasaki A, 2014, J EXP BOT, V65, P6013, DOI 10.1093/jxb/eru340; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Sebastian A, 2015, PLANTA, V241, P1519, DOI 10.1007/s00425-015-2276-6; Shao GS, 2008, SCI CHINA SER C, V51, P245, DOI 10.1007/s11427-008-0031-y; Suda A, 2016, GEODERMA, V270, P68, DOI 10.1016/j.geoderma.2015.12.017; Takahashi R, 2012, PLANT SIGNAL BEHAV, V7, P1605, DOI 10.4161/psb.22454; Takahashi R, 2011, PLANT SIGNAL BEHAV, V6, P1813, DOI 10.4161/psb.6.11.17587; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Tiwari M, 2014, PLANT CELL ENVIRON, V37, P140, DOI 10.1111/pce.12138; Tripathi RD, 2014, METALLOMICS, V6, P1789, DOI 10.1039/c4mt00111g; Wang J, 2019, ENVIRON SCI TECHNOL, V53, P2500, DOI 10.1021/acs.est.8b06863; Wu ZC, 2018, ENVIRON EXP BOT, V155, P734, DOI 10.1016/j.envexpbot.2018.08.024; XLSTAT A, 2013, DAT AN STAT SOFTW MI; Yang M, 2014, J EXP BOT, V65, P4849, DOI 10.1093/jxb/eru259; Yang YJ, 2018, CHEMOSPHERE, V193, P547, DOI 10.1016/j.chemosphere.2017.11.061; Yu HY, 2016, ENVIRON POLLUT, V209, P38, DOI 10.1016/j.envpol.2015.11.021; Zhang BL, 2018, ECOTOX ENVIRON SAFE, V147, P913, DOI 10.1016/j.ecoenv.2017.09.064; Zheng RL, 2012, CHEMOSPHERE, V89, P856, DOI 10.1016/j.chemosphere.2012.05.008; Zhou H, 2018, ECOTOX ENVIRON SAFE, V152, P91, DOI 10.1016/j.ecoenv.2018.01.031; Zornoza P, 2010, J PLANT PHYSIOL, V167, P1027, DOI 10.1016/j.jplph.2010.02.011	55	9	10	16	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243174	10.1371/journal.pone.0243174	http://dx.doi.org/10.1371/journal.pone.0243174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301482	Green Published, gold			2022-12-26	WOS:000600143100079
J	Maru, S; Patil, U; Carroll-Bennett, R; Baum, A; Bohn-Hemmerdinger, T; Ditchik, A; Scanlon, ML; Krishnan, P; Bogaert, K; Woodbury, C; Maru, D; Noble, L; Wasserman, R; Brown, B; Vreeman, R; Masci, J				Maru, Sheela; Patil, Uday; Carroll-Bennett, Rachel; Baum, Aaron; Bohn-Hemmerdinger, Tracy; Ditchik, Andrew; Scanlon, Michael L.; Krishnan, Parvathy; Bogaert, Kelly; Woodbury, Carson; Maru, Duncan; Noble, Lawrence; Wasserman, Randi; Brown, Barry; Vreeman, Rachel; Masci, Joseph			Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York	PLOS ONE			English	Article								Background Universal screening for SARS-CoV-2 infection on Labor and Delivery (L&D) units is a critical strategy to manage patient and health worker safety, especially in a vulnerable high-prevalence community. We describe the results of a SARS-CoV-2 universal screening program at the L&D Unit at Elmhurst Hospital in Queens, NY, a 545-bed public hospital serving a diverse, largely immigrant and low-income patient population and an epicenter of the global pandemic. Methods and findings We conducted a retrospective cross-sectional study. All pregnant women admitted to the L&D Unit of Elmhurst Hospital from March 29, 2020 to April 22, 2020 were included for analysis. The primary outcomes of the study were: (1) SARS-CoV-2 positivity among universally screened pregnant women, stratified by demographic characteristics, maternal comorbidities, and delivery outcomes; and (2) Symptomatic or asymptomatic presentation at the time of testing among SARS-CoV-2 positive women. A total of 126 obstetric patients were screened for SARS-CoV-2 between March 29 and April 22. Of these, 37% were positive. Of the women who tested positive, 72% were asymptomatic at the time of testing. Patients who tested positive for SARS-CoV-2 were more likely to be of Hispanic ethnicity (unadjusted difference 24.4 percentage points, CI 7.9, 41.0) and report their primary language as Spanish (unadjusted difference 32.9 percentage points, CI 15.8, 49.9) than patients who tested negative. Conclusions In this retrospective cross-sectional study of data from a universal SARS-Cov-2 screening program implemented in the L&D unit of a safety-net hospital in Queens, New York, we found over one-third of pregnant women testing positive, the majority of those asymptomatic. The rationale for universal screening at the L&D Unit at Elmhurst Hospital was to ensure safety of patients and staff during an acute surge in SARS-Cov-2 infections through appropriate identification and isolation of pregnant women with positive test results. Women were roomed by their SARS-CoV-2 status given increasing space limitations. In addition, postpartum counseling was tailored to infection status. We quickly established discharge counseling and follow-up protocols tailored to their specific social needs. The experience at Elmhurst Hospital is instructive for other L&D units serving vulnerable populations and for pandemic preparedness.	[Maru, Sheela; Baum, Aaron; Scanlon, Michael L.; Maru, Duncan; Vreeman, Rachel] Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA; [Maru, Sheela; Baum, Aaron; Scanlon, Michael L.; Maru, Duncan; Vreeman, Rachel] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA; [Maru, Sheela; Carroll-Bennett, Rachel; Bohn-Hemmerdinger, Tracy; Ditchik, Andrew; Bogaert, Kelly; Woodbury, Carson; Brown, Barry] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Maru, Sheela; Patil, Uday; Carroll-Bennett, Rachel; Bohn-Hemmerdinger, Tracy; Ditchik, Andrew; Krishnan, Parvathy; Bogaert, Kelly; Woodbury, Carson; Maru, Duncan; Noble, Lawrence; Wasserman, Randi; Brown, Barry; Masci, Joseph] New York City Hlth Hosp Elmhurst, New York, NY 11373 USA; [Patil, Uday; Krishnan, Parvathy; Maru, Duncan; Noble, Lawrence; Wasserman, Randi] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Maru, Duncan; Masci, Joseph] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Maru, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA.; Maru, S (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA.; Maru, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA.; Maru, S (corresponding author), New York City Hlth Hosp Elmhurst, New York, NY 11373 USA.	Sheela.Maru@mssm.edu		Maru, Duncan/0000-0002-5923-6910				Andrikopoulou M, 2020, OBSTET GYNECOL, V136, P291, DOI 10.1097/AOG.0000000000003996; [Anonymous], 2019, COMM HLTH NEEDS ASS; Bianco A, 2020, OBSTET GYNECOL, V136, P283, DOI 10.1097/AOG.0000000000003985; Government of New York City, 2020, COVID 19 DEATHS RAC; Khoury R, 2020, OBSTET GYNECOL, V136, P273, DOI 10.1097/AOG.0000000000004025; Krieger N, 2020, HLTH AFFAIRS BLOG, DOI DOI 10.1377/HBL0G20200414.238084/FULL/; Miller ES, 2020, OBSTET GYNECOL, V136, P232, DOI 10.1097/AOG.0000000000003983; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; NYC Health, COVID 19 DAT; Rothfeld M, 2020, NEW YORK TIMES; Shear, 2020, NEW YORK TIMES; Stringer SM, 2015, NYC HOUSING BRIEF HI; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Vintzileos WS, 2020, AM J OBSTET GYNECOLO; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, p411e5, DOI DOI 10.15585/mmwr.mm6914e1	16	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0238409	10.1371/journal.pone.0238409	http://dx.doi.org/10.1371/journal.pone.0238409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301498	Green Published, gold, Green Submitted			2022-12-26	WOS:000600143100044
J	Sime, WT; Biazin, H; Zeleke, TA; Desalegn, Z				Sime, Wondewosen Tseagye; Biazin, Habtamu; Zeleke, Tamrat Abebe; Desalegn, Zelalem			Urinary tract infection in cancer patients and antimicrobial susceptibility of isolates in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; RESISTANCE; BACTERIAL; EPIDEMIOLOGY; UNIVERSITY; PROFILE	Background Urinary tract infections are the most common causes of morbidity and mortality in patients with cancer. The emergence of multiple-drug-resistant (MDR) strains of gram-negative bacteria causing urinary tract infection has become a serious concern in cancer patients. Therefore, the present study aimed to determine the spectrum and antibiotic resistance pattern of bacterial isolates related to urinary tract infections among cancer patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Methods and materials Hospital based prospective cross-sectional study was conducted for three months from January to March 2018 in tertiary care hospital located in the capital city of the country. Gram-negative bacteria isolated from urine specimens from hospitalized patients with cancer were characterized using standard microbiological methods. Modified Kirby-Bauer disk diffusion technique was applied for antimicrobial susceptibility testing in accordance with CLSI 2019 criteria. Results Of totally 292 urine samples tested, eighteen (6.3%) were culture positive cases, Escherichia coli (44.4%) was the highest proportion isolated uropathogen followed by Klebsiella pneumoniae (22.2%) and Citrobacter diversus (16.7%). The antibiotic susceptibility results showed meropenem and nitrofurantoin as the most effective antibiotics for E. coli, K. pneumoniae, and Citrobacter diversus isolates. The rate of multidrug resistant (MDR) isolates were 33.3% (6/18), and meropenem and nitrofurantoin were the most effective antibiotic against MDR isolates. Conclusion The study findings showed a significant distribution of MDR gram-negative bacteria which may increase the burden of urinary tract associated infections in cancer patients. Carbapenem (meropenem) can be considered as effective agents to treat MDR cases in our region.	[Sime, Wondewosen Tseagye] St Pauls Hosp, Dept Microbiol Immunol & Parasitol, Millennium Med Coll, Addis Ababa, Ethiopia; [Biazin, Habtamu; Zeleke, Tamrat Abebe; Desalegn, Zelalem] Addis Ababa Univ, Sch Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia	Addis Ababa University	Sime, WT (corresponding author), St Pauls Hosp, Dept Microbiol Immunol & Parasitol, Millennium Med Coll, Addis Ababa, Ethiopia.	wondewosentsg@gmail.com	Kebede, Habtamu Biazin/ABG-2536-2021	Kebede, Habtamu/0000-0001-8884-8791; Sime, Wondewosen Tsegaye/0000-0001-7040-579X	St. Paul's Hospital Millennium Medical College	St. Paul's Hospital Millennium Medical College	Though we have not got financial grant specifically for this research, work, St. Paul's Hospital Millennium Medical College supported financially for this study for the purchase laboratory consumable."	[Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Arega B, 2018, INFECT DRUG RESIST, V11, P1511, DOI 10.2147/IDR.S168867; Ashour HM, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-14; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bitew A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2743-8; Chesbrougn M, 2000, MANUAL MED MICROBIOL, P251; Clinical and Laboratory Standards Institute (CLSI), 2016, M100 PERFORMANCE STA, V26th; Custovic Amer, 2014, Mater Sociomed, V26, P7, DOI 10.5455/msm.2014.26.7-11; Fazeli Hossein, 2018, Adv Biomed Res, V7, P69, DOI 10.4103/abr.abr_164_17; Fentie A, 2018, INFECT DRUG RESIST, V11, P2169, DOI 10.2147/IDR.S183283; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Fukushima H, 2017, IN VIVO, V31, P1215, DOI 10.21873/invivo.11193; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamboj M, 2009, LANCET ONCOL, V10, P589, DOI 10.1016/S1470-2045(09)70069-5; Kawecki D, 2014, TRANSPL P, V46, P2733, DOI 10.1016/j.transproceed.2014.09.115; Kim SI, 2014, WORLD J GASTROENTERO, V20, P6211, DOI 10.3748/wjg.v20.i20.6211; Leber M, 2018, CLIN MICROBIOLOGY PR, V4 th; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Rahn David D, 2008, Urol Nurs, V28, P333; Richards KA, 2016, INT J UROL, V23, P42, DOI 10.1111/iju.12959; Rosa RG, 2014, AM J INFECT CONTROL, V42, P74, DOI 10.1016/j.ajic.2013.06.025; See I, 2016, CLIN INFECT DIS, V62, P1203, DOI 10.1093/cid/ciw113; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Struelens MJ, 1998, BRIT MED J, V317, P652, DOI 10.1136/bmj.317.7159.652; Tigabu A, 2020, INT J MICROBIOL, V2020, DOI 10.1155/2020/3091564	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243474	10.1371/journal.pone.0243474	http://dx.doi.org/10.1371/journal.pone.0243474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301465	gold, Green Published			2022-12-26	WOS:000600143100039
J	Towett, EK; Drake, LB; Acquah, GE; Haefele, SM; McGrath, SP; Shepherd, KD				Towett, Erick K.; Drake, Lee B.; Acquah, Gifty E.; Haefele, Stephan M.; McGrath, Steve P.; Shepherd, Keith D.			Comprehensive nutrient analysis in agricultural organic amendments through non-destructive assays using machine learning	PLOS ONE			English	Article							SOIL-FERTILITY; FARMING SYSTEMS; MANAGEMENT; MANURE; SPECTROSCOPY; FARMERS	Portable X-ray fluorescence (pXRF) and Diffuse Reflectance Fourier Transformed Mid-Infrared (DRIFT-MIR) spectroscopy are rapid and cost-effective analytical tools for material characterization. Here, we provide an assessment of these methods for the analysis of total Carbon, Nitrogen and total elemental composition of multiple elements in organic amendments. We developed machine learning methods to rapidly quantify the concentrations of macro- and micronutrient elements present in the samples and propose a novel system for the quality assessment of organic amendments. Two types of machine learning methods, forest regression and extreme gradient boosting, were used with data from both pXRF and DRIFT-MIR spectroscopy. Cross-validation trials were run to evaluate generalizability of models produced on each instrument. Both methods demonstrated similar broad capabilities in estimating nutrients using machine learning, with pXRF being suitable for nutrients and contaminants. The results make portable spectrometry in combination with machine learning a scalable solution to provide comprehensive nutrient analysis for organic amendments.	[Towett, Erick K.; Shepherd, Keith D.] World Agroforestry ICRAF, Nairobi, Kenya; [Drake, Lee B.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Acquah, Gifty E.; Haefele, Stephan M.; McGrath, Steve P.] Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England	CGIAR; World Agroforestry (ICRAF); University of New Mexico; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Towett, EK (corresponding author), World Agroforestry ICRAF, Nairobi, Kenya.; Drake, LB (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	e.towett@cgiar.org; b.lee.drake@gmail.com	Haefele, Stephan M/E-1256-2017; McGrath, Steve P/B-5127-2008	Haefele, Stephan M/0000-0003-0389-8373; McGrath, Steve P/0000-0003-0952-8947; Acquah, Gifty/0000-0003-4269-0903	Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS); CGIAR Research Program on Water, Land and Ecosystems (WLE); CGIAR Trust Fund; Institute Strategic Programme grant, "Soils to Nutrition" UK-BBSRC [BBS/E/C/000I0310]; BBSRC [BBS/E/C/000I0310, BB/P023126/1] Funding Source: UKRI	Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS); CGIAR Research Program on Water, Land and Ecosystems (WLE)(CGIAR); CGIAR Trust Fund(CGIAR); Institute Strategic Programme grant, "Soils to Nutrition" UK-BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work received support from the Bill & Melinda Gates Foundation (BMGF), through the Africa Soil Information Service (AfSIS), and the CGIAR Research Program on Water, Land and Ecosystems (WLE), supported by the CGIAR Trust Fund: wle.cgiar.org/donors. SPM and SH were funded by the Institute Strategic Programme grant, "Soils to Nutrition" UK-BBSRC grant number BBS/E/C/000I0310. The funders were not involved in the study design, the collection, management, analysis, and interpretation of data, the writing of the report or the decision to submit the report for publication.	Bindraban PS, 2015, BIOL FERT SOILS, V51, P897, DOI 10.1007/s00374-015-1039-7; Bosco GL, 2013, TRAC-TREND ANAL CHEM, V45, P121, DOI 10.1016/j.trac.2013.01.006; Guerra MBB, 2014, J ANAL ATOM SPECTROM, V29, P1667, DOI [10.1039/C4JA00083H, 10.1039/c4ja00083h]; Chen T., 2016, ARXIV160302754V3; Clark LF, 2018, OUTLOOK AGR, V47, P11, DOI 10.1177/0030727018760601; Enyong LA, 1999, NUTR CYCL AGROECOSYS, V53, P177, DOI 10.1023/A:1009745225465; Frahm E, 2013, J ARCHAEOL SCI, V40, P1080, DOI 10.1016/j.jas.2012.06.038; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Harris F, 2002, EXP AGR, V38, P131, DOI 10.1017/S0014479702000212; Harris F, 2001, EXPT AGR, V36, P1; Heginbotham A, 2017, ARCHAEOMETRY, V59, P714, DOI 10.1111/arcm.12282; Hughes R. E., 1998, UNIT ISSUES ARCHAEOL, P103; Kaiser B., 2012, STUDIES ARCHAEOLOGIC, P449; Li SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17219-y; Lopez-Nunez R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224317; Lucas-Tooth H.J., 1961, METALLURGIA, V64, P149; Materechera SA, 2010, NUTR CYCL AGROECOSYS, V87, P415, DOI 10.1007/s10705-010-9347-7; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; Mkhabela TS, 2006, J PLANT NUTR, V29, P1157, DOI 10.1080/01904160600767179; Powell J. M., 1995, Livestock and sustainable nutrient cycling in mixed farming systems of sub-Saharan Africa. Volume II: Technical papers. Proceedings of an International Conference, International Livestock Centre for Africa (ILCA), Addis Ababa, Ethiopia 22-26 November 1993., P21; R Development Core Team, 2016, R LANG ENV STAT COMP; Rademaker K, 2013, GEOLOGY, V41, P779, DOI 10.1130/G34313.1; Roa-Espinosa A, 2016, J ENV ANAL CHEM, V3, P173, DOI [10.4172/2380-2391.1000173, DOI 10.4172/2380-2391.1000173]; Rousseau R. M, 2009, OPEN SPECTROSCOPY J, V3, P31, DOI [DOI 10.2174/1874383800903010031, 10.2174/1874383800903010031]; Rufino MC, 2007, LIVEST SCI, V112, P273, DOI 10.1016/j.livsci.2007.09.011; Sapkota Y, 2020, J ENVIRON QUAL, V49, P472, DOI 10.1002/jeq2.20013; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shepherd KD, 2007, J NEAR INFRARED SPEC, V15, P1, DOI 10.1255/jnirs.716; SOFA, 2017, LEV FOOD SYST INCL R; Thomas CL, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9120776; Towett EK, 2016, X-RAY SPECTROM, V45, P117, DOI 10.1002/xrs.2678; Towett EK, 2015, SOIL SCI SOC AM J, V79, P1375, DOI 10.2136/sssaj2014.11.0458; Vanlauwe B, 2010, OUTLOOK AGR, V39, P17, DOI 10.5367/000000010791169998; ZHAO F, 1994, COMMUN SOIL SCI PLAN, V25, P407, DOI 10.1080/00103629409369047	35	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242821	10.1371/journal.pone.0242821	http://dx.doi.org/10.1371/journal.pone.0242821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301449	Green Published, gold			2022-12-26	WOS:000600143100032
J	Gao, A; Li, JZ; Chen, K				Gao, Aji; Li, Jingzhong; Chen, Kai			A morphing approach for continuous generalization of linear map features	PLOS ONE			English	Article							SHAPE; REPRESENTATION; TRANSMISSION	With the development of web maps, people are no longer satisfied with fixed and limited scale map services but want to obtain personalized and arbitrary scale map data. Continuous map generalization technology can be used to generate arbitrary scale map data. This paper proposes a morphing method for continuously generalizing linear map features using shape context matching and hierarchical interpolation (SCM-HI). More specifically, shape characteristics are quantitatively described by shape context on which shape similarity is measured based on a chi-square method; then, two levels of interpolation, skeleton and detail interpolations, are employed to generate the geometry of intermediate curves. The main contributions of our approach include (1) exploiting both the geometry and spatial structure of a vector curve in shape matching by using shape context, and (2) preserving both the main shape structure as-rigid-as-possible and local geometric details as gradual and smooth as possible for intermediate curves by hierarchical interpolation. Experiments show that our method generates plausible morphing effects and can thus serve as a robust approach for continuous generalization of linear map features.	[Gao, Aji; Li, Jingzhong] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China; [Chen, Kai] Chengdu Res Inst Surveying & Invest, Chengdu, Sichuan, Peoples R China	Wuhan University	Li, JZ (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China.	00009232@whu.edu.cn		Gao, Aji/0000-0002-7939-7498	National Key Research and Development Program of China [2017YFB0503601, 2017YFB0503502]; National Natural Science Foundation of China [41671448]; Key Research and Development Program of Sichuan Province [19ZDYF0839]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Sichuan Province	This work was supported by the National Key Research and Development Program of China under Grant 2017YFB0503601 and 2017YFB0503502; the National Natural Science Foundation of China under Grant 41671448; the Key Research and Development Program of Sichuan Province under Grant 19ZDYF0839.	Alexa M, 2000, COMP GRAPH, P157, DOI 10.1145/344779.344859; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Baek SY, 2015, COMPUT GRAPH-UK, V46, P257, DOI 10.1016/j.cag.2014.09.025; BALLARD DH, 1981, COMMUN ACM, V24, P310, DOI 10.1145/358645.358661; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Belongie S, 2001, ADV NEUR IN, V13, P831; Buchin K, 2016, ACM TRANS SPAT ALGOR, V2, DOI 10.1145/2818373; Cecconi A, 2002, COMPUT GRAPH FORUM, V21, P787, DOI 10.1111/1467-8659.00636; Cecconi A., 2003, INTEGRATION CARTOGRA; Danciger J, 2009, GEOINFORMATICA, V13, P203, DOI 10.1007/s10707-008-0049-0; Deng M, 2015, T GIS, V19, P653, DOI 10.1111/tgis.12111; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Efrat A, 2001, SIAM PROC S, P680; Gomes J., 1999, WARPING MORPHING GRA; Gunther O, 1988, EFFICIENT STRUCTURES, V337; Li JZ, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6080242; Li JZ, 2017, ISPRS INT GEO-INF, V6, DOI 10.3390/ijgi6060173; Li Z L, 2008, P INT ARCH PHOTOG B2, V37, P637; Liu LG, 2004, 12TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, PROCEEDINGS, P111; Liu PC, 2016, CARTOGR GEOGR INF SC, V43, P454, DOI 10.1080/15230406.2015.1088799; Meijers B, 2011, SPACE SCALE CUBE INT; Mortara M, 2001, COMPUT GRAPH-UK, V25, P13, DOI 10.1016/S0097-8493(00)00104-7; Nollenburg M, 2008, COMPUT ENVIRON URBAN, V32, P248, DOI 10.1016/j.compenvurbsys.2008.06.004; Oosterom PJM, 1990, REACTIVE DATA STRUCT; Pantazis D, 2009, P 24 INT CART C; Pantazis D, 2009, URBAN REGIONAL DATA, P195, DOI DOI 10.1201/9780203869352.CH18; Papadimitrou CH, 1982, COMBINATORIAL OPTIMI; Reilly DF, 2004, PROC GRAPH INTERF, P231; Ruibin Ma, 2018, Computational Visual Media, V4, P305, DOI 10.1007/s41095-018-0127-7; Sederberg T. W., 1993, Computer Graphics Proceedings, P15, DOI 10.1145/166117.166118; SEDERBERG TW, 1992, COMP GRAPH, V26, P25, DOI 10.1145/142920.134001; Sester M, 2005, DEVELOPMENTS IN SPATIAL DATA HANDLING, P355, DOI 10.1007/3-540-26772-7_27; Shen YL, 2019, INT J APPL EARTH OBS, V79, P162, DOI 10.1016/j.jag.2019.02.008; Surazhsky V., 2003, International Journal of Shape Modeling, V9, P191, DOI 10.1142/S0218654303000115; Van Kreveld M., 2001, P 20 INT CART C, P2180; van Oosterom, 1995, GIS GEN METHODOLOGY, V1, P120, DOI 10.1201/9781003062646; van Oosterom P., 2014, ABSTRACTING GEOGRAPH, P83; van Oosterom P., 2005, CART GRAPHY GEOGR IN, V32, P331, DOI [10.1559/152304005775194782, DOI 10.1559/152304005775194782]; van Oosterom P, 2010, LECT NOTES COMPUT SC, V6292, P310, DOI 10.1007/978-3-642-15300-6_22; van Oosterom P, 2009, COMPUT ENVIRON URBAN, V33, P303, DOI 10.1016/j.compenvurbsys.2009.07.001; Wang SF, 2015, VISUAL COMPUT, V31, P1163, DOI 10.1007/s00371-014-1000-z; Whited B., 2009, P ACM SIAM JOINT C G, P187; Yang BS, 2007, INT J GEOGR INF SCI, V21, P215, DOI 10.1080/13658810600894281; Yang WW, 2009, COMPUT GRAPH-UK, V33, P414, DOI 10.1016/j.cag.2009.03.007; Zhang YF, 1996, IEEE COMPUT GRAPH, V16, P34, DOI 10.1109/38.511850; Zhang Z, 2015, INFORM SCIENCES, V315, P88, DOI 10.1016/j.ins.2015.04.007	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243328	10.1371/journal.pone.0243328	http://dx.doi.org/10.1371/journal.pone.0243328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290396	Green Published, gold			2022-12-26	WOS:000598620100003
J	Pothisiri, W; Prasitsiriphon, O; Aekplakorn, W				Pothisiri, Wiraporn; Prasitsiriphon, Orawan; Aekplakorn, Wichai			Extent of aging across education and income subgroups in Thailand: Application of a characteristic-based age approach	PLOS ONE			English	Article							GRIP STRENGTH; PHYSICAL PERFORMANCE; HANDGRIP STRENGTH; WALKING SPEED; PROGNOSTIC VALUE; OLDER-ADULTS; WOMEN; ASSOCIATION; DISABILITY; MORTALITY	Aim This study aimed to identify differences in physical performance across various socioeconomic groups within an older population and to convert those differences into a common metric to facilitate comparisons of aging speed across socioeconomic subgroups. Methods We employed data from the 2009 National Health Examination Survey of Thailand. Physical performance was assessed using three health characteristics: grip strength, as a measure of upper body strength; walking speed, as a measure of lower body strength; and a combined measure of grip strength and walking speed, to capture the strength of the whole body. Education level and income were used to distinguish socioeconomic subpopulations. We followed a characteristic-based age approach to transform these population characteristics, which were measured in different units, into a common and comparable aging metric, referred to as alpha - age. Results Physical aging trajectories varied by sex and socioeconomic status. Some education, particularly secondary or higher education levels, was significantly associated with greater physical strength in older age for both men and women, whereas higher income was significantly associated with physical strength only for men. Across the three health characteristics, having a primary education slowed age-related declines by up to 6.3 years among men and 2.8 years among women, whereas being in a higher income group slowed age-related declines by 8.2 years among men and up to 4.9 years among women. Conclusions This study adds new evidence from a developing Asian country regarding the difference in aging speeds across subpopulations associated with different levels of education and income.	[Pothisiri, Wiraporn; Prasitsiriphon, Orawan] Chulalongkorn Univ, Coll Populat Studies, Bangkok, Thailand; [Prasitsiriphon, Orawan] Hlth Syst Res Inst, Hlth Insurance Syst Res Off, Bang Khen, Nonthaburi, Thailand; [Aekplakorn, Wichai] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Community Med, Bangkok, Thailand	Chulalongkorn University; Mahidol University	Prasitsiriphon, O (corresponding author), Chulalongkorn Univ, Coll Populat Studies, Bangkok, Thailand.; Prasitsiriphon, O (corresponding author), Hlth Syst Res Inst, Hlth Insurance Syst Res Off, Bang Khen, Nonthaburi, Thailand.	orawan@hisro.or.th	Aekplakorn, Wichai/AAK-6867-2021	Prasitsiriphon, Orawan/0000-0001-6891-7040	Chulalongkorn University through the Population, Family Dynamics, and Social Policy Research Unit	Chulalongkorn University through the Population, Family Dynamics, and Social Policy Research Unit	This study was supported by Chulalongkorn University through the Population, Family Dynamics, and Social Policy Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aekplakorn W, 2011, DIABETES CARE, V34, P1980, DOI 10.2337/dc11-0099; Albert SM, 2015, J GERONTOL A-BIOL, V70, P71, DOI 10.1093/gerona/glu088; Andersen-Ranberg K, 2009, EUR J AGEING, V6, P227, DOI 10.1007/s10433-009-0128-6; [Anonymous], 2018, BMJ, V361, pk2475; Apinonkul B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153763; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Bohannon RW, 2019, CLIN INTERV AGING, V14, P1681, DOI 10.2147/CIA.S194543; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Foundation of Thai Gerontology Research, 2010, SIT THAI ELD 2009; Foundation of Thai Gerontology Research and Development institute, 2017, SIT THAI ELD 2017; Giampaoli S, 1999, AGE AGEING, V28, P283, DOI 10.1093/ageing/28.3.283; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hansen AM, 2016, J EPIDEMIOL COMMUN H, V70, P748, DOI 10.1136/jech-2015-205664; Karvonen-Gutierrez CA, 2018, AGE AGEING, V47, P685, DOI 10.1093/ageing/afy067; Knodel J, 2009, POPULATION AGEING WE; Knodel J., 2015, SITUATION THAILANDS; Kutner M., 2004, APPL LINEAR STAT MOD; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Loichinger E, 2018, ASIAN POPUL STUD, V14, P310, DOI 10.1080/17441730.2018.1532140; Oksuzyan A, 2010, J AGING HEALTH, V22, P589, DOI 10.1177/0898264310366752; Purser JL, 2012, ARTHRIT CARE RES, V64, P1028, DOI 10.1002/acr.21655; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Sanderson WC, 2016, J AGING HEALTH, V28, P1178, DOI 10.1177/0898264316656515; Sanderson WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096289; Steiber N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163917; Stewart raf D.I., 2014, DEF STUD, V14, P76, DOI [10.1080/14702436.2014.890336, DOI 10.1080/14702436.2014.890336]; Syddall H, 2009, J AGING HEALTH, V21, P913, DOI 10.1177/0898264309340793; Teerawichitchainan B., 2019, SITUATION THAILANDS; Veronese N, 2016, EXP GERONTOL, V81, P110, DOI 10.1016/j.exger.2016.05.008; Vianna LC, 2007, J STRENGTH COND RES, V21, P1310; Weber D, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0201-x; Welmer AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-641; World Bank Group, 2016, WORLD BANK GROUP A Z; Zaninotto P, 2013, J GERONTOL A-BIOL, V68, P1525, DOI 10.1093/gerona/glt058	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243081	10.1371/journal.pone.0243081	http://dx.doi.org/10.1371/journal.pone.0243081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8OF	33290428	Green Published, gold			2022-12-26	WOS:000598620100016
J	Andersson, N; Nilsson, MH; Slaug, B; Oswald, F; Iwarsson, S				Andersson, Nilla; Nilsson, Maria H.; Slaug, Bjorn; Oswald, Frank; Iwarsson, Susanne			The meaning of home questionnaire revisited: Psychometric analyses among people with Parkinson's disease reveals new dimensions	PLOS ONE			English	Article							THERAPEUTIC INTERVENTIONS; MULTIPLE-SCLEROSIS; ACCESSIBILITY; INSTRUMENTS; VALIDITY; QUALITY; WALKING; LIFE	Background Research addressing perceptions of housing in people with Parkinson's disease (PD) is rare, and existing instruments capturing perceived aspects of housing are rarely used. Perceived housing comprises of several domains and is associated with health in general older populations. One such domain is meaning of home, captured by the Meaning of Home Questionnaire (MOH). The aim of this study was to evaluate psychometric properties of the MOH among people with PD. Materials and methods The MOH was administrated to 245 participants with PD (mean age = 69.9 years; mean PD duration = 9.7 years). The instrument consisted of four sub-scales with 28 items, each with 11 response options (strongly disagree = 0; strongly agree = 10). We evaluated data quality, structural validity (factor analysis), construct validity (i.e., testing correlations with relevant constructs according to pre-defined hypotheses), corrected item total correlations, floor and ceiling effects and internal consistency. Results The data quality was high (0-1.2% missing data). The exploratory factor analysis suggested removal of five items and revealed three new factors; "My home is my castle", "My home is my prison" and "My home is my social hub". The 23-item MOH showed statistically significant correlations with life satisfaction, usability and ADL dependence, while not correlated with number of environmental barriers. These findings were largely as hypothesised, thus supporting construct validity (both convergent and discriminant). The corrected item total correlations were >0.3 for all items and the internal consistency was >0.70 for all sub-scales. No floor or ceiling effects were reported except for the sub-scale "My home is my castle" (ceiling effect = 15.6%). Conclusions The 23-item MOH version with three new sub-scales is sufficiently reliable and valid for use in PD populations. This paves the way for further research of meaning of home among people with PD, using the 23-item MOH version.	[Andersson, Nilla; Nilsson, Maria H.; Slaug, Bjorn; Iwarsson, Susanne] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Andersson, Nilla; Nilsson, Maria H.] Skane Univ Hosp, Memory Clin, Malmo, Sweden; [Nilsson, Maria H.] Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Lund, Sweden; [Oswald, Frank] Goethe Univ Frankfurt, Interdisciplinary Ageing Res IAW, Frankfurt, Germany	Lund University; Lund University; Skane University Hospital; Lund University; Goethe University Frankfurt	Andersson, N (corresponding author), Lund Univ, Dept Hlth Sci, Lund, Sweden.; Andersson, N (corresponding author), Skane Univ Hosp, Memory Clin, Malmo, Sweden.	nilla.andersson@med.lu.se		Slaug, Bjorn/0000-0001-7386-2224; Andersson, Nilla/0000-0003-3857-0183; Oswald, Frank/0000-0002-3811-1385	Strategic Research Area in neuroscience (MultiPark) at Lund University; Swedish Research Council [2013-08755-11, K2014-99X-22618-01-6, 2015-02616]; Ribbingska Foundation in Lund; Greta and Johan Kock Foundation; Swedish Parkinson Foundation; Norrbacka-Eugenia Foundation; Crafoord Foundation	Strategic Research Area in neuroscience (MultiPark) at Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ribbingska Foundation in Lund; Greta and Johan Kock Foundation; Swedish Parkinson Foundation; Norrbacka-Eugenia Foundation; Crafoord Foundation	The HHPD project was funded by the Strategic Research Area in neuroscience (MultiPark) at Lund University (MN), the Swedish Research Council (SI; grant number:2015-02616), Swedish Research Council (SI; 2013-08755-11, K2014-99X-22618-01-6), Neuro (SI), Neuro (MN), Ribbingska Foundation in Lund (SI), Greta and Johan Kock Foundation (MN), Swedish Parkinson Foundation (MN), Norrbacka-Eugenia Foundation (MN) and the Crafoord Foundation (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Andersson N, 2020, AGING CLIN EXP RES, V32, P2639, DOI 10.1007/s40520-020-01477-4; ASBERG KH, 1989, SCAND J REHABIL MED, V21, P171; Bhidayasiri R, 2015, PARKINSONISM RELAT D, V21, P1127, DOI 10.1016/j.parkreldis.2015.08.025; Bjorklund A, 2010, PROG BRAIN RES, V184, P325, DOI 10.1016/S0079-6123(10)84017-8; Chaudhury H, 2019, J AGING STUD, V51, DOI 10.1016/j.jaging.2019.100821; Cramm JM, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0027-y; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Fange A, 1999, Can J Occup Ther, V66, P250; Fange A, 2003, DISABIL REHABIL, V25, P1316, DOI 10.1080/09638280310001616286; Finch E, 2002, PHYS REHABILITATION; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Goodarzi Z, 2016, NEUROLOGY, V87, P426, DOI 10.1212/WNL.0000000000002898; Granbom M, 2014, J AGING STUD, V29, P9, DOI 10.1016/j.jaging.2013.12.005; Hammarlund CS, 2014, J PARKINSON DIS, V4, P657, DOI 10.3233/JPD-140399; Hariz GM, 2011, ACTA NEUROL SCAND, V123, P20, DOI 10.1111/j.1600-0404.2010.01344.x; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Hobart JC, 2004, HEALTH TECHNOL ASSES, V8, P1; Iwarsson S., 2001, HOUSING ENABLER INST; Iwarsson Susanne, 2007, Scand J Occup Ther, V14, P3, DOI 10.1080/11038120601094732; Iwarsson S, 2016, J HOUS ELDER, V30, P330, DOI 10.1080/02763893.2016.1198742; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; John O. P., 2000, HDB RES METHODS SOCI, P339; Jones D, 2008, DISABIL REHABIL, V30, P1213, DOI 10.1080/09638280701828955; Kylen M, 2019, EUR J AGEING, V16, P305, DOI 10.1007/s10433-019-00501-5; Kylen M, 2017, J ENVIRON PSYCHOL, V51, P239, DOI 10.1016/j.jenvp.2017.04.006; Mayo AM, 2015, CLIN NURSE SPEC, V29, P134, DOI 10.1097/NUR.0000000000000131; Mayring P., 2015, QUALITATIVE INHALTSA, Vtwelfth; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nilsson MH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-142; Nilsson MH, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/710839; Oswald F., 2003, J HOUS ELDERLY, V17, P135, DOI [DOI 10.1300/J081V17N01_, DOI 10.1300/J081v17n01_10]; Oswald F., 2005, HOME IDENTITY LATE L, P21; Oswald F, 2001, IAPS B PEOPLE ENV ST, V19, P8; Oswald F, 1999, QUESTIONNAIRE UNPUB; Oswald F., 2019, OXFORD RES ENCY PSYC, DOI [10.1093/acrefore/9780190236557.013.399, DOI 10.1093/ACREFORE/9780190236557.013.399]; Oswald F, 1996, HIER BIN ICH HAUSE B; Oswald F, 2005, HOME IDENTITY LATE L, P21; Oswald F, 2007, GERONTOLOGIST, V47, P96, DOI 10.1093/geront/47.1.96; Oswald Frank, 2004, Reviews on Environmental Health, V19, P223; Oswalda F, 2006, J ENVIRON PSYCHOL, V26, P187, DOI 10.1016/j.jenvp.2006.07.002; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Rowles GD, 2003, HIST HABIT HEART HLT; RUBINSTEIN RL, 1989, J GERONTOL, V44, pS45, DOI 10.1093/geronj/44.2.S45; Sjodahl Hammarlund C, 2018, PARKINSONS DIS, V2018; Slaug B, 2017, ACTA NEUROL SCAND, V136, P501, DOI 10.1111/ane.12763; Sniadecki Z, 2012, INTERMETALLICS, V26, P72, DOI 10.1016/j.intermet.2012.03.003; SONN U, 1991, SCAND J REHABIL MED, V23, P193; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tabachnik B. G., 2001, USING MULTIVARIATE S; Vossius C, 2009, EUR J NEUROL, V16, P194, DOI 10.1111/j.1468-1331.2008.02380.x; Wahl H-W, 2016, THEORIES ENV GERONTO, P621	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0242792	10.1371/journal.pone.0242792	http://dx.doi.org/10.1371/journal.pone.0242792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284817	gold, Green Published			2022-12-26	WOS:000597930500036
J	Lin, CH; Tseng, CY; Chao, MW				Lin, Ching-Hung; Tseng, Chia-Yi; Chao, Ming-Wei			Administration of Lactobacillus paracasei HB89 mitigates PM2.5-induced enhancement of inflammation and allergic airway response in murine asthma model	PLOS ONE			English	Article							PARTICULATE MATTER; POLLUTION; PM2.5; EXPOSURE; PARTICLES; RHINITIS; RELEASE; ROS	PM2.5 causes abnormal immune response and asthma in animals. In this study, a Balb/c mouse animal model was exposed to PM2.5 to induce asthma. Lactobacillus paracasei HB89 was fed at the same time, in order to observe whether L. paracasei HB89 mitigates respiratory tract allergies stimulated by PM2.5. The results showed that PM2.5 stimulated a significant increase in white blood cells and immunoglobulin (IgE) in OVA-induced allergic Balb/c mice, and IgE in the blood further triggered the release of histamine in the lung immune cells. This not only increased overall immune cell counts, but the lymphocyte counts also increased significantly, resulting in significant inhibitions of cytokines INF-r and TGF-beta, and induction of IL-4, IL-5, IL-13 and IL-17a. After feeding with HB89, apart from the absence of observable changes in body weight, the total white blood cell count in the animal blood and IgE response were also be reduced; the proliferation of immune cells in the lungs caused by PM2.5 was slowed down; and histamine and cytokines INF-r and TGF-beta were secreted in large quantities, but IL- 4, IL-5, IL-13, IL-17a were inhibited, which effectively reduced the possibility of asthma induction.	[Lin, Ching-Hung; Chao, Ming-Wei] Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan; [Lin, Ching-Hung; Tseng, Chia-Yi] Chung Yuan Christian Univ, Dept Biomed Engn, Taoyuan, Taiwan; [Tseng, Chia-Yi; Chao, Ming-Wei] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan	Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University	Chao, MW (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan, Taiwan.; Chao, MW (corresponding author), Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan.	chao@cycu.edu.tw		Chao, Ming-Wei/0000-0002-1574-6425	Yuan Li Tong Co., Ltd. [9405]	Yuan Li Tong Co., Ltd.	Yuan Li Tong Co., Ltd. provided support for this study in the form of a grant awarded to MWC (9405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Bai YS, 2001, FREE RADICAL BIO MED, V30, P555, DOI 10.1016/S0891-5849(00)00499-8; Becker S, 2005, ENVIRON HEALTH PERSP, V113, P1032, DOI 10.1289/ehp.7996; Bekki K, 2016, ENVIRON TOXICOL PHAR, V45, P362, DOI 10.1016/j.etap.2016.06.022; Chao MW, 2012, TOXICOLOGY, V297, P34, DOI 10.1016/j.tox.2012.03.009; Chao MW, 2017, ENVIRON TOXICOL, V32, P1412, DOI 10.1002/tox.22335; Chao MW, 2011, TOXICOLOGY, V279, P73, DOI 10.1016/j.tox.2010.09.011; Costal DJ, 2014, EUR J CLIN NUTR, V68, P602, DOI 10.1038/ejcn.2014.13; Dejmek J, 1999, ENVIRON HEALTH PERSP, V107, P475, DOI 10.2307/3434630; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Guarieiro LLN, 2015, IMPACT BIOFUELS BURN, DOI [10.1080/10962247.2014.988307, DOI 10.1080/10962247.2014.988307]; Ikeda U, 1998, CLIN CARDIOL, V21, P11, DOI 10.1002/clc.4960210103; Kang SH, 2016, INT J CARDIOL, V203, P1086, DOI 10.1016/j.ijcard.2015.11.100; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; Nembrini C, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0085-4; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Ostro B, 2014, ENVIRON RES, V132, P168, DOI 10.1016/j.envres.2014.03.042; Park J, 2018, ENVIRON INT, V117, P276, DOI 10.1016/j.envint.2018.05.018; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Pu FF, 2017, CLIN INTERV AGING, V12, P1223, DOI 10.2147/CIA.S141518; Rogers JF, 2000, AM J EPIDEMIOL, V151, P602, DOI 10.1093/oxfordjournals.aje.a010248; Rossoni RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173332; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Sorensen M, 2015, ENVIRON INT, V85, P238, DOI 10.1016/j.envint.2015.09.021; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Thiering E, 2015, TRENDS ENDOCRIN MET, V26, P384, DOI 10.1016/j.tem.2015.05.002; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Tseng C.-Y., 2019, SCI REP, V9, P1; United States Environmental Protection Agency, 2015, INT SCI ASS OX NITR; Valavanidis A, 2006, CHEMOSPHERE, V65, P760, DOI 10.1016/j.chemosphere.2006.03.052; van den Hooven EH, 2012, ENVIRON HEALTH PERSP, V120, P150, DOI 10.1289/ehp.1003316; Wang XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171721; Woodruff TJ, 2006, ENVIRON HEALTH PERSP, V114, P786, DOI 10.1289/ehp.8484; Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19; Yan DC, 2019, SKIN PHARMACOL PHYS, V32, P201, DOI 10.1159/000499436; Yang Gui, 2013, N Am J Med Sci, V5, P465, DOI 10.4103/1947-2714.117299; Zhang JX, 2019, J BIOMED NANOTECHNOL, V15, P382, DOI 10.1166/jbn.2019.2692; Zhang XY, 2018, AEROSOL AIR QUAL RES, V18, P456, DOI 10.4209/aaqr.2017.05.0167	39	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243062	10.1371/journal.pone.0243062	http://dx.doi.org/10.1371/journal.pone.0243062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284823	gold, Green Published			2022-12-26	WOS:000597930500009
J	Park, YH; Snook, JD; Zhuang, I; Shen, GF; Frankfort, BJ				Park, Yong H.; Snook, Joshua D.; Zhuang, Iris; Shen, Guofu; Frankfort, Benjamin J.			Optimized culture of retinal ganglion cells and amacrine cells from adult mice	PLOS ONE			English	Article							GENE-EXPRESSION; NEURONAL MODELS; MOUSE; HIPPOCAMPUS; SURVIVAL; BINDING; NUMBER	Cell culture is widely utilized to study the cellular and molecular biology of different neuronal cell populations. Current techniques to study enriched neurons in vitro are primarily limited to embryonic/neonatal animals and induced pluripotent stem cells (iPSCs). Although the use of these cultures is valuable, the accessibility of purified primary adult neuronal cultures would allow for improved assessment of certain neurological diseases and pathways at the cellular level. Using a modified 7-step immunopanning technique to isolate for retinal ganglion cells (RGCs) and amacrine cells (ACs) from adult mouse retinas, we have successfully developed a model of neuronal culture that maintains for at least one week. Isolations of Thy1.2(+) cells are enriched for RGCs, with the isolation cell yield being congruent to the theoretical yield of RGCs in a mouse retina. ACs of two different populations (CD15(+) and CD57(+)) can also be isolated. The populations of these three adult neurons in culture are healthy, with neurite outgrowths in some cases greater than 500 mu m in length. Optimization of culture conditions for RGCs and CD15(+) cells revealed that neuronal survival and the likelihood of neurite outgrowth respond inversely to different culture media. Serially diluted concentrations of puromycin decreased cultured adult RGCs in a dose-dependent manner, demonstrating the potential usefulness of these adult neuronal cultures in screening assays. This novel culture system can be used to model in vivo neuronal behaviors. Studies can now be expanded in conjunction with other methodologies to study the neurobiology of function, aging, and diseases.	[Park, Yong H.; Snook, Joshua D.; Zhuang, Iris; Shen, Guofu; Frankfort, Benjamin J.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Frankfort, Benjamin J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Frankfort, BJ (corresponding author), Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA.; Frankfort, BJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	benjamin.frankfort@bcm.edu		Park, Yong/0000-0001-7343-5652	Clayton Foundation for Research (Houston, TX); National Institutes of Health [R01 EY025601]; Research to Prevent Blindness (New York, NY)	Clayton Foundation for Research (Houston, TX); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB))	This project was funded by research awards from the Clayton Foundation for Research (Houston, TX) and the National Institutes of Health (R01 EY025601) to BJF, and a department award to Baylor College of Medicine from Research to Prevent Blindness (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Ahlemeyer B, 2005, J NEUROSCI METH, V149, P110, DOI 10.1016/j.jneumeth.2005.05.022; Allen LB, 2019, J INHERIT METAB DIS, V42, P934, DOI 10.1002/jimd.12088; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Barres Ben A, 2014, Cold Spring Harb Protoc, V2014, P1342, DOI 10.1101/pdb.ip073999; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Berry BJ, 2018, CELLS TISSUES ORGANS, V205, P331, DOI 10.1159/000493018; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Bott CJ, 2019, MOL BIOL CELL, V30, P1214, DOI 10.1091/mbc.E18-06-0361; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brown RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117615; Chan W, 2018, AM J PATHOL, V188, P160, DOI 10.1016/j.ajpath.2017.08.032; de Rus Jacquet Aurelie, 2019, Curr Protoc Cell Biol, V85, pe98, DOI 10.1002/cpcb.98; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Edwards D, 2017, ACS BIOMATER SCI ENG, V3, P3525, DOI 10.1021/acsbiomaterials.7b00596; Eide L, 2005, BIOTECHNIQUES, V38, P99, DOI 10.2144/05381RR02; Fileta JB, 2008, J NEUROSCI METH, V170, P1, DOI 10.1016/j.jneumeth.2007.12.008; Frade JM, 2015, CELL CYCLE, V14, P712, DOI 10.1080/15384101.2015.1004937; Genaro-Mattos TC, 2019, ACS CHEM NEUROSCI, V10, P3671, DOI 10.1021/acschemneuro.9b00248; Graber D. J., 2013, COLD SPRING HARB PRO, V2013, P319, DOI DOI 10.1101/PDB.PR0T074161; Handel AE, 2016, HUM MOL GENET, V25, P989, DOI 10.1093/hmg/ddv637; Hartwick ATE, 2008, J PHYSIOL-LONDON, V586, P3425, DOI 10.1113/jphysiol.2008.154609; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Ibad RT, 2011, J NEUROSCI, V31, P5495, DOI 10.1523/JNEUROSCI.0187-11.2011; Iwamoto K, 2013, NEUROSCIENCE, V237, P184, DOI 10.1016/j.neuroscience.2013.02.003; Jakobs TC, 2003, J COMP NEUROL, V465, P361, DOI 10.1002/cne.10845; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kano Y, 2001, NEUROSCI LETT, V303, P21, DOI 10.1016/S0304-3940(01)01676-7; Keller JM, 2019, ADV NEUROBIOL, V22, P3, DOI 10.1007/978-3-030-11135-9_1; Kleinsimlinghaus K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00277; Kobayashi W, 2018, INVEST OPHTH VIS SCI, V59, P776, DOI 10.1167/iovs.17-22406; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; Kumar A, 2016, J NEUROSCI METH, V263, P123, DOI 10.1016/j.jneumeth.2016.02.008; Kunzevitzky NJ, 2013, INVEST OPHTH VIS SCI, V54, P7603, DOI 10.1167/iovs.13-12691; Kunzevitzky NJ, 2010, INVEST OPHTH VIS SCI, V51, P3800, DOI 10.1167/iovs.09-4540; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Lukowski SW, 2019, EMBO J, V38, DOI 10.15252/embj.2018100811; Ma CHE, 2010, CELL TISSUE RES, V339, P297, DOI 10.1007/s00441-009-0897-4; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Menon M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12780-8; Newkirk GS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137702; Park YH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39141-1; Prilutsky D, 2014, TRENDS MOL MED, V20, P91, DOI 10.1016/j.molmed.2013.11.004; Rheaume BA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05134-3; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Schwieger J, 2016, J NEUROSCI METH, V268, P106, DOI 10.1016/j.jneumeth.2016.05.001; Sharma S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00983; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Sridhar A, 2020, CELL REP, V30, P1644, DOI 10.1016/j.celrep.2020.01.007; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tian RL, 2019, NEURON, V104, P239, DOI 10.1016/j.neuron.2019.07.014; Tran NM, 2019, NEURON, V104, P1039, DOI 10.1016/j.neuron.2019.11.006; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tukker AM, 2018, NEUROTOXICOLOGY, V67, P215, DOI 10.1016/j.neuro.2018.06.007; Wehrwein E, 2004, INVEST OPHTH VIS SCI, V45, P1531, DOI 10.1167/iovs.03-0406; Winzeler Alissa, 2013, Cold Spring Harb Protoc, V2013, P643, DOI 10.1101/pdb.prot074906; Xu H, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0213-z; Yan WJ, 2020, J NEUROSCI, V40, P5177, DOI 10.1523/JNEUROSCI.0471-20.2020; Zalis MC, 2017, J HISTOCHEM CYTOCHEM, V65, P223, DOI 10.1369/0022155416689675; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhu YL, 2014, J NEUROSCI, V34, P7845, DOI 10.1523/JNEUROSCI.2960-13.2014	65	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0242426	10.1371/journal.pone.0242426	http://dx.doi.org/10.1371/journal.pone.0242426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284815	Green Submitted, Green Published, gold			2022-12-26	WOS:000597930500022
J	Daffalla, SB; Mukhtar, H; Shaharun, MS				Daffalla, Samah Babiker; Mukhtar, Hilmi; Shaharun, Maizatul Shima			Preparation and characterization of rice husk adsorbents for phenol removal from aqueous systems	PLOS ONE			English	Article							WASTE-WATER; ACTIVATED CARBONS; METAL-IONS; ADSORPTION; SORPTION; PYROLYSIS; KINETICS; COLUMN; ASH	Rice husk is a base adsorbent for pollutant removal. It is a cost-effective material and a renewable resource. This study provides the physicochemical characterization of chemically and thermally treated rice husk adsorbents for phenol removal from aqueous solutions. We revealed new functional groups on rice husk adsorbents by Fourier transform infrared spectroscopy, and observed major changes in the pore structure (from macro-mesopores to micro-mesopores) of the developed rice husk adsorbents using scanning electron microscopy. Additionally, we studied their surface area and pore size distribution, and found a greater enhancement of the morphological structure of the thermally treated rice husk compared with that chemically treated. Thermally treated adsorbents presented a higher surface area (24-201 m(2).g(-1)) than those chemically treated (3.2 m(2).g(-1)). The thermal and chemical modifications of rice husk resulted in phenol removal efficiencies of 36%-64% and 28%, respectively. Thus, we recommend using thermally treated rice husk as a promising adsorbent for phenol removal from aqueous solutions.	[Daffalla, Samah Babiker] King Faisal Univ, Coll Agr & Food Sci, Dept Environm & Agr Nat Resources, Al Hasa, Saudi Arabia; [Mukhtar, Hilmi] Univ Teknol PETRONAS, Dept Chem Engn, Tronoh, Malaysia; [Shaharun, Maizatul Shima] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Malaysia	King Faisal University; Universiti Teknologi Petronas; Universiti Teknologi Petronas	Daffalla, SB (corresponding author), King Faisal Univ, Coll Agr & Food Sci, Dept Environm & Agr Nat Resources, Al Hasa, Saudi Arabia.	sbalal@kfu.edu.sa		Daffalla, Samah/0000-0001-7399-514X	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [IFT20133]	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia	The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research work through the project number IFT20133.	Ahmaruzzaman M, 2005, J COLLOID INTERF SCI, V287, P14, DOI 10.1016/j.jcis.2005.01.075; Akhtar M, 2006, J HAZARD MATER, V128, P44, DOI 10.1016/j.jhazmat.2005.07.025; Al-Baidhani J. H., 2016, International Journal of Chemical Engineering and Applications, V7, P6; Alexander D, 2017, MICROCHEM J, V135, P129, DOI 10.1016/j.microc.2017.08.001; Angelova D, 2011, CHEM ENG J, V172, P306, DOI 10.1016/j.cej.2011.05.114; Asadi F, 2008, J HAZARD MATER, V154, P451, DOI 10.1016/j.jhazmat.2007.10.046; Chen Y, 2013, BIORESOURCE TECHNOL, V144, P401, DOI 10.1016/j.biortech.2013.07.002; El-Shafey EI, 2007, J HAZARD MATER, V147, P546, DOI 10.1016/j.jhazmat.2007.01.051; Gani A, 2007, RENEW ENERG, V32, P649, DOI 10.1016/j.renene.2006.02.017; Goswami Ritusmita, 2018, Groundwater for Sustainable Development, V7, P446, DOI 10.1016/j.gsd.2017.12.010; Imyim A, 2010, J HAZARD MATER, V184, P775, DOI 10.1016/j.jhazmat.2010.08.108; Jain AK, 2002, J COLLOID INTERF SCI, V251, P39, DOI 10.1006/jcis.2002.8395; Karatay SE, 2014, ECOL ENG, V73, P224, DOI 10.1016/j.ecoleng.2014.09.061; Kaur P, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118699; Kong XD, 2020, CHEM PHYS LETT, V739, DOI 10.1016/j.cplett.2019.137046; Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027; Lowell S, 2012, SPRINGER SCI BUSINES; Lv SL, 2020, APPL SURF SCI, V510, DOI 10.1016/j.apsusc.2020.145425; Mandal A, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0203-3; Moawad NA., 2012, J BIOL AGR HEALTHCAR, V2, P77; Mohan S, 2008, J HAZARD MATER, V153, P75, DOI 10.1016/j.jhazmat.2007.08.021; Mullick A, 2018, INDIAN CHEM ENG, V60, P58, DOI 10.1080/00194506.2017.1288173; Nair DG, 2006, CEMENT CONCRETE RES, V36, P1062, DOI 10.1016/j.cemconres.2006.03.012; Nakbanpote W, 2007, COLLOID SURFACE A, V304, P7, DOI 10.1016/j.colsurfa.2007.04.013; Ngah WSW, 2008, BIORESOURCE TECHNOL, V99, P3935, DOI 10.1016/j.biortech.2007.06.011; Rahman IA, 2005, BIORESOURCE TECHNOL, V96, P1578, DOI 10.1016/j.biortech.2004.12.015; Sahu JN, 2009, J HAZARD MATER, V161, P317, DOI 10.1016/j.jhazmat.2008.03.094; Sarker N, 2017, APPL WATER SCI, V7, P1459, DOI 10.1007/s13201-015-0324-9; Shamsollahi Z, 2019, J ENVIRON MANAGE, V246, P314, DOI 10.1016/j.jenvman.2019.05.145; Sharma N, 2009, J HAZARD MATER, V163, P1338, DOI 10.1016/j.jhazmat.2008.07.135; Shukla N, 2019, J CLEAN PROD, V235, P1073, DOI 10.1016/j.jclepro.2019.07.042; Singha B, 2013, COLLOID SURFACE B, V107, P97, DOI 10.1016/j.colsurfb.2013.01.060; Srivastava VC, 2006, J HAZARD MATER, V134, P257, DOI 10.1016/j.jhazmat.2005.11.052; Stasinakis AS, 2008, J HAZARD MATER, V160, P408, DOI 10.1016/j.jhazmat.2008.03.012; Su FB, 2005, CARBON, V43, P1156, DOI 10.1016/j.carbon.2004.12.034; Sun J, 2019, COLLOID SURFACE A, V563, P22, DOI 10.1016/j.colsurfa.2018.11.042; Zou YP, 2019, RICE BRAN AND RICE BRAN OIL: CHEMISTRY, PROCESSING AND UTILIZATION, P207, DOI 10.1016/B978-0-12-812828-2.00009-3	37	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243540	10.1371/journal.pone.0243540	http://dx.doi.org/10.1371/journal.pone.0243540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275643	gold, Green Published			2022-12-26	WOS:000597150200013
J	Hassen, HY; Bastiaens, H; Van Royen, K; Abrams, S				Hassen, Hamid Yimam; Bastiaens, Hilde; Van Royen, Kathleen; Abrams, Steven			Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study	PLOS ONE			English	Article							RISK-FACTORS; HEART-DISEASE; MYOCARDIAL-INFARCTION; SOCIAL-ISOLATION; GRIP STRENGTH; MORTALITY; ASSOCIATION; RETIREMENT; MORBIDITY; RESIDENCE	Despite advances in the healthcare system, cardiovascular diseases (CVDs) are still an important public health problem with disparities in the burden within and between countries. Studies among the adult population documented that socioeconomic and environmental factors play a role in the incidence and progression of CVDs. However, evidence is scarce on the socioeconomic determinants and the interplay with behavioral risks among older adults. Therefore, we identified socioeconomic and behavioral determinants of CVDs among older adults. Our sample consisted of 14,322 people aged 50 years and above from Belgium and France who responded to the waves 4, 5, 6 and/or 7 of the Survey of Health Ageing and Retirement in Europe. The effect of determinants on the occurrence of CVD was examined using a Generalized Estimating Equation (GEE) approach for binary longitudinal data. The overall rate of heart attack was 8.3%, which is 7.6% in Belgium and 9.1% in France. Whereas, 2.6% and 2.3% in Belgium and France, respectively, had experienced stroke. In the multivariable GEE model, older age [AOR: 1.057, 95%CI: 1.055-1.060], living in large cities [AOR: 1.14, 95%CI: 1.07-1.18], and retirement [AOR: 1.21, 95%CI: 1.16-1.31] were associated with higher risk of CVD. Furthermore, higher level of education [AOR: 0.82, 95%CI: 0.79-0.90], upper wealth quantile [AOR: 0.82, 95%CI: 0.76-0.86] and having social support [AOR: 0.81, 95%CI: 0.77-0.84] significantly lowers the odds of having CVD. A higher hand grip strength was also significantly associated with lower risk of CVD [AOR: 0.987, 95%CI: 0.984-0.990]. This study demonstrated that older adults who do not have social support, live in big cities, belong to the lowest wealth quantile, and have a low level of education have a higher likelihood of CVD. Therefore, community-based interventions aimed at reducing cardiovascular risks need to give more emphasis to high-risk retired older adults with lower education, no social support and those who live in large cities.	[Hassen, Hamid Yimam; Bastiaens, Hilde; Van Royen, Kathleen] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Antwerp, Belgium; [Bastiaens, Hilde; Abrams, Steven] Univ Antwerp, Fac Med & Hlth Sci, Global Hlth Inst, Antwerp, Belgium; [Van Royen, Kathleen] Univ Antwerp, Fac Social Sci, Dept Commun Studies, Antwerp, Belgium; [Abrams, Steven] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Data Sci Inst, Diepenbeek, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; Hasselt University	Hassen, HY (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Antwerp, Belgium.	Hamid.Hassen@uantwerpen.be	Abrams, Steven/AAC-7351-2022; Hassen, Hamid/A-1105-2019; Van Royen, Kathleen/E-9669-2018	Abrams, Steven/0000-0001-7353-9304; Hassen, Hamid/0000-0001-6485-4193; Bastiaens, Hilde/0000-0002-5509-3406; Van Royen, Kathleen/0000-0001-8182-7971	European Commission (Horizon 2020); US National Institute on Aging, and various national sources; EU [733356]	European Commission (Horizon 2020)(European Commission); US National Institute on Aging, and various national sources; EU(European Commission)	This study utilized data from the SHARE wave 4 to 7. The SHARE data collection is primarily funded by the European Commission (Horizon 2020), the US National Institute on Aging, and various national sources (For a full list of funding institutions, see http://www.share-project.org).This specific analysis is supported by EU funded SPICES project (Grant agreement ID: 733356). All funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcser KH, 2005, SURVEY HLTH AGING RE; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2017, SURVEY HLTH AGEING R; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Compare A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00384; Degano IR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10775-3; Dowd JB, 2010, ANN EPIDEMIOL, V20, P743, DOI 10.1016/j.annepidem.2010.06.007; Godard M, 2016, J HEALTH ECON, V45, P27, DOI 10.1016/j.jhealeco.2015.11.002; Grazuleviciene R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/403012; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hardin JW, 2012, GEN ESTIMATING EQUAT; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Kardan O, 2015, SCI REP-UK, V5, DOI 10.1038/srep11610; Lanki T, 2017, ENVIRON RES, V159, P176, DOI 10.1016/j.envres.2017.07.039; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Lemstra M, 2015, CAN FAM PHYSICIAN, V61, P698; Lewis MW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2630-4; Lu XX, 2019, J COMMUN HEALTH, V44, P451, DOI 10.1007/s10900-018-00612-7; Marmot M, 2006, SOCIAL DETERMINANTS; Menotti A, 2003, EUR J EPIDEMIOL, V18, P113, DOI 10.1023/A:1023092415353; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Mookadam F, 2004, ARCH INTERN MED, V164, P1514, DOI 10.1001/archinte.164.14.1514; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; Nowicki GJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112388; Orth-Gomer K, 2016, HDB PSYCHOCARDIOLOGY, P701; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pedron S, 2020, ECON HUM BIOL, V38, DOI 10.1016/j.ehb.2020.100893; Psaltopoulou T, 2017, HELL J CARDIOL, V58, P32, DOI 10.1016/j.hjc.2017.01.022; Rein P, 2016, J AM COLL CARDIOL, V67, P2029, DOI 10.1016/S0735-1097(16)32030-7; Rosengren A, 2004, EUR HEART J, V25, P56, DOI 10.1016/j.ehj.2003.10.005; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Ruan Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5653-9; Rubin DB, 2004, MULTIPLE IMPUTATION; Sarrafzadegan N, 2012, SAUDI MED J, V33, P533; Schultz WM, 2018, CIRCULATION, V137, P2166, DOI 10.1161/CIRCULATIONAHA.117.029652; Seo S, 2019, ENVIRON INT, V125, P51, DOI 10.1016/j.envint.2019.01.038; Sillars A, 2019, MAYO CLIN PROC, V94, P2230, DOI 10.1016/j.mayocp.2019.04.041; Smedley BD, 2000, PROMOTING HLTH INTER; Solar O, 2010, POLICY PRACTICE; Stenholm S, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0539-2; Tikkanen E, 2018, CIRCULATION, V137, P2583, DOI [10.1161/circulationaha.117.032432, 10.1161/CIRCULATIONAHA.117.032432]; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; Tuppin P, 2014, INT J CARDIOL, V173, P430, DOI 10.1016/j.ijcard.2014.03.012; UNESCO, INT STAND CLASS ED 1; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van Buuren S, 2018, FLEXIBLE IMPUTATION, V2nd; van Buuren S, 2011, J STAT SOFTW, V45, P1; WHO, 2020, GLOB FACTSH CARD DIS; Xia N, 2018, ANTIOXID REDOX SIGN, V28, P837, DOI 10.1089/ars.2017.7312; Xue B, 2019, GERONTOLOGIST, DOI [10.1093/geront/gnz062, DOI 10.1093/GER0NT/GNZ062]; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	55	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243422	10.1371/journal.pone.0243422	http://dx.doi.org/10.1371/journal.pone.0243422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AS	33275617	Green Published, gold			2022-12-26	WOS:000597150200002
J	Rahmartani, LD; Carson, C; Quigley, MA				Rahmartani, Lhuri D.; Carson, Claire; Quigley, Maria A.			Prevalence of prelacteal feeding and associated risk factors in Indonesia: Evidence from the 2017 Indonesia Demographic Health Survey	PLOS ONE			English	Article							CARE WORKERS; PROMOTION; NEWBORNS; FORMULA; MOTHERS; INFANT; IMPACT; BIRTH; PACKS; URBAN	Background Prelacteal feeding (PLF) is a recognised challenge to optimal breastfeeding but remains common in Indonesia. Meanwhile, PLF-related epidemiological research is limited, particularly in this setting. This study examines the prevalence and determinants of overall PLF as well as common PLF types (formula, other milk, and honey) in Indonesia. Methods Data from 6127 mothers whose last child was <= 23-month-old were drawn from the 2017 Indonesia Demographic and Health Survey. Multivariable modified Poisson regression was used to measure the prevalence ratio (PR) for selected PLF risk factors. PLF was defined as anything to drink other than breast milk within three days after birth, before breastmilk flows. Additional analyses were performed on mothers who gave formula, other milk, and honey. Results About 45% babies in Indonesia received PLF with formula being the most frequent (25%), followed by other milk (14%), plain water (5%), and honey (3%). Factors associated with higher prevalence of any PLF were higher wealth quintiles in rural area (PR 1.07; 95% CI 1.03-1.11 per increase in quintile), baby perceived to be small at birth (PR 1.23; 95% CI 1.12-1.35), caesarean deliveries at either public (PR 1.27; 95% CI 1.13-1.44) or private facilities (PR 1.15; 95% CI 1.01-1.31), and not having immediate skin-to-skin contact after birth (PR 1.32; 95% CI 1.23-1.42). PLF was less prevalent among mothers who gave birth to second/subsequent child (PR 0.82; 95% CI 0.76-0.88) and who had an antenatal card (PR 0.89; 95% CI 0.80-0.99). These patterns did not apply uniformly across all PLF types. For example, honey was more common among home births than deliveries at health facilities, but formula and other milk were more common among caesarean deliveries. Conclusions Mapping risk factors for PLF, especially by types, could help to design more targeted interventions to reduce PLF and improve breastfeeding practices in Indonesia.	[Rahmartani, Lhuri D.; Carson, Claire; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Rahmartani, Lhuri D.] Univ Indonesia, Fac Publ Hlth, Dept Epidemiol, Depok, Jawa Barat, Indonesia	University of Oxford; University of Indonesia	Rahmartani, LD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.; Rahmartani, LD (corresponding author), Univ Indonesia, Fac Publ Hlth, Dept Epidemiol, Depok, Jawa Barat, Indonesia.	lhuri.rahmartani@dph.ox.ac.uk		Rahmartani, Lhuri/0000-0001-9968-5318; Quigley, Maria/0000-0002-8058-6181	Medical Research Council [MR/L019671/1]; U.S. Agency for International Development (USAID); Jardine Scholarship	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Jardine Scholarship	This study was conducted as part of LDR's Doctor of Philosophy in Population Health at the University of Oxford. LDR receives the Jardine Scholarship (https://www.jardines.com) for her doctoral study at the Nuffield Department of Population Health, University of Oxford. LDR is supervised by CC, who is funded by a Career Development Award MR/L019671/1 from the Medical Research Council (https://mrc.ukri.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Permission to use the 2017 Indonesia Demographic and Health Survey (IDHS) dataset was obtained from the Demographic and Health Surveys (DHS) Program, which was implemented by ICF and funded by the U.S. Agency for International Development (USAID). We thank ICF, National Population and Family Planning Board (BKKBN), Statistics Indonesia (BPS), and the Ministry of Health (Kemenkes) for conducting the survey, as well as all mothers who participated in the survey.	Akuse RM, 2002, EUR J CLIN NUTR, V56, P729, DOI 10.1038/sj.ejcn.1601385; Albokhary AA, 2014, SAUDI MED J, V35, P1400; Amele EA, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0604-3; [Anonymous], 2016, FUEL CELLS B, V3, P8; [Anonymous], 2019, LAP NAS RISK; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; [Anonymous], 2018, J CANC RES THER, V14, pS622; Barati Z, 2018, NUTR FOOD SCI, V48, P589, DOI 10.1108/NFS-07-2017-0144; Belachew AB, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0117-0; Benedict RK, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12697; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Berde AS, 2017, PUBLIC HEALTH NUTR, V20, P1953, DOI 10.1017/S1368980017000659; Berde AS, 2017, AFR HEALTH SCI, V17, P690, DOI 10.4314/ahs.v17i3.11; BKKBN BPS Kemenkes RI ICF International., 2018, SURV DEM DAN KES IND; Callen Jennifer, 2005, Adv Neonatal Care, V5, P93, DOI 10.1016/j.adnc.2004.12.005; Callen Jennifer, 2005, Adv Neonatal Care, V5, P72, DOI 10.1016/j.adnc.2004.12.003; Croft TN, 2018, GUIDE DHS STAT DHS 7; Feeley AB, 2016, MATERN CHILD NUTR, V12, P64, DOI 10.1111/mcn.12304; Flaherman VJ, 2018, PUBLIC HEALTH NUTR, V21, P2689, DOI 10.1017/S1368980018001453; General Directorate of Statistics (GDS) Ministry of Health ICF, 2018, TIM DEM HLTH SURV 20; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; ICF International, DHS OV ICF INT; ICF International, SURV SEARCH RES IND; Inayati DA, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-3; ITSB, 2016, J SCI ENG RES, V3, P63; Kementerian Kesehatan (Kemenkes-MOH) RI, 2009, BUK KES IBU DAN AN; Khanal V, 2014, J PEDIATR GASTR NUTR, V59, P162, DOI 10.1097/MPG.0000000000000429; Khanal V, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-9; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; McKenna KM, 2009, J MIDWIFERY WOM HEAL, V54, P78, DOI 10.1016/j.jmwh.2008.07.012; Mercado K, 2019, ADV NEONAT CARE, V19, P474, DOI 10.1097/ANC.0000000000000684; Merewood A, 2008, ARCH PEDIAT ADOL MED, V162, P823, DOI 10.1001/archpedi.162.9.823; Ministry of Health and Sports (MoHS) ICF., 2017, MYANM DEM HLTH SURV; National Population and Family Planning Board (BKKBN) Statistics Indonesia (BPS) Ministry of Health (Kemenkes) ICF, 2018, IND DEM HLTH SURV 20; Nguyen PH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-932; PerezEscamilla R, 1996, J NUTR, V126, P2765; Philippine Statistics Authority (PSA) ICF, 2018, PHIL NAT DEM HLTH SU; Nguyen P, 2020, ARCH DIS CHILD, V105, P122, DOI 10.1136/archdischild-2019-316937; Pries AM, 2016, MATERN CHILD NUTR, V12, P38, DOI 10.1111/mcn.12271; R Bunga Ch, 2013, PENELITIAN GIZI DAN, V36, P54; Rahmawati W., 2016, INDONES J HUM NUTR, V3, P20, DOI [10.21776/ub.ijhn.2016.003.Suplemen.3, DOI 10.21776/UB.IJHN.2016.003.SUPLEMEN.3]; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Rosenberg KD, 2008, AM J PUBLIC HEALTH, V98, P290, DOI 10.2105/AJPH.2006.103218; Sallam SA, 2013, BREASTFEED MED, V8, P312, DOI 10.1089/bfm.2012.0040; Smith HA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006462.pub4; StataCorp, 2017, INVENTORSTATA STAT S; Statistics Indonesia (Badan Pusat Statistik-BPS) Macro International, 2008, MACR IND DEM HLTH SU; Statistics Indonesia (Badan Pusat Statistik-BPS) National Population and Family Planning Board (BKKBN) Kementerian Kesehatan (Kemenkes-MOH) ICF International, 2013, IND DEM HLTH SURV 20; Susiloretni KA, 2015, MATERN CHILD HLTH J, V19, P1515, DOI 10.1007/s10995-014-1656-z; Takele WW, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0308-y; Temesgen H, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0193-6; The DHS Program, PROT PRIV DHS RESP; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; Utomo B, 1997, HLTH SOCIAL DIMENSIO; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, ACC MED REAS US BREA; WHO, BOT 2018; WHO/UNICEF, 1989, PROT PROM SUPP BREAS; World Bank Country and Lending Groups, WORLD BANK COUNTR LE; World Bank Group, OV IND 2019; World Health Organization, 10 STEPS SUCC BREAST; World Health Organization (WHO), INF YOUNG CHILD FEED; Zarshenas M, 2019, BIRTH-ISS PERINAT C, V46, P137, DOI 10.1111/birt.12385; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	66	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243097	10.1371/journal.pone.0243097	http://dx.doi.org/10.1371/journal.pone.0243097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270720	Green Published, gold			2022-12-26	WOS:000597149100078
J	Hamouda, NN; Van den Haute, C; Vanhoutte, R; Sannerud, R; Azfar, M; Mayer, R; Calabuig, AC; Swinnen, JV; Agostinis, P; Baekelandt, V; Annaert, W; Impens, F; Verhelst, SHL; Eggermont, J; Martin, S; Vangheluwe, P				Hamouda, Norin Nabil; Van den Haute, Chris; Vanhoutte, Roeland; Sannerud, Ragna; Azfar, Mujahid; Mayer, Rupert; Calabuig, Alvaro Cortes; Swinnen, Johannes, V; Agostinis, Patrizia; Baekelandt, Veerle; Annaert, Wim; Impens, Francis; Verhelst, Steven H. L.; Eggermont, Jan; Martin, Shaun; Vangheluwe, Peter			ATP13A3 is a major component of the enigmatic mammalian polyamine transport system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT-PROBE; CELLS; THERAPIES; SPERMINE; IDENTIFICATION; PARKINSONISM; GLYPICAN-1; MUTATIONS; CARRIER; GENE	Polyamines, such as putrescine, spermidine, and spermine, are physiologically important polycations, but the transporters responsible for their uptake in mammalian cells remain poorly characterized. Here, we reveal a new component of the mammalian polyamine transport system using CHO-MG cells, a widely used model to study alternative polyamine uptake routes and characterize polyamine transport inhibitors for therapy. CHO-MG cells present polyamine uptake deficiency and resistance to a toxic polyamine biosynthesis inhibitor methylglyoxal bis-(guanylhydrazone) (MGBG), but the molecular defects responsible for these cellular characteristics remain unknown. By genome sequencing of CHO-MG cells, we identified mutations in an unexplored gene, ATP13A3, and found disturbed mRNA and protein expression. ATP13A3 encodes for an orphan P5B-ATPase (ATP13A3), a P-type transport ATPase that represents a candidate polyamine transporter. Interestingly, ATP13A3 complemented the putrescine transport deficiency and MGBG resistance of CHO-MG cells, whereas its knockdown in WT cells induced a CHO-MG phenotype demonstrated as a decrease in putrescine uptake and MGBG sensitivity. Taken together, our findings identify ATP13A3, which has been previously genetically linked with pulmonary arterial hypertension, as a major component of the mammalian polyamine transport system that confers sensitivity to MGBG.	[Hamouda, Norin Nabil; Azfar, Mujahid; Eggermont, Jan; Martin, Shaun; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium; [Van den Haute, Chris; Baekelandt, Veerle] Katholieke Univ Leuven, Dept Neurosci, Lab Neurobiol & Gene Therapy, Leuven, Belgium; [Van den Haute, Chris] Katholieke Univ Leuven, Leuven Viral Vector Core, Leuven, Belgium; [Vanhoutte, Roeland; Verhelst, Steven H. L.] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Chem Biol, Leuven, Belgium; [Sannerud, Ragna; Annaert, Wim] Katholieke Univ Leuven, Dept Neurosci, VIB KU Leuven Lab Membrane Trafficking, Leuven, Belgium; [Calabuig, Alvaro Cortes] Katholieke Univ Leuven, Genom Core Leuven, Leuven, Belgium; [Swinnen, Johannes, V] Katholieke Univ Leuven, LKI Leuven Canc Inst, Dept Oncol, Lab Lipid Metab & Canc, Leuven, Belgium; [Agostinis, Patrizia] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cell Death Res & Therapy, Leuven, Belgium; [Agostinis, Patrizia] Katholieke Univ Leuven, VIB KU Leuven Ctr Canc Biol, Dept Oncol, Leuven, Belgium; [Mayer, Rupert; Impens, Francis] Univ Ghent, VIB Ctr Med Biotechnol, Dept Biomol Med, VIB Prote Core, Ghent, Belgium; [Verhelst, Steven H. L.] Leibniz Inst Analyt Sci ISAS, Chem Prote, Dortmund, Germany	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium.	peter.vangheluwe@kuleuven.be	Agostinis, Patrizia/ABI-1177-2020; Swinnen, Johannes V/AAA-2214-2022; Vangheluwe, Peter/P-5476-2017	Agostinis, Patrizia/0000-0003-1314-2115; Swinnen, Johannes V/0000-0002-7720-5077; Vangheluwe, Peter/0000-0002-7822-2944; Sannerud, Ragna/0000-0002-6694-3154; Impens, Francis/0000-0003-2886-9616; Mayer, Rupert/0000-0001-7104-0147; Vanhoutte, Roeland/0000-0001-9797-620X; Eggermont, Jan/0000-0002-8497-1159	KU Leuven C1 grant LysoCaN [C16/15/073]; C3 grant [C3/20/035]; Flemish Research Foundation FWO [G094219N]; Strategic Basic Research Neuro-Traffic [S006617N]; M. J. Fox Foundation/Aligning Science Across Parkinson's [ASAP-0458]	KU Leuven C1 grant LysoCaN; C3 grant; Flemish Research Foundation FWO(FWO); Strategic Basic Research Neuro-Traffic; M. J. Fox Foundation/Aligning Science Across Parkinson's	This work was funded by the KU Leuven C1 grant LysoCaN (C16/15/073 to P. V., W. A., P. A., and J. S.), C3 grant (C3/20/035 to. P. V. and S. V.), the Flemish Research Foundation FWO (G094219N), Strategic Basic Research Neuro-Traffic (S006617N to P. V., W. A., J. S., F. I., and V. B.), and the M. J. Fox Foundation/Aligning Science Across Parkinson's (ASAP-0458 to P. V. and V. B.).	Andrews S., 2010, FASTQC QUALITY CONTR; Barozzi C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37277-0; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Belting M, 1996, GLYCOBIOLOGY, V6, P121, DOI 10.1093/glycob/6.2.121; Brown AJ, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700259; BYERS TL, 1989, BIOCHEM J, V263, P745, DOI 10.1042/bj2630745; BYERS TL, 1987, AM J PHYSIOL, V252, pC663, DOI 10.1152/ajpcell.1987.252.6.C663; Chan EWC, 2015, POLYM CHEM-UK, V6, P7618, DOI 10.1039/c5py01033k; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dardonville C, 2006, BIOORGAN MED CHEM, V14, P6570, DOI 10.1016/j.bmc.2006.06.007; Das KC, 2004, MOL CELL BIOCHEM, V262, P127, DOI 10.1023/B:MCBI.0000038227.91813.79; Delcros JG, 2002, J MED CHEM, V45, P5098, DOI 10.1021/jm020843w; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Evageliou NF, 2016, CLIN CANCER RES, V22, P4391, DOI 10.1158/1078-0432.CCR-15-2539; Gamble LD, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau1099; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Graf S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03672-4; Hammond S, 2012, BIOTECHNOL BIOENG, V109, P1353, DOI 10.1002/bit.24374; HEATON MA, 1988, J CELL PHYSIOL, V136, P133, DOI 10.1002/jcp.1041360117; Hiasa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06836; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao CP, 2009, ANTIMICROB AGENTS CH, V53, P5259, DOI 10.1128/AAC.00662-09; LOVaas E., 1996, ADV PHARMACOL, V38, P119, DOI [10.1016/S1054-3589(08)60982-5, DOI 10.1016/S1054-3589(08)60982-5]; Madan M, 2016, AM J CANCER RES, V6, P1231; MANDEL JL, 1978, J CELL PHYSIOL, V97, P335, DOI 10.1002/jcp.1040970308; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Martin S, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9531917; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Morrell NW, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01899-2018; Muth A, 2014, J MED CHEM, V57, P348, DOI 10.1021/jm401174a; Nazifi SMR, 2019, STRUCT CHEM, V30, P175, DOI 10.1007/s11224-018-1175-4; Ning ZB, 2014, J MEMBRANE BIOL, V247, P941, DOI 10.1007/s00232-014-9668-6; Ning ZB, 2013, J PROTEOME RES, V12, P1512, DOI 10.1021/pr301064z; Osorio L, 2014, J BIOTECHNOL, V169, P71, DOI 10.1016/j.jbiotec.2013.11.004; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PERSSON L, 1988, CANCER RES, V48, P4807; Phanstiel O, 2012, POLYAMINE DRUG DISCO, P162; Poplin R., 2018, SCALING ACCURATE GEN; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rinaldi DE, 2015, BBA-BIOMEMBRANES, V1848, P1646, DOI 10.1016/j.bbamem.2015.04.008; SAUNDERS NA, 1989, J CELL PHYSIOL, V139, P624, DOI 10.1002/jcp.1041390324; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Sharpe JG, 2005, AMINO ACIDS, V29, P245, DOI 10.1007/s00726-005-0234-5; Sorensen DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193228; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; Soulet D, 2002, BIOCHEM J, V367, P347, DOI 10.1042/BJ20020764; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uemura T, 2008, J BIOL CHEM, V283, P26428, DOI 10.1074/jbc.M804714200; Uemura T, 2010, AM J PHYSIOL-GASTR L, V299, pG517, DOI 10.1152/ajpgi.00169.2010; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Veen S, 2020, NATURE, V578, P419, DOI 10.1038/s41586-020-1968-7; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; Vanhoutte R, 2018, CHEMBIOCHEM, V19, P907, DOI 10.1002/cbic.201800043; Wang Minpei, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040027	65	21	21	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100182	10.1074/jbc.RA120.013908	http://dx.doi.org/10.1074/jbc.RA120.013908			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33310703	Green Accepted, Green Published, gold			2022-12-26	WOS:000672866400160
J	Zygiel, EM; Obisesan, AO; Nelson, CE; Oglesby, AG; Nolan, EM				Zygiel, Emily M.; Obisesan, Adunoluwa O.; Nelson, Cassandra E.; Oglesby, Amanda G.; Nolan, Elizabeth M.			Heme protects Pseudomonas aeruginosa and Staphylococcus aureus from calprotectin-induced iron starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL SEQUESTRATION; UPTAKE SYSTEMS; HOST; DEFENSE; INFECTIONS; TRANSPORT; PATHWAYS; ROLES; LINK; ISDA	Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic bacterial pathogens that cause severe infections in immunocompromised individuals and patients with cystic fibrosis. Both P. aeruginosa and S. aureus require iron to infect the mammalian host. To obtain iron, these pathogens may rely on siderophore-mediated ferric iron uptake, ferrous iron uptake, or heme uptake at different points during infection. The preferred iron source depends on environmental conditions, including the presence of iron-sequestering host-defense proteins. Here, we investigate how the presence of heme, a highly relevant iron source during infection, affects bacterial responses to iron with-holding by the innate immune protein calprotectin (CP). Prior work has shown that P. aeruginosa is starved of iron in the presence of CP. We report that P. aeruginosa upregulates expression of heme uptake machinery in response to CP. Furthermore, we show that heme protects P. aeruginosa from CP-mediated inhibition of iron uptake and iron-starvation responses. We extend our study to a second bacterial pathogen, S. aureus, and demonstrate that CP also inhibits iron uptake and induces iron-starvation responses by this pathogen. Similarly to P. aeruginosa, we show that heme protects S. aureus from CP-mediated inhibition of iron uptake and iron-starvation responses. These findings expand our understanding of microbial responses to iron sequestration by CP and highlight the importance of heme utilization for bacterial adaptation to host iron-withholding strategies.	[Zygiel, Emily M.; Obisesan, Adunoluwa O.; Nolan, Elizabeth M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Nelson, Cassandra E.; Oglesby, Amanda G.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Oglesby, Amanda G.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Nolan, EM (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Oglesby, AG (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.; Oglesby, AG (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	aoglesby@rx.umaryland.edu; lnolan@mit.edu	Nelson, Cassandra/U-7963-2017	Nelson, Cassandra/0000-0002-7284-5198; Oglesby, Mandy/0000-0003-4440-3840	National Institutes of Health [R01 GM126376, T32 AI095190]; MIT Center for Environmental Health Sciences [NIH P30-ES002109]; NSF Graduate Research Fellowship; Whitaker Health Sciences Fund Fellowship; MIT Undergraduate Research Opportunities Program (UROP)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Center for Environmental Health Sciences; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Whitaker Health Sciences Fund Fellowship; MIT Undergraduate Research Opportunities Program (UROP)	This work was supported by the National Institutes of Health (R01 GM126376 to E. M. N. and A. G. O.; T32 AI095190 to C. E. N.). The inductively coupled plasmamass spectrometry instrument at MIT is maintained by the MIT Center for Environmental Health Sciences (NIH P30-ES002109). E. M. Z. is a recipient of an NSF Graduate Research Fellowship and a Whitaker Health Sciences Fund Fellowship. A. O. O. received support from the MIT Undergraduate Research Opportunities Program (UROP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlgren HG, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0062-7; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; Budzikiewicz Herbert, 2001, Current Topics in Medicinal Chemistry, V1, P1, DOI 10.2174/1568026013395560; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cho H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005026; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cornforth DM, 2018, P NATL ACAD SCI USA, V115, pE5125, DOI 10.1073/pnas.1717525115; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Damron FH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39172; Diaz-Ochoa VE, 2016, CELL HOST MICROBE, V19, P814, DOI 10.1016/j.chom.2016.05.005; Dieppois G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038148; Djapgne L, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00704-17; Garcia YM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006125; Ghio AJ, 2013, J CYST FIBROS, V12, P390, DOI 10.1016/j.jcf.2012.10.010; Gifford AH, 2011, PEDIATR PULM, V46, P160, DOI 10.1002/ppul.21335; Glasser NR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226578; Gonzalez MR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00039; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Hadley RC, 2019, METHODS MOL BIOL, V1929, P397, DOI 10.1007/978-1-4939-9030-6_25; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Laakso HA, 2016, J BIOL CHEM, V291, P29, DOI 10.1074/jbc.M115.696625; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MacDougall C, 2005, EMERG INFECT DIS, V11, P1197, DOI 10.3201/eid1108.050116; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Minandri F, 2016, INFECT IMMUN, V84, P2324, DOI 10.1128/IAI.00098-16; Nakashige TG, 2017, J AM CHEM SOC, V139, P8828, DOI 10.1021/jacs.7b01212; Nakashige TG, 2015, NAT CHEM BIOL, V11, P765, DOI [10.1038/NCHEMBIO.1891, 10.1038/nchembio.1891]; Nguyen AT, 2015, J BACTERIOL, V197, P2265, DOI 10.1128/JB.00072-15; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Park RY, 2005, J MICROBIOL, V43, P183; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Radin JN, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00642-18; Radin JN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006040; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Reinhart AA, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120126; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Shin SH, 2001, J MICROBIOL METH, V44, P89, DOI 10.1016/S0167-7012(00)00229-3; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Wakeman CA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11951; Wang JF, 2019, CELL CHEM BIOL, V26, P745, DOI 10.1016/j.chembiol.2019.02.011; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zygiel EM, 2019, ACCOUNTS CHEM RES, V52, P2301, DOI 10.1021/acs.accounts.9b00250; Zygiel EM, 2019, J BIOL CHEM, V294, P3549, DOI 10.1074/jbc.RA118.006819; Zygiel EM, 2018, ANNU REV BIOCHEM, V87, P621, DOI 10.1146/annurev-biochem-062917-012312	62	6	6	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100160	10.1074/jbc.RA120.015975	http://dx.doi.org/10.1074/jbc.RA120.015975			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273016	gold, Green Published			2022-12-26	WOS:000672866400138
J	Ferro, GM; Sornette, D				Ferro, Giuseppe M.; Sornette, Didier			Stochastic representation decision theory: How probabilities and values are entangled dual characteristics in cognitive processes	PLOS ONE			English	Article							SUBJECTIVE-PROBABILITY; LIKELIHOOD RATIO; PROSPECT-THEORY; FIELD-THEORY; CHOICE; UTILITY; RISK; ELICITATION; PREFERENCE; TIME	Humans are notoriously bad at understanding probabilities, exhibiting a host of biases and distortions that are context dependent. This has serious consequences on how we assess risks and make decisions. Several theories have been developed to replace the normative rational expectation theory at the foundation of economics. These approaches essentially assume that (subjective) probabilities weight multiplicatively the utilities of the alternatives offered to the decision maker, although evidence suggest that probability weights and utilities are often not separable in the mind of the decision maker. In this context, we introduce a simple and efficient framework on how to describe the inherently probabilistic human decision-making process, based on a representation of the deliberation activity leading to a choice through stochastic processes, the simplest of which is a random walk. Our model leads naturally to the hypothesis that probabilities and utilities are entangled dual characteristics of the real human decision making process. It predicts the famous fourfold pattern of risk preferences. Through the analysis of choice probabilities, it is possible to identify two previously postulated features of prospect theory: the inverse S-shaped subjective probability as a function of the objective probability and risk-seeking behavior in the loss domain. It also predicts observed violations of stochastic dominance, while it does not when the dominance is "evident". Extending the model to account for human finite deliberation time and the effect of time pressure on choice, it provides other sound predictions: inverse relation between choice probability and response time, preference reversal with time pressure, and an inverse double-S-shaped probability weighting function. Our theory, which offers many more predictions for future tests, has strong implications for psychology, economics and artificial intelligence.	[Ferro, Giuseppe M.; Sornette, Didier] ETH, Dept Management Technol & Econ, Zurich, Switzerland; [Sornette, Didier] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Inst Risk Anal Predict & Management, Shenzhen, Peoples R China; [Sornette, Didier] Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Tokyo, Tokyo, Japan; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Southern University of Science & Technology; Tokyo Institute of Technology; University of Geneva	Ferro, GM (corresponding author), ETH, Dept Management Technol & Econ, Zurich, Switzerland.	ferrog@ethz.ch		Ferro, Giuseppe/0000-0002-2088-4259				Abdellaoui M, 2000, MANAGE SCI, V46, P1497, DOI 10.1287/mnsc.46.11.1497.12080; Abdellaoui M, 2007, MANAGE SCI, V53, P1659, DOI 10.1287/mnsc.1070.0711; Academias Las, 1998, EDAD ORO, VXVII, P49; Agranov M, 2017, J POLIT ECON, V125, P40, DOI 10.1086/689774; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Nowaihi A., 2010, WILEY ENCY OPERATION; Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2008, INTRO PROBABILITY TH; [Anonymous], 2001, OVERSEAS ONLINE MAGA, V5, P10; Bachmann Kremena, 2018, BEHAV FINANCE PRIVAT; BENZUR H, 1981, ACTA PSYCHOL, V47, P89, DOI 10.1016/0001-6918(81)90001-9; Birnbaum MH, 1996, ORGAN BEHAV HUM DEC, V67, P91, DOI 10.1006/obhd.1996.0067; Birnbaum MH, 1999, ORGAN BEHAV HUM DEC, V77, P44, DOI 10.1006/obhd.1998.2816; Bossaerts P, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0138; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; BUSEMEYER JR, 1985, J EXP PSYCHOL LEARN, V11, P538, DOI 10.1037/0278-7393.11.3.538; Chae Y.K., 2009, PLOS ONE, V4, pe6523; CHATEAUNEUF A, 1994, J RISK UNCERTAINTY, V9, P77, DOI 10.1007/BF01073404; CHESLEY GR, 1978, J ACCOUNT RES, V16, P225, DOI 10.2307/2490564; CHEW SH, 1991, ECONOMETRICA, V59, P139, DOI 10.2307/2938244; COHEN MD, 1995, GENEVA PAP RISK INS, V20, P73, DOI 10.1007/BF01098959; DEBREU G, 1958, ECONOMETRICA, V26, P440, DOI 10.2307/1907622; Diecidue E, 2001, J RISK UNCERTAINTY, V23, P281, DOI 10.1023/A:1011877808366; Dodwell PC, 1961, REV INDIVIDUAL CHOIC; FISHBURN PC, 1978, J POLIT ECON, V86, P321, DOI 10.1086/260670; Fokker AD, 1914, ANN PHYS-BERLIN, V43, P810; HADAR J, 1969, AM ECON REV, V59, P25; HALPERN DF, 1973, J EXP PSYCHOL, V101, P105, DOI 10.1037/h0035463; HANDA J, 1977, J POLIT ECON, V85, P97, DOI 10.1086/260547; Harris AJL, 2009, COGNITION, V110, P51, DOI 10.1016/j.cognition.2008.10.006; HEY JD, 1984, KYKLOS, V37, P181, DOI 10.1111/j.1467-6435.1984.tb00748.x; Holtgrave D. R., 1990, M JUDGM MAK SOC NEW; IRWIN FW, 1953, J PERS, V21, P329, DOI 10.1111/j.1467-6494.1953.tb01775.x; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Jerome R Busemeyer, 1980, COMBINED EFFECTS EVE; JOPF Journal officiel de la Polynesie Francaise, 1982, JOPF, V8, P361; KADANE JB, 1988, J AM STAT ASSOC, V83, P357; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KARMARKAR US, 1978, ORGAN BEHAV HUM PERF, V21, P61, DOI 10.1016/0030-5073(78)90039-9; Kenneth Joseph Arrow, 1984, INDIVIDUAL CHOICE CE, V3; Kurtz-David V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09343-2; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; LOPES LL, 1981, J EXP PSYCHOL-HUM L, V7, P377; LUCE RD, 1977, J MATH PSYCHOL, V15, P215, DOI 10.1016/0022-2496(77)90032-3; LUCE RD, 1991, J RISK UNCERTAINTY, V4, P29, DOI 10.1007/BF00057885; Mata R, 2018, J ECON PERSPECT, V32, P155, DOI 10.1257/jep.32.2.155; McFadden D, 2001, AM ECON REV, V91, P351, DOI 10.1257/aer.91.3.351; Menger Karl, 1934, Z NATIONALOKONOMIE, P459; Michael D Weiss, 1987, CONCEPTUAL FDN RISK; Morgenstern Oskar, 1953, THEORY GAMES EC BEHA; Mosteller F, 1951, J POLIT ECON, V59, P371, DOI 10.1086/257106; MYERS JL, 1965, J MATH PSYCHOL, V2, P363, DOI 10.1016/0022-2496(65)90010-6; MYERS JL, 1962, PSYCHOL REP, V10, P483, DOI 10.2466/PR0.10.2.483-486; PAYNE JW, 1992, ANNU REV PSYCHOL, V43, P87, DOI 10.1146/annurev.ps.43.020192.000511; Petrovsky-Shtern Yohanan, 2004, ASS CIF JEWISH STUDI, V2, P217; PETRUSIC WM, 1978, J EXP PSYCHOL HUMAN, V4, P471, DOI 10.1037/0096-1523.4.3.471; Planck Max, 1917, SATZ STATISTISCHEN D; Pratt J.W, 1978, UNCERTAINTY EC, P59; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; PRUITT DG, 1965, J EXP PSYCHOL, V69, P483, DOI 10.1037/h0021721; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Robert Leslie Ellis, 1843, FDN THEORY PROBABILI; Robert Martin, 2011, STANFORD ENCY PHILOS; Roe RM, 2001, PSYCHOL REV, V108, P370, DOI 10.1037//0033-295X.108.2.370; ROTHSCHILD M, 1970, J ECON THEORY, V2, P225, DOI 10.1016/0022-0531(70)90038-4; SAVAGE LJ, 1971, J AM STAT ASSOC, V66, P783, DOI 10.2307/2284229; SCHKADE DA, 1989, ORGAN BEHAV HUM DEC, V44, P203, DOI 10.1016/0749-5978(89)90025-3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; SIMONSON I, 1992, J MARKETING RES, V29, P281, DOI 10.2307/3172740; SIMONSON I, 1989, J CONSUM RES, V16, P158, DOI 10.1086/209205; SLOVIC P, 1966, IEEE TRANS HUM FACT, VHFE7, P22, DOI 10.1109/THFE.1966.231980; Tasso JKaper, 1999, ANAL MULTISCALE PHEN, V56, P85; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Witelski T., 2009, SCHOLARPEDIA, V4, P3951; WRIGHT P, 1974, J APPL PSYCHOL, V59, P555, DOI 10.1037/h0037186; YAARI ME, 1987, ECONOMETRICA, V55, P95, DOI 10.2307/1911158	88	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243661	10.1371/journal.pone.0243661	http://dx.doi.org/10.1371/journal.pone.0243661			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315897	Green Published, gold			2022-12-26	WOS:000600186100006
J	Noguchi-Shinohara, M; Domoto, C; Yoshida, T; Niwa, K; Yuki-Nozaki, S; Samuraki-Yokohama, M; Sakai, K; Hamaguchi, T; Ono, K; Iwasa, K; Matsunari, I; Komai, K; Nakamura, H; Yamada, M				Noguchi-Shinohara, Moeko; Domoto, Chiaki; Yoshida, Taketoshi; Niwa, Kozue; Yuki-Nozaki, Sohshi; Samuraki-Yokohama, Miharu; Sakai, Kenji; Hamaguchi, Tsuyoshi; Ono, Kenjiro; Iwasa, Kazuo; Matsunari, Ichiro; Komai, Kiyonobu; Nakamura, Hiroyuki; Yamada, Masahito			A new computerized assessment battery for cognition (C-ABC) to detect mild cognitive impairment and dementia around 5 min	PLOS ONE			English	Article							MENTAL-STATE; DIAGNOSIS; CONSENSUS	This study aimed to develop a new computerized assessment battery for cognition (C-ABC) to detect mild cognitive impairment (MCI) and dementia. We performed C-ABC in subjects with dementia (n = 422), MCI (n = 145), and normal cognition (NC; n = 574), and analyzed by age stratum (50s, 60s, and 70-85 years). To distinguish MCI from NC, the C-ABC total combined score, which were calculated by dividing the C-ABC total score by the C-ABC required time, revealed the best area under the curves (AUC) at 0.838 and 0.735 in the 50s and 60s age groups, respectively; notably, this entire procedure took approximately 5 min. To distinguish dementia from NC and MCI, the partial items of C-ABC (items 3 + 6 combined score) revealed the best AUCs at 0.910, 0.874, and 0.882 in the 50s, 60s, and 70-85 age groups, respectively. Furthermore, the items 3 + 6 combined score established the best AUC at 0.794 in the 70-85 age group to distinguish MCI from NC; this entire procedure took around 2 min. Hence, this study suggests that C-ABC could be a useful tool for detecting dementia or MCI in a short time.	[Noguchi-Shinohara, Moeko; Domoto, Chiaki; Niwa, Kozue; Yuki-Nozaki, Sohshi; Samuraki-Yokohama, Miharu; Sakai, Kenji; Hamaguchi, Tsuyoshi; Ono, Kenjiro; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Noguchi-Shinohara, Moeko] Kanazawa Univ, Grad Sch Med Sci, Dept Preempt Med Dementia, Kanazawa, Ishikawa, Japan; [Yoshida, Taketoshi] Japan Adv Inst Sci & Technol JAIST, Dept Knowledge Sci, Nomi, Ishikawa, Japan; [Ono, Kenjiro] Showa Univ, Dept Internal Med, Div Neurol, Sch Med, Tokyo, Japan; [Iwasa, Kazuo] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa, Japan; [Matsunari, Ichiro] Saitama Med Univ Hosp, Dept Radiol, Div Nucl Med, Saitama, Japan; [Komai, Kiyonobu] Natl Hosp Org Iou Natl Hosp, Hokuriku Brain & Neuromuscular Dis Ctr, Dept Neurol, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Dept Publ Hlth, Grad Sch Adv Prevent Med Sci, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Adv Prevent Med Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Japan Advanced Institute of Science & Technology (JAIST); Showa University; Saitama Medical University; Kanazawa University; Kanazawa University; Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.	m-yamada@med.kanazawa-u.ac.jp			Japan Science and Technology Corporation, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Science and Technology Corporation, Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant for Development of Advanced Technology for Measurement and Evaluation of Brain Functions, Ishikawa Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence (to MY), from Japan Science and Technology Corporation, Japan, by a Grant for the Knowledge Cluster Initiative [High-Tech Sensing and Knowledge Handling Technology (Brain Technology)] (to MY) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. There was no additional external funding received for this study	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; [Anonymous], 2013, BONE MARROW TRANSPL, V48, P452; Curiel RE, 2016, J ALZHEIMERS DIS, V54, P793, DOI 10.3233/JAD-160370; Feenstra HEM, 2017, CLIN NEUROPSYCHOL, V31, P59, DOI 10.1080/13854046.2016.1190405; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Komatsu J, 2018, AM J NEURORADIOL, V39, P473, DOI 10.3174/ajnr.A5509; Loewenstein DA, 2000, INT J GERIATR PSYCH, V15, P434, DOI 10.1002/(SICI)1099-1166(200005)15:5<434::AID-GPS137>3.0.CO;2-2; Maruff Paul, 2013, BMC Psychol, V1, P30, DOI 10.1186/2050-7283-1-30; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zygouris S, 2015, AM J ALZHEIMERS DIS, V30, P13, DOI 10.1177/1533317514522852	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243469	10.1371/journal.pone.0243469	http://dx.doi.org/10.1371/journal.pone.0243469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306697	Green Published, gold			2022-12-26	WOS:000600144200005
J	Palladini, G; Ferrigno, A; Di Pasqua, LG; Berardo, C; Rizzo, V; Perlini, S; Vairetti, M				Palladini, Giuseppina; Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Rizzo, Vittoria; Perlini, Stefano; Vairetti, Mariapia			Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease	PLOS ONE			English	Article							URIC-ACID; METABOLIC SYNDROME; OXIDATIVE STRESS; TISSUE METAL; ZUCKER OBESE; CALCIUM; IRON; CHROMIUM; CHOLINE; COPPER	Background The comparison of hepatic steatosis animal models has allowed the understanding of mechanisms involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the progression to nonalcoholic steatohepatitis (NASH). We investigated the changes in serum levels of trace elements and inflammation markers in fatty livers using two rat models of NAFLD, the methionine and choline deficient (MCD) diet model and Obese-Zucker rats. Material and methods NAFLD was induced in male Wistar rats by 3-week MCD diet administration, after which, blood samples were collected. 12-week old Obese (fa/fa) and Lean (fa/-) male Zucker rats were also used. Serum levels of hepatic enzymes, Urea, Uric acid, Ca-2+,Ca- Cl, Fe, K, Na, Mg and Zn were quantified, as well as the inflammation markers TNF-alpha, IL-1beta and IL-6. Results In MCD rats, a serum increase in Cl, Mg and Na and a decrease in Ca-2+,Ca- Zn were detected in comparison with control rats. An increase in only serum Ca2+ was found in Obese-Zucker rats. In MCD rat serum, Zn was inversely correlated with IL-1beta, IL-6, TNF-alpha, Urea and Uric Acid; Ca2+ was inversely correlated with IL-1beta, IL-6 and Urea; Cl and Mg were directly correlated with Uric Acid and Urea, respectively. In Obese-Zucker rats, Cl and IL-1beta were inversely correlated, whereas Ca2+ and Urea where directly correlated, as well Fe and TNF-alpha. Conclusions The serum concentrations of trace elements change significantly only in MCD rats, which spontaneously progress to NASH. The causes of these changes may be a result of defense strategies of the organism, which is regulated by immunoregulatory cytokines. These results might suggest that the impairment of trace element status should be taken into account when the effectiveness of a pharmacological treatment is under evaluation.	[Palladini, Giuseppina; Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Perlini, Stefano; Vairetti, Mariapia] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy; [Palladini, Giuseppina] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Rizzo, Vittoria] Univ Pavia, Dept Mol Med, Pavia, Italy; [Perlini, Stefano] Fdn IRCCS Policlin San Matteo, Emergency Dept, Pavia, Italy	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo	Ferrigno, A (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy.	andrea.ferrigno@unipv.it	Palladini, Giuseppina/AAB-8694-2019; Di Pasqua, Laura Giuseppina/Y-3987-2019; Ferrigno, Andrea/J-2087-2019; Vairetti, Mariapia/AAM-1757-2020	Palladini, Giuseppina/0000-0003-1312-7513; Di Pasqua, Laura Giuseppina/0000-0003-0103-1493; Ferrigno, Andrea/0000-0003-2337-2897; Vairetti, Mariapia/0000-0002-2464-6127				Abe N, 2019, BIOL OPEN, V8, DOI 10.1242/bio.040519; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Asprouli E, 2019, BIOL TRACE ELEM RES, V188, P326, DOI 10.1007/s12011-018-1432-9; Bernardi M, 2005, LIVER INT, V25, P463, DOI 10.1111/j.1478-3231.2005.01115.x; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Brennan P, 2020, WORLD J GASTROENTERO, V26, P1683, DOI 10.3748/wjg.v26.i15.1683; Britton LJ, 2016, WORLD J GASTROENTERO, V22, P8112, DOI 10.3748/wjg.v22.i36.8112; de Lemos ET, 2009, NUTRITION, V25, P330, DOI 10.1016/j.nut.2008.08.014; DEBACQUER D, 1994, ATHEROSCLEROSIS, V108, P193, DOI 10.1016/0021-9150(94)90114-7; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Eshraghian A, 2018, UNITED EUR GASTROENT, V6, P97, DOI 10.1177/2050640617707863; FERNANDEZLOPEZ JA, 1994, BIOMETALS, V7, P117, DOI 10.1007/BF00140481; Gammoh NZ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060624; Gatiatulina ER, 2017, J TRACE ELEM MED BIO, V39, P91, DOI 10.1016/j.jtemb.2016.08.007; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Himoto T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010088; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Ito T, 2020, EUR J GASTROEN HEPAT, V32, P748, DOI 10.1097/MEG.0000000000001587; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P943, DOI 10.1016/j.bbadis.2018.06.023; Ji GY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0139-6; Kim MK, 2010, ATHEROSCLEROSIS, V212, P674, DOI 10.1016/j.atherosclerosis.2010.07.005; Kocyigit A, 2002, BIOL TRACE ELEM RES, V90, P47, DOI 10.1385/BTER:90:1-3:47; Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364; Lau JKC, 2017, J PATHOL, V241, P36, DOI 10.1002/path.4829; Liu T, 2019, WORLD J GASTROENTERO, V25, P5451, DOI 10.3748/wjg.v25.i36.5451; Lombardi R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040548; Martin-Cordero L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-42; Mirea AM, 2020, INFLAMMATION, V43, P1054, DOI 10.1007/s10753-020-01190-4; Palladini G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040799; Perry B, 2014, J INTEGR MED-JIM, V12, P447, DOI 10.1016/S2095-4964(14)60044-3; PHILLIPS AN, 1991, J HUM HYPERTENS, V5, P479; Pickett-Blakely O, 2018, CELL MOL GASTROENTER, V6, P451, DOI 10.1016/j.jcmgh.2018.07.004; Recasens M, 2004, Rev Med Univ Navarra, V48, P49; Reyes-Esparza J, 2013, BASIC CLIN PHARMACOL, V112, P222, DOI 10.1111/bcpt.12019; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Sacks Gordon S, 2004, J Pediatr Pharmacol Ther, V9, P235, DOI 10.5863/1551-6776-9.4.235; Scheiner B, 2017, J HEPATOL, V67, P1062, DOI 10.1016/j.jhep.2017.06.023; SERFASS RE, 1988, P SOC EXP BIOL MED, V189, P229; Shin JY, 2015, J GASTROEN HEPATOL, V30, P733, DOI 10.1111/jgh.12832; Staniek H, 2013, BIOL TRACE ELEM RES, V151, P373, DOI 10.1007/s12011-012-9565-8; Steensberg A, 2003, EXERC IMMUNOL REV, V9, P40; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Yuan HP, 2015, J CLIN ENDOCR METAB, V100, P4198, DOI 10.1210/jc.2015-2527; Zhao CQ, 2014, J INTEGR MED-JIM, V12, P401, DOI 10.1016/S2095-4964(14)60039-X	49	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243179	10.1371/journal.pone.0243179	http://dx.doi.org/10.1371/journal.pone.0243179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306695	gold, Green Published			2022-12-26	WOS:000600144200048
J	Ballard, PL; Oses-Prieto, J; Chapin, C; Segal, MR; Ballard, RA; Burlingame, AL				Ballard, Philip L.; Oses-Prieto, Juan; Chapin, Cheryl; Segal, Mark R.; Ballard, Roberta A.; Burlingame, Alma L.			Composition and origin of lung fluid proteome in premature infants and relationship to respiratory outcome	PLOS ONE			English	Article							D-BINDING PROTEIN; BRONCHOALVEOLAR LAVAGE FLUID; INHALED NITRIC-OXIDE; VITAMIN-D; PRETERM INFANTS; II CELLS; BRONCHOPULMONARY DYSPLASIA; GENE-EXPRESSION; FREE HEMOGLOBIN; DIFFERENTIATION	Background Infants born at extremely low gestational age are at high risk for bronchopulmonary dysplasia and continuing lung disease. There are no early clinical biomarkers for pulmonary outcome and limited therapeutic interventions. Objectives We performed global proteomics of premature infant tracheal aspirate (TA) and plasma to determine the composition and source of lung fluid proteins and to identify potential biomarkers of respiratory outcome. Methods TA samples were collected from intubated infants in the TOLSURF cohort before and after nitric oxide treatment, and plasma was collected from NO CLD infants. Protein abundance was assayed by HPLC/tandem mass spectrometry and Protein Prospector software. mRNA abundance in mid-gestation fetal lung was assessed by RNA sequencing. Pulmonary morbidity was defined as a need for ventilatory support at term and during the first year. Results Abundant TA proteins included albumin, hemoglobin, and actin-related proteins. 96 of 137 detected plasma proteins were present in TA (r = 0.69, p<0.00001). Based on lung RNAseq data, similar to 88% of detected TA proteins in injured infant lung are derived at least in part from lung epithelium with overrepresentation in categories of cell membrane/secretion and stress/inflammation. Comparing 37 infants at study enrollment (7-14 days) who did or did not develop persistent pulmonary morbidity, candidate biomarkers of both lung (eg., annexin A5) and plasma (eg., vitamin D-binding protein) origin were identified. Notably, levels of free hemoglobin were 2.9-fold (p = 0.03) higher in infants with pulmonary morbidity. In time course studies, hemoglobin decreased markedly in most infants after enrollment coincident with initiation of inhaled nitric oxide treatment. Conclusions We conclude that both lung epithelium and plasma contribute to the lung fluid proteome in premature infants with lung injury. Early postnatal elevation of free hemoglobin and heme, which are both pro-oxidants, may contribute to persistent lung disease by depleting nitric oxide and increasing oxidative/nitrative stress.	[Ballard, Philip L.; Chapin, Cheryl; Ballard, Roberta A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA; [Oses-Prieto, Juan; Burlingame, Alma L.] Univ Calif San Francisco, Dept Chem & Pharmaceut Chem, San Francisco, CA USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ballard, PL (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA.	Phil.ballard@ucsf.edu			NIH National Heart Lung Blood Institute [R21HL129910]; Department of Pediatrics University of California, San Francisco; National Institute of General Medical Sciences [P41 GM103481]	NIH National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Pediatrics University of California, San Francisco; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the NIH National Heart Lung Blood Institute R21HL129910 (PLB) and the Department of Pediatrics University of California, San Francisco (PLB). ALB is director of the Bio-Organic Biomedical Mass Spectrometry Resource at UCSF, which is supported by the National Institute of General Medical Sciences (P41 GM103481). Ikaria Inc. (now part of Mallinckrodt Pharmaceuticals https://www.mallinckrodt.ca/)Biotech) and ONY Inc. (https://www.onybiotech.com/) provided drug for the conduct of the parent TOLSURF trial, but neither company had input into study design, data analysis, data interpretation, decision to publish or manuscript preparation. No authors received salary support from either commercial company.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Askie LM, 2018, J PEDIATR-US, V193, P34, DOI 10.1016/j.jpeds.2017.10.004; Ballard PL, 2019, PEDIATR RES, V85, P305, DOI 10.1038/s41390-018-0144-3; Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Ballard RA, 2016, J PEDIATR-US, V168, P23, DOI 10.1016/j.jpeds.2015.09.031; Barrette AM, 2016, AM J RESP CELL MOL, V55, P623, DOI 10.1165/rcmb.2016-0068OC; Bhandari A, 2013, PAEDIATR RESPIR REV, V14, P173, DOI 10.1016/j.prrv.2013.02.008; Bhargava M, 2016, BIOL BLOOD MARROW TR, V22, P1383, DOI 10.1016/j.bbmt.2016.04.021; Bhargava M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109713; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Collard Keith James, 2014, World J Clin Pediatr, V3, P19, DOI 10.5409/wjcp.v3.i3.19; Davis JM, 2003, PEDIATRICS, V111, P469, DOI 10.1542/peds.111.3.469; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; Gibson AM, 2015, PEDIATR PULM, V50, P987, DOI 10.1002/ppul.23093; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Greenough A, 2013, J PERINAT MED, V41, P119, DOI 10.1515/jpm-2012-0084; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; HOLTER JF, 1986, J CLIN INVEST, V78, P1513, DOI 10.1172/JCI112743; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Keller RL, 2017, J PEDIATR-US, V183, P19, DOI 10.1016/j.jpeds.2016.12.059; Lei C, 2018, AM J RESP CRIT CARE, V198, P1279, DOI [10.1164/rccm.201710-2150OC, 10.1164/rccm.201708-1713RR]; Lykkedegn S, 2015, AM J PHYSIOL-LUNG C, V308, pL587, DOI 10.1152/ajplung.00117.2014; Magagnotti C, 2013, J PROTEOMICS, V94, P401, DOI 10.1016/j.jprot.2013.10.007; Malik S, 2013, CRIT REV CL LAB SCI, V50, P1, DOI 10.3109/10408363.2012.750262; Martinez-Bravo MJ, 2017, J ALLERGY CLIN IMMUN, V139, P1186, DOI 10.1016/j.jaci.2016.05.051; Nguyen EV, 2014, AM J PHYSIOL-LUNG C, V306, pL35, DOI 10.1152/ajplung.00140.2013; Nguyen EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058782; Olmeda B, 2014, J PROTEOMICS, V101, P179, DOI 10.1016/j.jprot.2014.02.019; Pehlevan OS, 2015, J PERINATOL, V35, P763, DOI 10.1038/jp.2015.58; Pereira-Fantini PM, 2019, AM J RESP CELL MOL, V61, P631, DOI 10.1165/rcmb.2019-0084OC; Pereira-Fantini PM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30868-x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015; Steinhorn RH, 2011, FREE RADICAL BIO MED, V51, P1027, DOI 10.1016/j.freeradbiomed.2011.01.006; Suski M, 2018, J PERINATOL, V38, P1182, DOI 10.1038/s41372-018-0150-7; Wade KC, 2006, AM J RESP CELL MOL, V34, P727, DOI 10.1165/rcmb.2004-0389OC; Yang MX, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0695-6	41	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243168	10.1371/journal.pone.0243168	http://dx.doi.org/10.1371/journal.pone.0243168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301538	gold, Green Published			2022-12-26	WOS:000600143100051
J	Abreu, R; Essler, L; Giri, P; Quinn, F				Abreu, Rodrigo; Essler, Lauren; Giri, Pramod; Quinn, Frederick			Interferon-gamma promotes iron export in human macrophages to limit intracellular bacterial replication	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; SALMONELLA-ENTERICA; HOST-DEFENSE; HEPCIDIN; FERROPORTIN; INFECTIONS; GROWTH; HOMEOSTASIS; MECHANISM	Salmonellosis and listeriosis together accounted for more than one third of foodborne illnesses in the United States and almost half the hospitalizations for gastrointestinal diseases in 2018 while tuberculosis afflicted over 10 million people worldwide causing almost 2 million deaths. Regardless of the intrinsic virulence differences among Listeria monocytogenes, Salmonella enterica and Mycobacterium tuberculosis, these intracellular pathogens share the ability to survive and persist inside the macrophage and other cells and thrive in iron rich environments. Interferon-gamma (IFN-gamma) is a central cytokine in host defense against intracellular pathogens and has been shown to promote iron export in macrophages. We hypothesize that IFN-gamma decreases iron availability to intracellular pathogens consequently limiting replication in these cells. In this study, we show that IFN-gamma regulates the expression of iron-related proteins hepcidin, ferroportin, and ferritin to induce iron export from macrophages. Listeria monocytogenes, S. enterica, and M. tuberculosis infections significantly induce iron sequestration in human macrophages. In contrast, IFN-gamma significantly reduces hepcidin secretion in S. enterica and M. tuberculosis infected macrophages. Similarly, IFN-gamma-activated macrophages express higher ferroportin levels than untreated controls even after infection with L. monocytogenes bacilli; bacterial infection greatly down-regulates ferroportin expression. Collectively, IFN-gamma significantly inhibits pathogen-associated intracellular iron sequestration in macrophages and consequently retards the growth of intracellular bacterial pathogens by decreasing iron availability.	[Abreu, Rodrigo; Essler, Lauren; Giri, Pramod; Quinn, Frederick] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Quinn, F (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	fquinn@uga.edu		Essler, Lauren/0000-0002-4930-393X	University of Georgia Athletic Association; Fulbright PhD Scholarship [11/278]	University of Georgia Athletic Association; Fulbright PhD Scholarship	This work was supported in part by an endowment from the University of Georgia Athletic Association to FDQ and a Fulbright PhD Scholarship to RA (11/278). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu R, 2018, BLOOD ADV, V2, P1089, DOI 10.1182/bloodadvances.2017015255; Abreu R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25480-y; Alli O A T, 2009, Afr J Med Med Sci, V38, P325; Arezes J, 2015, CELL HOST MICROBE, V17, P47, DOI 10.1016/j.chom.2014.12.001; Bao S, 2000, IMMUNOLOGY, V99, P464, DOI 10.1046/j.1365-2567.2000.00955.x; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Bureau USC, US AG POP; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; CDC, 2016, TOD HIV AIDS EP 2016; CDC, 2016, REP TUB US 2015; CDC, 2017, FOODB DIS ACT SUR NE; CDC, TUBERCULOSIS; CDC, HIV; Centers for Disease Control and Prevention (CDC), HIV AIDS; Chavez-Galan L, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4048235; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; DECKER CF, 1991, REV INFECT DIS, V13, P413; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; ECDC, LIST; ECDC, SALM; ECDC, 2016, ANN EP REP 2014 LIST; ECDC, 2014, FOOD WAT DIS ZOON; ECDC, 2015, TUB 2014 REP; ECDC/WHO, 2016, HIV AIDS SURV EUR; Eurostat, EU POP STRUCT; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gomes M. S., 1999, Tubercle and Lung Disease, V79, P321, DOI 10.1054/tuld.1999.0216; Gunawardena HP, 2013, J PROTEOME RES, V12, P5463, DOI 10.1021/pr400334k; Hameed Saif, 2015, Open Microbiol J, V9, P91, DOI 10.2174/1874285801509010091; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Haschka D, 2015, METALLOMICS, V7, P1036, DOI 10.1039/c4mt00328d; Hung CC, 2007, CLIN INFECT DIS, V45, pE60, DOI 10.1086/520681; Jellbauer S, 2016, INFECT IMMUN, V84, P2639, DOI 10.1128/IAI.00132-16; KALES CP, 1990, J ACQ IMMUN DEF SYND, V3, P139; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Kawakami K, 2004, MICROBES INFECT, V6, P339, DOI 10.1016/j.micinf.2004.01.003; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Kontoghiorghes GJ, 2010, HEMOGLOBIN, V34, P227, DOI 10.3109/03630269.2010.483662; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lechowicz J, 2015, BIOMETALS, V28, P587, DOI 10.1007/s10534-015-9849-5; Levine MM, 2011, CLIN INFECT DIS, V52, P349, DOI 10.1093/cid/ciq109; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moreira AC, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00353-17, 10.1128/iai.00353-17]; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nugent SL, 2015, APPL ENVIRON MICROB, V81, P3663, DOI 10.1128/AEM.04257-14; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parrow NL, 2013, INFECT IMMUN, V81, P3503, DOI 10.1128/IAI.00602-13; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sheldon JR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0010-2015; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Sritharan M, 2016, J BACTERIOL, V198, P2399, DOI 10.1128/JB.00359-16; Surguladze N, 2005, BIOCHEM J, V388, P731, DOI 10.1042/BJ20041853; Trivedi NH, 2018, INNATE IMMUN-LONDON, V24, P152, DOI 10.1177/1753425918760180; USDA, 2011, FOOD SAF PEOPL HIV A; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; WHO, TUBERCULOSIS; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104	76	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0240949	10.1371/journal.pone.0240949	http://dx.doi.org/10.1371/journal.pone.0240949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290416	gold, Green Published, Green Submitted			2022-12-26	WOS:000598620100014
J	Iqbal, E; Govind, R; Romero, A; Dzahini, O; Broadbent, M; Stewart, R; Smith, T; Kim, CH; Werbeloff, N; MacCabe, JH; Dobson, RJB; Ibrahim, ZM				Iqbal, Ehtesham; Govind, Risha; Romero, Alvin; Dzahini, Olubanke; Broadbent, Matthew; Stewart, Robert; Smith, Tanya; Kim, Chi-Hun; Werbeloff, Nomi; MacCabe, James H.; Dobson, Richard J. B.; Ibrahim, Zina M.			The side effect profile of Clozapine in real world data of three large mental health hospitals	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; CHILDHOOD-ONSET SCHIZOPHRENIA; WEIGHT-GAIN; DIABETES-MELLITUS; OPEN TRIAL; AGRANULOCYTOSIS; ANTIPSYCHOTICS; ADOLESCENTS; OLANZAPINE; CHILDREN	Objective Mining the data contained within Electronic Health Records (EHRs) can potentially generate a greater understanding of medication effects in the real world, complementing what we know from Randomised control trials (RCTs). We Propose a text mining approach to detect adverse events and medication episodes from the clinical text to enhance our understanding of adverse effects related to Clozapine, the most effective antipsychotic drug for the management of treatment-resistant schizophrenia, but underutilised due to concerns over its side effects. Material and methods We used data from de-identified EHRs of three mental health trusts in the UK (>50 million documents, over 500,000 patients, 2835 of which were prescribed Clozapine). We explored the prevalence of 33 adverse effects by age, gender, ethnicity, smoking status and admission type three months before and after the patients started Clozapine treatment. Where possible, we compared the prevalence of adverse effects with those reported in the Side Effects Resource (SIDER). Results Sedation, fatigue, agitation, dizziness, hypersalivation, weight gain, tachycardia, headache, constipation and confusion were amongst the highest recorded Clozapine adverse effect in the three months following the start of treatment. Higher percentages of all adverse effects were found in the first month of Clozapine therapy. Using a significance level of (p< 0.05) our chi-square tests show a significant association between most of the ADRs and smoking status and hospital admission, and some in gender, ethnicity and age groups in all trusts hospitals. Later we combined the data from the three trusts hospitals to estimate the average effect of ADRs in each monthly interval. In gender and ethnicity, the results show significant association in 7 out of 33 ADRs, smoking status shows significant association in 21 out of 33 ADRs and hospital admission shows the significant association in 30 out of 33 ADRs. Conclusion A better understanding of how drugs work in the real world can complement clinical trials.	[Iqbal, Ehtesham; Govind, Risha; Dobson, Richard J. B.; Ibrahim, Zina M.] Kings Coll London, Dept Biostat & Hlth Informat, Inst Psychiat Psychol & Neurosci, London, England; [Romero, Alvin] South London & Maudsley NHS Fdn Trust, SLAM BioResource Mental Hlth, London, England; [Romero, Alvin] Kings Coll London, London, England; [Dzahini, Olubanke] South London & Maudsley NHS Fdn Trust, Pharm Dept, London, England; [Broadbent, Matthew; Stewart, Robert; MacCabe, James H.; Dobson, Richard J. B.; Ibrahim, Zina M.] South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England; [Broadbent, Matthew; Stewart, Robert; Dobson, Richard J. B.; Ibrahim, Zina M.] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England; [Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Hlth Serv & Populat Res, London, England; [Smith, Tanya] Oxford Hlth NHS Fdn Trust, Oxford, England; [Smith, Tanya] Univ Oxford, NIHR Oxford Hlth Biomed Res Ctr, Oxford, England; [Kim, Chi-Hun] Univ Oxford, Dept Psychiat, Oxford, England; [Werbeloff, Nomi] UCL, UCL Div Psychiat, London, England; [Werbeloff, Nomi] NHS Fdn Trust, London, England; [MacCabe, James H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Psychosis Studies, Crespigny Pk, London, England; [Dobson, Richard J. B.; Ibrahim, Zina M.] UCL, Farr Inst Hlth Informat Res, UCL Inst Hlth Informat, London, England; [Dobson, Richard J. B.; Ibrahim, Zina M.] Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of Oxford; University of Oxford; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of London; King's College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Iqbal, E; Ibrahim, ZM (corresponding author), Kings Coll London, Dept Biostat & Hlth Informat, Inst Psychiat Psychol & Neurosci, London, England.; Ibrahim, ZM (corresponding author), South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr Mental Hlth, London, England.; Ibrahim, ZM (corresponding author), South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, London, England.; Ibrahim, ZM (corresponding author), UCL, Farr Inst Hlth Informat Res, UCL Inst Hlth Informat, London, England.; Ibrahim, ZM (corresponding author), Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England.	Ehtesham.iqbal@kcl.ac.uk; zina.ibrahim@kcl.ac.uk	MacCabe, James/E-5210-2010; Dzahini, Olubanke/HDM-6742-2022; dobson, richard/C-9269-2011	MacCabe, James/0000-0002-6754-1018; Dzahini, Olubanke/0000-0003-3878-2143; dobson, richard/0000-0003-4224-9245; Ibrahim, Zina/0000-0001-6203-2727	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; NIHR Oxford Health Biomedical Research Centre at Oxford University; Oxford Health NHS Foundation Trust [BRC-1215-20005]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Farr Institute of Health Informatics Research at UCL Partners; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Wellcome Trust [MR/K006584/1]; Case Record Interactive Search (CRIS) system; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; EPSRC [EP/N027280/1] Funding Source: UKRI; MRC [MC_PC_17214] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric); NIHR Oxford Health Biomedical Research Centre at Oxford University; Oxford Health NHS Foundation Trust; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Farr Institute of Health Informatics Research at UCL Partners; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Wellcome Trust(Wellcome Trust); Case Record Interactive Search (CRIS) system; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, and by the NIHR Oxford Health Biomedical Research Centre at Oxford University and Oxford Health NHS Foundation Trust (grant BRC-1215-20005). This research was supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and by awards establishing the Farr Institute of Health Informatics Research at UCL Partners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1). This study was supported by the Case Record Interactive Search (CRIS) system funded and developed by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London using the system within the NIHR Oxford Health Biomedical Research Centre (Oxford University and Oxford Health NHS Foundation Trust).	ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; AMSLER HA, 1977, ACTA PSYCHIAT SCAND, V56, P241, DOI 10.1111/j.1600-0447.1977.tb00224.x; Angermeyer MC, 2001, PSYCHOL MED, V31, P509, DOI 10.1017/S0033291701003749; Anthony Marietta, 2002, J Womens Health Gend Based Med, V11, P601, DOI 10.1089/152460902760360559; Baker E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178562; Camden and Islington NHS Foundation Trust, 2017, CAMD ISL NHS FDN TRU; Chaudhry IB, 2008, J PSYCHOPHARMACOL, V22, P673, DOI 10.1177/0269881107082105; Choi S, 2007, LIFE SCI, V81, P1024, DOI 10.1016/j.lfs.2007.08.009; Citrome LL, 2004, DRUG TODAY, V40, P445, DOI 10.1358/dot.2004.40.5.850492; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Cohen D, 2004, PHARMACOPSYCHIATRY, V37, P1, DOI 10.1055/s-2004-815468; Datapharm Communications Ltd, 2017, EL MED COMP EMC; De Fazio P, 2015, NEUROPSYCH DIS TREAT, V11, P1995, DOI 10.2147/NDT.S83989; Dickerson F, 2013, PSYCHIAT SERV, V64, P44, DOI [10.1176/appi.ps.201200143, 10.1176/appi.ps.001432012]; Flanagan RJ, 2008, CURR DRUG SAF, V3, P115, DOI 10.2174/157488608784529251; Fleischhaker C, 2008, J NEURAL TRANSM, V115, P1599, DOI 10.1007/s00702-008-0105-9; Fleischhaker C, 2006, J CHILD ADOL PSYCHOP, V16, P308, DOI 10.1089/cap.2006.16.308; FRAZIER JA, 1994, J AM ACAD CHILD PSY, V33, P658, DOI 10.1097/00004583-199406000-00006; Frogley C, 2012, INT J NEUROPSYCHOPH, V15, P1351, DOI 10.1017/S146114571100201X; Furukawa T, 2007, PHARMACOL THERAPEUT, V115, P106, DOI 10.1016/j.pharmthera.2007.04.008; Gareri P, 2008, EXPERT OPIN DRUG SAF, V7, P525, DOI [10.1517/14740338.7.5.525, 10.1517/14740338.7.5.525 ]; Gerbino-Rosen G, 2005, J AM ACAD CHILD PSY, V44, P1024, DOI 10.1097/01.chi.0000171904.23947.54; Gianfrancesco FD, 2002, J CLIN PSYCHIAT, V63, P920, DOI 10.4088/JCP.v63n1010; Gurcan G, 2017, EUR PSYCHIAT, V41, pS197, DOI 10.1016/j.eurpsy.2017.01.2139; Haas SJ, 2007, DRUG SAFETY, V30, P47, DOI 10.2165/00002018-200730010-00005; HAYES RD, 2014, SCHIZOPHR B, V41, P644, DOI DOI 10.1093/SCHBUL/SBU120; Hodge K, 2008, INT J MENT HEALTH NU, V17, P2, DOI 10.1111/j.1447-0349.2007.00506.x; Hofer-Dueckelmann C, 2011, INT J CLIN PHARM TH, V49, P577, DOI 10.5414/CP201514; Hynes C, 2015, SCHIZOPHR RES, V168, P505, DOI 10.1016/j.schres.2015.07.052; IDANPAANHEIKKILA J, 1977, EUR J CLIN PHARMACOL, V11, P193, DOI 10.1007/BF00606409; Iqbal E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187121; Iqbal MM, MOST COMMON SIDE EFF; Joint Formulary Committee, 2016, BRIT NAT FORM BNF 72; Kadra G, 2016, SCHIZOPHR RES, V174, P106, DOI 10.1016/j.schres.2016.04.010; Kar N, 2016, CLIN PSYCHOPHARM NEU, V14, P323, DOI 10.9758/cpn.2016.14.4.323; Kelly C., 2000, ADV PSYCHIAT TREATME, V6, P327, DOI [10.1192/apt.6.5.37, DOI 10.1192/apt.6.5.327, DOI 10.1192/APT.6.5.327]; Kelly DL, 2007, SCHIZOPHRENIA BULL, V33, P1221, DOI 10.1093/schbul/sbl068; Krupp P, 1992, BRIT J PSYCHIAT; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kumra S, 1996, ARCH GEN PSYCHIAT, V53, P1090; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEADBETTER R, 1992, AM J PSYCHIAT, V149, P68; Lieberman Jeffrey A., 1992, Psychiatric Quarterly (New York), V63, P51, DOI 10.1007/BF01064682; LIN KM, 1986, CULT MED PSYCHIAT, V10, P151, DOI 10.1007/BF00156581; LOHR JB, 1992, SCHIZOPHR RES, V8, P93, DOI 10.1016/0920-9964(92)90024-Y; Lucas C., 2013, AUST PRESCR, V36, P102, DOI [10.18773/austprescr.2013.037, DOI 10.18773/AUSTPRESCR.2013.037]; Miller DD, 2000, J CLIN PSYCHIAT; Mortimer Ann M, 2010, Clin Schizophr Relat Psychoses, V4, P49, DOI 10.3371/CSRP.4.1.4; Nielsen J, 2010, NEUROPSYCHOPHARMACOL, V35, P1997, DOI 10.1038/npp.2010.78; Oxford Health NHS Foundation Trust, 2018, OXF HLTH NHS FDN TRU; Perera G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008721; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rademaker M, 2001, Am J Clin Dermatol, V2, P349, DOI 10.2165/00128071-200102060-00001; Raja M, 2014, CURR DRUG SAF, V9, P163, DOI 10.2174/1574886309666140428115040; Raja M, 2011, CURR DRUG SAF, V6, P164, DOI 10.2174/157488611797579230; Rodenburg EM, 2011, BRIT J CLIN PHARMACO, V71, P95, DOI 10.1111/j.1365-2125.2010.03811.x; SAFFERMAN A, 1991, SCHIZOPHRENIA BULL, V17, P247, DOI 10.1093/schbul/17.2.247; Schneider C, 2014, EUR PSYCHIAT, V29, P1, DOI 10.1016/j.eurpsy.2013.08.001; Schulte PFJ, 2003, CLIN PHARMACOKINET, V42, P607, DOI 10.2165/00003088-200342070-00001; Sporn AL, 2007, J AM ACAD CHILD PSY, V46, P1349, DOI 10.1097/chi.0b013e31812eed10; Stahl SM., 2000, ESSENTIAL PSYCHOPHAR, V2nd ed; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Takeuchi H, 2016, SCHIZOPHR RES, V174, P200, DOI 10.1016/j.schres.2016.04.005; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Taylor DM, 2009, BRIT J PSYCHIAT, V194, P165, DOI 10.1192/bjp.bp.108.051979; Turetz M, 1997, BRIT J PSYCHIAT, V170, P507, DOI 10.1192/bjp.170.6.507; Wehmeier PM, 2004, J CHILD ADOL PSYCHOP, V14, P267, DOI 10.1089/1044546041648977; Werbeloff N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190703; Wudarsky M, 1999, J CHILD ADOL PSYCHOP, V9, P239, DOI 10.1089/cap.1999.9.239; Young CR, 1998, SCHIZOPHRENIA BULL, V24, P381, DOI 10.1093/oxfordjournals.schbul.a033333; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y	71	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243437	10.1371/journal.pone.0243437	http://dx.doi.org/10.1371/journal.pone.0243437			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8OF	33290433	Green Submitted, Green Published, gold			2022-12-26	WOS:000598620100026
J	Jin, J; Robeson, H; Fagan, P; Orloff, MS				Jin, Jing; Robeson, Heather; Fagan, Pebbles; Orloff, Mohammed S.			Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes	PLOS ONE			English	Article							DNA-REPAIR; PARP1; RISK; GENE; EXPRESSION; VARIANTS; XRCC1	Objective The carcinogenesis role of PARP1 in lung cancer is still not clear. Analysis at allelic levels cannot fully explain the function of PARP1 on lung cancer. Our study aims to further explore the relation between PARP1 haplotypes and lung cancer. Materials and methods DNA and RNA were extracted from non-small cell lung cancer (NSCLC) tumor and adjacent normal fresh frozen tissue. Five PARP1-SNPs were genotyped and PARP1-specific SNPs were imputed using IMPUTE and SHAPEIT software. The SNPs were subjected to allelic, haplotype and SNP-SNP interaction analyses. Correlation between SNPs and mRNA/protein expressions were performed. Results SNP imputation inferred the ungenotyped SNPs and increased the power for association analysis. Tumor tissue samples are more likely to carry rs1805414 (OR = 1.85; 95% CI: 1.12-3.06; P-value: 0.017) and rs1805404 (OR = 2.74; 95%CI 1.19-6.32; P-value: 0.015) compared to normal tissues. Our study is the first study to show that haplotypes comprising of 5 SNPs on PARP1 (rs1136410, rs3219073, rs1805414, rs1805404, rs1805415) is able to differentiate the NSCLC tumor from normal tissues. Interaction between rs3219073, rs1805415, and rs1805414 were significantly associated with the NSCLC tumor with OR ranging from 3.61-6.75; 95%CI from 1.82 to 19.9; P-valueConclusion PARP1 haplotypes may serve as a better predictor in lung cancer development and prognosis compared to single alleles.	[Jin, Jing; Robeson, Heather; Orloff, Mohammed S.] Univ Arkansas Med Sci, Dept Epidemiol, Little Rock, AR 72205 USA; [Fagan, Pebbles] Univ Arkansas Med Sci, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA; [Fagan, Pebbles; Orloff, Mohammed S.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Fagan, Pebbles; Orloff, Mohammed S.] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Ctr Studies Tobacco, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Orloff, MS (corresponding author), Univ Arkansas Med Sci, Dept Epidemiol, Little Rock, AR 72205 USA.; Orloff, MS (corresponding author), Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA.; Orloff, MS (corresponding author), Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Ctr Studies Tobacco, Little Rock, AR 72205 USA.	MSOrloff@uams.edu		Jin, Jing/0000-0003-1771-9938	Seeds of Science Grant; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Science; Center for the Studies of Tobacco, University of Arkansas for Medical Sciences	Seeds of Science Grant; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Science; Center for the Studies of Tobacco, University of Arkansas for Medical Sciences	This study was funded by Seeds of Science Grant, The Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Science, and Center for the Studies of Tobacco, University of Arkansas for Medical Sciences.	American Cancer Society, 2019, LUNG CANC SURV RAT 5; [Anonymous], 2011, DRUG SAFETY UPDATE, V4, pH1; [Anonymous], 2003, ALAA ANZ J SURG, V73, pA170; [Anonymous], 2009, GMS HLTH TECHNOL ASS, V5, pDoc14; [Anonymous], 2014, ORBITAL DEBRIS Q NEW, V18, P1; [Anonymous], 2019, CANCER DISCOV, V10, pOF5; Apopa PL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01757; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Cagle PT, 2013, ARCH PATHOL LAB MED, V137, P1191, DOI 10.5858/arpa.2013-0319-CR; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; CDC, 2016, USCS DAT VIS CDC; Choi EB, 2016, ONCOGENE, V35, P4569, DOI 10.1038/onc.2016.3; Choi JE, 2003, CANCER EPIDEM BIOMAR, V12, P947; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; El-Telbany Ahmed, 2012, Genes Cancer, V3, P467, DOI 10.1177/1947601912465177; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Jett JR, 2005, CLIN CANCER RES, V11, p4988S, DOI 10.1158/1078-0432.CCR-05-9000; Jiang Y, 2019, INT J CANCER, V144, P1092, DOI 10.1002/ijc.31770; Kim HC, 2014, INT J CLIN EXP PATHO, V7, P6743; Kim M, 2010, CANCER SCI, V101, P2436, DOI 10.1111/j.1349-7006.2010.01699.x; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Landi S, 2006, CANCER RES, V66, P11062, DOI 10.1158/0008-5472.CAN-06-1039; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Lukeman JM, 2015, WHAT IS LUNG CANC, P30; Lung Cancer Statistics, 2020, LUNG CANC STAT COMM; Malyuchenko NV, 2015, ACTA NATURAE, V7, P27, DOI 10.32607/20758251-2015-7-3-27-37; Ozdemir V, 2013, OMICS, V17, P1, DOI 10.1089/omi.2012.0111; Olaussen KA, 2013, LUNG CANCER, V80, P216, DOI 10.1016/j.lungcan.2013.01.014; Patel NT, 2015, PARP 1 INHIBITORS TH, P1; Pazzaglia S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010041; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robeson H, 2020, TAQMAN SNP GENOTYPIN, DOI [10.17504/protocols.io.bpapmidn, DOI 10.17504/PR0T0C0LS.I0.BPAPMIDN]; Robeson H, 2020, QIAGEN ALLPREP DNA R, DOI [10.17504/protocols.io.bn9kmh4w, DOI 10.17504/PR0T0C0LS.I0.BN9KMH4W]; Robeson H, 2020, INDIRECT ELISA PROTO, DOI [10.17504/protocols.io.bn8umhww, DOI 10.17504/PR0T0C0LS.I0.BN8UMHWW]; Robeson H, 2020, RNA CDNA RT PCR PROT, DOI [10.17504/protocols.io.bpatmien, DOI 10.17504/PR0T0C0LS.I0.BPATMIEN]; Schneider J, 2008, EXPERT REV MOL DIAGN, V8, P761, DOI 10.1586/14737159.8.6.761; Shi S, 2017, HUM HERED, V83, P107, DOI 10.1159/000489758; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M, 2004, DOCUMENTATION PHASE; The American Cancer Society Medical and Editorial Content Team, 2019, LUNG CANC RISK FACT; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Xie KJ, 2014, ASIAN PAC J CANCER P, V15, P2591, DOI 10.7314/APJCP.2014.15.6.2591; Zhang XM, 2005, CANCER RES, V65, P722	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243509	10.1371/journal.pone.0243509	http://dx.doi.org/10.1371/journal.pone.0243509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284833	gold, Green Published			2022-12-26	WOS:000597930500033
J	Kaushik, G; Seshacharyulu, P; Rauth, S; Nallasamy, P; Rachagani, S; Nimmakayala, RK; Vengoji, R; Mallya, K; Chirravuri-Venkata, R; Singh, AB; Foster, JM; Ly, QP; Smith, LM; Lele, SM; Malafa, MP; Jain, M; Ponnusamy, MP; Batra, SK				Kaushik, Garima; Seshacharyulu, Parthasarathy; Rauth, Sanchita; Nallasamy, Palanisamy; Rachagani, Satyanarayana; Nimmakayala, Rama Krishna; Vengoji, Raghupathy; Mallya, Kavita; Chirravuri-Venkata, Ramakanth; Singh, Amar B.; Foster, Jason M.; Ly, Quan P.; Smith, Lynette M.; Lele, Subodh M.; Malafa, Mokenge P.; Jain, Maneesh; Ponnusamy, Moorthy P.; Batra, Surinder K.			Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis	ONCOGENE			English	Article							ERBB FAMILY BLOCKER; DRUG-RESISTANCE; POOR-PROGNOSIS; TUMOR-GROWTH; CELLS; AFATINIB; EGFR; DIFFERENTIATION; OVEREXPRESSION; ADENOCARCINOMA	Pancreatic cancer (PC) is difficult to defeat due to mechanism (s) driving metastasis and drug resistance. Cancer stemness is a major challenging phenomenon associated with PC metastasis and limiting therapy efficacy. In this study, we evaluated the pre-clinical and clinical significance of eradicating pancreatic cancer stem cells (PCSC) and its components using a pan-EGFR inhibitor afatinib in combination with gemcitabine. Afatinib in combination with gemcitabine significantly reduced Kras(G12D/+); Pdx-1 Cre (KC) (P < 0.01) and Kras(G12D/+); p53(R172H/+); Pdx-1 Cre (KPC) (P < 0.05) derived mouse tumoroids and KPC-derived murine syngeneic cell line growth compared to gemcitabine/afatinib alone treatment. The drug combination also reduced PC xenograft tumor burden (P < 0.05) and the incidence of metastasis by affecting key stemness markers, as confirmed by co-localization studies. Moreover, the drug combination significantly decreases the growth of various PC patient-derived organoids (P < 0.001). We found that SOX9 is significantly overexpressed in high-grade PC tumors (P < 0.05) and in chemotherapy-treated patients compared to chemo-naive patients (P < 0.05). These results were further validated using publicly available datasets. Moreover, afatinib alone or in combination with gemcitabine decreased stemness and tumorspheres by reducing phosphorylation of EGFR family proteins, ERK, FAK, and CSC markers. Mechanistically, afatinib treatment decreased CSC markers by downregulating SOX9 via FOXA2. Indeed, EGFR and FOXA2 depletion reduced SOX9 expression in PCSCs. Taken together, pan-EGFR inhibition by afatinib impedes PCSCs growth and metastasis via the EGFR/ERK/FOXA2/SOX9 axis. This novel mechanism of pan-EGFR inhibitor and its ability to eradicate CSC may serve as a tailor-made approach to enhance chemotherapeutic benefits in other cancer types.	[Kaushik, Garima; Seshacharyulu, Parthasarathy; Rauth, Sanchita; Nallasamy, Palanisamy; Rachagani, Satyanarayana; Nimmakayala, Rama Krishna; Vengoji, Raghupathy; Mallya, Kavita; Chirravuri-Venkata, Ramakanth; Singh, Amar B.; Jain, Maneesh; Ponnusamy, Moorthy P.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Foster, Jason M.; Ly, Quan P.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Div Surg Oncol, Omaha, NE USA; [Smith, Lynette M.] UNMC, Dept Biostat, Omaha, NE USA; [Lele, Subodh M.; Batra, Surinder K.] UNMC, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Malafa, Mokenge P.] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA; [Jain, Maneesh; Ponnusamy, Moorthy P.; Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; H Lee Moffitt Cancer Center & Research Institute; University of Nebraska System; University of Nebraska Medical Center	Ponnusamy, MP; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Batra, SK (corresponding author), UNMC, Dept Pathol & Microbiol, Omaha, NE 68198 USA.; Ponnusamy, MP; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	mpalanim@unmc.edu; sbatra@unmc.edu	Kaushik, Garima/AAO-7279-2021; Nimmakayala, Rama Krishna/CAG-5670-2022; Nallasamy, Palanisamy/AAH-7727-2021; Seshacharyulu, Parthasarathy/AGL-7648-2022	Kaushik, Garima/0000-0002-7631-4028; Nimmakayala, Rama Krishna/0000-0003-4637-4828; Nallasamy, Palanisamy/0000-0001-8962-2487; Seshacharyulu, Parthasarathy/0000-0002-2348-3901	National Institutes of Health [P01 CA217798, R01 CA183459, R01 CA195586, R01 CA206444, R01 CA210637, R01 CA228524, R01 CA247471, U01 CA200466, U01 CA210240]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research paper is supported, in parts, by grants from the National Institutes of Health (This work was supported, in parts, by the National Institutes of Health (P01 CA217798, R01 CA183459, R01 CA195586, R01 CA206444, R01 CA210637, R01 CA228524, R01 CA247471, U01 CA200466, and U01 CA210240).	Abhold EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032459; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Chen K, 2014, ONCOL REP, V32, P755, DOI 10.3892/or.2014.3245; Clark PA, 2012, NEOPLASIA, V14, P420, DOI 10.1596/neo.12432; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Ding Q, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-15; Engle JA, 2014, AM J HEALTH-SYST PH, V71, P1933, DOI 10.2146/ajhp130654; Fitzgerald Timothy L., 2015, Advances in Biological Regulation, V59, P65, DOI 10.1016/j.jbior.2015.06.003; Fitzgerald Timothy L., 2014, Advances in Biological Regulation, V56, P45, DOI 10.1016/j.jbior.2014.05.001; Furuya T, 2017, J THORAC DIS, V9, pE890, DOI 10.21037/jtd.2017.09.123; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Han Haiyong, 2013, Cancer Cell, V23, P424, DOI 10.1016/j.ccr.2013.03.008; Hennig R, 2005, CANCER RES, V65, P6011, DOI 10.1158/0008-5472.CAN-04-4090; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hirsh V, 2015, BIODRUGS, V29, P167, DOI 10.1007/s40259-015-0130-9; Ioannou N, 2011, BRIT J CANCER, V105, P1554, DOI 10.1038/bjc.2011.396; Jiang H, 2015, MOL CANCER RES, V13, P1554, DOI 10.1158/1541-7786.MCR-15-0240; Karmakar S, 2017, ONCOTARGET, V8, P14806, DOI 10.18632/oncotarget.14775; Kelley RK, 2008, BIOL-TARGETS THER, V2, P83; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; Li YW, 2013, CANCER LETT, V338, P94, DOI 10.1016/j.canlet.2012.03.018; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Macha MA, 2017, ONCOTARGET, V8, P20961, DOI 10.18632/oncotarget.15468; Majhi PD, 2013, J THORAC ONCOL, V8, P398, DOI 10.1097/JTO.0b013e3182829e06; Modjtahedi H, 2014, N-S ARCH PHARMACOL, V387, P505, DOI 10.1007/s00210-014-0967-3; Mukhopadhyay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054455; Nimmakayala RK, 2018, GASTROENTEROLOGY, V155, P892, DOI 10.1053/j.gastro.2018.05.041; Nomura A, 2015, ONCOTARGET, V6, P8313, DOI 10.18632/oncotarget.3228; PASSARO A, 2019, ANN ONCOL         S2, V30, pii48, DOI DOI 10.1093/annonc/mdz063.013; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Seshacharyulu P, 2015, ONCOTARGET, V6, P5164, DOI 10.18632/oncotarget.3286; Seymour Philip A, 2014, Rev Diabet Stud, V11, P51, DOI 10.1900/RDS.2014.11.51; Shroff S, 2014, HUM PATHOL, V45, P456, DOI 10.1016/j.humpath.2013.10.008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Steelman LS, 2016, CURR PHARM DESIGN, V22, P2358, DOI 10.2174/1381612822666160304151011; Tanase CP, 2014, WORLD J GASTROENTERO, V20, P10790, DOI 10.3748/wjg.v20.i31.10790; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Ueda S, 2004, PANCREAS, V29, pE1, DOI 10.1097/00006676-200407000-00061; Van den Broeck A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-354; Vaz AP, 2014, BRIT J CANCER, V111, P486, DOI 10.1038/bjc.2014.152; Vengoji R, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1264-2; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097578; Zhou G, 2012, APPL BIOCHEM BIOTECH, V167, P2257, DOI 10.1007/s12010-012-9752-2; Zhou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096718	53	24	24	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2021	40	4					848	862		10.1038/s41388-020-01564-w	http://dx.doi.org/10.1038/s41388-020-01564-w		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QA4GO	33288882	Green Accepted			2022-12-26	WOS:000599015000002
J	Vega-Polo, P; Cobo, MM; Argudo, A; Gutierrez, B; Rowntree, J; Torres, MD				Vega-Polo, Pamela; Cobo, Maria Mercedes; Argudo, Andrea; Gutierrez, Bernardo; Rowntree, Jennifer; Torres, Maria de Lourdes			Characterizing the genetic diversity of the Andean blueberry (Vaccinium floribundum Kunth.) across the Ecuadorian Highlands	PLOS ONE			English	Article							MICROSATELLITE MARKERS; HABITAT FRAGMENTATION; POPULATION-STRUCTURE; SOUTHERN ANDES; R-PACKAGE; PROGRAM; DIFFERENTIATION; CONSEQUENCES; ERICACEAE; CULTIVARS	The Ecuadorian paramo, a high altitude tundra-like ecosystem, is a unique source of various ecosystem services and distinct biodiversity. Anthropogenic activities are associated with its fragmentation, which alters ecological factors and directly threatens resident species. Vaccinium floribundum Kunth., commonly known as Andean blueberry or mortino, is a wild shrub endemic to the Andean region and highly valued in Ecuador for its berries, which are widely used in food preparations and hold an important cultural value. Since it is a wild species, mortino could be vulnerable to environmental changes, resulting in a reduction of the size and distribution of its populations. To evaluate the extent of these effects on the mortino populations, we assessed the genetic diversity and population structure of the species along the Ecuadorian highlands. We designed and developed a set of 30 species-specific SSR (simple sequence repeats) markers and used 16 of these to characterize 100 mortino individuals from 27 collection sites. Our results revealed a high degree of genetic diversity (H-E = 0.73) for the Ecuadorian mortino, and a population structure analyses suggested the existence of distinct genetic clusters present in the northern, central and southern highlands. A fourth, clearly differentiated cluster was also found and included individuals from locations at higher elevations. We suggest that the population structure of the species could be explained by an isolation-by-distance model and can be associated with the geological history of the Andean region. Our results suggest that elevation could also be a key factor in the differentiation of mortino populations. This study provides an extensive overview of the species across its distribution range in Ecuador, contributing to a better understanding of its conservation status. These results can assist in the development of conservation programs for this valuable biological and cultural resource and for the paramo ecosystem as a whole.	[Vega-Polo, Pamela; Cobo, Maria Mercedes; Argudo, Andrea; Gutierrez, Bernardo; Torres, Maria de Lourdes] Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales, Lab Biotecnol Vegetal, Quito, Ecuador; [Cobo, Maria Mercedes] Univ Oxford, Dept Paediat, Oxford, England; [Gutierrez, Bernardo] Univ Oxford, Dept Zool, Oxford, England; [Rowntree, Jennifer] Manchester Metropolitan Univ, Dept Nat Sci, Ecol & Environm Res Ctr, Oxford, England	University of Oxford; University of Oxford; Manchester Metropolitan University	Torres, MD (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales, Lab Biotecnol Vegetal, Quito, Ecuador.	ltorres@usfq.edu.ec	Gutierrez, Bernardo/AAQ-6684-2021	Gutierrez, Bernardo/0000-0002-9220-2739; Cobo, Maria M./0000-0002-3961-1568; Vega Polo, Pamela/0000-0001-6272-861X; Rowntree, Jennifer/0000-0001-8249-8057	"USFQ's Collaboration Grants" of the Universidad San Francisco de Quito, Ecuador	"USFQ's Collaboration Grants" of the Universidad San Francisco de Quito, Ecuador	MLT received financial support by the "USFQ's Collaboration Grants" of the Universidad San Francisco de Quito, Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu OA, 2014, EMIR J FOOD AGR, V26, P577, DOI 10.9755/ejfa.v26i7.16404; Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Alarcon-Barrera KS, 2018, J BERRY RES, V8, P223, DOI 10.3233/JBR-180316; Andrews S., 2015, FASTQC QUALITY CONTR; [Anonymous], **DATA OBJECT**; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Astudillo PX, 2019, EMU, V119, P53, DOI 10.1080/01584197.2018.1512371; Beck M.W., 2017, GGORD ORDINATION PLO; Bell DJ, 2009, BOTANY, V87, P932, DOI 10.1139/B09-058; BERRY PE, 1989, AM J BOT, V76, P1602, DOI 10.2307/2444398; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Boches PS, 2005, MOL ECOL NOTES, V5, P657, DOI 10.1111/j.1471-8286.2005.01025.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chaparro de Valencia M, 2012, ACTA BIOL COLOMB, V4, P47; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Couvet D, 2002, CONSERV BIOL, V16, P369, DOI 10.1046/j.1523-1739.2002.99518.x; Debnath SC, 2007, GENET RESOUR CROP EV, V54, P509, DOI 10.1007/s10722-006-0007-3; Debnath SC, 2009, NORD J BOT, V27, P141, DOI 10.1111/j.1756-1051.2009.00402.x; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echeverry M a, 2009, RECUR NAT AMBIENT; ELLENBERG H, 1979, J ECOL, V67, P401, DOI 10.2307/2259105; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fajardo D, 2013, PLANT MOL BIOL REP, V31, P264, DOI 10.1007/s11105-012-0497-4; Gawronski J, 2017, ACTA SCI POL-HORTORU, V16, P129, DOI 10.24326/asphc.2017.3.13; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Griffiths SM, 2016, CONSERV GENET RESOUR, V8, P481, DOI 10.1007/s12686-016-0570-7; Guidugli MC, 2010, GENET MOL BIOL, V33, P131, DOI 10.1590/S1415-47572010000100022; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hahn CZ, 2017, J PLANT ECOL, V10, P213, DOI 10.1093/jpe/rtw054; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hazzi NA, 2018, P NATL ACAD SCI USA, V115, P7985, DOI 10.1073/pnas.1803908115; Hirai M, 2010, PLANT SYST EVOL, V287, P75, DOI 10.1007/s00606-010-0291-4; Jacquemyn H, 2002, OECOLOGIA, V130, P617, DOI 10.1007/s00442-001-0833-0; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; KLEIN SB, 1988, J PERS SOC PSYCHOL, V55, P5, DOI 10.1037/0022-3514.55.1.5; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Levy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163995; Lila MA, 2011, FUNCT FOODS HEALTH D, V1, P13; Linhart YB, 2003, ARCT ANTARCT ALP RES, V35, P429, DOI 10.1657/1523-0430(2003)035[0429:GVAIEI]2.0.CO;2; Llivisaca S, 2018, FOOD SCI NUTR, V6, P934, DOI 10.1002/fsn3.638; Luby J.J., 1991, ACTA HORTIC, V290, P391, DOI [10.17660/ActaHortic.1991.290.9, DOI 10.17660/ACTAHORTIC.1991.290.9]; Luteyn JL, 2002, BOT REV, V68, P55, DOI 10.1663/0006-8101(2002)068[0055:DAAEIN]2.0.CO;2; Luteyn JL., 1992, PARAMO ANDEAN ECOSYS; Magnitskiy S, 2011, AGRON COLOMB, V29, P191; Cobo MM, 2016, BIOCHEM SYST ECOL, V64, P14, DOI 10.1016/j.bse.2015.11.008; Moreno J, 2018, WOR SOIL BOOK SER, P79, DOI 10.1007/978-3-319-25319-0_3; Nazareno AG, 2009, GENET MOL BIOL, V32, P568, DOI 10.1590/S1415-47572009005000056; Nevado B, 2018, NEW PHYTOL, V219, P779, DOI 10.1111/nph.15243; Ortiz J, 2013, J FOOD SCI, V78, pC985, DOI 10.1111/1750-3841.12148; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peng YL, 2015, BIOTROPICA, V47, P59, DOI 10.1111/btp.12175; Persson HA, 2001, MOL ECOL, V10, P1385, DOI 10.1046/j.1365-294X.2001.01280.x; Peters T, 2013, ECOSYSTEM SERVICES B, DOI [10.2307/2259105, DOI 10.2307/2259105]; Prencipe FP, 2014, J PHARMACEUT BIOMED, V89, P257, DOI 10.1016/j.jpba.2013.11.016; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Ramsay PM, 1996, VEGETATIO, V124, P129; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schmid R, 1999, TAXON, DOI [10.2307/1224592, DOI 10.2307/1224592]; Schreckinger M, 2012, ACS S SER, DOI [10.1021/bk-2012-1109.ch006, DOI 10.1021/BK-2012-1109.CH006]; Schreckinger ME, 2010, J AGR FOOD CHEM, V58, P8966, DOI 10.1021/jf100975m; Sklenar P, 2005, FLORA, V200, P416, DOI 10.1016/j.flora.2004.12.006; Song GQ, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: TEMPERATE FRUITS, P197, DOI 10.1007/978-3-642-16057-8_10; Suarez E, 2001, ARCT ANTARCT ALP RES, V33, P158; Suguitan Jr AL, 2011, PLOS ONE, V6; Tailor S, 2017, GENET RESOUR CROP EV, V64, P2071, DOI 10.1007/s10722-017-0497-1; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; V de la Torre L., 2008, ENCICLOPEDIA PLANTAS; Vasco C, 2009, J AGR FOOD CHEM, V57, P8274, DOI 10.1021/jf9013586; Vasquez DLA, 2016, ALPINE BOT, V126, P135, DOI 10.1007/s00035-016-0165-7; Verweij PA, 1995, SPATIAL TEMPORAL MOD; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wesche K, 2006, ANN BOT-LONDON, V98, P1025, DOI 10.1093/aob/mcl182; Wolf J., 2002, ECOTROPICOS, V15, P3; Xin Z, 2006, DNA SEQUENCING 2 OPT, P47; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	91	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243420	10.1371/journal.pone.0243420	http://dx.doi.org/10.1371/journal.pone.0243420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284832	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000597930500016
J	Derington, CG; King, JB; Delate, T; Botts, SR; Kroehl, M; Kao, DP; Trinkley, KE				Derington, Catherine G.; King, Jordan B.; Delate, Thomas; Botts, Sheila R.; Kroehl, Miranda; Kao, David P.; Trinkley, Katy E.			Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety	PLOS ONE			English	Article							PROPENSITY-SCORE METHODS; BLOOD-PRESSURE; DOSING FREQUENCY; ELECTRONIC PRESCRIPTIONS; COMPARATIVE RISK; ADHERENCE; EFFICACY; PROPORTIONS; DIFFERENCE; QUALITY	Background Lisinopril and losartan manufacturer labels recommend twice-daily dosing (BID) if once-daily (QDay) is insufficient to lower blood pressure (BP). Methods and results Retrospective cohort study of patients taking QDay lisinopril and losartan who experienced a dose-doubling (index date). A text-processing tool categorized BID and QDay groups at the index date based on administration instructions. We excluded: pregnant/hospice, regimens other than BID/QDay, and without BP measurements -6 months/+12 months of the index date. The most proximal BP measurements -6 months and +2 weeks to 12 months of the index date were used to evaluate BP differences. Propensity scores were generated, and differences in BP and adverse events (angioedema, acute kidney injury, hyperkalemia) between BID/QDay groups were analyzed within dosing cohorts using inverse propensity of treatment-weighted regression models. Of 11,210 and 6,051 patients who met all criteria for lisinopril and losartan, 784 (7.0%) and 453 (7.5%) were taking BID, respectively. BID patients were older and had higher comorbidity and medication burdens. There were no differences in systolic/diastolic BP between BID and QDay, with absolute differences in mean systolic BP ranging from -1.8 to 0.7 mmHg and diastolic BP ranging from -1.1 to 0.1 mmHg (all 95% confidence intervals [CI] cross 0). Lisinopril 10mg BID was associated with an increased odds of angioedema compared to lisinopril 20mg QDay (odds ratio 2.27, 95%CI 1.13-4.58). Conclusions Adjusted models do not support improved effectiveness or safety of BID lisinopril and losartan.	[Derington, Catherine G.; King, Jordan B.] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84112 USA; [King, Jordan B.] Kaiser Permanente Colorado, Inst Hlth Res, Aurora, CO USA; [Delate, Thomas; Trinkley, Katy E.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Delate, Thomas] Kaiser Permanente Natl Pharm, Drug Use Management, Aurora, CO USA; [Botts, Sheila R.] Kaiser Permanente Colorado, Dept Pharm, Aurora, CO USA; [Kroehl, Miranda] Colorado Sch Publ Hlth, Aurora, CO USA; [Kao, David P.] Univ Colorado Hlth, Cardiac & Vasc Ctr, Aurora, CO USA; [Kao, David P.; Trinkley, Katy E.] Univ Colorado, Sch Med, Aurora, CO USA	Utah System of Higher Education; University of Utah; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Kaiser Permanente; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Derington, CG (corresponding author), Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84112 USA.	catherine.derington@utah.edu	Derington, Catherine G/AIB-1088-2022; King, Jordan/GSI-5222-2022; Kao, David P/K-3288-2013	Derington, Catherine G/0000-0001-7382-4607; Kao, David P/0000-0002-2832-9348	American Heart Association [19POST34380226/Derington/2019]; NIH/NCATS Colorado CTSA [UL1-TR002535]	American Heart Association(American Heart Association); NIH/NCATS Colorado CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by American Heart Association Grant #19POST34380226/Derington/2019. Support for Dr. Derington's training during the conduct of this research was provided by NIH/NCATS Colorado CTSA Grant Number UL1-TR002535. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2010, VASC HEALTH RISK MAN, V6, P449; Andersson Ove K., 1998, Blood Pressure, V7, P53; AstraZeneca Pharmaceuticals LP, 2008, ZESTR PACK INS; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bae JP, 2012, AM J MANAG CARE, V18, P139; Basile J, 2005, J CLIN HYPERTENS, V7, P54; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Chi VX, 1996, BIOMETRICS, V52, P286, DOI 10.2307/2533163; Derington CG, 2018, 2018 AM COLL CLIN PH, DOI [10.1002/jac5.1059, DOI 10.1002/JAC5.1059]; Dhavle AA, 2014, APPL CLIN INFORM, V5, P699, DOI 10.4338/ACI-2014-03-CR-0022; Dhavle AA, 2016, JAMA INTERN MED, V176, P463, DOI 10.1001/jamainternmed.2015.7786; Dhavle AA, 2015, J MANAG CARE SPEC PH, V21, P1025, DOI 10.18553/jmcp.2015.21.11.1025; Director General to the Executive Board World Health Organization, 1994, ASHE ERIC HIGH ED RE, V23, piii; Fogari R, 1997, J HYPERTENS, V15, P1511, DOI 10.1097/00004872-199715120-00020; Girvin B, 1999, J HYPERTENS, V17, P1627, DOI 10.1097/00004872-199917110-00017; Goyal D, 2007, J HUM HYPERTENS, V21, P525, DOI 10.1038/sj.jhh.1002174; Hedner T, 1999, J HYPERTENS, V17, P129, DOI 10.1097/00004872-199917010-00019; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Jarari Noah, 2015, Clin Hypertens, V22, P7, DOI 10.1186/s40885-016-0042-0; Kronish IM, 2019, J GEN INTERN MED, V34, P839, DOI 10.1007/s11606-019-04831-z; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Merck and Co. Inc, 2003, COZ PACK INS; MEREDITH PA, 1994, ARCH MAL COEUR VAISS, V87, P1423; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Patorno E, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8940; POIRIER L, 1993, J CLIN PHARMACOL, V33, P832, DOI 10.1002/j.1552-4604.1993.tb01959.x; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ross Tyler R, 2014, EGEMS (Wash DC), V2, P1049, DOI 10.13063/2327-9214.1049; Saini SD, 2009, AM J MANAG CARE, V15, pE22; Sakai Y, 2013, INT J NEPHROL RENOV, V6, P223, DOI 10.2147/IJNRD.S52905; Samuel JP, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-1818; Sarafidis P, 2008, J CLIN HYPERTENS, V10, P112, DOI 10.1111/j.1751-7176.2008.08021.x; Shah SJ, 2017, AM J HYPERTENS, V30, P1008, DOI 10.1093/ajh/hpx085; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Srivastava K, 2013, PATIENT PREFER ADHER, V7, P419, DOI 10.2147/PPA.S44646; Toh S, 2012, ARCH INTERN MED, V172, P1582, DOI 10.1001/2013.jamainternmed.34; Tsai T, 2017, J CLIN HYPERTENS, V19, P868, DOI 10.1111/jch.13011; WEBER MA, 1995, ARCH INTERN MED, V155, P405, DOI 10.1001/archinte.155.4.405; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x; Yang YZ, 2018, J MANAG CARE SPEC PH, V24, P691, DOI 10.18553/jmcp.2018.17404; Zannad F, 1996, AM J HYPERTENS, V9, P633, DOI 10.1016/0895-7061(96)00021-0; Zuschke CA, 1999, CLIN THER, V21, P464, DOI 10.1016/S0149-2918(00)88302-2	45	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243371	10.1371/journal.pone.0243371	http://dx.doi.org/10.1371/journal.pone.0243371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270787	Green Published, gold			2022-12-26	WOS:000597149100075
J	Ito, H; Takemura, Y; Aoki, Y; Hattori, M; Horikawa, H; Yamazaki, M				Ito, Hisakatsu; Takemura, Yoshinori; Aoki, Yuta; Hattori, Mizuki; Horikawa, Hideyo; Yamazaki, Mitsuaki			Analysis of the effects of a tricyclic antidepressant on secondary sleep disturbance induced by chronic pain in a preclinical model	PLOS ONE			English	Article							AMITRIPTYLINE; INSOMNIA; INVOLVEMENT; ACTIVATION; RECEPTORS; WAKING	Chronic pain and sleep have a bidirectional relationship that promotes a vicious circle making chronic pain more difficult to treat. Therefore, pain and sleep should be treated simultaneously. In our previous study, we suggested that hyperactivation of ascending serotonergic neurons could cause secondary sleep disturbance in chronic pain. This study aimed to demonstrate the effects of a tricyclic antidepressant (amitriptyline) and a selective 5-hydroxy-tryptamine 2A (5-HT2A) antagonist (MDL 100907) that adjust serotonergic transmission, on secondary sleep disturbance induced in a preclinical chronic pain model. We produced a chronic neuropathic pain model by partial sciatic nerve ligation in mice, analyzed their electroencephalogram (EEG) and electromyogram (EMG) using the SleepSign software, and evaluated the sleep condition of the pain model mice after administration of amitriptyline or MDL 100907. Amitriptyline improved thermal hyperalgesia and the amount of sleep, especially non-REM sleep. Time change of normalized power density of delta wave in the nerve ligation group with amitriptyline administration showed a normal pattern that was similar to sham mice. In addition, MDL 100907 normalized sleep condition similar to amitriptyline, without improvement in pain threshold. In conclusion, amitriptyline could improve sleep quantity and quality impaired by chronic pain. 5-HT2A receptor antagonism could partially contribute to this sleep improvement, but is not associated with pain relief.	[Ito, Hisakatsu; Takemura, Yoshinori; Aoki, Yuta; Hattori, Mizuki; Horikawa, Hideyo; Yamazaki, Mitsuaki] Univ Toyama, Dept Anesthesiol, Toyama, Japan	University of Toyama	Ito, H (corresponding author), Univ Toyama, Dept Anesthesiol, Toyama, Japan.	hisa@med.u-toyama.ac.jp		ITO, HISAKATSU/0000-0002-8492-6550	Japan Society for the Promotion of Science [26893092]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	HI received grant below. Grant numbers: 26893092 Grant name:Grant-in-Aid for Research Activity start-up from Japan Society for the Promotion of Science Website: https://kaken.nii.ac.jp/ja/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre C, 2017, NAT MED, V23, P768, DOI 10.1038/nm.4329; Alsaadi SM, 2012, EUR SPINE J, V21, P554, DOI 10.1007/s00586-011-1954-8; Atkin T, 2018, PHARMACOL REV, V70, P197, DOI 10.1124/pr.117.014381; Boyle J, 2012, DIABETES CARE, V35, P2451, DOI 10.2337/dc12-0656; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; CHOI A, 1994, PHARMACOLOGY, V48, P293, DOI 10.1159/000139192; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; Dance A, 2019, NATURE, V567, P448, DOI 10.1038/d41586-019-00895-3; Dinges DF, 1997, SLEEP, V20, P267; Emery PC, 2014, PAIN RES MANAG, V19, P35, DOI 10.1155/2014/480859; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Ito H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-59; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Koh K, 2015, NEUROSCI LETT, V589, P200, DOI 10.1016/j.neulet.2014.12.002; Krause AJ, 2019, J NEUROSCI, V39, P2291, DOI 10.1523/JNEUROSCI.2408-18.2018; McCracken LM, 2011, PAIN MED, V12, P904, DOI 10.1111/j.1526-4637.2011.01115.x; Mika J, 2015, NEUROSCIENCE, V294, P38, DOI 10.1016/j.neuroscience.2015.03.003; Mims KN, 2016, SLEEP MED CLIN, V11, P39, DOI 10.1016/j.jsmc.2015.10.009; Monti JM, 2006, PROG NEURO-PSYCHOPH, V30, P1189, DOI 10.1016/j.pnpbp.2006.02.013; Monti JM, 2006, EUR J PHARMACOL, V553, P163, DOI 10.1016/j.ejphar.2006.09.027; Morairty SR, 2008, SLEEP, V31, P34, DOI 10.1093/sleep/31.1.34; Narita M, 2011, PAIN, V152, P1358, DOI 10.1016/j.pain.2011.02.016; Nijs J, 2018, PHYS THER, V98, P325, DOI 10.1093/ptj/pzy020; PEROUTKA SJ, 1988, ANN NEUROL, V23, P500, DOI 10.1002/ana.410230512; Sanna MD, 2017, EUR J PHARMACOL, V798, P85, DOI 10.1016/j.ejphar.2017.01.025; Sawynok J, 1999, PAIN, V80, P45, DOI 10.1016/S0304-3959(98)00195-X; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Simpson NS, 2018, PAIN, V159, P33, DOI 10.1097/j.pain.0000000000001053; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Tang NKY, 2007, J SLEEP RES, V16, P85, DOI 10.1111/j.1365-2869.2007.00571.x; Vande Griend JP, 2012, J AM PHARM ASSOC, V52, pE210, DOI 10.1331/JAPhA.2012.12051; Vyazovskiy VV, 2014, NEUROSCIENTIST, V20, P203, DOI 10.1177/1073858413518152	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243325	10.1371/journal.pone.0243325	http://dx.doi.org/10.1371/journal.pone.0243325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270791	gold, Green Published			2022-12-26	WOS:000597149100128
J	Johnson, CH; Beer, L; Harding, RL; Iachan, R; Moyse, D; Lee, A; Kyle, T; Chowdhury, PP; Shouse, RL; Jafarabadi, MA				Johnson, Christopher H.; Beer, Linda; Harding, R. Lee; Iachan, Ronaldo; Moyse, Davia; Lee, Adam; Kyle, Tonja; Chowdhury, Pranesh P.; Shouse, R. Luke; Jafarabadi, Mohammad Asghari			Changes to the sample design and weighting methods of a public health surveillance system to also include persons not receiving HIV medical care	PLOS ONE			English	Article								Objectives The Medical Monitoring Project (MMP) is a public health surveillance system that provides representative estimates of the experiences and behaviors of adults with diagnosed HIV in the United States. In 2015, the sample design and frame of MMP changed from a system that only included HIV patients to one that captures the experiences of persons receiving and not receiving HIV care. We describe methods investigated for calculating survey weights, the approach chosen, and the benefits of using a dynamic surveillance registry as a sampling frame. Methods MMP samples adults with diagnosed HIV from the National HIV Surveillance System, the HIV case surveillance registry for the United States. In the methodological study presented in this manuscript, we compared methods that account for sample design and nonresponse, including weighting class adjustment vs. propensity weighting and a single-stage nonresponse adjustment vs. sequential adjustments for noncontact and nonresponse. We investigated how best to adjust for non-coverage using surveillance data to post-stratify estimates. Results After assessing these methods, we chose as our preferred procedure weighting class adjustments and a single-stage nonresponse adjustment. Classes were constructed using variables associated with respondents' characteristics and important survey outcomes, chief among them laboratory results available from surveillance that served as a proxy for medical care. Conclusions MMPs weighting procedures reduced sample bias by leveraging auxiliary information on medical care available from the surveillance registry sampling frame. Expanding MMPs population of focus provides important information on characteristics of persons with diagnosed HIV that complement the information provided by the surveillance registry. MMP methods can be applied to other disease registries or population-monitoring systems when more detailed information is needed for a population, with the detailed information obtained efficiently from a representative sample of the population covered by the registry.	[Johnson, Christopher H.; Beer, Linda; Chowdhury, Pranesh P.; Shouse, R. Luke; Jafarabadi, Mohammad Asghari] Ctr Dis Control, Div HIV Aids Prevent, Atlanta, GA 30333 USA; [Harding, R. Lee; Iachan, Ronaldo; Moyse, Davia; Lee, Adam; Kyle, Tonja] ICF Int Inc, Calverton, MD USA	Centers for Disease Control & Prevention - USA	Beer, L (corresponding author), Ctr Dis Control, Div HIV Aids Prevent, Atlanta, GA 30333 USA.	LBeer@cdc.gov		Moyse, Davia/0000-0002-9871-4321; Beer, Linda/0000-0002-5781-8626	US Centers for Disease Control and Prevention (CDC) [PS15-1503]	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the Medical Monitoring Project is provided by a cooperative agreement (PS15-1503) from the US Centers for Disease Control and Prevention (CDC). CDC has a contract with ICF International, Inc. for operational and technical support to conduct the Medical Monitoring Project The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	[Anonymous], 2012, Hepatol Int, V6, P67, DOI 10.1007/s12072-011-9333-4; [Anonymous], 1999, SAMPLING TECHNIQUES; [Anonymous], 2007, PLOS ONE, V2, pe779; Centers for Disease Control and Prevention, 2018, 20 CTR DIS CONTR PRE; Centers for Disease Control and Prevention, ASS CONF; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V28; DEVILLE JC, 1992, J AM STAT ASSOC, V87, P376, DOI 10.2307/2290268; Harding L, 2013, JSM P SECTION SURVEY, P3756; Iachan Ronaldo, 2016, Open AIDS J, V10, P164, DOI 10.2174/1874613601610010164; Institute of Medicine, 2012, MONITORING HIV CARE; Kennet J., 2005, DHHS PUBLICATION, VSMA 05-4044; Kennet J., 2005, METHODOLOGY SERIES M, VM-5; Nakashima AK, 2003, JAIDS-J ACQ IMM DEF, V32, pS68, DOI 10.1097/00126334-200302011-00011; Padilla M, 2018, PUBLIC HEALTH REP, V133, P147, DOI 10.1177/0033354918754541; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Valliant R., 2013, PRACTICAL TOOLS DESI; Van den Brakel J, 2017 CBS	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243351	10.1371/journal.pone.0243351	http://dx.doi.org/10.1371/journal.pone.0243351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270798	Green Published, gold			2022-12-26	WOS:000597149100116
J	Konno, M; Yamauchi, Y; Inoue, K; Kandori, H				Konno, Masae; Yamauchi, Yumeka; Inoue, Keiichi; Kandori, Hideki			Expression analysis of microbial rhodopsin-like genes in Guillardia theta	PLOS ONE			English	Article							PURPLE MEMBRANE; LIGHT; BACTERIAL; CHANNELRHODOPSIN-1; DIVERSITY; HOMOLOGS; ARCHAEAL; PROTEIN; HSP30	The Cryptomonad Guillardia theta has 42 genes encoding microbial rhodopsin-like proteins in their genomes. Light-driven ion-pump activity has been reported for some rhodopsins based on heterologous E. coli or mammalian cell expression systems. However, neither their physiological roles nor the expression of those genes in native cells are known. To reveal their physiological roles, we investigated the expression patterns of these genes under various growth conditions. Nitrogen (N) deficiency induced color change in exponentially growing G. theta cells from brown to green. The 29 rhodopsin-like genes were expressed in native cells. We found that the expression of 6 genes was induced under N depletion, while that of another 6 genes was reduced under N depletion.	[Konno, Masae; Yamauchi, Yumeka; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Grad Sch Engn, Life Sci & Appl Chem, Nagoya, Aichi, Japan; [Konno, Masae; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Nagoya, Aichi, Japan; [Konno, Masae] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Konno, Masae; Inoue, Keiichi] Univ Tokyo, Inst Solid State Phys ISSP, Kashiwa, Chiba, Japan	Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); University of Tokyo	Konno, M; Kandori, H (corresponding author), Nagoya Inst Technol, Grad Sch Engn, Life Sci & Appl Chem, Nagoya, Aichi, Japan.; Konno, M; Kandori, H (corresponding author), Nagoya Inst Technol, OptoBioTechnol Res Ctr, Nagoya, Aichi, Japan.; Konno, M (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan.; Konno, M (corresponding author), Univ Tokyo, Inst Solid State Phys ISSP, Kashiwa, Chiba, Japan.	kandori@nitech.ac.jp; masaek@issp.u-tokyo.ac.jp	Inoue, Keiichi/AEO-3337-2022; Konno, Masae/C-1066-2009	Inoue, Keiichi/0000-0002-6898-4347; Konno, Masae/0000-0002-0605-1816	Japan Society for the Promotion of Science (JSPS) [17H04694, 25104009, 15H02391]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI), Japan (grant numbers 17H04694 to K.I. and 25104009 and 15H02391 to H.K.). There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Campbell BJ, 2008, ENVIRON MICROBIOL, V10, P99, DOI 10.1111/j.1462-2920.2007.01436.x; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Chattopadhyay S, 2000, J BACTERIOL, V182, P6418, DOI 10.1128/JB.182.22.6418-6423.2000; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Govorunova EG, 2016, BIOPHYS J, V110, P2302, DOI 10.1016/j.bpj.2016.05.001; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1016/S0168-6445(99)00022-4; HILL DRA, 1990, CAN J BOT, V68, P1873, DOI 10.1139/b90-245; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Kim SY, 2014, MOL MICROBIOL, V93, P403, DOI 10.1111/mmi.12635; Kotajima T, 2014, FEMS MICROBIOL LETT, V351, P88, DOI 10.1111/1574-6968.12346; LANYI JK, 1986, ANNU REV BIOPHYS BIO, V15, P11, DOI 10.1146/annurev.bb.15.060186.000303; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Not F, 2012, ADV BOT RES, V64, P1, DOI 10.1016/B978-0-12-391499-6.00001-3; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Philosof A, 2013, ENV MICROBIOL REP, V5, P475, DOI 10.1111/1758-2229.12037; Pinhassi J, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00003-16; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; Pushkarev A, 2018, NATURE, V558, P595, DOI 10.1038/s41586-018-0225-9; RACKER E, 1974, J BIOL CHEM, V249, P662; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scherholz ML, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-39; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Yamamoto S, 2020, AQUACULTURE, V516, DOI 10.1016/j.aquaculture.2019.734648; Yamauchi Y, 2019, PHOTOCHEM PHOTOBIOL, V95, P1116, DOI 10.1111/php.13114; Yamauchi Y, 2017, BIOPHYS PHYSICOBIOL, V14, P57, DOI 10.2142/biophysico.14.0_57; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243387	10.1371/journal.pone.0243387	http://dx.doi.org/10.1371/journal.pone.0243387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270796	gold, Green Published			2022-12-26	WOS:000597149100022
J	Kosztolowicz, T; Metzler, R; Wasik, S; Arabski, M				Kosztolowicz, Tadeusz; Metzler, Ralf; Wasik, Slawomir; Arabski, Michal			Modelling experimentally measured of ciprofloxacin antibiotic diffusion in Pseudomonas aeruginosa biofilm formed in artificial sputum medium	PLOS ONE			English	Article							ANOMALOUS DIFFUSION; RESISTANCE; MECHANISMS; AMPICILLIN; DYNAMICS	We study the experimentally measured ciprofloxacin antibiotic diffusion through a gel-like artificial sputum medium (ASM) mimicking physiological conditions typical for a cystic fibrosis layer, in which regions occupied by Pseudomonas aeruginosa bacteria are present. To quantify the antibiotic diffusion dynamics we employ a phenomenological model using a subdiffusion-absorption equation with a fractional time derivative. This effective equation describes molecular diffusion in a medium structured akin Thompson's plumpudding model; here the 'pudding' background represents the ASM and the 'plums' represent the bacterial biofilm. The pudding is a subdiffusion barrier for antibiotic molecules that can affect bacteria found in plums. For the experimental study we use an interferometric method to determine the time evolution of the amount of antibiotic that has diffused through the biofilm. The theoretical model shows that this function is qualitatively different depending on whether or not absorption of the antibiotic in the biofilm occurs. We show that the process can be divided into three successive stages: (1) only antibiotic subdiffusion with constant biofilm parameters, (2) subdiffusion and absorption of antibiotic molecules with variable biofilm transport parameters, (3) subdiffusion and absorption in the medium but the biofilm parameters are constant again. Stage 2 is interpreted as the appearance of an intensive defence build-up of bacteria against the action of the antibiotic, and in the stage 3 it is likely that the bacteria have been inactivated. Times at which stages change are determined from the experimentally obtained temporal evolution of the amount of antibiotic that has diffused through the ASM with bacteria. Our analysis shows good agreement between experimental and theoretical results and is consistent with the biologically expected biofilm response. We show that an experimental method to study the temporal evolution of the amount of a substance that has diffused through a biofilm is useful in studying the processes occurring in a biofilm. We also show that the complicated biological process of antibiotic diffusion in a biofilm can be described by a fractional subdiffusion-absorption equation with subdiffusion and absorption parameters that change over time.	[Kosztolowicz, Tadeusz; Wasik, Slawomir] Jan Kochanowski Univ Humanities & Sci, Inst Phys, Kielce, Poland; [Metzler, Ralf] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Arabski, Michal] Jan Kochanowski Univ Humanities & Sci, Inst Biol, Kielce, Poland	Jan Kochanowski University; University of Potsdam; Jan Kochanowski University	Metzler, R (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	rmetzler@uni-potsdam.de	Arabski, Michał/S-9907-2019; Metzler, Ralf/J-9088-2013	Arabski, Michał/0000-0002-9712-9286; Metzler, Ralf/0000-0002-6013-7020; Wasik, Slawomir/0000-0003-0107-4493; Kosztolowicz, Tadeusz/0000-0001-5710-2970	German Science Foundation (DFG) [ME 1535/7-1]; Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej, FNP); Jan Kochanowski University [SMGR RN.20.222.628]; Polish National Science Centre [UMO2016/21/B/NZ6/01157]	German Science Foundation (DFG)(German Research Foundation (DFG)); Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej, FNP); Jan Kochanowski University; Polish National Science Centre	R.M. acknowledges funding from the German Science Foundation (DFG Grant ME 1535/7-1) and a Humboldt Honorary Polish Research Scholarship from the Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej, FNP). This paper was also partially supported by the Jan Kochanowski University under grant SMGR. RN.20.222.628 (T.K. and S.W) and the Polish National Science Centre under grant no. UMO2016/21/B/NZ6/01157 (M.A.). There was no additional external funding received for this study.	Alcazar-Cano N, 2018, SOFT MATTER, V14, P9937, DOI 10.1039/c8sm01961d; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Arabski M, 2007, J MEMBRANE SCI, V299, P268, DOI 10.1016/j.memsci.2007.05.003; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Cherstvy AG, 2019, SOFT MATTER, V15, P2526, DOI 10.1039/c8sm02096e; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Danis-Wlodarczyk K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127603; Delle Side D, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171586; Dilanji GE, 2012, J AM CHEM SOC, V134, P5618, DOI 10.1021/ja211593q; Godec A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/9/092002; Grebenkov DS, 2018, COMMUN CHEM, V1, DOI 10.1038/s42004-018-0096-x; Haley CL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-181; Holcman D, 2017, J PHYS A-MATH THEOR, V50, DOI 10.1088/1751-8121/50/9/093002; Huang JX, 2015, ANTIMICROB AGENTS CH, V59, P5925, DOI 10.1128/AAC.00808-15; Jacobs M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004782; Jeon JH, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/045011; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Kindler O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48525-2; Kirchner S, 2012, JOVE-J VIS EXP, DOI 10.3791/3857; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Kosztolowicz T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170602; Kosztolowicz T, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.032408; Kosztolowicz T, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.022127; Kosztolowicz T, 2017, INT J HEAT MASS TRAN, V111, P1322, DOI 10.1016/j.ijheatmasstransfer.2017.04.058; Lesouhaitier O, 2019, J INNATE IMMUN, V11, P227, DOI 10.1159/000493926; Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012; Lu ST, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062706; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; o A, 2013, DTSCH ARZTEBL, V110, pA; Olszak T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121089; Olszak T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16411-4; Parsek MR, 2008, CURR OPIN MICROBIOL, V11, P560, DOI 10.1016/j.mib.2008.09.015; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Singla S, 2013, J ANTIBIOT, V66, P61, DOI 10.1038/ja.2012.101; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00307-19; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; STEWART PS, 1994, ANTIMICROB AGENTS CH, V38, P1052, DOI 10.1128/AAC.38.5.1052; Stewart PS, 1996, ANTIMICROB AGENTS CH, V40, P2517, DOI 10.1128/AAC.40.11.2517; Suzuki T., 2017, MATH METHODS CANC EV; Wasik S, 2013, EUR BIOPHYS J BIOPHY, V42, P549, DOI 10.1007/s00249-013-0904-2; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101; 2012, DRUG DISCOV TODAY TE, V9	48	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243003	10.1371/journal.pone.0243003	http://dx.doi.org/10.1371/journal.pone.0243003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270697	Green Published, gold			2022-12-26	WOS:000597149100049
J	Oda, N; Kajikawa, M; Maruhashi, T; Kishimoto, S; Yusoff, FM; Goto, C; Nakashima, A; Tomiyama, H; Takase, B; Yamashina, A; Higashi, Y				Oda, Nozomu; Kajikawa, Masato; Maruhashi, Tatsuya; Kishimoto, Shinji; Yusoff, Farina Mohamad; Goto, Chikara; Nakashima, Ayumu; Tomiyama, Hirofumi; Takase, Bonpei; Yamashina, Akira; Higashi, Yukihito			Endothelial function is preserved in light to moderate alcohol drinkers but is impaired in heavy drinkers in women: Flow-mediated Dilation Japan (FMD-J) study	PLOS ONE			English	Article							NITROGLYCERINE-INDUCED VASODILATION; DENSITY-LIPOPROTEIN CHOLESTEROL; OXIDATIVE STRESS; BRACHIAL-ARTERY; CONSUMPTION; RISK; ADULTS; DYSFUNCTION; DISEASE; PREDICTION	Light to moderate alcohol consumption has protective effects on all-cause death and coronary artery disease in women. It is thought that light to moderate alcohol consumption has a beneficial effect on vascular function in women. We measured flow-mediated vasodilation (FMD) in 702 women aged 17-86 years who provided information on alcohol consumption. We divided the subjects into four groups: non-drinkers (0 g/week), light drinkers (>0 to 140 g/week), moderate drinkers (>140 to 280 g/week) and heavy drinkers (>280 g/week). There was no significant difference in FMD among the four groups. Multivariate regression analysis revealed that alcohol consumption in non-drinkers and light drinkers was not an independent predictor of FMD (beta = -0.001, P = 0.98). We compared 50 moderate drinkers and 50 non-drinkers matched for age and medical histories and 22 heavy drinkers and 22 non-drinkers in matched pair analysis. There was no significant difference in FMD between moderate drinkers and non-drinkers (8.2 +/- 4.3% vs. 8.1 +/- 3.5, P = 0.91), while FMD in heavy drinkers was significantly lower than that in non-drinkers (5.9 +/- 2.5% vs. 8.9 +/- 3.5%, P = 0.002). These findings suggest that heavy alcohol consumption is associated with endothelial dysfunction but that light to moderate alcohol consumption is not associated with endothelial dysfunction in women.	[Oda, Nozomu] Hiroshima Prefectural Hosp, Dept Cardiol, Hiroshima, Japan; [Kajikawa, Masato; Higashi, Yukihito] Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan; [Maruhashi, Tatsuya; Kishimoto, Shinji; Yusoff, Farina Mohamad; Higashi, Yukihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cardiovasc Regenerat & Med, Hiroshima, Japan; [Goto, Chikara] Hiroshima Int Univ, Dept Phys Therapy, Hiroshima, Japan; [Nakashima, Ayumu] Hiroshima Univ, Dept Stem Cell Biol & Med, Grad Sch Biomed Sci, Hiroshima, Japan; [Tomiyama, Hirofumi; Takase, Bonpei; Yamashina, Akira] Tokyo Med Univ, Dept Cardiol, Tokyo, Japan; [Takase, Bonpei] Natl Def Med Coll, Div Biomed Engn, Res Inst, Tokorozawa, Saitama, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Tokyo Medical University; National Defense Medical College - Japan	Higashi, Y (corresponding author), Hiroshima Univ Hosp, Med Ctr Translat & Clin Res, Div Regenerat & Med, Hiroshima, Japan.; Higashi, Y (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cardiovasc Regenerat & Med, Hiroshima, Japan.	yhigashi@hiroshima-u.ac.jp	Nakashima, Ayumu/N-9158-2017; Nakashima, Ayumu/CAF-0274-2022	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494				Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; CASTELLI WP, 1977, LANCET, V2, P153; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Di Gennaro C, 2012, ALCOHOL CLIN EXP RES, V36, P242, DOI 10.1111/j.1530-0277.2011.01636.x; Djousse L, 2009, CIRCULATION, V120, P237, DOI 10.1161/CIRCULATIONAHA.108.832360; ELGUEBALY N, 1981, INT J ADDICT, V16, P1207, DOI 10.3109/10826088109039174; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; French MT, 2009, AM J HEALTH PROMOT, V24, P2, DOI 10.4278/ajhp.0801104; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HASHIMOTO M, 1995, CIRCULATION, V92, P3431, DOI 10.1161/01.CIR.92.12.3431; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Hwang CL, 2020, ALCOHOL CLIN EXP RES, V44, P407, DOI 10.1111/acer.14254; Kajikawa M, 2016, HYPERTENSION, V67, P1045, DOI 10.1161/HYPERTENSIONAHA.115.06839; Kiechl S, 1996, BRIT MED J, V313, P1040; LAUG WE, 1983, JAMA-J AM MED ASSOC, V250, P772, DOI 10.1001/jama.250.6.772; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; LINN S, 1993, AM J PUBLIC HEALTH, V83, P811, DOI 10.2105/AJPH.83.6.811; Maruhashi T, 2013, ARTERIOSCL THROM VAS, V33, P1401, DOI 10.1161/ATVBAHA.112.300934; MAYER EJ, 1993, CIRCULATION, V88, P2190, DOI 10.1161/01.CIR.88.5.2190; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Oda N, 2017, INT J CARDIOL, V230, P523, DOI 10.1016/j.ijcard.2016.12.065; Okwuosa TM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002944; Oncul M, 2020, REPROD BIOL, V20, P396, DOI 10.1016/j.repbio.2020.04.006; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Soardo G, 2005, ALCOHOL CLIN EXP RES, V29, P1889, DOI 10.1097/01.alc.0000183004.28587.23; Solomon CG, 2000, CIRCULATION, V102, P494; STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002; Suzuki K, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-8; Vatsalya V, 2012, ALCOHOL CLIN EXP RES, V36, P207, DOI 10.1111/j.1530-0277.2011.01600.x; Williams MRI, 2001, J CLIN ENDOCR METAB, V86, P5389, DOI 10.1210/jc.86.11.5389; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; WILSON PWF, 1987, AM J CARDIOL, V59, pG91, DOI 10.1016/0002-9149(87)90165-2; World Health Organization, 2014, GLOB STAT REP ALC HL, DOI [10.1007/s10903-013-9949-7, DOI 10.1007/S10903-013-9949-7]	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243216	10.1371/journal.pone.0243216	http://dx.doi.org/10.1371/journal.pone.0243216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270724	gold, Green Published			2022-12-26	WOS:000597149100152
J	Socolovithc, RL; Fumis, RRL; Tomazini, BM; Pastore, L; Galas, FRBG; de Azevedo, LCP; Costa, ELV				Socolovithc, Rachel Lane; Lins Fumis, Renata Rego; Tomazini, Bruno Martins; Pastore, Laerte; Barbosa Gomes Galas, Filomena Regina; Pontes de Azevedo, Luciano Cesar; Vieira Costa, Eduardo Leite			Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: A cohort study	PLOS ONE			English	Article								Background The coronavirus disease (COVID-19) pandemic has brought significant challenges worldwide, with high mortality, increased use of hospital resources, and the collapse of healthcare systems. We aimed to describe the clinical outcomes of critically ill COVID-19 patients and assess the impact on the use of hospital resources and compare with critically ill medical patients without COVID-19. Methods and findings In this retrospective cohort study, we included patients diagnosed with COVID-19 admitted to a private ICU in Sao Paulo, Brazil from March to June 2020. We compared these patients with those admitted to the unit in the same period of the previous year. A total of 212 consecutive patients with a confirmed diagnosis of COVID-19 were compared with 185 medical patients from the previous year. Patients with COVID-19 were more frequently males (76% vs. 56%, p<0.001) and morbidly obese (7.5% vs. 2.2%, p = 0.027), and had lower SAPS 3 (49.65 (12.19) vs. 55.63 (11.94), p<0.001) and SOFA scores (3.78 (3.53) vs. 4.48 (3.11), p = 0.039). COVID-19 patients had a longer ICU stay (median of 7 vs. 3 days, p<0.001), longer duration of mechanical ventilation (median of 9 vs. 4 days, p = 0.003), and more frequent tracheostomies (10.8 vs. 1.1%, p<0.001). Survival rates until 28 days were not statistically different (91% vs. 85.4%, p = 0.111). After multivariable adjustment for age, gender, SAPS 3, and Charlson Comorbidity Index, COVID-19 remained not associated with survival at 28 days (HR 0.59, 95% CI 0.33-1.06, p = 0.076). Among patients who underwent invasive mechanical ventilation, the observed mortality at 28-days was 16.2% in COVID-19 patients compared to 34.6% in the previous year. Conclusions COVID-19 required more hospital resources, including invasive and non-invasive ventilation, had a longer duration of mechanical ventilation, and a more prolonged ICU and hospital length of stay. There was no difference in all-cause mortality at 28 and 60 days, suggesting that health systems preparedness be an important determinant of clinical outcomes.	[Socolovithc, Rachel Lane; Lins Fumis, Renata Rego; Tomazini, Bruno Martins; Pastore, Laerte] Hosp Sirio Libanes, Adult Intens Care Unit, Sao Paulo, Brazil; [Lins Fumis, Renata Rego; Tomazini, Bruno Martins; Pontes de Azevedo, Luciano Cesar; Vieira Costa, Eduardo Leite] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Barbosa Gomes Galas, Filomena Regina] Hosp Sirio Libanes, Cardiol Intens Care Unit, Sao Paulo, Brazil; [Barbosa Gomes Galas, Filomena Regina] Univ Sao Paulo, Heart Inst Incor, Intens Care Unit, Sao Paulo, Brazil; [Pontes de Azevedo, Luciano Cesar] Univ Sao Paulo, Hosp Clin, Emergency Med, Sao Paulo, Brazil; [Vieira Costa, Eduardo Leite] Univ Sao Paulo, Heart Inst Incor, Cardiopulm Dept, Pulm Div, Sao Paulo, Brazil	Hospital Sirio Libanes; Hospital Sirio Libanes; Hospital Sirio Libanes; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Fumis, RRL (corresponding author), Hosp Sirio Libanes, Adult Intens Care Unit, Sao Paulo, Brazil.; Fumis, RRL (corresponding author), Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil.	renata.rlfumis@hsl.org.br		Martins Tomazini, Bruno/0000-0001-6763-6132	Sirio-Libanes Hospital	Sirio-Libanes Hospital	The study was funded by the Sirio-Libanes Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Ferguson J, 2020, EMERG INFECT DIS, V26, P1679, DOI 10.3201/eid2608.201776; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hentschker C, LANCET RESP MED; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Mitra AR, 2020, CAN MED ASSOC J, V192, pE694, DOI 10.1503/cmaj.200794; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Ribeiro ALP, 2016, CIRCULATION, V133, P422, DOI 10.1161/CIRCULATIONAHA.114.008727; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Saghazadeh A, 2020, EXPERT REV CLIN IMMU, V16, P465, DOI 10.1080/1744666X.2020.1750954; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	21	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243269	10.1371/journal.pone.0243269	http://dx.doi.org/10.1371/journal.pone.0243269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270741	Green Published, gold			2022-12-26	WOS:000597149100009
J	Gonzalez-Block, MA; Gutierrez-Calderon, E; Pelcastre-Villafuerte, BE; Arroyo-Laguna, J; Comes, Y; Crocco, P; Fachel-Leal, A; Noboa, L; Riva-Knauth, D; Rodriguez-Zea, B; Ruoti, M; Sarti, E; Puentes-Rosas, E				Angel Gonzalez-Block, Miguel; Gutierrez-Calderon, Emilio; Estela Pelcastre-Villafuerte, Blanca; Arroyo-Laguna, Juan; Comes, Yamila; Crocco, Pedro; Fachel-Leal, Andrea; Noboa, Laura; Riva-Knauth, Daniela; Rodriguez-Zea, Berenice; Ruoti, Monica; Sarti, Elsa; Puentes-Rosas, Esteban			Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates	PLOS ONE			English	Article								Introduction Influenza morbidity and mortality are significant in the countries of South America, yet influenza vaccination is as low as 56.7% among pregnant women, reaching 76.7% of adults with chronic diseases. This article measures the relative values for the vaccination hesitancy indicators of confidence, complacency and convenience by risk-groups in urban areas of five countries of South America with contrasting vaccination rates, analyzing their association with sociodemographic variables and self-reported immunization status. Methods An exit survey was applied to 640 individuals per country in Brazil, Chile, Paraguay, Peru and Uruguay, distributed equally across risk groups of older adults, adults with risk factors, children <= 6 and pregnant women. Indicators were constructed for vaccine confidence, complacency and convenience. Analysis of variance and multiple logistic analysis was undertaken. Results Adults with risk factors are somewhat more confident of the influenza vaccine yet also more complacent. Convenience is higher for mothers of minors. Children and older adults report higher levels of vaccination. The 3Cs are more different across countries than across risk groups, with values for Chile higher for confidence and those for Uruguay the lowest. Complacency is lower in Brazil and higher in Uruguay. Results suggest that confidence and complacency affect vaccination rates across risk groups and countries. Conclusions Influenza vaccine confidence, complacency and convenience have to be bolstered to improve effective coverage across all risk groups in the urban areas of the countries studied. The role played by country contextual and national vaccination programs has to be further researched in relation to effective coverage of influenza vaccine.	[Angel Gonzalez-Block, Miguel] Univ Anahuac, Mexico City, DF, Mexico; [Angel Gonzalez-Block, Miguel; Estela Pelcastre-Villafuerte, Blanca] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Angel Gonzalez-Block, Miguel; Rodriguez-Zea, Berenice; Ruoti, Monica] Evisys Consulting, Mexico City, DF, Mexico; [Gutierrez-Calderon, Emilio] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [Arroyo-Laguna, Juan] Pontificia Univ Catolica Peru, Lima, Peru; [Comes, Yamila] Univ ISALUD, Maestria Sistemas Salud & Seguridad Social, Buenos Aires, DF, Argentina; [Crocco, Pedro] Escuela Salud Publ Chile, Santiago, Chile; [Fachel-Leal, Andrea; Riva-Knauth, Daniela] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Noboa, Laura] Univ Republica, Fac Ciencias Sociales, Montevideo, Uruguay; [Sarti, Elsa] Sanofi Pasteur LATAM, Mexico City, DF, Mexico; [Puentes-Rosas, Esteban] Sanofi Pasteur LATAM, Panama City, Panama	Universidad Anahuac; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Pontificia Universidad Catolica del Peru; Universidade Federal do Rio Grande do Sul; Universidad de la Republica, Uruguay	Gonzalez-Block, MA (corresponding author), Univ Anahuac, Mexico City, DF, Mexico.; Gonzalez-Block, MA (corresponding author), Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.; Gonzalez-Block, MA (corresponding author), Evisys Consulting, Mexico City, DF, Mexico.	miguel.gonzalezblock@gmail.com	Sarti, Elsa/ABB-8450-2021; Arroyo-Laguna, Juan/GLR-5662-2022; Pelcastre, Blanca/AFD-6340-2022	Gonzalez-Block, Miguel Angel/0000-0002-7215-4768; Pelcastre-Villafuerte, Blanca Estela/0000-0003-4755-1881; Rodriguez Zea, Berenice/0000-0003-3745-8878	Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur provided support for this study in the form of a grant to Evisys Consulting and in the form of salaries for ES and EPR. Evysis Consulting provided support in the form of salaries to MAGB, EGC, BEP, JA, YC, PC, AFL, LN, DRK, BRZ and MR. BRZ and MR participated in the research as paid, pro-tempore employees of Evisys. EGC, BEP, JA, YC, PC, AFL, LN, DRK participated as Evisys consultants. The specific roles of these authors are articulated in the `author contributions' section. The grant provided by Sanofi Pasteur to Evisys was used to pay consulting fees and salaries and to pay for the data acquisition. Both Sanofi Pasteur and Evisys participated in study design and manuscript review, but had no further role in data collection and analysis, decision to publish, or preparation of the manuscript.	Betsch C., 2015, POLICY INSIGHTS BEHA, V2, P61, DOI [10.1177/2372732215600716, DOI 10.1177/2372732215600716]; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Gentile A, 2019, VACCINE, V37, P2670, DOI 10.1016/j.vaccine.2019.03.081; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Palekar R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219595; Pan American Health Organization (PAHO), 2019, US IND MAP INTERNET; Quinn SC, 2019, VACCINE, V37, P1168, DOI 10.1016/j.vaccine.2019.01.033; Reinders S, 2020, VACCINE, V38, P1194, DOI 10.1016/j.vaccine.2019.11.016; Shimizu Yoshi, 2019, 8 THINGS KNOW PANDEM; The SAGE Working Group, 2014, REP SAG WORK GROUP V; Wheelock A., JOURNEY VACCINATION; World Health Organization, 2019, GLOBAL INFLUENZA STR; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2015, PAND H1N1 2009 UPD 1; World Health Organization, 2005, BARR INFL VACC INT B; World Health Organization, 2009, INFL SEAS FACT SHEET	17	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243833	10.1371/journal.pone.0243833	http://dx.doi.org/10.1371/journal.pone.0243833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306744	gold, Green Published			2022-12-26	WOS:000600144200023
J	Azuma, T; Sato, Y; Ohno, T; Azuma, M; Kume, H				Azuma, Takeshi; Sato, Yujiro; Ohno, Tatsukuni; Azuma, Miyuki; Kume, Haruki			Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer	PLOS ONE			English	Article							UROTHELIAL CARCINOMA; STAGE TA; EXPRESSION; CELL; ASSOCIATION; RECURRENCE; INFLAMMATION; PROGRESSION; MOLECULE; SURVIVAL	Background B7-H3 is a member of the B7 family of immune-regulatory ligands and is a costimulatory molecule promoting the T cell response in vitro. We herein investigated the clinical utility of serum soluble B7-H3 (sB7-H3) in patients with non-muscle invasive bladder cancer (NMIBC). Methods We analyzed 555 patients in whom NMIBC was diagnosed at Tokyo Metropolitan Tama Medical Center between 2008 and 2013. We measured the serum sB7-H3 (sB7-H3) level using the enzyme-linked immunosorbent assay (ELISA) and evaluated the utility of sB7-H3 as a prognostic biomarker for NMIBC. We used the Cox proportional hazards regression model to assess recurrence-free survival (RFS) and progression-free survival (PFS) with the sB7-H3 level. Results We detected high levels of sB7-H3 in the sera of 47% of patients with NMIBC versus only 8% in healthy donors. The increase of sB7-H3 was significantly associated with poor RFS and PFS. Multivariate analysis showed that elevated sB7-H3 was an independent prognostic factor of RFS and PFS. According to the European Organization for Research and Treatment of Cancer (EORTC), in intermediate-low and intermediate-high risk groups, the presence of sB7-H3 significantly determined the rate of recurrence and progression. Conclusions Our data suggested that evaluating serum sB7-H3 expression is a useful tool for predicting the prognosis of patients with NMIBC.	[Azuma, Takeshi; Sato, Yujiro] Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan; [Azuma, Takeshi; Azuma, Miyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Hongo, Tokyo, Japan; [Azuma, Takeshi; Kume, Haruki] Univ Tokyo, Dept Urol, Grad Sch Med, Hongo, Tokyo, Japan; [Ohno, Tatsukuni] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Hongo, Tokyo, Japan.; Azuma, T (corresponding author), Univ Tokyo, Dept Urol, Grad Sch Med, Hongo, Tokyo, Japan.	tazuma-tky@umin.ac.jp	Azuma, Miyuki/AAT-8928-2021	Azuma, Miyuki/0000-0002-3529-4585; Azuma, Takeshi/0000-0002-4921-2122	JSPS KAKENHI [16K11037, 17K11169]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI, Grant Number 16K11037 to Y. Sato and JSPS KAKENHI, Grant Number 17K11169 to T. Azuma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Allard P, 1998, BRIT J UROL, V81, P692; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Baral A, 2014, ONCOL LETT, V8, P1195, DOI 10.3892/ol.2014.2268; Boorjian SA, 2008, CLIN CANCER RES, V14, P4800, DOI 10.1158/1078-0432.CCR-08-0731; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; KURTH KH, 1995, EUR J CANCER, V31A, P1840, DOI 10.1016/0959-8049(95)00287-S; Liu H, 2011, MOL CANCER THER, V10, P960, DOI 10.1158/1535-7163.MCT-11-0072; Luo LQ, 2006, INT J CANCER, V118, P1823, DOI 10.1002/ijc.21557; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Lupu CM, 2006, J GASTROINTEST SURG, V10, P635, DOI 10.1016/j.gassur.2006.02.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Oblak A., 2011, CLIN DEV IMMUNOL, V2011, P2011; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Saatian B, 2004, AM J PHYSIOL-LUNG C, V287, pL217, DOI 10.1152/ajplung.00132.2003; Sakano S, 2011, BJU INT, V107, P1598, DOI 10.1111/j.1464-410X.2010.09850.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu CP, 2006, WORLD J GASTROENTERO, V12, P457, DOI 10.3748/wjg.v12.i3.457; Xie C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27528; Xu ZL, 2018, ONCOL LETT, V15, P6519, DOI 10.3892/ol.2018.8173; Xylinas E, 2014, EJSO-EUR J SURG ONC, V40, P121, DOI 10.1016/j.ejso.2013.08.023; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhao L, 2017, J GASTROINTEST SURG, V21, P807, DOI 10.1007/s11605-017-3386-1	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243379	10.1371/journal.pone.0243379	http://dx.doi.org/10.1371/journal.pone.0243379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306717	Green Published, gold			2022-12-26	WOS:000600144200053
J	Fleming, M; McLay, JS; Clark, D; King, A; Mackay, DF; Pell, JP				Fleming, Michael; McLay, James S.; Clark, David; King, Albert; Mackay, Daniel F.; Pell, Jill P.			Health, educational and employment outcomes among children treated for a skin disorder: Scotland-wide retrospective record linkage cohort study of 766,244 children	PLOS ONE			English	Article							ATOPIC-DERMATITIS; UNITED-STATES; PSORIASIS; BURDEN; ECZEMA; COMORBIDITY; ASSOCIATION; PREVALENCE; MORTALITY; RISK	Background To compare health, educational and employment outcomes of schoolchildren receiving medication for a skin disorder with peers. Methods This retrospective population cohort study linked eight Scotland-wide databases, covering dispensed prescriptions, hospital admissions, maternity records, death certificates, annual pupil census, school examinations, school absences/exclusions and unemployment to investigate educational (absence, exclusion, special educational need, academic attainment), employment, and health (admissions and mortality) outcomes of 766,244 children attending local authority run primary, secondary and special schools in Scotland between 2009 and 2013. Results After adjusting for sociodemographic and maternity confounders the 130,087 (17.0%) children treated for a skin disorder had increased hospitalisation, particularly within one year of commencing treatment (IRR 1.38, 95% CI 1.35-1.41, p<0.001) and mortality (HR 1.50, 95% CI 1.18-1.90, p<0.001). They had greater special educational need (OR 1.19, 95% CI 1.17-1.21, p<0.001) and more frequent absences from school (IRR 1.07, 95% CI 1.06-1.08, p<0.001) but did not exhibit poorer exam attainment or increased post-school unemployment. The associations remained after further adjustment for comorbid chronic conditions. Conclusions Despite increased hospitalisation, school absenteeism, and special educational need, children treated for a skin disorder did not have poorer exam attainment or employment outcomes. Whilst findings relating to educational and employment outcomes are reassuring, the association with increased risk of mortality is alarming and merits further investigation.	[Fleming, Michael; Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [McLay, James S.] Univ Aberdeen, Dept Child Hlth, Aberdeen, Scotland; [Clark, David] Publ Hlth Scotland, Edinburgh, Midlothian, Scotland; [King, Albert] Scottish Govt, ScotXed, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Aberdeen	Fleming, M (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	michael.fleming@glasgow.ac.uk		fleming, michael/0000-0002-2185-4502	Health Data Research UK [MR/S003800/1]; National Institute for Health Research (England); Chief Scientist Office (Scotland); Health and Care Research Wales; Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland); Engineering and Physical Sciences Research Council; Economic and Social Research Council; British Heart Foundation; Wellcome Trust; MRC [MR/S003800/1] Funding Source: UKRI	Health Data Research UK; National Institute for Health Research (England)(National Institute for Health Research (NIHR)); Chief Scientist Office (Scotland); Health and Care Research Wales; Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was sponsored by Health Data Research UK (www.hdruk.ac.uk) (grant reference number MR/S003800/1 awarded to Dr Michael Fleming) which is a joint investment led by the Medical Research Council, together with the National Institute for Health Research (England), the Chief Scientist Office (Scotland), Health and Care Research Wales, Health and Social Care Research and Development Division (Public Health Agency, Northern Ireland), the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the British Heart Foundation and Wellcome Trust. The sponsor and funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review or approval of the manuscript, or decision to submit the manuscript for publication.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Augustin M, 2010, BRIT J DERMATOL, V162, P633, DOI 10.1111/j.1365-2133.2009.09593.x; Augustin M, 2015, DERMATOLOGY, V231, P35, DOI 10.1159/000381913; Barbarot S, 2018, ALLERGY, V73, P1284, DOI 10.1111/all.13401; Brezinski EA, 2015, JAMA DERMATOL, V151, P651, DOI 10.1001/jamadermatol.2014.3593; Cui J, 2007, STATA J, V7, P209, DOI 10.1177/1536867X0700700205; Dhana A, 2019, J AM ACAD DERMATOL, V80, P1332, DOI 10.1016/j.jaad.2018.12.037; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Feng LJ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020801; Ferreira Barbara Isabel Roque Cunha, 2016, J Clin Aesthet Dermatol, V9, P36; Fleming M., 2017, THESIS; Fleming M, 2020, INT J EPIDEMIOL, V49, P1380, DOI 10.1093/ije/dyaa002; Fleming M, 2019, DIABETES CARE, V42, P1700, DOI 10.2337/dc18-2423; Fleming M, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02309-2018; Fleming M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6888-9; Fleming M, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0691; Horev A, 2017, ACTA DERMATOVENER CR, V25, P210; Hunt IJD, 2020, CLIN EXP DERMATOL, V45, P5, DOI 10.1111/ced.14021; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; Kemp AS, 2003, PHARMACOECONOMICS, V21, P105, DOI 10.2165/00019053-200321020-00003; Kimball AB, 2012, J AM ACAD DERMATOL, V67, P651, DOI 10.1016/j.jaad.2011.11.948; Kuniyoshi Y, 2018, ALLERGOL INT, V67, P481, DOI 10.1016/j.alit.2018.02.009; Kuzina OE, 2020, IIOAB J, V11, P12; Kwa L, 2017, J AM ACAD DERMATOL, V77, P1023, DOI 10.1016/j.jaad.2017.08.034; Kyung Y, 2020, ANN ALLERG ASTHMA IM, V125, P55, DOI 10.1016/j.anai.2020.03.023; Kyung Y, 2020, J DERMATOL, V47, P699, DOI 10.1111/1346-8138.15386; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; Lee S, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1160-7; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Narla S, 2019, J AM ACAD DERMATOL, V80, P382, DOI 10.1016/j.jaad.2018.09.025; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Olsen JR, 2016, BRIT J DERMATOL, V174, P853, DOI 10.1111/bjd.14361; Patel KR, 2019, DERMATOLOGY, V235, P276, DOI 10.1159/000499564; Randa H, 2017, ACTA DERM-VENEREOL, V97, P555, DOI 10.2340/00015555-2600; Reed B, 2018, ALLERGY ASTHMA PROC, V39, P406, DOI 10.2500/aap.2018.39.4175; Ruijsbroek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134780; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; ScotPHO, 2016, SCOTT BURD DIS STUD; Shaker M, 2014, CURR OPIN PEDIATR, V26, P516, DOI 10.1097/MOP.0000000000000120; Smirnova J, 2019, BRIT J DERMATOL, V180, P559, DOI 10.1111/bjd.17330; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Strom MA, 2016, BRIT J DERMATOL, V175, P920, DOI 10.1111/bjd.14697; Thyssen JP, 2018, J AM ACAD DERMATOL, V78, P506, DOI 10.1016/j.jaad.2017.10.032; Twisk JW, 2013, APPL LONGITUDINAL DA; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Verboom P, 2002, BRIT J DERMATOL, V147, P716, DOI 10.1046/j.1365-2133.2002.04964.x; von Kobyletzki LB, 2017, BRIT J DERMATOL, V177, pE47, DOI 10.1111/bjd.15242; Wan J, 2020, J ALLER CL IMM-PRACT, V8, P2808, DOI 10.1016/j.jaip.2020.04.032; Wan J, 2020, J AM ACAD DERMATOL, V82, P1368, DOI 10.1016/j.jaad.2019.10.019; Wood R, 2013, LANCET, V382, P10; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Zuberbier T, 2006, J ALLERGY CLIN IMMUN, V118, P226, DOI 10.1016/j.jaci.2006.02.031	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243383	10.1371/journal.pone.0243383	http://dx.doi.org/10.1371/journal.pone.0243383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306713	Green Accepted, Green Published, gold			2022-12-26	WOS:000600144200008
J	Bajaj, S; Blair, KS; Schwartz, A; Dobbertin, M; Blair, RJR				Bajaj, Sahil; Blair, Karina S.; Schwartz, Amanda; Dobbertin, Matthew; Blair, R. James R.			Worry and insomnia as risk factors for depression during initial stages of COVID-19 pandemic in India	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; PSYCHIATRIC-DISORDERS; GENDER-DIFFERENCES; SEVERITY INDEX; STRESS; SYMPTOMS; POPULATION; ASSOCIATION; PREVALENCE; RUMINATION	The biggest nationwide COVID-19 pandemic lockdown worldwide was enforced in India for an initial period of 21-days. Emerging evidence suggests that pandemic situations and associated lockdowns have an adverse impact on sleep and mental health. However, prediction of sleep health from sociodemographic characteristics and the public's worry during the initial stages of the COVID-19 pandemic has not been extensively explored so far. It's also unclear whether sleep outcomes mediate the association between worry and mental health during pandemic situations. A web-survey (N = 391) on sociodemographic characteristics, COVID-19 related worry, sleep health (insomnia and daytime sleepiness), and depression was conducted during the initial 21-days of the COVID-19 stringent lockdown in India. Multiple regression analyses showed that variables, including sex, age, income level, and worry score, contributed to the significant regression equation for insomnia but not for daytime sleepiness. Specifically, the female, younger, lower income, and highly worried populations contributed significantly more than the male, elderly, higher income, and less worried populations, respectively, to the prediction of insomnia. Mediation analyses showed that insomnia, but not daytime sleepiness, fully mediated the relationship between worry score and severity of depressive symptoms. We provide evidence that the female, younger, lower income, and worried populations may be at higher risk for insomnia during pandemic situations. Current evidence gives hope that improving sleep may reduce depressive symptoms during a pandemic situation. This underscores the importance of the implementation of effective public health policies in conjunction with strategical responses to the COVID-19 pandemic.	[Bajaj, Sahil; Blair, Karina S.; Schwartz, Amanda; Dobbertin, Matthew; Blair, R. James R.] Boys Town Natl Res Hosp, Ctr Neurobehav Res, Multimodal Clin Neuroimaging Lab MCNL, Boys Town, NE 68010 USA; [Bajaj, Sahil; Blair, Karina S.; Schwartz, Amanda; Dobbertin, Matthew; Blair, R. James R.] Boys Town Natl Res Hosp, Ctr Neurobehav Res, Program Trauma & Anxiety PTAC, Boys Town, NE 68010 USA	Boys Town National Research Hospital; Boys Town National Research Hospital	Bajaj, S (corresponding author), Boys Town Natl Res Hosp, Ctr Neurobehav Res, Multimodal Clin Neuroimaging Lab MCNL, Boys Town, NE 68010 USA.; Bajaj, S (corresponding author), Boys Town Natl Res Hosp, Ctr Neurobehav Res, Program Trauma & Anxiety PTAC, Boys Town, NE 68010 USA.	sahil.bajaj@boystown.org	Bajaj, Sahil/C-6580-2016	Bajaj, Sahil/0000-0003-0629-6036; Blair, Robert James/0000-0002-6377-2361				Angold A, 1995, INT J METHOD PSYCH, V5, P237; Nguyen ATD, 2006, J CLIN SLEEP MED, V2, P170; [Anonymous], 2009, GUARDIAN, V5, P20; Arnett JJ, 2014, LANCET PSYCHIAT, V1, P569, DOI 10.1016/S2215-0366(14)00080-7; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bernert RA, 2007, J FAM PSYCHOL, V21, P58, DOI 10.1037/0893-3200.21.1.58; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Besedovsky L, 2019, PHYSIOL REV, V99, P1325, DOI 10.1152/physrev.00010.2018; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Boccabella A, 2017, J CLIN SLEEP MED, V13, P685, DOI 10.5664/jcsm.6584; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Breslau N, 1997, AM J PUBLIC HEALTH, V87, P1649, DOI 10.2105/AJPH.87.10.1649; Chaplin TM, 2008, ALCOHOL CLIN EXP RES, V32, P1242, DOI 10.1111/j.1530-0277.2008.00679.x; Chiang JJ, 2017, J ADOLESCENT HEALTH, V61, P501, DOI 10.1016/j.jadohealth.2017.04.011; Clancy F, 2020, HEALTH PSYCHOL REV, V14, P427, DOI 10.1080/17437199.2019.1700819; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; Dijk DJ, 2010, SLEEP, V33, P211, DOI 10.1093/sleep/33.2.211; Fatani A, 2015, J EPIDEMIOL GLOB HEA, V5, pS59, DOI 10.1016/j.jegh.2015.05.005; Felden Erico Pereira Gomes, 2015, Rev Paul Pediatr, V33, P467, DOI 10.1016/j.rpped.2015.01.011; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Goldstein AN, 2014, ANNU REV CLIN PSYCHO, V10, P679, DOI 10.1146/annurev-clinpsy-032813-153716; Goring HJ, 2008, COGNITIVE THER RES, V32, P554, DOI 10.1007/s10608-007-9146-x; Government of India Ministry of Statistics and Programme Implementation, 2019, PROV EST ANN NAT INC; Grandner MA, 2013, J CLIN SLEEP MED, V9, P897, DOI 10.5664/jcsm.2990; Grandner MA, 2010, SLEEP MED, V11, P470, DOI 10.1016/j.sleep.2009.10.006; Hall M, 2000, PSYCHOSOM MED, V62, P227, DOI 10.1097/00006842-200003000-00014; Hamilton NA, 2007, HEALTH PSYCHOL, V26, P288, DOI 10.1037/0278-6133.26.3.288; Hara C, 2004, SLEEP MED, V5, P31, DOI 10.1016/j.sleep.2003.09.009; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hayley AC, 2013, AUST NZ J PSYCHIAT, V47, P772, DOI 10.1177/0004867413490036; Hong RY, 2007, BEHAV RES THER, V45, P277, DOI 10.1016/j.brat.2006.03.006; Isac C, 2020, CLIN EPIDEMIOL GLOB, V8, P739, DOI 10.1016/j.cegh.2020.01.012; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalmbach DA, 2018, NAT SCI SLEEP, V10, P193, DOI 10.2147/NSS.S138823; Killgore WDS, 2020, PSYCHIAT RES, P113134, DOI [10.1016/j.psychres.2020.113134, DOI 10.1016/J.PSYCHRES.2020.1131343]; Kim HC, 2011, J OCCUP HEALTH, V53, P164, DOI 10.1539/joh.10-0032-OA; Krystal AD, 2012, NEUROL CLIN, V30, P1389, DOI 10.1016/j.ncl.2012.08.018; Lallukka T, 2012, BMC PUBLIC HEALTH, P12, DOI [10.1186/1471-2458-12-12, DOI 10.1186/1471-2458-12-12]; Lee J, 2017, ASIA PAC J CLIN NUTR, V26, P906, DOI 10.6133/apjcn.082016.04; Leggett A, 2016, J GERONTOL B-PSYCHOL, V71, P118, DOI 10.1093/geronb/gbv072; Linton SJ, 2004, BRIT J HEALTH PSYCH, V9, P127, DOI 10.1348/135910704773891005; Liu XC, 2000, PSYCHIAT RES, V93, P1, DOI 10.1016/S0165-1781(99)00119-5; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Maggio M, 2013, MATURITAS, V76, P22, DOI 10.1016/j.maturitas.2013.06.006; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; McCall W Vaughn, 2004, Prim Care Companion J Clin Psychiatry, V6, P9; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Meltzer H, 2011, PSYCHOL MED, V41, P771, DOI 10.1017/S0033291710001261; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Muris P, 2005, PERS INDIV DIFFER, V39, P1105, DOI 10.1016/j.paid.2005.04.005; Nishishiba M, 2017, REGRESSION ANAL RES, P253, DOI [10.4135/9781544307763, DOI 10.4135/9781544307763]; Pahwa P, 2012, CAN RESPIR J, V19, pE10, DOI 10.1155/2012/287309; Pallant J, 2001, SPSS SURVIVAL MANUAL, P85; Pallesen S, 2002, SCAND J PSYCHOL, V43, P425, DOI 10.1111/1467-9450.00311; Panda S, 2012, NEUROL INDIA, V60, P68, DOI 10.4103/0028-3886.93601; Papadopoulos D, 2018, SLEEP SCI, V11, P92, DOI 10.5935/1984-0063.20180018; Paparrigopoulos T, 2010, BMC PUBLIC HEALTH, P10, DOI [10.1186/1471-2458-10-10, DOI 10.1186/1471-2458-10-10]; Patel D, 2018, J CLIN SLEEP MED, V14, P1017, DOI 10.5664/jcsm.7172; Pharr JR., 2012, ISRN PUBLIC HLTH, V2012, P1, DOI DOI 10.5402/2012/483432; Reardon S, 2015, NATURE, V519, P13, DOI 10.1038/519013a; Riedel BW, 2000, SLEEP MED REV, V4, P277, DOI 10.1053/smrv.1999.0074; Ronnlund M, 2018, FRONT PSYCHOL, P9, DOI [10.3389/fpsyg.2018.00009, DOI 10.3389/FPSYG.2018.00009]; Rood L, 2010, COGNITIVE THER RES, V34, P333, DOI 10.1007/s10608-009-9261-y; Sareen J, 2011, ARCH GEN PSYCHIAT, V68, P419, DOI 10.1001/archgenpsychiatry.2011.15; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Singh LK, 2019, INDIAN J PSYCHIAT, V61, P265, DOI 10.4103/psychiatry.IndianJPsychiatry_412_18; Thabrew H, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1610; Tutek J, 2021, BEHAV SLEEP MED, V19, P192, DOI 10.1080/15402002.2020.1725012; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; Utsugi M, 2005, SLEEP, V28, P728, DOI 10.1093/sleep/28.6.728; Veqar Zubia, 2017, Int J Adolesc Med Health, V32, DOI 10.1515/ijamh-2016-0090; Veqar Zubia, 2018, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2016-0151; Voitsidis P, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113076; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Warth J, 2019, BMC PUBLIC HEALTH, P19, DOI [10.1186/s12889-018-6340-6, DOI 10.1186/S12889-018-6340-6]; Wennberg AM, 2013, MATURITAS, V76, P247, DOI 10.1016/j.maturitas.2013.05.007; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	81	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243527	10.1371/journal.pone.0243527	http://dx.doi.org/10.1371/journal.pone.0243527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301508	Green Published, gold			2022-12-26	WOS:000600143100062
J	Hou, TY; Zhang, RK; Song, XR; Zhang, F; Cai, WP; Liu, Y; Dong, W; Deng, GH				Hou, Tianya; Zhang, Ruike; Song, Xiangrui; Zhang, Fan; Cai, Wenpeng; Liu, Ying; Dong, Wei; Deng, Guanghui			Self-efficacy and fatigue among non-frontline health care workers during COVID-19 outbreak: A moderated mediation model of posttraumatic stress disorder symptoms and negative coping	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; SOCIAL SUPPORT; PREVALENCE; BELIEFS; ALCOHOL; CANCER; SAMPLE; PAIN; LIFE	Purposes Since a considerable number of health care workers (HCWs) were sent to Wuhan to aid COVID-19 control during the epidemic, non-frontline HCWs who stayed in local hospitals had to work overload to provide daily health care services for other health issues, which makes them more vulnerable to experience fatigue. Self-efficacy is suggested as a protective factor for fatigue. Nonetheless, less is known regarding the underlying mechanisms. This research aimed to explore the prevalence of fatigue among non-frontline HCWs during the pandemic, investigate the mediating effect of posttraumatic stress disorder (PTSD) symptoms and moderating effect of negative coping in the association between self-efficacy and fatigue. Methods General Self-Efficacy Scale, PTSD Checklist-Civilian Version, Simplified Coping Style Questionnaire and 14-item Fatigue Scale were administrated to 527 non-frontline HCWs from Anhui Province, China. The mediating effect was examined by Mackinnon's four-step procedure, while Hayes PROCESS macro was used to test the moderated mediation model. Results The prevalence of fatigue among non-frontline HCWs was 56.7%. The effect of self-efficacy on fatigue was partially mediated by PTSD symptoms (ab = -0.146, SE = 0.030, 95% CI = [-0.207, -0.095]). Additionally, negative coping moderated both the direct effect of self-efficacy on fatigue (beta = -0.158, P<0.001) and the mediating effect of PTSD symptoms (beta = 0.077, P = 0.008). When the standard score of negative coping increased to 1.49 and over, the direct association between self-efficacy and fatigue became insignificant. Likewise, the effect of self-efficacy on PTSD symptoms had no statistical significance when the standard score of negative coping was -1.40 and lower. Conclusions More than half non-frontline HCWs suffered from fatigue during COVID-19. For those who tend to use negative coping, it might be crucial to design programs combining the enhancement of self-efficacy, preventions for PTSD symptoms and interventions for fatigue.	[Hou, Tianya; Zhang, Ruike; Song, Xiangrui; Zhang, Fan; Cai, Wenpeng; Liu, Ying; Dong, Wei; Deng, Guanghui] Second Mil Med Univ, Fac Psychol, Shanghai, Peoples R China	Naval Medical University	Hou, TY; Dong, W; Deng, GH (corresponding author), Second Mil Med Univ, Fac Psychol, Shanghai, Peoples R China.	liumi9512@126.com; sophiedongwei@163.com; bfbedu@126.com						Aiken MP, 2015, VIRTUAL REAL-LONDON, V19, P95, DOI 10.1007/s10055-015-0260-x; Alshehri FS, 2020, SAUDI PHARM J, V28, P1666, DOI 10.1016/j.jsps.2020.10.013; AmericanPsychiatricAssociation, 2013, DIAGN STAT MAN MENT, V5TH; [Anonymous], 2005, Health News, V11, P2; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2013, BJU INT, V112, pE191; [Anonymous], 2011, J PHARM PRACT, V24, P251; [Anonymous], 2016, PHI DELTA KAPPAN, V98, pK7, DOI 10.1177/0031721716666049; [Anonymous], 1993, PUBLIC HIST REV, V2, pvi; [Anonymous], 2007, J CHINESE HLTH PSYCH; [Anonymous], 2018, J HIST MODERN THEOLO, V25, p[1, 21]; Aylaz R, 2015, JPN J NURS SCI, V12, P367, DOI 10.1111/jjns.12076; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Barker LM, 2011, ERGONOMICS, V54, P815, DOI 10.1080/00140139.2011.597878; Blackburn L, 2015, J CLIN PSYCHOL, V71, P219, DOI 10.1002/jclp.22133; Bouwmans T, 2017, COMPUT SCI REV, V23, P1, DOI 10.1016/j.cosrev.2016.11.001; Brown AD, 2012, MEMORY, V20, P374, DOI 10.1080/09658211.2012.667110; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027; Cheung SK, 1999, PSYCHOL REP, V85, P1221, DOI 10.2466/pr0.1999.85.3f.1221; Chung MC, 2013, PSYCHIAT RES, V210, P1033, DOI 10.1016/j.psychres.2013.07.041; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Courtney JA, 2010, AUST NZ J ORG PSYCHO, V3, P32, DOI DOI 10.1375/AJOP.3.1.32; Craig A, 2013, J PAIN, V14, P911, DOI 10.1016/j.jpain.2013.03.002; da Silva FJ, 2016, WORK, V53, P225, DOI 10.3233/WOR-152241; de Pablo GS, 2020, J AFFECT DISORDERS, V275, P48, DOI 10.1016/j.jad.2020.06.022; Demmel R, 2005, ADDICT DISORD TREAT, V4, P5, DOI 10.1097/00132576-200503000-00002; Gao Y., 2011, CLIN MED ENG, V12, P1964; Graham JD, 2017, SPORT EXERC PERFORM, V6, P70, DOI 10.1037/spy0000074; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831; Hu YY, 2020, BRAIN BEHAV IMMUN, V89, P587, DOI 10.1016/j.bbi.2020.07.016; JENKINS R, 1985, PSYCHOL MED, P1; Johansson AC, 2018, J CLIN NURS, V27, pE1537, DOI 10.1111/jocn.14300; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lazarus R. S., 1984, STRESS APPRAISAL COP, DOI 10.1007/978-1-4419-1005-9_215; Levin C, 2007, PSYCHOL ADDICT BEHAV, V21, P108, DOI 10.1037/0893-164X.21.1.108; Liedl A, 2010, PSYCHOL MED, V40, P1215, DOI 10.1017/S0033291709991310; Lin JY, 2020, J AFFECT DISORDERS, V265, P32, DOI 10.1016/j.jad.2020.01.026; Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172; Liu F, 2020, CHILD ABUSE NEGLECT, V106, DOI 10.1016/j.chiabu.2020.104531; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Mack TM, 2005, LANCET, V365, P1370, DOI 10.1016/S0140-6736(05)66352-0; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MAHASE E, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4084; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; Moos RH, 2003, J CLIN PSYCHOL, V59, P1387, DOI 10.1002/jclp.10229; Morina N, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1680-4; National Health Commission, 2020, 42000 MED STAFF SUPP; Nygaard E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00913; O'Donnell EP, 2015, MAYO CLIN PROC, V90, P194, DOI 10.1016/j.mayocp.2014.12.011; Phillips SM, 2013, CANCER EPIDEM BIOMAR, V22, P773, DOI 10.1158/1055-9965.EPI-12-0983; Raftopoulos V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-457; s NA, 2018, LANCET INFECT DIS, V18, pe228; Shigemoto Y, 2020, STRESS HEALTH, V36, P365, DOI 10.1002/smi.2935; Soderlund A, 2002, J WHIPLASH RELAT DIS, V1, P25; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Tang WJ, 2020, J AFFECT DISORDERS, V274, P1, DOI 10.1016/j.jad.2020.05.009; Theofilou P, 2015, HEALTH PSYCHOL RES, V3, P18, DOI 10.4081/hpr.2015.1556; Tian FQ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00012; Titcombe-Parekh RF, 2018, J PSYCHIATR RES, V104, P58, DOI 10.1016/j.jpsychires.2018.06.009; Tu ZH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020769; Vlachantoni A, EUR POP C 2016; Vlachantoni A, 2020, AGEING SOC, V40, P1490, DOI 10.1017/S0144686X19000047; Wagner LI, 2004, BRIT J CANCER, V91, P822, DOI 10.1038/sj.bjc.6602012; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Weathers FW, ANN M INT SOC TRAUM; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; World Health Organization, 2020, 12020 WHO; Xie, 1998, CHIN J CLIN PSYCHOL, V2, P114, DOI DOI 10.16128/j.cnki.1005-3611.1998.02.018; Yang Ting, 2015, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V33, P100; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174	73	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243884	10.1371/journal.pone.0243884	http://dx.doi.org/10.1371/journal.pone.0243884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301523	gold, Green Published			2022-12-26	WOS:000600143100052
J	Soholm, J; Hansen, JF; Mossner, B; Roge, BT; Lauersen, A; Hansen, JB; Weis, N; Barfod, TS; Lunding, S; Ovrehus, A; Mohey, R; Thielsen, P; Christensen, PB				Soholm, Jacob; Hansen, Janne Fuglsang; Mossner, Belinda; Roge, Birgit Thorup; Lauersen, Alex; Hansen, Jesper Bach; Weis, Nina; Barfod, Toke Seieroe; Lunding, Suzanne; Ovrehus, Anne; Mohey, Rajesh; Thielsen, Peter; Brehm Christensen, Peer			Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs	PLOS ONE			English	Article							NONINVASIVE TESTS; HEPATOCELLULAR-CARCINOMA; FIBROSIS; OUTCOMES	Background and aims To evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained virological response (SVR) after treatment with direct-acting antivirals (DAAs). Methods 773 CHC patients with SVR after DAA treatment and no prior liver complications were identified retrospectively. Optimized cut-off of 17.5 kPa for incident HCC was selected by maximum Youden's index. Patients were grouped by pLSM: <10 kPa [reference], 10-17.4 kPa and >= 17.5 kPa. Primary outcomes were incident hepatocellular carcinoma and secondary outcomes were incident decompensated cirrhosis and all-cause mortality, analyzed using cox-regression. Results Median follow-up was 36 months and 43.5% (336) had cirrhosis (LSM>12.5 kPa). The median pLSM was 11.6 kPa (IQR 6.7-17.8, range 2.5-75) and pLSM of <10 kPa, 10-17.4 kPa and 17.5-75 kPa was seen in 41.5%, 32.2% and 26.3%. During a median follow-up time of 36 months, 11 (1.4%) developed HCC, 14 (1.5%) developed decompensated cirrhosis, and 38 (4.9%) patients died. A pLSM of 17.5 kPa identified patients with a high risk of HCC with a negative predictive value of 98.9% and incidence rate of HCC in the 17.5-75 kPa group of 1.40/100 person years compared to 0.14/100 person years and 0.12/100 person years in the 10-17.4 kPa and <10 kPa groups, pConclusion Pretreatment LSM predicts risk of HCC, decompensation and all-cause mortality in patients with SVR after DAA treatment. Patients with a pLSM <17.5 kPa and no other risk factors for chronic liver disease appear not to benefit from HCC surveillance for the first 3 years after treatment. Longer follow-up is needed to clarify if they can be safely excluded from post treatment HCC screening hereafter.	[Soholm, Jacob; Hansen, Janne Fuglsang; Mossner, Belinda; Brehm Christensen, Peer] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Soholm, Jacob; Mossner, Belinda; Brehm Christensen, Peer] Odense Univ Hosp, Odense Patient Data Explorat Network, OPEN, Odense, Denmark; [Soholm, Jacob] Univ Southern Denmark, Clin Inst, Odense, Denmark; [Roge, Birgit Thorup] Lillebaelt Hosp, Dept Med, Kolding, Denmark; [Lauersen, Alex] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Hansen, Jesper Bach] Aalborg Univ Hosp, Dept Gastroenterol, Aalborg, Denmark; [Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Barfod, Toke Seieroe] Zealand Univ Hosp, Dept Med, Roskilde, Denmark; [Lunding, Suzanne] North Zealand Univ Hosp, Dept Pulm & Infect Dis, Hillerod, Denmark; [Ovrehus, Anne] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Copenhagen, Denmark; [Mohey, Rajesh] Herning Hosp, Dept Med, Infect Dis Unit, Herning, Denmark; [Thielsen, Peter] Copenhagen Univ Hosp, Dept Gastroenterol, Herlev, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen	Soholm, J (corresponding author), Odense Univ Hosp, Dept Infect Dis, Odense, Denmark.; Soholm, J (corresponding author), Odense Univ Hosp, Odense Patient Data Explorat Network, OPEN, Odense, Denmark.; Soholm, J (corresponding author), Univ Southern Denmark, Clin Inst, Odense, Denmark.	Jacob.Soeholm@rsyd.dk	Weis, Nina/GLT-4232-2022; Soholm, Jacob/D-2650-2019	Christensen, Peer Brehm/0000-0003-1394-058X; Soholm, Jacob/0000-0002-7019-2269; Ovrehus, Anne Lindebo Holm/0000-0002-2594-6500				[Anonymous], 2015, J HEPATOL, V63, P743, DOI DOI 10.1016/J.JHEP.2015.05.022.; Atiq O, 2017, HEPATOLOGY, V65, P1196, DOI 10.1002/hep.28895; Authorities TDH, 2019, NAT REG ALC TREATM; Authorities TDH, 2019, REG DRUG AB UND TREA; Backus LI, 2019, HEPATOLOGY, V69, P487, DOI 10.1002/hep.29408; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Cheung MCM, 2016, J HEPATOL, V65, P741, DOI 10.1016/j.jhep.2016.06.019; Christensen PB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-178; Christiansen KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111912; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Corma-Gomez A, 2020, CLIN INFECT DIS, V71, P2354, DOI 10.1093/cid/ciz1140; de Ledinghen V, 2013, ALIMENT PHARM THER, V37, P979, DOI 10.1111/apt.12307; Degasperi E, 2019, CLIN GASTROENTEROL H, V17, P1183, DOI 10.1016/j.cgh.2018.10.038; Echosens, 2019, FIBR REC; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Fehily SR, 2019, SEMIN LIVER DIS, V39, P341, DOI 10.1055/s-0039-1685538; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hansen JF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212036; Ioannou GN, 2019, GASTROENTEROLOGY, V157, P1264, DOI 10.1053/j.gastro.2019.07.033; Ioannou GN, 2019, GASTROENTEROLOGY, V156, P446, DOI 10.1053/j.gastro.2018.10.033; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lazarus JV, 2019, J INTERN MED, V286, P503, DOI 10.1111/joim.12972; Lusivika-Nzinga C, 2019, J VIRAL HEPATITIS, V26, P1489, DOI 10.1111/jvh.13186; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nouch S, 2018, INT J DRUG POLICY, V59, P76, DOI 10.1016/j.drugpo.2018.06.019; Pons M, 2020, J HEPATOL, V72, P472, DOI 10.1016/j.jhep.2019.10.005; Ravaioli F, 2018, DIGEST LIVER DIS, V50, P573, DOI 10.1016/j.dld.2018.02.010; Rodriguez-Osorio I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217052; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shiha G, 2020, J VIRAL HEPATITIS, V27, P671, DOI 10.1111/jvh.13276; Stasi C, 2020, CURR MED RES OPIN, V36, P245, DOI 10.1080/03007995.2019.1691517; StatBank Denmark, 2019, FOLK3 POP 1; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Weis Nina, 2012, Ugeskr Laeger, V174, P2521; Zangneh HF, 2019, CLIN GASTROENTEROL H, V17, P1840, DOI 10.1016/j.cgh.2018.12.018	39	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243725	10.1371/journal.pone.0243725	http://dx.doi.org/10.1371/journal.pone.0243725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301499	Green Published, gold			2022-12-26	WOS:000600143100061
J	Dechaumet, B; Cleret, D; Linossier, MT; Vanden-Bossche, A; Chanon, S; Lefai, E; Laroche, N; Lafage-Proust, MH; Vico, L				Dechaumet, Benoit; Cleret, Damien; Linossier, Marie-Therese; Vanden-Bossche, Arnaud; Chanon, Stephanie; Lefai, Etienne; Laroche, Norbert; Lafage-Proust, Marie-Helene; Vico, Laurence			Hypergravity as a gravitational therapy mitigates the effects of knee osteoarthritis on the musculoskeletal system in a murine model	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HIP OSTEOARTHRITIS; PHYSICAL-ACTIVITY; SUBCHONDRAL BONE; CANCELLOUS BONE; MUSCLE; EXERCISE; OSTEOPOROSIS; METABOLISM; MECHANISMS	Insights into the effects of osteoarthritis (OA) and physical interventions on the musculoskeletal system are limited. Our goal was to analyze musculoskeletal changes in OA mice and test the efficacy of 8-week exposure to hypergravity, as a replacement of physical activity. 16-week-old male (C57BL/6J) mice allocated to sham control and OA groups not centrifuged (Ctrl 1g and OA 1g, respectively) or centrifuged at 2g acceleration (Ctrl 2g and OA 2g). OA 1g displayed decreased trabecular bone in the proximal tibia metaphysis and increased osteoclastic activity and local TNF alpha gene expression, all entirely prevented by 2g gravitational therapy. However, while cortical bone of tibia midshaft was preserved in OA 1g (vs. ctrl), it is thinner in OA 2g (vs. OA 1g). In the hind limb, OA at 1g increased fibers with lipid droplets by 48% in the tibialis anterior, a fact fully prevented by 2g. In Ctrl, 2g increased soleus, tibialis anterior and gastrocnemius masses. In the soleus of both Ctrl and OA, 2g induced larger fibers and a switch from type-II to type-I fiber. Catabolic (myostatin and its receptor activin RIIb and visfatine) and anabolic (FNDC5) genes dramatically increased in Ctrl 2g and OA 2g (p<0.01 vs 1g). Nevertheless, the overexpression of FNDC5 (and follistatine) was smaller in OA 2g than in Ctrl 2g. Thus, hypergravity in OA mice produced positive effects for trabecular bone and muscle typology, similar to resistance exercises, but negative effects for cortical bone.	[Dechaumet, Benoit; Cleret, Damien; Linossier, Marie-Therese; Vanden-Bossche, Arnaud; Laroche, Norbert; Lafage-Proust, Marie-Helene; Vico, Laurence] Univ Lyon, INSERM, SAINBIOSE Lab, St Etienne, France; [Chanon, Stephanie; Lefai, Etienne] Univ Lyon, INRA, INSERM, CarMeN Lab, Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vico, L (corresponding author), Univ Lyon, INSERM, SAINBIOSE Lab, St Etienne, France.	vico@univ-st-etienne.fr	Vico, Laurence/ABG-7239-2020; Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019	Vico, Laurence/0000-0002-2110-287X; Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Chanon, Stephanie/0000-0001-6930-6671	CNES (Centre National d'Etudes Spatiales) [4800000899];  [ANR-10-EQPX-06-01]	CNES (Centre National d'Etudes Spatiales)(Centre National D'etudes Spatiales); 	LV: CNES (Centre National d'Etudes Spatiales, contract n degrees 4800000899) https://www.cnes.fr/LV and MHLP: ANR-10-EQPX-06-01 https://anr.fr/ProjetIA-10-EQPX-0006 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2010, OSTEOARTHR CARTILAGE, V18, pS2, DOI 10.1016/j.joca.2010.07.013; Bartholdy C, 2017, SEMIN ARTHRITIS RHEU, V47, P9, DOI 10.1016/j.semarthrit.2017.03.007; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Birrell SA, 2007, GAIT POSTURE, V26, P611, DOI 10.1016/j.gaitpost.2006.12.008; Bojados M, 2014, BEHAV BRAIN RES, V264, P64, DOI 10.1016/j.bbr.2014.01.018; Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642; Burger H, 1996, ARTHRITIS RHEUM, V39, P81, DOI 10.1002/art.1780390111; Chi MMY, 1998, AVIAT SPACE ENVIR MD, V69, pA9; Chughtai M, 2016, J KNEE SURG, V29, P194, DOI 10.1055/s-0035-1569147; Cleveland RJ, 2019, CLIN EXP RHEUMATOL, V37, P24; de Zwart AH, 2018, J REHABIL MED, V50, P140, DOI 10.2340/16501977-2284; DEACON RMJ, 2013, JOVE J VIS EXP JUN, DOI DOI 10.3791/2610; Fang H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21184-5; Fuller PM, 2006, AM J PHYSIOL-REG I, V290, pR442, DOI 10.1152/ajpregu.00578.2005; Galkin R A, 2003, Vestn Khir Im I I Grek, V162, P82; Geusens PP, 2016, CURR OPIN RHEUMATOL, V28, P97, DOI 10.1097/BOR.0000000000000256; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Gnyubkin V, 2015, J APPL PHYSIOL, V119, P908, DOI 10.1152/japplphysiol.00364.2015; HART DJ, 1994, ANN RHEUM DIS, V53, P158, DOI 10.1136/ard.53.3.158; Henique C, 2015, FASEB J, V29, P2473, DOI 10.1096/fj.14-257717; Hirschfeld HP, 2017, OSTEOPOROSIS INT, V28, P2781, DOI 10.1007/s00198-017-4151-8; Huang MH, 2003, SEMIN ARTHRITIS RHEU, V32, P398, DOI 10.1053/sarh.2003.50021; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Kruger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079069; Kus G, 2019, RHEUMATOL INT, V39, P203, DOI 10.1007/s00296-018-4199-6; Liao LF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02490-w; Linde KN, 2017, CALCIFIED TISSUE INT, V101, P593, DOI 10.1007/s00223-017-0315-y; Lorenz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105858; Loureiro A, 2013, ARTHRIT CARE RES, V65, P340, DOI 10.1002/acr.21806; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; MARTIN WD, 1980, AVIAT SPACE ENVIR MD, V51, P473; McGuigan FE, 2017, BEST PRACT RES CL RH, V31, P145, DOI 10.1016/j.berh.2017.11.002; Minshull C, 2017, ARCH PHYS MED REHAB, V98, P1842, DOI 10.1016/j.apmr.2017.02.026; Murphy SL, 2016, ARCH PHYS MED REHAB, V97, pS201, DOI 10.1016/j.apmr.2015.05.025; Osterberga A, 2017, JOINT BONE SPINE, V84, P71, DOI 10.1016/j.jbspin.2015.11.012; Petersson J, 2006, J APPL PHYSIOL, V100, P240, DOI 10.1152/japplphysiol.01430.2004; Pugh TD, 2013, AGING CELL, V12, P672, DOI 10.1111/acel.12091; Rabe KG, 2018, PM&R, V10, P1301, DOI 10.1016/j.pmrj.2018.05.014; Roche B, 2012, BONE, V50, P390, DOI 10.1016/j.bone.2011.09.051; Roos EM, 2016, NAT REV RHEUMATOL, V12, P92, DOI 10.1038/nrrheum.2015.135; Runhaar J, 2016, ARTHRIT CARE RES, V68, P1428, DOI 10.1002/acr.22854; Saito M, 2012, OSTEOARTHR CARTILAGE, V20, P1574, DOI 10.1016/j.joca.2012.08.023; Shih M, 2006, AM J PREV MED, V30, P385, DOI 10.1016/j.amepre.2005.12.005; SYLVESTER PW, 1989, J APPL PHYSIOL, V67, P804, DOI 10.1152/jappl.1989.67.2.804; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Williams MF, 2016, J DIABETES COMPLICAT, V30, P944, DOI 10.1016/j.jdiacomp.2016.02.016; Xu C, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034216; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yu XC, 2013, J IMMUNOL, V190, P205, DOI 10.4049/jimmunol.1201469; Zhang YQ, 2000, J RHEUMATOL, V27, P1032	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243098	10.1371/journal.pone.0243098	http://dx.doi.org/10.1371/journal.pone.0243098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296408	Green Published, gold			2022-12-26	WOS:000598626100065
J	Kong, DG; Zhou, HB; Neelakantan, D; Hughes, CJ; Hsu, JY; Srinivasan, RR; Lewis, MT; Ford, HL				Kong, Deguang; Zhou, Hengbo; Neelakantan, Deepika; Hughes, Connor J.; Hsu, Jessica Y.; Srinivasan, Ramakrishnan Rajaram; Lewis, Michael T.; Ford, Heide L.			VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; INTRATUMOR HETEROGENEITY; HEDGEHOG PATHWAY; STEM-CELLS; LYMPHANGIOGENESIS; AXIS; RECEPTOR; CONTRIBUTES; INHIBITION; EXPRESSION	It is well established that a subset of cells within primary breast cancers can undergo an epithelial-to-mesenchymal transition (EMT), although the role of EMT in metastasis remains controversial. We previously demonstrated that breast cancer cells that had undergone an oncogenic EMT could increase metastasis of neighboring cancer cells via non-canonical paracrine-mediated activation of GLI activity that is dependent on SIX1 expression in the EMT cancer cells. However, the mechanism by which these SIX1-expressing EMT cells activate GLI signaling remained unclear. In this study, we demonstrate a novel mechanism for activation of GLI-mediated signaling in epithelial breast tumor cells via EMT cell-induced production and secretion of VEGF-C. We show that VEGF-C, secreted by breast cancer cells that have undergone an EMT, promotes paracrine-mediated increases in proliferation, migration, and invasion of epithelial breast cancer cells, via non-canonical activation of GLI-signaling. We further show that the aggressive phenotypes, including metastasis, imparted by EMT cells on adjacent epithelial cancer cells can be disrupted by either inhibiting VEGF-C in EMT cells or by knocking down NRP2, a receptor which interacts with VEGF-C, in neighboring epithelial cancer cells. Interrogation of TCGA and GEO public datasets supports the relevance of this pathway in human breast cancer, demonstrating that VEGF-C strongly correlates with activation of Hedgehog signaling and EMT in the human disease. Our study suggests that the VEGF-C/NRP2/GLI axis is a novel and conserved paracrine means by which EMT cells enhance metastasis, and provides potential targets for therapeutic intervention in this heterogeneous disease.	[Kong, Deguang; Zhou, Hengbo; Neelakantan, Deepika; Hughes, Connor J.; Hsu, Jessica Y.; Ford, Heide L.] Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA; [Kong, Deguang] Wuhan Univ, Zhongnan Hosp, Dept Gen Surg, Wuhan, Hubei, Peoples R China; [Zhou, Hengbo; Ford, Heide L.] Univ Colorado, Program Canc Biol, Anschutz Med Campus, Aurora, CO 80045 USA; [Neelakantan, Deepika; Ford, Heide L.] Univ Colorado, Program Mol Biol, Anschutz Med Campus, Aurora, CO 80045 USA; [Hughes, Connor J.; Hsu, Jessica Y.; Ford, Heide L.] Univ Colorado, Program Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA; [Hughes, Connor J.; Ford, Heide L.] Univ Colorado, Med Scientist Training Program, Anschutz Med Campus, Aurora, CO 80045 USA; [Srinivasan, Ramakrishnan Rajaram; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Wuhan University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine	Ford, HL (corresponding author), Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA.; Ford, HL (corresponding author), Univ Colorado, Program Canc Biol, Anschutz Med Campus, Aurora, CO 80045 USA.; Ford, HL (corresponding author), Univ Colorado, Program Mol Biol, Anschutz Med Campus, Aurora, CO 80045 USA.; Ford, HL (corresponding author), Univ Colorado, Program Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA.; Ford, HL (corresponding author), Univ Colorado, Med Scientist Training Program, Anschutz Med Campus, Aurora, CO 80045 USA.	Heide.Ford@cuanschutz.edu		Hughes, Connor/0000-0001-6295-8167; Zhou, Hengbo/0000-0002-9948-7909; Ford, Heide/0000-0002-2860-9841	Animal Imaging SR of the University of Colorado Cancer Center [P30CA046934]; Dan L. Duncan Comprehensive Cancer Center (BCM) [P30CA125123]; Cancer Prevention and Research Initiative of Texas (CPRIT) (BCM) [RP170691];  [R01CA224867];  [F99CA234940]	Animal Imaging SR of the University of Colorado Cancer Center; Dan L. Duncan Comprehensive Cancer Center (BCM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Initiative of Texas (CPRIT) (BCM); ; 	This work was supported by R01CA224867 to HLF and MTL, and F99CA234940 to HZ. We would like to thank the Functional Genomics Shared Resource (SR), the Cell Technologies SR, and the Animal Imaging SR of the University of Colorado Cancer Center (P30CA046934) for help with these studies. We would also like to acknowledge support from The Dan L. Duncan Comprehensive Cancer Center (BCM, P30CA125123) and the Cancer Prevention and Research Initiative of Texas (CPRIT) (BCM, RP170691).	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Blevins MA, 2015, EXPERT OPIN THER TAR, V19, P213, DOI 10.1517/14728222.2014.978860; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chen JC, 2013, INT J MOL SCI, V14, P88, DOI 10.3390/ijms14010088; Dias S, 2002, BLOOD, V99, P2179, DOI 10.1182/blood.V99.6.2179; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Jimeno A, 2013, CLIN CANCER RES, V19, P2766, DOI 10.1158/1078-0432.CCR-12-3654; Joukov V, 1996, EMBO J, V15, P290; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kampen KR, 2018, CANCER RES, V78, P5940, DOI 10.1158/0008-5472.CAN-18-0250; Kong DG, 2016, ONCOTARGET, V7, P50755, DOI 10.18632/oncotarget.9394; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Lin L, 2019, CANCERS, V11, DOI 10.3390/cancers11081156; Lindstrom LS, 2018, JNCI-J NATL CANCER I, V110, P726, DOI 10.1093/jnci/djx270; Liu D, 2014, CANCER RES, V74, P5597, DOI 10.1158/0008-5472.CAN-13-3598; Liu Q, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0339-1; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Ma F, 2020, INT J CANCER, V146, P1359, DOI 10.1002/ijc.32536; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Neelakantan D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15773; Pietrobono S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00556; Pinskey JM, 2017, J BIOL CHEM, V292, P15192, DOI 10.1074/jbc.M117.783845; Po A, 2017, ONCOGENE, V36, P4641, DOI 10.1038/onc.2017.91; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Towers CG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10077; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang CA, 2015, EXP BIOL MED, V240, P718, DOI 10.1177/1535370215583802; Wang CA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0462-2; Wang CA, 2012, J CLIN INVEST, V122, P1895, DOI 10.1172/JCI59858; Wang JW, 2018, CANCER LETT, V418, P176, DOI 10.1016/j.canlet.2018.01.040; Wei T, 2017, R PACKAGE CORRPLOT V; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yang F, 2017, CARCINOGENESIS, V38, P900, DOI 10.1093/carcin/bgx071; Yang F, 2016, INT J BIOL SCI, V12, P1568, DOI 10.7150/ijbs.16874; Yeh YW, 2017, ONCOTARGET, V8, P5603, DOI 10.18632/oncotarget.13629; Zhang DP, 2010, CANCER RES, V70, P2495, DOI 10.1158/0008-5472.CAN-09-3488; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	54	24	27	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					964	979		10.1038/s41388-020-01539-x	http://dx.doi.org/10.1038/s41388-020-01539-x		DEC 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33299122	Green Accepted			2022-12-26	WOS:000599028900001
J	Pritchard, A; Robison, C; Nguyen, T; Nielsen, BD				Pritchard, Abb; Robison, Cara; Nguyen, Tristin; Nielsen, Brian D.			Silicon supplementation affects mineral metabolism but not bone density or strength in male broilers	PLOS ONE			English	Article							STIMULATES COLLAGEN TYPE-1; OSTEOBLAST-LIKE CELLS; DIETARY SILICON; BREAKING STRENGTH; ENVIRONMENTAL ENRICHMENT; ORTHOSILICIC ACID; STOCKING DENSITY; GROWTH-RATE; CALCIUM; RATS	Because leg injuries produce welfare concerns and impact production for broilers, numerous interventions have been suggested as potential solutions. One mineral which may affect bone quality is silicon. The objective of this study was to determine if supplementing bioavailable silicon could affect bone morphology, mineralization, and strength without negatively influencing welfare and meat quality. Male broilers were raised from d 1 after hatching until 42 d of age and randomly assigned to treatment groups for silicon supplementation in water: Control (no supplement, C; n = 125), Normal (0.011 ml supplement/kg bodyweight, N; n = 125) and High (0.063 ml supplement/kg bodyweight, H; n = 125). Toe damage, footpad dermatitis, hock burn, and keel blisters were assessed on d 42. Blood samples were collected from wing veins for serum osteocalcin, pyridinoline cross-links, and mineral analysis. Clinical QCT scans and analysis were conducted immediately before four-point bending tests of tibias. Texture analysis was performed on cooked fillets. Silicon supplementation tended to increase daily water consumption in N and H as compared to C (P = 0.07). Footpad dermatitis and hock burn scores were higher in H than in N or C (P < 0.05 for both comparisons). Supplementation altered serum minerals (P < 0.001), but bone density, morphology, and strength measures were similar among groups. The highest level of supplementation in the current study on a kg bodyweight basis was above recommended intakes but below previous amounts demonstrating silicon's positive influence on bone, indicating that previously suggested minimum thresholds need to be reevaluated. Factors such as growth rate and mechanical loading likely play a greater role in developing bone quality than trying to supplement on top of good basic nutrition alone.	[Pritchard, Abb; Robison, Cara; Nguyen, Tristin; Nielsen, Brian D.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University	Pritchard, A (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	abby.pritchard@bcm.edu		Pritchard, Abby/0000-0001-9689-5520	Michigan Animal Agriculture Alliance [M-AAA-18-010]	Michigan Animal Agriculture Alliance	This project was funded as part of a grant awarded to B.D.N. from the Michigan Animal Agriculture Alliance (M-AAA-18-010). M-AAA provided support in the form of salary for author A. P. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The supplement included in research materials was provided by Agro-Solutions, but this funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2018, ROSS BROILER MANAGEM; ANSI/ASAE, 2017, S459 ANSIASAE; Arora M., 2017, J ARTHROSC JT SURG, V4, P103, DOI [10.1016/j.jajs.2017.10.003, DOI 10.1016/J.JAJS.2017.10.003]; Averos X, 2018, POULTRY SCI, V97, P3767, DOI 10.3382/ps/pey243; Belton DJ, 2012, FEBS J, V279, P1710, DOI 10.1111/j.1742-4658.2012.08531.x; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Bilgili SF, 2006, J APPL POULTRY RES, V15, P433, DOI 10.1093/japr/15.3.433; Bradbury EJ, 2017, ANIM PROD SCI, V57, P2016, DOI 10.1071/AN16142; Buijs S, 2012, POULTRY SCI, V91, P1759, DOI 10.3382/ps.2011-01859; Calomme MR, 1997, BIOL TRACE ELEM RES, V56, P153, DOI 10.1007/BF02785389; CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619; CARLISLE EM, 1980, J NUTR, V110, P1046, DOI 10.1093/jn/110.5.1046; CARLISLE EM, 1982, NUTR REV, V40, P193, DOI 10.1111/j.1753-4887.1982.tb05307.x; Cheled-Shoval SL, 2017, POULTRY SCI, V96, P2206, DOI 10.3382/ps/pex003; Diab R, 2017, ADV COLLOID INTERFAC, V249, P346, DOI 10.1016/j.cis.2017.04.005; Dong M, 2016, BIOL TRACE ELEM RES, V173, P306, DOI 10.1007/s12011-016-0686-3; ELLIOT MA, 1991, J NUTR, V121, P201, DOI 10.1093/jn/121.2.201; Food and Agriculture Organization of the United Nations, 2018, FAOSTAT; Guz BC, 2019, POULTRY SCI, V98, P6552, DOI 10.3382/ps/pez427; Hartcher KM, 2020, WORLD POULTRY SCI J, V76, P154, DOI 10.1080/00439339.2019.1680025; JACOBS HL, 1957, POULTRY SCI, V36, P8, DOI 10.3382/ps.0360008; Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99; Jugdaohsingh R, 2015, OSTEOPOROSIS INT, V26, P1405, DOI 10.1007/s00198-014-3016-7; Jugdaohsingh R, 2015, BONE, V75, P40, DOI 10.1016/j.bone.2015.02.004; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; Jurkic LM, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-2; Kayongo-Male H, 2008, BIOL TRACE ELEM RES, V123, P191, DOI 10.1007/s12011-008-8102-2; Kim MH, 2014, BIOL TRACE ELEM RES, V158, P238, DOI 10.1007/s12011-014-9936-4; Kim MH, 2009, BIOL TRACE ELEM RES, V128, P239, DOI 10.1007/s12011-008-8273-x; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; Lang KJ, 2001, J EQUINE VET SCI, V21, P550, DOI 10.1016/S0737-0806(01)70161-X; Lewis PD, 2009, BRIT POULTRY SCI, V50, P673, DOI 10.1080/00071660903365612; Maehira F, 2009, NUTRITION, V25, P581, DOI 10.1016/j.nut.2008.10.023; NAJDA J, 1993, BIOL TRACE ELEM RES, V37, P107, DOI 10.1007/BF02783786; Nakhon S, 2019, ANIM NUTR, V5, P152, DOI 10.1016/j.aninu.2018.11.003; Nielsen FH, 2004, J TRACE ELEM EXP MED, V17, P137, DOI 10.1002/jtra.20004; Nielsen FH, 2014, J TRACE ELEM MED BIO, V28, P379, DOI 10.1016/j.jtemb.2014.06.024; Nielsen FH, 2009, GASTROENTEROLOGY, V137, pS55, DOI 10.1053/j.gastro.2009.07.072; O'Connor CI, 2008, J ANIM PHYSIOL AN N, V92, P173, DOI 10.1111/j.1439-0396.2007.00724.x; Opengart K, 2018, J APPL POULTRY RES, V27, P424, DOI 10.3382/japr/pfy002; Pedersen IJ, 2020, POULTRY SCI, V99, P1946, DOI 10.1016/j.psj.2019.11.061; Perez-Granados A M, 2002, J Nutr Health Aging, V6, P154; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; Riber AB, 2018, POULTRY SCI, V97, P378, DOI 10.3382/ps/pex344; Robison CI, 2019, POULTRY SCI, V98, P3611, DOI 10.3382/ps/pez165; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0; Seaborn CD, 2002, BIOL TRACE ELEM RES, V89, P239, DOI 10.1385/BTER:89:3:239; Sgavioli S, 2016, BRIT POULTRY SCI, V57, P693, DOI 10.1080/00071668.2016.1206190; Sharir A, 2008, VET J, V177, P8, DOI 10.1016/j.tvjl.2007.09.012; Shepherd EM, 2010, POULTRY SCI, V89, P2043, DOI 10.3382/ps.2010-00770; Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023; Shim MY, 2012, POULTRY SCI, V91, P1790, DOI 10.3382/ps.2011-01968; Sripanyakorn S, 2009, BRIT J NUTR, V102, P825, DOI 10.1017/S0007114509311757; Tablante NL, 2003, J APPL POULTRY RES, V12, P53, DOI 10.1093/japr/12.1.53; Tedesco E, 2020, FASEB J, V34, P12229, DOI 10.1096/fj.202000060RR; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Venalainen E, 2006, BRIT POULTRY SCI, V47, P301, DOI 10.1080/00071660600741776; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; Williams B, 2004, CALCIFIED TISSUE INT, V74, P236, DOI 10.1007/s00223-002-2124-0; Williams CL, 2013, J APPL POULTRY RES, V22, P934, DOI 10.3382/japr.2013-00767	62	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243007	10.1371/journal.pone.0243007	http://dx.doi.org/10.1371/journal.pone.0243007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284796	Green Published, gold			2022-12-26	WOS:000597930500039
J	Smolinsky, R; Balaz, V; Nurnberger, B				Smolinsky, Radovan; Balaz, Vojtech; Nurnberger, Beate			Tadpoles of hybridising fire-bellied toads (B. bombina and B. variegata) differ in their susceptibility to predation	PLOS ONE			English	Article							HOST RACE FORMATION; ECOLOGICAL SPECIATION; NATURAL-SELECTION; PHENOTYPIC PLASTICITY; LITTORINA-SAXATILIS; BREEDING PHENOLOGY; INDUCIBLE DEFENSE; ESCAPE BEHAVIOR; LIFE-HISTORY; TRADE-OFFS	The role of adaptive divergence in the formation of new species has been the subject of much recent debate. The most direct evidence comes from traits that can be shown to have diverged under natural selection and that now contribute to reproductive isolation. Here, we investigate differential adaptation of two fire-bellied toads (Anura, Bombinatoridae) to two types of aquatic habitat. Bombina bombina and B. variegata are two anciently diverged taxa that now reproduce in predator-rich ponds and ephemeral aquatic sites, respectively. Nevertheless, they hybridise extensively wherever their distribution ranges adjoin. We show in laboratory experiments that, as expected, B. variegata tadpoles are at relatively greater risk of predation from dragonfly larvae, even when they display a predator-induced phenotype. These tadpoles spent relatively more time swimming and so prompted more attacks from the visually hunting predators. We argue in the discussion that genomic regions linked to high activity in B. variegata should be barred from introgression into the B. bombina gene pool and thus contribute to gene flow barriers that keep the two taxa from merging into one.	[Smolinsky, Radovan; Nurnberger, Beate] Czech Acad Sci, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic; [Balaz, Vojtech] Univ Vet & Pharmaceut Sci, Fac Vet Hyg & Ecol, Brno, Czech Republic; [Smolinsky, Radovan] Masaryk Univ, Dept Biol, Fac Educ, Brno, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Veterinary Sciences Brno; Masaryk University Brno	Nurnberger, B (corresponding author), Czech Acad Sci, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic.	bdnurnberger@gmail.com	Baláž, Vojtech/M-5314-2013	Baláž, Vojtech/0000-0001-6521-5350	Czech Science Foundation (Grantova' agentura CR) [1626714S]; University of Veterinary and Pharmaceutical Sciences Brno [FVHE/Pikula/ITA2020]	Czech Science Foundation (Grantova' agentura CR); University of Veterinary and Pharmaceutical Sciences Brno	This study was supported by grant 1626714S from the Czech Science Foundation (Grantova ' agentura CR) to Beate Nu<spacing diaeresis> rnberger and by grant FVHE/Pikula/ITA2020 from the University of Veterinary and Pharmaceutical Sciences Brno to Vojtech Balaz	Anholt BR, 2000, ECOLOGY, V81, P3509, DOI 10.2307/177510; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Arendt J, 2010, J MORPHOL, V271, P1044, DOI 10.1002/jmor.10851; Arnegard ME, 2014, NATURE, V511, P307, DOI 10.1038/nature13301; AZEVEDORAMOS C, 1992, J HERPETOL, V26, P335, DOI 10.2307/1564891; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Balaz V, 2014, DIS AQUAT ORGAN, V112, P1, DOI 10.3354/dao02799; Barandun J, 1997, J HERPETOL, V31, P107, DOI 10.2307/1565337; Barandun Jonas, 1997, Amphibia-Reptilia, V18, P347, DOI 10.1163/156853897X00404; BARTON N, 1986, HEREDITY, V57, P357, DOI 10.1038/hdy.1986.135; BARTON NH, 1983, EVOLUTION, V37, P454, DOI 10.1111/j.1558-5646.1983.tb05563.x; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Bay RA, 2017, CURR BIOL, V27, P3344, DOI 10.1016/j.cub.2017.09.037; Bierne N, 2013, CURR ZOOL, V59, P72, DOI 10.1093/czoolo/59.1.72; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Boll S, 2002, THESIS; Boulenger GA, 1886, P ZOOL SOC LOND, P1886; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Chovanec Andreas, 1992, Amphibia-Reptilia, V13, P341, DOI 10.1163/156853892X00049; Cressler CE, 2010, AM NAT, V176, P276, DOI 10.1086/655425; CZOPKOWA G., 1955, BULL ACAD POLONAISE SCI CL II, V3, P313; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Dijk B, 2016, BEHAV ECOL SOCIOBIOL, V70, P237, DOI 10.1007/s00265-015-2040-8; Eklov P, 2000, OIKOS, V88, P250, DOI 10.1034/j.1600-0706.2000.880203.x; Faria R, 2014, MOL ECOL, V23, P513, DOI 10.1111/mec.12616; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Feder JL, 2003, GENETICS, V163, P939; Fijarczyk A, 2011, MOL ECOL, V20, P3381, DOI 10.1111/j.1365-294X.2011.05175.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Fischer N, 2006, THESIS; Gollmann B, 2002, GELBBAUCHUNKE SUHLE; Gosner K. L., 1960, Herpetologica, V16, P183; Hantzschmann AM, 2019, PEERJ, V7, DOI 10.7717/peerj.8233; Hartel T, 2008, NORTH-WEST J ZOOL, V4, P79; Hartel Tibor, 2007, Acta Zoologica Lituanica, V17, P56; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Innes-Gold AA, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2347; JANSON K, 1983, OECOLOGIA, V59, P58, DOI 10.1007/BF00388072; JOHANNESSON B, 1986, J EXP MAR BIOL ECOL, V102, P183, DOI 10.1016/0022-0981(86)90175-9; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Kohler SC, 2003, THESIS; Kovar R, 2009, AMPHIBIA-REPTILIA, V30, P367, DOI 10.1163/156853809788795236; Kraft PG, 2006, J EVOLUTION BIOL, V19, P1813, DOI 10.1111/j.1420-9101.2006.01185.x; Kruuk LEB, 1999, EVOLUTION, V53, P1611, DOI 10.1111/j.1558-5646.1999.tb05425.x; Kruuk LEB, 1997, P ROY SOC B-BIOL SCI, V264, P105, DOI 10.1098/rspb.1997.0016; Kurali A, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2503-9; Laurila A, 1998, OIKOS, V83, P307, DOI 10.2307/3546842; LAWLER SP, 1989, ANIM BEHAV, V38, P1039, DOI 10.1016/S0003-3472(89)80142-3; Le Pennec G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186901; Lemcke C, 2002, THESIS; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; Linn CE, 2004, P NATL ACAD SCI USA, V101, P17753, DOI 10.1073/pnas.0408255101; LORCHER K, 1969, OECOLOGIA, V3, P84, DOI 10.1007/BF00344635; McCollum SA, 1996, EVOLUTION, V50, P583, DOI 10.1111/j.1558-5646.1996.tb03870.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; McGee MD, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-277; Melvin SD, 2012, OECOLOGIA, V169, P861, DOI 10.1007/s00442-012-2260-9; Meyers PJ, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0534; Michel MJ, 2011, EVOL ECOL, V25, P915, DOI 10.1007/s10682-010-9441-y; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; NEWMAN RA, 1987, OECOLOGIA, V71, P301, DOI 10.1007/BF00377299; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Nurnberger B, 1995, EVOLUTION, V49, P1224, DOI 10.1111/j.1558-5646.1995.tb04449.x; Nurnberger B, 2020, DENSE LINKAGE MAP LA; Orizaola G, 2016, ECOLOGY, V97, P2470, DOI 10.1002/ecy.1464; Philippi Daniel, 2014, Acta ZooBot Austria, V150, P25; R Core Team, 2018, R LANG ENV STAT COMP; RAFINSKA A, 1991, BIOL J LINN SOC, V43, P197, DOI 10.1111/j.1095-8312.1991.tb00593.x; Reichwaldt E, 1999, THESIS; Relyea RA, 2002, ECOL MONOGR, V72, P523, DOI 10.1890/0012-9615(2002)072[0523:CIPITC]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 1999, ECOLOGY, V80, P2117, DOI 10.1890/0012-9658(1999)080[2117:QTRBPI]2.0.CO;2; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Richardson JML, 2001, AM NAT, V157, P282, DOI 10.1086/319196; Richter-Boix A, 2007, HYDROBIOLOGIA, V583, P43, DOI 10.1007/s10750-006-0475-7; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Sachdeva H, 2018, GENETICS, V209, P1279, DOI 10.1534/genetics.118.301018; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; SMITH DC, 1995, AM NAT, V145, P211, DOI 10.1086/285737; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; SZYMURA JM, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P261; SZYMURA JM, 1991, EVOLUTION, V45, P237, DOI 10.1111/j.1558-5646.1991.tb04400.x; Teplitsky C, 2005, J EVOLUTION BIOL, V18, P180, DOI 10.1111/j.1420-9101.2004.00790.x; Teplitsky C, 2003, OECOLOGIA, V134, P270, DOI 10.1007/s00442-002-1106-2; Thiesmeier B, 2019, FOTOATLAS AMPHIBIENL; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, 2018, EVOLUTION, V72, P2758, DOI 10.1111/evo.13632; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2003, DIVERS DISTRIB, V9, P399; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Van Buskirk J, 1998, BIOL J LINN SOC, V65, P301, DOI 10.1006/bijl.1998.0249; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; Van Buskirk J, 2017, EVOLUTION, V71, P1670, DOI 10.1111/evo.13236; Van Buskirk J, 2009, ECOL MONOGR, V79, P681, DOI 10.1890/08-1692.1; Vorndran IC, 2002, ECOLOGY, V83, P1648, DOI 10.2307/3071985; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; Winter B., 2013, ARXIV13085499; WOODWARD BD, 1983, ECOLOGY, V64, P1549, DOI 10.2307/1937509; Yanchukov Alexey, 2006, Evolution, V60, P583	114	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0231804	10.1371/journal.pone.0231804	http://dx.doi.org/10.1371/journal.pone.0231804			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33285552	Green Submitted, Green Published, gold			2022-12-26	WOS:000597930500024
J	Arroyo-Quiroz, C; O'Flaherty, M; Guzman-Castillo, M; Capewell, S; Chuquiure-Valenzuela, E; Jerjes-Sanchez, C; Barrientos-Gutierrez, T				Arroyo-Quiroz, Carmen; O'Flaherty, Martin; Guzman-Castillo, Maria; Capewell, Simon; Chuquiure-Valenzuela, Eduardo; Jerjes-Sanchez, Carlos; Barrientos-Gutierrez, Tonatiuh			Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012	PLOS ONE			English	Article							3RD NATIONAL REGISTRY; CEREBROVASCULAR DISEASES; DIABETES-MELLITUS; DECLINE; PREVALENCE; DECREASE; ENGLAND; AMERICA; DEATHS; TRENDS	Background Mexico is still in the growing phase of the epidemic of coronary heart disease (CHD), with mortality increasing by 48% since 1980. However, no studies have analyzed the drivers of these trends. We aimed to model CHD deaths between 2000 and 2012 in Mexico and to quantify the proportion of the mortality change attributable to advances in medical treatments and to changes in population-wide cardiovascular risk factors. Methods We performed a retrospective analysis using the previously validated IMPACT model to explain observed changes in CHD mortality in Mexican adults. The model integrates nationwide data at two-time points (2000 and 2012) to quantify the effects on CHD mortality attributable to changes in risk factors and therapeutic trends. Results From 2000 to 2012, CHD mortality rates increased by 33.8% in men and by 22.8% in women. The IMPACT model explained 71% of the CHD mortality increase. Most of the mortality increases could be attributed to increases in population risk factors, such as diabetes (43%), physical inactivity (28%) and total cholesterol (24%). Improvements in medical and surgical treatments together prevented or postponed 40.3% of deaths; 10% was attributable to improvements in secondary prevention treatments following MI, while 5.3% to community heart failure treatments. Conclusions CHD mortality in Mexico is increasing due to adverse trends in major risk factors and suboptimal use of CHD treatments. Population-level interventions to reduce CHD risk factors are urgently needed, along with increased access and equitable distribution of therapies.	[Arroyo-Quiroz, Carmen; Barrientos-Gutierrez, Tonatiuh] Natl Inst Publ Hlth, Ctr Res Populat Hlth, Cuernavaca, Morelos, Mexico; [Arroyo-Quiroz, Carmen] Univ Autonoma Metropolitana, Unidad Lerma, Lerma De Villada, Mexico; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England; [Guzman-Castillo, Maria] Univ Helsinki, Fac Social Sci, Populat Res Unit, Helsinki, Finland; [Chuquiure-Valenzuela, Eduardo] Natl Inst Cardiol, Mexico City, DF, Mexico; [Jerjes-Sanchez, Carlos] TecSalud, Inst Cardiol & Med Vasc, Escuela Med & Ciencias Salud, Inst Tecnol Monterrey, Monterrey, Mexico	Instituto Nacional de Salud Publica; Universidad Autonoma Metropolitana - Mexico; University of Liverpool; University of Helsinki; National Institute of Cardiology - Mexico; Tecnologico de Monterrey	Barrientos-Gutierrez, T (corresponding author), Natl Inst Publ Hlth, Ctr Res Populat Hlth, Cuernavaca, Morelos, Mexico.	tbarrientos@insp.mx	Shao, Ruitai/AAU-7642-2021; Arroyo-Quiroz, Carmen/AAE-8204-2020	Arroyo-Quiroz, Carmen/0000-0002-4934-0394	CONACyT's Scholarship Program for Doctoral Studies; Harvard University through the Lown Scholar's program	CONACyT's Scholarship Program for Doctoral Studies; Harvard University through the Lown Scholar's program	Carmen Arroyo-Quiroz received support from CONACyT's Scholarship Program for Doctoral Studies. Tonatiuh Barrientos-Gutierrez received support from Harvard University through the Lown Scholar's program (https://www.hsph.harvard.edu/lownscholars/scholars/).The funders had no role in the study design or the analysis and interpretation of the data. All authors and their institutions reserve intellectual freedom from the funders.	Marron-Ponce JA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010045; [Anonymous], 2015, HLTH GLANC 2015; [Anonymous], 2007, AM J KIDNEY DIS, V49, pS12; Alcocer-Gamba MA, 2015, ARCH CARDIOL MEX, V85, P270, DOI 10.1016/j.acmx.2015.01.004; Arroyo-Quiroz C, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8297-5; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Barrientos-Gutierrez T, 2018, SALUD PUBLICA MEXICO, V60, P586, DOI 10.21149/9534; Basto-Abreu A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003221; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Cavanaugh WT, 2004, MOD THEOL, V20, P243, DOI DOI 10.1111/J.1468-0025.2004.00252.X; Ruiz AC, 2018, HEALTH SYST REFORM, V4, P194, DOI 10.1080/23288604.2018.1488505; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Curtis Gannon L, 2017, J Clin Med Res, V9, P375, DOI 10.14740/jocmr3001w; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Flores-Mateo G GM, 2011, REV ESP CARDIOL, V64; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Ilarraza-Lomeli H, 2017, ARCH CARDIOL MEX, V87, P270, DOI 10.1016/j.acmx.2016.04.010; Jerjes-Sanchez C, 2015, ARCH CARDIOL MEX, V85, P207, DOI 10.1016/j.acmx.2015.04.001; Joensen AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194793; Koopman C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166139; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Martinez-Sanchez C, 2016, ARCH CARDIOL MEX, V86, P221, DOI 10.1016/j.acmx.2016.04.007; Medina C, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01050-3; Medina C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1063; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Ogata S, 2019, INT J CARDIOL, V291, P183, DOI 10.1016/j.ijcard.2019.02.022; Pagan E, 2017, AM J CARDIOL, V119, P862, DOI 10.1016/j.amjcard.2016.11.040; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Pereira M, 2013, CIRC-CARDIOVASC QUAL, V6, P634, DOI 10.1161/CIRCOUTCOMES.113.000264; Poblacion CNd, 2018, TABULADOS POBLACION; Publica INdS, 2002, ENC NAC SAL NUTR 200; Publica INdS, 2014, ENCUESTA NACL SALUD; Rastam S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-754; RENASICA GC, REG NAC SINDR COR AG; Rodriguez T, 2006, HEART, V92, P453, DOI 10.1136/hrt.2004.059295; Rojas-Martinez R, 2018, SALUD PUBLICA MEXICO, V60, P224, DOI 10.21149/8566; Saidi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063202; Salud SdIdlSd, BAS DAT EGR HOSP; Salud SdIdlSd, BAS DAT DEF; Sd Salud, 2019, INSABI RESP NEC SAL; Secretaria de Salud, 2017, AT INF AG MIOC MEX E; Secretaria de Salud M., 2019, BASES DATOS DEFUNCIO; Social. CNdEdlPdD, 2014, IND ACC US EF SERV S; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Vicens Jimena, 2019, Rev Fac Cien Med Univ Nac Cordoba, V76, P92, DOI 10.31053/1853.0605.v76.n2.22915; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005	55	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242930	10.1371/journal.pone.0242930	http://dx.doi.org/10.1371/journal.pone.0242930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270684	Green Published, gold			2022-12-26	WOS:000597149100100
J	Gupta, S; Kishore, A; Alvi, MF; Singh, V				Gupta, Shweta; Kishore, Avinash; Alvi, Muzna Fatima; Singh, Vartika			Designing better input support programs: Lessons from zinc subsidies in Andhra Pradesh, India	PLOS ONE			English	Article							FERTILIZER USE; MALNUTRITION; ALLEVIATION; CONSTRAINTS	India has one of the largest agricultural input support programs in the world, delivered in the form of subsidies to farmers, raising concerns about its sustainability. This paper evaluates the performance of one such support, the micronutrient subsidy program in the state of Andhra Pradesh (AP) and presents a case for providing this support in the form of direct cash transfers. Under the program, key soil micronutrients- zinc, boron, and gypsum were distributed free of cost to farmers living in micronutrient-deficient areas, with identification and targeting managed entirely by the state. We survey 1621 farmers, 61 agriculture extension officers, and 78 agriculture input dealers to assess the efficacy of the program and to identify bottlenecks preventing effective targeting, with a focus on zinc. We find that use of non-subsidized zinc is high in AP, and awareness of benefits of zinc and physical access to input dealer shops are significant predictors of zinc use. We argue that the free provision of micronutrients may have created demand among farmers, but there is little justification to continue subsidizing such a program at such high rates or resorting to public distribution. We find that micronutrient procurement and distribution has become a burden on extension staff and crowds out the private sector. Our analysis shows that the subsidy can benefit more farmers if it is channeled through the network of private fertilizer dealers. We use administrative data on budgetary outlays and digital soil maps to suggest fiscal redistribution in the form of direct cash transfers that may ensure more effective targeting at a lower cost to the state.	[Gupta, Shweta; Alvi, Muzna Fatima; Singh, Vartika] Int Food Policy Res Inst, Environm & Prod Technol Div, New Delhi, India; [Kishore, Avinash] Int Food Policy Res Inst, South Asia Reg Off, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI)	Alvi, MF (corresponding author), Int Food Policy Res Inst, Environm & Prod Technol Div, New Delhi, India.	m.alvi@cgiar.org		Gupta, Shweta/0000-0001-6381-6857	Bill and Melinda Gates Foundation (BMGF); CGIAR Research Program on Policies, Institutions, and Markets (PIM); International Maize and Wheat Improvement Center (CIMMYT); International Rice Research Institute (IRRI); Department of Agriculture; Adventz Group; Government of Andhra Pradesh; Yara International	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); CGIAR Research Program on Policies, Institutions, and Markets (PIM)(CGIAR); International Maize and Wheat Improvement Center (CIMMYT)(CGIAR); International Rice Research Institute (IRRI)(CGIAR); Department of Agriculture; Adventz Group; Government of Andhra Pradesh; Yara International	This work was undertaken as part of the Soil Intelligence Systems (SIS) and Cereal Systems Initiative for South Asia (CSISA) projects funded by the Bill and Melinda Gates Foundation (BMGF) and the CGIAR Research Program on Policies, Institutions, and Markets (PIM). MFA and AK were the PIs for these projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was undertaken as part of the Soil Intelligence Systems (SIS) and Cereal Systems Initiative for South Asia (CSISA) projects funded by the Bill and Melinda Gates Foundation (BMGF) and the CGIAR Research Program on Policies, Institutions, and Markets (PIM). The authors would like to thank the International Maize and Wheat Improvement Center (CIMMYT), the International Rice Research Institute (IRRI), the Department of Agriculture, Government of Andhra Pradesh, Adventz Group and Yara International for their support in the implementation of the study. The authors are also grateful to Network for Engineering and Economics Research and Management (NEERMAN) Pvt Ltd and Kabil Professional Services Pvt. Ltd for support in data collection. The opinions expressed here belong to the authors, and do not necessarily reflect those of IFPRI, PIM or CGIAR.	Anjum N. A., 2008, P271, DOI 10.1007/978-3-540-76326-0_13; [Anonymous], 2019, ECON POLIT WEEKLY, VLIV, P19; [Anonymous], 2018, ASSESSMENT DIRECT BE; [Anonymous], 2014, 20465 NAT BUR EC RES; Anriquez G, 2020, DEV POLICY REV, V38, P140, DOI 10.1111/dpr.12389; Ashraf N, 2013, J ECON BEHAV ORGAN, V88, P133, DOI 10.1016/j.jebo.2012.12.031; Cakmak I, 2009, J TRACE ELEM MED BIO, V23, P281, DOI 10.1016/j.jtemb.2009.05.002; Chand R, 2009, MARGIN, V3, P409, DOI 10.1177/097380100900300404; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Cole S, 2017, INDIA POLICY FORUM; Commission of Agricultural Costs and Prices, DIRECTORATE ECONOMIC; CSISA, 2019, SOIL INTELLIGENCE SY; Dar V, 2020, INT CONCLAVE GLOBALI; Devesh Kapur, 2011, Economic and Political Weekly, V46, P80; Easterly W., 2006, WHITE MANS BURDEN WH; Fan S, 2007, AGR EC; Fishman R., 2016, EXPT EVIDENCE BIHAR, P28; Gibson RS, 2006, P NUTR SOC, V65, P51, DOI 10.1079/PNS2005474; GoAP, 2019, AGR DEP DISTRIBUTION; GoAP, 2019, WHITE PAPER AGR HORT; GoAP, 2017, AGRICULTURAL STAT GL; Gomez C, 2011, WORLD BANK POLICY RE; Government of Andhra Pradesh (GoAP), 2018, AGR ACTION PLAN; Government of India (GoI), 2019, SOIL HLTH CARD; Gulati A, 1995, EC POLIT WKLY, P93; Gupta A, 1984, EC POLIT WKLY, V39, P48; Hassan SZ, 2021, MANAGE DECIS, V59, P829, DOI 10.1108/MD-12-2018-1392; Jayne TS, 2013, AGR ECON-BLACKWELL, V44, P687, DOI 10.1111/agec.12082; Johnson JP, 2006, AM ECON REV, V96, P756, DOI 10.1257/aer.96.3.756; Kishore A, 2013, ECON POLIT WEEKLY, V48, P54; Koszegi B, 2006, Q J ECON, V121, P1133, DOI 10.1093/qje/121.4.1133; Kremer M, 2007, Q J ECON, V122, P1007, DOI 10.1162/qjec.122.3.1007; Kumar S, 2010, SUSTAINABILITY CONCE, DOI [10.2139/ssrn.1709898, DOI 10.2139/SSRN.1709898]; Liu NJ, 2014, FOOD SECUR, V6, P629, DOI 10.1007/s12571-014-0377-x; Liverpool-Tasie LSO, 2014, AGR ECON-BLACKWELL, V45, P663, DOI 10.1111/agec.12114; Mahler RL, 2018, ZINC IDAHO; Modi A., 2020, Indian Research Journal of Extension Education, V20, P72; Nandi R., 2019, RES J AGRIC SCI, V10, P473; Omotilewa OJ, 2019, AM J AGR ECON, V101, P753, DOI 10.1093/ajae/aay108; Prasad R, 2013, AGR RES, V2, P111, DOI 10.1007/s40003-013-0064-8; Ricker-Gilbert J, 2011, AM J AGR ECON, V93, P26, DOI 10.1093/ajae/aaq122; Shampanier K, 2007, MARKET SCI, V26, P742, DOI 10.1287/mksc.1060.0254; Sharma V., 1982, EC POLIT WKLY, V47, P66; Shukla A. K., 2019, Indian Journal of Fertilisers, V15, P522; Shukla A.K., 2016, COORDINATORS REPORT, P1; Somasekhar M, 2019, HINDU BUSINESS LINE; Srinivasa Rao K., 2017, HINDU; Subbarao K., 1985, Indian Journal of Agricultural Economics, V40, P494; Thomas S, LINKING WELFARE DIST; Venkatesh S, 2018, DOWNTOEARTH; Wei YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045428; Wood BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105203; Xu Z, 2009, AGR ECON-BLACKWELL, V40, P79, DOI 10.1111/j.1574-0862.2008.00361.x; Yi FJ, 2015, FOOD POLICY, V50, P114, DOI 10.1016/j.foodpol.2014.10.009	55	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242161	10.1371/journal.pone.0242161	http://dx.doi.org/10.1371/journal.pone.0242161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270687	gold, Green Published			2022-12-26	WOS:000597149100069
J	Kim, YT; Kim, SE; Lee, WJ; Fumei, Z; Cho, MS; Moon, JS; Oh, HW; Park, HY; Kim, SU				Kim, Young Tae; Kim, Sung Eun; Lee, Won Jung; Fumei, Zhao; Cho, Min Sub; Moon, Jae Sun; Oh, Hyun-Woo; Park, Ho-Yong; Kim, Sung Uk			Isolation and characterization of a high iturin yielding Bacillus velezensis UV mutant with improved antifungal activity	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; LIPOPEPTIDES ITURIN; CYCLIC LIPOPEPTIDES; BIOCONTROL AGENT; SUBTILIS; FENGYCIN; SURFACTIN; IDENTIFICATION; STRAINS; ROT	To isolate Bacillus velezensis mutants with improved antifungal activity for use in the biological control of phytopathogenic fungi, wild-type Bacillus velezensis KRF-001 producing iturin, surfactin, and fengycin was irradiated by ultraviolet (UV) rays. The in vitro and in vivo antifungal activities of UV mutants and characterization of the cyclic lipopeptides produced by a selected mutant were examined. A mutant strain yielding high levels of iturin showed over 2-fold higher antifungal activity than the wild-type against Fusarium oxysporum. A potent suppressive effect of the mutant was also observed on spore germination of Botrytis cinerea, the causative agent of cucumber gray mold, at different butanol extract concentrations. Further analysis of the mutant by real-time PCR and high-performance liquid chromatography revealed increased expression of iturin and surfactin biosynthesis genes as well as enhanced production of iturin and surfactin metabolites. However, the amounts of fengycin obtained from the mutant strain BSM54 were significantly lesser than those of iturin and surfactin. Particularly, iturin A production by the mutant was 3.5-fold higher than that of the wild-type, suggesting that the higher antifungal activity of the mutant against F. oxysporum resulted from the increased expression of biosynthesis genes associated with iturin production. The commercial greenhouse experiment using soil naturally infested with Sclerotinia sclerotiorum (sclerotinia rot) and F. oxysporum (fusarium wilt) showed that the mutant strain reduced sclerotinia rot and fusarium wilt diseases (P = 0.05) more effectively than the wild-type and commercially available product Cillus (R) in Korea. These results suggest that the mutant with high iturin yield is a potential candidate for the development of a biological control agent in agriculture.	[Kim, Young Tae; Kim, Sung Eun; Lee, Won Jung; Park, Ho-Yong; Kim, Sung Uk] Korea Res Inst Biosci & Biotechnol KRIBB, Ind Biomat Res Ctr, Daejeon, South Korea; [Fumei, Zhao; Moon, Jae Sun] KRIBB, Mol Biofarming Res Ctr, Daejeon, South Korea; [Cho, Min Sub] Green Biotech Co, Paju, South Korea; [Oh, Hyun-Woo] KRIBB, Core Facil Management Ctr, Daejeon, South Korea; [Kim, Sung Uk] Seowon Univ, Dept Food Sci & Engn, Cheongju, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seowon University	Kim, SU (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ind Biomat Res Ctr, Daejeon, South Korea.; Kim, SU (corresponding author), Seowon Univ, Dept Food Sci & Engn, Cheongju, South Korea.	kimsu@kribb.re.kr	PARK, HO-YONG/AAP-2225-2021		Bioindustry Technology Development Program - Ministry of Agriculture, Food, and Rural Affairs [111048-03]; Bio & Medical Technology Development Program (National Research Foundation) - Ministry of Science and ICT [2016M3A9A5922628]; KRIBB Research Initiative program, Republic of Korea [KGM 5492012]	Bioindustry Technology Development Program - Ministry of Agriculture, Food, and Rural Affairs; Bio & Medical Technology Development Program (National Research Foundation) - Ministry of Science and ICT; KRIBB Research Initiative program, Republic of Korea	This work was supported by grants (111048-03) from the Bioindustry Technology Development Program funded by the Ministry of Agriculture, Food, and Rural Affairs, the Bio & Medical Technology Development Program (National Research Foundation grant No. 2016M3A9A5922628) funded by the Ministry of Science and ICT, and the KRIBB Research Initiative program (KGM 5492012), Republic of Korea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Green Biotech Co., who employs author Min Sub Cho, participated in our project as a cooperative research institute by performing the large-scale fermentation and in vivo field test. The specific roles of this author are articulated in the author contributions section.	Alvarez F, 2012, J APPL MICROBIOL, V112, P159, DOI 10.1111/j.1365-2672.2011.05182.x; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Arrebola E, 2010, J APPL MICROBIOL, V108, P386, DOI 10.1111/j.1365-2672.2009.04438.x; BERNHEIMER AW, 1970, J GEN MICROBIOL, V61, P361, DOI 10.1099/00221287-61-3-361; BESSON F, 1978, J ANTIBIOT, V31, P284, DOI 10.7164/antibiotics.31.284; BESSON F, 1987, J ANTIBIOT, V40, P437, DOI 10.7164/antibiotics.40.437; Brannen PM, 1997, J IND MICROBIOL BIOT, V19, P169, DOI 10.1038/sj.jim.2900439; Calvo H, 2017, FOOD MICROBIOL, V63, P101, DOI 10.1016/j.fm.2016.11.004; Cazorla FM, 2006, MOL PLANT MICROBE IN, V19, P418, DOI 10.1094/MPMI-19-0418; Chiou AL, 2003, J PHYTOPATHOL, V151, P13, DOI 10.1046/j.1439-0434.2003.00669.x; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Deleu M, 2005, J COLLOID INTERF SCI, V283, P358, DOI 10.1016/j.jcis.2004.09.036; Dunlap CA, 2016, INT J SYST EVOL MICR, V66, P1212, DOI 10.1099/ijsem.0.000858; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P2104, DOI 10.1099/ijs.0.000226; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Fan B, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00022; Fan HY, 2017, MICROBIOL RES, V199, P89, DOI 10.1016/j.micres.2017.03.004; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Grover M, 2010, CURR MICROBIOL, V60, P99, DOI 10.1007/s00284-009-9508-6; Hsieh FC, 2008, CURR MICROBIOL, V56, P1, DOI 10.1007/s00284-007-9003-x; Hu LB, 2007, FEMS MICROBIOL LETT, V272, P91, DOI 10.1111/j.1574-6968.2007.00743.x; Kalai-Grami L, 2016, J BASIC MICROB, V56, P864, DOI 10.1002/jobm.201500683; Kim JC, 2001, PEST MANAG SCI, V57, P554, DOI 10.1002/ps.318; Kim SK, 1991, KOR J APPL MICROBIOL, V19, P598; Kim SW, 1991, KOR J APPL MICROBIOL, V19, P337; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; Liu B, 2009, BIOL CONTROL, V49, P277, DOI 10.1016/j.biocontrol.2009.02.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAGETDANA R, 1992, BIOCHIMIE, V74, P1047, DOI 10.1016/0300-9084(92)90002-V; Mora I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127738; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; PHAE CG, 1990, J FERMENT BIOENG, V69, P1; Restuccia C, 2006, J FOOD PROTECT, V69, P2465, DOI 10.4315/0362-028X-69.10.2465; Romero D, 2004, APPL MICROBIOL BIOT, V64, P263, DOI 10.1007/s00253-003-1439-8; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Shoda M, 2000, J BIOSCI BIOENG, V89, P515, DOI 10.1016/S1389-1723(00)80049-3; Tang QY, 2014, J MICROBIOL, V52, P675, DOI 10.1007/s12275-014-3605-3; Tendulkar SR, 2007, J APPL MICROBIOL, V103, P2331, DOI 10.1111/j.1365-2672.2007.03501.x; THIMON L, 1992, BIOTECHNOL APPL BIOC, V16, P144; Yang H, 2015, ANAL BIOANAL CHEM, V407, P2529, DOI 10.1007/s00216-015-8486-8; Yao SY, 2003, CURR MICROBIOL, V47, P272, DOI 10.1007/s00284-002-4008-y; Zeriouh H, 2011, MOL PLANT MICROBE IN, V24, P1540, DOI 10.1094/MPMI-06-11-0162	48	7	7	9	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0234177	10.1371/journal.pone.0234177	http://dx.doi.org/10.1371/journal.pone.0234177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270634	Green Published, gold			2022-12-26	WOS:000597149100148
J	Psichogiou, M; Karabinis, A; Pavlopoulou, ID; Basoulis, D; Petsios, K; Roussos, S; Pratikaki, M; Jahaj, E; Protopapas, K; Leontis, K; Rapti, V; Kotanidou, A; Antoniadou, A; Poulakou, G; Paraskevis, D; Sypsa, V; Hatzakis, A				Psichogiou, Mina; Karabinis, Andreas; Pavlopoulou, Ioanna D.; Basoulis, Dimitrios; Petsios, Konstantinos; Roussos, Sotirios; Pratikaki, Maria; Jahaj, Edison; Protopapas, Konstantinos; Leontis, Konstantinos; Rapti, Vasiliki; Kotanidou, Anastasia; Antoniadou, Anastasia; Poulakou, Garyphallia; Paraskevis, Dimitrios; Sypsa, Vana; Hatzakis, Angelos			Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19	PLOS ONE			English	Article								Introduction Greece is a country with limited spread of SARS-CoV-2 and cumulative infection attack rate of 0.12% (95% CI 0.06-0.26). Health care workers (HCWs) are a well-recognized risk group for COVID-19. The study aimed to estimate the seroprevalence of antibodies to SARS-CoV-2 in a nosocomial setting and assess potential risk factors. Methods HCWs from two hospitals participated in the study. Hospital-1 was a tertiary university affiliated center, involved in the care of COVID-19 patients while hospital-2 was a tertiary specialized cardiac surgery center not involved in the care of these patients. A validated, CE, rapid, IgM/IgG antibody point-of-care test was used. Comparative performance with a reference globally available assay was assessed. Results 1,495 individuals consented to participate (response rate 77%). The anti-SARS-CoV-2 weighted prevalence was 1.26% (95% CI 0.43, 3.26) overall and 0.53% (95% CI 0.06, 2.78) and 2.70% (95% CI 0.57, 9.19) in hospital-1 and hospital-2, respectively although the study was underpowered to detect statistically significant differences. The overall, hospital-1, and hospital-2 seroprevalence was 10, 4 and 22 times higher than the estimated infection attack rate in general population, respectively. Suboptimal use of personal protective equipment was noted in both hospitals. Conclusions These data have implications for the preparedness of a second wave of COVID-19 epidemic, given the low burden of SARS-CoV-2 infection rate, in concordance with national projections.	[Psichogiou, Mina; Basoulis, Dimitrios] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Med Sch, Dept Internal Med 1, Athens, Greece; [Karabinis, Andreas] Onassis Cardiac Surg Ctr, Athens, Greece; [Pavlopoulou, Ioanna D.] Natl & Kapodistrian Univ Athens, Fac Nursing, Pediat Res Lab, Athens, Greece; [Petsios, Konstantinos] Onassis Cardiac Surg Ctr, Clin Res Off, Athens, Greece; [Roussos, Sotirios; Paraskevis, Dimitrios; Sypsa, Vana; Hatzakis, Angelos] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Pratikaki, Maria; Jahaj, Edison; Kotanidou, Anastasia] Natl & Kapodistrian Univ Athens, Evangelismos Hosp, Med Sch, Dept Crit Care & Pulm Serv 1, Athens, Greece; [Protopapas, Konstantinos; Antoniadou, Anastasia] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece; [Leontis, Konstantinos; Rapti, Vasiliki; Poulakou, Garyphallia] Natl & Kapodistrian Univ Athens, Sotiria Gen Hosp, Med Sch, Dept Internal Med 3, Athens, Greece	Laiko General Hospital; National & Kapodistrian University of Athens; Onassis Cardiac Surgery Center; National & Kapodistrian University of Athens; Onassis Cardiac Surgery Center; National & Kapodistrian University of Athens; Evangelismos Hospital; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Psichogiou, M (corresponding author), Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Med Sch, Dept Internal Med 1, Athens, Greece.	mpsichog@med.uoa.gr	Rapti, Vasiliki/AGY-3601-2022; Jahaj, Edison/AAB-5502-2020; Pavlopoulou, Ioanna D./J-4341-2012; Petsios, Konstantinos/O-5035-2019; Petsios, Konstantinos/GLR-8422-2022	Rapti, Vasiliki/0000-0002-8322-635X; Jahaj, Edison/0000-0002-7306-713X; Pavlopoulou, Ioanna D./0000-0003-0607-8266; Petsios, Konstantinos/0000-0002-7962-040X; Petsios, Konstantinos/0000-0002-7962-040X; Roussos, Sotirios/0000-0003-2347-0817; SYPSA, VANA/0000-0002-9430-7614; Paraskevis, Dimitrios/0000-0001-6167-7152	Gilead Hellas [GR-515-03.2020]; Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases	Gilead Hellas; Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases	Gilead Hellas (https://www.gilead.com/utility/global-operations/europe/greece/greek) has funded the study with a grant bearing an approval code number GR-515-03.2020 after the approval by the Gilead Hellas Grants Committee at the colloquy of March 23d, 2020. Recipient of the grant was Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases. AH was the Principal Investigator. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaizu A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-541; [Anonymous], 2020, COVID 19 SIT UPD EUE; [Anonymous], 2020, EVIDENCE SUMMARY IMM; Barrett ES, 2020, PREVALENCE SARS COV, DOI [10.1101/2020.04.20.20072470, DOI 10.1101/2020.04.20.2007247032511600]; Bogogiannidou Z, 2020, EUROSURVEILLANCE, V25, P8, DOI 10.2807/1560-7917.ES.2020.25.31.2001369; Brandstetter S, 2020, PEDIAT ALLERG IMM-UK, V31, P841, DOI 10.1111/pai.13278; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Eurosurveillance Editorial Team, 2020, EURO SURVEILL, V25; Folgueira MD, 2020, MEDRXIV, DOI 10.1101/2020.04.07.20055723; Galan I, 2020, SARS COV 2 SEROPREVA, DOI [10.1101/2020.05.29.20116731, DOI 10.1101/2020.05.29.20116731]; Garcia-Basteiro, 2020, SEROPREVALENCE ANTIB, DOI 10.1101/2020.04.27.20082289; Hains DS, 2020, JAMA-J AM MED ASSOC; Houlihan C., 2020, SARS COV 2 VIRUS ANT, DOI [10.1101/2020.06.08.20120584, DOI 10.1101/2020.06.08.20120584V1]; Kawana A, 2006, JPN J INFECT DIS, V59, P377; Khalil A, 2021, LANCET INFECT DIS, V21, P23, DOI 10.1016/S1473-3099(20)30403-5; Kim J, 2022, NAT PROD RES, V36, P1084, DOI 10.1080/14786419.2020.1849200; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Lombardi A., 2020, CLIN MICROBIOL INFEC, V26, DOI DOI 10.1016/J.CMI.2020.06.013; Mansour M, 2020, PREVALENCE SARS COV, DOI 10.1101/2020.05.27.20090811; National Academies of Sciences Engineering and Medicine 2020, 2020, RAP EXP CONS SARS CO, DOI [10.17226/25774, DOI 10.17226/25774]; Ran L, 2020, CLIN INFECT DIS, V71, P2218, DOI 10.1093/cid/ciaa287; Rosenberg ES, 2020, ANN EPIDEMIOL, V48, P23, DOI 10.1016/j.annepidem.2020.06.004; Shields AM, 2020, SARS COV 2 SEROCONVE, DOI [DOI 10.1101/2020.05.18.20105197, 10.1101/2020.05.18.20105197]; Solodky ML, 2020, ANN ONCOL, DOI [10.1016/j.annonc.2020.04.475, DOI 10.1016/J.ANNONC.2020.04.47532360743]; Stoesser N, 2020, LANCET INFECT DIS, V20, P1390, DOI 10.1016/S1473-3099(20)30634-4; Sypsa V, 2020, MODELLING SARS COV 2, DOI [10.1101/2020.05.27.20114017, DOI 10.1101/2020.05.27.20114017]; Treibel TA, 2020, LANCET, V395, P1608, DOI 10.1016/S0140-6736(20)31100-4; Vahidy F, 2020, PREVALENCE SARS COV, DOI 10.1101/2020.05.21.20107581; World Health Organization, 2020, 131 WHO; Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696; Zheng L, 2020, CLIN INFECT DIS	33	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243025	10.1371/journal.pone.0243025	http://dx.doi.org/10.1371/journal.pone.0243025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270691	Green Submitted, gold, Green Published			2022-12-26	WOS:000597149100002
J	Roh, YH; Kang, BK; Song, SY; Lee, CM; Jung, YK; Kim, M; Wellner, U				Roh, Yun Hwa; Kang, Bo Kyeong; Song, Soon-Young; Lee, Chul-Min; Jung, Yun Kyung; Kim, Mimi; Wellner, Ulrich			Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy	PLOS ONE			English	Article							SARCOPENIC OBESITY; VISCERAL OBESITY; IMPACT; CANCER; EXPERIENCE; OUTCOMES; FAT; ELASTOGRAPHY; MANAGEMENT; SURVIVAL	Postoperative pancreatic fistula (POPF) is a common complication following pancreaticoduodenectomy (PD). However, risk factors for this complication remain controversial. We conducted a retrospective analysis of 107 patients who underwent PD. POPF was diagnosed in strict accordance with the definition of the 2016 update of pancreatic fistula from the International Study Group on Pancreatic Fistula (ISGPF). Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for POPF. A total of 19 (17.8%) subjects of pancreatic fistula occurred after PD, including 15 (14.1%) with grade B POPF and 4 (3.7%) with grade C POPF. There were 33 (30.8%) patients with biochemical leak. Risk factors for POPF (grade B and C) were larger area of visceral fat (odds ratio [OR], 1.40; p = 0.040) and pathology other than pancreatic adenocarcinoma or pancreatitis (OR, 12.45; p = 0.017) in the multivariate regression analysis. This result could assist the surgeon to identify patients at a high risk of developing POPF.	[Roh, Yun Hwa; Kang, Bo Kyeong; Song, Soon-Young; Lee, Chul-Min; Kim, Mimi; Wellner, Ulrich] Hanyang Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Jung, Yun Kyung] Hanyang Univ, Dept Surg, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University	Wellner, U (corresponding author), Hanyang Univ, Dept Radiol, Coll Med, Seoul, South Korea.	bluefish010@naver.com	song, song/GWN-2626-2022	Lee, Chul-min/0000-0001-7621-3377; Kim, Mimi/0000-0002-8266-0226	Hanyang University (HY-2019)	Hanyang University (HY-2019)	This work was supported by the research fund of Hanyang University (HY-2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BMC P S6, V7, pO1; Assifi MM, 2012, J GASTROINTEST SURG, V16, P275, DOI 10.1007/s11605-011-1733-1; Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Callery MP, 2013, J AM COLL SURGEONS, V216, P1, DOI 10.1016/j.jamcollsurg.2012.09.002; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Cameron JL, 2015, J AM COLL SURGEONS, V220, P530, DOI 10.1016/j.jamcollsurg.2014.12.031; Centonze L, 2020, DIGEST SURG, V37, P312, DOI 10.1159/000504703; Crippa Stefano, 2007, HPB (Oxford), V9, P8, DOI 10.1080/13651820600641357; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donahue TR, 2015, SEMIN ONCOL, V42, P98, DOI 10.1053/j.seminoncol.2014.12.009; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gaujoux S, 2012, ANN SURG ONCOL, V19, P2908, DOI 10.1245/s10434-012-2301-y; Goh BKP, 2008, ARCH SURG-CHICAGO, V143, P956, DOI 10.1001/archsurg.143.10.956; Hu BY, 2016, WORLD J GASTROENTERO, V22, P7797, DOI 10.3748/wjg.v22.i34.7797; Jang M, 2019, EUR RADIOL, V29, P2417, DOI 10.1007/s00330-018-5790-7; Joglekar S, 2015, J SURG ONCOL, V111, P771, DOI 10.1002/jso.23862; Kawabata Y, 2020, PANCREAS, V49, P799, DOI 10.1097/MPA.0000000000001576; Kawai M, 2011, J HEPATO-BIL-PAN SCI, V18, P601, DOI 10.1007/s00534-011-0373-x; Kimura W, 2014, ANN SURG, V259, P773, DOI 10.1097/SLA.0000000000000263; Kolipaka A, 2017, MAGN RESON IMAGING, V42, P1, DOI 10.1016/j.mri.2017.04.015; Lim KI, 2010, CLIN ENDOCRINOL, V73, P588, DOI 10.1111/j.1365-2265.2010.03841.x; Mintziras I, 2018, INT J SURG, V59, P19, DOI 10.1016/j.ijsu.2018.09.014; Neeland IJ, 2019, LANCET DIABETES ENDO, V7, P715, DOI 10.1016/S2213-8587(19)30084-1; Nishida Y, 2016, J GASTROINTEST SURG, V20, P1586, DOI 10.1007/s11605-016-3146-7; Nishigori T, 2016, ANN SURG ONCOL, V23, P524, DOI 10.1245/s10434-016-5385-y; Noun R, 2008, J PANCREAS, V9, P468; Onesti JK, 2016, PANCREATOLOGY, V16, P284, DOI 10.1016/j.pan.2016.01.009; Otsuji H, 2015, WORLD J SURG, V39, P1494, DOI 10.1007/s00268-015-2988-6; Park CM, 2012, J INVEST SURG, V25, P169, DOI 10.3109/08941939.2011.616255; Pecorelli N, 2016, BRIT J SURG, V103, P434, DOI 10.1002/bjs.10063; Pecorelli N, 2018, ANN SURG ONCOL, V25, P308, DOI 10.1245/s10434-017-6216-5; Peng YP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00311-8; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Ratnayake CBB, 2018, PANCREATOLOGY, V18, P996, DOI 10.1016/j.pan.2018.09.011; Reid-Lombardo KM, 2007, J GASTROINTEST SURG, V11, P1451, DOI 10.1007/s11605-007-0270-4; Schmidt CM, 2004, ARCH SURG-CHICAGO, V139, P718, DOI 10.1001/archsurg.139.7.718; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tranchart H, 2012, ANN SURG, V256, P139, DOI 10.1097/SLA.0b013e318256c32c; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Witkowski ER, 2013, J SURG ONCOL, V107, P97, DOI 10.1002/jso.23267; Yang TH, 2015, ANZ J SURG, V85, P507, DOI 10.1111/ans.13132; Zhang XY, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-018-1622-9	42	7	7	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243515	10.1371/journal.pone.0243515	http://dx.doi.org/10.1371/journal.pone.0243515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270774	gold, Green Published			2022-12-26	WOS:000597149100110
J	Park, H; Kim, H; Hassebroek, V; Azuma, Y; Slawson, C; Azuma, M				Park, Hyewon; Kim, Haeyoung; Hassebroek, Victoria; Azuma, Yoshiaki; Slawson, Chad; Azuma, Mizuki			Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEINS; EWS; GENE; EWS-FLI1; KINASE; FAMILY; TRANSLOCATION; TRANSCRIPTION; MIDZONE; SPINDLE	Ewing sarcoma is a pediatric bone cancer that expresses the chimeric protein EWSR1/FLI1. We previously demonstrated that EWSR1/FLI1 impairs the localization of Aurora B kinase to the midzone (the midline structure located between segregating chromosomes) during anaphase. While localization of Aurora B is essential for faithful cell division, it is unknown whether interference with midzone organization by EWSR1/FLI1 induces aneuploidy. To address this, we generated stable Tet-on inducible cell lines with EWSR1/FLI1, using CRISPR/Cas9 technology to integrate the transgene at the safe-harbor AAVS1 locus in DLD-1 cells. Induced cells expressing EWSR1/FLI1 displayed an increased incidence of aberrant localization of Aurora B, and greater levels of aneuploidy, compared with noninduced cells. Furthermore, the expression of EWSR1/FLI1-T79A, containing a threonine (Thr) to alanine (Ala) substitution at amino acid 79, failed to induce these phenotypes, indicating that Thr 79 is critical for EWSR1/FLI1 interference with mitosis. In contrast, the phosphomimetic mutant EWSR1/FLI1-T79D (Thr to aspartic acid (Asp)) retained the high activity as wild-type EWSR1/FLI1. Together, these findings suggest that phosphorylation of EWSR1/FLI1 at Thr 79 promotes the colocalization of EWSR1/FLI1 and Aurora B on the chromosomes during prophase and metaphase and, in addition, impairs the localization of Aurora B during anaphase, leading to induction of aneuploidy. This is the first demonstration of the mechanism for EWSR1/FLI1-dependent induction of aneuploidy associated with mitotic dysfunction and the identification of the phosphorylation of the Thr 79 of EWSR1/FLI1 as a critical residue required for this induction.	[Park, Hyewon; Kim, Haeyoung; Hassebroek, Victoria; Azuma, Yoshiaki; Azuma, Mizuki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA	University of Kansas; University of Kansas; University of Kansas Medical Center	Azuma, M (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	azumam@ku.edu			University of Kansas General Research Fund (GRF) [P30CA168524, R03CA223949]; Midwest Cancer Alliance (MCA) Advisory Board Funding	University of Kansas General Research Fund (GRF); Midwest Cancer Alliance (MCA) Advisory Board Funding	This study was supported by the grants P30CA168524, R03CA223949, University of Kansas General Research Fund (GRF), and Midwest Cancer Alliance (MCA) Advisory Board Funding.	Anderson ND, 2018, SCIENCE, V361, DOI 10.1126/science.aam8419; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Chansky HA, 2001, CANCER RES, V61, P3586; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Embree LJ, 2009, CANCER RES, V69, P4363, DOI 10.1158/0008-5472.CAN-08-3229; Ewing J, 1972, CA Cancer J Clin, V22, P95, DOI 10.3322/canjclin.22.2.95; Ferreira BI, 2008, ONCOGENE, V27, P2084, DOI 10.1038/sj.onc.1210845; Gorthi A, 2018, NATURE, V555, P387, DOI 10.1038/nature25748; Hassebroek VA, 2020, MOL BIOL CELL, V31, P2537, DOI 10.1091/mbc.E20-03-0180; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; JEON IS, 1995, ONCOGENE, V10, P1229; Johnson KM, 2017, P NATL ACAD SCI USA, V114, P9870, DOI 10.1073/pnas.1701872114; Kaneko Y, 1996, GENE CHROMOSOME CANC, V15, P115, DOI 10.1002/(SICI)1098-2264(199602)15:2<115::AID-GCC6>3.0.CO;2-6; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Klevernic IV, 2009, BIOCHEM J, V418, P625, DOI 10.1042/BJ20082097; Kotynkova K, 2016, CELL REP, V17, P2672, DOI 10.1016/j.celrep.2016.11.029; Lanza C, 2016, CELL CYCLE, V15, P1363, DOI 10.1080/15384101.2016.1167297; Lawlor Elizabeth R., 2015, Critical Reviews in Oncogenesis, V20, P155, DOI 10.1615/CritRevOncog.2015013553; LEITH JT, 1982, CANCER RES, V42, P30; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Li Q, 2014, BIOCHEM BIOPH RES CO, V450, P588, DOI 10.1016/j.bbrc.2014.06.013; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merkes C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116627; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nicholson JM, 2015, ELIFE, V4, DOI 10.7554/eLife.05068; Park H, 2016, SCI REP-UK, V6, DOI 10.1038/srep32297; Park H, 2014, CELL CYCLE, V13, P2391, DOI 10.4161/cc.29337; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Selvanathan SP, 2015, P NATL ACAD SCI USA, V112, pE1307, DOI 10.1073/pnas.1500536112; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Sohn EJ, 2010, CANCER RES, V70, P1154, DOI 10.1158/0008-5472.CAN-09-1993; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Sudharsan R, 2012, J CELL SCI, V125, P5819, DOI 10.1242/jcs.110825; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	48	0	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100164	10.1074/jbc.RA120.014328	http://dx.doi.org/10.1074/jbc.RA120.014328			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33293370	Green Published, gold			2022-12-26	WOS:000672866400142
J	Takano, W; Hisabori, T; Wakabayashi, K				Takano, Wakako; Hisabori, Toru; Wakabayashi, Ken-ichi			Rapid estimation of cytosolic ATP concentration from the ciliary beating frequency in the green alga Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER DYNEIN ARM; 2 FLAGELLA; MOTILITY; MODELS; SPERM; CHLOROPLAST; DEFICIENT; DIFFUSION; TRANSPORT; MOVEMENT	Determination of cellular ATP levels, a key indicator of metabolic status, is essential for the quantitative analysis of metabolism. The biciliate green alga Chlamydomonas reinhardtii is an excellent experimental organism to study ATP production pathways, including photosynthesis and respiration, particularly because it can be cultured either photoautotrophically or heterotrophically. Additionally, its cellular ATP concentration, [ATP], is reflected in the beating of its cilia. However, the methods currently used for quantifying the cellular ATP levels are time consuming or invasive. In this study, we established a rapid method for estimating cytosolic [ATP] from the ciliary beating frequency in C. reinhardtii. Using an improved method of motility reactivation in demembranated cell models, we obtained calibration curves for [ATP]-ciliary beating frequency over a physiological range of ATP concentrations. These curves allowed rapid estimation of the cytosolic [ATP] in live wild-type cells to be similar to 2.0 mM in the light and similar to 1.5 mM in the dark: values comparable to those obtained by other methods. Furthermore, we used this method to assess the effects of genetic mutations or inhibitors of photosynthesis or respiration quantitatively and noninvasively. This sensor-free method is a convenient tool for quickly estimating cytosolic [ATP] and studying the mechanism of ATP production in C. reinhardtii or other ciliated organisms.	[Takano, Wakako; Hisabori, Toru; Wakabayashi, Ken-ichi] Tokyo Inst Technol, Lab Chem & Life Sci, Inst Innovat Res, Yokohama, Kanagawa, Japan; [Takano, Wakako; Hisabori, Toru; Wakabayashi, Ken-ichi] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Wakabayashi, K (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Inst Innovat Res, Yokohama, Kanagawa, Japan.; Wakabayashi, K (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan.	wakaba@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Wakabayashi, Ken-ichi/D-2440-2015	Hisabori, Toru/0000-0003-2046-0277; Wakabayashi, Ken-ichi/0000-0002-1025-9249	JSPS KAKENHI [JP16K14752, JP19H03242, JP16H06556]; Ohsumi Frontier Science Foundation [2-G0008]; Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ohsumi Frontier Science Foundation; Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	Funding was provided by grants from JSPS KAKENHI [JP16K14752 and JP19H03242 to K. W., JP16H06556 to T. H.], Ohsumi Frontier Science Foundation 2-G0008 to K. W. and by Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials to T. H. and K. W.	Arai S, 2018, ANGEW CHEM INT EDIT, V57, P10873, DOI 10.1002/anie.201804304; BISHOP DW, 1959, J CELL COMPAR PHYSL, V53, P445, DOI 10.1002/jcp.1030530308; BROKAW CJ, 1967, SCIENCE, V156, P76, DOI 10.1126/science.156.3771.76; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Cardol P., 2009, CHLAMYDOMONAS SOURCE, P445; Cardol P., 2009, CHLAMYDOMONAS SOURCE, P469; De Col V, 2017, ELIFE, V6, DOI [10.7554/eLife.26770, 10.7554/elife.26770]; de Vitry C, 2009, CHLAMYDOMONAS SOURCE, P603; DORTHU MP, 1992, PLANT MOL BIOL, V18, P759, DOI 10.1007/BF00020017; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Finazzi G., 2009, CHLAMYDOMONAS SOURCE, P639, DOI [10.1016/0092-8674(90)90467-S., DOI 10.1016/0092-8674(90)90467-S]; Forti G, 2003, PLANT PHYSIOL, V132, P1464, DOI 10.1104/pp.102.018861; Furuta A, 2009, J BIOL CHEM, V284, P5927, DOI 10.1074/jbc.M807830200; GAFFAL KP, 1995, ARCH PROTISTENKD, V145, P10, DOI 10.1016/S0003-9365(11)80297-6; Gokhale Z., 2009, CHLAMYDOMONAS SOURCE, P573; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harris E. H, 2009, CHLAMYDOMONAS SOURCE, P25; Harris E. H, 1989, CHLAMYDOMONAS SOURCE, DOI [10.1016/C2009-0-02778-0, DOI 10.1016/C2009-0-02778-0]; HAYASHI M, 1976, BIOCHIM BIOPHYS ACTA, V422, P225, DOI 10.1016/0005-2744(76)90021-8; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; KAMIYA R, 1984, J CELL BIOL, V98, P97, DOI 10.1083/jcb.98.1.97; KAMIYA R, 1985, J CELL SCI, V74, P181; Kamiya R, 2000, METHODS, V22, P383, DOI 10.1006/meth.2000.1090; Kikushima K, 2004, FEBS LETT, V563, P119, DOI 10.1016/S0014-5793(04)00278-9; Magidson V, 2013, METHOD CELL BIOL, V114, P545, DOI 10.1016/B978-0-12-407761-4.00023-3; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; NAITOH Y, 1972, SCIENCE, V176, P523, DOI 10.1126/science.176.4034.523; Redding K. E., 2009, CHLAMYDOMONAS SOURCE, P541; Rosenbaum JL, 1999, J CELL BIOL, V144, P385, DOI 10.1083/jcb.144.3.385; Saegusa Y, 2015, CYTOSKELETON, V72, P412, DOI 10.1002/cm.21235; SZENTGYORGYI A, 1949, BIOL BULL, V96, P140, DOI 10.2307/1538196; Takada S, 1997, CELL MOTIL CYTOSKEL, V36, P68; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; Takao D, 2008, J EXP BIOL, V211, P3594, DOI 10.1242/jeb.021923; Takao D, 2010, BIOPHYS J, V98, P1582, DOI 10.1016/j.bpj.2009.12.4314; Voon CP, 2018, P NATL ACAD SCI USA, V115, pE10778, DOI 10.1073/pnas.1711497115; Wakabayashi K, 2006, J CELL BIOL, V173, P743, DOI 10.1083/jcb.200603019; Wakabayashi K, 2009, CELL MOTIL CYTOSKEL, V66, P736, DOI 10.1002/cm.20402; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; WOESSNER JP, 1984, PLANT MOL BIOL, V3, P177, DOI 10.1007/BF00016065; Wostrikoff K., 2009, CHLAMYDOMONAS SOURCE, P303; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yoshida T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39618; Zhang H, 2004, J CELL SCI, V117, P4179, DOI 10.1242/jcs.01297	46	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100156	10.1074/jbc.RA120.015263	http://dx.doi.org/10.1074/jbc.RA120.015263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273011	Green Published, gold			2022-12-26	WOS:000672866400134
J	Ward, RJ; Pediani, JD; Marsango, S; Jolly, R; Stoneman, MR; Biener, G; Handel, TM; Raicu, V; Milligan, G				Ward, Richard J.; Pediani, John D.; Marsango, Sara; Jolly, Richard; Stoneman, Michael R.; Biener, Gabriel; Handel, Tracy M.; Raicu, Valerica; Milligan, Graeme			Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVEALS; ORGANIZATION; GPCR; DIMERIZATION; MOLECULE; AGONIST	CXCR4, a member of the family of chemokine-activated G protein-coupled receptors, is widely expressed in immune response cells. It is involved in both cancer development and progression as well as viral infection, notably by HIV-1. A variety of methods, including structural information, have suggested that the receptor may exist as a dimer or an oligomer. However, the mechanistic details surrounding receptor oligomerization and its potential dynamic regulation remain unclear. Using both biochemical and biophysical means, we confirm that CXCR4 can exist as a mixture of monomers, dimers, and higher-order oligomers in cell membranes and show that oligomeric structure becomes more complex as receptor expression levels increase. Mutations of CXCR4 residues located at a putative dimerization interface result in monomerization of the receptor. Additionally, binding of the CXCR4 antagonist IT1t-a small drug-like isothiourea derivative-rapidly destabilizes the oligomeric structure, whereas AMD3100, another well-characterized CXCR4 antagonist, does not. Although a mutation that regulates constitutive activity of CXCR4 also results in monomerization of the receptor, binding of IT1t to this variant promotes receptor dimerization. These results provide novel insights into the basal organization of CXCR4 and how antagonist ligands of different chemotypes differentially regulate its oligomerization state.	[Ward, Richard J.; Pediani, John D.; Marsango, Sara; Jolly, Richard; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Ctr Translat Pharmacol, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Stoneman, Michael R.; Biener, Gabriel; Raicu, Valerica] Univ Wisconsin, Phys Dept, Milwaukee, WI USA; [Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Glasgow; University of Wisconsin System; University of Wisconsin Milwaukee; University of California System; University of California San Diego	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Ctr Translat Pharmacol, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Pediani, John/F-2708-2019	Pediani, John/0000-0001-6615-537X	Medical Research Council UK [MR/L023806/1]; European Union [641833]; National Science Foundation Major Instrumentation Program [DBI-1919670]; University of Wisconsin Milwaukee Research Growth Initiative [101X396, R01AI118985, R01GM133157]; MRC [MR/L023806/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Science Foundation Major Instrumentation Program(National Science Foundation (NSF)); University of Wisconsin Milwaukee Research Growth Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (grant number: MR/L023806/1) and European Union's Horizon 2020 Marie Sklodowska-Curie actions Program under grant agreement 641833 (Oncogenic Receptor Network of Excellence and Training). In addition, this work was partly supported by a grant from the National Science Foundation Major Instrumentation Program (grant number: DBI-1919670) and the University of Wisconsin Milwaukee Research Growth Initiative (101X396). T. M. H. was supported by grants R01AI118985 and R01GM133157.	Armando S, 2014, FASEB J, V28, P4509, DOI 10.1096/fj.13-242446; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Cutrale F, 2019, NAT PROTOC, V14, P616, DOI 10.1038/s41596-018-0111-9; Ehrhardt C., 2006, SIGNAL TRANSDUCTION; Farran B, 2017, PHARMACOL RES, V117, P303, DOI 10.1016/j.phrs.2017.01.008; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Isbilir A, 2020, P NATL ACAD SCI USA, V117, P29144, DOI 10.1073/pnas.2013319117; Jameson David M, 2009, Biophys Rev, V1, P105, DOI 10.1007/s12551-009-0013-8; Kufareva Irina, 2013, Methods Mol Biol, V1013, P93, DOI 10.1007/978-1-62703-426-5_7; Lao J, 2017, J PHYS CHEM B, V121, P1466, DOI 10.1021/acs.jpcb.6b10969; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Marshall-Pescini S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46636; Martinez-Munoz L, 2018, J LEUKOCYTE BIOL, V104, P323, DOI 10.1002/JLB.2MR1217-503R; Milligan G, 2019, CURR OPIN CELL BIOL, V57, P40, DOI 10.1016/j.ceb.2018.10.007; Mueller A, 2002, BRIT J PHARMACOL, V135, P1033, DOI 10.1038/sj.bjp.0704540; Mueller A, 2006, BIOCHEM PHARMACOL, V72, P739, DOI 10.1016/j.bcp.2006.06.001; Nagy A, 2005, BIOPHYS J, V89, P2077, DOI 10.1529/biophysj.104.052779; Pediani JD, 2018, TRENDS PHARMACOL SCI, V39, P175, DOI 10.1016/j.tips.2017.09.001; Pediani JD, 2016, J BIOL CHEM, V291, P13132, DOI 10.1074/jbc.M115.712562; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Robertson N, 2018, NATURE, V553, P111, DOI 10.1038/nature25025; Rosenberg EM, 2019, CELL CHEM BIOL, V26, P662, DOI 10.1016/j.chembiol.2019.01.012; Scales N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226063; Schiedel AC, 2018, CURR TOP MED CHEM, V18, P714, DOI 10.2174/1568026618666180604082610; Sleno R, 2019, NEUROPHARMACOLOGY, V152, P4, DOI 10.1016/j.neuropharm.2019.01.018; Smit MJ, 2019, MOL PHARMACOL, V96, P735, DOI 10.1124/mol.119.118364; Steel E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093646; Stenkamp RE, 2018, ACTA CRYSTALLOGR D, V74, P655, DOI 10.1107/S2059798318008136; Stoneman MR, 2020, NAT METHODS, V17, P276, DOI 10.1038/s41592-020-0735-x; Stoneman MR, 2019, NAT METHODS, V16, P493, DOI 10.1038/s41592-019-0408-9; Unruh JR, 2008, BIOPHYS J, V95, P5385, DOI 10.1529/biophysj.108.130310; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang JZ, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.105010; Ward RJ, 2017, BIOCHEM J, V474, P1879, DOI 10.1042/BCJ20170184; Ward RJ, 2015, J BIOL CHEM, V290, P12844, DOI 10.1074/jbc.M115.644724; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu TR, 2011, BIOCHEM J, V439, P171, DOI 10.1042/BJ20110230; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhou XE, 2019, PROTEIN SCI, V28, P487, DOI 10.1002/pro.3526	44	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100139	10.1074/jbc.RA120.016612	http://dx.doi.org/10.1074/jbc.RA120.016612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268380	Green Published, gold, Green Accepted			2022-12-26	WOS:000672866400118
J	Amano, K; Xiao, K; Wuerger, S; Meyer, G				Amano, Kinjiro; Xiao, Kaida; Wuerger, Sophie; Meyer, Georg			A colorimetric comparison of sunless with natural skin tan	PLOS ONE			English	Article							COLOR; DIHYDROXYACETONE; INSIGHT	The main ingredient of sunless tanning products is dihydroxyacetone (DHA). DHA reacts with the protein and amino acid composition in the surface layers of the skin, producing melanoidins, which changes the skin colour, imitating natural skin tan caused by melanin. The purpose of this study was to characterise DHA-induced skin colour changes and to test whether we can predict the outcome of DHA application on skin tone changes. To assess the DHA-induced skin colour shift quantitatively, colorimetric and spectral measurements of the inner forearm were obtained before, four hours and 24 hours after application of a 7.5% concentration DHA gel in the experimental group (n = 100). In a control group (n = 60), the same measurements were obtained on both the inner forearm (infrequently sun-exposed) and the outer forearm (frequently sun-exposed); the difference between these two areas was defined as the naturally occurring tan. Skin colour shifts caused by DHA tanning and by natural tanning were compared in terms of lightness (L*), redness (a*) and yellowness (b*) in the standard CIELAB colour space. Naturalness of the DHA-induced skin tan was evaluated by comparing the trajectory of the chromaticity distribution in (L*, b*) space with that of naturally occurring tan. Twenty-four hours after DHA application, approximately 20% of the skin colour samples became excessively yellow, with chromaticities outside the natural range in (L*, b*) space. A principal component analysis was used to characterise the tanning pathway. Skin colour shifts induced by DHA were predicted by a multiple regression on the chromaticities and the skin properties. The model explained up to 49% of variance in colorimetric components with a median error of less than 2 Delta E. We conclude that the control of both the magnitude and the direction of the colour shift is a critical factor to achieve a natural appearance.	[Amano, Kinjiro; Wuerger, Sophie; Meyer, Georg] Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England; [Xiao, Kaida] Univ Leeds, Sch Design, Leeds, W Yorkshire, England; [Amano, Kinjiro] Univ Manchester, Sch Med Sci, Manchester, Lancs, England	University of Liverpool; University of Leeds; University of Manchester	Amano, K (corresponding author), Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England.; Amano, K (corresponding author), Univ Manchester, Sch Med Sci, Manchester, Lancs, England.	kinjiro.amano@manchester.ac.uk		xiao, kaida/0000-0001-7197-7159; Wuerger, Sophie/0000-0003-0080-5813	EPSRC [EP/K040057]; PZ Cussons (Manchester, UK); EPSRC [EP/K040057/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); PZ Cussons (Manchester, UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The control group data were part of a larger project on skin appearance funded by the EPSRC (EP/K040057) (SW). PZ Cussons (Manchester, UK) funded the DHA induced skin colour measurements and gave advice on the study design but was not involved in data collection and analysis, or the decision to publish the results (KA, SW, GM).	Adbi A, 2018, ACAD MANAGEMENT P, V2018, P12261, DOI [10.5465/AMBPP.2018.12261abstract, DOI 10.5465/AMBPP.2018.12261ABSTRACT]; Beckmann KR, 2001, MED J AUSTRALIA, V174, P75, DOI 10.5694/j.1326-5377.2001.tb143158.x; BOBIN MF, 1984, J SOC COSMET CHEM, V35, P265; Brooks K, 2006, J AM ACAD DERMATOL, V54, P1060, DOI 10.1016/j.jaad.2006.01.014; CHARDON A, 1991, INT J COSMETIC SCI, V13, P191, DOI 10.1111/j.1467-2494.1991.tb00561.x; Chauhan T, 2019, J VISION, V19, DOI 10.1167/19.1.13; Ciriminna R, 2018, CHEMISTRYOPEN, V7, P233, DOI 10.1002/open.201700201; Commission Internationale De L'Eclairage (CIE), 2004, CIE PUB, V3rd; Del Bino S, 2013, BRIT J DERMATOL, V169, P33, DOI 10.1111/bjd.12529; Dennis Leslie K, 2009, Ped Health, V3, P565, DOI 10.2217/phe.09.55; Desmedt B, 2016, J EUR ACAD DERMATOL, V30, P943, DOI 10.1111/jdv.13595; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Lee G, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1, DOI 10.1109/CEC.2014.6900246; LEVY SB, 1992, J AM ACAD DERMATOL, V27, P989, DOI 10.1016/0190-9622(92)70300-5; Lister T, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090901; Muizzuddin N, 2000, SKIN RES TECHNOL, V6, P199, DOI 10.1034/j.1600-0846.2000.006004199.x; Pollock Samara, 2021, Int J Womens Dermatol, V7, P158, DOI 10.1016/j.ijwd.2020.09.006; Rajatanavin N, 2008, INT J DERMATOL, V47, P402, DOI 10.1111/j.1365-4632.2008.03356.x; Sahn RE, 2012, ARCH DERMATOL, V148, P448, DOI 10.1001/archdermatol.2011.2072; Sohaib A, 2018, INT J ADV MANUF TECH, V96, P881, DOI 10.1007/s00170-017-1480-x; Sweet J, 2000, AVIRIS WORKSH; Wang M, 2015, COL IM C COL SCI SYS; Wang MM, 2018, COLOR RES APPL, V43, P458, DOI 10.1002/col.22230; WITTGENSTEIN E, 1960, SCIENCE, V132, P894, DOI 10.1126/science.132.3431.894; Xiao K, 2017, SKIN RES TECHNOL, V23, P21, DOI 10.1111/srt.12295; Xiao KD, 2016, OPT EXPRESS, V24, P14934, DOI 10.1364/OE.24.014934; Yoo JJ, 2018, FASH TEXT, V5, DOI 10.1186/s40691-018-0147-z; Zonios G, 2001, J INVEST DERMATOL, V117, P1452, DOI 10.1046/j.0022-202x.2001.01577.x	28	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0233816	10.1371/journal.pone.0233816	http://dx.doi.org/10.1371/journal.pone.0233816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315862	gold, Green Published, Green Submitted			2022-12-26	WOS:000600186100060
J	Mori, A; Saito, T; Takahashi, M; Shibata, M; Tsuji, G; Hatachi, S; Takahashi, S; Kumagai, S				Mori, Ayano; Saito, Toshiharu; Takahashi, Miho; Shibata, Miho; Tsuji, Goh; Hatachi, Saori; Takahashi, Soshi; Kumagai, Shunichi			Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR INHIBITORS; FACTOR-ALPHA THERAPY; IMMUNOGENICITY; LUPUS; AUTOANTIBODIES; DISEASES; UTILITY	This study aimed to directly analyze the potential relationship of anti-nuclear antibodies (ANA) before and after the administration of TNF-alpha inhibitors (TNFi) with the appearance of anti-drug antibodies (ADrA) in patients with rheumatoid arthritis (RA). A total of 121 cases, viz., 38, 53, and 30 cases treated with infliximab (IFX), adalimumab (ADA), and etanercept (ETN), respectively, were enrolled. The ANA titers were measured using indirect immunefluorescence assay (IF-ANA) and multiplex flow immunoassay (ANA Screen) before and serially during the therapy. The anti-IFX antibodies (HACA) and anti-ADA antibodies (AAA) were measured with a radioimmunoassay. ADrA turned positive in 14 (36.8%) among 38 patients treated with IFX, and 16 (30.2%) among 53 treated with ADA. All of them were positive for IF-ANA before TNFi administration, while ADrA never appeared in any of the 15 patients negative for IF-ANA (< 40). IF-ANA of high titers (<greater than or equal to> 320 and >= 640) before IFX treatment showed a significant association with the appearance of HACA 52 weeks after IFX (P = 0.040 and 0.017, respectively), whereas AAA appearance was not related to IF-ANA titers before treatment. Moreover, IF-ANA of high titers before IFX treatment was significantly associated with inefficacy and discontinuation of the treatment. The positivity of anti-SS-A antibodies before therapy might be a risk factor for ADrA appearance in patients treated with IFX or ADA. The percentage of patients whose IF-ANA titers increased was significantly higher with IFX than with ADA or ETN treatments (P = 0.026 and 0.022, respectively). High ANA titers and positive ANA Screen after IFX therapy showed a significant association with HACA appearance and possibly led to treatment failure. Among the three TNFi, only IFX showed a close relationship with IF-ANA and ADrA appearance, suggesting the interaction of immunogenicity with autoimmunity as well as the advantage of ANA measurement before TNFi therapy.	[Mori, Ayano; Saito, Toshiharu; Takahashi, Miho; Shibata, Miho; Takahashi, Soshi; Kumagai, Shunichi] Shinko Hosp, Shinko Inst Med Res, Kobe, Hyogo, Japan; [Tsuji, Goh; Hatachi, Saori; Takahashi, Soshi; Kumagai, Shunichi] Shinko Hosp, Ctr Rheumat Dis, Kobe, Hyogo, Japan		Kumagai, S (corresponding author), Shinko Hosp, Shinko Inst Med Res, Kobe, Hyogo, Japan.; Kumagai, S (corresponding author), Shinko Hosp, Ctr Rheumat Dis, Kobe, Hyogo, Japan.	kumagais@kobe-u.ac.jp						[Anonymous], 2012, DIABETES CARE S1, V35, pS12; De Bandt M, 2005, ARTHRITIS RES THER, V7, pR545, DOI 10.1186/ar1715; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Hagiwara S, 2016, MOD RHEUMATOL, V26, P857, DOI 10.3109/14397595.2016.1153567; Hoffmann JHO, 2011, BRIT J DERMATOL, V165, P1355, DOI 10.1111/j.1365-2133.2011.10555.x; Hoxha A, 2016, JOINT BONE SPINE, V83, P167, DOI 10.1016/j.jbspin.2015.04.020; Ishikawa Y, 2019, SEMIN ARTHRITIS RHEU, V49, P204, DOI 10.1016/j.semarthrit.2019.02.003; Jani M, 2018, RHEUMATOLOGY, V57, P1896, DOI 10.1093/rheumatology/kex434; Jani M, 2015, ARTHRITIS RHEUMATOL, V67, P2011, DOI 10.1002/art.39169; Kalden JR, 2017, NAT REV RHEUMATOL, V13, P707, DOI 10.1038/nrrheum.2017.187; Matsudaira R, 2011, J RHEUMATOL, V38, P2346, DOI 10.3899/jrheum.101295; Moots RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175207; Vaz JLP, 2016, CLIN RHEUMATOL, V35, P325, DOI 10.1007/s10067-015-3140-6; Maneiro JR, 2013, JAMA INTERN MED, V173, P1416, DOI 10.1001/jamainternmed.2013.7430; Ramos-Casals M, 2007, MEDICINE, V86, P242, DOI 10.1097/MD.0b013e3181441a68; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Takase K, 2014, ANN RHEUM DIS, V73, P1695, DOI 10.1136/annrheumdis-2014-205318; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Wetter DA, 2009, MAYO CLIN PROC, V84, P979, DOI 10.4065/84.11.979; Yukawa N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3546	20	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243729	10.1371/journal.pone.0243729	http://dx.doi.org/10.1371/journal.pone.0243729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315881	Green Published, gold			2022-12-26	WOS:000600186100088
J	Breidenbach, N; Gailing, O; Krutovsky, KV				Breidenbach, Natalie; Gailing, Oliver; Krutovsky, Konstantin, V			Genetic structure of coast redwood (Sequoia sempervirens [D. Don] Endl.) populations in and outside of the natural distribution range based on nuclear and chloroplast microsatellite markers	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MITOCHONDRIAL-DNA; CHANGE IMPACTS; NORWAY SPRUCE; DIVERSITY; PLANT; FOREST; FOG; HETEROPLASMY; ASSIGNMENT	Coast redwood (Sequoia sempervirens) naturally growing in southern Oregon and northern California is one of the few conifer tree species that are polyploid. Despite its unique ecological and economic importance, its population genetic structure is still insufficiently studied. To obtain additional data on its population genetic structure we genotyped 317 samples collected from populations in California (data set C) and 144 trees growing in a provenance trial in France (data set F) using 12 nuclear (five random nuclear genomic nSSRs and seven expressed sequence tag EST-SSRs) and six chloroplast (cpSSRs) microsatellite or simple sequence repeat (SSR) markers, respectively. These data sets were also used as reference to infer the origin of 147 coast redwood trees growing in Germany (data set G). Coast redwood was introduced to Europe, including Germany as an ornamental species, decades ago. Due to its fast growth and high timber quality, it could be considered as a potential commercial timber species, especially in perspective to climate warming that makes more regions in Germany suitable for its growing. The well performing trees in colder Germany could be potential frost resistant genotypes, but their genetic properties and origin are mostly unknown. Within the natural range in southern Oregon and northern California, only two relatively weak clusters were identified, one northern and one southern, separated by the San Francisco Bay. High genetic diversity, but low differentiation was found based on the 12 nuclear SSR markers for all three data sets F, C and G. We found that investigated 147 German trees represented only 37 different genotypes. They showed genetic diversity at the level less than diversity observed within the natural range in the northern or southern cluster, but more similar to the diversity observed in the southern cluster. It was difficult to assign German trees to the original single native populations using the six cpSSR markers, but rather to either the northern or southern cluster. The high number of haplotypes found in the data sets based on six cpSSR markers and low genetic differentiation based on 12 nuclear SSRs found in this study helps us study and better understand population genetic structure of this complex polyploid tree and supports the selection of potential genotypes for German forestry.	[Breidenbach, Natalie; Gailing, Oliver; Krutovsky, Konstantin, V] Georg August Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany; [Gailing, Oliver; Krutovsky, Konstantin, V] Georg August Univ Gottingen, Ctr Integrated Breeding Res, Gottingen, Germany; [Krutovsky, Konstantin, V] Russian Acad Sci, Vavilov Inst Gen Genet, Lab Populat Genet, Moscow, Russia; [Krutovsky, Konstantin, V] Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Genome Res & Educ Ctr, Lab Forest Genom, Krasnoyarsk, Russia; [Krutovsky, Konstantin, V] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA	University of Gottingen; University of Gottingen; Russian Academy of Sciences; Vavilov Institute of General Genetics; Siberian Federal University; Texas A&M University System; Texas A&M University College Station	Krutovsky, KV (corresponding author), Georg August Univ Gottingen, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany.; Krutovsky, KV (corresponding author), Georg August Univ Gottingen, Ctr Integrated Breeding Res, Gottingen, Germany.; Krutovsky, KV (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Lab Populat Genet, Moscow, Russia.; Krutovsky, KV (corresponding author), Siberian Fed Univ, Inst Fundamental Biol & Biotechnol, Genome Res & Educ Ctr, Lab Forest Genom, Krasnoyarsk, Russia.; Krutovsky, KV (corresponding author), Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA.	Konstantin.krutovsky@forst.uni-goettingen.de	Krutovsky, Konstantin V./A-5419-2012	Krutovsky, Konstantin V./0000-0002-8819-7084	German Federal Ministry of Food and Agriculture (Bundesministeriums fur Ernahrung und Landwirtschaft - BMEL); Fachagentur Nachwachsende Rohstoffe e. V. (FNR) [FKZ 22018614]	German Federal Ministry of Food and Agriculture (Bundesministeriums fur Ernahrung und Landwirtschaft - BMEL); Fachagentur Nachwachsende Rohstoffe e. V. (FNR)	This study is part of the "Genetische Anpassung und Variation an der Forsttoleranz beteiligter Gene in der eingefuhrten Baumart Sequoia sempervirens, einer schnell wachsenden Wertholzbaumart und ihre Perspektive fur die deutsche Forstwirtschaft" project funded by the German Federal Ministry of Food and Agriculture (Bundesministeriums fur Ernahrung und Landwirtschaft -BMEL) and managed by the Fachagentur Nachwachsende Rohstoffe e. V. (FNR), grant number FKZ 22018614 to KVK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja MR, 2011, PLANT GENET RESOUR-C, V9, P411, DOI 10.1017/S1479262111000153; Ahuja MR, 2009, EUPHYTICA, V165, P5, DOI 10.1007/s10681-008-9813-3; Ahuja MR, 1991, WOODY PLANT BIOTECHN; [Anonymous], 2015, URBAN RAPID RAIL TRA; [Anonymous], 1905, MAKEDONYA MEKTUBU DE, V23, P1; [Anonymous], 2005, FIRE ECOL; ARNAUD Y, 1993, ANN SCI FOREST, V50, P273, DOI 10.1051/forest:19930305; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Bjornstad G, 2002, ANIM GENET, V33, P264, DOI 10.1046/j.1365-2052.2002.00868.x; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; Breidenbach N, 2019, PLANT GENET RESOUR-C, V17, P293, DOI 10.1017/S147926211800045X; Brinegar C, 2011, GEN TECHNICAL REPORT, P241; Bruno D, 2004, MOL ECOL NOTES, V4, P482, DOI 10.1111/j.1471-8286.2004.00720.x; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Busing RT, 2005, PLANT ECOL, V177, P177, DOI 10.1007/s11258-005-2322-8; Chakraborty D, 2016, EUR J FOREST RES, V135, P919, DOI 10.1007/s10342-016-0984-5; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Cornuet JM, 1999, GENETICS, V153, P1989; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; De Silva HN, 2005, HEREDITY, V95, P327, DOI 10.1038/sj.hdy.6800728; Douhovnikoff V, 2004, AM J BOT, V91, P1140, DOI 10.3732/ajb.91.7.1140; Douhovnikoff V, 2011, AM MIDL NAT, V165, P22, DOI 10.1674/0003-0031-165.1.22; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J, PHYLIP PHYLOGENY INF; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Hansen OK, 2005, TREE GENET GENOMES, V1, P116, DOI 10.1007/s11295-005-0016-y; HARRIS SA, 1991, TAXON, V40, P393, DOI 10.2307/1223218; Hintsteiner WJ, 2018, EUR J FOREST RES, V137, P447, DOI 10.1007/s10342-018-1115-2; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; JOHNSON LB, 1989, PLANT MOL BIOL, V12, P3, DOI 10.1007/BF00017442; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones DA, 2012, FORESTRY, V85, P99, DOI 10.1093/forestry/cpr063; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krutovsky K. V., 2012, GENOMICS TREE CROPS, P71, DOI [10.1016/j.jenvrad.2011.11.013, DOI 10.1016/J.JENVRAD.2011.11.013]; Lambertini C, 2016, BIOL INVASIONS, V18, P2443, DOI 10.1007/s10530-016-1193-3; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lorimer CG, 2009, FOREST ECOL MANAG, V258, P1038, DOI 10.1016/j.foreco.2009.07.008; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Mason AS, 2015, METHODS MOL BIOL, V1245, P161, DOI 10.1007/978-1-4939-1966-6_12; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Nazareno AG, 2014, CONSERV GENET, V15, P441, DOI 10.1007/s10592-013-0552-1; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Neuner S, 2017, CLIMATIC CHANGE, V140, P519, DOI 10.1007/s10584-016-1891-y; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; O'Hara KL, 2017, FORESTS, V8, DOI 10.3390/f8050144; Olson DF, 1990, ENDL REDWOOD SILVICS, V654, P541; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palmer DJ, 2012, NZ J FORESTRY SCI, V42, P81; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2005, MOL ECOL, V14, P885, DOI 10.1111/j.1365-294X.2005.02446.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pettenkofer T, 2019, EUR J FOREST RES, V138, P275, DOI 10.1007/s10342-019-01167-5; Pfeiffer T, 2011, J HERED, V102, P479, DOI 10.1093/jhered/esr024; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pompe S, 2008, BIOL LETTERS, V4, P564, DOI 10.1098/rsbl.2008.0231; Potter KM, 2013, AM J BOT, V100, P1562, DOI 10.3732/ajb.1300039; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Provan J, 1999, GENETICS, V153, P943; Provan J, 2008, CONSERV GENET, V9, P1521, DOI 10.1007/s10592-007-9484-y; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., FIGTREE V1 3 1; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ribeiro MM, 2002, MOL ECOL, V11, P869, DOI 10.1046/j.1365-294X.2002.01490.x; Ribeiro MM, 2002, ANN FOR SCI, V59, P53, DOI [10.1051/forest:2001005, 10.1051/forest:2002100]; Rogers DL, 1997, HEREDITY, V78, P166, DOI 10.1038/hdy.1997.24; Rogers DL, 1999, J HERED, V90, P429, DOI 10.1093/jhered/90.3.429; Rogers DL, 2000, CAN J BOT, V78, P1408, DOI 10.1139/cjb-78-11-1408; Rogers JE, 2007, SER DEATH DYING, P59; Rousseau-Gueutin M, 2018, PLANT GROWTH REGULAT; Roy DF, 1966, SILVICAL CHARACTERIS, V28, P20; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Sawyer JO, 2000, REDWOOD FOREST; Scott AD, 2016, NEW PHYTOL, V211, P186, DOI 10.1111/nph.13930; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Stauffer D., 1994, INTRO PERCOLATION TH; STEBBINS GL, 1948, SCIENCE, V108, P95, DOI 10.1126/science.108.2796.95; Templer PH, 2015, J ECOL, V103, P1397, DOI 10.1111/1365-2745.12462; Terrab A, 2007, TAXON, V56, P409, DOI 10.1002/tax.562012; Ibanez MT, 2009, J ZHEJIANG UNIV-SC B, V10, P112, DOI 10.1631/jzus.B0820162; Torregrosa A, 2016, EARTH SPACE SCI, V3, P46, DOI 10.1002/2015EA000119; Urli M, 2014, J VEG SCI, V25, P147, DOI 10.1111/jvs.12079; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vendramin GG, 2000, GENOME, V43, P68, DOI 10.1139/gen-43-1-68; Verhaegen D, 2010, TREE GENET GENOMES, V6, P717, DOI 10.1007/s11295-010-0286-x; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Yoshida T, 2014, DNA RES, V21, P127, DOI 10.1093/dnares/dst045; ZHIVOTOVSKY LA, 1979, ZH OBSHCH BIOL, V40, P587	105	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243556	10.1371/journal.pone.0243556	http://dx.doi.org/10.1371/journal.pone.0243556			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306715	gold, Green Published, Green Submitted			2022-12-26	WOS:000600144200022
J	Slettedal, JK; Traustadottir, VD; Sandvik, L; Ringvold, A				Slettedal, Jon Klokk; Traustadottir, Valgerdur Dora; Sandvik, Leiv; Ringvold, Amund			The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NORDIC COUNTRIES; EYE	Purpose To describe prevalence, life-time prevalence and incidence of glaucoma in Norway over a 15-year period. Materials and methods Data from The Norwegian Prescription Database was used to identify all prescriptions for glaucoma medication during the period 2004 to 2018. Population figures and lifespan data were obtained from The National Bureau of Statistics. Results Of a population of 5.3 million, a total of 75733 patients using glaucoma eye drops were identified in 2018. The national prevalence was thus 1.4%, whilst in those over 70 years of age, 8.0%. When divided into counties, the prevalence varied between 1.1 and 1.9%. Overall, the prevalence was stable in the period 2004-2018. Life time prevalence was found to be 9.4% for men and 10.2% for women. National one-year incidence proportion per 10000 was 17.0 for the total population and a peak incidence of 93.8/10000 in the 80-89 year age group was identified. Conclusions Glaucoma prevalence remained stable during the period 2004-2018, while incidence decreased slightly in the elderly population.	[Slettedal, Jon Klokk; Traustadottir, Valgerdur Dora; Ringvold, Amund] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Slettedal, Jon Klokk; Ringvold, Amund] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Slettedal, JK (corresponding author), Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway.; Slettedal, JK (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	j.k.lettedal@medisin.uio.no						Alyahya GA, 2005, ACTA OPHTHALMOL SCAN, V83, P711, DOI 10.1111/j.1600-0420.2005.00513.x; BENGTSSON B, 1981, BRIT J OPHTHALMOL, V65, P46, DOI 10.1136/bjo.65.1.46; BENGTSSON B, 1989, BRIT J OPHTHALMOL, V73, P483, DOI 10.1136/bjo.73.7.483; Day AC, 2012, BRIT J OPHTHALMOL, V96, P1162, DOI 10.1136/bjophthalmol-2011-301189; Ekstrom C, 2008, ACTA OPHTHALMOL, V86, P747, DOI 10.1111/j.1755-3768.2008.01244.x; Founti P, 2018, ACTA OPHTHALMOL, V96, pE859, DOI 10.1111/aos.13758; GOLDSCHMIDT E, 1989, ACTA OPHTHALMOL, V67, P204; Heijl A, 2013, OPHTHALMOLOGY, V120, P1541, DOI 10.1016/j.ophtha.2013.01.043; Hohn R, 2018, GRAEF ARCH CLIN EXP, V256, P1695, DOI 10.1007/s00417-018-4011-z; Jonas Jost B, 2017, LANCET LOGO, V390, P2083; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; Kapetanakis VV, 2016, BRIT J OPHTHALMOL, V100, P86, DOI 10.1136/bjophthalmol-2015-307223; Kolko M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132048; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Minassian DC, 2000, BRIT J OPHTHALMOL, V84, P1159, DOI 10.1136/bjo.84.10.1159; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RINGVOLD A, 1991, ACTA OPHTHALMOL, V69, P273; Ringvold A, 1996, Eur J Ophthalmol, V6, P26; Schoff EO, 2001, OPHTHALMOLOGY, V108, P882, DOI 10.1016/S0161-6420(01)00550-4; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Topouzis F, 2007, AM J OPHTHALMOL, V144, P511, DOI 10.1016/j.ajo.2007.06.029; Wang W, 2019, ACTA OPHTHALMOL, V97, pE349, DOI 10.1111/aos.14044; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242786	10.1371/journal.pone.0242786	http://dx.doi.org/10.1371/journal.pone.0242786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301476	gold, Green Published			2022-12-26	WOS:000600143100036
J	de Andrade, CLT; Pereira, CCD; Martins, M; Lima, SML; Portela, MC				Tavares de Andrade, Carla Lourenco; de Aguiar Pereira, Claudia Cristina; Martins, Monica; Lemos Lima, Sheyla Maria; Portela, Margareth Crisostomo			COVID-19 hospitalizations in Brazil's Unified Health System (SUS)	PLOS ONE			English	Article							COMORBIDITY MEASURES	Objective To study the profile of hospitalizations due to COVID-19 in the Unified Health System (SUS) in Brazil and to identify factors associated with in-hospital mortality related to the disease. Methods Cross-sectional study, based on secondary data on COVID-19 hospitalizations that occurred in the SUS between late February through June. Patients aged 18 years or older with primary or secondary diagnoses indicative of COVID-19 were included. Bivariate analyses were performed and generalized linear mixed models (GLMM) were estimated with random effects intercept. The modeling followed three steps, including: attributes of the patients; elements of the care process; and characteristics of the hospital and place of hospitalization. Results 89,405 hospitalizations were observed, of which 24.4% resulted in death. COVID-19 patients hospitalized in the SUS were predominantly male (56.5%) with a mean age of 58.9 years. The length of stay ranged from less than 24 hours to 114 days, with a mean of 6.9 (+/- 6.5) days. Of the total number of hospitalizations, 22.6% reported ICU use. The odds on in-hospital death were 16.8% higher among men than among women and increased with age. Black individuals had a higher likelihood of death. The behavior of the Charlson and Elixhauser indices was consistent with the hypothesis of a higher risk of death among patients with comorbidities, and obesity had an independent effect on increasing this risk. Some states, such as Amazonas and Rio de Janeiro, had a higher risk of in-hospital death from COVID-19. The odds on in-hospital death were 72.1% higher in municipalities with at least 100,000 inhabitants, though being hospitalized in the municipality of residence was a protective factor. Conclusion There was broad variation in COVID-19 in-hospital mortality in the SUS, associated with demographic and clinical factors, social inequality, and differences in the structure of services and quality of health care.	[Tavares de Andrade, Carla Lourenco; de Aguiar Pereira, Claudia Cristina; Martins, Monica; Lemos Lima, Sheyla Maria; Portela, Margareth Crisostomo] Fundacao Oswaldo Cruz, Dept Adm & Planejamento Saude, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	Portela, MC (corresponding author), Fundacao Oswaldo Cruz, Dept Adm & Planejamento Saude, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil.	mportela@ensp.fiocruz.br	Portela, Margareth C/G-6699-2012; Pereira, Claudia/AAZ-9123-2021; Pereira, Claudia/AAZ-9108-2021	Portela, Margareth C/0000-0002-9858-9276; Pereira, Claudia/0000-0003-1389-9214; Pereira, Claudia/0000-0003-1389-9214	PrInt Fiocruz-CAPES Program; Brazilian National Council of Scientific and Technological Development (CNPq)	PrInt Fiocruz-CAPES Program; Brazilian National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful for support from PrInt Fiocruz-CAPES Program. CCAP, MM e MCP are recipients of productivity fellowships from the Brazilian National Council of Scientific and Technological Development (CNPq).	Aldridge Robert W, 2020, Wellcome Open Res, V5, P88, DOI [10.12688/wellcomeopenres.15922.1, 10.12688/wellcomeopenres.15922.2]; Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Brasil. Ministerio da Saude, DATASUS; Brasil. Ministerio da Saude, PORT GM MS N 245 24; Brasil. Ministerio da Saude. Secretaria de Assistencia Especializada a Saude. Departamento de RegulacAo AvaliacAo e Controle, COVID 19 OR TECN OP; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2020, B EP ESP COE COVID 1; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2020, B EP ESP 78 DOENC PE; Castro MC, 2019, LANCET, V394, P345, DOI 10.1016/S0140-6736(19)31243-7; Caussy C, 2020, LANCET DIABETES ENDO, V8, P562, DOI [10.1016/S2213-8587(20)30160-0, 10.1016/S2213-8587(20)30160-1]; Charlotte P, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20314; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Drager LF, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01057-x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Goel S, 2020, CARDIOL THER, P1, DOI [10.1007/s40119-020-00166-7, DOI 10.1007/S40119-020-00166-7]; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Marmot M, 2020, J EPIDEMIOL COMMUN H, V74, P681, DOI 10.1136/jech-2020-214720; Martins M, 2010, REV SAUDE PUBL, V44, P448, DOI 10.1590/S0034-89102010005000003; Noronha KVMD, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00115320; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Portela MC, REGIOES SAUDE CAPACI; Portela MC, LIMITES POSSIBILIDAD; Portela MC, DISPONIBILIDADE RECU; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramasamy R, 2020, BRIT J HAEMATOL, V190, pE78, DOI 10.1111/bjh.16869; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Tartof SY, 2020, ANN INTERN MED, V173, P773, DOI 10.7326/M20-3742; Tavares FF, 2020, VULNERABILITY POVERT; World Health Organization, 2020, OX SOURC DISTR COVID; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	35	18	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243126	10.1371/journal.pone.0243126	http://dx.doi.org/10.1371/journal.pone.0243126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301479	Green Submitted, Green Published, gold			2022-12-26	WOS:000600143100053
J	Green, KJ; Dods, K; Hammer, KA				Green, Kathryn J.; Dods, Kenneth; Hammer, Katherine A.			Development and validation of a new microplate assay that utilises optical density to quantify the antibacterial activity of honeys including Jarrah, Marri and Manuka	PLOS ONE			English	Article							SUSCEPTIBILITY; SENSITIVITY; ANTIOXIDANT; BACTERIA; AUREUS	The phenol equivalence assay is the current industry-adopted test used to quantify the antibacterial activity of honeys in Australia and New Zealand. Activity is measured based on the diffusion of honey through agar and resulting zone of growth inhibition. Due to differences in the aqueous solubilities of antibacterial compounds found in honeys, this method may not be optimal for quantifying activity. Therefore, a new method was developed based on the existing broth microdilution assay that is widely used for determining minimum inhibitory concentrations (MICs). It utilises the four organisms Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853, and an optical density endpoint to quantify bacterial growth. Decreases in bacterial growth in the presence of honey, relative to the positive growth control, are then used to derive a single value to represent the overall antibacterial activity of each honey. Antibacterial activity was quantified for a total of 77 honeys using the new method, the phenol equivalence assay and the standard broth microdilution assay. This included 69 honeys with undisclosed floral sources and the comparators Manuka, Jarrah (Eucalyptus marginata), Marri (Corymbia calophylla), artificial and multifloral honey. For the 69 honey samples, phenol equivalence values ranged from 0-48.5 with a mean of 34 (% w/v phenol). Mean MICs, determined as the average of the MICs obtained for each of the four organisms for each honey ranged from 7-24% (w/v honey). Using the new assay, values for the 69 honeys ranged from 368 to 669 activity units, with a mean of 596. These new antibacterial activity values correlated closely with mean MICs (R-2 = 0.949) whereas the relationship with phenol equivalence values was weaker (R-2 = 0.649). Limit of detection, limit of quantitation, measuring interval, limit of reporting, sensitivity, selectivity, repeatability, reproducibility, and ruggedness were also investigated and showed that the new assay was both robust and reproducible.	[Green, Kathryn J.; Hammer, Katherine A.] Univ Western Australia, Sch Biomed Sci, Crawley, WA, Australia; [Green, Kathryn J.; Dods, Kenneth; Hammer, Katherine A.] Univ Western Australia, CRC Honey Bee Prod, Crawley, WA, Australia; [Dods, Kenneth] ChemCentre, Resources & Chem Precinct, Bentley, WA, Australia	University of Western Australia; University of Western Australia	Hammer, KA (corresponding author), Univ Western Australia, Sch Biomed Sci, Crawley, WA, Australia.; Hammer, KA (corresponding author), Univ Western Australia, CRC Honey Bee Prod, Crawley, WA, Australia.	katherine.hammer@uwa.edu.au	Hammer, Katherine/B-7023-2012	Hammer, Katherine/0000-0001-7878-4851	Bee Industry Council of Western Australia (BICWA); Department of Primary Industry and Regional Development's (DPIRD) Grower Group Research and Development Program [GGRD 2015-0028-AGSC]; CRC for Honeybee Products [015]	Bee Industry Council of Western Australia (BICWA); Department of Primary Industry and Regional Development's (DPIRD) Grower Group Research and Development Program; CRC for Honeybee Products	The authors acknowledge the Bee Industry Council of Western Australia (BICWA) for the provision of Industry Funding and for the Western Australian mono-floral honeys used in this study.; This study was funded by grants from the Department of Primary Industry and Regional Development's (DPIRD) Grower Group Research and Development Program to KD (GGRD 2015-0028-AGSC; https://dpird.wa.gov.au/), and CRC for Honeybee Products to KD (Grant no. 015; http://www.crchoneybeeproducts.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Alnaimat S, 2012, J MICROB BIOTEC FOOD, V1, P1328; Anand S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00263; Anand S, 2018, MOLECULES, V23, DOI 10.3390/molecules23010108; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2008, PT MAGAZINE PHYS THE, V16, P24; [Anonymous], 2013, 2300822013 ISOIEC, V1, P20; [Anonymous], 2007, PLOS ONE, V2, pe779; Baltrusaityte V, 2007, FOOD TECHNOL BIOTECH, V45, P201; Beretta G, 2005, ANAL CHIM ACTA, V533, P185, DOI 10.1016/j.aca.2004.11.010; Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090; Breskia BA, 2013, SPECIFICATION DRUG S, V2nd, P313; Brudzynski K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08072-0; Brudzynski K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00036; Brudzynski K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00213; Bucekova M, 2019, MOLECULES, V24, DOI 10.3390/molecules24081573; Bucekova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27449-3; Chen C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00265; Cianciosi D, 2018, MOLECULES, V23, DOI 10.3390/molecules23092322; Clinical and Laboratory Standards Institute, 2019, M100 CLSI, V29th; Clinical and Laboratory Standards Institute, 2018, M07A11 CLSI, V11th; Cokcetin NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167780; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2009, WOUNDS, V21, P29; Dryden M, 2014, J GLOB ANTIMICROB RE, V2, P168, DOI 10.1016/j.jgar.2014.03.006; Eloff JN, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2519-3; Girma A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224495; Haase H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188304; Henriques AF, 2011, EUR J CLIN MICROBIOL, V30, P167, DOI 10.1007/s10096-010-1065-1; Hussain MB, 2017, COMPLEMENT THER CLIN, V27, P57, DOI 10.1016/j.ctcp.2017.04.003; Hussain R, 2015, RURAL REMOTE HEALTH, V15; Irish J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018229; Jenkins R, 2015, ARCH MICROBIOL, V197, P597, DOI 10.1007/s00203-015-1091-6; Karatuna O., 2012, LATEST RES QUALITY C, P413; Kenny CR, 2015, BRIT J BIOMED SCI, V72, P191, DOI 10.1080/09674845.2015.11665752; Kirby JE, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01270-19; Kwakman PHS, 2012, IUBMB LIFE, V64, P48, DOI 10.1002/iub.578; Manning R., 2011, RES W AUSTR HONEYS; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Merckoll P, 2009, SCAND J INFECT DIS, V41, P341, DOI 10.1080/00365540902849383; Mohan A, 2017, FOOD QUAL SAF-OXFORD, V1, P107, DOI 10.1093/fqsafe/fyx015; MOLAN PC, 1992, BEE WORLD, V73, P59, DOI 10.1080/0005772X.1992.11099118; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; NATA, 17 NATA; National Center for Biotechnology Information, PUBCHEM COMP SUMM CI; Nixon KR, 2019, ADV WOUND CARE, V8, P403, DOI 10.1089/wound.2018.0848; Oses SM, 2016, NJAS-WAGEN J LIFE SC, V78, P29, DOI 10.1016/j.njas.2015.12.005; Parker AE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30282-3; Patel JB, 2013, CLIN MICROBIOL NEWSL, V35, P103, DOI DOI 10.1016/J.CLINMICNEWS.2013.06.001; Patton T, 2006, J MICROBIOL METH, V64, P84, DOI 10.1016/j.mimet.2005.04.007; Rosanske TW, 2013, SPECIFICATION DRUG S, V2nd, P73; Roshan N, 2017, ARCH MICROBIOL, V199, P347, DOI 10.1007/s00203-016-1308-3; Sanz ML, 2005, J AGR FOOD CHEM, V53, P2914, DOI 10.1021/jf0500684; Schumacher A, 2018, EUR J CLIN MICROBIOL, V37, P187, DOI 10.1007/s10096-017-3089-2; Sherlock O, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-47; Sindi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54217-8; Sobiesiak M., 2017, PHENOLIC COMPOUNDS N; Sultanbawa Y, 2015, FOOD CHEM, V172, P207, DOI 10.1016/j.foodchem.2014.09.067; Tan JBL, 2015, FOOD CHEM, V172, P814, DOI 10.1016/j.foodchem.2014.09.141; Tsang AS, 2017, AUST VET J, V95, P333, DOI 10.1111/avj.12616; United States Pharmacopeia and National Formulary, 2017, 41NF36 USP; WILLIX DJ, 1992, J APPL BACTERIOL, V73, P388, DOI 10.1111/j.1365-2672.1992.tb04993.x; Zainol MI, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-129	63	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243246	10.1371/journal.pone.0243246	http://dx.doi.org/10.1371/journal.pone.0243246			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296391	Green Published, gold			2022-12-26	WOS:000598626100034
J	Mahmood, AM; Dunwell, JM				Mahmood, Asaad M.; Dunwell, Jim M.			2-oxoglutarate-dependent dioxygenases: A renaissance in attention for ascorbic acid in plants	PLOS ONE			English	Article							L-GALACTOSE PHOSPHORYLASE; VITAMIN-C; FEEDBACK-REGULATION; SEED-GERMINATION; ABSCISIC-ACID; GDP-MANNOSE; BIOSYNTHESIS; INHIBITION; PHOSPHATASE; MYOINOSITOL	L-Ascorbic acid (ascorbate, Vitamin C) is an essential human micronutrient that is predominantly obtained from plants. It is known to work as the major antioxidant in plants, and it underpins several environmentally induced stresses due to its use as a co-factor by certain 2-oxoglutarate-dependent (2-OG) dioxygenases [2(OG)-dioxygenases]. It is important to understand the role of 2(OG)-dioxygenases in the biosynthesis of ascorbate. The present study examined contents of ascorbate and protein-protein interaction in nine T-DNA mutants of Arabidopsis containing an insert in their respective (2-OG) dioxygenase genes (At1g20270, At1g68080, At2g17720, At3g06290, At3g28490, At4g35810, At4g35820, At5g18900, At5g66060). In this study, the amount of ascorbate in five of the mutants was shown to be almost two-fold or more than two-fold higher than in the wild type. This result may be a consequence of the insertion of the T-DNA. The prediction of possible protein interactions between 2(OG)-dioxygenases and relevant ascorbate-function players may indicate the oxidative effects of certain dioxygenase proteins in plants. It is expected that certain dioxygenases are actively involved in the metabolic and biosynthetic pathways of ascorbate. This involvement may be of importance to increase ascorbate amounts in plants for human nutrition, and to protect plant species against stress conditions.	[Mahmood, Asaad M.] Univ Garmian, Coll Educ, Dept Biol, Kalar, Krg, Iraq; [Dunwell, Jim M.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	University of Reading	Mahmood, AM (corresponding author), Univ Garmian, Coll Educ, Dept Biol, Kalar, Krg, Iraq.	asaad@garmian.edu.krd	Mahmood, Asaad/AAD-3912-2021	Mahmood, Asaad/0000-0002-6281-9797	Kurdistan Regional Government (KRG)/Iraq	Kurdistan Regional Government (KRG)/Iraq	This work was financially supported by Kurdistan Regional Government (KRG)/Iraq	Barth C, 2010, J EXP BOT, V61, P379, DOI 10.1093/jxb/erp310; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; BORGES AA, 2014, FRONT PLANT SCI, V5, pNIL1, DOI DOI 10.3389/fpls.2014.00642; Broad RC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051790; Bulley S, 2016, CURR OPIN PLANT BIOL, V33, P15, DOI 10.1016/j.pbi.2016.04.010; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Conklin PL, 2013, J EXP BOT, V64, P2793, DOI 10.1093/jxb/ert140; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; De Tullio MC, 2020, ENVIRON EXP BOT, V178, DOI 10.1016/j.envexpbot.2020.104173; Foyer CH, 2020, ANTIOXID REDOX SIGN, V32, P463, DOI 10.1089/ars.2019.7819; Gao Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1783, DOI 10.1271/bbb.110320; Gao Y, 2015, FEBS J, V282, P685, DOI 10.1111/febs.13173; Giberti S, 2014, NEW PHYTOL, V202, P911, DOI 10.1111/nph.12701; Hernandez A, 2020, REV ESP ANEST REANIM, V67, P245, DOI 10.1016/j.redar.2020.03.004; Laing WA, 2015, PLANT CELL, V27, P772, DOI 10.1105/tpc.114.133777; Lewandowska-Sabat AM, 2012, PLANT SCI, V185, P143, DOI 10.1016/j.plantsci.2011.10.009; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Luo M, 2012, BBA-GENE REGUL MECH, V1819, P129, DOI 10.1016/j.bbagrm.2011.06.008; Macknight RC, 2017, CURR OPIN BIOTECH, V44, P153, DOI 10.1016/j.copbio.2017.01.011; Mahmood AM, J U GARMIAN, V4, P676; Mahmood AM, 2019, AIMS GENET, V6, P70, DOI 10.3934/genet.2019.4.70; Martinez-Andujar C, 2020, PLANT SCI, V295, DOI 10.1016/j.plantsci.2019.110268; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Cecchini NM, 2011, PLANT PHYSIOL, V155, P1947, DOI 10.1104/pp.110.167163; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Smimoff N, 2003, NAT BIOTECHNOL, V21, P134, DOI 10.1038/nbt0203-134; Smirnoff N, 2001, VITAM HORM, V61, P241; Smirnoff N, 2018, FREE RADICAL BIO MED, V122, P116, DOI 10.1016/j.freeradbiomed.2018.03.033; Suzuki N, 2013, J EXP BOT, V64, P253, DOI 10.1093/jxb/ers335; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Torabinejad J, 2009, PLANT PHYSIOL, V150, P951, DOI 10.1104/pp.108.135129; Van Akent O, 2015, TRENDS PLANT SCI, V20, P754, DOI 10.1016/j.tplants.2015.08.002; Veljovic-Jovanovic S., 2018, ASCORBIC ACID PLANT, P47, DOI DOI 10.1007/978-3-319-74057-7_3; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Ye NH, 2012, PLANT SIGNAL BEHAV, V7, P563, DOI 10.4161/psb.19919; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934	42	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0242833	10.1371/journal.pone.0242833	http://dx.doi.org/10.1371/journal.pone.0242833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290424	Green Accepted, Green Published, gold			2022-12-26	WOS:000598620100006
J	Tanhua, T; Gutekunst, SB; Biastoch, A				Tanhua, Toste; Gutekunst, Soren B.; Biastoch, Arne			A near-synoptic survey of ocean microplastic concentration along an around-the-world sailing race	PLOS ONE			English	Article							ATLANTIC-OCEAN; INGESTION; POLLUTION; PATHWAYS; DEBRIS	Litter and plastic pollution in the marine environment is of major concern when considering the health of ocean ecosystems, and have become an important focus of ocean research during recent years. There is still significant uncertainty surrounding the distribution and impact of marine plastic litter on ocean ecosystems, and in particular on the nano- and microplastic fractions that are difficult to observe and may be harmful to marine organisms. Current estimates of ocean plastic concentrations only account for a small fraction of the approximated 8 million tons of plastic litter entering the oceans on an annual basis. Here, we present the distribution of 100-500 mu m microplastic particles within the ocean mixed layer, covering a significant fraction of the ocean, in a near-synoptic survey. During The Ocean Race 2017/2018 edition (formerly known as Volvo Ocean Race), two yachts served as ships of opportunity that regularly took samples of microplastics on a regular schedule during their circumnavigation. This effort resulted in information on microplastic distribution along the race track in the ocean's upper, well-mixed, layer. We found concentrations ranging from 0-349 particles per cubic meter, but with large spatial variability. There was a tendency toward higher concentrations off south-western Europe and in the southwest Pacific, and indications of long-range transport of microplastic with major ocean currents.	[Tanhua, Toste; Gutekunst, Soren B.; Biastoch, Arne] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Gutekunst, Soren B.] Ocean Race, Alicante, Spain; [Gutekunst, Soren B.] SCG Sci Consulting Dr Ing, Koblenz, Germany; [Biastoch, Arne] Christian Albrechts Univ Kiel, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Tanhua, T (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	ttanhua@geomar.de		Tanhua, Toste/0000-0002-0313-2557	Cluster of Excellence - Future Ocean in Kiel, Germany [CP1756]; bbe Moldaenke GmbH	Cluster of Excellence - Future Ocean in Kiel, Germany; bbe Moldaenke GmbH	This study was funded by the Cluster of Excellence - Future Ocean in Kiel, Germany (project number CP1756). Volvo Cars provided support to purchase instrumentation, and instrumentation developers SubCtech GmbH and bbe Moldaenke GmbH also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrady AL, 2015, MARINE ANTHROPOGENIC LITTER, P57, DOI 10.1007/978-3-319-16510-3_3; Biastoch A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10082; Carbery M, 2018, ENVIRON INT, V115, P400, DOI 10.1016/j.envint.2018.03.007; Carlstrom CT, 2017, AM ECON J-MACROECON, V9, P205, DOI 10.1257/mac.20150179; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Cowger W, 2020, APPL SPECTROSC, V74, P1066, DOI 10.1177/0003702820930292; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Dehaut A, 2019, TRAC-TREND ANAL CHEM, V116, P346, DOI 10.1016/j.trac.2018.11.011; Desforges JPW, 2015, ARCH ENVIRON CON TOX, V69, P320, DOI 10.1007/s00244-015-0172-5; Desforges JPW, 2014, MAR POLLUT BULL, V79, P94, DOI 10.1016/j.marpolbul.2013.12.035; Enders K, 2015, MAR POLLUT BULL, V100, P70, DOI 10.1016/j.marpolbul.2015.09.027; Fackelmann G, 2019, MAR POLLUT BULL, V143, P193, DOI 10.1016/j.marpolbul.2019.04.030; Gewert B, 2015, ENVIRON SCI-PROC IMP, V17, P1513, DOI 10.1039/c5em00207a; Hall NM, 2015, MAR BIOL, V162, P725, DOI 10.1007/s00227-015-2619-7; Hartmann NB, 2019, ENVIRON SCI TECHNOL, V53, P1039, DOI 10.1021/acs.est.8b05297; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kanhai LK, 2017, MAR POLLUT BULL, V115, P307, DOI 10.1016/j.marpolbul.2016.12.025; Lenz R, 2015, MAR POLLUT BULL, V100, P82, DOI 10.1016/j.marpolbul.2015.09.026; Lu YF, 2016, ENVIRON SCI TECHNOL, V50, P4054, DOI 10.1021/acs.est.6b00183; Lusher AL, 2014, MAR POLLUT BULL, V88, P325, DOI 10.1016/j.marpolbul.2014.08.023; Lutjeharms JRE, 2006, AGULHAS CURRENT; Maximenko N, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00447; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Ostle C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09506-1; Reisser J, 2015, BIOGEOSCIENCES, V12, P1249, DOI 10.5194/bg-12-1249-2015; Stelfox M, 2016, MAR POLLUT BULL, V111, P6, DOI 10.1016/j.marpolbul.2016.06.034; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; Vroom RJE, 2017, ENVIRON POLLUT, V231, P987, DOI 10.1016/j.envpol.2017.08.088; Wardrop P, 2016, ENVIRON SCI TECHNOL, V50, P4037, DOI 10.1021/acs.est.5b06280; Wilcox C, 2015, P NATL ACAD SCI USA, V112, P11899, DOI 10.1073/pnas.1502108112	32	5	5	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243203	10.1371/journal.pone.0243203	http://dx.doi.org/10.1371/journal.pone.0243203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290395	Green Published, Green Accepted, gold			2022-12-26	WOS:000598620100002
J	Campo, DS; Gussler, JW; Sue, A; Skums, P; Khudyakov, Y				Campo, David S.; Gussler, Joseph W.; Sue, Amanda; Skums, Pavel; Khudyakov, Yury			Accurate spatiotemporal mapping of drug overdose deaths by machine learning of drug-related web-searches	PLOS ONE			English	Article							HIV-INFECTION; INTERNET SEARCHES; OXYMORPHONE; OUTBREAK; INDIANA	Persons who inject drugs (PWID) are at increased risk for overdose death (ODD), infections with HIV, hepatitis B (HBV) and hepatitis C virus (HCV), and noninfectious health conditions. Spatiotemporal identification of PWID communities is essential for developing efficient and cost-effective public health interventions for reducing morbidity and mortality associated with injection-drug use (IDU). Reported ODDs are a strong indicator of the extent of IDU in different geographic regions. However, ODD quantification can take time, with delays in ODD reporting occurring due to a range of factors including death investigation and drug testing. This delayed ODD reporting may affect efficient early interventions for infectious diseases. We present a novel model, Dynamic Overdose Vulnerability Estimator (DOVE), for assessment and spatiotemporal mapping of ODDs in different U.S. jurisdictions. Using Google(R) Web-search volumes (i.e., the fraction of all searches that include certain words), we identified a strong association between the reported ODD rates and drug-related search terms for 2004-2017. A machine learning model (Extremely Random Forest) was developed to produce yearly ODD estimates at state and county levels, as well as monthly estimates at state level. Regarding the total number of ODDs per year, DOVE's error was only 3.52% (Median Absolute Error, MAE) in the United States for 2005-2017. DOVE estimated 66,463 ODDs out of the reported 70,237 (94.48%) during 2017. For that year, the MAE of the individual ODD rates was 4.43%, 7.34%, and 12.75% among yearly estimates for states, yearly estimates for counties, and monthly estimates for states, respectively. These results indicate suitability of the DOVE ODD estimates for dynamic IDU assessment in most states, which may alert for possible increased morbidity and mortality associated with IDU. ODD estimates produced by DOVE offer an opportunity for a spatiotemporal ODD mapping. Timely identification of potential mortality trends among PWID might assist in developing efficient ODD prevention and HBV, HCV, and HIV infection elimination programs by targeting public health interventions to the most vulnerable PWID communities.	[Campo, David S.; Gussler, Joseph W.; Sue, Amanda; Khudyakov, Yury] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Gussler, Joseph W.; Skums, Pavel] Georgia State Univ, Atlanta, GA 30303 USA; [Sue, Amanda] SUNY Albany, Albany, NY 12222 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Campo, DS (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	fyv6@cdc.gov		Campo, David S./0000-0002-8970-3436				[Anonymous], 2017, MMWR-MORBID MORTAL W, V66, P465; [Anonymous], 2013, CLIN INFECT DIS, V57, pi; Bowen DA, 2019, J GEN INTERN MED, V34, P2702, DOI 10.1007/s11606-019-05255-5; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Campbell EM, 2017, J INFECT DIS, V216, P1053, DOI 10.1093/infdis/jix307; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Domnich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127754; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Kandula S, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007258; Lippi G, 2019, J EPIDEMIOL GLOB HEA, V9, P146, DOI 10.2991/jegh.k.190314.003; Lippi G, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2018.11.55; Longmire AG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4268-3; Maree R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S2; NCHS, 2020, PROV DRUG OV DEATH C; NCHS, 2019, ICD 10 CM INT CLASS; NCHS, 2019, UND CAUS DEATH 1999; Okolie C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008981; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perlman DC, 2018, CURR HIV-AIDS REP, V15, P96, DOI 10.1007/s11904-018-0390-3; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Ramachandran S, 2016, NETWORKS HCV TRANSMI; Saab S, 2018, HEPATOLOGY, V67, P2449, DOI 10.1002/hep.29685; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Sandahl M, 2016, STAT ANAL GOOGLE FLU; Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085; Urbanowicz RJ, 2018, J BIOMED INFORM, V85, P168, DOI 10.1016/j.jbi.2018.07.015; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; Varian, 2009, PREDICTING PRESENT G; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Young SD, 2018, DRUG ALCOHOL DEPEN, V190, P166, DOI 10.1016/j.drugalcdep.2018.05.009	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243622	10.1371/journal.pone.0243622	http://dx.doi.org/10.1371/journal.pone.0243622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284864	Green Published, gold			2022-12-26	WOS:000597930500005
J	Lu, J; Bang, H; Kim, SM; Cho, SJ; Ashktorab, H; Smoot, DT; Zheng, CH; Ryeom, SW; Yoon, SS; Yoon, C; Lee, JH				Lu, Jun; Bang, Heejin; Kim, Su Mi; Cho, Soo-Jeong; Ashktorab, Hassan; Smoot, Duane T.; Zheng, Chao-hui; Ryeom, Sandra W.; Yoon, Sam S.; Yoon, Changhwan; Lee, Jun Ho			Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DRUG-RESISTANCE; DOWN-REGULATION; BREAST-CANCER; PROMOTES LYMPHANGIOGENESIS; CHEMOTHERAPY RESISTANCE; LUNG; EXPRESSION; CHEMORESISTANCE; PATHWAY	The poor prognosis of gastric cancer (GC) results largely from metastasis and chemotherapy resistance. Toward novel therapeutic strategies that target or evade these phenomena, we evaluated the function of the transcriptional regulator transducin (beta)-like 1 X-linked receptor 1 (TBL1XR1) in GC cells, including stem-like cells. In this study, the correlation of expression of TBL1XR1 and clinical features and GC patients' outcomes was evaluated. Knockdown or exogenous expression of TBL1XR1 was combined with in vitro (2D and 3D cultures) and in vivo (mouse lung and lymphatic metastasis models) assays to evaluate the function of TBL1XR1. TBL1XR1's downstream signaling was delineated by phospho-kinase array and knockdown of candidate mediators. Analysis of clinical data showed that TBL1XR1 overexpression was correlated with worse prognosis. Functional assays showed that TBL1XR1 promoted stemness, epithelial-mesenchymal transition (EMT), and lung and lymphatic metastasis in GC cells. TBL1XR1 activated ERK1/2-Sox2 signaling and was dependent on signaling via PI3K/AKT, in GC stem-like cells distinguished by CD44 expression. Moreover, inhibition of these signaling proteins reversed chemoresistance in in vitro and in vivo models. Taken together, our results indicate that TBL1XR1 promotes stemness and metastasis in GC, making it a potential prognostic indicator. The PI3K/AKT-TBL1XR1-ERK1/2-Sox2 axis may represent a target for the treatment of GC.	[Lu, Jun; Yoon, Sam S.; Yoon, Changhwan] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Lu, Jun; Zheng, Chao-hui] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian, Peoples R China; [Bang, Heejin] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Pathol, Seoul, South Korea; [Kim, Su Mi; Lee, Jun Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Su Mi] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Surg, Seongnam, Gyeonggi Do, South Korea; [Cho, Soo-Jeong] Seoul Natl Univ Hosp, Liver Res Inst, Dept Internal Med, Seoul, South Korea; [Ashktorab, Hassan; Smoot, Duane T.] Howard Univ, Dept Med, Washington, DC 20059 USA; [Ryeom, Sandra W.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Fujian Medical University; Hallym University; Sungkyunkwan University (SKKU); Samsung Medical Center; Pochon Cha University; Seoul National University (SNU); Seoul National University Hospital; Howard University; University of Pennsylvania	Yoon, C (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Lee, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea.	yoonc1@mskcc.org; gsjunholee@gmail.com	Lu, Jun/AAP-1222-2021; Yoon, Changhwan/AAK-7842-2021; Zheng, Chao-hui/HGE-3348-2022	Yoon, Changhwan/0000-0002-8420-9818; Zheng, Chao-hui/0000-0001-8680-3127; CHO, SOO-JEONG/0000-0001-7144-0589	NIH/NCI [1R01 CA158301-01]; Cancer Center Support Grant [P30 CA008748]; Natural Science Foundation of Fujian Province [2019J01155]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This research was supported by NIH/NCI through 1R01 CA158301-01 (SSY), Cancer Center Support Grant P30 CA008748 (MSKCC), and Natural Science Foundation of Fujian Province (2019J01155). Authors thank Jessica Moore, MS, senior editor and grant writer at MSK, for help in editing and revising the manuscript.	An YF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2308-4; Banerjee A, 2017, NEURO-ONCOLOGY, V19, P1135, DOI 10.1093/neuonc/now282; Bekaii-Saab T, 2017, CANCER-AM CANCER SOC, V123, P1303, DOI 10.1002/cncr.30538; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen SP, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-195; Cho SJ, 2018, CLIN CANCER RES, V24, P6556, DOI 10.1158/1078-0432.CCR-17-1679; Cho SJ, 2015, INT J CANCER, V136, P810, DOI 10.1002/ijc.29056; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Dawood S, 2014, ONCOLOGY-NY, V28, P1101; Dong H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1776-x; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Etoh T, 2001, CANCER RES, V61, P2145; Farley J, 2013, LANCET ONCOL, V14, P134, DOI 10.1016/S1470-2045(12)70572-7; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garcia-Mayea Y, 2020, SEMIN CANCER BIOL, V60, P166, DOI 10.1016/j.semcancer.2019.07.022; Han ME, 2011, CELL MOL LIFE SCI, V68, P3589, DOI 10.1007/s00018-011-0672-z; Hao SN, 2014, TUMOR BIOL, V35, P5675, DOI 10.1007/s13277-014-1751-1; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Hu J, 2010, INT J CANCER, V127, P2455, DOI 10.1002/ijc.25253; Huang WF, 2014, INT J MOL SCI, V15, P3432, DOI 10.3390/ijms15033432; Ji RB, 2015, CELL CYCLE, V14, P2473, DOI 10.1080/15384101.2015.1005530; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Khurana SS, 2013, J BIOL CHEM, V288, P16085, DOI 10.1074/jbc.M112.445551; Lee KM, 2017, CELL METAB, V26, P633, DOI 10.1016/j.cmet.2017.09.009; Li XH, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0465-z; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Liu SQ, 2006, DIGEST LIVER DIS, V38, P310, DOI 10.1016/j.dld.2006.01.012; Lu J, 2019, GASTRIC CANCER, V22, P536, DOI 10.1007/s10120-018-0892-0; Martelli AM, 2011, CURR MED CHEM, V18, P2715; Martins-Neves SR, 2018, PHARMACOL RES, V137, P193, DOI 10.1016/j.phrs.2018.10.011; Mashino K, 2002, CANCER RES, V62, P2937; Masters JRW, 2000, BRIT J CANCER, V82, P1495; Nasarre P, 2013, CANCER RES, V73, P7111, DOI 10.1158/0008-5472.CAN-13-1755; Ono H, 2012, ONCOGENE, V31, P4923, DOI 10.1038/onc.2011.646; Nguyen PH, 2017, CLIN CANCER RES, V23, P1586, DOI 10.1158/1078-0432.CCR-15-2157; Ruan XH, 2019, MOL THER-ONCOLYTICS, V14, P94, DOI 10.1016/j.omto.2019.04.002; Salaroglio IC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102505; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Sciacovelli M, 2017, FEBS J, V284, P3132, DOI 10.1111/febs.14090; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Skog M, 2011, BRIT J CANCER, V105, P1346, DOI 10.1038/bjc.2011.297; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Till JE, 2017, CANCER RES, V77, P5349, DOI 10.1158/0008-5472.CAN-17-0061; Turk CM, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-17; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wang J, 2014, BRIT J CANCER, V111, P112, DOI 10.1038/bjc.2014.278; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Wu G, 2014, INT J CLIN EXP PATHO, V7, P1449; Xi XH, 2019, EUR J PHARMACOL, V844, P259, DOI 10.1016/j.ejphar.2018.12.013; Xia P, 2015, AM J CANCER RES, V5, P1602; Yang J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0954-x; Yoon C, 2019, MOL CANCER RES, V17, P1945, DOI 10.1158/1541-7786.MCR-19-0077; Yoon C, 2016, CLIN CANCER RES, V22, P971, DOI 10.1158/1078-0432.CCR-15-1356; Yoon C, 2014, CLIN CANCER RES, V20, P3974, DOI 10.1158/1078-0432.CCR-14-0011; Yoon SS, 1999, CANCER RES, V59, P6251; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-4057; Zhang HZ, 2019, INT J BIOL MACROMOL, V128, P574, DOI 10.1016/j.ijbiomac.2019.01.195; Zhang JX, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0586-y; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhao YY, 2015, MOL MED REP, V12, P7335, DOI 10.3892/mmr.2015.4367; Zhou L, 2018, CANCER SCI, V109, P1044, DOI 10.1111/cas.13538; Zhou Q, 2017, ONCOGENE, V36, P1873, DOI 10.1038/onc.2016.352	65	6	6	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					922	936		10.1038/s41388-020-01571-x	http://dx.doi.org/10.1038/s41388-020-01571-x		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33288885				2022-12-26	WOS:000599011200003
J	Gao, YT; Li, RJ; Yang, WQ; Zhou, M; Wang, L; Ma, CB; Xi, XP; Chen, TB; Shaw, C; Wu, D				Gao, Yitian; Li, Renjie; Yang, Wenqing; Zhou, Mei; Wang, Lei; Ma, Chengbang; Xi, Xinping; Chen, Tianbao; Shaw, Chris; Wu, Di			Identification of a new myotropic decapeptide from the skin secretion of the red-eyed leaf frog, Agalychnis callidryas	PLOS ONE			English	Article							BRADYKININ-RELATED PEPTIDES; PHYLLOMEDUSA-HYPOCHONDRIALIS-AZUREA; STRUCTURAL-CHARACTERIZATION; PRECURSOR CDNAS; SMOOTH-MUSCLE; CLONING; TACHYKININS	Bradykinin-related peptides (BRPs) family is one of the most significant myotropic peptide families derived from frog skin secretions. Here, a novel BRP callitide was isolated and identified from the red-eyed leaf frog, Agalychnis callidryas, with atypical primary structure FRPAILVRPK-NH2. The mature peptide was cleaved N-terminally at a classic propeptide convertase cleavage site (-KR-) and at the C-terminus an unusual -GKGKGK sequence was removed using the first G residue as an amide donor for the C-terminally-located K residue. Thereafter, the synthetic replicates of callitide were assessed the myotropic activity and showed a significant contraction of balder, with the 0.63 nM EC50 value, more potent than most discovered myotropic peptides. The binding mode was further speculated by molecular docking and stimulation. The result indicated that the C-terminal of callitide might selectively bind to bradykinin receptor B2 (BKRB2). Further investigation of the callitide needs to be done in the future to be exploited as potential future drug leads.	[Gao, Yitian; Yang, Wenqing] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Gao, Yitian; Li, Renjie; Zhou, Mei; Wang, Lei; Ma, Chengbang; Xi, Xinping; Chen, Tianbao; Shaw, Chris] Queens Univ Belfast, Sch Pharm, Nat Drug Discovery Grp, Belfast, Antrim, North Ireland; [Wu, Di] Wenzhou Med Univ, Chem Biol Res Ctr, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China	Wenzhou University; Queens University Belfast; Wenzhou Medical University	Wu, D (corresponding author), Wenzhou Med Univ, Chem Biol Res Ctr, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China.	wudi2017@wmu.edu.cn		Wu, Di/0000-0001-5492-6106	Natural Science Foundation of Zhejiang Province [LY20H310006]; National Natural Science Foundation of China [81803590, 81803345]; Wenzhou Municipal Science and Technology Bureau [Y20180178]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau	Funding: This work was supported by the Natural Science Foundation of Zhejiang Province [LY20H310006] to D.W.; the National Natural Science Foundation of China [81803590] to Y.G. and [81803345] to D.W.; and the Wenzhou Municipal Science and Technology Bureau [Y20180178] to Y.G.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, FRONT MICROBIOL, V9, P1; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2011, NUCLEIC ACIDS RES, V39, pD214; Brand GD, 2013, MOLECULES, V18, P7058, DOI 10.3390/molecules18067058; Chen TB, 2004, REGUL PEPTIDES, V117, P25, DOI 10.1016/j.regpep.2003.08.004; Chen TB, 2002, EUR J BIOCHEM, V269, P4693, DOI 10.1046/j.1432-1033.2002.03174.x; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Conlon JM, 1997, PEPTIDES, V18, P361, DOI 10.1016/S0196-9781(96)00339-7; Gao YT, 2016, MOLECULES, V21, DOI 10.3390/molecules21121667; Joedicke L, 2018, NAT CHEM BIOL, V14, P284, DOI [10.1038/NCHEMBIO.2551, 10.1038/nchembio.2551]; Lai R, 2003, PEPTIDES, V24, P199, DOI 10.1016/S0196-9781(03)00027-5; Lai R, 2001, BIOCHEM BIOPH RES CO, V286, P259, DOI 10.1006/bbrc.2001.5359; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lin Y, 2019, TOXINS, V11, DOI 10.3390/toxins11040204; Mignogna G, 1997, PEPTIDES, V18, P367, DOI 10.1016/S0196-9781(96)00342-7; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Thompson AH, 2007, J PROTEOME RES, V6, P3604, DOI 10.1021/pr0702666; Thompson AH, 2006, RAPID COMMUN MASS SP, V20, P3780, DOI 10.1002/rcm.2791; Wang L, 2010, PEPTIDES, V31, P979, DOI 10.1016/j.peptides.2010.01.016; Wang L, 2009, PEPTIDES, V30, P1557, DOI 10.1016/j.peptides.2009.04.019; Wang L, 2009, BIOCHIMIE, V91, P613, DOI 10.1016/j.biochi.2009.03.003; Wang L, 2009, BIOCHEM BIOPH RES CO, V383, P240, DOI 10.1016/j.bbrc.2009.04.003; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu D, 2016, MOLECULES, V21, DOI 10.3390/molecules21111429; Wu Y, 2019, TOXINS, V11, DOI 10.3390/toxins11070376; Xi XP, 2015, TOXINS, V7, P951, DOI 10.3390/toxins7030951; Xu XQ, 2015, CHEM REV, V115, P1760, DOI 10.1021/cr4006704; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhou JW, 2007, PEPTIDES, V28, P781, DOI 10.1016/j.peptides.2007.01.014; Zhou XW, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8070225	30	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243326	10.1371/journal.pone.0243326	http://dx.doi.org/10.1371/journal.pone.0243326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270804	gold, Green Published			2022-12-26	WOS:000597149100130
J	Pasztak-Opilka, A; de Jonge, R; Zachurzok, A; Gornik-Durose, ME				Pasztak-Opilka, Agnieszka; de Jonge, Romana; Zachurzok, Agnieszka; Gornik-Durose, Malgorzata E.			Adult attachment styles and mothers' life satisfaction in relation to eating behaviors in the families with overweight and obese children	PLOS ONE			English	Article							HEALTH; ASSOCIATIONS; CARE	Family plays a significant role in shaping children's eating behaviors. The aim of the study was to assess whether mothers' attachment style, their life satisfaction and their own body weight can be associated with family eating behaviors. The results from 52 dyads (mothers/children) covered by the Metabolic Disease Clinic were analyzed. A targeted sample selection was used, taking into account the weight (overweight/obesity) and age (>= 11 years) criteria of the child. The results have shown that the mother's body weight is a significant determinant of her child's body weight. The anxiety-ambivalent attachment style in mothers is a significant predictor of behaviors aimed at regulating and controlling affective states by food. A decrease in the knowledge of nutrition is associated with an increase in the level of anxiety-ambivalent and avoidant style. The avoidant attachment style is significantly associated with the nutrition organisation and control. Dysfunctional eating behaviors predominate among mothers with a lower level of life satisfaction. The lower the level of life satisfaction, the greater the tendency to regulate affective states and family relationships through nutrition, and to manifest improper organisation of nutrition. Mothers with obesity, compared to mothers with overweight and with normal body weight show a higher level of regulating emotions through food, improper organisation of nutrition and lower control in this area. The research results indicateshow significant relationships between insecure attachment styles, life satisfaction, and the mother's weight with eating behaviors unfavorable to health. It is therefore necessary to include family factors in the process of creating effective intervention strategies.	[Pasztak-Opilka, Agnieszka; de Jonge, Romana; Gornik-Durose, Malgorzata E.] Univ Silesia, Fac Social Sci, Inst Psychol, Katowice, Poland; [Zachurzok, Agnieszka] Med Univ Silesia, Sch Med Katowice, Dept Paediat & Paediat Endocrinol, Katowice, Poland	University of Silesia in Katowice; Medical University Silesia	Gornik-Durose, ME (corresponding author), Univ Silesia, Fac Social Sci, Inst Psychol, Katowice, Poland.	malgorzata.gornik-durose@us.edu.pl		Pasztak-Opilka, Agnieszka/0000-0001-5618-0061; Gornik-Durose, Malgorzata E./0000-0003-3395-5324				Ainsworth MDS, 1995, MONOGR SOC RES CHILD, V60, P3, DOI 10.1111/j.1540-5834.1995.tb00200.x; AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; [Anonymous], 2013, SMU SCI TECH L REV, V16, P43; Moreno-Murcia JA, 2017, REV LAT AM PSICOL, V49, P194, DOI 10.1016/j.rlp.2016.08.002; Arcan C, 2007, PUBLIC HEALTH NUTR, V10, P1257, DOI 10.1017/S1368980007687151; Bahreynian M, 2017, J CLIN RES PEDIATR E, V9, P111, DOI 10.4274/jcrpe.3790; Bowlby J, 2007, ATTACHMENT; Cichecka-Wilk M, 2013, LUBELSKI ROCZNIK PED, V32, P243; Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23; Cimoszuk D, 2003, BORGIS POSTEPY NAUK, V2, P75; CROWELL JA, 1995, SOC DEV, V4, P294, DOI 10.1111/j.1467-9507.1995.tb00067.x; Dhana K, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2486; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Fleming MS, 2015, 445 SEN HON PROJ; Fox S, 2017, HEALTH PSYCHOL BEHAV, V5, P337, DOI 10.1080/21642850.2017.1378580; Freitas A, 2018, ANN NUTR METAB, V73, P19, DOI 10.1159/000489824; Gibson LY, 2007, MED J AUSTRALIA, V186, P591, DOI 10.5694/j.1326-5377.2007.tb01061.x; Golabek R, 2018, JANA DLUGOSZA CZESTO, V17, P119; Hansford S, 2015, JAMA ONCOL, V1, P23, DOI 10.1001/jamaoncol.2014.168; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Headey B., 1991, SUBJECTIVE WELL BEIN, P49; Huntsinger ET, 2004, PSYCHOL HEALTH, V19, P515, DOI 10.1080/0887044042000196728; Juczynski Z, 2009, NARZEDZIA POMIARU PR; Kaleta K, 2012, PROBL HIG EPIDEMIL, V93, P779; Keane E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043503; Kosiba G., 2017, TERA NIEJSZO CZ OWIE, V20, P79; Kumar S, 2010, INDIAN J PEDIATR, V77, P255, DOI 10.1007/s12098-010-0015-3; Kuroki M., 2016, INT J WELLBEING, V6, P93, DOI [10.5502/ijw.v6i2.519, DOI 10.5502/IJW.V6I2.519]; Liberska H., 2011, PSYCHOL ROZWOJ, V16, P25; Liberska H, 2013, J HEALTH SCI, V3, P419; Luszczynska A, 2014, NADWAGA I OTYLOSC IN; Maher EJ, 2008, PEDIATRICS, V122, P322, DOI 10.1542/peds.2007-2233; Marmola M., 2017, FIDES ET RATIO, V32, P185; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; Mazur J., 2019, ZDROWIE UCZNIOW 2018; Mazzeschi C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00791; McWilliams LA, 2010, HEALTH PSYCHOL, V29, P446, DOI 10.1037/a0020061; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Moore ES, 2017, J CONSUM RES, V43, P824, DOI 10.1093/jcr/ucw059; Narodowe Centrum Edukacji Zywieniowej, 2018, NADWAGA I OTYLOSC WS; Ogden J., 2011, PSYCHOLOGIA ODZYWIAN; OGINSKABULIK N, 2002, ACTA U LODZIENSIS FO, V6, P51; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Pietromonaco PR, 2015, ATTACHMENT THEORY RE; Plopa M., 2015, PSYCHOL RODZINY TEOR; Plopa M, 2008, KWESTIONARIUSZ STYLO; Pradeepa S., 2018, International Journal of Medical Science and Public Health, V7, P760; Raque-Bogdan TL, 2011, J COUNS PSYCHOL, V58, P272, DOI 10.1037/a0023041; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; South SC, 2013, PSYCHOL SCI, V24, P373, DOI 10.1177/0956797612453116; Stapleton P., 2015, INT J HEALING CARING, V15, P1; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Szanecka E, 2006, ENDOKRYNOL OTYLOSC Z, V2, P102; Szczepanska E., 2014, Nowa Pediatria, V18, P87; Timoszyk-Tomczak C., 2013, OPUSC SOCIOL, V2, P83; Valmorbida JL, 2017, REV ASSOC MED BRAS, V63, P736, DOI 10.1590/1806-9282.63.09.736; WITANOWSKA J, 2007, ENDOKRYN OTYL I ZAB, V3, P39; World Health Organization, 2017, OB OV	60	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243448	10.1371/journal.pone.0243448	http://dx.doi.org/10.1371/journal.pone.0243448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270767	Green Published, gold			2022-12-26	WOS:000597149100132
J	Ceraudo, E; Horioka, M; Mattheisen, JM; Hitchman, TD; Moore, AR; Kazmi, MA; Chi, P; Chen, Y; Sakmar, TP; Huber, T				Ceraudo, Emilie; Horioka, Mizuho; Mattheisen, Jordan M.; Hitchman, Tyler D.; Moore, Amanda R.; Kazmi, Manija A.; Chi, Ping; Chen, Yu; Sakmar, Thomas P.; Huber, Thomas			Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIONAL MODELS; ARRESTIN; SELECTIVITY; MUTATIONS	Uveal melanoma is the most common eye cancer in adults and is clinically and genetically distinct from skin cutaneous melanoma. In a subset of cases, the oncogenic driver is an activating mutation in CYSLTR2, the gene encoding the G protein-coupled receptor cysteinyl-leukotriene receptor 2 (CysLTR2). The mutant CYSLTR2 encodes for the CysLTR2-L129Q receptor, with the substitution of Leu to Gln at position 129 (3.43). The ability of CysLTR2-L129Q to cause malignant transformation has been hypothesized to result from constitutive activity, but how the receptor could escape desensitization is unknown. Here, we characterize the functional properties of CysLTR2-L129Q. We show that CysLTR2-L129Q is a constitutively active mutant that strongly drives Gq/11 signaling pathways. However, CysLTR2-L129Q only poorly recruits beta-arrestin. Using a modified Slack-Hall operational model, we quantified the constitutive activity for both pathways and conclude that CysLTR2-L129Q displays profound signaling bias for Gq/11 signaling pathways while escaping beta-arrestin-mediated down-regulation. CYSLTR2 is the first known example of a G protein-coupled receptor driver oncogene that encodes a highly biased constitutively active mutant receptor. These results provide new insights into the mechanism of CysLTR2-L129Q oncoprotein signaling and suggest CYSLTR2 as a promising potential therapeutic target in uveal melanoma.	[Ceraudo, Emilie; Horioka, Mizuho; Mattheisen, Jordan M.; Kazmi, Manija A.; Sakmar, Thomas P.; Huber, Thomas] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA; [Horioka, Mizuho; Mattheisen, Jordan M.] Triinst PhD Program Chem Biol, New York, NY USA; [Hitchman, Tyler D.; Moore, Amanda R.; Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Hitchman, Tyler D.; Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Moore, Amanda R.; Chi, Ping; Chen, Yu] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Chi, Ping; Chen, Yu] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Sakmar, Thomas P.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Solna, Sweden; [Moore, Amanda R.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Karolinska Institutet; Roche Holding; Genentech	Sakmar, TP; Huber, T (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA.; Sakmar, TP (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Solna, Sweden.	sakmar@rockefeller.edu; hubert@rockefeller.edu	Huber, Thomas/A-8016-2008; Sakmar, Thomas/D-1833-2015	Huber, Thomas/0000-0002-1844-262X; Ceraudo, Emilie/0000-0001-6563-9751; Hitchman, Tyler/0000-0002-3228-412X; kazmi, manija/0000-0003-0855-0827; Mattheisen, Jordan/0000-0002-9334-9521; Sakmar, Thomas/0000-0002-2836-8953; Horioka, Mizuho/0000-0003-0947-2744	Francois Wallace Monahan Fellowship; Tom Haines Fellowship in Membrane Biology; Tri-Institutional Training Program in Chemical Biology; Robertson Foundation; Crowley Family Fund; Danica Foundation; Memorial Sloan Kettering Cancer Center (MSKCC) [P30 CA008748]; National Cancer Institute (NCI) [K08CA140946, R01CA193837, P50CA092629, P50CA140146, K08CA151660, DP2 CA174499]; U.S. Department of Defense (US DOD) [W81XWH-10-1-0197]; Prostate Cancer Foundation; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Bressler Scholars Fund; Cycle for Survival;  [T32 GM115327]	Francois Wallace Monahan Fellowship; Tom Haines Fellowship in Membrane Biology; Tri-Institutional Training Program in Chemical Biology; Robertson Foundation; Crowley Family Fund; Danica Foundation; Memorial Sloan Kettering Cancer Center (MSKCC); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense (US DOD)(United States Department of Defense); Prostate Cancer Foundation; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Bressler Scholars Fund; Cycle for Survival; 	E. C. was funded by the Francois Wallace Monahan Fellowship and the Tom Haines Fellowship in Membrane Biology. M. H. and J. M. M. were supported by the Tri-Institutional Training Program in Chemical Biology and M. H. by T32 GM115327. We also acknowledge grant support from the Robertson Foundation, the Crowley Family Fund, and the Danica Foundation to T. P. S. and T. H. The work was further supported by Memorial Sloan Kettering Cancer Center (MSKCC) support grant/core grant (P30 CA008748) and grants from the National Cancer Institute (NCI) (K08CA140946 Y. C.; R01CA193837, Y. C.; P50CA092629, Y. C.; P50CA140146, P. C.; K08CA151660, P. C.; DP2 CA174499, P. C.), U.S. Department of Defense (US DOD) (W81XWH-10-1-0197, P. C.), Prostate Cancer Foundation (Y. C.), Starr Cancer Consortium (Y. C. and P. C.), Geoffrey Beene Cancer Research Center (Y. C. and P. C.), Gerstner Family Foundation (Y. C.), Bressler Scholars Fund (Y. C.), and Cycle for Survival (Y. C.).	Berchiche YA, 2016, MOL PHARMACOL, V90, P483, DOI 10.1124/mol.116.105502; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Chua V., 2020, CLIN CANCER RES; de Rubio RG, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1210; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hitchman T. D., 2020, CLIN CANCER RES; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kusters-Vandevelde HVN, 2018, BRAIN TUMOR PATHOL, V35, P127, DOI 10.1007/s10014-018-0308-1; Lorenzen E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2778; Moore AR, 2018, CELL REP, V22, P2455, DOI 10.1016/j.celrep.2018.01.081; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Nguyen AH, 2019, NAT STRUCT MOL BIOL, V26, P1123, DOI 10.1038/s41594-019-0330-y; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Slack RJ, 2012, BRIT J PHARMACOL, V166, P1774, DOI 10.1111/j.1476-5381.2012.01901.x; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Wu V, 2019, J BIOL CHEM, V294, P11062, DOI 10.1074/jbc.REV119.005601; Yan D, 2011, MOL PHARMACOL, V79, P270, DOI 10.1124/mol.110.069054; Zhou B, 2019, TRENDS PHARMACOL SCI, V40, P156, DOI 10.1016/j.tips.2019.01.002; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	25	8	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100163	10.1074/jbc.RA120.015352	http://dx.doi.org/10.1074/jbc.RA120.015352			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33288675	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400141
J	Raymond, SJ; Maragh, J; Masic, A; Williams, JR				Raymond, Samuel J.; Maragh, Janille; Masic, Admir; Williams, John R.			Towards an understanding of the chemo-mechanical influences on kidney stone failure via the material point method	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; ELASTIC-MODULUS; THIN-FILMS; FRACTURE; NANOINDENTATION; COMMINUTION; DAMAGE; FRAGMENTATION; EPIDEMIOLOGY; INDENTATION	This paper explores the use of the meshfree computational mechanics method, the Material Point Method (MPM), to model the composition and damage of typical renal calculi, or kidney stones. Kidney stones are difficult entities to model due to their complex structure and failure behavior. Better understanding of how these stones behave when they are broken apart is a vital piece of knowledge to medical professionals whose aim is to remove these stone by breaking them within a patient's body. While the properties of individual stones are varied, the common elements and proportions are used to generate synthetic stones that are then placed in a digital experiment to observe their failure patterns. First a more traditional engineering model of a Brazil test is used to create a tensile fracture within the center of these stones to observe the effect of stone consistency on failure behavior. Next a novel application of MPM is applied which relies on an ultrasonic wave being carried by surrounding fluid to model the ultrasonic treatment of stones commonly used by medical practitioners. This numerical modeling of Extracorporeal Shock Wave Lithotripsy (ESWL) reveals how these different stones failure in a more real-world situation and could be used to guide further research in this field for safer and more effective treatments.	[Raymond, Samuel J.; Maragh, Janille; Masic, Admir; Williams, John R.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Raymond, Samuel J.; Williams, John R.] MIT, Ctr Computat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Raymond, SJ (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Raymond, SJ (corresponding author), MIT, Ctr Computat Sci & Engn, Cambridge, MA 02139 USA.	sjr@mit.edu	Raymond, Samuel/AAV-5908-2021	Raymond, Samuel/0000-0003-2691-652X				Aggarwal KP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/292953; Bardenhagen SG, 2004, CMES-COMP MODEL ENG, V5, P477; Blanco F, 2015, J BIOPHOTONICS, V8, P457, DOI 10.1002/jbio.201300201; Blanco F, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076027; Caballero A, 2010, INT J ENG SCI, V48, P253, DOI 10.1016/j.ijengsci.2009.11.002; Canseco G, 2011, ULTRASONICS, V51, P803, DOI 10.1016/j.ultras.2011.03.008; Cao SX, 2019, INT J SOLIDS STRUCT, V169, P55, DOI 10.1016/j.ijsolstr.2019.04.002; Chattaraj KG, 2019, J CHEM PHYS, V151, DOI 10.1063/1.5094220; Chen X, 2001, J MATER RES, V16, P2974, DOI 10.1557/JMR.2001.0408; Cleveland RO, 2005, J ACOUST SOC AM, V118, P2667, DOI 10.1121/1.2032187; Delobelle P, 2006, THIN SOLID FILMS, V515, P1385, DOI 10.1016/j.tsf.2006.03.062; Esch E, 2010, UROL RES, V38, P315, DOI 10.1007/s00240-010-0298-x; Fovargue D, 2018, INT J FRACTURE, V211, P203, DOI 10.1007/s10704-018-0283-x; Gulley-Stahl HJ, 2010, APPL SPECTROSC, V64, P15, DOI 10.1366/000370210792966161; Harrogate SR, 2016, J ENDOUROL, V30, P406, DOI 10.1089/end.2015.0388; Igarashi S, 2004, CEMENT CONCRETE COMP, V26, P977, DOI 10.1016/j.cemconcomp.2004.02.031; JOHRDE LG, 1985, J MATER SCI LETT, V4, P1264, DOI 10.1007/BF00723476; Kocaba V, 2012, CEMENT CONCRETE RES, V42, P511, DOI 10.1016/j.cemconres.2011.11.010; Lokhandwalla M, 2000, PHYS MED BIOL, V45, P1923, DOI 10.1088/0031-9155/45/7/316; Lopez M, 2010, PEDIATR NEPHROL, V25, P49, DOI 10.1007/s00467-008-0960-5; M Tanguay, 2003, PROGR MODELING SIMUL; Maeda K, 2018, P 10 INT S CAV CAV20, DOI [10.1115/1.861851_ch119, DOI 10.1115/1.861851_CH119]; Maragh JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210710; Masic A, 2015, J STRUCT BIOL, V189, P269, DOI 10.1016/j.jsb.2014.12.005; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Mota A, 2006, J PHYS CONF SER, V46, P299, DOI 10.1088/1742-6596/46/1/041; Navamathavan R, 2006, APPL SURF SCI, V253, P464, DOI 10.1016/j.apsusc.2005.12.078; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pishchalnikov YA, 2019, J ACOUST SOC AM, V146, P516, DOI 10.1121/1.5116693; Pruessner MW, 2003, SENSOR ACTUAT A-PHYS, V105, P190, DOI 10.1016/S0924-4247(03)00102-X; Pucetaite M, 2013, J MOL STRUCT, V1031, P38, DOI 10.1016/j.molstruc.2012.07.029; Randall NX, 2009, J MATER RES, V24, P679, DOI 10.1557/JMR.2009.0149; Raymond SJ, 2021, COMPUT PART MECH, V8, P259, DOI 10.1007/s40571-020-00327-4; Raymond SJ, 2019, COMPUT PART MECH, V6, P371, DOI 10.1007/s40571-018-00218-9; Raymond SJ, 2018, COMPUT PART MECH, V5, P49, DOI 10.1007/s40571-016-0149-9; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Sadeghirad A, 2013, INT J NUMER METH ENG, V95, P928, DOI 10.1002/nme.4526; Sadeghirad A, 2011, INT J NUMER METH ENG, V86, P1435, DOI 10.1002/nme.3110; Sapozhnikov OA, 2007, J ACOUST SOC AM, V121, P1190, DOI 10.1121/1.2404894; Schuetz R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7494; Stollberg DW, 2003, MAT SCI ENG A-STRUCT, V359, P112, DOI 10.1016/S0921-5093(03)00339-3; STRANNE SK, 1990, J BIOMED MATER RES, V24, P1049, DOI 10.1002/jbm.820240807; SULSKY D, 1994, COMPUT METHOD APPL M, V118, P179, DOI 10.1016/0045-7825(94)00033-6; Tham LM, 2007, J UROLOGY, V178, P314, DOI 10.1016/j.juro.2007.03.009; Vandamme M, 2013, CEMENT CONCRETE RES, V52, P38, DOI 10.1016/j.cemconres.2013.05.006; Volinsky AA, 2003, THIN SOLID FILMS, V429, P201, DOI 10.1016/S0040-6090(03)00406-1; Wijerathne MLL, 2010, IOP CONF SER-MAT SCI, V10, DOI 10.1088/1757-899X/10/1/012120; Zhang Y, 2016, ULTRASOUND MED BIOL, V42, P2662, DOI 10.1016/j.ultrasmedbio.2016.06.018; Zhu SL, 2002, ULTRASOUND MED BIOL, V28, P661, DOI 10.1016/S0301-5629(02)00506-9; Ziemba JB, 2017, INVESTIG CLIN UROL, V58, P299, DOI 10.4111/icu.2017.58.5.299; Zohdi TI, 2005, J BIOMED MATER RES B, V75B, P351, DOI 10.1002/jbm.b.30307	52	1	1	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240133	10.1371/journal.pone.0240133	http://dx.doi.org/10.1371/journal.pone.0240133			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306670	gold, Green Published			2022-12-26	WOS:000600144200043
J	Young-Xu, YN; Smith, J; Mahmud, SM; Van Aalst, R; Thommes, EW; Neupane, N; Lee, JKH; Chit, A				Young-Xu, Yinong; Smith, Jeremy; Mahmud, Salaheddin M.; Van Aalst, Robertus; Thommes, Edward W.; Neupane, Nabin; Lee, Jason K. H.; Chit, Ayman			Laboratory-confirmed influenza infection and acute myocardial infarction among United States senior Veterans	PLOS ONE			English	Article							MORTALITY BENEFITS; ELDERLY-PEOPLE; VACCINATION; RISK; PNEUMONIA; DISEASE; STROKE	Background Previous studies established an association between laboratory-confirmed influenza infection (LCI) and hospitalization for acute myocardial infarction (AMI) but not causality. We aimed to explore the underlying mechanisms by adding biological mediators to an established study design used by earlier studies. Methods With data on biomarkers, we used a self-controlled case-series design to evaluate the effect of LCI on hospitalization for AMI among Veterans Health Administration (VHA) patients. We included senior Veterans (age 65 years and older) with LCI between 2010 through 2015. Patient-level data from VHA electronic medical records were used to capture laboratory results, hospitalizations, and baseline patient characteristics. We defined the "risk interval" as the first 7 days after specimen collection and the "control interval" as 1 year before and 1 year after the risk interval. More importantly, using mediation analysis, we examined the role of abnormal white blood cell (WBC) and platelet count in the relationship between LCI and AMI to explore the thrombogenic nature of this association, thus potential causality. Results We identified 391 hospitalizations for AMI that occurred within +/-1 year of a positive influenza test, of which 31 (31.1 admissions/week) occurred during the risk interval and 360 (3.5/per week) during the control interval, resulting in an incidence ratio (IR) for AMI admission of 8.89 (95% confidence interval [CI]: 6.16-12.84). In stratified analyses, AMI risk was significantly elevated among patients with high WBC count (IR, 12.43; 95% CI: 6.99-22.10) and high platelet count (IR, 15.89; 95% CI: 3.59-70.41). Conclusion We confirmed a significant association between LCI and AMI. The risk was elevated among those with high WBC or platelet count, suggesting a potential role for inflammation and platelet activation in the underlying mechanism.	[Young-Xu, Yinong; Smith, Jeremy; Neupane, Nabin] Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA; [Mahmud, Salaheddin M.] Univ Manitoba, Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Van Aalst, Robertus] Univ Groningen, Fac Med Sci, Groningen, Netherlands; [Van Aalst, Robertus; Thommes, Edward W.; Chit, Ayman] Sanofi Pasteur, Swiftwater, PA USA; [Thommes, Edward W.] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada; [Lee, Jason K. H.; Chit, Ayman] Univ Toronto, Leslie Dan Sch Pharm, Toronto, ON, Canada; [Lee, Jason K. H.] Sanofi Pasteur, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Manitoba; University of Groningen; Sanofi-Aventis; University of Guelph; University of Toronto; Sanofi-Aventis	Young-Xu, YN (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Program, White River Jct, VT 05009 USA.	Yinong.Young-Xu@va.gov		Lee, Jason/0000-0001-8875-607X; van Aalst, Robertus/0000-0003-3025-7811	Sanofi Pasteur [1037291-7]	Sanofi Pasteur	This work was supported by an unrestricted research grant (CRADA#1037291-7) from Sanofi Pasteur. The funder provided support in the form of salaries for authors RVA, EWT, JKL, and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P837; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jansen AJG, 2020, BLOOD ADV, V4, P2967, DOI 10.1182/bloodadvances.2020001640; Koupenova M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09607-x; Koupenova M, 2018, CIRC RES, V122, P337, DOI 10.1161/CIRCRESAHA.117.310795; Kreutz RP, 2005, J THROMB HAEMOST, V3, P2108, DOI 10.1111/j.1538-7836.2005.01474.x; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lucero-Obusan C, 2018, INFLUENZA OTHER RESP, V12, P293, DOI 10.1111/irv.12512; MacIntyre CR, 2013, HEART, V99, P1843, DOI 10.1136/heartjnl-2013-304320; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Musher DM, 2019, NEW ENGL J MED, V380, P171, DOI 10.1056/NEJMra1808137; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; Rose Stacey R, 2012, J Clin Med Res, V4, P415, DOI 10.4021/jocmr1125w; Shen HH, 2013, CLIN LAB, V59, P337, DOI 10.7754/Clin.Lab.2012.120417; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Warren-Gash C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002604; Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Young-Xu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169344	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243248	10.1371/journal.pone.0243248	http://dx.doi.org/10.1371/journal.pone.0243248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306675	Green Published, gold			2022-12-26	WOS:000600144200041
J	Schonger, M; Sele, D				Schonger, Martin; Sele, Daniela			How to better communicate the exponential growth of infectious diseases	PLOS ONE			English	Article							MISPERCEPTION; DECISION; CHOICE; BIAS	Exponential growth bias is the phenomenon whereby humans underestimate exponential growth. In the context of infectious diseases, this bias may lead to a failure to understand the magnitude of the benefit of non-pharmaceutical interventions. Communicating the same scenario in different ways (framing) has been found to have a large impact on people's evaluations and behavior in the contexts of social behavior, risk taking and health care. We find that framing matters for people's assessment of the benefits of non-pharmaceutical interventions. In two commonly used frames, most subjects in our experiment drastically underestimate the number of cases avoided by adopting non-pharmaceutical interventions. Framing growth in terms of doubling times rather than growth rates reduces the bias. When the scenario is framed in terms of time gained rather than cases avoided, the median subject assesses the benefit of non-pharmaceutical interventions correctly. These findings suggest changes that could be adopted to better communicate the exponential spread of infectious diseases.	[Schonger, Martin] Hsch Luzern, Lucerne Sch Business, Luzern, Switzerland; [Schonger, Martin; Sele, Daniela] Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Ctr Law & Econ, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schonger, M (corresponding author), Hsch Luzern, Lucerne Sch Business, Luzern, Switzerland.; Schonger, M; Sele, D (corresponding author), Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Ctr Law & Econ, Zurich, Switzerland.	martin.schonger@hslu.ch; dsele@ethz.ch		Sele, Daniela/0000-0003-1870-6530	Swiss National Science Foundation [100011_176353]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by Swiss National Science Foundation grant no. 100011_176353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alighieri D, EARLY 14 CENTURY; Almenberg J, 2012, APPL ECON LETT, V19, P1693, DOI 10.1080/13504851.2011.652772; Ambuehl S, 2017, METHOD EVALUATING QU, DOI [10.3386/w20618, DOI 10.3386/W20618]; [Anonymous], 2020, ZEIT; BAZERMAN MH, 1984, J MANAGE, V10, P333, DOI 10.1177/014920638401000307; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Capraro V., 2020, PREPRINT; Christandl F, 2009, J ECON PSYCHOL, V30, P381, DOI 10.1016/j.joep.2009.01.002; Dalton C., 2020, GUARDIAN; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Di Paolo R, 2020, EFFECT NORM BASED ME, DOI DOI 10.31234/OSF.IO/7863G; Everett J.A.C., 2020, PREPRINT, DOI 10.31234/osf.io/9yqs8; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Foltice B, 2018, J BEHAV EXP FINANC, V19, P56, DOI 10.1016/j.jbef.2018.04.002; Goda GS, 2014, J PUBLIC ECON, V119, P80, DOI 10.1016/j.jpubeco.2014.08.005; Haggard P, 2008, SENSORIMOTOR FDN HIG, P527; Heffner J, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110420; HERSHEY JC, 1980, J RISK INSUR, V47, P111, DOI 10.2307/252685; Howard K, 2009, VALUE HEALTH, V12, P354, DOI 10.1111/j.1524-4733.2008.00417.x; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Jordan J., 2020, PREPRINT; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Khallikan I, 1868, ORIENTAL TRANSLATION, V3, P1274; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lammers J, 2020, P NATL ACAD SCI USA, V117, P16264, DOI 10.1073/pnas.2006048117; Levy M, 2016, J EUR ECON ASSOC, V14, P545, DOI 10.1111/jeea.12149; Levy MR, 2017, J ECON PSYCHOL, V58, P1, DOI 10.1016/j.joep.2016.11.001; McKenzie CRM, 2011, J MARKETING RES, V48, pS1, DOI 10.1509/jmkr.48.SPL.S1; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Raiffa H, 1968, DECISION ANAL INTRO, P80; SAVAGE LEONARD J., 1954, FDN STAT, P101; Song CC, 2020, REV FINANC STUD, V33, P916, DOI 10.1093/rfs/hhz074; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wagenaar W, 1978, ENV ASSESSMENT SOCIO; WAGENAAR WA, 1975, PERCEPT PSYCHOPHYS, V18, P416, DOI 10.3758/BF03204114; WAGENAAR WA, 1979, ACTA PSYCHOL, V43, P239, DOI 10.1016/0001-6918(79)90028-3	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242839	10.1371/journal.pone.0242839	http://dx.doi.org/10.1371/journal.pone.0242839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296387	gold, Green Published, Green Submitted			2022-12-26	WOS:000598626100071
J	Akand, EH; Maher, SJ; Murray, JM				Akand, Elma H.; Maher, Stephen J.; Murray, John M.			Mutational networks of escape from transmitted HIV-1 infection	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; IDENTIFICATION; SENSITIVITY; DIALIGN; SITE	Human immunodeficiency virus (HIV) is subject to immune selective pressure soon after it establishes infection at the founder stage. As an individual progresses from the founder to chronic stage of infection, immune pressure forces a history of mutations that are embedded in envelope sequences. Determining this pathway of coevolving mutations can assist in understanding what is different with the founder virus and the essential pathways it takes to maintain infection. We have combined operations research and bioinformatics methods to extract key networks of mutations that differentiate founder and chronic stages for 156 subtype B and 107 subtype C envelope (gp160) sequences. The chronic networks for both subtypes revealed strikingly different hub-and-spoke topologies compared to the less structured transmission networks. This suggests that the hub nodes are impacted by the immune response and the resulting loss of fitness is compensated by mutations at the spoke positions. The major hubs in the chronic C network occur at positions 12, 137 (within the N136 glycan), and 822, and at position 306 for subtype B. While both founder networks had a more heterogeneous connected network structure, interestingly founder B subnetworks around positions 640 and 837 preferentially contained CD4 and coreceptor binding domains. Finally, we observed a differential effect of glycosylation between founder and chronic subtype B where the latter had mutational pathways significantly driven by N-glycosylation. Our study provides insights into the mutational pathways HIV takes to evade the immune response, and presents features more likely to establish founder infection, valuable for effective vaccine design.	[Akand, Elma H.; Murray, John M.] UNSW Sydney, Sch Math & Stat, Kensington, NSW, Australia; [Maher, Stephen J.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England	University of New South Wales Sydney; University of Exeter	Murray, JM (corresponding author), UNSW Sydney, Sch Math & Stat, Kensington, NSW, Australia.	j.murray@unsw.edu.au	Murray, John/B-5481-2009	Murray, John/0000-0001-9314-2283; Maher, Stephen/0000-0003-3773-6882; Akand, Elma/0000-0002-1710-3693	Australian Research Council [DP180103893]	Australian Research Council(Australian Research Council)	This work was funded by an Australian Research Council Discovery grant (DP180103893), awarded to JMM. The Australian Research Council (arc.gov.au) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Akand EH, BMC BIOINFORMATICS, DOI [10.24433/CO.5631899.v1, DOI 10.24433/C0.5631899.V1]; Al Ait L, 2013, NUCLEIC ACIDS RES, V41, pW3, DOI 10.1093/nar/gkt283; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Asmal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023673; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Champeimont R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26401; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Das D, 2015, ANTIMICROB AGENTS CH, V59, P1895, DOI 10.1128/AAC.04654-14; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Didigu CA, 2012, VIRUSES-BASEL, V4, P309, DOI 10.3390/v4020309; Dorsten RT, 2020, J VIROL, V94, DOI [10.1128/JVI.01533-19, DOI 10.1128/JVI.01533-19]; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Korber B., 1998, HUMAN RETROVIRUSES A, V3, P102; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Louie RHY, 2018, P NATL ACAD SCI USA, V115, pE564, DOI 10.1073/pnas.1717765115; Mathys L, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0107-7; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Mota TM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-54; Murray JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171572; Murray JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067254; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Rourke SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119608; O'Rourke SM, 2012, J VIROL, V86, P12105, DOI 10.1128/JVI.01352-12; Pacheco-Martinez E, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0486-6; Ping LH, 2013, J VIROL, V87, P7218, DOI 10.1128/JVI.03577-12; Pollakis G, 2004, J VIROL, V78, P2841, DOI 10.1128/JVI.78.6.2841-2852.2004; Shaik MM, 2019, NATURE, V565, P318, DOI 10.1038/s41586-018-0804-9; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243391	10.1371/journal.pone.0243391	http://dx.doi.org/10.1371/journal.pone.0243391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284837	gold, Green Published			2022-12-26	WOS:000597930500021
J	Wright, B; Phillips, H; Le Couteur, A; Sweetman, J; Hodkinson, R; Ralph-Lewis, A; Hayward, E; Brennan, A; Mulloy, J; Day, N; Bland, M; Allgar, V				Wright, Barry; Phillips, Helen; Le Couteur, Ann; Sweetman, Jennifer; Hodkinson, Rachel; Ralph-Lewis, Amelia; Hayward, Emily; Brennan, Alice; Mulloy, Josie; Day, Natalie; Bland, Martin; Allgar, Victoria			Modifying and validating the social responsiveness scale edition 2 for use with deaf children and young people	PLOS ONE			English	Article							DELPHI TECHNIQUE; DIAGNOSTIC INTERVIEW; MENTAL-HEALTH; AUTISM; SPECTRUM; COMMUNICATION; CONSENSUS; LANGUAGE	A Delphi consensus methodology was used to adapt a screening tool, the Social Responsiveness Scale- 2 (SRS-2), for use with deaf children including those whose preferred communication method is sign language. Using this approach; 27 international experts (The Delphi International Expert Panel), on the topic of autism spectrum disorder (ASD) in deaf people, contributed to the review of item content. A criterion for agreement was set at 80% of experts on each item (with 75% acceptable in the final fourth round). The agreed modifications are discussed. The modified SRS-2 research adaptation for deaf people (referred to here as the "SRS-2 Deaf adaptation") was then translated into British Sign Language using a robust translation methodology and validated in England in a sample of 198 deaf children, 76 with Autism Spectrum Disorders (ASD) and 122 without ASD. The SRS-2 Deaf adaptation was compared blind to a NICE (National Institute for Health and Care Excellence) guideline standard clinical assessment. The area under the Receiver Operating (ROC) curve was 0.811 (95% CI: 0.753, 0.869), with an optimal cut-off value of 73, which gave a sensitivity of 82% and a specificity of 67%. The Cronbach Alpha coefficient was 0.968 suggesting high internal consistency. The Intraclass Correlation Coefficient was 0.897, supporting test-retest reliability. This performance is equivalent to similar instruments used for screening ASD in the hearing population.	[Wright, Barry; Bland, Martin; Allgar, Victoria] Univ York, York, N Yorkshire, England; [Phillips, Helen; Sweetman, Jennifer; Hodkinson, Rachel; Hayward, Emily; Brennan, Alice; Day, Natalie] Leeds & York Partnership NHS Fdn Trust, York, N Yorkshire, England; [Le Couteur, Ann] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Ralph-Lewis, Amelia] South London & Maudsley NHS Fdn Trust, London, England; [Mulloy, Josie] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England	University of York - UK; Newcastle University - UK; South London & Maudsley NHS Trust	Wright, B (corresponding author), Univ York, York, N Yorkshire, England.	barry.wright1@nhs.net		Allgar, Victoria/0000-0002-5228-2623; Sweetman, Jenny/0000-0003-1969-4586; Hodkinson, Rachel/0000-0002-3972-2890; Hayward, Emily/0000-0002-2413-0104; Wright, Barry/0000-0002-8692-6001	Medical Research Council [MR/K015435/1]; MRC [MR/K015435/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is funded by Medical Research Council as part of the Diagnostic Instruments for Screening Deaf Children Study (DIADS) -BW, AL-C, MR/K015435/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://gtr.ukri.org/projects?ref=MR% 2FK015435%2F1.	[Anonymous], 2016, FORTUNE, V15, pF29; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2013, 2013 14 NHS STAND CO; [Anonymous], 2012, KIDNEY INT, V2, ps1; Ariyaratana Suzie, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000336; Baldwin SA, 2016, PSYCHOL STAT PSYCHOM; Batten G, 2014, J DEAF STUD DEAF EDU, V19, P285, DOI 10.1093/deafed/ent052; Beech B, 1999, J Nurs Manag, V7, P281; Beresford B., 2008, EVALUATION SPECIALIS; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brenman NF, 2017, CULT MED PSYCHIAT, V41, P431, DOI 10.1007/s11013-017-9526-y; Brett D, 2016, J AUTISM DEV DISORD, V46, P1974, DOI 10.1007/s10803-016-2716-6; Chandler S, 2007, J AM ACAD CHILD PSY, V46, P1324, DOI 10.1097/chi.0b013e31812f7d8d; Charman T, 2013, CHILD ADOL MENT H-UK, V18, P52, DOI 10.1111/j.1475-3588.2012.00664.x; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Fiorillo CE, 2017, OTOL NEUROTOL, V38, P1456, DOI 10.1097/MAO.0000000000001583; Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037; Gallaudet Research Institute, 2011, REG NAT SUMM REP DAT; Gibson JME, 1998, J CLIN NURS, V7, P451, DOI 10.1046/j.1365-2702.1998.00175.x; Hanafin S., 2004, REV LIT DELPHI TECHN; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2014, HDB AUTISM PERVASIVE; Lord C., 2008, AUTISM DIAGNOSTIC OB, V2nd; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; National Deaf Children's Society, 2016, CRIDE 2016 UK WID SU; O'Halpin R, 2001, CLIN LINGUIST PHONET, V15, P529, DOI 10.1080/02699200110078131; Roberts S, 2015, NIHR J LIB       FEB, P2; Roehr B, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3591; Roper L, 2003, AUTISM, V7, P245, DOI 10.1177/1362361303007003002; Rutter M., 2003, ANGELES CA W PSYCHOL, V29, P30; Schick B, 2007, CHILD DEV, V78, P376, DOI 10.1111/j.1467-8624.2007.01004.x; Sharkey SB, 2001, NURS EDUC TODAY, V21, P398, DOI 10.1054/nedt.2001.0573; Sheikh A, 2008, RESP MED, V102, P1089, DOI 10.1016/j.rmed.2008.03.006; Shield A, 2015, J AUTISM DEV DISORD, V45, P2128, DOI 10.1007/s10803-015-2377-x; Szarkowski A, 2014, SEMIN SPEECH LANG, V35, P241, DOI 10.1055/s-0034-1389097; Szymanski C., 2008, ODYSSEY, V9, P10; Szymanski CA, 2012, J AUTISM DEV DISORD, V42, P2027, DOI 10.1007/s10803-012-1452-9; Vaccari C, 1997, J CHILD PSYCHOL PSYC, V38, P793, DOI 10.1111/j.1469-7610.1997.tb01597.x; Wigham S, 2012, RES DEV DISABIL, V33, P944, DOI 10.1016/j.ridd.2011.12.017; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Wright B, 2012, ADV MENT HEALTH, V11, P95, DOI 10.5172/jamh.2012.11.1.95; Young A, 2019, J DEAF STUD DEAF EDU, V24, P280, DOI 10.1093/deafed/enz002	45	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243162	10.1371/journal.pone.0243162	http://dx.doi.org/10.1371/journal.pone.0243162			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284813	gold, Green Published, Green Accepted			2022-12-26	WOS:000597930500041
J	Irmi, ZI; Ng, CJ; Lee, PY; Hussein, N				Irmi, Z. I.; Ng, C. J.; Lee, P. Y.; Hussein, N.			Factors influencing pregnancy planning of multi-ethnic Asian women with diabetes: A qualitative study	PLOS ONE			English	Article							PRECONCEPTION CARE; RELIGIOUS BELIEFS; PREPREGNANCY CARE; MELLITUS; POPULATION; ATTITUDES; HEALTH; TYPE-1; TRENDS; EXPLORATION	Introduction Pregnancy planning varies among women with diabetes. Observing that the literature examining the factors affecting diabetic women's pregnancy intentions in multi-ethnic Asian populations is limited, we sought to explore these factors to give a better perspective on these women's pregnancy planning. Methods This qualitative study used individual in-depth interviews to capture the views and experiences of non-pregnant diabetic women of reproductive age in four public health clinics in a southwestern state of peninsular Malaysia from May 2016 to February 2017. The participants were purposively sampled according to ethnicity and were interviewed using a semi-structured topic guide. Interviews were audio-recorded, and transcripts were analysed using thematic analysis. Results From the 33 interviews that were analysed, four important factors influencing participants' decisions regarding pregnancy planning were identified. Participants' perception of poor pregnancy outcomes due to advanced age and medical condition was found to have an impact. However, despite these fears and negative relationships with doctors, personal, family and cultural influences supported by religious 'up to God' beliefs took centre stage in the pregnancy intention of some participants. Participants demonstrated a variety of understandings of pregnancy planning. They outlined some activities for pregnancy preparation, although many also reported limited engagement with pre-pregnancy care. Conclusions This study emphasised the known dilemma experienced by diabetic women considering their desire for an ideal family structure against their perceived pregnancy risks, heterogeneous religious beliefs and the impact of cultural demands on pregnancy intention. This study urges healthcare providers to increase their engagement with the women in pregnancy planning in a more personalised approach.	[Irmi, Z. I.; Ng, C. J.; Hussein, N.] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Irmi, Z. I.; Lee, P. Y.] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia	Universiti Malaya; Universiti Putra Malaysia	Ng, CJ (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia.	ngcj@um.edu.my		Ismail, Irmi/0000-0002-7770-7966	UM [PG282-2016A]	UM	This study was funded by a grant from the Postgraduate Research Fund, UM to II and NCJ (PG282-2016A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Aldrighi JD, 2016, REV ESC ENFERM USP, V50, P509, DOI 10.1590/S0080-623420160000400019; Aris T, 2015, NATL HLTH MORBIDITY, VII; Arousell J, 2016, BEST PRACT RES CL OB, V32, P77, DOI 10.1016/j.bpobgyn.2015.08.011; Azmi, 2013, MINIST HLTH MALAYS, V1, P2009; Bell R, 2008, BJOG-INT J OBSTET GY, V115, P445, DOI 10.1111/j.1471-0528.2007.01644.x; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chuang CH, 2010, MATERN CHILD HLTH J, V14, P713, DOI 10.1007/s10995-009-0518-6; Dalberg Global Development Advisors, 2017, ADV WOM EMP ICT SKIL, P40; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; Deerochanawong C, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-11; Devido JA, 2016, DIABETES EDUCATOR, V42, P721, DOI 10.1177/0145721716671008; Earle S, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21140; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Forde R, 2016, INT J WOMENS HEALTH, V8, P691, DOI 10.2147/IJWH.S115955; Glinianaia SV, 2014, DIABETIC MED, V31, P1104, DOI 10.1111/dme.12460; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0360-1; Griffiths F, 2008, BRIT J GEN PRACT, V58, P184, DOI 10.3399/bjgp08X277294; Holing E V, 2000, J Matern Fetal Med, V9, P10, DOI 10.3109/14767050009020506; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Kachoria R, 2014, DIABETIC MED, V31, P1690, DOI 10.1111/dme.12546; Kampan N., 2013, MALAYSIAN J PUBLIC H, V13, P1; Lavender T, 2010, MIDWIFERY, V26, P589, DOI 10.1016/j.midw.2009.01.003; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Mahmud M, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-5; McBrien Barry, 2008, Br J Nurs, V17, P1286; McCorry NK, 2012, J MIDWIFERY WOM HEAL, V57, P396, DOI 10.1111/j.1542-2011.2011.00143.x; Ministry of Health, 2013, PER CAR MAN, V3rd; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN PREC, P12; Nekuei Nafisehsadat, 2015, J Educ Health Promot, V4, P8, DOI 10.4103/2277-9531.151891; Nwolise CH, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5615; Peterson C, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.09.009; Platts J, 2015, DIABETES PRIMARY CAR, V17, P88; Poels M, 2016, OBSTET GYNECOL SURV, V71, P603, DOI 10.1097/OGX.0000000000000360; Santelli JS, EXPLORING KEY DIMENS; Shawe J, 2015, EUR J CONTRACEP REPR, V20, P77, DOI 10.3109/13625187.2014.990088; Spence M, 2010, DIABETIC MED, V27, P1385, DOI 10.1111/j.1464-5491.2010.03117.x; Srikanthan A, 2008, J OBSTET GYNAECOL CA, V30, P129, DOI 10.1016/S1701-2163(16)32736-0; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; World Health Organization, 2013, PREC HLTH MAX GAINS; Yew Kong L, 2015, HLTH BEHAV SEL THEOR; Zhu HD, 2012, AUST NZ J OBSTET GYN, V52, P593, DOI 10.1111/ajo.12010	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242690	10.1371/journal.pone.0242690	http://dx.doi.org/10.1371/journal.pone.0242690			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270663	Green Published, gold, Green Accepted			2022-12-26	WOS:000597149100013
J	Lu, PN; Yang, T; Li, LJ; Zhao, BP; Liu, JH				Lu, Peina; Yang, Tony; Li, Lijun; Zhao, Baoping; Liu, Jinghui			Response of oat morphologies, root exudates, and rhizosphere fungal communities to amendments in a saline-alkaline environment	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; ORGANIC AMENDMENT; CARBON SOURCE; SOIL; BACTERIAL; GROWTH; DIVERSITY; STRAW; WHEAT; BIOFERTILIZERS	The application of organic amendments to saline-alkaline soil has been recommended as an agricultural strategy to improve crop productivity and soil health. However, there has been limited research on how organic soil amendment strategies affect the health of oats and their associated rhizosphere fungal communities in saline-alkaline conditions. Thus, the objectives of this study were to understand the effects of oat cultivars with contrasting saline-alkaline tolerances and different amendments on plant morphologies, root exudates (soluble sugars and organic acids), and rhizosphere fungal communities in a saline-alkaline environment. Experiments were conducted on a saline-alkaline tolerant cultivar, Baiyan2, and a saline-alkaline sensitive cultivar, Caoyou1, under four different organic amendment strategies: 1. control (no amendment application), 2. bio-fertilizer application, 3. rotten straw application, and 4. a co-application of bio-fertilizer and rotten straw. Results showed that plant morphological characters of Baiyan2 were better than Caoyou1, and that soluble sugar and organic acid levels in the rhizosphere of Baiyan2 were significantly lower than Caoyou1. Compared to the control, oat root and plant development was significantly improved by the combined bio-fertilizer and rotten straw amendment. Bio-fertilizer application promoted malic and citric acid levels, contributing to a higher total organic acid level, and significantly increased the abundance of Rhizopus arrhizus and decreased the abundance of the fungal pathogens Alternaria, Cladosporium, Sarocladium and Heydenia of Ascomycota in both oat cultivars. All amendment treatments containing rotten straw, except the combined amendment in Baiyan2, significantly increased the relative abundance of Ascomycota (specifically Gibberella, Talaromyces, Fusarium, and Bipolaris) and decreased the relative abundance of R. arrhizus by reducing soluble sugar and organic acid levels. For the combined amendment in Baiyan2, there were no significant changes in Gibberella and Rhizopus between the control and amendment treatment. Our results suggest that co-application of bio-fertilizer and rotten straw, combined with a tolerant oat cultivar, is an effective method to increase crop productivity and enhance soil health in a saline-alkaline environment.	[Lu, Peina; Li, Lijun; Zhao, Baoping; Liu, Jinghui] Inner Mongolia Agr Univ, Coll Agron, Hohhot, Inner Mongolia, Peoples R China; [Lu, Peina; Yang, Tony] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada	Inner Mongolia Agricultural University; Agriculture & Agri Food Canada	Liu, JH (corresponding author), Inner Mongolia Agr Univ, Coll Agron, Hohhot, Inner Mongolia, Peoples R China.	cauljh@aliyun.com	Zhao, Baoping/AFZ-2806-2022	Lu, Peina/0000-0003-4187-1577	Scientific and Technological Innovation Team of Inner Mongolia; Multi-grain Engineering and Technology Center of Inner Mongolia; Talent Introduction Project of Inner Mongolia Agricultural University [NDYB2018-29]; MOE-AAFC PhD Research program [201808150135]	Scientific and Technological Innovation Team of Inner Mongolia; Multi-grain Engineering and Technology Center of Inner Mongolia; Talent Introduction Project of Inner Mongolia Agricultural University; MOE-AAFC PhD Research program	This work was funded by Scientific and Technological Innovation Team of Inner Mongolia; Multi-grain Engineering and Technology Center of Inner Mongolia; Talent Introduction Project of Inner Mongolia Agricultural University (NDYB2018-29) and MOE-AAFC PhD Research program (201808150135).	Abd-Alla MH, 2014, MICROBIOL RES, V169, P49, DOI 10.1016/j.micres.2013.07.007; [Anonymous], 2017, COMPETITION L POLY D, V3, p[41, 38]; Bai JH, 2013, J INTEGR AGR, V12, P1441, DOI 10.1016/S2095-3119(13)60556-0; Bai JH, 2017, ENVIRON SCI POLLUT R, V24, P3387, DOI 10.1007/s11356-016-8092-0; Baruah N, 2018, INT J CURRENT MICROB, V7; Bawa G, 2019, PLANT MOL BIOL, V101, P315, DOI 10.1007/s11103-019-00906-x; Bekele WA, 2018, PLANT BIOTECHNOL J, V16, P1452, DOI 10.1111/pbi.12888; Bishnoi NR, 2005, IND RES, V94, P93; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Boldt-Burisch K, 2019, PEDOSPHERE, V29, P34, DOI [10.1016/S1002-0160(18)60056-6, 10.1016/s1002-0160(18)60056-6]; Borrell AN, 2017, PLANT SOIL, V414, P13, DOI 10.1007/s11104-016-3075-y; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chen HL, 2013, J FOOD AGRIC ENVIRON, V11, P1017; D'Amico M, 2008, MYCOL RES, V112, P100, DOI 10.1016/j.mycres.2007.11.007; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Durand M, 2018, PLANTA, V247, P587, DOI 10.1007/s00425-017-2807-4; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eisenhauer N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44641; Garcia-Fraile P, 2015, AIMS BIOENG, V2, P183, DOI 10.3934/bioeng.2015.3.183; Gomes T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42391-8; Guo SH, 2018, SCI HORTIC-AMSTERDAM, V227, P255, DOI 10.1016/j.scienta.2017.09.051; Haichar FE, 2014, SOIL BIOL BIOCHEM, V77, P69, DOI 10.1016/j.soilbio.2014.06.017; HANSEN J, 1975, ANAL BIOCHEM, V68, P87, DOI 10.1016/0003-2697(75)90682-X; He F, 2016, APPL SOIL ECOL, V100, P162, DOI 10.1016/j.apsoil.2015.12.014; Hennion N, 2019, PHYSIOL PLANTARUM, V165, P44, DOI 10.1111/ppl.12751; Huang RD, 2018, J INTEGR AGR, V17, P739, DOI [10.1016/S2095-3119(17)61728-3, 10.1016/s2095-3119(17)61728-3]; Huang XF, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0225; Huang YL, 2016, BIOL CONTROL, V98, P27, DOI 10.1016/j.biocontrol.2016.02.013; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kumar R., 2015, BIOSCAN, V10, P403; Liu J, 2019, INT J BIOL MACROMOL, V140, P851, DOI 10.1016/j.ijbiomac.2019.08.227; Lombardi N, 2018, MOL PLANT MICROBE IN, V31, P982, DOI [10.1094/MPMI-12-17-0310-R, 10.1094/mpmi-12-17-0310-r]; [卢培娜 Lu Peina], 2016, [麦类作物学报, Journal of Triticeae Crops], V36, P1510; Lu T, 2018, J AGR FOOD CHEM, V66, P2645, DOI 10.1021/acs.jafc.7b06155; Maarastawi SA, 2019, SOIL BIOL BIOCHEM, V135, P235, DOI 10.1016/j.soilbio.2019.05.007; Magnuson J.K., 2004, ADV FUNGAL BIOTECHNO, P307, DOI DOI 10.1007/978-1-4419-8859-1_12; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meena MD, 2016, SOIL RES, V54, P958, DOI 10.1071/SR15342; Minemba D, 2019, SCI HORTIC-AMSTERDAM, V256, DOI 10.1016/j.scienta.2019.108572; Momma Noriaki, 2006, Journal of General Plant Pathology, V72, P247, DOI 10.1007/s10327-006-0274-z; Nordby JN, 2007, PLANT DIS, V91, P171, DOI 10.1094/PDIS-91-2-0171; Okello PN, 2019, PLANT HLTH PROG, V20, P38, DOI 10.1094/PHP-11-18-0075-RS; Peng M, 2017, CURR MICROBIOL, V74, P325, DOI 10.1007/s00284-017-1195-0; Ruan CJ, 2010, CRIT REV PLANT SCI, V29, P329, DOI 10.1080/07352689.2010.524517; Shafique S, 2019, PAK J BOT, V51, P755, DOI [10.30848/pjb2019-2(43), 10.30848/PJB2019-2(43)]; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Shen ZZ, 2015, APPL SOIL ECOL, V93, P111, DOI 10.1016/j.apsoil.2015.04.013; Singh PP, 2019, PGPR AMELIORATION IN SUSTAINABLE AGRICULTURE: FOOD SECURITY AND ENVIRONMENTAL MANAGEMENT, P17, DOI 10.1016/B978-0-12-815879-1.00002-1; Sun Jing, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P153; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Turmuktini T., 2012, ASIAN J AGR RURAL DE, V2, P519, DOI [10.22004/ag.econ.197998, DOI 10.22004/AG.ECON.197998]; UNGER PW, 1994, AGRON J, V86, P759, DOI 10.2134/agronj1994.00021962008600050004x; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wu YP, 2013, EUR J SOIL BIOL, V54, P32, DOI 10.1016/j.ejsobi.2012.10.006; Zhou DM, 2016, PLANT SOIL, V401, P259, DOI 10.1007/s11104-015-2743-7	61	1	2	10	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243301	10.1371/journal.pone.0243301	http://dx.doi.org/10.1371/journal.pone.0243301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270753	gold, Green Published			2022-12-26	WOS:000597149100006
J	Tocto-Erazo, MR; Espindola-Zepeda, JA; Montoya-Laos, JA; Acuna-Zegarra, MA; Olmos-Liceaga, D; Reyes-Castro, PA; Figueroa-Preciado, G				Tocto-Erazo, Mayra R.; Espindola-Zepeda, Jorge A.; Montoya-Laos, Jose A.; Acuna-Zegarra, Manuel A.; Olmos-Liceaga, Daniel; Reyes-Castro, Pablo A.; Figueroa-Preciado, Gudelia			Lockdown, relaxation, and acme period in COVID-19: A study of disease dynamics in Hermosillo, Sonora, Mexico	PLOS ONE			English	Article							OUTBREAK; WUHAN	Lockdown and social distancing measures have been implemented for many countries to mitigate the impacts of the COVID-19 pandemic and prevent overwhelming of health services. However, success on this strategy depends not only on the timing of its implementation, but also on the relaxation measures adopted within each community. We developed a mathematical model to evaluate the impacts of the lockdown implemented in Hermosillo, Mexico. We compared this intervention with some hypothetical ones, varying the starting date and also the population proportion that is released, breaking the confinement. A Monte Carlo study was performed by considering three scenarios to define our baseline dynamics. Results showed that a hypothetical delay of two weeks, on the lockdown measures, would result in an early acme around May 9 for hospitalization prevalence and an increase on cumulative deaths, 42 times higher by May 31, when compared to baseline. On the other hand, results concerning relaxation dynamics showed that the acme levels depend on the proportion of people who gets back to daily activities as well as the individual behavior with respect to prevention measures. Analysis regarding different relaxing mitigation measures were provided to the Sonoran Health Ministry, as requested. It is important to stress that, according to information provided by health authorities, the acme occurring time was closed to the one given by our model. Hence, we considered that our model resulted useful for the decision-making assessment, and that an extension of it can be used for the study of a potential second wave.	[Tocto-Erazo, Mayra R.; Espindola-Zepeda, Jorge A.; Montoya-Laos, Jose A.; Acuna-Zegarra, Manuel A.; Olmos-Liceaga, Daniel; Figueroa-Preciado, Gudelia] Univ Sonora, Dept Matemat, Hermosillo, Sonora, Mexico; [Reyes-Castro, Pablo A.] Colegio Sonora, Ctr Estudios Salud & Soc, Hermosillo, Sonora, Mexico	Universidad de Sonora	Figueroa-Preciado, G (corresponding author), Univ Sonora, Dept Matemat, Hermosillo, Sonora, Mexico.	gudelia.figueroa@unison.mx	Acuña-Zegarra, Manuel Adrian/AAU-2200-2020; Reyes, Pablo/AAS-3346-2021	Acuña-Zegarra, Manuel Adrian/0000-0002-5895-2456; Reyes, Pablo/0000-0002-3091-5530; Tocto, Mayra/0000-0002-7758-0504	Consejo Nacional de Ciencia y Tecnologi PRIME [313269]	Consejo Nacional de Ciencia y Tecnologi PRIME	This work was supported by Consejo Nacional de Ciencia y Tecnologi ' a, Project 313269 (GFP). This funding source had no role in the definition of the study design, interpretation or publication of the results.	Acuna-Zegarra MA, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108370; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Arenas A, 2020, PHYS REV X, DOI DOI 10.1103/PHYSREVX.10.041055; Bugalia S, 2020, MATH BIOSCI ENG, V17, P5961, DOI 10.3934/mbe.2020318; CapistruYn M., 2020, FORECASTING HOSP DEM; Chatterjee Kaustuv, 2020, Med J Armed Forces India, V76, P147, DOI 10.1016/j.mjafi.2020.03.022; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Figueroa Preciado G, 2020, ESCENARIOS MODELACIO; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740; Ibarra-Vega D, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138917; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Liu Xiuli, 2020, MODELING SITUATION C, DOI [10.1101/2020.03.09.20033498, DOI 10.1101/2020.03.09.20033498]; Mandal M, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109889; Mi YN, 2020, INT J INFECT DIS, V97, P1, DOI 10.1016/j.ijid.2020.04.055; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Okuonghae D, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110032; Pablos-Mendez A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2939; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang CZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3391; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5	38	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242957	10.1371/journal.pone.0242957	http://dx.doi.org/10.1371/journal.pone.0242957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270705	Green Published, Green Submitted, gold			2022-12-26	WOS:000597149100087
J	Johnston, CL; Marzano, NR; Paudel, BP; Wright, G; Benesch, JLP; van Oijen, AM; Ecroyd, H				Johnston, Caitlin L.; Marzano, Nicholas R.; Paudel, Bishnu P.; Wright, George; Benesch, Justin L. P.; van Oijen, Antoine M.; Ecroyd, Heath			Single-molecule fluorescence-based approach reveals novel mechanistic insights into human small heat shock protein chaperone function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; INTRACELLULAR CHANNEL PROTEIN; SOLUBLE FORM; SUBSTRATE; CLIC1; OLIGOMERIZATION; POLYDISPERSITY; DYNAMICS; SPECTRUM; BINDING	Small heat shock proteins (sHsps) are a family of ubiquitous intracellular molecular chaperones; some sHsp family members are upregulated under stress conditions and play a vital role in protein homeostasis (proteostasis). It is commonly accepted that these chaperones work by trapping misfolded proteins to prevent their aggregation; however, fundamental questions regarding the molecular mechanism by which sHsps interact with misfolded proteins remain unanswered. The dynamic and polydisperse nature of sHsp oligomers has made studying them challenging using traditional biochemical approaches. Therefore, we have utilized a single-molecule fluorescence-based approach to observe the chaperone action of human alphaB-crystallin (alpha Bc, HSPB5). Using this approach we have, for the first time, determined the stoichiometries of complexes formed between alpha Bc and a model client protein, chloride intracellular channel 1. By examining the dispersity and stoichiometries of these complexes over time, and in response to different concentrations of alpha Bc, we have uncovered unique and important insights into a two-step mechanism by which alpha Bc interacts with misfolded client proteins to prevent their aggregation.	[Johnston, Caitlin L.; Marzano, Nicholas R.; Paudel, Bishnu P.; van Oijen, Antoine M.; Ecroyd, Heath] Univ Wollongong, Mol Horizons, Wollongong, NSW, Australia; [Johnston, Caitlin L.; Marzano, Nicholas R.; Paudel, Bishnu P.; van Oijen, Antoine M.; Ecroyd, Heath] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [Johnston, Caitlin L.; Marzano, Nicholas R.; Paudel, Bishnu P.; van Oijen, Antoine M.; Ecroyd, Heath] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Wright, George; Benesch, Justin L. P.] Univ Oxford, Dept Chem Phys & Theoret Chem, Oxford, England	University of Wollongong; University of Wollongong; University of Wollongong; University of Oxford	van Oijen, AM; Ecroyd, H (corresponding author), Univ Wollongong, Mol Horizons, Wollongong, NSW, Australia.; van Oijen, AM; Ecroyd, H (corresponding author), Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW, Australia.; van Oijen, AM; Ecroyd, H (corresponding author), Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	vanojen@uow.edu.au; heathe@uow.edu.au	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Benesch, Justin/0000-0002-1507-3742; Ecroyd, Heath/0000-0001-7574-0044; Paudel, Bishnu/0000-0003-3518-3882; Marzano, Nicholas/0000-0002-8436-8683	Australian Government Research Training Program Scholarship; ARC Laureate Fellowship [FL140100027]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); ARC Laureate Fellowship(Australian Research Council)	This research performed by C. L. J. and N. R. M. has been conducted with the support of the Australian Government Research Training Program Scholarship. A. M. v. O. is supported by an ARC Laureate Fellowship (FL140100027).	Alderson TR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08557-8; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Avellaneda MJ, 2017, PROTEIN SCI, V26, P1291, DOI 10.1002/pro.3161; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Berry KL, 2006, J MOL BIOL, V359, P1316, DOI 10.1016/j.jmb.2006.04.046; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Cross M, 2015, MOL CELL BIOCHEM, V398, P83, DOI 10.1007/s11010-014-2207-z; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Duderstadt KE, 2016, MOL CELL, V64, P1035, DOI 10.1016/j.molcel.2016.10.028; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Fanucchi S, 2008, BIOCHEMISTRY-US, V47, P11674, DOI 10.1021/bi801147r; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Fu XM, 2014, ACTA BIOCH BIOPH SIN, V46, P347, DOI 10.1093/abbs/gmt152; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Hadzic M. C., 2016, SPIE; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M., 2015, BIG BOOK SMALL HEAT, P155, DOI [10.1007/978-3-319-16077-1_6, DOI 10.1007/978-3-319-16077-1_6]; Haslbeck M, 2019, J BIOL CHEM, V294, P2121, DOI 10.1074/jbc.REV118.002809; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayashi J, 2020, CELL STRESS CHAPERON, V25, P639, DOI 10.1007/s12192-020-01098-w; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Johnston CL, 2018, J MOL BIOL, V430, P4525, DOI 10.1016/j.jmb.2018.05.021; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; McLoughlin F, 2016, PLANT PHYSIOL, V172, P1221, DOI 10.1104/pp.16.00536; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Mogk A, 2019, ANNU REV MICROBIOL, V73, P89, DOI 10.1146/annurev-micro-020518-115515; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Pan H, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/045006; Pan YL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15873-x; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Regini JW, 2010, MOL VIS, V16, P2446; Santhanagopalan I, 2018, J BIOL CHEM, V293, P19511, DOI 10.1074/jbc.RA118.005421; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Watkins LP, 2005, J PHYS CHEM B, V109, P617, DOI 10.1021/jp0467548; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839; Zwirowski S, 2017, EMBO J, V36, P783, DOI 10.15252/embj.201593378	61	3	3	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100161	10.1074/jbc.RA120.015419	http://dx.doi.org/10.1074/jbc.RA120.015419			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33288678	gold, Green Published			2022-12-26	WOS:000672866400139
J	Kumar, R; Poria, DK; Ray, PS				Kumar, Ravi; Poria, Dipak Kumar; Ray, Partho Sarothi			RNA-binding proteins La and HuR cooperatively modulate translation repression of PDCD4 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PDCD4; CELL-DEATH 4; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; MEDIATED TRANSLATION; MICRORNA EXPRESSION; INFLAMMATION; RESOLUTION; PUMILIO; TARGET	Posttranscriptional regulation of gene expression plays a critical role in controlling the inflammatory response. An uncontrolled inflammatory response results in chronic inflammation, often leading to tumorigenesis. Programmed cell death 4 (PDCD4) is a proinflammatory tumor-suppressor gene which helps to prevent the transition from chronic inflammation to cancer. PDCD4 mRNA translation is regulated by an interplay between the oncogenic microRNA miR-21 and the RNA-binding protein (RBP) human antigen R (HuR) in response to lipopolysaccharide stimulation, but the role of other regulatory factors remains unknown. Here, we report that the RBP lupus antigen (La) interacts with the 3'-untranslated region of PDCD4 mRNA and prevents miR-21-mediated translation repression. While lipopolysaccharide causes nuclear-cytoplasmic translocation of HuR, it enhances cellular La expression. Remarkably, La and HuR were found to bind cooperatively to the PDCD4 mRNA and mitigate miR-21-mediated translation repression. The cooperative action of La and HuR reduced cell proliferation and enhanced apoptosis, reversing the pro-oncogenic function of miR-21. Together, these observations demonstrate a cooperative interplay between two RBPs, triggered differentially by the same stimulus, which exerts a synergistic effect on PDCD4 expression and thereby helps maintain a balance between inflammation and tumorigenesis.	[Kumar, Ravi; Poria, Dipak Kumar; Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol Sci, Nadia, W Bengal, India; [Poria, Dipak Kumar] NCI, Frederick, MD 21701 USA	Indian Institute of Science Education & Research (IISER) - Kolkata; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ray, PS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Nadia, W Bengal, India.	psray@iiserkol.ac.in	Poria, Dipak Kumar/AAM-2084-2021; Ray, Partho Sarothi/H-3020-2019	Poria, Dipak Kumar/0000-0002-6935-4160; Ray, Partho Sarothi/0000-0002-8795-3060; Kumar, Ravi/0000-0001-7137-1632	Wellcome Trust/DBT India Alliance intermediate fellowship [WT500139/Z/09/Z]; CSIR-India	Wellcome Trust/DBT India Alliance intermediate fellowship(Wellcome Trust DBT India Alliance); CSIR-India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a Wellcome Trust/DBT India Alliance intermediate fellowship (WT500139/Z/09/Z) to P. S. R and CSIR-India senior research fellowships to R. K and D. K. P.	Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Ahuja D, 2016, RNA BIOL, V13, P1152, DOI 10.1080/15476286.2016.1229734; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Arvola RM, 2017, RNA BIOL, V14, P1445, DOI 10.1080/15476286.2017.1306168; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Becker WR, 2019, RNA, V25, P702, DOI 10.1261/rna.068585.118; Biyanee A, 2015, ONCOGENE, V34, P1384, DOI 10.1038/onc.2014.83; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Campbell ZT, 2012, CELL REP, V1, P570, DOI 10.1016/j.celrep.2012.04.003; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chen YG, 2017, NAT IMMUNOL, V18, P962, DOI 10.1038/ni.3771; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Chu PC, 2012, J BIOL CHEM, V287, P43639, DOI 10.1074/jbc.M112.393678; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Cienikova Z, 2015, RNA, V21, P1931, DOI 10.1261/rna.052373.115; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Fan J, 2005, EUR RESPIR J, V26, P933, DOI 10.1183/09031936.05.00120204; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; GOTTLIEB EL, 1989, EMBO J, V8, P841, DOI 10.1002/j.1460-2075.1989.tb03445.x; Guha A, 2019, ISCIENCE, V15, P342, DOI 10.1016/j.isci.2019.05.002; Ha SH, 2016, SCIENCE, V352, P990, DOI 10.1126/science.aad5937; HafezQorani S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw048; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Ho JJD, 2014, WIRES RNA, V5, P69, DOI 10.1002/wrna.1197; Jiang Y, 2017, CELL MOL IMMUNOL, V14, P884, DOI 10.1038/cmi.2017.84; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Liang CY, 2013, J BIOL CHEM, V288, P723, DOI 10.1074/jbc.M112.401323; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nakamura H, 2011, MOL CELL BIOL, V31, P1997, DOI 10.1128/MCB.01424-10; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pabis M, 2019, NUCLEIC ACIDS RES, V47, P1011, DOI 10.1093/nar/gky1138; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Poria DK, 2016, ONCOGENE, V35, P1703, DOI 10.1038/onc.2015.235; Poria D. K., 2017, BIO-PROTOCOL, V7, P1; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2002, NUCLEIC ACIDS RES, V30, P4500, DOI 10.1093/nar/gkf583; Scheiba RM, 2014, RNA BIOL, V11, P1250, DOI 10.1080/15476286.2014.996069; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Sternburg EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33596-4; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Turner M, 2018, NAT IMMUNOL, V19, P120, DOI 10.1038/s41590-017-0028-4; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wigington CP, 2015, J BIOL CHEM, V290, P3468, DOI 10.1074/jbc.M114.631937; Wu XY, 2013, NUCLEIC ACIDS RES, V41, P2644, DOI 10.1093/nar/gks1453; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006	76	6	6	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100154	10.1074/jbc.RA120.014894	http://dx.doi.org/10.1074/jbc.RA120.014894			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33288677	gold, Green Published			2022-12-26	WOS:000672866400132
J	Nitschke, S; Chown, EE; Zhao, XC; Gabrielian, S; Petkovic, S; Guisso, DR; Perri, AM; Wang, PX; Ahonen, S; Nitschke, F; Minassian, BA				Nitschke, Silvia; Chown, Erin E.; Zhao, Xiaochu; Gabrielian, Shoghig; Petkovic, Sara; Guisso, Dikran R.; Perri, Ami M.; Wang, Peixiang; Ahonen, Saija; Nitschke, Felix; Minassian, Berge A.			An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; MYOCLONUS EPILEPSY; MOUSE MODEL; GENE; MALIN; CRE; NEURODEGENERATION; RECOMBINATION; ACCUMULATION; BODIES	Malstructured glycogen accumulates over time in Lafora disease (LD) and precipitates into Lafora bodies (LBs), leading to neurodegeneration and intractable fatal epilepsy. Constitutive reduction of glycogen synthase-1 (GYS1) activity prevents murine LD, but the effect of GYS1 reduction later in disease course is unknown. Our goal was to knock out Gys1 in laforin (Epm2a)-deficient LD mice after disease onset to determine whether LD can be halted in midcourse, or even reversed. We generated Epm2a-deficient LD mice with tamoxifen-inducible Cre-mediated Gys1 knockout. Tamoxifen was administered at 4 months and disease progression assessed at 12 months. We verified successful knockout at mRNA and protein levels using droplet digital PCR and Western blots. Glycogen determination and periodic acid-Schiff-diastase staining were used to analyze glycogen and LB accumulation. Immunohistochemistry using astrocytic (glial fibrillary acidic protein) and microglial (ionized calcium-binding adapter molecule 1) markers was performed to investigate neuroinflammation. In the disease-relevant organ, the brain, Gys1 mRNA levels were reduced by 85% and GYS1 protein depleted. Glycogen accumulation was halted at the 4-month level, while LB formation and neuroinflammation were significantly, though incompletely, prevented. Skeletal muscle analysis confirmed that Gys1 knockout inhibits glycogen and LB accumulation. However, tamoxifen-independent Cre recombination precluded determination of disease halting or reversal in this tissue. Our study shows that Gys1 knockdown is a powerful means to prevent LD progression, but this approach did not reduce brain glycogen or LBs to levels below those at the time of intervention. These data suggest that endogenous mechanisms to clear brain LBs are absent or, possibly, compromised in laforin deficient murine LD.	[Nitschke, Silvia; Guisso, Dikran R.; Nitschke, Felix; Minassian, Berge A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Neurol, Dallas, TX 75390 USA; [Nitschke, Felix] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Nitschke, Silvia; Chown, Erin E.; Zhao, Xiaochu; Gabrielian, Shoghig; Petkovic, Sara; Perri, Ami M.; Wang, Peixiang; Ahonen, Saija; Minassian, Berge A.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Nitschke, F; Minassian, BA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Neurol, Dallas, TX 75390 USA.; Nitschke, F (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Minassian, BA (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada.	felix.nitschke@utsouthwestern.edu; berge.minassian@utsouthwestern.edu		Guisso, Dikran Richard/0000-0003-0191-6478; Nitschke, Felix/0000-0002-1118-2693; Nitschke, Silvia/0000-0002-6129-6103; Chown, Erin/0000-0003-1144-0821; Ahonen, Saija/0000-0003-3313-784X	Chelsea's Hope Lafora Disease Research Fund; Associazione Italiana Lafora (AILA), France-Lafora; Milana and Tatjana Gajic Lafora Disease Foundation; Ontario Brain Institute; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) [P01 NS097197]	Chelsea's Hope Lafora Disease Research Fund; Associazione Italiana Lafora (AILA), France-Lafora; Milana and Tatjana Gajic Lafora Disease Foundation; Ontario Brain Institute; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by families and friends of the Chelsea's Hope Lafora Disease Research Fund, Associazione Italiana Lafora (AILA), France-Lafora, the Milana and Tatjana Gajic Lafora Disease Foundation, the Ontario Brain Institute, and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number P01 NS097197. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. B. A. M. holds the University of Texas Southwestern UTSW Jimmy Elizabeth Westcott Distinguished Chair in Pediatric Neurology.	Auge E, 2018, GLIA, V66, P2094, DOI 10.1002/glia.23463; Brewer MK, 2019, CELL METAB, V30, P689, DOI 10.1016/j.cmet.2019.07.002; Buelow B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003264; Bult C., 2019, MOUSE GENOME DATABAS; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Chappell-Maor L, 2020, EUR J IMMUNOL, V50, P353, DOI 10.1002/eji.201948342; Chatzikonstantinou A, 2014, FRONT NEUROL NEUROSC, V34, P121, DOI 10.1159/000356435; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Delgado-Escueta AV, 2001, AM J MED GENET, V106, P129, DOI 10.1002/ajmg.1575; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dienel GA, 2017, NEUROSCI LETT, V637, P18, DOI 10.1016/j.neulet.2015.02.052; Donocoff RS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72179-0; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Duran J, 2013, J CEREBR BLOOD F MET, V33, P550, DOI 10.1038/jcbfm.2012.200; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.106839; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kristianto J, 2017, TRANSGENIC RES, V26, P411, DOI 10.1007/s11248-017-0018-1; Lahuerta M, 2020, MOL NEUROBIOL, V57, P1607, DOI 10.1007/s12035-019-01842-z; Liu J, 2013, GENESIS, V51, P436, DOI 10.1002/dvg.22384; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Lopez-Gonzalez I, 2017, MOL NEUROBIOL, V54, P3119, DOI 10.1007/s12035-016-9884-4; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mingote S, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00165; Nitschke F, 2018, NAT REV NEUROL, V14, P606, DOI 10.1038/s41582-018-0057-0; Nitschke F, 2017, EMBO MOL MED, V9, P906, DOI 10.15252/emmm.201707608; Nitschke S, 2020, J BIOL CHEM, V295, P14698, DOI 10.1074/jbc.RA120.015061; Pederson BA, 2013, ANN NEUROL, V74, P297, DOI 10.1002/ana.23899; Rai A, 2017, HUM MOL GENET, V26, P4778, DOI 10.1093/hmg/ddx357; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rubio-Villena C, 2018, HUM MOL GENET, V27, P1290, DOI 10.1093/hmg/ddy044; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Sinadinos C, 2014, AGING CELL, V13, P935, DOI 10.1111/acel.12254; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stifter SA, 2020, EUR J IMMUNOL, V50, P338, DOI 10.1002/eji.202048546; Sullivan MA, 2019, CELL REP, V27, P1334, DOI 10.1016/j.celrep.2019.04.017; Sullivan MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081743; Tang BY, 2020, J MED CHEM, V63, P3538, DOI 10.1021/acs.jmedchem.9b01851; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Van Hove H, 2020, EUR J IMMUNOL, V50, P459, DOI 10.1002/eji.201948162; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006	49	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100150	10.1074/jbc.RA120.015773	http://dx.doi.org/10.1074/jbc.RA120.015773			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33277363	Green Published, gold			2022-12-26	WOS:000672866400128
J	Kilani, HA; Bataineh, MF; Al-Nawayseh, A; Atiyat, K; Obeid, O; Abu-Hilal, MM; Mansi, T; Al-Kilani, M; Al-Kitani, M; El-Saleh, M; Jaber, RM; Sweidan, A; Himsi, M; Yousef, I; Alzeer, F; Nasrallah, M; Al Dhaheri, AS; Al-Za'abi, A; Allala, O; Al-Kilani, L; Alhasan, AM; Ghieda, M; Najah, Y; Alsheekhly, S; Alhaifi, A; Shukri, R; Al Adwani, J; Waly, M; Kilani, L; Kilani, LH; al Shareef, AS; Kilani, A				Kilani, Hashem A.; Bataineh, Mo'ath F.; Al-Nawayseh, Ali; Atiyat, Khaled; Obeid, Omar; Abu-Hilal, Maher M.; Mansi, Taiysir; Al-Kilani, Maher; Al-Kitani, Mahfoodha; El-Saleh, Majed; Jaber, Ruba M.; Sweidan, Ahmad; Himsi, Mawaheb; Yousef, Iyad; Alzeer, Faten; Nasrallah, Monther; Al Dhaheri, Ayesha S.; Al-Za'abi, Abdulsalam; Allala, Osama; Al-Kilani, Laila; Alhasan, Asma M.; Ghieda, Mohamed; Najah, Yasir; Alsheekhly, Saad; Alhaifi, Ahmad; Shukri, Raghda; Al Adwani, Jamal; Waly, Mostafa; Kilani, Laila; Kilani, Leen H.; al Shareef, Ahmad S.; Kilani, Areej			Healthy lifestyle behaviors are major predictors of mental wellbeing during COVID-19 pandemic confinement: A study on adult Arabs in higher educational institutions	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEROTONIN; INTERVENTION; QUARANTINE; DISORDERS	Background In the past infectious diseases affected the quality of lifestyle during home confinement. The study conducted examines the influence of home confinement during the COVID-19 pandemic outbreak on lifestyle, mental wellbeing, nutritional status, and sleeping pattern. Method An online multicategorical questionnaire was distributed to collect demographic information combined with the following tools: Food Frequency Questionnaire (FFQ), International Physical Activity Questionnaire (IPAQ), WHO-5 wellbeing score, and Pittsburgh Sleep Quality Index (PSQI). A snowball non-discriminate sampling procedure was conducted to collect data from people attending or working at higher institutions from March 1, 2020 to April 24, 2020. A total of 1723 completed responses (917 males, 37.4 13.4 years old and 806 females 32.2 11.5 years old) were collected. Results The female participants had significantly lower mental health scores than males (53.9% vs. 46.1%). The mental wellbeing scores were higher among participants with medium and high physical activity (PA) levels (p < 0.00). Additionally, the mental wellbeing scores were significantly improved by dietary quality and it's sleeping score (p < 0.001). However, PA was by far the major determinant of the mental health scores. Conclusion Factors such as PA, diet, and sleeping patterns were associated with mental wellbeing during the COVID-19 confinement among Arab participants.	[Kilani, Hashem A.; Atiyat, Khaled; Mansi, Taiysir] Univ Jordan, Sch Sport Sci, Kinesiol & Training Dept, Amman, Jordan; [Bataineh, Mo'ath F.; Al-Nawayseh, Ali; Al-Kilani, Maher] Hashemite Univ, Dept Sport Rehabil, Coll Phys Educ & Sport Sci, Zarqa, Jordan; [Obeid, Omar] Amer Univ Beirut, Dept Nutr & Food Sci, Beirut, Lebanon; [Abu-Hilal, Maher M.] Sultan Qaboos Univ, Psychol Dept, Coll Educ, Muscat, Oman; [Al-Kitani, Mahfoodha] Sultan Qaboos Univ, Coll Educ, Phys Educ & Sports Sci, Muscat, Oman; [El-Saleh, Majed] Al Ain Univ, Coll Educ Humanities & Social Sci, Al Ain, U Arab Emirates; [Jaber, Ruba M.] Univ Jordan, Sch Med, Family Med, Amman, Jordan; [Sweidan, Ahmad; Alhasan, Asma M.] Minist Educ, Amman, Jordan; [Himsi, Mawaheb] Actness Acad, Wellness Dept, Amman, Jordan; [Yousef, Iyad] Beir Zeit Univ, Phys Educ Dept, Ramallah, Palestine; [Alzeer, Faten] Khadouri Univ, Phys Educ Dept, Ramallah, Palestine; [Nasrallah, Monther] Al Istiqlal Univ, Mil Phys Training Dept, Jericho, Palestine; [Al Dhaheri, Ayesha S.] United Arab Emirates Univ, Food Nutr & Hlth Dept, Al Ain, U Arab Emirates; [Al-Za'abi, Abdulsalam] UAEU, Hlth & Phys Educ Dept, Coll Educ, Abu Dhabi, U Arab Emirates; [Allala, Osama] Abu Dhabi Sports Council, Abu Dhabi, U Arab Emirates; [Al-Kilani, Laila] Princess Nourah Bint Abdulrahman Univ, Dept Phys & Sport Sci, Riyadh, Saudi Arabia; [Ghieda, Mohamed] Mansoura Univ, Sport Kinesiol Dept, Mansoura, Egypt; [Najah, Yasir] Univ Baghdad, Coll Phys Educ & Sports Sci, Baghdad, Iraq; [Alsheekhly, Saad] Univ Baghdad, Coll Polit Sci, Baghdad, Iraq; [Alhaifi, Ahmad] Publ Author Appl Educ & Training, Coll Hlth Sci, Adailiya, Kuwait; [Shukri, Raghda] Tokyo Human Hlth Sci Univ Vietnam, Nursing Dept, Ho Chi Minh City, Vietnam; [Al Adwani, Jamal] Minist Awqaf & Islamic Affairs, Kuwait, Kuwait; [Waly, Mostafa] Sultan Qaboos Univ, Food Sci & Nutr Dept, Coll Agr & Marine Sci, Muscat, Oman; [Kilani, Laila] Univ Jordan, Amman, Jordan; [Kilani, Leen H.] Univ Jordan, Coll Engn, Amman, Jordan; [al Shareef, Ahmad S.] Drassa Acad, Dubai, U Arab Emirates; [Kilani, Areej] Jordan Univ Hosp, Internal Med Dept, Amman, Jordan	University of Jordan; Hashemite University; American University of Beirut; Sultan Qaboos University; Sultan Qaboos University; University of Jordan; United Arab Emirates University; United Arab Emirates University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Mansoura University; University of Baghdad; University of Baghdad; Sultan Qaboos University; University of Jordan; University of Jordan; University of Jordan	Kilani, HA (corresponding author), Univ Jordan, Sch Sport Sci, Kinesiol & Training Dept, Amman, Jordan.	hashemkilani@gmail.com	Obeid, Omar/AAS-4457-2021; KILANI, HASHEM/AAM-9951-2021	Bataineh, Moath/0000-0001-8469-9581; KILANI, HASHEM/0000-0002-2540-3055; Mansi, Taiysir/0000-0001-7560-9855	Ministry of Higher Education and Scientific Research [84811]	Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR))	This study was supported by the Ministry of Higher Education and Scientific Research (JO) (84811) to HAK. Additionally, MH is a paid employee of Actness, but was not representing Actness when working on this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazzaa HM, 2010, SAUDI MED J, V31, P210; Alomari MA, 2011, CLIN EXP HYPERTENS, V33, P345, DOI 10.3109/10641963.2010.531848; Altena E, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13052; [Anonymous], 2018, ARCH RELIGIONSGESCHI, V20, P91; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005; Childs CE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081933; Duncan GE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237695; Goethals L, 2020, JMIR AGING, V3, DOI 10.2196/19007; Gundy T, 1996, EGYPT J PSYCHIAT, V88, P167; Habsi A, 2015, SULTAN QABOOS U MED, V15, P241; Haduch A, 2016, DRUG METAB DISPOS, V44, P445, DOI 10.1124/dmd.115.067413; Huang Y, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.112963; Husby SR, 2020, J COMMUNITY PSYCHOL, V48, P1028, DOI 10.1002/jcop.22323; Jenkins TA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010056; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Josefsson T, 2014, SCAND J MED SCI SPOR, V24, P259, DOI 10.1111/sms.12050; Kilani H., 2013, EUR SCI J, V9, P156; Kilani H, 2018, EURPEAN J SPORT TECH, P2; Kilani H, 2020, WELLN JO C HLTH LIF; Kilani Hashem, 2013, Sultan Qaboos Univ Med J, V13, P510; Kim Y, 2016, ARCH CARDIOVASC DIS, V109, P39, DOI 10.1016/j.acvd.2015.09.005; Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951; Lin SH, 2014, CLIN PSYCHOPHARM NEU, V12, P196, DOI 10.9758/cpn.2014.12.3.196; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Mason OJ, 2012, J MENT HEALTH, V21, P274, DOI 10.3109/09638237.2011.648344; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; McIntyre RS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113104; Nakamaru-Ogiso E, 2012, EUR J NEUROSCI, V35, P1762, DOI 10.1111/j.1460-9568.2012.08077.x; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; On the Beat, 2014, ISLAMIC STATE REPORT, V2, P5, DOI DOI 10.7243/2052-6962-2-5; Pieh C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238906; Rohr S, 2020, PSYCHIAT PRAX, V47, P179, DOI 10.1055/a-1159-5562; Schaefer C, 2017, CURR ALZHEIMER RES, V14, P1084, DOI 10.2174/1567205014666170523094938; Simpson RJ, 2020, EXERC IMMUNOL REV, V26, P8; Song B, 2020, OSF PREPR, DOI [10.31219/osf.io/umtvh, DOI 10.31219/OSF.I0/UMTVH]; Swinkels JC, 2019, GERONTOLOGIST, V59, P1103, DOI 10.1093/geront/gny132; Tejeda HA, 2014, CELL, V157, P1500, DOI 10.1016/j.cell.2014.06.009; Tognotti E, 2013, EMERG INFECT DIS, V19, P254, DOI 10.3201/eid1902.120312; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; WHO, 2004, LANCET, V363, P902; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhang Y, 2020, INT J COMP METH-SING, V17, DOI 10.1142/S0219876219500312	44	32	32	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243524	10.1371/journal.pone.0243524	http://dx.doi.org/10.1371/journal.pone.0243524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315880	gold, Green Submitted, Green Published			2022-12-26	WOS:000600186100015
J	Mohammad, AM; Dawad, MM; Kashmoola, MA; Al-Allawi, N				Mohammad, Ameen M.; Dawad, Mohammed M.; Kashmoola, Muna A.; Al-Allawi, Nasir			Doppler-defined pulmonary hypertension in beta-thalassemia major in Kurdistan, Iraq	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; RISK-FACTORS; PLATELET ACTIVATION; ECHOCARDIOGRAPHY; COMPLICATIONS; ASSOCIATION; PREVALENCE; GUIDELINES; DIAGNOSIS	Cardiopulmonary complications are among the most important complications of thalassemia major. Pulmonary hypertension is among these complications and studies addressing its frequency and associations in the latter disorder are sparse from Iraq. For this purpose a total 100 thalassemia major patients (>= 8 years old) were enrolled from a main thalassemia center in Kurdistan, Northern Iraq. All patients had a full history and clinical examination. Full blood count, biochemical tests and viral screen including hepatitis B surface antigen and hepatitis C virus antibody, in addition to transthoracic Doppler echocardiography for tricuspid regurgitation jet velocity (TRV). The enrolled patients had a mean (SD) age of 17.6 (5.5) years, and included 52 males and 48 females. Pulmonary hypertension as defined by TRV> 2.8 m/s coupled with both exertional dyspnea and an absence of left sided heart failure, was identified in nine patients (9%). The latter subgroup of patients had significantly higher reticulocyte counts, S. LDH, S. ferritin, and hepatitis C sero-positivity compared to those without this complication by univariate analysis. While by multivariate logistic regression only reticulocytes and hepatitis C sero-positivity remained significant. Furthermore, TRV as a continuous variable was positively correlated with reticulocytes, S. bilirubin and LDH (p<0.001, p = 0.002 and p<0.001 respectively), but not with age or S. ferritin (p = 0.77, and p = 0.93 respectively). In conclusion, pulmonary hypertension is not uncommon in Iraqi patients with thalassemia major, and it appears to be linked to chronic hemolysis rather than iron overload.	[Mohammad, Ameen M.] Univ Duhok, Coll Med, Dept Internal Med, Duhok, Iraq; [Dawad, Mohammed M.] Alkhansa Teaching Hosp, Dept Hematol, Mousel, Iraq; [Kashmoola, Muna A.] Univ Mousel, Coll Med, Dept Pathol, Mousel, Iraq; [Al-Allawi, Nasir] Univ Duhok, Coll Med, Dept Pathol, Duhok, Iraq	University of Duhok; University of Duhok	Mohammad, AM (corresponding author), Univ Duhok, Coll Med, Dept Internal Med, Duhok, Iraq.	doctoramb@yahoo.com	Kashmoola, Muna/ABF-1832-2021					Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Aessopos A, 2005, ANN NY ACAD SCI, V1054, P342, DOI 10.1196/annals.1345.041; Al-Allawi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162036; Al-Allawi NAS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/262853; Amid A, 2015, ARCH DIS CHILD, V100, P1051, DOI 10.1136/archdischild-2014-308112; Amoozgar H, 2010, EUR J HAEMATOL, V85, P549, DOI 10.1111/j.1600-0609.2010.01509.x; Atichartakarn V, 2003, INT J HEMATOL, V78, P139, DOI 10.1007/BF02983382; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Colah R, 2010, EXPERT REV HEMATOL, V3, P103, DOI [10.1586/ehm.09.74, 10.1586/EHM.09.74]; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; Demir C, 2015, BIOMED RES-INDIA, V26, P183; Derchi G, 1999, AM HEART J, V138, P384, DOI 10.1016/S0002-8703(99)70129-8; Derchi G, 2014, CIRCULATION, V129, P338, DOI 10.1161/CIRCULATIONAHA.113.002124; Du ZD, 1997, AM HEART J, V134, P532, DOI 10.1016/S0002-8703(97)70091-7; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Fraidenburg DR, 2016, ANN NY ACAD SCI, V1368, P127, DOI 10.1111/nyas.13037; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Hagar RW, 2006, BRIT J HAEMATOL, V133, P433, DOI 10.1111/j.1365-2141.2006.06053.x; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Janda S, 2011, HEART, V97, P1112, DOI 10.1136/hrt.2010.212084corr1; Karimi M, 2011, EUR J INTERN MED, V22, P607, DOI 10.1016/j.ejim.2011.05.013; Kiter G, 2010, PEDIATR HEMAT ONCOL, V27, P597, DOI 10.3109/08880018.2010.503338; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Machado RF, 2013, CLIN CHEST MED, V34, P739, DOI 10.1016/j.ccm.2013.08.006; Mandell MS, 1996, CLIN CHEST MED, V17, P17, DOI 10.1016/S0272-5231(05)70296-3; Meloni A, 2015, BLOOD CELL MOL DIS, V54, P189, DOI 10.1016/j.bcmd.2014.11.003; Morris CR, 2011, BLOOD, V118, P3794, DOI 10.1182/blood-2010-11-319152; Morris CR, 2010, ANN NY ACAD SCI, V1202, P205, DOI 10.1111/j.1749-6632.2010.05580.x; Morris CR, 2005, ANN NY ACAD SCI, V1054, P481, DOI 10.1196/annals.1345.058; Phrommintikul A, 2006, HEART, V92, P1467, DOI 10.1136/hrt.2005.079970; Pugh ME, 2010, EXPERT REV CARDIOVAS, V8, P1549, DOI [10.1586/erc.10.137, 10.1586/ERC.10.137]; Rachmilewitz EA, 2011, BLOOD, V118, P3479, DOI 10.1182/blood-2010-08-300335; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Ruf A, 1997, BRIT J HAEMATOL, V98, P51, DOI 10.1046/j.1365-2141.1997.1502965.x; Salvi SS, 2000, GUT, V47, P595, DOI 10.1136/gut.47.4.595; Sayani FA, 2015, ANN MED, V47, P592, DOI 10.3109/07853890.2015.1091942; Singer ST, 2006, AM J HEMATOL, V81, P670, DOI 10.1002/ajh.20640; Taher AT, 2018, BLOOD, V132, P1781, DOI 10.1182/blood-2018-06-818187; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Thuret I, 2010, HAEMATOL-HEMATOL J, V95, P724, DOI 10.3324/haematol.2009.018051; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697	43	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243648	10.1371/journal.pone.0243648	http://dx.doi.org/10.1371/journal.pone.0243648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301537	Green Published, gold			2022-12-26	WOS:000600143100060
J	Iikuni, S; Watanabe, H; Shimizu, Y; Nakamoto, Y; Ono, M				Iikuni, Shimpei; Watanabe, Hiroyuki; Shimizu, Yoichi; Nakamoto, Yuji; Ono, Masahiro			PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; MOLECULE-DRUG CONJUGATE; CA-IX; BIOLOGICAL EVALUATION; XII INHIBITORS; CANCER-CELLS; HYPOXIA; GROWTH; DERIVATIVES; METASTASIS	Carbonic anhydrase-IX (CA-IX) is attracting much attention as a target molecule for cancer treatment since high expression of CA-IX can lead to a poor prognosis of patients. We previously reported low-molecular-weight In-111/Y-90 complexes with a bivalent ureidosulfonamide scaffold ([In-111/Y-90]In/Y-US2) as cancer radiotheranostic agents for single photon emission computed tomography and radionuclide-based therapy targeting CA-IX. Here, we applied the US2 platform to positron emission tomography (PET) imaging and pharmacological therapy targeting CA-IX high-expressing tumors by introducing Ga-68 and In-nat, respectively. In an in vitro cell binding assay, [Ga-67]Ga-US2, an alternative complex of [Ga-68]Ga-US2 with a longer half-life, markedly bound to CA-IX high-expressing (HT-29) cells compared with low-expressing (MDA-MB-231) cells. In a biodistribution study with HT-29 and MDA-MB-231 tumor-bearing mice, [Ga-67]Ga-US2 showed accumulation in the HT-29 tumor (3.81% injected dose/g at 60 min postinjection) and clearance from the blood pool with time. PET with [Ga-68]Ga-US2 clearly visualized the HT-29 tumor in model mice at 60 min postinjection. In addition, the administration of [In-nat]In-US2 to HT-29 tumor-bearing mice led to tumor growth delay and prolonged mouse survival, while no critical toxicity was observed. These results indicate that [Ga-68]Ga-US2 and [In-nat]In-US2 may be useful imaging and therapeutic agents targeting CA-IX, respectively, and that US2 may serve as an effective cancer theranostic platform utilizing CA-IX.	[Iikuni, Shimpei; Watanabe, Hiroyuki; Shimizu, Yoichi; Ono, Masahiro] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Kyoto, Japan; [Shimizu, Yoichi; Nakamoto, Yuji] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan	Kyoto University; Kyoto University	Iikuni, S; Ono, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Kyoto, Japan.	iikuni@pharm.kyoto-u.ac.jp; ono@pharm.kyoto-u.ac.jp		Nakamoto, Yuji/0000-0001-5783-8048	AMED [JP19im0210819]; JSPS KAKENHI [JP19K17166]	AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by AMED under Grant Number JP19im0210819 and JSPS KAKENHI Grant Numbers JP19K17166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akurathi V, 2014, EUR J MED CHEM, V71, P374, DOI 10.1016/j.ejmech.2013.10.027; Akurathi V, 2010, NUCL MED BIOL, V37, P557, DOI 10.1016/j.nucmedbio.2010.02.006; Alterio V, 2012, CHEM REV, V112, P4421, DOI 10.1021/cr200176r; Andreucci E, 2019, J ENZYM INHIB MED CH, V34, P117, DOI 10.1080/14756366.2018.1532419; Andreucci E, 2017, J MOL MED, V95, P1341, DOI 10.1007/s00109-017-1590-9; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Brouwers AH, 2003, CLIN CANCER RES, V9, p3953S; Bryant JL, 2018, INT J CANCER, V142, P191, DOI 10.1002/ijc.31042; Divgi CR, 2013, J CLIN ONCOL, V31, P187, DOI 10.1200/JCO.2011.41.2445; Eder M, 2012, BIOCONJUGATE CHEM, V23, P688, DOI 10.1021/bc200279b; Gieling RG, 2012, J MED CHEM, V55, P5591, DOI 10.1021/jm300529u; Grandane A, 2015, J MED CHEM, V58, P3975, DOI 10.1021/acs.jmedchem.5b00523; Guenter P, 2014, NUTR CLIN PRACT, V29, P249, DOI 10.1177/0884533614522497; Heppeler A, 1999, CHEM-EUR J, V5, P1974, DOI 10.1002/(SICI)1521-3765(19990702)5:7<1974::AID-CHEM1974>3.3.CO;2-O; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hoeben BAW, 2010, J NUCL MED, V51, P1076, DOI 10.2967/jnumed.109.073189; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Iikuni S, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127255; Iikuni S, 2018, THERANOSTICS, V8, P2992, DOI 10.7150/thno.20982; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Krall N, 2014, CHEM SCI, V5, P3640, DOI 10.1039/c4sc00685b; Krall N, 2016, J NUCL MED, V57, P943, DOI 10.2967/jnumed.115.170514; Krall N, 2014, ANGEW CHEM INT EDIT, V53, P4231, DOI 10.1002/anie.201310709; Lau J, 2016, MOL PHARMACEUT, V13, P1137, DOI 10.1021/acs.molpharmaceut.5b00934; Lau J, 2015, J NUCL MED, V56, P1434, DOI 10.2967/jnumed.114.153288; Li GR, 2001, CLIN CANCER RES, V7, P89; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Lv PC, 2016, BIOCONJUGATE CHEM, V27, P1762, DOI 10.1021/acs.bioconjchem.6b00271; Maresca A, 2009, J AM CHEM SOC, V131, P3057, DOI 10.1021/ja809683v; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minn I, 2016, ONCOTARGET, V7, P56471, DOI 10.18632/oncotarget.10602; MINN IL, 2016, J NUCL MED S2, V57; More KN, 2018, BIOORG MED CHEM LETT, V28, P915, DOI 10.1016/j.bmcl.2018.01.060; Muller C, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0189-4; Muselaers CHJ, 2013, EUR UROL, V63, P1101, DOI 10.1016/j.eururo.2013.02.022; Nakai M, 2018, J INORG BIOCHEM, V185, P63, DOI 10.1016/j.jinorgbio.2018.04.009; Oosterwijk E, 2014, SUBCELL BIOCHEM, V75, P181, DOI 10.1007/978-94-007-7359-2_10; Pacchiano F, 2011, J MED CHEM, V54, P1896, DOI 10.1021/jm101541x; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Pastorek J, 2015, SEMIN CANCER BIOL, V31, P52, DOI 10.1016/j.semcancer.2014.08.002; Pastorekova S, 2019, CANCER METAST REV, V38, P65, DOI 10.1007/s10555-019-09799-0; Peeters SGJA, 2015, MOL IMAGING BIOL, V17, P615, DOI 10.1007/s11307-015-0831-y; Peperidou A, 2018, MOLECULES, V23, DOI 10.3390/molecules23010153; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rami M, 2013, J MED CHEM, V56, P8512, DOI 10.1021/jm4009532; Ratcliffe PJ, 2000, NAT MED, V6, P1315, DOI 10.1038/82113; Riemann A, 2018, ONCOL RES, V26, P191, DOI 10.3727/096504017X14965111926391; Semenza GL, 2007, CANCER METAST REV, V26, P223, DOI 10.1007/s10555-007-9058-y; Sneddon D, 2016, J MED CHEM, V59, P6431, DOI 10.1021/acs.jmedchem.6b00623; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2003, MED RES REV, V23, P146, DOI 10.1002/med.10025; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Tanc M, 2013, BIOORGAN MED CHEM, V21, P4502, DOI 10.1016/j.bmc.2013.05.032; Tars K, 2013, J MED CHEM, V56, P293, DOI 10.1021/jm301625s; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Touisni N, 2011, J MED CHEM, V54, P8271, DOI 10.1021/jm200983e; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; Verhoeff SR, 2019, EUR J NUCL MED MOL I, V46, P1931, DOI 10.1007/s00259-019-04358-9; Vullo D, 2003, BIOORG MED CHEM LETT, V13, P1005, DOI 10.1016/S0960-894X(03)00091-X; Wadas TJ, 2010, CHEM REV, V110, P2858, DOI 10.1021/cr900325h; Ward C, 2015, ONCOTARGET, V6, P24856, DOI 10.18632/oncotarget.4498; Yang X, 2015, ONCOTARGET, V6, P33733, DOI 10.18632/oncotarget.5254; Zhang ZX, 2017, J ENZYM INHIB MED CH, V32, P722, DOI 10.1080/14756366.2017.1308928	64	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243327	10.1371/journal.pone.0243327	http://dx.doi.org/10.1371/journal.pone.0243327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296398	Green Published, gold			2022-12-26	WOS:000598626100037
J	Jiang, YF; Wang, Y; Sun, Y; Jiang, H				Jiang, Yunfeng; Wang, Yue; Sun, Yu; Jiang, Hong			Long non-coding RNA Peg13 attenuates the sevoflurane toxicity against neural stem cells by sponging microRNA-128-3p to preserve Sox13 expression	PLOS ONE			English	Article							DIFFERENTIATION; NEUROTOXICITY; HIPPOCAMPUS; PLASTICITY; EXPOSURE; BRAIN	Background Exposure to anesthetics during brain development may impair neurological function, however, the mechanisms underlying anesthetic neurotoxicity are unclear. Recent studies indicate that long non-coding RNAs (lncRNAs) are crucial for regulating the functional brain development during neurogenesis. This study aimed to determine the regulatory effects and potential mechanisms of lncRNA Peg13 (Peg13) on sevoflurane exposure-related neurotoxicity against neural stem cells (NSCs). Methods Mouse embryotic NSCs were isolated and their self-renewal and differentiation were characterized by immunofluorescence. NSCs were exposed to 4.1% sevoflurane 2 h daily for three consecutive days. The potential toxicities of sevoflurane against NSCs were evaluated by neurosphere formation, 5-ethynyl-2'-deoxyuridine (EdU) incorporation and flow cytometry assays. The Peg13, miR-128-3p and Sox13 expression in NSCs were quantified. The potential interactions among Peg13, miR-128-3p and Sox13 were analyzed by luciferase reporter assay. The effects of Peg13 and/or miR-128-3p over-expression on the sevoflurane-related neurotoxicity and Sox13 expression were determined in NSCs. Results The isolated mouse embryotic NSCs displayed potent self-renewal ability and differentiated into neurons, astrocytes and oligodendrocytes in vitro, which were significantly inhibited by sevoflurane exposure. Sevoflurane exposure significantly down-regulated Peg13 and Sox13, but enhanced miR-128-3p expression in NSCs. Transfection with miR-128-3p mimics, but not the control, significantly mitigated the Peg13 or Sox13-regulated luciferase expression in 293T cells. Peg13 over-expression significantly reduced the sevoflurane-related neurotoxicity and increased Sox13 expression in NSCs, which were mitigated by miR-128-3p transfection. Conclusion Such data indicated that Peg13 mitigated the sevoflurane-related neurotoxicity by sponging miR-128-3p to preserve Sox13 expression in NSCs.	[Jiang, Yunfeng; Wang, Yue; Sun, Yu; Jiang, Hong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, China Hosp,Dev Inst, Dept Anesthesiol,Sch Med,Ctr Specialty Strategy R, Shanghai, Peoples R China	Shanghai Jiao Tong University	Sun, Y; Jiang, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, China Hosp,Dev Inst, Dept Anesthesiol,Sch Med,Ctr Specialty Strategy R, Shanghai, Peoples R China.	Dr_sunyu@163.com; drjianghongjy@163.com			Department of Anaesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; Natural Science Foundation of Shanghai [18ZR1422900]; Science and Technology Commission of Shanghai Municipality (Shanghai Administration of Foreign Experts Affairs)	Department of Anaesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Science and Technology Commission of Shanghai Municipality (Shanghai Administration of Foreign Experts Affairs)	This study was supported by the Department of Anaesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. This study was also supported by a grant from the Natural Science Foundation of Shanghai (18ZR1422900) and the Science and Technology Commission of Shanghai Municipality (Shanghai Administration of Foreign Experts Affairs).	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Amrock LG, 2015, ANESTHESIOLOGY, V122, P87, DOI 10.1097/ALN.0000000000000477; Badwal SPS, 2018, WIRES ENERGY ENVIRON, V7, DOI 10.1002/wene.286; Baroti T, 2016, J NEUROCHEM, V136, P316, DOI 10.1111/jnc.13414; Bi CJ, 2018, BIOMED PHARMACOTHER, V108, P1469, DOI 10.1016/j.biopha.2018.09.111; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farrell BC, 2011, INT J DEV NEUROSCI, V29, P31, DOI 10.1016/j.ijdevneu.2010.10.001; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Grade S, 2013, INT J DEV NEUROSCI, V31, P692, DOI 10.1016/j.ijdevneu.2013.01.004; Graham MR, 2017, CURR OPIN ANESTHESIO, V30, P682, DOI 10.1097/ACO.0000000000000520; He ZW, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1065-7; Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021; Hu XY, 2019, J CELL BIOCHEM, V120, P18209, DOI 10.1002/jcb.29127; Jalali S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1282-9; Kukurba Kimberly R, 2015, Cold Spring Harb Protoc, V2015, P951, DOI 10.1101/pdb.top084970; Liang C, 2019, ANESTH ANALG, V129, P608, DOI 10.1213/ANE.0000000000003844; Lorenc A, 2014, MOL BIOL EVOL, V31, P3240, DOI 10.1093/molbev/msu257; Lu GL, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109334; Lu GL, 2018, NEUROREPORT, V29, P605, DOI 10.1097/WNR.0000000000000980; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Lu Y, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00135; Mancini M, 2020, METHODS MOL BIOL, V2154, P175, DOI 10.1007/978-1-0716-0648-3_15; MuhChyi C, 2013, INT J DEV NEUROSCI, V31, P424, DOI 10.1016/j.ijdevneu.2013.02.006; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Rockne RC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199967; Shao CZ, 2019, J CELL PHYSIOL, V234, P3864, DOI 10.1002/jcp.27158; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang JY, 2018, J MOL NEUROSCI, V64, P346, DOI 10.1007/s12031-018-1029-y; Wang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171359; Wang XN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216372; Wang Y, 2006, J HISTOCHEM CYTOCHEM, V54, P1327, DOI 10.1369/jhc.6A6923.2006; Warner DO, 2018, ANESTHESIOLOGY, V129, P89, DOI 10.1097/ALN.0000000000002232; Xiao HY, 2016, INT J DEV NEUROSCI, V48, P38, DOI 10.1016/j.ijdevneu.2015.11.001; Yan R, 2018, BIOMED PHARMACOTHER, V103, P1490, DOI 10.1016/j.biopha.2018.04.184; Yi XW, 2016, CELL TISSUE RES, V365, P319, DOI 10.1007/s00441-016-2394-x; Zhang J, 2016, EXP NEUROL, V277, P162, DOI 10.1016/j.expneurol.2015.12.014; Zhang L, 2019, EBIOMEDICINE, V43, P473, DOI 10.1016/j.ebiom.2019.04.048; Zhang L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42991-4; Zhang M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00042; Zhang W, 2016, ELIFE, V5, DOI 10.7554/eLife.11324; Zhao YL, 2020, J CELL PHYSIOL, V235, P957, DOI 10.1002/jcp.29011; Zimering JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159637	46	3	3	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243644	10.1371/journal.pone.0243644	http://dx.doi.org/10.1371/journal.pone.0243644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296418	gold, Green Published			2022-12-26	WOS:000598626100036
J	Lubkowska, A; Szymanski, S; Chudecka, M				Lubkowska, Anna; Szymanski, Slawomir; Chudecka, Monika			Neonatal thermal response to childbirth: Vaginal delivery vs. caesarean section	PLOS ONE			English	Article							HEAT-LOSS PREVENTION; EPIDERMAL WATER-LOSS; BODY-TEMPERATURE; NEWBORN-INFANTS; MODE; RISK; BIRTH; THERMOREGULATION; THERMOGENESIS; SENSITIZATION	Newborns, regardless of the method of termination of pregnancy, are exposed to the first exogenous stress factors during delivery. The purpose of the study was to evaluate the differences in newborns' thermal response to vaginal (VD) vs caesarean section (CS) delivery. The temperature was measured during the first minutes of life within 122 healthy full-term newborns, on the forehead, chest and upper-back by infrared camera (FLIR T1030sc HD). The lowest temperatures were recorded in the forehead of VD newborns (significantly difference with CS; p < 0.001), the warmest was the chest. A significant correlation was found between the duration of the second stage of natural childbirth and surface temperature and pO2 in the newborn blood. The temperatures of selected body surface areas correlate highly positively, regardless of the mode of delivery. In the case of healthy neonates, with normal birth weight and full-term, VD creates more favourable conditions stimulating the mechanisms of adaptation for a newborn than CS.	[Lubkowska, Anna] Pomeranian Med Univ, Fac Hlth Sci, Chair & Dept Funct Diagnost & Phys Med, Szczecin, Poland; [Szymanski, Slawomir] Pomeranian Med Univ, Dept Obstet & Pathol Pregnancy, Szczecin, Poland; [Chudecka, Monika] Univ Szczecin, Fac Phys Educ & Hlth, Inst Phys Culture Sci, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; University of Szczecin	Chudecka, M (corresponding author), Univ Szczecin, Fac Phys Educ & Hlth, Inst Phys Culture Sci, Szczecin, Poland.	monikachudecka@wp.pl						ADAMSONS K, 1965, ANESTHESIOLOGY, V26, P531, DOI 10.1097/00000542-196507000-00017; ADAMSONS K, 1966, PEDIATR CLIN N AM, V13, P599; Alba BK, 2019, EXP PHYSIOL, V104, P1202, DOI 10.1113/EP087718; Asakura Hirobumi, 2004, Journal of Nippon Medical School, V71, P360, DOI 10.1272/jnms.71.360; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Bissinger Robin L, 2010, Adv Neonatal Care, V10, P230, DOI 10.1097/ANC.0b013e3181f0ae63; Blustein J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2410; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Carter Brett W, 2008, Proc (Bayl Univ Med Cent), V21, P328; Chang HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131976; Charkoudian N, 2010, J APPL PHYSIOL, V109, P1221, DOI 10.1152/japplphysiol.00298.2010; Charpak N, 2005, ACTA PAEDIATR, V94, P514, DOI 10.1080/08035250510027381; Chis A, 2017, PSYCHONEUROENDOCRINO, V86, P203, DOI 10.1016/j.psyneuen.2017.09.024; Cho CE, 2013, AM J OBSTET GYNECOL, V208, P249, DOI 10.1016/j.ajog.2012.08.009; CHRISTENSSON K, 1993, ACTA PAEDIATR, V82, P128, DOI 10.1111/j.1651-2227.1993.tb12622.x; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Department of Reproductive Health and Research WHO, 1997, WHORHTMSM972; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; EFSA (European Food Safety Authority), 2006, EFSA J, V4, p78r; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Elk Grove IL, 1988, GUID PER CAR; Fransson AL, 2005, ARCH DIS CHILD-FETAL, V90, pF500, DOI 10.1136/adc.2004.066589; Fujimasa I., 1995, BIOMED THERMOL, V15, P63; GUNN TR, 1989, BAILLIERE CLIN ENDOC, V3, P869, DOI 10.1016/S0950-351X(89)80057-6; HAGNEVIK K, 1984, ACTA PAEDIATR SCAND, V73, P602, DOI 10.1111/j.1651-2227.1984.tb09982.x; HAMMARLUND K, 1980, ACTA PAEDIATR SCAND, V69, P385, DOI 10.1111/j.1651-2227.1980.tb07097.x; HAMMARLUND K, 1982, ACTA PAEDIATR SCAND, V71, P369, DOI 10.1111/j.1651-2227.1982.tb09436.x; Heimann K, 2013, J PERINAT MED, V41, P613, DOI 10.1515/jpm-2012-0239; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; JESSEN C, 1985, PHARMACOL THERAPEUT, V28, P107, DOI 10.1016/0163-7258(85)90085-3; Jones EJ, 2003, MED PHYSL CELLULAR M, P1190; Khashan AS, 2014, PEDIATRICS, V134, pE806, DOI 10.1542/peds.2014-0819; Kiriakopoulos N, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081112; Kiwanja, 2007, KIWANJA, V3, P1, DOI DOI 10.1017/CBO9781107415324.004; Knobel R, 2007, JOGNN-J OBST GYN NEO, V36, P280, DOI 10.1111/j.1552-6909.2007.00149.x; Knobel Robin B, 2005, J Perinatol, V25, P514, DOI 10.1038/sj.jp.7211344; Knobel RB, 2011, BIOL RES NURS, V13, P274, DOI 10.1177/1099800411403467; Knobel-Dail RB, 2017, J THERM BIOL, V69, P118, DOI 10.1016/j.jtherbio.2017.06.005; Knobel-Dail RB, 2014, RES REP NEONATOL, V4, P147, DOI 10.2147/RRN.S52377; Koplin J, 2008, PEDIAT ALLERG IMM-UK, V19, P682, DOI 10.1111/j.1399-3038.2008.00731.x; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Laburn H, 2001, PHYSL PATHOPHYSIOLOG, P87; LAGERCRANTZ H, 1986, SCI AM, V254, P100, DOI 10.1038/scientificamerican0486-100; Levine EM, 2001, OBSTET GYNECOL, V97, P439, DOI 10.1016/S0029-7844(00)01150-9; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Lubkowska A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081312; Leante-Castellanos JL, 2012, J PERINAT MED, V40, P571, DOI 10.1515/jpm-2011-0269; Lunze K, 2012, J PERINATOL, V32, P317, DOI 10.1038/jp.2012.11; Lyon AJ, 2011, ARCH DIS CHILD-FETAL, V96, pF71, DOI 10.1136/adc.2009.161158; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Marshall A, 1997, J NEONATAL NURS, V3, P32; Morrison Shaun F, 2016, F1000Res, V5, DOI 10.12688/f1000research.7958.1; Mullany LC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-43; Nalepka C D, 1976, JOGN Nurs, V5, P17, DOI 10.1111/j.1552-6909.1976.tb02346.x; Narendran V, 1999, J PEDIATR-US, V134, P529, DOI 10.1016/S0022-3476(99)70232-5; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Oya A, 1997, J PERINAT MED, V25, P447, DOI 10.1515/jpme.1997.25.5.447; Pei ZC, 2014, J PEDIATR-US, V164, P1068, DOI 10.1016/j.jpeds.2013.12.044; PIPER JM, 1991, AM J OBSTET GYNECOL, V165, P976, DOI 10.1016/0002-9378(91)90452-W; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; RANDALL NJ, 1991, J BIOMED ENG, V13, P481, DOI 10.1016/0141-5425(91)90094-N; Rizzo A, 2011, IMMUNOPHARM IMMUNOT, V33, P581, DOI 10.3109/08923973.2010.549137; Rutter N, 2005, ROBERTSONS TXB NEONA, P267; Sedin G, 2004, FETAL NEONATAL PHYSL, P570, DOI 10.1016/B978-0-7216-9654-6.50060-6; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; SLOTKIN TA, 1988, J DEV PHYSIOL, V10, P1; Soll RF, 2008, J PERINATOL, V28, pS57, DOI 10.1038/jp.2008.51; Tan CL, 2018, NEURON, V98, P31, DOI 10.1016/j.neuron.2018.02.022; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Xiong FX, 2013, FRONT NEUROENDOCRIN, V34, P27, DOI 10.1016/j.yfrne.2012.11.002; Yuan C, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2385; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]	74	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243453	10.1371/journal.pone.0243453	http://dx.doi.org/10.1371/journal.pone.0243453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296407	gold, Green Published			2022-12-26	WOS:000598626100069
J	Paek, JH; Kim, Y; Park, WY; Jin, K; Hyun, M; Lee, JY; Kim, HA; Kwon, YS; Park, JS; Han, S				Paek, Jin Hyuk; Kim, Yaerim; Park, Woo Yeong; Jin, Kyubok; Hyun, Miri; Lee, Ji Yeon; Kim, Hyun Ah; Kwon, Yong Shik; Park, Jae Seok; Han, Seungyeup			Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality	PLOS ONE			English	Article							CORONAVIRUS; PROGNOSIS; DISEASE; WUHAN; COV	Although the lungs are major targets for COVID-19 invasion, other organs-such as the kidneys-are also affected. However, the renal complications of COVID-19 are not yet well explored. This study aimed to identify the incidence of acute kidney injury (AKI) in patients with COVID-19 and to evaluate its impact on patient outcomes. This retrospective study included 704 patients with COVID-19 who were hospitalized at two hospitals in Daegu, Korea from February 19 to March 31, 2020. AKI was defined according to the serum creatinine criteria in the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. The final date of follow-up was May 1, 2020. Of the 704 patients, 28 (4.0%) developed AKI. Of the 28 patients with AKI, 15 (53.6%) were found to have AKI stage 1, 3 (10.7%) had AKI stage 2, and 10 (35.7%) had AKI stage 3. Among these patients, 12 (42.9%) recovered from AKI. In the patients with AKI, the rates of admission to intensive care unit (ICU), administration of mechanical ventilator (MV), and in-hospital mortality were significantly higher than in patients without AKI. Multivariable analysis revealed that old age (Hazard ratio [HR] = 4.668, 95% confidence interval [CI] = 1.250-17.430, p = 0.022), high neutrophil-to-lymphocyte ratio (HR = 1.167, 95% CI = 1.078-1.264, p < 0.001), elevated creatinine kinase (HR = 1.002, 95% CI = 1.001-1.004, p = 0.007), and severe AKI (HR = 12.199, 95% CI = 4.235-35.141, p < 0.001) were independent risk factors for in-hospital mortality. The Kaplan-Meier curves showed that the cumulative survival rate was lowest in the AKI stage 3 group (p < 0.001). In conclusion, the incidence of AKI in patients with COVID-19 was 4.0%. Severe AKI was associated with in-hospital death.	[Paek, Jin Hyuk; Kim, Yaerim; Park, Woo Yeong; Jin, Kyubok; Han, Seungyeup] Keimyung Univ, Sch Med, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Paek, Jin Hyuk; Kim, Yaerim; Park, Woo Yeong; Jin, Kyubok; Han, Seungyeup] Keimyung Univ, Kidney Inst, Daegu, South Korea; [Hyun, Miri; Lee, Ji Yeon; Kim, Hyun Ah] Keimyung Univ, Sch Med, Dept Internal Med, Div Infect Dis, Daegu, South Korea; [Kwon, Yong Shik; Park, Jae Seok] Keimyung Univ, Sch Med, Dept Internal Med, Div Pulmonol, Daegu, South Korea	Keimyung University; Keimyung University; Keimyung University; Keimyung University	Han, S (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Div Nephrol, Daegu, South Korea.; Han, S (corresponding author), Keimyung Univ, Kidney Inst, Daegu, South Korea.	hansy@dsmc.or.kr		Han, Seungyeup/0000-0002-7561-6534	Daegu Medical Association COVID-19 scientific committee	Daegu Medical Association COVID-19 scientific committee	This study was supported by a research grant from the Daegu Medical Association COVID-19 scientific committee.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; BORGES O, 1989, ACTA PHYSIOL SCAND, V136, P29, DOI 10.1111/j.1748-1716.1989.tb08626.x; Brouwer WP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2588-1; Carbajo-Lozoya J, 2012, VIRUS RES, V165, P112, DOI 10.1016/j.virusres.2012.02.002; Cavagna L, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8070977; Cha RH, 2015, J KOREAN MED SCI, V30, P1807, DOI 10.3346/jkms.2015.30.12.1807; Cheng Y, 2020, KIDNEY DIS IS ASS HO; Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Giacomelli A, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104931; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Hoffmann M, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00754-20; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Isaac V, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003832; Kim SW, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e152; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Morgera S, 2003, NEPHRON CLIN PRACT, V94, pC75, DOI 10.1159/000072024; Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001; Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1; Park HC, 2020, KIDNEY RES CLIN PRAC, V39, P145, DOI 10.23876/j.krcp.20.046; Park S, 2018, AM J KIDNEY DIS, V71, P9, DOI 10.1053/j.ajkd.2017.06.008; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Portoles J, 2020, NEPHROL DIAL TRANSPL, V35, P1353, DOI 10.1093/ndt/gfaa189; Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0; Shao MJ, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105107; Silver SA, 2018, J AM SOC NEPHROL, V29, P1001, DOI 10.1681/ASN.2017080882; Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3; United Nations DoE Social Affairs PD, 2019, STESASERA430 UN DOE; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang LW, 2020, AM J NEPHROL, V51, P343, DOI 10.1159/000507471; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yang XH, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03065-4; Zahid U, 2020, AM J NEPHROL, V51, P786, DOI 10.1159/000511160; Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	40	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243528	10.1371/journal.pone.0243528	http://dx.doi.org/10.1371/journal.pone.0243528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296419	Green Published, gold			2022-12-26	WOS:000598626100073
J	Cordon, B; Vilades, E; Orduna, E; Satue, M; Perez-Velilla, J; Sebastian, B; Polo, V; Larrosa, JM; Pablo, LE; Garcia-Martin, E				Cordon, Beatriz; Vilades, Elisa; Orduna, Elvira; Satue, Maria; Perez-Velilla, Javier; Sebastian, Berta; Polo, Vicente; Larrosa, Jose Manuel; Pablo, Luis Emilio; Garcia-Martin, Elena			Angiography with optical coherence tomography as a biomarker in multiple sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; NERVE-FIBER LAYER; IMPAIRMENT; DISABILITY	Purpose To investigate superficial retinal microvascular plexuses detected by optical coherence tomography angiography (OCT-A) in multiple sclerosis (MS) subjects and compare them with healthy controls. Methods A total of 92 eyes from 92 patients with relapsing-remitting MS and 149 control eyes were included in this prospective observational study. OCT-A imaging was performed using Triton Swept-Source OCT (Topcon Corporation, Japan). The vessel density (VD) percentage in the superficial retinal plexus and optic disc area (6 x 6 mm grid) was measured and compared between groups. Results MS patients showed a significant decrease VD in the superior (p = 0.005), nasal (p = 0.029) and inferior (p = 0.040) parafoveal retina compared with healthy subjects. Patients with disease durations of more than 5 years presented lower VD in the superior (p = 0.002), nasal (p = 0.017) and inferior (p = 0.022) parafoveal areas compared with healthy subjects. Patients with past optic neuritis episodes did not show retinal microvasculature alterations, but patients with an EDSS score of less than 3 showed a significant decrease in nasal (p = 0.024) and superior (p = 0.006) perifoveal VD when compared with healthy subjects. Conclusions MS produces a decrease in retinal vascularization density in the superficial plexus of the parafoveal retina. Alterations in retinal vascularization observed in MS patients are independent of the presence of optic nerve inflammation. OCT-A has the ability to detect subclinical vascular changes and is a potential biomarker for diagnosing the presence and progression of MS.	[Cordon, Beatriz; Vilades, Elisa; Orduna, Elvira; Satue, Maria; Perez-Velilla, Javier; Polo, Vicente; Larrosa, Jose Manuel; Pablo, Luis Emilio; Garcia-Martin, Elena] Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain; [Cordon, Beatriz; Vilades, Elisa; Orduna, Elvira; Satue, Maria; Perez-Velilla, Javier; Polo, Vicente; Larrosa, Jose Manuel; Pablo, Luis Emilio; Garcia-Martin, Elena] Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Miguel Servet Ophthalmol Innovat & Res Grp GIMSO, Zaragoza, Spain; [Sebastian, Berta] Miguel Servet Univ Hosp, Neurol Dept, Zaragoza, Spain; [Polo, Vicente; Larrosa, Jose Manuel; Pablo, Luis Emilio; Garcia-Martin, Elena] Carlos III Inst Hlth, Natl Ocular Pathol Network OFTARED, Madrid, Spain	Miguel Servet University Hospital; University of Zaragoza; Miguel Servet University Hospital; Instituto de Salud Carlos III	Cordon, B (corresponding author), Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain.; Cordon, B (corresponding author), Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Miguel Servet Ophthalmol Innovat & Res Grp GIMSO, Zaragoza, Spain.	beatrizcordonc@gmail.com	Ciordia, Beatriz Cordón/AAO-4050-2020	Ciordia, Beatriz Cordón/0000-0001-5470-8977; GARCIA-MARTIN, ELENA/0000-0001-6258-2489				Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Akcam HT, 2014, EYE, V28, P1206, DOI 10.1038/eye.2014.178; Bhaduri B, 2016, BIOMED OPT EXPRESS, V7, P2321, DOI 10.1364/BOE.7.002321; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Feucht N, 2019, MULT SCLER J, V25, P224, DOI 10.1177/1352458517750009; Garcia-Martin E, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/7361212; Garcia-Martin E, 2019, ACTA OPHTHALMOL, V97, pE77, DOI 10.1111/aos.13807; Garcia-Martin E, 2017, OPHTHALMOLOGY, V124, P688, DOI 10.1016/j.ophtha.2017.01.005; Garcia-Martin E, 2013, ACTA OPHTHALMOL, V91, pE628, DOI 10.1111/aos.12156; Garcia-Martin E, 2013, NEUROLOGY, V81, P76, DOI 10.1212/WNL.0b013e318299ccd9; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Heiskanen S, 2007, SCAND J CARING SCI, V21, P199, DOI 10.1111/j.1471-6712.2007.00456.x; Jiang H, 2020, AM J OPHTHALMOL, V213, P34, DOI 10.1016/j.ajo.2019.12.021; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lamirel C, 2010, REV NEUROL-FRANCE, V166, P978, DOI 10.1016/j.neurol.2010.03.024; Lanzillo R, 2018, MULT SCLER J, V24, P1706, DOI 10.1177/1352458517729463; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Meyers AR, 2000, ARCH NEUROL-CHICAGO, V57, P1224, DOI 10.1001/archneur.57.8.1224; Murphy OC, 2020, MULT SCLER J, V26, P815, DOI 10.1177/1352458519845116; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Orlov NV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215916; del Palomar AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216410; Pillay G, 2018, INDIAN J OPHTHALMOL, V66, P114, DOI 10.4103/ijo.IJO_539_17; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; PRINEAS J, 1975, HUM PATHOL, V6, P531, DOI 10.1016/S0046-8177(75)80040-2; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Satue M, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/8503859; Spain RI, 2018, BRIT J OPHTHALMOL, V102, P520, DOI 10.1136/bjophthalmol-2017-310477; Stanga PE, 2016, DEV OPHTHALMOL, V56, P13, DOI 10.1159/000442771; Tang FY, 2020, EYE VISION, V7, DOI 10.1186/s40662-019-0173-y; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Wakita H, 2002, BRAIN RES, V924, P63, DOI 10.1016/S0006-8993(01)03223-1; Wang XG, 2014, BRIT J OPHTHALMOL, V98, P1368, DOI 10.1136/bjophthalmol-2013-304547; Yilmaz H, 2020, EYE, V34, P771, DOI 10.1038/s41433-019-0746-y; Yoon SP, 2019, OPHTHALMOL RETINA, V3, P489, DOI 10.1016/j.oret.2019.02.002	37	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243236	10.1371/journal.pone.0243236	http://dx.doi.org/10.1371/journal.pone.0243236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290417	gold, Green Published			2022-12-26	WOS:000598620100023
J	Shi, CX; Yang, EJ; Liu, YF; Mou, PK; Ren, GW; Shim, JS				Shi, Changxiang; Yang, Eun Ju; Liu, Yifan; Mou, Pui Kei; Ren, Guowen; Shim, Joong Sup			Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; TUMOR-SUPPRESSOR; C-MYC; DOSE-ESCALATION; DNA-BINDING; DPC4; EXPRESSION; DOMAIN; GENE	The tumor suppressor SMAD4 is frequently mutated in colorectal cancer (CRC). However, no effective targeted therapies exist for CRC with SMAD4 loss. Here, we employed a synthetic lethality drug screening in isogenic SMAD4(+/+) and SMAD4(-/-) HCT116 CRC cells and found that bromodomain and extra-terminal motif (BET) inhibitors, as selective drugs for the growth of SMAD4(-/-) HCT116 cells. BET inhibition selectively induced G1 cell cycle arrest in SMAD4(-/-) cells and this effect was accompanied by the reprogramming of the MYC-p21 axis. Mechanistically, SMAD4 is a transcription repressor of MYC, and MYC in turn represses p21 transcription. SMAD4(-/-) cells lost MYC repression ability, thereby causing the cells addicted to the MYC oncogenic signaling. BET inhibition significantly reduced MYC level and restored p21 expression in SMAD4(-/-) cells, inducing the selective growth arrest. The ectopic overexpression of MYC or the silencing of p21 could rescue the BET inhibitor-induced growth arrest in SMAD4(-/-) cells, verifying this model. Tumor xenograft mouse experiments further demonstrated the synthetic lethality interaction between BET and SMAD4 in vivo. Taken together, our data suggest that BET could be a potential drug target for the treatment of SMAD4-deficient CRC.	[Shi, Changxiang; Yang, Eun Ju; Liu, Yifan; Mou, Pui Kei; Ren, Guowen; Shim, Joong Sup] Univ Macau, Fac Hlth Sci, Canc Ctr, Ave Univ, Taipa, Macau, Peoples R China	University of Macau	Shim, JS (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Ave Univ, Taipa, Macau, Peoples R China.	jsshim@um.edu.mo	Shim, Joong Sup/G-8383-2011	Shim, Joong Sup/0000-0003-0167-7307	University of Macau [MYRG2019-00116-FHS, MYRG2017-00176-FHS]	University of Macau	We thank to the members of the FHS Animal Facility, Biological Imaging and Stem Cell Core, and Genomics, Bioinformatics and Single Cell Core at the University of Macau for experimental and technical supports. This study was supported by the Multi-Year Research Grants (MYRG2019-00116-FHS and MYRG2017-00176-FHS) to JSS from the University of Macau.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Alazzouzi H, 2005, CLIN CANCER RES, V11, P2606, DOI 10.1158/1078-0432.CCR-04-1458; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Alqahtani A, 2019, FUTUR SCI OA, V5, DOI 10.4155/fsoa-2018-0115; Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Choi PS, 2014, P NATL ACAD SCI USA, V111, pE3316, DOI 10.1073/pnas.1406123111; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dong XC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0181-6; Doroshow DB, 2017, ANN ONCOL, V28, P1776, DOI 10.1093/annonc/mdx157; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Gutierrez L, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030244; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Jones JB, 2000, NUCLEIC ACIDS RES, V28, P2363, DOI 10.1093/nar/28.12.2363; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Lewin J, 2018, J CLIN ONCOL, V36, P3007, DOI 10.1200/JCO.2018.78.2292; Li Y, 2014, J INTERN MED, V276, P52, DOI 10.1111/joim.12237; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MacGrogan D, 1997, ONCOGENE, V15, P1111, DOI 10.1038/sj.onc.1201232; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Peterfia B, 2017, J CANCER, V8, P162, DOI 10.7150/jca.16037; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stathis A, 2018, CANCER DISCOV, V8, P24, DOI 10.1158/2159-8290.CD-17-0605; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Wang H, 2006, CANCER RES, V66, P9722, DOI 10.1158/0008-5472.CAN-05-4602; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yan P, 2016, CLIN CANCER RES, V22, P3037, DOI 10.1158/1078-0432.CCR-15-0939; Zhang BY, 2018, ONCOGENE, V37, P6341, DOI 10.1038/s41388-018-0408-8	61	8	8	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					937	950		10.1038/s41388-020-01580-w	http://dx.doi.org/10.1038/s41388-020-01580-w		DEC 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33293694				2022-12-26	WOS:000599053400001
J	de la Cruz-Ku, G; Chambergo-Michilot, D; Torres-Roman, JS; Rebaza, P; Pinto, J; Araujo, J; Morante, Z; Enriquez, D; Flores, C; Luque, R; Saavedra, A; Lujan, M; Gomez, H; Valcarcel, B				de la Cruz-Ku, Gabriel; Chambergo-Michilot, Diego; Torres-Roman, J. Smith; Rebaza, Pamela; Pinto, Joseph; Araujo, Jhajaira; Morante, Zaida; Enriquez, Daniel; Flores, Claudio; Luque, Renato; Saavedra, Antonella; Lujan, Maria; Gomez, Henry; Valcarcel, Bryan			Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; RESIDUAL DISEASE; CHEMOTHERAPY; EXPERIENCE	Background The aim of this study was to determine the utility of the neutrophil-to-lymphocyte ratio (NLR) as a biomarker for predicting early-mortality (<2 years) among females with metastatic triple-negative breast cancer (mTNBC). Methods We reviewed 118 medical records of females with mTNBC. The cut-off value for the NLR (<2.5 and >= 2.5) was determined with receiver operating characteristic curves (area under the curve: 0.73; 95% CI: 0.62-0.85). Survival curves were estimated using the Kaplan-Meier method and compared with the Log-rank test. Multivariate Cox regression was used to identify the risk of mortality at two years. Moreover, we performed sensitivity analyses with different cut-off values and a subgroup analysis in females that only received chemotherapy. Results The median follow-up was 24 months. Females with NLR >= 2.5 had a poor overall survival compared to females with NLR <2.5 (6% vs. 28%, p<0.001) at two years. This outcome remained when we stratified for females that only received chemotherapy (8% vs. 36%, p = 0.001). Multivariate analyses identified NLR >= 2.5 as a poor prognostic risk factor for mortality in the entire population (HR: 2.12, 95% CI: 1.32-3.39) and among females that received chemotherapy (HR: 2.68, 95% CI: 1.46-4.92). Conclusion The NLR is an accessible and reliable biomarker that predicts early mortality among females with mTNBC. Our results suggest that females with high NLR values have poor prognosis despite receiving standard chemotherapy. Health providers should evaluate the possibility to enroll these patients in novel immunotherapy trials.	[de la Cruz-Ku, Gabriel; Chambergo-Michilot, Diego; Torres-Roman, J. Smith; Luque, Renato; Saavedra, Antonella; Lujan, Maria] Univ Cient Sur, Escuela Med Humana, Fac Ciencias Salud, Lima, Peru; [de la Cruz-Ku, Gabriel; Pinto, Joseph; Flores, Claudio] Oncosalud AUNA, Unidad Invest Basica & Translac, Lima, Peru; [de la Cruz-Ku, Gabriel] Mayo Clin, Dept Surg, Rochester, MN USA; [de la Cruz-Ku, Gabriel; Torres-Roman, J. Smith; Valcarcel, Bryan] Latin Amer Network Canc Res LAN Canc, Lima, Peru; [Chambergo-Michilot, Diego] Torres Salud Natl Res Ctr, Dept Cardiol Res, Lima, Peru; [Rebaza, Pamela] Natl Inst Neoplast Dis, Dept Breast Surg Oncol, Lima, Peru; [Araujo, Jhajaira] Univ Privada San Juan Bautista, Escuela Med Humana, Lima, Peru; [Morante, Zaida; Enriquez, Daniel; Gomez, Henry] Natl Inst Neoplast Dis, Dept Hematol & Med Oncol, Lima, Peru	Universidad Cientifica del Sur (CIENTIFICA); Mayo Clinic; Instituto Nacional de Enfermedades Neoplasicas; Universidad Privada San Juan Bautista; Instituto Nacional de Enfermedades Neoplasicas	de la Cruz-Ku, G (corresponding author), Univ Cient Sur, Escuela Med Humana, Fac Ciencias Salud, Lima, Peru.; de la Cruz-Ku, G (corresponding author), Oncosalud AUNA, Unidad Invest Basica & Translac, Lima, Peru.; de la Cruz-Ku, G (corresponding author), Mayo Clin, Dept Surg, Rochester, MN USA.; de la Cruz-Ku, G (corresponding author), Latin Amer Network Canc Res LAN Canc, Lima, Peru.	gabrieldelacruzku@gmail.com	Valcarcel, Bryan/GNW-3851-2022; Araujo, Jhajaira/AFV-3434-2022; Flores, Claudio J./AEW-9264-2022; Araujo, Jhajaira M/I-6759-2016; Flores, Claudio J./AAZ-5919-2020	Araujo, Jhajaira M/0000-0002-9639-8070; Flores, Claudio J./0000-0002-3659-4993; De la Cruz-Ku, Gabriel/0000-0003-4203-3890; Valcarcel, Bryan/0000-0003-3853-2603; Torres-Roman, J. Smith/0000-0001-5310-6077; Chambergo-Michilot, Diego/0000-0002-3904-7514; Enriquez-Vera, Daniel/0000-0002-0855-8936				Abdel-Rahman O, 2019, BREAST J, V25, P823, DOI 10.1111/tbj.13346; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2017, DISCOUR CONTEXT MEDI, V19, P1, DOI DOI 10.1080/14613808.2015.1077799; [Anonymous], 2017, MEDICINE, V96, pe6504; Bozkurt O, 2015, JBUON, V12, P14; Braithwaite D, 2009, INT J CANCER, V124, P1213, DOI 10.1002/ijc.24054; Carvalho FM, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-102; Dieci MV, 2014, ANN ONCOL, V25, P611, DOI 10.1093/annonc/mdt556; Duan J, 2018, MEDICINE, V97, P49; Edge SB, 2010, AJCC CANC STAGING MA; Guo WY, 2019, CANCER MED-US, V8, P4135, DOI 10.1002/cam4.2281; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Iimori N, 2018, IN VIVO, V32, P669, DOI 10.21873/invivo.11292; Kumar R, 2015, BRIT J CANCER, V112, P1157, DOI 10.1038/bjc.2015.67; Lara-Medina F, 2011, CANCER-AM CANCER SOC, V117, P3658, DOI 10.1002/cncr.25961; Luen SJ, 2019, ANN ONCOL, V30, P236, DOI 10.1093/annonc/mdy547; Malorni L, 2012, BREAST CANCER RES TR, V136, P795, DOI 10.1007/s10549-012-2315-y; Miyagawa Y, 2018, CLIN BREAST CANCER, V18, P400, DOI 10.1016/j.clbc.2018.03.002; National Comprehensive Cancer Network, BREAST CANC VERS 3 2; Pistelli M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1204-2; Qiu XT, 2018, IUBMB LIFE, V70, P529, DOI 10.1002/iub.1745; Ramos-Esquivel Allan, 2017, Breast Dis, V37, P1, DOI 10.3233/BD-160251; Swierczak A, 2015, CANCER METAST REV, V34, P735, DOI 10.1007/s10555-015-9594-9; Takuwa H, 2018, ONCOL LETT, V15, P6681, DOI 10.3892/ol.2018.8145; Uribe-Querol E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/983698; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Wei BJ, 2016, ONCOTARGETS THER, V9, P5567, DOI 10.2147/OTT.S108419; World Health Organization, 1992, INT CLASS DIS REL HL; Zhang J, 2015, ONCOTARGET, V6, P43135, DOI 10.18632/oncotarget.5654	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243447	10.1371/journal.pone.0243447	http://dx.doi.org/10.1371/journal.pone.0243447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284847	gold, Green Published			2022-12-26	WOS:000597930500038
J	Contreras-Salinas, H; Meza-Rios, A; Garcia-Banuelos, J; Sandoval-Rodriguez, A; Sanchez-Orozco, L; Garcia-Benavides, L; De la Rosa-Bibiano, R; Ramirez, HCM; Gutierrez-Cuevas, J; Santos-Garcia, A; Armendariz-Borunda, J				Contreras-Salinas, Homero; Meza-Rios, Alejandra; Garcia-Banuelos, Jesus; Sandoval-Rodriguez, Ana; Sanchez-Orozco, Laura; Garcia-Benavides, Leonel; De la Rosa-Bibiano, Ricardo; Monroy Ramirez, Hugo Christian; Gutierrez-Cuevas, Jorge; Santos-Garcia, Arturo; Armendariz-Borunda, Juan			Fibrosis regression is induced by AdhMMP8 in a murine model of chronic kidney injury	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; MATRIX METALLOPROTEINASE-8; LIVER; COXSACKIEVIRUS; EXPRESSION; GENERATION; CIRRHOSIS; ABLATION; DELIVERY; TROPISM	Adenoviral vector AdhMMP8 (human Metalloproteinase-8 cDNA) administration has been proven beneficial in various experimental models of liver injury improving liver function and decreasing fibrosis. In this study, we evaluated the potential therapeutic AdhMMP8 effect in a chronic kidney damage experimental model. Chronic injury was induced by orogastric adenine administration (100mg/kg/day) to Wistar rats for 4 weeks. AdhMMP8 (3x10(11)vp/kg) was administrated in renal vein during an induced-ligation-ischemic period to facilitate kidney transduction causing no-additional kidney injury as determined by histology and serum creatinine. Animals were sacrificed at 7- and 14-days post-Ad injection. Fibrosis, histopathological features, serum creatinine (sCr), BUN, and renal mRNA expression of alpha SMA, Col-1 alpha, TGF-beta 1, CTGF, BMP7, IL-1, TNF alpha, VEGF and PAX2 were analyzed. Interestingly, AdhMMP8 administration resulted in cognate human MMP8 protein detection in both kidneys, whereas hMMP8 mRNA was detected only in the left kidney. AdhMMP8 significantly reduced kidney tubule-interstitial fibrosis and glomerulosclerosis. Also, tubular atrophy and interstitial inflammation were clearly decreased rendering improved histopathology, and down regulation of profibrogenic genes expression. Functionally, sCr and BUN were positively modified. The results showed that AdhMMP8 decreased renal fibrosis, suggesting that MMP8 could be a possible therapeutic candidate for kidney fibrosis treatment.	[Contreras-Salinas, Homero; Garcia-Banuelos, Jesus; Sandoval-Rodriguez, Ana; Sanchez-Orozco, Laura; De la Rosa-Bibiano, Ricardo; Monroy Ramirez, Hugo Christian; Gutierrez-Cuevas, Jorge; Armendariz-Borunda, Juan] Univ Guadalajara, Hlth Sci Univ Ctr, Inst Mol Biol Med & Gene Therapy, Dept Mol Biol & Genom, Guadalajara, Jalisco, Mexico; [Meza-Rios, Alejandra; Santos-Garcia, Arturo; Armendariz-Borunda, Juan] Tecnol Monterrey, Sch Med & Hlth Sci, Monterrey, Mexico; [Garcia-Benavides, Leonel] Univ Guadalajara, Tonala Univ Ctr, Dept Biomed Sci, Tonala, Jalisco, Mexico	Universidad de Guadalajara; Tecnologico de Monterrey; Universidad de Guadalajara	Armendariz-Borunda, J (corresponding author), Univ Guadalajara, Hlth Sci Univ Ctr, Inst Mol Biol Med & Gene Therapy, Dept Mol Biol & Genom, Guadalajara, Jalisco, Mexico.; Armendariz-Borunda, J (corresponding author), Tecnol Monterrey, Sch Med & Hlth Sci, Monterrey, Mexico.	armdbo@gmail.com	Contreras-Salinas, Homero/ABG-5838-2020; Garcia-Banuelos, Jesus/W-2927-2019; Armendáriz-Borunda, Juan/AAU-1471-2021; Garcia Benavides, Leonel/GPP-7463-2022; garcia, leonel/V-9040-2017	Contreras-Salinas, Homero/0000-0001-9918-2024; Garcia Benavides, Leonel/0000-0001-8087-3597; garcia, leonel/0000-0001-8087-3597; Sanchez-Orozco, Laura Veronica/0000-0001-6418-349X; Monroy-Ramirez, Hugo Christian/0000-0001-8891-5317	Conacyt [CB-2015-259096-M]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The work related to this manuscript was supported by Conacyt grant CB-2015-259096-M to the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; [Anonymous], 2012, AM J PHYSIOL-LUNG C, V302, pL976; Armendariz-Borunda J, 2011, J BIOSCI BIOENG, V112, P415, DOI 10.1016/j.jbiosc.2011.07.018; Bai Wenxia, 2018, Oncotarget, V9, P15498, DOI 10.18632/oncotarget.24125; Basu RK, 2015, RENAL FAILURE, V37, P469, DOI 10.3109/0886022X.2014.996842; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corridon PR, 2013, AM J PHYSIOL-RENAL, V304, pF1217, DOI 10.1152/ajprenal.00070.2013; Davis L, 2019, PHYSIOL GENOMICS, V51, P449, DOI 10.1152/physiolgenomics.00052.2019; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fujigaki Yoshihide, 2012, World J Nephrol, V1, P92, DOI 10.5527/wjn.v1.i4.92; Galvez-Gastelum FJ, 2011, GENE THER, V18, P88, DOI 10.1038/gt.2010.107; Garcia-Banuelos J, 2002, GENE THER, V9, P127, DOI 10.1038/sj.gt.3301647; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Hewitson TD, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S14; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ikeda Y, 2018, J AM SOC NEPHROL, V29, P2287, DOI 10.1681/ASN.2018040426; Rivera-Valdes JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187907; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Marquez-Aguirre A, 2009, J GENE MED, V11, P207, DOI 10.1002/jgm.1303; Mendez-Duran A, 2010, DIALISIS TRASPL, V31, P7, DOI DOI 10.1016/S1886-2845(10)70004-7; Meza-Rios A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166849; MOULLIER P, 1994, KIDNEY INT, V45, P1220, DOI 10.1038/ki.1994.162; Nahman NS, 2000, KIDNEY INT, V58, P1500, DOI 10.1046/j.1523-1755.2000.00312.x; Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rubin JD, 2019, HUM GENE THER, V30, P1559, DOI 10.1089/hum.2019.127; Salgado S, 2000, MOL THER, V2, P545, DOI 10.1006/mthe.2000.0210; Siller-Lopez F, 2004, GASTROENTEROLOGY, V126, P1122, DOI 10.1053/j.gastro.2003.12.045; Siller-Lopez F, 2000, J HEPATOL, V33, P758, DOI 10.1016/S0168-8278(00)80307-4; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Zhu G, 1996, GENE THER, V3, P298	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243307	10.1371/journal.pone.0243307	http://dx.doi.org/10.1371/journal.pone.0243307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275619	Green Published, gold			2022-12-26	WOS:000597150200008
J	Criste, A; Copolovici, L; Copolovici, D; Kovacs, M; Madden, RH; Corcionivoschi, N; Gundogdu, O; Berchez, M; Urcan, AC				Criste, Adriana; Copolovici, Lucian; Copolovici, Dana; Kovacs, Melinda; Madden, Robert H.; Corcionivoschi, Nicolae; Gundogdu, Ozan; Berchez, Mihaela; Urcan, Adriana Cristina			Determination of changes in the microbial and chemical composition of aga cheese during maturation	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SENSORY CHARACTERISTICS; RAW-MILK; FLAVOR; IDENTIFICATION; PRODUCTS; PROFILE; CURD	aga cheese is a traditional Romanian smear-ripened cheese made from bovine milk and identified with the name of the village and caves where it is produced. As no previously reported microbiological and chemical studies have been undertaken on this product, this research aimed to investigate the microbiological and biochemical characteristics which ensure the uniqueness of aga cheese during the ripening process, to inform producers as to key quality determinants. Cheese samples, consisting of retail blocks, were collected on days 2, 5, 12, 18, and 25 of the ripening process. The evolution of lactic microbiota during the production and maturation of traditional cheeses involves isolating lactic acid microorganisms present in cheese. Cheese samples were analyzed for pH, fat, NaCl, fatty acids, and volatile compounds. The microbial ecosystem naturally changes during the maturation process, leading to variation in the microorganisms involved during ripening. Our results show that specific bacteria were identified in high levels during the entire ripening process and may be responsible for milk fat lipolysis contributing directly to cheese flavor by imparting detailed fatty acid flavor notes, or indirectly as precursors formation of other flavor compounds.	[Criste, Adriana; Corcionivoschi, Nicolae; Berchez, Mihaela; Urcan, Adriana Cristina] Univ Agr Sci & Vet Med, Fac Anim Sci & Biotechnol, Dept Microbiol & Immunol, Cluj Napoca, Romania; [Copolovici, Lucian; Copolovici, Dana] Aurel Vlaicu Univ Arad, Fac Food Engn Tourism & Environm Protect, Res Ctr Tech & Nat Sci, Arad, Romania; [Kovacs, Melinda] Subsidiary Res Inst Analyt Instrumentat, INCDO INOE 2000, Cluj Napoca, Romania; [Madden, Robert H.; Corcionivoschi, Nicolae] Agrifood & Biosci Inst, Vet Sci Div, Bacteriol Branch, Belfast, Antrim, North Ireland; [Gundogdu, Ozan] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Aurel Vlaicu University of Arad; National Research & Development Institute Optoelectronics INOE 2000; Agri-Food & Biosciences Institute; University of London; London School of Hygiene & Tropical Medicine	Criste, A; Urcan, AC (corresponding author), Univ Agr Sci & Vet Med, Fac Anim Sci & Biotechnol, Dept Microbiol & Immunol, Cluj Napoca, Romania.	adriana.criste@usamvcluj.ro; adriana.urcan@usamcluj.ro	Urcan, Adriana/AAJ-1701-2021; Copolovici, Dana Maria/C-5207-2012; Copolovici, Lucian/B-6552-2011	Copolovici, Dana Maria/0000-0002-1491-0473; Copolovici, Lucian/0000-0002-4454-200X; Gundogdu, Ozan/0000-0002-3550-0545; Criste, Adriana Dalila/0000-0001-6309-9181; Urcan, Adriana Cristina/0000-0002-9009-8413	Romanian Ministry of Research and Innovation through Program 1 -Development of the National Research and Development System, Subprogram 1.2-Institutional Performance -Projects for Financing the Excellence in CDI [37PFE-2018-2020]	Romanian Ministry of Research and Innovation through Program 1 -Development of the National Research and Development System, Subprogram 1.2-Institutional Performance -Projects for Financing the Excellence in CDI	Funding: This paper was published with the support of the Romanian Ministry of Research and Innovation through Program 1 -Development of the National Research and Development System, Subprogram 1.2-Institutional Performance -Projects for Financing the Excellence in CDI, Contract No. 37PFE-2018-2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenzio M, 2001, INT J FOOD MICROBIOL, V67, P35, DOI 10.1016/S0168-1605(00)00533-X; [Anonymous], 2008, AM J HLTH SYST PHARM, V65, pe3; Arboatti AS, 2014, DAIRY SCI TECHNOL, V94, P373, DOI 10.1007/s13594-014-0169-2; Arenas R, 2004, FOOD CONTROL, V15, P271, DOI 10.1016/S0956-7135(03)00067-7; Ballesteros C, 2006, FOOD CONTROL, V17, P249, DOI 10.1016/j.foodcont.2004.10.008; Battelli G, 2019, LWT-FOOD SCI TECHNOL, V116, DOI 10.1016/j.lwt.2019.108576; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Bertuzzi AS, 2018, COMPR REV FOOD SCI F, V17, P371, DOI 10.1111/1541-4337.12332; BHOWMIK T, 1990, J DAIRY SCI, V73, P859, DOI 10.3168/jds.S0022-0302(90)78740-1; Bintsis T, 2018, AIMS MICROBIOL, V4, P665, DOI 10.3934/microbiol.2018.4.665; Blaya J, 2018, J DAIRY SCI, V101, P3611, DOI 10.3168/jds.2017-13345; Broadbent JR, 2013, J DAIRY SCI, V96, P4212, DOI 10.3168/jds.2012-6443; Cakmakci S, 2012, INT J FOOD SCI TECH, V47, P2405, DOI 10.1111/j.1365-2621.2012.03116.x; Callon C, 2005, J DAIRY SCI, V88, P3840, DOI 10.3168/jds.S0022-0302(05)73069-1; Castada HZ, 2019, FOODS, V8, DOI 10.3390/foods8020078; Cetinkaya A, 2018, UKR FOOD J, V7, P409, DOI 10.24263/2304-974X-2018-7-3-6; Copolovici D, 2017, REV CHIM-BUCHAREST, V68, P507; Dan T, 2019, FRONT MICROBIOL, P10, DOI [10.3389/fmicb.2019.00010, DOI 10.3389/FMICB.2019.00010]; DEAPODACA MJO, 1993, FOOD RES INT, V26, P319, DOI 10.1016/0963-9969(93)90074-S; Dolci P, 2008, INT J FOOD MICROBIOL, V122, P302, DOI 10.1016/j.ijfoodmicro.2007.12.018; Domingos LD, 2019, FOOD RES INT, V119, P793, DOI 10.1016/j.foodres.2018.10.062; Elgersma A, 2015, EUR J LIPID SCI TECH, V117, P1345, DOI 10.1002/ejlt.201400469; FOX PF, 1995, ADV EXP MED BIOL, V367, P59; Hickey DK, 2007, J DAIRY RES, V74, P9, DOI 10.1017/S0022029906002032; Kara R, 2015, J SCI ENG, V15, P1, DOI DOI 10.5578/FMBD.8717; Karaca OB, 2018, FOODS, V7, DOI 10.3390/foods7080125; Labrie SJ, 2014, APPL ENVIRON MICROB, V80, P6992, DOI 10.1128/AEM.01365-14; MARCELLINO N, 1992, APPL ENVIRON MICROB, V58, P3448, DOI 10.1128/AEM.58.11.3448-3454.1992; Marilley L, 2004, INT J FOOD MICROBIOL, V90, P139, DOI 10.1016/S0168-1605(03)00304-0; Markiewicz-Zukowska R, 2013, J APIC SCI; Marshall V. M. E., 1997, P153; Mayer HK, 2012, INT DAIRY J, DOI [10.1016/j.idairyj.2011.08.001, DOI 10.1016/J.IDAIRYJ.2011.08.001]; McSweeney P. L. H., 2011, ENCY DAIRY SCI, P667, DOI [10.1016/8978-0-12-374407-4.00080-7, DOI 10.1016/8978-0-12-374407-4.00080-7]; Metz M, 2020, FOOD MICROBIOL, V85, DOI 10.1016/j.fm.2019.103283; Mitani T, 2016, ANIM SCI J, V87, P233, DOI 10.1111/asj.12422; Molimard P, 1996, J DAIRY SCI, V79, P169, DOI 10.3168/jds.S0022-0302(96)76348-8; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Park J, 2017, FORENS SCI INT-GEN S, V6, pE510, DOI 10.1016/j.fsigss.2017.09.210; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Rattray FP, 1999, J DAIRY SCI, V82, P891, DOI 10.3168/jds.S0022-0302(99)75308-7; SEILER H, 1986, J DAIRY RES, V53, P439, DOI 10.1017/S002202990002505X; Shami A, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1569-5; Suzuki-Iwashima A, 2020, J BIOSCI BIOENG, V129, P333, DOI 10.1016/j.jbiosc.2019.09.005; Thierry A, 2017, CHEESE: CHEMISTRY, PHYSICS AND MICROBIOLOGY, VOL 1-2, 4TH EDITION, P423, DOI 10.1016/B978-0-12-417012-4.00017-X; Urbach G, 1997, INT J DAIRY TECHNOL, V50, P79, DOI 10.1111/j.1471-0307.1997.tb01743.x; Urbach G, 1993, INT DAIRY J, V3, P389, DOI 10.1016/0958-6946(93)90025-U; Yvon M, 2001, INT DAIRY J, V11, P185, DOI 10.1016/S0958-6946(01)00049-8	47	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242824	10.1371/journal.pone.0242824	http://dx.doi.org/10.1371/journal.pone.0242824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270702	gold, Green Published			2022-12-26	WOS:000597149100064
J	Feige, K; Raupach, A; Torregroza, C; Muehlenbernd, J; Stroethoff, M; Bunte, S; Hollmann, MW; Huhn, R				Feige, Katharina; Raupach, Annika; Torregroza, Carolin; Muehlenbernd, Jan; Stroethoff, Martin; Bunte, Sebastian; Hollmann, Markus W.; Huhn, Ragnar			Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles	PLOS ONE			English	Article							HUMORAL-FACTORS; RAT HEARTS; REPERFUSION; INJURY	Coronary effluent collected from ischemic preconditioning (IPC) treated hearts induces myocardial protection in non-ischemic-preconditioned hearts. So far, little is known about the number of IPC cycles required for the release of cardioprotective factors into the coronary effluent to successfully induce cardioprotection. This study investigated the cardioprotective potency of effluent obtained after various IPC cycles in the rat heart. Experiments were performed on isolated hearts of male Wistar rats, mounted onto a Langendorff system and perfused with Krebs-Henseleit buffer. In a first part, effluent was taken before (Con) and after each IPC cycle (Eff 1, Eff 2, Eff 3). IPC was induced by 3 cycles of 5 min of global myocardial ischemia followed by 5 minutes of reperfusion. In a second part, hearts of male Wistar rats were randomized to four groups (each group n = 4-5) and underwent 33 min of global ischemia followed by 60 min of reperfusion. The previously obtained coronary effluent was administered for 10 minutes before ischemia as a preconditioning stimulus. Infarct size was determined at the end of reperfusion by triphenyltetrazoliumchloride (TTC) staining. Infarct size with control effluent was 54 +/- 12%. Effluent obtained after IPC confers a strong infarct size reduction independent of the number of IPC cycles (Eff 1: 27 +/- 5%; Eff 2: 35 +/- 7%; Eff 3: 35 +/- 8%, each P<0.05 vs. Con). Effluent extracted after one cycle IPC is comparably protective as after two or three cycles IPC.	[Feige, Katharina; Raupach, Annika; Torregroza, Carolin; Muehlenbernd, Jan; Stroethoff, Martin; Bunte, Sebastian; Huhn, Ragnar] Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, Germany; [Bunte, Sebastian] Elbe Clin Stade Buxtehude, Dept Internal Med, Stade, Germany; [Hollmann, Markus W.] Amsterdam Univ Med Ctr AUMC, Dept Anesthesiol, Amsterdam, Netherlands		Raupach, A (corresponding author), Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, Germany.	Annika.Raupach@med.uni-duesseldorf.de	Huhn, Ragnar/X-6466-2018	Huhn, Ragnar/0000-0002-3114-7190; Hollmann, Markus/0000-0001-8248-0244				[Anonymous], 1999, AM J PHYSIOL-CELL PH, V277, pC1; [Anonymous], 1993, POLITICKA MISAO, V4, P163; [Anonymous], 2012, RADIO SCIENCE, V47, P1; Anttila V, 2016, SCAND CARDIOVASC J, V50, P355, DOI 10.1080/14017431.2016.1233351; Barbosa V, 1996, AM HEART J, V131, P224, DOI 10.1016/S0002-8703(96)90345-2; Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0; Bunte S, 2019, CRIT CARE MED, V47, pE250, DOI 10.1097/CCM.0000000000003629; Cohen MV, 2015, BRIT J PHARMACOL, V172, P1913, DOI 10.1111/bph.12903; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Gross Eric R, 2007, Drug Discov Today Dis Mech, V4, P165, DOI 10.1016/j.ddmec.2007.10.005; Hausenloy DJ, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0588-8; Heinen A, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1480-0; Heinen A, 2014, EXP GERONTOL, V56, P99, DOI 10.1016/j.exger.2014.03.029; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Maciel L, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0641-2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OVIZE M, 1992, CIRC RES, V71, P1165, DOI 10.1161/01.RES.71.5.1165; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Raupach A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040507; Schulman D, 2001, AM J PHYSIOL-HEART C, V281, pH1630, DOI 10.1152/ajpheart.2001.281.4.H1630; Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Wider J, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0674-1	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243220	10.1371/journal.pone.0243220	http://dx.doi.org/10.1371/journal.pone.0243220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270768	Green Published, gold			2022-12-26	WOS:000597149100101
J	Oluwole, EO; Adeyemo, TA; Osanyin, GE; Odukoya, OO; Kanki, PJ; Afolabi, BB				Oluwole, Esther O.; Adeyemo, Titilope A.; Osanyin, Gbemisola E.; Odukoya, Oluwakemi O.; Kanki, Phyllis J.; Afolabi, Bosede B.			Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study	PLOS ONE			English	Article							CHILDREN; NEWBORNS; SURVIVAL; COHORT	In Nigeria, about 150000 babies are born annually with sickle cell disease (SCD), and this figure has been estimated to increase by 100% by the year 2050 without effective and sustainable control strategies. Despite the high prevalence, newborn screening for SCD which allows for early prophylactic treatment, education of parents/guardians and comprehensive management is not yet available. This study explored a strategy for screening in early infancy during the first and second immunization visits, determined the prevalence, feasibility and acceptability of early infant screening for SCD and the evaluation of the HemoTypeSC diagnostic test as compared to the high-performance liquid chromatography (HPLC) gold standard. A cross-sectional study was conducted in two selected primary health care centres in Somolu local government area (LGA) in Lagos, Nigeria. Two hundred and ninety-one mother-infant pairs who presented for the first or second immunization visit were consecutively enrolled in the study following written informed consent. The haemoglobin genotype of mother-infant pairs was determined using the HemoTypeSC rapid test kit. Confirmation of the infants' Hb genotype was done with HPLC. Data were analysed with SPSS version 22. Validity and Predictive value of HemotypeSC rapid screening test were also calculated. Infant screening for SCD was acceptable to 86% of mothers presenting to the immunization clinics. The prevalence of SCD among the infant cohort was 0.8%. The infants diagnosed with SCD were immediately enrolled in the paediatric SCD clinic for disease-specific care. The HemoTypeSC test had 100% sensitivity and specificity for sickle cell disease in early infancy compared to HPLC. This study affirms that it is feasible and acceptable for mothers to implement a SCD screening intervention program in early infancy in Lagos State. The study also demonstrates the utility of the HemotypeSC rapid testing for ease and reduced cost of screening infants for SCD.	[Oluwole, Esther O.; Odukoya, Oluwakemi O.] Univ Lagos, Coll Med, Dept Community Hlth & Primary Care, Lagos, Nigeria; [Adeyemo, Titilope A.] Univ Lagos, Coll Med, Dept Haematol & Blood Transfus, Lagos, Nigeria; [Osanyin, Gbemisola E.; Afolabi, Bosede B.] Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria; [Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	University of Lagos; University of Lagos; University of Lagos; Harvard University; Harvard T.H. Chan School of Public Health	Oluwole, EO (corresponding author), Univ Lagos, Coll Med, Dept Community Hlth & Primary Care, Lagos, Nigeria.	oluester2005@yahoo.com		Afolabi, Bosede/0000-0002-7511-7567	Fogarty International Center of the National Institutes of Health [D43TW010134]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	EO This research was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW010134. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolayan JA, 2011, STUD ETHNO-MED, V5, P33, DOI 10.1080/09735070.2011.11886389; [Anonymous], 2015, NATL POP COMM NIG 20; [Anonymous], STUD COMM EMB KINGD; Bazuaye GN., 2009, WORLD J MED SCI, V4, P46; Brandelise S, 2004, CLIN LAB HAEMATOL, V26, P15, DOI 10.1111/j.0141-9854.2003.00576.x; Couque N, 2016, BRIT J HAEMATOL, V173, P927, DOI 10.1111/bjh.14015; de Montalembert M, 2009, EXPERT REV HEMATOL, V2, P455, DOI 10.1586/ehm.09.33; Ejiofor OS, 2018, J BLOOD DISORD TRANS, V9, P398; GAMIT CL, 2014, INT J MED SCI PUBLIC, V3, P365; Gardner K, 2016, BLOOD, V128, P1436, DOI 10.1182/blood-2016-05-716910; Government LS, 2019, LAGOS 2019; Hsu Lewis, 2018, J Trop Dis Public Health, V6, P260, DOI 10.4172/2329-891X.1000260; Inusa BP, 2015, PEDIAT THERAPEUT, V5, P3, DOI DOI 10.4172/2161-0665.1000262; King L, 2014, W INDIAN MED J, V63, P147, DOI 10.7727/wimj.2013.107; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Makani J, 2007, ANN TROP MED PARASIT, V101, P3, DOI 10.1179/136485907X154638; McGann PT, 2013, AM J HEMATOL, V88, P984, DOI 10.1002/ajh.23578; National Population Commission, 2013, NIG DEM HLTH SURV AB; National Population Commission (Nigeria) ICF, 2019, NIG DEM HLTH SURV 20; Nnodu O, 2019, BLOOD CELL MOL DIS, V78, P22, DOI 10.1016/j.bcmd.2019.01.007; Nnodu OE, 2020, LANCET HAEMATOL, V7, pE534, DOI 10.1016/S2352-3026(20)30143-5; Obaro SK, 2016, PUBLIC HEALTH GENOM, V19, P102, DOI 10.1159/000444475; Odame I, 2014, NATURE, V515, pS10, DOI 10.1038/515S10a; Odunvbun ME, 2008, PUBLIC HEALTH, V122, P1111, DOI 10.1016/j.puhe.2008.01.008; Ohene-Frempong K, 2008, PEDIATRICS, V121, pS120, DOI 10.1542/peds.2007-2022UUU; Ojewunmi OO, 2019, EXPERT REV HEMATOL, V12, P609, DOI 10.1080/17474086.2019.1631155; Omotade O O, 1998, West Afr J Med, V17, P91; Park K, 2019, PARKS TXB PREVENTIVE; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piety NZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45488; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sickle cell anaemia, 2006, 5920 WHA; Steele C, 2019, AM J HEMATOL, V94, P39, DOI 10.1002/ajh.25305; Telfer P, 2007, HAEMATOLOGICA, V92, P905, DOI 10.3324/haematol.10937; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Tubman VN, 2016, PEDIATR BLOOD CANCER, V63, P671, DOI 10.1002/pbc.25875; Ugwu NI., 2016, ASIAN J MED SCI, V7, P87, DOI [10.3126/ajms.v7i5.15044, DOI 10.3126/AJMS.V7I5.15044]; 2018, CURR OPIN TOXICOL, V10	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242861	10.1371/journal.pone.0242861	http://dx.doi.org/10.1371/journal.pone.0242861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270733	gold, Green Published			2022-12-26	WOS:000597149100044
J	Su, XF; Li, Y				Su, Xianfang; Li, Yong			Dynamic sentiment spillovers among crude oil, gold, and Bitcoin markets: Evidence from time and frequency domain analyses	PLOS ONE			English	Article							INVESTOR SENTIMENT; SAFE HAVEN; US; HEDGE; RISK; IMPACT; UK	This paper examines the sentiment spillovers among oil, gold, and Bitcoin markets by employing spillovers index methods in a time-frequency framework. We find that the total sentiment spillover among crude oil, gold and Bitcoin markets is time-varying and is greatly affected by major market events. The directional sentiment spillovers are also time-varying. On average, the Bitcoin market is the major transmitter of directional sentiment spillovers, whereas the crude oil and gold markets are the major receivers. In particular, the sentiment spillover effects are major created at high-frequency components, implying that the markets rapidly process the sentiment spillover effects and the shock is transmitted over the short-term. Moreover, we also find that the sentiment spillover effects differ significantly in term of intensity and direction when compared with return and volatility spillover effects. The present study has certain applications for investors and policymakers.	[Su, Xianfang; Li, Yong] Guizhou Univ Finance & Econ, Sch Big Data Applicat & Econ, Guiyang, Peoples R China	Guizhou University of Finance & Economics	Su, XF (corresponding author), Guizhou Univ Finance & Econ, Sch Big Data Applicat & Econ, Guiyang, Peoples R China.	xfsu@hnu.edu.cn			Green Finance Research Project of Guizhou University of Finance and Economics [00090002011]	Green Finance Research Project of Guizhou University of Finance and Economics	This research is supported by the Green Finance Research Project of Guizhou University of Finance and Economics under grants No.00090002011.	Aguilera RF, 2017, RESOUR POLICY, V54, P81, DOI 10.1016/j.resourpol.2017.09.005; Al-Yahyaee KH, 2019, N AM J ECON FINANC, V49, P104, DOI 10.1016/j.najef.2019.04.001; Alizadeh S, 2002, J FINANC, V57, P1047, DOI 10.1111/1540-6261.00454; [Anonymous], 2013, J BIOL AGR HEALTHCAR, V3, P61; Antonakakis N, 2016, INT REV FINANC ANAL, V48, P406, DOI 10.1016/j.irfa.2015.03.008; Audrino F, 2019, J BANK FINANC, V106, P542, DOI 10.1016/j.jbankfin.2019.07.022; Baig A, 2019, FINANC RES LETT, V29, P111, DOI 10.1016/j.frl.2019.03.013; Baker M, 2007, J ECON PERSPECT, V21, P129, DOI 10.1257/jep.21.2.129; Baker M, 2006, J FINANC, V61, P1645, DOI 10.1111/j.1540-6261.2006.00885.x; Baker M, 2012, J FINANC ECON, V104, P272, DOI 10.1016/j.jfineco.2011.11.002; Barone-Adesi G, 2013, HANDBOOK ON SYSTEMIC RISK, P714; Barunik J, 2018, J FINANC ECONOMET, V16, P271, DOI 10.1093/jjfinec/nby001; Bouoiyour J, 2016, ECON BULL, V36, P843; Bouri E, 2017, FINANC RES LETT, V20, P192, DOI 10.1016/j.fri.2016.09.025; Brown GW, 2005, J BUS, V78, P405, DOI 10.1086/427633; Corbet S, 2018, ECON LETT, V165, P28, DOI 10.1016/j.econlet.2018.01.004; Corredor P, 2013, INT REV ECON FINANC, V27, P572, DOI 10.1016/j.iref.2013.02.001; Coulton JJ, 2016, ACCOUNT FINANC, V56, P669, DOI 10.1111/acfi.12128; Das D, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2019.101335; Diebold FX, 2012, INT J FORECASTING, V28, P57, DOI 10.1016/j.ijforecast.2011.02.006; Eom C, 2019, PHYSICA A, V514, P511, DOI 10.1016/j.physa.2018.09.063; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; He LT, 2015, ENERG ECON, V47, P121, DOI 10.1016/j.eneco.2014.11.005; Hudson Y, 2015, J BEHAV EXP FINANC, V5, P46, DOI 10.1016/j.jbef.2015.02.004; Ji Q, 2019, FINANC RES LETT, V30, P420, DOI 10.1016/j.frl.2019.02.005; Jin JY, 2019, PHYSICA A, V527, DOI 10.1016/j.physa.2019.121121; Karalevicius V, 2018, J RISK FINANC, V19, P56, DOI 10.1108/JRF-06-2017-0092; Khalfaoui R, 2018, PHYSICA A, V503, P86, DOI 10.1016/j.physa.2018.02.198; Kumar A, 2006, J FINANC, V61, P2451, DOI 10.1111/j.1540-6261.2006.01063.x; Lee YH, 2014, GLOB FINANC J, V25, P17, DOI 10.1016/j.gfj.2014.03.003; Lei LK, 2019, FINANC RES LETT, V30, P341, DOI 10.1016/j.frl.2018.10.016; Li X, 2017, DECIS SUPPORT SYST, V95, P49, DOI 10.1016/j.dss.2016.12.001; Liu BY, 2017, ENERG ECON, V68, P53, DOI 10.1016/j.eneco.2017.09.011; Pant DR, 2018, PROCEEDINGS ON 2018 IEEE 3RD INTERNATIONAL CONFERENCE ON COMPUTING, COMMUNICATION AND SECURITY (ICCCS), P128, DOI 10.1109/CCCS.2018.8586824; Reboredo JC, 2013, J BANK FINANC, V37, P2665, DOI 10.1016/j.jbankfin.2013.03.020; Selmi R, 2018, ENERG ECON, V74, P787, DOI 10.1016/j.eneco.2018.07.007; Stambaugh RF, 2012, J FINANC ECON, V104, P288, DOI 10.1016/j.jfineco.2011.12.001; Tiwari AK, 2018, Q REV ECON FINANC, V70, P194, DOI 10.1016/j.qref.2018.05.001; Tsai IC, 2017, INT REV ECON FINANC, V47, P22, DOI 10.1016/j.iref.2016.10.008; Vidal-Tomas D, 2019, FINANC RES LETT, V30, P181, DOI 10.1016/j.frl.2018.09.008; Yarovaya L, 2016, INT REV FINANC ANAL, V43, P96, DOI 10.1016/j.irfa.2015.09.004; Zhang YJ, 2019, QUANT FINANC, V19, P1357, DOI 10.1080/14697688.2019.1581368	42	10	10	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242515	10.1371/journal.pone.0242515	http://dx.doi.org/10.1371/journal.pone.0242515			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270645	gold, Green Published			2022-12-26	WOS:000597149100136
J	Yin, XM; Zhan, RL; He, YD; Song, S; Wang, LX; Ge, Y; Chen, D				Yin, Xiaomin; Zhan, Rulin; He, Yingdui; Song, Shun; Wang, Lixia; Ge, Yu; Chen, Di			Morphological description of a novel synthetic allotetraploid(A(1)A(1)G(3)G(3)) of Gossypium herbaceum L.and G.nelsonii Fryx. suitable for disease-resistant breeding applications	PLOS ONE			English	Article							HIRSUTUM L.; INTERSPECIFIC HYBRIDIZATION; SOMATIC HYBRIDS; LINKAGE MAP; COTTON; EVOLUTION; GENOME; PLANT	Wild species of Gossypium ssp. are an important source of traits for improving commercial cotton cultivars. Previous reports show that Gossypium herbaceum L. and Gossypium nelsonii Fryx. have better disease resistance characteristics than commercial cotton varieties. However, chromosome ploidy and biological isolation make it difficult to hybridize diploid species with the tetraploid Gossypium hirsutum L. We developed a new allotetraploid cotton genotype (A(1)A(1)G(3)G(3)) using a process of distant hybridization within wild cotton species to create new germplasms. First of all, G. herbaceum and G. nelsonii were used for interspecific hybridization to obtain F-1 generation. Afterwards, apical meristems of the F-1 diploid cotton plants were treated with colchicine to induce chromosome doubling. The new interspecific F-1 hybrid and S-1 cotton plants originated from chromosome duplication, were tested via morphological and molecular markers and confirmed their tetraploidy through flowrometric and cytological identification. The S-1 tetraploid cotton plants was crossed with a TM-1 line and fertile hybrid offspring were obtained. These S-2 offsprings were tested for resistance to Verticillium wilt and demonstrated adequate tolerance to this fungi. The results shows that the new S-1 cotton line could be used as parental material for hybridization with G. hirsutum to produce pathogen-resistant cotton hybrids. This new S-1 allotetraploid genotype will contributes to the enrichment of Gossypium germplasm resources and is expected to be valuable in polyploidy evolutionary studies.	[Yin, Xiaomin; Zhan, Rulin; He, Yingdui; Song, Shun; Wang, Lixia; Ge, Yu; Chen, Di] Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Chen, D (corresponding author), Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China.	chendi209@163.com			National Natural Science Foundation of China [31701478]; Central Public-interest Scientific institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences [1630092017004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences	This research work was financially supported by the National Natural Science Foundation of China (No. 31701478) and Central Public-interest Scientific institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences(No.1630092017004).	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Baytar AA, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1787-y; Bl Li, 1987, ACTA GENET SINICA, V14, P121; Campbell BT, 2010, CROP SCI, V50, P2198, DOI 10.2135/cropsci2009.09.0551er; Chen D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127023; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128981; Chen Y, 2014, THEOR APPL GENET, V127, P1105, DOI 10.1007/s00122-014-2283-1; CULP TW, 1973, CROP SCI, V13, P686, DOI 10.2135/cropsci1973.0011183X001300060030x; ENDRIZZI JOHN E., 1960, CANADIAN JOUR GENET AND CYTOL, V2, P311; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fryxell P.A., 1992, RHEEDEA, V2, P108; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo WZ, 1997, ACTA GOSSYPII SINICA, V9, P21; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Jena SN, 2012, THEOR APPL GENET, V124, P565, DOI 10.1007/s00122-011-1729-y; Kashkush K, 2002, GENETICS, V160, P1651; Liu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123209; Liu S, 2000, J HERED, V91, P326, DOI 10.1093/jhered/91.4.326; Loren H, 2009, CURR BIOL, V19, P119, DOI [10.1016/j.cub.2008.12.016, DOI 10.1016/J.CUB.2008.12.016]; MURAMOTO H, 1969, CROP SCI, V9, P27, DOI 10.2135/cropsci1969.0011183X000900010009x; Newaskar GS, 2013, PLANT BREEDING, V132, P211, DOI 10.1111/pbr.12031; OAKES AJ, 1966, CAN J GENET CYTOL, V8, P818, DOI 10.1139/g66-098; Qian SY, 1992, SCI AGR SINICA, V25, P44, DOI [DOI 10.1093/GENETICS/51.5.689, 10.1093/genetics/51.5.689]; Ram SG, 2008, PLANT BREEDING, V127, P295, DOI 10.1111/j.1439-0523.2007.01453.x; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Sacks EJ, 2008, PLANT CELL TISS ORG, V93, P15, DOI 10.1007/s11240-007-9316-2; Saitwal V. M., 2003, Cytologia (Tokyo), V68, P317, DOI 10.1508/cytologia.68.317; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stephens S.G., 1949, Q REV BIOL, V24, P143; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Wang KB, 2018, J COTTON RES, V1, DOI 10.1186/s42397-018-0002-1; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wu YX, 2011, CARYOLOGIA, V64, P343, DOI 10.1080/00087114.2011.10589801; Yu XS, 2012, THEOR APPL GENET, V125, P1503, DOI 10.1007/s00122-012-1929-0; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; Zhang X, 2014, CROP J, V2, P272, DOI 10.1016/j.cj.2014.06.009	41	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242620	10.1371/journal.pone.0242620	http://dx.doi.org/10.1371/journal.pone.0242620			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270669	gold, Green Published			2022-12-26	WOS:000597149100040
J	Nair, AR; Johnson, EA; Yang, HJ; Cokic, I; Francis, J; Dharmakumar, R				Nair, Anand R.; Johnson, Eric A.; Yang, Hsin-Jung; Cokic, Ivan; Francis, Joseph; Dharmakumar, Rohan			Reperfused hemorrhagic myocardial infarction in rats	PLOS ONE			English	Article							CARDIAC MAGNETIC-RESONANCE; PERCUTANEOUS CORONARY INTERVENTION; LEFT-VENTRICULAR FUNCTION; INTRAMYOCARDIAL HEMORRHAGE; MICROVASCULAR OBSTRUCTION; OXIDATIVE STRESS; SIZE	Background Intramyocardial hemorrhage following reperfusion is strongly associated with major adverse cardiovascular events in myocardial infarction (MI) patients; yet the mechanisms contributing to these outcomes are not well understood. Large animal models have been used to investigate intramyocardial hemorrhage, but they are exorbitantly expensive and difficult to use for mechanistic studies. In contrast, rat models are widely used to investigate mechanistic aspects of cardiovascular physiology, but a rat model that consistently recapitulates the characteristics of an hemorrhagic MI does not exist. To bridge this gap, we investigated the physiological conditions of MI that would create intramyocardial hemorrhage in rats so that a reliable model of hemorrhagic MI would become available for basic research. Methods & results Sprague-Dawley rats underwent either a 90-minute (90-min) ischemia and then reperfusion (I/R) (n = 22) or 30-minute (30-min) I/R (n = 18) of the left anterior descending coronary artery. Sham rats (n = 12) were used as controls. 90-min I/R consistently yielded hemorrhagic MI, while 30-min I/R consistently yielded non-hemorrhagic MI. Twenty-four hours post-reperfusion, ex-vivo late-gadolinium-enhancement (LGE) and T2* cardiac MRI performed on excised hearts from 90-min I/R rats revealed colocalization of iron deposits within the scarred tissue; however, in 30-min I/R rats scar was evident on LGE but no evidence of iron was found on T2* CMR. Histological studies verified tissue damage (H&E) detected on LGE and the presence of iron (Perl's stain) observed on T2*-CMR. At week 4 post-reperfusion, gene and protein expression of proinflammatory markers (TNF-alpha, IL-1 beta and MMP-9) were increased in the 90-min I/R group when compared to 30-min I/R groups. Further, transmission electron microscopy performed on 90-min I/R myocardium that were positive for iron on T2* CMR and Perl's stain showed accumulation of granular iron particles within the phagosomes. Conclusion Ischemic time prior to reperfusion is a critical factor in determining whether a MI is hemorrhagic or non-hemorrhagic in rats. Specifically, a period of 90-min of ischemia prior to reperfusion can produce rat models of hemorrhagic MI, while 30-minutes of ischemia prior to reperfusion can ensure that the MIs are non-hemorrhagic. Hemorrhagic MIs in rats result in marked increase in iron deposition, proinflammatory burden and adverse left-ventricular remodeling compared to rats with non-hemorrhagic MIs.	[Nair, Anand R.; Johnson, Eric A.; Yang, Hsin-Jung; Cokic, Ivan; Dharmakumar, Rohan] Cedars Sinai Med Ctr, Dept Biomed Sci, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA; [Johnson, Eric A.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Cokic, Ivan; Dharmakumar, Rohan] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA; [Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Dharmakumar, R (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA.	rohan.dharmakumar@cshs.org		Dharmakumar, Rohan/0000-0003-4120-4635	National Institute of Health (NIH) [R01 HL147133]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research grant from the National Institute of Health (NIH) R01 HL147133 awarded to RD and JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agoro R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196921; [Anonymous], 2008, ZHIBEK ZHOLY; Bricker RS, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005355; Chen W, 2016, J MAGN RESON IMAGING, V44, P194, DOI 10.1002/jmri.25145; Cokic I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073193; Degano IR, 2017, INT J CARDIOL, V249, P83, DOI 10.1016/j.ijcard.2017.07.054; Dodd T, 2011, J MOL CELL CARDIOL, V51, P1015, DOI 10.1016/j.yjmcc.2011.08.012; Eitel I, 2011, CIRC-CARDIOVASC IMAG, V4, P354, DOI 10.1161/CIRCIMAGING.110.960500; Ganame J, 2009, EUR HEART J, V30, P1440, DOI 10.1093/eurheartj/ehp093; Ghugre NR, 2011, MAGN RESON MED, V66, P1129, DOI 10.1002/mrm.22855; Guggilam A, 2007, AM J PHYSIOL-HEART C, V293, pH599, DOI 10.1152/ajpheart.00286.2007; Husser O, 2013, INT J CARDIOL, V167, P2047, DOI 10.1016/j.ijcard.2012.05.055; Kali A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004996; Kali A, 2014, CIRC-CARDIOVASC IMAG, V7, P471, DOI 10.1161/CIRCIMAGING.113.001541; Kali A, 2013, CIRC-CARDIOVASC IMAG, V6, P218, DOI 10.1161/CIRCIMAGING.112.000133; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kosmidou I, 2017, EUR HEART J, V38, P1656, DOI 10.1093/eurheartj/ehx159; Kristiansen SB, 2017, NITRIC OXIDE-BIOL CH, V70, P68, DOI 10.1016/j.niox.2017.09.002; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Nepper-Christensen L, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004823; Phoon Colin K L, 2016, Curr Protoc Mouse Biol, V6, P15, DOI 10.1002/9780470942390.mo150122; Robbers LFHJ, 2013, EUR HEART J, V34, P2346, DOI 10.1093/eurheartj/eht100; Sezer M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009949; Shu LL, 2017, CELL PHYSIOL BIOCHEM, V44, P1939, DOI 10.1159/000485884; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tian Ming, 2015, Chronic Dis Transl Med, V1, P18, DOI 10.1016/j.cdtm.2015.02.002; Torpy Janet M, 2004, JAMA, V291, P778, DOI 10.1001/jama.291.6.778; Van Linthout Sophie, 2017, Curr Heart Fail Rep, V14, P251, DOI 10.1007/s11897-017-0337-9; Tavares AMV, 2012, EXP CLIN CARDIOL, V17, P263; Wang G, 2019, JACC-CARDIOVASC IMAG, V12, P693, DOI 10.1016/j.jcmg.2018.01.018; Xiong Shigang, 2004, Comp Hepatol, V3 Suppl 1, pS36, DOI 10.1186/1476-5926-2-S1-S36; Ye YX, 2013, CIRCULATION, V128, P1878, DOI 10.1161/CIRCULATIONAHA.113.000731	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243207	10.1371/journal.pone.0243207	http://dx.doi.org/10.1371/journal.pone.0243207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264359	Green Published, gold			2022-12-26	WOS:000596569200049
J	Stopp, M; Steinmetz, PA; Schubert, C; Griesinger, C; Schneider, D; Unden, G				Stopp, Marius; Steinmetz, Philipp Aloysius; Schubert, Christopher; Griesinger, Christian; Schneider, Dirk; Unden, Gottfried			Transmembrane signaling and cytoplasmic signal conversion by dimeric transmembrane helix 2 and a linker domain of the DcuS sensor kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; ESCHERICHIA-COLI; HISTIDINE-KINASE; MEMBRANE-PROTEINS; BINDING-SITE; SEQUENCE; TRANSDUCTION; RECOGNITION; ASSOCIATION; SYSTEM	Transmembrane (TM) signaling is a key process of membrane-bound sensor kinases. The C-4-dicarboxylate (fumarate) responsive sensor kinase DcuS of Escherichia coli is anchored by TM helices TM1 and TM2 in the membrane. Signal transmission across the membrane relies on the piston-type movement of the periplasmic part of TM2. To define the role of TM2 in TM signaling, we use oxidative Cys cross-linking to demonstrate that TM2 extends over the full distance of the membrane and forms a stable TM homodimer in both the inactive and fumarate-activated state of DcuS. An S(186)xxxGxxxG(194) motif is required for the stability and function of the TM2 homodimer. The TM2 helix further extends on the periplasmic side into the alpha 6-helix of the sensory PASP domain and on the cytoplasmic side into the alpha 1-helix of PAS(C). PAS(C) has to transmit the signal to the C-terminal kinase domain. A helical linker on the cytoplasmic side connecting TM2 with PAS(C) contains an LxxxLxxxL sequence. The dimeric state of the linker was relieved during fumarate activation of DcuS, indicating structural rearrangements in the linker. Thus, DcuS contains a long alpha-helical structure reaching from the sensory PASP (alpha 6) domain across the membrane to alpha 1(PAS(C)). Taken together, the results suggest piston-type TM signaling by the TM2 homodimer from PASP across the full TM region, whereas the fumarate-destabilized linker dimer converts the signal on the cytoplasmic side for PAS(C) and kinase regulation.	[Stopp, Marius; Steinmetz, Philipp Aloysius; Schubert, Christopher; Unden, Gottfried] Johannes Gutenberg Univ Mainz, Inst Mol Physiol, Microbiol & Wine Res, Mainz, Germany; [Griesinger, Christian] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany; [Schneider, Dirk] Johannes Gutenberg Univ Mainz, Dept Chem Biochem, Mainz, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; Johannes Gutenberg University of Mainz	Unden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Physiol, Microbiol & Wine Res, Mainz, Germany.	unden@uni-mainz.de		Unden, Gottfried/0000-0003-4906-1835; Schubert, Christopher/0000-0002-7921-1470	Deutsche Forschungsgemeinschaft, Germany [UN 49/21-1, GR 1211/17-1]; Johannes Gutenberg University (NMFZ), Germany	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); Johannes Gutenberg University (NMFZ), Germany	Financial support was received from grants from the Deutsche Forschungsgemeinschaft, Germany (UN 49/21-1 and GR 1211/17-1) and from Johannes Gutenberg University (NMFZ), Germany.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Dmitrova M, 1998, MOL GEN GENET, V257, P205; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Falke JJ, 2014, STRUCTURE, V22, P1219, DOI 10.1016/j.str.2014.08.011; Fleming KG, 2001, P NATL ACAD SCI USA, V98, P14340, DOI 10.1073/pnas.251367498; Gushchin I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093110; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hughson AG, 1996, P NATL ACAD SCI USA, V93, P11546, DOI 10.1073/pnas.93.21.11546; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Karimova G, 2000, INT J MED MICROBIOL, V290, P441; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kitanovic S, 2011, J BACTERIOL, V193, P5062, DOI 10.1128/JB.05683-11; Kleefeld A, 2009, J BIOL CHEM, V284, P265, DOI 10.1074/jbc.M807856200; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Kneuper H, 2005, J BIOL CHEM, V280, P20596, DOI 10.1074/jbc.M502015200; Kneuper H., 2010, SENSORY MECH BACTERI; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE GF, 1995, P NATL ACAD SCI USA, V92, P3391, DOI 10.1073/pnas.92.8.3391; Lemmin T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002878; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lesne E, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00114-17; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Molnar KS, 2014, STRUCTURE, V22, P1239, DOI 10.1016/j.str.2014.04.019; Monzel C, 2015, P NATL ACAD SCI USA, V112, P11042, DOI 10.1073/pnas.1507217112; Monzel C, 2013, MICROBIOLOGYOPEN, V2, P912, DOI 10.1002/mbo3.127; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Riek RP, 2001, J MOL BIOL, V306, P349, DOI 10.1006/jmbi.2000.4402; Salvi M, 2017, P NATL ACAD SCI USA, V114, P3115, DOI 10.1073/pnas.1620286114; Sambrook J., 2001, MOL CLONING LAB MANU; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; Scheu PD, 2010, FUTURE MICROBIOL, V5, P1383, DOI 10.2217/FMB.10.103; Scheu PD, 2010, J BACTERIOL, V192, P3474, DOI 10.1128/JB.00082-10; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; Unden Gottfried, 2016, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0021-2015; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Weisenburger S, 2017, NAT METHODS, V14, P141, DOI [10.1038/NMETH.4141, 10.1038/nmeth.4141]; Witan J, 2012, MOL MICROBIOL, V85, P846, DOI 10.1111/j.1365-2958.2012.08143.x; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	70	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100148	10.1074/jbc.RA120.015999	http://dx.doi.org/10.1074/jbc.RA120.015999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33277358	gold, Green Published			2022-12-26	WOS:000672866400126
J	Chapman, TJ; Morris, MC; Xu, L; Pichichero, ME				Chapman, Timothy J.; Morris, Matthew C.; Xu, Lei; Pichichero, Michael E.			Nasopharyngeal colonization with pathobionts is associated with susceptibility to respiratory illnesses in young children	PLOS ONE			English	Article							ACUTE-OTITIS-MEDIA; BACTERIAL; RISK; MANAGEMENT; MICROBIOTA; INFECTION; DIAGNOSIS; ROCHESTER; SEVERITY; STRAINS	Some children are more susceptible to viral and bacterial respiratory infections in the first few years of life than others. However, the factors contributing to this susceptibility are incompletely understood. In a retrospective analysis of clinical samples collected from a prospectively-enrolled cohort of 358 children we sought associations between physician-attended illness visits and bacterial colonization in the first five years of life. A subset of children was identified by unsupervised clustering analysis as infection and allergy prone (IAP). Several respiratory infection- and allergy-mediated illnesses co-occurred at higher rates in IAP children, while the rates of other illnesses were not significantly different between the groups. Analyses of nasopharyngeal (NP) pathobionts and microbiota commensals showed that early age of first colonization with pathobionts Streptococcus pneumonia, non-typeable Haemophilus influenzae, and Moraxella catarrhalis was associated with IAP children, and particularly Moraxella abundance was negatively associated with NP microbiome diversity. We conclude that mucosal pathobiont exposures in early life can influence susceptibility to respiratory illnesses in children.	[Chapman, Timothy J.; Xu, Lei; Pichichero, Michael E.] Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Immunol, Rochester, NY 14621 USA; [Morris, Matthew C.] Rochester Gen Hosp, Ctr Clin Syst Biol, Med Off Bldg, Rochester, NY 14621 USA	Rochester General Hospital; Rochester General Hospital	Pichichero, ME (corresponding author), Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Immunol, Rochester, NY 14621 USA.	michael.pichichero@rochesterregional.org	Pichichero, Michael E/AID-7886-2022; Core, UNC Microbiome/AAB-3304-2022	Chapman, Timothy/0000-0002-2337-2136; Pichichero, Michael/0000-0002-8276-3938	NIH NIDCD [R01 08671]	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded in part by NIH NIDCD R01 08671 to MEP.	[Anonymous], 2019, AESTHET SURG J S1, V38, pS1; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Budden KF, 2019, LANCET RESP MED, V7, P907, DOI 10.1016/S2213-2600(18)30510-1; Chonmaitree T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180630; Dagan R, 2016, LANCET INFECT DIS, V16, P480, DOI 10.1016/S1473-3099(15)00549-6; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dumas A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02656; Friedel V, 2013, PEDIATR INFECT DIS J, V32, P27, DOI 10.1097/INF.0b013e31826f6144; Hauk L, 2014, AM FAM PHYSICIAN, V89, P676; Kalu SU, 2011, PEDIATR INFECT DIS J, V30, P95, DOI 10.1097/INF.0b013e3181f253d5; Kassambara A, 2019, **DATA OBJECT**; Kaur R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0181; Kaur R, 2016, PEDIATR INFECT DIS J, V35, P901, DOI 10.1097/INF.0000000000001206; Ladogana S, 2017, BLOOD TRANSFUS-ITALY, V15, P259, DOI 10.2450/2016.0072-16; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Mahr TA, 2005, PEDIATR REV, V26, P284, DOI 10.1542/pir.26-8-284; Murray P, 2003, MANUAL CLIN MICROBIO, V412-429, P770; Navne JE, 2016, EPIDEMIOL INFECT, V144, P3226, DOI 10.1017/S0950268816001461; Negi S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01142; Papadopoulos NG, 2012, ALLERGY, V67, P976, DOI 10.1111/j.1398-9995.2012.02865.x; Patel JA, 2009, PEDIATR INFECT DIS J, V28, P1002, DOI 10.1097/INF.0b013e3181aa5b13; Pichichero ME, 2020, J INFECTION, V80, P614, DOI 10.1016/j.jinf.2020.03.017; Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1033, DOI 10.1097/INF.0000000000001217; Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1027, DOI 10.1097/INF.0000000000001216; Pichichero ME, 2013, PEDIATR INFECT DIS J, V32, P1163, DOI 10.1097/INF.0b013e31829e887e; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; R Core Team, 2021, R LANGUAGE ENV STAT; Ren DB, 2019, CLIN INFECT DIS, V68, P1566, DOI 10.1093/cid/ciy750; Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Therneau T., 2021, PACKAGE SURVIVAL ANA, DOI DOI 10.1198/TECH.2004.S740; Tollefson MM, 2014, PEDIATRICS, V134, pE1735, DOI 10.1542/peds.2014-2812; Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9; Xu QF, 2012, PEDIATR INFECT DIS J, V31, P638, DOI 10.1097/INF.0b013e31824ba6f7; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yatsyshina S, 2016, DIAGN MICR INFEC DIS, V85, P125, DOI 10.1016/j.diagmicrobio.2016.02.010	43	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243942	10.1371/journal.pone.0243942	http://dx.doi.org/10.1371/journal.pone.0243942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306743	Green Published, gold			2022-12-26	WOS:000600144200004
J	Dumaidi, K; Qaraqe, H; Al-Jawabreh, A; Abu-Helu, R; Samarah, F; Al-Jawabreh, H				Dumaidi, Kamal; Qaraqe, Hayah; Al-Jawabreh, Amer; Abu-Helu, Rasmi; Samarah, Fekri; Al-Jawabreh, Hanan			Genetic diversity, haplotype analysis, and risk factor assessment of hepatitis A virus isolates from the West Bank, Palestine during the period between 2014 and 2016	PLOS ONE			English	Article							UNIVERSAL VACCINATION; MIDDLE-EAST; DNA; INFECTION; REGION; SEROPREVALENCE; EPIDEMIOLOGY; KOREA; AGE	Background Hepatitis A virus (HAV) infection is one of the major causes of acute viral hepatitis. HAV genotypes and its genetic diversity is rarely investigated in our region as well as worldwide. Aims The aims of the present study were to determine the HAV genotypes and its risk factors and to investigate the genetic diversity of the HAV isolates in the West Bank, Palestine. Study design A cohort of 161 clinically and laboratory-confirmed HAV (IgM-positive) cases and 170 apparently healthy controls from all the districts of the West Bank, Palestine during the period of 2014 to 2016 were tested for HAV infection using IgM antibodies, RT-PCR and sequence analysis of the VP3/VP1 junction region of the HAV genome. Phylogenetic analysis, genetic diversity and haplotypes analysis were used to characterize the VP3/VP1 sequences. Results All the 34 sequences of the HAV were found to be of HAV-IB sub-genotype. The phylogenetic analysis showed four main clusters with cluster III exclusively consisting of 18 Palestinian isolates (18/23-78%), but with weak bootstrap values. A high haplotype diversity (Hd) and low nucleotide diversity (pi) were observed. Cluster III showed high number of haplotypes (h = 8), but low haplotype (gene) diversity (Hd = 0.69). A total of 28 active haplotypes with some consisting of more than one sequence were observed using haplotype network analysis. The Palestinian haplotypes are characterized by closely related viral haplotypes with one SNV away from each other which ran parallel to cluster III in the phylogenetic tree. A smaller Palestinian haplotype (4 isolates) was three SNVs away from the major haplotype cluster (n = 10) and closer to others haplotypes from Iran, Spain, and South Africa. Young age, low level of parent's education, infrequent hand washing before meals, and drinking of un-treated water were considered the major HAV risk factors in the present study. Conclusion Haplotype network analysis revealed haplotype variation among the HAV Palestinian sequences despite low genetic variation and nucleotide diversity. In addition, this study reconfirmed that age and parent's level of education as HAV risk factors, while hand washing and treating drinking water as protective factors.	[Dumaidi, Kamal; Al-Jawabreh, Amer; Samarah, Fekri] Arab Amer Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Jenin, Palestine; [Qaraqe, Hayah] Palestinian Minist Hlth, Ramallah Primary Hlth Care, Ramallah, Palestine; [Al-Jawabreh, Amer; Al-Jawabreh, Hanan] Leishmaniases Res Unit, Jericho, Palestine; [Abu-Helu, Rasmi] Al Quds Univ, Fac Hlth Profess, Dept Med Lab Sci, Jerusalem, Palestine	Arab American University	Dumaidi, K (corresponding author), Arab Amer Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Jenin, Palestine.	Kamal.dumaidi@aaup.edu	Al-Jawabreh, Amer/I-9960-2019	Al-Jawabreh, Amer/0000-0001-5929-8743; samarah, fekri/0000-0003-2925-4875				[Anonymous], 2012, Wkly Epidemiol Rec, V87; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battikhi MNG, 2004, MICROBIOLOGICA, V27, P215; Bellou M, 2013, FOOD ENVIRON VIROL, V5, P13, DOI 10.1007/s12560-012-9097-6; Bruni R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2596-1; Cella E, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009632; Cristina J, 2007, VIRUS RES, V127, P151, DOI 10.1016/j.virusres.2007.01.005; D'Andrea L, 2015, INT J MOL SCI, V16, P6842, DOI 10.3390/ijms16046842; de Almeida LM, 2002, T ROY SOC TROP MED H, V96, P605, DOI 10.1016/S0035-9203(02)90325-1; Dinc B, 2012, TURK J GASTROENTEROL, V23, P714, DOI 10.4318/tjg.2012.0450; Fiore AE, 2006, ADVISORY COMMITTEE I; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Hayajneh WA, 2015, J MED VIROL, V87, P569, DOI 10.1002/jmv.24137; Heathcote J, 2007, MANAGEMENT ACUTE VIR; HUDSON RR, 1992, GENETICS, V132, P583; Hughes JA, 2014, TRANSFUSION, V54, P2202, DOI 10.1111/trf.12648; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Juniastuti,, 2019, J MED VIROL, V91, P1048, DOI 10.1002/jmv.25403; Koroglu M, 2017, J INFECT PUBLIC HEAL, V10, P513, DOI 10.1016/j.jiph.2016.09.020; Kotwal Atul, 2014, Med J Armed Forces India, V70, P225, DOI 10.1016/j.mjafi.2014.06.016; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee H, 2012, J CLIN MICROBIOL, V50, P1252, DOI 10.1128/JCM.01114-11; Maunula L, 2013, INT J FOOD MICROBIOL, V167, P177, DOI 10.1016/j.ijfoodmicro.2013.09.003; Melhem NM, 2014, J VIRAL HEPATITIS, V21, P605, DOI 10.1111/jvh.12282; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; PalestineMinistryofHealth, 2018, HLTH ANN REP; PINHEIRO Raquel Silva, 2015, Arq. Gastroenterol., V52, P200, DOI 10.1590/S0004-28032015000300009; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Seo JY, 2013, J KOREAN MED SCI, V28, P908, DOI 10.3346/jkms.2013.28.6.908; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toukan A U, 1988, Trop Gastroenterol, V9, P76; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074752; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yassin K, 2001, EPIDEMIOL INFECT, V127, P335, DOI 10.1017/S0950268801005970	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240339	10.1371/journal.pone.0240339	http://dx.doi.org/10.1371/journal.pone.0240339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306686	Green Published, gold			2022-12-26	WOS:000600144200070
J	Cassimeris, L; Engiles, JB; Galantino-Homer, H				Cassimeris, Lynne; Engiles, Julie B.; Galantino-Homer, Hannah			Interleukin-17A pathway target genes are upregulated in Equus caballus supporting limb laminitis	PLOS ONE			English	Article							SUSPENSORY APPARATUS; DIGITAL HYPOTHERMIA; DISTAL PHALANX; EXPRESSION; HORSES; CYTOKINES; MODEL; SKIN; CELL; PSORIASIS	Supporting Limb Laminitis (SLL) is a painful and crippling secondary complication of orthopedic injuries and infections in horses, often resulting in euthanasia. SLL causes structural alterations and inflammation of the interdigitating layers of specialized epidermal and dermal tissues, the lamellae, which suspend the equine distal phalanx from the hoof capsule. Activation of the interleukin-17A (IL-17A)-dependent inflammatory pathway is an epidermal stress response that contributes to physiologic cutaneous wound healing as well as pathological skin conditions. As a first test of the hypothesis that hoof lamellae of horses diagnosed with SLL also respond to stress by activating the IL-17A pathway, the expression of IL-17A, IL-17 receptor subunit A and 11 IL-17A effector genes was measured by RT-PCR or qPCR. Lamellar tissue was isolated from Thoroughbreds euthanized due to naturally occurring SLL and in age and breed matched non-laminitic controls. By RT-PCR, the IL-17 Receptor A subunit was expressed in both non-laminitic and laminitic tissues, while IL-17A was primarily detectable in laminitic tissues. IL-17A target gene expression was undetectable in non-laminitic samples with the exception of weak detection of DEFB4B, S100A9 and PTSG2. In contrast, all target genes examined, except CCL20, were expressed by some or all laminitic samples. By qPCR, severe acute (n = 7) SLL expressed similar to 15-100 fold higher levels of DEFB4B and S100A9 genes compared to non-laminitic controls (n = 8). DEFB4B was also upregulated in developmental/subclinical (n = 8) and moderate acute (n = 7) by similar to 5-fold, and in severe chronic (n = 5) by similar to 15-200 fold. In situ hybridization (DEFB4) and immunofluorescence (calprotectin, a dimer of S100A9/S100A8 proteins) demonstrated expression in keratinocytes, primarily in suprabasal cell layers, from SLL samples. These data demonstrate upregulation of a cohort of IL-17A target genes in SLL and support the hypothesis that similarities in the response to stresses and damage exist between equine and human epidermal tissues.	[Cassimeris, Lynne] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Engiles, Julie B.; Galantino-Homer, Hannah] Univ Penn, Dept Clin Studies, Sch Vet Med, New Bolton Ctr, Kennett Sq, Philadelphia, PA 19104 USA; [Engiles, Julie B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Lehigh University; University of Pennsylvania; University of Pennsylvania	Cassimeris, L (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	lc07@lehigh.edu		Cassimeris, Lynne/0000-0003-1058-0734	New Directions Fellowship (Lehigh University College of Arts and Sciences); Laminitis Research Fund (University of Pennsylvania School of Veterinary Medicine); Raker-Tulleners Fund (University of Pennsylvania School of Veterinary Medicine); American Association of Equine Practioners Foundation; Grayson Jockey Club Research Foundation; Bernice Barbour Foundation [0048.412012]	New Directions Fellowship (Lehigh University College of Arts and Sciences); Laminitis Research Fund (University of Pennsylvania School of Veterinary Medicine); Raker-Tulleners Fund (University of Pennsylvania School of Veterinary Medicine); American Association of Equine Practioners Foundation; Grayson Jockey Club Research Foundation; Bernice Barbour Foundation	Support was provided by: 1. New Directions Fellowship (Lehigh University College of Arts and Sciences) to LC. No grant number was assigned. 2. The Laminitis Research Fund (University of Pennsylvania School of Veterinary Medicine) to HGH No grant number was assigned. https://www.vet.upenn.edu/giving/how-to-support-penn-vet 3. The Raker-Tulleners Fund (University of Pennsylvania School of Veterinary Medicine) to HGH. No grant number was assigned. https://www.vet.upenn.edu/giving/how-to-support-penn-vet 4. The American Association of Equine Practioners Foundation to HGH. No grant number was assigned https://foundation.aaep.org/5.The Laminitis Discovery Database (sample archive) was supported by The Grayson Jockey Club Research Foundation (No number was assigned) (https://www.graysonjockeyclub.org/) and The Bernice Barbour Foundation (Number 0048.412012) (https://bernicebarbour.org/) Funders and sponsors did not play any role in the following: study design, data collection and analysis, decision to publish and preparation of the manuscript.	Amatya N, 2017, TRENDS IMMUNOL, V38, P310, DOI 10.1016/j.it.2017.01.006; [Anonymous], OLIGOPERFECT PRIMER; Armstrong C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219234; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; Blikslager AT, 2006, J VET INTERN MED, V20, P1191, DOI 10.1892/0891-6640(2006)20[1191:CEITES]2.0.CO;2; Bragulla H, 2003, J EXP ZOOL PART B, V298B, P140, DOI 10.1002/jez.b.00031; Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Burns TA, 2010, J VET INTERN MED, V24, P932, DOI 10.1111/j.1939-1676.2010.0551.x; Carter RA, 2011, EQUINE VET J, V43, P543, DOI 10.1111/j.2042-3306.2010.00325.x; Carter RA, 2010, J ANIM SCI, V88, P3843, DOI 10.2527/jas.2010-2964; Cassimeris L, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1748-x; Chen X, 2019, J EXP MED, V216, P195, DOI 10.1084/jem.20171849; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Clark RK, 2014, EXP DERMATOL, V23, P677, DOI 10.1111/exd.12495; Collins SN, 2010, VET CLIN N AM-EQUINE, V26, P179, DOI 10.1016/j.cveq.2010.01.004; Coyne MJ, 2009, VET IMMUNOL IMMUNOP, V129, P231, DOI 10.1016/j.vetimm.2008.11.022; de Laat MA, 2014, VET IMMUNOL IMMUNOP, V157, P78, DOI 10.1016/j.vetimm.2013.10.010; de Laat MA, 2011, VET IMMUNOL IMMUNOP, V140, P275, DOI 10.1016/j.vetimm.2011.01.013; Dern K, 2018, J VET INTERN MED, V32, P450, DOI 10.1111/jvim.15027; Dern K, 2017, J VET INTERN MED, V31, P575, DOI 10.1111/jvim.14633; Engiles JB, 2015, VET PATHOL, V52, P928, DOI 10.1177/0300985815588604; Faleiros RR, 2009, J VET INTERN MED, V23, P174, DOI 10.1111/j.1939-1676.2008.0241.x; Faleiros RR, 2011, VET IMMUNOL IMMUNOP, V144, P45, DOI 10.1016/j.vetimm.2011.07.005; GALANTINOHOMER H, 2010, J EQUINE VET SCI, V30, P101, DOI DOI 10.1016/j.jevs.2010.01.016; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hawkes JE, 2018, J IMMUNOL, V201, P1605, DOI 10.4049/jimmunol.1800013; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Karikoski NP, 2015, VET PATHOL, V52, P945, DOI 10.1177/0300985814549212; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V139, P923, DOI 10.1016/j.jaci.2016.06.038; Krueger JG, 2018, EXP DERMATOL, V27, P115, DOI 10.1111/exd.13467; Kuwano A, 2002, J VET MED SCI, V64, P893, DOI 10.1292/jvms.64.893; Kyoto Encyclopedia of Genes and Genomes, IL 17 SIGN PATHW HOM; Leise BS, 2015, EQUINE VET J, V47, P478, DOI 10.1111/evj.12283; Leise BS, 2011, EQUINE VET J, V43, P54, DOI 10.1111/j.2042-3306.2010.00122.x; Leise B, 2018, CELL TISSUE RES, V371, P541, DOI 10.1007/s00441-018-2788-z; Linardi RL, 2015, VET DERMATOL, V26, P213, DOI 10.1111/vde.12214; Loftus JP, 2009, VET IMMUNOL IMMUNOP, V129, P221, DOI 10.1016/j.vetimm.2008.11.003; Marth CD, 2016, VET RES, V47, DOI 10.1186/s13567-016-0398-x; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; Modelski M., 2014, ANN M AM SOC CELL BI; Moss KL, 2020, HUM GENE THER, V31, P110, DOI 10.1089/hum.2019.195; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Noschka E, 2009, VET IMMUNOL IMMUNOP, V129, P242, DOI 10.1016/j.vetimm.2008.11.002; Patterson-Kane JC, 2018, VET J, V231, P33, DOI 10.1016/j.tvjl.2017.11.011; Pawlak EA, 2014, EQUINE VET J, V46, P203, DOI 10.1111/evj.12092; Pollitt CC, 2016, EQUINE VET J, V48, P496, DOI 10.1111/evj.12459; Pollitt CC, 2010, VET CLIN N AM-EQUINE, V26, P29, DOI 10.1016/j.cveq.2010.01.005; Prinz I, 2020, J EXP MED, V217, DOI 10.1084/jem.20191397; Tadros EM, 2012, VET IMMUNOL IMMUNOP, V150, P90, DOI 10.1016/j.vetimm.2012.09.002; Thomason JJ, 2005, ANAT REC PART A, V283A, P366, DOI 10.1002/ar.a.20173; van Eps AW, 2019, VET CLIN N AM-EQUINE, V35, P379, DOI 10.1016/j.cveq.2019.04.001; WANG J, 2010, THESIS; Wang L, 2014, J VET INTERN MED, V28, P215, DOI 10.1111/jvim.12252; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Watts MR, 2019, J VET INTERN MED, V33, P1483, DOI 10.1111/jvim.15480; Wolenski FS, 2013, NAT PROTOC, V8, P900, DOI 10.1038/nprot.2013.014; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; Zhao JJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20190297	60	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0232920	10.1371/journal.pone.0232920	http://dx.doi.org/10.1371/journal.pone.0232920			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301461	gold, Green Published, Green Submitted			2022-12-26	WOS:000600143100086
J	Li, AL; Grant, D; Gbakie, M; Kanneh, L; Mustafa, I; Bond, N; Engel, E; Schieffelin, J; Vandy, MJ; Yeh, S; Shantha, JG				Li, Alexa L.; Grant, Donald; Gbakie, Michael; Kanneh, Lansana; Mustafa, Ibrahim; Bond, Nell; Engel, Emily; Schieffelin, John; Vandy, Matthew J.; Yeh, Steven; Shantha, Jessica G.			Ophthalmic manifestations and vision impairment in Lassa fever survivors	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CLINICAL-FEATURES; EBOLA-VIRUS; CHORIORETINITIS; EPIDEMIOLOGY; POPULATION; MANAGEMENT; DIAGNOSIS; BLINDNESS; EYE	The purpose of this study was to describe the ocular findings, structural ocular complications, and vision impairment in a cohort of Lassa fever survivors in Kenema, Sierra Leone. A retrospective, uncontrolled, cross-sectional study of 31 Lassa fever survivors (62 eyes) who underwent an ophthalmic evaluation in January 2018 at the Kenema Government Hospital in Kenema, Sierra Leone was performed. Data collection included demographic information, ocular/systemic symptoms, visual acuity (VA), and ophthalmic examination findings. Main outcome measures included anterior and posterior segment ophthalmic manifestations and level of VA impairment in Lassa fever survivors. Anterior segment findings included cataract (18%) and pterygium (2%), while posterior segment manifestations consisted of glaucoma (6%), preretinal hemorrhage (2%), and lattice degeneration (2%). Findings suggestive of prior sequelae of uveitis included chorioretinal scarring (5%), retinal fibrosis (3%), and vitreous opacity (2%). Visual acuity was normal/mildly impaired in 53 eyes (85%), moderately impaired in 6 eyes (10%), and 3 eyes (5%) were considered blind by the World Health Organization (WHO) criteria. Median VA was worse in Lassa fever survivors with ophthalmic disease findings (p<0.0001) for both anterior segment (p<0.0001) and posterior segment disease (p<0.013). Untreated cataract was a significant cause of visual acuity impairment (p<0.0001). Lassa fever survivors in this cohort were found to have cataract and posterior segment findings that potentially represent sequelae of uveitis associated with visual impairment. Future studies are warranted to improve our understanding of the spectrum of ocular disease in this emerging infectious disease of public health consequence.	[Li, Alexa L.; Yeh, Steven; Shantha, Jessica G.] Emory Univ, Sch Med, Dept Ophthalmol, Sect Vitreoretinal Dis & Surg,Emory Eye Ctr, Atlanta, GA 30322 USA; [Grant, Donald; Gbakie, Michael; Kanneh, Lansana; Mustafa, Ibrahim] Kenema Govt Hosp, Viral Hemorrhag Fever Program, Kenema, Sierra Leone; [Grant, Donald] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Bond, Nell; Engel, Emily] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Schieffelin, John] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Vandy, Matthew J.] Minist Hlth & Sanitat, Natl Eye Program, Freetown, Sierra Leone	Emory University; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Tulane University; Tulane University; Ministry of Health & Sanitation Sierra Leone	Yeh, S; Shantha, JG (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, Sect Vitreoretinal Dis & Surg,Emory Eye Ctr, Atlanta, GA 30322 USA.	steven.yeh@emory.edu; jshanth@emory.edu		Li, Alexa/0000-0002-5235-6741	National Eye Institute/National Institutes of Health [P30-EY06360]; National Eye Institute, National Institutes of Health [RO1 EY029594, K23 EY030158]; Research to Prevent Blindness (Emory Eye Center, Emory University School of Medicine); Retina Research Foundation - Mills and Margaret Cox Macula Society Grant; Bayer Global Ophthalmology Awards; Santen, Inc; Sitaraman Family Foundation; National Institute of Allergy and Infectious Disease [1R01AI123535-01A1]	National Eye Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (Emory Eye Center, Emory University School of Medicine); Retina Research Foundation - Mills and Margaret Cox Macula Society Grant; Bayer Global Ophthalmology Awards; Santen, Inc; Sitaraman Family Foundation; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the National Eye Institute/National Institutes of Health core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine), National Eye Institute, National Institutes of Health RO1 EY029594 (SY) and K23 EY030158 (JGS). Funding support was also provided via an Unrestricted Grant from Research to Prevent Blindness (Emory Eye Center, Emory University School of Medicine). Funding support was also provided by the Retina Research Foundation - Mills and Margaret Cox Macula Society Grant (SY), Bayer Global Ophthalmology Awards Program (SY; JGS), Santen, Inc, and the Sitaraman Family Foundation. The National Institute of Allergy and Infectious Disease under award number 1R01AI123535-01A1 (JS; DG) also provided funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Asogun DA, 2019, INFECT DIS CLIN N AM, V33, P933, DOI 10.1016/j.idc.2019.08.002; Boisen ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24246-w; Brezin AP, 2000, AM J OPHTHALMOL, V130, P245, DOI 10.1016/S0002-9394(00)00563-8; Budenz DL, 2012, OPHTHALMOLOGY, V119, P1744, DOI 10.1016/j.ophtha.2012.04.017; Centers for Disease Control and Prevention, INF CONTR STAND PREC; Centers for Disease Control and Prevention, 2020, LASS FEV NIG; Ezeomah C, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz512; Gary JM, 2019, EMERG INFECT DIS, V25, P865, DOI 10.3201/eid2505.181254; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Ilori EA, 2019, EMERG INFECT DIS, V25, P1066, DOI 10.3201/eid2506.181035; KUMING BS, 1977, BRIT J OPHTHALMOL, V61, P265, DOI 10.1136/bjo.61.4.265; Malu Keziah N, 2014, Niger Med J, V55, P166, DOI 10.4103/0300-1652.129664; Mateer EJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006187; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; Mets MB, 2000, AM J OPHTHALMOL, V130, P209, DOI 10.1016/S0002-9394(00)00570-5; Prescott JB, 2017, NAT REV IMMUNOL, V17, P195, DOI 10.1038/nri.2016.138; RONDAY MJH, 1994, BRIT J OPHTHALMOL, V78, P690, DOI 10.1136/bjo.78.9.690; Shantha JG, 2018, EBIOMEDICINE, V30, P217, DOI 10.1016/j.ebiom.2018.03.020; Shantha JG, 2017, OPHTHALMOLOGY, V124, P170, DOI 10.1016/j.ophtha.2016.10.011; Shantha JG, 2016, OPHTHALMOLOGY, V123, P2626, DOI 10.1016/j.ophtha.2016.07.013; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; WALKER DH, 1982, J INFECT DIS, V146, P360, DOI 10.1093/infdis/146.3.360; WHITE HA, 1972, T ROY SOC TROP MED H, V66, P390, DOI 10.1016/0035-9203(72)90269-6; WHO, PRIOR DIS RES DEV EM; Wright R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e9; Yeh S, 2018, OCUL IMMUNOL INFLAMM, V26, P1128, DOI 10.1080/09273948.2018.1484493; Yun NE, 2016, J VIROL, V90, P2920, DOI 10.1128/JVI.02948-15; Yun NE, 2012, VIRUSES-BASEL, V4, P2031, DOI 10.3390/v4102031; Zinkernagel MS, 2009, J VIROL, V83, P159, DOI 10.1128/JVI.01211-08	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243766	10.1371/journal.pone.0243766	http://dx.doi.org/10.1371/journal.pone.0243766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301526	gold, Green Published			2022-12-26	WOS:000600143100056
J	Nishiwaki, S; Saito, S; Takeshita, K; Kato, H; Ueda, R; Takami, A; Naoe, T; Ogawa, M; Nakayama, T				Nishiwaki, Satoshi; Saito, Shigeki; Takeshita, Kyosuke; Kato, Hidefumi; Ueda, Ryuzo; Takami, Akiyoshi; Naoe, Tomoki; Ogawa, Mika; Nakayama, Takayuki			In vivo tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomes	PLOS ONE			English	Article							CELLS; ACTIVATION	Macrophages play an indispensable role in both innate and acquired immunity, while the persistence of activated macrophages can sometimes be harmful to the host, resulting in multi-organ damage. Macrophages develop from monocytes in the circulation. However, little is known about the organ affinity of macrophages in the normal state. Using in vivo imaging with XenoLight DiR (R), we observed that macrophages showed strong affinity for the liver, spleen and lung, and weak affinity for the gut and bone marrow, but little or no affinity for the kidney and skin. We also found that administered macrophages were still alive 168 hours after injection. On the other hand, treatment with clodronate liposomes, which are readily taken up by macrophages via phagocytosis, strongly reduced the number of macrophages in the liver, spleen and lung.	[Nishiwaki, Satoshi] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan; [Saito, Shigeki] Japanese Red Cross Nagoya Daiini Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Takeshita, Kyosuke] Saitama Med Ctr, Dept Clin Lab, Kawagoe, Saitama, Japan; [Kato, Hidefumi] Aichi Med Univ, Dept Transfus Med, Nagakute, Aichi, Japan; [Ueda, Ryuzo] Aichi Med Univ, Tumor Immunol, Nagakute, Aichi, Japan; [Takami, Akiyoshi] Aichi Med Univ, Hematol, Nagakute, Aichi, Japan; [Naoe, Tomoki] Nagoya Med Ctr, Dept Hematol, Nagoya, Aichi, Japan; [Ogawa, Mika; Nakayama, Takayuki] Aichi Med Univ, Clin Lab, Nagakute, Aichi, Japan	Nagoya University; Saitama Medical University; Aichi Medical University; Aichi Medical University; Aichi Medical University; Nagoya Medical Center; Aichi Medical University	Nakayama, T (corresponding author), Aichi Med Univ, Clin Lab, Nagakute, Aichi, Japan.	tnaka@aichi-med-u.ac.jp	Takeshita, Kyosuke/AAD-9515-2020	Takeshita, Kyosuke/0000-0002-8283-3799; Nakayama, Takayuki/0000-0003-2389-2542; Takami, Akiyoshi/0000-0002-1822-9976	 [17K09944]		Japanese Grant-in-Aid for Scientific Research (https://www.jsps.go.jp/) Grant number [(C) 17K09944] was awarded to T. Nakayama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, AM J PHYSIOL-CELL PH, V314, pC404; Cook AD, 2003, J IMMUNOL, V171, P4816, DOI 10.4049/jimmunol.171.9.4816; Eisenblatter M, 2009, J NUCL MED, V50, P1676, DOI 10.2967/jnumed.108.060707; Frith JC, 1997, J BONE MINER RES, V12, P1358, DOI 10.1359/jbmr.1997.12.9.1358; Griessinger CM, 2014, J NUCL MED, V55, P301, DOI 10.2967/jnumed.113.126318; Guth AM, 2013, VET COMP ONCOL, V11, P296, DOI 10.1111/j.1476-5829.2012.00319.x; Inoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031070; Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Kondo S, 2002, CANCER LETT, V179, P87, DOI 10.1016/S0304-3835(01)00859-X; Kurihara R, 2010, INFLAMM RES, V59, P659, DOI 10.1007/s00011-010-0178-4; LEONG ASY, 1986, J PATHOL, V148, P183, DOI 10.1002/path.1711480209; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Minoia F, 2014, ARTHRITIS RHEUMATOL, V66, P3160, DOI 10.1002/art.38802; Nishiwaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096252; Nishiwaki S, 2012, INT J HEMATOL, V95, P428, DOI 10.1007/s12185-012-1023-z; Parente-Pereira AC, 2011, J CLIN IMMUNOL, V31, P710, DOI 10.1007/s10875-011-9532-8; Saito S, 2011, AM J PATHOL, V179, P1088, DOI 10.1016/j.ajpath.2011.05.027; SchmidtWeber CB, 1996, J LEUKOCYTE BIOL, V60, P230, DOI 10.1002/jlb.60.2.230; Sen ES, 2017, ARCH DIS CHILD, V102, P279, DOI 10.1136/archdischild-2016-310772; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Stoy N, 2001, PATHOBIOLOGY, V69, P179, DOI 10.1159/000055944; Toyokuni S, 2003, PATHOL INT, V53, P259, DOI 10.1046/j.1320-5463.2003.01465.x; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANROOIJEN N, 1994, ADV EXP MED BIOL, V355, P69; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Xia W, 2009, BLOOD, V113, P438, DOI 10.1182/blood-2008-04-150789	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242488	10.1371/journal.pone.0242488	http://dx.doi.org/10.1371/journal.pone.0242488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301448	Green Published, gold			2022-12-26	WOS:000600143100083
J	Porta, A; Fantinato, A; Bari, V; Gelpi, F; Cairo, B; De Maria, B; Bertoldo, EG; Fiolo, V; Callus, E; De Vincentiis, C; Volpe, M; Molfetta, R; Ranucci, M				Porta, Alberto; Fantinato, Angela; Bari, Vlasta; Gelpi, Francesca; Cairo, Beatrice; De Maria, Beatrice; Bertoldo, Enrico Giuseppe; Fiolo, Valentina; Callus, Edward; De Vincentiis, Carlo; Volpe, Marianna; Molfetta, Raffaella; Ranucci, Marco			Evaluation of the impact of surgical aortic valve replacement on short-term cardiovascular and cerebrovascular controls through spontaneous variability analysis	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DYNAMIC CEREBRAL AUTOREGULATION; SYSTOLIC ARTERIAL-PRESSURE; SYMPATHETIC-NERVE ACTIVITY; NONLINEAR DYNAMICS; BAROREFLEX SENSITIVITY; AUTONOMIC FUNCTION; SPECTRUM ANALYSIS; UP TILT; COMPLEXITY	We assessed the effect of surgical aortic valve replacement (SAVR) on cardiovascular and cerebrovascular controls via spontaneous variability analyses of heart period, approximated as the temporal distance between two consecutive R-wave peaks on the electrocardiogram (RR), systolic, diastolic and mean arterial pressure (SAP, DAP and MAP) and mean cerebral blood flow (MCBF). Powers in specific frequency bands, complexity, presence of nonlinear dynamics and markers of cardiac baroreflex and cerebral autoregulation were calculated. Variability series were acquired before (PRE) and after (POST) SAVR in 11 patients (age: 76 +/- 5 yrs, 7 males) at supine resting and during active standing. Parametric spectral analysis was performed based on the autoregressive model. Complexity was assessed via a local nonlinear prediction approach exploiting the k-nearest-neighbor strategy. The presence of nonlinear dynamics was checked by comparing the complexity marker computed over the original series with the distribution of the same index assessed over a set of surrogates preserving distribution and power spectral density of the original series. Cardiac baroreflex and cerebral autoregulation were estimated by assessing the transfer function from SAP to RR and from MAP to MCBF and squared coherence function via the bivariate autoregressive approach. We found that: i) orthostatic challenge had no effect on cardiovascular and cerebrovascular control markers in PRE; ii) RR variance was significantly reduced in POST; iii) complexity of SAP, DAP and MAP variabilities increased in POST with a greater likelihood of observing nonlinear dynamics over SAP compared to PRE at supine resting; iv) the amplitude of MCBF variations and MCBF complexity in POST remained similar to PRE; v) cardiac baroreflex sensitivity decreased in POST, while cerebrovascular autoregulation was preserved. SAVR induces important changes of cardiac and vascular autonomic controls and baroreflex regulation in patients exhibiting poor reactivity of cardiovascular regulatory mechanisms, while cerebrovascular autoregulation seems to be less affected.	[Porta, Alberto; Cairo, Beatrice; Callus, Edward] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto; Fantinato, Angela; Bari, Vlasta; Gelpi, Francesca; Ranucci, Marco] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [De Maria, Beatrice] IRCCS, Ist Clin Scientif Maugeri, Milan, Italy; [Bertoldo, Enrico Giuseppe; Fiolo, Valentina; Callus, Edward] IRCCS Policlin San Donato, Clin Psychol Serv, Milan, Italy; [De Vincentiis, Carlo] IRCCS Policlin San Donato, Dept Cardiac Surg, Milan, Italy; [Volpe, Marianna; Molfetta, Raffaella] IRCCS Policlin San Donato, Dept Cardiac Rehabil, Milan, Italy	University of Milan; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato	Porta, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.; Porta, A (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy.	alberto.porta@unimi.it	Fiolo, Valentina/AAB-3181-2021; Bari, Vlasta/J-8591-2016; Cairo, Beatrice/AAG-7863-2020; Ranucci, Marco/K-1040-2016; Bertoldo, Enrico Giuseppe/AAA-7220-2021; De Maria, Beatrice/K-3293-2018; Gelpi, Francesca/ABG-9613-2020; de Vincentiis, Carlo/ABG-3272-2020; Callus, Edward/G-3246-2018; Porta, Alberto/K-4390-2016	Fiolo, Valentina/0000-0002-9819-3546; Bari, Vlasta/0000-0002-5346-2677; Cairo, Beatrice/0000-0003-3396-6883; Ranucci, Marco/0000-0002-4915-3572; Bertoldo, Enrico Giuseppe/0000-0002-8840-5859; De Maria, Beatrice/0000-0001-5360-3137; Gelpi, Francesca/0000-0002-9221-6153; de Vincentiis, Carlo/0000-0002-9945-0057; Callus, Edward/0000-0001-9286-1825; Porta, Alberto/0000-0002-6720-9824	Italian Ministry of Health [RF-2016-02361069]	Italian Ministry of Health(Ministry of Health, Italy)	Research was supported by the Italian Ministry of Health via the grant RF-2016-02361069 to Policlinico San Donato (project PEARL, principal investigator: A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bari V, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01319; Bari V, 2017, PHYSIOL MEAS, V38, P976, DOI 10.1088/1361-6579/aa638c; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; Baselli G, 2006, IEEE T BIO-MED ENG, V53, P53, DOI 10.1109/TBME.2005.859787; Bauernschmitt R, 2007, PACE, V30, P77, DOI 10.1111/j.1540-8159.2007.00568.x; Caldas JR, 2018, INTERACT CARDIOV TH, V26, P494, DOI 10.1093/icvts/ivx357; Camm AJ, 1996, EUR HEART J, V17, P354; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Compostella L, 2015, INT J CARDIOL, V197, P11, DOI 10.1016/j.ijcard.2015.06.004; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; De Maria B, 2019, AM J PHYSIOL-REG I, V317, pR539, DOI 10.1152/ajpregu.00112.2019; De Maria B, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00342; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P352, DOI 10.1007/BF02441589; Fortrat JO, 1997, BIOL CYBERN, V77, P1, DOI 10.1007/s004220050361; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; HOGUE CW, 1994, ANESTHESIOLOGY, V81, P1356, DOI 10.1097/00000542-199412000-00009; Kanters JK, 1997, AM J PHYSIOL-REG I, V272, pR1149, DOI 10.1152/ajpregu.1997.272.4.R1149; KAY SM, 1981, P IEEE, V69, P1380, DOI 10.1109/PROC.1981.12184; Knai K, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14423; Kuo CD, 1999, AM J CARDIOL, V83, P776, DOI 10.1016/S0002-9149(98)00989-8; Lotric MB, 2000, PHYSICA A, V283, P451, DOI 10.1016/S0378-4371(00)00204-1; Marchi A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00438; Marchi A, 2016, AM J PHYSIOL-REG I, V310, pR1134, DOI 10.1152/ajpregu.00541.2015; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Pagani M, 1997, CIRCULATION, V95, P1441; Penzel T, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00460; Pinna GD, 2002, CLIN SCI, V103, P81; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2000, IEEE T BIO-MED ENG, V47, P1555, DOI 10.1109/10.887936; Porta A, 2012, J APPL PHYSIOL, V113, P1810, DOI 10.1152/japplphysiol.00755.2012; Porta A, 2007, AM J PHYSIOL-HEART C, V293, pH702, DOI 10.1152/ajpheart.00006.2007; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Porta A, 2020, IEEE ENG MED BIO, P2569, DOI 10.1109/EMBC44109.2020.9175321; Porta A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00071; Porta A, 2013, J APPL PHYSIOL, V115, P1032, DOI 10.1152/japplphysiol.00537.2013; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; Ranucci M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175008; Retzlaff B, 2009, PHILOS T R SOC A, V367, P1251, DOI 10.1098/rsta.2008.0272; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Tegeler CH, 2013, J NEUROIMAGING, V23, P466, DOI 10.1111/j.1552-6569.2012.00711.x; Vaini E, 2020, 2020 11TH CONFERENCE OF THE EUROPEAN STUDY GROUP ON CARDIOVASCULAR OSCILLATIONS (ESGCO): COMPUTATION AND MODELLING IN PHYSIOLOGY NEW CHALLENGES AND OPPORTUNITIES; Vaini E, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab21b1; Silva LEV, 2017, J APPL PHYSIOL, V123, P344, DOI 10.1152/japplphysiol.00059.2017; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	52	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243869	10.1371/journal.pone.0243869	http://dx.doi.org/10.1371/journal.pone.0243869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301491	gold, Green Published			2022-12-26	WOS:000600143100045
J	Tangtammaruk, P; Petpiroon, P; Supakonatanasan, W; Teekhasaenee, C; Suwan, Y				Tangtammaruk, Phantaraporn; Petpiroon, Purit; Supakonatanasan, Wasu; Teekhasaenee, Chaiwat; Suwan, Yanin			Peripapillary perfused capillary density in true versus pseudoexfoliation syndrome: An OCTA study	PLOS ONE			English	Article							EXFOLIATION SYNDROME; GLAUCOMA; PREVALENCE; DISEASE	Purpose To compare peripapillary perfused capillary density (PCD) among eyes with true exfoliation syndrome (TEX), eyes with pseudoexfoliation syndrome (PEX), and healthy control eyes. Materials and methods In this observational cross-sectional study, eyes with and without TEX or PEX were assessed by optical coherence tomography angiography (OCTA) imaging. Bilateral OCTA images (4.5 x 4.5 mm(2)) centered at the optic nerve head were obtained using a commercial spectral domain OCTA system. Optic nerve head perfusion was quantified using the split-spectrum amplitude decorrelation angiography algorithm. Categorical and continuous variables were compared using the chi-squared test and one-way analysis of variance, respectively. The generalized estimating equation was used to adjust for confounding factors and determine inter-ocular associations. Results We enrolled 39 eyes with TEX, 31 eyes with PEX, and 32 control eyes. There were no significant differences among the three groups regarding age, intraocular pressure, cup-to-disc ratio, blood pressure, or axial length (all p>0.05). There were significant differences in global PCD among the three groups (p = 0.01). There were significant differences in annular PCD between the TEX and PEX groups (p = 0.027). Conclusions While both global and annular PCDs did not differ between the TEX and control groups, greater loss of annular PCD in the PEX group than in the TEX and control groups suggests more pronounced microvascular disturbance in PEX. Synopsis/Precis Greater microvascular attenuation in PEX compared with TEX and normal control measured by OCTA.	[Tangtammaruk, Phantaraporn; Petpiroon, Purit; Supakonatanasan, Wasu; Teekhasaenee, Chaiwat; Suwan, Yanin] Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok, Thailand	Mahidol University	Suwan, Y (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok, Thailand.	yanin.suwan@gmail.com		Tangtammaruk, Phantaraporn/0000-0001-7390-1545				Andrikopoulos GK, 2013, EYE LOND, V23, P442; ASANO N, 1995, OPHTHALMOLOGY, V102, P1279, DOI 10.1016/S0161-6420(95)30873-1; CASHWELL LF, 1989, OPHTHALMOLOGY, V96, P348, DOI 10.1016/S0161-6420(89)32885-5; Citirik M, 2007, EYE, V21, P11, DOI 10.1038/sj.eye.6702177; Djordjevic-Jocic J, 2012, CURR EYE RES, V37, P617, DOI 10.3109/02713683.2012.665120; Elschnig A, 1922, KLIN MONATSBL AUGENH, V69, P732; French DD, 2012, N AM J MED SCI, V4, P468, DOI 10.4103/1947-2714.101987; Geyman LS, 2017, BRIT J OPHTHALMOL, V101, P1261, DOI 10.1136/bjophthalmol-2016-309642; Harju M, 2008, CLIN EXP OPHTHALMOL, V36, P738, DOI 10.1111/j.1442-9071.2008.01884.x; Katsi Vasiliki, 2013, N Am J Med Sci, V5, P454, DOI 10.4103/1947-2714.117294; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Ozge G, 2016, POSTGRAD MED, V128, P444, DOI 10.1080/00325481.2016.1170579; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Philip S, 2019, INVEST OPHTH VIS SCI, V60, P1244, DOI 10.1167/iovs.18-25986; Praveen MR, 2011, EYE, V25, P174, DOI 10.1038/eye.2010.175; RINGVOLD A, 1970, VIRCHOWS ARCH A, V349, P1, DOI 10.1007/BF00548518; Ritch R, 1994, J Glaucoma, V3, P176; Ritch R, 2010, ACTA OPHTHALMOL, V88, P91, DOI 10.1111/j.1755-3768.2009.01578.x; Ritland JS, 2014, AM J OPHTHALMOL, V124, P685; Scripsema Nicole K, 2016, Invest Ophthalmol Vis Sci, V57, pOCT611, DOI 10.1167/iovs.15-18945; Sekeroglu MA, 2008, EUR J OPHTHALMOL, V18, P551, DOI 10.1177/112067210801800408; Suwan Y, 2018, ASIA-PAC J OPHTHALMO, V7, P84, DOI 10.22608/APO.2017318; Teekhasaenee C, 2016, OPHTHALMOLOGY, V123, P2328, DOI 10.1016/j.ophtha.2016.07.030; Theobold GD, 1954, AM J OPHTHALMOL, V37, P1; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092767; Yuksel N, 2007, OPHTHALMOLOGICA, V221, P299, DOI 10.1159/000104759	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0239109	10.1371/journal.pone.0239109	http://dx.doi.org/10.1371/journal.pone.0239109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301460	Green Published, Green Submitted, gold			2022-12-26	WOS:000600143100068
J	Davies, G; Jordan, S; Thayer, D; Tucker, D; Humphreys, I				Davies, Gareth; Jordan, Sue; Thayer, Daniel; Tucker, David; Humphreys, Ioan			Medicines prescribed for asthma, discontinuation and perinatal outcomes, including breastfeeding: A population cohort analysis	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; GROWTH RESTRICTION; MATERNAL ASTHMA; PREGNANCY; WOMEN; EPIDEMIOLOGY; PREVALENCE; EXPOSURE; IMPACT; RISK	Objectives To explore associations between exposures to medicines prescribed for asthma and their discontinuation in pregnancy and preterm birth [<37 or <32 weeks], SGA [<10th and <3rd centiles], and breastfeeding at 6-8 weeks. Methods Design. A population-based cohort study. Setting. The Secure Anonymised Information Linkage [SAIL] databank in Wales, linking maternal primary care data with infant outcomes. Population. 107,573, 105,331, and 38,725 infants born 2000-2010 with information on premature birth, SGA and breastfeeding respectively, after exclusions. Exposures. maternal prescriptions for asthma medicines or their discontinuation in pregnancy. Methods. Odds ratios for adverse pregnancy outcomes were calculated for the exposed versus the unexposed population, adjusted for smoking, parity, age and socio-economic status. Results Prescriptions for asthma, whether continued or discontinued during pregnancy, were associated with birth at<32 weeks' gestation, SGA <10th centile, and no breastfeeding (aOR 1.33 [1.10-1.61], 1.10 [1.03-1.18], 0.93 [0.87-1.01]). Discontinuation of asthma medicines in pregnancy was associated with birth at<37 weeks' and <32 weeks' gestation (aOR 1.22 [1.06-1.41], 1.53 [1.11-2.10]). All medicines examined, except ICS and SABA prescribed alone, were associated with SGA Conclusions Prescription of asthma medicines before or during pregnancy was associated with higher prevalence of adverse perinatal outcomes, particularly if prescriptions were discontinued during pregnancy. Women discontinuing medicines during pregnancy could be identified from prescription records. The impact of targeting close monitoring and breastfeeding support warrants exploration.	[Davies, Gareth; Jordan, Sue; Thayer, Daniel; Humphreys, Ioan] Swansea Univ, Fac Hlth & Life Sci, Swansea, W Glam, Wales; [Tucker, David] Publ Hlth Wales, Cardiff, Wales	Swansea University	Jordan, S (corresponding author), Swansea Univ, Fac Hlth & Life Sci, Swansea, W Glam, Wales.	s.e.jordan@swansea.ac.uk		jordan, sue/0000-0002-5691-2987; Thayer, Dan/0000-0003-1847-4362	European Union [HEALTH-F5-2011-260598]; UK Research and Innovation funding through an Administrative Data Research Centre grant (2018-2021) [ES/S007393/1]	European Union(European Commission); UK Research and Innovation funding through an Administrative Data Research Centre grant (2018-2021)	This paper was developed from the EUROmediCAT project, and uses the cohort identified in that project. The analyses presented here were completed outside the funded period. Financial support for the EUROmediCAT study was provided by the European Union under the 7th Framework Program [grant agreement HEALTH-F5-2011-260598]. Start date: 1 March 2011. Duration: 48 months. Coordinator: Prof. Helen Dolk, University of Ulster. Further information can be found at www.euromedicat.eu.The paper is based on data in the all-Wales SAIL databank, which is supported by UK Research and Innovation funding to Swansea University through an Administrative Data Research Centre grant (2018-2021), project reference: ES/S007393/1, Principal Investigator: Professor David Ford. The funder played no part in the study or production of the paper.	Ali Z, 2016, RESP MED, V120, P124, DOI 10.1016/j.rmed.2016.10.004; Aljazaf K, 2003, BRIT J CLIN PHARMACO, V56, P18, DOI 10.1046/j.1365-2125.2003.01822.x; [Anonymous], 2017, NHS WALES DATA DICT; [Anonymous], 2015, GUID ATC CLASS DDD A; [Anonymous], 2013, PER TERM BIRTH FACT; [Anonymous], 2008, LANCET, V372, P917; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Bain E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010660.pub2; Bakhireva LN, 2008, ANN ALLERG ASTHMA IM, V101, P137, DOI 10.1016/S1081-1206(10)60201-3; Belanger K, 2010, OBSTET GYNECOL, V115, P559, DOI 10.1097/AOG.0b013e3181d06945; BNF, 2019, BRIT NAT FORM 78; Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5; Broekema M, 2011, AM J RESP CRIT CARE, V183, P310, DOI 10.1164/rccm.201003-0494OC; Brozek JL, 2012, ARCH INTERN MED, V172, P1365, DOI 10.1001/archinternmed.2012.3250; BTS 2019, 2003, SIGN 158 BRIT GUID M; Burr ML, 2006, THORAX, V61, P296, DOI 10.1136/thx.2005.045682; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Chamberlain Chervonne, 2014, Open Nurs J, V8, P56, DOI 10.2174/1874434601408010056; Charlton RA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009237; Christiaens I, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0353-0; Clifton VL, 2009, AUST NZ J OBSTET GYN, V49, P619, DOI 10.1111/j.1479-828X.2009.01077.x; Cooper DL, 2013, J EPIDEMIOL COMMUN H, V67, P821, DOI 10.1136/jech-2012-202303; Corp IBM, REL 2011 IBM SPSS ST; Cossette B, 2014, ANN ALLERG ASTHMA IM, V112, P459, DOI 10.1016/j.anai.2014.02.010; Cossette B, 2013, THORAX, V68, P724, DOI 10.1136/thoraxjnl-2012-203122; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; Ellfolk M, 2015, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 3RD EDITION, P651; Eltonsy S, 2014, RESP MED, V108, P9, DOI 10.1016/j.rmed.2013.07.009; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; EUROCAT, 2013, EUROCAT EUR SURV CON; EUROmediCAT, 2015, EMC SEL SER REUPT IN; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gage S, 2015, J PEDIAT, V167, P875, DOI [10.1016/j.jpeds.2015.06.048, DOI 10.1016/J.JPEDS.2015.06.04826254835]; Garne E, 2016, BJOG-INT J OBSTET GY, V123, P1609, DOI 10.1111/1471-0528.14026; Global initiative for Asthma, 2020, GLOB STRAT ASTHM MAN; Gluck JC, 2006, IMMUNOL ALLERGY CLIN, V26, P63, DOI 10.1016/j.iac.2005.10.008; Gluck PA, 2005, CURR MED RES OPIN, V21, P1075, DOI 10.1185/030079905X50570; Greenland S, 2016, INT J EPIDEMIOL, V45, P565, DOI 10.1093/ije/dyw040; Grzeskowiak LE, 2016, EUR J OBSTET GYN R B, V197, P48, DOI 10.1016/j.ejogrb.2015.11.038; Hale T., 2010, MEDICATIONS MOTHERS; Harvey SM, 2020, PEDIATR PULM, V55, P1690, DOI 10.1002/ppul.24756; Heffler E, 2015, J ASTHMA, V52, P931, DOI 10.3109/02770903.2015.1026442; Herrera EA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00149; IFF Research, 2013, INFANT FEEDING SURVE, DOI 10.5255/UKDA-SN-7281-2; Jonathan ACSterne, 2019, COCHRANE; Jordan S., 2015, ARCH WOMEN MENT HLTH, V18, P269, DOI [10.1007/S00737-014-0488-6, DOI 10.1007/S00737-014-0488-6]; Jordan S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225133; Jordan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067912; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Kemppainen M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197593; Kwon HL, 2006, IMMUNOL ALLERGY CLIN, V26, P29, DOI 10.1016/j.iac.2005.11.002; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu XP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11881-8; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Malm H, 2003, EUR J CLIN PHARMACOL, V59, P127, DOI 10.1007/s00228-003-0584-4; Martins ACM, 2014, J CLIN PHARM THER, V39, P609, DOI 10.1111/jcpt.12204; McLaughlin K, 2018, WOMEN BIRTH, V31, pE349, DOI 10.1016/j.wombi.2018.01.008; Mehta N, 2015, BEST PRACT RES CL OB, V29, P598, DOI 10.1016/j.bpobgyn.2015.04.005; Milovanovic I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100337; Miquel-Verges F, 2015, J PERINATOL, V35, P198, DOI 10.1038/jp.2014.180; Mori K, 2016, RESP MED, V119, P1, DOI 10.1016/j.rmed.2016.08.007; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Murphy VE, 2014, BJOG, V121, P812; Namazy JA, 2013, EUR RESPIR J, V41, P1082, DOI 10.1183/09031936.00195111; Nunes V NJ, 2009, CLIN GUIDELINES EVID; Oldereid NB, 2018, HUM REPROD UPDATE, V24, P320, DOI 10.1093/humupd/dmy005; Olesen C, 1999, ACTA OBSTET GYN SCAN, V78, P686, DOI 10.1034/j.1600-0412.1999.780805.x; Ostgard HF, 2014, J PEDIAT, V165, P921, DOI [10.1016/j.jpeds.2014.07.045, DOI 10.1016/J.JPEDS.2014.07.04525217202]; Platt MJ, 2014, PUBLIC HEALTH, V128, P399, DOI 10.1016/j.puhe.2014.03.010; Price T., 2009, ASTHMA SWANSEA; Rejno G, 2017, J ALLERGY CLIN IMMUN, V6, P916; Rejno G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104755; Renfrew M, 2012, PREVENTING DIS SAVIN; Rey E, 2007, BMJ-BRIT MED J, V334, P582, DOI 10.1136/bmj.39112.717674.BE; Robijn AL, 2019, CLIN EXP ALLERGY, V49, P1403, DOI 10.1111/cea.13474; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Royal College of Paediatrics and Child Health, 2015, EARL YEARS UK WHO GR; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Saha MR, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0053-6; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schatz M, 2006, AM J OBSTET GYNECOL, V194, P120, DOI 10.1016/j.ajog.2005.06.028; Schnitzer ME, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.426; Schulz KF, 2006, LANCET HDB ESSENTIAL; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Sillesen M, 2011, EUR J CARDIO-THORAC, V40, P448, DOI 10.1016/j.ejcts.2010.12.011; Stats Wales, 2019, BREASTF Q COUNTS AG; The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), EMA950982010 ENCEPP; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; Townsend PP., 1988, HLTH DEPRIVATION INE; Turkeltaub PC, 2017, J ALLER CL IMM-PRACT, V5, P1679, DOI 10.1016/j.jaip.2017.03.036; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Wales Statistics, 2013, BIRTH STAT NAT COMM; Wareing M, 2014, MICROCIRCULATION, V21, P58, DOI 10.1111/micc.12069; York R, 2012, SOC SCI RES, V41, P1379, DOI 10.1016/j.ssresearch.2012.05.014; Zetstra van der Woude AP., 2016, THESIS, P145	101	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242489	10.1371/journal.pone.0242489	http://dx.doi.org/10.1371/journal.pone.0242489			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296383	gold, Green Published			2022-12-26	WOS:000598626100067
J	Ahmed, S; Kim, BC; Lee, KH; Jung, HY				Ahmed, Samsuddin; Kim, Byeong C.; Lee, Kun Ho; Jung, Ho Yub		Alzheimer's Dis Neuroimaging Initi	Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging	PLOS ONE			English	Article							DEEP; DIAGNOSIS; CORTEX; CLASSIFICATION; HIPPOCAMPUS; PARIETAL; ATROPHY	Patches from three orthogonal views of selected cerebral regions can be utilized to learn convolutional neural network (CNN) models for staging the Alzheimer disease (AD) spectrum including preclinical AD, mild cognitive impairment due to AD, and dementia due to AD and normal controls. Hippocampi, amygdalae and insulae were selected from the volumetric analysis of structured magnetic resonance images (MRIs). Three-view patches (TVPs) from these regions were fed to the CNN for training. MRIs were classified with the SoftMax-normalized scores of individual model predictions on TVPs. The significance of each region of interest (ROI) for staging the AD spectrum was evaluated and reported. The results of the ensemble classifier are compared with state-of-the-art methods using the same evaluation metrics. Patch-based ROI ensembles provide comparable diagnostic performance for AD staging. In this work, TVP-based ROI analysis using a CNN provides informative landmarks in cerebral MRIs and may have significance in clinical studies and computer-aided diagnosis system design.	[Ahmed, Samsuddin; Jung, Ho Yub] Chosun Univ, Dept Comp Engn, Gwangju, South Korea; [Kim, Byeong C.; Lee, Kun Ho] Chosun Univ, Gwangju Alzheimers Dis & Related Dementias Cohort, Gwangju, South Korea; [Lee, Kun Ho] Chosun Univ, Dept Biomed Sci, Gwangju, South Korea; [Kim, Byeong C.] Chonnam Natl Univ, Med Sch, Dept Neurol, Gwangju, South Korea; [Lee, Kun Ho] Korea Brain Res Inst, Daegu, South Korea	Chosun University; Chosun University; Chosun University; Chonnam National University; Korea Brain Research Institute (KBRI)	Jung, HY (corresponding author), Chosun Univ, Dept Comp Engn, Gwangju, South Korea.	hoyub@chosun.ac.kr	Ahmed, Samsuddin/S-6912-2019	Ahmed, Samsuddin/0000-0002-1267-0533; Jung, Ho Yub/0000-0002-2906-9170	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2019R1A4A1029769]; Chosun University	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Chosun University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2019R1A4A1029769). This study was supported by research fund from Chosun University, 2020.	Aderghal K, 2017, PROCEEDINGS OF THE 2017 ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA RETRIEVAL (ICMR'17), P494, DOI 10.1145/3078971.3079010; Ahmed S, 2019, IEEE ACCESS, V7, P73373, DOI 10.1109/ACCESS.2019.2920011; [Anonymous], 2020, ALZHEIMERS DEMENT, V16, P391, DOI 10.1002/alz.12068; [Anonymous], 2019, TR2195 3GPP; [Anonymous], 2016, CANC DISCOV; Barthel H, 2011, LANCET NEUROL, V10, P424, DOI 10.1016/S1474-4422(11)70077-1; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Chicco D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6413-7; Chincarini A, 2011, NEUROIMAGE, V58, P469, DOI 10.1016/j.neuroimage.2011.05.083; Chitradevi D, 2020, APPL SOFT COMPUT, V86, DOI 10.1016/j.asoc.2019.105857; Choi KY, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081236; DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5; Ebrahimighahnavieh MA, 2020, COMPUT METH PROG BIO, V187, DOI 10.1016/j.cmpb.2019.105242; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Foundas AL, 1997, NEUROPSY NEUROPSY BE, V10, P81; Foundas AL, 1996, PROG NEURO-PSYCHOPH, V20, P1131, DOI 10.1016/S0278-5846(96)00101-7; Franko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071354; Gao SH, 2016, IEEE T CIRC SYST VID, V26, P1646, DOI 10.1109/TCSVT.2015.2469571; Gessert N, 2019, CORR; Gessert N, 2020, IEEE T BIO-MED ENG, V67, P495, DOI 10.1109/TBME.2019.2915839; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Goceri E, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3225; Hampel Harald, 2009, Dialogues Clin Neurosci, V11, P141; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hett K, 2016, LECT NOTES COMPUT SC, V9993, P76, DOI 10.1007/978-3-319-47118-1_10; Hosseini-Asl E, 2016, IEEE IMAGE PROC, P126, DOI 10.1109/ICIP.2016.7532332; Kingma DP., 2014, ADAM METHOD STOCHAST; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Korolev S, 2017, I S BIOMED IMAGING, P835, DOI 10.1109/ISBI.2017.7950647; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li F, 2015, IEEE J BIOMED HEALTH, V19, P1610, DOI 10.1109/JBHI.2015.2429556; Li HM, 2019, ALZHEIMERS DEMENT, V15, P1059, DOI 10.1016/j.jalz.2019.02.007; Lian CF, 2020, IEEE T PATTERN ANAL, V42, P880, DOI 10.1109/TPAMI.2018.2889096; Liu MX, 2018, MED IMAGE ANAL, V43, P157, DOI 10.1016/j.media.2017.10.005; Liu SQ, 2015, IEEE T BIO-MED ENG, V62, P1132, DOI 10.1109/TBME.2014.2372011; Long XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173372; Marzban EN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230409; Duc NT, 2020, NEUROINFORMATICS, V18, P71, DOI 10.1007/s12021-019-09419-w; Oh K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54548-6; Ortiz A, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500258; Ozsahin I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226577; Payan A., 2015, ARXIV150202506; Poudel P, 2019, IEEE ENG MED BIO, P5828, DOI 10.1109/EMBC.2019.8857929; Prochazka A, 2019, COMPUT MED IMAG GRAP, V71, P9, DOI 10.1016/j.compmedimag.2018.10.001; Punjabi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225759; Qureshi MNI, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00008; Reiss PT, 2010, BIOMETRICS, V66, P636, DOI 10.1111/j.1541-0420.2009.01300.x; Reuter M, FREESURFER; Roy K, 2019, COMPUT MED IMAG GRAP, V71, P90, DOI 10.1016/j.compmedimag.2018.11.003; Salvatore C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00307; Seeley WW, 2010, BRAIN STRUCT FUNCT, V214, P465, DOI 10.1007/s00429-010-0263-z; Shi J, 2018, IEEE J BIOMED HEALTH, V22, P173, DOI 10.1109/JBHI.2017.2655720; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Suk HI, 2017, MED IMAGE ANAL, V37, P101, DOI 10.1016/j.media.2017.01.008; Suk HI, 2015, BRAIN STRUCT FUNCT, V220, P841, DOI 10.1007/s00429-013-0687-3; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Wang SH, 2018, J MED SYST, V42, DOI 10.1007/s10916-017-0845-x; Xu B., 2015, ARXIV150500853, V1505, P853; Yaakub SN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57951-6; Yu, 2014, FOND T SIGN PROC, V7, P197, DOI [10.1561/2000000039, DOI 10.1561/2000000039]; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhang J, 2017, IEEE J BIOMED HEALTH, V21, P1607, DOI 10.1109/JBHI.2017.2704614	65	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0242712	10.1371/journal.pone.0242712	http://dx.doi.org/10.1371/journal.pone.0242712			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290403	gold, Green Published			2022-12-26	WOS:000598620100005
J	Kennedy, AP; Yam, SCP				Kennedy, Adrian Patrick; Yam, Sheung Chi Phillip			On the authenticity of COVID-19 case figures	PLOS ONE			English	Article							BENFORDS LAW; ZIPFS LAW; CITIES; DIGIT; SYSTEM	In this article, we study the applicability of Benford's law and Zipf's law to national COVID-19 case figures with the aim of establishing guidelines upon which methods of fraud detection in epidemiology, based on formal statistical analysis, can be developed. Moreover, these approaches may also be used in evaluating the performance of public health surveillance systems. We provide theoretical arguments for why the empirical laws should hold in the early stages of an epidemic, along with preliminary empirical evidence in support of these claims. Based on data published by the World Health Organization and various national governments, we find empirical evidence that suggests that both Benford's law and Zipf's law largely hold across countries, and deviations can be readily explained. To the best of our knowledge, this paper is among the first to present a practical application of Zipf's law to fraud detection.	[Kennedy, Adrian Patrick; Yam, Sheung Chi Phillip] Chinese Univ Hong Kong, Dept Stat, Hong Kong, Peoples R China	Chinese University of Hong Kong	Yam, SCP (corresponding author), Chinese Univ Hong Kong, Dept Stat, Hong Kong, Peoples R China.	scpyam@sta.cuhk.edu.hk		Kennedy, Adrian/0000-0002-9986-2756	Hong Kong University Grant Council; CUHK [HKGRF-14300717, HKGRF-14300319, 4053141]	Hong Kong University Grant Council; CUHK(Chinese University of Hong Kong)	APK acknowledges the Hong Kong University Grant Council for their support of him pursuing his PhD at the Chinese University of Hong Kong, and that this work will constitute part of his dissertation. SCPY acknowledges financial support from HKGRF-14300717 with the project title "New kinds of Forward-backward Stochastic Systems with Applications", HKGRF-14300319 with the project title "Shape-constrained Inference: Testing for Monotonicity", and Direct Grant for Research 2014/15 (Project No. 4053141) offeredby CUHK. No additional funding was received for this study.	Allen L.J.S., 2008, MATH EPIDEMIOLOGY; [Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, CANADA COVID 19 CASE; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Berger A., 2015, INTRO BENFORDS LAW; Berger A, 2011, PROBAB SURV, V8, P1, DOI 10.1214/11-PS175; Bolton RJ, 2002, STAT SCI, V17, P235; BOYLE J, 1994, AM MATH MON, V101, P879, DOI 10.2307/2975136; Cerioli A, 2019, P NATL ACAD SCI USA, V116, P106, DOI 10.1073/pnas.1806617115; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cristelli M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00812; Daniel W. W., 1990, APPL NONPARAMETRIC S, V2nd; Deckert J, 2011, POLIT ANAL, V19, P245, DOI 10.1093/pan/mpr014; Deleanu IS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169632; Devereux C, 2020, BLOOMBERG; Diekmann A, 2007, J APPL STAT, V34, P321, DOI 10.1080/02664760601004940; Diwanji S, 2020, CORONAVIRUS CASES IN; Durtschi C., 2004, J FORENSIC ACCOUNT, V5, P17; Elflein J, 2020, US COVID 19 CASES ST; Forte F, 2020, SPAIN CORONAVIRUS CA; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; Golbeck J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135169; Gomez-Camponovo M, 2016, BIOMEDICA, V36, P583, DOI 10.7705/biomedica.v36i4.2731; HILL BM, 1975, ANN STAT, V3, P1163, DOI 10.1214/aos/1176343247; HILL TP, 1995, AM MATH MON, V102, P322, DOI 10.2307/2974952; Idrovo AJ, 2011, EPIDEMIOL INFECT, V139, P1827, DOI 10.1017/S095026881100015X; Idrovo AJ, 2020, ASIA-PAC J PUBLIC HE, V32, P165, DOI 10.1177/1010539520927265; Jiang B, 2015, INT J GEOGR INF SCI, V29, P498, DOI 10.1080/13658816.2014.988715; Klimek P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204975; Koptyug E., 2020, CORONAVIRUS COVID 19; Krugman P, 1996, J JPN INT ECON, V10, P399, DOI 10.1006/jjie.1996.0023; Krugman P. R., 1998, SELF ORG EC; Manrique-Hernandez EF, 2017, PUBLIC HEALTH, V143, P14, DOI 10.1016/j.puhe.2016.10.023; Montanez A, 2020, MEXICO COVID 19 CASE; Montanez A, 2020, BRAZIL COVID 19 CASE; Moreno-Montoya J, 2020, SALUD UIS, V52, P161; Moreno-Sanchez I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147073; Moura NJ, 2006, PHYSICA A, V367, P441, DOI 10.1016/j.physa.2005.11.038; Muller J, 2020, MALAYSIA COVID 19 CA; Nigrini M.J., 2012, BENFORDS LAW APPL FO; Norrestad F, 2020, SWEDEN CORONAVIRUS C; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; ROSEN KT, 1980, J URBAN ECON, V8, P165, DOI 10.1016/0094-1190(80)90043-1; SETHI SP, 1978, J OPER RES SOC, V29, P265, DOI 10.1057/jors.1978.55; Slepkov AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117972; Statistica Research Department, 2020, RUSS COR STAT; Statistica Research Department, 2020, ROM CONF COVID 19 CA; Statistica Research Department, 2020, IT COR CAS REG; Stewart C, 2020, UK REGIONAL CORONAVI; Thomala L, 2020, GREATER CHINA CORONA; Wang J, 2020, FUTURE INTERNET, V12, DOI 10.3390/fi12020026; Whoriskey P., 2020, WASHINGTON POST; World Health Organization, 2020, COR COVID 19 CAS DEA COR COVID 19 CAS DEA; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243123	10.1371/journal.pone.0243123	http://dx.doi.org/10.1371/journal.pone.0243123			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8OF	33290420	Green Published, gold			2022-12-26	WOS:000598620100012
J	Reiss, S; Franchina, V; Jutzi, C; Willardt, R; Jonas, E				Reiss, Stefan; Franchina, Vittoria; Jutzi, Chiara; Willardt, Robin; Jonas, Eva			From anxiety to action-Experience of threat, emotional states, reactance, and action preferences in the early days of COVID-19 self-isolation in Germany and Austria	PLOS ONE			English	Article							SYSTEM-JUSTIFICATION; SHORT VERSION; SCALE; UNCERTAINTY; LONELINESS; DEFENSE; SENSE	The COVID-19 pandemic has interrupted everyday life virtually everywhere in the world, enabling real-life research on threat-and-defense processes. In a survey conducted within the first days of implementing social distancing measures in Austria and Germany, we aimed to explore the pathways from threat perception to preferences of defense strategies. We found that anxiety, approach-related affect, and reactance were specifically elicited by motivational (vs. epistemic) discrepancies. In a second step, we tested the mediating effect of anxiety, approach-related affect, and reactance on preferences regarding personal-social and concrete-abstract defenses. Experiencing anxiety was related to interest in security-related actions, and approach-affect was related to both personal projects and social media use. Participants experiencing reactance were more inclined to pursue personal projects (personal-abstract) and less interested in security-related (personal-concrete) actions. They also showed marginally lower system justification (social-abstract). Additionally, we examined the relationship of loneliness with defense strategies, showing that loneliness was associated with lower system justification and security behaviors. The results suggest that individuals deal with threat in their own ways, mostly depending on affective state and motivational orientation: Anxiety was related to security, approach-state to action (both social and personal), reactance to derogation of the system and disregard for security, while loneliness was associated with inaction.	[Reiss, Stefan; Franchina, Vittoria; Jutzi, Chiara; Jonas, Eva] Univ Salzburg, Dept Psychol, Salzburg, Austria; [Willardt, Robin] Swiss Fed Inst Technol, Dept Psychol, Zurich, Switzerland	Salzburg University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Reiss, S (corresponding author), Univ Salzburg, Dept Psychol, Salzburg, Austria.	stefan.reiss@sbg.ac.at	Reiss, Stefan/AAA-6155-2021; cohort, Doctoral College Imaging the Mind - third/AAL-4936-2020; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018	Reiss, Stefan/0000-0001-8188-6664; 	Austrian Science Fund [FWF-P27457]; Doctoral College "Imaging the Mind" of the Austrian Science Fund [FWF-W1233-B]	Austrian Science Fund(Austrian Science Fund (FWF)); Doctoral College "Imaging the Mind" of the Austrian Science Fund	Our research was funded by the Austrian Science Fund (FWF-P27457; https://www.fwf.ac.at/en/).CJ and VF were supported by the Doctoral College "Imaging the Mind" of the Austrian Science Fund (FWF-W1233-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agroskin D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01583; ARD, 2020, DEUTSCHLANDTREND; Banerjee D, 2020, INT J SOC PSYCHIATR, V66, P525, DOI 10.1177/0020764020922269; Bieber F, 2022, NATL PAP, V50, P13, DOI 10.1017/nps.2020.35; Bol D, 2021, EUR J POLIT RES, V60, P497, DOI 10.1111/1475-6765.12401; Brehm SS, 1980, PSYCHOL REACTANCE TH; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Celik V, 2014, EURASIA J MATH SCI T, V10, P581; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Clark LE, 1994, PANAS X MANUAL POSIT, P1, DOI 10.17077/48vt-m4t2; Corr PJ, 2016, PERS INDIV DIFFER, V89, P60, DOI 10.1016/j.paid.2015.09.045; Carvalho PMD, 2020, PSYCHIAT RES, V286, DOI 10.1016/j.psychres.2020.112902; DeFranza D, 2021, AM PSYCHOL, V76, P744, DOI 10.1037/amp0000717; DiTommaso E, 2004, EDUC PSYCHOL MEAS, V64, P99, DOI 10.1177/0013164403258450; Foulk TA, 2020, PERS PSYCHOL, V73, P363, DOI 10.1111/peps.12358; Gray J. A., 1982, NEUROPSYCHOLOGY ANXI, DOI [10.1017/S0140525X00013066, DOI 10.1017/S0140525X00013066]; Greenaway KH, 2015, J EXP SOC PSYCHOL, V56, P235, DOI 10.1016/j.jesp.2014.10.009; Hennes EP, 2012, SOC COGNITION, V30, P669, DOI 10.1521/soco.2012.30.6.669; HONG SM, 1989, PSYCHOL REP, V64, P1323, DOI 10.2466/pr0.1989.64.3c.1323; Jonas E, 2014, ADV EXP SOC PSYCHOL, V49, P219, DOI 10.1016/B978-0-12-800052-6.00004-4; Jonas E, 2009, J EXP SOC PSYCHOL, V45, P1068, DOI 10.1016/j.jesp.2009.06.005; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Jutzi CA, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.578586; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Killgore WDS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113117; Knight CG, 2014, J EXP SOC PSYCHOL, V54, P139, DOI 10.1016/j.jesp.2014.04.012; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; Landau MJ, 2015, PSYCHOL BULL, V141, P694, DOI 10.1037/a0038703; Luchetti M, 2020, AM PSYCHOL, V75, P897, DOI 10.1037/amp0000690; McGregor I, 2007, PERS SOC PSYCHOL B, V33, P1587, DOI 10.1177/0146167207306280; McGregor I, 2010, J PERS SOC PSYCHOL, V99, P133, DOI 10.1037/a0019701; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Moss SA, 2019, J SOC CLIN PSYCHOL, V38, P301, DOI 10.1521/jscp.2019.38.4.301; Nilsson MH, 2015, ACTA NEUROL SCAND, V132, P89, DOI 10.1111/ane.12368; Proulx T, 2012, PSYCHOL INQ, V23, P317, DOI 10.1080/1047840X.2012.702372; Pyszczynski T, 2021, J HUMANIST PSYCHOL, V61, P173, DOI 10.1177/0022167820959488; Reiss S, 2020, EXPLORING LAND UNPUB; Reiss S, 2019, GIO-GRUP-INTERAKT-OR, V50, P145, DOI 10.1007/s11612-019-00469-x; Sittenthaler S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00632; Soveri A, 2020, UNWILLINGNESS ENGAGE, DOI [10.31234/osf.io/mhc, DOI 10.31234/OSF.IO/MHC]; Statistisches Bundesamt, 2020, KORREKTUR COR KRIS E; Tabri N., 2020, FRAMING COVID 19 EXI, DOI [10.31234/osf.io/mpbtr, DOI 10.31234/OSF.IO/MPBTR]; Taylor S, 2020, J AFFECT DISORDERS, V277, P94, DOI 10.1016/j.jad.2020.08.002; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Weiss R. S, 1973, LONELINESS EXPERIENC	47	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243193	10.1371/journal.pone.0243193	http://dx.doi.org/10.1371/journal.pone.0243193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8OF	33290398	Green Published, gold			2022-12-26	WOS:000598620100028
J	Llabres, M; Valiente, G				Llabres, Merce; Valiente, Gabriel			Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2	PLOS ONE			English	Article							SEQUENCE	Motivation Beside socio-economic issues, coronavirus pandemic COVID-19, the infectious disease caused by the newly discovered coronavirus SARS-CoV-2, has caused a deep impact in the scientific community, that has considerably increased its effort to discover the infection strategies of the new virus. Among the extensive and crucial research that has been carried out in the last months, the analysis of the virus-host relationship plays an important role in drug discovery. Virus-host protein-protein interactions are the active agents in virus replication, and the analysis of virus-host protein-protein interaction networks is fundamental to the study of the virus-host relationship. Results We have adapted and implemented a recent integer linear programming model for protein-protein interaction network alignment to virus-host networks, and obtained a consensus alignment of the SARS-CoV-1 and SARS-CoV-2 virus-host protein-protein interaction networks. Despite the lack of shared human proteins in these virus-host networks, and the low number of preserved virus-host interactions, the consensus alignment revealed aligned human proteins that share a function related to viral infection, as well as human proteins of high functional similarity that interact with SARS-CoV-1 and SARS-CoV-2 proteins, whose alignment would preserve these virus-host interactions.	[Llabres, Merce] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain; [Valiente, Gabriel] Tech Univ Catalonia, Algorithms Bioinformat Complex & Formal Methods R, Barcelona, Spain	Universitat de les Illes Balears; Universitat Politecnica de Catalunya	Valiente, G (corresponding author), Tech Univ Catalonia, Algorithms Bioinformat Complex & Formal Methods R, Barcelona, Spain.	gabriel.valiente@upc.edu	Llabrés, Mercè/R-1954-2019; Valiente, Gabriel/AAH-4424-2021; Llabrés Segura, Maria de la Mercè/K-8725-2014; Valiente, Gabriel/K-4265-2014	Llabrés, Mercè/0000-0002-5358-6768; Llabrés Segura, Maria de la Mercè/0000-0002-5358-6768; Valiente, Gabriel/0000-0001-9194-2703	Spanish Ministry of Science, Innovation and Universities [PGC2018-096956-B-C43]; European Regional Development Fund [PGC2018-096956-B-C43]	Spanish Ministry of Science, Innovation and Universities; European Regional Development Fund(European Commission)	This work has been supported by the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund through project PGC2018-096956-B-C43 (FEDER/MICINN/AEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala A, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3502-1; [Anonymous], 2014, J ORTHOP RES S1, V32, pS158; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Fourer R., 2002, AMPL MODELING LANGUA; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Guirimand T, 2015, NUCLEIC ACIDS RES, V43, pD583, DOI 10.1093/nar/gku1121; Hashemifar S, 2014, BIOINFORMATICS, V30, pI438, DOI 10.1093/bioinformatics/btu450; Li Zhenping, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5527; Llabres M, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03733-w; Malod-Dognin N, 2015, BIOINFORMATICS, V31, P2182, DOI 10.1093/bioinformatics/btv130; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pan A, 2016, BRIEF BIOINFORM, V17, P517, DOI 10.1093/bib/bbv059; Phan HTT, 2012, BIOINFORMATICS, V28, P1239, DOI 10.1093/bioinformatics/bts119; Pomaznoy M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2533-3; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Zhao CG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33219-y	20	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0236304	10.1371/journal.pone.0236304	http://dx.doi.org/10.1371/journal.pone.0236304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284827	Green Published, gold, Green Submitted			2022-12-26	WOS:000597930500028
J	Carter, KJ; Castro, F; Morcos, RN				Carter, Kimbroe J.; Castro, Frank; Morcos, Roy N.			A method for evaluating breast cancer screening strategies using screen-preventable loss of life	PLOS ONE			English	Article							MAMMOGRAPHY; BENEFITS; UPDATE; OVERDIAGNOSIS; TRIAL; WOMEN; MODEL	The objective of this study is to describe how screen-preventable loss of life (screen-PLL) can be used to analyze the distribution of life savings with mammographic screening. The determination of screen-PLL with mammography is possible using a natural history model of breast cancer that simulates clinical and pathologic events of this disease. This investigation uses a Monte Carlo Markov model with data from the Surveillance, Epidemiology, and End Results Program; American Cancer Society; and National Vital Statistics System. Populations of one million women per screening strategy are simulated over a lifetime with mammographic screening based on current guidelines of the American Cancer Society (ACS), United States Preventive Services Task Force (USPSTF), triennial screening from age 50-70, and no screening. Screen-PLL curves are generated and show guideline performance over a lifetime. The screen-PLL curve with no screening is determined by tumor discovery through clinical awareness and has the highest values of screen-PLL. The ACS and USPSTF strategies demonstrate screen-PLL curves favoring the elderly. The curve for triennial screening is more uniform than the ACS or USPSTF curves but could be improved by adding screen(s) at either end of the 50-70 age range. This study introduces the use of screen-PLL as a tool to improve the understanding of screening guidelines and allowing a more balanced allocation of life savings across an aging population. The method presented shows how screen-PLL can be used to analyze and potentially improve breast cancer screening guidelines.	[Carter, Kimbroe J.] Northeast Ohio Med Univ, Dept Pathol, Rootstown, OH 44272 USA; [Carter, Kimbroe J.] Kent State Univ, Sch Technol, Trumbull Campus, Warren, OH 44483 USA; [Carter, Kimbroe J.; Castro, Frank] St Elizabeth Youngstown Hosp, Med Decis Making Soc Youngstown Ohio, Youngstown, OH 44504 USA; [Morcos, Roy N.] Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH USA; [Morcos, Roy N.] St Elizabeth Boardman Family Med Residency Progra, Youngstown, OH USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Trumbull; Northeast Ohio Medical University (NEOMED)	Carter, KJ (corresponding author), Northeast Ohio Med Univ, Dept Pathol, Rootstown, OH 44272 USA.; Carter, KJ (corresponding author), Kent State Univ, Sch Technol, Trumbull Campus, Warren, OH 44483 USA.; Carter, KJ (corresponding author), St Elizabeth Youngstown Hosp, Med Decis Making Soc Youngstown Ohio, Youngstown, OH 44504 USA.	mdmyo2@hotmail.com		Carter, Kimbroe/0000-0003-0079-2223	Mercy Health Youngstown, LLC Medical Research Committee [M2018-3]; Mercy Health Foundation Mahoning Valley	Mercy Health Youngstown, LLC Medical Research Committee; Mercy Health Foundation Mahoning Valley	Author KJC, Grant M2018-3 Mercy Health Youngstown, LLC Medical Research Committee. Author KJC, Mercy Health Foundation Mahoning Valley, https://foundation.mercy.com/youngstown.aspx, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; [Anonymous], 1986, SOC ECON STUD, V35, P1; Arias Elizabeth, 2017, Natl Vital Stat Rep, V66, P1; Bleyer A, 2016, ACAD RADIOL, V23, P119, DOI 10.1016/j.acra.2015.10.002; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Carter KJ, 2018, AM J ROENTGENOL, V210, P564, DOI 10.2214/AJR.17.18484; Dickinson J, 2011, CAN MED ASSOC J, V183, P1991, DOI 10.1503/cmaj.110334; Donegan WL, 2009, CANC BREAST, P342; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Edge SB, 2010, AJCC CANC STAGING MA; Howlader NNA, 2020, SEER CANC STAT REV; JORGENSEN KJ, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B2587; KARSSEMEIJER N, 1993, INVEST RADIOL, V28, P413, DOI 10.1097/00004424-199305000-00005; Kopans DB, 2016, ACAD RADIOL, V23, P116, DOI 10.1016/j.acra.2015.08.035; KOSCIELNY S, 1984, BRIT J CANCER, V49, P709, DOI 10.1038/bjc.1984.112; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Morabia A, 2004, POSTGRAD MED J, V80, P463, DOI 10.1136/pgmj.2003.018226; National Health Service, 2017, NHS BREAST SCREEN HE; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; NORTON L, 1988, CANCER RES, V48, P7067; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Renard F, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-34; Schiffman Joshua D, 2015, Am Soc Clin Oncol Educ Book, P57, DOI 10.14694/EdBook_AM.2015.35.57; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Skaane P, 2009, ACTA RADIOL, V50, P3, DOI 10.1080/02841850802563269; Society AC, 2017, BREAST CANC FACTS FI; US Cancer Statistics Working Group, 2013, US CANC STAT 1999 20; Waluchow Wil, 2015, Probl. anu. filos. teor. derecho, P23; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243113	10.1371/journal.pone.0243113	http://dx.doi.org/10.1371/journal.pone.0243113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275605	gold, Green Published			2022-12-26	WOS:000597150200023
J	Tesfaw, A; Alebachew, W; Tiruneh, M				Tesfaw, Aragaw; Alebachew, Wubet; Tiruneh, Mulu			Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study	PLOS ONE			English	Article							DIAGNOSIS; STAGE; SURVIVAL	Background Although early diagnosis is a key determinant factor for breast cancer survival, delay in presentation and advanced stage diagnosis are common challenges in low and middle income countries including Ethiopia. Long patient delays in presentation to health facility and advanced stage diagnosis are common features in breast cancer care in Ethiopia but the reasons for patient delays are not well explored in the country. Therefore we aimed to explore the reasons for patient delay in seeking early medical care for breast cancer in North-west Ethiopia. Methods A qualitative study was conducted from November to December 2019 using in-depth interviews from newly diagnosed breast cancer patients in the two comprehensive specialized hospitals in North West Ethiopia. Verbal informed consent was taken from each participant before interviews. A thematic content analysis was performed using Open Code software version 4.02. Results Lack of knowledge and awareness about breast cancer, cultural and religious beliefs, economic hardships, lack of health care and transportation access, fear of surgical procedures and lack of trusts on medical care were the major reasons for late presentation of breast cancer identified from the patient's narratives. Conclusions The reasons for late presentation of patients to seek early medical care for breast cancer had multidimensional nature in Northwest Ethiopia. Health education and promotion programs about breast cancer should be designed to increase public awareness to facilitate early detection of cases before advancement on the existing health care delivery system.	[Tesfaw, Aragaw; Tiruneh, Mulu] Debre Tabor Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Tabor, Ethiopia; [Alebachew, Wubet] Debre Tabor Univ, Coll Hlth Sci, Dept Nursing, Debre Tabor, Ethiopia		Tesfaw, A (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Tabor, Ethiopia.	aragetesfa05@gmail.com	Bayih, Wubet Alebachew/AAF-5099-2019; Tiruneh, Mulu/AGE-3852-2022	Bayih, Wubet Alebachew/0000-0003-1439-4402; Tiruneh, Mulu/0000-0001-6312-4244				Abeje S, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-018-0695-9; Agide FD, 2019, AFR HEALTH SCI, V19, P3009, DOI 10.4314/ahs.v19i4.22; Akuoko CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171024; American Cancer Society, 2019, BREAST CANC FACTS FI; [Anonymous], 2015, CONCURR COMPUT PRACT, V27, pi; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chaka B, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5958-8; Dagne AH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221356; Deressa BT, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5612-6; Dibisa TM, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.144.18062; Donkor A., 2015, ARCH MED, V8, P2; Dye TD, 2011, GLOB PUBLIC HEALTH, V6, P719, DOI 10.1080/17441692.2010.510479; Ermiah Eramah, 2012, BMC Res Notes, V5, P452, DOI 10.1186/1756-0500-5-452; Espina C, 2017, ANN EPIDEMIOL, V27, P659, DOI 10.1016/j.annepidem.2017.09.007; Ferlay J, 2013, GLOBOCAN 2012 V 10 C; FMOH Federal Ministry of Health Ethiopia, 2015, NAT CANC CONTR PLAN; Gakunga R, 2019, ONCOLOGIST, V24, P1549, DOI 10.1634/theoncologist.2019-0257; Gebremariam A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032228; Gebremariam A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220769; Getachew S, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00909-7; Hiom SC, 2015, BRIT J CANCER, V112, pS1, DOI 10.1038/bjc.2015.23; Howlader N, 2015, SEER CANC STAT REV 1; Jassem J, 2014, EUR J PUBLIC HEALTH, V24, P761, DOI 10.1093/eurpub/ckt131; Jedy-Agba E, 2017, CANCER CAUSE CONTROL, V28, P685, DOI 10.1007/s10552-017-0894-y; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Mousa SM, 2011, BREAST, V20, P555, DOI 10.1016/j.breast.2011.07.001; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Sibhat SG, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1239-1; Stapleton JM, 2011, PSYCHO-ONCOLOGY, V20, P532, DOI 10.1002/pon.1767; Tesfaw A, 2021, CLIN BREAST CANCER, V21, pE112, DOI 10.1016/j.clbc.2020.08.011; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; Trotter RT, 2012, PREV MED, V55, P398, DOI 10.1016/j.ypmed.2012.07.003; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Walters S, 2013, BRIT J CANCER, V108, P1195, DOI 10.1038/bjc.2013.6; Weiner CM, 2018, BREAST, V42, P23, DOI 10.1016/j.breast.2018.08.095; World Health Organization, 2015, CANC A GROW PUBL HLT; Yip HC, 2008, CANCER, V113, P2244, DOI [10.1002/cncr.23842, DOI 10.1002/CNCR.23842]	40	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243551	10.1371/journal.pone.0243551	http://dx.doi.org/10.1371/journal.pone.0243551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275642	Green Published, gold			2022-12-26	WOS:000597150200034
J	Yang, X; Xiong, ZZ; Li, ZX; Li, X; Xiang, WY; Yuan, YW; Li, Z				Yang, Xiao; Xiong, Zhenzhen; Li, Zhixiong; Li, Xiao; Xiang, Weiyi; Yuan, Yiwen; Li, Zhe			Perceived psychological stress and associated factors in the early stages of the coronavirus disease 2019 (COVID-19) epidemic: Evidence from the general Chinese population	PLOS ONE			English	Article							SOCIAL SUPPORT; MENTAL-HEALTH; SUICIDE RISK; OUTBREAK; SYMPTOMS; DISORDER; MIDLIFE; IMPACT; LIFE; SARS	Introduction Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by novel coronavirus 2019. Many individuals suffered psychological symptoms in the early stage when the epidemic was uncertain. We explored the perceived psychological stress and associated factors in the early stage of COVID-19 epidemic. Method The Perceived Stress Scale, Simplified Coping Style Questionnaire, Social Support Rating Scale and a general information questionnaire were integrated in an on-line survey conducted from February 1, 2020 until February 4, 2020. Multiple linear regression analysis was performed to explore whether coping style, social support or other factors contributed to psychological stress. Results A total of 1638 participants were included, of whom 44.3% showed moderate psychological stress. Individuals who were younger, female, unmarried, spent more time on the disease, felt more concern about it, reported lower social support (Subjective Social support; Objective social support; Utilization social support), or showed a negative coping style were more likely to suffer higher psychological stress in the early stages of the COVID-19 epidemic. Conclusion Psychological interventions may be targeted to individuals with the risk characteristics identified in this study. It may be helpful to promote social support and positive coping style in the early stage of infectious disease epidemics. This initial evidence from the general Chinese population may be relevant to interventions in other countries for dealing with the COVID-19 and other epidemics.	[Yang, Xiao; Li, Xiao; Yuan, Yiwen] Sichuan Univ, West China Hosp, Mental Hlth Ctr & Psychiat Lab, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Yang, Xiao] Sichuan Univ, West China Hosp, West China Brain Res Ctr, Chengdu, Sichuan, Peoples R China; [Xiong, Zhenzhen] Chengdu Med Coll, Sch Nursing, Chengdu, Sichuan, Peoples R China; [Li, Zhixiong] Karamay Municipal Peoples Hosp, Dept Clin Psychol 3, Karamay, Xinjiang, Peoples R China; [Xiang, Weiyi] Sichuan Univ, West China Coll Med, Chengdu, Sichuan, Peoples R China; [Li, Zhe] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Li, Zhe] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chengdu Medical College; Sichuan University; Sichuan University; Sichuan University	Li, Z (corresponding author), Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China.; Li, Z (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China.	jay_li@163.com		li, zhe/0000-0001-8233-7149				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Aldwin CM, 1996, J GERONTOL B-PSYCHOL, V51, pP179, DOI 10.1093/geronb/51B.4.P179; Ausin B, 2021, J GENDER STUD, V30, P29, DOI 10.1080/09589236.2020.1799768; Baik SH, 2019, J HEALTH PSYCHOL, V24, P628, DOI 10.1177/1359105316684938; Bell CM, 2018, SUICIDE LIFE-THREAT, V48, P87, DOI 10.1111/sltb.12327; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Cheng SKW, 2005, CLIN PSYCHOL PSYCHOT, V12, P80, DOI 10.1002/cpp.429; Clarke D, 2009, PERS INDIV DIFFER, V46, P460, DOI 10.1016/j.paid.2008.11.014; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dai WJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2871-x; de Grey RGK, 2018, HEALTH PSYCHOL, V37, P787, DOI [10.1037/hea0000628.supp, 10.1037/hea0000628]; Elliott JO, 2011, EPILEPSY BEHAV, V20, P533, DOI 10.1016/j.yebeh.2011.01.013; FLANNERY RB, 1991, HOSP COMMUNITY PSYCH, V42, P935; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; Guerreiro DF, 2013, ARCH SUICIDE RES, V17, P91, DOI 10.1080/13811118.2013.776439; Hollifield M, 2008, BRIT J PSYCHIAT, V192, P39, DOI 10.1192/bjp.bp.107.038422; Horwitz AG, 2018, BEHAV THER, V49, P225, DOI 10.1016/j.beth.2017.07.010; Huang JH, 2013, NEURAL REGEN RES, V8, P1898, DOI 10.3969/j.issn.1673-5374.2013.20.009; Kleiman EM, 2014, ARCH SUICIDE RES, V18, P144, DOI 10.1080/13811118.2013.826155; Lachman ME, 2015, INT J BEHAV DEV, V39, P20, DOI 10.1177/0165025414533223; Le XTT, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00824; Liao ChuanJing, 2014, Health, V6, P1714, DOI 10.4236/health.2014.614204; Lin JY, 2020, J AFFECT DISORDERS, V265, P32, DOI 10.1016/j.jad.2020.01.026; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Prati G, 2010, J COMMUNITY PSYCHOL, V38, P403, DOI 10.1002/jcop.20371; Salim S, 2014, CURR NEUROPHARMACOL, V12, P140, DOI 10.2174/1570159X11666131120230309; Santarnecchi E, 2018, COGN AFFECT BEHAV NE, V18, P495, DOI 10.3758/s13415-018-0583-7; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Scott SB, 2013, J GERONTOL B-PSYCHOL, V68, P464, DOI 10.1093/geronb/gbs166; Sliter M, 2014, J ORGAN BEHAV, V35, P257, DOI 10.1002/job.1868; Soni M, 2013, NEUROBIOL LEARN MEM, V104, P32, DOI 10.1016/j.nlm.2013.04.003; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang JY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1736-5; Westerhuis W, 2011, J NEUROL, V258, P37, DOI 10.1007/s00415-010-5677-2; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923549; Xie Y.N., 1998, CHIN J CLIN PSYCHOL, V6, P114, DOI [10.16128/j.cnki.1005- 3661.1998.02.018, DOI 10.16128/J.CNKI.1005-3661.1998.02.018]; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Yang NX, 2018, PATIENT PREFER ADHER, V12, P1305, DOI 10.2147/PPA.S166460; Yang X, 2020, NURS OUTLOOK, DOI [10.1016/j.outlook.2020.08.008, DOI 10.1016/J.0UTL00K.2020.08.008]; Yang Y., 2003, CHIN J PSYCHIAT, V6, P183, DOI [DOI 10.3760/J:ISSN:1006-7884.2003.03.024, 10.3760/j:issn:1006-7884.2003.03.024]; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Ye Q, 2020, J TROPICAL MED, P2; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; 马征, 2004, [中华精神科杂志, Chinese Journal of Psychiatry], V37, P119; 2008, B EPIDEMIOL HEBD, V16, P131	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243605	10.1371/journal.pone.0243605	http://dx.doi.org/10.1371/journal.pone.0243605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AS	33275635	gold, Green Published			2022-12-26	WOS:000597150200038
J	Almuhaideb, E; Chintapenta, LK; Abbott, A; Parveen, S; Ozbay, G				Almuhaideb, Esam; Chintapenta, Lathadevi K.; Abbott, Amanda; Parveen, Salina; Ozbay, Gulnihal			Assessment of Vibrio parahaemolyticus levels in oysters (Crassostrea virginica) and seawater in Delaware Bay in relation to environmental conditions and the prevalence of molecular markers to identify pathogenic Vibrio parahaemolyticus strains	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; TDH-RELATED HEMOLYSIN; RAPID DETECTION; UNITED-STATES; NEW-ZEALAND; TRH GENES; PCR; CHOLERAE; METALLOPROTEASE; AMPLIFICATION	This study identified Vibrio parahaemolyticus in oyster and seawater samples collected from Delaware Bay from June through October of 2016. Environmental parameters including water temperature, salinity, dissolved oxygen, pH, and chlorophyll a were measured per sampling event. Oysters homogenate and seawater samples were 10-fold serially diluted and directly plated on CHROMagar Vibrio medium. Presumptive V. parahaemolyticus colonies were counted and at least 20% of these colonies were selected for molecular chracterization. V. parahaemolyticus isolates (n = 165) were screened for the presence of the species-specific thermolabile hemolysin (tlh) gene, the pathogenic thermostable direct hemolysin (tdh)/ thermostable related hemolysin (trh) genes, the regulatory transmembrane DNA-binding gene (toxR), and V. parahaemolyticus metalloprotease (vpm) gene using a conventional PCR. The highest mean levels of the presumptive V. parahaemolyticus were 9.63x10(3) CFU/g and 1.85x10(3) CFU/mL in the oyster and seawater samples, respectively, during the month of July. V. parahaemolyticus levels in oyster and seawater samples were significantly positively correlated with water temperature. Of the 165 isolates, 137 (83%), 110 (66.7%), and 108 (65%) were tlh(+), vpm(+), and toxR(+), respectively. Among the V. parahaemolyticus (tlh(+)) isolates, 7 (5.1%) and 15 (10.9%) were tdh(+) and trh(+), respectively, and 24 (17.5%), only oyster isolates, were positive for both genes. Potential pathogenic strains that possessed tdh and/or trh were notably higher in oyster (39%) than seawater (15.6%) isolates. The occurrence of total V. parahaemolyticus (tlh(+)) was not necessarily proportional to the potential pathogenic V. parahaemolyticus. Co-occurrence of the five genetic markers were observed only among oyster isolates. The co-occurrence of the gene markers showed a relatedness potential of tdh occurrence with vpm. We believe exploring the role of V. parahaemolyticus metalloprotease and whether it is involved in the toxic activity of the thermostable direct hemolysin (TDH) protein can be of significance. The outcomes of this study will provide some foundation for future studies regarding pathogenic Vibrio dynamics in relation to environmental quality.	[Almuhaideb, Esam] Delaware State Univ, Dept Human Ecol, Dover, DE USA; [Chintapenta, Lathadevi K.; Abbott, Amanda; Ozbay, Gulnihal] Delaware State Univ, Dept Agr & Nat Resources, Dover, DE 19901 USA; [Almuhaideb, Esam; Parveen, Salina] Univ Maryland Eastern Shore, Dept Agr Food & Resource Sci, Princess Anne, MD USA; [Chintapenta, Lathadevi K.] Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA	Delaware State University; Delaware State University; University System of Maryland; University of Maryland Eastern Shore; University of Wisconsin System	Ozbay, G (corresponding author), Delaware State Univ, Dept Agr & Nat Resources, Dover, DE 19901 USA.	gozbay@desu.edu		CHINTAPENTA, LATHADEVI/0000-0001-6302-8279	United States Department of Agriculture-National Institute of Food and Agriculture-Capacity Building Grant for Vibrio Project [2014-38821-22430]; United States Department of Agriculture-Evans-Allen Grant (DELXDSUGO2015 Award); National Science Foundation-Established Program to Stimulate Competitive Research Grant [EPS-1301765]	United States Department of Agriculture-National Institute of Food and Agriculture-Capacity Building Grant for Vibrio Project; United States Department of Agriculture-Evans-Allen Grant (DELXDSUGO2015 Award); National Science Foundation-Established Program to Stimulate Competitive Research Grant	1-United States Department of Agriculture-National Institute of Food and Agriculture-Capacity Building Grant for Vibrio Project (2014-38821-22430) -funded AA, GO, and SP (https://nifa.usda.gov/). 2-United States Department of Agriculture-Evans-Allen Grant (DELXDSUGO2015 Award) -funded KC (https://nifa.usda.gov/program/agricultural-research-1890land-grant-institutions). 3-National Science Foundation-Established Program to Stimulate Competitive Research Grant (EPS-1301765), funded GO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association, 1970, REC PROC EX SEA WAT, pviii; [Anonymous], 2017, NATL SHELLF SAN PROG; Balter S., 2006, Morbidity and Mortality Weekly Report, V55, P854; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Benitez JA, 2016, TOXICON, V115, P55, DOI 10.1016/j.toxicon.2016.03.003; Binesse J, 2008, APPL ENVIRON MICROB, V74, P7108, DOI 10.1128/AEM.01261-08; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; Canzonier WJ, 2005, AGR SEAFOOD; Centers for Disease Control and Prevention FDASNF, 2017, FOODNET 2015 SURV RE; Centers for Disease Control and Prevention NCEZID, 2019, MULT OUTBR GASTR ILL; Cook DW, 2003, J FOOD PROTECT, V66, P2276, DOI 10.4315/0362-028X-66.12.2276; Croci L, 2007, J AOAC INT, V90, P1588; Cruz CD, 2015, APPL ENVIRON MICROB, V81, P2320, DOI 10.1128/AEM.04020-14; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Davis BJK, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01147-17, 10.1128/aem.01147-17]; Deepanjali A, 2005, APPL ENVIRON MICROB, V71, P3575, DOI 10.1128/AEM.71.7.3575-3580.2005; Delaware Department of Natural Resources and Environmental Control (DNREC), 2020, SURF WAT QUAL MON PR; DEPAOLA A, 1990, APPL ENVIRON MICROB, V56, P2299, DOI 10.1128/AEM.56.8.2299-2302.1990; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; DePaola A, 2010, APPL ENVIRON MICROB, V76, P2754, DOI 10.1128/AEM.02590-09; Di Pinto A, 2011, FOOD CONTROL, V22, P124, DOI 10.1016/j.foodcont.2010.06.013; FAO/WHO, 2020, MICR RISK ASS SER, V20; Food Safety Authority of Ireland, 2020, GUID FOOD BUS SAF VI; Froelich BA, 2015, APPL ENVIRON MICROB, V81, P1111, DOI 10.1128/AEM.03206-14; Fujino T, 1953, MED J OSAKA U, V4, P299; Garcia K, 2009, APPL ENVIRON MICROB, V75, P7482, DOI 10.1128/AEM.01662-09; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; Haendiges J, 2014, EMERG INFECT DIS, V20, P718, DOI 10.3201/eid2004.130818; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Honda S, 1987, Kansenshogaku Zasshi, V61, P1070; HONDA T, 1980, J CLIN MICROBIOL, V11, P600, DOI 10.1128/JCM.11.6.600-603.1980; Hubbard TP, 2016, P NATL ACAD SCI USA, V113, P6283, DOI 10.1073/pnas.1601718113; Iwamoto M, 2010, CLIN MICROBIOL REV, V23, P399, DOI 10.1128/CMR.00059-09; Johnson CN, 2012, APPL ENVIRON MICROB, V78, P7249, DOI 10.1128/AEM.01296-12; Khimmakthong U, 2017, MICROB PATHOGENESIS, V113, P107, DOI 10.1016/j.micpath.2017.10.028; Kim SK, 2002, GENE, V283, P277, DOI 10.1016/S0378-1119(01)00882-4; Kim YB, 1999, J CLIN MICROBIOL, V37, P1173, DOI 10.1128/JCM.37.4.1173-1177.1999; Kirs M, 2011, INT J FOOD MICROBIOL, V147, P149, DOI 10.1016/j.ijfoodmicro.2011.03.012; Klein SL, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw232; Klein SL, 2014, APPL ENVIRON MICROB, V80, P595, DOI 10.1128/AEM.02895-13; Lee CT, 2015, P NATL ACAD SCI USA, V112, P10798, DOI 10.1073/pnas.1503129112; Li RC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00044; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Lo CLH, 2008, J APPL MICROBIOL, V105, P575, DOI 10.1111/j.1365-2672.2008.03776.x; Luan XY, 2007, LETT APPL MICROBIOL, V44, P242, DOI 10.1111/j.1472-765X.2006.02074.x; Luan XY, 2007, CAN J MICROBIOL, V53, P1168, DOI 10.1139/W07-085; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Marquis ND, 2015, PARASITOL INT, V64, P299, DOI 10.1016/j.parint.2015.04.001; Martinez-Urtaza J, 2008, APPL ENVIRON MICROB, V74, P265, DOI 10.1128/AEM.01307-07; Miyoshi S, 2008, FEMS MICROBIOL LETT, V283, P176, DOI 10.1111/j.1574-6968.2008.01159.x; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Nagamune K, 1996, INFECT IMMUN, V64, P4655, DOI 10.1128/IAI.64.11.4655-4658.1996; National Ocean Service Education, 2020, EST DISS OX NAT OC A; National Shellfish Sanitation Program (NSSP), 2017, INT SHELLF SAN C; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Okuda J, 1997, J CLIN MICROBIOL, V35, P1965, DOI 10.1128/JCM.35.8.1965-1971.1997; Ozbay G, 2018, J FOOD QUALITY, DOI 10.1155/2018/8765149; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Parveen S, 2008, INT J FOOD MICROBIOL, V128, P354, DOI 10.1016/j.ijfoodmicro.2008.09.019; Provenzano D, 2000, INFECT IMMUN, V68, P1491, DOI 10.1128/IAI.68.3.1491-1497.2000; Rojas MVR, 2011, REV INST MED TROP SP, V53, P201, DOI 10.1590/S0036-46652011000400005; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; SHIRAI H, 1990, INFECT IMMUN, V58, P3568, DOI 10.1128/IAI.58.11.3568-3573.1990; TADA J, 1992, MOL CELL PROBE, V6, P477, DOI 10.1016/0890-8508(92)90044-X; Taiwo M, 2017, FOOD CONTROL, V77, P116, DOI 10.1016/j.foodcont.2017.02.009; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; TANIGUCHI H, 1985, J BACTERIOL, V162, P510, DOI 10.1128/JB.162.2.510-515.1985; Tey YH, 2015, J FOOD PROTECT, V78, P969, DOI 10.4315/0362-028X.JFP-14-405; U.S. Department of Agriculture ERS, 2014, COST EST FOODB ILLN; Urquhart EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155018; Wagley S, 2008, INT J ENVIRON HEAL R, V18, P283, DOI 10.1080/09603120801911064; Wagley S, 2009, J FOOD PROTECT, V72, P60, DOI 10.4315/0362-028X-72.1.60; Whitaker WB, 2012, INFECT IMMUN, V80, P1834, DOI 10.1128/IAI.06284-11; Williams TC, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix071; Yamazaki W, 2010, APPL ENVIRON MICROB, V76, P820, DOI 10.1128/AEM.02284-09; Yang Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02566; Yu WT, 2013, INT J FOOD MICROBIOL, V160, P185, DOI 10.1016/j.ijfoodmicro.2012.11.002; Zimmerman AM, 2007, APPL ENVIRON MICROB, V73, P7589, DOI 10.1128/AEM.01700-07	79	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242229	10.1371/journal.pone.0242229	http://dx.doi.org/10.1371/journal.pone.0242229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270659	Green Published, gold			2022-12-26	WOS:000597149100035
J	Madhav, KC; Oral, E; Straif-Bourgeois, S; Rung, AL; Peters, ES				Madhav, K. C.; Oral, Evrim; Straif-Bourgeois, Susanne; Rung, Ariane L.; Peters, Edward S.			The effect of area deprivation on COVID-19 risk in Louisiana	PLOS ONE			English	Article							NEIGHBORHOOD SOCIOECONOMIC-STATUS; BUILT ENVIRONMENT; SOCIAL DETERMINANTS; HEALTH; DISPARITIES; DISADVANTAGE; INEQUALITIES; MORTALITY; POVERTY; BLACKS	Background Louisiana in the summer of 2020 had the highest per capita case count for COVID-19 in the United States and COVID-19 deaths disproportionately affects the African American population. Neighborhood deprivation has been observed to be associated with poorer health outcomes. The purpose of this study was to examine the relationship between neighborhood deprivation and COVID-19 in Louisiana. Methods The Area Deprivation Index (ADI) was calculated and used to classify neighborhood deprivation at the census tract level. A total of 17 US census variables were used to calculate the ADI for each of the 1148 census tracts in Louisiana. The data were extracted from the American Community Survey (ACS) 2018. The neighborhoods were categorized into quintiles as well as low and high deprivation. The publicly available COVID-19 cumulative case counts by census tract were obtained from the Louisiana Department of Health website on July 31, 2020. Descriptive and Poisson regression analyses were performed. Results Neighborhoods in Louisiana were substantially different with respect to deprivation. The ADI ranged from 136.00 for the most deprived neighborhood and -33.87 in the least deprived neighborhood. We observed that individuals residing in the most deprived neighborhoods had almost a 40% higher risk of COVID-19 compared to those residing in the least deprived neighborhoods. Conclusion While the majority of previous studies were focused on very limited socio-environmental factors such as crowding and income, this study used a composite area-based deprivation index to examine the role of neighborhood environment on COVID-19. We observed a positive relationship between neighborhood deprivation and COVID-19 risk in Louisiana. The study findings can be utilized to promote public health preventions measures besides social distancing, wearing a mask while in public and frequent handwashing in vulnerable neighborhoods with greater deprivation.	[Madhav, K. C.; Straif-Bourgeois, Susanne; Rung, Ariane L.; Peters, Edward S.] Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Publ Hlth, Epidemiol Program, New Orleans, LA 70112 USA; [Oral, Evrim] Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Publ Hlth, Biostat Program, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Peters, ES (corresponding author), Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Publ Hlth, Epidemiol Program, New Orleans, LA 70112 USA.	epete1@lsuhsc.edu	Peters, Edward S/H-1077-2015	Peters, Edward S/0000-0003-4928-6532; Straif-Bourgeois, Susanne/0000-0002-7545-1610; KC, Madhav/0000-0002-4659-4348				Algren MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139297; [Anonymous], 2020, WHAT IS IMP CHRON DI; Arslan M, 2020, SCI TOTAL ENVIRON, V743, DOI 10.1016/j.scitotenv.2020.140709; Bilal U, SPATIAL INEQUITIES C; Borjas GJ., 2020, DEMOGRAPHIC DETERMIN; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; CalMatters, 2020, NEIGHB COVID COLL OV; Calvert S, 2020, THE WALL STREET J; Carrion Daniel, 2020, medRxiv, DOI 10.1101/2020.06.02.20120790; Centres for Disease Control and Prevention, 2020, WEEKL SURV SUMM US C; Chen JT, 2020, 1 HARV CTR POP DEV S; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Davilla K, 2020, HLTH EQUITY CONNECTI; Divringi E, 2020, WHICH NEIGHBORHOODS; Economic Research Service, 2020, RUR URB COMM AR RUCA; Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370; Fairlie R.W., 2020, IMPACTS COVID 19 MIN; Firebaugha G, 2016, P NATL ACAD SCI USA, V113, P13372, DOI 10.1073/pnas.1607220113; Gormley M, 2020, LANCET GLOB HEALTH, V8, pE643, DOI 10.1016/S2214-109X(20)30112-1; Gradin C, 2012, APPL ECON, V44, P3793, DOI 10.1080/00036846.2011.581219; Jackson RJ, 2003, AM J PUBLIC HEALTH, V93, P1382, DOI 10.2105/AJPH.93.9.1382; Kawachi I, NEIGHBORHOODS HLTH; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Knighton Andrew J, 2016, EGEMS (Wash DC), V4, P1238, DOI 10.13063/2327-9214.1238; Koma W, 2020, LOW INCOME COMMUNITI; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Liu H, 2020, AGING DIS, V11, P668, DOI 10.14336/AD.2020.0502; Louisiana Department of Health, 2020, GOV EDW CONF LOUIS 1; Louisiana Department of Health, 2020, LOUIS COR COVID 19 I; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Montenovo L., 2020, DETERMINANTS DISPARI; Nathan A, 2018, AM J HEALTH PROMOT, V32, P1460, DOI 10.1177/0890117118779463a; Northridge ME, 2003, J URBAN HEALTH, V80, P556, DOI 10.1093/jurban/jtg064; Office for National Statistics, 2020, MAL BLUE COLL WORK T; Office of the Governor, 2020, COVID 19 LOUIS RESP; Palmer RC, 2019, AM J PUBLIC HEALTH, V109, pS70, DOI 10.2105/AJPH.2019.304964; Pluemper T., 2020, COVID 19 PANDEMIC PR; Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003; Reichberg SB, 2020, CLIN INFECT DIS; Robinette JW, 2017, J COMMUN HEALTH, V42, P865, DOI 10.1007/s10900-017-0327-6; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Scarpino S., 2020, CROWDING EPIDEMIC IN; Schneider B, SF WEEKLY; Selden TM, 2020, HEALTH AFFAIR, V39, P1624, DOI 10.1377/hlthaff.2020.00897; Shah GLH, 2020, J PUBLIC HEALTH MAN, V26, P317, DOI 10.1097/PHH.0000000000001200; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815; Takian A, 2020, INT J PUBLIC HEALTH, V65, P521, DOI 10.1007/s00038-020-01398-z; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; U.S. Census Bureau, 2018, AM COMM SURV ACS 201; US Bureau of Labor Statistics, 2018, WORK WHO COULD WORK; Wang XH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/2402961; Wilder JM, 2021, CLIN INFECT DIS, V72, P707, DOI 10.1093/cid/ciaa959	57	43	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243028	10.1371/journal.pone.0243028	http://dx.doi.org/10.1371/journal.pone.0243028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270701	Green Published, gold, Green Submitted			2022-12-26	WOS:000597149100010
J	Ishii, M; Nakakido, M; Caaveiro, JMM; Kuroda, D; Okumura, CJ; Maruyama, T; Entzminger, K; Tsumoto, K				Ishii, Misaki; Nakakido, Makoto; Caaveiro, Jose M. M.; Kuroda, Daisuke; Okumura, C. J.; Maruyama, Toshiaki; Entzminger, Kevin; Tsumoto, Kouhei			Structural basis for antigen recognition by methylated lysine-specific antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN METHYLATION; GENERATION; FRAGMENTS; LESSONS; SITES	Proteins are modulated by a variety of posttranslational modifications including methylation. Despite its importance, the majority of protein methylation modifications discovered by mass spectrometric analyses are functionally uncharacterized, partly owing to the difficulty in obtaining reliable methylsite-specific antibodies. To elucidate how functional methylsite-specific antibodies recognize the antigens and lead to the development of a novel method to create such antibodies, we use an immunized library paired with phage display to create rabbit monoclonal antibodies recognizing trimethylated Lys260 of MAP3K2 as a representative substrate. We isolated several methylsite-specific antibodies that contained unique complementarity determining region sequence. We characterized the mode of antigen recognition by each of these antibodies using structural and biophysical analyses, revealing the molecular details, such as binding affinity toward methylated/nonmethylated antigens and structural motif that is responsible for recognition of the methylated lysine residue, by which each antibody recognized the target antigen. In addition, the comparison with the results of Western blotting analysis suggests a critical antigen recognition mode to generate cross-reactivity to protein and peptide antigen of the antibodies. Computational simulations effectively recapitulated our biophysical data, capturing the antibodies of differing affinity and specificity. Our exhaustive characterization provides molecular architectures of functional methylsite-specific antibodies and thus should contribute to the development of a general method to generate functional methylsite-specific antibodies by de novo design.	[Ishii, Misaki; Nakakido, Makoto; Kuroda, Daisuke; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan; [Nakakido, Makoto; Kuroda, Daisuke; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Kuroda, Daisuke; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Med Device Dev & Regulat Res Ctr, Tokyo, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Lab Med Prote, Tokyo, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Global Healthcare, Fukuoka, Japan; [Okumura, C. J.; Maruyama, Toshiaki; Entzminger, Kevin] Abwiz Bio Inc, San Diego, CA USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Kyushu University	Nakakido, M; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan.; Nakakido, M; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Med Device Dev & Regulat Res Ctr, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Lab Med Prote, Tokyo, Japan.	nakakido@protein.t.u-tokyo.ac.jp; tsmoto@bioeng.tu-tokyo.ac.jp	Kuroda, Daisuke/AAZ-5672-2020; Caaveiro, Jose M.M./J-2790-2013	Kuroda, Daisuke/0000-0003-2390-4785; Caaveiro, Jose M.M./0000-0001-5568-2369	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from Japan Agency for Medical Research and Development (AMED) [JP19am0101070]; Japan Society for the Promotion of Science [16H02420, 16H06693]; Japan Agency for Medical Research and Development [JP18am0101094j, JP18dm0107064h, JP18mk0101081h, JP18fm0208030h, JP18fk0108073h, JP18ak0101100h, JP 19am0401010h0001]	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This research was partially supported by Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from Japan Agency for Medical Research and Development (AMED) under Grant Number JP19am0101070.; This work was funded in part by Japan Society for the Promotion of Science (grant no. 16H02420 to K. T. and 16H06693 to M. N.) and by Japan Agency for Medical Research and Development (grant no. JP18am0101094j, JP18dm0107064h, JP18mk0101081h, JP18fm0208030h, JP18fk0108073h to K. T., JP18ak0101100h and JP 19am0401010h0001 to M. N.). The supercomputing resources used in this study were provided by the Human Genome Center at Institute of Medical Science, The University of Tokyo, Japan. Access to beamline BL1A and BL5A was granted by the Photon Factory Advisory Committee (Proposal 2018G116).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Borras L, 2010, J BIOL CHEM, V285, P9054, DOI 10.1074/jbc.M109.072876; Carboni F, 2017, P NATL ACAD SCI USA, V114, P5017, DOI 10.1073/pnas.1701885114; Chen YX, 2013, J VIROL, V87, P10232, DOI 10.1128/JVI.00837-13; Colon-Bolea P, 2014, BIOESSAYS, V36, P1162, DOI 10.1002/bies.201400120; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Geoghegan V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7758; Gruber T, 2018, CHEMBIOCHEM, V19, P2324, DOI 10.1002/cbic.201800398; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Hattori T, 2018, CURR OPIN STRUC BIOL, V51, P141, DOI 10.1016/j.sbi.2018.04.006; Hattori T, 2016, P NATL ACAD SCI USA, V113, P2092, DOI 10.1073/pnas.1522691113; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murn J, 2017, NAT REV MOL CELL BIO, V18, P517, DOI 10.1038/nrm.2017.35; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIO M, 1995, TETRAHEDRON, V51, P8665, DOI 10.1016/0040-4020(94)01066-9; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Strohl William R, 2014, Curr Drug Discov Technol, V11, P3; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Van Aller GS, 2016, STRUCTURE, V24, P774, DOI 10.1016/j.str.2016.03.010; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winstead CR, 1999, J IMMUNOL, V162, P6602	40	4	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100176	10.1074/jbc.RA120.015996	http://dx.doi.org/10.1074/jbc.RA120.015996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303630	Green Published, gold			2022-12-26	WOS:000672866400154
J	Miyamoto, T; Miura, K; Kizuka, T; Ono, S				Miyamoto, Takeshi; Miura, Kenichiro; Kizuka, Tomohiro; Ono, Seiji			Properties of smooth pursuit and visual motion reaction time to second-order motion stimuli	PLOS ONE			English	Article							EYE-MOVEMENTS; AREA MT; PERCEPTION; DIRECTION; 1ST-ORDER; SIGNALS; LESIONS; SPEED; MECHANISMS; CONTRAST	A large number of psychophysical and neurophysiological studies have demonstrated that smooth pursuit eye movements are tightly related to visual motion perception. This could be due to the fact that visual motion sensitive cortical areas such as meddle temporal (MT), medial superior temporal (MST) areas are involved in motion perception as well as pursuit initiation. Although the directional-discrimination and perceived target velocity tasks are used to evaluate visual motion perception, it is still uncertain whether the speed of visual motion perception, which is determined by visuomotor reaction time (RT) to a small target, is related to pursuit initiation. Therefore, we attempted to determine the relationship between pursuit latency/acceleration and the visual motion RT which was measured to the visual motion stimuli that moved leftward or rightward. The participants were instructed to fixate on a stationary target and press one of the buttons corresponding to the direction of target motion as soon as possible once the target starts to move. We applied five different visual motion stimuli including first- and second-order motion for smooth pursuit and visual motion RT tasks. It is well known that second-order motion induces lower retinal image motion, which elicits weaker responses in MT and MST compared to first-order motion stimuli. Our results showed that pursuit initiation including latency and initial eye acceleration were suppressed by second-order motion. In addition, second-order motion caused a delay in visual motion RT. The better performances in both pursuit initiation and visual motion RT were observed for first-order motion, whereas second-order (theta motion) induced remarkable deficits in both variables. Furthermore, significant Pearson's correlation and within-subjects correlation coefficients were obtained between visual motion RT and pursuit latency/acceleration. Our findings support the suggestion that there is a common neuronal pathway involved in both pursuit initiation and the speed of visual motion perception.	[Miyamoto, Takeshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Miura, Kenichiro] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Pathol Mental Dis, Tokyo, Japan; [Miura, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto, Japan; [Kizuka, Tomohiro; Ono, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Center for Neurology & Psychiatry - Japan; Kyoto University; University of Tsukuba	Ono, S (corresponding author), Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan.	ono.seiji.fp@u.tsukuba.ac.jp	Miyamoto, Takeshi/CAG-9124-2022	Miyamoto, Takeshi/0000-0002-5265-0529				ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Braun DI, 2008, J NEUROPHYSIOL, V100, P1287, DOI 10.1152/jn.00747.2007; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Churan J, 2001, J OPT SOC AM A, V18, P2297, DOI 10.1364/JOSAA.18.002297; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Cooper SA, 2012, J NEUROL NEUROSUR PS, V83, P229, DOI 10.1136/jnnp.2010.223727; DERRINGTON AM, 1993, VISION RES, V33, P1785, DOI 10.1016/0042-6989(93)90169-W; Ding L, 2012, CEREB CORTEX, V22, P1052, DOI 10.1093/cercor/bhr178; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Ellemberg D, 2003, VISION RES, V43, P651, DOI 10.1016/S0042-6989(03)00006-3; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; Gegenfurtner KR, 1996, VISION RES, V36, P1281, DOI 10.1016/0042-6989(95)00198-0; HARRIS LR, 1992, VISUAL NEUROSCI, V9, P565, DOI 10.1017/S0952523800001802; Hawken MJ, 2001, J OPT SOC AM A, V18, P2282, DOI 10.1364/JOSAA.18.002282; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; Hulsdunker T, 2017, MED SCI SPORT EXER, V49, P1097, DOI 10.1249/MSS.0000000000001198; Hulsdunker T, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00165; Ilg UJ, 2004, J NEUROPHYSIOL, V92, P1512, DOI 10.1152/jn.01174.2003; Ilg UJ, 2010, DYNAMICS OF VISUAL MOTION PROCESSING: NEURONAL, BEHAVIORAL, AND COMPUTATIONAL APPROACHES, P117, DOI 10.1007/978-1-4419-0781-3_6; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krukowski AE, 2005, NEURON, V45, P315, DOI 10.1016/j.neuron.2005.01.005; Larcombe SJ, 2018, HUM BRAIN MAPP, V39, P145, DOI 10.1002/hbm.23832; Ledgeway T, 2002, VISION RES, V42, P1739, DOI 10.1016/S0042-6989(02)00106-2; Ledgeway T, 2008, VISION RES, V48, P208, DOI 10.1016/j.visres.2007.11.008; LELKENS AMM, 1984, VISION RES, V24, P1083, DOI 10.1016/0042-6989(84)90086-5; Lindner A, 2000, EXP BRAIN RES, V133, P450, DOI 10.1007/s002210000459; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Liu LD, 2017, NEURON, V95, P436, DOI 10.1016/j.neuron.2017.06.024; Matsuda K., 2017, INT C HUMAN COMPUTER, P593; Mukherjee T, 2015, J NEUROSCI, V35, P8515, DOI 10.1523/JNEUROSCI.4320-14.2015; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Ono S, 2007, J NEUROPHYSIOL, V98, P2918, DOI 10.1152/jn.00115.2007; Ono S, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14187; Ono S, 2016, J NEUROPHYSIOL, V116, P210, DOI 10.1152/jn.00203.2016; Ono S, 2015, VISION RES, V110, P257, DOI 10.1016/j.visres.2014.06.008; Ono S, 2012, CEREB CORTEX, V22, P1139, DOI 10.1093/cercor/bhr188; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osborne LC, 2007, J NEUROSCI, V27, P2987, DOI 10.1523/JNEUROSCI.5072-06.2007; Piponnier JC, 2016, J NEUROTRAUM, V33, P242, DOI 10.1089/neu.2014.3832; Raghavan RT, 2017, J NEUROPHYSIOL, V118, P2216, DOI 10.1152/jn.00317.2017; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schutz AC, 2010, J VISION, V10, DOI 10.1167/10.13.26; Spering M, 2005, J VISION, V5, P455, DOI 10.1167/5.5.6; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Donkelaar P, 2000, PERCEPT PSYCHOPHYS, V62, P378, DOI 10.3758/BF03205557; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X; ZANKER JM, 1993, VISION RES, V33, P553, DOI 10.1016/0042-6989(93)90258-X; Zwierko T, 2010, J HUM KINET, V23, P21, DOI 10.2478/v10078-010-0003-8	62	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243430	10.1371/journal.pone.0243430	http://dx.doi.org/10.1371/journal.pone.0243430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315877	Green Published, gold			2022-12-26	WOS:000600186100011
J	Rayan, DM; Linkie, M				Rayan, Mark D.; Linkie, Matthew			Managing threatened ungulates in logged-primary forest mosaics in Malaysia	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; GAUR BOS-GAURUS; CONSERVATION; OCCUPANCY; MAMMALS; PERSISTENCE; IMPACTS; DECLINE; TIGERS	Across the tropics, large-bodied mammals have been affected by selective logging in ways that vary with levels of timber extraction, collateral damage, species-specific traits and secondary effects of hunting, as facilitated by improved access through logging roads. In Peninsular Malaysia, 3.0 million hectares or 61 percent of its Permanent Reserved Forests is officially assigned for commercial selective logging. Understanding how wildlife adapts and uses logged forest is critical for its management and, for threatened species, their conservation. In this study, we quantify the population status of four tropical ungulate species in a large selectively logged forest reserve and an adjacent primary forest protected area. We then conduct finer scale analyses to identify the species-specific factors that determine their occurrence. A combined indirect sign-camera trapping approach with a large sampling effort (2,665 km and 27,780 trap nights surveyed) covering a wide area (560 km(2)) generated species-specific detection probabilities and site occupancies. Populations of wild boar were widespread across both logged and primary forests, whereas sambar and muntjac occupancy was lower in logged forest (48.4% and 19.2% respectively), with gaur showing no significant difference. Subsequent modelling revealed the importance of conserving lower elevation habitat in both habitat types, particularly <1,000 m asl, for which occupancies of sambar, muntjac and gaur were typically higher. This finding is important because 75 percent (similar to 13,400 km(2)) of Peninsular Malaysia's Main Range Forest (Banjaran Titiwangsa) is under 1,000 m asl and therefore at risk of being converted to industrial timber plantations, which calls for renewed thinking around forest management planning.	[Rayan, Mark D.] World Wide Fund Nat WWF Malaysia, Petaling Jaya, Selangor, Malaysia; [Rayan, Mark D.; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol DICE, Canterbury, Kent, England; [Linkie, Matthew] Wildlife Conservat Soc WCS, Bogor, Indonesia	University of Kent	Rayan, DM (corresponding author), World Wide Fund Nat WWF Malaysia, Petaling Jaya, Selangor, Malaysia.; Rayan, DM (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol DICE, Canterbury, Kent, England.	markrayan78@gmail.com			WWFNetherlands; U.S Fish and Wildlife Service; Mohamed bin Zayed Species Conservation Fund; Malaysian Wildlife Conservation Fund; WWF-US Kathryn Fuller Science for Nature Fellowship; Pulau Banding Foundation	WWFNetherlands; U.S Fish and Wildlife Service(US Fish & Wildlife Service); Mohamed bin Zayed Species Conservation Fund; Malaysian Wildlife Conservation Fund; WWF-US Kathryn Fuller Science for Nature Fellowship; Pulau Banding Foundation	This study was supported by WWFNetherlands, the U.S Fish and Wildlife Service, Mohamed bin Zayed Species Conservation Fund and Malaysian Wildlife Conservation Fund. D. Mark Rayan was supported by WWF-US Kathryn Fuller Science for Nature Fellowship and the Pulau Banding Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Brodie JF, 2015, CONSERV BIOL, V29, P110, DOI 10.1111/cobi.12389; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cannon CH, 2007, CURR SCI INDIA, V93, P1558; Choudhury A, 2002, MAMMAL REV, V32, P199, DOI 10.1046/j.1365-2907.2002.00107.x; Cliff A. D., 1981, SPATIAL PROCESSES MO; CONRY PJ, 1989, BIOL CONSERV, V49, P47, DOI 10.1016/0006-3207(89)90112-2; Darmaraj MR, 2012, THESIS; Davies Glyn, 2001, P93; Department of Wildlife and National Parks (DWNP), 2008, NAT TIG ACT PLAN MAL; Djojosudharmo Suharto, 1992, Tropical Biodiversity, V1, P11; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; FDPM, 2018, ANN REPORT; FDPM, 2003, GUID RED IMP LOGG PE; Fimbel R., 2001, CUTTING EDGE CONSERV; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; Guillera-Arroita Gurutzeta, 2010, Endangered Species Research, V11, P157, DOI 10.3354/esr00274; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Hines JE, 2006, PRESENCE V4 SOFTWARE; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; ITTO, 2007, ANN REV ASS WORLD TI; Jamhuri J, 2018, BIOL CONSERV, V227, P40, DOI 10.1016/j.biocon.2018.09.004; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kawanishi K, 2013, ORYX, V47, P420, DOI 10.1017/S0030605312000294; Kawanishi Kae, 2011, Cat News, V55, P38; Kawanishi Kae, 2006, Suiform Soundings, V6, P13; Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Kushwaha SPS, 2004, CURR SCI INDIA, V86, P1390; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Madhusudan MD, 2004, J APPL ECOL, V41, P858, DOI 10.1111/j.0021-8901.2004.00950.x; Meijaard E, 2008, BIOTROPICA, V40, P76, DOI 10.1111/j.1744-7429.2007.00340.x; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Plumptre Andrew J., 2001, P71; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Rayan DM, 2016, BIOL CONSERV, V204, P360, DOI 10.1016/j.biocon.2016.11.009; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; Roopsind A, 2017, BIOTROPICA, V49, P565, DOI 10.1111/btp.12446; Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036; Steinmetz R, 2008, BIOTROPICA, V40, P344, DOI 10.1111/j.1744-7429.2007.00367.x; Tan Win Sim, 2018, Journal of Threatened Taxa, V10, P11245, DOI 10.11609/jott.3519.10.2.11245-11253; WHITMORE T C, 1989, P1	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243932	10.1371/journal.pone.0243932	http://dx.doi.org/10.1371/journal.pone.0243932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315909	Green Published, gold			2022-12-26	WOS:000600186100050
J	Gomes, DF; Azevedo, J; Murta-Fonseca, R; Faurby, S; Antonelli, A; Passos, P				Gomes, Daniel Faustino; Azevedo, Josue; Murta-Fonseca, Roberta; Faurby, Soren; Antonelli, Alexandre; Passos, Paulo			Taxonomic revision of the genus Xenopholis Peters, 1869 (Serpentes: Dipsadidae): Integrating morphology with ecological niche	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ATLANTIC FOREST; SYSTEMATIC REVISION; SCALARIS WUCHERER; SOUTH-AMERICA; ANOLE LIZARDS; FOOD-HABITS; RAIN-FOREST; SNAKES; COLUBRIDAE	A reliable identification and delimitation of species is an essential pre-requisite for many fields of science and conservation. The Neotropical herpetofauna is the world's most diverse, including many taxa of uncertain or debated taxonomy. Here we tackle one such species complex, by evaluating the taxonomic status of species currently allocated in the snake genus Xenopholis (X. scalaris, X. undulatus, and X. werdingorum). We base our conclusions on concordance between quantitative (meristic and morphometric) and qualitative (color pattern, hemipenes and skull features) analyses of morphological characters, in combination with ecological niche modeling. We recognize all three taxa as valid species and improve their respective diagnosis, including new data on color in life, pholidosis, bony morphology, and male genitalia. We find low overlap among the niches of each species, corroborating the independent source of phenotypic evidence. Even though all three species occur in the leaf litter of distinct forested habitats, Xenopholis undulatus is found in the elevated areas of the Brazilian Shield (Caatinga, Cerrado and Chaco), whereas X. scalaris occurs in the Amazon and Atlantic rainforests, and X. werdingorum in the Chiquitanos forest and Pantanal wetlands. We discuss the disjunct distribution between Amazonian and Atlantic Forest snake species in the light of available natural history and ecological aspects. This study shows the advantages of combining multiple data sources for reliable identification and circumscription of ecologically similar species.	[Gomes, Daniel Faustino; Murta-Fonseca, Roberta; Passos, Paulo] Univ Fed Rio de Janeiro, Dept Vertebrados, Museu Nacl, Rio De Janeiro, Brazil; [Azevedo, Josue; Faurby, Soren; Antonelli, Alexandre] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Azevedo, Josue; Faurby, Soren; Antonelli, Alexandre] Univ Gothenburg, Gothenburg Global Biodivers Ctr, Gothenburg, Sweden; [Azevedo, Josue] Inst Nacl de Pesquisas da Amazonia, Programa Colecoes Cient Biol, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Murta-Fonseca, Roberta] Univ Fed Mato Grosso do Sul, Bairro Univ, Lab Zool Campus Pantanal, Corumba, MS, Brazil; [Antonelli, Alexandre] Royal Bot Gardens, Surrey, England; [Antonelli, Alexandre] Univ Oxford, Dept Plant Sci, Oxford, England	Universidade Federal do Rio de Janeiro; University of Gothenburg; University of Gothenburg; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Mato Grosso do Sul; Royal Botanic Gardens, Kew; University of Oxford	Gomes, DF (corresponding author), Univ Fed Rio de Janeiro, Dept Vertebrados, Museu Nacl, Rio De Janeiro, Brazil.	faustino.biologia13@outlook.com		Faustino Gomes, Daniel/0000-0003-0343-1191; Murta-Fonseca, Roberta/0000-0002-3666-2087	Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico e Cientifico; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Royal Botanic Gardens, Kew	Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico e Cientifico; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Royal Botanic Gardens, Kew	Financial support for P. Passos was provided by Conselho Nacional de Pesquisa (http://www.cnpq.br/) e Desenvolvimento Tecnologico e Cientifico and Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/).A.Antonelli is financially supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research and the Royal Botanic Gardens, Kew (https://www.kew.org/).	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amaral A., 1923, Proceedings of the New England Zoological Club, V8, P85; Amaral A., 1929, MEM I BUTANTAN, V4, P126; [Anonymous], 2017, HABITAT SUITABILITY, DOI DOI 10.1017/9781139028271; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Argolo A.J., 2004, SERPENTES CACAUAIS S, P250; Azevedo JAR, 2016, J BIOGEOGR, V43, P2454, DOI 10.1111/jbi.12803; Bernarde PS, 2010, BIOTA NEOTROP, V10, P167, DOI 10.1590/S1676-06032010000100017; Boulenger G.A, 1896, CATALOGUE SNAKES BRI, VIII; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Cope ED., 1874, P ACAD NAT SCI PHILA, V26, P64; Costa GC, 2018, GLOBAL ECOL BIOGEOGR, V27, P285, DOI 10.1111/geb.12694; Costa Henrique Caldeira, 2013, Herpetologia Brasileira, V2, P36; Costa HC, 2013, ZOOTAXA, V3716, P349; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cundall David, 2008, Contributions to Herpetology, V23, P349; Cunha O.R., 1978, B MUSEU PARAENSE EMI, V31, P1; Prudente Ana Lúcia da Costa, 2010, Acta Amaz., V40, P381, DOI 10.1590/S0044-59672010000200016; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; Dal Vechio F, 2018, J BIOGEOGR, V45, P2415, DOI 10.1111/jbi.13421; Danielson J.J., 2011, GLOBAL MULTIRESOLUTI, P1; de Carvalho M A, 1998, Cad Saude Publica, V14, P753, DOI 10.1590/S0102-311X1998000400017; De Lima AC, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2203.1.3; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Resende FC, 2015, ANAT HISTOL EMBRYOL, V44, P225, DOI 10.1111/ahe.12132; Ledo RMD, 2017, J BIOGEOGR, V44, P2551, DOI 10.1111/jbi.13049; Dixon J.R., 1993, MUSEU REGIONALE SCI, VXIII; Dowling H.G., 1960, GUIDE SNAKE HEMIPENI; Dowling Herndon G., 2003, Herpetological Review, V91, P20; DOWLING HG, 1951, COPEIA, P131; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fernandes D.S., 2002, B MUS NAC, V481; Fernandes DS, 2004, HERPETOLOGICA, V60, P245, DOI 10.1655/02-85; Ficetola GF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28796-x; Franca Rafaela C., 2019, Herpetology Notes, V12, P57; Franco Francisco L., 2002, Phyllomedusa, V1, P57; Freire EMX, 2010, ZOOTAXA, P62; Gainsbury AM, 2003, BIOTROPICA, V35, P503, DOI 10.1111/j.1744-7429.2003.tb00607.x; Gotelli NJ, 2011, PRINCIPIOS ESTATISTI, DOI DOI 10.1007/s10533-006-9007-9; Grazziotin FG, 2012, CLADISTICS, V28, P437, DOI 10.1111/j.1096-0031.2012.00393.x; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hamdan Breno, 2015, Check List, V11, P1746; Harvey MB, 2008, HERPETOL MONOGR, V22, P54, DOI 10.1655/07-023.1; Henderson RW, 2009, COPEIA, P572, DOI 10.1643/CH-08-190; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; HOGE A R, 1974, Memorias do Instituto Butantan (Sao Paulo), V38, P137; Hollis JL, 2006, HERPETOLOGICA, V62, P435, DOI 10.1655/0018-0831(2006)62[435:POTGCF]2.0.CO;2; Hoogmoed MS, 2019, S AM J HERPETOL, V14, P88, DOI 10.2994/SAJH-D-17-00014.1; Jadin RC, 2014, J ZOOL SYST EVOL RES, V52, P257, DOI 10.1111/jzs.12055; Janitza S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-119; Jansen M, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2222.1.3; Jensen A.S, 1900, VIDENSK MEDD NATURHI, P99; Jingzhou diqu bowuguan, 1985, WENWU, V1, P1; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Le Lay G, 2010, ECOGRAPHY, V33, P1015, DOI 10.1111/j.1600-0587.2010.06338.x; Leite YLR, 2016, P NATL ACAD SCI USA, V113, P1008, DOI 10.1073/pnas.1513062113; Lembrechts JJ, 2019, ECOGRAPHY, V42, P1267, DOI 10.1111/ecog.03947; Marques O., 2015, SERPENTES CERRADO; Marques O.A.V., 2005, SERPENTES PANTANAL G; Martins Marcio, 1999, Herpetological Natural History, V6, P78; Mayr E, 1942, SYSTEMATICS ORIGIN S; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Mumaw M.N., 2015, ATLAS SERPIENTES VEN; Myers CW, 2014, B AM MUS NAT HIST, P1; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Nogueira CC, 2019, S AM J HERPETOL, V14, pS1, DOI 10.2994/SAJH-D-19-00120.1; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Passos P, 2016, HERPETOL MONOGR, V30, P1, DOI 10.1655/HERPMONOGRAPHS-D-14-00009; Passos P, 2008, HERPETOL MONOGR, V22, P1; Passos P, 2009, HERPETOLOGICA, V65, P384, DOI 10.1655/08-024.1; Pellegrino KCM, 2011, MOL PHYLOGENET EVOL, V61, P446, DOI 10.1016/j.ympev.2011.07.010; PESANTES OS, 1994, J HERPETOL, V28, P93, DOI 10.2307/1564686; Peters J.A., 1970, SNAKES 1, P348; Peters J. A., 1960, SNAKES SUBFAMILY DIP; Peters W., 1869, Monatsberichte Akad Wiss Berlin, P432; Powell Randy L., 2016, Check List, V12, P1985; Prado CPA, 2012, MOL ECOL, V21, P921, DOI 10.1111/j.1365-294X.2011.05409.x; Prates I, 2017, MOL PHYLOGENET EVOL, V113, P49, DOI 10.1016/j.ympev.2017.05.009; Prates I, 2015, MOL PHYLOGENET EVOL, V82, P258, DOI 10.1016/j.ympev.2014.10.005; Pyron RA, 2009, ZOOTAXA, P22, DOI 10.11646/zootaxa.2241.1.2; Ranc N, 2017, ECOGRAPHY, V40, P1076, DOI 10.1111/ecog.02414; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; ROBERTO IGOR JOVENTINO, 2017, Pap. Avulsos Zool., V57, P347, DOI 10.11606/0031-1049.2017.57.27; Rodrigues MT, 2014, MOL PHYLOGENET EVOL, V81, P137, DOI 10.1016/j.ympev.2014.07.019; Sabaj MH, 2020, COPEIA, V108, P593, DOI 10.1643/ASIHCODONS2020; Schenkel E., 1902, VERHANDLUNGEN NATURF, V13, P152; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 2000, TRENDS ECOL EVOL, V15, P221, DOI 10.1016/S0169-5347(00)01853-X; SHINE R, 1988, J HERPETOL, V22, P307, DOI 10.2307/1564154; Magnago LFS, 2015, BIODIVERS CONSERV, V24, P2305, DOI 10.1007/s10531-015-0961-1; Soria-Auza RW, 2010, ECOL MODEL, V221, P1221, DOI 10.1016/j.ecolmodel.2010.01.004; Statsoft inc, 1998, STAT WIND VERS 5 1; Uzzell T., 1973, Postilla, VNo. 159, P1; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003; Wallach V., 2014, SNAKES WORLD CATALOG; Werner F, 1913, REPTILIEN AMPHIBIEN, P1; Werner F., 1925, SITZUNGSB AKAD WISS, P45; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wucherer O., 1861, ANN MAGAZINE NATURAL, V3, P318; Zaher H, 1999, J HERPETOL, V33, P698, DOI 10.2307/1565589; Zaher H, 2011, BIOTA NEOTROP, V11, P67, DOI 10.1590/S1676-06032011000500005; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x; Zar J.H, 1999, BIOESTATICAL ANAL, P633; Zizka A, 2020, DIVERS DISTRIB, V26, P183, DOI 10.1111/ddi.13004	113	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243210	10.1371/journal.pone.0243210	http://dx.doi.org/10.1371/journal.pone.0243210			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306700	Green Published, gold			2022-12-26	WOS:000600144200062
J	Hallenberg, GS; Jiwakanon, J; Angkititrakul, S; Kang-Air, S; Osbjer, K; Lunha, K; Sunde, M; Jarhult, JD; Van Boeckel, TP; Rich, KM; Magnusson, U				Hallenberg, Gunilla Strom; Jiwakanon, Jatesada; Angkititrakul, Sunpetch; Kang-Air, Seri; Osbjer, Kristina; Lunha, Kamonwan; Sunde, Marianne; Jarhult, Josef D.; Van Boeckel, Thomas P.; Rich, Karl M.; Magnusson, Ulf			Antibiotic use in pig farms at different levels of intensification-Farmers' practices in northeastern Thailand	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANIMALS	Understanding the patterns and drivers of antibiotic use in livestock is crucial for tailoring efficient incentives for responsible use of antibiotics. Here we compared routines for antibiotic use between pig farms of two different levels of intensification in Khon Kaen province in Thailand. Among the 113 family-owned small-scale farms (up to 50 sows) interviewed did 76% get advice from the pharmacy about how to use the antibiotics and 84% used it primarily for treating disease. Among the 51 medium-scale-farms (100-500 sows) belonging to two companies did 100% get advice about antibiotic use from the company's veterinarian (P<0.0001) and 94% used antibiotics mostly as disease preventive measure (P<0.0001). In 2 small scale farms 3(rd) generation cephalosporins, tylosin or colistin were used; antibiotics belonging to the group of highest priority critically important antimicrobials for human medicine. Enrofloxacin, belonging to the same group of antimicrobials, was used in 33% of the small-scale and 41% of the medium-scale farms. In the latter farms, the companies supplied 3-4 antibiotics belonging to different classes and those were the only antibiotics used in the farms. The median and mean estimated expenditure on antibiotics per sow was 4.8 USD (IQR = 5.8) for small-scale farms and 7 USD and 3.4 USD for the medium-scale farms belonging to the two respective companies. Our observations suggest to target the following areas when pig farming transitions from small-scale to medium-scale: (i) strengthening access to professional animal health services for all farmers, (ii) review of the competence and role of veterinary pharmacies in selling antibiotics and (iii) adjustment of farming company animal health protocols towards more medically rational use of antibiotics.	[Hallenberg, Gunilla Strom; Osbjer, Kristina; Lunha, Kamonwan; Magnusson, Ulf] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Jiwakanon, Jatesada; Angkititrakul, Sunpetch] Khon Kaen Univ, Res Grp Anim Hlth Technol, Khon Kaen, Thailand; [Kang-Air, Seri] Khon Khon Univ, Fac Vet Med, Khon Kaen, Thailand; [Sunde, Marianne] Norwegian Vet Inst, Sect Food Safety & AMR, Oslo, Norway; [Jarhult, Josef D.] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Sci, Uppsala, Sweden; [Van Boeckel, Thomas P.] Swiss Fed Inst Technol, Inst Environm Decis, Zurich, Switzerland; [Van Boeckel, Thomas P.] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Rich, Karl M.] Int Livestock Res Inst, Policies Inst & Livelihoods Program, West Africa Reg Off, Dakar, Senegal; [Hallenberg, Gunilla Strom] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Lunha, Kamonwan] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	Swedish University of Agricultural Sciences; Khon Kaen University; Khon Kaen University; Norwegian Veterinary Institute; Uppsala University; Swiss Federal Institutes of Technology Domain; ETH Zurich; CGIAR; International Livestock Research Institute (ILRI); Public Health Agency of Sweden; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Magnusson, U (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	ulf.magnusson@slu.se	Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059; Sunde, Marianne/0000-0002-2326-4338; Osbjer, Kristina/0000-0002-0902-8232; Magnusson, Ulf/0000-0002-7087-6820; Lunha, Kamonwan/0000-0002-4080-763X	Joint Programming Initiative on antimicrobial resistance (JPIAMR)	Joint Programming Initiative on antimicrobial resistance (JPIAMR)	GSH, KO,KL,MS,JDJ,TPVB and UM were funded by the Joint Programming Initiative on antimicrobial resistance (JPIAMR)https://www.jpiamr.eu/supportedprojects/fifth-joint-callresult/The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaechi N., 2014, GLOBAL J BIOL AGR HL, V3, P50; [Anonymous], 2014, PIG PRODUCTION THAIL; Bengtsson B, 2006, ANIM BIOTECHNOL, V17, P147, DOI 10.1080/10495390600956920; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Dang Pham Kim, 2013, Food and Public Health, V3, P247; FAO, 2011, 2 FAO AN PROD HLTH; FAO, 2016, DRIV DYN EP ANT RES; FAO, 2020, UNL POT AGR INN ACH; Gilbert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133381; HNP/Agriculture Global Antimicrobial Resistance Initiative, 2017, DRUG RESISTANT INFEC; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Lekagul A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001918; Li Y, 2019, ANTIMICROBIAL USE FA; Magnusson U., 2019, ANIMAL PRODUCTION HL; Magnusson U, 2020, J ANIM SCI, V98, pS4, DOI 10.1093/jas/skaa148; Muloi D, 2018, FOODBORNE PATHOG DIS, V15, P467, DOI 10.1089/fpd.2017.2411; ODK, 2020, OP DAT KIT 2020; Perry BD, 2013, P NATL ACAD SCI USA, V110, P20871, DOI 10.1073/pnas.1012953108; RATTANARONCHART S, 1994, PRESENT SITUATION TH; Robinson TP, 2017, ANIMAL, V11, P1, DOI 10.1017/S1751731116001828; Strom G, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0328-y; Strom G, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0233-9; Tantasuparuk W, 2000, THERIOGENOLOGY, V54, P481, DOI 10.1016/S0093-691X(00)00364-2; TAS, 2019, 90322009 TAS; Thanapongtharm W, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0849-7; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Van Boeckel TP, 2019, SCIENCE, V365, P1266, DOI 10.1126/science.aaw1944; Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; WHO, 2019, CRIT IMP ANT HUM MED; Wieland B., 2019, AMUSE LIVESTOCK VERS	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243099	10.1371/journal.pone.0243099	http://dx.doi.org/10.1371/journal.pone.0243099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306684	Green Published, gold			2022-12-26	WOS:000600144200060
J	Nowossadeck, E; Prutz, F; Teti, A				Nowossadeck, Enno; Prutz, Franziska; Teti, Andrea			Population change and the burden of hospitalization in Germany 2000-2040: Decomposition analysis and projection	PLOS ONE			English	Article							DEMOGRAPHIC TIME-BOMB; CARE; REHABILITATION; MULTIMORBIDITY; OUTPATIENT; MEDICINE.; DISEASE; IMPACT	Demographic factors, such as population aging and shrinkage, and non-demographic factors, such as hospitalization rate and length of hospital stay, generate challenges for inpatient care. This paper used decomposition analysis to assess how changes in these factors affected the number of hospital treatment days from 2000 to 2015 in Germany. Demographic aging was linked to increases in the number of treatment days for women (+10.0%) and men (+19.2%) and in hospitalization rates for women +6.0% and men +5.4%. However, these increases were offset by decreases in the number of hospital days (women: 16.5%; men: 7.3%) and length of stay (women: -27.4%; men -26.3%). For the projection up to 2040, 12 scenarios were developed (six for women and six for men) using three variants for future population demographics and two variants for future length of stay and hospitalization rates. One of the two variants for future length of stay and hospitalization rates provides for a constant value for the year 2015. For the second of these two variants variant, a logarithmic model was estimated on the basis of values from 2000 to 2015. and the trends were extrapolated using this model until 2040. The strongest overall predicted increase was 18.4% between 2015 and 2040, including a 22.4% increase for men. In two scenarios for women, only slight declines were predicted. All results, both for the decomposition analysis and projection, indicated a moderate but sustained effect of demographic aging on the number of hospital treatment days, leading to a significant increase in hospital treatment days over the study period. Non-demographic factors also had strong influences, especially in shorter time periods, but these effects offset each other over time. The change in the population size in the period under study had very little effect on the number of hospital treatment days.	[Nowossadeck, Enno] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany; [Prutz, Franziska] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Hlth Reporting, Berlin, Germany; [Teti, Andrea] Univ Vechta, Inst Gerontol, Vechta, Germany	Robert Koch Institute; Robert Koch Institute	Nowossadeck, E (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany.	NowossadeckE@rki.de	Nowossadeck, Enno/O-7898-2016	Nowossadeck, Enno/0000-0002-8534-0463				[Anonymous], 2013, J LABEL COMPD RADIOP, V56, pS88, DOI 10.1002/jlcr.3058; [Anonymous], 2014, J NURS REGUL, V5, pS3; [Anonymous], 2013, OFF J EUR UNION L, VL13, P46; [Anonymous], 2014, CANC DISCOV, V4, pOF1; AQUA-Institut, 2012, BESCHR QUAL ERF 2012; Astolfi R, 2012, HEALTH POLICY, V107, P1, DOI 10.1016/j.healthpol.2012.05.001; Balk BM, 2004, ECON LETT, V82, P107, DOI 10.1016/j.econlet.2003.09.006; Baumann W, 2016, ONKOLOGE, V22, P158, DOI 10.1007/s00761-016-0003-y; Biermann J, 2010, MED KLIN, V105, P876, DOI 10.1007/s00063-010-1152-1; Braun B, 2009, GESUNDHEITSVERSORGUN, P117; Braun GE, 2008, INFRASTRUKTURPROBLEM, P207; Braun T, 2008, KRANKENHAUSVERGUTUNG, P3; Busse R, 2017, LANCET, V390, P882, DOI 10.1016/S0140-6736(17)31280-1; Busse R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3197; Christiansen M, 2018, GESUNDHEITSWESEN, V80, P489, DOI 10.1055/s-0042-121597; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Contrast Media Research 2017 Durango CU, 2017, INVEST RADIOL, V52, P758; Dieleman JL, 2017, JAMA-J AM MED ASSOC, V318, P1668, DOI 10.1001/jama.2017.15927; Dietzenbacher E., 1998, ECON SYST RES, V10, P307, DOI [10.1080/09535319800000023, DOI 10.1080/09535319800000023, 10.1080/]; Dinkel RH, 2008, WAS IST ALTERN NEUE, P97; Doblhammer G, 2011, BUNDESGESUNDHEITSBLA, V54, P907, DOI 10.1007/s00103-011-1315-0; Flintrop J., 2006, DTSCH ARZTEBL, V103, P46; Frank J, 2015, GESUNDHEITSWESEN, V77, P932, DOI 10.1055/s-0034-1390417; Fuchs J, 2015, ATHENS J SOCIAL SCI, V2, P109, DOI DOI 10.30958/AJSS.2-2-3; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Herbermann JD, 2012, B WORLD HEALTH ORGAN, V90, P6, DOI 10.2471/BLT.12.020112; Hilgers S., 2011, DRG VERGUTUNG DTSCH; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kis A, 2017, J DTSCH DERMATOL GES, V15, P1199, DOI 10.1111/ddg.13379; Klosterman RE, 1990, COMMUNITY ANAL PLANN; Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8; Kolb GF, 2017, Z GERONTOL GERIATR, V50, P657, DOI 10.1007/s00391-017-1281-8; Kwok CL, 2017, INT J HEALTH POLICY, V6, P155, DOI 10.15171/ijhpm.2016.108; Layzell B, 2009, STUD HEALTH TECHNOL, V146, P166, DOI 10.3233/978-1-60750-024-7-166; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Nations United, 2013, GLOB TRENDS CHALL SU; Neiner Jennifer A, 2004, Health Promot Pract, V5, P69, DOI 10.1177/1524839903257692; Niermann I, 2007, DTSCH ARZTEBL INT, V104, P923; Ha NT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0554-9; Nowossadeck E, 2010, BUNDESGESUNDHEITSBLA, V53, P427, DOI 10.1007/s00103-010-1048-5; Nowossadeck E, 2019, REHABILITATION, V58, P96, DOI 10.1055/a-0603-6864; Nowossadeck E, 2018, BUNDESGESUNDHEITSBLA, V61, P358, DOI 10.1007/s00103-018-2695-1; Nowossadeck E, 2012, DTSCH ARZTEBL INT, V109, P151, DOI 10.3238/arztebl.2012.0151; Potzsch O., 2015, BEV DEUTSCHL BIS 206; Reinhold T, 2009, GESUNDHEITSWESEN, V71, P306, DOI 10.1055/s-0028-1119399; Casado JMR, 2012, EUR GERIATR MED, V3, P228, DOI 10.1016/j.eurger.2012.01.002; Roeder N, 2006, INTERNIST, V47, P684, DOI 10.1007/s00108-006-1646-3; Schulz E, 2004, HEALTH POLICY, V67, P57, DOI 10.1016/S0168-8510(03)00083-6; Schulz E., 2015, DIW WOCHENBERICHT, V82, P330; Standl T, 2016, AMBULANTES OPERIEREN, V3; Statistische Amter des Bundes und der Lander, 2010, DEM WAND DEUTSCHL HE, V2, P2010; Statistisches Bundesamt, 2016, BEV ERW BEV GRUNDL Z, P2016; Statistisches Bundesamt, 2016, KRANK DIAGN PAT PAT; Stock C, 2015, GESUNDHEITSWESEN, V77, P939, DOI 10.1055/s-0034-1398605; Tikkanen T, 2011, ENABLING INNOVATION: INNOVATIVE CAPABILITY - GERMAN AND INTERNATIONAL VIEWS, P249, DOI 10.1007/978-3-642-24503-9_26; von Eiff W, 2011, DTSCH ARZTEBLATT, V108, P1164; Wiedemann A, 2015, Z ALLG MED, V91, P494; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243322	10.1371/journal.pone.0243322	http://dx.doi.org/10.1371/journal.pone.0243322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306705	gold, Green Published			2022-12-26	WOS:000600144200037
J	Thapa, K; Thapa, GJ; Bista, D; Jnawali, SR; Acharya, KP; Khanal, K; Kandel, RC; Thapa, MK; Shrestha, S; Lama, ST; Sapkota, NS				Thapa, Kanchan; Thapa, Gokarna Jung; Bista, Damber; Jnawali, Shant Raj; Acharya, Krishna Prasad; Khanal, Kapil; Kandel, Ram Chandra; Thapa, Madhuri Karki; Shrestha, Saroj; Lama, Sonam Tashi; Sapkota, Netra Sharma			Landscape variables affecting the Himalayan red panda Ailurus fulgens occupancy in wet season along the mountains in Nepal	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; NATIONAL-PARK; CONSERVATION; BIODIVERSITY; VEGETATION; COMMUNITY; PATTERNS; ECOLOGY; MODELS; FIT	The Himalayan red panda is an endangered mammal endemic to Eastern Himalayan and South Western China. Data deficiency often hinders understanding of their spatial distribution and habitat use, which is critical for species conservation planning. We used sign surveys covering the entire potential red panda habitat over 22,453 km(2) along the mid-hills and high mountains encompassing six conservation complexes in Nepal. To estimate red panda distribution using an occupancy framework, we walked 1,451 km along 446 sampled grid cells out of 4,631 grid cells in the wet season of 2016. We used single-species, single-season models to make inferences regarding covariates influencing detection and occupancy. We estimated the probability of detection and occupancy based on model-averaging techniques and drew predictive maps showing site-specific occupancy estimates. We observed red panda in 213 grid cells and found covariates such as elevation, distance to water sources, and bamboo cover influencing the occupancy. Red panda detection probability (p) over cap (SE) estimated at 0.70 (0.02). We estimated red panda site occupancy (sampled grid cells) and landscape occupancy (across the potential habitat) (psi) over cap (SE) at 0.48 (0.01) and 0.40 (0.02) respectively. The predictive map shows a site-specific variation in the spatial distribution of this arboreal species along the priority red panda conservation complexes. Data on their spatial distribution may serve as a baseline for future studies and are expected to aid in species conservation planning in priority conservation complexes.	[Thapa, Kanchan; Thapa, Gokarna Jung; Jnawali, Shant Raj; Khanal, Kapil] WWF Nepal, Kathmandu, Nepal; [Bista, Damber; Shrestha, Saroj; Lama, Sonam Tashi] Red Panda Network, Kathmandu, Nepal; [Acharya, Krishna Prasad] Minist Forests & Environm, Kathmandu, Nepal; [Kandel, Ram Chandra] Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal; [Thapa, Madhuri Karki] Dept Forest & Soil Conservat, Kathmandu, Nepal; [Sapkota, Netra Sharma] US Agcy Int Dev, Kathmandu, Nepal	World Wildlife Fund; United States Agency for International Development (USAID)	Thapa, K (corresponding author), WWF Nepal, Kathmandu, Nepal.; Bista, D (corresponding author), Red Panda Network, Kathmandu, Nepal.	kanchan.thapa@wwfnepal.org; damb.2007@gmail.com	Thapa, Kanchan/AGU-3365-2022; Bista, Damber/K-1215-2019; Lama, Sonam Tashi/Z-4025-2019	Bista, Damber/0000-0003-2699-1642; Lama, Sonam Tashi/0000-0002-3390-6496	USAID's Hariyo Ban Program/WWF Nepal	USAID's Hariyo Ban Program/WWF Nepal	We are thankful to the USAID's Hariyo Ban Program/WWF Nepal for supporting this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2002, INT FOREST REV, V4, P149, DOI 10.1505/IFOR.4.2.149.17447; Acharya KP, 2018, GLOB ECOL CONSERV, V15, DOI 10.1016/j.gecco.2018.e00420; Altwegg R, 2019, METHODS ECOL EVOL, V10, P8, DOI 10.1111/2041-210X.13090; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Bisi F, 2019, ENVIRON CONSERV, V46, P163, DOI 10.1017/S0376892918000486; Bista D, 2020, HUM DIMENS WILDL, V25, P324, DOI 10.1080/10871209.2020.1728788; Bista D, 2019, ECOL EVOL, V9, P5260, DOI 10.1002/ece3.5116; Bista D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178797; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choudhury A, 2001, ORYX, V35, P250, DOI 10.1046/j.1365-3008.2001.00181.x; *DNPWC, 2018, RED PAND CONS ACT PL; DoF, 2018, BIJ PTER MARS ROXB C; DoFSC, 2019, RHOD CONS ACT PLAN 2; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; DUPONT WD, 2002, STAT MODELING BIOMED; Efron B., 1994, INTRO BOOTSTRAP; Ferrez J, 2011, AGR FOREST METEOROL, V151, P992, DOI 10.1016/j.agrformet.2011.03.005; Fox J, 1996, CONSERV BIOL, V10, P562, DOI 10.1046/j.1523-1739.1996.10020562.x; Glatston A, 2016, IUCN RED LIST THREAT, V2015, peT714A45195924; Glatston A., 2015, IUCN RED LIST THREAT; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gray TNE, 2011, RAFFLES B ZOOL, V59, P311; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jnawali S., 2012, RED PANDA AILURUS FU; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Kandel Pratikshya, 2016, Journal of Asia-Pacific Biodiversity, V9, P1; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manne LL, 2020, ECOL EVOL, V10, P602, DOI 10.1002/ece3.5505; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Panthi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180978; Paudel PK, 2015, APPL GEOGR, V56, P127, DOI 10.1016/j.apgeog.2014.11.018; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; Pradhan Sunita, 2011, Zoos' Print, V26, P11; Putkonen JK, 2004, ARCT ANTARCT ALP RES, V36, P244, DOI 10.1657/1523-0430(2004)036[0244:CSARDA]2.0.CO;2; ROBERTS M S, 1984, Mammalian Species, P1, DOI 10.2307/3503840; Schickhoff U, 2015, EARTH SYST DYNAM, V6, P1407; SD, 2001, NAT TOP BAS MAPS; Shrestha UB, 2010, MOUNTAIN RES DEV, V30, P282; Shrestha UB, 2010, MT RES DEV, V30, P282, DOI 10.1659/MRD-JOURNAL-D-10-00019.1; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Thapa A, 2020, GLOB ECOL CONSERV, V21, DOI 10.1016/j.gecco.2019.e00890; Thapa A, 2018, ECOL EVOL, V8, P10542, DOI 10.1002/ece3.4526; Thapa A, 2018, BIOL CONSERV, V220, P112, DOI 10.1016/j.biocon.2018.02.014; Thapa K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216504; Thapa K, 2017, INTEGR ZOOL, V12, P211, DOI 10.1111/1749-4877.12240; Wang F, 2018, DIVERS DISTRIB, V24, P415, DOI 10.1111/ddi.12692; Wang TJ, 2009, PHOTOGRAMM ENG REM S, V75, P37, DOI 10.14358/PERS.75.1.37; Yonzon P., 1989, THESIS; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zhang Y, 2016, AGR FOREST METEOROL, V224, P1, DOI 10.1016/j.agrformet.2016.04.009	66	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243450	10.1371/journal.pone.0243450	http://dx.doi.org/10.1371/journal.pone.0243450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306732	Green Published, gold			2022-12-26	WOS:000600144200058
J	Mohammedhussein, M; Hajure, M; Shifa, JE; Hassen, TA				Mohammedhussein, Mustefa; Hajure, Mohammedamin; Shifa, Jemal Ebrahim; Hassen, Tahir Ahmed			Perceived stigma among patient with pulmonary tuberculosis at public health facilities in southwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							TB-RELATED STIGMA; STIGMATIZATION; DETERMINANTS; DEPRESSION	Objectives Although tuberculosis (TB) related stigma has a significant impact on the diagnosis, patient adherence with treatment, and recovery from the disease, there is limited evidence from Ethiopia regarding perceived stigma among patient with pulmonary tuberculosis (PTB).The purpose of this study was to assess perceived stigma and associated factors among patient with PTB on treatment in southwest Ethiopia. Methods Institution-based cross-sectional study was conducted from April to May 2019 among 410 patient with PTB. Data were collected by using the perceived tuberculosis stigma scale. Epi data v3.1 and SPSSv23 were used for data entry and analysis. Multivariable logistic regression models were fitted to identify factors associated with perceived stigma. Results are presented as adjusted odds ratios (AORs) with 95% confidence intervals (CIs). Result Prevalence of perceived stigma among patient with Pulmonary tuberculosis was 57.1% (95% CI: 52.2, 61.7). Poor social support (AOR = 2.41; 95% CI: 1.06, 5.48), above a month duration of illness (AOR = 2.48; 95% CI: 1.33, 4.64), high perceived stress (AOR = 1.95; 95% CI:1.09, 3.49), current khat use (AOR = 1.88; 95% CI:1.05, 3.37), and presence of depression (AOR = 8.18; 95% CI:4.40, 15.22) were significantly associated with perceived stigma. Patient with HIV co-infection were 5.67 times (AOR = 5.67; 95% CI: 2.32, 13.87) more likely to have Perceived stigma than their counterparts. Conclusion TB related stigma was reported by more than half of the study participant. Stigma reduction measures are needed to lower TB related stigma perceived by the patient, the level of distress associated with it, and to promote the psychological wellbeing of patient with TB.	[Mohammedhussein, Mustefa; Hajure, Mohammedamin] Mettu Univ, Fac Publ Hlth & Med Sci, Dept Psychiat, Mettu, Ethiopia; [Shifa, Jemal Ebrahim] Mada Walabu Univ, Sch Hlth Sci, Dept Psychiat, Shashemene Campus, Shashemene, Ethiopia; [Hassen, Tahir Ahmed] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia	Haramaya University	Mohammedhussein, M (corresponding author), Mettu Univ, Fac Publ Hlth & Med Sci, Dept Psychiat, Mettu, Ethiopia.	mustefamohammed1984@gmail.com	Mohammed, Mustefa/GYU-0399-2022; Hajure, Mohammedamin/AAZ-9559-2020	Desalegn, Defaru/0000-0001-7264-9966; Hassen, Dr Tahir/0000-0003-3486-2111				Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Abioye IA, 2011, AFR HEALTH SCI, V11, pS100; Adilo TM, 2017, ECON MICROBIOL, V12, P37; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2018, TOXICOL ANAL CLIN, V30, P1; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Datiko DG, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-7915-6; Deribew Amare, 2010, BMC Res Notes, V3, P249, DOI 10.1186/1756-0500-3-249; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Dodor EA, 2009, PSYCHOL HEALTH MED, V14, P170, DOI 10.1080/13548500802199753; Duko Bereket, 2019, Tuberc Res Treat, V2019, P5917537, DOI 10.1155/2019/5917537; Eldahshan NA, 2015, WORLD FAM MED, V13, P21, DOI 10.5742/MEWFM.2015.92687; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Kane JC, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1250-8; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kumar Kunal, 2016, J Family Med Prim Care, V5, P150, DOI 10.4103/2249-4863.184641; Lee LY, 2017, J CLIN NURS, V26, P4813, DOI 10.1111/jocn.13837; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Mitchell E., 2018, TB STIGMA MEASUREMEN, P1; Moya EM, 2014, PUBLIC HEALTH ACTION, V4, P226, DOI 10.5588/pha.14.0065; Mukerji R, 2018, ANN GLOB HEALTH, V84, P727, DOI 10.29024/aogh.2383; Ozturk FO, 2014, INT J COMMUNITY MED, V1, P37, DOI DOI 10.5455/2394-; Przybylski G, 2014, MED SCI MONITOR, V20, P2125, DOI 10.12659/MSM.890709; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Sendhilkumar Muthappan, 2017, Indian J Endocrinol Metab, V21, P56, DOI 10.4103/2230-8210.196006; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Suganthi P, 2008, INT J TUBERC LUNG D, V12, P1268; Tadesse S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152900; Vancampfort D, 2017, AM J EPIDEMIOL, V186, P979, DOI 10.1093/aje/kwx159; Vaz Manjulika, 2016, Indian J Med Ethics, V1, P8; WHO, 2019, GLOB TUB REP; Yilmaz A, 2016, ACTA PAUL ENFERM, V29, P549, DOI 10.1590/1982-0194201600076	36	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243433	10.1371/journal.pone.0243433	http://dx.doi.org/10.1371/journal.pone.0243433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8OF	33290413	Green Published, gold			2022-12-26	WOS:000598620100021
J	Hailemeskel, HS; Assebe, T; Alemayehu, T; Belay, DM; Teshome, F; Baye, A; Bayih, WA				Hailemeskel, Habtamu Shimels; Assebe, Tesfaye; Alemayehu, Tadesse; Belay, Demeke Mesfin; Teshome, Fentaw; Baye, Alemwork; Bayih, Wubet Alebachew			Determinants of short birth interval among ever married reproductive age women: A community based unmatched case control study at Dessie city administration, Northern Ethiopia	PLOS ONE			English	Article							INTERPREGNANCY INTERVAL; PREGNANCY INTERVAL; HEALTH; INFANT; RISK	Background Short birth interval is a universal public health problem resulting in adverse fetal, neonatal, child and maternal outcomes. In Ethiopia, more than 50% of the overall inter birth spacing is short. However, prior scientific evidence on its determinants is limited and even then findings are inconsistent. Methods A community -based unmatched case-control study was employed on 218 cases and 436 controls. Cases were ever married reproductive age women whose last delivery has been in the past five years with birth interval of less than 3 years between the latest two successive live births whereas those women with birth interval of 3-5 years were taken as controls. A multistage sampling technique was employed on 30% of the kebeles in Dessie city administration. A pre-tested interviewer based questionnaire was used to collect data by 16 trained diploma nurses and 8 health extension workers supervised by 4 BSc nurses. The collected data were cleaned, coded and double entered into Epi-data version 4.2 and exported to SPSS version 22. Binary logistic regression model was considered and those variables with PResult In this study, contraceptive use (AOR = 11.2, 95% CI: 5.95-21.15), optimal breast feeding for at least 2 years (AOR = 0.098, 95% CI:0.047-0.208), age at first birth <25 years (AOR = 0.36, 95% CI: 0.282-0.761), having male preceding child (AOR = 0.46, 95% CI: 0.166-0.793) and knowing the duration of optimum birth interval correctly (AOR = 0.45, 95% CI: 0.245-0.811) were significant determinants of short birth interval. Conclusion Contraceptive use, duration of breast feeding, age at first birth, preceding child sex and correct understanding of the duration of birth interval were significant determinants of short birth interval. Fortunately, all these significant factors are likely modifiable. Thus, the existing efforts of optimizing birth interval should be enhanced through proper designation and implementation of different strategies on safe breastfeeding practice, modern contraceptive use and maternal awareness about the health merits of optimum birth interval.	[Hailemeskel, Habtamu Shimels; Belay, Demeke Mesfin; Bayih, Wubet Alebachew] Debre Tabor Univ, Coll Hlth Sci, Dept Nursing, Debre Tabor, Ethiopia; [Assebe, Tesfaye] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia; [Alemayehu, Tadesse] Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Harar, Ethiopia; [Teshome, Fentaw] Debre Tabor Univ, Dept Hlth Serv Management, Debre Tabor, Ethiopia; [Baye, Alemwork] Wollo Univ, Dept Environm Hlth, Dessie, Ethiopia	Haramaya University; Haramaya University	Hailemeskel, HS (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Nursing, Debre Tabor, Ethiopia.	habtamushimels21@gmail.com	Teshome, Fentaw/ADZ-0398-2022; Bayih, Wubet Alebachew/AAF-5099-2019; Belay, Demeke Mesfin/ABD-7714-2021	Bayih, Wubet Alebachew/0000-0003-1439-4402; Belay, Demeke Mesfin/0000-0003-4786-2866; Teshome Dagnaw, Fentaw/0000-0002-4496-9089; Hailemeskel, Habtamu/0000-0002-5972-4818				[Anonymous], 2014, SPECIAL ISSUE LIBELL, V10, P5; [Anonymous], 2013, PANCREATOLOGY, V13, pe1; Appareddy S, 2017, J MATERN-FETAL NEO M, V30, P2640, DOI 10.1080/14767058.2016.1260115; Begna Z, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-116; Bener Abdulbari, 2012, Rev. Bras. Saude Mater. Infant., V12, P233, DOI 10.1590/S1519-38292012000300003; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Class QA, 2018, INT J EPIDEMIOL, V47, P1159, DOI 10.1093/ije/dyy042; Class QA, 2017, OBSTET GYNECOL, V130, P1304, DOI 10.1097/AOG.0000000000002358; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; CSA (Comite de la Securite Alimentaire Mondiale), 2012, P COM S CUR AL MOND, P1; Dadi AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126759; de Jonge HCC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0427-6; Dereje Tesfaye, 2015, TURKIYEKLINIKLERI J, V7, P63; Durkin MS, 2015, J AUTISM DEV DISORD, V45, P2056, DOI 10.1007/s10803-015-2368-y; Geidam Ad, 2016, BORNO MED J BORNO MED J, V13, P132; Gemmill A, 2013, OBSTET GYNECOL, V122, P64, DOI 10.1097/AOG.0b013e3182955e58; Hailu Desta, 2016, Int J Reprod Med, V2016, P6072437, DOI 10.1155/2016/6072437; Hanley GE, 2017, OBSTET GYNECOL, V129, P408, DOI 10.1097/AOG.0000000000001891; Kesetebirhan A., 2011, NATL GUIDELINE FAMIL; Mahande MJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0929-5; OsotsiAwiti Japheth, 2013, PRECEDING BIRTH INTE; Owonikoko KM., 2015, INT J REPROD CONTRAC, V4, P316, DOI [10.5455/2320-1770.ijrcog20150406, DOI 10.5455/2320-1770.IJRCOG20150406]; Rabbi AMF., 2013, DHAKA U J SCI, V61, P105, DOI 10.3329/dujs.v61i1.15105; Saadehl R., 1990, WHO B OMS, V68; Shahjada A., 2014, INT J MED SCI PUBLIC, V3, P723, DOI [10.5455/ijmsph.2014.070420141, DOI 10.5455/IJMSPH.2014.070420141]; Thapaliya R., 2015, Health Renaissance, V13, P169, DOI 10.3126/hren.v13i3.17965; Tsegaye D, 2017, INT J NURSING MIDWIF, V9, P102, DOI DOI 10.5897/IJNM2017.0258; UNICEF, 2015, BREASTF NUTR; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; World Health Organization, 2004, CONTR ISS AD HLTH DE; World Health Organization, 2006, REP WHO TECHN CONS B; Yohannes S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-38	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243046	10.1371/journal.pone.0243046	http://dx.doi.org/10.1371/journal.pone.0243046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275603	gold, Green Published			2022-12-26	WOS:000597150200016
J	Patil, S; Rao, A; Pathak, P; Kurle, S; Mane, A; Nirmalkar, A; Singhal, AK; Verma, V; Singh, MK; Reddy, DCS; Shete, A; Singh, M; Gangakhedkar, R; Panda, S				Patil, Sandip; Rao, Amrita; Pathak, Preety; Kurle, Swarali; Mane, Arati; Nirmalkar, Amit; Singhal, A. K.; Verma, Vinita; Singh, Mukesh Kumar; Reddy, D. C. S.; Shete, Ashwini; Singh, Manjula; Gangakhedkar, Raman; Panda, Samiran			Unsterile injection equipment associated with HIV outbreak and an extremely high prevalence of HCV-A case-control investigation from Unnao, India	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-USERS; INFECTION	The integrated counseling and testing center (ICTC) located in the district hospital, Unnao in the northern state of Uttar Pradesh (UP), India witnessed an increased detection of HIV among its attendees in July 2017. Subsequently, health camps were organized by the UP State AIDS Control Society in the villages and townships contributing to such detection. We conducted a case-control study to identify factors associated with this increased detection; 33 cases and 125 controls were enrolled. Cases were individuals, detected HIV sero-reactive during November 2017-April 2018 from three locations namely Premganj, Karimuddinpur and Chakmeerapur in the Bangarmau block of the district of Unnao. Controls hailed from the same geographical setting and tested HIV sero-nonreactive either in health camps or at ICTC centers from where the cases were detected. Misclassification bias was avoided by confirming HIV sero-status of both cases as well as controls prior to final analysis. Study participants were interviewed on various risk practices and invasive treatment procedures. They were also tested for HIV and other bio-markers reflecting unsafe injecting and sexual exposures such as hepatitis B surface antigen (HBsAg), anti-HCV antibody (HCV Ab), anti-herpes simplex-2 Immunoglobulin G (HSV-2 IgG) and rapid plasma regain (RPR) test for syphilis. Secondary data analysis on three time points during 2015 through 2018 revealed a rising trend of HIV among attendees of the ICTCs (ICTC-Hasanganj, ICTC-Unnao district hospital and ICTC- Nawabganj) catering to the entire district of Unnao. While there was a seven fold rise of HIV among ICTC attendees of Hasanganj (chi(2) value for trend 23.83; p < 0.001), the rise in Unnao district hospital was twofold (chi(2) value for trend 4.37; p < 0.05) and was tenfold at ICTC-Nawabganj (chi(2) value for trend 5.23; p < 0.05) indicating risk of infection prevailing throughout the district. Primary data was generated through interviews and laboratory investigations as mentioned above. The median age of cases and controls was 50 year (minimum 18 -maximum 68; IQR 31-57) and 38 year (minimum 18 -maximum 78; IQR 29-50) respectively. Thirty six percent of the cases and 47% of controls were male. A significantly higher proportion of cases (85%) had HCV Ab compared to controls (56%; OR 4.4, 95% CI 1.5-12.1); none reported injection drug use. However, cases and controls did not differ significantly regarding presence of HSV-2 IgG (6% versus 8% respectively). Neither any significant difference existed between cases and controls in terms of receiving blood transfusion, undergoing invasive surgical procedures, tattooing, tonsuring of head or skin piercing. In multivariate logistic regression model, 'unsafe injection exposure during treatment-seeking'(AOR 6.61, 95% CI 1.80-24.18) and 'receipt of intramuscular injection in last five years' (AOR 7.20, 95% CI 1.48-34.88) were independently associated with HIV sero-reactive status. The monophyletic clustering of HIV sequences from 14 cases (HIV-1 pol gene amplified) indicated a common ancestry. Availability of auto-disabled syringes and needles, empowerment of the local communities and effective regulatory practices across care settings would serve as important intervention measures in this context.	[Patil, Sandip; Rao, Amrita; Kurle, Swarali; Mane, Arati; Nirmalkar, Amit; Shete, Ashwini; Panda, Samiran] Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India; [Pathak, Preety] Uttar Pradesh State AIDS Control Soc, Lucknow, Uttar Pradesh, India; [Singhal, A. K.; Singh, Mukesh Kumar] Community Hlth Ctr, Dept Med & Hlth, Govt Uttar Pradesh, Bangarmau, India; [Verma, Vinita] Natl AIDS Control Org, New Delhi, India; [Reddy, D. C. S.] Natl AIDS Control Org, Tech Resource Grp, New Delhi, India; [Singh, Manjula; Gangakhedkar, Raman; Panda, Samiran] Indian Council Med Res Headquarter, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Panda, S (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India.; Panda, S (corresponding author), Indian Council Med Res Headquarter, New Delhi, India.	director@nariindia.org			Indian Council of Medical Research, New Delhi [HIV/50/183/2/2018-ECD II]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This case control study received funds from Indian Council of Medical Research, New Delhi under Short Term New Scheme (Order no. HIV/50/183/2/2018-ECD II, dated 22-03-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2019, LANCET HIV, V6, pE418, DOI 10.1016/S2352-3018(19)30179-1; Altaf A, 2016, J PAK MED ASSOC, V66, P1510; [Anonymous], 1990, TELEGRAPH; [Anonymous], 2014, NAT INT BIOL BEH SUR; [Anonymous], 2018, AL QURAAN, V7, P157; [Anonymous], CENS IND WEBS OFF RE; Ansari JA, 2013, J EPIDEMIOL GLOB HEA, V3, P261, DOI 10.1016/j.jegh.2013.06.001; Chaturbhuj DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087441; Dodge Jennifer L, 2014, J Coagul Disord, V4, P38; FOX R, 1994, LANCET, V344, P1038, DOI 10.1016/S0140-6736(94)91705-1; Goel A, 2019, J GASTROEN HEPATOL, V34, P321, DOI 10.1111/jgh.14466; Khatoon R, 2017, ANN TROP MED PUBLIC, V10, P199, DOI 10.4103/1755-6783.205586; Martinello M, 2016, AIDS REV, V18, P69; Ministry of Health & Family Welfare Government of India; National Health Mission, 2019, NAT ACT PLAN COMB VI; NAIK TN, 1991, AIDS, V5, P117, DOI 10.1097/00002030-199101000-00026; Panda S, 2014, INT J STD AIDS, V25, P596, DOI 10.1177/0956462413515659; Rouet F, 2018, CLIN INFECT DIS, V66, P1733, DOI 10.1093/cid/cix1071; Sarkar S., 1993, Bulletin on Narcotics, V45, P91; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Shantanu P, 2014, CLIN EPIDEMIOLOGY GL, V2, P19, DOI [10.1016/j.cegh.2013.03.001, DOI 10.1016/J.CEGH.2013.03.001]; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; UNDP, HUM DEV REP 2007; Wal N, BIOMEDICAL RES, V23, P390; World Health Organization, 1993, HIV AIDS PAND 1993 O; Zaid M, 2018, LANCET INFECT DIS, V18, P601, DOI 10.1016/S1473-3099(18)30281-0	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243534	10.1371/journal.pone.0243534	http://dx.doi.org/10.1371/journal.pone.0243534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275646	Green Published, gold			2022-12-26	WOS:000597150200026
J	Konishi, T				Konishi, Tomokazu			Principal component analysis of coronaviruses reveals their diversity and seasonal and pandemic potential	PLOS ONE			English	Article							SARS CORONAVIRUS; MECHANISMS; INFECTION	Coronaviruses and influenza viruses have similarities and differences. In order to comprehensively compare them, their genome sequencing data were examined by principal component analysis. Coronaviruses had fewer variations than a subclass of influenza viruses. In addition, differences among coronaviruses that infect a variety of hosts were also small. These characteristics may have facilitated the infection of different hosts. Although many of the coronaviruses were conservative, those repeatedly found among humans showed annual changes. If SARS-CoV-2 changes its genome like the Influenza H type, it will repeatedly spread every few years. In addition, the coronavirus family has many other candidates for new pandemics.	[Konishi, Tomokazu] Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan	Akita Prefectural University	Konishi, T (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan.	konishi@akita-pu.ac.jp	Konishi, Tomokazu/K-8067-2012	Konishi, Tomokazu/0000-0003-4826-6265				Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; Agol VI, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00067-17; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; CDC, 2020, SIM DIFF FLU COVID 1; Dawson P, 2019, VECTOR-BORNE ZOONOT, V19, P174, DOI 10.1089/vbz.2017.2191; Decaro N, 2020, VET MICROBIOL, V244, DOI 10.1016/j.vetmic.2020.108693; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Faust JS, 2020, JAMA INTERN MED, V180, P1045, DOI 10.1001/jamainternmed.2020.2306; Fu SH, 2011, PLOS NEGLECT TROP D, V5, pe1231; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Haber JE, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700229; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Konishi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55253-0; Konishi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55254-z; Konishi T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S7; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lu HC, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-3; MCCAULEY JW, 1983, BIOCHEM J, V211, P281, DOI 10.1042/bj2110281; National Genomics Data Center M Partners, 2020, NUCLEIC ACIDS RES, V48, pD24; RCore Team, 2020, R LANG ENV STAT COMP; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sarkar M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237300; Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059; Surya W, 2018, BBA-BIOMEMBRANES, V1860, P1309, DOI 10.1016/j.bbamem.2018.02.017; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Talbot HKB, 2009, J MED VIROL, V81, P853, DOI 10.1002/jmv.21443; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; World Health Organization, COR DIS COVID 19 PAN; World Health Organization, 2020, SEV AC RESP SYNDR SA; World Health Organization, MIDDL E RESP SYNDR C; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yuen KS, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00404-4; Zhang SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191789; Zhou CR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21190-7; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	38	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242954	10.1371/journal.pone.0242954	http://dx.doi.org/10.1371/journal.pone.0242954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270726	Green Published, gold			2022-12-26	WOS:000597149100052
J	Xia, X; Yu, CY; Bian, MJ; Sun, CB; Tanasa, B; Chang, KC; Bruffett, DM; Thakur, H; Shah, SH; Knasel, C; Cameron, EG; Kapiloff, MS; Goldberg, JL				Xia, Xin; Yu, Caroline Y.; Bian, Minjuan; Sun, Catalina B.; Tanasa, Bogdan; Chang, Kun-Che; Bruffett, Dawn M.; Thakur, Hrishikesh; Shah, Sahil H.; Knasel, Cara; Cameron, Evan G.; Kapiloff, Michael S.; Goldberg, Jeffrey L.			MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury	PLOS ONE			English	Article							NEURONAL SURVIVAL; PHOTORECEPTOR; PHOSPHORYLATION; NEUROTOXICITY; EXPRESSION; PLAYS	Loss of retinal ganglion cells (RGCs) in optic neuropathies results in permanent partial or complete blindness. Myocyte enhancer factor 2 (MEF2) transcription factors have been shown to play a pivotal role in neuronal systems, and in particular MEF2A knockout was shown to enhance RGC survival after optic nerve crush injury. Here we expanded these prior data to study bi-allelic, tri-allelic and heterozygous allele deletion. We observed that deletion of all MEF2A, MEF2C, and MEF2D alleles had no effect on RGC survival during development. Our extended experiments suggest that the majority of the neuroprotective effect was conferred by complete deletion of MEF2A but that MEF2D knockout, although not sufficient to increase RGC survival on its own, increased the positive effect of MEF2A knockout. Conversely, MEF2A over-expression in wildtype mice worsened RGC survival after optic nerve crush. Interestingly, MEF2 transcription factors are regulated by post-translational modification, including by calcineurin-catalyzed dephosphorylation of MEF2A Ser-408 known to increase MEF2A-dependent transactivation in neurons. However, neither phospho-mimetic nor phospho-ablative mutation of MEF2A Ser-408 affected the ability of MEF2A to promote RGC death in vivo after optic nerve injury. Together these findings demonstrate that MEF2 gene expression opposes RGC survival following axon injury in a complex hierarchy, and further support the hypothesis that loss of or interference with MEF2A expression might be beneficial for RGC neuroprotection in diseases such as glaucoma and other optic neuropathies.	[Xia, Xin; Yu, Caroline Y.; Bian, Minjuan; Sun, Catalina B.; Tanasa, Bogdan; Chang, Kun-Che; Bruffett, Dawn M.; Thakur, Hrishikesh; Shah, Sahil H.; Knasel, Cara; Cameron, Evan G.; Kapiloff, Michael S.; Goldberg, Jeffrey L.] Stanford Univ, Sch Med, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol,Byers Eye Inst, Palo Alto, CA 94304 USA; [Kapiloff, Michael S.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Kapiloff, Michael S.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Kapiloff, MS; Goldberg, JL (corresponding author), Stanford Univ, Sch Med, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol,Byers Eye Inst, Palo Alto, CA 94304 USA.; Kapiloff, MS (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.; Kapiloff, MS (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA.	kapiloff@stanford.edu; jlgoldbe@stanford.edu		Shah, Sahil/0000-0002-6601-219X; Kapiloff, Michael/0000-0002-7005-6953; Goldberg, Jeffrey/0000-0002-1390-7360; Chang, Kun-Che/0000-0002-0871-5612	National Institutes of Health [EY026766, EY031167, P30EY026877]; Medical Technologies Enterprise Consortium; Research to Prevent Blindness, Inc..	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Technologies Enterprise Consortium; Research to Prevent Blindness, Inc..(Research to Prevent Blindness (RPB))	This work was supported in part by National Institutes of Health Grants EY026766 (M. S.K. and J.L.G.), EY031167 (M.S.K.), P30EY026877 to Stanford University, the Medical Technologies Enterprise Consortium, and an unrestricted grant from Research to Prevent Blindness, Inc.. M.S.K., and J.L.G. designed research; M.S.K., and J.L.G. wrote and revised the paper; M.S.K., and J.L.G made decision to publish.	Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; Andzelm MM, 2015, NEURON, V86, P247, DOI 10.1016/j.neuron.2015.02.038; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Boczek T, 2019, J NEUROSCI, V39, P5466, DOI 10.1523/JNEUROSCI.2752-18.2019; Cameron EG, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3559; Chan SF, 2014, J NEUROSCI, V34, P4640, DOI 10.1523/JNEUROSCI.2510-12.2014; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Galvao J, 2018, INVEST OPHTH VIS SCI, V59, P2736, DOI 10.1167/iovs.17-23319; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Li JL, 2019, J BIOL CHEM, V294, P2543, DOI 10.1074/jbc.RA118.005465; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Majidi SP, 2019, CELL REP, V29, P2001, DOI 10.1016/j.celrep.2019.10.033; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Masuda T, 2015, NEURON, V86, P7, DOI 10.1016/j.neuron.2015.03.057; Nagar S, 2017, INVEST OPHTH VIS SCI, V58, P3741, DOI 10.1167/iovs.17-21767; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Omori Y, 2015, GENES CELLS, V20, P408, DOI 10.1111/gtc.12233; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Perry RLS, 2009, MOL CELL BIOL, V29, P3355, DOI 10.1128/MCB.00227-08; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Prasov L, 2012, DEV BIOL, V368, P214, DOI 10.1016/j.ydbio.2012.05.005; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rashid AJ, 2014, GENES BRAIN BEHAV, V13, P118, DOI 10.1111/gbb.12058; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Vargas MAX, 2012, CELL SIGNAL, V24, P1496, DOI 10.1016/j.cellsig.2012.03.017; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Wang Y, 2015, EBIOMEDICINE, V2, P1880, DOI 10.1016/j.ebiom.2015.10.025; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Wolf A, 2017, BIOCHEM BIOPH RES CO, V483, P346, DOI 10.1016/j.bbrc.2016.12.141; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2	39	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242884	10.1371/journal.pone.0242884	http://dx.doi.org/10.1371/journal.pone.0242884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315889	Green Published, gold			2022-12-26	WOS:000600186100081
J	Bae, IS; Bak, KH; Chun, HJ; Il Ryu, J; Park, SJ; Lee, SJ				Bae, In-Suk; Bak, Koang-Hum; Chun, Hyoung-Joon; Il Ryu, Je; Park, Sung-Jae; Lee, Sung-Jae			Biomechanical analysis of a newly developed interspinous process device conjunction with interbody cage based on a finite element model	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; ADJACENT SEGMENT DISEASE; LUMBAR SPINE; INVITED SUBMISSION; PERIPHERAL-NERVES; IN-VITRO; FUSION; SYSTEM; DISC; STABILIZATION	Purpose This study aimed to investigate the biomechanical effects of a newly developed interspinous process device (IPD), called TAU. This device was compared with another IPD (SPIRE) and the pedicle screw fixation (PSF) technique at the surgical and adjacent levels of the lumbar spine. Materials and methods A three-dimensional finite element model analysis of the L1-S1 segments was performed to assess the biomechanical effects of the proposed IPD combined with an interbody cage. Three surgical models-two IPD models (TAU and SPIRE) and one PSF model-were developed. The biomechanical effects, such as range of motion (ROM), intradiscal pressure (IDP), disc stress, and facet loads during extension were analyzed at surgical (L3-L4) and adjacent levels (L2-L3 and L4-L5). The study analyzed biomechanical parameters assuming that the implants were perfectly fused with the lumbar spine. Results The TAU model resulted in a 45%, 49%, 65%, and 51% decrease in the ROM at the surgical level in flexion, extension, lateral bending, and axial rotation, respectively, when compared to the intact model. Compared to the SPIRE model, TAU demonstrated advantages in stabilizing the surgical level, in all directions. In addition, the TAU model increased IDP at the L2-L3 and L4-L5 levels by 118.0% and 78.5% in flexion, 92.6% and 65.5% in extension, 84.4% and 82.3% in lateral bending, and 125.8% and 218.8% in axial rotation, respectively. Further, the TAU model exhibited less compensation at adjacent levels than the PSF model in terms of ROM, IDP, disc stress, and facet loads, which may lower the incidence of the adjacent segment disease (ASD). Conclusion The TAU model demonstrated more stabilization at the surgical level than SPIRE but less stabilization than the PSF model. Further, the TAU model demonstrated less compensation at adjacent levels than the PSF model, which may lower the incidence of ASD in the long term. The TAU device can be used as an alternative system for treating degenerative lumbar disease while maintaining the physiological properties of the lumbar spine and minimizing the degeneration of adjacent segments.	[Bae, In-Suk] Eulji Univ, Dept Neurosurg, Eulji Hosp, Seoul, South Korea; [Bak, Koang-Hum; Chun, Hyoung-Joon] Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea; [Il Ryu, Je] Hanyang Univ, Dept Neurosurg, Guri Hosp, Guri, Gyonggi Do, South Korea; [Park, Sung-Jae] GS Med Co Ltd, R&D Ctr, Cheongju, Chungcheongbuk, South Korea; [Lee, Sung-Jae] Inje Univ, Coll Biomed Sci & Engn, Dept Biomed Engn, Gimhae Si, Gyeongsangnam D, South Korea	Eulji University; Hanyang University; Hanyang University; Inje University	Bak, KH (corresponding author), Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea.	pkh2325@hanyang.ac.kr			Hanyang University [HY201900000003361]; GS Medical Co., Ltd.	Hanyang University; GS Medical Co., Ltd.	This work was supported by the research fund of Hanyang University (HY201900000003361). This work was also supported by a grant from the GS Medical Co., Ltd. The funder provided support in the form of salaries for authors [S-J, Park], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Barbagallo GMV, 2009, NEUROSURGERY, V65, P111, DOI 10.1227/01.NEU.0000346254.07116.31; Bellini CM, 2007, J SPINAL DISORD TECH, V20, P423, DOI 10.1097/BSD.0b013e318031af6f; Bono CM, 2007, J SPINAL DISORD TECH, V20, P255, DOI 10.1097/BSD.0b013e3180331352; Bono CM, 2004, SPINE, V29, P455, DOI 10.1097/01.BRS.0000090825.94611.28; Chen WM, 2009, SPINE, V34, pE716, DOI 10.1097/BRS.0b013e3181ae23d1; Choi J, 2016, J KOREAN NEUROSURG S, V59, P91, DOI 10.3340/jkns.2016.59.2.91; Erbulut DU, 2013, ADV ORTHOP, V2013, DOI 10.1155/2013/451956; Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013; Gazzeri R, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15244; Godzik J, 2016, SPINE, V41, pE902, DOI 10.1097/BRS.0000000000001480; GOEL VK, 1995, SPINE, V20, P689, DOI 10.1097/00007632-199503150-00010; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Jutte PC, 2002, EUR SPINE J, V11, P594, DOI 10.1007/s00586-002-0469-8; Karahalios DG, 2010, J NEUROSURG-SPINE, V12, P372, DOI 10.3171/2009.10.SPINE09305; Kim HJ, 2012, J KOREAN NEUROSURG S, V52, P359, DOI 10.3340/jkns.2012.52.4.359; Kim HJ, 2010, MED BIOL ENG COMPUT, V48, P703, DOI 10.1007/s11517-010-0621-2; Kim TY, 2012, SPINE, V37, P1456, DOI 10.1097/BRS.0b013e31824da81d; Kim YH, 2015, INT J PRECIS ENG MAN, V16, P997, DOI 10.1007/s12541-015-0129-7; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Panjabi M, 2007, SPINE, V32, P959, DOI 10.1097/01.brs.0000260792.13893.88; Panjabi MM, 2007, CLIN BIOMECH, V22, P257, DOI 10.1016/j.clinbiomech.2006.08.006; Papp T, 1997, SPINE, V22, P151, DOI 10.1097/00007632-199701150-00005; Park P, 2004, SPINE, V29, P1938, DOI 10.1097/01.brs.0000137069.88904.03; Richards JC, 2005, SPINE, V30, P744, DOI 10.1097/01.brs.0000157483.28505.e3; Swanson KE, 2003, SPINE, V28, P26, DOI 10.1097/00007632-200301010-00008; Techy F, 2013, SPINE J, V13, P572, DOI 10.1016/j.spinee.2013.01.042; Wang JC, 2006, J NEUROSURG-SPINE, V4, P132, DOI 10.3171/spi.2006.4.2.132; Wang JC, 2006, J NEUROSURG-SPINE, V4, P160, DOI 10.3171/spi.2006.4.2.160; WEINSTEIN JN, 1988, SPINE, V13, P1012, DOI 10.1097/00007632-198809000-00008; Wilke HJ, 2008, EUR SPINE J, V17, P1049, DOI 10.1007/s00586-008-0657-2; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020; Zander T, 2001, CLIN BIOMECH, V16, pS73, DOI 10.1016/S0268-0033(00)00108-X	33	1	1	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243771	10.1371/journal.pone.0243771	http://dx.doi.org/10.1371/journal.pone.0243771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306706	Green Published, gold			2022-12-26	WOS:000600144200061
J	Lee, S; Kim, JH; Moon, H; Lee, HJ; Han, JK				Lee, Seunghyun; Kim, Jung Hoon; Moon, Hyungwon; Lee, Hak Jong; Han, Joon Koo			Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; TREATMENT RESPONSE; THERAPY; RESISTANCE; DELIVERY	Purpose To assess the feasibility of the combined sorafenib (SOR) and doxorubicin-loaded microbubble-albumin nanoparticle complex (DOX-MAC) treatment effect in an orthotopic rat model of hepatocellular carcinoma (HCC). Materials and methods Sixty-two rats with N1-S1 hepatoma were divided into four groups according to the treatment methods, i.e. G1 (SOR and DOX-MAC; n = 12), G2 (SOR; n = 15), G3 (DOX-MAC; n = 12), G4 (DOX; n = 11), and G5 (normal saline; n = 12). We performed the theragnostic, contrast-enhanced ultrasound examination and treatment at the baseline, one-week, and two-weeks. Tumor volume and perfusion parameters were compared at each time point and the differences between all of the groups over time were analyzed using repeated measures ANOVA. We also analyzed the apoptotic index and microvessel density (MVD) per each tumor specimen in all of the groups. Results The tumors increased from the beginning in all of the groups to the final follow-up, whereas the tumor growth in the G1 group and the G2 group was inhibited during the treatment period compared to the baseline tumor volume (P = 0.016 and P = 0.031). The G1 group resulted in tumor growth inhibition compared to the control group (P = 0.008). The G1 group showed that the peak enhancement and wash-in area under the curve were lower than that of the G4 group (P = 0.010 and 0.022). However, there was no difference in perfusion parameters in the other treated group compared to control group. The MVD of the G1 group tumor was lower than that of the G4 group (P = .016). Conclusion Our results suggest that the combination therapy of SOR and DOX-MAC can cause inhibition of tumor growth after treatment and that this therapy can be adequately monitored using the theragnostic DOX-MAC agent.	[Lee, Seunghyun; Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Lee, Hak Jong; Han, Joon Koo] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Moon, Hyungwon; Lee, Hak Jong] IMGT Co Ltd, Seongnam, South Korea; [Lee, Hak Jong] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.	jhkim2008@gmail.com		Lee, Seunghyun/0000-0003-1858-0640	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B4004951]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by a grant from the research supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B4004951).The IGMT Co. (Seongnam, Republic of Korea, http://nanoimgt.com) provided support in the form of salaries for authors [H.M., and H.J.L.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Alfa G, 2016, P AM SOC CLIN ONC S4, V34, P192, DOI DOI 10.1200/jco.2016.34.4_suppl.192; Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; Buijs M, 2012, J VASC INTERV RADIOL, V23, P1685, DOI 10.1016/j.jvir.2012.08.025; CHEN Y, 1994, J CONTROL RELEASE, V31, P49, DOI 10.1016/0168-3659(94)90250-X; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi JW, 2016, ABDOM RADIOL, V41, P257, DOI 10.1007/s00261-015-0591-9; Chowdhury SM, 2016, J CONTROL RELEASE, V238, P272, DOI 10.1016/j.jconrel.2016.08.005; Cochran MC, 2011, ACAD RADIOL, V18, P1341, DOI 10.1016/j.acra.2011.06.013; Duan WD, 2018, DRUG DES DEV THER, V12, P2149, DOI 10.2147/DDDT.S166402; Froehlich E, 2015, J ULTRAS MED, V34, P179, DOI 10.7863/ultra.34.2.179; Goetti R, 2012, INVEST RADIOL, V47, P18, DOI 10.1097/RLI.0b013e318229ff0d; Golla K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051960; Hoyt K, 2010, J ULTRAS MED, V29, P577, DOI 10.7863/jum.2010.29.4.577; Ignee A, 2010, EUR J RADIOL, V73, P153, DOI 10.1016/j.ejrad.2008.10.016; Kang JA, 2010, J ULTRAS MED, V29, P61, DOI 10.7863/jum.2010.29.1.61; Kim DW, 2017, J GASTROINTEST ONCOL, V8, P256, DOI 10.21037/jgo.2016.09.07; Kim YI, 2014, ANTICANCER RES, V34, P1715; Kuczynski EA, 2015, CANCER RES, V75, P2510, DOI 10.1158/0008-5472.CAN-14-3687; Kudo M, 2018, CANCERS, V10, DOI 10.3390/cancers10110412; Lassau N, 2010, CLIN CANCER RES, V16, P1216, DOI 10.1158/1078-0432.CCR-09-2175; Lee JH, 2019, CANCERS, V11, DOI 10.3390/cancers11040581; Lee S, 2018, EUR RADIOL, V28, P372, DOI 10.1007/s00330-017-4960-3; Lee TK, 2014, NUCL MED MOLEC IMAG, V48, P173, DOI 10.1007/s13139-014-0288-y; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Merz M, 2012, INVEST RADIOL, V47, P422, DOI 10.1097/RLI.0b013e31824f635a; Moon H, 2015, J BIOMED NANOTECHNOL, V11, P1183, DOI 10.1166/jbn.2015.2056; Mullick S, 2017, LASER ENG, V36, P3; Sirsi SR, 2014, ADV DRUG DELIVER REV, V72, P3, DOI 10.1016/j.addr.2013.12.010; Tinkov S, 2010, J CONTROL RELEASE, V148, P368, DOI 10.1016/j.jconrel.2010.09.004; WEIDNER N, 1995, AM J PATHOL, V147, P9; Yoon YI, 2014, THERANOSTICS, V4, P1133, DOI 10.7150/thno.9945; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhu FY, 2015, J DRUG TARGET, V23, P323, DOI 10.3109/1061186X.2014.996759	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243815	10.1371/journal.pone.0243815	http://dx.doi.org/10.1371/journal.pone.0243815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306731	gold, Green Published			2022-12-26	WOS:000600144200010
J	Mouritzen, NJ; Larsen, LH; Lauritzen, MH; Kjaer, TW				Mouritzen, Nanna J.; Larsen, Lisbeth H.; Lauritzen, Maja H.; Kjaer, Troels W.			Assessing the performance of a commercial multisensory sleep tracker	PLOS ONE			English	Article							POLYSOMNOGRAPHY; ACTIGRAPHY; ACCELEROMETER; RELIABILITY; VALIDATION; AGREEMENT; CHILDREN	Wearable sleep technology allows for a less intruding sleep assessment than PSG, especially in long-term sleep monitoring. Though such devices are less accurate than PSG, sleep trackers may still provide valuable information. This study aimed to validate a commercial sleep tracker, Garmin Vivosmart 4 (GV4), against polysomnography (PSG) and to evaluate intra-device reliability (GV4 vs. GV4). Eighteen able-bodied adults (13 females, M = 56.1 +/- 12.0 years) with no self-reported sleep disorders were simultaneously sleep monitored by GV4 and PSG for one night while intra-device reliability was monitored in one participant for 23 consecutive nights. Intra-device agreement was considered sufficient (observed agreement = 0.85 +/- 0.13, Cohen's kappa = 0.68 +/- 0.24). GV4 detected sleep with high accuracy (0.90) and sensitivity (0.98) but low specificity (0.28). Cohen's kappa was calculated for sleep/wake detection (0.33) and sleep stage detection (0.20). GV4 significantly underestimated time awake (p = 0.001) including wake after sleep onset (WASO) (p = 0.001), and overestimated light sleep (p = 0.045) and total sleep time (TST) (p = 0.001) (paired t-test). Sleep onset and sleep end differed insignificantly from PSG values. Our results suggest that GV4 is not able to reliably describe sleep architecture but may allow for detection of changes in sleep onset, sleep end, and TST (ICC >= 0.825) in longitudinally followed groups. Still, generalizations are difficult due to our sample limitations.	[Mouritzen, Nanna J.; Larsen, Lisbeth H.; Lauritzen, Maja H.; Kjaer, Troels W.] Zealand Univ Hosp, Ctr Neurophysiol, Dept Neurol, Roskilde, Denmark; [Mouritzen, Nanna J.; Kjaer, Troels W.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen	Mouritzen, NJ (corresponding author), Zealand Univ Hosp, Ctr Neurophysiol, Dept Neurol, Roskilde, Denmark.; Mouritzen, NJ (corresponding author), Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.	namou@regionsjaelland.dk			EU Interreg Deutschland-Danmark [087-1.1-18]; Lundbeck Foundation	EU Interreg Deutschland-Danmark; Lundbeck Foundation(Lundbeckfonden)	The project was funded by the EU Interreg Deutschland-Danmark (087-1.1-18) and a pre-graduate research scholarship was awarded by the Lundbeck Foundation to NJM.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; [Anonymous], 2018, VIVOSMART 4 OWNERS M; [Anonymous], 2017, NATL SUNDHEDSPROFIL; Beattie Z, 2017, PHYSIOL MEAS, V38, P1968, DOI 10.1088/1361-6579/aa9047; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cook JD, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12789; De Zambotti M, 2019, MED SCI SPORT EXER, V51, P1538, DOI 10.1249/MSS.0000000000001947; de Zambotti M, 2018, CHRONOBIOL INT, V35, P465, DOI 10.1080/07420528.2017.1413578; de Zambotti M, 2018, NEUROSCI BIOBEHAV R, V90, P84, DOI 10.1016/j.neubiorev.2018.03.027; de Zambotti M, 2015, SLEEP, V38, P1461, DOI 10.5665/sleep.4990; de Zambotti M, 2015, CHRONOBIOL INT, V32, P1024, DOI 10.3109/07420528.2015.1054395; Deng SJ, 2019, SLEEP BREATH, V23, P719, DOI 10.1007/s11325-019-01801-x; Edinger JD, 1997, SLEEP, V20, P1119, DOI 10.1093/sleep/20.12.1119; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gruwez A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210569; Gruwez A, 2017, INT J MED INFORM, V102, P87, DOI 10.1016/j.ijmedinf.2017.03.008; Kahawage P, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.12931; Kang SG, 2017, J PSYCHOSOM RES, V97, P38, DOI 10.1016/j.jpsychores.2017.03.009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mansukhani MP, 2017, CLEV CLIN J MED, V84, P451, DOI 10.3949/ccjm.84a.15173; Mantua J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050646; Matthews KA, 2018, SLEEP HEALTH, V4, P96, DOI 10.1016/j.sleh.2017.10.011; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; Miglis MG, 2017, SLEEP AND NEUROLOGIC DISEASE, P227, DOI 10.1016/B978-0-12-804074-4.00018-2; Montgomery-Downs HE, 2012, SLEEP BREATH, V16, P913, DOI 10.1007/s11325-011-0585-y; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Rosenberg RS, 2013, J CLIN SLEEP MED, V9, P81, DOI 10.5664/jcsm.2350; Sim I, 2019, NEW ENGL J MED, V381, P956, DOI 10.1056/NEJMra1806949; Stevens S, 2019, NEUROLOGY, V92; Su H, 2011, NEURAL COMPUT APPL, V20, P183, DOI 10.1007/s00521-010-0512-3; Toon E, 2016, J CLIN SLEEP MED, V12, P343, DOI 10.5664/jcsm.5580	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243214	10.1371/journal.pone.0243214	http://dx.doi.org/10.1371/journal.pone.0243214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306678	gold, Green Published			2022-12-26	WOS:000600144200051
J	Layton, JB; Li, WH; Yuan, JC; Gilman, JP; Horton, DB; Setoguchi, S				Layton, J. Bradley; Li, Wenhong; Yuan, Jiacan; Gilman, Joshua P.; Horton, Daniel B.; Setoguchi, Soko			Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions	PLOS ONE			English	Article							RISK; MORTALITY; ILLNESS; WAVE; MORBIDITY; DEHYDRATION; ADMISSIONS; MEDICINES; CLAIMS	Background Heatwaves kill more people than floods, tornadoes, and earthquakes combined and disproportionally affect older persons and those with chronic conditions. Commonly used medications for chronic conditions, e.g., diuretics, antipsychotics disrupt thermoregulation or fluid/electrolyte balance and may sensitive patients to heat. However, the effect of heat-sensitizing medications and their interactions with heatwaves are not well-quantified. We evaluated effects of potentially heat-sensitizing medications in vulnerable older patients. Methods US Medicare data were linked at the zip code level to climate data with surface air temperatures for June-August of 2007-2012. Patients were Medicare beneficiaries aged >= 65 years with chronic conditions including diabetes, dementia, and cardiovascular, lung, or kidney disease. Exposures were potentially heat-sensitizing medications including diuretics, anticholinergics, antipsychotics, beta blockers, stimulants, and anti-hypertensives. A heatwave was defined as >= 2 days above the 95(th) percentile of historical zip code-specific surface air temperatures. We estimated associations of heat-sensitizing medications and heatwaves with heat-related hospitalization using self-controlled case series analysis. Results We identified 9,721 patients with at least one chronic condition and heat-related hospitalization; 42.1% of these patients experienced a heatwave. Heatwaves were associated with an increase in heat-related hospitalizations ranging from 21% (95% CI: 7% to 38%) to 33% (95% CI: 14% to 55%) across medication classes. Several drug classes were associated with moderately elevated risk of heat-related hospitalization in the absence of heatwaves, with rate ratios ranging from 1.16 (95% CI: 1.00 to 1.35) to 1.37 (95% CI: 1.14 to 1.66). We did not observe meaningful synergistic interactions between heatwaves and medications. Conclusions Older patients with chronic conditions may be at heightened risk for heat-related hospitalization due to the use of heat-sensitizing medications throughout the summer months, even in the absence of heatwaves. Further studies are needed to confirm these findings and also to understand the effect of milder and shorter heat exposure.	[Layton, J. Bradley] RTI Hlth Solut, Raleigh, NC USA; [Li, Wenhong; Yuan, Jiacan] Duke Univ, Nicholas Sch Environm, Earth & Ocean Sci, Durham, NC 27708 USA; [Gilman, Joshua P.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Gilman, Joshua P.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Horton, Daniel B.] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ USA; [Horton, Daniel B.; Setoguchi, Soko] Rutgers Ctr Pharmacoepidemiol & Treatment Sci, New Brunswick, NJ 08901 USA; [Setoguchi, Soko] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA	Research Triangle Institute; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Setoguchi, S (corresponding author), Rutgers Ctr Pharmacoepidemiol & Treatment Sci, New Brunswick, NJ 08901 USA.; Setoguchi, S (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.	ss2894@rwjms.rutgers.edu	Layton, J. Bradley/B-4950-2018; Yuan, Jiacan/AAI-5731-2021; Horton, Daniel/R-5623-2017	Layton, J. Bradley/0000-0003-0994-5820; Yuan, Jiacan/0000-0003-3847-4490; Horton, Daniel/0000-0002-1831-1339	National Institutes of Health, National Institute on Aging [R21 AG044294]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23 AR070286]; Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults [GIL 200811.0010]; Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; CER Strategic Initiative of UNC's Clinical & Translational Science Award [UL1TR001111]; Cecil G. Sheps Center for Health Services Research, UNC; UNC School of Medicine; National Institutes of Health; Cystic Fibrosis Foundation; Pfizer Inc.,; Bristol-Myers Squibb	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults; Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; CER Strategic Initiative of UNC's Clinical & Translational Science Award; Cecil G. Sheps Center for Health Services Research, UNC; UNC School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Pfizer Inc.,(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was supported by the National Institutes of Health, National Institute on Aging (grant number R21 AG044294) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant number K23 AR070286). The sponsor had no role in the study design, data collection, analysis, interpretation, study report writing, or publication decision. The database infrastructure used for this project was funded by the Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults (GIL 200811.0010), Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; the CER Strategic Initiative of UNC's Clinical & Translational Science Award (UL1TR001111); the Cecil G. Sheps Center for Health Services Research, UNC; and the UNC School of Medicine. Portions of this work were presented as a poster at the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, August 2019. JBL was formerly employed by UNC where he received unrestricted salary support from the Center for Pharmacoepidemiology in the UNC Department of Epidemiology; member companies at the time included GlaxoSmithKline, Merck, and UCB Biosciences. JBL is currently an employee of RTI International, an independent, non-profit research organization which performs research for governmental and commercial clients, including pharmaceutical companies. SS has served as a member of the US FDA advisory committee and a consultant for Pfizer Inc., Medtronic, and Merck. SS has also received research funding from the National Institutes of Health, the Cystic Fibrosis Foundation, Pfizer Inc., and Bristol-Myers Squibb. All other authors have no conflicts to declare.	Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; [Anonymous], 2009, W STAR CORNER B 0310, V10, P3; [Anonymous], 2009, ENV PROT, V18, P7; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Bierbaum R, 2014, CLIMATE CHANGE IMPAC; Bobb JF, 2014, JAMA-J AM MED ASSOC, V312, P2659, DOI 10.1001/jama.2014.15715; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Ellett LMK, 2016, J CLIN PHARM THER, V41, P503, DOI 10.1111/jcpt.12418; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hallas J, 2014, J INTERN MED, V275, P581, DOI 10.1111/joim.12186; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hopp S, 2018, PREV MED, V110, P81, DOI 10.1016/j.ypmed.2018.02.001; JONES TS, 1982, JAMA-J AM MED ASSOC, V247, P3327, DOI 10.1001/jama.247.24.3327; KILBOURNE EM, 1982, JAMA-J AM MED ASSOC, V247, P3332, DOI 10.1001/jama.247.24.3332; Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743; Kwok JSS, 2005, ANN PHARMACOTHER, V39, P1940, DOI 10.1345/aph.1G130; Levitan EB, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0682-3; Liss A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39581; Majeed H, 2020, GEOHEALTH, V4, DOI 10.1029/2019GH000220; Martiello MA, 2010, SCAND J PUBLIC HEALT, V38, P826, DOI 10.1177/1403494810377685; Martin-Latry K, 2007, EUR PSYCHIAT, V22, P335, DOI 10.1016/j.eurpsy.2007.03.007; McCloskey A, 2000, COST OVERDOSE GROWTH; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; Mora C, 2017, NAT CLIM CHANGE, V7, P501, DOI [10.1038/nclimate3322, 10.1038/NCLIMATE3322]; Morano LH, 2017, PUBLIC HEALTH REP, V132, P326, DOI 10.1177/0033354917699826; ONEILL PA, 1990, AGE AGEING, V19, P68, DOI 10.1093/ageing/19.1.68; Pillai SK, 2014, J COMMUN HEALTH, V39, P90, DOI 10.1007/s10900-013-9743-4; Rebholz CM, 2015, AM J KIDNEY DIS, V66, P231, DOI 10.1053/j.ajkd.2015.01.016; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; RUBIN RM, 1995, J GERONTOL B-PSYCHOL, V50, pS291, DOI 10.1093/geronb/50B.5.S291; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sica D A, 2001, Congest Heart Fail, V7, P325, DOI 10.1111/j.1527-5299.2001.00274.x; Smith TT, 2013, CLIMATIC CHANGE, V118, P811, DOI 10.1007/s10584-012-0659-2; Sommet A, 2012, PHARMACOEPIDEM DR S, V21, P285, DOI 10.1002/pds.2307; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Szekely Miklos, 2015, Temperature (Austin), V2, P452, DOI 10.1080/23328940.2015.1051207; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; U.S. Global Change Research Program, 2016, IMPACTS CLIMATE CHAN, P54; Walsh J, 2014, HIGHER EDUCATION IN IRELAND: PRACTICES, POLICIES AND POSSIBILITIES, P5; Westaway K, 2015, J CLIN PHARM THER, V40, P363, DOI 10.1111/jcpt.12294; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2015, USING SAS SELF CONTR	45	7	7	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243665	10.1371/journal.pone.0243665	http://dx.doi.org/10.1371/journal.pone.0243665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301532	Green Published, gold			2022-12-26	WOS:000600143100003
J	Shiotani, T; Mino, S; Sato, W; Nishikawa, S; Yonezawa, M; Sievert, SM; Sawabe, T				Shiotani, Taiki; Mino, Sayaka; Sato, Wakana; Nishikawa, Sayo; Yonezawa, Masanori; Sievert, Stefan M.; Sawabe, Tomoo			Nitrosophilus alvini gen. nov., sp. nov., a hydrogen-oxidizing chemolithoautotroph isolated from a deep-sea hydrothermal vent in the East Pacific Rise, inferred by a genome-based taxonomy of the phylum "Campylobacterota"	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; EPSILON-PROTEOBACTERIA; BACTERIA; IDENTIFICATION; ANNOTATION; ALIGNMENT; SYSTEM	A novel bacterium, strain EPR55-1(T), was isolated from a deep-sea hydrothermal vent on the East Pacific Rise. The cells were motile rods. Growth was observed at temperatures between 50 and 60 degrees C (optimum, 60 degrees C), at pH values between 5.4 and 8.6 (optimum, pH 6.6) and in the presence of 2.4-3.2% (w/v) NaCl (optimum, 2.4%). The isolate used molecular hydrogen as its sole electron donor, carbon dioxide as its sole carbon source, ammonium as its sole nitrogen source, and thiosulfate, sulfite (0.01 to 0.001%, w/v) or elemental sulfur as its sole sulfur source. Nitrate, nitrous oxide (33%, v/v), thiosulfate, molecular oxygen (0.1%, v/v) or elemental sulfur could serve as the sole electron acceptor to support growth. Phylogenetic analyses based on both 16S rRNA gene sequences and whole genome sequences indicated that strain EPR55-1(T) belonged to the family Nitratiruptoraceae of the class "Campylobacteria", but it had the distinct phylogenetic relationship with the genus Nitratiruptor. On the basis of the physiological and molecular characteristics of the isolate, the name Nitrosophilus alvini gen. nov. sp. nov. is proposed, with EPR55-1(T) as the type strain (= JCM 32893(T) = KCTC 15925(T)). In addition, it is shown that "Nitratiruptor labii" should be transferred to the genus Nitrtosophilus; the name Nitrosophilus labii comb. nov. (JCM 34002(T) = DSM 111345(T)) is proposed for this organism. Furthermore, 16S rRNA gene-based and genome-based analyses showed that Cetia pacifica is phylogenetically associated with Caminibacter species. We therefore propose the reclassification of Cetia pacifica as Caminibacter pacificus comb. nov. (DSM 27783(T) = JCM 19563(T)). Additionally, AAI thresholds for genus classification and the reclassification of subordinate taxa within "Campylobacteria" are also evaluated, based on the analyses using publicly available genomes of all the campylobacterial species.	[Shiotani, Taiki; Mino, Sayaka; Sato, Wakana; Nishikawa, Sayo; Yonezawa, Masanori; Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries Sci, Lab Microbiol, Hakodate, Hokkaido, Japan; [Sievert, Stefan M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Hokkaido University; Woods Hole Oceanographic Institution	Mino, S (corresponding author), Hokkaido Univ, Fac Fisheries Sci, Lab Microbiol, Hakodate, Hokkaido, Japan.	sayaka.mino@fish.hokudai.ac.jp			JSPS KAKENHI [12J03037, 15H05991]; Takahashi Industrial and Economic Research Foundation; US National Science Foundation [OCE-1559198]; WHOI Investment in Science Fund	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takahashi Industrial and Economic Research Foundation; US National Science Foundation(National Science Foundation (NSF)); WHOI Investment in Science Fund	This study was partially supported by the JSPS KAKENHI (No. 12J03037 and No. 15H05991), the Takahashi Industrial and Economic Research Foundation, and US National Science Foundation grant OCE-1559198 and the WHOI Investment in Science Fund to S.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barco RA, 2020, MBIO, V11, DOI 10.1128/mBio.02475-19; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2001, APPL ENVIRON MICROB, V67, P4566, DOI 10.1128/AEM.67.10.4566-4572.2001; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319; Fukushi M, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101462; Gabriel MW, 2014, APPL ENVIRON MICROB, V80, P5359, DOI 10.1128/AEM.01206-14; Glaeser SP, 2015, SYST APPL MICROBIOL, V38, P237, DOI 10.1016/j.syapm.2015.03.007; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grosche A, 2015, INT J SYST EVOL MICR, V65, P1144, DOI 10.1099/ijs.0.000070; Harris HMB, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000115; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inoue A, 2016, J BIOL CHEM, V291, P15551, DOI 10.1074/jbc.M115.713230; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo CW, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku169; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mannion A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5171-2; McNichol J, 2018, P NATL ACAD SCI USA, V115, P6756, DOI 10.1073/pnas.1804351115; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mino S, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00184; Mino S, 2017, ISME J, V11, P909, DOI 10.1038/ismej.2016.178; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]; Nagata R, 2017, SYST APPL MICROBIOL, V40, P352, DOI 10.1016/j.syapm.2017.06.002; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P925, DOI 10.1099/ijs.0.63480-0; Nakagawa S, 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0021895, DOI 10.1002/9780470015902.A0021895]; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nakagawa T, 2006, ENVIRON MICROBIOL, V8, P37, DOI 10.1111/j.1462-2920.2005.00884.x; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Perez-Cataluna A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02077; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qin QL, 2014, J BACTERIOL, V196, P2210, DOI 10.1128/JB.01688-14; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rodriguez-R LM, 2018, NUCLEIC ACIDS RES, V46, pW282, DOI 10.1093/nar/gky467; Rodriguez-R LM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00014-18; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; SKIRROW MB, 1994, J COMP PATHOL, V111, P113, DOI 10.1016/S0021-9975(05)80046-5; Takai K, 2000, EXTREMOPHILES, V4, P9, DOI 10.1007/s007920050132; Takai K, 2004, INT J SYST EVOL MICR, V54, P25, DOI 10.1099/ijs.0.02787-0; Takai K, 2003, FEMS MICROBIOL LETT, V218, P167, DOI 10.1111/j.1574-6968.2003.tb11514.x; Tanizawa Y, 2018, BIOINFORMATICS, V34, P1037, DOI 10.1093/bioinformatics/btx713; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; Waite D. W., 2019, BERGEYS MANUAL SYSTE, P1, DOI [10.1002/9781118960608.bm00040, DOI 10.1002/9781118960608.BM00040]; Waite DW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00682; Wick RR, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006583; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Xu L, 2019, NUCLEIC ACIDS RES, V47, pW52, DOI 10.1093/nar/gkz333; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	60	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0241366	10.1371/journal.pone.0241366	http://dx.doi.org/10.1371/journal.pone.0241366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301463	Green Published, gold			2022-12-26	WOS:000600143100014
J	Tanaka, H; Yamaguchi, M; Katsuno, T; Sugiyama, H; Iwagaitsu, S; Nobata, H; Kinashi, H; Banno, S; Ishimoto, T; Ito, Y				Tanaka, Hiroya; Yamaguchi, Makoto; Katsuno, Takayuki; Sugiyama, Hirokazu; Iwagaitsu, Shiho; Nobata, Hironobu; Kinashi, Hiroshi; Banno, Shogo; Ishimoto, Takuji; Ito, Yasuhiko			Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis	PLOS ONE			English	Article							TREATMENT RESISTANCE; WEGENERS-GRANULOMATOSIS; RISK-FACTORS; VASCULITIS; ANCA; PREDICTORS; DIAGNOSIS	Previous studies have evaluated the risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and the biomarkers of AAV for predicting relapse. However, little is known about the association between the presence of sinusitis and relapse and changes in the ANCA levels in AAV. This single-center, retrospective cohort study included 104 consecutive patients who were newly diagnosed with myeloperoxidase (MPO)-ANCA-positive microscopic polyangiitis (MPA) between 2006 and 2018 and were treated at the Aichi Medical University Hospital in Japan. The relationships between sinusitis and relapse of vasculitis and elevated MPO-ANCA levels were assessed using multivariate Cox proportional hazards models that were adjusted for clinically relevant factors. During the entire follow-up period (median, 24 months; interquartile range, 7-54 months), 93 (89.4%) patients achieved remission. After achieving remission, 38 (40.9%) patients experienced at least one relapse (13 [65.0%] in the sinusitis group; 25 [34.3%] in the non-sinusitis group). Sinusitis was identified as a significant predictor of relapse (adjusted hazard ratio: 2.41, 95% confidence interval [CI]: 1.19-4.88; P = 0.015). Furthermore, sinusitis was more likely to be associated with elevated MPO-ANCA levels (adjusted hazard ratio: 2.59, 95% CI: 1.14-5.92; P = 0.024). In conclusion, sinusitis was associated with a higher risk of relapse and elevated MPO-ANCA levels in MPA patients, suggesting that careful management may be required to reduce the risk of relapse in patients with sinusitis. Further studies are needed to elucidate the optimal treatment strategy for these patients.	[Tanaka, Hiroya; Yamaguchi, Makoto; Katsuno, Takayuki; Sugiyama, Hirokazu; Iwagaitsu, Shiho; Nobata, Hironobu; Kinashi, Hiroshi; Banno, Shogo; Ito, Yasuhiko] Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan; [Tanaka, Hiroya] Suzuka Gen Hosp, Dept Nephrol, Suzuka, Japan; [Ishimoto, Takuji] Nagoya Univ, Dept Nephrol & Renal Replacement Therapy, Grad Sch Med, Nagoya, Aichi, Japan	Aichi Medical University; Nagoya University	Ito, Y (corresponding author), Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan.	yasuito@aichi-med-u.ac.jp	Ishimoto, Takuji/M-4873-2014	Ishimoto, Takuji/0000-0002-9861-5331; Ito, Yasuhiko/0000-0002-9676-6961				Beck L, 2013, AM J KIDNEY DIS, V62, P403, DOI 10.1053/j.ajkd.2013.06.002; Bhattacharyya N, 2003, LARYNGOSCOPE, V113, P125, DOI 10.1097/00005537-200301000-00023; Despujol CPD, 2010, RHEUMATOLOGY, V49, P2181, DOI 10.1093/rheumatology/keq244; Hara A, 2018, J RHEUMATOL, V45, P521, DOI 10.3899/jrheum.170508; Hogan SL, 2005, ANN INTERN MED, V143, P621, DOI 10.7326/0003-4819-143-9-200511010-00005; Huang L, 2020, CLIN EXP MED, V20, P199, DOI 10.1007/s10238-020-00614-7; Hutton HL, 2017, SEMIN NEPHROL, V37, P418, DOI 10.1016/j.semnephrol.2017.05.016; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jones RB, 2015, ANN RHEUM DIS, V74, P1178, DOI 10.1136/annrheumdis-2014-206404; Kemna MJ, 2015, J AM SOC NEPHROL, V26, P537, DOI 10.1681/ASN.2013111233; Li ZY, 2014, ARTHRITIS RHEUMATOL, V66, P1920, DOI 10.1002/art.38621; LUQMANI RA, 1994, Q J MED, V87, P671; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McClure M, 2019, CLIN J AM SOC NEPHRO, V14, P967, DOI 10.2215/CJN.06250519; Pagnoux C, 2008, ARTHRITIS RHEUM-US, V58, P2908, DOI 10.1002/art.23800; Salama AD, 2020, KIDNEY INT REP, V5, P7, DOI 10.1016/j.ekir.2019.10.005; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; TERVAERT JWC, 1990, LANCET, V336, P709; Tomasson G, 2012, RHEUMATOLOGY, V51, P100, DOI 10.1093/rheumatology/ker280; Walsh M, 2012, ARTHRITIS RHEUM-US, V64, P542, DOI 10.1002/art.33361; Watanabe H, 2018, ARTHRITIS RHEUMATOL, V70, P1626, DOI 10.1002/art.40538; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Yamaguchi M, 2020, RHEUMATOL INT, V40, P1291, DOI 10.1007/s00296-020-04562-z; Yamaguchi M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4300-0; Yamaguchi M, 2015, J RHEUMATOL, V42, P1853, DOI 10.3899/jrheum.141622; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243572	10.1371/journal.pone.0243572	http://dx.doi.org/10.1371/journal.pone.0243572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301468	gold, Green Published			2022-12-26	WOS:000600143100082
J	Jones, MD; Marshall, BM; Smith, SN; Christie, JT; Waengsothorn, S; Artchawakom, T; Suwanwaree, P; Strine, CT				Jones, Max Dolton; Marshall, Benjamin Michael; Smith, Samantha Nicole; Christie, Jack Taylor; Waengsothorn, Surachit; Artchawakom, Taksin; Suwanwaree, Pongthep; Strine, Colin Thomas			Can post-capture photographic identification as a wildlife marking technique be undermined by observer error? A case study using King Cobras in northeast Thailand	PLOS ONE			English	Article							R PACKAGE; LONG-TERM; POPULATION; SNAKE; RECOGNITION; SURVIVAL; MODELS; GROWTH; DEVICE; SIZE	Identifying individuals with natural markings is increasing in popularity to non-invasively support population studies. However, applying natural variation among individuals requires careful evaluation among target species, snakes for example have little validation of such methods. Here we introduce a mark-free identification method for King Cobras (Ophiophagus hannah) from the Sakaerat Biosphere Reserve, in northeast Thailand using both subcaudal scale pholidosis (scale arrangement and number) and unique ventral body markings to distinguish individuals. This project aims to evaluate the impact of observer error on individual identification. Observers of varying expertise, will distinguish between King Cobra individuals using identifying photographs from a previous study. We will ask randomly assigned observers to distinguish individuals via: 1) subcaudal pholidosis, 2) ventral body markings, and 3) combination of both measures. Using Bayesian logistic regression, we will assess the probability observers correctly distinguish individuals. Based on exploratory observations, we hypothesise that there will be a high probability of correct identifications using subcaudal pholidosis and ventral body markings. We aim to stimulate other studies implementing identification techniques for scrutinous assessment of such methods, in order to avoid subsequent errors during long-term population studies.	[Jones, Max Dolton; Marshall, Benjamin Michael; Smith, Samantha Nicole; Suwanwaree, Pongthep; Strine, Colin Thomas] Suranaree Univ Technol, Sch Biol, Nakhon Ratchasima, Thailand; [Christie, Jack Taylor; Waengsothorn, Surachit] Thailand Inst Sci & Technol Res, Nakhon Ratchasima, Thailand; [Artchawakom, Taksin] Populat & Community Dev Assoc, Bangkok, Thailand	Suranaree University of Technology	Jones, MD; Strine, CT (corresponding author), Suranaree Univ Technol, Sch Biol, Nakhon Ratchasima, Thailand.	maxdoltonjones@gmail.com; colin_strine@sut.ac.th	Marshall, Benjamin Michael/AAK-2091-2021; Strine, Colin/AAF-9968-2021	Marshall, Benjamin Michael/0000-0001-9554-0605; Strine, Colin/0000-0001-5614-292X; Jones, Max Dolton/0000-0002-3556-9796	National Science and Technological Development Agency of Thailand; Wildlife Reserves Singapore	National Science and Technological Development Agency of Thailand; Wildlife Reserves Singapore	We were supported by the National Science and Technological Development Agency of Thailand via P.S. and Wildlife Reserves Singapore via C.T.S. and M.D.J. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Baird P, 2017, WILDLIFE SOC B, V41, P785, DOI 10.1002/wsb.832; Bauwens D, ECOL EVOL, DOI [10.1002/ece3.3917, DOI 10.1002/ECE3.391729531711]; Bell SLM, 2007, NORTHEAST NAT, V14, P279, DOI 10.1656/1092-6194(2007)14[279:EOTSER]2.0.CO;2; BROWN W S, 1976, Journal of Herpetology, V10, P247, DOI 10.2307/1562986; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Senar JC, 2012, J FIELD ORNITHOL, V83, P180, DOI 10.1111/j.1557-9263.2012.00367.x; CARLSTROM D, 1946, NATURE, V158, P748, DOI 10.1038/158748b0; Castro ALF, 2005, ENVIRON BIOL FISH, V72, P213, DOI 10.1007/s10641-004-1479-7; Chaloupka M, 1999, MAR ECOL PROG SER, V184, P291, DOI 10.3354/meps184291; Cox MJ, 2012, SNAKES THAILAND CHUL; Dixon DR, 2003, MAMMAL REV, V33, P92, DOI 10.1046/j.1365-2907.2003.00001.x; Dubey S, 2008, MOL ECOL, V17, P3506, DOI 10.1111/j.1365-294X.2008.03859.x; Dyugmedzhiev Angel, 2018, Biharean Biologist, V12, P92; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Fabien A, 2004, AMPHIBIA-REPTILIA, V25, P9, DOI 10.1163/156853804322992797; Ferner JW, 2016, TECH ECOL CONSERVAT, P45; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Grafe TU, 2011, J HERPETOL, V45, P28, DOI 10.1670/10-016.1; Griesser M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051891; Guimaraes M, 2014, ECOL EVOL, V4, P1480, DOI 10.1002/ece3.1047; HAILEY A, 1985, J ZOOL, V207, P191; Heilbrun RD, 2003, WILDLIFE SOC B, V31, P748; Johansson O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63367-z; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kay M., 2019, TIDYBAYES TIDY DATA; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; Kendall WL, 2003, ECOLOGY, V84, P1058, DOI 10.1890/0012-9658(2003)084[1058:AMCMFM]2.0.CO;2; Koronkiewicz TJ, 2005, J FIELD ORNITHOL, V76, P94, DOI 10.1648/0273-8570-76.1.94; Le Chevalier H, 2017, ACTA HERPETOL, V12, P79, DOI 10.13128/Acta_Herpetol-19158; Lu HJ, 2020, REV FISH SCI AQUAC, V28, P117, DOI 10.1080/23308249.2019.1681358; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Madsen T, 2001, HERPETOLOGICA, V57, P147; Major T, 2020, HERPETOL J, V30, P173, DOI 10.33256/hj30.3.173176; Marshall BM, 2018, TROP CONSERV SCI, V11, DOI 10.1177/1940082918818401; Marshall BM, 2020, MOV ECOL, V8, DOI 10.1186/s40462-020-00219-5; Marshall BM, 2019, AMPHIBIA-REPTILIA, V40, P163, DOI 10.1163/15685381-18000008; McFarlane G., 1990, AM FISHERIES SOC S, V7, P9; McMahon CR, 2006, J WILDLIFE MANAGE, V70, P1484, DOI 10.2193/0022-541X(2006)70[1484:AHACFP]2.0.CO;2; McMahon CR, 2006, NATURE, V439, P392, DOI 10.1038/439392c; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Merrick MJ, 2017, BIOL CONSERV, V209, P34, DOI 10.1016/j.biocon.2017.01.021; Nalborczyk L, 2019, J SPEECH LANG HEAR R, V62, P1225, DOI 10.1044/2018_JSLHR-S-18-0006; Pierce Andrew J., 2007, Ringing & Migration, V23, P205; R Core Team, 2020, R LANG ENV STAT COMP; R Studio Team, 2020, RSTUDIO INT DEV ENV; Schmidt K, 2010, HERPETOL J, V20, P99; Seidel Dana, 2019, SCALES SCALE FUNCTIO; Shankar P. Gowri, 2013, Hamadryad, V36, P62; SHINE C, 1988, Herpetological Review, V19, P79; Silvy NJ, 2012, WILDLIFE TECHNIQUES, P339; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Sreekar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055935; van Roon Jierry, 2006, P191; Wickham H, 2020, DPLYR GRAMMAR DATA M; Wickham H, 2016, ELEGANT GRAPHICS DAT, VSecond; Wickham H, 2007, J STAT SOFTW, V21, P1; Wilke CO, 2018, GGRIDGES RIDGELINE P; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Winne Christopher T., 2006, Herpetological Review, V37, P52; Yang DD, 2013, ASIAN HERPETOL RES, V4, P134, DOI 10.3724/SP.J.1245.2013.00134; Zappalorti R. T., 2011, ENV IND, V6, P17; Zuiderwijk Annie, 1995, Levende Natuur, V96, P72	66	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242826	10.1371/journal.pone.0242826	http://dx.doi.org/10.1371/journal.pone.0242826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296389	gold, Green Published			2022-12-26	WOS:000598626100053
J	Taniguchi, C; Saka, H; Oze, I; Nakamura, S; Nozaki, Y; Tanaka, H				Taniguchi, Chie; Saka, Hideo; Oze, Isao; Nakamura, Sumie; Nozaki, Yasuhiro; Tanaka, Hideo			Relationship between the strength of craving as assessed by the Tobacco Craving Index and success of quitting smoking in Japanese smoking cessation therapy	PLOS ONE			English	Article							WITHDRAWAL SYMPTOMS; ABSTINENCE; DEPENDENCE; DYNAMICS; RELAPSE; SMOKERS; URGES	Background We previously developed the Tobacco Craving Index (TCI) to assess craving of smokers. In the present study, we validated the relationship between the TCI grade over the 5 sessions of Japanese smoking cessation therapy (SCT) and success of quitting smoking among 889 Japanese patients. Methods The Japanese SCT consists of 5 sessions of SCT (first session and sessions 2, 4, 8 and 12 weeks later). In the TCI questionnaire, patients are asked to rate their strength of craving and frequency of craving, each on a four-point Likert scale. Patients are classified into one of four grades based on their responses (0, I, II, III, with III indicating severe craving). The TCI questionnaire was administered to each participant at each session of the SCT. This study included participants of Japanese SCT who answered the TCI at the first session of the SCT at five Japanese smoking cessation clinics. Patients who dropped out of the SCT from the second to the fifth sessions were considered to have failed smoking cessation. To elucidate how much the TCI grade predicts smoking status at the last session, we performed multivariate logistic regression analysis with adjustment for confounding factors. Results Participants who had higher TCI grade(III) in the 2(nd) through 5(th) sessions showed significantly lower probability for success of quitting smoking than those who had lower TCI grades(0 or I) (adjusted odds ratio: 2(nd) session: 0.30, 3(rd) session: 0.15, 4(th) session: 0.06, 5(th) session: 0.02). Conclusions We validated the usefulness of the TCI grade for assessing probability of quitting smoking by using a large number of smoking cessation settings.	[Taniguchi, Chie] Aichi Med Univ, Coll Nursing, Nagakute, Aichi, Japan; [Taniguchi, Chie] Natl Hosp Org Nagoya Med Ctr, Dept Clin Res Ctr, Nagoya, Aichi, Japan; [Saka, Hideo] Matsunami Gen Hosp, Dept Resp Med, Gifu, Japan; [Saka, Hideo] Natl Hosp Org Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan; [Oze, Isao] Aichi Canc Ctr, Div Canc Epidemiol & Prevent, Dept Prevent Med, Res Inst, Nagoya, Aichi, Japan; [Nakamura, Sumie] Natl Hosp Org Nagoya Med Ctr, Dept Nursing, Nagoya, Aichi, Japan; [Nozaki, Yasuhiro] Japan Community Healthcare Org, Dept Resp Med, Chukyo Hosp, Nagoya, Aichi, Japan; [Nozaki, Yasuhiro] Tokoname Municipal Hosp, Dept Resp Med, Tokoname, Aichi, Japan; [Tanaka, Hideo] Fujiidera Publ Hlth Ctr Osaka Prefecture, Fujidera, Osaka, Japan	Aichi Medical University; Nagoya Medical Center; Nagoya Medical Center; Aichi Cancer Center; Nagoya Medical Center	Taniguchi, C (corresponding author), Aichi Med Univ, Coll Nursing, Nagakute, Aichi, Japan.; Taniguchi, C (corresponding author), Natl Hosp Org Nagoya Med Ctr, Dept Clin Res Ctr, Nagoya, Aichi, Japan.	c-taniguchi@aichi-med-u.ac.jp		Taniguchi, Chie/0000-0002-2529-8697	MEXT KAKENHI [19K19582]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a MEXT KAKENHI Grant-in-Aid for Young Scientist, Grant Number 19K19582 who received C.T. (https://www.jsps.go.jp/j-grantsinaid/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SS, 2008, NICOTINE TOB RES, V10, P35, DOI 10.1080/14622200701705076; Brown J, 2013, PSYCHOPHARMACOLOGY, V229, P209, DOI 10.1007/s00213-013-3100-2; Drummond DC, 2001, ADDICTION, V96, P33, DOI 10.1046/j.1360-0443.2001.961333.x; Durcan MJ, 2002, CLIN THER, V24, P540, DOI 10.1016/S0149-2918(02)85130-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2010, NICOTINE TOB RES, V12, P459, DOI [10.1093/ntr/ntq009, 10.1093/ntr/ntq059]; Javitz HS, 2012, ADDICTION, V107, P1501, DOI 10.1111/j.1360-0443.2012.03838.x; Moreno-Rius J, 2017, DRUG ALCOHOL DEPEN, V173, P151, DOI 10.1016/j.drugalcdep.2016.12.028; Motschman CA, 2018, PSYCHOPHARMACOLOGY, V235, P2001, DOI 10.1007/s00213-018-4898-4; Padovano HT, 2020, NICOTINE TOB RES, V22, P492, DOI 10.1093/ntr/ntz002; Piasecki TM, 2003, EXP CLIN PSYCHOPHARM, V11, P276, DOI 10.1037/1064-1297.11.4.276; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reese ED, 2016, NICOTINE TOB RES, V18, P48, DOI 10.1093/ntr/ntv054; Reid HH, 2016, ADDICT RES THEORY, V24, P48, DOI 10.3109/16066359.2015.1060967; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; SHIFFMAN SM, 1976, PSYCHOPHARMACOLOGY, V50, P35, DOI 10.1007/BF00634151; Strong DR, 2011, J ABNORM PSYCHOL, V120, P999, DOI 10.1037/a0023666; Swan GE, 1996, ADDICT BEHAV, V21, P481, DOI 10.1016/0306-4603(95)00070-4; Sweitzer MM, 2013, NICOTINE TOB RES, V15, P36, DOI 10.1093/ntr/nts080; Taniguchi C, 2019, TOB INDUC DIS, V17, DOI 10.18332/tid/114164; Taniguchi C, 2017, J ADV NURS, V73, P1681, DOI 10.1111/jan.13258; Taniguchi C, 2013, NURS RES, V62, P414, DOI 10.1097/NNR.0000000000000000; Watson NL, 2018, DRUG ALCOHOL DEPEN, V185, P75, DOI 10.1016/j.drugalcdep.2017.11.037; Wray JM, 2013, NICOTINE TOB RES, V15, P1167, DOI 10.1093/ntr/nts268; Zuo YT, 2017, PSYCHOPHARMACOLOGY, V234, P761, DOI 10.1007/s00213-016-4509-1	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243374	10.1371/journal.pone.0243374	http://dx.doi.org/10.1371/journal.pone.0243374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284809	Green Published, gold			2022-12-26	WOS:000597930500055
J	Consoli, A; Nettel-Aguirre, A; Spence, JC; Mchugh, TL; Mummery, K; McCormack, GR				Consoli, Anna; Nettel-Aguirre, Alberto; Spence, John C.; Mchugh, Tara-Leigh; Mummery, Kerry; McCormack, Gavin R.			Associations between objectively-measured and self-reported neighbourhood walkability on adherence and steps during an internet-delivered pedometer intervention	PLOS ONE			English	Article							INCREASE PHYSICAL-ACTIVITY; WALKING INTERVENTION; BLOOD-PRESSURE; URBAN FORM; ADULTS; ENVIRONMENT; METAANALYSIS; EXERCISE; MAINTENANCE; VALIDATION	Background Accumulating evidence suggests that the built environment is associated with physical activity. The extent to which the built environment may support adherence to physical activity interventions is unclear. The aim of this study was to investigate whether the neighbourhood built environment constrains or facilitates adherence and steps taken during a 12-week internet-delivered pedometer-based physical activity intervention (UWALK). Method The study was undertaken in Calgary (Canada) between May 2016 and August 2017. Inactive adults (n = 573) completed a telephone survey measuring sociodemographic characteristics and perceived neighbourhood walkability. Following the survey, participants were mailed a pedometer and instructions for joining UWALK. Participants were asked to report their daily pedometer steps into the online program on a weekly basis for 12 weeks (84 days). Walk Score (R) estimated objective neighbourhood walkability and the Neighbourhood Environment Walkability Scale-Abbreviated (NEWS-A) measured participants self-reported neighbourhood walkability. Regression models estimated covariate-adjusted associations of objective and self-reported walkability with: 1) adherence to the UWALK intervention (count of days with steps reported and count of days with 10000 steps reported), and; 2) average daily pedometer steps. Results On average, participants undertook 8565 (SD = 3030) steps per day, reported steps on 67 (SD = 22.3) of the 84 days, and achieved >= 10000 steps on 22 (SD = 20.5) of the 84 days. Adjusting for covariates, a one-unit increase in self-reported walkability was associated on average with 45.76 (95CI 14.91, 76.61) more daily pedometer steps. Walk Score (R) was not significantly associated with steps. Neither objective nor self-reported walkability were significantly associated with the UWALK adherence outcomes. Conclusion The neighbourhood built environment may support pedometer-measured physical activity but may not influence adherence to pedometer interventions. Perceived walkability may be more important than objectively-measured walkability in supporting physical activity during pedometer interventions.	[Consoli, Anna; Nettel-Aguirre, Alberto; McCormack, Gavin R.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Spence, John C.; Mchugh, Tara-Leigh; Mummery, Kerry] Univ Alberta, Fac Kinesiol Sport & Recreat, Edmonton, AB, Canada; [McCormack, Gavin R.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [McCormack, Gavin R.] Univ Calgary, Sch Architecture Planning & Landscape, Calgary, AB, Canada; [McCormack, Gavin R.] Waseda Univ, Fac Sport Sci, Tokyo, Japan	University of Calgary; University of Alberta; University of Calgary; University of Calgary; Waseda University	McCormack, GR (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.; McCormack, GR (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.; McCormack, GR (corresponding author), Univ Calgary, Sch Architecture Planning & Landscape, Calgary, AB, Canada.; McCormack, GR (corresponding author), Waseda Univ, Fac Sport Sci, Tokyo, Japan.	Gavin.McCormack@ucalgary.ca	Nettel-Aguirre, Alberto/ABB-9412-2021; Spence, John C/D-1548-2009	Spence, John C/0000-0001-8485-1336; Nettel-Aguirre, Alberto/0000-0001-6604-0652	Canadian Institutes of Health Research [MOP-142261, FDN-154331]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research [MOP-142261, FDN-154331].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, AESTHET SURG J, V39, P1, DOI 10.1093/asj/sjz164; [Anonymous], 2008, Drug Ther Bull, V46, P46, DOI 10.1136/dtb.2008.05.0013; [Anonymous], 2005, ELECT GOVT, V2, P11; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Baranowski T, 2009, INT J BEHAV NUTR PHY, V6, DOI [10.1186/1479-5868-6-32, 10.1186/1479-5868-6-6]; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Brown WJ, 2006, J PHYS ACT HEALTH, V3, P1, DOI DOI 10.1123/JPAH.3.1.1; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Canadian Society for Exercise Physiology (CSEP), CAN PHYS ACT GUID; Carr LJ, 2010, AM J PREV MED, V39, P460, DOI 10.1016/j.amepre.2010.07.007; CDC, 2017, STATUS REPORT STEP I; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Chan CB, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-21; Chan CB, 2008, J PHYS ACT HEALTH, V5, P648, DOI 10.1123/jpah.5.5.648; Choi J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4255-2; Cole R, 2015, HEALTH PLACE, V35, P60, DOI 10.1016/j.healthplace.2015.06.011; Colley RC, 2013, APPL PHYSIOL NUTR ME, V38, P520, DOI 10.1139/apnm-2012-0321; Conn VS, 2011, AM J PUBLIC HEALTH, V101, P751, DOI 10.2105/AJPH.2010.194381; Crouter SE, 2005, MED SCI SPORT EXER, V37, P1673, DOI 10.1249/01.mss.0000181677.36658.a8; Dawson J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.033340; De Cocker KA, 2007, AM J PREV MED, V33, P455, DOI 10.1016/j.amepre.2007.07.037; Duncan DT, 2013, GEOJOURNAL, V78, P407, DOI 10.1007/s10708-011-9444-4; Duncan DT, 2011, INT J ENV RES PUB HE, V8, P4160, DOI 10.3390/ijerph8114160; Dunn LA, 1998, EXERCISE, V30, P1076, DOI [10.1097/00005768-199807000-00009, DOI 10.1097/00005768-199807000-00009]; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Gebel K, 2011, HEALTH PLACE, V17, P519, DOI 10.1016/j.healthplace.2010.12.008; Grasser G, 2013, INT J PUBLIC HEALTH, V58, P615, DOI 10.1007/s00038-012-0435-0; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hanibuchi T, 2015, INT J ENV RES PUB HE, V12, P13350, DOI 10.3390/ijerph121013350; Hardman AE, 1998, BRIT J SPORT MED, V32, P184; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Heesch KC, 2005, WOMEN HEALTH, V41, P97, DOI 10.1300/J013v41n02_07; Hillsdon M, 2002, INT J EPIDEMIOL, V31, P808, DOI 10.1093/ije/31.4.808; Hino Kimihiro, 2017, Prev Med Rep, V8, P15, DOI 10.1016/j.pmedr.2017.07.009; Hirsch JA, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2013.301773; Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023; Jack E, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-71; Jones David B, 2009, Res Q Exerc Sport, V80, P710; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Kerr J, 2010, HEALTH PLACE, V16, P903, DOI 10.1016/j.healthplace.2010.05.002; King AC, 2006, AM J HEALTH PROMOT, V21, P24, DOI 10.4278/0890-1171-21.1.24; Krumm EM, 2006, J WOMENS HEALTH, V15, P202, DOI 10.1089/jwh.2006.15.202; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; Lee LL, 2010, INT J NURS STUD, V47, P1545, DOI 10.1016/j.ijnurstu.2010.08.008; Leslie E, 2010, LANDSCAPE URBAN PLAN, V95, P28, DOI 10.1016/j.landurbplan.2009.11.002; Manaugh K, 2011, TRANSPORT RES D-TR E, V16, P309, DOI 10.1016/j.trd.2011.01.009; MARCUS BH, 1993, J SPORT MED PHYS FIT, V33, P83; McCormack GR, 2019, PSYCHOL SPORT EXERC, V45, DOI 10.1016/j.psychsport.2019.101549; McCormack GR, 2013, J PHYS ACT HEALTH, V10, P961, DOI 10.1123/jpah.10.7.961; McCormack GR, 2012, HEALTH PLACE, V18, P1079, DOI 10.1016/j.healthplace.2012.04.014; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; McCormack GR, 2010, HEALTH PLACE, V16, P712, DOI 10.1016/j.healthplace.2010.03.003; McGinn AP, 2007, J URBAN HEALTH, V84, P162, DOI 10.1007/s11524-006-9136-4; McKercher CM, 2009, AM J PREV MED, V36, P161, DOI 10.1016/j.amepre.2008.09.036; Merom D, 2009, ANN BEHAV MED, V38, P137, DOI 10.1007/s12160-009-9138-z; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Muller-Riemenschneider F, 2008, PREV MED, V47, P354, DOI 10.1016/j.ypmed.2008.07.006; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Murray JM, 2017, SOC SCI MED, V192, P125, DOI 10.1016/j.socscimed.2017.09.021; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Orstad SL, 2017, ENVIRON BEHAV, V49, P904, DOI 10.1177/0013916516670982; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Perez LG, 2018, AM J HEALTH PROMOT, V32, P334, DOI 10.1177/0890117117742999; Prins RG, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-70; Prochaska J. O., 1994, ADV EXERCISE ADHEREN, P161; Ricbardson CR, 2008, ANN FAM MED, V6, P69, DOI 10.1370/afm.761; Robertson LB, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/974786; Robertson R., 2012, MENT HEALTH PHYS ACT, V5, P66, DOI DOI 10.1016/J.MHPA.2012.03.002; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Schmidt MD, 2009, AM J PREV MED, V37, P278, DOI 10.1016/j.amepre.2009.05.020; Seymour RB, 2010, AM J HEALTH BEHAV, V34, P660; Shaw R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-200; SIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706, DOI 10.2105/AJPH.85.5.706; Smith M, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0613-9; Spence JC, 2006, CAN J PUBLIC HEALTH, V97, pS36; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Statistics Canada, CANADIAN HLTH MEASUR; Sugiyama T, 2013, PREV MED, V57, P178, DOI 10.1016/j.ypmed.2013.05.015; Thielman J, 2015, PREV MED, V77, P174, DOI 10.1016/j.ypmed.2015.05.011; Thomas B, 2017, J CIV WAR ERA, V7, P16, DOI 10.1353/cwe.2017.0011; Togo F, 2005, INT J BIOMETEOROL, V50, P83, DOI 10.1007/s00484-005-0277-z; Tuckel P, 2015, AM J HEALTH BEHAV, V39, P241, DOI 10.5993/AJHB.39.2.11; Tudor-Locke C, 2009, SPORTS MED, V39, P981, DOI 10.2165/11319600-000000000-00000; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; WalkScore, 2012, WALK SCORE METHODOLO; Wallmann B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-33; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; White JL, 2005, WOMEN HEALTH, V41, P123, DOI 10.1300/J013v41n04_07; Winters M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2224-1; Zenk SN, 2009, HEALTH EDUC BEHAV, V36, P167, DOI 10.1177/1090198108321249	95	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242999	10.1371/journal.pone.0242999	http://dx.doi.org/10.1371/journal.pone.0242999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270692	gold, Green Published			2022-12-26	WOS:000597149100133
J	Darwish, HW; Bakheit, AH; Al-shakliah, NS; Rahman, AFMM; Darwish, IA				Darwish, Hany W.; Bakheit, Ahmed H.; Al-shakliah, Nasser S.; Rahman, A. F. M. Motiur; Darwish, Ibrahim A.			Experimental and computational evaluation of kolliphor RH 40 as a new fluorescence enhancer in development of a micellar-based spectrofluorimetric method for determination of lapatinib in tablets and urine	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; QUANTIFICATION; VALIDATION; PHARMACOKINETICS; SORAFENIB; DASATINIB; SUNITINIB	This study describes, for the first time, the experimental and computational investigations for evaluation of kolliphor RH 40 as a fluorescence enhancer surfactant in development of a spectrofluorimetric method for determination of lapatinib (LAP), a tyrosine kinase-inhibitor drug approved for targeted therapy of breast cancer. The investigations involved the ability of kolliphor RH 40 to form micelles with LAP and its enhancing effect on the weak native fluorescence of LAP at 420 nm after its excitation at 292 nm. Different variables were experimentally investigated: types of organized media, diluting solvent, buffer type and its pH value. The optimum values of the most influencing variables on the interaction of kolliphor RH 40 with LAP were refined by the computational response surface methodology (RSM). Under the optimized conditions, it was found that kolliphor RH 40 forms micelles with LAP, and its fluorescence enhancing ability was higher than other surfactants tested by similar to 10-folds. This micellar-enhanced effect of kolliphor RH 40 was employed in the development of a new sensitive spectrofluorimetric method for the accurate determination of LAP. The method was validated according to the guidelines of the International Conference on Harmonization (ICH) for validation of analytical procedures. The relative fluorescence intensity (RFI) was in excellent linear relationship (correlation coefficient was 0.998) with the LAP concentrations in the range of 50-1000 ng/mL. The method limit of detection (LOD) was 27.31 ng/mL and its accuracy was >= 99.82%. The method was successfully applied to the determination of LAP in its pharmaceutical tablets, tablets dissolution testing and content uniformity. The method application was extended to the determination of LAP in urine samples with an accuracy of 99.82 +/- 3.45%. The method is considered as an eco-friendly green approach and more efficient alternative method to the existing analytical methodologies for determination of LAP.	[Darwish, Hany W.; Bakheit, Ahmed H.; Al-shakliah, Nasser S.; Rahman, A. F. M. Motiur; Darwish, Ibrahim A.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Darwish, Hany W.] Cairo Univ, Dept Analyt Chem, Fac Pharm, Cairo, Egypt; [Bakheit, Ahmed H.] Al Neelain Univ, Fac Sci & Technol, Dept Chem, Khartoum, Sudan; [Al-shakliah, Nasser S.] Aden Univ, Coll Pharm, Dept Pharmaceut Chem, Aden, Yemen	King Saud University; Egyptian Knowledge Bank (EKB); Cairo University	Darwish, HW; Darwish, IA (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia.; Darwish, HW (corresponding author), Cairo Univ, Dept Analyt Chem, Fac Pharm, Cairo, Egypt.	hdarwish@ksu.edu.sa; idarwish@ksu.edu.sa	bakheit, ahmed H./S-5846-2019; bakheit, ahmed H./AAX-9051-2021; Rahman, A. F. M. Motiur/N-1340-2019; salem, nasser/GOJ-7865-2022	bakheit, ahmed H./0000-0002-0445-1357; bakheit, ahmed H./0000-0002-0445-1357; Rahman, A. F. M. Motiur/0000-0002-5807-5625; salem, nasser/0000-0002-3386-5145; Darwish, Ibrahim A/0000-0003-3821-623X	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [IFKSURG-322]	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia	This study was funded by the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia (project number IFKSURG-322).	Andriamanana I, 2013, J CHROMATOGR B, V926, P83, DOI 10.1016/j.jchromb.2013.01.037; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2019, INST CHEM SOL; [Anonymous], 2005, METH Q2AR1 INT C HAR; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bai F, 2006, J CHROMATOGR B, V831, P169, DOI 10.1016/j.jchromb.2005.11.044; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bouchet S, 2011, CLIN CHIM ACTA, V412, P1060, DOI 10.1016/j.cca.2011.02.023; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Burris HA, 2009, CLIN CANCER RES, V15, P6702, DOI 10.1158/1078-0432.CCR-09-0369; Couchman L, 2012, ANAL BIOANAL CHEM, V403, P1685, DOI 10.1007/s00216-012-5970-2; Devriese LA, 2014, INVEST NEW DRUG, V32, P481, DOI 10.1007/s10637-013-0055-4; Drugs.com, 2010, FDA APPR TYK 1 LIN C; Escudero-Ortiz V, 2013, THER DRUG MONIT, V35, P796, DOI 10.1097/FTD.0b013e3182959080; Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; FIDLER AT, 1987, BRIT J IND MED, V44, P292; Garrido-Cano I, 2015, TALANTA, V144, P1287, DOI 10.1016/j.talanta.2015.07.078; Ghasemi JB, 2013, SPECTROCHIM ACTA A, V115, P357, DOI 10.1016/j.saa.2013.06.054; Gotze L, 2012, CLIN CHIM ACTA, V413, P143, DOI 10.1016/j.cca.2011.09.012; Haouala A, 2009, J CHROMATOGR B, V877, P1982, DOI 10.1016/j.jchromb.2009.04.045; Higa GM, 2007, EXPERT REV ANTICANC, V7, P1183, DOI 10.1586/14737140.7.9.1183; Koch KM, 2013, CLIN PHARM DRUG DEV, V2, P336, DOI 10.1002/cpdd.45; Kristensen P, 2008, EUR J EPIDEMIOL, V23, P11, DOI 10.1007/s10654-007-9203-5; Lankheet NAG, 2013, BIOMED CHROMATOGR, V27, P466, DOI 10.1002/bmc.2814; LEUNG R, 1986, J COLLOID INTERF SCI, V113, P484, DOI 10.1016/0021-9797(86)90183-9; LINDBOHM ML, 1990, AM J IND MED, V17, P449, DOI 10.1002/ajim.4700170404; Miller J., 2010, CALIBRATION METHODS, Vsixth, P110; Nevado JJB, 2001, TALANTA, V53, P951, DOI 10.1016/S0039-9140(00)00580-4; Pesez M.J.B, 1974, COLORIMETRIC FLUORIM; Rockville M., 2007, US PHARMACOPOEIA 30; Saadat E, 2015, J CHROMATOGR SCI, V53, P932, DOI 10.1093/chromsci/bmu150; Sandra R, 2009, J CHROMATOGR B, V877, P3982; Tevaarwerk AJ, 2009, CLIN THER, V31, P2332, DOI 10.1016/j.clinthera.2009.11.029; Transchem corporation, 2017, KOLL RH 40; U.S. Food and Drug Administration, 1997, GUID IND DISTEST I; van Dyk M, 2016, J CHROMATOGR B, V1033, P17, DOI 10.1016/j.jchromb.2016.07.046; Walash MI, 2015, LUMINESCENCE, V30, P823, DOI 10.1002/bio.2828; Wan X, 2015, COLLOID SURFACE B, V136, P817, DOI 10.1016/j.colsurfb.2015.10.018; Wang CC, 2008, TALANTA, V75, P135, DOI 10.1016/j.talanta.2007.10.041; Wennborg H, 2002, SCAND J WORK ENV HEA, V28, P5, DOI 10.5271/sjweh.640; Wennborg H, 2000, J OCCUP ENVIRON MED, V42, P438, DOI 10.1097/00043764-200004000-00022; Wetterskog D, 2014, ONCOGENE, V33, P966, DOI 10.1038/onc.2013.41	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0239918	10.1371/journal.pone.0239918	http://dx.doi.org/10.1371/journal.pone.0239918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270656	gold, Green Published			2022-12-26	WOS:000597149100165
J	Fritz, B; Horvath, G; Hunig, R; Pereszlenyi, A; Egri, A; Guttmann, M; Schneider, M; Lemmer, U; Kriska, G; Gomard, G				Fritz, Benjamin; Horvath, Gabor; Hunig, Ruben; Pereszlenyi, Adam; Egri, Adam; Guttmann, Markus; Schneider, Marc; Lemmer, Uli; Kriska, Gyorgy; Gomard, Guillaume			Bioreplicated coatings for photovoltaic solar panels nearly eliminate light pollution that harms polarotactic insects	PLOS ONE			English	Article							ASPHALT ROADS; PV MODULE; ATTRACTIVENESS; PATTERNS; DECLINE; FLOWER	Many insect species rely on the polarization properties of object-reflected light for vital tasks like water or host detection. Unfortunately, typical glass-encapsulated photovoltaic modules, which are expected to cover increasingly large surfaces in the coming years, inadvertently attract various species of water-seeking aquatic insects by the horizontally polarized light they reflect. Such polarized light pollution can be extremely harmful to the entomofauna if polarotactic aquatic insects are trapped by this attractive light signal and perish before reproduction, or if they lay their eggs in unsuitable locations. Textured photovoltaic cover layers are usually engineered to maximize sunlight-harvesting, without taking into consideration their impact on polarized light pollution. The goal of the present study is therefore to experimentally and computationally assess the influence of the cover layer topography on polarized light pollution. By conducting field experiments with polarotactic horseflies (Diptera: Tabanidae) and a mayfly species (Ephemeroptera: Ephemera danica), we demonstrate that bioreplicated cover layers (here obtained by directly copying the surface microtexture of rose petals) were almost unattractive to these species, which is indicative of reduced polarized light pollution. Relative to a planar cover layer, we find that, for the examined aquatic species, the bioreplicated texture can greatly reduce the numbers of landings. This observation is further analyzed and explained by means of imaging polarimetry and ray-tracing simulations. The results pave the way to novel photovoltaic cover layers, the interface of which can be designed to improve sunlight conversion efficiency while minimizing their detrimental influence on the ecology and conservation of polarotactic aquatic insects.	[Fritz, Benjamin; Lemmer, Uli; Gomard, Guillaume] Karlsruhe Inst Technol KIT, Light Technol Inst LTI, Karlsruhe, Germany; [Horvath, Gabor; Pereszlenyi, Adam] Eotvos Lorand Univ, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary; [Hunig, Ruben] Ctr Solar Energy & Hydrogen Res Baden Wurttemberg, Stuttgart, Germany; [Egri, Adam; Kriska, Gyorgy] MTA Ctr Ecol Res, Danube Res Inst, Budapest, Hungary; [Egri, Adam] MTA Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary; [Guttmann, Markus; Schneider, Marc; Lemmer, Uli; Gomard, Guillaume] Karlsruhe Inst Technol KIT, Inst Microstruct Technol IMT, Eggenstein Leopoldshafen, Germany; [Kriska, Gyorgy] Eotvos Lorand Univ, Biol Inst, Grp Methodol Biol Teaching, Budapest, Hungary	Helmholtz Association; Karlsruhe Institute of Technology; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Helmholtz Association; Karlsruhe Institute of Technology; Eotvos Lorand University	Horvath, G (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary.	gh@arago.elte.hu	Lemmer, Uli/F-8257-2012	Lemmer, Uli/0000-0001-9892-329X; , Benjamin/0000-0001-6905-2309; Horvath, Gabor/0000-0002-9008-2411	Hungarian National Research, Development and Innovation Office [NKFIH K-123930, PD_19-131738]; Hungarian Economic Development and Innovation Operational Programme [GINOP-2.3.2-15-2016-00057]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Karlsruhe School of Optics and Photonics (KSOP); German Federal Ministry for Economic Affairs and Energy (BMWi) [0324179]	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Economic Development and Innovation Operational Programme; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Karlsruhe School of Optics and Photonics (KSOP); German Federal Ministry for Economic Affairs and Energy (BMWi)	This work was supported by the grant NKFIH K-123930 received by Gabor Horvath from the Hungarian National Research, Development and Innovation Office. Adam Egri was supported by the Hungarian Economic Development and Innovation Operational Programme (GINOP-2.3.2-15-2016-00057), the Hungarian National Research, Development and Innovation Office (grant PD_19-131738) and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. Benjamin Fritz acknowledges the support of the Karlsruhe School of Optics and Photonics (KSOP, www.ksop.idschools.kit.edu).Furthermore, this study was supported by the German Federal Ministry for Economic Affairs and Energy (BMWi) under contract number 0324179 (CISHiTec).	Black TV, 2020, J INSECT CONSERV, V24, P241, DOI 10.1007/s10841-019-00191-5; Blaho M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103339; Blaho M, 2013, PHYSIOL BEHAV, V119, P168, DOI 10.1016/j.physbeh.2013.06.013; Blaho M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041138; Christensen K. I., 1998, OPERA BOT, V135, P5, DOI DOI 10.1093/AOB/MCP211; Dong SY, 2019, APPL PHYS LETT, V115, DOI 10.1063/1.5111363; Egri A, 2017, J INSECT BEHAV, V30, P374, DOI 10.1007/s10905-017-9623-3; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; Fassbender B, 2011, 30 ISES BIENN SOL WO, P722, DOI 10.18086/swc.2011.03.04; Forister ML, 2019, CONSERV SCI PRACT, V1, DOI 10.1111/csp2.80; Fritz B, 2020, SOL ENERGY, V201, P666, DOI 10.1016/j.solener.2020.03.020; Fritz B, 2018, PROC SPIE, V10730, DOI 10.1117/12.2320555; Fritz B, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa6c46; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Herczeg T, 2015, PARASITOL RES, V114, P1087, DOI 10.1007/s00436-014-4280-3; Herczeg T, 2014, PARASITOL RES, V113, P4251, DOI 10.1007/s00436-014-4103-6; Hochkirch A, 2016, NATURE, V539, P141, DOI 10.1038/539141a; HORRIDGE GA, 1982, PROC R SOC SER B-BIO, V216, P25, DOI 10.1098/rspb.1982.0059; Horvath G., 2004, POLARIZED LIGHT ANIM; Horvath G., 2014, POLARIZED LIGHT POLA; Horvath G, 2014, SPR SER VIS RES, V2, P333, DOI 10.1007/978-3-642-54718-8_16; Horvath G, 2010, CONSERV BIOL, V24, P1644, DOI 10.1111/j.1523-1739.2010.01518.x; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Hunig R, 2016, ADV OPT MATER, V4, P1487, DOI 10.1002/adom.201600046; Huh D, 2019, RENEW ENERG, V135, P525, DOI 10.1016/j.renene.2018.12.055; Huh D, 2017, SOL ENERG MAT SOL C, V170, P33, DOI 10.1016/j.solmat.2017.05.031; Jager-Waldau A, 2018, PV STATUS REPORT; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Kriska G, 1998, J EXP BIOL, V201, P2273; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Lee E, 2019, SOL ENERG MAT SOL C, V194, P222, DOI 10.1016/j.solmat.2019.02.015; Liu Y, 2014, NANO ENERGY, V3, P127, DOI 10.1016/j.nanoen.2013.11.002; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Meglic A, 2019, P NATL ACAD SCI USA, V116, P21843, DOI 10.1073/pnas.1910807116; Powalla M, 2009, THIN SOLID FILMS, V517, P2111, DOI 10.1016/j.tsf.2008.10.126; Roslizar A, 2019, SOL ENERG MAT SOL C, V189, P188, DOI 10.1016/j.solmat.2018.09.017; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Schmager R, 2017, ACS PHOTONICS, V4, P2687, DOI 10.1021/acsphotonics.7b01153; SCHWIND R, 1995, J COMP PHYSIOL A, V177, P439; Seibold S, 2019, NATURE, V574, P671, DOI 10.1038/s41586-019-1684-3; Szaz D, 2016, J INSECT CONSERV, V20, P663, DOI 10.1007/s10841-016-9897-3; Vullers F, 2018, ACS APPL MATER INTER, V10, P2929, DOI 10.1021/acsami.7b15579; Whitney HM, 2011, ANN BOT-LONDON, V108, P609, DOI 10.1093/aob/mcr065; Zhu LX, 2014, OPTICA, V1, P32, DOI 10.1364/OPTICA.1.000032	44	3	3	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243296	10.1371/journal.pone.0243296	http://dx.doi.org/10.1371/journal.pone.0243296			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270747	Green Published, Green Accepted, gold			2022-12-26	WOS:000597149100159
J	Gustafsson, J; Robinson, J; Inda-Diaz, JS; Bjornson, E; Jornsten, R; Nielsen, J				Gustafsson, Johan; Robinson, Jonathan; Inda-Diaz, Juan S.; Bjornson, Elias; Jornsten, Rebecka; Nielsen, Jens			DSAVE: Detection of misclassified cells in single-cell RNA-Seq data	PLOS ONE			English	Article							EXPRESSION; LANDSCAPE	Single-cell RNA sequencing has become a valuable tool for investigating cell types in complex tissues, where clustering of cells enables the identification and comparison of cell populations. Although many studies have sought to develop and compare different clustering approaches, a deeper investigation into the properties of the resulting populations is lacking. Specifically, the presence of misclassified cells can influence downstream analyses, highlighting the need to assess subpopulation purity and to detect such cells. We developed DSAVE (Down-SAmpling based Variation Estimation), a method to evaluate the purity of single-cell transcriptome clusters and to identify misclassified cells. The method utilizes down-sampling to eliminate differences in sampling noise and uses a log-likelihood based metric to help identify misclassified cells. In addition, DSAVE estimates the number of cells needed in a population to achieve a stable average gene expression profile within a certain gene expression range. We show that DSAVE can be used to find potentially misclassified cells that are not detectable by similar tools and reveal the cause of their divergence from the other cells, such as differing cell state or cell type. With the growing use of single-cell RNA-seq, we foresee that DSAVE will be an increasingly useful tool for comparing and purifying subpopulations in single-cell RNA-Seq datasets.	[Gustafsson, Johan; Robinson, Jonathan; Bjornson, Elias; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Gustafsson, Johan; Robinson, Jonathan; Nielsen, Jens] Chalmers Univ Technol, Wallenberg Ctr Prot Res, Gothenburg, Sweden; [Inda-Diaz, Juan S.; Jornsten, Rebecka] Univ Gothenburg, Math Sci, Gothenburg, Sweden; [Inda-Diaz, Juan S.; Jornsten, Rebecka] Chalmers Univ Technol, Gothenburg, Sweden; [Bjornson, Elias] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab Cardiovasc & Metab Res, Gothenburg, Sweden; [Nielsen, Jens] BioInnovat Inst, Copenhagen, Denmark	Chalmers University of Technology; Chalmers University of Technology; University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.; Nielsen, J (corresponding author), Chalmers Univ Technol, Wallenberg Ctr Prot Res, Gothenburg, Sweden.; Nielsen, J (corresponding author), BioInnovat Inst, Copenhagen, Denmark.	nielsenj@chalmers.se		Bjornson, Elias/0000-0002-0003-6463; Gustafsson, Johan/0000-0001-5072-2659; Inda Diaz, Juan Salvador/0000-0002-3735-8300	Knut and Alice Wallenberg foundation; National Cancer Institute of the National Institutes of Health [F32CA220848]; Swedish Foundation for Strategic Research [BD15-0088]; European Union [282510 -BLUEPRINT]	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Union(European Commission)	This work was supported by funding from the Knut and Alice Wallenberg foundation (J. N.), the National Cancer Institute of the National Institutes of Health under award number F32CA220848 (J.R.), and the Swedish Foundation for Strategic Research under award number BD15-0088 (R.J.). This study makes use of data generated by the BLUEPRINT Consortium. A full list of the investigators who contributed to the generation of the data is available from www.blueprint-epigenome.eu. Funding for the project was provided by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 282510 -BLUEPRINT.	AlJanahi AA, 2018, MOL THER-METH CLIN D, V10, P189, DOI 10.1016/j.omtm.2018.07.003; Andrews TS, 2018, MOL ASPECTS MED, V59, P114, DOI 10.1016/j.mam.2017.07.002; [Anonymous], 2016, BLUEPRINT EPIGENOME; Arzalluz-Luque A, 2017, INT J BIOCHEM CELL B, V90, P161, DOI 10.1016/j.biocel.2017.07.006; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen JG, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1578-4; Chung NC, 2020, BIOINFORMATICS, V36, P3107, DOI 10.1093/bioinformatics/btaa087; de Kanter JK, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz543; Du A, 2018, F1000RESEARCH, P7, DOI 10.12688/f1000research.15666.3; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Gustafsson J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239495; Hicks SC, 2018, BIOSTATISTICS, V19, P562, DOI 10.1093/biostatistics/kxx053; Hwang WL, 2014, NAT CELL BIOL, V16; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kim J, 2015, NAT COMMUN, V6, P6781; Kim TY, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6305-x; Kiselev VY, 2018, NAT METHODS, V15, P359, DOI 10.1038/nmeth.4644; Konjar S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01683; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Li B., 2018, CENSUS IMMUNE CELLS; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Lun Aaron T L, 2016, F1000Res, V5, P2122; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Nicolas D, 2017, MOL BIOSYST, V13, P1280, DOI 10.1039/c7mb00154a; Opdam S, 2017, CELL SYST, V4, P318, DOI 10.1016/j.cels.2017.01.010; Picot J, 2012, CYTOTECHNOLOGY, V64, P109, DOI 10.1007/s10616-011-9415-0; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a; Schelker M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02289-3; Svensson V, 2020, NAT BIOTECHNOL, V38, P147, DOI 10.1038/s41587-019-0379-5; Townes FW, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1861-6; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243360	10.1371/journal.pone.0243360	http://dx.doi.org/10.1371/journal.pone.0243360			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270740	Green Published, gold			2022-12-26	WOS:000597149100056
J	King, BH; Baumgartner, JM; Kelly, KJ; Marmor, RA; Lowy, AM; Veerapong, J				King, Bradley H.; Baumgartner, Joel M.; Kelly, Kaitlyn J.; Marmor, Rebecca A.; Lowy, Andrew M.; Veerapong, Jula			Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; ENDOTHELIAL GROWTH-FACTOR; NEOADJUVANT CHEMOTHERAPY; PERITONEAL DISSEMINATION; TUMOR ANGIOGENESIS; FLUOROURACIL; OXALIPLATIN; COMBINATION; LEUCOVORIN; THERAPY	Background Preoperative bevacizumab has been reported to increase postoperative complication risk following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). We sought to review our experience with preoperative bevacizumab in patients undergoing CRS/HIPEC for peritoneal surface malignancy. Methods This is a retrospective review of patients who received neoadjuvant systemic therapy with or without bevacizumab prior to CRS/HIPEC at a high-volume academic center from 2007-2018. Results Of 499 patients, a total of 88 patients received neoadjuvant chemotherapy alone (n = 34) or in combination with bevacizumab (n = 54) within 3 months prior to CRS/HIPEC. No differences existed in 60-day major morbidity (17.6 vs. 16.7%, p = 0.81) or 60-day mortality (0 vs. 0%) between the two cohorts, and neoadjuvant bevacizumab was not associated with increased odds of overall complications (OR 0.86, 95% CI 0.35-2.09, p = 0.73) or major morbidity (OR 0.86, 95% CI 0.24-3.00, p = 0.81). Stratifying patients by primary tumor origin and post-operative complications did not reveal any significant differences between the two treatment groups. In addition, progression-free survival (PFS) and overall survival (OS) were similar in both cohorts. Conclusions Preoperative bevacizumab is not associated with increased morbidity or mortality following CRS/HIPEC. Neoadjuvant therapy employing this biologic agent is safe and should not be a deterrent for aggressive cytoreduction with curative intent.	[King, Bradley H.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Baumgartner, Joel M.; Kelly, Kaitlyn J.; Marmor, Rebecca A.; Lowy, Andrew M.; Veerapong, Jula] Univ Calif San Diego, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Veerapong, J (corresponding author), Univ Calif San Diego, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA.	jveerapong@ucsd.edu						Cao C, 2009, ANN SURG ONCOL, V16, P2152, DOI 10.1245/s10434-009-0487-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Ceelen W, 2014, ANN SURG ONCOL, V21, P3023, DOI 10.1245/s10434-014-3713-7; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eveno C, 2014, ANN SURG ONCOL, V21, P1792, DOI 10.1245/s10434-013-3442-3; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz H, 2006, SEMIN ONCOL, V33, pS26, DOI 10.1053/j.seminoncol.2006.08.001; Jafari MD, 2014, JAMA SURG, V149, P170, DOI 10.1001/jamasurg.2013.3640; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kozloff M, 2009, ONCOLOGIST, V14, P862, DOI 10.1634/theoncologist.2009-0071; Kudsk KA, 2003, JPEN-PARENTER ENTER, V27, P1, DOI 10.1177/014860710302700101; Moghaddam SM, 2012, CANCER METAST REV, V31, P143, DOI 10.1007/s10555-011-9337-5; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Scappaticci FA, 2005, J SURG ONCOL, V91, P173, DOI 10.1002/jso.20301; Turner KM, 2013, ANN SURG ONCOL, V20, P1068, DOI 10.1245/s10434-012-2789-1	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243252	10.1371/journal.pone.0243252	http://dx.doi.org/10.1371/journal.pone.0243252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270763	gold, Green Published			2022-12-26	WOS:000597149100080
J	Saka, HK; Garcia-Soto, S; Dabo, NT; Lopez-Chavarrias, V; Muhammad, B; Ugarte-Ruiz, M; Alvarez, J				Saka, Habeeb Kayode; Garcia-Soto, Silvia; Dabo, Nasir Tukur; Lopez-Chavarrias, Vicente; Muhammad, Bashir; Ugarte-Ruiz, Maria; Alvarez, Julio			Molecular detection of extended spectrum beta-lactamase genes in Escherichia coli clinical isolates from diarrhoeic children in Kano, Nigeria	PLOS ONE			English	Article							ESBL-PRODUCING ENTEROBACTERIACEAE; PREVALENCE; COMMUNITY; RESISTANCE; CARRIAGE	The increase in antimicrobial resistance in developed and developing countries is a global public health challenge. In this context beta-lactamase production is a major contributing factor to resistance globally. The aim of this study was to determine the prevalence of phenotypic and genotypic extended spectrum beta-lactamases (ESBLs) in 296 E. coli isolates recovered from diarrhoeic children younger than five years in Kano whose susceptibility profile against 7 antimicrobials had been determined. The E. coli isolates were subjected to double disc synergy test for phenotypic ESBLs detection and ESBL associated genes (bla(CTX-M), bla(TEM) and bla(SHV)) were detected using conventional PCR. Phenotypically, 12.8% (38/296) E. coli isolates presented a ESBLs phenotype, with a significantly higher proportion in isolates from females compared with males (P-value = 0.024). bla(CTX-M) 73.3% and bla(TEM) 73.3% were the predominant resistance genes in the ESBLs positive E. coli (each detected in 22/30 isolates, of which 14 harboured both). In addition, 1/30 harboured bla(CTX-M) + bla(TEM) + bla(SHV) genes simultaneously. This study demonstrates the presence of ESBLs E. coli isolates in clinically affected children in Kano, and demonstrates the circulation of bla(CTX-M) and bla(TEM) associated with those phenotypes. Enactment of laws on prudent antibiotic use is urgently needed in Kano.	[Saka, Habeeb Kayode] Nigerian Stored Prod Res Inst, Kano, Nigeria; [Saka, Habeeb Kayode; Muhammad, Bashir] Bayero Univ Kano, Dept Microbiol, Kano, Nigeria; [Garcia-Soto, Silvia; Lopez-Chavarrias, Vicente; Ugarte-Ruiz, Maria; Alvarez, Julio] Univ Complutense, VISAVET Hlth Surveillance Ctr, Madrid, Spain; [Dabo, Nasir Tukur] Bayero Univ Kano, Dept Biol Sci, Kano, Nigeria; [Alvarez, Julio] Univ Complutense, Fac Vet, Dept Sanidad Anim, Madrid, Spain	Bayero University; Complutense University of Madrid; Bayero University; Complutense University of Madrid	Saka, HK (corresponding author), Nigerian Stored Prod Res Inst, Kano, Nigeria.; Saka, HK (corresponding author), Bayero Univ Kano, Dept Microbiol, Kano, Nigeria.	saka.habeeb@yahoo.com	Ugarte-Ruiz, Maria/H-3316-2013; Alvarez, Julio/H-8292-2013	Ugarte-Ruiz, Maria/0000-0002-4509-6021; Alvarez, Julio/0000-0002-8999-9417; Garcia-Soto, Silvia/0000-0002-4123-3850				Abrar S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0309-1; Ahmed SF, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-22; Al-Agamy MH, 2016, FECAL COLONIZATION E, DOI [10.1155/2016/3704150, DOI 10.1155/2016/3704150]; Alizade Hesam, 2015, Gastroenterol Hepatol Bed Bench, V8, P207; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; [Anonymous], 2016, INNOVATION SYSTEME S, V2, P7; Bai L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00144; Bali EB, 2010, AFR J MICROBIOL RES, V4, P650; Bush K, 2019, NAT REV MICROBIOL, V17, P295, DOI 10.1038/s41579-019-0159-8; Chandramohan L, 2012, ANTIMICROB AGENTS CH, V56, P4765, DOI 10.1128/AAC.00666-12; Dabo N.T., 2019, J MICROBIOL BIOTECHN, V4, P94; Dashti AA, 2009, KUWAIT MED J, V41, P117; Faculty of Economics and Management University of Yaounde II Yaounde Cameroon Departamento de Economia de la Empresa Universidad de las Islas Baleares Palma de Mallorca Spain, 2017, INT J QUALITY RELIAB, V34, P18, DOI DOI 10.3354/ESR00836; Fernandez-Reyes M, 2014, ANTIMICROB AGENTS CH, V58, P1822, DOI 10.1128/AAC.01503-13; Gutkind GO, 2013, CURR PHARM DESIGN, V19, P164; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamprecht A, 2016, J ANTIMICROB CHEMOTH, V71, P2957, DOI 10.1093/jac/dkw216; Hampton T, 2013, JAMA-J AM MED ASSOC, V310, P1661, DOI 10.1001/jama.2013.280695; Hijazi SM, 2016, J INFECT DEV COUNTR, V10, P947, DOI 10.3855/jidc.7593; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Kangethe SK, 2015, E CENTRAL AFRICA MED, V2, P64; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Klein EY, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001315; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Miao ZM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00063; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Natarajan M, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0147-z; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Olowe O.A., 2015, J ENVIRON PUBLIC HEA, V2015, DOI [DOI 10.1155/2015/497980, 10.1155/2015/497980]; Pitout JDD, 2013, CURR PHARM DESIGN, V19, P257, DOI 10.2174/138161213804070348; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Polse RF, 2016, J MICROBIOL INFECT D, V6, P163; Rauch U, 2013, CELL BIOL RES THER, V2, P1, DOI [10.4172/2324-9293.1000101, DOI 10.4172/2324-9293.1000101]; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Tellevik MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168024; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; Vatopoulos A. C., 1998, Clin Microbiol Infect, V4, P563, DOI 10.1111/j.1469-0691.1998.tb00038.x	39	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243130	10.1371/journal.pone.0243130	http://dx.doi.org/10.1371/journal.pone.0243130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270734	gold, Green Published			2022-12-26	WOS:000597149100079
J	Sanchez-Ortiz, K; Taylor, KJM; De Palma, A; Essl, F; Dawson, W; Kreft, H; Pergl, J; Pysek, P; van Kleunen, M; Weigelt, P; Purvis, A				Sanchez-Ortiz, Katia; Taylor, Kara J. M.; De Palma, Adriana; Essl, Franz; Dawson, Wayne; Kreft, Holger; Pergl, Jan; Pysek, Petr; van Kleunen, Mark; Weigelt, Patrick; Purvis, Andy			Effects of land-use change and related pressures on alien and native subsets of island communities	PLOS ONE			English	Article							PLANT INVASIONS; BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; SPECIES RICHNESS; EXTINCTION RISK; GLOBAL PATTERNS; BETA-DIVERSITY; URBAN FLORAS; MAJOR CAUSE; BIODIVERSITY	Island species and habitats are particularly vulnerable to human disturbances, and anthropogenic changes are increasingly overwriting natural island biogeographic patterns. However, quantitative comparisons of how native and alien assemblages respond to human disturbances are scarce. Using data from 6,242 species of vertebrates, invertebrates and plants, from 7,718 sites on 81 islands, we model how land-use change, human population density and distance to the nearest road affect local assemblages of alien and native species on islands. We found that land-use change reduces both richness and abundance of native species, whereas the number and abundance of alien species are high in plantation forests and agricultural or urban sites. In contrast to the long-established pattern for native species (i.e., decline in species number with island isolation), more isolated islands have more alien species across most land uses than do less isolated islands. We show that alien species play a major role in the turnover of island assemblages: our models show that aliens outnumber natives among the species present at disturbed sites but absent from minimally-disturbed primary vegetation. Finally, we found a homogenization pattern for both native and alien assemblages across sites within most land uses. The declines of native species on islands in the face of human pressures, and the particular proneness to invasions of the more remote islands, highlight the need to reduce the intensity of human pressures on islands and to prevent the introduction and establishment of alien species.	[Sanchez-Ortiz, Katia; De Palma, Adriana; Purvis, Andy] Nat Hist Museum, Dept Life Sci, London, England; [Sanchez-Ortiz, Katia; Purvis, Andy] Imperial Coll London, Dept Life Sci, London, England; [Taylor, Kara J. M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Essl, Franz] Univ Vienna, Dept Bot & Biodivers Res, Macroecol Grp, BioInvas,Global Change, Vienna, Austria; [Dawson, Wayne] Univ Durham, Dept Biosci, Durham, England; [Kreft, Holger; Weigelt, Patrick] Univ Goettingen, Biodivers Macroecol & Biogeog, Gottingen, Germany; [Kreft, Holger] Univ Goettingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany; [Pergl, Jan; Pysek, Petr] Czech Acad Sci, Inst Bot, Dept Invas Ecol, Pruhonice, Czech Republic; [Pysek, Petr] Fac Sci, Charles Dept Ecol, Prague, Czech Republic; [van Kleunen, Mark] Univ Konstanz, Dept Biol, Ecol, Constance, Germany; [van Kleunen, Mark] Taizhou Univ, Zhejiang Prov Key Lab Plant Evolutionary Ecol & C, Taizhou 318000, Zhejiang, Peoples R China	Natural History Museum London; Imperial College London; University System of Ohio; Ohio State University; University of Vienna; Durham University; University of Gottingen; University of Gottingen; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Konstanz; Taizhou University	Sanchez-Ortiz, K (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Sanchez-Ortiz, K (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	k.sanchez-ortiz@nhm.ac.uk	Pergl, Jan/H-1071-2011; De Palma, Adriana/H-9591-2019; Purvis, Andy/A-7529-2008; Kreft, Holger/AAY-7573-2020; Kreft, Holger/A-4736-2008; Weigelt, Patrick/E-2122-2014; van Kleunen, Mark/B-3769-2009	Pergl, Jan/0000-0002-0045-1974; De Palma, Adriana/0000-0002-5345-4917; Purvis, Andy/0000-0002-8609-6204; Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236; Weigelt, Patrick/0000-0002-2485-3708; van Kleunen, Mark/0000-0002-2861-3701; Dawson, Wayne/0000-0003-3402-0774	NERC [NE/M014533/1]; Prince Albert II of Monaco Foundation ("Plants Under Pressure 2"); Austrian Science Foundation FWF [I2086-B16, I 4011B32]; EXPRO (Czech Science Foundation) [19-28807X]; Czech Academy of Sciences [RVO 67985939]; National Council of Science and Technology (CONACyT -Mexico)	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Prince Albert II of Monaco Foundation ("Plants Under Pressure 2"); Austrian Science Foundation FWF(Austrian Science Fund (FWF)); EXPRO (Czech Science Foundation); Czech Academy of Sciences(Czech Academy of Sciences); National Council of Science and Technology (CONACyT -Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The project received support from NERC (grant NE/M014533/1) and the Prince Albert II of Monaco Foundation ("Plants Under Pressure 2"). Author KSO was funded by the National Council of Science and Technology (CONACyT -Mexico). FE appreciates funding by the Austrian Science Foundation FWF (grants I2086-B16 and I 4011B32). Authors PP and JP were supported by EXPRO grant no. 19-28807X (Czech Science Foundation) and long-term research development project RVO 67985939 (Czech Academy of Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2008, DIVERS DISTRIB, V14, P114, DOI 10.1111/j.1472-4642.2007.00435.x; ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Allen VG, 2011, GRASS FORAGE SCI, V66, P2, DOI 10.1111/j.1365-2494.2010.00780.x; [Anonymous], 2015, LAND POL; [Anonymous], 2017, BMJ, V357, pj350; Arevalo JR, 2005, PERSPECT PLANT ECOL, V7, P185, DOI 10.1016/j.ppees.2005.09.003; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blackburn TM, 2008, GLOBAL ECOL BIOGEOGR, V17, P246, DOI 10.1111/j.1466-8238.2007.00361.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Brummitt NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135152; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Capinha C, 2017, DIVERS DISTRIB, V23, P1313, DOI 10.1111/ddi.12617; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Catford JA, 2012, PERSPECT PLANT ECOL, V14, P231, DOI 10.1016/j.ppees.2011.12.002; CIESIN IFPRI, 2011, GLOBAL RURAL URBAN M, DOI 10.1126/science.1208821; CIESIN ITOS, 2013, GLOB ROADS OP ACC DA; Collen B, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0843; Dalmazzone S, 2014, ECOL ECON, V105, P154, DOI 10.1016/j.ecolecon.2014.05.008; Dawson W, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0186; De Palma A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31153; De Rosario-Martinez H, 2015, PHIA PACKAGE VER 0 2; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Diaz S, 2019, SCIENCE, V366, P1327, DOI 10.1126/science.aax3100; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dyer EE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000942; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Essl F, 2019, AOB PLANTS, V11, DOI 10.1093/aobpla/plz051; Florencio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128276; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillespie RG, 2008, MOL ECOL, V17, P45, DOI 10.1111/j.1365-294X.2007.03466.x; Gillespie RG, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P358; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Helmus MR, 2014, NATURE, V513, P543, DOI 10.1038/nature13739; Herben T, 2005, ECOL LETT, V8, P909, DOI 10.1111/j.1461-0248.2005.00790.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2017, GEOSPHERE PACKAGE VE; Hudson LN, 2017, ECOL EVOL, V7, P145, DOI 10.1002/ece3.2579; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; La Sorte FA, 2014, GLOBAL ECOL BIOGEOGR, V23, P769, DOI 10.1111/geb.12159; Lembrechts JJ, 2016, P NATL ACAD SCI USA, V113, P14061, DOI 10.1073/pnas.1608980113; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Manor R, 2008, BIOL INVASIONS, V10, P507, DOI 10.1007/s10530-007-9147-4; Marini L, 2012, GLOBAL ECOL BIOGEOGR, V21, P534, DOI 10.1111/j.1466-8238.2011.00702.x; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; McCreless EE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12488; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McKinney ML, 2004, GLOBAL ECOL BIOGEOGR, V13, P47, DOI 10.1111/j.1466-882X.2004.00059.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meijer SS, 2011, J INSECT CONSERV, V15, P505, DOI 10.1007/s10841-010-9330-2; Meiri S, 2012, GLOBAL ECOL BIOGEOGR, V21, P592, DOI 10.1111/j.1466-8238.2011.00700.x; Monroe AP, 2017, RESTOR ECOL, V25, P539, DOI 10.1111/rec.12472; Moser D, 2018, P NATL ACAD SCI USA, V115, P9270, DOI 10.1073/pnas.1804179115; Murphy GEP, 2014, ECOL EVOL, V4, P91, DOI 10.1002/ece3.909; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Newbold T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006841; Newbold T, 2016, ECOGRAPHY, V39, P1151, DOI 10.1111/ecog.01932; Newbold T, 2016, SCIENCE, V353, P288, DOI 10.1126/science.aaf2201; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Partners TIB, 2017, THREATENED ISLAND BI; PAULAY G, 1994, AM ZOOL, V34, P134; Perrings C, 2000, EC BIOL INVASIONS, P17, DOI DOI 10.4337/9781781008645.00010; Phillips HRP, 2018, ECOGRAPHY, V41, P1220, DOI 10.1111/ecog.02956; Phillips HRP, 2017, BIODIVERS CONSERV, V26, P2251, DOI 10.1007/s10531-017-1356-2; Pouteau R, 2015, ECOGRAPHY, V38, P462, DOI 10.1111/ecog.00963; Purvis A, 2018, ADV ECOLOGICAL RES; Pysek P, 1998, J BIOGEOGR, V25, P155, DOI 10.1046/j.1365-2699.1998.251177.x; Pysek Petr, 2007, V193, P97; Pysek P, 2017, PRESLIA, V89, P203, DOI 10.23855/preslia.2017.203; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; R Core Team, 2021, R LANGUAGE ENV STAT; Redding DW, 2019, NATURE, V571, P103, DOI 10.1038/s41586-019-1292-2; Rembold K, 2017, BIOL CONSERV, V213, P234, DOI 10.1016/j.biocon.2017.07.020; Ripple WJ, 2017, P NATL ACAD SCI USA, V114, P10678, DOI 10.1073/pnas.1702078114; Roderick GK, 2009, ENCY ISLANDS, P475; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sakai AK, 2002, SYST BIOL, V51, P276, DOI 10.1080/10635150252899770; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; Siliceo I, 2010, BIOL CONSERV, V143, P2601, DOI 10.1016/j.biocon.2010.07.002; Simberloff D, 2000, RAFFLES B ZOOL, V48, P1; Simberloff Daniel, 1995, Pacific Science, V49, P87; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; UNEP-WCMC, 2015, DAT GLOB ISL DAT VER; van der Loo M, 2017, GOWER PACKAGE VER 0; van Kleunen M, 2018, BIOL REV, V93, P1421, DOI 10.1111/brv.12402; van Kleunen M, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2542; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weigelt P, 2020, J BIOGEOGR, V47, P16, DOI 10.1111/jbi.13623; Weigelt P, 2013, P NATL ACAD SCI USA, V110, P15307, DOI 10.1073/pnas.1306309110; Weigelt P, 2013, ECOGRAPHY, V36, P417, DOI 10.1111/j.1600-0587.2012.07669.x; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wilford G.E., 1994, HIST AUSTR VEGETATIO, P5; Zuur AF, 2007, STAT BIOL HEALTH, P163; Zuur Alain F., 2009, P1	111	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0227169	10.1371/journal.pone.0227169	http://dx.doi.org/10.1371/journal.pone.0227169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270641	gold, Green Published, Green Submitted			2022-12-26	WOS:000597149100045
J	Koda, E; Yamashiro, T; Onoe, R; Handa, H; Azagami, S; Matsushita, S; Tomita, H; Inoue, T; Mineshita, M				Koda, Eriko; Yamashiro, Tsuneo; Onoe, Rintaro; Handa, Hiroshi; Azagami, Shinya; Matsushita, Shoichiro; Tomita, Hayato; Inoue, Takeo; Mineshita, Masamichi			CT texture analysis of mediastinal lymphadenopathy: Combining with US-based elastographic parameter and discrimination between sarcoidosis and lymph node metastasis from small cell lung cancer	PLOS ONE			English	Article							BREAST-LESIONS; TOMOGRAPHY; F-18-FLUORODEOXYGLUCOSE; DIFFERENTIATION; ULTRASOUND; DIAGNOSIS; RATIO	Objectives To investigate the potential of computed tomography (CT)-based texture analysis and elastographic data provided by endobronchial ultrasonography (EBUS) for differentiating the mediastinal lymphadenopathy by sarcoidosis and small cell lung cancer (SCLC) metastasis. Methods Sixteen patients with sarcoidosis and 14 with SCLC were enrolled. On CT images showing the largest mediastinal lymph node, a fixed region of interest was drawn on the node, and texture features were automatically measured. Among the 30 patients, 19 (12 sarcoidosis and 7 SCLC) underwent endobronchial ultrasound transbronchial needle aspiration, and the fat-to-lesion strain ratio (FLR) was recorded. Texture features and FLRs were compared between the 2 patient groups. Logistic regression analysis was performed to evaluate the diagnostic accuracy of these measurements. Results Of the 31 texture features, the differences between 11 texture features of CT ROIs in the patients with sarcoidosis versus patients with SCLC were significant. Among them, the grey-level run length matrix with high gray-level run emphasis (GLRLM-HGRE) showed the greatest difference (P<0.01). Differences between FLRs were significant (P<0.05). Logistic regression analysis together with receiver operating characteristic curve analysis demonstrated that the FLR combined with the GLRLM-HGRE showed a high diagnostic accuracy (100% sensitivity, 92% specificity, 0.988 area under the curve) for discriminating between sarcoidosis and SCLC. Conclusion Texture analysis, particularly combined with the FLR, is useful for discriminating between mediastinal lymphadenopathy caused by sarcoidosis from that caused by metastasis from SCLC.	[Koda, Eriko; Onoe, Rintaro; Handa, Hiroshi; Azagami, Shinya; Inoue, Takeo; Mineshita, Masamichi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp Med, Kawasaki, Kanagawa, Japan; [Yamashiro, Tsuneo; Matsushita, Shoichiro; Tomita, Hayato] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Yamashiro, Tsuneo] Yokohama City Univ, Dept Diagnost Radiol, Yokohama, Kanagawa, Japan	Saint Marianna University; Saint Marianna University; Yokohama City University	Mineshita, M (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Resp Med, Kawasaki, Kanagawa, Japan.	m-mine@marianna-u.ac.jp	Yamashiro, Tsuneo/H-6409-2019; Tomita, Hayato/AAG-2617-2019	Yamashiro, Tsuneo/0000-0002-1904-2548; Tomita, Hayato/0000-0002-7024-3521; Koda, Eriko/0000-0003-2087-9908				Andersen MB, 2016, ACTA RADIOL, V57, P669, DOI 10.1177/0284185115598808; Bayanati H, 2015, EUR RADIOL, V25, P480, DOI 10.1007/s00330-014-3420-6; Dennie C, 2017, QUANT IMAGING MED SU, V7, P614, DOI 10.21037/qims.2017.11.01; Dennie C, 2016, QUANT IMAG MED SURG, V6, P6, DOI 10.3978/j.issn.2223-4292.2016.02.01; Digumarthy SR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011172; Fournier C, 2019, J BRONCHOL INTERN PU, V26, P193, DOI 10.1097/LBR.0000000000000551; Roca MH, 2019, J BRONCHOL INTERN PU, V26, P184, DOI 10.1097/LBR.0000000000000550; Iannarelli A, 2018, RADIOL MED, V123, P345, DOI 10.1007/s11547-017-0845-4; Ikeda K, 2012, BREAST CANCER-TOKYO, V19, P71, DOI 10.1007/s12282-011-0274-5; Izumo T, 2014, JPN J CLIN ONCOL, V44, P956, DOI 10.1093/jjco/hyu105; Ji C, 2014, INT J CLIN EXP PATHO, V7, P8227; Kaira K, 2007, CHEST, V131, P1019, DOI 10.1378/chest.06-2160; Kirienko M, 2018, EUR J NUCL MED MOL I, V45, P1649, DOI 10.1007/s00259-018-3987-2; Korrungruang P, 2017, RESPIROLOGY, V22, P972, DOI 10.1111/resp.12979; Lin CK, 2019, J FORMOS MED ASSOC, V118, P436, DOI 10.1016/j.jfma.2018.06.021; Nakajima T, 2015, RESPIRATION, V90, P499, DOI 10.1159/000441798; Ou XJ, 2019, CONTRAST MEDIA MOL I, DOI 10.1155/2019/4507694; Pham TD, 2017, SCI REP-UK, V7, DOI 10.1038/srep43209; Rozman A, 2015, RADIOL ONCOL, V49, P334, DOI 10.1515/raon-2015-0020; Sollini M, 2017, EUR J HYBRID IMAG, V1, DOI 10.1186/s41824-017-0009-8; Sun Q, 2019, CLIN RADIOL, V74, P59, DOI 10.1016/j.crad.2018.07.103; Travis WD, 2012, MODERN PATHOL, V25, pS18, DOI 10.1038/modpathol.2011.150; Zhou JQ, 2014, EUR RADIOL, V24, P3171, DOI 10.1007/s00330-014-3366-8	23	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243181	10.1371/journal.pone.0243181	http://dx.doi.org/10.1371/journal.pone.0243181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264372	gold, Green Published			2022-12-26	WOS:000596569200011
J	Li, B; Deng, XY; Kim, SH; Buhrow, L; Tomchick, DR; Phillips, MA; Michael, AJ				Li, Bin; Deng, Xiaoyi; Kim, Sok Ho; Buhrow, Leann; Tomchick, Diana R.; Phillips, Margaret A.; Michael, Anthony J.			Alternative pathways utilize or circumvent putrescine for biosynthesis of putrescine-containing rhizoferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; FRANCISELLA-TULARENSIS; SIDEROPHORE BIOSYNTHESIS; STAPHYLOCOCCUS-AUREUS; SUBSTRATE-SPECIFICITY; LYSINE DECARBOXYLASE; IDENTIFICATION; POLYAMINES; EVOLUTION; SEQUENCE	The siderophore rhizoferrin (N-1,N-4-dicitrylputrescine) is produced in fungi and bacteria to scavenge iron. Putrescine-producing bacterium Ralstonia pickettii synthesizes rhizoferrin and encodes a single nonribosomal peptide synthetase-independent siderophore (NIS) synthetase. From biosynthetic logic, we hypothesized that this single enzyme is sufficient for rhizoferrin biosynthesis. We confirmed this by expression of R. pickettii NIS synthetase in Escherichia coli, resulting in rhizoferrin production. This was further confirmed in vitro using the recombinant NIS synthetase, synthesizing rhizoferrin from putrescine and citrate. Heterologous expression of homologous lbtA from Legionella pneumophila, required for rhizoferrin biosynthesis in that species, produced siderophore activity in E. coli. Rhizoferrin is also synthesized by Francisella tularensis and Francisella novicida, but unlike R. pickettii or L. pneumophila, Francisella species lack putrescine biosynthetic pathways because of genomic decay. Francisella encodes a NIS synthetase FslA/FigA and an ornithine decarboxylase homolog FslC/FigC, required for rhizoferrin biosynthesis. Ornithine decarboxylase produces putrescine from ornithine, but we show here in vitro that FigA synthesizes N-citrylornithine, and FigC is an N-citrylornithine decarboxylase that together synthesize rhizoferrin without using putrescine. We co-expressed F. novicida figA and figC in E. coli and produced rhizoferrin. A 2.1 A X-ray crystal structure of the FigC N-citrylornithine decarboxylase reveals how the larger substrate is accommodated and how active site residues have changed to recognize N-citrylornithine. FigC belongs to a new subfamily of alanine racemase-fold PLP-dependent decarboxylases that are not involved in polyamine biosynthesis. These data reveal a natural product biosynthetic workaround that evolved to bypass a missing precursor and re-establish it in the final structure.	[Li, Bin; Deng, Xiaoyi; Kim, Sok Ho; Buhrow, Leann; Phillips, Margaret A.; Michael, Anthony J.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Tomchick, Diana R.] UT Southwestern Med Ctr, Dept Biophys, Dallas, TX USA; [Kim, Sok Ho] Quest Diagnost Nichols Inst, Chantilly, VA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Michael, AJ (corresponding author), UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643	National Institutes of Health [R37AI034432]; Welch Foundation [I-1257]; UT Southwestern Medical Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UT Southwestern Medical Center	This work was supported by funds from the National Institutes of Health grant, R37AI034432 (to M. A. P.). M. A. P. acknowledges the support of the Welch Foundation (I-1257). M. A. P. holds the Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry. A. J. M. was supported by UT Southwestern Medical Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allard KA, 2006, J BACTERIOL, V188, P1351, DOI 10.1128/JB.188.4.1351-1363.2006; Baars O, 2018, ENVIRON MICROBIOL, V20, P1667, DOI 10.1111/1462-2920.14078; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Burnside DM, 2015, INFECT IMMUN, V83, P3937, DOI 10.1128/IAI.00808-15; Burrell M, 2012, MOL MICROBIOL, V86, P485, DOI 10.1111/j.1365-2958.2012.08208.x; Carroll CS, 2017, INT J BIOCHEM CELL B, V89, P136, DOI 10.1016/j.biocel.2017.06.005; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P4706, DOI 10.1128/AEM.69.8.4706-4713.2003; Codd R, 2018, J BIOL INORG CHEM, V23, P969, DOI 10.1007/s00775-018-1585-1; Codd R, 2018, ACS CHEM BIOL, V13, P11, DOI 10.1021/acschembio.7b00851; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Deng XY, 2010, J BIOL CHEM, V285, P25708, DOI 10.1074/jbc.M110.121137; DRECHSEL H, 1992, BIOMETALS, V5, P141, DOI 10.1007/BF01061320; DRECHSEL H, 1991, BIOL MET, V4, P238, DOI 10.1007/BF01141187; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrega A, 2010, ANTIMICROB AGENTS CH, V54, P1218, DOI 10.1128/AAC.00944-09; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; Hamana K., 1998, MICROBIOL CULT COLL, V14, P1; Hamana K., 2000, MICROBIOL CULT COLL, V16, P63; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Igarashi K, 2001, RES MICROBIOL, V152, P271, DOI 10.1016/S0923-2508(01)01198-6; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Kulikovsky A, 2014, J AM CHEM SOC, V136, P11168, DOI 10.1021/ja505982c; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li B, 2019, BIOCHEM J, V476, P2579, DOI 10.1042/BCJ20190561; Li B, 2019, MOL MICROBIOL, V111, P159, DOI 10.1111/mmi.14145; Li B, 2016, ACS CHEM BIOL, V11, P2782, DOI 10.1021/acschembio.6b00629; Li YY, 2005, CHEM BIOL, V12, P665, DOI 10.1016/j.chembiol.2005.04.010; Lowe-Power TM, 2018, ENVIRON MICROBIOL, V20, P1330, DOI 10.1111/1462-2920.14020; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Meibom KL, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00140; MEIWES J, 1990, FEMS MICROBIOL LETT, V67, P201, DOI 10.1111/j.1574-6968.1990.tb13863.x; Michael AJ, 2017, BIOCHEM J, V474, P2277, DOI 10.1042/BCJ20160823; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Morimoto N, 2010, J BACTERIOL, V192, P4991, DOI 10.1128/JB.00279-10; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Munzinger M, 1999, BIOMETALS, V12, P189, DOI 10.1023/A:1009259118034; Nasrallah GK, 2011, J BACTERIOL, V193, P4346, DOI 10.1128/JB.01506-10; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohnuma M, 2005, J BIOL CHEM, V280, P30073, DOI 10.1074/jbc.M413332200; ONG SA, 1979, J BIOL CHEM, V254, P1860; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oves-Costales D, 2009, CHEM COMMUN, P6530, DOI 10.1039/b913092f; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PAGE WJ, 1988, J GEN MICROBIOL, V134, P453; PEGG AE, 1994, BIOCHEM SOC T, V22, P846, DOI 10.1042/bst0220846; Phillips RS, 2019, BIOCHEMISTRY-US, V58, P1038, DOI 10.1021/acs.biochem.8b01319; Phillips RS, 2017, ARCH BIOCHEM BIOPHYS, V634, P83, DOI 10.1016/j.abb.2017.09.010; Ramakrishnan G, 2019, ACS CHEM BIOL, V14, P1760, DOI 10.1021/acschembio.9b00297; Ramakrishnan G, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00107; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Sarva ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158631; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Tang JY, 2019, J MOL BIOL, V431, P4868, DOI 10.1016/j.jmb.2019.10.009; THIEKEN A, 1992, FEMS MICROBIOL LETT, V94, P37, DOI 10.1111/j.1574-6968.1992.tb05285.x; TRAUB A, 1955, J BACTERIOL, V70, P60, DOI 10.1128/JB.70.1.60-69.1955; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WISE R, 1983, ANTIMICROB AGENTS CH, V23, P559, DOI 10.1128/AAC.23.4.559; Zajdowicz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034591	82	4	4	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100146	10.1074/jbc.RA120.016738	http://dx.doi.org/10.1074/jbc.RA120.016738			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33277357	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400124
J	Fomeju, BF; Brunel, D; Berard, A; Rivoal, JB; Gallois, P; Le Paslier, MC; Bouverat-Bernier, JP				Fomeju, Berline Fopa; Brunel, Dominique; Berard, Aurelie; Rivoal, Jean-Baptiste; Gallois, Philippe; Le Paslier, Marie-Christine; Bouverat-Bernier, Jean-Pierre			Quick and efficient approach to develop genomic resources in orphan species: Application in Lavandula angustifolia	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SESQUITERPENE SYNTHASE; GLANDULAR TRICHOMES; TRANSCRIPTOME; DISCOVERY; GENERATION; CLONING; RECONSTRUCTION; ORGANIZATION; ANNOTATION	Next-Generation Sequencing (NGS) technologies, by reducing the cost and increasing the throughput of sequencing, have opened doors to generate genomic data in a range of previously poorly studied species. In this study, we propose a method for the rapid development of a large-scale molecular resources for orphan species. We studied as an example the true lavender (Lavandula angustifolia Mill.), a perennial sub-shrub plant native from the Mediterranean region and whose essential oil have numerous applications in cosmetics, pharmaceuticals, and alternative medicines. The heterozygous clone "Maillette" was used as a reference for DNA and RNA sequencing. We first built a reference Unigene, compound of coding sequences, thanks to de novo RNA-seq assembly. Then, we reconstructed the complete genes sequences (with introns and exons) using an Unigene-guided DNA-seq assembly approach. This aimed to maximize the possibilities of finding polymorphism between genetically close individuals despite the lack of a reference genome. Finally, we used these resources for SNP mining within a collection of 16 commercial lavender clones and tested the SNP within the scope of a genetic distance analysis. We obtained a cleaned reference of 8, 030 functionally in silico annotated genes. We found 359K polymorphic sites and observed a high SNP frequency (mean of 1 SNP per 90 bp) and a high level of heterozygosity (more than 60% of heterozygous SNP per genotype). On overall, we found similar genetic distances between pairs of clones, which is probably related to the out-crossing nature of the species and the restricted area of cultivation. The proposed method is transferable to other orphan species, requires little bioinformatics resources and can be realized within a year. This is also the first reported large-scale SNP development on Lavandula angustifolia. All the genomics resources developed herein are publicly available and provide a rich pool of molecular resources to explore and exploit lavender genetic diversity in breeding programs.	[Fomeju, Berline Fopa; Gallois, Philippe; Bouverat-Bernier, Jean-Pierre] ITEIPMAI, Chemille En Anjou, France; [Fomeju, Berline Fopa; Brunel, Dominique; Berard, Aurelie; Le Paslier, Marie-Christine] Univ Paris Saclay, INRA, US1279 Etud Polymorphisme Genomes Vegetaux EPGV, Evry, France; [Rivoal, Jean-Baptiste] CRIEPPAM, Quintrands, Manosque, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fomeju, BF (corresponding author), ITEIPMAI, Chemille En Anjou, France.; Fomeju, BF; Le Paslier, MC (corresponding author), Univ Paris Saclay, INRA, US1279 Etud Polymorphisme Genomes Vegetaux EPGV, Evry, France.	berline.fopa-fomeju@iteipmai.fr; marie-christine.le-paslier@inrae.fr		Berline, FOPA FOMEJU/0000-0002-7187-7278	Trust account for "Agricultural and Rural Development"(CASDAR) [C-201705]	Trust account for "Agricultural and Rural Development"(CASDAR)	This project was funded by the Trust account for "Agricultural and Rural Development"(CASDAR), project number C-201705, on behalf of French Ministry of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adal AM, 2015, PLANTA, V241, P987, DOI 10.1007/s00425-014-2226-8; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; [Anonymous], 2018, LANCET HAEMATOL, V5, P378; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cabau C, 2017, PEERJ, V5, DOI 10.7717/peerj.2988; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; Cerveau N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1406-x; Chaisse E., 2012, INNOVATIONS AGRONOMI, V25, P179; Chen X, 2017, ASIA-PAC CONF COMMUN, P47; Cogan NOI, 2006, MOL GENET GENOMICS, V276, P101, DOI 10.1007/s00438-006-0126-8; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Darwish O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1221-1; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Demissie ZA, 2013, J BIOL CHEM, V288, P6333, DOI 10.1074/jbc.M112.431171; Demissie ZA, 2012, PLANT MOL BIOL, V79, P393, DOI 10.1007/s11103-012-9920-3; Demissie ZA, 2011, PLANTA, V233, P685, DOI 10.1007/s00425-010-1332-5; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FranceAgriMer, 2020, MARCH PLANT PARF AR; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Honaas LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146062; Huang X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2923-8; Humble Emily, 2016, BMC Research Notes, V9, P418, DOI 10.1186/s13104-016-2209-x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jullien F, 2014, PLANT MOL BIOL, V84, P227, DOI 10.1007/s11103-013-0131-3; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lane A, 2010, PLANTA, V231, P835, DOI 10.1007/s00425-009-1090-4; Leggett RM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S10; MacManes M. D., 2016, BIORXIV, DOI [10.1101/035642, DOI 10.1101/035642]; Malli RPN, 2019, PLANTA, V249, P251, DOI 10.1007/s00425-018-3012-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; Sarker LS, 2015, PLANTA, V242, P709, DOI 10.1007/s00425-015-2325-1; Sarker LS, 2013, PLANTA, V238, P983, DOI 10.1007/s00425-013-1937-6; Sarker LS, 2012, ARCH BIOCHEM BIOPHYS, V528, P163, DOI 10.1016/j.abb.2012.09.013; Scheben A, 2017, PLANT BIOTECHNOL J, V15, P149, DOI 10.1111/pbi.12645; Semetey O, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01507-18; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Soltani R, 2013, INT J PEDIATR OTORHI, V77, P1579, DOI 10.1016/j.ijporl.2013.07.014; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tanwar UK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00091; Trapp SC, 2001, GENETICS, V158, P811; Unamba CIN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01074; Upson T, 2004, THE GENUS LAVANDULA; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Wang BB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-17; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	57	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243853	10.1371/journal.pone.0243853	http://dx.doi.org/10.1371/journal.pone.0243853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306734	gold, Green Published, Green Submitted			2022-12-26	WOS:000600144200054
J	Tiba, MH; McCracken, BM; Dickson, RP; Nemzek, JA; Colmenero, CI; Leander, DC; Flott, TL; Daniels, RC; Konopka, KE; VanEpps, JS; Stringer, KA; Ward, KR				Tiba, Mohamad Hakam; McCracken, Brendan M.; Dickson, Robert P.; Nemzek, Jean A.; Colmenero, Carmen, I; Leander, Danielle C.; Flott, Thomas L.; Daniels, Rodney C.; Konopka, Kristine E.; VanEpps, J. Scott; Stringer, Kathleen A.; Ward, Kevin R.			A comprehensive assessment of multi-system responses to a renal inoculation of uropathogenic E. coli in swine	PLOS ONE			English	Article							PATHOGENICITY ISLAND; PORCINE MODEL; UNITED-STATES; SEVERE SEPSIS; SEPTIC SHOCK; OVINE MODEL; SEQUENCES; CFT073	Background The systemic responses to infection and its progression to sepsis remains poorly understood. Progress in the field has been stifled by the shortcomings of experimental models which include poor replication of the human condition. To address these challenges, we developed and piloted a novel large animal model of severe infection that is capable of generating multi-system clinically relevant data. Methods Male swine (n = 5) were anesthetized, mechanically ventilated, and surgically instrumented for continuous hemodynamic monitoring and serial blood sampling. Animals were inoculated with uropathogenic E. coli by direct injection into the renal parenchyma and were maintained until a priori endpoints were met. The natural history of the infection was studied. Animals were not resuscitated. Multi-system data were collected hourly to 6 hours; all animals were euthanized at predetermined physiologic endpoints. Results Core body temperature progressively increased from mean (SD) 37.9(0.8)degrees C at baseline to 43.0(1.2)degrees C at experiment termination (p = 0.006). Mean arterial pressure did not begin to decline until 6h post inoculation, dropping from 86(9) mmHg at baseline to 28(5) mmHg (p = 0.005) at termination. Blood glucose progressively declined but lactate levels did not elevate until the last hours of the experiment. There were also temporal changes in whole blood concentrations of a number of metabolites including increases in the catecholamine precursors, tyrosine (p = 0.005) and phenylalanine (p = 0.005). Lung, liver, and kidney function parameters worsened as infection progressed and at study termination there was histopathological evidence of injury in these end-organs. Conclusion We demonstrate a versatile, multi-system, longitudinal, swine model of infection that could be used to further our understanding of the mechanisms that underlie infection-induced multi-organ dysfunction and failure, optimize resuscitation protocols and test therapeutic interventions. Such a model could improve translation of findings from the bench to the bedside, circumventing a significant obstacle in sepsis research.	[Tiba, Mohamad Hakam; McCracken, Brendan M.; Colmenero, Carmen, I; Leander, Danielle C.; VanEpps, J. Scott; Ward, Kevin R.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Tiba, Mohamad Hakam; McCracken, Brendan M.; Dickson, Robert P.; Nemzek, Jean A.; Colmenero, Carmen, I; Leander, Danielle C.; Daniels, Rodney C.; Konopka, Kristine E.; VanEpps, J. Scott; Stringer, Kathleen A.; Ward, Kevin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Dickson, Robert P.; Stringer, Kathleen A.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Nemzek, Jean A.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI USA; [Nemzek, Jean A.; Konopka, Kristine E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Flott, Thomas L.; Stringer, Kathleen A.] Univ Michigan, Coll Pharm, Dept Clin Pharm, Ann Arbor, MI USA; [Daniels, Rodney C.] Univ Michigan, Dept Pediat, Pediat Crit Care Med, Ann Arbor, MI USA; [Daniels, Rodney C.; VanEpps, J. Scott; Ward, Kevin R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI USA; [VanEpps, J. Scott] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tiba, MH (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Tiba, MH (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.	tibam@med.umich.edu		VanEpps, J. Scott/0000-0002-0805-0913; Flott, Thomas/0000-0002-3962-6014; Tiba, Mohamad/0000-0002-6789-7532; Dickson, Robert/0000-0002-6875-4277; Stringer, Kathleen/0000-0003-0238-7774	Michigan Center for Integrative Research in Critical Care; National Institute of General Medical Sciences (NIGMS) [R01GM111400, R35GM13631201]; National Institute of Allergy and Infectious Diseases (NIAID) [K08AI128006]; NIGMS [R01GM112799]	Michigan Center for Integrative Research in Critical Care; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in full by the Michigan Center for Integrative Research in Critical Care (https://mcircc.umich.edu/); K.A. Stringer's contribution was supported, in part, by grants from the National Institute of General Medical Sciences (NIGMS; R01GM111400 and R35GM13631201; https://www.nigms.nih.gov/); J. VanEpps' effort was supported, in part, by a grant from the National Institute of Allergy and Infectious Diseases (NIAID; K08AI128006; https://www.niaid.nih.gov/); J. Nemzek's effort was supported, in part, by a grant from the NIGMS (R01GM112799). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS, NIAID, or the National Institutes of Health. With the exception of MCIRCC, none of the sponsors played any role in the study design. None of the sponsors played any role in data collection and analysis, decision to publish or the preparation of the manuscript. The authors declare no conflict of interest.	Alverdy JC, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00942-19; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; [Anonymous], 2016, SEPS DAT REP; Bellomo R, 2011, CRIT CARE MED, V39, P2367, DOI 10.1097/CCM.0b013e31822a5be5; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; Boerio D, 2018, MUSCLE NERVE, V57, P808, DOI 10.1002/mus.26013; Byrne L, 2018, SHOCK, V49, P99, DOI 10.1097/SHK.0000000000000904; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Ferrario M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00011; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Gattinoni L, 2019, AM J RESP CRIT CARE, V200, P582, DOI 10.1164/rccm.201812-2342OC; Goldfarb RD, 2005, SHOCK, V24, P75, DOI 10.1097/01.shk.0000191337.01036.b7; Goldfarb RD, 1996, SHOCK, V6, P442, DOI 10.1097/00024382-199612000-00009; Guyer DM, 1998, INFECT IMMUN, V66, P4411; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; KARJALAINEN J, 1986, ARCH INTERN MED, V146, P1169, DOI 10.1001/archinte.146.6.1169; KAZARIAN KK, 1994, SHOCK, V1, P201, DOI 10.1097/00024382-199403000-00008; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Libert C, 2019, SHOCK, V51, P23, DOI 10.1097/SHK.0000000000001242; Ljungstrom L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181704; Machado FR, 2018, CRIT CARE MED, V46, P454, DOI 10.1097/CCM.0000000000002899; [National Research Council (U.S.) Institute for Laboratory Animal Research (U.S.) & National Academies Press (U.S.).], 2011, COMM UPD GUID CAR US; Osuchowski MF, 2018, SHOCK, V50, P377, DOI 10.1097/SHK.0000000000001212; Passmore MR, 2019, THROMB RES, V176, P39, DOI 10.1016/j.thromres.2019.02.015; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rimmele T, 2006, J INFECTION, V53, P199, DOI 10.1016/j.jinf.2005.10.023; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Srisangthong P, 2013, 33 INT S INT CAR EM, pS13; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077; Torio C. M., 2011, NATL INPATIENT HOSP; Toth J, 2017, THROMB RES, V158, P25, DOI 10.1016/j.thromres.2017.07.030; Venkata C, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-9; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Walkey AJ, 2015, ANN AM THORAC SOC, V12, P216, DOI 10.1513/AnnalsATS.201411-498BC; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1375-5; Wiles TJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003175; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243577	10.1371/journal.pone.0243577	http://dx.doi.org/10.1371/journal.pone.0243577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306742	Green Published, gold			2022-12-26	WOS:000600144200052
J	Castellvi, I; Simeon, CP; Sarmiento, M; Casademont, J; Corominas, H; Fonollosa, V				Castellvi, Ivan; Simeon, Carmen Pilar; Sarmiento, Monica; Casademont, Jordi; Corominas, Hector; Fonollosa, Vicenc			Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; PLACEBO-CONTROLLED TRIAL; ARTERIAL-HYPERTENSION; DOUBLE-BLIND; SCLERODERMA PATIENTS; DISEASE; SURVIVAL; PREVENTION; THERAPY; CLASSIFICATION	Systemic sclerosis is a disease where microcirculation damage is critical in their beginning and vascular complications have similar pathogenic findings. Digital ulcers are a frequent complication in systemic sclerosis patients and pulmonary hypertension is one of the leading causes of death. The use of bosentan has been shown to be useful for the treatment of pulmonary arterial hypertension and to prevent new digital ulcers. However, is unknown if bosentan can prevent pulmonary hypertension. Our objective was to determine if bosentan is useful to prevent pulmonary hypertension in SSc patients. A retrospective study in 237 systemic sclerosis patients with digital ulcers history treated or not with bosentan to prevent it was made. We analyzed the occurrence of pulmonary hypertension defined by an echocardiogram pulmonary arterial pressure > 40 mmHg in the entire cohort. Demographic, clinical, and treatment variables were recorded for all patients. Statistical significance was denoted by p values < 0.05. Fifty-nine patients were treated with bosentan a median of 34 months. 13.8% of treated patients had pulmonary hypertension vs 23.7% of untreated patients (p 0.13) during the follow up. In multivariate analysis patients not treated with bosentan had 3.9fold-increased risk of pulmonary hypertension compared with patients under bosentan treatment (p < 0.02). Moreover the percentage carbon monoxide diffusing capacity (DLCO) in bosentan treated patients did not decrease from baseline to the end of follow-up (61.8 +/- 14% vs 57 +/- 20.1%, p = 0.89). We concluded that Systemic sclerosis patients with digital ulcers treated with bosentan seems to have less risk to develop pulmonary hypertension and to stabilize DLCO	[Castellvi, Ivan; Sarmiento, Monica; Corominas, Hector] Hosp Univ Santa Creu & St Pau, Dept Rheumatol, Barcelona, Spain; [Simeon, Carmen Pilar; Fonollosa, Vicenc] Hosp Univ Vall Hebron, Dept Internal Med, Barcelona, Spain; [Casademont, Jordi] Hosp Univ Santa Creu & St Pau, Dept Internal Med, Barcelona, Spain	Hospital Universitari Vall d'Hebron	Castellvi, I (corresponding author), Hosp Univ Santa Creu & St Pau, Dept Rheumatol, Barcelona, Spain.	icastellvi@santpau.cat	Corominas, Hèctor/P-5045-2019; Casademont, Jordi/GPK-8669-2022	Corominas, Hèctor/0000-0002-7738-6787; Casademont, Jordi/0000-0002-8100-1827; Castellvi, Ivan/0000-0002-5410-5807				Abraham D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2186; Agard C, 2014, SCAND J RHEUMATOL, V43, P398, DOI 10.3109/03009742.2014.887768; Airo P, 2007, CLIN EXP RHEUMATOL, V25, P722; Allanore Y, 2008, ARTHRITIS RHEUM-US, V58, P284, DOI 10.1002/art.23187; Allanore Y, 2018, ARTHRITIS RHEUMATOL, V70, P162, DOI 10.1002/art.40377; Amanzi L, 2010, RHEUMATOLOGY, V49, P1374, DOI 10.1093/rheumatology/keq097; Avouac J, 2010, J RHEUMATOL, V37, P2290, DOI 10.3899/jrheum.100245; Baron M, 2014, CLIN RHEUMATOL, V33, P207, DOI 10.1007/s10067-013-2460-7; Berezne A, 2011, ARTHRIT CARE RES, V63, P277, DOI 10.1002/acr.20342; Caramaschi P, 2012, RHEUMATOL INT, V32, P1933, DOI 10.1007/s00296-011-1878-y; Cavagna L, 2010, J RHEUMATOL, V37, P2064, DOI 10.3899/jrheum.090997; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Chung L, 2010, CHEST, V138, P1383, DOI 10.1378/chest.10-0260; Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC; Cozzi F, 2013, CLIN RHEUMATOL, V32, P679, DOI 10.1007/s10067-013-2172-z; Denton CP, 1997, BRIT J RHEUMATOL, V36, P239; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Gliddon AE, 2007, ARTHRITIS RHEUM, V56, P3837, DOI 10.1002/art.22965; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Hachulla E, 2007, J RHEUMATOL, V34, P2423; Khimdas S, 2011, ARTHRIT CARE RES, V63, P142, DOI 10.1002/acr.20336; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Kovacs G, 2012, ARTHRITIS RHEUM-US, V64, P1257, DOI 10.1002/art.33460; Mathai SC, 2010, EUR RESPIR J, V35, P95, DOI 10.1183/09031936.00074309; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; McLaughlin VV, 2006, EUR J CLIN INVEST, V36, P10, DOI 10.1111/j.1365-2362.2006.01688.x; Murdaca G, 2016, J INT MED RES, V44, P85, DOI 10.1177/0300060515593257; Romaniello A, 2014, RHEUMATOLOGY, V53, P570, DOI 10.1093/rheumatology/ket424; Rubenfire M, 2013, CHEST, V144, P1282, DOI 10.1378/chest.12-0653; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Seibold JR, 2010, ARTHRITIS RHEUM-US, V62, P2101, DOI 10.1002/art.27466; Steen V, 2005, ARTHRITIS RHEUM, V52, P3698, DOI 10.1002/art.21613; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Steen V, 2009, RHEUMATOLOGY, V48, P19, DOI 10.1093/rheumatology/kep105; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Sunderkotter C, 2009, BRIT J DERMATOL, V160, P835, DOI 10.1111/j.1365-2133.2008.09004.x; Thakkar V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4383; Tiev KP, 2009, J RHEUMATOL, V36, P1470, DOI 10.3899/jrheum.081044; Tolosa-Vilella C, 2016, SEMIN ARTHRITIS RHEU, V46, P200, DOI 10.1016/j.semarthrit.2016.04.007; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Williams MH, 2006, EUR HEART J, V27, P1485, DOI 10.1093/eurheartj/ehi891	44	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243651	10.1371/journal.pone.0243651	http://dx.doi.org/10.1371/journal.pone.0243651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301540	gold, Green Published			2022-12-26	WOS:000600143100085
J	Guo, E; Guo, HL				Guo, Elisa; Guo, Hailong			CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention	PLOS ONE			English	Article							SARS-COV; IMMUNE-RESPONSE; NEURAL-NETWORKS; CORONAVIRUS; LYMPHOCYTE; SEQUENCE; ESCAPE; IDENTIFICATION; PNEUMONIA; VACCINE	The ongoing pandemic of SARS-CoV-2 has brought tremendous crisis on global health care systems and industrial operations that dramatically affect the economic and social life of numerous individuals worldwide. Understanding anti-SARS-CoV-2 immune responses in population with different genetic backgrounds and tracking the viral evolution are crucial for successful vaccine design. In this study, we reported the generation of CD8 T cell epitopes by a total of 80 alleles of three major class I HLAs using NetMHC 4.0 algorithm for the SARS-CoV-2 spike protein, which can be targeted by both B cells and T cells. We found diverse capacities of S protein specific epitope presentation by different HLA alleles with very limited number of predicted epitopes for HLA-B*2705, HLA-B*4402 and HLA-B*4403 and as high as 132 epitopes for HLA-A*6601. Our analysis of 1000 S protein sequences from field isolates collected globally over the past few months identified three recurrent point mutations including L5F, D614G and G1124V. Differential effects of these mutations on CD8 T cell epitope generation by corresponding HLA alleles were observed. Finally, our multiple alignment analysis indicated the absence of seasonal CoV induced cross-reactive CD8 T cells to drive these mutations. Our findings suggested that individuals with certain HLA alleles, such as B*44 are more prone to SARS-CoV-2 infection. Studying anti-S protein specific CD8 T cell immunity in diverse genetic background is critical for better control and prevention of the SARS-CoV-2 pandemic.	[Guo, Elisa] Mounds View High Sch, Arden Hills, MN USA			jhguo2000@gmail.com		Guo, Hailong/0000-0003-2619-335X				Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; Chen YZ, 2010, INT J IMMUNOPATH PH, V23, P165, DOI 10.1177/039463201002300115; Correale P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155205; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Enjuanes L, 2016, ADV VIRUS RES, V96, P245, DOI 10.1016/bs.aivir.2016.08.003; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; HOMBACH J, 1995, J EXP MED, V182, P1615, DOI 10.1084/jem.182.5.1615; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Laha S, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104445; Lau SY, 2020, EMERG MICROBES INFEC, V9, P837, DOI 10.1080/22221751.2020.1756700; Lima NS, 2020, J IMMUNOL, V205, P699, DOI 10.4049/jimmunol.1900811; Lissina A, 2016, CURR OPIN VIROL, V16, P77, DOI 10.1016/j.coviro.2016.01.017; Liu YC, 2020, BIOMED J, V43, P328, DOI 10.1016/j.bj.2020.04.007; Lv YB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-61; McMichael A, 2002, ARTHRITIS RES THER, V4, pS153, DOI 10.1186/ar571; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Poh CM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16638-2; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Saha P, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201312; Sun XM, 2016, CELL REP, V15, P2279, DOI 10.1016/j.celrep.2016.05.017; Timm J, 2015, MED MICROBIOL IMMUN, V204, P29, DOI 10.1007/s00430-014-0372-z; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Urra JM, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108486; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wang BM, 2004, BLOOD, V104, P200, DOI 10.1182/blood-2003-11-4072; Wang MJ, 2020, J VIROL, V94, DOI 10.1128/JVI.00567-20; Wang YD, 2004, J VIROL, V78, P5612, DOI 10.1128/JVI.78.11.5612-5618.2004; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6; Yin SX, 2020, J INFECTION, V81, pE31, DOI 10.1016/j.jinf.2020.06.076; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhao K, 2010, VACCINE, V28, P6666, DOI 10.1016/j.vaccine.2010.08.013; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	48	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0239566	10.1371/journal.pone.0239566	http://dx.doi.org/10.1371/journal.pone.0239566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301503	Green Published, Green Submitted, gold			2022-12-26	WOS:000600143100017
J	Lawal, MA; Adeniyi, OF; Akintan, PE; Salako, AO; Omotosho, OS; Temiye, EO				Lawal, Mary Adetola; Adeniyi, Oluwafunmilayo Funke; Akintan, Patricia Eyanya; Salako, Abideen Olurotimi; Omotosho, Olorunfemi Sunday; Temiye, Edamisan Olusoji			Prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos, Nigeria	PLOS ONE			English	Article							VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; SEROPREVALENCE; EPIDEMIOLOGY; VACCINE; BURDEN	Introduction The study was carried out to determine the prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos. Method A cross-sectional study conducted to determine the prevalence and risk factors for hepatitis B and C viral co-infection in children aged 2 months to 13 years. There were 187 HIV infected and 187 HIV naive age, sex-matched controls. Blood samples of participants were assayed for the serologic markers [HBsAg, anti-HBc, and anti-HCV)] of HBV and HCV viral infections using the Enzyme-Linked Immunosorbent assay (ELISA) method. Result The prevalence of HBV infection using HBsAg was 5.3% and 4.8% (p = 0.814), among HIV-infected and HIV naive children respectively, while using anti-HBc the prevalence was 7.0% and 7.5% (p = 0.842) among HIV- infected and HIV naive children respectively. The prevalence of HCV infection among HIV- infected and HIV naive children were equal to 0.5% (p = 1.000). There was also no significant association with the identifiable risk factors (sharing of a toothbrush, sharing of needles, incision marks/tattoo, hepatitis B immunization status, history of blood transfusion, previous surgical operation, sexual exposure/abuse, history of jaundice, and genital circumcision) and the HBV and or HCV status among both groups of children. History of sexual exposure/abuse and history of jaundice were however found to be predictors of the presence of HBsAg among HIV infected children only, using a binary logistic regression model. Conclusion The prevalence of HBV and or HCV infection among HIV-infected children is similar to the prevalence among HIV naive children, suggesting that HIV-infected children are not more predisposed to viral hepatitis than healthy children. Also, there was no significant difference in the prevalence of HBV infection irrespective of the use of HBsAg or anti-HBc.	[Lawal, Mary Adetola; Adeniyi, Oluwafunmilayo Funke; Akintan, Patricia Eyanya; Salako, Abideen Olurotimi; Temiye, Edamisan Olusoji] Lagos Univ, Dept Paediat, Teaching Hosp, Lagos, Nigeria; [Adeniyi, Oluwafunmilayo Funke; Akintan, Patricia Eyanya; Temiye, Edamisan Olusoji] Univ Lagos, Coll Med, Dept Paediat, Lagos, Nigeria; [Omotosho, Olorunfemi Sunday] Obafemi Awolowo Univ, Dept Community Hlth, Teaching Hosp, Ife, Osun State, Nigeria; [Lawal, Mary Adetola] Massey St Childrens Hosp, Dept Paediat, Lagos, Nigeria; [Salako, Abideen Olurotimi] GlaxoSmithKline, Lagos, Nigeria; [Omotosho, Olorunfemi Sunday] Nigeria Inst Med Res, Dept Clin Sci, Lagos, Nigeria	University of Lagos; Obafemi Awolowo University	Lawal, MA (corresponding author), Lagos Univ, Dept Paediat, Teaching Hosp, Lagos, Nigeria.; Lawal, MA (corresponding author), Massey St Childrens Hosp, Dept Paediat, Lagos, Nigeria.	shalomti@yahoo.com	Adeniyi, Oluwafunmilayo/CAF-6583-2022	Adeniyi, Oluwafunmilayo/0000-0003-2564-6118				Abera Bayeh, 2014, BMC Res Notes, V7, P838, DOI 10.1186/1756-0500-7-838; Adeyinka D, 2016, NATL GUIDELINES HIV, P13; Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2815; [Anonymous], 2011, ICON-INT J CONST LAW, V9, P1, DOI 10.1093/icon/mor030; [Anonymous], 2015, OFITSIINYI VISNYK PR, V2, P14; [Anonymous], 2017, INNOV SURG SCI, V2, P1, DOI DOI 10.5334/gjgl.276; [Anonymous], 2015, NIGERIAN J PAEDIAT; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; [Anonymous], 2013, GASTROENTEROL HEP S3, P1, DOI DOI 10.1017/S1743923X12000670; Ashir G M, 2009, Niger J Med, V18, P260; Askari A, 2014, IRAN J PUBLIC HEALTH, V43, P705; AWOLEYE OJ, 2015, J AIDS HIV RES, V7, P117; Balogun TM, 2012, PAN AFR MED J, V12; Chakraborty R, 2003, CLIN INFECT DIS, V36, P922, DOI 10.1086/368207; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Cooper CL, 2009, INT J INFECT DIS, V13, P302, DOI 10.1016/j.ijid.2008.06.042; Durowaye MO, 2014, INT J CLIN MED RES, V1, P42; EJELIOGU EU, 2014, OPEN SCI J CLIN MED, V2, P69; Ejeliogu EU, 2014, INT J TROP DIS HLTH, V4, P773; Eke CB, 2015, J TROP PEDIATRICS, V61, P407, DOI 10.1093/tropej/fmv035; Esan A., 2014, AM J BIOMEDICAL RES, V2, P11, DOI [10.12691/ajbr-2-1-3, DOI 10.12691/AJBR-2-1-3]; Fox JM, 2015, TROP MED INT HEALTH, V20, P638, DOI 10.1111/tmi.12465; Freitas SZ, 2014, BRAZ J INFECT DIS, V18, P473, DOI 10.1016/j.bjid.2014.01.005; Hamza M., 2013, NIGER J BASIC CLIN S, V10, P76, DOI [10.4103/0331-8540.122765, DOI 10.4103/0331-8540.122765]; Ikobah J, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.128.8756; Ikpeme EE, 2013, AFR HEALTH SCI, V13, P955, DOI 10.4314/ahs.v13i4.14; Isa MA, 2015, INT J ADV RES BIO SC, V2, P128; Jhaveri R, 2006, J PEDIATR-US, V148, P353, DOI 10.1016/j.jpeds.2005.10.031; Khaderi S, 2014, WORLD J GASTROENTERO, V20, P11281, DOI 10.3748/wjg.v20.i32.11281; Khakshour A, 2014, INT J PEDIATR-MASSHA, V2, P145; Kliegman R, 2007, NELSON TXB PEDIAT, P1680; Lar P. M., 2013, African Journal of Clinical and Experimental Microbiology, V14, P120; Lemoine M, 2015, J HEPATOL, V62, P469, DOI 10.1016/j.jhep.2014.10.008; Mdlalose N, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.283; Muriuki Beatrice Mukami, 2013, BMC Res Notes, V6, P363, DOI 10.1186/1756-0500-6-363; National Blood Transfusion Service Federal Ministry of Health [Nigeria], 2006, NAT BLOOD POL; National Population Commission ICF, 2019, NAT SPEC LIST KOR 3, P224; Nel E, 2012, J PEDIATR GASTR NUTR, V55, P500, DOI 10.1097/MPG.0b013e318272aee7; Nigeria, 2017, WHO UNICEF ESTIMATES; Nwolisa E, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.89.1711; O'Leary M, 2017, J INFECT PUBLIC HEAL, V10, P470, DOI 10.1016/j.jiph.2016.08.001; Odusanya OO, 2011, HUM VACCINES, V7, P625, DOI 10.4161/hv.7.6.14990; Ogboghodo BC, 2009, AFR J BIOMED RES, V12, P1; Omeje KN., 2017, NIGER J PAEDIAT, V44, P14, DOI [10.4314/njp.v44i1.3, DOI 10.4314/NJP.V44I1.3]; Oni AO, 1996, J MED VIROL, V49, P178, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;178::AID-JMV4&gt;3.0.CO;2-1; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Oyedeji G.A., 1985, NIG J PAEDIAT, V12, P111; Paganelli M, 2012, J HEPATOL, V57, P885, DOI 10.1016/j.jhep.2012.03.036; Puoti M, 2008, CLIN INFECT DIS, V46, P367, DOI 10.1086/525532; Rouet F, 2008, CLIN INFECT DIS, V46, P361, DOI 10.1086/525531; Sadoh AE, 2011, S AFR J CHILD HEALTH, V5, P7; Sadoh AE, 2014, AFR HEALTH SCI, V14, P377, DOI 10.4314/ahs.v14i2.13; Schuval S, 2004, ARCH PEDIAT ADOL MED, V158, P1007, DOI 10.1001/archpedi.158.10.1007; Telatela SP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-338; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Toussi SS, 2007, CLIN INFECT DIS, V45, P795, DOI 10.1086/521169; Ugwuja E, 2008, INTERNET J TROPICAL, V6, P1; Zhou ST, 2010, JAIDS-J ACQ IMM DEF, V54, P191, DOI 10.1097/QAI.0b013e3181c99226	58	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243656	10.1371/journal.pone.0243656	http://dx.doi.org/10.1371/journal.pone.0243656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301507	Green Published, gold			2022-12-26	WOS:000600143100075
J	Fudolig, M; Howard, R				Fudolig, Miguel; Howard, Reka			The local stability of a modified multi-strain SIR model for emerging viral strains	PLOS ONE			English	Article							PULSE VACCINATION STRATEGY; INFLUENZA EPIDEMIC; ANTIGENIC DRIFT; VIRUS; EMERGENCE; MUMPS	We study a novel multi-strain SIR epidemic model with selective immunity by vaccination. A newer strain is made to emerge in the population when a preexisting strain has reached equilbrium. We assume that this newer strain does not exhibit cross-immunity with the original strain, hence those who are vaccinated and recovered from the original strain become susceptible to the newer strain. Recent events involving the COVID-19 virus shows that it is possible for a viral strain to emerge from a population at a time when the influenza virus, a well-known virus with a vaccine readily available, is active in a population. We solved for four different equilibrium points and investigated the conditions for existence and local stability. The reproduction number was also determined for the epidemiological model and found to be consistent with the local stability condition for the disease-free equilibrium.	[Fudolig, Miguel; Howard, Reka] Univ Nebraska, Dept Stat, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Fudolig, M (corresponding author), Univ Nebraska, Dept Stat, Lincoln, NE 68588 USA.	mfudolig@huskers.unl.edu		Fudolig, Miguel/0000-0002-0148-8090				Albertson JP, 2016, MMWR-MORBID MORTAL W, V65, P731, DOI 10.15585/mmwr.mm6529a2; Allen L. J. S., 2007, INTRO MATH BIOL; [Anonymous], 2016, EVIDENCE, V8, pe1000; Attanayake A, 2020, PHENOMENOLOGICAL MOD; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Binti Hamzah F., 2020, B WORLD HEALTH ORGAN, V1, P32, DOI [10.2471/BLT.20.255695, DOI 10.2471/BLT.20.255695]; Blackwood JC., 2018, LETT BIOMATH, V5, P195, DOI [10.30707/LiB5.1Blackwood, DOI 10.30707/LIB5.1BLACKWOOD]; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Casagrandi R, 2006, MATH BIOSCI, V200, P152, DOI 10.1016/j.mbs.2005.12.029; Centers for Disease Control and Prevention, 2018, FLU SEAS; Centers for Disease Control and Prevention, 2019, FLU VACC COV US 2018; Centers for Disease Control and Prevention, 2019, MEASL CAS OUTBR; Centers for Disease Control and Prevention, 2019, MUMPS CAS OUTBR; Centers for Disease Control and Prevention, 2020, SYMPT COR DIS; Centers for Disease Control and Prevention, 2020, FREQ ASK INFL FLU QU; Centers for Diseases Control and Prevention (CDCb), 2017, FLU VIR CAN CHANG DR; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cuadrado-Payan E, 2020, LANCET, V395, pE84, DOI 10.1016/S0140-6736(20)31052-7; d'Onofrio A, 2005, APPL MATH LETT, V18, P729, DOI 10.1016/j.aml.2004.05.012; d'Onofrio A, 2002, MATH BIOSCI, V179, P57, DOI 10.1016/S0025-5564(02)00095-0; Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dusheck J., 2015, VIRAL INFECT LEAVE S; Edelstein-Keshet L, 2005, MATH MODELS BIOL; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Han LT, 2001, MATH COMPUT MODEL, V34, P849, DOI 10.1016/S0895-7177(01)00104-2; He SB, 2020, NONLINEAR DYNAM, V101, P1667, DOI 10.1007/s11071-020-05743-y; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Iwami S, 2007, MATH BIOSCI, V207, P1, DOI 10.1016/j.mbs.2006.08.001; JACQUEZ JA, 1996, COMPARTMENTAL ANAL B; Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Li T, 2016, PHYSICA A, V450, P649, DOI 10.1016/j.physa.2016.01.045; Liu ZF, 2015, INT J INFECT DIS, V41, P73, DOI 10.1016/j.ijid.2015.11.003; Lopez L., 2020, MODIFIED SEIR MODEL, DOI DOI 10.2139/SSRN.3576802; Maier B.F., 2020, ARXIV200207572; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Ning J, 2021, SCI CHINA CHEM, V64, P1103, DOI 10.1007/s11426-020-9867-x; O'Neill PD, 2002, MATH BIOSCI, V180, P103, DOI 10.1016/S0025-5564(02)00109-8; Pan J., 2020, EFFECTIVENESS CONTRO; Pandey G, 2020, ARXIV200400958; Park JK, 2018, MBIO, V9, DOI [10.1128/mBio.02284-17, 10.1128/mbio.02284-17]; Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967; Peirlinck M, 2020, BIOMECH MODEL MECHAN, V19, P2179, DOI 10.1007/s10237-020-01332-5; Pell B, 2018, EPIDEMICS-NETH, V22, P62, DOI 10.1016/j.epidem.2016.11.002; Peng L., 2020, ARXIV200206563; R Core Team, 2020, R LANG ENV STAT COMP; Roche B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-87; Sanchez D. A, 1979, ORDINARY DIFFERENTIA; Schuster M, 2015, VACCINE, V33, P4157, DOI 10.1016/j.vaccine.2015.04.035; Shi P, 2010, EPIDEMIOL INFECT, V138, P1472, DOI 10.1017/S0950268810000300; Shrestha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002135; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Sinha S., 2014, AM J COMP APPL MATH, V4, P17; Smith LE, 2017, VACCINE, V35, P6059, DOI 10.1016/j.vaccine.2017.09.046; Steinmeyer SH, 2010, PHILOS T R SOC B, V365, P1931, DOI 10.1098/rstb.2010.0065; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Stockdale JE, 2017, EPIDEMICS-NETH, V19, P13, DOI 10.1016/j.epidem.2016.11.005; Tang L, 2020, INT STAT REV, V88, P462, DOI 10.1111/insr.12402; Tolles J, 2020, JAMA-J AM MED ASSOC, V323, P2515, DOI 10.1001/jama.2020.8420; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002; Wendorf K, 2014, MMWR-MORBID MORTAL W, V63; Wilson JN, 2000, EPIDEMIOL INFECT, V124, P295, DOI 10.1017/S0950268800003605; Wolfram Research Inc., 2018, MATH VERS 11 3; World Health Organization, 2020, ARCH WHO TIM COVID 1; Yaari R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0298; Yamauchi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39057-w; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018; Yee Jane, 2020, J Am Coll Emerg Physicians Open, V1, P63, DOI 10.1002/emp2.12034; Youssef M, 2011, J THEOR BIOL, V283, P136, DOI 10.1016/j.jtbi.2011.05.029; Zaman G, 2008, BIOSYSTEMS, V93, P240, DOI 10.1016/j.biosystems.2008.05.004; Zhang JP, 2011, APPL MATH COMPUT, V217, P7053, DOI 10.1016/j.amc.2010.09.063; Zipprich J, 2014, MMWR-MORBID MORTAL W, V63, P362	77	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243408	10.1371/journal.pone.0243408	http://dx.doi.org/10.1371/journal.pone.0243408			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296417	Green Submitted, gold, Green Published			2022-12-26	WOS:000598626100074
J	Mudaliar, RK; Schaerf, TM				Mudaliar, Rajnesh K.; Schaerf, Timothy M.			Examination of an averaging method for estimating repulsion and attraction interactions in moving groups	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; DECISION-MAKING; MODEL; DYNAMICS; RULES; STATE	Groups of animals coordinate remarkable, coherent, movement patterns during periods of collective motion. Such movement patterns include the toroidal mills seen in fish shoals, highly aligned parallel motion like that of flocks of migrating birds, and the swarming of insects. Since the 1970's a wide range of collective motion models have been studied that prescribe rules of interaction between individuals, and that are capable of generating emergent patterns that are visually similar to those seen in real animal group. This does not necessarily mean that real animals apply exactly the same interactions as those prescribed in models. In more recent work, researchers have sought to infer the rules of interaction of real animals directly from tracking data, by using a number of techniques, including averaging methods. In one of the simplest formulations, the averaging methods determine the mean changes in the components of the velocity of an individual over time as a function of the relative coordinates of group mates. The averaging methods can also be used to estimate other closely related quantities including the mean relative direction of motion of group mates as a function of their relative coordinates. Since these methods for extracting interaction rules and related quantities from trajectory data are relatively new, the accuracy of these methods has had limited inspection. In this paper, we examine the ability of an averaging method to reveal prescribed rules of interaction from data generated by two individual based models for collective motion. Our work suggests that an averaging method can capture the qualitative features of underlying interactions from trajectory data alone, including repulsion and attraction effects evident in changes in speed and direction of motion, and the presence of a blind zone. However, our work also illustrates that the output from a simple averaging method can be affected by emergent group level patterns of movement, and the sizes of the regions over which repulsion and attraction effects are apparent can be distorted depending on how individuals combine interactions with multiple group mates.	[Mudaliar, Rajnesh K.; Schaerf, Timothy M.] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Mudaliar, Rajnesh K.] Fiji Natl Univ, Sch Math & Comp Sci, Suva, Fiji	University of New England; Fiji National University (FNU)	Schaerf, TM (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	tschaerf@une.edu.au	; Schaerf, Timothy/M-7821-2015	Mudaliar, Dr Rajnesh/0000-0002-7093-2802; Schaerf, Timothy/0000-0001-6642-8374	Australian Research Council [DP190100660]	Australian Research Council(Australian Research Council)	This work was supported by funding from the Australian Research Council under project DP190100660. There was no additional external funding received for this study.	AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Attanasi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003697; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bhaskar D, 2019, CHAOS, V29, DOI 10.1063/1.5125493; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Calovi DS, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005933; Canizo JA, 2010, ARBOR, V186, P1035, DOI 10.3989/arbor.2010.746n1252; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Chuang YL, 2007, PHYSICA D, V232, P33, DOI 10.1016/j.physd.2007.05.007; Chuang YL, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.043112; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; Escobedo R, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0380; Fetecau RC, 2012, B MATH BIOL, V74, P2600, DOI 10.1007/s11538-012-9769-2; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; Hansen MJ, 2015, BEHAVIOUR, V152, P1657, DOI 10.1163/1568539X-00003298; Hansen MJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1713, DOI 10.1007/s00265-015-1983-0; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Heras FJH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006566; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; KRAKAUER DC, 1995, BEHAV ECOL SOCIOBIOL, V36, P421, DOI 10.1007/s002650050165; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Makinson JC, 2011, BEHAV ECOL SOCIOBIOL, V65, P945, DOI 10.1007/s00265-010-1095-9; Miller JM, 2012, B MATH BIOL, V74, P536, DOI 10.1007/s11538-011-9676-y; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Romey WL, 1996, ECOL MODEL, V92, P65, DOI 10.1016/0304-3800(95)00202-2; Sakai Sumiko, 1973, BIOPHYSICS-USSR, V13, P82, DOI [10.2142/biophys.13.82, DOI 10.2142/BIOPHYS.13.82]; Schaerf TM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603201; Schaerf TM, 2020, IDENTIFYING SI UNPUB; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Strombom D, 2011, J THEOR BIOL, V283, P145, DOI 10.1016/j.jtbi.2011.05.019; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Ward A., 2016, SOCIALITY BEHAV GROU; Ward AJW, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170043	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243631	10.1371/journal.pone.0243631	http://dx.doi.org/10.1371/journal.pone.0243631			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296438	gold, Green Published			2022-12-26	WOS:000598626100017
J	Donnelly, PM; Larson, K; Matskewich, T; Yeatman, JD				Donnelly, Patrick M.; Larson, Kevin; Matskewich, Tanya; Yeatman, Jason D.			Annotating digital text with phonemic cues to support decoding in struggling readers	PLOS ONE			English	Article							DEVELOPMENTAL READING DISABILITIES; REMEDIAL INSTRUCTION; COMPUTER; STUDENTS; INTERVENTION; TECHNOLOGY; DYSLEXIA; CHILDREN; OUTCOMES; PROGRAMS	An advantage of digital media is the flexibility to personalize the presentation of text to an individual's needs and embed tools that support pedagogy. The goal of this study was to develop a tablet-based reading tool, grounded in the principles of phonics-based instruction, and determine whether struggling readers could leverage this technology to decode challenging words. The tool presents a small icon below each vowel to represent its sound. Forty struggling child readers were randomly assigned to an intervention or control group to test the efficacy of the phonemic cues. We found that struggling readers could leverage the cues to improve pseudoword decoding: after two weeks of practice, the intervention group showed greater improvement than controls. This study demonstrates the potential of a text annotation, grounded in intervention research, to help children decode novel words. These results highlight the opportunity for educational technologies to support and supplement classroom instruction.	[Donnelly, Patrick M.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Donnelly, Patrick M.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Larson, Kevin; Matskewich, Tanya] Microsoft Corp, Redmond, WA 98052 USA; [Yeatman, Jason D.] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Yeatman, Jason D.] Stanford Univ, Sch Med, Div Dev Behav Pediat, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Microsoft; Stanford University; Stanford University	Donnelly, PM (corresponding author), Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA.; Donnelly, PM (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	pdonne@uw.edu		Yeatman, Jason/0000-0002-2686-1293; Donnelly, Patrick/0000-0002-5850-7248	NSF [BCS 1551330]; NICHD [R21HD092771]; Microsoft Research Grants; Jacobs Foundation Research Fellowship	NSF(National Science Foundation (NSF)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Microsoft Research Grants(Microsoft); Jacobs Foundation Research Fellowship	This work was funded by NSF BCS 1551330, NICHD R21HD092771, Microsoft Research Grants and Jacobs Foundation Research Fellowship to J.D.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two authors [K.L. and T.M], are employed by Microsoft Corporation. Microsoft Corporation provided support in the form of salaries for authors [K.L. and T.M.] and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2011, ICMR PUBLICATION, VP 97, P1; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2015, HUMAN TECHNOLOGY INT, DOI [10.17011/ht/um.201511113637, 10.17011/ht/urn.201511113637]; AUERBACH ER, 1989, HARVARD EDUC REV, V59, P165, DOI 10.17763/haer.59.2.h23731364l283156; Beach KD, 2018, READ WRIT Q, V34, P263, DOI 10.1080/10573569.2018.1446859; Berninger VW, 2013, ANN DYSLEXIA, V63, P1, DOI 10.1007/s11881-011-0054-0; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; BRYANT ND, 1965, READ TEACH, V18, P567; Castles A, 2018, PSYCHOL SCI PUBL INT, V19, P5, DOI 10.1177/1529100618772271; Chall J. S, 1983, LEARNING READ GREAT; Cheung ACK, 2013, READ RES QUART, V48, P277, DOI 10.1002/rrq.50; Clark DB, 2016, REV EDUC RES, V86, P79, DOI 10.3102/0034654315582065; Cunningham PM, 1999, RUTG INV SYMP EDUC S, P68; Daugherty L, 2014, GETTING SAME PAGE ID; de Souza GN, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02531; Dexter S, 2020, J RES TECHNOL EDUC, V52, P17, DOI 10.1080/15391523.2019.1668316; Dowker A, 2005, J LEARN DISABIL-US, V38, P324, DOI 10.1177/00222194050380040801; Farkas WA, 2019, READ WRIT Q, V35, P305, DOI 10.1080/10573569.2018.1541770; Foorman BR, 1998, J EDUC PSYCHOL, V90, P37, DOI 10.1037//0022-0663.90.2.235; Francom GM, 2020, J RES TECHNOL EDUC, V52, P1, DOI 10.1080/15391523.2019.1679055; Goodall J., 2017, NARROWING ACHIEVEMEN; Guernsey L., 2015, TAP CLICK READ GROWI; Hannon P., 1990, BRIT EDUC RES J, V16, P259; Hornung C, 2017, LEARN INDIVID DIFFER, V57, P85, DOI 10.1016/j.lindif.2017.06.006; Hutchison A, 2012, READ TEACH, V66, P15, DOI 10.1002/TRTR.01090; Kim MK, 2017, REM SPEC EDUC, V38, P233, DOI 10.1177/0741932517693396; Kraft MA, 2017, ANN AM ACAD POLIT SS, V674, P85, DOI 10.1177/0002716217732009; Kyle F, 2013, READ RES QUART, V48, P61, DOI 10.1002/rrq.038; Laurillard D, 2016, AUSTRALAS J EDUC TEC, V32, P32, DOI 10.14742/ajet.3116; Lindeblad E, 2017, DISABIL REHABIL-ASSI, V12, P713, DOI 10.1080/17483107.2016.1253116; Lovett MW, 2017, J EDUC PSYCHOL, V109, P889, DOI 10.1037/edu0000181; Lovett MW, 2000, J EDUC PSYCHOL, V92, P263, DOI 10.1037/0022-0663.92.2.263; Lynch J, 2006, READ PSYCHOL, V27, P1, DOI 10.1080/02702710500468708; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Medler D. A., 2005, MCWORD ORTHOGRAPHIC; Messer D, 2018, J RES READ, V41, P140, DOI 10.1111/1467-9817.12107; Moats LouisaC., 2020, AM EDUC, V44, P4; Morris RD, 2012, J LEARN DISABIL-US, V45, P99, DOI 10.1177/0022219409355472; National Assessment of Educational Progress, 2006, NATL ASSESSMENT ED P; National Assessment of Educational Progress, 2019, NATL ASSESSMENT ED P; National Reading Panel, 2000, TEACH CHILDR READ EV; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; O'Brien BA, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02625; Oakland T, 1998, J LEARN DISABIL, V31, P140, DOI 10.1177/002221949803100204; OLSON RK, 1992, READ WRIT, V4, P107, DOI 10.1007/BF01027488; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Rose D.H., 2007, UNIVERSAL ACCESS IN, V5, P381, DOI [10.1007/s10209-006-0062-8, DOI 10.1007/S10209-006-0062-8, https://doi.org/10.1007/s10209-006-0062-8]; Scanlon D. M., 1997, SCI STUD READ, V1, P191, DOI [10.1207/s1532799xssr0103_2, DOI 10.1207/S1532799XSSR0103_2]; Seward R., 2014, VISIBLE LANG, V48, P87; Shaheen NL, 2019, J RES TECHNOL EDUC, V51, P187, DOI 10.1080/15391523.2019.1566037; Slavin RE, 2008, READ RES QUART, V43, P290, DOI 10.1598/RRQ.43.3.4; Slavin RE, 2011, EDUC RES REV-NETH, V6, P1, DOI 10.1016/j.edurev.2010.07.002; Snow CE, 1998, PREVENTING READING D, DOI [10.2307/495689, DOI 10.2307/495689]; Storch SA, 2002, DEV PSYCHOL, V38, P934, DOI 10.1037//0012-1649.38.6.934; Takacs ZK, 2015, REV EDUC RES, V85, P698, DOI 10.3102/0034654314566989; The MathWorks I, 2017, MATLAB STAT MACH LEA; Tichnor-Wagner A, 2016, LEARN DISABIL RES PR, V31, P6, DOI 10.1111/ldrp.12090; Torgesen JK, 2001, J LEARN DISABIL-US, V34, P33, DOI 10.1177/002221940103400104; Torgesen JK, 2010, ANN DYSLEXIA, V60, P40, DOI 10.1007/s11881-009-0032-y; Vaughn S, 2008, LEARN INDIVID DIFFER, V18, P338, DOI 10.1016/j.lindif.2008.05.001; Wanzek J, 2018, J LEARN DISABIL-US, V51, P612, DOI 10.1177/0022219418775110; WISE BW, 1995, ANN DYSLEXIA, V45, P99, DOI 10.1007/BF02648214; Wolf M, 2000, J LEARN DISABIL-US, V33, P322, DOI 10.1177/002221940003300404; Wolf M., 2001, SCIENT STUD READ, V5, P211, DOI DOI 10.1207/S1532799XSSR0503_2; Wolf M., 2008, PROUST SQUID STORY S; Wolf M, 2009, MIND BRAIN EDUC, V3, P84, DOI 10.1111/j.1751-228X.2009.01058.x	66	1	1	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243435	10.1371/journal.pone.0243435	http://dx.doi.org/10.1371/journal.pone.0243435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284838	Green Published, Green Submitted, gold			2022-12-26	WOS:000597930500018
J	Long, Z				Long, Zheng			Computational analysis of the metal selectivity of matrix metalloproteinase 8	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; COPPER; BINDING; CANCER; MECHANISM; COORDINATION; COLLAGENASE; ACTIVATION; INHIBITORS; PROTEINS	Matrix metalloproteinase (MMP) is a class of metalloenzyme that cleaves peptide bonds in extracellular matrices. Their functions are important in both health and disease of animals. Here using quantum mechanics simulations of the MMP8 protein, the coordination chemistry of different metal cofactors is examined. Structural comparisons reveal that Jhan-Teller effects induced by Cu(II) coordination distorts the wild-type MMP8 active site corresponding to a significant reduction in activity observed in previous experiments. In addition, further analysis suggests that a histidine to glutamine mutation at residue number 197 can potentially allow the MMP8 protein to utilize Cu(II) in reactions. Simulations also demonstrates the requirement of a conformational change in the ligand before enzymatic cleavage. The insights provided here will assist future protein engineering efforts utilizing the MMP8 protein.	[Long, Zheng] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA	University of California System; University of California San Diego	Long, Z (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA.	longzheng26@gmail.com		Long, Zheng/0000-0003-3463-9024				Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Borowski T, 2015, ADV PROTEIN CHEM STR, V100, P187, DOI 10.1016/bs.apcsb.2015.06.005; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; COATES RJ, 1989, CANCER RES, V49, P4353; Dennington R., 2009, GAUSS VIEW VERSION 5; Denoyer D, 2015, METALLOMICS, V7, P1459, DOI 10.1039/c5mt00149h; Fields GB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090984; Gogoi P, 2016, J BIOMOL STRUCT DYN, V34, P1470, DOI 10.1080/07391102.2015.1080629; Hahn PF, 1936, J BIOL CHEM, V113, P161; Heitzer M, 2002, J BIOL CHEM, V277, P28280, DOI 10.1074/jbc.M203925200; Hwang JJ, 2007, J NEUROSCI RES, V85, P2160, DOI 10.1002/jnr.21350; Juurikka K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184506; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; Lentsch AB, 2001, AM J PHYSIOL-LUNG C, V281, pL387, DOI 10.1152/ajplung.2001.281.2.L387; LOVEJOY B, 1994, BIOCHEMISTRY-US, V33, P8207, DOI 10.1021/bi00193a006; MACARTNEY HW, 1981, H-S Z PHYSIOL CHEM, V362, P1523, DOI 10.1515/bchm2.1981.362.2.1523; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; MARGALIOTH EJ, 1983, CANCER, V52, P868, DOI 10.1002/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K; McGuffin LJ, 2019, NUCLEIC ACIDS RES, V47, pW408, DOI 10.1093/nar/gkz322; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Parr-Sturgess CA, 2012, MOL CANCER RES, V10, P1282, DOI 10.1158/1541-7786.MCR-12-0312; Pelmenschikov V, 2002, INORG CHEM, V41, P5659, DOI 10.1021/ic0255656; Prior SH, 2016, J BIOL CHEM, V291, P7888, DOI 10.1074/jbc.M115.703124; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Sakharov DV, 2005, J AM CHEM SOC, V127, P4921, DOI 10.1021/ja0429115; Siegbahn PEM, 2009, J BIOL INORG CHEM, V14, P643, DOI 10.1007/s00775-009-0511-y; Stiebritz MT, 2019, METHODS MOL BIOL, V1876, P245, DOI 10.1007/978-1-4939-8864-8_16; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; Tauro M, 2016, J ENZYM INHIB MED CH, V31, P25, DOI 10.1080/14756366.2016.1217853; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Warren JJ, 2012, J INORG BIOCHEM, V115, P119, DOI 10.1016/j.jinorgbio.2012.05.002; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243321	10.1371/journal.pone.0243321	http://dx.doi.org/10.1371/journal.pone.0243321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275641	gold, Green Published			2022-12-26	WOS:000597150200017
J	Mazhari, R; Brewster, J; Fong, R; Bourke, C; Liu, ZSJ; Takashima, E; Tsuboi, T; Tham, WH; Harbers, M; Chitnis, C; Healer, J; Ome-Kaius, M; Sattabongkot, J; Kazura, J; Robinson, LJ; King, C; Mueller, I; Longley, RJ				Mazhari, Ramin; Brewster, Jessica; Fong, Rich; Bourke, Caitlin; Liu, Zoe S. J.; Takashima, Eizo; Tsuboi, Takafumi; Tham, Wai-Hong; Harbers, Matthias; Chitnis, Chetan; Healer, Julie; Ome-Kaius, Maria; Sattabongkot, Jetsumon; Kazura, James; Robinson, Leanne J.; King, Christopher; Mueller, Ivo; Longley, Rhea J.			A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX)	PLOS ONE			English	Article								Multiplexed bead-based assays that use Luminex(R) xMAP(R) technology have become popular for measuring antibodies against proteins of interest in many fields, including malaria and more recently SARS-CoV-2/COVID-19. There are currently two formats that are widely used: non-magnetic beads or magnetic beads. Data are lacking regarding the comparability of results obtained using these two types of beads, and for assays run on different instruments. Whilst non-magnetic beads can only be run on flow-based instruments (such as the Luminex(R) 100/200 (TM) or Bio-Plex(R) 200), magnetic beads can be run on both these and the newer MAGPIX(R) instruments. In this study we utilized a panel of purified recombinant Plasmodium vivax proteins and samples from malaria-endemic areas to measure P. vivax-specific IgG responses using different combinations of beads and instruments. We directly compared: i) non-magnetic versus magnetic beads run on a Bio-Plex(R) 200, ii) magnetic beads run on the Bio-Plex(R) 200 versus MAGPIX(R) and iii) non-magnetic beads run on a Bio-Plex(R) 200 versus magnetic beads run on the MAGPIX(R). We also performed an external comparison of our optimized assay. We observed that IgG antibody responses, measured against our panel of P. vivax proteins, were moderately-strongly correlated in all three of our comparisons (pearson r>0.5 for 18/19 proteins), however higher amounts of protein were required for coupling to magnetic beads. Our external comparison indicated that results generated in different laboratories using the same coupled beads are also highly comparable (pearson r>0.7), particularly if a reference standard curve is used.	[Mazhari, Ramin; Brewster, Jessica; Bourke, Caitlin; Liu, Zoe S. J.; Tham, Wai-Hong; Healer, Julie; Ome-Kaius, Maria; Robinson, Leanne J.; Mueller, Ivo; Longley, Rhea J.] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Mazhari, Ramin; Bourke, Caitlin; Liu, Zoe S. J.; Tham, Wai-Hong; Healer, Julie; Robinson, Leanne J.; Mueller, Ivo; Longley, Rhea J.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Fong, Rich; Kazura, James; King, Christopher] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Takashima, Eizo; Tsuboi, Takafumi] Ehime Univ, Proteo Sci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan; [Harbers, Matthias] CellFree Sci Co Ltd, Yokohama, Kanagawa, Japan; [Harbers, Matthias] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Chitnis, Chetan] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasite Biol & Vaccines, Paris, France; [Ome-Kaius, Maria; Robinson, Leanne J.] PNG Inst Med Res, Vector Borne Dis Unit, Madang, Papua N Guinea; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [Robinson, Leanne J.] Burnet Inst, Melbourne, Vic, Australia; [Mueller, Ivo] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasites & Hosts Unit, Paris, France	Walter & Eliza Hall Institute; University of Melbourne; Case Western Reserve University; Ehime University; RIKEN; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; PNG Institute Of Medical Research; Mahidol University; Burnet Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Longley, RJ (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia.; Longley, RJ (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	Longley.r@wehi.edu.au	Tsuboi, Takafumi/AAK-6145-2021; Prachumsri, Jetsumon/AAZ-7732-2021; Tham, Wai-Hong/L-3173-2018	Bourke, Caitlin/0000-0002-4466-6563; Tham, Wai-Hong/0000-0001-7950-8699; Harbers, Matthias/0000-0002-5613-7220; Sattabongkot, Jetsumon/0000-0002-3938-4588; Liu, Zoe Shih-Jung/0000-0002-0269-0119	National Health and Medical Research Council Australia [1092789, 1134989, 1043345, 1143187]; National Institute of Allergy and Infectious Diseases (NIH) [5R01 AI 104822]; Global Health Innovative Technology Fund [T2015-142]; TransEPI consortium by the Bill and Melinda Gates Foundation; NHMRC Early Career Investigator Fellowship [1173210]; National Research Council of Thailand	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Global Health Innovative Technology Fund; TransEPI consortium by the Bill and Melinda Gates Foundation; NHMRC Early Career Investigator Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the National Health and Medical Research Council Australia (https://www.nhmrc.gov.au/) (#1092789, #1134989 and #1043345 to IM and #1143187 to W-HT), the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/grants-contracts/opportunities) (NIH grant 5R01 AI 104822 to JS) and the Global Health Innovative Technology Fund (https://www.ghitfund.org/) (T2015-142 to IM). Additional funding directly supporting field studies was from the TransEPI consortium (supported by the Bill and Melinda Gates Foundation, https://www.gatesfoundation.org/).RJL is currently supported by an NHMRC Early Career Investigator Fellowship (1173210). W. H.T. is a Howard Hughes Medical InstituteWellcome Trust International Research Scholar (https://www.hhmi.org/programs/biomedicalresearch/international-programs, 208693/Z/17/Z). We also acknowledge support from the National Research Council of Thailand. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional support for this study was provided by CellFree Sciences in the form of salary for MH. The specific roles of these authors are articulated in the `author contributions' section.	Bryan D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1958-x; Dobano C, 2020, 147363 BIORXIV, DOI 10.1128/JCM.01731-20; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Germeraad E, 2019, METHODS, V158, P54, DOI 10.1016/j.ymeth.2019.01.012; Liechti T, 2018, J IMMUNOL METHODS, V454, P48, DOI 10.1016/j.jim.2017.12.003; Lin A, 2015, METHODS MOL BIOL, V1318, P107, DOI 10.1007/978-1-4939-2742-5_11; Longley RJ, 2020, NAT MED, V26, P741, DOI 10.1038/s41591-020-0841-4; Longley RJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1826-8; Manaskova SH, 2016, J IMMUNOL METHODS, V436, P29, DOI 10.1016/j.jim.2016.06.003; Nguitragool W, 2019, INT J PARASITOL, V49, P455, DOI 10.1016/j.ijpara.2019.01.004; Ondigo BN, 2019, PEERJ, V7, DOI 10.7717/peerj.6120; Quah YW, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2727-9; Rosado J, 2020, 20093963 MEDRXIV, DOI 10.1101/2020.05.07.20093963; Selva KJ, 2020, 20098459 MEDRXIV, DOI 10.1101/2020.05.11.20098459; Ubillos I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199278; Ubillos I, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2369-3; Varela ML, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2465-4; Whitelegg AME, 2012, J IMMUNOL METHODS, V377, P37, DOI 10.1016/j.jim.2012.01.007; Wu Lindsey, 2019, Wellcome Open Res, V4, P26, DOI [10.12688/wellcomeopenres.14950.2, 10.12688/wellcomeopenres.14950.1]	19	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0238010	10.1371/journal.pone.0238010	http://dx.doi.org/10.1371/journal.pone.0238010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275613	Green Submitted, Green Published, gold			2022-12-26	WOS:000597150200004
J	Borgstedt, L; Blobner, M; Musiol, M; Bratke, S; Syryca, F; Rammes, G; Jungwirth, B; Schmid, S				Borgstedt, Laura; Blobner, Manfred; Musiol, Maximilian; Bratke, Sebastian; Syryca, Finn; Rammes, Gerhard; Jungwirth, Bettina; Schmid, Sebastian			Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia	PLOS ONE			English	Article							MODIFIED HOLE-BOARD; A-BETA; ALZHEIMERS-DISEASE; MOUSE MODELS; PROTEIN; BEHAVIOR; PEPTIDE; PLAQUES; TRENDS; TAU	Background The aim of this study was to assess different amyloid beta subspecies' effects on behaviour and cognition in mice and their interaction with isoflurane anaesthesia. Methods After governmental approval, cannulas were implanted in the lateral cerebral ventricle. After 14 days the mice were randomly intracerebroventricularly injected with A beta 1-40 (A beta 40), A beta 1-42 (A beta 42), 3NTyr10-A beta (A beta nitro), A beta pE3-42 (A beta pyro), or phosphate buffered saline. Four days after the injection, 30 mice (6 animals per subgroup) underwent general anaesthesia with isoflurane. A "sham" anaesthetic procedure was performed in another 30 mice (6 animals per subgroup, 10 subgroups in total). During the next eight consecutive days a blinded assessor evaluated behavioural and cognitive performance using the modified hole-board test. Following the testing we investigated 2 brains per subgroup for insoluble amyloid deposits using methoxy staining. We used western blotting in 4 brains per subgroup for analysis of tumour-necrosis factor alpha, caspase 3, glutamate receptors NR2B, and mGlu5. Data were analysed using general linear modelling and analysis of variance. Results A beta pyro improved overall cognitive performance (p = 0.038). This cognitive improvement was reversed by isoflurane anaesthesia (p = 0.007), presumably mediated by decreased exploratory behaviour (p = 0.022 and p = 0.037). Injection of A beta 42 was associated with increased anxiety (p = 0.079). Explorative analysis on a limited number of brains did not reveal insoluble amyloid deposits or differences in the expression of tumour-necrosis factor alpha, NR2B, mGlu5, or caspase 3. Conclusions Testing cognitive performance after intracerebroventricular injection of different amyloid beta subspecies revealed that A beta pyro might be less harmful, which was reversed by isoflurane anaesthesia. There is minor evidence for A beta 42-mediated neurotoxicity. Preliminary molecular analysis of biomarkers did not clarify pathophysiological mechanisms.	[Borgstedt, Laura; Blobner, Manfred; Musiol, Maximilian; Bratke, Sebastian; Syryca, Finn; Rammes, Gerhard; Schmid, Sebastian] Tech Univ Munich, Dept Anaesthesiol & Intens Care Med, Klinikum Rechts Isar, Munich, Germany; [Blobner, Manfred; Jungwirth, Bettina; Schmid, Sebastian] Ulm Univ, Univ Hosp Ulm, Dept Anaesthesiol & Intens Care Med, Ulm, Germany	Technical University of Munich; Ulm University	Schmid, S (corresponding author), Tech Univ Munich, Dept Anaesthesiol & Intens Care Med, Klinikum Rechts Isar, Munich, Germany.; Schmid, S (corresponding author), Ulm Univ, Univ Hosp Ulm, Dept Anaesthesiol & Intens Care Med, Ulm, Germany.	seb.schmid@tum.de	Schmid, Sebastian/AAW-3026-2021; Blobner, Manfred/R-4411-2017	Schmid, Sebastian/0000-0002-1232-5350; Musiol, Maximilian/0000-0003-3241-8148; Jungwirth, Bettina/0000-0001-9749-7460; Borgstedt, Laura/0000-0002-9729-0723; Blobner, Manfred/0000-0002-0370-5247				Anger JT, 2009, UROLOGY, V74, P283, DOI 10.1016/j.urology.2009.02.011; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 1998, ABIA STATE U LAW J, V5, P1, DOI DOI 10.1116/1.1247880; Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bilkei-Gorzo A, 2014, PHARMACOL THERAPEUT, V142, P244, DOI 10.1016/j.pharmthera.2013.12.009; Burgold S, 2011, ACTA NEUROPATHOL, V121, P327, DOI 10.1007/s00401-010-0787-6; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Carrillo-Mora P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/795375; Culley DJ, 2007, CURR OPIN ANESTHESIO, V20, P408, DOI 10.1097/ACO.0b013e3282efd18b; Dammers C, 2017, CHEM SCI, V8, P4996, DOI 10.1039/c6sc04797a; DEADY JE, 1981, ANESTH ANALG, V60, P380; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V57, P1171, DOI 10.3233/JAD-170045; Evans CE, 2020, ACTA NEUROPATHOL, V139, P485, DOI 10.1007/s00401-019-02098-6; Fonio E, 2006, GENES BRAIN BEHAV, V5, P380, DOI 10.1111/j.1601-183X.2005.00170.x; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; Gordan ML, 2012, BEHAV BRAIN RES, V235, P7, DOI 10.1016/j.bbr.2012.07.027; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Hussain M, 2014, CLIN INTERV AGING, V9, P1619, DOI 10.2147/CIA.S49680; Jiang JJ, 2017, ONCOTARGET, V8, P59628, DOI 10.18632/oncotarget.19524; Jiang J, 2015, MOL MED REP, V12, P3, DOI 10.3892/mmr.2015.3424; Kayed R, 2009, CURR OPIN IMMUNOL, V21, P359, DOI 10.1016/j.coi.2009.05.001; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P1760, DOI 10.1001/jama.297.16.1760; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lai JE, 2014, NEUROPHARMACOLOGY, V79, P707, DOI 10.1016/j.neuropharm.2014.01.011; Lazarevic V, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00221; Liu SS, 2009, INT ORTHOP, V33, P643, DOI 10.1007/s00264-008-0549-4; McCarter JF, 2013, ACTA NEUROPATHOL, V126, P179, DOI 10.1007/s00401-013-1137-2; MORI H, 1992, J BIOL CHEM, V267, P17082; Mroczko B, 2018, J NEURAL TRANSM, V125, P177, DOI 10.1007/s00702-017-1820-x; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Ohl F, 2001, J PSYCHIAT RES, V35, P147, DOI 10.1016/S0022-3956(01)00017-6; Pavel MA, 2020, P NATL ACAD SCI USA, V117, P13757, DOI 10.1073/pnas.2004259117; Perez-Garmendia R, 2013, CURR NEUROPHARMACOL, V11, P491, DOI 10.2174/1570159X11311050004; Perucho J, 2010, J ALZHEIMERS DIS, V19, P1245, DOI 10.3233/JAD-2010-1318; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quiroga C, 2014, NEUROTOX RES, V26, P414, DOI 10.1007/s12640-014-9478-8; Rammes G, 2018, NEUROPHARMACOLOGY, V140, P184, DOI 10.1016/j.neuropharm.2018.07.021; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Schmid S, 2017, BEHAV BRAIN RES, V324, P15, DOI 10.1016/j.bbr.2017.02.007; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sprung J, 2020, BRIT J ANAESTH, V124, P594, DOI 10.1016/j.bja.2020.01.015; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Wang MC, 2009, SPINE, V34, P955, DOI 10.1097/BRS.0b013e31819e2fd5; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Xu ZP, 2011, CURR ALZHEIMER RES, V8, P741, DOI 10.2174/156720511797633223; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang B, 2013, ANESTHESIOLOGY, V119, P52, DOI 10.1097/ALN.0b013e31828ce55d; Zhang S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175654; Zhou R, 2017, ANESTH ANALG, V124, P582, DOI 10.1213/ANE.0000000000001698	68	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242989	10.1371/journal.pone.0242989	http://dx.doi.org/10.1371/journal.pone.0242989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270674	Green Published, gold			2022-12-26	WOS:000597149100147
J	Lee, Y; Kwon, D; Park, C; Seo, M; Seo, T				Lee, Youngjoo; Kwon, Daesung; Park, Changmin; Seo, Myoungjae; Seo, TaeWon			Automated technique for high-pressure water-based window cleaning and accompanying parametric study	PLOS ONE			English	Article							NUMERICAL-SIMULATION; ROBOT; SYSTEM; GLASS; DEVICE; FIELD	The maintenance of buildings has become an important issue with the construction of many high-rise buildings in recent years. However, the cleaning of the outer walls of buildings is performed in highly hazardous environments over long periods, and many accidents occur each year. Various robots are being studied and developed to reduce these incidents and to relieve workers from hazardous tasks. Herein, we propose a method of spraying high-pressure water using a pump and nozzle, which differs from conventional methods. The cleaning performance parameters, such as water pressure, spray angle, and spray distance, were optimized using the Taguchi method. Cleaning experiments were performed on window specimens that were contaminated artificially. The cleaning performance of the proposed method was evaluated using the image-evaluation method. The optimum condition was determined based on the results of a sensitive analysis performed on the image data. In addition, the reaction force due to high pressure and impact force on the specimens were investigated. These forces were not sufficient to affect the propeller thrust or cause damage to the building's surface. We expect to perform field tests in the near future based on the output of this research.	[Lee, Youngjoo; Kwon, Daesung; Park, Changmin; Seo, Myoungjae; Seo, TaeWon] Hanyang Univ, Sch Mech Engn, Seoul, South Korea	Hanyang University	Seo, T (corresponding author), Hanyang Univ, Sch Mech Engn, Seoul, South Korea.	taewonseo@hanyang.ac.kr	Seo, TaeWon/AID-4436-2022	Seo, TaeWon/0000-0001-9447-7675	National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF2018M3C1B9088328, 2018M3C1B9088330, 2018M3C1B9088331, 2018M3C1B9088332]	National Research Foundation of Korea (NRF) - Ministry of Science and ICT	(T. Seo) This research was supported by the National Research Foundation of Korea (NRF) Grant funded by the Ministry of Science and ICT for First-Mover Program for Accelerating Disruptive Technology Development (Management: NRF2018M3C1B9088328 (Specification No.1: 2018M3C1B9088330, Specification No.2: 2018M3C1B9088331, Specification No.3: 2018M3C1B9088332)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinfiev T, 2009, IND ROBOT, V36, P352, DOI 10.1108/01439910910957110; Cepolina F, 2000, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON CLIMBING AND WALKING ROBOTS, P803; Cepolina F., 2003, 1 INT WORKSH ADV SER; Chen R., INT C INT MAN INT TH; Dalvand MM, 2006, AUTON ROBOT, V20, P3, DOI 10.1007/s10514-006-5364-4; Giorgi P, 2013, P S COMP ARITHM, P135, DOI 10.1109/ARITH.2013.20; Guha A., 2011, J MAT PROCESSING TEC; Hong J, 2019, INT J PRECIS ENG MAN, V20, P233, DOI 10.1007/s12541-019-00043-x; IPC Eagle, HIGHRISE TM HR 202; Jun Y., INT S AUT ROB CONSTR; KACKER RN, 1991, J RES NATL INST STAN, V96, P577, DOI 10.6028/jres.096.034; Kang M, 2011, INT S AUT ROB CONSTR, V28, P1432; Lee, 2011, P 28 INT C CLIMB WAL, P1453; Lee YS, 2018, AUTOMAT CONSTR, V94, P39, DOI 10.1016/j.autcon.2017.12.030; Liu ZQ, 2019, POWDER TECHNOL, V350, P62, DOI 10.1016/j.powtec.2019.03.029; Medan N., MAGAZINE HYDRAULICS; Moon SM, 2015, INT J PR ENG MAN-GT, V2, P65, DOI 10.1007/s40684-015-0009-8; Pang, 2015, OPEN MECH ENG J, V9, P527, DOI 10.2174/1874155X01509010527; Peng HJ, 2018, CMES-COMP MODEL ENG, V114, P59, DOI 10.3970/cmes.2018.114.059; Rajesh S., 2018, INT J APPL ENG RES, V13, P6881; Seo T, 2019, INT J PR ENG MAN-GT, V6, P367, DOI 10.1007/s40684-019-00079-4; Sertore D., P PAC07 ALB NEW MEX; Shin E., 2018, CONCEPTUAL DESIGN CL; Spray system. CO, SPRAY NOZZL; Spraying systems Co, NOZZL SEL GUID; Tun TT, 2018, AUTOMAT CONSTR, V96, P180, DOI 10.1016/j.autcon.2018.09.006; Vega-Heredia M, 2019, AUTOMAT CONSTR, V103, P268, DOI 10.1016/j.autcon.2019.01.025; Vishaal R., 2019, AUTOMAT CONSTR, V101, P209; Wu G., 2018 7 INT C EN ENV; Xu CW, 2019, ENERGY, V182, P544, DOI 10.1016/j.energy.2019.05.201; Yang K., 2008, DESIGN 6 SIGMA ROADM, P469; Yang SB, 2019, POWDER TECHNOL, V343, P754, DOI 10.1016/j.powtec.2018.11.042; Yoo S, 2019, IEEE ACCESS, V7, P30174, DOI 10.1109/ACCESS.2019.2902386; Zhang HX, 2006, IEEE ROBOT AUTOM MAG, V13, P32; Zhong ZW, 2003, MATER MANUF PROCESS, V18, P965, DOI 10.1081/AMP-120025082	35	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242413	10.1371/journal.pone.0242413	http://dx.doi.org/10.1371/journal.pone.0242413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270672	gold, Green Published			2022-12-26	WOS:000597149100099
J	Li, Y; Pang, Y; Zhang, TH; Xian, XP; Yang, J; Wang, R; Wang, PT; Zhang, M; Chen, W				Li, Yan; Pang, Yu; Zhang, Tianhua; Xian, Xiaoping; Yang, Jian; Wang, Rui; Wang, Panting; Zhang, Meng; Chen, Wei			Genotypes of Mycobacterium tuberculosis isolates circulating in Shaanxi Province, China	PLOS ONE			English	Article							GENETIC DIVERSITY; BEIJING FAMILY; POPULATION; PROFILE	Objectives The prevalence of drug-resistant TB in Shaanxi Province is higher than other areas. This study was aimed to investigate the genetic diversity and epidemiology of Mycobacterium tuberculosis clinical strains in Shaanxi Province, China. Methods From January to December 2016, a total of 298 Mycobacterium tuberculosis clinical isolates from smear-positive pulmonary tuberculosis patients were genotyped by Mcspoligotyping and 15-locus VNTR. Results We found that the Beijing family strains was the most prominent family(81.54%, 243/298). Other family strains included T family(9.06%, 27/298), U family(0.67%, 2/298), LAM9 family(0.34%, 1/298) and Manu family(0.34%, 1/298). The rates of multidrug-resistant (MDR) M.Tuberculosis, age, type of case and education between Beijing and non-Beijing family strains were not statistically different, while the distribution in the three different regions among these was statistically significant. VNTR results showed that strains were classified into 280 genotypes, and 33 (11.07%) strains could be grouped into 14 clusters. 11 of the 15-VNTR loci were highly or moderately discriminative according to the Hunter-Gaston discriminatory index. Conclusions We concluded that the Beijing family genotype was the most prevalent genotype and 15-locus VNTR typing might be suitable for genotyping of M. tuberculosis in Shaanxi Province. There was less association between Beijing family genotypes and drug resistance in our study area.	[Li, Yan; Chen, Wei] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Clin Lab, Xian, Peoples R China; [Li, Yan; Zhang, Tianhua; Xian, Xiaoping; Yang, Jian; Wang, Rui; Wang, Panting; Zhang, Meng] Shaanxi Prov Inst TB Control & Prevent, Clin Lab, Xian, Peoples R China; [Pang, Yu] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Inst, Natl Clin Lab TB, Beijing, Peoples R China	Xi'an Jiaotong University; Capital Medical University	Chen, W (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Clin Lab, Xian, Peoples R China.	chenwei_xjtu2016@163.com	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022		Department of Health of Shaanxi Province [2014D25]; Department of Science and Technology of Shaanxi Province, China	Department of Health of Shaanxi Province; Department of Science and Technology of Shaanxi Province, China	This study was financially supported by the Department of Health of Shaanxi Province (No. 2014D25), http://sxwjw.shaanxi.gov.cn and the Department of Science and Technology of Shaanxi Province, China(No.2016SF-272), http://kjt.shaanxi.gov.cn.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-151; Alonso-Rodriguez N, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-34; Amlerova J, 2018, FOLIA MICROBIOL, V63, P537, DOI 10.1007/s12223-018-0599-y; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2015, J INFECTION, DOI DOI 10.1016/j.jinf.2015.04.028; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Chen LY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2505172; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Dou HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01580-z; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; Hu Y, 2011, EPIDEMIOL INFECT, V139, P130, DOI 10.1017/S0950268810000890; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019206; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Li Wei-min, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P381; Liang QF, 2013, INT J TUBERC LUNG D, V17, P655, DOI 10.5588/ijtld.12.0615; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099357; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Pang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-354; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; World Health Organization, 1998, LAB SERVICES TUBERCU; World Health Organization, 2008, ANTITUBERCULOSIS DRU; Zeng XH, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00539-18, 10.1128/jcm.00539-18]; Zhang TianHua, 2017, China Tropical Medicine, V17, P226	36	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242971	10.1371/journal.pone.0242971	http://dx.doi.org/10.1371/journal.pone.0242971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270700	Green Published, gold			2022-12-26	WOS:000597149100005
J	Oga, T; Harakawa, R; Minewaki, S; Umeki, Y; Matsuda, Y; Iwahashi, M				Oga, Takahiro; Harakawa, Ryosuke; Minewaki, Sayaka; Umeki, Yo; Matsuda, Yoko; Iwahashi, Masahiro			River state classification combining patch-based processing and CNN	PLOS ONE			English	Article								This paper proposes a method for classifying the river state (a flood risk exists or not) from river surveillance camera images by combining patch-based processing and a convolutional neural network (CNN). Although CNN needs much training data, the number of river surveillance camera images is limited because flood does not frequently occur. Also, river surveillance camera images include objects that are irrelevant to the flood risk. Therefore, the direct use of CNN may not work well for the river state classification. To overcome this limitation, this paper develops patch-based processing for adjusting CNN to the river state classification. By increasing training data via the patch segmentation of an image and selecting patches that are relevant to the river state, the adjustment of general CNNs to the river state classification becomes feasible. The proposed patch-based processing and CNN are developed independently. This yields the practical merits that any CNN can be used according to each user's purposes, and the maintenance and improvement of each component of the whole system can be easily performed. In the experiment, river state classification is defined as the following problems using two datasets, to verify the effectiveness of the proposed method. First, river images from the public dataset called Places are classified to images with Muddy labels and images with Clear labels. Second, images from the river surveillance camera in Nagaoka City, Japan are classified to images captured when the government announced heavy rain or flood warning and the other images.	[Oga, Takahiro; Harakawa, Ryosuke; Iwahashi, Masahiro] Nagaoka Univ Technol, Dept Elect Elect & Informat Engn, Nagaoka, Niigata, Japan; [Minewaki, Sayaka; Umeki, Yo] Natl Inst Technol, Yuge Coll, Dept Comp Sci & Engn, Kamijima, Ehime, Japan; [Matsuda, Yoko] Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata, Japan	Nagaoka University of Technology; Nagaoka University of Technology	Harakawa, R (corresponding author), Nagaoka Univ Technol, Dept Elect Elect & Informat Engn, Nagaoka, Niigata, Japan.	harakawa@vos.nagakaut.ac.jp			SECOM Science and Technology Foundation; Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST) [JPMJTM20DJ]	SECOM Science and Technology Foundation; Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST)	This research is partially supported by SECOM Science and Technology Foundation, and Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST) Grant Number JPMJTM20DJ. There was no additional external funding received for this study.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bishop Christopher M., 2006, PATTERN RECOGNITION; Burt A, 2013, 99002 IRR TRAIN RES; Coates Adam, 2011, P 14 INT C ART INT S, P215, DOI DOI 10.1177/1753193410390845; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Endorsed Amer Acad Pediatrics, 2011, DISASTER MED PUBLIC, V5, P125, DOI 10.1001/dmp.2011.41; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Gomez L, 2017, PATTERN RECOGN, V67, P85, DOI 10.1016/j.patcog.2017.01.032; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Iwahashi M, 2006, P INT C COMP COMM NE, P826; Iwahashi M, 2007, P INT WORKSH IM TECH, P918; Krizhevsky A, 2009, THESIS U TORONTO TOR; Krizhevsky A., 2012, ADV NEURAL INF PROCE; KROGH A, 1992, ADV NEUR IN, V4, P950; Lee E., 2012, NEURAL NETWORKS TRIC, V1, P1, DOI [10.1007/978-3-642-35289-8_25, DOI 10.1007/978-3-642-35289-8_25]; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Minella JPG, 2008, HYDROL PROCESS, V22, P1819, DOI 10.1002/hyp.6763; Natsev A, 2004, IEEE T KNOWL DATA EN, V16, P301, DOI 10.1109/TKDE.2003.1262183; Netzer Y., 2011, READING DIGITS NATUR, DOI DOI 10.2118/18761-MS; Oga T, 2018, ASIAPAC SIGN INFO PR, P1305, DOI 10.23919/APSIPA.2018.8659554; Saito A, 2006, P IEICE CIRC SYST KA, P525; Sarker C, 2016, P 2016 INT C DIG IM, P1; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Takagi Y, 2001, P GLOB 2001 NOV 18 2, P309; Tao Y, 2017, CHIN CONTR CONF, P4288, DOI 10.23919/ChiCC.2017.8028032; Tsubaki R, 2009, ADV RIVER ENG, V15, P501; UM JH, 2000, B KOREA ENV ENG ASS, V162, P30; Walach E, 2016, LECT NOTES COMPUT SC, V9906, P660, DOI 10.1007/978-3-319-46475-6_41; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Yorozuya A, 2016, J JAPAN SOC CIVIL EN, V72, P305; Zagoruyko S., 2016, WIDE RESIDUAL NETWOR, DOI DOI 10.5244/C.30.87; Zhou BL, 2019, INT J COMPUT VISION, V127, P302, DOI 10.1007/s11263-018-1140-0; Zhou BL, 2018, IEEE T PATTERN ANAL, V40, P1452, DOI 10.1109/TPAMI.2017.2723009	39	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243073	10.1371/journal.pone.0243073	http://dx.doi.org/10.1371/journal.pone.0243073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270730	Green Published, gold			2022-12-26	WOS:000597149100112
J	Gutierrez-Jara, JP; Cordova-Lepe, F; Munoz-Quezada, MT; Chowell, G				Pablo Gutierrez-Jara, Juan; Cordova-Lepe, Fernando; Teresa Munoz-Quezada, Maria; Chowell, Gerardo			Pesticide application, educational treatment and infectious respiratory diseases: A mechanistic model with two impulsive controls	PLOS ONE			English	Article							COMPARTMENTAL EPIDEMIC MODELS; THRESHOLD DYNAMICS; CHRONIC-BRONCHITIS; EXPOSURE; INTERVENTION; HEALTH; CHILDREN; FARMERS; VARIABILITY; FARMWORKERS	In this paper, we develop and analyze an SIS-type epidemiological-mathematical model of the interaction between pesticide use and infectious respiratory disease transmission for investigating the impact of pesticide intoxication on the spread of these types of diseases. We further investigate the role of educational treatment for appropriate pesticide use on the transmission dynamics. Two impulsive control events are proposed: pesticide use and educational treatment. From the proposed model, it was obtained that the rate of forgetfulness towards educational treatment is a determining factor for the reduction of intoxicated people, as well as for the reduction of costs associated with educational interventions. To get reduced intoxications, the population's fraction to which is necessary to apply the educational treatment depends on its individual effectiveness level and the educational treatments' forgetfulness rate. In addition, the turnover of agricultural workers plays a fundamental role in the dynamics of agrotoxic use, particularly in the application of educational treatment. For illustration, a flu-like disease with a basic reproductive number below the epidemic threshold of 1.0 is shown can acquire epidemic potential in a population at risk of pesticide exposure. Hence, our findings suggest that educational treatment targeting pesticide exposure is an effective tool to reduce the transmission rate of an infectious respiratory disease in a population exposed to the toxic substance.	[Pablo Gutierrez-Jara, Juan] Univ Catolica Maule, Ctr Invest Estudios Avanzados Maule CIEAM, Talca, Chile; [Cordova-Lepe, Fernando] Univ Catolica Maule, Fac Ciencias Basicas, Talca, Chile; [Teresa Munoz-Quezada, Maria] Univ Catolica Maule, Fac Ciencias Salud, Talca, Chile; [Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, Atlanta, GA USA	Universidad Catolica del Maule; Universidad Catolica del Maule; Universidad Catolica del Maule; University System of Georgia; Georgia State University	Gutierrez-Jara, JP (corresponding author), Univ Catolica Maule, Ctr Invest Estudios Avanzados Maule CIEAM, Talca, Chile.	jpgutierrezjara@gmail.com	Muñoz-Quezada, María Teresa/AAQ-4185-2020	Muñoz-Quezada, María Teresa/0000-0002-8008-8625; Gutierrez-Jara, Juan Pablo/0000-0001-9723-4978	National Commission on Science and Technology (CONICYT) of Chile; FONDECYT [11150784]	National Commission on Science and Technology (CONICYT) of Chile; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by a research project of the National Commission on Science and Technology (CONICYT) of Chile, FONDECYT of Initiation #11150784. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkon A, 2016, J PEDIATR HEALTH CAR, V30, pE27, DOI 10.1016/j.pedhc.2016.07.004; Amaral AFS, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00006; [Anonymous], 2014, J CACHEXIA SARCOPENI, V5, P35, DOI 10.1007/s13539-014-0129-y; Benchohra M, 2006, CONT MATH ITS APPL, P2; Bradman A, 2009, J EXPO SCI ENV EPID, V19, P79, DOI 10.1038/jes.2008.18; Castro TA, 2012, THER DRUG MONIT, V34, P209, DOI 10.1097/FTD.0b013e318248b0e6; Chalupka S, 2010, JOGNN-J OBST GYN NEO, V39, P84, DOI 10.1111/j.1552-6909.2009.01091.x; Chiang GPK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184533; Cordova-Lepe F, 2012, APPL MATH MODEL, V9, P101; Cortes S, 2020, ATMOS POLLUT RES, V11, DOI 10.1016/j.apr.2019.12.023; Diaz G, 2002, DIRECT COSTS ACUTE P; FAO, 2006, INT COD COND DISTR U; FAO, 2012, GUID PREV MAN PEST R; Gao S, 2018, NONLINEAR ANAL REAL; Garcia J E, 1998, Rev Panam Salud Publica, V4, P383; Garfitt SJ, 2002, TOXICOL LETT, V134, P105, DOI 10.1016/S0378-4274(02)00178-9; Giannandrea F, 2014, J ENV, V1, P25; Grason HA, 2009, PUBLIC HEALTH REP, V124, P629, DOI 10.1177/003335490912400505; Gutierrez-Jara JP, 2020, J THEOR BIOL, V488, DOI 10.1016/j.jtbi.2019.110133; Gutierrez-Jara JP, 2019, MATH BIOSCI, V309, P66, DOI 10.1016/j.mbs.2019.01.005; Harrison E., 2009, ENV TOXICANTS MATERN; Hernandez AF, 2011, CURR OPIN ALLERGY CL, V11, P90, DOI 10.1097/ACI.0b013e3283445939; Hoppin JA, 2007, AM J IND MED, V50, P969, DOI 10.1002/ajim.20523; Hu RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128766; Keifer MC, 2000, AM J PREV MED, V18, P80, DOI 10.1016/S0749-3797(00)00144-6; Kim JY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216310; Lakshmikantham V, 1989, SERIES MODERN APPL M, P6; Larsen AE, 2019, SCI TOTAL ENVIRON, V651, P828, DOI 10.1016/j.scitotenv.2018.09.206; Liu JH, 2012, WORKPLACE HEALTH SAF, V60, P235, DOI 10.3928/21650799-20120426-73; Lucas Sharon Frost, 2009, Pediatr Nurs, V35, P308; Matychyn I, 2012, INT J DIFFERENCE EQU, V9, P101; Meuling WJA, 2005, INT ARCH OCC ENV HEA, V78, P44, DOI 10.1007/s00420-004-0558-6; Mostafalou S, 2017, ARCH TOXICOL, V91, P549, DOI 10.1007/s00204-016-1849-x; Pierangeli A, 2012, CLIN MICROBIOL INFEC, V18, P366, DOI 10.1111/j.1469-0691.2011.03590.x; Rippy MA, 2017, WATER RES, V115, P245, DOI 10.1016/j.watres.2017.03.010; Rogers B, 2009, ENVIRON HEALTH PERSP, V117, P850, DOI 10.1289/ehp.0800203; Salvatore AL, 2015, J EXPO SCI ENV EPID, V25, P608, DOI 10.1038/jes.2015.39; Sandel M, 2010, J PUBLIC HEALTH MAN, V16, pS24, DOI 10.1097/PHH.0b013e3181e3cc2a; Taghdisi MH, 2019, INT J OCCUP ENV MED, V10, P66, DOI 10.15171/ijoem.2019.1479; Munoz-Quezada MT, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141512; Munoz-Quezada MT, 2019, ENVIRON RES, V176, DOI 10.1016/j.envres.2019.108554; Thompson B, 2008, ENVIRON HEALTH PERSP, V116, P687, DOI 10.1289/ehp.10882; Thompson B, 2017, J OCCUP ENVIRON MED, V59, P982, DOI 10.1097/JOM.0000000000001107; Tual S, 2013, ANN EPIDEMIOL, V23, P539, DOI 10.1016/j.annepidem.2013.06.005; US Department of Health and Human Services, 2002, DIAZ; Valcin M, 2007, J OCCUP ENVIRON MED, V49, P574, DOI 10.1097/JOM.0b013e3180577768; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002; Wang WD, 2008, J DYN DIFFER EQU, V20, P699, DOI 10.1007/s10884-008-9111-8; WHO, 2009, WHO REC CLASS PEST H; Wilson C, 2001, ECOL ECON, V39, P449, DOI 10.1016/S0921-8009(01)00238-5; Yang TX, 2017, J AGR FOOD CHEM, V65, P9744, DOI 10.1021/acs.jafc.7b03118; Yang YP, 2012, NONLINEAR ANAL-REAL, V13, P224, DOI 10.1016/j.nonrwa.2011.07.028; Ye M, 2017, J ENVIRON SCI, V51, P361, DOI 10.1016/j.jes.2016.11.012; Zuniga-Venegas L, 2015, J TOXICOL ENV HEAL A, V78, P357, DOI 10.1080/15287394.2014.982843	55	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243048	10.1371/journal.pone.0243048	http://dx.doi.org/10.1371/journal.pone.0243048			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270758	gold, Green Published			2022-12-26	WOS:000597149100127
J	Hupfauf, S; Etemadi, M; Juarez, MFD; Gomez-Brandon, M; Insam, H; Podmirseg, SM				Hupfauf, Sebastian; Etemadi, Mohammad; Juarez, Marina Fernandez-Delgado; Gomez-Brandon, Maria; Insam, Heribert; Podmirseg, Sabine Marie			CoMA - an intuitive and user-friendly pipeline for amplicon-sequencing data analysis	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; QUALITY-CONTROL; MICROBIOTA; DIVERSITY; IDENTIFICATION; PROFILES; REVEALS; CATALOG; TOOLS	In recent years, there has been a veritable boost in next-generation sequencing (NGS) of gene amplicons in biological and medical studies. Huge amounts of data are produced and need to be analyzed adequately. Various online and offline analysis tools are available; however, most of them require extensive expertise in computer science or bioinformatics, and often a Linux-based operating system. Here, we introduce "CoMA-Comparative Microbiome Analysis" as a free and intuitive analysis pipeline for amplicon-sequencing data, compatible with any common operating system. Moreover, the tool offers various useful services including data pre-processing, quality checking, clustering to operational taxonomic units (OTUs), taxonomic assignment, data post-processing, data visualization, and statistical appraisal. The workflow results in highly esthetic and publication-ready graphics, as well as output files in standardized formats (e.g. tab-delimited OTU-table, BIOM, NEWICK tree) that can be used for more sophisticated analyses. The CoMA output was validated by a benchmark test, using three mock communities with different sample characteristics (primer set, amplicon length, diversity). The performance was compared with that of Mothur, QIIME and QIIME2-DADA2, popular packages for NGS data analysis. Furthermore, the functionality of CoMA is demonstrated on a practical example, investigating microbial communities from three different soils (grassland, forest, swamp). All tools performed well in the benchmark test and were able to reveal the majority of all genera in the mock communities. Also for the soil samples, the results of CoMA were congruent to those of the other pipelines, in particular when looking at the key microbial players.	[Hupfauf, Sebastian; Juarez, Marina Fernandez-Delgado; Insam, Heribert; Podmirseg, Sabine Marie] Univ Innsbruck, Dept Microbiol, Innsbruck, Austria; [Etemadi, Mohammad] Shiraz Univ, Sch Agr, Dept Hort Sci, Shiraz, Iran; [Gomez-Brandon, Maria] Univ Vigo, Dept Ecol & Anim Biol, GEA Grp, Vigo, Spain	University of Innsbruck; Shiraz University; Universidade de Vigo	Hupfauf, S (corresponding author), Univ Innsbruck, Dept Microbiol, Innsbruck, Austria.	Sebastian.Hupfauf@uibk.ac.at	Podmirseg, Sabine/C-2760-2019; Insam, Heribert/AAM-4543-2021; Insam, Heribert/B-4649-2013; Fernandez-Delgado Juarez, Marina/V-1032-2018	Podmirseg, Sabine/0000-0003-1775-2412; Insam, Heribert/0000-0002-5136-2752; Hupfauf, Sebastian/0000-0002-2012-9966; Fernandez-Delgado Juarez, Marina/0000-0002-1487-6906; Etemadi, Mohammad/0000-0003-2093-9173	Federal Ministry of Education, Science and Research; University of Innsbruck; doctoral fellowship (LFU Doktoratsstipendium) of the University of Innsbruck, Austria; Programa Ramon y Cajal [RYC-2016-21231]; Ministerio de Economia y Competitividad; Fonds zur Forderung der Wissenschaftlichen Forschung [989]	Federal Ministry of Education, Science and Research; University of Innsbruck; doctoral fellowship (LFU Doktoratsstipendium) of the University of Innsbruck, Austria; Programa Ramon y Cajal(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was supported by the Federal Ministry of Education, Science and Research (https://www.bmbwf.gv.at/), and by the University of Innsbruck (https://www.uibk.ac.at/) within the scope of the project "MicrobeEnergy". SH was further supported by the doctoral fellowship (LFU Doktoratsstipendium) of the University of Innsbruck, Austria. MG acknowledges support by the Programa Ramo ' n y Cajal (RYC-2016-21231; Ministerio de Economi ' a y Competitividad, https://www.mineco.gob.es/).The publication fees are sponsored by the "Fonds zur Forderung der Wissenschaftlichen Forschung" (https://www.fwf.ac.at/; Project I 989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Nurul Ashyikin Noor, 2019, Biotechnology Reports, V21, pe00303, DOI 10.1016/j.btre.2019.e00303; Albanese D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09743; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, ANN FAM MED S1, V3, pS2; Anslan S, 2017, MOL ECOL RESOUR, V17, pe234, DOI 10.1111/1755-0998.12692; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Balvociute M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3501-4; Bokulich NA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00062-16; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Cai WW, 2018, WATER RES, V136, P192, DOI 10.1016/j.watres.2018.02.062; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole EJ, 2019, APPL SOIL ECOL, V136, P80, DOI 10.1016/j.apsoil.2018.12.010; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P8795, DOI 10.1128/AEM.05491-11; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dong XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01461; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC, 2018, BIOINFORMATICS, V34, P2371, DOI 10.1093/bioinformatics/bty113; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Epelde L, 2019, CHEMOSPHERE, V220, P600, DOI 10.1016/j.chemosphere.2018.12.164; Fernandes KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112846; Ferro Milene, 2014, BMC Res Notes, V7, P857, DOI 10.1186/1756-0500-7-857; Fosso B, 2012, EMBNET J, V18, P619; Fosso B, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0595-z; Glassman SI, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00148-18; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guo B, 2019, SCI TOTAL ENVIRON, V662, P779, DOI 10.1016/j.scitotenv.2019.01.207; Gweon HS, 2015, METHODS ECOL EVOL, V6, P973, DOI 10.1111/2041-210X.12399; Hauswedell H, 2014, BIOINFORMATICS, V30, pI349, DOI 10.1093/bioinformatics/btu439; Heller D., 2020, SDIP NOVEL GRAPH BAS, DOI 10.1101/2020.02.25.964445; Herbold CW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00731; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hu HL, 2019, J INFECTION, V78, P335, DOI 10.1016/j.jinf.2019.01.003; Hugerth LW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01561; Hupfauf S, 2020, BIORESOURCE TECHNOL, V300, DOI 10.1016/j.biortech.2019.122671; Hupfauf S, 2018, BIORESOURCE TECHNOL, V269, P309, DOI 10.1016/j.biortech.2018.08.106; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; IUSS Working Group WRB, 2014, WORLD REFERENCE BASE, DOI [10.1017/S0014479706394902, DOI 10.1017/S0014479706394902]; Iwai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166104; Jones JC, 2018, ECOL EVOL, V8, P441, DOI 10.1002/ece3.3597; Juarez MFD, 2015, FOREST ECOL MANAG, V357, P42, DOI 10.1016/j.foreco.2015.08.014; Jung SW, 2018, AQUACULTURE, V490, P297, DOI 10.1016/j.aquaculture.2018.02.053; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Krakova L, 2018, INT BIODETER BIODEGR, V131, P51, DOI 10.1016/j.ibiod.2017.02.015; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu Y, 2019, BIORESOURCE TECHNOL, V287, DOI 10.1016/j.biortech.2019.121339; Machida RJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.27; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McLaren MR, 2019, ELIFE, V8, DOI 10.7554/eLife.46923; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nagler M, 2019, J BIOTECHNOL, V300, P1, DOI 10.1016/j.jbiotec.2019.05.004; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Parlapani FF, 2018, FOOD MICROBIOL, V76, P518, DOI 10.1016/j.fm.2018.08.004; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Probst M, 2018, ENVIRON MICROBIOL, V20, P3657, DOI 10.1111/1462-2920.14359; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ravi A, 2018, J MICROBIOL METH, V149, P44, DOI 10.1016/j.mimet.2018.02.016; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Ritari J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2265-y; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seena S, 2019, SCI TOTAL ENVIRON, V661, P306, DOI 10.1016/j.scitotenv.2019.01.122; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon BA, 2008, PROSTATE, V68, P1487, DOI 10.1002/pros.20822; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin JM, 2018, J ENDODONT, V44, P1080, DOI 10.1016/j.joen.2018.04.003; Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Vlckova K, 2018, INT J PARASITOL, V48, P519, DOI 10.1016/j.ijpara.2017.11.008; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westcott SL, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00073-17; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; White JR, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-6; van de wijgert JH, 2016, ANN EPIDEMIOL, V26, P336, DOI 10.1016/j.annepidem.2016.03.009; Yamada T, 2019, EBIOMEDICINE, V48, P513, DOI 10.1016/j.ebiom.2019.09.008; Zafeiropoulos H, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa022; Zamyadi A, 2019, WATER RES, V152, P96, DOI 10.1016/j.watres.2019.01.002	89	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243241	10.1371/journal.pone.0243241	http://dx.doi.org/10.1371/journal.pone.0243241			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264369	Green Published, gold			2022-12-26	WOS:000596569200053
J	Lagarde, D; Jeanson, Y; Barreau, C; Moro, C; Peyriga, L; Cahoreau, E; Guissard, C; Arnaud, E; Galinier, A; Bouzier-Sore, AK; Pellerin, L; Chouchani, ET; Penicaud, L; Ader, I; Portais, JC; Casteilla, L; Carriere, A				Lagarde, Damien; Jeanson, Yannick; Barreau, Corinne; Moro, Cedric; Peyriga, Lindsay; Cahoreau, Edern; Guissard, Christophe; Arnaud, Emmanuelle; Galinier, Anne; Bouzier-Sore, Anne-Karine; Pellerin, Luc; Chouchani, Edward T.; Penicaud, Luc; Ader, Isabelle; Portais, Jean-Charles; Casteilla, Louis; Carriere, Audrey			Lactate fluxes mediated by the monocarboxylate transporter-1 are key determinants of the metabolic activity of beige adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; ENERGY-EXPENDITURE; WHITE FAT; GLUCOSE; MCT1; GLYCOLYSIS; PROGENITORS; EXPRESSION; AZD3965; PROTEIN	Activation of energy-dissipating brown/beige adipocytes represents an attractive therapeutic strategy against metabolic disorders. While lactate is known to induce beiging through the regulation of Ucp1 gene expression, the role of lactate transporters on beige adipocytes' ongoing metabolic activity remains poorly understood. To explore the function of the lactate-transporting monocarboxylate transporters (MCTs), we used a combination of primary cell culture studies, C-13 isotopic tracing, laser microdissection experiments, and in situ immunofluorescence of murine adipose fat pads. Dissecting white adipose tissue heterogeneity revealed that the MCT1 is expressed in inducible beige adipocytes as the emergence of uncoupling protein 1 after cold exposure was restricted to a subpopulation of MCT1-expressing adipocytes suggesting MCT1 as a marker of inducible beige adipocytes. We also observed that MCT1 mediates bidirectional and simultaneous inward and outward lactate fluxes, which were required for efficient utilization of glucose by beige adipocytes activated by the canonical beta 3-adrenergic signaling pathway. Finally, we demonstrated that significant lactate import through MCT1 occurs even when glucose is not limiting, which feeds the oxidative metabolism of beige adipocytes. These data highlight the key role of lactate fluxes in finely tuning the metabolic activity of beige adipocytes according to extracellular metabolic conditions and reinforce the emerging role of lactate metabolism in the control of energy homeostasis.	[Lagarde, Damien; Jeanson, Yannick; Barreau, Corinne; Guissard, Christophe; Arnaud, Emmanuelle; Galinier, Anne; Penicaud, Luc; Ader, Isabelle; Portais, Jean-Charles; Casteilla, Louis; Carriere, Audrey] Univ Toulouse, Univ Paul Sabatier, CNRS ERL5311, EFS,INP ENVT,STROMALab,INSERM U1031, Toulouse, France; [Lagarde, Damien; Jeanson, Yannick; Barreau, Corinne; Guissard, Christophe; Arnaud, Emmanuelle; Galinier, Anne; Penicaud, Luc; Ader, Isabelle; Portais, Jean-Charles; Casteilla, Louis; Carriere, Audrey] Univ Paul Sabatier, CNRS 5070, Inst RESTORE, UMR 1301 INSERM, Toulouse, France; [Moro, Cedric] Paul Sabatier Univ, INSERM UMR1048, Inst Metab & Cardiovasc Dis, Toulouse, France; [Peyriga, Lindsay; Cahoreau, Edern; Portais, Jean-Charles] Toulouse Biotechnol Inst TBI, INSA Toulouse INSA, CNRS 5504, UMR INSA,INRA 7924, Toulouse, France; [Peyriga, Lindsay; Cahoreau, Edern; Portais, Jean-Charles] Natl Infrastruct Metabol & Flux, MetaboHUB MetaToul, Toulouse, France; [Galinier, Anne] CHU Purpan, Inst Federat Biol, Toulouse, France; [Bouzier-Sore, Anne-Karine] Univ Bordeaux, CNRS, CRMSB, UMR 5536, Bordeaux, France; [Pellerin, Luc] Univ Poitiers, INSERM U1082, Poitiers, France; [Chouchani, Edward T.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chouchani, Edward T.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Carriere, A (corresponding author), Univ Toulouse, Univ Paul Sabatier, CNRS ERL5311, EFS,INP ENVT,STROMALab,INSERM U1031, Toulouse, France.; Carriere, A (corresponding author), Univ Paul Sabatier, CNRS 5070, Inst RESTORE, UMR 1301 INSERM, Toulouse, France.	audrey.carriere-pazat@inserm.fr	Chouchani, Edward T./HCH-3775-2022; Pellerin, Luc/A-8912-2017	GUISSARD, CHRISTOPHE/0000-0003-0777-7683; Jeanson, Yannick/0000-0001-5325-3130; Pellerin, Luc/0000-0002-1016-1970; Moro, Cedric/0000-0003-4294-0597; PEYRIGA, Lindsay/0000-0002-6138-7961; Lagarde, Damien/0000-0001-6922-8642; Carriere, Audrey/0000-0002-4277-7905; Bouzier-Sore, Anne-Karine/0000-0002-3470-0940	European Union FP7 project DIABAT [HEALTH-F2-2011-278373]; La Societe Francaise de Nutrition, l'Agence Nationale pour la Recherche [ANR-18-CE18-0006]; Inspire Program (Region Occitanie/Pyrenees-Mediterranee) [1901175]; European Regional Development Fund [MP0022856]; National Institutes of Health [DK123095]; Claudia Adams Barr Program; LabEx TRAIL [ANR-10-LABX-57]; ANR grant [MetaboHUB-ANR-11-INBS-0010]	European Union FP7 project DIABAT; La Societe Francaise de Nutrition, l'Agence Nationale pour la Recherche(French National Research Agency (ANR)); Inspire Program (Region Occitanie/Pyrenees-Mediterranee); European Regional Development Fund(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr Program; LabEx TRAIL; ANR grant(French National Research Agency (ANR))	This work was supported by the European Union FP7 project DIABAT (HEALTH-F2-2011-278373), La Societe Francaise de Nutrition, l'Agence Nationale pour la Recherche (Projet-ANR-18-CE18-0006), and The Inspire Program (supported by grants from the Region Occitanie/Pyrenees-Mediterranee (reference number: 1901175), the European Regional Development Fund (project number: MP0022856). E. Ch. was supported by National Institutes of Health DK123095 and Claudia Adams Barr Program. A.-K. B. S. and L. Pel. were supported by the LabEx TRAIL (ANR-10-LABX-57). MetaboHub-MetaToul (Metabolomics & Fluxomics facilities, Toulouse, France; http://www.metatoul.fr) is supported by the ANR grant MetaboHUB-ANR-11-INBS-0010.	Baba M, 2008, BIOCHEM BIOPH RES CO, V374, P111, DOI 10.1016/j.bbrc.2008.06.122; Bai Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.75; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Barreau C, 2016, OBESITY, V24, P1081, DOI 10.1002/oby.21455; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Bola BM, 2014, MOL CANCER THER, V13, P2805, DOI 10.1158/1535-7163.MCT-13-1091; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Cahoreau E, 2012, ANAL BIOCHEM, V427, P158, DOI 10.1016/j.ab.2012.05.021; Carriere A, 2020, J PHYSIOL BIOCHEM, V76, P241, DOI 10.1007/s13105-019-00723-2; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; COUSIN B, 1992, J CELL SCI, V103, P931; Curtis NJ, 2017, ONCOTARGET, V8, P69219, DOI 10.18632/oncotarget.18215; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Dichamp J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43130-9; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Felmlee MA, 2020, PHARMACOL REV, V72, P466, DOI 10.1124/pr.119.018762; Ferguson BS, 2018, EUR J APPL PHYSIOL, V118, P691, DOI 10.1007/s00421-017-3795-6; Fukano K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166579; Giordano A, 2016, NAT REV DRUG DISCOV, V15, P405, DOI 10.1038/nrd.2016.31; Hankir MK, 2018, EMBO REP, V19, DOI 10.15252/embr.201846404; Held NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27875-3; Hepler C, 2017, GENE DEV, V31, P127, DOI 10.1101/gad.293704.116; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Iwanaga T, 2009, BIOMED RES-TOKYO, V30, P217, DOI 10.2220/biomedres.30.217; Jeanson Y, 2016, BIOCHEM J, V473, P685, DOI 10.1042/BJ20150808; Jeanson Y, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00158; Jeong JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25265-3; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim N, 2017, SCI REP-UK, V7, DOI 10.1038/srep41066; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Laurens C, 2016, MOL METAB, V5, P527, DOI 10.1016/j.molmet.2016.04.004; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Nguyen HP, 2020, MOL CELL, V77, P600, DOI 10.1016/j.molcel.2019.12.002; Okamatsu-Ogura Y, 2018, J APPL PHYSIOL, V124, P99, DOI 10.1152/japplphysiol.00622.2017; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Petersen C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13298-z; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schweizer S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800136; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Tasdogan A, 2020, NATURE, V577, P115, DOI 10.1038/s41586-019-1847-2; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weir G, 2018, CELL METAB, V27, P1348, DOI 10.1016/j.cmet.2018.04.020; Winther S, 2018, AM J PHYSIOL-ENDOC M, V314, pE214, DOI 10.1152/ajpendo.00218.2017; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	54	12	12	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100137	10.1074/jbc.RA120.016303	http://dx.doi.org/10.1074/jbc.RA120.016303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268383	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400116
J	Nakamura, S; Fu, N; Kondo, K; Wakabayashi, KI; Hisabori, T; Sugiura, K				Nakamura, Shungo; Fu, Nae; Kondo, Kumiko; Wakabayashi, Ken-Ichi; Hisabori, Toru; Sugiura, Kazunori			A luminescent Nanoluc-GFP fusion protein enables readout of cellular pH in photosynthetic organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT PROTEIN; CHLOROPLAST ENVELOPE; DEPENDENT REGULATION; INDICATORS; ATP; BIOLUMINESCENCE; MUTAGENESIS; ELECTRON; VARIANT; SYSTEM	pH is one of the most critical physiological parameters determining vital cellular activities, such as photosynthetic performance. Fluorescent sensor proteins capable of measuring in situ pH in animal cells have been reported. However, these proteins require an excitation laser for pH measurement that may affect photosynthetic performance and induce auto-fluorescence from chlorophyll. As a result, it is not possible to measure the intracellular or intraorganelle pH changes in plants. To overcome this problem, we developed a luminescent pH sensor by fusing the luminescent protein Nanoluc to a uniquely designed pH-sensitive GFP variant protein. In this system, an excitation laser is unnecessary because the fused GFP variant reports on the luminescent signal by bioluminescence resonance energy transfer from Nanoluc. The ratio of two luminescent peaks from the sensor protein was approximately linear with respect to pH in the range of 7.0 to 8.5. We designated this sensor protein as "luminescent pH indicator protein" (Luphin). We applied Luphin to the in situ pH measurement of a photosynthetic organism under fluctuating light conditions, allowing us to successfully observe the cytosolic pH changes associated with photosynthetic electron transfer in the cyanobacterium Synechocystis sp. PCC 6803. Detailed analyses of the mechanisms of the observed estimated pH changes in the cytosol in this alga suggested that the photosynthetic electron transfer is suppressed by the reduced plastoquinone pool under light conditions. These results indicate that Luphin may serve as a helpful tool to further illuminate pH-dependent processes throughout the photosynthetic organisms.	[Nakamura, Shungo; Fu, Nae; Kondo, Kumiko; Wakabayashi, Ken-Ichi; Hisabori, Toru; Sugiura, Kazunori] Inst Innovat Res, Lab Chem & Life Sci, Midori Ku, Yokohama, Kanagawa, Japan; [Nakamura, Shungo; Fu, Nae; Wakabayashi, Ken-Ichi; Hisabori, Toru; Sugiura, Kazunori] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Kanagawa, Japan; [Sugiura, Kazunori] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Tokyo Institute of Technology; Osaka University	Hisabori, T (corresponding author), Inst Innovat Res, Lab Chem & Life Sci, Midori Ku, Yokohama, Kanagawa, Japan.; Hisabori, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Kanagawa, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Wakabayashi, Ken-ichi/D-2440-2015	Hisabori, Toru/0000-0003-2046-0277; Wakabayashi, Ken-ichi/0000-0002-1025-9249	JSPS KAKENHI [16H06556]; Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	This study was supported by JSPS KAKENHI Grant Number 16H06556 (to T. H.) and by Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials.	Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Awaji T, 2001, BIOCHEM BIOPH RES CO, V289, P457, DOI 10.1006/bbrc.2001.6004; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CORMIER MJ, 1974, BIOCHIM BIOPHYS ACTA, V346, P137, DOI 10.1016/0304-4173(74)90007-X; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Gjetting KSK, 2012, J EXP BOT, V63, P3207, DOI 10.1093/jxb/ers040; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Heiber T, 1995, BIOCHEMISTRY-US, V34, P15906, DOI 10.1021/bi00049a005; HELDT HW, 1973, BIOCHIM BIOPHYS ACTA, V314, P224, DOI 10.1016/0005-2728(73)90137-0; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; JAGENDORF AT, 1966, P NATL ACAD SCI USA, V55, P170, DOI 10.1073/pnas.55.1.170; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Osanai T, 2011, J BIOL CHEM, V286, P30962, DOI 10.1074/jbc.M111.231183; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; ROBINSON SP, 1985, BIOCHIM BIOPHYS ACTA, V806, P187, DOI 10.1016/0005-2728(85)90096-9; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; Shu X, 2007, PROTEIN SCI, V16, P2703, DOI 10.1110/ps.073112007; Sonoike K, 2001, PLANT CELL PHYSIOL, V42, P379, DOI 10.1093/pcp/pce046; Su PH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02079; Sugiura K, 2015, BIOCHEM BIOPH RES CO, V457, P242, DOI 10.1016/j.bbrc.2014.12.095; Suzuki K., 2016, NAT COMMUN, V7; Tikhonov AN, 2013, PHOTOSYNTH RES, V116, P511, DOI 10.1007/s11120-013-9845-y; Wang CJ, 2019, PLANT PHYSIOL, V181, P762, DOI 10.1104/pp.19.00766; WOODROW IE, 1988, ANNU REV PLANT PHYS, V39, P533, DOI 10.1146/annurev.pp.39.060188.002533; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Zhang YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043072	38	8	8	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100134	10.1074/jbc.RA120.016847	http://dx.doi.org/10.1074/jbc.RA120.016847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268379	gold, Green Published			2022-12-26	WOS:000672866400113
J	Ali, N; Bello, GL; Rossetti, MLR; Krieger, MA; Costa, ADT				Ali, Nasir; Bello, Graziele Lima; Rosa Rossetti, Maria Lucia; Krieger, Marco Aurelio; Tavares Costa, Alexandre Dias			Demonstration of a fast and easy sample-to-answer protocol for tuberculosis screening in point-of-care settings: A proof of concept study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PCR; DNA; DIAGNOSTICS; EXTRACTION; SEQUENCE; CULTURE; SYSTEM; IS6110	We sought to develop a smooth and low cost sample preparation and DNA extraction protocol, streamlined with a ready-to-use qPCR in a portable instrument to overcome some of the existing hurdles. Several solutions were evaluated as to their ability to liquefy a mucin-based matrix. Each liquefied matrix, supplemented with either Mycobacterium tuberculosis (MTB) H37Rv strain DNA or intact cells, was aliquoted onto a filter paper embedded with solubilizing agents, and was subsequently dried up. Most of the nucleic acids, including genomic DNA from the bacilli and the host, binds to the filter paper. Next, several protocols were evaluated to elute the DNA from the paper, using qPCR to detect the insertion sequence IS6110, a M. tuberculosis complex genomic marker. The limit of detection (LOD) of the best protocol was then evaluated using parallel seeding and colony counting. The protocol was also evaluated using seventeen sputum samples, previously characterized by the GeneXpert or culture. Two instruments (the ABI7500 Standard and the Q3-Plus system) and two reagents storage formats (frozen or ready-to-use) were evaluated. Solutions containing guanidine isothiocyanate exerted the best liquefying effect on the mucin-based matrix extracted from one 6-mm punches, followed by a brief incubation at 95 degrees C. The resulting DNA contained impurities, but a simple 1:10 dilution elicited the detection of MTB and human genomic targets. The described protocol presented an apparent LOD of 02 CFU/mL of MTB. Challenging the protocol with previously characterized samples showed substantial agreement with GeneXpert MTB/RIF results (sensitivity of 90%, agreement of 88.9%, kappa coefficient of 0.77), and moderate agreement with culture results (sensitivity of 100%, agreement of 78.9%, kappa coefficient of 0.58). This work presents a sensitive proof-of-concept protocol for sputum liquefaction and decontamination followed by a simple DNA extraction procedure, in which the extraction steps are streamlined with a ready-to-use qPCR in a portable instrument that can be employed in low infrastructure settings.	[Ali, Nasir; Krieger, Marco Aurelio; Tavares Costa, Alexandre Dias] Inst Biol Mol Parana IBMP, Curitiba, Parana, Brazil; [Ali, Nasir; Krieger, Marco Aurelio] Univ Fed Parana UFPR, Dept Engn Bioproc & Biotecnol, Curitiba, Parana, Brazil; [Bello, Graziele Lima; Rosa Rossetti, Maria Lucia] Ctr Desenvolvimento Cient & Tecnol, Secretaria Estadual Saude, Porto Alegre, RS, Brazil; [Bello, Graziele Lima; Rosa Rossetti, Maria Lucia] Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicado Saud, Canoas, RS, Brazil; [Krieger, Marco Aurelio; Tavares Costa, Alexandre Dias] Fundacao Oswaldo Cruz FIOCRUZ, Inst Carlos Chagas ICC, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Luterana do Brasil; Fundacao Oswaldo Cruz	Costa, ADT (corresponding author), Inst Biol Mol Parana IBMP, Curitiba, Parana, Brazil.; Costa, ADT (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Carlos Chagas ICC, Curitiba, Parana, Brazil.	alexandre.costa@fiocruz.br	Costa, Alexandre Dias Tavares/ABB-1896-2021; Costa, Alexandre Augusto da/HCJ-0140-2022	Costa, Alexandre Dias Tavares/0000-0001-8434-2152; Costa, Alexandre Augusto da/0000-0001-7558-5435; Bello, Graziele/0000-0001-8537-8413; Krieger, Marco Aurelio/0000-0003-0030-3952	Brazilian funding agency CNPq; Brazilian funding agency CAPES; Banco Nacional de Desenvolvimento Economico e Social (BNDES) [15.2.0473.1, 4.816.864]; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) [17/25510001542-8]	Brazilian funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Banco Nacional de Desenvolvimento Economico e Social (BNDES); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Several authors received grants or fellowships from the Brazilian funding agencies CNPq and CAPES. This work was funded by a grant from the Banco Nacional de Desenvolvimento Economico e Social (BNDES), contract no. 15.2.0473.1 (Operation #4.816.864), and by a grant from the Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS grant #17/25510001542-8). There was no additional external funding received for this study. IBMP, BNDES, FAPERGS, CAPES or CNPq had no participation in the present study's design, data collection, analysis or interpretation, or writing of the report and decision to submit for publication.	Ali N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9306564; Allen V., 2016, RES REV J MICROBIOL, V5, P96; [Anonymous], 2017, EPLASTY, V17, pic25; Arora J, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104230; Aziz M, 2007, INT J TUBERC LUNG D, V11, P247; Brasil M da S, 2008, MANUAL NACL VIGILANC; Castan P, 2014, J CLIN MICROBIOL, V52, P502, DOI 10.1128/JCM.02209-13; Cereda M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082583; Clinghan R, 2013, J CLIN MICROBIOL, V51, P2010, DOI 10.1128/JCM.00923-13; Manta FSD, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008325; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Ferguson TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19541; Govindarajan AV, 2012, LAB CHIP, V12, P174, DOI 10.1039/c1lc20622b; Guio H, 2006, INT J TUBERC LUNG D, V10, P906; Huckle D, 2015, EXPERT REV MOL DIAGN, V15, P815, DOI 10.1586/14737159.2015.1033405; Iglesias N, 2014, PARASITOL RES, V113, P2587, DOI 10.1007/s00436-014-3911-z; Khan IUH, 2004, J CLIN MICROBIOL, V42, P453, DOI 10.1128/JCM.42.1.453-457.2004; Kolia-Diafouka P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02224; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Machado D, 2019, INFECT GENET EVOL, V72, P93, DOI 10.1016/j.meegid.2018.11.021; Millan-Lou MI, 2013, J CLIN MICROBIOL, V51, P3631, DOI 10.1128/JCM.00970-13; Pawlowski DR, 2012, JOVE-J VIS EXP, DOI 10.3791/4202; Rampazzo RDP, 2017, VET PARASITOL, V246, P100, DOI 10.1016/j.vetpar.2017.09.009; Rampazzo RCP, 2019, J MOL DIAGN, V21, P839, DOI 10.1016/j.jmoldx.2019.04.008; Reed JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03930-3; Rosado P.M.F.S., 2002, Patent No. [02/072002A3, 02072002]; Sambrook J., 2001, MOL CLONING LAB MANU; Sankar S, 2011, BIOINFORMATION, V6, P283, DOI 10.6026/97320630006283; Spositto FLE, 2014, BRAZ J MICROBIOL, V45, P841, DOI 10.1590/S1517-83822014000300012; Stop TB Partnership, 2014, MYC LAB IN, P147; Sun Y, 2013, LAB CHIP, V13, P1509, DOI 10.1039/c2lc41386h; Walzl G, 2018, LANCET INFECT DIS, V18, pE199, DOI 10.1016/S1473-3099(18)30111-7; Wang SQ, 2016, EXPERT REV MOL DIAGN, V16, P449, DOI 10.1586/14737159.2016.1142877; Wolfgramm ED, 2009, FORENSIC SCI INT-GEN, V3, P125, DOI 10.1016/j.fsigen.2008.11.008; World Health Organization, 2021, 10 THREATS GLOB HLTH; 2012, DRUG DISCOV TODAY TE, V9	37	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0242408	10.1371/journal.pone.0242408	http://dx.doi.org/10.1371/journal.pone.0242408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315885	gold, Green Published			2022-12-26	WOS:000600186100062
J	Wood, KM; Spear, ED; Mossberg, OW; Odinammadu, KO; Xu, WX; Michaelis, S				Wood, Kaitlin M.; Spear, Eric D.; Mossberg, Otto W.; Odinammadu, Kamsi O.; Xu, Wenxin; Michaelis, Susan			Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24	PLOS ONE			English	Article							LAMIN-A; SACCHAROMYCES-CEREVISIAE; RESTRICTIVE DERMOPATHY; PROTEIN; MUTATIONS; STE24P; PROTEOLYSIS; PROGERIA; BIOGENESIS; MATURATION	The integral membrane zinc metalloprotease ZMPSTE24 plays a key role in the proteolytic processing of farnesylated prelamin A, the precursor of the nuclear scaffold protein lamin A. Failure of this processing step results in the accumulation of permanently farnesylated forms of prelamin A which cause the premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS), as well as related progeroid disorders, and may also play a role in physiological aging. ZMPSTE24 is an intriguing and unusual protease because its active site is located inside of a closed intramembrane chamber formed by seven transmembrane spans with side portals in the chamber permitting substrate entry. The specific features of prelamin A that make it the sole known substrate for ZMPSTE24 in mammalian cells are not well-defined. At the outset of this work it was known that farnesylation is essential for prelamin A cleavage in vivo and that the C-terminal region of prelamin A (41 amino acids) is sufficient for recognition and processing. Here we investigated additional features of prelamin A that are required for cleavage by ZMPSTE24 using a well-established humanized yeast system. We analyzed the 14-residue C-terminal region of prelamin A that lies between the ZMPSTE24 cleavage site and the farnesylated cysteine, as well 23-residue region N-terminal to the cleavage site, by generating a series of alanine substitutions, alanine additions, and deletions in prelamin A. Surprisingly, we found that there is considerable flexibility in specific requirements for the length and composition of these regions. We discuss how this flexibility can be reconciled with ZMPSTE24's selectivity for prelamin A.	[Wood, Kaitlin M.; Spear, Eric D.; Mossberg, Otto W.; Odinammadu, Kamsi O.; Xu, Wenxin; Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA; [Xu, Wenxin] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Peoples R China	Johns Hopkins University; Southern University of Science & Technology	Michaelis, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	michaelis@jhmi.edu		Michaelis, Susan/0000-0001-5851-5021	National Institute of Health (NIH) [5R35GM127073]; Hay Fellowship from the Department of Cell Biology, Johns Hopkins School of Medicine	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hay Fellowship from the Department of Cell Biology, Johns Hopkins School of Medicine	This work was funded by a National Institute of Health (NIH) grant to SM (5R35GM127073). Kaitlin Wood was funded in part by a Hay Fellowship from the Department of Cell Biology, Johns Hopkins School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for author [KMW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Babatz TD, 2020, BIORXIV, DOI [10.1101/2020.08.17.254532, DOI 10.1101/2020.08.17.254532]; Barrowman J, 2011, ENZYMES, V30, P13, DOI 10.1016/B978-0-12-415922-8.00002-1; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Berger BM, 2018, GENETICS, V210, P1301, DOI 10.1534/genetics.118.301454; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Clark KM, 2017, PROTEIN SCI, V26, P242, DOI 10.1002/pro.3074; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Feral J, 2002, SUB-STANCE, P94; Fu BS, 2017, J EXP MED, V214, P919, DOI 10.1084/jem.20161270; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Fukumori A, 2020, SEMIN CELL DEV BIOL, V105, P54, DOI 10.1016/j.semcdb.2020.03.006; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goblirsch BR, 2020, J MOL BIOL, V432, P5079, DOI 10.1016/j.jmb.2020.03.016; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Hildebrandt ER, 2016, J BIOL CHEM, V291, P14185, DOI 10.1074/jbc.M116.718197; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hosomi A, 2020, J BIOL CHEM, V295, P10406, DOI 10.1074/jbc.RA120.012575; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kayatekin C, 2018, CELL, V173, P62, DOI 10.1016/j.cell.2018.02.026; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li ST, 2017, DNA CELL BIOL, V36, P513, DOI 10.1089/dna.2017.3791; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mehmood S, 2016, NAT CHEM, V8, P1152, DOI [10.1038/NCHEM.2591, 10.1038/nchem.2591]; Michaelis S, 2013, SCIENCE, V339, P1529, DOI 10.1126/science.1236764; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Navarro CL, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.258; Nie L, 2020, BIORXIV, DOI [10.1101/2020.05.13.093849, DOI 10.1101/2020.05.13.093849]; Palsuledesai CC, 2015, ACS CHEM BIOL, V10, P51, DOI 10.1021/cb500791f; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Smigiel R, 2010, AM J MED GENET A, V152A, P447, DOI 10.1002/ajmg.a.33221; Spear ED, 2019, METHODS, V157, P47, DOI 10.1016/j.ymeth.2019.01.001; Spear ED, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033670; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wolfe MS, 2020, SEMIN CELL DEV BIOL, V105, P3, DOI 10.1016/j.semcdb.2020.01.005; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679	61	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0239269	10.1371/journal.pone.0239269	http://dx.doi.org/10.1371/journal.pone.0239269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315887	gold, Green Published, Green Submitted			2022-12-26	WOS:000600186100020
J	Daci, A; Dalt, L; Alaj, R; Shurdhiqi, S; Neziri, B; Ferizi, R; Norata, GD; Krasniqi, S				Daci, Armond; Dalt, Lorenzo; Alaj, Rame; Shurdhiqi, Shpejtim; Neziri, Burim; Ferizi, Rrahman; Norata, Giuseppe Danilo; Krasniqi, Shaip			Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models	PLOS ONE			English	Article							ACTIVATED RECEPTOR-2 PAR-2; COAGULATION-FACTOR XA; ORAL ANTICOAGULANT; APOLIPOPROTEIN-E; GENE-EXPRESSION; MOUSE MODEL; IN-VIVO; RATS; DEFICIENT; INHIBITION	Rivaroxaban (RVX) was suggested to possess anti-inflammatory and vascular tone modulatory effects. The goal of this study was to investigate whether RVX impacts lipopolysaccharide (LPS)-induced acute vascular inflammatory response. Male rats were treated with 5 mg/kg RVX (oral gavage) followed by 10 mg/kg LPS i.p injection. Circulating levels of IL-6, MCP-1, VCAM-1, and ICAM-1 were measured in plasma 6 and 24 hours after LPS injection, while isolated aorta was used for gene expression analysis, immunohistochemistry, and vascular tone evaluation. RVX pre-treatment significantly reduced LPS mediated increase after 6h and 24h for IL-6 (4.4 +/- 2.2 and 2.8 +/- 1.7 fold), MCP-1 (1.4 +/- 1.5 and 1.3 +/- 1.4 fold) VCAM-1 (1.8 +/- 2.0 and 1.7 +/- 2.1 fold). A similar trend was observed in the aorta for iNOS (5.5 +/- 3.3 and 3.3 +/- 1.9 folds reduction, P<0.01 and P<0.001, respectively), VCAM-1 (1.3 +/- 1.2 and 1.4 +/- 1.3 fold reduction, P<0.05), and MCP-1 (3.9 +/- 2.2 and 1.9 +/- 1.6 fold reduction, P<0.01). Moreover, RVX pre-treatment, improved LPS-induced PE contractile dysfunction in aortic rings (Control vs LPS, Emax reduction = 35.4 and 31.19%, Pvs LPS+RVX, Emax reduction = 10.83 and 11.48%, P>0.05, respectively), resulting in 24.5% and 19.7% change in maximal constriction in LPS and LPS+RVX respectively. These data indicate that RVX pre-treatment attenuates LPS-induced acute vascular inflammation and contractile dysfunction.	[Daci, Armond] Univ Prishtina, Fac Med, Dept Pharm, Prishtina, Kosovo; [Daci, Armond; Krasniqi, Shaip] Univ Prishtina, Fac Med, Inst Pharmacol & Toxicol, Prishtina, Kosovo; [Dalt, Lorenzo; Norata, Giuseppe Danilo] Univ Milan, Dept Excellence Pharmacol & Biomol Sci, Milan, Italy; [Alaj, Rame; Shurdhiqi, Shpejtim] Univ Clin Ctr Kosovo, Cardiovasc Surg Clin, Prishtina, Kosovo; [Neziri, Burim] Univ Prishtina, Fac Med, Inst Pathophysiol, Prishtina, Kosovo; [Ferizi, Rrahman] Univ Prishtina, Fac Med, Dept Premed Courses Biol, Prishtina, Kosovo; [Norata, Giuseppe Danilo] Osped Bassini, Ctr SISA Studio Aterosclerosi, Cinisello Balsamo, Italy	University of Milan; Universiteti i Prishtines	Krasniqi, S (corresponding author), Univ Prishtina, Fac Med, Inst Pharmacol & Toxicol, Prishtina, Kosovo.	shaip.krasniqi@uni-pr.edu	Krasniqi, Shaip/C-2623-2019; DA DALT, Lorenzo/L-6919-2019; Daci, Armond/J-8529-2019	Krasniqi, Shaip/0000-0003-0312-5258; DA DALT, Lorenzo/0000-0002-6298-8689; Daci, Armond/0000-0003-1276-4561; Norata, Giuseppe Danilo/0000-0002-6081-1257	Research Fund of Ministry of Education, Science and Technology-Republic of Kosovo [2616]; Kosovo Interdisciplinary Knowledge Triangle Center (KIKTC, Tempus IV grant); Fondazione Cariplo [2016-0852]; EFSD/Lilly European Diabetes Research Programme 2018; Fondazione Telethon [GGP19146];  [PRIN 2017K55HLC]	Research Fund of Ministry of Education, Science and Technology-Republic of Kosovo; Kosovo Interdisciplinary Knowledge Triangle Center (KIKTC, Tempus IV grant); Fondazione Cariplo(Fondazione Cariplo); EFSD/Lilly European Diabetes Research Programme 2018; Fondazione Telethon(Fondazione TelethonEuropean Commission); 	This research project was supported by the Research Fund of Ministry of Education, Science and Technology-Republic of Kosovo. Project No. 2616. Facilities and infrastructure were provided by Kosovo Interdisciplinary Knowledge Triangle Center (KIKTC, Tempus IV grant). GDN is supported by Fondazione Cariplo 2016-0852; EFSD/Lilly European Diabetes Research Programme 2018, Fondazione Telethon GGP19146 and PRIN 2017K55HLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane K, 2001, SURGERY, V130, P809, DOI 10.1067/msy.2001.116452; Akkaya G, 2017, ANATOL J CARDIOL, V18, P261, DOI 10.14744/AnatolJCardiol.2017.7898; Al Said S, 2018, HAMOSTASEOLOGIE, V38, P240, DOI 10.1055/s-0038-1673412; Alvarez E, 2018, BRIT J CLIN PHARMACO, V84, P280, DOI 10.1111/bcp.13440; [Anonymous], 2015, EUROPEAN ENERGY J, V14, P81; Barnes GD, 2016, HEART, V102, P1620, DOI 10.1136/heartjnl-2015-309075; Bermejo A, 2003, J CARDIOVASC PHARM, V42, P329, DOI 10.1097/00005344-200309000-00003; Bode MF, 2018, THROMB RES, V167, P128, DOI 10.1016/j.thromres.2018.05.015; Bonacina F, 2016, BBA-MOL BASIS DIS, V1862, P1182, DOI 10.1016/j.bbadis.2016.03.007; Bonacina F, 2019, CARDIOVASC RES, V115, P1861, DOI 10.1093/cvr/cvz068; Bonacina F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05322-1; Burris RL, 2014, EUR J NUTR, V53, P135, DOI 10.1007/s00394-013-0509-7; Chen CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174971; Cicala C, 1999, CIRCULATION, V99, P2590, DOI 10.1161/01.CIR.99.19.2590; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Dittmeier M, 2016, THROMB HAEMOSTASIS, V115, P835, DOI 10.1160/TH15-08-0631; Ebrahimi S, 2017, J CELL PHYSIOL, V232, P1966, DOI 10.1002/jcp.25714; da Silva-Santos JE, 2009, CRIT CARE MED, V37, P1716, DOI 10.1097/CCM.0b013e31819efb43; Ellinghaus P, 2016, THROMB RES, V142, P44, DOI 10.1016/j.thromres.2016.04.008; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fink MP, 2008, KIDNEY INT, V74, P991, DOI 10.1038/ki.2008.442; Foley JH, 2016, CIRC RES, V118, P1392, DOI 10.1161/CIRCRESAHA.116.306853; Fujiwara Y, 2017, J PHARMACOL SCI, V134, P234, DOI 10.1016/j.jphs.2017.08.001; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Gomez-Outes A, 2015, EUR J HAEMATOL, V95, P389, DOI 10.1111/ejh.12610; Goto M, 2016, INT J CARDIOL, V220, P602, DOI 10.1016/j.ijcard.2016.06.212; Guo XJ, 2020, JACC-BASIC TRANSL SC, V5, P69, DOI 10.1016/j.jacbts.2019.10.006; Hara T, 2018, CIRCULATION, V138, P1706, DOI 10.1161/CIRCULATIONAHA.118.033544; Hara T, 2018, EUR J PHARMACOL, V820, P222, DOI 10.1016/j.ejphar.2017.12.037; Hara T, 2015, ATHEROSCLEROSIS, V242, P639, DOI 10.1016/j.atherosclerosis.2015.03.023; Ichikawa H, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012195; Ishibashi Y, 2015, THROMB RES, V135, P770, DOI 10.1016/j.thromres.2015.01.023; Jesmin S, 2007, INFLAMMATION, V30, P14, DOI 10.1007/s10753-006-9017-8; Jones DP, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7040049; Kawabata A, 2001, BIOCHEM BIOPH RES CO, V282, P432, DOI 10.1006/bbrc.2001.4597; Kim M, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11030133; Kondo H, 2018, J CARDIOL, V71, P310, DOI 10.1016/j.jjcc.2017.08.007; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056331; Linghu KG, 2020, EUR J PHARMACOL, V868, DOI 10.1016/j.ejphar.2019.172854; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Liu JY, 2019, J ATHEROSCLER THROMB, V26, P915, DOI 10.5551/jat.48405; Lou XJ, 2019, EXP THER MED, V18, P1619, DOI 10.3892/etm.2019.7726; Fiusa MML, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0327-2; Mabley J, 2019, THROMB RES, V176, P36, DOI 10.1016/j.thromres.2019.02.014; Milesi V, 2001, MEDICINA B AIRES; Monux G, 2017, BRIT J CLIN PHARMACO, V83, P2661, DOI 10.1111/bcp.13383; Murakami A, 2000, CANCER RES, V60, P5059; Nakanishi N, 2018, CIRC C; Oe Y, 2016, ARTERIOSCL THROM VAS, V36, P1525, DOI 10.1161/ATVBAHA.116.307883; Olie RH, 2018, RES PRACT THROMB HAE, V2, P188, DOI 10.1002/rth2.12080; Ozturk OH, 2006, J PHYSIOL BIOCHEM, V62, P27; Papadaki S, 2019, ANGIOLOGY, V70, P896, DOI 10.1177/0003319719840861; Papapetropoulos A, 1998, P NATL ACAD SCI USA, V95, P4738, DOI 10.1073/pnas.95.8.4738; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Perzborn E, 2007, BLOOD, V110, p284A, DOI 10.1182/blood.V110.11.935.935; Pham PT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47474-0; Posthuma JJ, 2019, SCI REP, P9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; Rosenkranz AC, 2011, THROMB HAEMOSTASIS, V106, P561, DOI 10.1160/TH11-04-0275; Rupprecht HJ, 2010, DRUGS, V70, P2153, DOI 10.2165/11538030-000000000-00000; Saifeddine M, 1996, BRIT J PHARMACOL, V118, P521, DOI 10.1111/j.1476-5381.1996.tb15433.x; Sanmartin M, 2019, EXPERT REV CLIN PHAR, V12, P771, DOI 10.1080/17512433.2019.1637732; Schaeffer P, 1997, CIRC RES, V81, P824; Schochl H, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1636-y; Senden NH, 1998, J IMMUNOL; Shantsila E, 2016, NONVITAMIN K ANTAGON, P25, DOI [10.1007/978-3-319-25460-9_3, DOI 10.1007/978-3-319-25460-9_3]; Shi M, 2018, AM J TRANSL RES; Shi Meng, 2019, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V31, P468, DOI 10.3760/cma.j.issn.2095-4352.2019.04.019; Shih CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163690; Shukla P, 2014, BRIT J PHARMACOL, V171, P5011, DOI 10.1111/bph.12829; Sparkenbaugh EM, 2014, BLOOD, V123, P1747, DOI 10.1182/blood-2013-08-523936; Terry CM, 2016, THROMB RES, V144, P106, DOI 10.1016/j.thromres.2016.06.008; Torramade-Moix S, 2021, CARDIOVASC DRUG THER, V35, P521, DOI 10.1007/s10557-020-07010-z; Turgeon RD, 2019, J CARDIOVASC PHARM T, V24, P103, DOI 10.1177/1074248418795889; Venu VKP, 2015, THROMB HAEMOSTASIS, V114, P186, DOI 10.1160/TH14-09-0790; Villari A, 2017, FRONT PHARMACOL, P8, DOI [10.3389/fphar.2017.00008, DOI 10.3389/FPHAR.2017.00008]; Weinz C, 2005, XENOBIOTICA, V35, P891, DOI 10.1080/00498250500250493; Weitz JI, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00019; Zhou QX, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/432080	79	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0240669	10.1371/journal.pone.0240669	http://dx.doi.org/10.1371/journal.pone.0240669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301454	Green Published, gold			2022-12-26	WOS:000600143100016
J	Mostowy, J; Malca, E; Rasmuson, L; Vasquez-Yeomans, L; Gerard, T; Cordero, ES; Carrillo, L; Lamkin, JT				Mostowy, Jason; Malca, Estrella; Rasmuson, Leif; Vasquez-Yeomans, Lourdes; Gerard, Trika; Sosa Cordero, Eloy; Carrillo, Laura; Lamkin, John T.			Early life ecology of the invasive lionfish (Pterois spp.) in the western Atlantic	PLOS ONE			English	Article							CORAL-REEF FISH; GULF-OF-MEXICO; DENDROCHIRUS-BRACHYPTERUS; RECRUITMENT SUCCESS; VERTICAL MIGRATIONS; SALINITY TOLERANCE; SPAWN-FORMATION; GROWTH; LARVAE; VOLITANS	The invasion of the western Atlantic by the Indo-Pacific lionfish (Pterois volitans/miles) is a serious threat to the ecological stability of the region. The early life history of the lionfish remains poorly understood despite the important role that larval supply plays reef fish population dynamics. In this study, we characterized patterns in the horizontal and vertical distributions of larval lionfish collected in the western Caribbean, US Caribbean, and the Gulf of Mexico from 19 ichthyoplankton surveys conducted from 2009-2016. Using generalized additive models (GAMs), we assessed the relative effects of spatiotemporal and environmental variation on the distribution of lionfish larvae. We also examined otoliths to determine larval ages and report the first larval growth rate estimates for this species. Lionfish larvae were present at 7.8% of all stations sampled and our model suggests that lionfish presence is related to sea surface temperature and the lunar cycle. Year and location also strongly affected the larval distribution, likely reflecting the ongoing expansion of the species during our sampling timeframe. Much of the variation in larval lionfish presence remained unexplained, and future studies should incorporate additional environmental factors to improve model predictions. This study improves our understanding of the lionfish life cycle and accentuates the need for further research into the early life history of this invasive species. The design and implementation of effective long-term lionfish control mechanisms will require an understanding of their entire life history.	[Mostowy, Jason] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Mostowy, Jason; Malca, Estrella; Rasmuson, Leif] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33146 USA; [Malca, Estrella; Rasmuson, Leif; Gerard, Trika; Lamkin, John T.] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA; [Rasmuson, Leif] Oregon Dept Fish & Wildlife, Marine Resources Program, Newport, OR USA; [Vasquez-Yeomans, Lourdes; Sosa Cordero, Eloy] Colegio Frontera Sur, Dept Sistemat & Ecol Acuat, Chetmal, Quintana Roo, Mexico; [Gerard, Trika] Univ Phoenix, South Florida Campus, Miramar, FL USA; [Carrillo, Laura] Colegio Frontera Sur, Dept Observac & Estudio Tierra, Atmosfera & Oceano, Chetmal, Quintana Roo, Mexico	Texas A&M University System; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR)	Mostowy, J (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.; Mostowy, J (corresponding author), Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33146 USA.	jmostowy@tamu.edu	Carrillo, Laura/AAC-5556-2022	Carrillo, Laura/0000-0001-8296-007X; Mostowy, Jason/0000-0003-1601-7141	National Aeronautics and Space Administration [NNX11AP76G]; National Oceanographic and Atmospheric Administration	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Oceanographic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	National Aeronautics and Space Administration (Grant No. NNX11AP76G) National Oceanographic and Atmospheric Administration; Institutional support for TG, JL University of Miami Cooperative Institute for Marine and Atmospheric Studies; Institutional support for JM, EM, LR El Colegio de la Frontera Sur, Unidad Chetumal; Institutional support for LVY, FESC, LC The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; American Fisheries Society, 2014, GUIDELINES USE FISHE; Andradi-Brown DA, 2017, BIOL INVASIONS, V19, P939, DOI 10.1007/s10530-016-1358-0; [Anonymous], 2011, J MARITIME RES, V13, P21; [Anonymous], 2012, ANNUAIRE FRANCAISE D, VLVIII, P1; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Bergenius MAJ, 2005, MAR BIOL, V147, P291, DOI 10.1007/s00227-005-1575-z; Bergenius MAJ, 2002, OECOLOGIA, V131, P521, DOI 10.1007/s00442-002-0918-4; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Claydon JAB, 2012, MAR ECOL PROG SER, V448, P119, DOI 10.3354/meps09534; COLIN PL, 1987, B MAR SCI, V40, P220; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cressie N., 1992, TERRA NOVA, V4, P613, DOI DOI 10.1111/J.1365-3121.1992.TB00605.X; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; Dahl KA, 2019, MAR ECOL PROG SER, V623, P145, DOI 10.3354/meps13028; Dahl KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105852; Donelson JM, 2008, J EXP MAR BIOL ECOL, V360, P109, DOI 10.1016/j.jembe.2008.04.007; Estudillo CB, 2000, AQUACULTURE, V190, P155, DOI 10.1016/S0044-8486(00)00390-2; Ferreira CEL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123002; Fishelson L, 1997, ENVIRON BIOL FISH, V50, P391, DOI 10.1023/A:1007331304122; FISHELSON L, 1978, MAR BIOL, V46, P341, DOI 10.1007/BF00391406; Fishelson L., 1975, Pubblicazioni Staz Zool Napoli, V39, P635; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; Fogg AQ, 2017, B MAR SCI, V93, P791, DOI 10.5343/bms.2016.1095; Fogg Alexander Q., 2013, Gulf and Caribbean Research, V25, P111; Gardner PG, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00007; Harms-Tuohy CA, 2016, MAR ECOL PROG SER, V558, P181, DOI 10.3354/meps11738; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Huebert KB, 2011, LIMNOL OCEANOGR, V56, P1653, DOI 10.4319/lo.2011.56.5.1653; HYCOM Consortium, HYBR COORD OC MOD; Imamura Hisashi, 1996, Bulletin of the Faculty of Fisheries Hokkaido University, V47, P41; Irisson JO, 2010, LIMNOL OCEANOGR, V55, P909, DOI 10.4319/lo.2009.55.2.0909; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnston MW, 2011, MAR POLLUT BULL, V62, P1218, DOI 10.1016/j.marpolbul.2011.03.028; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kitchens LL, 2017, BIOL INVASIONS, V19, P1971, DOI 10.1007/s10530-017-1417-1; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; LEIS JM, 1986, MAR BIOL, V90, P505, DOI 10.1007/BF00409271; Leis JM, 1999, MAR BIOL, V134, P51, DOI 10.1007/s002270050524; Llopiz JK, 2013, J MARINE SYST, V109, P69, DOI 10.1016/j.jmarsys.2012.05.002; Malca E, 2017, FISH RES, V190, P24, DOI 10.1016/j.fishres.2017.01.019; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; MCCORMICK MI, 1995, MAR ECOL PROG SER, V118, P59, DOI 10.3354/meps118059; Morris JA, 2011, SCI MAR, V75, P147, DOI 10.3989/scimar.2011.75n1147; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Muhling BA, 2013, FISH OCEANOGR, V22, P409, DOI 10.1111/fog.12031; Muhling BA, 2012, MAR ECOL PROG SER, V450, P37, DOI 10.3354/meps09540; NASA, NASA AQ MODIS MOD RE; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Peake J, 2018, BIOL INVASIONS, V20, P2567, DOI 10.1007/s10530-018-1720-5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROBERTSON DR, 1992, MAR BIOL, V114, P527, DOI 10.1007/BF00357250; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schmitz WJ, 2005, GEOPH MONOG SERIES, V161, P11; Schofield PJ, 2017, PTEROIS VOLITANS MIL; Searcy SP, 2001, ECOLOGY, V82, P2452; Simms JR, 2010, FISH B-NOAA, V108, P478; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Sponaugle S, 2005, J FISH BIOL, V66, P822, DOI 10.1111/j.0022-1112.2005.00657.x; Sponaugle S, 2019, BIOL INVASIONS, V21, P3013, DOI 10.1007/s10530-019-02070-1; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Tregarot Ewan, 2015, Marine Biodiversity Records, V8, pe1, DOI 10.1017/S1755267214001341; U.S. Office of Science and Technology Policy, 1985, Fed Regist, V50, P20864; Arellano-Mendez LU, 2017, BIOINVASIONS REC, V6, P255, DOI 10.3391/bir.2017.6.3.11; USNO, USNO ASTR APPL DEP P; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wood S., 2012, MGCV MIXED GAM COMPU; Zuur Alain F., 2009, P1	82	1	1	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243138	10.1371/journal.pone.0243138	http://dx.doi.org/10.1371/journal.pone.0243138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301531	gold, Green Published			2022-12-26	WOS:000600143100073
J	Chen, BJ; Sterling, KL; Bluestein, MA; Kuk, AE; Harrell, MB; Perry, CL; Perez, A				Chen, Baojiang; Sterling, Kymberle L.; Bluestein, Meagan A.; Kuk, Arnold E.; Harrell, Melissa B.; Perry, Cheryl L.; Perez, Adriana			Age of initiation of cigarillos, filtered cigars and/or traditional cigars among youth: Findings from the Population Assessment of Tobacco and Health (PATH) study, 2013-2017	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; UNITED-STATES; PRODUCT USE; RISK PERCEPTIONS; YOUNG-ADULTS; USA FINDINGS; SMOKING; MIDDLE; EXPERIMENTATION; ADOLESCENTS	Significance Early age of initiation of tobacco use is associated with sustained tobacco use and lower rates of smoking cessation. Although much is known about age of initiation of cigarette use, much less is known about the age of initiation of cigar product use among youth. Methods Survival analyses of the Population Assessment of Tobacco and Health youth annual datasets (ages 12-17) from 2013 to 2017 were conducted for any cigar product use, cigarillos or filtered cigars, and traditional cigars across four cigar use outcomes, age of initiation of: susceptibility to use, ever use, past 30-day use and "fairly regular" use. An interval censoring survival method was implemented to estimate the probability of each outcome for age of initiation of each cigar product overall. Differences in age of initiation by sex and race/ethnicity were assessed using weighted Cox proportional hazards models for interval-censored data. Results For each outcome across the three cigar products, striking increases in the probability of initiation begin before 17 years old. For cigarillo or filtered cigars, males had a higher risk of onset of susceptibility to use, initiating ever use, and initiating past 30-day use at earlier ages than females. Compared to Non-Hispanic Whites, Hispanic and Non-Hispanic Other had lower risk of initiating ever use and past 30-day use at earlier ages. Non-Hispanic Black youth had higher risk of initiating past 30-day use and "fairly regular" use than Non-Hispanic White youth at earlier ages. Similar findings are reported for any cigar use and traditional cigar use. Conclusion Developmentally and culturally appropriate cigar use interventions and communication campaigns should be provided to youth before 17 years of age to prevent the onset and progression of cigar products. Regulatory policies that reduce appeal of all cigar products should be implemented to curb cigar initiation among youth.	[Chen, Baojiang; Perez, Adriana] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Biostat & Data Sci, Austin, TX 78701 USA; [Chen, Baojiang; Bluestein, Meagan A.; Kuk, Arnold E.; Harrell, Melissa B.; Perry, Cheryl L.; Perez, Adriana] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Michael & Susan Dell Ctr Hlth Living, Austin, TX 78701 USA; [Sterling, Kymberle L.; Perry, Cheryl L.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Hlth Promot & Behav Sci, Austin, TX USA; [Harrell, Melissa B.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Austin, TX USA		Perez, A (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Biostat & Data Sci, Austin, TX 78701 USA.; Perez, A (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Michael & Susan Dell Ctr Hlth Living, Austin, TX 78701 USA.	adriana.perez@uth.tmc.edu			National Cancer Institute (NCI) [1R01CA234205-01A1]; FDA Center for Tobacco Products	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products	Research reported in this publication was supported by grant number [1R01CA234205-01A1] from the National Cancer Institute (NCI) and the FDA Center for Tobacco Products (https://projectreporter.nih.gov/project_info_description.cfm?aid=9928017&icde=51197168) to Dr. Adriana Perez. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH) or the Food and Drug Administration (FDA).	Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Barrington-Trimis JL, 2019, ADDICT BEHAV, V96, P50, DOI 10.1016/j.addbeh.2019.03.017; Carey Felicia R, 2018, Addict Behav Rep, V8, P95, DOI 10.1016/j.abrep.2018.08.005; Caruso RV, 2015, NICOTINE TOB RES, V17, P1331, DOI 10.1093/ntr/ntu341; Centers for Disease Control and Prevention Newsroom, 2019, 6 2 MILL MIDDL HIGH; Chang CM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1617-5; Choi SH, 2017, AM J PREV MED, V53, P33, DOI 10.1016/j.amepre.2016.12.009; Corey CG, 2018, NICOTINE TOB RES, V20, P1457, DOI 10.1093/ntr/ntx209; Corey CG, 2014, MMWR-MORBID MORTAL W, V63, P650; Delnevo Cristine D, 2017, Tob Regul Sci, V3, pS8; Delnevo CD, 2015, TOB CONTROL, V24, P389, DOI 10.1136/tobaccocontrol-2013-051408; Do EK, 2018, SUBST USE MISUSE, V53, P2291, DOI 10.1080/10826084.2018.1473435; England LJ, 2015, AM J PREV MED, V49, P286, DOI 10.1016/j.amepre.2015.01.015; FINKELSTEIN DM, 1986, BIOMETRICS, V42, P845, DOI 10.2307/2530698; Ford K, 2013, 141 APHA ANN M EXP 2; Gentzke AS, 2019, MMWR-MORBID MORTAL W, V68, P157, DOI 10.15585/mmwr.mm6806e1; Goodall RL, 2004, STAT MED, V23, P1131, DOI 10.1002/sim.1682; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hyland A, 2017, TOB CONTROL, V26, P371, DOI 10.1136/tobaccocontrol-2016-052934; Judkins DR., 1990, J OFF STAT, V6, P223, DOI DOI 10.1016/J.AMJMED.2017.09.025.(ADVANCE; Kasza KA, 2020, TOB CONTROL, V29, pS191, DOI 10.1136/tobaccocontrol-2020-055671; King JL, 2020, NICOTINE TOB RES, V22, P2092, DOI 10.1093/ntr/ntaa098; Klein JP., 2003, SURVIVAL ANAL TECHNI; Kong Grace, 2017, Tob Regul Sci, V3, pS48, DOI 10.18001/TRS.3.2(Suppl1).6; Kostygina G, 2016, TOB CONTROL, V25, P66, DOI 10.1136/tobaccocontrol-2014-051830; MITTELMARK MB, 1987, AM J PUBLIC HEALTH, V77, P206, DOI 10.2105/AJPH.77.2.206; National Cancer Institute, 2010, CIG SMOK CANC; National Cancer Institute, 1998, NUTR REQ SWIN, V98-4302, P9; Perkins JM, 2019, J STUD ALCOHOL DRUGS, V80, P659, DOI 10.15288/jsad.2019.80.659; Pierce J. P., 1995, TOBACCO CONTROL S1, V4, pS47, DOI DOI 10.1136/TC.4.SUPPL1.S47; Pierce JP, 2018, JAMA PEDIATR, V172, P444, DOI 10.1001/jamapediatrics.2017.5756; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sakai-Bizmark R, 2020, J ADOLESCENT HEALTH, V66, P431, DOI 10.1016/j.jadohealth.2019.10.022; Sartor CE, 2020, J STUD ALCOHOL DRUGS, V81, P180; Schreuders M, 2019, NICOTINE TOB RES; Stanton CA, 2020, TOB CONTROL, V29, pS178, DOI 10.1136/tobaccocontrol-2019-055573; Sterling KL, 2017, NICOTINE TOB RES, V19, P1351, DOI 10.1093/ntr/ntw244; Sterling KL, 2016, NICOTINE TOB RES, V18, P827, DOI 10.1093/ntr/ntv151; Sterling KL, 2016, NICOTINE TOB RES, V18, P2234, DOI 10.1093/ntr/ntw170; Trapl ES, 2018, ETHNIC DIS, V28, P135, DOI 10.18865/ed.28.3.135; Trapl ES, 2018, NICOTINE TOB RES, V20, P370, DOI 10.1093/ntr/ntw328; Trapl ES, 2016, NICOTINE TOB RES, V18, P834, DOI 10.1093/ntr/ntv201; Trinidad DR, 2017, PREV MED, V101, P8, DOI 10.1016/j.ypmed.2017.05.010; United States Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse Food and Drug Administration Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States], 2020, POP ASS TOB HLTH PAT; United States Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse Food and Drug Administration Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files, 2019, POP ASS TOB HLTH PAT; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; USDHHS, 2016, E CIGARETTE USE YOUT; Villanti AC, 2017, AM J PREV MED, V53, P139, DOI 10.1016/j.amepre.2017.01.026; Wang TW, 2019, MMWR SURVEILL SUMM, V68, P1, DOI 10.15585/mmwr.ss6812a1	49	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243372	10.1371/journal.pone.0243372	http://dx.doi.org/10.1371/journal.pone.0243372			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296394	Green Published, gold			2022-12-26	WOS:000598626100064
J	Saito, M; Itagaki, K; Sekiryu, T				Saito, Masaaki; Itagaki, Kanako; Sekiryu, Tetsuju			Fundus autofluorescence of retinal angiomatous proliferation	PLOS ONE			English	Article							NEAR-INFRARED AUTOFLUORESCENCE; COMBINED INTRAVITREAL RANIBIZUMAB; PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; NEOVASCULARIZATION; FLUORESCENCE; AFLIBERCEPT; LIPOFUSCIN; ATROPHY; RISK	Purpose The present study aimed to evaluate the characteristics of fundus autofluorescence in Japanese patients with retinal angiomatous proliferation (RAP). Methods We retrospectively reviewed 100 eyes from 76 patients (male, n = 45; female, n = 31; age range, 50-94 years; mean +/- standard deviation, 81.4 +/- 6.4 years) with treatment-naive RAP, which was diagnosed based on the identification of retinal-retinal anastomosis on early-phase fluorescein angiography or indocyanine green angiography (ICGA) and the identification of a hot spot on late-phase ICGA. RAP was classified into the following three stages: stage 1, proliferation of intraretinal capillaries originating from the deep retinal complex (intraretinal neovascularization); stage 2, growth of the retinal vessels into the subretinal space (subretinal neovascularization); and stage 3, clinically or angiographically observed choroidal neovascularization. In all cases, short-wavelength and near-infrared autofluorescence (SW-AF, NIR-AF) was evaluated using a confocal scanning laser ophthalmoscope. Results The conditions of the 100 eyes were as follows: stage 1 RAP, n = 6 (6%); stage 2 RAP without retinal pigment epithelial detachment (PED), n = 40 (40%); stage 2 RAP with PED, n = 44 (44%); and stage 3 RAP, 10 (10%). On NIR-AF imaging, the number of abnormalities that were observed to correspond to the RAP lesions on ICGA (87 eyes, 87%) was significantly greater in comparison to SW-AF imaging (27 eyes, 27%). The mean follow-up period in all 76 patients was 39.2 months. In the 76 patients with unilateral disease, 21 (21%) eyes developed RAP in the fellow eye during the follow-up period. Among 18 eyes that were examined by both SW-AF and NIR-AF imaging before the onset of RAP lesions, NIR-AF imaging showed hypoautofluorescence in 15 (83%) eyes before the onset of RAP lesions. Conclusions SW-AF and NIR-AF abnormalities may be related to the dysfunction of the photoreceptor/retinal pigment epithelium complex. Hypoautofluorescence on NIR-AF imaging may accurately indicate the presence or onset of RAP lesions.	[Saito, Masaaki; Itagaki, Kanako; Sekiryu, Tetsuju] Fukushima Med Univ, Sch Med, Dept Ophthalmol, Fukushima, Japan; [Saito, Masaaki] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan	Fukushima Medical University; Hirosaki University	Saito, M (corresponding author), Fukushima Med Univ, Sch Med, Dept Ophthalmol, Fukushima, Japan.; Saito, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan.	masaaki@hirosaki-u.ac.jp	Saito, Masaaki/ABI-2783-2020	Saito, Masaaki/0000-0003-1494-6350				[Anonymous], 2016, CRIT CARE NURSE, V36, pe11; Bottoni F, 2005, ARCH OPHTHALMOL-CHIC, V123, P1644, DOI 10.1001/archopht.123.12.1644; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Cho HJ, 2015, AM J OPHTHALMOL, V159, P285, DOI 10.1016/j.ajo.2014.10.035; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Gross NE, 2005, RETINA-J RET VIT DIS, V25, P713, DOI 10.1097/00006982-200509000-00005; Hartnett ME, 1996, OPHTHALMOLOGY, V103, P2042, DOI 10.1016/S0161-6420(96)30389-8; Hasegawa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106507; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Kellner U, 2010, RETINA-J RET VIT DIS, V30, P6, DOI 10.1097/IAE.0b013e3181b8348b; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Matsumoto H, 2016, RETINA-J RET VIT DIS, V36, P2282, DOI 10.1097/IAE.0000000000001104; Matsumoto H, 2010, RETINA-J RET VIT DIS, V30, P425, DOI 10.1097/IAE.0b013e3181bd2d95; McBain VA, 2011, RETINA-J RET VIT DIS, V31, P1043, DOI 10.1097/IAE.0b013e3181fe54c7; Montero JA, 2009, BRIT J OPHTHALMOL, V93, P166, DOI 10.1136/bjo.2008.141903; Piccolino FC, 1996, OPHTHALMOLOGY, V103, P1837; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saito M, 2016, JPN J OPHTHALMOL, V60, P42, DOI 10.1007/s10384-015-0417-x; Saito M, 2013, JPN J OPHTHALMOL, V57, P211, DOI 10.1007/s10384-012-0215-7; Saito M, 2012, AM J OPHTHALMOL, V153, P504, DOI 10.1016/j.ajo.2011.08.038; Saito M, 2010, AM J OPHTHALMOL, V149, P472, DOI 10.1016/j.ajo.2009.09.016; Saito M, 2008, AM J OPHTHALMOL, V146, P935, DOI 10.1016/j.ajo.2008.06.033; Sekiryu T, 2010, INVEST OPHTH VIS SCI, V51, P4956, DOI 10.1167/iovs.09-5009; Spaide RF, 2020, OPHTHALMOLOGY, V127, P616, DOI 10.1016/j.ophtha.2019.11.004; Sutter FK, 2006, KLIN MONATSBL AUGENH, V223, P376, DOI 10.1055/s-2006-926564; Toju R, 2012, AM J OPHTHALMOL, V153, P314, DOI 10.1016/j.ajo.2011.06.026; VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407; vonRuckmann A, 1997, ARCH OPHTHALMOL-CHIC, V115, P609, DOI 10.1001/archopht.1997.01100150611006; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yannuzzi LA, 2010, DEGENERATION AGE REL, P592	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243458	10.1371/journal.pone.0243458	http://dx.doi.org/10.1371/journal.pone.0243458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296421	gold, Green Published			2022-12-26	WOS:000598626100060
J	Scherr, T; Loffler, K; Bohland, M; Mikut, R				Scherr, Tim; Loeffler, Katharina; Boehland, Moritz; Mikut, Ralf			Cell segmentation and tracking using CNN-based distance predictions and a graph-based matching strategy	PLOS ONE			English	Article							NUCLEUS SEGMENTATION	The accurate segmentation and tracking of cells in microscopy image sequences is an important task in biomedical research, e.g., for studying the development of tissues, organs or entire organisms. However, the segmentation of touching cells in images with a low signal-to-noise-ratio is still a challenging problem. In this paper, we present a method for the segmentation of touching cells in microscopy images. By using a novel representation of cell borders, inspired by distance maps, our method is capable to utilize not only touching cells but also close cells in the training process. Furthermore, this representation is notably robust to annotation errors and shows promising results for the segmentation of microscopy images containing in the training data underrepresented or not included cell types. For the prediction of the proposed neighbor distances, an adapted U-Net convolutional neural network (CNN) with two decoder paths is used. In addition, we adapt a graph-based cell tracking algorithm to evaluate our proposed method on the task of cell tracking. The adapted tracking algorithm includes a movement estimation in the cost function to re-link tracks with missing segmentation masks over a short sequence of frames. Our combined tracking by detection method has proven its potential in the IEEE ISBI 2020 Cell Tracking Challenge () where we achieved as team KIT-Sch-GE multiple top three rankings including two top performances using a single segmentation model for the diverse data sets.	[Scherr, Tim; Loeffler, Katharina; Boehland, Moritz; Mikut, Ralf] Karlsruhe Inst Technol, Inst Automat & Appl Informat, Eggenstein Leopoldshafen, Germany; [Loeffler, Katharina] Karlsruhe Inst Technol, Inst Biol & Chem Syst Biol Informat Proc, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Scherr, T (corresponding author), Karlsruhe Inst Technol, Inst Automat & Appl Informat, Eggenstein Leopoldshafen, Germany.	tim.scherr@kit.edu	Mikut, Ralf/A-5949-2013	Mikut, Ralf/0000-0001-9100-5496; Scherr, Tim/0000-0001-8755-2825; Bohland, Moritz/0000-0002-9321-8169; Loffler, Katharina/0000-0001-9769-3517	Helmholtz Association in the programs BioInterfaces in Technology and Medicine; Helmholtz Information & Data Science School for Health; KIT-Publication Fund of the Karlsruhe Institute of Technology	Helmholtz Association in the programs BioInterfaces in Technology and Medicine(Helmholtz Association); Helmholtz Information & Data Science School for Health; KIT-Publication Fund of the Karlsruhe Institute of Technology	We are grateful for funding by the Helmholtz Association in the programs BioInterfaces in Technology and Medicine (TS, RM) and the Helmholtz Information & Data Science School for Health (KL, RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support by the KIT-Publication Fund of the Karlsruhe Institute of Technology.	Caicedo JC, 2019, NAT METHODS, V16, P1247, DOI 10.1038/s41592-019-0612-7; Chhetri RK, 2015, NAT METHODS, V12, P1171, DOI 10.1038/nmeth.3632; Ciaparrone G, 2020, NEUROCOMPUTING, V381, P61, DOI 10.1016/j.neucom.2019.11.023; Dendorfer P., 2019, CVPR19 TRACKING DETE; Graham S, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101563; He T, 2017, IMAGE VISION COMPUT, V60, P142, DOI 10.1016/j.imavis.2016.11.010; Hollandi R, 2020, CELL SYST, V10, P453, DOI 10.1016/j.cels.2020.04.003; Huang CB, 2020, IEEE ACCESS, V8, P110189, DOI 10.1109/ACCESS.2020.3001571; Khairy K, 2011, GENESIS, V49, P488, DOI 10.1002/dvg.20698; KingmaDP BaJL, 2015, P INT C LEARN REPRES; Kobitski AY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08601; Kuglin C. D., 1975, Proceedings of the 1975 International Conference on Cybernetics and Society, P163; Li JH, 2019, LECT NOTES COMPUT SC, V11492, P394, DOI 10.1007/978-3-030-20351-1_30; Li XL, 2019, IEEE ACCESS, V7, P84040, DOI 10.1109/ACCESS.2019.2924744; Ljosa V, 2012, NAT METHODS, V9, P637, DOI 10.1038/nmeth.2083; Magnusson KEG, 2015, IEEE T MED IMAGING, V34, P911, DOI 10.1109/TMI.2014.2370951; Maska M, 2014, BIOINFORMATICS, V30, P1609, DOI 10.1093/bioinformatics/btu080; Matula P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144959; Moshkov N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61808-3; Padfield D, 2011, MED IMAGE ANAL, V15, P650, DOI 10.1016/j.media.2010.07.006; Payer C, 2019, MED IMAGE ANAL, V57, P106, DOI 10.1016/j.media.2019.06.015; Pena FAG, 2020, 2020 IEEE 17 INT S B, P1; Pont-Tuset J, 2018, 2017 DAVIS CHALLENGE; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Scherr T, 2018, P WORKSHOP COMPUT IN, V28, P175; Schott B, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006128; Sixta T, 2020, MACH VISION APPL, V31, DOI 10.1007/s00138-020-01072-7; Stegmaier J., 2017, NEW METHODS IMPROVE; Stegmaier J, 2016, I S BIOMED IMAGING, P684, DOI 10.1109/ISBI.2016.7493359; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Svoboda D, 2009, CYTOM PART A, V75A, P494, DOI 10.1002/cyto.a.20714; Ulman V, 2017, NAT METHODS, V14, P1141, DOI 10.1038/nmeth.4473; Vicar T, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2880-8; Wolff C, 2018, ELIFE, V7, DOI 10.7554/eLife.34410; Xu Ning, 2018, YOUTUBE VOS LARGE SC; Yao R, 2020, ACM T INTEL SYST TEC, V11, DOI 10.1145/3391743	36	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243219	10.1371/journal.pone.0243219	http://dx.doi.org/10.1371/journal.pone.0243219			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290432	Green Published, Green Submitted, gold			2022-12-26	WOS:000598620100027
J	Myers-Hansen, JL; Abuaku, B; Oyebola, MK; Mensah, BA; Ahorlu, C; Wilson, MD; Awandare, G; Koram, KA; Ngwa, AA; Ghansah, A				Myers-Hansen, James L.; Abuaku, Benjamin; Oyebola, Muyiwa K.; Mensah, Benedicta A.; Ahorlu, Collins; Wilson, Michael D.; Awandare, Gordon; Koram, Kwadwo A.; Ngwa, Alfred Amambua; Ghansah, Anita			Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; CHLOROQUINE-RESISTANCE; ARTEMISININ RESISTANCE; DIHYDROFOLATE-REDUCTASE; MALARIA TRANSMISSION; DIHYDROARTEMISININ-PIPERAQUINE; DIHYDROPTEROATE SYNTHASE; ARTEMETHER-LUMEFANTRINE; AMODIAQUINE RESISTANCE; TREATMENT FAILURE	Background Drug resistance remains a concern for malaria control and elimination. The effect of interventions on its prevalence needs to be monitored to pre-empt further selection. We assessed the prevalence of Plasmodium falciparum gene mutations associated with resistance to the antimalarial drugs: sulfadoxine-pyrimethamine (SP), chloroquine (CQ) and artemisinin combination therapy (ACTs) after the scale-up of a vector control activity that reduced transmission. Methods A total of 400 P. falciparum isolates from children under five years were genotyped for seventeen single nucleotide polymorphisms (SNPs) in pfcrt, pfmdr1, pfdhfr, pfdhps and pfk13 genes using polymerase chain reaction (PCR) and high resolution melting (HRM) analysis. These included 80 isolates, each randomly selected from cross-sectional surveys of asymptomatic infections across 2010 (baseline), 2011, 2012, 2013 (midline: post-IRS) and 2014 (endline: post-IRS) during the peak transmission season, when IRS intervention was rolled out in Bunkpurugu Yunyoo (BY) District, Ghana. The proportions of isolates with drug resistant alleles were assessed over this period. Results There were significant decreases in the prevalence of pfdhfr- I51R59N108 haplotype from 2010 to 2014, while the decline in pfdhfr/pfdhps- I(51)R(59)N(108)G(437) during the same period was not significant. The prevalence of lumefantrine (LM), mefloquine (MQ) and amodiaquine (AQ) resistance-associated haplotypes pfmdr1-N86F184D1246 and pfmdr1-Y86Y184Y1246 showed decreasing trends (z = -2.86, P = 0.004 and z = -2.71, P = 0.007, respectively). Each of pfcrt-T76 and pfmdr1-Y86 mutant alleles also showed a declining trend in the asymptomatic reservoir, after the IRS rollout in 2014 (z = -2.87, P = 0.004 and z = -2.65, P = 0.008, respectively). Similarly, Pyrimethamine resistance mediating polymorphisms pfdhfr-N108, pfdhfr-I51 and pfdhfr-R59 also declined (z = -2.03, P = 0.042, z = -3.54, P<0.001 and z = -4.63, P<0.001, respectively), but not the sulphadoxine resistance mediating pfdhps-G437 and pfdhps-F436 (z = -0.36, P = 0.715 and z = 0.41, P = 0.684, respectively). No mutant pfk13-Y580 were detected during the study period. Conclusion The study demonstrated declining trends in the prevalence of drug resistant mutations in asymptomatic P. falciparum infections following transmission reduction after an enhanced IRS intervention in Northern Ghana.	[Myers-Hansen, James L.; Abuaku, Benjamin; Mensah, Benedicta A.; Ahorlu, Collins; Wilson, Michael D.; Koram, Kwadwo A.; Ghansah, Anita] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Oyebola, Muyiwa K.; Awandare, Gordon] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana; [Ngwa, Alfred Amambua] Gambia LSHTM, Med Res Council Unit, Banjul, Gambia	University of Ghana; University of Ghana; University of London; London School of Hygiene & Tropical Medicine	Ghansah, A (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana.	aghansah@noguchi.ug.edu.gh	; Ahorlu, Collins/H-5866-2016	Awandare, Gordon/0000-0002-8793-3641; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Ahorlu, Collins/0000-0001-8116-3984; Myers-Hansen, James Leslie/0000-0001-7125-1673; OYEBOLA, KOLAPO/0000-0002-1003-2570	African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107740/Z/15/Z]; UK government	African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	AG, AAN and LAE-DELTAS Africa Initiative an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DELGEME Grant #107740/Z/15/Z] and the UK government.	Abuaku B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2848-1; Abuaku B, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3130-z; Afari Edwin A., 1995, Afr J Health Sci, V2, P312; Afriyie DK, 2015, J INFECT DEV COUNTR, V9, P409, DOI 10.3855/jidc.5578; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Alifrangis M, 2003, AM J TROP MED HYG, V69, P238, DOI 10.4269/ajtmh.2003.69.238; Amato R, 2018, LANCET INFECT DIS, V18, P337, DOI [10.1016/S1473-3099(18)30068-9, 10.1016/s1473-3099(18)30068-9]; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; [Anonymous], 2015, J INT ASS PROVIDE S1, V14, pS3; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; [Anonymous], 2018, VOX             0919; [Anonymous], 2016, THE TOTAL AUDIENCE R; Apinjoh TO, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0350-y; Ariey F, 2003, TRENDS PARASITOL, V19, P158, DOI 10.1016/S1471-4922(03)00054-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; BABIKER HA, 1995, AM J TROP MED HYG, V53, P7, DOI 10.4269/ajtmh.1995.53.7; Babiker HA, 2001, J INFECT DIS, V183, P1535, DOI 10.1086/320195; Bacon DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006762; Baraka V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191922; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Boussaroque A, 2016, ANTIMICROB AGENTS CH, V60, P624, DOI 10.1128/AAC.01346-15; Brasil. Ministerio da Saude, 2014, GUID BAL NUTR IND, P1; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chhibber-Goel J, 2019, INT J PARASITOL-DRUG, V11, P49, DOI 10.1016/j.ijpddr.2019.10.001; Coalson JE, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2295-4; Conrad MD, 2014, J INFECT DIS, V210, P344, DOI 10.1093/infdis/jiu141; Daniels R, 2012, ANTIMICROB AGENTS CH, V56, P2976, DOI 10.1128/AAC.05737-11; Danquah I, 2010, ACTA TROP, V114, P63, DOI 10.1016/j.actatropica.2009.12.008; Diallo DA, 2007, AM J TROP MED HYG, V76, P237, DOI 10.4269/ajtmh.2007.76.237; Duah NO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-377; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Froeschl G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2389-z; Ghana Health Service, 2016, NAT MAL CONTR PROGR, P1; Ghana Health Service G, 2015, NAT MAL CONTR PROGR; Ghana Statistical Sercive G Ghana Health Service G ICF, 2017, GHAN MAL IND SURV 20; Ghana Statistical Service G Ghana Health Service G ICF I, 2015, GHAN DEM HLTH SURV 2; Goncalves BP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01270-4; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hankins EG, 2001, MOL BIOCHEM PARASIT, V117, P91, DOI 10.1016/S0166-6851(01)00335-8; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Hyde JE, 2002, MICROBES INFECT, V4, P165, DOI 10.1016/S1286-4579(01)01524-6; Jiang TT, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2734-x; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Katureebe A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002167; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Li J, 2016, INT J PARASITOL-DRUG, V6, P54, DOI 10.1016/j.ijpddr.2015.11.002; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; Malmberg M, 2013, J INFECT DIS, V207, P842, DOI 10.1093/infdis/jis747; Matrevi SA, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00802-19; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Mensah BA, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01423-19; Mharakurwa S, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-35; Ministry of Health, 2014, GUID CAS MAN MAL GHA, P1; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P901, DOI 10.1111/j.1365-3156.2005.01471.x; Mukherjee A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1845-5; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; Oguike MC, 2016, INT J PARASITOL-DRUG, V6, P220, DOI 10.1016/j.ijpddr.2016.08.004; Ord R, 2007, J INFECT DIS, V196, P1613, DOI 10.1086/522154; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Raman J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025992; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349; SCHMIDT KF, 1995, SCIENCE, V269, P1670, DOI 10.1126/science.7569890; Shah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026746; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Tinto H, 2008, TROP MED INT HEALTH, V13, P238, DOI 10.1111/j.1365-3156.2007.01995.x; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Voumbo-Matoumona DF, 2018, INFECT DRUG RESIST, V11, P1329, DOI 10.2147/IDR.S160164; Warhurst DC, 2001, NEW ENGL J MED, V344, P299, DOI 10.1056/NEJM200101253440411; WERNSDORFER WH, 1994, ACTA TROP, V56, P143, DOI 10.1016/0001-706X(94)90060-4; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2019, WORLD MALARIA REPORT; Wurtz N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-197; 2018, CURR OPIN TOXICOL, V10	96	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0233478	10.1371/journal.pone.0233478	http://dx.doi.org/10.1371/journal.pone.0233478			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284800	Green Published, gold			2022-12-26	WOS:000597930500029
J	McGehee, AJ; Bhattacharya, S; Roche, R; Bhattacharya, D				McGehee, Andrew J.; Bhattacharya, Sutanu; Roche, Rahmatullah; Bhattacharya, Debswapna			PolyFold: An interactive visual simulator for distance-based protein folding	PLOS ONE			English	Article							STRUCTURE PREDICTION; STRUCTURE RECONSTRUCTION; NEURAL-NETWORKS	Recent advances in distance-based protein folding have led to a paradigm shift in protein structure prediction. Through sufficiently precise estimation of the inter-residue distance matrix for a protein sequence, it is now feasible to predict the correct folds for new proteins much more accurately than ever before. Despite the exciting progress, a dedicated visualization system that can dynamically capture the distance-based folding process is still lacking. Most molecular visualizers typically provide only a static view of a folded protein conformation, but do not capture the folding process. Even among the selected few graphical interfaces that do adopt a dynamic perspective, none of them are distance-based. Here we present PolyFold, an interactive visual simulator for dynamically capturing the distance-based protein folding process through real-time rendering of a distance matrix and its compatible spatial conformation as it folds in an intuitive and easy-to-use interface. PolyFold integrates highly convergent stochastic optimization algorithms with on-demand customizations and interactive manipulations to maximally satisfy the geometric constraints imposed by a distance matrix. PolyFold is capable of simulating the complex process of protein folding even on modest personal computers, thus making it accessible to the general public for fostering citizen science. Open source code of PolyFold is freely available for download at . It is implemented in cross-platform Java and binary executables are available for macOS, Linux, and Windows.	[McGehee, Andrew J.; Bhattacharya, Sutanu; Roche, Rahmatullah; Bhattacharya, Debswapna] Auburn Univ, Dept Comp Sci & Software Engn, Auburn, AL 36849 USA; [Bhattacharya, Debswapna] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Bhattacharya, D (corresponding author), Auburn Univ, Dept Comp Sci & Software Engn, Auburn, AL 36849 USA.; Bhattacharya, D (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	bhattacharya@aubum.edu	Bhattacharya, Sutanu/CAH-3444-2022		National Science Foundation CAREER Award [DBI1942692]; National Science Foundation [IIS-2030722]; National Institute of General Medical Sciences Maximizing Investigators' Research Award (MIRA) [R35GM138146]	National Science Foundation CAREER Award(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences Maximizing Investigators' Research Award (MIRA)	This work was partially supported by the National Science Foundation CAREER Award DBI1942692 to DB, the National Science Foundation grant IIS-2030722 to DB, and the National Institute of General Medical Sciences Maximizing Investigators' Research Award (MIRA) R35GM138146 to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriata LA, 2019, PROTEINS, V87, P1100, DOI 10.1002/prot.25787; Adolf-Bryfogle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066856; [Anonymous], 2019, FRONTIERS PLANT SCI; ASZODI A, 1995, J MOL BIOL, V251, P308, DOI 10.1006/jmbi.1995.0436; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Heffernan R, 2017, BIOINFORMATICS, V33, P2842, DOI 10.1093/bioinformatics/btx218; Hou J, 2019, PROTEINS, V87, P1165, DOI 10.1002/prot.25697; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kleffner R, 2017, BIOINFORMATICS, V33, P2765, DOI 10.1093/bioinformatics/btx283; Kloczkowski Andrzej, 2009, Journal of Structural and Functional Genomics, V10, P67, DOI 10.1007/s10969-009-9062-2; Kryshtafovych A, 2019, PROTEINS, V87, P1011, DOI 10.1002/prot.25823; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li XM, 2007, ICNC 2007: Third International Conference on Natural Computation, Vol 4, Proceedings, P256; Lund O, 1996, PROTEIN SCI, V5, P2217, DOI 10.1002/pro.5560051108; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietal MJ, 2015, BIOINFORMATICS, V31, P3499, DOI 10.1093/bioinformatics/btv390; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruder S., 2017, ARXIV160904747; Schenkelberg CD, 2015, BIOINFORMATICS, V31, P4023, DOI 10.1093/bioinformatics/btv492; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Senior AW, 2019, PROTEINS, V87, P1141, DOI 10.1002/prot.25834; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Vassura M, 2008, BIOINFORMATICS, V24, P1313, DOI 10.1093/bioinformatics/btn115; Vassura M, 2007, LECT N BIOINFORMAT, V4463, P578; Xu JB, 2019, PROTEINS, V87, P1069, DOI 10.1002/prot.25810; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang CX, 2020, BIOINFORMATICS, V36, P2105, DOI 10.1093/bioinformatics/btz863; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhao F, 2008, PROTEINS, V73, P228, DOI 10.1002/prot.22057	38	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243331	10.1371/journal.pone.0243331	http://dx.doi.org/10.1371/journal.pone.0243331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270805	Green Published, gold, Green Submitted			2022-12-26	WOS:000597149100163
J	Mogensen, I; Jacinto, T; Alving, K; Fonseca, JA; Janson, C; Malinovschi, A				Mogensen, Ida; Jacinto, Tiago; Alving, Kjell; Fonseca, Joao A.; Janson, Christer; Malinovschi, Andrei			Inflammatory patterns in fixed airflow obstruction are dependent on the presence of asthma	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; REFERENCE VALUES; BLOOD; OBESITY; DETERMINANTS; EOSINOPHILIA; LIMITATION; PHENOTYPES; SMOKING; DECLINE	Rationale Fixed airflow obstruction (FAO) can complicate asthma. Inflammation is a proposed underlying mechanism. Objective Our aim in this cross-sectional investigation was to evaluate the blood leucocyte pattern and level of exhaled nitric oxide in asthmatics and non-asthmatics with or without FAO. Methods A total of 11,579 individuals aged >= 20 years from the US National Health and Nutrition Examination Survey were included. They were grouped as: controls without asthma and FAO (n = 9,935), asthmatics without FAO (n = 674), asthmatics with FAO (n = 180) and non-asthmatics with FAO (n = 790). FAO was defined as post-bronchodilator FEV1/FVC < lower limit of normal. Exhaled nitric oxide >= 25ppb, blood eosinophil levels >= 300 cells/mu L, and blood neutrophil levels >= 5100 cells/mu L were defined as elevated. Stratified analyses for smoking and smoking history were performed. Results Elevated blood eosinophil levels were more common in all groups compared to the controls, with the highest prevalence in the group with asthma and fixed airflow obstruction (p<0.01). In a multiple logistic regression model adjusted for potential confounders including smoking, the asthma groups had significantly higher odds ratios for elevated B-Eos levels compared to the control group (odds ratio 1.4, (confidence interval: 1.1-1.7) for the asthma group without fixed airflow obstruction and 2.5 (1.4-4.2) for the asthma group with fixed airflow obstruction). The group with fixed airflow obstruction without asthma had higher odds ratio for elevated blood neutrophil levels compared to the controls: 1.4 (1.1-1.8). Smoking and a history of smoking were associated to elevated B-Neu levels. Conclusion Fixed airflow obstruction in asthma was associated with elevated blood eosinophil levels, whereas fixed airflow obstruction without asthma was associated with elevated blood neutrophil levels.	[Mogensen, Ida; Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden; [Mogensen, Ida; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Jacinto, Tiago; Fonseca, Joao A.] Univ Porto, Fac Med, CINTESIS, Porto, Portugal; [Jacinto, Tiago; Fonseca, Joao A.] Inst & Hosp CUF, Porto, Portugal; [Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth, Pediat Res, Uppsala, Sweden	Uppsala University; Universidade do Porto; Uppsala University	Mogensen, I (corresponding author), Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden.; Mogensen, I (corresponding author), Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden.	ida.mogensen@medsci.uu.se	Jacinto, Tiago/G-9826-2014; Fonseca, João A./B-7562-2008	Jacinto, Tiago/0000-0002-7897-1101; Fonseca, João A./0000-0002-0887-8796	U4 Network (Uppsala University); Bror Hjerpstedts Stiftelse; Swedish Heart-Lung Foundation; Uppsala City Council	U4 Network (Uppsala University); Bror Hjerpstedts Stiftelse; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Uppsala City Council	The U4 Network (Uppsala University), financial support and salary for Ida Mogensen (IM) Uppsala City Council, financial support Bror Hjerpstedts Stiftelse, financial support The Swedish Heart-Lung Foundation, travel grants (IM) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2013, 2013PEDIATRICS, V132, pe1089; Backman H, 2018, RESP MED, V138, P115, DOI 10.1016/j.rmed.2018.03.036; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Chalmers GW, 2001, CHEST, V120, P1917, DOI 10.1378/chest.120.6.1917; CHANYEUNG M, 1988, THORAX, V43, P462, DOI 10.1136/thx.43.6.462; Coumou H, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01785-2017; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Desai D, 2013, AM J RESP CRIT CARE, V188, P657, DOI 10.1164/rccm.201208-1470OC; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Ferreira DS, 2018, ALLERGY, V73, P635, DOI 10.1111/all.13323; FRETTE C, 1991, AM REV RESPIR DIS, V143, P987, DOI 10.1164/ajrccm/143.5_Pt_1.987; Giovannelli J, 2015, CLIN EXP ALLERGY; Hancox RJ, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02536-2017; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hartjes FJ, 2018, RESPIROLOGY, V23, P1023, DOI 10.1111/resp.13312; Higuchi Takakazu, 2016, Prev Med Rep, V4, P417, DOI 10.1016/j.pmedr.2016.08.009; Jacinto T, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa746b; Jacinto T, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/3/036005; KHARITONOV SA, 1995, AM J RESP CRIT CARE, V152, P609, DOI 10.1164/ajrccm.152.2.7543345; Konstantellou E, 2015, RESP MED, V109, P1404, DOI 10.1016/j.rmed.2015.09.009; Lamprecht B, 2015, CHEST, V148, P971, DOI 10.1378/chest.14-2535; Lezmi G, 2018, CLIN EXP ALLERGY, V48, P806, DOI 10.1111/cea.13143; Mansur AH, 2018, RESP MED, V143, P31, DOI 10.1016/j.rmed.2018.08.005; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; Mogensen I, 2018, CLIN EXP ALLERGY, V48, P935, DOI 10.1111/cea.13137; Mogensen I, 2019, CLIN EXP ALLERGY, V49, P155, DOI 10.1111/cea.13302; Nadif R, 2016, EUR RESPIR J, V48, P1040, DOI 10.1183/13993003.00336-2016; Nerpin E, 2018, RESP MED, V142, P94, DOI 10.1016/j.rmed.2018.07.011; NHANES, 2012, **NON-TRADITIONAL**; NHANES, 2008, NAT HLTH NUTR EX SUR; Olin AC, 2006, CHEST, V130, P1319, DOI 10.1378/chest.130.5.1319; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; Rutgers SR, 2000, EUR RESPIR J, V15, P109, DOI 10.1183/09031936.00.15110900; Rutting S, 2020, J APPL PHYSIOL, V128, P168, DOI 10.1152/japplphysiol.00482.2019; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Schleich F, 2014, RESP MED, V108, P1723, DOI 10.1016/j.rmed.2014.10.007; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; SIMMONS A, 1974, J CLIN PATHOL, V27, P55, DOI 10.1136/jcp.27.1.55; Sunyer J, 2003, CLIN EXP ALLERGY, V33, P1500, DOI 10.1046/j.1365-2222.2003.01730.x; Telenga ED, 2012, ALLERGY, V67, P1060, DOI 10.1111/j.1398-9995.2012.02855.x; ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744, DOI 10.1164/ajrccm.164.5.2011026; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Tran TN, 2014, ANN ALLERG ASTHMA IM, V113, P19, DOI 10.1016/j.anai.2014.04.011; Utokaparch S, 2014, COPD, V11, P197, DOI 10.3109/15412555.2013.836166; Wang XB, 2004, AM J RESP CRIT CARE, V169, P941, DOI 10.1164/rccm.2201011; Zeig-Owens R, 2018, ANN AM THORAC SOC, V15, P173, DOI 10.1513/AnnalsATS.201703-276OC	48	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243109	10.1371/journal.pone.0243109	http://dx.doi.org/10.1371/journal.pone.0243109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270766	gold, Green Published			2022-12-26	WOS:000597149100095
J	Nyadanu, D; Lowor, ST; Akpertey, A; Tchokponhoue, DA; Pobee, P; Dogbatse, JA; Okyere, D; Amon-Armah, F; Brako-Marfo, M				Nyadanu, Daniel; Lowor, Samuel Tetteh; Akpertey, Abraham; Tchokponhoue, Dedeou Apocalypse; Pobee, Prince; Dogbatse, Jerome Agbesi; Okyere, Daniel; Amon-Armah, Frederick; Brako-Marfo, Micheal			Genetic variability of bioactive compounds and selection for nutraceutical quality in kola [Cola nitida (Vent) Schott. and Endl.]	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDS; ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; EGGPLANT FRUIT; L.; STRAWBERRY; DIVERSITY; TRAITS; COLLECTION; PARAMETERS	Cola nitida known as Kola serves as flavouring ingredient in the food industry and is also of great importance during traditional rites in Africa. Despite the well-known pharmaceutical values of the species, efforts to develop improved varieties with enhanced nutraceutical quality is limited due to unavailability of information on variation of genotypes in bioactive compounds in the nuts. The objectives of this research were to evaluate 25 genotypes of kola for bioactive contents, determine relationship between nutritional and phenolic traits and to identify kola genotypes with good nutraceutical quality for use in developing improved varieties. The kola genotypes were established in the field using a randomized complete block design with three replicates. Nuts harvested from the blocks, were bulked and used to quantify soluble and insoluble sugars, total protein, moisture, ash, fats, pH, polyphenols, tannins and flavonoids using completely randomized design with three replicates in the laboratory. Data were analysed by combining Analysis of Variance, Kruskal-Wallis test, correlation test and multivariate analysis. Significant variations (P < 0.05) were observed among the kola genotypes for the bioactive traits evaluated. Phenolic traits were more heritable than nutritional traits. Although not significant (P > 0.05), correlation between nutritional and phenolic traits was negative, whereas correlations among nutritional traits were weak. On the contrary, significant and positive correlations (P < 0.05) were observed among phenolic traits. The hierarchical clustering analysis based on the traits evaluated grouped the 25 genotypes of kola evaluated into four clusters. Genotypes A12, JB4, JB19, JB36, P2-1b, and P2-1c were identified as potential parental lines for phenolic traits selection in kola whereas genotypes A10, Club, Atta1 and JB10 can be considered for soluble and insoluble sugar-rich variety development. These findings represent an important step towards improving nutritional and nutraceutical quality of kola nuts.	[Nyadanu, Daniel; Lowor, Samuel Tetteh; Akpertey, Abraham; Pobee, Prince; Dogbatse, Jerome Agbesi; Amon-Armah, Frederick; Brako-Marfo, Micheal] Cocoa Res Inst, New Tafo Akim, Ghana; [Tchokponhoue, Dedeou Apocalypse] Univ Abomey Calvi, Fac Agron Sci, Lab Genet Biotechnol & Seed Sci, Abomey Calavi, Benin; [Okyere, Daniel] Kwame Nkrumah Univ Sci & Technol, Dept Crop & Soil Sci, Kumasi, Ghana	University of Abomey Calavi; Kwame Nkrumah University Science & Technology	Nyadanu, D (corresponding author), Cocoa Res Inst, New Tafo Akim, Ghana.	dnyadanu@gmail.com	, Frederick/ABF-4841-2020	, Frederick/0000-0003-2696-6922; Nyadanu, Daniel/0000-0003-1674-7400; Tchokponhoue, Dedeou Apocalypse/0000-0002-1285-245X				Adebola P, 2003, GENETIC CHARACTERIZA; Adeyeye EI, 2007, INT J FOOD SCI NUTR, V58, P241, DOI 10.1080/09637480701486108; Adu MO, 2019, FIELD CROP RES, V232, P106, DOI 10.1016/j.fcr.2018.12.015; Akanitapichat P, 2010, FOOD CHEM TOXICOL, V48, P3017, DOI 10.1016/j.fct.2010.07.045; Akpertey A, 2017, SCI HORTIC-AMSTERDAM, V216, P264, DOI 10.1016/j.scienta.2017.01.018; Amon-Armah F, 2020, KOLA NUT IND GHANA P; [Anonymous], 2013, PT MOTION, V5, P10; Asogwa E. U., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P463; Atoyebi J. O., 2017, International Journal of Plant Research, V7, P29; Barzergar R, BIOCH SYST ECOL, V50, P187; Battino M, 2006, PUBLIC HEALTH NUTR, V9, P1099, DOI 10.1017/S1368980007668554; Belay G, 2008, AFR J AGR RES, V3, P22; Benor S, 2012, GENET RESOUR CROP EV, V59, P1125, DOI 10.1007/s10722-011-9748-8; Blades M., 2000, Nutrition & Food Science, P73, DOI 10.1108/00346650010314313; Burdock GA, 2009, FOOD CHEM TOXICOL, V47, P1725, DOI 10.1016/j.fct.2009.04.019; Capocasa F, 2008, BIOFACTORS, V34, P67, DOI 10.1002/biof.5520340107; Capocasa F, 2008, FOOD CHEM, V111, P872, DOI 10.1016/j.foodchem.2008.04.068; Chowdhury MA, 2002, EUPHYTICA, V127, P317, DOI 10.1023/A:1020366819075; Dadzie MA, 2013, USDA TECHNICAL B, P25; Dah-Nouvlessounon D., 2015, Food and Nutrition Sciences, V6, P1395, DOI 10.4236/fns.2015.615145; Dalda-Sekerci A, 2020, GENET RESOUR CROP EV, V67, P533, DOI 10.1007/s10722-020-00883-x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duke JA, 2000, HDB NUTS HERBAL REFE; Eka O. U., 1971, Journal of the West African Science Association, V16, P167; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fereday N, 1997, DOMESTIC MARKET POTE; Ferriol M, 2003, THEOR APPL GENET, V107, P271, DOI 10.1007/s00122-003-1242-z; Fontenot K, 2007, TOXICOL APPL PHARM, V220, P25, DOI 10.1016/j.taap.2006.12.012; Frary A, 2003, THEOR APPL GENET, V107, P359, DOI 10.1007/s00122-003-1257-5; Gerrano Abe S., 2015, South African Journal of Plant and Soil, V32, P165, DOI 10.1080/02571862.2015.1014435; Girish G., 2006, Environment and Ecology, V24S, P1172; Gomez L, 2002, J SCI FOOD AGR, V82, P360, DOI 10.1002/jsfa.1046; Jackson M. L., 1958, Soil Chemical Analysis.; Kafkas E, 2007, FOOD CHEM, V100, P1229, DOI 10.1016/j.foodchem.2005.12.005; Kassambara A., 2017, R PACKAGE VERSION, V1, P4; Kaushik P, 2017, FOOD RES INT, V102, P392, DOI 10.1016/j.foodres.2017.09.028; Kwarteng AO, 2018, SCI HORTIC-AMSTERDAM, V235, P124, DOI 10.1016/j.scienta.2018.02.046; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leakey R. R. B., 2007, INDIGENOUS FRUIT TRE; Leakey RRB, 1997, AGROFOREST SYST, V38, P165, DOI 10.1023/A:1005912729225; Lowor S. T., 2010, Agriculture and Biology Journal of North America, V1, P1206, DOI 10.5251/abjna.2010.1.6.1206.1214; Lowor ST, 2008, AFR J AGR RES, V3, P130; Malek MA, 2014, SCI WORLD J, DOI 10.1155/2014/968796; Nyadanu D, 2021, GENET RESOUR CROP EV, V68, P69, DOI 10.1007/s10722-020-01036-w; Nyadanu D, 2017, GENET RESOUR CROP EV, V64, P1313, DOI 10.1007/s10722-016-0438-4; Nyadanu D, 2012, EUPHYTICA, V188, P253, DOI 10.1007/s10681-012-0717-x; Nyadanu D, 2018, KOLA GERMPLASM COLLE, V2018/19, P195; Odebode AC, 1996, REV BIOL TROP, V44, P513; Olas B, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00078; Onomo P. E., 2006, Pakistan Journal of Biological Sciences, V9, P391, DOI 10.3923/pjbs.2006.391.397; Opeke L. K., 2005, TROPICAL COMMODITY T; Plazas M, 2013, J AGR FOOD CHEM, V61, P8871, DOI 10.1021/jf402429k; PRICE MR, 1978, CANCER IMMUNOL IMMUN, V3, P247; Prohens J, 2013, ANN APPL BIOL, V162, P242, DOI 10.1111/aab.12017; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; Pursglove J, 1969, TROPICAL CROPS DICOT; R Core Team, 2021, R LANGUAGE ENV STAT; Russell T. A., 1955, Tropical Agriculture, Trinidad and Tobago, V32, P210; Samoticha J, 2017, FOOD CHEM, V215, P263, DOI 10.1016/j.foodchem.2016.07.147; Sheeba A, 2019, ELECT J PLANT BREEDI, V10, P1441, DOI DOI 10.5958/0975-928X.2019.00185.6; Shukla S, 2006, PLANT FOOD HUM NUTR, V61, P23, DOI 10.1007/s11130-006-0004-x; Solipuram R, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/530279; Stommell JR, 2003, J AM SOC HORTIC SCI, V128, P704, DOI 10.21273/JASHS.128.5.0704; Tchokponhoue DA, COMP ANAL MANAGEMENT; Tongoona P., 2017, The business of plant breeding: market-led approaches to new variety design in Africa, P63, DOI 10.1079/9781786393814.0063; Topo E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-120; Tuberosa R, 2003, ABIOTIC STRESSES IN PLANTS, P71; Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959; Tulipani S, 2011, FOOD CHEM, V124, P906, DOI 10.1016/j.foodchem.2010.07.018; VL S, 1965, AM J ENOL VITICULT, V16, P114; WEILMALHERBE H, 1950, PHYSIOL REV, V30, P549, DOI 10.1103/PhysRev.80.549; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Witcombe JR, 2005, EXP AGR, V41, P299, DOI 10.1017/S0014479705002656; Woisky RG, 1998, J APICULT RES, V37, P99, DOI 10.1080/00218839.1998.11100961; 2009, ICLR, V11, P1; 2005, EMORY LAW J, V54, P42	76	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242972	10.1371/journal.pone.0242972	http://dx.doi.org/10.1371/journal.pone.0242972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270707	gold, Green Published			2022-12-26	WOS:000597149100008
J	Rajneesh, CP; Liou, JC; Hsieh, TH; Lin, JH; Peng, CW				Rajneesh, Chellappan Praveen; Liou, Jian-Chiun; Hsieh, Tsung-Hsun; Lin, Jia-Hong; Peng, Chih-Wei			The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections	PLOS ONE			English	Article							PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; BLADDER DYSFUNCTION; 6-HYDROXYDOPAMINE; PREVALENCE; SYMPTOMS; BEHAVIOR	Bladder dysfunction is a common phenomenon in Parkinson's disease (PD) patients. A research attempt was made to analyze the voiding efficiency (VE) and bladder functions in rats with PD induced by unilateral or bilateral injections of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle. PD rats were divided into unilateral- and bilateral-injected groups and subjected to rotation and beam walking tests. Further, the experimental rats underwent cystometric measurements for analyses of bladder dysfunction and VE. Immunohistochemical analysis was performed to analyze the dopaminergic neuron depletion on the target area. Outcomes of the rotation and beam walking tests revealed the extent of parkinsonism in the experimental rats. Urodynamic observations denoted that rats with unilateral PD exhibited a significantly decreased VE (from 68.3 +/- 3.5% to 32.7 +/- 5.8%), while rats with bilateral PD displayed a much-reduced and substantially lower level of VE of 18.3 +/- 5.1% compared to the control value and to that of rats with unilateral PD. Rats with bilateral PD showed more-extensive behavioral deficits and urodynamic changes than did rats with unilateral PD. These significant changes in motor, behavioral, bladder function and VE were due to an extensive degeneration of dopaminergic neurons in the substantia nigra region on both sides of the brain. The obtained results were substantiated with appropriate immunohistochemical results.	[Rajneesh, Chellappan Praveen; Liou, Jian-Chiun; Lin, Jia-Hong; Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Linkou, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Res Ctr Biomed Device, Taipei, Taiwan	Taipei Medical University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University	Peng, CW (corresponding author), Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Res Ctr Biomed Device, Taipei, Taiwan.	cwpeng@tmu.edu.tw		Peng, Chih-Wei/0000-0001-9744-4094	Taiwan Ministry of Science and Technology [109-2314-B-038-132, MOST106-2221-E-038010-MY3, 109-2221-E-038-005-MY3]; Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan [DP2-109-21121-01N-02-01]	Taiwan Ministry of Science and Technology; Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	This study was supported by grants from the Taiwan Ministry of Science and Technology (109-2314-B-038-132, MOST106-2221-E-038010-MY3, and 109-2221-E-038-005-MY3) and the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (DP2-109-21121-01N-02-01) to C.W. Peng.	Allbutt HN, 2007, J NEUROSCI METH, V159, P195, DOI 10.1016/j.jneumeth.2006.07.006; Araki I, 2000, J NEUROL NEUROSUR PS, V68, P429, DOI 10.1136/jnnp.68.4.429; Araki I, 2000, J UROLOGY, V164, P1640, DOI 10.1016/S0022-5347(05)67048-6; Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; BRUNO JP, 1986, BEHAV NEUROSCI, V100, P125, DOI 10.1037/0735-7044.100.1.125; Campos-Sousa RN, 2003, ARQ NEURO-PSIQUIAT, V61, P359, DOI 10.1590/S0004-282X2003000300007; Cannon JR, 2005, NEUROSCI LETT, V373, P189, DOI 10.1016/j.neulet.2004.10.089; Carvalho MM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-14; DEGROAT WC, 1993, NERVOUS CONTROL UROG, P227; Fang X, 2006, BRAIN RES, V1120, P202, DOI 10.1016/j.brainres.2006.08.073; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Horning MA, 2019, APPL NURS RES, V50, DOI 10.1016/j.apnr.2019.151193; Hsieh TH, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046001; Hsieh TH, 2011, BEHAV BRAIN RES, V222, P1, DOI 10.1016/j.bbr.2011.03.031; Liu X, 2002, CLIN NEUROPHYSIOL, V113, P1667, DOI 10.1016/S1388-2457(02)00256-0; MALLORY BS, 1991, BRAIN RES, V546, P310, DOI 10.1016/0006-8993(91)91495-M; Margolesky J, 2020, CLIN GERIATR MED, V36, P69, DOI 10.1016/j.cger.2019.09.011; PAPA SM, 1994, BRAIN RES, V662, P69, DOI 10.1016/0006-8993(94)90796-X; Peng CW, 2006, NEUROUROL URODYNAM, V25, P388, DOI 10.1002/nau.20229; Rajneesh CP, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110325; Rajneesh CP, 2019, INT UROL NEPHROL, V51, P41, DOI 10.1007/s11255-018-2028-1; Sakakibara R, 2001, AUTON NEUROSCI-BASIC, V92, P76, DOI 10.1016/S1566-0702(01)00295-8; Soler R, 2011, NEUROUROL URODYNAM, V30, P188, DOI 10.1002/nau.20917; Stocchi F, 1997, J NEUROL NEUROSUR PS, V62, P507, DOI 10.1136/jnnp.62.5.507; Terayama K, 2012, MOVEMENT DISORD, V27, P1775, DOI 10.1002/mds.25225; Truong L, 2006, BEHAV BRAIN RES, V169, P1, DOI 10.1016/j.bbr.2005.11.026; Uchiyama T, 2011, J NEUROL NEUROSUR PS, V82, P1382, DOI 10.1136/jnnp.2011.241075; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; WATANABE H, 1979, JPN J PHARMACOL, V29, P93, DOI 10.1254/jjp.29.93; Winge K, 2006, MOVEMENT DISORD, V21, P737, DOI 10.1002/mds.20867; Xu D, 2019, PARKINSONS DIS-US, V2019, DOI 10.1155/2019/6820937; Yoon MC, 2007, NEUROSCI LETT, V423, P12, DOI 10.1016/j.neulet.2007.06.031; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243452	10.1371/journal.pone.0243452	http://dx.doi.org/10.1371/journal.pone.0243452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270757	gold, Green Published			2022-12-26	WOS:000597149100164
J	Koehler, A; Corbellini, VA; Heidrich, D; Scroferneker, ML				Koehler, Alessandra; Corbellini, Valeriano Antonio; Heidrich, Daiane; Scroferneker, Maria Lucia			Prediction of itraconazole minimum inhibitory concentration for Fonsecaea pedrosoi using Fourier Transform Infrared Spectroscopy (FTIR) and chemometrics	PLOS ONE			English	Article							IDENTIFICATION; SUSCEPTIBILITY; CHROMOBLASTOMYCOSIS; MICROSCOPY	Fonsecaea pedrosoi is one of the main agents of chromoblastomycosis, a chronic subcutaneous mycosis. Itraconazole (ITC) is the most used antifungal in its treatment, however, in vitro antifungal susceptibility tests are important to define the best therapy. These tests are standardized by the Clinical and Laboratory Standards Institute (CLSI), but these protocols have limitations such as the high complexity, cost and time to conduct. An alternative to in vitro susceptibility test, which overcomes these limitations, is FTIR. This study determined the minimum inhibitory concentration (MIC) of itraconazole for F. pedrosoi, using FTIR and chemometrics. The susceptibility to ITC of 36 strains of F. pedrosoi was determined according to CLSI and with the addition of tricyclazole (TCZ), to inhibit 1,8-dihydroxynaphthalene (DHN)-melanin biosynthesis. Strains were grown in Sabouraud agar and prepared for Attenuated Total Reflection (ATR)/FTIR. Partial least squares (PLS) regression was performed using leave-one-out cross-validation (by steps of quintuplicates), then tested on an external validation set. A coefficient of determination (R-2) higher than 0.99 was obtained for both the MIC-ITC and MIC-ITC+TCZ ATR/PLS models, confirming a high correlation of the reference values with the ones predicted using the FTIR spectra. This is the first study to propose the use of FTIR and chemometric analyses according to the M38-A2 CLSI protocol to predict ITC MICs of F. pedrosoi. Considering the limitations of the conventional methods to test in vitro susceptibility, this is a promising methodology to be used for other microorganisms and drugs.	[Koehler, Alessandra; Heidrich, Daiane; Scroferneker, Maria Lucia] Univ Fed Rio Grande do Sul, Postgrad Program Med Med Sci, Porto Alegre, RS, Brazil; [Corbellini, Valeriano Antonio] Univ Santa Cruz do Sul, Postgrad Program Environm Technol, Postgrad Program Hlth Promot, Dept Sci Humanities & Educ, Santa Cruz Do Sul, RS, Brazil; [Scroferneker, Maria Lucia] Univ Fed Rio Grande do Sul, ICBS, Dept Microbiol Immunol & Parasitol, Porto Alegre, RS, Brazil; [Heidrich, Daiane] Univ Vale Taquari, Postgrad Program Biotechnol, Lajeado, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Santa Cruz do Sul; Universidade Federal do Rio Grande do Sul	Corbellini, VA (corresponding author), Univ Santa Cruz do Sul, Postgrad Program Environm Technol, Postgrad Program Hlth Promot, Dept Sci Humanities & Educ, Santa Cruz Do Sul, RS, Brazil.	valer@unisc.br	Corbellini, Valeriano Antonio/F-6641-2019	Corbellini, Valeriano Antonio/0000-0002-8052-5354; Koehler, Alessandra/0000-0002-4596-1724				[Anonymous], 2017, J ADOLESCENT HEALT S, V61, pS1; ASTM, 2005, ANN BOOK ASTM STAND; Balan V, 2019, MATERIALS, V12, DOI 10.3390/ma12182884; Bellisola G, 2012, AM J CANCER RES, V2, P1; Bonifaz A, 2004, EXPERT OPIN PHARMACO, V5, P247, DOI 10.1517/14656566.5.2.247; CLSI, 2017, REFERENCE METHOD BRO, V3rd ed.; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; Daboit TC, 2014, MYCOSES, V57, P116, DOI 10.1111/myc.12111; Khan ZA, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9020049; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Lecellier A, 2014, INT J FOOD MICROBIOL, V168, P32, DOI 10.1016/j.ijfoodmicro.2013.10.011; Lechowicz L, 2013, ACTA BIOCHIM POL, V60, P713; Posteraro B, 2014, FUTURE MICROBIOL, V9, P947, DOI [10.2217/FMB.14.55, 10.2217/fmb.14.55]; Queiroz-Telles F, 2017, CLIN MICROBIOL REV, V30, P233, DOI 10.1128/CMR.00032-16; Salman A, 2010, SPECTROSC-INT J, V24, P261, DOI 10.1155/2010/723489; Salman A, 2017, ANALYST, V142, P2136, DOI 10.1039/c7an00192d; Salman A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017002; Santos ALS, 2007, FEMS MICROBIOL REV, V31, P570, DOI 10.1111/j.1574-6976.2007.00077.x; Shapaval V, 2010, J BIOPHOTONICS, V3, P512, DOI 10.1002/jbio.201000014; Sharaha U, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800478; Sharaha U, 2017, ANAL CHEM, V89, P8782, DOI 10.1021/acs.analchem.7b01025; Sockalingum GD, 1997, BIOCHEM BIOPH RES CO, V232, P240, DOI 10.1006/bbrc.1997.6263; USDA (DEPARTMENT OF AGRICULTURE), 2007, FED REGISTER, V72, P61; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243231	10.1371/journal.pone.0243231	http://dx.doi.org/10.1371/journal.pone.0243231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264365	Green Published, gold			2022-12-26	WOS:000596569200032
J	Tjondro, HC; Ugonotti, J; Kawahara, R; Chatterjee, S; Loke, I; Chen, SY; Soltermann, F; Hinneburg, H; Parker, BL; Venkatakrishnan, V; Dieckmann, R; Grant, OC; Bylund, J; Rodger, A; Woods, RJ; Karlsson-Bengtsson, A; Struwe, WB; Thaysen-Andersen, M				Tjondro, Harry C.; Ugonotti, Julian; Kawahara, Rebeca; Chatterjee, Sayantani; Loke, Ian; Chen, Siyun; Soltermann, Fabian; Hinneburg, Hannes; Parker, Benjamin L.; Venkatakrishnan, Vignesh; Dieckmann, Regis; Grant, Oliver C.; Bylund, Johan; Rodger, Alison; Woods, Robert J.; Karlsson-Bengtsson, Anna; Struwe, Weston B.; Thaysen-Andersen, Morten			Hyper-truncated Asn355-and Asn391-glycans modulate the activity of neutrophil granule myeloperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; PROTEOME; GLYCAN; MASS; PLASMINOGEN; DEFICIENCY; EXPRESSION; HEALTH; ROLES	Myeloperoxidase (MPO) plays essential roles in neutrophil-mediated immunity via the generation of reactive oxidation products. Complex carbohydrates decorate MPO at discrete sites, but their functional relevance remains elusive. To this end, we have characterised the structure-biosynthesis-activity relationship of neutrophil MPO (nMPO). Mass spectrometry demonstrated that nMPO carries both characteristic under-processed and hyper-truncated glycans. Occlusion of the Asn355/Asn391-glycosylation sites and the Asn323-/Asn483-glycans, located in the MPO dimerisation zone, was found to affect the local glycan processing, thereby providing a molecular basis of the site-specific nMPO glycosylation. Native mass spectrometry, mass photometry and glycopeptide profiling revealed significant molecular complexity of diprotomeric nMPO arising from heterogeneous glycosylation, oxidation, chlorination and polypeptide truncation variants and a previously unreported low-abundance monoprotomer. Longitudinal profiling of maturing, mature, granule-separated and pathogen-stimulated neutrophils demonstrated that nMPO is dynamically expressed during granulopoiesis, unevenly distributed across granules and degranulated upon activation. We also show that proMPO-to-MPO maturation occurs during early/mid-stage granulopoiesis. While similar global MPO glycosylation was observed across conditions, the conserved Asn355-/Asn391-sites displayed elevated glycan hyper-truncation, which correlated with higher enzyme activities of MPO in distinct granule populations. Enzymatic trimming of the Asn355-/Asn391-glycans recapitulated the activity gain and showed that nMPO carrying hyper-truncated glycans at these positions exhibits increased thermal stability, polypeptide accessibility and ceruloplasmin-mediated inhibition potential relative to native nMPO. Finally, molecular modelling revealed that hyper-truncated Asn355-glycans positioned in the MPO-ceruloplasmin interface are critical for uninterrupted inhibition. Here, through an innovative and comprehensive approach, we report novel functional roles of MPO glycans, providing new insight into neutrophil-mediated immunity.	[Tjondro, Harry C.; Ugonotti, Julian; Kawahara, Rebeca; Chatterjee, Sayantani; Hinneburg, Hannes; Rodger, Alison; Thaysen-Andersen, Morten] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia; [Tjondro, Harry C.; Ugonotti, Julian; Kawahara, Rebeca; Chatterjee, Sayantani; Hinneburg, Hannes; Rodger, Alison; Thaysen-Andersen, Morten] Macquarie Univ, Biomol Discovery Res Ctr, Sydney, NSW, Australia; [Loke, Ian] Cordlife Grp Ltd, Singapore, Singapore; [Chen, Siyun; Soltermann, Fabian; Struwe, Weston B.] Univ Oxford, Dept Chem, Oxford, England; [Parker, Benjamin L.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Venkatakrishnan, Vignesh; Dieckmann, Regis; Karlsson-Bengtsson, Anna] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Grant, Oliver C.; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Bylund, Johan] Univ Gothenburg, Dept Oral Microbiol & Immunol, Inst Odontol, Sahlgrenska Acad, Gothenburg, Sweden; [Karlsson-Bengtsson, Anna] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden	Macquarie University; Macquarie University; University of Oxford; University of Melbourne; University of Gothenburg; University System of Georgia; University of Georgia; University of Gothenburg; Chalmers University of Technology	Thaysen-Andersen, M (corresponding author), Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia.; Thaysen-Andersen, M (corresponding author), Macquarie Univ, Biomol Discovery Res Ctr, Sydney, NSW, Australia.	morten.andersen@mq.edu.au	; Kawahara, Rebeca/B-1532-2015; Loke, Ian/I-4496-2015	Ugonotti, Julian/0000-0002-3455-6766; Tjondro, Harry/0000-0001-5037-0091; Karlsson, Anna/0000-0001-6796-1154; Woods, Robert/0000-0002-2400-6293; Kawahara, Rebeca/0000-0002-0292-2637; Thaysen-Andersen, Morten/0000-0001-8327-6843; Loke, Ian/0000-0002-2558-0975; Soltermann, Fabian/0000-0002-8616-9346; Chatterjee, Sayantani/0000-0002-7007-0333; Rodger, Alison/0000-0002-7111-3024	Australian Cystic Fibrosis postgraduate studentship award; international Macquarie University Research Excellence Scholarship (iMQRES); iMQRES; Macquarie University Research Excellence Scholarship (MQRES); Early Career Fellowship from the Cancer Institute NSW; Macquarie University Safety Net Grant	Australian Cystic Fibrosis postgraduate studentship award; international Macquarie University Research Excellence Scholarship (iMQRES); iMQRES; Macquarie University Research Excellence Scholarship (MQRES); Early Career Fellowship from the Cancer Institute NSW; Macquarie University Safety Net Grant	H. C. T. was supported by an Australian Cystic Fibrosis postgraduate studentship award and an international Macquarie University Research Excellence Scholarship (iMQRES). S. Chatterjee was supported by an iMQRES. J. U. was supported by a Macquarie University Research Excellence Scholarship (MQRES). R. K. was supported by an Early Career Fellowship from the Cancer Institute NSW. M. T.-A. was supported by a Macquarie University Safety Net Grant.	AGNER K, 1958, ACTA CHEM SCAND, V12, P89, DOI 10.3891/acta.chem.scand.12-0089; Aratani Y, 2006, J MED MICROBIOL, V55, P1291, DOI 10.1099/jmm.0.46620-0; Ashwood C, 2018, J AM SOC MASS SPECTR, V29, P1194, DOI 10.1007/s13361-018-1932-z; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Bjornsdottir H, 2016, DATA BRIEF, V6, P386, DOI 10.1016/j.dib.2015.12.003; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Caval T., 2020, MOL CELL PROTEOMICS; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Cheng D, 2019, ARTERIOSCL THROM VAS, V39, P1448, DOI 10.1161/ATVBAHA.119.312725; Clemmensen SN, 2014, METHODS MOL BIOL, V1124, P53, DOI 10.1007/978-1-62703-845-4_5; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Damme M, 2010, MOL CELL BIOL, V30, P273, DOI 10.1128/MCB.01143-09; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Delporte C, 2018, J BIOL CHEM, V293, P6374, DOI 10.1074/jbc.M117.801076; Dissing-Olesen L, 2008, J PHARMACOL EXP THER, V326, P338, DOI 10.1124/jpet.108.138263; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Feuk-Lagerstedt E, 2007, PROTEOMICS, V7, P194, DOI 10.1002/pmic.200600482; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Gault J, 2016, NAT METHODS, V13, P333, DOI [10.1038/NMETH.3771, 10.1038/nmeth.3771]; Gorudko IV, 2018, BIOCHEM CELL BIOL, V96, P592, DOI 10.1139/bcb-2017-0290; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Gray E, 2008, BRAIN PATHOL, V18, P86, DOI 10.1111/j.1750-3639.2007.00110.x; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Haussermann K, 2019, ANGEW CHEM INT EDIT, V58, P7662, DOI 10.1002/anie.201901734; Hinneburg H, 2019, ANAL CHEM, V91, P4559, DOI 10.1021/acs.analchem.8b05720; Hoogendijk AJ, 2019, CELL REP, V29, P2505, DOI 10.1016/j.celrep.2019.10.082; Hubber S. J., 1993, NACCESS COMPUTER PRO; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Kawahara Rebeca, 2018, Oncotarget, V9, P33077, DOI 10.18632/oncotarget.26005; Khalilova IS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192952; Kim HJ, 2019, J CEREBR BLOOD F MET, V39, P1864, DOI 10.1177/0271678X18771978; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; LEHRER RI, 1969, J CLIN INVEST, V48, P1478, DOI 10.1172/JCI106114; Loke I, 2017, MOL CELL PROTEOMICS, V16, P1507, DOI 10.1074/mcp.M116.066746; Loke I, 2015, BIOMOLECULES, V5, P1832, DOI 10.3390/biom5031832; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Nauseef WM, 2018, ARCH BIOCHEM BIOPHYS, V642, P1, DOI 10.1016/j.abb.2018.02.001; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; Nauseef WM, 2014, METHODS MOL BIOL, V1124, P13, DOI 10.1007/978-1-62703-845-4_2; NAUSEEF WM, 1986, BLOOD, V67, P865; Nauseef WM, 1998, J LEUKOCYTE BIOL, V63, P264, DOI 10.1002/jlb.63.2.264; NAUSEEF WM, 1987, BLOOD, V70, P1143; NAUSEEF WM, 1992, BLOOD, V80, P2622; PAREKH RB, 1989, BIOCHEMISTRY-US, V28, P7670, DOI 10.1021/bi00445a023; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Reiding KR, 2019, J BIOL CHEM, V294, P20233, DOI 10.1074/jbc.RA119.011098; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; Samygina VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067145; Silvescu CI, 2014, P NATL ACAD SCI USA, V111, P10696, DOI 10.1073/pnas.1320833111; Soltermann F, 2020, ANGEW CHEM INT EDIT, V59, P10774, DOI 10.1002/anie.202001578; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Sumer-Bayraktar Z, 2016, J BIOL CHEM, V291, P17727, DOI 10.1074/jbc.M116.735258; Sumer-Bayraktar Z, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009100; Takeuchi K, 2012, INFLAMM RES, V61, P197, DOI 10.1007/s00011-011-0401-y; Thaysen-Andersen M, 2016, MOL CELL PROTEOMICS, V15, P1773, DOI 10.1074/mcp.O115.057638; Thaysen-Andersen M, 2015, J BIOL CHEM, V290, P8789, DOI 10.1074/jbc.M114.631622; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Tjondro HC, 2019, BIOL REV, V94, P2068, DOI 10.1111/brv.12548; Ugonotti J, 2021, MOL ASPECTS MED, V79, DOI 10.1016/j.mam.2020.100882; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Vanhamme L, 2018, ARCH BIOCHEM BIOPHYS, V649, P1, DOI 10.1016/j.abb.2018.03.037; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Venkatakrishnan V, 2020, J BIOL CHEM, V295, P12648, DOI 10.1074/jbc.RA120.014011; Wang J, 2018, NEPHROLOGY, V23, P46, DOI 10.1111/nep.12926; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839; Yu JT, 2017, KIDNEY INT, V91, P1410, DOI 10.1016/j.kint.2016.12.012	78	15	15	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100144	10.1074/jbc.RA120.016342	http://dx.doi.org/10.1074/jbc.RA120.016342			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273015	gold, Green Published			2022-12-26	WOS:000672866400122
J	Aguilar, MO; Gobbi, A; Browne, PD; Ellegaard-Jensen, L; Hansen, LH; Semorile, L; Pistorio, M				Aguilar, Monica Oyuela; Gobbi, Alex; Browne, Patrick D.; Ellegaard-Jensen, Lea; Hansen, Lars Hestbjerg; Semorile, Liliana; Pistorio, Mariano			Influence of vintage, geographic location and cultivar on the structure of microbial communities associated with the grapevine rhizosphere in vineyards of San Juan Province, Argentina	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; VITIS-VINIFERA L.; RNA GENES DIFFERENTIATION; SOIL BACTERIAL DIVERSITY; SOLUBILIZATION; TERROIR	Soil microbiomes, as a primary reservoir for plant colonizing fungi and bacteria, play a major role in determining plant productivity and preventing invasion by pathogenic microorganisms. The use of 16S rRNA and ITS high-throughput amplicon sequencing for analysis of complex microbial communities have increased dramatically in recent years, establishing links between wine specificity and, environmental and viticultural factors, which are framed into the elusive terroir concept. Given the diverse and complex role these factors play on microbial soil structuring of agricultural crops, the main aim of this study is to evaluate how external factors, such as vintage, vineyard location, cultivar and soil characteristics, may affect the diversity of the microbial communities present. Additionally, we aim to compare the influence these factors have on the structuring of bacterial and fungal populations associated with Malbec grapevine rhizosphere with that of the more widespread Cabernet Sauvignon grapevine cultivar. Samples were taken from Malbec and Cabernet Sauvignon cultivars from two different vineyards in the San Juan Province of Argentina. Total DNA extracts from the rhizosphere soil samples were sequenced using Illumina's Miseq technology, targeting the V3-V4 hypervariable 16S rRNA region in prokaryotes and the ITS1 region in yeasts. The major bacterial taxa identified were Proteobacteria, Bacteroidetes and Firmicutes, while the major fungal taxa were Ascomycetes, Basidiomycetes, Mortierellomycetes and a low percentage of Glomeromycetes. Significant differences in microbial community composition were found between vintages and vineyard locations, whose soils showed variances in pH, organic matter, and content of carbon, nitrogen, and absorbable phosphorus.	[Aguilar, Monica Oyuela; Pistorio, Mariano] UNLP, Inst Biotecnol & Biol Mol IBBM, CCT La Plata, CONICET,Dept Cs Biol,Fac Cs Exactas, La Plata, Argentina; [Gobbi, Alex; Browne, Patrick D.; Hansen, Lars Hestbjerg] Univ Copenhagen, Sect Microbial Ecol & Biotechnol, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Ellegaard-Jensen, Lea] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Semorile, Liliana] Univ Nacl Quilmes UNQ, Lab Microbiol Mol, Dept Ciencia & Tecnol, Inst Microbiol Basica & Aplicada, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Copenhagen; Aarhus University	Pistorio, M (corresponding author), UNLP, Inst Biotecnol & Biol Mol IBBM, CCT La Plata, CONICET,Dept Cs Biol,Fac Cs Exactas, La Plata, Argentina.	pistorio@biol.unlp.edu.ar	Ellegaard, Lea/ABG-4693-2021	Ellegaard-Jensen, Lea/0000-0002-7235-9026; Gobbi, Alex/0000-0003-3541-4732; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Pistorio, Mariano/0000-0001-7931-8721; Browne, Patrick/0000-0001-8300-7758	Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine" [643063]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT-2017-2833]	Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine"; Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT)	This study was funded by the Horizon 2020 Programme of the European Commission within the Marie Sklodowska-Curie Innovative Training Network "MicroWine" (grant number 643063), and by Agencia Nacional de Promocio ' n Cienti ' fica y Te ' cnica PICT-2017-2833 to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alori ET, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00971; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azziz G, 2012, APPL SOIL ECOL, V61, P320, DOI 10.1016/j.apsoil.2011.10.004; Bacon CW, 2016, SYMBIOSIS, V68, P87, DOI 10.1007/s13199-015-0350-2; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Belda I., 2021, COMPREHENSIVE FOODOM, P438, DOI [10.1016/B978-0-08-100596-5.22875-8., DOI 10.1016/B978-0-08-100596-5.22875-8]; Belda I, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.01065, 10.3389/fmicb.2017.00821]; Belda I, 2016, YEAST, V33, P329, DOI 10.1002/yea.3165; Bokulich NA, 2016, MBIO, V7, DOI 10.1128/mBio.00631-16; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Bremner JM, 1960, DETERMINATION NITROG, DOI [10.1017/S0021859600021572, DOI 10.1017/S0021859600021572]; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Burns KN, 2016, SOIL BIOL BIOCHEM, V103, P337, DOI 10.1016/j.soilbio.2016.09.007; Burns KN, 2015, SOIL BIOL BIOCHEM, V91, P232, DOI 10.1016/j.soilbio.2015.09.002; Campisano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112763; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castagno LN, 2011, J APPL MICROBIOL, V110, P1151, DOI 10.1111/j.1365-2672.2011.04968.x; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Chou MY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29346-1; DAVIES BE, 1974, SOIL SCI SOC AM J, V38, P150, DOI 10.2136/sssaj1974.03615995003800010046x; Deacon LJ, 2006, SOIL BIOL BIOCHEM, V38, P7, DOI 10.1016/j.soilbio.2005.04.013; Del Frari G, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00910; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frac M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00707; Gilbert JA, 2014, P NATL ACAD SCI USA, V111, P5, DOI 10.1073/pnas.1320471110; Gobbi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56741-z; Gobbi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0200979; Gupta VVSR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01607; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; INV, 2018, INF AN SUP 2018; Jacoby R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01617; KILMER VJ, 1949, SOIL SCI, V68, P15, DOI 10.1097/00010694-194907000-00003; Knight S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14233; Koorem K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091998; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lagkouvardos I, 2017, PEERJ, V5, DOI 10.7717/peerj.2836; Likar M, 2013, MYCORRHIZA, V23, P209, DOI 10.1007/s00572-012-0463-x; Linu MS, 2019, COMMUN SOIL SCI PLAN, V50, P444, DOI 10.1080/00103624.2019.1566469; Marasco R, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0391-2; Marban L, 2005, AACS, VII, P65; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mozell M. R., 2014, Wine Economics and Policy, V3, P81, DOI 10.1016/j.wep.2014.08.001; Muller LM, 2019, CURR OPIN PLANT BIOL, V50, P132, DOI 10.1016/j.pbi.2019.05.004; Novello G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01528; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Perazzolli M, 2014, APPL ENVIRON MICROB, V80, P3585, DOI 10.1128/AEM.00415-14; Pieterse CMJ, 2016, TRENDS PLANT SCI, V21, P171, DOI 10.1016/j.tplants.2016.01.018; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Roca P., 2019, STATE VITIVINICULTUR; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Schreiter S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00144; Setati ME, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01358; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Singh P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50839-0; Singh P, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040096; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Son HJ, 2006, BIORESOURCE TECHNOL, V97, P204, DOI 10.1016/j.biortech.2005.02.021; Steenwerth KL, 2008, SOIL BIOL BIOCHEM, V40, P1330, DOI 10.1016/j.soilbio.2007.04.031; Tak H. I., 2012, International Journal of Plant Research, V2, P6; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Trouvelot S, 2015, AGRON SUSTAIN DEV, V35, P1449, DOI 10.1007/s13593-015-0329-7; Vega-Avila AD, 2015, ANTON LEEUW INT J G, V107, P575, DOI 10.1007/s10482-014-0353-7; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wei YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193097; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zhang XX, 2014, INT J SYST EVOL MICR, V64, P1373, DOI 10.1099/ijs.0.056325-0; Zuccaro A, 2020, EMBO J, V39, DOI 10.15252/embj.2019104144	74	10	10	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243848	10.1371/journal.pone.0243848	http://dx.doi.org/10.1371/journal.pone.0243848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315910	Green Published, gold			2022-12-26	WOS:000600186100087
J	Horiuchi, S; Shinohara, R; Otawa, S; Akiyama, Y; Ooka, T; Kojima, R; Yokomichi, H; Miyake, K; Yamagata, Z				Horiuchi, Sayaka; Shinohara, Ryoji; Otawa, Sanae; Akiyama, Yuka; Ooka, Tadao; Kojima, Reiji; Yokomichi, Hiroshi; Miyake, Kunio; Yamagata, Zentaro			Caregivers' mental distress and child health during the COVID-19 outbreak in Japan	PLOS ONE			English	Article							PARENTAL PSYCHOPATHOLOGY; SOCIAL PHOBIA; K6; POPULATION; SCALE	To clarify the physical and mental conditions of children during the coronavirus disease 2019 pandemic and consequent social distancing in relation to the mental condition of their caregivers. This internet-based nationwide cross-sectional study was conducted between April 30 and May 13, 2020. The participants were 1,200 caregivers of children aged 3-14 years. Child health issues were categorized into "at least one" or "none" according to caregivers' perception. Caregivers' mental status was assessed using the Japanese version of the Kessler Psychological Distress Scale-6. The association between caregivers' mental status and child health issues was analyzed using logistic regression models. Among the participants, 289 (24.1%) had moderate and 352 (29.3%) had severe mental distress and 69.8% of children in their care had health issues. The number of caregivers with mental distress was more than double that reported during the 2016 national survey. After adjusting for covariates, child health issues increased among caregivers with moderate mental distress (odds ratio 2.24, 95% confidence interval 1.59-3.16) and severe mental distress (odds ratio 3.05, 95% confidence interval 2.17-4.29) compared with caregivers with no mental distress. The results highlight parents' psychological stress during the pandemic, suggesting the need for adequate parenting support. However, our study did not consider risk factors of caregivers' mental distress such as socioeconomic background. There is an urgent need for further research to identify vulnerable populations and children's needs to develop sustainable social support programs for those affected by the outbreak.	[Horiuchi, Sayaka; Shinohara, Ryoji; Otawa, Sanae] Univ Yamanashi, Ctr Birth Cohort Studies, Chuo, Yamanashi, Japan; [Akiyama, Yuka; Ooka, Tadao; Kojima, Reiji; Yokomichi, Hiroshi; Miyake, Kunio; Yamagata, Zentaro] Univ Yamanashi, Sch Med, Dept Hlth Sci, Chuo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Horiuchi, S (corresponding author), Univ Yamanashi, Ctr Birth Cohort Studies, Chuo, Yamanashi, Japan.	Sayakahoriuchi@gmail.com	Ooka, Tadao/AAR-1205-2021; Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	University of Yamanashi	University of Yamanashi(University of Yamanashi)	The study was funded by the running expense of University of Yamanashi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, RES REPORT EARLY DET; Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3; Flouri E, 2019, J AM ACAD CHILD PSY, V58, P453, DOI 10.1016/j.jaac.2018.06.041; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Green P, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1669; Gulenc A, 2018, CHILD CARE HLTH DEV, V44, P892, DOI 10.1111/cch.12607; Human Rights Watch, COVID 19 CHILDR RIGH; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Knappe S, 2009, DEPRESS ANXIETY, V26, P363, DOI 10.1002/DA.20527; Lieb R, 2000, ARCH GEN PSYCHIAT, V57, P859, DOI 10.1001/archpsyc.57.9.859; Lissak G, 2018, ENVIRON RES, V164, P149, DOI 10.1016/j.envres.2018.01.015; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Marques ES, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00074420; McDermott BM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-55; Ministry of Education Culture Sports Science and Technology, INF MEXTS MEAS COVID; Ministry of Health Labour and Welfare, COMPR SURV LIV COND; Najman JM, 2001, SOC PSYCH PSYCH EPID, V36, P186, DOI 10.1007/s001270170062; National Center for Child Health and Development, NAT ONL SURV CHILDR; Prime Minister of Japan and His Cabinet, COVID 19 DECL LIFT S; Prime Minister of Japan and his Cabinet, COVID 19 DECL STAT E; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Radesky J, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2591; Sampasa-Kanyinga H, 2019, J PRIM PREV, V40, P189, DOI 10.1007/s10935-019-00543-6; Sandro G, 2005, EPIDEMIOL REV, V27, P78, DOI [10.1093/epirev/mxi003, DOI 10.1093/EPIREV/MXI003]; Talevi D, 2020, RIV PSICHIATR, V55, P137, DOI 10.1708/3382.33569; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X	31	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243702	10.1371/journal.pone.0243702	http://dx.doi.org/10.1371/journal.pone.0243702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301517	Green Published			2022-12-26	WOS:000600143100010
J	Qian, CH; Qiu, YH; He, ZY; Mu, WW; Tang, YM; Wang, HJ; Xie, MM; Ji, WX				Qian, Chenhao; Qiu, Yuanhe; He, Ziyang; Mu, Weiwei; Tang, Yongmeng; Wang, Haijun; Xie, Mengmeng; Ji, Weixi			Effects of interstitial carbon atoms on texture structure and mechanical properties of FeMnCoCr alloys	PLOS ONE			English	Article								In this paper, a (Fe50Mn30Co10Cr10)(100-x)C-x high-entropy alloy (HEA) was successfully prepared by using the vacuum arc melting method. The peak shape analysis of the X-ray diffraction patterns, the EBSD observations, and the EDS spectra of the alloys with different compositions show that the characteristics of the dendrites and the hard phase, Cr23C6, into the initial single-phase face-centered cubic (FCC) matrix becomes gradually visible as the carbon content increases from 0 to 4%. The crystal phase variations lead to a non-linear orientation of the microstructure, to a refinement of the grains, and to a higher elastic modulus. This study presents the solid saturation limit of the interstitial carbon atoms in such alloys and establishes an empirical relation between an alloy's elastic modulus and its carbon content.	[Qian, Chenhao; Mu, Weiwei; Tang, Yongmeng; Wang, Haijun; Xie, Mengmeng; Ji, Weixi] Jiangnan Univ, Sch Mech Engn, Wuxi, Jiangsu, Peoples R China; [Qian, Chenhao; Ji, Weixi] Jiangnan Univ, Jiangsu Key Lab Adv Food Mfg Equipment & Technol, Wuxi, Jiangsu, Peoples R China; [Qiu, Yuanhe] China Unicom Guangzhou Branch, Guangzhou, Guangdong, Peoples R China; [He, Ziyang] UnionPay Int Headquarter, Shanghai, Peoples R China	Jiangnan University; Jiangnan University	Qian, CH (corresponding author), Jiangnan Univ, Sch Mech Engn, Wuxi, Jiangsu, Peoples R China.; Qian, CH (corresponding author), Jiangnan Univ, Jiangsu Key Lab Adv Food Mfg Equipment & Technol, Wuxi, Jiangsu, Peoples R China.	qianch@jiangnan.edu.cn		Qian, Chenhao/0000-0003-2039-2884; DU, MENG/0000-0002-3537-4278	National Natural Science Foundation of China [51905215]; National College Students Innovation and Entrepreneurship Training Program of China [201910295014Z, 201810295022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National College Students Innovation and Entrepreneurship Training Program of China	This paper was funded by the National Natural Science Foundation of China (51905215) and the National College Students Innovation and Entrepreneurship Training Program of China (201910295014Z, 201810295022). Chenhao Qian is the author who received these awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, J HOSP PALLIAT NURS, V20, pE1; Hirota K, 2005, MAT SCI ENG A-STRUCT, V399, P154, DOI 10.1016/j.msea.2005.02.062; Jerban S, 2016, MATER CHARACT, V119, P216, DOI 10.1016/j.matchar.2016.08.008; Jiao DL, 2018, CURR APPL PHYS, V18, P1523, DOI 10.1016/j.cap.2018.09.009; Li YC, 2018, ACS APPL MATER INTER, V10, P43144, DOI 10.1021/acsami.8b11561; Lu ZP, 2018, ACTA METALL SIN, V54, P1553, DOI 10.11900/0412.1961.2018.00372; Mu S, 2018, J MATER RES, V33, P2857, DOI 10.1557/jmr.2018.300; Sarker P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07160-7; Xing QW, 2018, ACS COMB SCI, V20, P602, DOI 10.1021/acscombsci.8b00055; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567	10	1	1	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242322	10.1371/journal.pone.0242322	http://dx.doi.org/10.1371/journal.pone.0242322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296382	gold, Green Published			2022-12-26	WOS:000598626100068
J	Sajko, S; Grishkovskaya, I; Kostan, J; Graewert, M; Setiawan, K; Trubestein, L; Niedermuller, K; Gehin, C; Sponga, A; Puchinger, M; Gavin, AC; Leonard, TA; Svergun, DI; Smith, TK; Morriswood, B; Djinovic-Carugo, K				Sajko, Sara; Grishkovskaya, Irina; Kostan, Julius; Graewert, Melissa; Setiawan, Kim; Truebestein, Linda; Niedermueller, Korbinian; Gehin, Charlotte; Sponga, Antonio; Puchinger, Martin; Gavin, Anne-Claude; Leonard, Thomas A.; Svergun, Dimitri I.; Smith, Terry K.; Morriswood, Brooke; Djinovic-Carugo, Kristina			Structures of three MORN repeat proteins and a re-evaluation of the proposed lipid-binding properties of MORN repeats	PLOS ONE			English	Article							RECOGNITION NEXUS DOMAIN; TRYPANOSOMA-BRUCEI; BLOOD-STREAM; PHOSPHATIDYLSERINE TRANSPORT; BIOLOGICAL MACROMOLECULES; MEMBRANE OCCUPATION; SOLUTION SCATTERING; MOLECULAR-CLONING; FLAGELLAR POCKET; ENDOCYTOSIS	MORN (Membrane Occupation and Recognition Nexus) repeat proteins have a wide taxonomic distribution, being found in both prokaryotes and eukaryotes. Despite this ubiquity, they remain poorly characterised at both a structural and a functional level compared to other common repeats. In functional terms, they are often assumed to be lipid-binding modules that mediate membrane targeting. We addressed this putative activity by focusing on a protein composed solely of MORN repeats-Trypanosoma brucei MORN1. Surprisingly, no evidence for binding to membranes or lipid vesicles by TbMORN1 could be obtained either in vivo or in vitro. Conversely, TbMORN1 did interact with individual phospholipids. High- and low-resolution structures of the MORN1 protein from Trypanosoma brucei and homologous proteins from the parasites Toxoplasma gondii and Plasmodium falciparum were obtained using a combination of macromolecular crystallography, small-angle X-ray scattering, and electron microscopy. This enabled a first structure-based definition of the MORN repeat itself. Furthermore, all three structures dimerised via their C-termini in an antiparallel configuration. The dimers could form extended or V-shaped quaternary structures depending on the presence of specific interface residues. This work provides a new perspective on MORN repeats, showing that they are protein-protein interaction modules capable of mediating both dimerisation and oligomerisation.	[Sajko, Sara; Grishkovskaya, Irina; Kostan, Julius; Truebestein, Linda; Sponga, Antonio; Puchinger, Martin; Leonard, Thomas A.; Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max Perutz Labs, Vienna, Austria; [Graewert, Melissa; Svergun, Dimitri I.] European Mol Biol Lab, Hamburg Unit, Hamburg, Germany; [Setiawan, Kim; Niedermueller, Korbinian; Morriswood, Brooke] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Gehin, Charlotte; Gavin, Anne-Claude] European Mol Biol Lab, Heidelberg Unit, Heidelberg, Germany; [Gehin, Charlotte] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lab Lipid Cell Biol, Lausanne, Switzerland; [Gavin, Anne-Claude] Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, Geneva, Switzerland; [Smith, Terry K.] Univ St Andrews, Sch Biol, BSRC, St Andrews, Fife, Scotland; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana, Slovenia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); European Molecular Biology Laboratory (EMBL); University of Wurzburg; European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of St Andrews; University of Ljubljana	Djinovic-Carugo, K (corresponding author), Univ Vienna, Dept Struct & Computat Biol, Max Perutz Labs, Vienna, Austria.; Morriswood, B (corresponding author), Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany.; Djinovic-Carugo, K (corresponding author), Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana, Slovenia.	brooke.morriswood@uni-wuerzburg.de; kristina.djinovic@univie.ac.at	Djinovic-Carugo, Kristina/AAW-1167-2021	Djinovic-Carugo, Kristina/0000-0003-0252-2972; Sponga, Antonio/0000-0003-2216-4199; Graewert, Melissa/0000-0001-7547-636X; Kostan, Julius/0000-0002-8347-111X; Sajko, Sara/0000-0002-2563-8786; Gavin, Anne-Claude/0000-0003-4917-2340	Austrian Science Fund (FWF) [P22265-B12, P27016-B21, P28135, P30584, I525, I1593, P22276, P19060, W1221]; Austrian Federal Ministry of Economy, Family and Youth (BMWFJ) [253275]; Wellcome Trust (WT) [201543/Z/16]; COST action [BM1405]; Vienna Science and Technology Fund (WWTF) [LS17-008]; Universitat Wien (University of Vienna); LouisJeantet Foundation (Fondation Louis-Jeantet); UK Research and Innovation \ Medical Research Council (MRC) [MR/Mo20118/1]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Economy, Family and Youth (BMWFJ); Wellcome Trust (WT)(Wellcome Trust); COST action(European Cooperation in Science and Technology (COST)); Vienna Science and Technology Fund (WWTF); Universitat Wien (University of Vienna); LouisJeantet Foundation (Fondation Louis-Jeantet); UK Research and Innovation \ Medical Research Council (MRC)	Austrian Science Fund (FWF):Julius Kostan,Brooke Morriswood,Kristina DjinovicCarugo P22265-B12; Austrian Science Fund (FWF): Sara Sajko,Irina Grishkovskaya,Julius Kostan,Kim Setiawan,Korbinian Niedermuller,Brooke Morriswood,Kristina Djinovic-Carugo P27016-B21; Austrian Science Fund (FWF):Linda Truebestein, Thomas A Leonard P28135; Austrian Science Fund (FWF):Linda Truebestein,Thomas A Leonard P30584; Austrian Science Fund (FWF):Sara Sajko, Irina Grishkovskaya,Julius Kostan,Antonio Sponga, Martin Puchinger,Kristina Djinovic-Carugo I525; Austrian Science Fund (FWF):Sara Sajko,Irina Grishkovskaya,Julius Kostan,Antonio Sponga, Martin Puchinger,Kristina Djinovic-Carugo I1593; Austrian Science Fund (FWF):Sara Sajko,Irina Grishkovskaya,Julius Kostan,Antonio Sponga, Martin Puchinger,Kristina Djinovic-Carugo P22276; Austrian Science Fund (FWF):Sara Sajko,Irina Grishkovskaya,Julius Kostan,Antonio Sponga, Martin Puchinger,Kristina Djinovic-Carugo P19060; Austrian Science Fund (FWF):Kristina DjinovicCarugo W1221; Austrian Federal Ministry of Economy, Family and Youth (BMWFJ):Antonio Sponga,Martin Puchinger,Kristina Djinovic-Carugo 253275; Wellcome Trust (WT):Antonio Sponga, Martin Puchinger,Kristina Djinovic-Carugo 201543/Z/16; COST action:Antonio Sponga,Martin Puchinger,Kristina Djinovic-Carugo BM1405; Vienna Science and Technology Fund (WWTF): Sara Sajko,Irina Grishkovskaya,Julius Kostan, Antonio Sponga,Martin Puchinger,Kristina Djinovic-Carugo LS17-008; Universitat Wien (University of Vienna):Sara Sajko,Irina Grishkovskaya,Julius Kostan,Antonio Sponga, Martin Puchinger,Kristina Djinovic-Carugo; LouisJeantet Foundation (Fondation Louis-Jeantet): Charlotte Gehin,Anne-Claude Gavin; UK Research and Innovation vertical bar Medical Research Council (MRC): Terry K. Smith MR/Mo20118/1.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adl SM, 2019, J EUKARYOT MICROBIOL, V66, P4, DOI 10.1111/jeu.12691; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; [Anonymous], 2006, YB INT LAW COMMISSIO, VII; BANGS JD, 1993, J CELL SCI, V105, P1101; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Batram C, 2014, ELIFE, V3, DOI 10.7554/eLife.02324; Bennett HJ, 2013, BIOCHEM J, V456, P205, DOI 10.1042/BJ20130591; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennich ME, 2017, JOVE-J VIS EXP, DOI 10.3791/54861; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Camacho L, 2009, J CELL SCI, V122, P4383, DOI 10.1242/jcs.053488; Carman Peter J, 2018, Biophys Rev, V10, P1587, DOI 10.1007/s12551-018-0467-7; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Doyle SA, 2005, METH MOL B, V310, P107; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fyffe SA, 2006, MOL CELL, V21, P1, DOI 10.1016/j.molcel.2005.12.001; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Graewert MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10734; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Guo A, 2018, SCIENCE, V362, P1375, DOI 10.1126/science.aan3303; Habicht J, 2015, J EUKARYOT MICROBIOL, V62, P694, DOI 10.1111/jeu.12216; Hatzopoulos GN, 2013, STRUCTURE, V21, P2069, DOI 10.1016/j.str.2013.08.019; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Im YJ, 2007, J BIOL CHEM, V282, P5443, DOI 10.1074/jbc.M611342200; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jayasinghe I, 2018, CELL REP, V22, P557, DOI 10.1016/j.celrep.2017.12.045; Jiang M, 2019, J BIOL CHEM, V294, P13487, DOI 10.1074/jbc.RA118.006772; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Li JC, 2019, STRUCTURE, V27, P1366, DOI 10.1016/j.str.2019.06.004; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lorestani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012302; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Marvin RG, 2012, CHEM BIOL, V19, P731, DOI 10.1016/j.chembiol.2012.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mecklenburg KL, 2007, MOL GENET GENOMICS, V277, P481, DOI 10.1007/s00438-007-0211-7; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mikami K, 2010, PLANT SIGNAL BEHAV, V5, P1241, DOI 10.4161/psb.5.10.12922; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Morriswood B, 2015, EUKARYOT CELL, V14, P1081, DOI 10.1128/EC.00094-15; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Munro ML, 2016, J CELL SCI, V129, P4388, DOI 10.1242/jcs.196873; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada T, 2018, P NATL ACAD SCI USA, V115, P4507, DOI 10.1073/pnas.1716649115; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Perni S, 2017, P NATL ACAD SCI USA, V114, P13822, DOI 10.1073/pnas.1716461115; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Rossi D, 2019, P NATL ACAD SCI USA, V116, P15716, DOI 10.1073/pnas.1820980116; Saliba AE, 2016, NAT PROTOC, V11, P1021, DOI 10.1038/nprot.2016.059; Saliba AE, 2014, NAT METHODS, V11, P47, DOI 10.1038/nmeth.2734; Salzer U, 2017, CELL MOL LIFE SCI, V74, P2413, DOI 10.1007/s00018-017-2478-0; Scholz J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-12; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tsuchida J, 1998, DEV BIOL, V197, P67, DOI 10.1006/dbio.1998.8885; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Woo JS, 2016, P NATL ACAD SCI USA, V113, P2762, DOI 10.1073/pnas.1524229113; Xds Kabsch W., 2010, ACTA CRYSTALLOGR D, V66, P125, DOI DOI 10.1107/S0907444909047337; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yuan ZF, 2012, PROTEOMICS, V12, P226, DOI 10.1002/pmic.201100081; Zens B, 2015, METHODS, V75, P37, DOI 10.1016/j.ymeth.2014.11.004; 2004, ACTA CRYSTALLOGR D, V60, P2126	106	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242677	10.1371/journal.pone.0242677	http://dx.doi.org/10.1371/journal.pone.0242677			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296386	Green Published, gold, Green Submitted			2022-12-26	WOS:000598626100043
J	Choi, ES; Saberski, E; Lorimer, T; Smith, C; Kandage-don, U; Burton, RS; Sugihara, G				Choi, Emma S.; Saberski, Erik; Lorimer, Tom; Smith, Cameron; Kandage-don, Unduwap; Burton, Ronald S.; Sugihara, George			The importance of making testable predictions: A cautionary tale	PLOS ONE			English	Article							INTERANNUAL VARIATION; REPRODUCTIVE-CYCLE; TEMPERATURE; RECRUITMENT; CLIMATE; STOCK; DYNAMICS; BIOMASS; ROACH; ONSET	We found a startling correlation (Pearson rho > 0.97) between a single event in daily sea surface temperatures each spring, and peak fish egg abundance measurements the following summer, in 7 years of approximately weekly fish egg abundance data collected at Scripps Pier in La Jolla California. Even more surprising was that this event-based result persisted despite the large and variable number of fish species involved (up to 46), and the large and variable time interval between trigger and response (up to similar to 3 months). To mitigate potential over-fitting, we made an out-of-sample prediction beyond the publication process for the peak summer egg abundance observed at Scripps Pier in 2020 (available on bioRxiv). During peer-review, the prediction failed, and while it would be tempting to explain this away as a result of the record-breaking toxic algal bloom that occurred during the spring (9x higher concentration of dinoflagellates than ever previously recorded), a re-examination of our methodology revealed a potential source of over-fitting that had not been evaluated for robustness. This cautionary tale highlights the importance of testable true out-of-sample predictions of future values that cannot (even accidentally) be used in model fitting, and that can therefore catch model assumptions that may otherwise escape notice. We believe that this example can benefit the current push towards ecology as a predictive science and support the notion that predictions should live and die in the public domain, along with the models that made them.	[Choi, Emma S.; Saberski, Erik; Lorimer, Tom; Smith, Cameron; Kandage-don, Unduwap; Burton, Ronald S.; Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Burton, R/F-7694-2010	Burton, R/0000-0002-6995-5329; Saberski, Erik/0000-0002-6475-6187; Kandage Don, Unduwap/0000-0001-6857-6549	DoDStrategic Environmental Research and Development Program [15 RC-2509]; NSF [DEB-1655203, ABI-1667584]; DOI USDI-NPS [P20AC00527]; Scripps Institution of Oceanography Postdoctoral Fellowship; McQuown Fund; McQuown Chair in Natural Sciences, University of California, San Diego; Richard Grand Foundation; California Ocean Protection Council [R/OPCSFAQ-12]	DoDStrategic Environmental Research and Development Program; NSF(National Science Foundation (NSF)); DOI USDI-NPS; Scripps Institution of Oceanography Postdoctoral Fellowship; McQuown Fund; McQuown Chair in Natural Sciences, University of California, San Diego; Richard Grand Foundation; California Ocean Protection Council	This work was supported by DoDStrategic Environmental Research and Development Program 15 RC-2509 (GS), NSF DEB-1655203 (GS), NSF ABI-1667584 (GS), DOI USDI-NPS P20AC00527 (GS), the Scripps Institution of Oceanography Postdoctoral Fellowship (TL), the McQuown Fund and the McQuown Chair in Natural Sciences, University of California, San Diego (GS). Fish egg collection and identification was supported in part by the Richard Grand Foundation and the California Ocean Protection Council R/OPCSFAQ-12 (RB).	Bruch RM, 2002, J APPL ICHTHYOL, V18, P570, DOI 10.1046/j.1439-0426.2002.00421.x; Bye VJ, 1984, FISH REPROD STRATEGI; Choi ES, 2020, BIORXIV; Dabrowski K, 1996, J APPL ICHTHYOL, V12, P139, DOI 10.1111/j.1439-0426.1996.tb00079.x; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Duke EM, 2018, MAR ECOL PROG SER, V604, P199, DOI 10.3354/meps12738; Furtado LE, 2019, MONITORING TEMPORAL; Gillet C, 2006, J FISH BIOL, V69, P518, DOI 10.1111/j.1095-8649.2006.01123.x; Harada AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134647; Henderson ME, 2017, REV FISH BIOL FISHER, V27, P411, DOI 10.1007/s11160-017-9487-9; Hjort J., 1926, Journal du Conseil Copenhague, V1, P5; Hjort J, FLUCTUATIONS GREAT F; HOKANSON KEF, 1977, J FISH RES BOARD CAN, V34, P1524, DOI 10.1139/f77-217; Huber M, 1999, J EXP MAR BIOL ECOL, V240, P285, DOI 10.1016/S0022-0981(99)00064-7; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; JACOBSON LD, 1995, CAN J FISH AQUAT SCI, V52, P566, DOI 10.1139/f95-057; Kayes TB, 1979, P WORLD MARICULTURE; Kim J, 2001, FISH OCEANOGR, V10, P297, DOI 10.1046/j.1365-2419.2001.00175.x; McClatchie S, 2010, CAN J FISH AQUAT SCI, V67, P1782, DOI 10.1139/F10-101; Munch SB, 2018, FISH FISH, V19, P964, DOI 10.1111/faf.12304; Neuheimer AB, 2014, ECOLOGY, V95, P3364, DOI 10.1890/13-2370.1; Ottersen G, 2013, MAR ECOL PROG SER, V480, P205, DOI 10.3354/meps10249; Pankhurst NW, 2010, J FISH BIOL, V76, P69, DOI 10.1111/j.1095-8649.2009.02484.x; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Park J, 2020, EDM EMPIRICAL DYNAMI; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; SCOTT SG, 1992, J FISH BIOL, V41, P685, DOI 10.1111/j.1095-8649.1992.tb02698.x; STACEY NE, 1984, GEN COMP ENDOCR, V56, P333, DOI 10.1016/0016-6480(84)90076-5; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Van Der Kraak Glen, 1997, Society for Experimental Biology Seminar Series, V61, P159; VOLLESTAD LA, 1987, ENVIRON BIOL FISH, V18, P219, DOI 10.1007/BF00000361; WINANT CD, 1981, J PHYS OCEANOGR, V11, P71, DOI 10.1175/1520-0485(1981)011<0071:TACOTS>2.0.CO;2	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0236541	10.1371/journal.pone.0236541	http://dx.doi.org/10.1371/journal.pone.0236541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290401	Green Published, gold			2022-12-26	WOS:000598620100034
J	Cartaud, A; Quesque, F; Coello, Y				Cartaud, Alice; Quesque, Francois; Coello, Yann			Wearing a face mask against Covid-19 results in a reduction of social distancing	PLOS ONE			English	Article							PERSONAL-SPACE; UNIVERSAL DIMENSIONS; PERCEPTION; WARMTH	In the context of the Covid-19 pandemic, barrier gestures such as regular hand-washing, social distancing, and wearing a face mask are highly recommended. Critically, interpersonal distance (IPD) depends on the affective dimension of social interaction, which might be affected by the current Covid-19 context. In the present internet-based experimental study, we analyzed the preferred IPD of 457 French participants when facing human-like characters that were either wearing a face mask or displaying a neutral, happy or angry facial expression. Results showed that IPD was significantly reduced when characters were wearing a face mask, as they were perceived as more trustworthy compared to the other conditions. Importantly, IPD was even more reduced in participants infected with Covid-19 or living in low-risk areas, while it was not affected by the predicted health of the characters. These findings shed further light on the psychological factors that motivate IPD adjustments, in particular when facing a collective threat. They are also of crucial importance for policy makers as they reveal that despite the indisputable value of wearing a face mask in the current pandemic context, their use should be accompanied by an emphasis on social distancing to prevent detrimental health consequences.	[Cartaud, Alice; Coello, Yann] Univ Lille, CNRS, UMR 9193, SCALab Sci Cognit & Sci Affect, Lille, France; [Quesque, Francois] Univ Lille, INSERM, U1172, CHU Lille,LilNCog Lille Neurosci & Cognit, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Coello, Y (corresponding author), Univ Lille, CNRS, UMR 9193, SCALab Sci Cognit & Sci Affect, Lille, France.	yann.coello@univ-lille.fr		Cartaud, Alice/0000-0002-0918-8869	French National Research Agency [ANR-11-EQPX-0023]; Region Hauts-de-France; University of Lille	French National Research Agency(French National Research Agency (ANR)); Region Hauts-de-France(Region Hauts-de-France); University of Lille	This work was funded by the French National Research Agency (ANR-11-EQPX-0023). A.C. was financed by a grant from the Region Hauts-de-France and the University of Lille.	[Anonymous], 2012, REGEN MED S3, V7, pS14; Beaudry O, 2014, COGNITION EMOTION, V28, P416, DOI 10.1080/02699931.2013.833500; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Canzoneri E, 2013, EXP BRAIN RES, V228, P25, DOI 10.1007/s00221-013-3532-2; Carbon CC, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566886; Cartaud A, 2020, PSYARXIV; Cartaud A, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13600; Cartaud A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00657; Coello Y., 2015, FDN EMBODIED COGNITI, P198, DOI DOI 10.4324/9781315751979; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dezecache G, 2020, CURR BIOL, V30, pR417, DOI 10.1016/j.cub.2020.04.010; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; El Zein M, 2019, NAT HUM BEHAV, V3, P554, DOI 10.1038/s41562-019-0596-4; Fini C, 2020, PSYCHOL RES-PSYCH FO, V84, P757, DOI 10.1007/s00426-018-1091-7; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Givon-Benjio N, 2020, J ANXIETY DISORD, V69, DOI 10.1016/j.janxdis.2019.102171; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hediger H., 1968, PSYCHOL BEHAV ANIMAL; Henninger F, 2019, PSYARXIV; Iachini T, 2015, ACTA PSYCHOL, V161, P131, DOI 10.1016/j.actpsy.2015.09.003; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Mawson A.R., 2017, MASS PANIC SOCIAL AT; Morrison I, 2016, ADAPT HUM BEHAV PHYS, V2, P344, DOI 10.1007/s40750-016-0052-x; Nandrino JL, 2017, EUR EAT DISORD REV, V25, P179, DOI 10.1002/erv.2506; Quesque F, 2017, PSYCHOL RES-PSYCH FO, V81, P709, DOI 10.1007/s00426-016-0782-1; Ruggiero G, 2017, PSYCHOL RES-PSYCH FO, V81, P1232, DOI 10.1007/s00426-016-0806-x; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; SIEGMAN AW, 2014, NONVERBAL BEHAV COMM; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Worby CJ, 2020, FACE MASK USE GEN PO	33	55	55	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243023	10.1371/journal.pone.0243023	http://dx.doi.org/10.1371/journal.pone.0243023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284812	Green Published, gold			2022-12-26	WOS:000597930500014
J	Gaskin, PS; Chami, P; Nancoo, T; Warner, P; Barrett, P; Mayers, Y				Gaskin, Pamela S.; Chami, Peter; Nancoo, Tamara; Warner, Patricia; Barrett, Patrick; Mayers, Yvette			Electronic based reported anthropometry-A useful tool for interim monitoring of obesity prevalence in developing states	PLOS ONE			English	Article							RESPONSE RATES; SELF-REPORT; VALIDITY; WEB	Background Wide participation in electronic surveys and reliable reporting of anthropometry can serve to reduce costs associated with monitoring of obesity among adolescents where resources are limited. We conducted a single school pilot study among Caribbean adolescents to assess use of electronic surveys and whether face to face encouragement could promote enrollment. In addition, we assessed students' ability to reliably report simple anthropometry. Methods Students were provided with access to an electronic survey on anthropometry and food preferences regarding school-based food offerings. Responses to survey questions were presented as percentages. A sample of students also had their heights and weights measured after reporting these measures from memory. Intra-class correlation coefficients were used to assess reliability among measurers and Bland-Altman plots, consistency between student reported and recorded anthropometric measures and Support Vector Machine to assess robustness of anthropometry prediction models. Results Response rate to the electronic survey was low (9%). Students were able to interpret questions; open-ended options were inappropriately used 13% of the time. Post survey qualitative responses indicated displeasure with use of school-associated e-mail addresses. Concerns with confidentiality were expressed as well as preference for completion of surveys during school time. Students reliably reported anthropometry most measures fell within the 95% CI of Bland-Altman plots. SVM classified with a prediction accuracy of 95%. Estimates of overweight from recorded and reported measures were similar. Conclusions Adolescents are able to report simple anthropometry, and this can be used to help with monitoring of growth and overweight. Although they are capable of competently completing electronic surveys, school-based email is an ineffective contact tool. In-person school-based contact and administration of surveys are preferred. Adolescents can reliably report simple anthropometry that can be utilized for estimation of overweight/obesity prevalence. This method can be widely applied.	[Gaskin, Pamela S.; Nancoo, Tamara] Univ West Indies, Fac Med Sci, Cave Hill, Barbados; [Chami, Peter] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Chami, Peter; Barrett, Patrick] Univ West Indies, Fac Sci & Technol, Cave Hill, Barbados; [Warner, Patricia] Minist Educ, Technol & Vocat Training Barbados, Bridgetown, Barbados; [Mayers, Yvette] St Michael Sch Barbados, Bridgetown, Barbados	University West Indies Mona Jamaica; University West Indies Cave Hill Campus; Brown University; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Gaskin, PS (corresponding author), Univ West Indies, Fac Med Sci, Cave Hill, Barbados.	pamela.gaskin@cavehill.uwi.edu		Gaskin, Pamela/0000-0003-3185-6840				Abello J, 2006, DIMACS SER DISCRET M, V70, P1; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chassiakos YR, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2593; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dodge N, 2018, INT J SOC RES METHOD, V21, P149, DOI 10.1080/13645579.2017.1336596; Ember Melvin, 2001, COUNTRIES THEIR CULT; Fonseca H, 2010, ACTA PAEDIATR, V99, P83, DOI 10.1111/j.1651-2227.2009.01518.x; Gaskin PS, 2019, PUBLIC HEALTH NUTR, V22, P2721, DOI 10.1017/S1368980019002933; Gaskin PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121107; Houghton S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/1471-2458-15-5; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Magro MJ, 2015, QUAL QUANT, V49, P2145, DOI 10.1007/s11135-014-0098-4; Millar MM, 2011, PUBLIC OPIN QUART, V75, P249, DOI 10.1093/poq/nfr003; REUBEN DB, 1992, J GERONTOL, V47, pM106, DOI 10.1093/geronj/47.4.M106; Rodriguez G, 2000, J PEDIATR GASTR NUTR, V30, P305, DOI 10.1097/00005176-200003000-00017; Sheehan KimBartel., 2001, J COMPUT-MEDIAT COMM, V6, pJCMC621, DOI [DOI 10.1111/J.1083-6101.2001.TB00117.X, 10.1111/j.1083-6101.2001.tb00117.x]; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Tokmakidis SP, 2007, J ADOLESCENT HEALTH, V40, P305, DOI 10.1016/j.jadohealth.2006.10.001; Twenge J.M., 2018, PSYCHOL POPULAR MEDI; 2007, GENEVA SWITZERLAND B, V85, P660	24	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243202	10.1371/journal.pone.0243202	http://dx.doi.org/10.1371/journal.pone.0243202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284831	Green Published, gold			2022-12-26	WOS:000597930500035
J	Wu, CL; Hung, YL; Wang, YR; Huang, HM; Chang, CH; Wu, CC; Hung, CJ; Yeh, TF				Wu, Chieh-Liang; Hung, Yin-Lurn; Wang, Yan-Ru; Huang, Hui-Mei; Chang, Chia-Hui; Wu, Chih-Cheng; Hung, Chih-Jen; Yeh, Te-Feng			Pain prevalence in hospitalized patients at a tertiary academic medical center: Exploring severe persistent pain	PLOS ONE			English	Article							CARE-RELATED PAIN; PERCEPTION; MANAGEMENT	Objective The pain prevalence of inpatients is not a well-studied medical issue in Asia. We have aimed to evaluate pain prevalence and characterize those patients who have suffered from severe, persistent pain. Methods We investigated pain prevalence using a quota sampling from 19 general wards during the year 2018. Using a structured questionnaire, eight interviewers visited patients at an age >= 20 years, and who had been staying in general wards for >= 3 days. Those patients were excluded if they were unable to respond to the interview questions. If they reported pain during hospitalization, the maximum pain level and the duration of pain suffered in the past 24 hours were assessed. Care-related pain was also surveyed. Results A total of 1,034 patients (M/F, 537/497) completed the survey. Amongst them, 719 patients (69.5%) experienced pain, with moderate and severe pain levels being 27.3% and 43%, respectively. Surgery was considered as it related to pain, including significantly severe pain. The top 3 care-related pain causes were needle pain, wound dressing, and change in position/chest percussion. Change in position/chest percussion and rehabilitation were associated with severe, persistent pain. Conclusions Pain is common in approximately 70% of inpatients, with surgery being associated with severe pain. Mobilization and rehabilitation may lead to severe, persistent pain. The periodic study of pain prevalence is essential in order to provide precise pain management.	[Wu, Chieh-Liang] Taichung Vet Gen Hosp, Dept Crit Care Med, Taichung, Taiwan; [Wu, Chieh-Liang] Feng Chia Univ, Dept Automat Control Engn, Taichung, Taiwan; [Wu, Chieh-Liang; Hung, Yin-Lurn] Taichung Vet Gen Hosp, Ctr Qual Management, Taichung, Taiwan; [Hung, Yin-Lurn] Taichung Vet Gen Hosp, Dept Adm, Taichung, Taiwan; [Wang, Yan-Ru; Yeh, Te-Feng] Cent Taiwan Univ Sci & Technol, Dept Healthcare Adm, Taichung, Taiwan; [Huang, Hui-Mei; Chang, Chia-Hui] Taichung Vet Gen Hosp, Dept Nursing, Taichung, Taiwan; [Wu, Chih-Cheng; Hung, Chih-Jen] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan	Taichung Veterans General Hospital; Feng Chia University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Central Taiwan University Science & Technology; Taichung Veterans General Hospital; Taichung Veterans General Hospital	Yeh, TF (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Healthcare Adm, Taichung, Taiwan.	tfyeh@ctust.edu.tw	Yeh, Te-Feng/ABB-1096-2021	Yeh, Te-Feng/0000-0001-9787-6567				Ambrogi V, 2015, EUR J PAIN, V19, P313, DOI 10.1002/ejp.549; [Anonymous], 2008, Mayo Clin Womens Healthsource, V12, P3; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Favre C, 2015, ANN PHYS REHABIL MED, V58, P132, DOI 10.1016/j.rehab.2014.08.005; Gianni W, 2010, ARCH GERONTOL GERIAT, V51, P273, DOI 10.1016/j.archger.2009.11.016; Gupta A, 2014, PAIN PHYSICIAN, V17, P369; Melotti RM, 2005, EUR J PAIN, V9, P485, DOI 10.1016/j.ejpain.2004.09.010; Parsons Gareth, 2012, Evid Based Nurs, V15, P40, DOI 10.1136/ebnurs-2011-100047; Pasero CL, 1997, AM J NURS, V97, P15, DOI 10.2307/3465480; Rottenberg Y, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.12.006; Salomon L, 2002, J PAIN SYMPTOM MANAG, V24, P586, DOI 10.1016/S0885-3924(02)00528-6; Strohbuecker B, 2005, J PAIN SYMPTOM MANAG, V29, P498, DOI 10.1016/j.jpainsymman.2004.08.012; Tsai YF, 2010, J PAIN SYMPTOM MANAG, V40, P575, DOI 10.1016/j.jpainsymman.2010.02.013; Visentin M, 2005, EUR J PAIN, V9, P61, DOI 10.1016/j.ejpain.2004.04.004; Wadensten B, 2011, J CLIN NURS, V20, P624, DOI 10.1111/j.1365-2702.2010.03482.x; Xiao H, 2018, MED SCI MONITOR, V24, P7809, DOI 10.12659/MSM.912273; Yeo SN, 2009, ANN ACAD MED SINGAP, V38, P937; Zoega S, 2015, PAIN PRACT, V15, P236, DOI 10.1111/papr.12166	18	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243574	10.1371/journal.pone.0243574	http://dx.doi.org/10.1371/journal.pone.0243574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33285554	Green Published, gold			2022-12-26	WOS:000597930500056
J	Mjorud, M; Selbaek, G; Bjertness, E; Edwin, TH; Engedal, K; Knapskog, AB; Strand, BH				Mjorud, Marit; Selbaek, Geir; Bjertness, Espen; Edwin, Trine Holt; Engedal, Knut; Knapskog, Anne-Brita; Strand, Bjorn Heine			Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PREDICTORS; CARE; INSTITUTIONALIZATION; MORTALITY; PEOPLE; HEALTH; RISK; PLACEMENT; INEQUALITIES	Objectives To estimate transition times from dementia diagnosis to nursing-home (NH) admission or death and to examine whether sex, education, marital status, level of cognitive impairment and dementia aetiology are associated with transition times. Design Markov multistate survival analysis and flexible parametric models. Setting Participants were recruited from the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) in specialist healthcare between 2008 and 2017 and followed until August 2019, a maximum of 10.6 years follow-up time (mean 4.4 years, SD 2.2). Participants' address histories, emigration and vital status were retrieved from the National Population Registry from time of diagnosis and linked to NorCog clinical data. Participants 2,938 home-dwelling persons with dementia, ages 40-97 years at time of diagnosis (mean 76.1, SD 8.5). Results During follow-up, 992 persons (34%) were admitted to nursing-homes (NHs) and 1,556 (53%) died. Approximately four years after diagnosis, the probability of living in a NH peaked at 19%; thereafter, the probability decreased due to mortality. Median elapsed time from dementia diagnosis to NH admission among those admitted to NHs was 2.28 years (IQR 2.32). The probability of NH admission was greater for women than men due to women ' s lower mortality rate. Persons living alone, particularly men, had a higher probability of NH admission than cohabitants. Age, dementia aetiology and severity of cognitive impairment at time of diagnosis did not influence the probability of NH admission. Those with fewer than 10 years of education had a lower probability of NH admission than those with 10 years or more, and this was independent of the excess mortality in the less-educated group. Conclusion Four years after diagnosis, half of the participants still lived at home, while NH residency peaked at 19%. Those with fewer than 10 years of education were less often admitted to NH.	[Mjorud, Marit; Selbaek, Geir; Edwin, Trine Holt; Engedal, Knut; Strand, Bjorn Heine] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Mjorud, Marit; Selbaek, Geir; Edwin, Trine Holt; Engedal, Knut; Knapskog, Anne-Brita; Strand, Bjorn Heine] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Selbaek, Geir] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Bjertness, Espen] Univ Oslo, Fac Med, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway; [Edwin, Trine Holt] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Strand, Bjorn Heine] Norwegian Inst Publ Hlth, Dept Chron Dis & Ageing, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Mjorud, M (corresponding author), Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway.; Mjorud, M (corresponding author), Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway.	marit.mjorud@aldringoghelse.no	Strand, Bjørn/AAV-7948-2021	Strand, Bjørn/0000-0003-4385-8886; Edwin, Trine Holt/0000-0002-0530-8771; Mjorud, Marit/0000-0002-2604-4074; Selbaek, Geir/0000-0001-6511-8219	Norwegian Association for Public Health	Norwegian Association for Public Health	This study was funded by The Norwegian Association for Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ELR, V40, P256; Aspell N, 2019, INT J GERIATR PSYCH, V34, P999, DOI 10.1002/gps.5101; Belger M, 2019, EUR J HEALTH ECON, V20, P343, DOI 10.1007/s10198-018-1001-3; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; BRODATY H, 1993, ARCH NEUROL-CHICAGO, V50, P643, DOI 10.1001/archneur.1993.00540060073021; Cepoiu-Martin M, 2016, INT J GERIATR PSYCH, V31, P1151, DOI 10.1002/gps.4449; Crowther MJ, 2017, STAT MED, V36, P4719, DOI 10.1002/sim.7448; Drame M, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.03.002; Elstad JI, 2018, SCAND J PUBLIC HEALT, V46, P74, DOI 10.1177/1403494817705998; Engedal K, 2012, DEMENT GERIATR COGN, V34, P263, DOI 10.1159/000345435; Enroth L, 2019, EUR J AGEING, V16, P415, DOI 10.1007/s10433-019-00517-x; Eska K, 2013, DEMENT GER COGN D EX, V3, P426, DOI 10.1159/000355079; Garcia-Ptacek S, 2017, AGE AGEING, V46, P314, DOI 10.1093/ageing/afw189; Garcia-Ptacek S, 2014, J ALZHEIMERS DIS, V41, P467, DOI 10.3233/JAD-131856; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Grande G, 2019, NEUROSCI BIOBEHAV R, V107, P96, DOI 10.1016/j.neubiorev.2019.09.001; Hajek A, 2016, SOC PSYCH PSYCH EPID, V51, P607, DOI 10.1007/s00127-015-1138-7; Helvik AS, 2015, DEMENT GERIATR COGN, V40, P166, DOI 10.1159/000433525; Honinx E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7532-4; Howard R, 2015, LANCET NEUROL, V14, P1171, DOI 10.1016/S1474-4422(15)00258-6; Joling KJ, 2020, ALZHEIMERS DEMENT, V16, P662, DOI 10.1002/alz.12063; Kansal K, 2016, DEMENT GERIATR COGN, V41, P109, DOI 10.1159/000443205; Kao SL, 2019, INT J GERIATR PSYCH, V34, P1900, DOI 10.1002/gps.5207; Kjelvik J, 2017, BOTID SYKEHJEM VARIG; Knapp M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013591; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; McCann M, 2012, AGE AGEING, V41, P416, DOI 10.1093/ageing/afs022; McMichael AJ, 2020, J ALZHEIMERS DIS, V73, P1233, DOI 10.3233/JAD-190751; Mueller C, 2019, AGEING RES REV, V50, P72, DOI 10.1016/j.arr.2019.01.005; Park DG, 2018, J CLIN NEUROL, V14, P191, DOI 10.3988/jcn.2018.14.2.191; Reilev M, 2020, AGE AGEING, V49, P67, DOI 10.1093/ageing/afz136; Roheger M, 2018, SCAND J CARING SCI, V32, P1308, DOI 10.1111/scs.12574; Rongve A, 2014, INT J GERIATR PSYCH, V29, P392, DOI 10.1002/gps.4015; Staekenborg SS, 2016, J ALZHEIMERS DIS, V53, P135, DOI 10.3233/JAD-151063; Strand BH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204436; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Toot S, 2017, INT PSYCHOGERIATR, V29, P195, DOI 10.1017/S1041610216001654; Touraine C, 2016, STAT METHODS MED RES, V25, P1452, DOI 10.1177/0962280213489234; Vikum E, 2013, EUR J PUBLIC HEALTH, V23, P1003, DOI 10.1093/eurpub/ckt053; Wang JJ, 2020, J AM MED DIR ASSOC, V21, P627, DOI 10.1016/j.jamda.2019.11.002; Wattmo C, 2015, DEMENT GERIATR COGN, V40, P297, DOI 10.1159/000437050	42	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243513	10.1371/journal.pone.0243513	http://dx.doi.org/10.1371/journal.pone.0243513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AS	33275638	Green Published, gold			2022-12-26	WOS:000597150200027
J	Alamian, A; Marrs, JA; Clark, WA; Thomas, KL; Peterson, JM				Alamian, Arsham; Marrs, Jo-Ann; Clark, W. Andrew; Thomas, Kristy L.; Peterson, Jonathan M.			CTRP3 and serum triglycerides in children aged 7-10 years	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP3; FOR-DISEASE-CONTROL; 2000 GROWTH CHARTS; NATIONAL CENTER; ADIPOSE-TISSUE; UNITED-STATES; ADIPONECTIN; FAMILY; PREVALENCE; OBESITY	Introduction The prevalence of obesity-related disorders has been steadily increasing over the past couple of decades. Diseases that were once only detected in adults are now prevalent in children, such as hyperlipidemia. The adipose tissue-derived hormonal factor C1q TNF Related Protein 3 (CTRP3) has been linked to triglyceride regulation especially in animal models. However, the relationship between circulating CTRP3 levels and obesity-related disorders in human subjects is controversial. CTRP3 can circulate in different oligomeric complexes: trimeric (<100 kDa), middle molecular weight (100-300 kDa), and high molecular weight (HMW) oligomeric complexes (>300 kDa). Previous work has identified that it is not the total amount of CTRP3 present in the serum, but the specific circulating oligomeric complexes that appear to be indicative of the relationship between CTRP3 and serum lipids levels. However, this work has not been examined in children. Therefore, the purpose of this study was to compare the levels of different oligomeric complexes of CTRP3 and circulating lipid levels among young children (aged 7-10 years). Methods Morphometric data and serum samples were collected and analyzed from a cross-sectional population of 62 children of self-identified Hispanic origin from a community health center, between 2015 and 2016. Serum analysis included adiponectin, insulin, leptin, ghrelin, glucagon, C-reactive peptide, triglyceride, cholesterol, IL-6, TNF, and CTRP3. Correlation analyses were conducted to explore the relationships between CTRP3 and other biomarkers. Results Total CTRP3 concentrations were significantly positively correlated with total cholesterol and HDL cholesterol. Whereas, HMW CTRP3 was not significantly associated with any variable measured. Conversely, the middle molecular weight (MMW) CTRP3 was negatively correlated with triglycerides levels, and very low-density lipoprotein (VLDL), insulin, and body mass index (BMI). The negative correlations between MMW CTRP3 and triglycerides and VLDLs were particularly strong (r(2) = -0.826 and -0.827, respectively). Conclusion Overall, these data indicate that the circulating oligomeric state of CTRP3 and not just total CTRP3 level is important for understanding the association between CTRP3 and metabolic diseases. Further, this work indicates that MMW CTRP3 plays an important role in triglyceride and VLDL regulation which requires further study.	[Alamian, Arsham] Univ Miami, Sch Nursing & Hlth Studies, Coral Gables, FL 33124 USA; [Marrs, Jo-Ann] East Tennessee State Univ, Coll Nursing, Johnson City, TN USA; [Clark, W. Andrew] East Tennessee State Univ, Coll Clin & Rehabil Hlth Sci, Johnson City, TN USA; [Thomas, Kristy L.; Peterson, Jonathan M.] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Peterson, Jonathan M.] East Tennessee State Univ, Coll Publ Hlth, Dept Hlth Sci, Johnson City, TN 37614 USA	University of Miami; East Tennessee State University; East Tennessee State University; East Tennessee State University; East Tennessee State University	Peterson, JM (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.; Peterson, JM (corresponding author), East Tennessee State Univ, Coll Publ Hlth, Dept Hlth Sci, Johnson City, TN 37614 USA.	petersonjm1@etsu.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880	Tennessee Board of Regents [TBR E210029]; National Institute of Diabetes and Digestive and Kidney Diseases [R15 DK114740-01A1]	Tennessee Board of Regents; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Tennessee Board of Regents [Diversity Research Grant TBR E210029] and the National Institute of Diabetes and Digestive and Kidney Diseases [R15 DK114740-01A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan BA, 2018, PEERJ, V6, DOI 10.7717/peerj.6100; Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; [Anonymous], 2013, J CLIN ENDOCR METAB, V98, pE409; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Coleman DL, 2010, NAT MED, V16, P1097, DOI 10.1038/nm1010-1097; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Deng WQ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0029-0; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Kuczmarski RJ, 2000, HEALTH, V11, P1; Li Y, 2017, COMPR PHYSIOL, V7, P863, DOI 10.1002/cphy.c160044; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164593; Maligie M, 2012, J PEDIATR-US, V161, P875, DOI 10.1016/j.jpeds.2012.05.003; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pardo M, 2012, ENDOCRINE, V41, P374, DOI 10.1007/s12020-012-9617-z; Petersen PS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12735; Peterson J. M, 2016, FASEB J, V30, P1249; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qu H, 2015, J CLIN LIPIDOL, V9, P289, DOI 10.1016/j.jacl.2015.03.006; Schaffler A, 2007, TRENDS IMMUNOL, V28, P393, DOI 10.1016/j.it.2007.07.003; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schwarz NG, 2008, PUBLIC HEALTH NUTR, V11, P714, DOI 10.1017/S1368980007001449; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Trogen G, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14306; Trogen G, 2018, AM J PHYSIOL-ENDOC M, V315, pE949, DOI 10.1152/ajpendo.00050.2018; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Wagner RM, 2016, PEERJ, V4, DOI 10.7717/peerj.2573; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wolf RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133955; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wurm S, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-7; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; 2014, REG ANESTH PAIN MED, V9	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0241813	10.1371/journal.pone.0241813	http://dx.doi.org/10.1371/journal.pone.0241813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270666	Green Published, gold			2022-12-26	WOS:000597149100146
J	Koda, H; Arai, Z; Matsuda, I				Koda, Hiroki; Arai, Zin; Matsuda, Ikki			Agent-based simulation for reconstructing social structure by observing collective movements with special reference to single-file movement	PLOS ONE			English	Article							WILD; BEHAVIOR; FISSION; NETWORK; MULTILEVEL; EVOLUTION; PRIMATES; INSIGHTS; MONKEYS; ROLES	Understanding social organization is fundamental for the analysis of animal societies. In this study, animal single-file movement data-serialized order movements generated by simple bottom-up rules of collective movements-are informative and effective observations for the reconstruction of animal social structures using agent-based models. For simulation, artificial 2-dimensional spatial distributions were prepared with the simple assumption of clustered structures of a group. Animals in the group are either independent or dependent agents. Independent agents distribute spatially independently each one another, while dependent agents distribute depending on the distribution of independent agents. Artificial agent spatial distributions aim to represent clustered structures of agent locations-a coupling of "core" or "keystone" subjects and "subordinate" or "follower" subjects. Collective movements were simulated following two simple rules, 1) initiators of the movement are randomly chosen, and 2) the next moving agent is always the nearest neighbor of the last moving agents, generating "single-file movement" data. Finally, social networks were visualized, and clustered structures reconstructed using a recent major social network analysis (SNA) algorithm, the Louvain algorithm, for rapid unfolding of communities in large networks. Simulations revealed possible reconstruction of clustered social structures using relatively minor observations of single-file movement, suggesting possible application of single-file movement observations for SNA use in field investigations of wild animals.	[Koda, Hiroki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan; [Arai, Zin; Matsuda, Ikki] Chubu Univ, Acad Emerging Sci, Kasugai, Aichi, Japan; [Matsuda, Ikki] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Matsuda, Ikki] Japan Monkey Ctr, Inuyama, Aichi, Japan; [Matsuda, Ikki] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia	Kyoto University; Chubu University; Kyoto University; Kyoto University; Universiti Malaysia Sabah	Koda, H (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan.	koda.hiroki.7a@kyoto-u.ac.jp	Arai, Zin/AGF-1779-2022	Koda, Hiroki/0000-0002-0927-3473; Matsuda, Ikki/0000-0002-0861-7801	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology [17941861, JPMJCR17A4]; MEXT [4903, 17H06380]	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was mainly funded by the Japan Science and Technology Agency, Core Research for Evolutional Science and Technology 17941861 (#JPMJCR17A4) and partly by MEXT Grant-in-aid for Scientific Research on Innovative Areas #4903 (Evolinguistics), 17H06380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2006, AM J PHYS ANTHROPOL, V131, P486, DOI 10.1002/ajpa.20451; Baigger A, 2013, NATURWISSENSCHAFTEN, V100, P895, DOI 10.1007/s00114-013-1090-x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boenisch F, 2018, FRONT ROBOT AI, V5, DOI 10.3389/frobt.2018.00035; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Castles M, 2014, ANIM BEHAV, V96, P59, DOI 10.1016/j.anbehav.2014.07.023; Chapman CA, 2017, J MAMMAL, V98, P652, DOI 10.1093/jmammal/gyw157; Clutton-Brock T., 2016, MAMMAL SOC; Clutton-Brock T, 2012, EVOL ANTHROPOL, V21, P136, DOI 10.1002/evan.21316; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Dore KM, 2020, PRIMATES, V61, P389, DOI 10.1007/s10329-020-00800-x; Dunbar RIM, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0490; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Farine DR, 2015, ANIM BEHAV, V104, pE1, DOI 10.1016/j.anbehav.2014.11.019; Fehlmann G, 2016, CURR BIOL, V26, pR830, DOI 10.1016/j.cub.2016.05.033; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Funkhouser JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191898; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hockings KJ, 2011, PRIMATOL MONOGR, P221, DOI 10.1007/978-4-431-53921-6_24; Hongo S, 2014, PRIMATES, V55, P473, DOI 10.1007/s10329-014-0438-y; Ilany A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12084; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kappeler PM, 2012, LONG TERM FIELD STUD; Kawazoe T, 2019, PRIMATES, V60, P213, DOI 10.1007/s10329-018-0702-7; Krause J, 2015, ANIMAL SOCIAL NETWORKS, P1; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann J, 2016, BEHAV ECOL, V27, P20, DOI 10.1093/beheco/arv169; Lesmerises F, 2018, ANIM BEHAV, V140, P39, DOI 10.1016/j.anbehav.2018.03.014; Leve M, 2016, PRIMATES, V57, P73, DOI 10.1007/s10329-015-0494-y; Matsuda I, 2008, AM J PRIMATOL, V70, P1097, DOI 10.1002/ajp.20604; Matsuda I, 2015, PRIMATOL MONOGR, P231, DOI 10.1007/978-4-431-55480-6_10; Mitani J., 2012, EVOLUTION PRIMATE SO; Mitani JC, 2005, ANIM BEHAV, V70, P1079, DOI 10.1016/j.anbehav.2005.02.012; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Mittermeier RA., 2013, HDB MAMMALS WORLD PR; Mizuno K, 2017, BEHAVIOUR, V154, P1215, DOI 10.1163/1568539X-00003465; Morita T, 2020, ECOL INFORM, V56, DOI 10.1016/j.ecoinf.2020.101057; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Pasquaretta C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07600; Perony N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052834; Peterson R.O., 1977, WOLF ECOLOGY PREY RE; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; PRINS HHT, 1989, ETHOLOGY, V81, P47, DOI 10.1111/j.1439-0310.1989.tb00757.x; Puga-Gonzalez I, 2019, PRIMATES, V60, P163, DOI 10.1007/s10329-019-00720-5; Qi XG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6296; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sigaud M, 2017, ECOL LETT, V20, P33, DOI 10.1111/ele.12698; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Squires V. R., 1975, Applied Animal Ethology, V1, P263, DOI 10.1016/0304-3762(75)90019-X; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Sueur C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032566; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Tavares SB, 2017, BEHAV ECOL, V28, P500, DOI 10.1093/beheco/arw179; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Westley PAH, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0004; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	63	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243173	10.1371/journal.pone.0243173	http://dx.doi.org/10.1371/journal.pone.0243173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270712	Green Submitted, Green Published, gold			2022-12-26	WOS:000597149100155
J	Leung, TW; Chan, CT; Lam, CH; Tong, YK; Kee, CS				Leung, Tsz Wing; Chan, Chui-Ting; Lam, Chi-Hin; Tong, Yuk-Kwan; Kee, Chea-Su			Changes in corneal astigmatism and near heterophoria after smartphone use while walking and sitting	PLOS ONE			English	Article							INDUCED TRANSIENT MYOPIA; WAVE-FRONT ABERRATIONS; SUSTAINED CONVERGENCE; POWER VECTORS; HEAD; WORK; REPEATABILITY; DIRECTION; DISTANCE; QUALITY	Background/Aims Smartphone use has become an indispensable part of our daily life. The handy design and powerful processor allow smartphone users to perform diversified tasks even when walking. This study aimed to investigate and compare the optical aftereffect and vergence adaptation of using a smartphone while walking and sitting. Methods Twenty-nine young healthy adults (aged 19 to 24 years old) with normal binocular and accommodative functions were recruited. Participants were asked to watch a movie for 30 minutes using a smartphone while either walking on a treadmill or sitting on a chair. Corneal aberrations and near heterophoria were measured before and after smartphone use by a corneal topographer and modified Thorington heterophoria test, respectively. Results Using the smartphone while walking induced a change in corneal H/V astigmatism, becoming 0.11 +/- 0.03 mu m less negative (two-way ANOVA repeated measures, Bonferroni post-hoc test, p = 0.001). This optical aftereffect was significantly higher than after smartphone use while sitting by 0.10 +/- 0.03 mu m (paired t-test, p = 0.003). Although smartphone use did not result in a significant change in near heterophoria (Bonferroni post-hoc test, p > 0.15), the vergence adaptation showed relatively more eso- or less exo-deviation by 0.79 +/- 0.36(Delta) in the walking than the sitting condition (paired t-test, p = 0.037). Conclusions Eyecare practitioners should be cautious of the potential optical after effect and vergence adaptation after prolonged smartphone usage.	[Leung, Tsz Wing; Chan, Chui-Ting; Lam, Chi-Hin; Tong, Yuk-Kwan; Kee, Chea-Su] Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Peoples R China; [Leung, Tsz Wing] Hong Kong Polytech Univ, Ctr Myopia Res, Sch Optometry, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Leung, TW (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Peoples R China.; Leung, TW (corresponding author), Hong Kong Polytech Univ, Ctr Myopia Res, Sch Optometry, Hong Kong, Peoples R China.	jeffrey.TW.leung@polyu.edu.hk		Leung, Tsz Wing/0000-0001-9588-2891; Kee, Chea-Su/0000-0002-5177-129X	Departmental General Research Fund - Hong Kong Polytechnic University, Hong Kong [P0031874]	Departmental General Research Fund - Hong Kong Polytechnic University, Hong Kong	This study is supported by a grant from the Departmental General Research Fund, funded by the Hong Kong Polytechnic University, Hong Kong (Grant number: P0031874).	American Academy of Orthopaedic Surgeons, 2015, DISTRACTED WALKING S; Bababekova Y, 2011, OPTOMETRY VISION SCI, V88, P795, DOI 10.1097/OPX.0b013e3182198792; Borsting E., 2014, OPTOMETRY VISION SCI, V91, pe86; Buehren T, 2005, VISION RES, V45, P1297, DOI 10.1016/j.visres.2004.10.026; Buehren T, 2003, OPTOMETRY VISION SCI, V80, P159, DOI 10.1097/00006324-200302000-00012; Cebrian JL, 2014, OPTOMETRY VISION SCI, V91, P786, DOI 10.1097/OPX.0000000000000297; [Census and Statistics Department Hong Kong Special Administrative Region Census and Statistics Department], 2018, INFORM TECHNOLOGY US; Chen PL, 2018, INT J SUSTAIN TRANSP, V12, P12, DOI 10.1080/15568318.2017.1321706; Choy Camus K, 2000, Clin Exp Optom, V83, P12; Chung R, 2013, MODERN FAMILY LIFEST; Collins MJ, 2006, ACTA OPHTHALMOL SCAN, V84, P216, DOI 10.1111/j.1600-0420.2005.00547.x; EHRLICH DL, 1987, OPHTHAL PHYSL OPT, V7, P353, DOI 10.1111/j.1475-1313.1987.tb00760.x; Goss DA, 2010, J BEHAV OPTOM, V21, P99; He JC, 2003, J VISION, V3, P456, DOI 10.1167/3.7.1; Howarth PA, 2000, OPTOMETRY VISION SCI, V77, P616, DOI 10.1097/00006324-200011000-00013; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Leung TW, 2012, OPTOMETRY VISION SCI, V89, P984, DOI 10.1097/OPX.0b013e31825da156; Lin MIB, 2017, ACCIDENT ANAL PREV, V101, P87, DOI 10.1016/j.aap.2017.02.005; MCKEE MC, 1987, AM J OPTOM PHYS OPT, V64, P909; Montes-Mico R, 2004, INVEST OPHTH VIS SCI, V45, P1752, DOI 10.1167/iovs.03-0839; MONWILLIAMS M, 1993, OPHTHAL PHYSL OPT, V13, P387, DOI 10.1111/j.1475-1313.1993.tb00496.x; Morse SE, 1999, OPTOMETRY VISION SCI, V76, P637, DOI 10.1097/00006324-199909000-00021; ODea Simon, 2020, SMARTPHONE USERS WOR; OP026, 2016, J CROHNS COLITIS, V10, pS21; OWENS DA, 1987, INVEST OPHTH VIS SCI, V28, P743; PAAP KR, 1977, PERCEPT PSYCHOPHYS, V21, P307, DOI 10.3758/BF03199479; PICKWELL D, 1987, OPHTHAL PHYSL OPT, V7, P345, DOI 10.1111/j.1475-1313.1987.tb00758.x; Rainey BB, 1998, OPTOMETRY VISION SCI, V75, P719, DOI 10.1097/00006324-199810000-00016; Read SA, 2010, OPTOMETRY VISION SCI, V87, P45; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Remon L, 2009, OPTOMETRY VISION SCI, V86, P1182, DOI 10.1097/OPX.0b013e3181baac2c; ROSENFIELD M, 1991, INVEST OPHTH VIS SCI, V32, P142; ROSENFIELD M, 1993, OPHTHAL PHYSL OPT, V13, P266, DOI 10.1111/j.1475-1313.1993.tb00469.x; Rosenfield M, 2016, OPTOMETRY PRACTICE, V17, P1, DOI DOI 10.3109/02713683.2015.1031352; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; SHENI DD, 1988, AM J OPTOM PHYS OPT, V65, P76; Sheppard AL, 2018, BMJ OPEN OPHTHALMOL, V3, DOI 10.1136/bmjophth-2018-000146; Sreenivasan V, 2012, VISION RES, V57, P9, DOI 10.1016/j.visres.2012.01.011; The Vision Concil, 2016, EYE OVEREXPOSED DIGI; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Vasudevan B, 2008, INVEST OPHTH VIS SCI, V49, P836, DOI 10.1167/iovs.07-0197; Wolffsohn JS, 2003, INVEST OPHTH VIS SCI, V44, P2284, DOI 10.1167/iovs.02-0373; 2007, J ALLERGY CLIN IMMUN, V2007	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243072	10.1371/journal.pone.0243072	http://dx.doi.org/10.1371/journal.pone.0243072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270709	gold, Green Published			2022-12-26	WOS:000597149100111
J	Schirm, S; Ahnert, P; Berger, S; Nouailles, G; Wienhold, SM; Muller-Redetzky, H; Suttorp, N; Loeffler, M; Witzenrath, M; Scholz, M				Schirm, Sibylle; Ahnert, Peter; Berger, Sarah; Nouailles, Geraldine; Wienhold, Sandra-Maria; Muller-Redetzky, Holger; Suttorp, Norbert; Loeffler, Markus; Witzenrath, Martin; Scholz, Markus			A biomathematical model of immune response and barrier function in mice with pneumococcal lung infection	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; INNATE; CHEMOKINES; PNEUMONIA; CXCL5	Pneumonia is one of the leading causes of death worldwide. The course of the disease is often highly dynamic with unforeseen critical deterioration within hours in a relevant proportion of patients. Besides antibiotic treatment, novel adjunctive therapies are under development. Their additive value needs to be explored in preclinical and clinical studies and corresponding therapy schedules require optimization prior to introduction into clinical practice. Biomathematical modeling of the underlying disease and therapy processes might be a useful aid to support these processes. We here propose a biomathematical model of murine immune response during infection with Streptococcus pneumoniae aiming at predicting the outcome of different treatment schedules. The model consists of a number of non-linear ordinary differential equations describing the dynamics and interactions of the pulmonal pneumococcal population and relevant cells of the innate immune response, namely alveolar- and inflammatory macrophages and neutrophils. The cytokines IL-6 and IL-10 and the chemokines CCL2, CXCL1 and CXCL5 are considered as major mediators of the immune response. We also model the invasion of peripheral blood monocytes, their differentiation into macrophages and bacterial penetration through the epithelial barrier causing blood stream infections. We impose therapy effects on this system by modelling antibiotic therapy and treatment with the novel C5a-inactivator NOX-D19. All equations are derived by translating known biological mechanisms into equations and assuming appropriate response kinetics. Unknown model parameters were determined by fitting the predictions of the model to time series data derived from mice experiments with close-meshed time series of state parameters. Parameter fittings resulted in a good agreement of model and data for the experimental scenarios. The model can be used to predict the performance of alternative schedules of combined antibiotic and NOX-D19 treatment. We conclude that we established a comprehensive biomathematical model of pneumococcal lung infection, immune response and barrier function in mice allowing simulations of new treatment schedules. We aim to validate the model on the basis of further experimental data. We also plan the inclusion of further novel therapy principles and the translation of the model to the human situation in the near future.	[Schirm, Sibylle; Ahnert, Peter; Loeffler, Markus; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Berger, Sarah; Nouailles, Geraldine; Wienhold, Sandra-Maria; Muller-Redetzky, Holger; Witzenrath, Martin] Charite Univ Med Berlin, Div Pulm Inflammat, Berlin, Germany; [Berger, Sarah; Nouailles, Geraldine; Wienhold, Sandra-Maria; Muller-Redetzky, Holger; Suttorp, Norbert; Witzenrath, Martin] Free Univ Berlin, Berlin, Germany; [Berger, Sarah; Nouailles, Geraldine; Wienhold, Sandra-Maria; Muller-Redetzky, Holger; Suttorp, Norbert; Witzenrath, Martin] Humboldt Univ, Berlin, Germany; [Berger, Sarah; Nouailles, Geraldine; Wienhold, Sandra-Maria; Muller-Redetzky, Holger; Suttorp, Norbert; Witzenrath, Martin] Berlin Inst Hlth, Berlin, Germany; [Muller-Redetzky, Holger; Suttorp, Norbert; Witzenrath, Martin] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Scholz, Markus] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany	Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Scholz, M (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.; Scholz, M (corresponding author), Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany.	markus.scholz@imise.uni-leipzig.de	Nouailles, Geraldine/AAM-4285-2020; Ahnert, Peter/I-8150-2015	Nouailles, Geraldine/0000-0003-1973-3119; , Sibylle/0000-0002-5497-2791; Berger, Sarah/0000-0003-0538-8457; Ahnert, Peter/0000-0002-1771-0856	CAPSyS ("Medical Systems Biology of Pulmonary Barrier Failure in Community Acquired Pneumonia") [01ZX1304B]; German Federal Ministry of Education and Research (BMBF); DFG [SFB-TR84]; German Research Foundation (DFG); University of Leipzig; Sympath ("Systems-medicine of pneumonia-aggravated atherosclerosis") [01ZX1906B]	CAPSyS ("Medical Systems Biology of Pulmonary Barrier Failure in Community Acquired Pneumonia"); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig; Sympath ("Systems-medicine of pneumonia-aggravated atherosclerosis")	SS was funded by CAPSyS ("Medical Systems Biology of Pulmonary Barrier Failure in Community Acquired Pneumonia", grant number 01ZX1304B) and Sympath ("Systems-medicine of pneumonia-aggravated atherosclerosis", grant number 01ZX1906B). Both research projects are funded by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept. MWwas funded by the DFG; SFB-TR84, C6 and C9. We acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anevlavis S, 2010, EXPERT OPIN PHARMACO, V11, P361, DOI 10.1517/14656560903508770; Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; [Anonymous], 2014, INT C PRECL DAT NOXX; Becker S, 1994, AM J PHYSL 1, V266, pL278; Berger S, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2224-5; Boianelli A, 2015, VIRUSES-BASEL, V7, P5274, DOI 10.3390/v7102875; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Diep JK, 2015, CPT-PHARMACOMET SYST, V6, P503; Dominguez-Huttinger E, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00115; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; FIGGE M, 2015, FRONT MICROBIOL, V503, P1; Fry DE, 2012, AM SURGEON, V78, P1; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Gutbier B, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1851-6; Hartung D, 2008, MOL IMAGING CONTRAST, P2004; Hoehlig K, 2013, MOL THER, V21, P2236, DOI 10.1038/mt.2013.178; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Meegan JE, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12352; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Mochan E, 2014, J THEOR BIOL, V353, P44, DOI 10.1016/j.jtbi.2014.02.021; Muller-Redetzky HC, 2015, J ANTIMICROB CHEMOTH, V70, P830, DOI 10.1093/jac/dku446; Muller-Redetzky HC, 2019, ANESTHESIOLOGY, V132, P795; Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030; Paudel S, 2019, BLOOD, V133, P1335, DOI 10.1182/blood-2018-10-878082; Pechous RD, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00160; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; Pollmacher J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111630; Rechenberg I., 1994, EVOLUTIONSSTRATEGIE; Schirm S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156047; SCHWEFEL H, 1984, ANN OPER RES, V1, P65, DOI DOI 10.1007/BF01876146; Smith AM, 2011, J THEOR BIOL, V276, P106, DOI 10.1016/j.jtbi.2011.01.052; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Palomino DCT, 2015, EINSTEIN-SAO PAULO, V13, P469, DOI 10.1590/S1679-45082015RB3438; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Welte T, 2018, INTENS CARE MED, V44, P438, DOI 10.1007/s00134-018-5143-7; Witzenrath M, 2009, CRIT CARE MED, V37, P584, DOI 10.1097/CCM.0b013e3181959814; World Health Organization, 2014, PNEUM DIS; Yamamoto K, 2012, J IMMUNOL, V189, P2450, DOI 10.4049/jimmunol.1200634; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243147	10.1371/journal.pone.0243147	http://dx.doi.org/10.1371/journal.pone.0243147			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270742	gold, Green Published			2022-12-26	WOS:000597149100007
J	Specktor, P; Yalonetsky, S; Agmon, Y; Sprecher, E; Ali, FH; Telman, G				Specktor, Polina; Yalonetsky, Sergey; Agmon, Yoram; Sprecher, Elliot; Ali, Faten Haj; Telman, Gregory			The effect of TEE on treatment change in patients with acute ischemic stroke	PLOS ONE			English	Article							PATENT FORAMEN OVALE; ROUTINE TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIAC SOURCES; AORTIC-ARCH; CARDIOGENIC EMBOLISM; CRYPTOGENIC STROKE; MEDICAL THERAPY; SINUS RHYTHM; CLOSURE	Background and purpose Ischemic stroke is a widespread disease carrying high morbidity and mortality. Transesophageal echocardiography (TEE) is considered an important tool in the work-up of patients with acute ischemic stroke (AIS) and transient ischemic attack (TIA) patients; its utility is limited by a semi-invasive nature. The purpose of this study was to evaluate the probability of treatment change due to TEE findings (yield) in the work-up of AIS and TIA patients. Methods Retrospective data on patients with AIS or TIA who underwent TEE examination between 2000-2013 were collected from the institutional registry. Results The average age of 1284 patients who were included in the study was 57 +/- 10.4, 66% of patients were male. The most frequent TEE findings included aortic plaques in 54% and patent foramen ovale (PFO) in 15%. TEE findings led to treatment change in 135 (10.5%) patients; anticoagulant treatment was initiated in 110 of them (81%). Most common etiology for switch to anticoagulation was aortic plaques (71 patients); PFO was second most common reason (26 patients). Significant TEE findings (thrombus, endocarditis, tumor) were found in 1.9% of patients, they were more common in young patients (<55; 56% of the patients). Conclusions The beginning of anticoagulation treatment in patients with thick and complicated plaques was found frequently in our study. Significant TEE findings, were infrequent, constituted an absolute indication for treatment change and were more common in younger patients.	[Specktor, Polina; Yalonetsky, Sergey; Agmon, Yoram; Sprecher, Elliot; Ali, Faten Haj; Telman, Gregory] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel; [Specktor, Polina] Carmel Hosp, Dept Neurol, Haifa, Israel; [Telman, Gregory] Technion Israel Inst Technol, Haifa, Israel	Rambam Health Care Campus; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology	Telman, G (corresponding author), Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel.; Telman, G (corresponding author), Technion Israel Inst Technol, Haifa, Israel.	g_telman@rambam.health.gov.il		, Polina/0000-0002-9555-8044				Abdelghani M, 2019, CARDIOLOGY, V143, P62, DOI 10.1159/000501028; Agmon Y, 2002, CIRCULATION, V105, P27, DOI 10.1161/hc0102.101776; Al-Khaled M, 2018, NEURAL REGEN RES, V13, P1212, DOI 10.4103/1673-5374.235058; Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; Amarenco P, 2014, STROKE, V45, P1248, DOI 10.1161/STROKEAHA.113.004251; ASINGER RW, 1989, ARCH NEUROL-CHICAGO, V46, P727; Becker EI, 2001, VASA-J VASCULAR DIS, V30, P43, DOI 10.1024/0301-1526.30.1.43; Blum A, 2004, MED SCI MONITOR, V10, pCR521; BOGOUSSLAVSKY J, 1991, NEUROLOGY, V41, P855, DOI 10.1212/WNL.41.6.855; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Dawn B, 2006, ECHOCARDIOGR-J CARD, V23, P202, DOI 10.1111/j.1540-8175.2006.00195.x; de Abreu TT, 2008, VASC HEALTH RISK MAN, V4, P167; de Bruijn SFTM, 2006, STROKE, V37, P2531, DOI 10.1161/01.STR.0000241064.46659.69; Di Tullio MR, 2009, CIRCULATION, V119, P2376, DOI 10.1161/CIRCULATIONAHA.108.811935; Fowler VG, 1997, J AM COLL CARDIOL, V30, P1072, DOI 10.1016/S0735-1097(97)00250-7; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Hahn RT, 2013, J AM SOC ECHOCARDIOG, V26, P921, DOI 10.1016/j.echo.2013.07.009; Harloff A, 2006, STROKE, V37, P859, DOI 10.1161/01.STR.0000202592.87021.b7; HART RG, 1992, LANCET, V339, P589, DOI 10.1016/0140-6736(92)90873-2; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Homma S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.86; JOB FP, 1995, AM J CARDIOL, V75, P1033, DOI 10.1016/S0002-9149(99)80719-X; KARALIS DG, 1991, J AM COLL CARDIOL, V17, P73, DOI 10.1016/0735-1097(91)90706-F; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Lee TH, 2002, STROKE, V33, P1950, DOI 10.1161/01.STR.0000021409.16314.16; LEUNG DY, 1995, STROKE, V26, P1820, DOI 10.1161/01.STR.26.10.1820; Macleod MR, 2004, LANCET NEUROL, V3, P408, DOI 10.1016/S1474-4422(04)00806-3; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Mendel T, 1998, ACTA NEUROL SCAND, V97, P63; Miguel CE, 2011, INT J CARDIOL, V149, P358, DOI 10.1016/j.ijcard.2010.02.016; O'Brien PJ, 1998, AM J CARDIOL, V81, P1144, DOI 10.1016/S0002-9149(98)00132-5; Omran H, 2000, AM HEART J, V140, P658, DOI 10.1067/mhj.2000.109213; PEARSON AC, 1991, J AM COLL CARDIOL, V17, P66, DOI 10.1016/0735-1097(91)90705-E; PEDERSEN WR, 1991, CHEST, V100, P351, DOI 10.1378/chest.100.2.351; POP G, 1990, STROKE, V21, P560, DOI 10.1161/01.STR.21.4.560; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Saver JL, 2018, STROKE, V49, P1541, DOI 10.1161/STROKEAHA.117.018153; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; SHAPIRO SM, 1994, CHEST, V105, P377, DOI 10.1378/chest.105.2.377; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; Strandberg M, 2008, CLIN PHYSIOL FUNCT I, V28, P156, DOI 10.1111/j.1475-097X.2007.00785.x; Tamin SS, 2015, J AM COLL CARDIOL, V65, P2420, DOI 10.1016/j.jacc.2015.03.569; TUNICK PA, 1990, AM HEART J, V120, P658, DOI 10.1016/0002-8703(90)90024-R; Tunick PA, 2002, AM J CARDIOL, V90, P1320, DOI 10.1016/S0002-9149(02)02870-9; TUNICK PA, 1991, ANN INTERN MED, V115, P423, DOI 10.7326/0003-4819-115-6-423; Van Woerkom RC, 2018, AM J CARDIOL, V122, P2142, DOI 10.1016/j.amjcard.2018.09.001; Vitebskiy S, 2005, ECHOCARDIOGR-J CARD, V22, P770, DOI 10.1111/j.1540-8175.2005.00079.x; Warner MF, 1996, ARCH INTERN MED, V156, P1719, DOI 10.1001/archinte.156.15.1719; Yahia AM, 2004, SOUTH MED J, V97, P1055, DOI 10.1097/01.SMJ.0000144612.87267.36; Zuker I, 2019, ICDC ISR CTR DIS CON, P388	55	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243142	10.1371/journal.pone.0243142	http://dx.doi.org/10.1371/journal.pone.0243142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270736	Green Published, gold			2022-12-26	WOS:000597149100019
J	Jones, B; McGlone, ER; Fang, ZJ; Pickford, P; Correa, IR; Oishi, A; Jockers, R; Inoue, A; Kumar, S; Gorlitz, F; Dunsby, C; French, PMW; Rutter, GA; Tan, T; Tomas, A; Bloom, SR				Jones, Ben; McGlone, Emma Rose; Fang, Zijian; Pickford, Phil; Correa, Ivan R., Jr.; Oishi, Atsuro; Jockers, Ralf; Inoue, Asuka; Kumar, Sunil; Gorlitz, Frederik; Dunsby, Chris; French, Paul M. W.; Rutter, Guy A.; Tan, Tricia; Tomas, Alejandra; Bloom, Stephen R.			Genetic and biased agonist-mediated reductions in beta-arrestin recruitment prolong cAMP signaling at glucagon family receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; DIPEPTIDYL PEPTIDASE IV; GLP-1 RECEPTOR; REGULATED KINASE; PROTEIN-KINASE; GLUCOSE; TRAFFICKING; ACTIVATION; SECRETION; AFFINITY	Receptors for the peptide hormones glucagon-like peptide-1 (GLP-1R), glucose-dependent insulinotropic polypeptide (GIPR), and glucagon (GCGR) are important regulators of insulin secretion and energy metabolism. GLP-1R agonists have been successfully deployed for the treatment of type 2 diabetes, but it has been suggested that their efficacy is limited by target receptor desensitization and downregulation due to recruitment of beta-arrestins. Indeed, recently described GLP-1R agonists with reduced beta-arrestin-2 recruitment have delivered promising results in preclinical and clinical studies. We therefore aimed to determine if the same phenomenon could apply to the closely related GIPR and GCGR. In HEK293 cells depleted of both beta-arrestin isoforms the duration of G protein-dependent cAMP/PKA signaling was increased in response to the endogenous ligand for each receptor. Moreover, in wildtype cells, "biased" GLP-1, GCG, and GIP analogs with selective reductions in beta-arrestin-2 recruitment led to reduced receptor endocytosis and increased insulin secretion over a prolonged stimulation period, although the latter effect was only seen at high agonist concentrations. Biased GCG analogs increased the duration of cAMP signaling, but this did not lead to increased glucose output from hepatocytes. Our study provides a rationale for the development of GLP-1R, GIPR, and GCGR agonists with reduced beta-arrestin recruitment, but further work is needed to maximally exploit this strategy for therapeutic purposes.	[Jones, Ben; McGlone, Emma Rose; Fang, Zijian; Pickford, Phil; Tan, Tricia; Bloom, Stephen R.] Imperial Coll London, Sect Endocrinol & Invest Med, London, England; [Correa, Ivan R., Jr.] New England Biolabs Inc, Ipswich, MA USA; [Oishi, Atsuro; Jockers, Ralf] Univ Paris, Inst Cochin, INSERM, CNRS, Paris, France; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Kumar, Sunil; Gorlitz, Frederik; Dunsby, Chris; French, Paul M. W.] Imperial Coll London, Dept Phys, London, England; [Rutter, Guy A.; Tomas, Alejandra] Imperial Coll London, Sect Cell Biol & Funct Genom, London, England; [Rutter, Guy A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Fang, Zijian] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England; [Fang, Zijian] Univ Cambridge, Dept Haematol, Cambridge, England; [Oishi, Atsuro] Kyorin Univ, Dept Anat, Fac Med, Tokyo, Japan	Imperial College London; New England Biolabs; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Tohoku University; Imperial College London; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Cambridge; University of Cambridge; Kyorin University	Jones, B (corresponding author), Imperial Coll London, Sect Endocrinol & Invest Med, London, England.; Tomas, A (corresponding author), Imperial Coll London, Sect Cell Biol & Funct Genom, London, England.	ben.jones@imperial.ac.uk; a.tomas-catala@imperial.ac.uk	French, Paul/E-8649-2011; Jones, Ben/GXG-7037-2022	French, Paul/0000-0002-0478-6755; Rutter, Guy/0000-0001-6360-0343; Jones, Benjamin/0000-0003-0461-2584; OISHI, Atsuro/0000-0003-1788-5485; Correa, Ivan/0000-0002-3169-6878; McGlone, Emma Rose/0000-0002-0968-6972	MRC [MR/R010676/1]; BBSRC; NIHR; Integrative Mammalian Biology (IMB) Capacity Building Award; FP7-HEALTH EuroCHIP [241592]; NIHR Biomedical Research Centre Funding Scheme; Academy of Medical Sciences; Society for Endocrinology; British Society for Neuroendocrinology; European Federation for the Study of Diabetes; EPSRC capital award; Diabetes UK; Wellcome Trust Investigator [212625/Z/18/Z]; MRC Programme [MR/R022259/1]; Experimental Challenge Grant (DIVA) [MR/L02036X/1]; Diabetes UK [BDA/11/0004210, BDA/15/0005275, BDA 16/0005485]; EU/EFPIA/Innovative Medicines Initiative 2 Joint Undertaking (RHAPSODY) [115881]; Fondation de la Recherche Medicale (Equipe FRM) [DEQ20130326503, EQU201903008055]; Agence Nationale de la Recherche [ANR-2011-BSV1-012-01, ANR-2011-META, ANR-19-CE16-0025-01, ANR-15-CE14-0025-02]; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Japan Agency for Medical Research and Development (AMED) [JP19gm5910013, JP19gm0010004]; MRC [MR/P01870X/1, MR/R022259/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR(National Institute for Health Research (NIHR)); Integrative Mammalian Biology (IMB) Capacity Building Award; FP7-HEALTH EuroCHIP; NIHR Biomedical Research Centre Funding Scheme(National Institute for Health Research (NIHR)); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Society for Endocrinology; British Society for Neuroendocrinology; European Federation for the Study of Diabetes; EPSRC capital award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Diabetes UK(Diabetes UK); Wellcome Trust Investigator(Wellcome Trust); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Experimental Challenge Grant (DIVA); Diabetes UK(Diabetes UK); EU/EFPIA/Innovative Medicines Initiative 2 Joint Undertaking (RHAPSODY); Fondation de la Recherche Medicale (Equipe FRM); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by MRC project grant MR/R010676/1 to A. T., B. J., S. R. B., and G. A. R. The Section of Endocrinology and Investigative Medicine is funded by grants from the MRC, BBSRC, NIHR, an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EuroCHIP grant and is supported by the NIHR Biomedical Research Centre Funding Scheme. The views expressed are those of the author(s) and not necessarily those of the funder. B. J. acknowledges support from the Academy of Medical Sciences, Society for Endocrinology, The British Society for Neuroendocrinology, the European Federation for the Study of Diabetes, and an EPSRC capital award. A. T. acknowledges support from Diabetes UK and the European Federation for the Study of Diabetes. G. A. R. was supported by Wellcome Trust Investigator (212625/Z/18/Z) Awards, MRC Programme (MR/R022259/1) and Experimental Challenge Grant (DIVA, MR/L02036X/1), and Diabetes UK (BDA/11/0004210, BDA/15/0005275, BDA 16/0005485) grants. This work has received support from the EU/EFPIA/Innovative Medicines Initiative 2 Joint Undertaking (RHAPSODY grant No 115881) to G. A. R. This work was also supported by grants from FP7-HEALTH-2009-241592 EuroCHIP, the Fondation de la Recherche Medicale (Equipe FRM DEQ20130326503, EQU201903008055), Agence Nationale de la Recherche (ANR-2011-BSV1-012-01 "MLT2D" and ANR-2011-META "MELA-BETES", ANR-19-CE16-0025-01, ANR-15-CE14-0025-02), Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS) to R. J. A. I. was funded by the PRIME JP19gm5910013 and the LEAP JP19gm0010004 from the Japan Agency for Medical Research and Development (AMED).	Abdullah N, 2016, CELL REP, V17, P2966, DOI 10.1016/j.celrep.2016.11.050; Al-Sabah S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106890; Al-Zamel N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143532; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Buenaventura T, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000097; Buenaventura T, 2018, DIABETES, V67, P385, DOI 10.2337/db17-0639; Bugliani M, 2018, MOL CELL ENDOCRINOL, V473, P186, DOI 10.1016/j.mce.2018.01.019; Campbell JE, 2016, NAT MED, V22, P84, DOI 10.1038/nm.3997; Cegla J, 2017, ENDOCRINOLOGY, V158, P2680, DOI 10.1210/en.2016-1755; Darbalaei S, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114150; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; de Menthiere CS, 2004, EUR J MED CHEM, V39, P473, DOI 10.1016/j.ejmech.2004.02.002; Deacon CF, 1998, DIABETOLOGIA, V41, P271, DOI 10.1007/s001250050903; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fang ZJ, 2020, ACS PHARMACOL TRANSL, V3, P345, DOI 10.1021/acsptsci.0c00022; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Fletcher MM, 2018, BIOCHEM PHARMACOL, V156, P406, DOI 10.1016/j.bcp.2018.09.003; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Gabe MBN, 2018, BIOCHEM PHARMACOL, V150, P97, DOI 10.1016/j.bcp.2018.01.040; Gault VA, 2003, J ENDOCRINOL, V176, P133, DOI 10.1677/joe.0.1760133; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Hager MV, 2016, J AM CHEM SOC, V138, P14970, DOI 10.1021/jacs.6b08323; Hansen LS, 2016, BRIT J PHARMACOL, V173, P826, DOI 10.1111/bph.13384; Hareter A, 1997, ENDOCR J, V44, P701, DOI 10.1507/endocrj.44.701; Herbst KJ, 2011, MOL CELL BIOL, V31, P4063, DOI 10.1128/MCB.05459-11; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Hinke SA, 2003, BIOL CHEM, V384, P403, DOI 10.1515/BC.2003.046; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUPESODMANN K, 1995, REGUL PEPTIDES, V58, P149, DOI 10.1016/0167-0115(95)00063-H; Ismail S, 2016, BIOCHEM PHARMACOL, V120, P33, DOI 10.1016/j.bcp.2016.09.009; Jaccard N, 2014, BIOTECHNOL BIOENG, V111, P504, DOI 10.1002/bit.25115; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; Jones B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03941-2; Jorgensen R, 2005, MOL ENDOCRINOL, V19, P812, DOI 10.1210/me.2004-0312; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Kenakin T, 2018, MOL PHARMACOL, V93, P266, DOI 10.1124/mol.117.111187; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Khajavi N, 2018, CELL SIGNAL, V51, P13, DOI 10.1016/j.cellsig.2018.07.006; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Lu J, 2019, BIOCHEM J, V476, P513, DOI 10.1042/BCJ20180853; Lucey M, 2020, MOL METAB, V37, DOI 10.1016/j.molmet.2020.100991; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Malm-Erjefalt M, 2010, DRUG METAB DISPOS, V38, P1944, DOI 10.1124/dmd.110.034066; Manchanda Y., 2021, CURR OPIN ENDOCR MET, V16, P19, DOI [10.1016/J.COEMR.2020.07.003, DOI 10.1016/J.COEMR.2020.07.003]; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Naylor J, 2016, BIOCHEM J, V473, P2881, DOI 10.1042/BCJ20160476; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; O'Hayre M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3395; Oishi A, 2020, ACS SENSORS, V5, P57, DOI 10.1021/acssensors.9b01414; Peng TY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14836; Pickford P, 2020, BRIT J PHARMACOL, V177, P3905, DOI 10.1111/bph.15134; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Sage D, 2017, METHODS, V115, P28, DOI 10.1016/j.ymeth.2016.12.015; Schmid CL, 2017, CELL, V171, P1165, DOI 10.1016/j.cell.2017.10.035; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Stahl EL, 2015, MOL PHARMACOL, V87, P866, DOI 10.1124/mol.114.096503; Svendsen B, 2018, CELL REP, V25, P1127, DOI 10.1016/j.celrep.2018.10.018; Tan TM, 2013, DIABETES, V62, P1131, DOI 10.2337/db12-0797; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Willard FS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140532; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Yuliantie E, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.114001; Zhang HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9918; Zhu L, 2017, J CLIN INVEST, V127, P2941, DOI 10.1172/JCI92913	82	14	14	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100133	10.1074/jbc.RA120.016334	http://dx.doi.org/10.1074/jbc.RA120.016334			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268378	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400112
J	Sun, YJ; Zhang, DL; Ma, ML; Lin, H; Song, YC; Wang, JY; Ma, CS; Yu, K; An, WT; Guo, SC; He, DF; Yang, Z; Xiao, P; Hou, GG; Yu, X; Sun, JP				Sun, Yujing; Zhang, Daolai; Ma, Ming-Liang; Lin, Hui; Song, Youchen; Wang, Junyan; Ma, Chuanshun; Yu, Ke; An, Wentao; Guo, Shengchao; He, Dongfang; Yang, Zhao; Xiao, Peng; Hou, Guige; Yu, Xiao; Sun, Jin-Peng			Optimization of a peptide ligand for the adhesion GPCR ADGRG2 provides a potent tool to explore receptor biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; STRESS-RESPONSE PATHWAY; PHARMACOLOGY; ACTIVATION; VLGR1; GS	The adhesion GPCR ADGRG2, also known as GPR64, is a critical regulator of male fertility that maintains ion/pH homeostasis and CFTR coupling. The molecular basis of ADGRG2 function is poorly understood, in part because no endogenous ligands for ADGRG2 have been reported, thus limiting the tools available to interrogate ADGRG2 activity. It has been shown that ADGRG2 can be activated by a peptide, termed p15, derived from its own N-terminal region known as the Stachel sequence. However, the low affinity of p15 limits its utility for ADGRG2 characterization. In the current study, we used alanine scanning mutagenesis to examine the critical residues responsible for p15-induced ADGRG2 activity. We next designed systematic strategies to optimize the peptide agonist of ADGRG2, using natural and unnatural amino acid substitutions. We obtained an optimized ADGRG2 Stachel peptide T1V/F3Phe(4-Me) (VPM-p15) that activated ADGRG2 with significantly improved (>2 orders of magnitude) affinity. We then characterized the residues in ADGRG2 that were important for ADGRG2 activation in response to VPM-p15 engagement, finding that the toggle switch W-6.53 and residues of the ECL2 region of ADGRG2 are key determinants for VPM-p15 interactions and VPM-p15-induced Gs or arrestin signaling. Our study not only provides a useful tool to investigate the function of ADGRG2 but also offers new insights to guide further optimization of Stachel peptides to activate adhesion GPCR members.	[Sun, Yujing; Zhang, Daolai; Ma, Chuanshun; Yu, Ke; Hou, Guige; Sun, Jin-Peng] Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China; [Sun, Yujing] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Endocrinol, Jinan, Peoples R China; [Sun, Yujing; Zhang, Daolai; Ma, Ming-Liang; Lin, Hui; Wang, Junyan; Ma, Chuanshun; An, Wentao; Guo, Shengchao; He, Dongfang; Yang, Zhao; Xiao, Peng; Sun, Jin-Peng] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China; [Sun, Yujing; Zhang, Daolai; Ma, Ming-Liang; Lin, Hui; Wang, Junyan; Ma, Chuanshun; An, Wentao; Guo, Shengchao; He, Dongfang; Yang, Zhao; Xiao, Peng; Sun, Jin-Peng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan, Shandong, Peoples R China; [Sun, Yujing; Zhang, Daolai; Ma, Ming-Liang; Lin, Hui; Wang, Junyan; Ma, Chuanshun; An, Wentao; Guo, Shengchao; He, Dongfang; Yang, Zhao; Xiao, Peng; Yu, Xiao] Shandong Univ, Sch Basic Med Sci, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China; [Sun, Yujing; Zhang, Daolai; Ma, Ming-Liang; Lin, Hui; Wang, Junyan; Ma, Chuanshun; An, Wentao; Guo, Shengchao; He, Dongfang; Yang, Zhao; Xiao, Peng; Yu, Xiao] Shandong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Jinan, Shandong, Peoples R China; [Song, Youchen] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sun, Jin-Peng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Minist Educ,Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China	Binzhou Medical University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; University of Toronto; Peking University	Sun, JP (corresponding author), Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan, Shandong, Peoples R China.; Yu, X (corresponding author), Shandong Univ, Sch Basic Med Sci, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China.; Yu, X (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Jinan, Shandong, Peoples R China.; Sun, JP (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Minist Educ,Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China.	yuxiao@sdu.edu.cn; sunjinpeng@sdu.edu.cn		An, Wentao/0000-0002-1526-6157; Ma, Ming-liang/0000-0002-0045-4876; Yu, Ke/0000-0002-9747-3466; Song, Youchen/0000-0001-8780-5941; Zhang, Daolai/0000-0003-4428-8731	National Key Basic Research Program of China [2018YFC1003600, 2019YFA0904200]; National Science Fund for Excellent Young Scholars Grant [81822008]; National Science Fund for Distinguished Young Scholars Grants [81825022]; National Natural Science Foundation of China [31671197, 81773704, 81901548, 31971195, 31700692]; Distinguished Young Scholars Grants of Shandong Province [JQ201517]; Fundamental Research Funds of Shandong University [2017JQ02]; COVID-19 Emergency Tackling Research Program of Shandong University [2020XGB02]; Shandong Provincial Natural Science Foundation [ZR2019BC078]; Shandong Provincial Medicine and Health Science Technology Development Program [2017WS692]; Innovation and entrepreneurship training program for College Students [201910440030]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Fund for Excellent Young Scholars Grant; National Science Fund for Distinguished Young Scholars Grants(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Young Scholars Grants of Shandong Province; Fundamental Research Funds of Shandong University; COVID-19 Emergency Tackling Research Program of Shandong University; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Provincial Medicine and Health Science Technology Development Program; Innovation and entrepreneurship training program for College Students	This work was primarily supported by the National Key Basic Research Program of China Grant (2018YFC1003600 to J.-P. S. and X. Y., 2019YFA0904200 to J.-P. S. and P. X.), the National Science Fund for Excellent Young Scholars Grant (81822008 to X. Y.), the National Science Fund for Distinguished Young Scholars Grants (81825022 to J.-P. S.), the National Natural Science Foundation of China (31671197 to X. Y., 81773704 to J.-P. S., 81901548 to D. Z., 31971195 and 31700692 to P. X.), the Distinguished Young Scholars Grants of Shandong Province (JQ201517 to J.-P. S.), the Fundamental Research Funds of Shandong University (2017JQ02 to J.-P. S.), the COVID-19 Emergency Tackling Research Program of Shandong University (2020XGB02 to J.-P. S.), the Shandong Provincial Natural Science Foundation (ZR2019BC078 to D. Z.), the Shandong Provincial Medicine and Health Science Technology Development Program (2017WS692 to D. Z.), and the Innovation and entrepreneurship training program for College Students (201910440030 to K. Y.).	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Azimzadeh P, 2019, ANN NY ACAD SCI, V1456, P26, DOI 10.1111/nyas.14227; Balenga N, 2017, J BONE MINER RES, V32, P654, DOI 10.1002/jbmr.3023; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Dong JH, 2017, BIOL PSYCHIAT, V81, P654, DOI 10.1016/j.biopsych.2016.09.025; Folts CJ, 2019, TRENDS PHARMACOL SCI, V40, P278, DOI 10.1016/j.tips.2019.02.003; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Himmelreich S, 2017, CELL REP, V21, P2074, DOI 10.1016/j.celrep.2017.10.108; Hu QX, 2014, J BIOL CHEM, V289, P24215, DOI 10.1074/jbc.M114.549816; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Kishore A, 2017, J BIOL CHEM, V292, P9711, DOI 10.1074/jbc.M117.780551; Kishore A, 2016, HANDB EXP PHARMACOL, V234, P127, DOI 10.1007/978-3-319-41523-9_7; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Liebscher I, 2016, HANDB EXP PHARMACOL, V234, P111, DOI 10.1007/978-3-319-41523-9_6; Liebscher I, 2015, CELL REP, V10, P1021, DOI 10.1016/j.celrep.2015.01.065; Liebscher I, 2013, BIOL CHEM, V394, P937, DOI 10.1515/hsz-2013-0109; Liu CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14335; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Muller A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005624; Obermann H, 2003, MOL REPROD DEV, V64, P13, DOI 10.1002/mrd.10220; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Purcell RH, 2018, ANNU REV PHARMACOL, V58, P429, DOI 10.1146/annurev-pharmtox-010617-052933; Sando R, 2019, SCIENCE, V363, P837, DOI 10.1126/science.aav7969; Scholz N, 2017, ELIFE, V6, DOI 10.7554/eLife.28360; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Sun JP, 2013, J MOL NEUROSCI, V50, P204, DOI 10.1007/s12031-012-9911-5; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Wang HM, 2014, DIABETOLOGIA, V57, P1899, DOI 10.1007/s00125-014-3290-0; Wang XJ, 2014, J NEUROCHEM, V131, P699, DOI 10.1111/jnc.12955; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zhang DL, 2018, ELIFE, V7, DOI 10.7554/eLife.33432	41	12	12	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100174	10.1074/jbc.RA120.014726	http://dx.doi.org/10.1074/jbc.RA120.014726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303626	gold, Green Published			2022-12-26	WOS:000672866400152
J	Gadicherla, S; Krishnappa, L; Madhuri, B; Mitra, SG; Ramaprasad, A; Seevan, R; Sreeganga, SD; Thodika, NK; Mathew, S; Suresh, V				Gadicherla, Suman; Krishnappa, Lalitha; Madhuri, Bindu; Mitra, Susanna G.; Ramaprasad, Arkalgud; Seevan, Raja; Sreeganga, S. D.; Thodika, Nibras K.; Mathew, Salu; Suresh, Vani			Envisioning a learning surveillance system for tuberculosis	PLOS ONE			English	Article								Surveillance is critical for interrupting transmission of global epidemics. Research has highlighted gaps in the surveillance for tuberculosis that range from failure to collect real-time data to lack of standardization of data for informed decision-making at different levels of the health system. Our research aims to advance conceptual and methodological foundations for the development of a learning surveillance system for Tuberculosis, that involves systematic collection, analysis, interpretation, and feedback of outcome-specific data. It would concurrently involve the health care delivery system, public health laboratory, and epidemiologists. For our study, we systemically framed the cyber environment of TB surveillance as an ontology of the learning surveillance system. We validated the ontology by binary coding of dimensions and elements of the ontology with the metadata from an existing surveillance platform-GPMS TB Transportal. Results show GPMS TB Transportal collects a critical range of data for active case investigation and presumptive case screening for identifying and detecting confirmed TB cases. It is therefore targeted at assisting the Active Case Finding program. Building on the results, we demonstrate enhanced surveillance strategies for GPMS that are enumerated as pathways in the ontology. Our analysis reveals the scope for embedding learning surveillance pathways for digital applications in Direct Benefit Transfer, and Drug Resistance Treatment in National TB Elimination Programme in India. We discuss the possibilities of developing the transportal into a multi-level computer-aided decision support system for TB, using the innumerable pathways encapsulated in the ontology.	[Gadicherla, Suman; Krishnappa, Lalitha] MS Ramaiah Med Coll, Dept Community Med, Bengaluru, Karnataka, India; [Madhuri, Bindu; Seevan, Raja; Mathew, Salu; Suresh, Vani] Indian Ctr Social Transformat Indian CST, Bengaluru, Karnataka, India; [Mitra, Susanna G.; Ramaprasad, Arkalgud; Sreeganga, S. D.; Thodika, Nibras K.] Ramaiah Publ Policy Ctr, Bengaluru, Karnataka, India; [Ramaprasad, Arkalgud] Univ Illinois, Informat & Decis Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mitra, SG (corresponding author), Ramaiah Publ Policy Ctr, Bengaluru, Karnataka, India.	susanna.mitra@rppc.ac.in		Ramaprasad, Arkalgud/0000-0003-1551-6854; Sreeganga, S D/0000-0001-7308-6851; K. Thodika, Nibras/0000-0001-9115-6382; G. Mitra, Susanna/0000-0001-5784-5950				[Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2019, BRAIN STIMUL MAR; Balsari S, 2018, J MED INTERNET RES, V20, DOI 10.2196/10725; Brooks I, 2008, ADV DIS SURVEILLANCE, P5; Cabibbe A M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS40, DOI 10.1016/j.ijmyco.2016.09.010; Cameron JD, 2017, INT J MED INFORM, V100, P16, DOI 10.1016/j.ijmedinf.2017.01.007; Degeling C, 2020, BMC MED ETHICS, V21, DOI 10.1186/s12910-020-00474-6; Goel S, 2018, INT J NONCOMMUNICABL, V3, P9; Gopichandran V, 2019, ETHICAL CHALLENGES D; Groseclose SL, 2017, ANNU REV PUBL HEALTH, V38, P57, DOI 10.1146/annurev-publhealth-031816-044348; Institute of Medicine (US) Forum on Drug Discovery D Africa A of S of S, 2011, EM THREAT DRUG RES T; Jeon Pil-Hyun, 2018, [Journal of Radiation Protection and Research, 방사선방어학회지], V43, P1, DOI 10.14407/jrpr.2018.43.1.1; John TJ, 2013, INDIAN PEDIATR, V50, P93, DOI 10.1007/s13312-013-0021-4; Kendall AE, 2012, GLOBAL CHALLENGE HIV, P55; Lee Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/15727; Lessard L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026204; Mani M, 2019, LUNG INDIA, V36, P28, DOI 10.4103/lungindia.lungindia_324_18; Migliori GB, 2020, INT J INFECT DIS, V92, pS15, DOI 10.1016/j.ijid.2020.01.042; Ministry of Health and Family Welfare (MoHFW) Central TB Division, 2017, TB IND 2017 ANN STAT; Mitra SG, 2020, ONTOLOGY CYBERENVIRO; Mondaca AN, 2015, STUD HEALTH TECHNOL, V216, P1105, DOI 10.3233/978-1-61499-564-7-1105; NTEP, 2020, NAT STRAT PLAN END T; Nunez A, 2021, J PUBLIC HEALTH-HEID, V29, P1411, DOI 10.1007/s10389-020-01265-4; Polonsky J, 2019, WEEKLY EPIDEMIOLOGIC, V94, P23; Ragonnet R, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1452-0; Rajarajan K, 2016, J Family Med Prim Care, V5, P817, DOI 10.4103/2249-4863.201146; Ramanathan SK, 2016, EPM GLOCAL PROJECT M; RAMAPRASAD A, 1983, BEHAV SCI, V28, P4, DOI 10.1002/bs.3830280103; Rosenthal A, 2017, J CLIN MICROBIOL, V55, P3267, DOI 10.1128/JCM.01013-17; Saunders MJ, 2019, LANCET INFECT DIS, V19, P519, DOI 10.1016/S1473-3099(18)30753-9; Shriraam Vanishree, 2020, Indian J Tuberc, V67, P38, DOI 10.1016/j.ijtb.2019.09.003; Sreeganga SD, 2020, ARKALGUD RAMAPRASAD	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243610	10.1371/journal.pone.0243610	http://dx.doi.org/10.1371/journal.pone.0243610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315902	Green Published, gold			2022-12-26	WOS:000600186100077
J	Fan, KJ; Spassova, I; Gravemeyer, J; Ritter, C; Horny, K; Lange, A; Gambichler, T; Odum, N; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC				Fan, Kaiji; Spassova, Ivelina; Gravemeyer, Jan; Ritter, Cathrin; Horny, Kai; Lange, Anja; Gambichler, Thilo; Odum, Niels; Schrama, David; Schadendorf, Dirk; Ugurel, Selma; Becker, Juergen C.			Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53	ONCOGENE			English	Article							DOWN-REGULATION; EXPRESSION; MICRORNAS; MELANOMA; GENE; ANGIOGENESIS; RELEVANCE; YAP1; CSL	Merkel cell carcinoma (MCC) is a highly invasive and metastatic skin cancer. While high expression of miR-375 is a characteristic of MCC, it seems not to contribute to the malignant phenotype of MCC cells. miR-375 enrichment in MCC-derived extracellular vesicles suggests its intercellular signaling function. Here, we demonstrate that horizontally transferred miR-375 causes fibroblast polarization toward cancer-associated fibroblasts (CAFs). The polarization is evidenced by phenotypic changes and induction of alpha-SMA, CXCL2, and IL-1 beta. Fibroblast polarization is inhibited by specific antagomirs and mimicked by experimental miR-375 expression. Mechanistically, miR-375 downregulates RBPJ and p53, two key players regulating fibroblast polarization. In clinical MCC samples, in situ hybridization located miR-375 in CAFs, which correlated with high alpha-SMA protein and low RBPJ and TP53 expression; single-cell RNAseq revealed a disparate fibroblast polarization negatively correlating with p53 pathway-related gene expression. Thus, the functional role of miR-375 in MCC is to generate a pro-tumorigenic microenvironment by inducing fibroblast polarization.	[Fan, Kaiji; Spassova, Ivelina; Gravemeyer, Jan; Ritter, Cathrin; Horny, Kai; Becker, Juergen C.] Univ Hosp Essen, Dept Translat Skin Canc Res, Essen, Germany; [Fan, Kaiji; Spassova, Ivelina; Gravemeyer, Jan; Ritter, Cathrin; Horny, Kai; Schadendorf, Dirk; Becker, Juergen C.] German Canc Consortium DKTK, Essen, Germany; [Fan, Kaiji; Spassova, Ivelina; Gravemeyer, Jan; Ritter, Cathrin; Horny, Kai; Becker, Juergen C.] German Canc Res Ctr, Heidelberg, Germany; [Fan, Kaiji] Med Univ Graz, Dept Dermatol, Graz, Austria; [Lange, Anja] Univ Duisburg Essen, Fac Biol, Res Grp Bioinformat, Essen, Germany; [Gambichler, Thilo] Ruhr Univ Bochum, Dept Dermatol, Skin Canc Ctr, Bochum, Germany; [Odum, Niels] Univ Copenhagen, Dept Immunol & Microbiol, LEO Fdn, Skin Immunol Res Ctr, Copenhagen, Denmark; [Schrama, David] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Schadendorf, Dirk; Ugurel, Selma; Becker, Juergen C.] Univ Hosp Essen, Dept Dermatol, Essen, Germany	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Graz; University of Duisburg Essen; Ruhr University Bochum; University of Copenhagen; University of Wurzburg; University of Duisburg Essen	Becker, JC (corresponding author), Univ Hosp Essen, Dept Translat Skin Canc Res, Essen, Germany.; Becker, JC (corresponding author), German Canc Consortium DKTK, Essen, Germany.; Becker, JC (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Becker, JC (corresponding author), Univ Hosp Essen, Dept Dermatol, Essen, Germany.	j.becker@dkfz.de		Schadendorf, Dirk/0000-0003-3524-7858; Fan, Kaiji/0000-0003-4310-4515; Schrama, David/0000-0002-6931-8194	Deutsches Krebsforschungszentrum (DKFZ) [DKTK ED03]; Projekt DEAL	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Projekt DEAL	This work was funded by DKTK ED03 from Deutsches Krebsforschungszentrum (DKFZ) including funding for KF. Open Access funding enabled and organized by Projekt DEAL.	Abraham KJ, 2016, AM J PATHOL, V186, P1025, DOI 10.1016/j.ajpath.2015.11.020; Arandkar S, 2018, P NATL ACAD SCI USA, V115, P6410, DOI 10.1073/pnas.1719076115; Becker JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.77; Bhome R, 2018, CANCER LETT, V420, P228, DOI 10.1016/j.canlet.2018.02.002; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cui H, 2015, ONCOGENE, V34, P3640, DOI 10.1038/onc.2014.300; Dror S, 2016, NAT CELL BIOL, V18, P1006, DOI 10.1038/ncb3399; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fan KJ, 2020, CANCERS, V12, DOI 10.3390/cancers12030529; Fan KJ, 2020, J INVEST DERMATOL, V140, P56, DOI 10.1016/j.jid.2019.06.135; Fan K, 2018, CLIN CANCER RES, V24, P5873, DOI 10.1158/1078-0432.CCR-18-1184; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Frank AC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08989-2; Goruppi S, 2017, CELL REP, V20, P2468, DOI 10.1016/j.celrep.2017.08.048; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hudson J, 2013, EXP MOL PATHOL, V95, P62, DOI 10.1016/j.yexmp.2013.05.001; Ishii G, 2016, ADV DRUG DELIVER REV, V99, P186, DOI 10.1016/j.addr.2015.07.007; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Khare D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03053; Kogure T, 2011, HEPATOLOGY, V54, p1278A; Konstantinell A, 2016, PROTEOMICS, V16, P2587, DOI 10.1002/pmic.201600223; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Liang XL, 2016, J CELL SCI, V129, P2182, DOI 10.1242/jcs.170373; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lindahl LM, 2016, ONCOTARGET, V7, P45730, DOI 10.18632/oncotarget.10160; Liu JT, 2019, HEPATOLOGY, V70, P241, DOI 10.1002/hep.30607; Liu Y, 2016, CANCER LETT, V370, P125, DOI 10.1016/j.canlet.2015.10.011; Liu YX, 2013, DNA REPAIR, V12, P741, DOI 10.1016/j.dnarep.2013.06.002; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Nishikawa E, 2011, CANCER RES, V71, P6165, DOI 10.1158/0008-5472.CAN-11-1020; Pang WJ, 2015, CANCER SCI, V106, P1362, DOI 10.1111/cas.12747; Paulson KG, 2014, AM J CLIN PATHOL, V142, P452, DOI 10.1309/AJCPIKDZM39CRPNC; Popp S, 2002, INT J CANCER, V99, P352, DOI 10.1002/ijc.10321; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Renwick N, 2013, J CLIN INVEST, V123, P2694, DOI 10.1172/JCI68760; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Seto AG, 2018, BRIT J HAEMATOL, V183, P428, DOI 10.1111/bjh.15547; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Thayanithy V, 2014, TRANSL RES, V164, P359, DOI 10.1016/j.trsl.2014.05.011; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Walsh NM, 2016, HUM PATHOL, V52, P190, DOI 10.1016/j.humpath.2016.02.002; Wardhani LO, 2019, HUM PATHOL, V84, P52, DOI 10.1016/j.humpath.2018.09.003; Wheat R, 2014, CANCERS, V6, P1047, DOI 10.3390/cancers6021047; Xie H, 2014, J INVEST DERMATOL, V134, P507, DOI 10.1038/jid.2013.355; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	60	16	16	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					980	996		10.1038/s41388-020-01576-6	http://dx.doi.org/10.1038/s41388-020-01576-6		DEC 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33311552	hybrid, Green Published			2022-12-26	WOS:000598100200001
J	Kayal, M; Cigala, M; Cambra, E; Soulat, N; Mercader, M; Lebras, A; Ivanoff, P; Sebesi, L; Lassus-Debat, A; Hartmann, V; Bradtke, M; Lenfant, P; Jabouin, C; Dubreuil, J; Pelletier, D; Joguet, M; Le Mellionnec, S; Brichet, M; Binche, JL; Payrot, J; Saragoni, G; Crec'hriou, R; Verdoit-Jarraya, M				Kayal, Mohsen; Cigala, Marine; Cambra, Eleonore; Soulat, Nelly; Mercader, Manon; Lebras, Audrey; Ivanoff, Pauline; Sebesi, Lea; Lassus-Debat, Aurelie; Hartmann, Virginie; Bradtke, Melissa; Lenfant, Philippe; Jabouin, Coraline; Dubreuil, Julien; Pelletier, Dominique; Joguet, Manon; Le Mellionnec, Solene; Brichet, Marion; Binche, Jean-Louis; Payrot, Jerome; Saragoni, Gilles; Crec'hriou, Romain; Verdoit-Jarraya, Marion			Marine reserve benefits and recreational fishing yields: The winners and the losers	PLOS ONE			English	Article							PROTECTED AREAS; FISHERIES; CONSERVATION; POPULATIONS; IMPACT; SEA	Marine reserves constitute effective tools for preserving fish stocks and associated human benefits. However, not all reserves perform equally, and predicting the response of marine communities to management actions in the long run is challenging. Our decadal-scale survey of recreational fishing yields at France's 45-year old Cerbere-Banyuls marine reserve indicated significant protection benefits, with 40-50% higher fishing yields per unit effort in the partial-protection zone of the reserve (where fishing is permitted but at a lower level) than in surrounding non-reserve areas. Over the period 2005-2014, catch per unit effort (CPUE) declined both inside and outside the reserve, while weight per unit effort (WPUE) increased by 131% inside and decreased by 60% outside. Different CPUE and WPUE trajectories among fish families indicated changing catch assemblages, with yields increasing for the family most valued by fisheries, Sparidae (the ecological winners). However, reserve benefits were restricted to off-shore fishermen (the social winners), as on-shore yields were similar to 4 times lower and declining, even inside the reserve. Our study illustrates how surveys of recreational fishing yields can help evaluate the effectiveness of marine protected areas for key social and ecological protagonists. We show that, more than four decades after its establishment, fishing efficiencies at the historical Cerbere-Banyuls marine reserve are still changing, but benefits in terms of catch abundance, weight, and composition remain predominantly restricted to off-shore fishermen. Further regulations appear necessary to guarantee that conservation strategies equitably benefit societal groups.	[Kayal, Mohsen; Cigala, Marine; Cambra, Eleonore; Soulat, Nelly; Mercader, Manon; Lebras, Audrey; Ivanoff, Pauline; Sebesi, Lea; Lassus-Debat, Aurelie; Bradtke, Melissa; Lenfant, Philippe; Dubreuil, Julien; Le Mellionnec, Solene; Saragoni, Gilles; Crec'hriou, Romain; Verdoit-Jarraya, Marion] Univ Perpignan, UPVD CNRS, Ctr Format & Rech Environm Mediterraneens, UMR 5110, Via Domitia, Perpignan, France; [Kayal, Mohsen; Cigala, Marine; Cambra, Eleonore; Soulat, Nelly; Mercader, Manon; Lebras, Audrey; Ivanoff, Pauline; Sebesi, Lea; Lassus-Debat, Aurelie; Bradtke, Melissa; Lenfant, Philippe; Dubreuil, Julien; Le Mellionnec, Solene; Saragoni, Gilles; Crec'hriou, Romain; Verdoit-Jarraya, Marion] Ctr Rech Ecosyst Marins CREM, Port Barcares, France; [Kayal, Mohsen] Univ Nouvelle Caledonie, Univ La Reunion, Inst Rech Dev, CNRS,UMR 9220,ENTROPIE,IRD,IFREMER, Noumea, New Caledonia; [Hartmann, Virginie; Binche, Jean-Louis; Payrot, Jerome] Reserve Nat Marine Cerbere Banyuls, Dept Pyrenees Orientales, Banyuls Sur Mer, France; [Jabouin, Coraline; Joguet, Manon] Parc Nat Marin Golfe Lion, Argeles Sur Mer, France; [Pelletier, Dominique] Inst Francais Rech Explorat Mer IFREMER, EMH, Nantes, France; [Brichet, Marion] Direct Interreg Mer Mediterranee, Marseille, France; [Soulat, Nelly] SEANEO, Perpignan, France; [Lassus-Debat, Aurelie] Parc Nat Reg Camargue, Arles, France; [Dubreuil, Julien] Com Reg Peches Maritimes & Elevages Marins Bretag, Rennes, France; [Joguet, Manon] FROM Nord, Boulogne Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite Nouvelle Caledonie; Ifremer	Kayal, M (corresponding author), Univ Perpignan, UPVD CNRS, Ctr Format & Rech Environm Mediterraneens, UMR 5110, Via Domitia, Perpignan, France.; Kayal, M (corresponding author), Ctr Rech Ecosyst Marins CREM, Port Barcares, France.	mohsen.kayal@ird.fr		Kayal, Mohsen/0000-0003-3675-9855; VERDOIT-JARRAYA, Marion/0000-0003-1021-1891; Pelletier, Dominique/0000-0003-2420-1942	French Agency for Biodiversity; Region Occitanie/Pyrenees-Mediterranee; Departement des Pyrenees-Orientales; French Ministry of Ecology, Energy, Sustainable Development and Regional Planning; European Fisheries Fund; Pays Pyrenees Mediterranee; Regional Direction for the Environment, Planning and Housing Occitanie; French MPA Agency; French Ministry of Ecology	French Agency for Biodiversity; Region Occitanie/Pyrenees-Mediterranee(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Departement des Pyrenees-Orientales; French Ministry of Ecology, Energy, Sustainable Development and Regional Planning; European Fisheries Fund; Pays Pyrenees Mediterranee; Regional Direction for the Environment, Planning and Housing Occitanie; French MPA Agency; French Ministry of Ecology	This study was funded by multiple sources including the French Agency for Biodiversity (https://ofb.gouv.fr) and Region Occitanie/Pyrenees-Mediterranee (www.laregion.fr), Departement des Pyrenees-Orientales (www.ledepartement66.fr), French Ministry of Ecology, Energy, Sustainable Development and Regional Planning (www.ecologique-solidaire.gouv.fr), European Fisheries Fund (https://ec.europa.eu), Pays Pyrenees Mediterranee (www.payspyreneesmediterranee.org), as well as the Regional Direction for the Environment, Planning and Housing Occitanie (www.occitanie.developpement-durable.gouv.fr).Data were collected in part during the PAMPA project on Indicators of MPA Performance funded by the French Ministry of Ecology and the French MPA Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; Andrello M, 2015, ECOGRAPHY, V38, P273, DOI 10.1111/ecog.00975; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2019, MEZHDUNARODNAYA ZHIZ, P4; Arlinghaus R, 2019, P NATL ACAD SCI USA, V116, P5209, DOI 10.1073/pnas.1902796116; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Cabral RB, 2018, NAT ECOL EVOL, V2, P650, DOI 10.1038/s41559-018-0499-1; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2011, CONSERV BIOL, V25, P105, DOI 10.1111/j.1523-1739.2010.01586.x; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Crec'hriou R, 2012, J APPL ICHTHYOL, V28, P861, DOI 10.1111/j.1439-0426.2012.02030.x; Curnick DJ, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00318; Di Franco A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38135; Dunn P.K., 2018, GEN LINEAR MODELS EX, DOI DOI 10.1007/978-1-4419-0118-7; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Font T, 2014, REV FISH SCI AQUAC, V22, P73, DOI 10.1080/10641262.2013.823907; Food and Agriculture Organization of the United Nations, 2018, STAT WORLD FISH AQ 2; Galaz V, 2018, NAT ECOL EVOL, V2, P1352, DOI 10.1038/s41559-018-0497-3; Gaudin C., 2007, RECREATIONAL FISHERI; Giovos I, 2018, FISHERIES MANAG ECOL, V25, P287, DOI 10.1111/fme.12293; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Howarth LM, 2017, ICES J MAR SCI, V74, P263, DOI 10.1093/icesjms/fsw166; Hussein C, 2011, FISH RES, V108, P163, DOI 10.1016/j.fishres.2010.12.017; Hussein C, 2011, FISH RES, V108, P174, DOI 10.1016/j.fishres.2010.12.018; Jouvenel JY, 2001, AQUAT CONSERV, V11, P1, DOI 10.1002/aqc.424; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Lenfant P, 2012, DEBARQUEMENTS PECHE; Marengo M, 2015, FISHERIES MANAG ECOL, V22, P249, DOI 10.1111/fme.12110; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mercader M, 2018, MAR ENVIRON RES, V137, P60, DOI 10.1016/j.marenvres.2018.02.030; Michailidis N, 2020, FISH RES, V231, DOI 10.1016/j.fishres.2020.105711; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Piante C., 2015, BLUE GROWTH MEDITERR, P192; PNMGL, 2014, MER HOMM; Pollock K.H., 1994, ANGLER SURVEY METHOD; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Randone M., 2017, REVIVING EC MEDITERR; Ripley B., 2019, PACKAGE MASS; Rocklin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023820; Roncin N, 2008, J NAT CONSERV, V16, P256, DOI 10.1016/j.jnc.2008.09.006; Snir Reuven, 2002, J MODERN JEWISH STUD, V1, P182; Verdoit M, 2003, AQUAT LIVING RESOUR, V16, P467, DOI 10.1016/j.aquliv.2003.07.002; Verdoit-Jarraya M, 2014, SUIVI EFFORT PECHE C; Zafra-Calvo N, 2019, BIOSCIENCE, V69, P191, DOI 10.1093/biosci/biy143	54	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0237685	10.1371/journal.pone.0237685	http://dx.doi.org/10.1371/journal.pone.0237685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301445	Green Submitted, Green Published, gold			2022-12-26	WOS:000600143100069
J	Macias-Toronjo, I; Rojas-Ocana, MJ; Sanchez-Ramos, JL; Garcia-Navarro, EB				Macias-Toronjo, Israel; Jesus Rojas-Ocana, Maria; Luis Sanchez-Ramos, Jose; Begona Garcia-Navarro, E.			Pain catastrophizing, kinesiophobia and fear-avoidance in non-specific work-related low-back pain as predictors of sickness absence	PLOS ONE			English	Article							ROUTINE-CLINICAL-PRACTICE; SPANISH VERSION; PSYCHOMETRIC PROPERTIES; PRIMARY-CARE; TAMPA SCALE; GLOBAL BURDEN; NECK PAIN; DISABILITY; BELIEFS; VALIDATION	The influence of pain catastrophizing, kinesiophobia and fear-avoidance attitudes towards non-specific low-back pain has been scarcely studied in an occupational insurance provider context. The objective of this work is to ascertain the relationship between these psychosocial variables with work absence, its duration and the disability of subjects with work-related low back pain. This is a descriptive observational methodological strategy. All patients with work-related non-specific low back pain who attended to an occupational health hospital during the study period were included consecutively. Clinical variables of kinesiophobia, pain catastrophizing, fear-avoidance attitudes, disability and pain were collected; sociodemographic variables of sex, age, type of work, educational level, occupational status and duration in days of work absence were recorded. Kinesiophobia (b = 1.43, P = 0.011, r = 0.333), fear-avoidance beliefs in its global dimension (b = 0.910, P = 0.014, r = 0.321), fear-avoidance beliefs in its work dimension (b = 1.255, P = 0.016, r = 0.321) and pain catastrophizing (b = 0.997, P = 0.013, r = 0.340) show individual association with the duration of sickness absence. Kinesiophobia (b = 0.821, P = 0.011, r = 0.30) and fear-avoidance beliefs (b = 1.760, P = 0.016, r = 0.28) are associated with disability (Kinesiophobia, b = 0.880, P = 0.045, r = 0.26; Fear-avoidance beliefs, b = 0.724, P = 0.010, r = 0.34). Kinesiophobia, fear-avoidance beliefs and pain catastrophizing are related to an increase in the duration of work absence and disability in patients with back pain in an occupational insurance provider context.	[Macias-Toronjo, Israel] Huelva Fremap Hosp, Dept Rehabil, Phys Therapy, Huelva, Andalucia, Spain; [Jesus Rojas-Ocana, Maria; Luis Sanchez-Ramos, Jose; Begona Garcia-Navarro, E.] Univ Huelva, Dept Nursing & Hlth Sci, Huelva, Spain; [Begona Garcia-Navarro, E.] Univ Huelva, Ctr Res Contemporary Thought & Innovat Dev COIDES, Social Studies & Social Intervent, Res Grp ESEIS, Huelva, Spain	Universidad de Huelva; Universidad de Huelva	Rojas-Ocana, MJ (corresponding author), Univ Huelva, Dept Nursing & Hlth Sci, Huelva, Spain.	mariaj.rojas@denf.uhu.es	Rojas Ocaña, María Jesús/AAE-1739-2020; Garcia-Navarro, E. Begoña/ABH-3242-2020; Sánchez-Ramos, José Luis/G-1259-2011	Rojas Ocaña, María Jesús/0000-0003-1781-4548; Garcia-Navarro, E. Begoña/0000-0001-6913-8882; Sánchez-Ramos, José Luis/0000-0001-7187-9989; MACIAS, ISRAEL/0000-0003-3846-038X				[Anonymous], 2018, CLIN PRACT GUID NONS; [Anonymous], 2010, NATL CLASSIFICATION; [Anonymous], 2018, STAT ACC WORK YEAR 2; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Coenen P, 2014, OCCUP ENVIRON MED, V71, P871, DOI 10.1136/oemed-2014-102346; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Campayo JG, 2008, MED CLIN-BARCELONA, V131, P487; Gheldof ELM, 2006, EUR J PAIN, V10, P513, DOI 10.1016/j.ejpain.2005.07.005; Gomez-Perez L, 2011, J PAIN, V12, P425, DOI 10.1016/j.jpain.2010.08.004; Haldeman S, 2018, EUR SPINE J, V27, P901, DOI 10.1007/s00586-018-5721-y; Heneweer H, 2007, SPINE, V32, P586, DOI 10.1097/01.brs.0000256447.72623.56; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hurwitz EL, 2018, EUR SPINE J, V27, P796, DOI 10.1007/s00586-017-5432-9; Ioannou L, 2018, INJURY, V49, P990, DOI 10.1016/j.injury.2018.03.013; Kovacs FM, 2006, SPINE, V31, P104, DOI 10.1097/01.brs.0000193912.36742.4f; Kovacs FM, 2005, SPINE, V30, pE676, DOI 10.1097/01.brs.0000186468.29359.e4; Kovacs FM, 2002, SPINE, V27, P538, DOI 10.1097/00007632-200203010-00016; Kovacs FM, 2007, SPINE, V32, P1761, DOI 10.1097/BRS.0b013e3180b9f5f7; Kovacs FM, 2012, SPINE J, V12, P545, DOI 10.1016/j.spinee.2012.06.002; Kovacs FM, 2011, SPINE, V36, P339, DOI 10.1097/BRS.0b013e3181cfba29; Lochting I, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0593-0; Diaz-Cerrillo JL, 2019, ATEN PRIM, V51, P3, DOI 10.1016/j.aprim.2017.07.003; Luque-Suarez A, 2019, BRIT J SPORT MED, V53, P554, DOI 10.1136/bjsports-2017-098673; Niederstrasser NG, 2015, J PAIN, V16, P1065, DOI 10.1016/j.jpain.2015.07.008; Oliveira CB, 2018, EUR SPINE J, V27, P2791, DOI 10.1007/s00586-018-5673-2; Olmedilla Zafra Aurelio, 2013, CPD, V13, P83, DOI 10.4321/s1578-84232013000100009; OzFoodNet, 2011, COMMUN DIS INTELL, V36, pE188; Parr JJ, 2012, J PAIN, V13, P370, DOI 10.1016/j.jpain.2011.12.011; Ramirez-Maestre C, 2017, INT J BEHAV MED, V24, P239, DOI 10.1007/s12529-016-9600-9; Rogers M, 2016, RISK MANAG HEALTHC P, V9, P185, DOI [10.2147/RMHP.S107721, DOI 10.2147/RMHP.S107721]; Schaafsma FG, 2015, BEST PRACT RES CL RH, V29, P483, DOI 10.1016/j.berh.2015.04.028; Shankar S, 2015, J BACK MUSCULOSKELET, V28, P481, DOI 10.3233/BMR-140544; SKOVRON ML, 1992, BAILLIERE CLIN RHEUM, V6, P559, DOI 10.1016/S0950-3579(05)80127-X; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Swinkels-Meewisse IEJ, 2006, PAIN, V120, P36, DOI 10.1016/j.pain.2005.10.005; Tkachuk GA, 2012, J PAIN, V13, P970, DOI 10.1016/j.jpain.2012.07.001; Virtanen M, 2006, OCCUP ENVIRON MED, V63, P212, DOI 10.1136/oem.2005.020297; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waongenngarm P, 2018, APPL ERGON, V68, P230, DOI 10.1016/j.apergo.2017.12.003; Wertli MM, 2014, SPINE J, V14, P2639, DOI 10.1016/j.spinee.2014.03.003; Westman AE, 2011, CLIN J PAIN, V27, P567, DOI 10.1097/AJP.0b013e318219ab6c; Wideman TH, 2011, PAIN, V152, P376, DOI 10.1016/j.pain.2010.10.044; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Yang HO, 2016, AM J IND MED, V59, P549, DOI 10.1002/ajim.22602; Zale EL, 2013, J PAIN, V14, P1019, DOI 10.1016/j.jpain.2013.05.005	47	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242994	10.1371/journal.pone.0242994	http://dx.doi.org/10.1371/journal.pone.0242994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301458	Green Published, gold			2022-12-26	WOS:000600143100054
J	Aheto, JMK; Udofia, EA; Kallson, E; Mensah, G; Nadia, M; Nirmala, N; Chatterji, S; Kowal, P; Biritwum, R; Yawson, AE				Aheto, Justice Moses K.; Udofia, Emilia A.; Kallson, Eugene; Mensah, George; Nadia, Minicuci; Nirmala, Naidoo; Chatterji, Somnath; Kowal, Paul; Biritwum, Richard; Yawson, Alfred E.			Prevalence, socio-demographic and environmental determinants of asthma in 4621 Ghanaian adults: Evidence from Wave 2 of the World Health Organization's study on global AGEing and adult health	PLOS ONE			English	Article							CHRONIC NONCOMMUNICABLE DISEASES; RISK-FACTORS; COMMUNITIES	Background A previous multi-site study involving lower- and middle-income countries demonstrated that asthma in older adults is associated with long-term exposure to particulate matter, male gender and smoking. However, variations may occur within individual countries, which are relevant to inform health promoting policies as populations live longer. The present study estimates asthma prevalence and examines the sociodemographic characteristics and environmental determinants associated with asthma in older adults in Ghana. Methods This study utilised data from the nationally representative World Health Organization Study on global AGEing and adult health (SAGE) Ghana Wave 2. A final sample of 4621 individuals residing in 3970 households was used in analytical modelling. Factors associated with asthma were investigated using single level and multilevel binary logistic regression models. Results Asthma was reported by 102 (2.2%) respondents. Factors associated with asthma in the univariate model were: those aged 60-69 (OR = 5.22, 95% CI: 1.24, 21.95) and 70 or more (OR = 5.56, 95% CI: 1.33, 23.26) years, Ga-Adangbe dialect group (OR = 1.65, 95% CI: 1.01, 2.71), no religion (OR = 3.59, 95% CI: 1.77, 7.28), having moderate (OR = 1.76, 95% CI: 1.13, 2.75) and bad/very bad (OR = 2.75, 95% CI: 1.58, 4.80) health state, and severe/extreme difficulty with self-care (OR = 3.49, 95% CI: 1.23, 9.88) and non-flush toilet facility (OR = 0.62, 95% CI: 0.39, 0.99). Factors independently associated with asthma in the adjusted models were: those aged 60-69 (OR = 4.49, 95% CI: 1.03, 19.55) years, father with primary education or less (OR = 0.40, 95% CI: 0.17, 0.94), no religion (OR = 2.52, 95% CI: 1.18, 5.41), and households with non-flush toilet facility (OR = 0.58, 95% CI: 0.35, 0.96). Significant residual household-level variation in asthma was observed. Over 40% of variance in asthma episodes could be attributable to residual household-level variations. Conclusion Individual as well as household factors were seen to influence the prevalence of asthma in this national survey. Clinical management of these patients in health facilities should consider household factors in addition to individual level factors.	[Aheto, Justice Moses K.; Yawson, Alfred E.] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Udofia, Emilia A.; Mensah, George; Biritwum, Richard; Yawson, Alfred E.] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Accra, Ghana; [Kallson, Eugene] Deloitte Consulting, West Africa Deloitte & Touche, Accra, Ghana; [Nadia, Minicuci] CNR, Inst Neurosci, Padua, Italy; [Nirmala, Naidoo; Chatterji, Somnath; Kowal, Paul] World Hlth Org HIS HIS MCS, Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Newcastle, NSW, Australia	University of Ghana; University of Ghana; Consiglio Nazionale delle Ricerche (CNR); University of Newcastle	Aheto, JMK (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Accra, Ghana.	justiceaheto@yahoo.com	Aheto, Justice Moses K./H-8890-2019; Udofia, Emilia Asuquo/AAQ-6729-2020	Aheto, Justice Moses K./0000-0003-1384-2461; Udofia, Emilia Asuquo/0000-0002-7279-1839; Kallson, Eugene/0000-0002-1148-7227	US National Institute on Aging [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01]; World Health Organization; Ministry of Health, Ghana;  [R01 AG034479-64401A1]	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); World Health Organization(World Health Organization); Ministry of Health, Ghana; 	We are grateful to the World Health Organization and her partners who made the SAGE study possible and provided us with the data at no cost. We are also thankful to all respondents and interviewers who participated in the SAGE survey in Ghana. The Ministry of Health, Ghana, is supportive of SAGE. The University of Ghana's Department of Community Health contributed training facilities, data entry support, and storage of materials. The Ghana Statistical Service provided the sampling information for the sampling frame and updates.; Funding was obtained for the main WHO SAGE Wave 2 Survey in Ghana with financial support provided by the US National Institute on Aging through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) with the World Health Organization and a Research Project Grant (R01 AG034479-64401A1). The funder provided support in the form of salaries for authors [RB, AEY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. However, the work in this study did not receive any funding support. Also, Deloitte Consulting, West Africa Deloitte & Touche did not provide any financial support for the study and played no role in the study".	Abalo EM, 2018, GERONTOL GERIATR MED, V4, DOI 10.1177/2333721418796663; Addo-Yobo EOD, 2001, J ALLERGY CLIN IMMUN, V108, P363, DOI 10.1067/mai.2001.117464; Aggarwal A N, 2006, Indian J Chest Dis Allied Sci, V48, P13; Ahmedani BK, 2013, ANN ALLERG ASTHMA IM, V110, P75, DOI 10.1016/j.anai.2012.11.006; Akinbami Lara J, 2012, NCHS Data Brief, P1; Allen S, 2009, THORAX, V64, P610, DOI 10.1136/thx.2008.101469; Amoah A S, 2012, Ghana Med J, V46, P23; Anum Philip O, 2017, J Pharm Policy Pract, V10, P8, DOI 10.1186/s40545-017-0097-7; Arokiasamy P, 2017, AM J EPIDEMIOL, V185, P414, DOI 10.1093/aje/kww125; Ayaaba E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030337; Badasu DM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5211-5; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Calys-Tagoe B N L, 2014, Ghana Med J, V48, P178, DOI 10.4314/gmj.v48i4.2; Charlton K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013316; Cotton S, 2012, J RELIG HEALTH, V51, P118, DOI 10.1007/s10943-010-9408-x; Desalu O O, 2009, Afr J Med Med Sci, V38, P149; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Druedahl LC, 2018, PHARMACY-BASEL, V6, DOI 10.3390/pharmacy6030073; Fu QL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111084; Global Initiative for Asthma, GLOB STRAT ASTH MAN; Goldberg S, 2007, CHEST, V131, P1747, DOI 10.1378/chest.06-2818; Hahn RA, 2015, INT J HEALTH SERV, V45, P657, DOI 10.1177/0020731415585986; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Harvey IS, 2007, J CROSS-CULT GERONTO, V22, P205, DOI 10.1007/s10823-007-9038-2; Hayek S, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.170038; Hedeker D, 1996, COMPUT METH PROG BIO, V49, P157, DOI 10.1016/0169-2607(96)01720-8; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Idler E, 2014, RELIG SOCIAL DETERMI, P1, DOI DOI 10.1093/ACPR0F:0S0/9780199362202.001.0001; Jie Y, 2013, REV ENVIRON CONTAM T, V226, P33, DOI 10.1007/978-1-4614-6898-1_2; Johnson DL, 2013, AM J INFECT CONTROL, V41, P254, DOI 10.1016/j.ajic.2012.04.330; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Kumar R, 2008, CURR OPIN PEDIATR, V20, P682, DOI 10.1097/MOP.0b013e3283154f26; Letamo G, 2017, INT HEALTH, V9, P11, DOI 10.1093/inthealth/ihw052; Leung R, 1997, EUR RESPIR J, V10, P354, DOI 10.1183/09031936.97.10020354; Lin JT, 2018, RESP MED, V137, P48, DOI 10.1016/j.rmed.2018.02.010; Maselli DJ, 2018, PULM PHARMACOL THER, V52, P27, DOI 10.1016/j.pupt.2018.08.006; Morgan BW, 2018, J ALLER CL IMM-PRACT, V6, P1580, DOI 10.1016/j.jaip.2017.11.032; Nafti S, 2009, RESP MED, V103, pS2, DOI 10.1016/S0954-6111(09)70022-8; Nkosi V, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0018-7; Obel KB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176875; Pefura-Yone EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123099; Petronella SA, 2003, NURS CLIN N AM, V38, P725, DOI 10.1016/S0029-6465(03)00099-9; Shukla SK, 2003, EIGHTH IEEE INTERNATIONAL HIGH-LEVEL DESIGN VALIDATION AND TEST WORKSHOP, PROCEEDINGS, P3, DOI 10.1109/HLDVT.2003.1252467; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Sonia T, 2018, CLIN RESPIR J, V12, P608, DOI 10.1111/crj.12570; Soriano JB, 2020, LANCET RESP MED, V8, P585, DOI 10.1016/S2213-2600(20)30105-3; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; StataCorp, 2015, STAT SOFTW REL 14; Steele F, 2007, HANDB STAT, V26, P401, DOI 10.1016/S0169-7161(06)26012-7; Stevens W, 2011, CLIN EXP ALLERGY, V41, P1587, DOI 10.1111/j.1365-2222.2011.03832.x; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Sullivan A, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0479-4; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Urbstonaitis R, 2019, RES SOC ADMIN PHARM, V15, P61, DOI 10.1016/j.sapharm.2018.03.003; Walraven GEL, 2001, CLIN EXP ALLERGY, V31, P1679, DOI 10.1046/j.1365-2222.2001.01094.x; Wang CS, 2018, RESPIROLOGY, V23, P901, DOI 10.1111/resp.13339; Wjst M, 2007, PLOS MED, V4, P203, DOI 10.1371/journal.pmed.0040072; Zemedkun K, 2014, ETHIOP J HEALTH SCI, V24, P49, DOI 10.4314/ejhs.v24i1.7	59	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243642	10.1371/journal.pone.0243642	http://dx.doi.org/10.1371/journal.pone.0243642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296442	Green Published, gold			2022-12-26	WOS:000598626100035
J	Hefele, L; Syphan, S; Xayavong, D; Homsana, A; Kleine, D; Chanthavilay, P; Nouanthong, P; Xaydalasouk, K; Phathammavong, O; Billamay, S; Xeuatvongsa, A; Reinharz, D; Black, AP; Muller, CP				Hefele, Lisa; Syphan, Sengdavanh; Xayavong, Dalouny; Homsana, Anousin; Kleine, Daria; Chanthavilay, Phetsavanh; Nouanthong, Phonethipsavanh; Xaydalasouk, Kinnaly; Phathammavong, Outavong; Billamay, Somxay; Xeuatvongsa, Anonh; Reinharz, Daniel; Black, Antony P.; Muller, Claude P.			Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study	PLOS ONE			English	Article							CHILDHOOD VACCINATIONS; COMPLETION; CHILDREN	Background The timely administration of vaccines is considered to be important for both individual and herd immunity. In this study, we investigated the timeliness of the diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b (pentavalent) vaccine, scheduled at 6, 10 and 14 weeks of age in the Lao People's Democratic Republic. We also investigated factors associated with delayed immunization. Methods 1162 children aged 8-28 months who had received the full course of the pentavalent vaccine at different levels of the health care system were enrolled. Vaccination dates documented in hospital records and/or immunisation cards were recorded. Age at vaccination and time intervals between doses were calculated. Predictors for timely completion with the pentavalent vaccine at 24 weeks were assessed by bivariate and multivariable analyses. Results Several discrepancies in dates between vaccination documents were observed. In general, vaccination with the pentavalent vaccine was found to be delayed, especially in health care settings below the provincial hospital level. Compared to the central hospital level, less participants who were vaccinated at the district/health center level received the third dose by 16 (48% at the central hospital level vs. 7.1% at the district and 12.4% at the health center level) and 24 weeks of age (94.4% at the central hospital level vs 64.6% at the district-outreach and 57.4% at the health center level) respectively. In logistic regression analyses, lower education level of the mother as well as vaccination by outreach service, were independently associated with delayed completion of vaccination. Conclusion We observed a general delay of vaccination, especially at lower ranked facilities, which correlated with indicators of poor access to health services. This highlights the need for further improving health equity in rural areas. Age-appropriate vaccination should become a quality indicator for the national immunization programme. In addition, we recommend further training of the health care staff regarding the importance of reliable documentation of dates.	[Hefele, Lisa; Kleine, Daria; Nouanthong, Phonethipsavanh; Xaydalasouk, Kinnaly; Black, Antony P.; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos; [Hefele, Lisa; Kleine, Daria; Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Syphan, Sengdavanh; Xayavong, Dalouny; Homsana, Anousin; Chanthavilay, Phetsavanh; Reinharz, Daniel] Lao Trop & Publ Hlth Inst, Viangchan, Laos; [Phathammavong, Outavong] Luxembourg Dev Cooperat Agcy, Viangchan, Laos; [Billamay, Somxay] Children Hosp, Viangchan, Laos; [Xeuatvongsa, Anonh] Expanded Programme Immunisat, Viangchan, Laos; [Reinharz, Daniel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Syphan, Sengdavanh] Minist Hlth, Dept Hyg & Hlth Promot, Viangchan, Laos; [Xayavong, Dalouny] Natl Ctr Lab & Epidemiol, Viangchan, Laos; [Homsana, Anousin] Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Kleine, Daria] Saarland Univ, Homburg, Germany; [Chanthavilay, Phetsavanh] Univ Hlth Sci, Inst Res & Educ Dev, Viangchan, Laos	Luxembourg Institute of Health; Laval University; Universitatsklinikum des Saarlandes	Hefele, L (corresponding author), Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos.	lisa.hefele@lih.lu			Ministry of Foreign and European Affairs, Luxembourg; Luxembourg Institute of Health; AUF (l'Agence universitaire de la Francophonie)	Ministry of Foreign and European Affairs, Luxembourg; Luxembourg Institute of Health; AUF (l'Agence universitaire de la Francophonie)	This work was supported by the Ministry of Foreign and European Affairs, Luxembourg (project "Luxembourg-Laos Partnership for Research and Capacity Building in Infectious Disease Surveillance II") and the Luxembourg Institute of Health and the AUF (l'Agence universitaire de la Francophonie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkhavong Kongsap Paphassarang C, 2014, HLTH SYSTEM REV; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2019, OIE B, V2, P2, DOI DOI 10.18254/S207751800005912-2.[ABRAM0V; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; CDC, ACIP GEN BEST PRACT; Choudhary TS, 2019, VACCINE, V37, P2331, DOI 10.1016/j.vaccine.2019.03.039; Christiansen TB, 2010, EPIDATA COMPREHENSIV; An DTM, 2016, GLOBAL HEALTH ACTION, V9, P38, DOI 10.3402/gha.v9.29189; ECCIL, 2017, LAO SOC IND SURV 2 2; Fox J., 2014, R COMPANION APPL REG; Hefele L, 2019, CLIN INFECT DIS, V69, P2136, DOI 10.1093/cid/ciz143; Kurosky SK, 2017, HUM VACC IMMUNOTHER, V13, P2494, DOI 10.1080/21645515.2017.1362515; Lao Statistics Bureau, 2012, LAO SOC IND SURV 1 2; Lao Statistics Bureau, 2018, YEARB; Laubereau B, 2002, EPIDEMIOL INFECT, V128, P185, DOI 10.1017/S0950268801006550; Mangiafico S, 2016, rcompanion: Functions to support extension education program evaluation [R statistical package]; Masters NB, 2019, HUM VACC IMMUNOTHER, V15, P2790, DOI 10.1080/21645515.2019.1616503; Mbengue Mouhamed Abdou Salam, 2017, Pan Afr Med J, V27, P8, DOI 10.11604/pamj.supp.2017.27.3.11534; Mvula H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154997; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Orije MRP, 2020, VACCINE, V38, P20, DOI 10.1016/j.vaccine.2019.10.025; Pholsena S, 2009, HLTH PROMOT SUSTAIN, V4, P71; Phoummalaysith B, 2018, VACCINE, V36, P2666, DOI 10.1016/j.vaccine.2018.03.051; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Saso A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01499; Strategic Advisory Group of Experts on Immunization, 2017, WEEKLY EPIDEMIOLOGIC, P369; Subbiah P, 2019, INT J COMMUNITY MED, V6, P2127; Sychareun V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-255; Tang XY, 2017, J EPIDEMIOL, V27, P317, DOI 10.1016/j.je.2016.08.006; Venables WN, 2002, MODERN; Walton S, 2017, VACCINE, V35, P7166, DOI 10.1016/j.vaccine.2017.10.085; WHO, 2019, TABL 1 SUMM WHO POS; WHO, 2012, INT REV EXP PROGR IM; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; World Health Organization, 2019, EPI FACTSH THAIL; World Health Organization, 2018, OV LAO HLTH SYST DEV, Vvii, P87; World Health Organization, 2012, HLTH SERVICE DELIVER; World Health Organization United Nations Children's Fund, 2017, LAO PEOPL DEM REP WH; World Health Organization United Nations Children's Fund, 2019, LAO PEOPL DEM REP WH; Zeileis A., R NEWS, V2, P7	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0242502	10.1371/journal.pone.0242502	http://dx.doi.org/10.1371/journal.pone.0242502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290386	Green Published, gold			2022-12-26	WOS:000598620100031
J	Savicki, C; Camargo, NHA; Gemelli, E				Savicki, Cristiane; Camargo, Nelson Heriberto Almeida; Gemelli, Enori			Crystallization of carboplatin-loaded onto microporous calcium phosphate using high-vacuum method: Characterization and release study	PLOS ONE			English	Article							DRUG-DELIVERY-SYSTEM; DENSITY-FUNCTIONAL THEORY; HYDROXYAPATITE NANOCRYSTALS; PHYSICOCHEMICAL CHARACTERIZATION; BONE REGENERATION; LOCAL-DELIVERY; IN-VIVO; NANOPARTICLES; BIOCERAMICS; ADSORPTION	Drug delivery systems are a new approach to increase therapeutic efficacy and to reduce the side effects of traditional treatments. Calcium phosphates (CaPs) have been studied as drug delivery systems, especially in bone diseases. However, each system has some particularities that depend on the physical and chemical characteristics of the biomaterials and drug interaction. In this work, granulated CaPs were used as a matrix for loading the anticancer drug carboplatin using the high-vacuum method. Five compositions were applied: hydroxyapatite (HA), beta-tricalcium phosphate (beta-TCP), biphasic HAp 60%/beta-TCP 40% (BCP), beta-TCP/MgO nanocomposite, and beta-TCP/SiO2 nanocomposite. Carboplatin drug in 50, 60, and 70 mg/g was precipitated on the surface of CaPs. Morphological, chemical and surface modifications in the carboplatin-CaPs were investigated by scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), backscattered electron microscopy (BSE), X-ray diffraction (XRD), X-ray fluorescence spectroscopy (XRF), Fourier transform infrared (FT-IR), and Raman spectroscopy. The characterization of the CaP-carboplatin biomaterials showed heterogeneous crystalline precipitation of the drug, and no morphological modifications of the CaPs biomaterials. The in vitro release profile of carboplatin from CaPs was evaluated by the ultraviolet-visible (UV-Vis) method. The curves showed a burst release of upon 60% of carboplatin loaded followed by a slow-release of the drug for the time of the study. The results were typical of a low-interaction system and physisorption mechanism. The high-vacuum method permitted to load the high amount of carboplatin drug on the surface of the biomaterials despite the low interaction between carboplatin and CaPs.	[Savicki, Cristiane; Camargo, Nelson Heriberto Almeida; Gemelli, Enori] Santa Catarina State Univ, Dept Mech Engn, Coll Technol Sci, Joinville, SC, Brazil	Universidade do Estado de Santa Catarina	Savicki, C (corresponding author), Santa Catarina State Univ, Dept Mech Engn, Coll Technol Sci, Joinville, SC, Brazil.	cristianesavicki@gmail.com		Savicki, Cristiane/0000-0002-7323-7573	Coordination for the Improvement of Higher Education Personnel -Brasil (CAPES) [001]; Foundation for the Support of the Scientific and Technological Research of Santa Catarina State (FAPESC)	Coordination for the Improvement of Higher Education Personnel -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for the Support of the Scientific and Technological Research of Santa Catarina State (FAPESC)	This study was financed in part by the Coordination for the Improvement of Higher Education Personnel -Brasil (CAPES) -Finance Code 001 -https://capes.gov.br, and Foundation for the Support of the Scientific and Technological Research of Santa Catarina State (FAPESC) -www.fapesc.sc.gov.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2015, ADV DRUG DELIVER REV, V94, P53, DOI 10.1016/j.addr.2015.03.013; [Anonymous], 2016, LANCET PSYCHIAT, V3, P187, DOI 10.1016/S2215-0366(16)00047-X; Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028; Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039; Arshad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132266; Baradari H, 2012, J EUR CERAM SOC, V32, P2679, DOI 10.1016/j.jeurceramsoc.2012.01.018; Barbosa MC, 2013, MAT SCI ENG C-MATER, V33, P2620, DOI 10.1016/j.msec.2013.02.027; Barroug A, 2004, J ORTHOP RES, V22, P703, DOI 10.1016/j.orthres.2003.10.016; Barroug A, 2002, J ORTHOPAED RES, V20, P274, DOI 10.1016/S0736-0266(01)00105-X; Benedetti M, 2016, J INORG BIOCHEM, V157, P73, DOI 10.1016/j.jinorgbio.2016.01.019; Benedetti M, 2015, J INORG BIOCHEM, V153, P279, DOI 10.1016/j.jinorgbio.2015.04.006; Benedini L, 2019, MAT SCI ENG C-MATER, V99, P180, DOI 10.1016/j.msec.2019.01.098; Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027; Bose S, 2011, JOM-US, V63, P93, DOI 10.1007/s11837-011-0065-7; Bose S, 2011, BONE, V48, P1282, DOI 10.1016/j.bone.2011.03.685; Bragta P, 2018, COLLOID SURFACE B, V166, P339, DOI 10.1016/j.colsurfb.2018.03.009; Bruni G, 2009, J THERM ANAL CALORIM, V95, P871, DOI 10.1007/s10973-008-9384-5; Camargo N.H.A., 2014, ADV MATER RES-KR, V936, P687, DOI [10.4028/www.scientific.net/AMR.936.687, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.936.687]; Cares-Pacheco MG, 2014, INT J PHARMACEUT, V475, P69, DOI 10.1016/j.ijpharm.2014.08.029; Chevalier E, 2009, DRUG DEV IND PHARM, V35, P1255, DOI 10.1080/03639040902882298; Ciobanu G, 2019, CERAM INT, V45, P2852, DOI 10.1016/j.ceramint.2018.07.290; da Silva NMP, 2016, KONA POWDER PART J, P219; Dalmonico GML, 2017, BIOMATER SCI-UK, V5, P1315, DOI 10.1039/c7bm00162b; Dhatchayani S, 2020, J DRUG DELIV SCI TEC, V60, DOI 10.1016/j.jddst.2020.101963; Minh DP, 2013, MAT SCI ENG C-MATER, V33, P2971, DOI 10.1016/j.msec.2013.03.023; Minh DP, 2013, IND ENG CHEM RES, V52, P1439, DOI 10.1021/ie302422d; Draenert M, 2013, MICROSC RES TECHNIQ, V76, P370, DOI 10.1002/jemt.22176; Drouet C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/490946; El-Shahawy AAG, 2018, MAT SCI ENG C-MATER, V91, P361, DOI 10.1016/j.msec.2018.05.042; Ficai D, 2015, DRUG DES DEV THER, V9, P1269, DOI 10.2147/DDDT.S62805; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P1, DOI DOI 10.1155/2015/528103; Gbureck U, 2007, J CONTROL RELEASE, V122, P173, DOI 10.1016/j.jconrel.2007.06.022; Giese B, 2002, BIOPOLYMERS, V67, P294, DOI 10.1002/bip.10091; Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008; Goldstein J.I., 2018, SCANNING ELECT MICRO, P550; Guinel MJF, 2013, J MICROSC-OXFORD, V252, P49, DOI 10.1111/jmi.12067; Hassanzadeganroudsari M, 2019, J NANOPART RES, V21, DOI 10.1007/s11051-019-4562-x; Iafisco M, 2012, J INORG BIOCHEM, V117, P237, DOI 10.1016/j.jinorgbio.2012.06.004; Ikawa N, 2010, CHEM COMMUN, V46, P4342, DOI 10.1039/c0cc00217h; Itokazu M, 1999, J MATER SCI-MATER M, V10, P249, DOI 10.1023/A:1008966314075; Jiang SH, 2017, ACS APPL MATER INTER, V9, P32308, DOI 10.1021/acsami.7b11045; Khalifehzadeh R, 2020, ADV COLLOID INTERFAC, V279, DOI 10.1016/j.cis.2020.102157; Kim IY, 2016, CERAM INT, V42, P1886, DOI 10.1016/j.ceramint.2015.09.156; Krukiewicz K, 2016, MAT SCI ENG C-MATER, V62, P927, DOI 10.1016/j.msec.2016.01.063; Kruppke B, 2018, J BIOMED MATER RES B, V106, P1165, DOI 10.1002/jbm.b.33931; Laurent F, 2008, J MATER SCI-MATER M, V19, P947, DOI 10.1007/s10856-007-0163-9; Lelli M, 2016, DALTON T, V45, P13187, DOI 10.1039/c6dt01976e; Lu CY, 2009, APPL CATAL A-GEN, V354, P57, DOI 10.1016/j.apcata.2008.11.011; Lucas-Aparicio J, 2020, MAT SCI ENG C-MATER, V106, DOI 10.1016/j.msec.2019.110173; Manchon A, 2017, CURR PHARM BIOTECHNO, V18, P52, DOI 10.2174/1389201018666161114145827; Marques CF, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5733-2; Mondal S, 2018, WIRES NANOMED NANOBI, V10, DOI 10.1002/wnan.1504; Moorthi PP, 2015, SPECTROCHIM ACTA A, V137, P412, DOI 10.1016/j.saa.2014.08.066; Munaweera I, 2015, MOL PHARMACEUT, V12, P3588, DOI 10.1021/acs.molpharmaceut.5b00304; Murata T, 2018, ANTICANCER RES, V38, P6715, DOI 10.21873/anticanres.13040; Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Nosenko VV, 2016, J RAMAN SPECTROSC, V47, P726, DOI 10.1002/jrs.4883; Nouri A, 2012, INT J PHARMACEUT, V434, P199, DOI 10.1016/j.ijpharm.2012.05.066; Parent M, 2017, J CONTROL RELEASE, V252, P1, DOI 10.1016/j.jconrel.2017.02.012; Pizzoccaro MA, 2016, ACTA BIOMATER, V41, P342, DOI 10.1016/j.actbio.2016.06.008; Ramirez-Agudelo R, 2018, MAT SCI ENG C-MATER, V83, P25, DOI 10.1016/j.msec.2017.08.012; Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Saber-Samandari S, 2016, CRIT REV THER DRUG, V33, P41, DOI 10.1615/CritRevTherDrugCarrierSyst.v33.i1.30; Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014; Shao FW, 2012, J MATER SCI, V47, P1054, DOI 10.1007/s10853-011-5894-9; Silva DF, 2016, J MATER CHEM B, V4, P6842, DOI 10.1039/c6tb02255c; Souza KC, 2009, J MATER SCI-MATER M, V20, P507, DOI 10.1007/s10856-008-3592-1; Swet JH, 2014, J BIOMED MATER RES B, V102, P190, DOI 10.1002/jbm.b.32995; Takeyama H, 2006, ANTICANCER RES, V26, P4603; Tarafder S, 2013, MAT SCI ENG C-MATER, V33, P3121, DOI 10.1016/j.msec.2013.02.049; Tseng CL, 2015, J BIOMATER APPL, V30, P388, DOI 10.1177/0885328215588307; UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317; Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586; Venkatasubbu GD, 2013, POWDER TECHNOL, V235, P437, DOI 10.1016/j.powtec.2012.11.003; Verron E, 2010, DRUG DISCOV TODAY, V15, P547, DOI 10.1016/j.drudis.2010.05.003; Wang J, 2017, ACTA BIOMATER, V51, P447, DOI 10.1016/j.actbio.2017.01.059; Wang XY, 2013, CHEM SOC REV, V42, P202, DOI 10.1039/c2cs35259a; Watanabe K, 2013, INT J PHARMACEUT, V446, P81, DOI 10.1016/j.ijpharm.2013.02.002; Wysokinski R, 2006, J MOL STRUC-THEOCHEM, V758, P169, DOI 10.1016/j.theochem.2005.10.032; Xiang AS, 2011, J MEMBRANE SCI, V371, P211, DOI 10.1016/j.memsci.2011.01.050; Xiang AS, 2011, J MEMBRANE SCI, V366, P104, DOI 10.1016/j.memsci.2010.09.052; Yelten-Yilmaz A, 2018, CERAM INT, V44, P9703, DOI 10.1016/j.ceramint.2018.02.201; Yue YT, 2005, J PHYS D APPL PHYS, V38, P1966, DOI 10.1088/0022-3727/38/12/017; Zhao QF, 2011, APPL SURF SCI, V257, P10126, DOI 10.1016/j.apsusc.2011.06.161; Zhu M, 2011, BIOMATERIALS, V32, P1986, DOI 10.1016/j.biomaterials.2010.11.025; Zhu Y, 2017, BIOMATERIALS, V147, P133, DOI 10.1016/j.biomaterials.2017.09.018	88	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0242565	10.1371/journal.pone.0242565	http://dx.doi.org/10.1371/journal.pone.0242565			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290399	gold, Green Published			2022-12-26	WOS:000598620100032
J	Jakes, AF; DeCesare, NJ; Jones, PF; Gates, CC; Story, SJ; Olimb, SK; Kunkel, KE; Hebblewhite, M				Jakes, Andrew F.; DeCesare, Nicholas J.; Jones, Paul F.; Gates, C. Cormack; Story, Scott J.; Olimb, Sarah K.; Kunkel, Kyran E.; Hebblewhite, Mark			Multi-scale habitat assessment of pronghorn migration routes	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; UNGULATE MIGRATION; SCALE DEPENDENCE; MULE DEER; PATTERNS; CONSERVATION; RESPONSES; MOVEMENT; FORAGE; TERRESTRIAL	We studied the habitat selection of pronghorn (Antilocapra americana) during seasonal migration; an important period in an animal's annual cycle associated with broad-scale movements. We further decompose our understanding of migration habitat itself as the product of both broad- and fine-scale behavioral decisions and take a multi-scale approach to assess pronghorn spring and fall migration across the transboundary Northern Sagebrush Steppe region. We used a hierarchical habitat selection framework to assess a suite of natural and anthropogenic features that have been shown to influence selection patterns of pronghorn at both broad (migratory neighborhood) and fine (migratory pathway) scales. We then combined single-scale predictions into a scale-integrated step selection function (ISSF) map to assess its effectiveness in predicting migration route habitat. During spring, pronghorn selected for native grasslands, areas of high forage productivity (NDVI), and avoided human activity (i.e., roads and oil and natural gas wells). During fall, pronghorn selected for native grasslands, larger streams and rivers, and avoided roads. We detected avoidance of paved roads, unpaved roads, and wells at broad spatial scales, but no response to these features at fine scales. In other words, migratory pronghorn responded more strongly to anthropogenic features when selecting a broad neighborhood through which to migrate than when selecting individual steps along their migratory pathway. Our results demonstrate that scales of migratory route selection are hierarchically nested within each other from broader (second-order) to finer scales (third-order). In addition, we found other variables during particular migratory periods (i.e., native grasslands in spring) were selected for across scales indicating their importance for pronghorn. The mapping of ungulate migration habitat is a topic of high conservation relevance. In some applications, corridors are mapped according to telemetry location data from a sample of animals, with the assumption that the sample adequately represents habitat for the entire population. Our use of multi-scale modelling to predict resource selection during migration shows promise and may offer another relevant alternative for use in future conservation planning and land management decisions where telemetry-based sampling is unavailable or incomplete.	[Jakes, Andrew F.; Gates, C. Cormack] Univ Calgary, Fac Environm Design, Calgary, AB, Canada; [DeCesare, Nicholas J.] Montana Fish Wildlife & Pk, Missoula, MT USA; [Jones, Paul F.] Alberta Conservat Assoc, Lethbridge, AB, Canada; [Story, Scott J.] Montana Fish Wildlife & Pk, Helena, MT USA; [Olimb, Sarah K.; Kunkel, Kyran E.] World Wildlife Fund Northern Great Plains, Bozeman, MT USA; [Hebblewhite, Mark] Univ Montana, Wildlife Biol Program, WA Franke Coll Forestry & Conservat, Missoula, MT 59812 USA; [Jakes, Andrew F.] Natl Wildlife Federat, Missoula, MT 59802 USA; [Story, Scott J.] Headwaters Econ, Bozeman, MT USA; [Kunkel, Kyran E.] Conservat Sci Collaborat Inc, Bozeman, MT USA	University of Calgary; University of Montana System; University of Montana	Jakes, AF (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB, Canada.; Jakes, AF (corresponding author), Natl Wildlife Federat, Missoula, MT 59802 USA.	jakesa@nwf.org	Hebblewhite, Mark/AAI-8101-2020; hebblewhite, mark/G-6164-2013	Hebblewhite, Mark/0000-0001-5382-1361; Olimb, Sarah/0000-0001-5714-6586	Alberta Conservation Association; PetroCanada; Sustainable Grasslands Applied Research Program; Montana Fish, Wildlife Parks; U.S. Bureau of Land Management [090-50778]; World Wildlife Fund; University of Calgary; Saskatchewan Ministry of Environment; MITACS; Alberta Sport Recreation Parks and Wildlife Foundation; MT chapter of The Wildlife Society: Counter Assault Inc.; Alberta Antelope Guides; Alberta Fish and Game Association; Alberta Professional Outfitters Society; Canadian Forces Base Suffield; Foundation for Northern American Wild Sheep - Eastern Chapter; Safari Club International; Safari Club International Alberta Chapter; Safari Club International Northern Alberta Chapter	Alberta Conservation Association; PetroCanada; Sustainable Grasslands Applied Research Program; Montana Fish, Wildlife Parks; U.S. Bureau of Land Management; World Wildlife Fund; University of Calgary; Saskatchewan Ministry of Environment; MITACS; Alberta Sport Recreation Parks and Wildlife Foundation; MT chapter of The Wildlife Society: Counter Assault Inc.; Alberta Antelope Guides; Alberta Fish and Game Association; Alberta Professional Outfitters Society; Canadian Forces Base Suffield; Foundation for Northern American Wild Sheep - Eastern Chapter; Safari Club International; Safari Club International Alberta Chapter; Safari Club International Northern Alberta Chapter	1) AFJ; Student Stipend #030-00-40-1064000; Alberta Conservation Association, PetroCanada, Sustainable Grasslands Applied Research Program; https://www.ab-conservation.com/; Yes funder had role in study design, data collection and analysis, and preparation of the manuscript. 2) AFJ; Graduate Research Stipend #080018; Montana Fish, Wildlife & Parks; http://fwp.mt.gov/; Yes -funder had role in study design, data collection and analysis; preparation of the manuscript. 3) AFJ, CCG; 090-50778; U.S. Bureau of Land Management; https://www.blm.gov; 4) AFJ; World Wildlife Fund; https://www.worldwildlife.org; Yes -funder had role in study design, data collection and analysis. 5) AFJ; University of Calgary; http://www.ucalgary.ca/6) AFJ; Saskatchewan Ministry of Environment; http://www.environment.gov.sk.ca; Yes -funder had role in study design, data collection and analysis. 7) AFJ; MITACS; http://www.mitacs.ca/accelerate 8) AFJ; Alberta Sport Recreation Parks and Wildlife Foundation; http://www.asrpwf.ca/9) AFJ; MT chapter of The Wildlife Society: Counter Assault Inc.; http://counterassault.com/10) PFJ; The Alberta Antelope Guides 11) PFJ; Alberta Fish and Game Association (Zone 1); https://www.afga.org 12) PFJ; Alberta Professional Outfitters Society; https://www.apos.ab.ca 13) PFJ; Canadian Forces Base Suffield 14) PFJ; Foundation for Northern American Wild Sheep - Eastern Chapter; https://ecwsf.org 15) PFJ; Safari Club International; https://www.safariclub.org 16) PFJ; Safari Club International Alberta Chapter; https://www.safariclub.org/alberta 17) PFJ; Safari Club International Northern Alberta Chapter; http://scinorthern.ab.ca/.	ANTONOVICS J, 1971, AM SCI, V59, P593; Bastille-Rousseau G, 2018, ECOGRAPHY, V41, P437, DOI 10.1111/ecog.02655; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann JP, 2012, BIOL CONSERV, V147, P222, DOI 10.1016/j.biocon.2012.01.003; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2006, BIOL LETT-UK, V2, P528, DOI 10.1098/rsbl.2006.0508; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Christie KS, 2017, J WILDLIFE MANAGE, V81, P154, DOI 10.1002/jwmg.21147; Collins GH, 2016, WEST N AM NATURALIST, V76, P101, DOI 10.3398/064.076.0111; Dalton K, 2009, THESIS; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Forrest SC, 2004, NO PLAINS CONSERVATI; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Gates CC, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P277, DOI 10.1007/978-1-4614-0902-1_15; Gavin SD, 2006, CAN J ZOOL, V84, P1775, DOI 10.1139/Z06-175; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hebblewhite Mark, 2011, P71; HOSKINSON RL, 1980, J WILDLIFE MANAGE, V44, P132, DOI 10.2307/3808359; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Jakes AF., 2015, THESIS; Jakes AF, 2018, J WILDLIFE MANAGE, V82, P1229, DOI 10.1002/jwmg.21485; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones PF, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2782; Jones Paul F., 2015, Prairie Naturalist, V47, P94; Kang S, 2005, INT J REMOTE SENS, V26, P1659, DOI 10.1080/01431160512331326693; Kawamura K, 2005, INT J REMOTE SENS, V26, P1423, DOI 10.1080/01431160512331326783; Kolar JL, 2011, J WILDLIFE MANAGE, V75, P198, DOI 10.1002/jwmg.32; Lendrum PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064548; Manly B.F.J., 2002, RESOURCE SELECTION A; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Meyer CB, 2006, DIVERS DISTRIB, V12, P288, DOI 10.1111/j.1366-9516.2006.00241.x; Mitchell GJ., 1980, PRONGHORN ANTELOPE A; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mysterud A, 2013, ECOLOGY, V94, P1257, DOI 10.1890/12-0505.1; National Snow and Ice Date Center (NSIDC), 2006, MODIS TERR SNOW COV; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Northrup JM, 2016, ECOL APPL, V26, P2744, DOI 10.1002/eap.1403; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; O'Gara Bart W., 2004, P109; Olimb S, 2018, GEOJOURNAL, V83, P819, DOI 10.1007/s10708-017-9805-8; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Poor EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083912; Prokopenko CM, 2017, J APPL ECOL, V54, P470, DOI 10.1111/1365-2664.12768; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sawyer H, 2005, WILDLIFE SOC B, V33, P1266, DOI 10.2193/0091-7648(2005)33[1266:MDAPMI]2.0.CO;2; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; SCHWARTZ CC, 1981, J APPL ECOL, V18, P343, DOI 10.2307/2402399; Seidler RG, 2015, CONSERV BIOL, V29, P99, DOI 10.1111/cobi.12376; Spitz DB, 2020, J ANIM ECOL, V89, P1032, DOI 10.1111/1365-2656.13167; Taylor A, 2006, TLS-TIMES LIT SUPPL, P29; TELFER ES, 1984, ECOLOGY, V65, P1828, DOI 10.2307/1937779; Therneau Terry M, 2021, CRAN; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; World Wildlife Fund (WWF), 2017, NO GREAT PLAINS PROG; Yoakum Jim D., 2004, P571; Zimmer K., 2012, SPATIAL TEMPORAL HAB	74	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0241042	10.1371/journal.pone.0241042	http://dx.doi.org/10.1371/journal.pone.0241042			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275623	Green Published, Green Submitted, gold			2022-12-26	WOS:000597150200006
J	AbdELminaam, DS; Almansori, AM; Taha, M; Badr, E				AbdELminaam, Diaa Salama; Almansori, Abdulrhman M.; Taha, Mohamed; Badr, Elsayed			A deep facial recognition system using computational intelligent algorithms	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS	The development of biometric applications, such as facial recognition (FR), has recently become important in smart cities. Many scientists and engineers around the world have focused on establishing increasingly robust and accurate algorithms and methods for these types of systems and their applications in everyday life. FR is developing technology with multiple real-time applications. The goal of this paper is to develop a complete FR system using transfer learning in fog computing and cloud computing. The developed system uses deep convolutional neural networks (DCNN) because of the dominant representation; there are some conditions including occlusions, expressions, illuminations, and pose, which can affect the deep FR performance. DCNN is used to extract relevant facial features. These features allow us to compare faces between them in an efficient way. The system can be trained to recognize a set of people and to learn via an online method, by integrating the new people it processes and improving its predictions on the ones it already has. The proposed recognition method was tested with different three standard machine learning algorithms (Decision Tree (DT), K Nearest Neighbor(KNN), Support Vector Machine (SVM)). The proposed system has been evaluated using three datasets of face images (SDUMLA-HMT, 113, and CASIA) via performance metrics of accuracy, precision, sensitivity, specificity, and time. The experimental results show that the proposed method achieves superiority over other algorithms according to all parameters. The suggested algorithm results in higher accuracy (99.06%), higher precision (99.12%), higher recall (99.07%), and higher specificity (99.10%) than the comparison algorithms.	[AbdELminaam, Diaa Salama; Almansori, Abdulrhman M.] Benha Univ, Fac Comp & Artificial Intelligence, Dept Informat Syst, Banha, Egypt; [AbdELminaam, Diaa Salama] Misr Int Univ, Fac Comp & Informat, Dept Comp Sci, Cairo, Egypt; [Taha, Mohamed] Benha Univ, Fac Comp & Artificial Intelligence, Dept Comp Sci, Banha, Egypt; [Badr, Elsayed] Benha Univ, Fac Comp & Artificial Intelligence, Dept Sci Comp, Banha, Egypt; [Badr, Elsayed] Higher Technol Inst, Dept Comp Sci, 10th Of Ramadan City, Egypt	Egyptian Knowledge Bank (EKB); Benha University; Egyptian Knowledge Bank (EKB); Misr International University; Egyptian Knowledge Bank (EKB); Benha University; Egyptian Knowledge Bank (EKB); Benha University; Egyptian Knowledge Bank (EKB); Higher Technological Institute - Egypt	AbdELminaam, DS (corresponding author), Benha Univ, Fac Comp & Artificial Intelligence, Dept Informat Syst, Banha, Egypt.; AbdELminaam, DS (corresponding author), Misr Int Univ, Fac Comp & Informat, Dept Comp Sci, Cairo, Egypt.	diaa.salama@fci.bu.edu.eg	Salama, Diaa/AAB-3018-2022; salama, Diaa/AAM-8669-2021; Taha, Mohamed/J-9714-2015	salama, Diaa/0000-0002-1544-9906; Taha, Mohamed/0000-0003-0885-0985	DSA Lab, Faculty of Computers and Artificial Intelligence, Benha University [28211231302952]	DSA Lab, Faculty of Computers and Artificial Intelligence, Benha University	This study was funded by a grant from DSA Lab, Faculty of Computers and Artificial Intelligence, Benha University to author DSA (28211231302952).	Al-Waisy AS, 2018, MACH VISION APPL, V29, P35, DOI 10.1007/s00138-017-0870-2; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bhatia R., 2013, INT J ADV RES COMPUT, V3, P93; Bobak AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148148; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Deng JK, 2019, PROC CVPR IEEE, P4685, DOI 10.1109/CVPR.2019.00482; Ding CX, 2018, IEEE T PATTERN ANAL, V40, P1002, DOI 10.1109/TPAMI.2017.2700390; Favelle S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209927; Gamaleldin AM, 2013, INTRO CLOUD COMPUTIN, DOI [10.1016/j.aju.2012.12.001, DOI 10.1016/J.AJU.2012.12.001]; Ghazi MM, 2016, IEEE COMPUT SOC CONF, P102, DOI 10.1109/CVPRW.2016.20; Guyon I, 1993, ADV NEURAL INFORM PR, V5, P147; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Kostopoulos SA, 2017, INT J MED INFORM, V105, P1, DOI 10.1016/j.ijmedinf.2017.05.016; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Masi I, 2016, LECT NOTES COMPUT SC, V9909, P579, DOI 10.1007/978-3-319-46454-1_35; Nasr-Esfahani E, 2016, IEEE ENG MED BIO, P1373, DOI 10.1109/EMBC.2016.7590963; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Power JD, 2018, P NATL ACAD SCI USA, V115, pE2105, DOI 10.1073/pnas.1720985115; Prakash R. Meena, 2019, 2019 International Conference on Smart Systems and Inventive Technology (ICSSIT). Proceedings, P861, DOI 10.1109/ICSSIT46314.2019.8987899; Premaladha J, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0460-2; Robertson DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150036; Roux-Sibilon A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193465; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Salama Abd-Elmiaam D, 2018, VISION 2020: SUSTAINABLE ECONOMIC DEVELOPMENT AND APPLICATION OF INNOVATION MANAGEMENT, P5733; Sareen P, 2014, INT J EMERG RES MANA, V3, P109; Schaefer G, 2014, MEMET COMPUT, V6, P233, DOI 10.1007/s12293-014-0144-8; Schiller Dominik, 2020, RELEVANCE BASED DATA; Scholkopf B, 2002, LEARNING KERNELS SUP, DOI [10.1074/mcp.m200054-mcp200, DOI 10.1074/MCP.M200054-MCP200]; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z; Sivalingam T, 2017, SSRG INT J ELECT COM, P213; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tao WD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225519; Tran L, 2017, PROC CVPR IEEE, P1283, DOI 10.1109/CVPR.2017.141; Pham TC, 2018, LECT NOTES ARTIF INT, V10752, P573, DOI 10.1007/978-3-319-75420-8_54; Valeriani D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212935; Wang H, 2018, PROC CVPR IEEE, P5265, DOI 10.1109/CVPR.2018.00552; White D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139827; Yin Y, 2011, DECIS ENG, P269	44	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242269	10.1371/journal.pone.0242269	http://dx.doi.org/10.1371/journal.pone.0242269			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270670	Green Published, gold			2022-12-26	WOS:000597149100118
J	Chung, PY; Liao, CT				Chung, Ping-Yuan; Liao, Chen-Tuo			Identification of superior parental lines for biparental crossing via genomic prediction	PLOS ONE			English	Article							SELECTION; POPULATION	A parental selection approach based on genomic prediction has been developed to help plant breeders identify a set of superior parental lines from a candidate population before conducting field trials. A classical parental selection approach based on genomic prediction usually involves truncation selection, i.e., selecting the top fraction of accessions on the basis of their genomic estimated breeding values (GEBVs). However, truncation selection inevitably results in the loss of genomic diversity during the breeding process. To preserve genomic diversity, the selection of closely related accessions should be avoided during parental selection. We thus propose a new index to quantify the genomic diversity for a set of candidate accessions, and analyze two real rice (Oryza sativa L.) genome datasets to compare several selection strategies. Our results showed that the pure truncation selection strategy produced the best starting breeding value but the least genomic diversity in the base population, leading to less genetic gain. On the other hand, strategies that considered only genomic diversity resulted in greater genomic diversity but less favorable starting breeding values, leading to more genetic gain but unsatisfactorily performing recombination inbred lines (RILs) in progeny populations. Among all strategies investigated in this study, compromised strategies, which considered both GEBVs and genomic diversity, produced the best or second-best performing RILs mainly because these strategies balance the starting breeding value with the maintenance of genomic diversity.	[Chung, Ping-Yuan; Liao, Chen-Tuo] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan	National Taiwan University	Liao, CT (corresponding author), Natl Taiwan Univ, Dept Agron, Taipei, Taiwan.	ctliao@ntu.edu.tw		Liao, Chen-Tuo/0000-0001-9777-3701	Ministry of Science and Technology, Taiwan [MOST 108-2118-M-002-002-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the Ministry of Science and Technology, Taiwan (grant number: MOST 108-2118-M-002-002-MY2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Atkison AC, 1992, OPTIMUM EXPT DESIGNS; Bernardo R, 2003, THEOR APPL GENET, V107, P1252, DOI 10.1007/s00122-003-1375-0; COVARRUBIASPAZARAN, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0156744; Gaynor RC, 2017, CROP SCI, V57, P2372, DOI 10.2135/cropsci2016.09.0742; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Haldane JBS, 1919, J GENET, V8, P299; Hayashi T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-34; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Henderson C. R, 1984, APPL LINEAR MODELS A; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Massman JM, 2013, CROP SCI, V53, P58, DOI 10.2135/cropsci2012.02.0112; Meuwissen THE, 2001, GENETICS, V157, P1819; Ou JH, 2019, THEOR APPL GENET, V132, P2781, DOI 10.1007/s00122-019-03387-0; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Rutkoski JE, 2019, ADV AGRON, V157, P217, DOI 10.1016/bs.agron.2019.05.001; Vanavermaete D, 2020, G3-GENES GENOM GENET, V10, P2753, DOI 10.1534/g3.120.401354; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Witcombe JR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-22; Yao J, 2018, CROP J, V6, P353, DOI 10.1016/j.cj.2018.05.003; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	26	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243159	10.1371/journal.pone.0243159	http://dx.doi.org/10.1371/journal.pone.0243159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270706	gold, Green Published			2022-12-26	WOS:000597149100029
J	Estermann, M; Huang, YL; Septiadi, D; Ritz, D; Liang, CY; Jacob, F; Drasler, B; Petri-Fink, A; Heinzelmann-Schwarz, V; Rothen-Rutishauser, B				Estermann, Manuela; Huang, Yen-Lin; Septiadi, Dedy; Ritz, Danilo; Liang, Ching-Yeu; Jacob, Francis; Drasler, Barbara; Petri-Fink, Alke; Heinzelmann-Schwarz, Viola; Rothen-Rutishauser, Barbara			Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; NECROSIS-FACTOR-ALPHA; DNA-DAMAGE; EXTRACELLULAR-MATRIX; RETINOBLASTOMA PROTEIN; POTENTIAL MECHANISM; DOWN-REGULATION; TNF-ALPHA; IN-VITRO; INTERLEUKIN-6	The presence of ascites in the peritoneal cavity leads to morphological and functional changes of the peritoneal mesothelial cell layer. Cells loose cell-cell interactions, rearrange their cytoskeleton, activate the production of fibronectin, and change their cell surface morphology in a proinflammatory environment. Moreover, ovarian cancer cell adhesion has been shown to be facilitated by these changes due to increased integrin- and CD44-mediated binding sites. In this study, the biological responsiveness of the human pleural mesothelial cell line MeT-5A to patient-derived and artificial ascites was studied in vitro and adhesion of ovarian cancer cells, i.e. SKOV-3 cells, investigated. Changes were mainly observed in cells exposed to artificial ascites containing higher cytokine concentrations than patient-derived ascites. Interestingly, reduced cell-cell interactions were already observed in untreated MeT-5A cells and effects on tight junction protein expression and permeability upon exposure to ascites were minor. Ascites induced upregulation of CDC42 effector protein 2 expression, which affects stress fiber formation, however significant F-actin reorganization was not observed. Moreover, fibronectin production remained unchanged. Analysis of mesothelial cell surface characteristics showed upregulated expression of intercellular adhesion molecule 1, slightly increased hyaluronic acid secretion and decreased microvillus expression upon exposure to ascites. Nevertheless, the observed changes were not sufficient to facilitate adhesion of SKOV-3 cells on MeT-5A cell layer. This study revealed that MeT-5A cells show a reduced biological responsiveness to the presence of ascites, in contrast to published studies on primary human peritoneal mesothelial cells.	[Estermann, Manuela; Septiadi, Dedy; Drasler, Barbara; Petri-Fink, Alke; Rothen-Rutishauser, Barbara] Univ Fribourg, Adolphe Merkle Inst, Fribourg, Switzerland; [Huang, Yen-Lin; Liang, Ching-Yeu; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Huang, Yen-Lin; Liang, Ching-Yeu; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Basel, Basel, Switzerland; [Ritz, Danilo] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland; [Petri-Fink, Alke] Univ Fribourg, Dept Chem, Fribourg, Switzerland	University of Fribourg; University of Basel; University of Basel; University of Basel; University of Fribourg	Rothen-Rutishauser, B (corresponding author), Univ Fribourg, Adolphe Merkle Inst, Fribourg, Switzerland.	barbara.rothen@unifr.ch	Huang, Yen-Lin/ABC-1546-2020; Jacob, Francis/C-7910-2009; Septiadi, Dedy/C-3926-2017	Huang, Yen-Lin/0000-0002-3678-3815; Jacob, Francis/0000-0002-0446-1942; Septiadi, Dedy/0000-0003-2353-7508; Fink, Alke/0000-0003-3952-7849; Estermann, Manuela/0000-0002-2930-1742	Swiss national science foundation [CRSII5_171037]; Adolphe Merkle Foundation	Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); Adolphe Merkle Foundation	V.H.-S. and B.R.-R. are grant recipients of the Swiss national science foundation (grant number: CRSII5_171037); URL: http://www.snf.ch/en/funding/programmes/sinergia/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.P.-F. and B.R.-R. received funding for the study from the Adolphe Merkle Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A., 2013, LATEST PERITONEAL DI, V21, P21; Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; ASPLUND T, 1993, CANCER RES, V53, P388; Banyard J, 2015, CONNECT TISSUE RES, V56, P403, DOI 10.3109/03008207.2015.1060970; Breborowicz A, 1998, PERITON DIALYSIS INT, V18, P382; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; Chassin C, 2012, EMBO MOL MED, V4, P1308, DOI 10.1002/emmm.201201298; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Durantie E, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5043373; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harris L, 2012, SOC TEXT, V30, P49, DOI 10.1215/01642472-1597332; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Johnson Aaron N., 2002, TheScientificWorldJOURNAL, V2, P892; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kelley LC, 2008, CLIN EXP METASTAS, V25, P289, DOI 10.1007/s10585-008-9154-6; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; KIMURA A, 1985, CANCER RES, V45, P4330; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Klapper W, 2003, LEUKEMIA, V17, P2007, DOI 10.1038/sj.leu.2403086; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Kolomeyevskaya N, 2015, GYNECOL ONCOL, V138, P352, DOI 10.1016/j.ygyno.2015.05.009; Leavesley DI, 1999, NEPHROL DIAL TRANSPL, V14, P1208, DOI 10.1093/ndt/14.5.1208; Li Y, 2012, CHIN J CANCER, V31, P364, DOI 10.5732/cjc.012.10086; Liu JH, 1999, ONCOGENE, V18, P269, DOI 10.1038/sj.onc.1202263; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Matte I, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-288; Matte I, 2012, AM J CANCER RES, V2, P566; Menghini R, 2013, ATHEROSCLEROSIS, V228, P12, DOI 10.1016/j.atherosclerosis.2013.01.024; Mochizuki Y, 2004, CLIN EXP METASTAS, V21, P39, DOI 10.1023/B:CLIN.0000017181.01474.35; MORADI MM, 1993, CANCER, V72, P2433, DOI 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L; Moran DM, 2008, J SURG RES, V147, P23, DOI 10.1016/j.jss.2007.04.022; Mutch DG, 2014, GYNECOL ONCOL, V133, P401, DOI 10.1016/j.ygyno.2014.04.013; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 1996, J PATHOL, V180, P333; Nakayama K, 2012, INT J MOL SCI, V13, P11705, DOI 10.3390/ijms130911705; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Nowak M, 2010, NEUROENDOCRINOL LETT, V31, P375; Ong YH, 2012, OPT EXPRESS, V20, P22158, DOI 10.1364/OE.20.022158; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Rodolosse A, 2004, GASTROENTEROLOGY, V127, P937, DOI 10.1053/j.gastro.2004.06.058; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Santin AD, 2001, BRIT J OBSTET GYNAEC, V108, P804, DOI 10.1111/j.1471-0528.2001.00206.x; Sehouli J, 2009, J SURG ONCOL, V99, P424, DOI 10.1002/jso.21288; Sevinc A, 2005, J NATL MED ASSOC, V97, P79; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singer Jack W, 2018, Oncotarget, V9, P33416, DOI 10.18632/oncotarget.26058; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Song LJ, 2018, BBA-MOL CELL RES, V1865, P1201, DOI 10.1016/j.bbamcr.2018.05.013; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; Stadlmann S, 2003, VIRCHOWS ARCH, V443, P678, DOI 10.1007/s00428-003-0867-2; Stadlmann S, 2014, INT J GYNECOL CANCER, V24, P192, DOI 10.1097/IGC.0000000000000036; TOPLEY N, 1993, KIDNEY INT, V43, P226, DOI 10.1038/ki.1993.36; Urschel K, 2015, INT J INTERFERON CYT, V7, P9, DOI [DOI 10.2147/IJICMR.S64894, 10.2147/IJICMR.S64894]; van Grevenstein WMU, 2006, PANCREAS, V32, P396, DOI 10.1097/01.mpa.0000220865.80034.2a; van Rossen MEE, 2001, J PATHOL, V193, P530; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Wilkosz S, 2005, ANAT EMBRYOL, V209, P251, DOI 10.1007/s00429-004-0446-6; Witkowicz Joanna, 2008, Pol Arch Med Wewn, V118, P307; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yang F, 2009, INT J BIOCHEM CELL B, V41, P2240, DOI 10.1016/j.biocel.2009.04.022; Yang WS, 1999, PERITON DIALYSIS INT, V19, P211; Yigit R, 2011, EUR J CANCER, V47, P1883, DOI 10.1016/j.ejca.2011.03.026; Yuan ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074624; Yung S, 1996, KIDNEY INT, V50, P1337, DOI 10.1038/ki.1996.446; Zhang SS, 2004, J CELL SCI, V117, P3935, DOI 10.1242/jcs.01249; Ziprin P, 2003, CELL COMMUN ADHES, V10, P141, DOI 10.1080/15419060390262561	78	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0241500	10.1371/journal.pone.0241500	http://dx.doi.org/10.1371/journal.pone.0241500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270665	Green Published, Green Submitted, gold			2022-12-26	WOS:000597149100057
J	Silva, SFM; Oliveira, LCA; Dias, FCR; Cordero-Schmidt, E; Vargas-Mena, JC; Silva, IGM; Bao, SN; Luna, JLS; Lima, RRM; Junior, RFA; Farias, NBS; Moura, CEB; Matta, SLP; Morais, DB				Silva, Soraia F. M.; Oliveira, Laryssa C. A.; Dias, Fernanda C. R.; Cordero-Schmidt, Eugenia; Vargas-Mena, Juan C.; Silva, Ingrid G. M.; Bao, Sonia N.; Luna, Joao L. S.; Lima, Ruthnaldo R. M.; Junior, Raimundo F. A.; Farias, Naisandra B. S.; Moura, Carlos E. B.; Matta, Sergio L. P.; Morais, Danielle B.			Seasonal evaluation of spermatogenesis of the hematophagous bat Desmodus rotundus in the Caatinga biome	PLOS ONE			English	Article							HISTOMORPHOMETRIC EVALUATION; INTERTUBULAR COMPARTMENT; SEMINIFEROUS EPITHELIUM; TESTICULAR REGRESSION; REPRODUCTIVE-CYCLE; CHIROPTERA; QUANTIFICATION; ORGANIZATION; TESTIS; RECRUDESCENCE	This study was aimed to characterize the spermatogenic process and its seasonal variation in Desmodus rotundus, in the Caatinga biome, a water-limited ecosystem, with marked water restriction during most of the year. Collections of adult animals were performed during the dry and rainy seasons, and after euthanasia, their testes were processed histologically to perform morphological, morphometric, ultrastructural and immunohistochemical analyzes. The percentage of seminiferous epithelium, number of Leydig cells per gram of testis, and population of Sertoli cells and A-type spermatogonia presented by D. rotundus were significantly higher in the rainy season, while the percentage of lumen, mitotic index, support capacity performed by Sertoli cells, and overall yield of spermatogenesis were higher in the dry season. The ultrastructure of spermatogenesis was similar to that described in other mammals, and the immunohistochemical analysis revealed activity of the aromatase enzyme in Sertoli cells, Leydig cells, spermatocytes and spermatids, as well as the presence of androgen receptors in Sertoli cells and Leydig cells. FGF2 activity was detected in primary spermatocytes in zygotene and pachytene, as well as secondary spermatocytes and rounded and elongated spermatids, while the BCL-2 protein was expressed in primary spermatocytes in zygotene and pachytene, secondary spermatocytes, and rounded spermatids. The activity of these molecules was similar in both seasons, and associated with the morphometric findings, indicates maintenance in the integrity of the seminiferous epithelium throughout the year. The seasonal study of D. rotundus spermatogenesis indicates a continuous spermatogenesis pattern and suggests a greater production of spermatozoa in the rainy season in the Caatinga biome.	[Silva, Soraia F. M.; Oliveira, Laryssa C. A.; Luna, Joao L. S.; Lima, Ruthnaldo R. M.; Junior, Raimundo F. A.; Farias, Naisandra B. S.; Morais, Danielle B.] Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil; [Dias, Fernanda C. R.; Matta, Sergio L. P.] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Cordero-Schmidt, Eugenia; Vargas-Mena, Juan C.] Univ Fed Rio Grande do Norte, Dept Ecol, Natal, RN, Brazil; [Silva, Ingrid G. M.; Bao, Sonia N.] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Moura, Carlos E. B.] Fed Rural Univ Semiarid Reg, Dept Anim Sci, Mossoro, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Vicosa; Universidade Federal do Rio Grande do Norte; Universidade de Brasilia; Universidade Federal Rural do Semi-Arido (UFERSA)	Morais, DB (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil.	daniellebmorias@gmail.com	Silva, Ingrid/AEV-9060-2022; Mena, Juan Carlos Vargas/AAO-5261-2021	Silva, Ingrid/0000-0001-7654-044X; Mena, Juan Carlos Vargas/0000-0003-3593-4674	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [401467/2014-7]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FINEP (Financiadora de Estudos e Projetos), Ministry of Education of Brazil	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos), Ministry of Education of Brazil	CNPq (Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico)financial support towards the sampling of animals (Project 401467/2014-7: "Ecology and Conservation of Bats in Caatinga Potiguar"); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior)-scholarship provided to SFMS; FINEP (Financiadora de Estudos e Projetos), Ministry of Education of Brazil.; The authors are thankful to LuA Barbalho de Macedo (UFERSA), Vinicius Garcia Barreto and Thais Gomes de Carvalho (UFRN), for their assistance in the immunohistochemical staining protocols.	Amann R.P., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; AMANN RP, 1962, J DAIRY SCI, V45, P774, DOI 10.3168/jds.S0022-0302(62)89487-9; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 1985, ARCHIPEL, V29, P203; Beguelini MR, 2014, GEN COMP ENDOCR, V201, P53, DOI 10.1016/j.ygcen.2014.03.044; Beguelini MR, 2014, REPROD FERT DEVELOP, V26, P834, DOI 10.1071/RD13109; Beguelini MR, 2013, MICROSC RES TECHNIQ, V76, P1035, DOI 10.1002/jemt.22264; Beguelini MR, 2011, MICRON, V42, P586, DOI 10.1016/j.micron.2011.02.004; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Bittencourt V. L., 2004, Revista Brasileira de Reproducao Animal, V28, P108; Bittencourt VL, 2007, REV CERES, V54, P329; BREED WG, 1985, MAMMALIA, V49, P403, DOI 10.1515/mamm.1985.49.3.403; Bueno LM, 2014, ANIM REPROD SCI, V148, P228, DOI 10.1016/j.anireprosci.2014.05.018; Caldeira Bianca Cabral, 2010, Rev. Ceres, V57, P569; Costa KLC, 2011, ANIM REPROD SCI, V127, P202, DOI 10.1016/j.anireprosci.2011.07.016; Carmignotto A. P., 2017, CAATINGA LARGEST TRO, P211, DOI DOI 10.1007/978-3-319-68339-3_8; Costa DS, 2007, ANIM REPROD SCI, V98, P322, DOI 10.1016/j.anireprosci.2006.03.014; Diaz M, 2015, IUCN RED LIST THREAT; FAWCETT DW, 1965, AM J ANAT, V116, P567, DOI 10.1002/aja.1001160306; Azevedo MHF, 2008, MICRON, V39, P1166, DOI 10.1016/j.micron.2008.05.005; de Azevedo MHF, 2010, ANIM REPROD SCI, V118, P83, DOI 10.1016/j.anireprosci.2009.05.018; Souza ACF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205023; Filho José Morais Pereira, 2013, Rev. bras. saúde prod. anim., V14, P77; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; Azua DJG, 2017, ANDROLOGY-US, V5, P990, DOI 10.1111/andr.12398; Gonzalez CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191126; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; HAN IS, 1993, MOL ENDOCRINOL, V7, P889, DOI 10.1210/me.7.7.889; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; JOHNSON L, 1981, BIOL REPROD, V25, P217, DOI 10.1095/biolreprod25.1.217; Johnson L, 2000, ANIM REPROD SCI, V60, P471, DOI 10.1016/S0378-4320(00)00108-1; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Lee J.H., 1992, KOREAN J ELECT MICRO, V22, P97; Lessaid T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219359; Lima Junior N. B., 2014, BRAZILIAN J VET RESE, V51, P263; LORD RD, 1992, J WILDLIFE DIS, V28, P292, DOI 10.7589/0090-3558-28.2.292; da Silva SFM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226558; Mascarenhas R. M., 2006, Revista Ceres, V53, P100; Mayen F, 2003, J VET MED B, V50, P469, DOI 10.1046/j.1439-0450.2003.00713.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Melo FCSA, 2010, BIOL RES, V43, P445, DOI [/S0716-97602010000400009, 10.4067/S0716-97602010000400009]; Morais DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101759; Morais DB, 2014, ANIM REPROD SCI, V147, P180, DOI 10.1016/j.anireprosci.2014.03.008; Morais DB, 2013, ANIM REPROD SCI, V140, P268, DOI 10.1016/j.anireprosci.2013.06.003; Morais DB, 2013, J ANAT, V222, P372, DOI 10.1111/joa.12016; Morais DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173856; Morais DB, 2013, MICROSC RES TECHNIQ, V76, P94, DOI 10.1002/jemt.22141; Neuweiler G., 2000, BIOL BATS; NIEDERBERGER CS, 1993, WORLD J UROL, V11, P120; Parapanov R, 2008, ANIM REPROD SCI, V107, P148, DOI 10.1016/j.anireprosci.2007.06.012; Paula T. A. R. de, 2002, Bioscience Journal, V18, P121; Phillips DM, 1997, MOL REPROD DEV, V48, P90; Racey P.A., 1982, P57; Racey PA, 2000, REPROD BIOL BATS, P364; Roosen-Runge EC, 1977, PROCESS SPERMATOGENE; ROOSENRU.EC, 1973, J REPROD FERTIL, V35, P339; Costa DS, 2006, BRAZ ARCH BIOL TECHN, V49, P725, DOI 10.1590/S1516-89132006000600006; Sarti P, 2011, ARQ BRAS MED VET ZOO, V63, P1060, DOI 10.1590/S0102-09352011000500003; SHALGI R, 1982, J ANDROL, V3, P382; Suphamungmee W, 2008, CELL TISSUE RES, V331, P687, DOI 10.1007/s00441-007-0557-5; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; WILSON DE, 1970, NATURE, V225, P1155, DOI 10.1038/2251155a0; Yang ZW, 1997, J ANDROL, V18, P681; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284	67	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242932	10.1371/journal.pone.0242932	http://dx.doi.org/10.1371/journal.pone.0242932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270698	gold, Green Published			2022-12-26	WOS:000597149100097
J	Wrigglesworth, DJ; Goonatilleke, E; Haydock, R; Hughes, KR; Lebrilla, CB; Swanson, KS; Jones, P; Watson, P				Wrigglesworth, David J.; Goonatilleke, Elisha; Haydock, Richard; Hughes, Kevin R.; Lebrilla, Carlito B.; Swanson, Kelly S.; Jones, Paul; Watson, Phillip			High-throughput glycomic analyses reveal unique oligosaccharide profiles of canine and feline milk samples	PLOS ONE			English	Article							SIALIC-ACID; BREAST-MILK; DIET; SUPPLEMENTATION; MICROBIOTA; COLOSTRUM; COUNTS	Oligosaccharides are important components of milk, serving as substrates for the intestinal microbiota, acting as antimicrobials that prevent pathogen colonization, and supporting the developing gastrointestinal immune system of neonates. Nutrient composition of canine and feline milk samples has been described previously, but little is known about the oligosaccharide content. Therefore, the objective of this study was to characterize canine and feline milk samples using a high-throughput glycomics approach. 23 dogs (9 Labrador retriever and 14 Labrador retriever x golden retriever crossbreed) and 6 domestic shorthair cats were recruited to the study. Milk samples were collected by manual expression at time points after parturition. Samples were collected across 2 phases per species, differentiated by maternal diet. Following extraction, oligosaccharide content was determined by liquid chromatography-mass spectrometry (LC-MS). In canine milk samples, 3 structures accounted for over 90% of all oligosaccharides detected across two diet groups. These were 3'-sialyllactose, 6'-sialyllactose, and 2'-fucosyllactose. In feline samples, a more diverse range of oligosaccharides was detected, with up to 16 structures present at relative abundance >1% of the total. Difucosyllactose-N-hexaose b, 3'-sialyllactose and lacto-N-neohexaose were all detected at abundances >10% in feline milk samples. Statistically significant differences (p<0.05) in oligosaccharide abundances were observed between collection time points and between diet groups within species. These data explore the oligosaccharide content of canine and feline maternal milk, representing an opportunity to generate a fundamental understanding of the nutritional needs of new-born puppies and kittens.	[Wrigglesworth, David J.; Haydock, Richard; Hughes, Kevin R.; Watson, Phillip] Waltham Petcare Sci Inst, Waltham, Leics, England; [Goonatilleke, Elisha; Lebrilla, Carlito B.] Univ Calif Davis, Dept Chem, Davis, CA USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Jones, Paul] Mars Inc, Mclean, VA USA; [Hughes, Kevin R.] Univ Nottingham, IP & Commercialisat Off, Nottingham, England; [Jones, Paul] Nexalist Consulting, Tinwell, Rutland, England	Mars; WALTHAM Petcare Science Institute; University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign; Mars; University of Nottingham	Wrigglesworth, DJ (corresponding author), Waltham Petcare Sci Inst, Waltham, Leics, England.	David.wrigglesworth@effem.com			Mars, Incorporated	Mars, Incorporated	This work was funded by Mars, Incorporated. The WALTHAM Pet Science Institute is the fundamental research centre for Mars Petcare. The funder provided support in the form of salaries for authors [DW, RH, KH, PJ, PW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albrecht S, 2014, BRIT J NUTR, V111, P1313, DOI 10.1017/S0007114513003772; Boehm G, 2007, J NUTR, V137, p847S, DOI 10.1093/jn/137.3.847S; Difilippo E, 2015, J AGR FOOD CHEM, V63, P4805, DOI 10.1021/acs.jafc.5b01127; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Elison E, 2016, BRIT J NUTR, V116, P1356, DOI 10.1017/S0007114516003354; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; Kerckhoffs APM, 2009, WORLD J GASTROENTERO, V15, P2887, DOI 10.3748/wjg.15.2887; LUCAS A, 1990, LANCET, V335, P1477, DOI 10.1016/0140-6736(90)93026-L; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Meyer KM, 2017, AM J OBSTET GYNECOL, V216, pS15, DOI 10.1016/j.ajog.2016.11.911; MORGAN BLG, 1980, J NUTR, V110, P416, DOI 10.1093/jn/110.3.416; MORGAN BLG, 1981, BRIT J NUTR, V46, P223, DOI 10.1079/BJN19810027; Rostami SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099824; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Senda A, 2010, ANIM SCI J, V81, P687, DOI 10.1111/j.1740-0929.2010.00787.x; Skibiel AL, 2013, J ANIM ECOL, V82, P1254, DOI 10.1111/1365-2656.12095; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sprenger N, 2012, ADV NUTR, V3, p392S, DOI 10.3945/an.111.001479; Sundekilde UK, 2012, J AGR FOOD CHEM, V60, P6188, DOI 10.1021/jf300015j; Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; Wang B, 2001, AM J CLIN NUTR, V74, P510; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wu LD, 2017, METHODS MOL BIOL, V1503, P121, DOI 10.1007/978-1-4939-6493-2_10; Zivkovic AM, 2013, FUNCT FOOD REV, V5, P3	29	7	7	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243323	10.1371/journal.pone.0243323	http://dx.doi.org/10.1371/journal.pone.0243323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270789	gold, Green Published			2022-12-26	WOS:000597149100124
J	Babatz, TD; Spear, ED; Xu, WX; Sun, OL; Nie, LY; Carpenter, EP; Michaelis, S				Babatz, Timothy D.; Spear, Eric D.; Xu, Wenxin; Sun, Olivia L.; Nie, Laiyin; Carpenter, Elisabeth P.; Michaelis, Susan			Site specificity determinants for prelamin A cleavage by the zinc metalloprotease ZMPSTE24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISPANNING MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; A-FACTOR; LAMIN-A; RESTRICTIVE DERMOPATHY; SUBSTRATE-SPECIFICITY; NUCLEAR LAMINS; MUTATIONS; STE24P; PROTEOLYSIS	The integral membrane zinc metalloprotease ZMPSTE24 is important for human health and longevity. ZMPSTE24 performs a key proteolytic step in maturation of prelamin A, the farnesylated precursor of the nuclear scaffold protein lamin A. Mutations in the genes encoding either prelamin A or ZMPSTE24 that prevent cleavage cause the premature aging disease Hutchinson-Gilford progeria syndrome (HGPS) and related progeroid disorders. ZMPSTE24 has a novel structure, with seven transmembrane spans that form a large water-filled membrane chamber whose catalytic site faces the chamber interior. Prelamin A is the only known mammalian substrate for ZMPSTE24; however, the basis of this specificity remains unclear. To define the sequence requirements for ZMPSTE24 cleavage, we mutagenized the eight residues flanking the prelamin A scissile bond (TRSY down arrow LLGN) to all other 19 amino acids, creating a library of 152 variants. We also replaced these eight residues with sequences derived from putative ZMPSTE24 cleavage sites from amphibian, bird, and fish prelamin A. Cleavage of prelamin A variants was assessed using an in vivo yeast assay that provides a sensitive measure of ZMPSTE24 processing efficiency. We found that residues on the C-terminal side of the cleavage site are most sensitive to changes. Consistent with other zinc metalloproteases, including thermolysin, ZMPSTE24 preferred hydrophobic residues at the P1' position (Leu647), but in addition, showed a similar, albeit muted, pattern at P2'. Our findings begin to define a consensus sequence for ZMPSTE24 that helps to clarify how this physiologically important protease functions and may ultimately lead to identifying additional substrates.	[Babatz, Timothy D.; Spear, Eric D.; Xu, Wenxin; Sun, Olivia L.; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Nie, Laiyin; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg, Oxford, England	Johns Hopkins University; Johns Hopkins Medicine; University of Oxford	Michaelis, S (corresponding author), Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	michaelis@jhmi.edu		Michaelis, Susan/0000-0001-5851-5021	National Institutes of Health (NIH) [5R35GM127073]; Medical Research Council [MR/L017458/1]; Structural Genomics Consortium (SGC); AbbVie [1097737]; Bayer Pharma AG [1097737]; Boehringer Ingelheim [1097737]; Canada Foundation for Innovation [1097737]; Genome Canada [1097737]; Janssen [1097737]; Lilly Canada [1097737]; Merck KGaA [1097737]; Merck Co [1097737]; Novartis [1097737]; Ontario Ministry of Economic Development and Innovation [1097737]; Pfizer [1097737]; Sao Paulo Research Foundation-FAPESP [1097737]; Takeda [1097737]; Innovative Medicines Initiative Joint Undertaking ULTRA-DD grant [115766]; Wellcome Trust [106169/Z/14/Z]; MRC [MR/L017458/1] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Structural Genomics Consortium (SGC); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Merck KGaA; Merck Co(Merck & Company); Novartis(Novartis); Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Innovative Medicines Initiative Joint Undertaking ULTRA-DD grant; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a National Institutes of Health (NIH) grant to SM (5R35GM127073) and a Medical Research Council grant (MR/L017458/1) to EPC. LN and EPC are funded by the Structural Genomics Consortium (SGC). The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, Janssen, Lilly Canada, Merck KGaA, Merck & Co, Novartis, the Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP and Takeda, as well as the Innovative Medicines Initiative Joint Undertaking ULTRA-DD grant 115766 and the Wellcome Trust (106169/Z/14/Z).	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Barrowman J, 2011, ENZYMES, V30, P13, DOI 10.1016/B978-0-12-415922-8.00002-1; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120; Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Boyartchuk VL, 1998, GENETICS, V150, P95; Boyd SE, 2009, BIOL CHEM, V390, P503, DOI 10.1515/BC.2009.064; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Clark KM, 2017, PROTEIN SCI, V26, P242, DOI 10.1002/pro.3074; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dorado B, 2017, CURR OPIN CELL BIOL, V46, P17, DOI 10.1016/j.ceb.2016.12.005; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fu BS, 2017, J EXP MED, V214, P919, DOI 10.1084/jem.20161270; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goblirsch BR, 2020, J MOL BIOL, V432, P5079, DOI 10.1016/j.jmb.2020.03.016; Goblirsch BR, 2020, PROTEINS, V88, P604, DOI 10.1002/prot.25841; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; HENNEKES H, 1994, J CELL SCI, V107, P1019; Hildebrandt ER, 2016, J BIOL CHEM, V291, P14185, DOI 10.1074/jbc.M116.718197; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hosomi A., 2020, J BIOL CHEM, V295, P10406; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Kayatekin C, 2018, CELL, V173, P62, DOI 10.1016/j.cell.2018.02.026; KROHNE G, 1989, J CELL BIOL, V109, P2003, DOI 10.1083/jcb.109.5.2003; Kuhnle N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.217745; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li ST, 2017, DNA CELL BIOL, V36, P513, DOI 10.1089/dna.2017.3791; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mercuri E, 2005, MUSCLE NERVE, V31, P602, DOI 10.1002/mus.20293; Michaelis S, 2013, SCIENCE, V339, P1529, DOI 10.1126/science.1236764; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Navarro CL, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.258; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; Nie L., 2020, NEW PARADIGM PRELAMI; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331; Ridky TW, 1996, J BIOL CHEM, V271, P4709, DOI 10.1074/jbc.271.9.4709; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; SIKORSKI RS, 1989, GENETICS, V122, P19; SINENSKY M, 1994, J CELL SCI, V107, P61; Smigiel R, 2010, AM J MED GENET A, V152A, P447, DOI 10.1002/ajmg.a.33221; Spear E. D., 2018, DIS MODEL MECH, V11; Spear ED, 2019, METHODS, V157, P47, DOI 10.1016/j.ymeth.2019.01.001; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Urban S, 2016, CELL, V167, P1898, DOI 10.1016/j.cell.2016.11.043; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wang YX, 2016, J CELL SCI, V129, P1975, DOI 10.1242/jcs.187302; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679	75	5	5	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100165	10.1074/jbc.RA120.015792	http://dx.doi.org/10.1074/jbc.RA120.015792			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33293369	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400143
J	Mondal, S; Narayan, KB; Powers, I; Botterbusch, S; Baumgart, T				Mondal, Samsuzzoha; Narayan, Karthik B.; Powers, Imania; Botterbusch, Samuel; Baumgart, Tobias			Endophilin recruitment drives membrane curvature generation through coincidence detection of GPCR loop interactions and negative lipid charge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-BAR; G-PROTEIN; MOLECULAR-MECHANISM; AMPHIPATHIC HELIX; RECEPTOR; BINDING; ENDOCYTOSIS; AMPHIPHYSIN; DOMAINS; RECONSTITUTION	Endophilin plays key roles during endocytosis of cellular receptors, including generating membrane curvature to drive internalization. Electrostatic interactions between endophilin's BIN/Amphiphysin/Rvs domain and anionic membrane lipids have been considered the major driving force in curvature generation. However, the SH3 domain of endophilin also interacts with the proline-rich third intracellular loop (TIL) of various G-protein-coupled receptors (GPCRs), and it is unclear whether this interaction has a direct role in generating membrane curvature during endocytosis. To examine this, we designed model membranes with a membrane density of 1400 receptors per mu m(2) represented by a covalently conjugated TIL region from the beta 1-adrenergic receptor. We observed that TIL recruits endophilin to membranes composed of 95 mol% of zwitterionic lipids via the SH3 domain. More importantly, endophilin recruited via TIL tubulates vesicles and gets sorted onto highly curved membrane tubules. These observations indicate that the cellular membrane bending and curvature sensing activities of endophilin can be facilitated through detection of the TIL of activated GPCRs in addition to binding to anionic lipids. Furthermore, we show that TIL electrostatically interacts with membranes composed of anionic lipids. Therefore, anionic lipids can modulate TIL/SH3 domain binding. Overall, our findings imply that an interplay between TIL, charged membrane lipids, BAR domain, and SH3 domain could exist in the biological system and that these components may act in coordination to regulate the internalization of cellular receptors.	[Mondal, Samsuzzoha; Narayan, Karthik B.; Powers, Imania; Botterbusch, Samuel; Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania	Baumgart, T (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	baumgart@sas.upenn.edu		Mondal, Samsuzzoha/0000-0002-2612-5974; Botterbusch, Samuel/0000-0002-1593-6069; Powers, Imania/0000-0002-6564-4873	National Institutes of Health [GM097552]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was financially supported by the National Institutes of Health, grant No GM097552. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambroso MR, 2014, P NATL ACAD SCI USA, V111, P6982, DOI 10.1073/pnas.1402233111; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Athavale SS, 2010, BIOCHEMISTRY-US, V49, P3525, DOI 10.1021/bi901279e; Bertot L, 2018, CELL REP, V22, P1574, DOI 10.1016/j.celrep.2018.01.039; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Brea RJ, 2017, J AM CHEM SOC, V139, P3607, DOI 10.1021/jacs.6b12830; BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001; Capraro BR, 2013, J BIOL CHEM, V288, P12533, DOI 10.1074/jbc.M112.435511; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Carman Peter J, 2018, Biophys Rev, V10, P1587, DOI 10.1007/s12551-018-0467-7; Casamento A, 2020, BIOCHEM J, V477, P2327, DOI 10.1042/BCJ20190342; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Chen SWW, 1997, J PHYS CHEM B, V101, P9113, DOI 10.1021/jp971521k; Chen Y, 2009, CHEM-EUR J, V15, P5327, DOI 10.1002/chem.200802305; Chen ZM, 2016, J AM CHEM SOC, V138, P14616, DOI 10.1021/jacs.6b06820; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; Eckert  AF, 2020, ELIFE, V9, DOI 10.7554/eLife.55286; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferreira APA, 2018, TRENDS CELL BIOL, V28, P188, DOI 10.1016/j.tcb.2017.11.004; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; HEIMBURG T, 1995, BIOPHYS J, V68, P536, DOI 10.1016/S0006-3495(95)80215-8; Hunter R.J., 2013, ZETA POTENTIAL COLLO; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Kimura T, 2012, J BIOL CHEM, V287, P4076, DOI 10.1074/jbc.M111.268425; Lo WT, 2017, DEV CELL, V43, P522, DOI 10.1016/j.devcel.2017.10.019; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Niu L, 2002, P NATL ACAD SCI USA, V99, P13409, DOI 10.1073/pnas.212518899; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Saygin D, 2018, CYTOM PART A, V93A, P563, DOI 10.1002/cyto.a.23358; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Shi Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6974; Simunovic M, 2016, P NATL ACAD SCI USA, V113, P11226, DOI 10.1073/pnas.1606943113; Snead WT, 2019, J CELL BIOL, V218, P664, DOI 10.1083/jcb.201807119; Snead WT, 2018, J MOL BIOL, V430, P2293, DOI 10.1016/j.jmb.2018.03.024; Snead WT, 2017, P NATL ACAD SCI USA, V114, pE3258, DOI 10.1073/pnas.1616199114; Song WL, 2019, STRUCTURE, V27, P392, DOI 10.1016/j.str.2018.10.024; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Watanabe S, 2018, NEURON, V98, P1184, DOI 10.1016/j.neuron.2018.06.005; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; Wu TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093060; Yen HY, 2018, NATURE, V559, P424, DOI 10.1038/s41586-018-0325-6; Yoon YD, 2012, J BIOL CHEM, V287, P34078, DOI 10.1074/jbc.M112.372789; Zeno WF, 2019, J AM CHEM SOC, V141, P10361, DOI 10.1021/jacs.9b03927; Zhang FN, 2015, ANAL CHEM, V87, P9960, DOI 10.1021/acs.analchem.5b02572; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	67	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100140	10.1074/jbc.RA120.016118	http://dx.doi.org/10.1074/jbc.RA120.016118			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268381	gold, Green Published			2022-12-26	WOS:000672866400119
J	Rosendahl, S; Sulniute, R; Eklund, M; Holm, CK; Johansson, MJO; Kindstedt, E; Lindquist, S; Lundberg, P				Rosendahl, Sara; Sulniute, Rima; Eklund, Michaela; Holm, Cecilia Koskinen; Johansson, Marcus J. O.; Kindstedt, Elin; Lindquist, Susanne; Lundberg, Pernilla			CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CHEMOKINE RECEPTORS; IDENTIFICATION; ACTIVATION; CYTOKINES; EOTAXIN; BINDING	Increasing evidence emphasizes the importance of chemokines and chemokine receptors as regulators of bone remodeling. The C-C chemokine receptor 3 (CCR3) is dramatically upregulated during osteoclastogenesis, but the role of CCR3 in osteoclast formation and bone remodeling in adult mice is unknown. Herein, we used bone marrow macrophages derived from adult male CCR3-proficient and CCR3-deficient mice to study the role of CCR3 in osteoclast formation and activity. CCR3 deficiency was associated with formation of giant hypernucleated osteoclasts, enhanced bone resorption when cultured on bone slices, and altered mRNA expression of related chemokine receptors and ligands. In addition, primary mouse calvarial osteoblasts isolated from CCR3-deficient mice showed increased mRNA expression of the osteoclast activator-related gene, receptor activator of nuclear factor kappa-B ligand, and osteoblast differentiation-associated genes. Microcomputed tomography analyses of femurs from CCR3-deficient mice revealed a bone phenotype that entailed less cortical thickness and volume. Consistent with our in vitro studies, the total number of osteoclasts did not differ between the genotypes in vivo. Moreover, an increased endocortical osteoid mineralization rate and higher trabecular and cortical bone formation rate was displayed in CCR3-deficient mice. Collectively, our data show that CCR3 deficiency influences osteoblast and osteoclast differentiation and that it is associated with thinner cortical bone in adult male mice.	[Rosendahl, Sara; Sulniute, Rima; Eklund, Michaela; Holm, Cecilia Koskinen; Johansson, Marcus J. O.; Kindstedt, Elin; Lindquist, Susanne; Lundberg, Pernilla] Umea Univ, Dept Odontol, Sect Mol Periodontol, Umea, Sweden; [Holm, Cecilia Koskinen; Kindstedt, Elin] Umea Univ, Wallenberg Ctr Mol Med, Umea, Sweden	Umea University; Umea University	Kindstedt, E; Lundberg, P (corresponding author), Umea Univ, Dept Odontol, Sect Mol Periodontol, Umea, Sweden.; Kindstedt, E (corresponding author), Umea Univ, Wallenberg Ctr Mol Med, Umea, Sweden.	elin.kindstedt@umu.se; pernilla.lundberg@umu.se		Kindstedt, Elin/0000-0003-2448-4049; Johansson, Marcus/0000-0001-7117-7426	Vasterbotten County Council [RV-832371, RV-639201]	Vasterbotten County Council	This study was supported by "Spjutspets" (RV-832371) and TUA-research (RV-639201) grant from the Vasterbotten County Council.	Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Bostrom EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134608; Brylka LJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02182; Hayashi Y., 2009, J JPN SOC PERIODONTO, V51, P51; Hsu YH, 2004, J CELL BIOCHEM, V93, P929, DOI 10.1002/jcb.20239; Khan UA, 2016, J CELL BIOCHEM, V117, P382, DOI 10.1002/jcb.25282; Khan UA, 2014, J CELL BIOCHEM, V115, P1290, DOI 10.1002/jcb.24781; Kindstedt E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05654-w; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Lee JW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02368-5; Liu X, 2017, CELL BIOL TOXICOL, V33, P15, DOI 10.1007/s10565-016-9356-7; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Mohan S, 2019, J CELL BIOCHEM, V120, P13974, DOI 10.1002/jcb.28672; Moriishi T, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008586; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Sul OJ, 2012, J CELL PHYSIOL, V227, P1619, DOI 10.1002/jcp.22879; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vimalraj S, 2020, GENE, V754, DOI 10.1016/j.gene.2020.144855; Wang W, 2019, J MED BIOCHEM, V38, P353, DOI 10.2478/jomb-2018-0042; Wintges K, 2013, J BONE MINER RES, V28, P2070, DOI 10.1002/jbmr.1937; Xuan WH, 2017, CELL BIOCHEM FUNCT, V35, P171, DOI 10.1002/cbf.3260; Yano S, 2005, ENDOCRINOLOGY, V146, P2324, DOI 10.1210/en.2005-0065; Ye JP, 2000, J BIOL CHEM, V275, P27250; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	29	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100177	10.1074/jbc.RA120.015571	http://dx.doi.org/10.1074/jbc.RA120.015571			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303631	gold, Green Published			2022-12-26	WOS:000672866400155
J	Shen, GM; Cui, WD; Cao, Q; Gao, M; Liu, HL; Su, GG; Gross, ML; Li, WK				Shen, Guomin; Cui, Weidong; Cao, Qing; Gao, Meng; Liu, Hongli; Su, Gaigai; Gross, Michael L.; Li, Weikai			The catalytic mechanism of vitamin K epoxide reduction in a cellular environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WARFARIN RESISTANCE; BACTERIAL HOMOLOG; RAT-LIVER; INHIBITION; VKORC1; SITE	Vitamin K epoxide reductases (VKORs) constitute a major family of integral membrane thiol oxidoreductases. In humans, VKOR sustains blood coagulation and bone mineralization through the vitamin K cycle. Previous chemical models assumed that the catalysis of human VKOR (hVKOR) starts from a fully reduced active site. This state, however, constitutes only a minor cellular fraction (5.6%). Thus, the mechanism whereby hVKOR catalysis is carried out in the cellular environment remains largely unknown. Here we use quantitative mass spectrometry (MS) and electrophoretic mobility analyses to show that KO likely forms a covalent complex with a cysteine mutant mimicking hVKOR in a partially oxidized state. Trapping of this potential reaction intermediate suggests that the partially oxidized state is catalytically active in cells. To investigate this activity, we analyze the correlation between the cellular activity and the cellular cysteine status of hVKOR. We find that the partially oxidized hVKOR has considerably lower activity than hVKOR with a fully reduced active site. Although there are more partially oxidized hVKOR than fully reduced hVKOR in cells, these two reactive states contribute about equally to the overall hVKOR activity, and hVKOR catalysis can initiate from either of these states. Overall, the combination of MS quantification and biochemical analyses reveals the catalytic mechanism of this integral membrane enzyme in a cellular environment. Furthermore, these results implicate how hVKOR is inhibited by warfarin, one of the most commonly prescribed drugs.	[Shen, Guomin; Cao, Qing; Gao, Meng; Liu, Hongli; Su, Gaigai] Henan Univ Sci & Technol, Sch Basic Med Sci, Henan Int Joint Lab Thrombosis & Hemostasis, Luoyang, Henan, Peoples R China; [Shen, Guomin; Li, Weikai] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Cui, Weidong; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO USA	Henan University of Science & Technology; Washington University (WUSTL); Washington University (WUSTL)	Shen, GM (corresponding author), Henan Univ Sci & Technol, Sch Basic Med Sci, Henan Int Joint Lab Thrombosis & Hemostasis, Luoyang, Henan, Peoples R China.; Shen, GM; Li, WK (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	shenguomin@haust.edu.cn; weikai@wustl.edu	Shen, Guomin/G-8407-2018	Shen, Guomin/0000-0002-5006-2790; Gao, Meng/0000-0002-8792-1093	National Natural Science Foundation of China [31900412, 81770140]; Henan Department of Science Technology [182102410079]; Henan Department of Education [2017GGJS069]; NEI [R21 EY028705]; NHLBI [R01 HL121718]; NIH NIGMS [P41 GM103422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Department of Science Technology; Henan Department of Education; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G. S. is supported by National Natural Science Foundation of China (81770140), Henan Department of Science & Technology (182102410079) and Henan Department of Education (2017GGJS069). M. Gao is supported by National Natural Science Foundation of China (31900412). W. Li is supported by NEI (R21 EY028705) and NHLBI (R01 HL121718). The MS measurement is supported by NIH NIGMS (P41 GM103422) to M. L. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen XJ, 2020, BLOOD, V136, P898, DOI 10.1182/blood.2019004234; Chen XJ, 2018, BLOOD, V132, P1974, DOI 10.1182/blood-2018-05-846592; Davis CH, 2007, J MOL GRAPH MODEL, V26, P401, DOI 10.1016/j.jmgm.2006.10.005; Deerfield D, 2006, INT J QUANTUM CHEM, V106, P2944, DOI 10.1002/qua.21119; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; Ferron M, 2015, J CELL BIOL, V208, P761, DOI 10.1083/jcb.201409111; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Li S, 2020, J MOL BIOL, V432, P5197, DOI 10.1016/j.jmb.2020.05.009; Li S, 2020, BLOOD ADV, V4, P2202, DOI 10.1182/bloodadvances.2020001750; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Liu SX, 2021, SCIENCE, V371, P43, DOI 10.1126/science.abc5667; Liu SX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4110; Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rishavy MA, 2011, J BIOL CHEM, V286, P7267, DOI 10.1074/jbc.M110.172213; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Sevier CS, 2005, PROTEIN SCI, V14, P1630, DOI 10.1110/ps.051355705; Shen G, 2018, J THROMB HAEMOST, V16, P1164, DOI 10.1111/jth.14127; Shen GM, 2018, BIOCHEMISTRY-US, V57, P286, DOI 10.1021/acs.biochem.7b00874; Shen GM, 2017, NAT STRUCT MOL BIOL, V24, P69, DOI 10.1038/nsmb.3333; SILVERMAN RB, 1981, J AM CHEM SOC, V103, P5939, DOI 10.1021/ja00409a068; Tie JK, 2016, J THROMB HAEMOST, V14, P236, DOI 10.1111/jth.13217; Tie JK, 2013, J THROMB HAEMOST, V11, P1556, DOI 10.1111/jth.12306; Tie JK, 2012, J BIOL CHEM, V287, P33945, DOI 10.1074/jbc.M112.402941; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; WALLIN R, 1986, BIOCHEM J, V236, P685, DOI 10.1042/bj2360685; Wu S, 2018, BLOOD, V132, P647, DOI 10.1182/blood-2018-01-830901	30	3	3	8	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100145	10.1074/jbc.RA120.015401	http://dx.doi.org/10.1074/jbc.RA120.015401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273012	Green Published, gold			2022-12-26	WOS:000672866400123
J	Dai, YN; Zhou, H; Zhang, QQ; Chu, ZD; de Koo, LCO; Chao, JR; Rezaei, KA; Saraf, SS; Wang, RKK				Dai, Yining; Zhou, Hao; Zhang, Qinqin; Chu, Zhongdi; de Koo, Lisa C. Olmos; Chao, Jennifer R.; Rezaei, Kasra A.; Saraf, Steven S.; Wang, Ruikang K.			Quantitative assessment of choriocapillaris flow deficits in diabetic retinopathy: A swept-source optical coherence tomography angiography study	PLOS ONE			English	Article							CAPILLARY NETWORKS; MACULAR EDEMA; VASCULATURE; MECHANISMS; RETINA	Purpose To quantitatively assess choriocapillaris (CC) flow deficits in eyes with diabetic retinopathy (DR) using swept-source optical coherence tomography angiography (SS-OCTA). Methods Diabetic subjects with different stages of DR and age-matched healthy subjects were recruited and imaged with SS-OCTA. The en face CC blood flow images were generated using previously published and validated algorithms. The percentage of CC flow deficits (FD%) and the mean CC flow deficit size were calculated in a 5-mm-diameter circle centered on the fovea from the 6x6-mm scans. Results Forty-five diabetic subjects and 27 control subjects were included in the study. The CC FD% in diabetic eyes was on average 1.4-fold greater than in control eyes (12.34 +/- 4.14% vs 8.82 +/- 2.61%, P < 0.001). The mean CC FD size in diabetic eyes was on average 1.4-fold larger than in control eyes (2151.3 +/- 650.8 mu m(2) vs 1574.4 +/- 255.0 mu m(2), P < 0.001). No significant difference in CC FD% or mean CC FD size was observed between eyes with nonproliferative DR and eyes with proliferative DR (P = 1.000 and P = 1.000, respectively). Conclusions CC perfusion in DR can be objectively and quantitatively assessed with FD% and FD size. In the macular region, both CC FD% and CC FD size are increased in eyes with DR. SS-OCTA provides new insights for the investigations of CC perfusion status in diabetes in vivo.	[Dai, Yining; Zhou, Hao; Zhang, Qinqin; Chu, Zhongdi; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Dai, Yining; de Koo, Lisa C. Olmos; Chao, Jennifer R.; Rezaei, Kasra A.; Saraf, Steven S.; Wang, Ruikang K.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Wang, RKK (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019	Wang, Ruikang/0000-0001-5169-8822; Chao, Jennifer/0000-0002-6859-5552; Olmos de Koo, Lisa/0000-0002-8146-4653	National Institutes of Health [NIH R01EY028753, R01AG060942]; Carl Zeiss Meditec; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Zeiss Meditec; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants (RKW) from the National Institutes of Health (NIH R01EY028753, R01AG060942) (https://www.nidcr.nih.gov), Carl Zeiss Meditec (https://www.zeiss.com), and an unrestricted grant from the Research to Prevent Blindness (https://www.rpbusa.org/rpb/grants-and-research/grants).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman JA, 2016, CIRC RES, V118, P1771, DOI 10.1161/CIRCRESAHA.115.306884; Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589; Chan G, 2015, MICROVASC RES, V100, P32, DOI 10.1016/j.mvr.2015.04.006; Chen CL, 2017, BIOMED OPT EXPRESS, V8, P1056, DOI 10.1364/BOE.8.001056; Choi W, 2017, RETINA-J RET VIT DIS, V37, P11, DOI 10.1097/IAE.0000000000001250; Conti FF, 2019, BRIT J OPHTHALMOL, V103, P452, DOI 10.1136/bjophthalmol-2018-311903; Dai YN, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.3.50; Forte R, 2020, RETINA-J RET VIT DIS, V40, P333, DOI 10.1097/IAE.0000000000002376; FRYCZKOWSKI AW, 1989, INT OPHTHALMOL, V13, P269, DOI 10.1007/BF02280087; FRYCZKOWSKI AW, 1988, ANN OPHTHALMOL, V20, P299; Fukushima I, 1997, AM J OPHTHALMOL, V124, P473, DOI 10.1016/S0002-9394(14)70863-3; Gendelman I, 2020, INT J RETINA VITR, V6, DOI 10.1186/s40942-020-00209-0; Giovanni Staurenghi FB, 2018, RYANS RETINA, V6th, P46; Grant MB, 2018, RYANS RETINA, P488; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Hosseini H, 2010, RETINA-J RET VIT DIS, V30, P1084, DOI 10.1097/IAE.0b013e3181d8e7d1; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Nassisi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207638; Nesper PL, 2017, INVEST OPHTH VIS SCI, V58, P307, DOI 10.1167/iovs.17-21787; OLVER JM, 1990, EYE, V4, P262, DOI 10.1038/eye.1990.38; Reiner A, 2018, PROG RETIN EYE RES, V64, P96, DOI 10.1016/j.preteyeres.2017.12.001; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; THULLIEZ M, 2019, IMAGING OPHTHALMOL R, V3, P478, DOI DOI 10.1016/j.oret.2019.01.024; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Weinberger D, 1998, AM J OPHTHALMOL, V126, P238, DOI 10.1016/S0002-9394(98)00148-2; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Zhang QQ, 2018, QUANT IMAG MED SURG, V8, P658, DOI 10.21037/qims.2018.08.10; Zhang QQ, 2018, INVEST OPHTH VIS SCI, V59, P203, DOI 10.1167/iovs.17-22953; Zheng F, 2019, AM J OPHTHALMOL, V200, P110, DOI 10.1016/j.ajo.2018.12.025	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243830	10.1371/journal.pone.0243830	http://dx.doi.org/10.1371/journal.pone.0243830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306736	Green Published, gold			2022-12-26	WOS:000600144200020
J	Bergamini, M; Iora, PH; Rocha, TAH; Tchuisseu, YP; Dutra, AD; Scheidt, JFHC; Nihei, OK; Carvalho, MDD; Staton, CA; Vissoci, JRN; de Andrade, L				Bergamini, Marcela; Iora, Pedro Henrique; Hernandes Rocha, Thiago Augusto; Tchuisseu, Yolande Pokam; Dutra, Amanda de Carvalho; Herman Costa Scheidt, Joao Felipe; Nihei, Oscar Kenji; de Barros Carvalho, Maria Dalva; Staton, Catherine Ann; Nickenig Vissoci, Joao Ricardo; de Andrade, Luciano			Mapping risk of ischemic heart disease using machine learning in a Brazilian state	PLOS ONE			English	Article							HEALTH; CARE; IMPACT	Cardiovascular diseases are the leading cause of deaths globally. Machine learning studies predicting mortality rates for ischemic heart disease (IHD) at the municipal level are very limited. The goal of this paper was to create and validate a Heart Health Care Index (HHCI) to predict risk of IHD based on location and risk factors. Secondary data, geographical information system (GIS) and machine learning were used to validate the HHCI and stratify the IHD municipality risk in the state of Parana. A positive spatial autocorrelation was found (Moran's I = 0.6472, p-value = 0.001), showing clusters of high IHD mortality. The Support Vector Machine, which had an RMSE of 0.789 and error proportion close to one (0.867), was the best for prediction among eight machine learning algorithms after validation. In the north and northwest regions of the state, HHCI was low and mortality clusters patterns were high. By creating an HHCI through ML, we can predict IHD mortality rate at municipal level, identifying predictive characteristics that impact health conditions of these localities' guided health management decisions for improvements for IHD within the emergency care network in the state of Parana.	[Bergamini, Marcela; Dutra, Amanda de Carvalho; de Barros Carvalho, Maria Dalva; de Andrade, Luciano] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil; [Iora, Pedro Henrique; Herman Costa Scheidt, Joao Felipe; de Andrade, Luciano] Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil; [Hernandes Rocha, Thiago Augusto; Tchuisseu, Yolande Pokam; Staton, Catherine Ann; Nickenig Vissoci, Joao Ricardo] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Nihei, Oscar Kenji] State Univ West Parana, Educ Letters & Hlth Ctr, Foz Do Iguacu, Parana, Brazil; [Staton, Catherine Ann; Nickenig Vissoci, Joao Ricardo] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Duke University; Universidade Estadual do Oeste do Parana; Duke University	de Andrade, L (corresponding author), Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil.; de Andrade, L (corresponding author), Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil.	landrade@uem.br	Carvalho, Maria Dalva/AAK-8411-2021	Carvalho, Maria Dalva/0000-0002-1377-3331; Scheidt, Joao Felipe/0000-0003-2638-5407; Staton, Catherine/0000-0002-6468-2894	Government Agency, Programa de Pesquisa para o SUS (PPSUS), 2015 edition, Fundacao Araucaria-PR/SESA-PR/CNPq/MS-Decit [028/2017]	Government Agency, Programa de Pesquisa para o SUS (PPSUS), 2015 edition, Fundacao Araucaria-PR/SESA-PR/CNPq/MS-Decit	This study received support in the form of the following grant, awarded to LA and MB: Government Agency - Grant number 028/2017, Programa de Pesquisa para o SUS (PPSUS), 2015 edition, Fundacao Araucaria-PR/SESA-PR/CNPq/MS-Decit; http://www.fappr.pr.gov.br/sites/fundacao-araucaria/arquivos_restritos/files/documento/2020-06/2017_atode_031_ resultadocp0116.pdf.	Alanazi HO, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0715-6; [Anonymous], 2004, VILL SPORTS ENT  L J, V11, P1, DOI DOI 10.18637/JSS.V011.I09; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Awan SE, 2018, CURR OPIN CARDIOL, V33, P190, DOI 10.1097/HCO.0000000000000491; Beldjazia A., 2016, INT J MANAGEMENT SCI, V5, P2226; Benke K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122796; Bini SA, 2018, J ARTHROPLASTY, V33, P2358, DOI 10.1016/j.arth.2018.02.067; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buja A, 2015, EUR J PUBLIC HEALTH, V25, P759, DOI 10.1093/eurpub/cku253; Chen C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174202; Chen ZF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071453; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DATASUS-Departamento de Informatica do SUS, INF SAUD EP MORB BAN; de Andrade Luciano, 2013, PLoS One, V8, pe59363, DOI 10.1371/journal.pone.0059363; Goldstein BA, 2017, EUR HEART J, V38, P1805, DOI 10.1093/eurheartj/ehw302; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Hertz JT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210502; Jollis JG, 2018, CIRCULATION, V137, P376, DOI 10.1161/CIRCULATIONAHA.117.032446; Jordan M.I., 2015, N ENGL J MED J MED I, V360, P2153; Koprowski Robert, 2018, Biomed Eng Online, V17, P17, DOI 10.1186/s12938-018-0449-9; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI 10.5123/S1679-49742011000400002; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mari-Dell'Olmo M, 2014, J URBAN HEALTH, V91, P46, DOI 10.1007/s11524-013-9799-6; Calvo MCM, 2016, EPIDEMIOL SERV SAUDE, V25, P767, DOI [10.5123/S1679-49742016000400010, 10.5123/s1679-49742016000400010]; Mensah GA, 2005, ELIMINATING DISPARIT; Muller EV, 2012, CAD SAUDE PUBLICA, V28, P1067, DOI 10.1590/S0102-311X2012000600006; PNUD-Programa das Nacoes Unidas para o Desenvolvimento, 2014, PANK IDHM MUN 2010; Reddy C.K., 2015, HEALTHCARE DATA ANAL; Rothenberg R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1827-x; Rouquayrol M. Z., 2006, INTRO EPIDEMIOLOGIA; Roy K, 2016, CHEMOMETR INTELL LAB, V152, P18, DOI 10.1016/j.chemolab.2016.01.008; Seligman B, 2018, SSM-POPUL HLTH, V4, P95, DOI 10.1016/j.ssmph.2017.11.008; Shameer K, 2018, HEART, V104, P1156, DOI 10.1136/heartjnl-2017-311198; UNDP, 2016, TECH NOTES, V37, P14; Vavalle JP, 2011, CIRCULATION, V124, P851, DOI 10.1161/CIRCULATIONAHA.110.012617; World Health Organization, INT STAT CLASS DIS R, V10th; Zheng A., 2015, EVALUATING MACHINE L	38	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243558	10.1371/journal.pone.0243558	http://dx.doi.org/10.1371/journal.pone.0243558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301451	Green Published, gold			2022-12-26	WOS:000600143100027
J	Onyeka, TC; Iloanusi, N; Namisango, E; Onu, JU; Okunade, KS; Mohammed, AD; Gadanya, MA; Nagoma, AU; Ojiakor, S; Ilo, C; Okuzu, O; Oduche, C; Ugwu, N; Allsop, MJ				Onyeka, Tonia C.; Iloanusi, Nneka; Namisango, Eve; Onu, Justus U.; Okunade, Kehinde S.; Mohammed, Alhassan Datti; Gadanya, Muktar A.; Nagoma, Abubakar U.; Ojiakor, Samuel; Ilo, Chukwudi; Okuzu, Okey; Oduche, Chinelo; Ugwu, Ngozi; Allsop, Matthew J.			Project OPUS: Development and evaluation of an electronic platform for pain management education of medical undergraduates in resource-limited settings	PLOS ONE			English	Article							LEARNING-PROGRAMS; PROFESSIONALS; EXPERIENCE; STUDENTS; CARE	Introduction Pain is a very frequent symptom that is reported by patients when they present to health professionals but remains undertreated or untreated, particularly in low-resource settings including Nigeria. Lack of training in pain management remains the most significant obstacle to pain treatment alongside an inadequate emphasis on pain education in undergraduate medical curricula, negatively impacting on subsequent care of patients. This study aimed to determine the effect of a 12-week structured e-Learning course on the knowledge of pain management among Nigerian undergraduate medical students. Methods Prospective, multisite, pre-post study conducted across five medical colleges in Nigeria. Structured modules covering aspects of pain management were delivered on an e-Learning platform. Pre- and post-test self-assessments were carried out in the 12-week duration of the study. User experience questionnaires and qualitative interviews were conducted via instant messaging to evaluate user experiences of the platform. User experience data was analysed using the UEQ Data Analysis Tool and Framework Analysis. Results A total of 216 of 659 eligible students completed all sections of the e-Learning course. Participant mean age was 23.52 years, with a slight female predominance (55.3%). Across all participants, an increase in median pre- and post-test scores occurred, from 40 to 60 (Z = 11.3, p<0.001, effect size = 1.3), suggestive of increased knowledge acquisition relating to pain management. Participants suggested e-Learning is a valuable approach to delivering pain education alongside identifying factors to address in future iterations. Conclusion e-Learning approaches to pain management education can enhance traditional learning methods and may increase students' knowledge. Future iterations of e-Learning approaches will need to consider facilitating the download of data and content for the platform to increase user uptake and engagement. The platform was piloted as an optional adjunct to existing curricula. Future efforts to advocate and support integration of e-Learning for pain education should be two-fold; both to include pain education in the curricula of medical colleges across Nigeria and the use of e-Learning approaches to enhance teaching where feasible.	[Onyeka, Tonia C.] Univ Nigeria, Dept Anaesthesia Pain & Palliat Care Unit, Coll Med, Ituku Ozalla Campus, Enugu, Enugu State, Nigeria; [Onyeka, Tonia C.; Iloanusi, Nneka; Onu, Justus U.] Univ Nigeria, Coll Med, EPAC Res Team, Ituku Ozalla Campus, Enugu, Enugu State, Nigeria; [Iloanusi, Nneka] Univ Nigeria, Dept Radiat Med, Coll Med, Ituku Ozalla Campus, Enugu, Enugu State, Nigeria; [Namisango, Eve] African Palliat Care Assoc, Kampala, Uganda; [Onu, Justus U.] Nnamdi Azikiwe Univ, Fac Med, Dept Mental Hlth, Awka, Anambra State, Nigeria; [Okunade, Kehinde S.] Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Oncol & Pathol Studies OPS Unit,Lagos Univ Teachi, Lagos, Nigeria; [Mohammed, Alhassan Datti; Nagoma, Abubakar U.] Bayero Univ, Coll Hlth Sci, Dept Anaesthesia, Aminu Kano Teaching Hosp, Kano, Kano State, Nigeria; [Gadanya, Muktar A.] Bayero Univ, Dept Community Med, Aminu Kano Teaching Hosp, Kano, Kano State, Nigeria; [Ojiakor, Samuel] Nnamdi Azikiwe Univ, Coll Med, Dept Anaesthesia, Awka, Anambra State, Nigeria; [Ilo, Chukwudi] Enugu State Univ Sci & Technol, Coll Med, Enugu, Enugu State, Nigeria; [Okuzu, Okey; Oduche, Chinelo] InStrat Global Hlth Solut, Abuja, Nigeria; [Ugwu, Ngozi] Alex Ekwueme Fed Univ Teaching Hosp, Dept Haematol, Abakaliki, Ebonyi State, Nigeria; [Allsop, Matthew J.] Univ Leeds, Acad Unit Palliat Care, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England	University of Nigeria; University of Nigeria; University of Nigeria; University of Lagos; Bayero University; Bayero University; University of Leeds	Allsop, MJ (corresponding author), Univ Leeds, Acad Unit Palliat Care, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England.	m.j.allsop@leeds.ac.uk	; OKUNADE, KEHINDE/A-8201-2017; ONYEKA, TONIA/F-3749-2012	Allsop, Matthew/0000-0002-7399-0194; OKUNADE, KEHINDE/0000-0002-0957-7389; ONYEKA, TONIA/0000-0001-8138-3100	International Association for the Study of Pain (IASP) through the 2019 IASP Developing Countries Project: Initiative for Improving Pain Education Grant, a scientific grant; IASP	International Association for the Study of Pain (IASP) through the 2019 IASP Developing Countries Project: Initiative for Improving Pain Education Grant, a scientific grant; IASP	The e-Learning platform development was funded by the International Association for the Study of Pain (IASP) through the 2019 IASP Developing Countries Project: Initiative for Improving Pain Education Grant, a scientific grant awarded to T.C. Onyeka, M. Allsop, N. Iloanusi and E. Namisango. IASP funding supported the development of the e-Learning platform. Institutional support was provided by the College of Medicine, University of Nigeria (Enugu, Nigeria) and the African Palliative Care Association (Kampala, Uganda) to support staff costs to undertake research and evaluation activities. The funders provided support in the form of salaries for authors [TO, EN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial partner for this study, InStrat Global Health Solutions [OO, CO], did not provide funding to support this project. InStrat Global Health Solutions did not contribute to the study design, analysis or decision to publish. The platform developed by InStrat Global Health Solutions supported the collection of study data entered by study participants and the company provided technical input into the manuscript, supporting the description of the functionality of the eLearning platform. The specific roles of these authors are articulated in the 'author contributions' section.	a R-M, 2020, J CLIN MED, V9; Acosta ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209004; Adam R, 2015, PATIENT EDUC COUNS, V98, P269, DOI 10.1016/j.pec.2014.11.003; African Palliative Care Association, 2010, BEAT PAIN; Allisy A., 1993, J INT COMMISSION RAD, V26, DOI 10.1093/jicru/ndq001; Ambler SW, 2012, DISCIPLINED AGILE DE; Ameringer S, 2012, J PALLIAT MED, V15, P978, DOI 10.1089/jpm.2011.0536; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; Aparicio M, 2016, EDUC TECHNOL SOC, V19, P292; Argyra E, 2015, PAIN MED, V16, P301, DOI 10.1111/pme.12568; Barteit S, 2019, J MED INTERNET RES, V21, DOI 10.2196/12449; Briggs EV, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006984; Chukwunyere N.D., 2019, PALLIATIVE CARE NIGE; Dabbs AD, 2009, CIN-COMPUT INFORM NU, V27, P175, DOI 10.1097/NCN.0b013e31819f7c7c; Degerfalt Jan, 2017, BMC Res Notes, V10, P39, DOI 10.1186/s13104-017-2372-8; Ebenso B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022174; Eze SC, 2018, INT J EDUC TECHNOL H, V15, DOI 10.1186/s41239-018-0116-z; Finnerup N.B., 2020, PAIN; Frehywot S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-4; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gibson K., 2020, QUALITATIVE RES PSYC, P1; Goucke CR, 2018, ANESTH ANALG, V126, P1283, DOI 10.1213/ANE.0000000000002736; Guder, 2013, AM J BUSINESS ED, V6, P333, DOI DOI 10.19030/ajbe.v6i3.7813; International Association for the Study of Pain, 2020, IASP CURR OUTL PAIN; Liossi C, 2018, PAIN, V159, P631, DOI 10.1097/j.pain.0000000000001146; Loeser JD, 2017, POSTGRAD MED, V129, P332, DOI 10.1080/00325481.2017.1297668; Mayadas AF, 2009, SCIENCE, V323, P85, DOI 10.1126/science.1168874; Mezei L, 2011, J PAIN, V12, P1199, DOI 10.1016/j.jpain.2011.06.006; Nicoll P, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9085; Onyeka TC, 2011, INDIAN J PALLIAT CAR, V17, P131, DOI 10.4103/0973-1075.84534; Otu A, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0100-4; Perkins GD, 2010, RESUSCITATION, V81, P877, DOI 10.1016/j.resuscitation.2010.03.019; Puljak L, 2011, PAIN MED, V12, P854, DOI 10.1111/j.1526-4637.2011.01104.x; Salkind NJ, 2010, ENCY RES DESIGN, DOI [10.1097/SMJ.0b013e3181eab419, DOI 10.1097/SMJ.0B013E3181EAB419]; Schrepp M, 2016, USER EXPERIENCE QUES; Schrepp M, 2017, INT J INTERACT MULTI, V4, P40, DOI 10.9781/ijimai.2017.445; Sinatra R, 2010, PAIN MED, V11, P1859, DOI 10.1111/j.1526-4637.2010.00983.x; Tellier PP, 2013, PAIN RES MANAG, V18, P259, DOI 10.1155/2013/920961; Tompkins DA, 2017, DRUG ALCOHOL DEPEN, V173, pS11, DOI 10.1016/j.drugalcdep.2016.12.002; Vadivelu N, 2012, PAIN PRACT, V12, P663, DOI 10.1111/j.1533-2500.2012.00580.x; Zhang Q, 2010, J INTERNET SERV APPL, V1, P7, DOI 10.1007/s13174-010-0007-6; 2019, BRAIN STIMUL MAR, V12	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243573	10.1371/journal.pone.0243573	http://dx.doi.org/10.1371/journal.pone.0243573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301477	Green Published, gold			2022-12-26	WOS:000600143100084
J	Szymanska, KJ; Goker, M; Bol, M; Van Dorpe, J; Weyers, S; Leybaert, L				Szymanska, Katarzyna J.; Goker, Menekse; Bol, Melissa; Van Dorpe, Jo; Weyers, Steven; Leybaert, Luc			Targeting connexins with Gap27 during cold storage of the human donor uterus protects against cell death	PLOS ONE			English	Article							REPERFUSION INJURY; DNA-DAMAGE; TRANSPLANTATION; ISCHEMIA; HEMICHANNELS; TRANSIENT; CHANNELS; TIME; RETRIEVAL; OCCLUSION	Uterus transplantation is an experimental infertility treatment for women with uterine factor infertility. During donor uterus retrieval and subsequent storage, ischemia and other stressors are likely to occur, resulting in the delayed restoration of organ function and increased graft rejection. The uterus expresses connexin-based hemichannels, the opening of which can promote ischemic cell death, as well as gap junctions that may expand cell death by bystander signaling. We investigated if connexin channel inhibition with connexin channel inhibitor Gap27 could protect the uterus against cell death during the storage period. The study involved 9 female patients undergoing gender-change surgery. Before uterus removal, it was exposed to in situ warm ischemia with or without reperfusion. Uterus biopsies were taken before, during, and after ischemia, with or without reperfusion, and were subsequently stored under cold (4C) or warm (37C) conditions. TUNEL cell death assay was done at various time points along the combined in vivo/ex vivo experimental timeline. We found that Gap27 protected against storage-related cell death under cold but not warm conditions when the uterus had experienced in situ ischemia/reperfusion. For in situ brief ischemia without reperfusion, Gap27 reduction of cell death was delayed and significantly less, suggesting that protection critically depends on processes initiated when the organ was still in the donor. Thus, the inclusion of the connexin channel inhibitor Gap27 during cold storage protects the uterus against cell death, and the degree of protection depends on the history of exposure to warm ischemia. Gap27 protection may be indicated for uteri from deceased donors, in which ischemia is likely because life-saving organs have retrieval priority.	[Szymanska, Katarzyna J.; Bol, Melissa; Leybaert, Luc] Univ Ghent, Dept Basic & Appl Med Sci, Ghent, Belgium; [Goker, Menekse; Weyers, Steven] Univ Ghent, Dept Obstet & Gynecol, Ghent, Belgium; [Van Dorpe, Jo] Univ Ghent, Dept Pathol, Ghent, Belgium; [Szymanska, Katarzyna J.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA	Ghent University; Ghent University; Ghent University; Yale University	Szymanska, KJ; Leybaert, L (corresponding author), Univ Ghent, Dept Basic & Appl Med Sci, Ghent, Belgium.; Szymanska, KJ (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.	katarzyna.s-v@yale.edu; luc.leybaert@ugent.be		Szymanska, Katarzyna/0000-0002-5932-8030				Adachi M, 2016, ACTA OBSTET GYN SCAN, V95, P991, DOI 10.1111/aogs.12943; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; [Anonymous], 2016, IEEE T MED IMAGING, V35, pn2; Bol M, 2013, EUR J VASC ENDOVASC, V45, P382, DOI 10.1016/j.ejvs.2012.12.012; Brannstrom M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082338; Brannstrom M, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5872-0; Brannstrom M, 2015, LANCET, V385, P607, DOI 10.1016/S0140-6736(14)61728-1; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Brannstrom M, 2012, FERTIL STERIL, V97, P1269, DOI 10.1016/j.fertnstert.2012.04.001; Cea LA, 2016, CELL MOL LIFE SCI, V73, P2583, DOI 10.1007/s00018-016-2132-2; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Del Priore G, 2007, OBSTET GYNECOL, V109, P101, DOI 10.1097/01.AOG.0000248535.58004.2f; Diaz-Garcia C, 2012, MOL HUM REPROD, V18, P68, DOI 10.1093/molehr/gar055; Ejzenberg D, 2018, LANCET; Feine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041633; Flyckt R, 2020, AM J OBSTET GYNECOL, V223, P143, DOI 10.1016/j.ajog.2020.03.001; Gadicherla AK, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0618-1; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039; Goncharenko K, 2014, J NEUROPHYSIOL, V112, P2067, DOI 10.1152/jn.00037.2013; Hauet T, 2001, NEPHROL DIAL TRANSPL, V16, P1982, DOI 10.1093/ndt/16.10.1982; Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Kisu I, 2017, HUM REPROD, V32, P2026, DOI 10.1093/humrep/dex250; Kwon YS, 2013, J LAPAROENDOSC ADV S, V23, P679, DOI 10.1089/lap.2012.0540; Laskowski I, 2000, Ann Transplant, V5, P29; Li XJ, 2015, GLIA, V63, P1553, DOI 10.1002/glia.22826; Liu LB, 2011, FERTIL STERIL, V95, P254, DOI 10.1016/j.fertnstert.2010.05.006; Ozkan O, 2013, FERTIL STERIL, V99, P470, DOI 10.1016/j.fertnstert.2012.09.035; Puntambekar S, 2018, J MINIM INVAS GYN, V25, P571, DOI 10.1016/j.jmig.2017.11.001; Retamal MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00411; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sieunarine K, 2008, INT SURG, V93, P366; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Tang HM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180442; Testa G, 2018, AM J TRANSPLANT, V18, P1270, DOI 10.1111/ajt.14737; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Wang Chin-Jung, 2008, Chang Gung Med J, V31, P463; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Winterhager E, 2015, HUM REPROD UPDATE, V21, P340, DOI 10.1093/humupd/dmv007; Wranning CA, 2005, HUM REPROD, V20, P2736, DOI 10.1093/humrep/dei125; Wranning CA, 2008, FERTIL STERIL, V90, P817, DOI 10.1016/j.fertnstert.2007.07.1340; Zitkute V, 2020, TRANSPLANT REV-ORLAN, V34, DOI 10.1016/j.trre.2020.100550	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243663	10.1371/journal.pone.0243663	http://dx.doi.org/10.1371/journal.pone.0243663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301511	gold, Green Published			2022-12-26	WOS:000600143100002
J	Huijser, S; Verkaik, M; van Vugt, MK; Taatgen, NA				Huijser, Stefan; Verkaik, Mathanja; van Vugt, Marieke K.; Taatgen, Niels A.			Captivated by thought: "Sticky" thinking leaves traces of perceptual decoupling in task-evoked pupil size	PLOS ONE			English	Article							SUSTAINED ATTENTION; ADAPTIVE GAIN; MIND; RUMINATION; DILATION; MODEL; ACTIVATION; FLUCTUATIONS; METAANALYSIS; REFLECTION	Throughout the day, we may sometimes catch ourselves in patterns of thought that we experience as rigid and difficult to disengage from. Such "sticky" thinking can be highly disruptive to ongoing tasks, and when it turns into rumination constitutes a vulnerability for mental disorders such as depression and anxiety. The main goal of the present study was to explore the stickiness dimension of thought, by investigating how stickiness is reflected in task performance and pupil size. To measure spontaneous thought processes, we asked participants to perform a sustained attention to response task (SART), in which we embedded the participant's concerns to potentially increase the probability of observing sticky thinking. The results indicated that sticky thinking was most frequently experienced when participants were disengaged from the task. Such episodes of sticky thought could be discriminated from neutral and non-sticky thought by an increase in errors on infrequent no-go trials. Furthermore, we found that sticky thought was associated with smaller pupil responses during correct responding. These results demonstrate that participants can report on the stickiness of their thought, and that stickiness can be investigated using pupillometry. In addition, the results suggest that sticky thought may limit attention and exertion of cognitive control to the task.	[Huijser, Stefan; Verkaik, Mathanja; van Vugt, Marieke K.; Taatgen, Niels A.] Univ Groningen, Bernoulli Inst Math Comp Sci & Artificial Intelli, Groningen, Netherlands	University of Groningen	Huijser, S (corresponding author), Univ Groningen, Bernoulli Inst Math Comp Sci & Artificial Intelli, Groningen, Netherlands.	stefanhuijser@outlook.com		, Stefan/0000-0002-1694-8424; Taatgen, Niels/0000-0001-7286-3460; van Vugt, Marieke/0000-0003-3200-0059	European Research Council [MULTITASK - 283597]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a grant from the European Research Council (MULTITASK - 283597; https://erc.europa.eu/) awarded to N.A. Taatgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baayen R. H., 1993, CELEX LEXICAL DATABA; Barlow DH, 2002, ANXIETY ITS DISORDER; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bastian M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00573; Bates D, 2018, LME4 LINEAR MIXED EF; Bates D, 2015, 150604967 ARXIV; Beckwe M, 2016, PSYCHOL RES-PSYCH FO, V80, P952, DOI 10.1007/s00426-015-0703-8; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Brisson J, 2013, BEHAV RES METHODS, V45, P1322, DOI 10.3758/s13428-013-0327-0; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Christoff K, 2012, BRAIN RES, V1428, P51, DOI 10.1016/j.brainres.2011.09.060; Dang JS, 2018, EXP BRAIN RES, V236, P2255, DOI 10.1007/s00221-018-5291-6; Denson TF, 2009, PSYCHOL BULL, V135, P823, DOI 10.1037/a0016909; Duque A, 2014, COGNITION EMOTION, V28, P1347, DOI 10.1080/02699931.2014.881327; Ellamil M, 2016, NEUROIMAGE, V136, P186, DOI 10.1016/j.neuroimage.2016.04.034; Finkbeiner KM, 2015, EXP BRAIN RES, V233, P1061, DOI 10.1007/s00221-014-4179-3; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Franklin MS, 2013, Q J EXP PSYCHOL, V66, P2289, DOI 10.1080/17470218.2013.858170; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Gagl B, 2011, BEHAV RES METHODS, V43, P1171, DOI 10.3758/s13428-011-0109-5; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Grandchamp R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00031; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Hiatt LM, 2013, COMPUTATIONAL MODEL, P914; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Huijser S, 2018, CONSCIOUS COGN, V58, P170, DOI 10.1016/j.concog.2017.12.004; Jin CY, 2019, COGN AFFECT BEHAV NE, V19, P1059, DOI 10.3758/s13415-019-00707-1; Joormann J, 2011, PSYCHOL SCI, V22, P979, DOI 10.1177/0956797611415539; Jubera-Garcia E, 2019, ATTEN PERCEPT PSYCHO, P1; Kam JWY, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00725; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kane MJ, 2017, PSYCHOL SCI, V28, P1271, DOI 10.1177/0956797617706086; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Klinger E., 2004, HDB MOTIVATIONAL COU, P3; Klinger E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00415; Konishi M, 2017, COGNITION, V168, P16, DOI 10.1016/j.cognition.2017.06.006; Koster EHW, 2013, ACTA PSYCHOL, V144, P563, DOI 10.1016/j.actpsy.2013.09.008; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Marchetti I, 2016, CLIN PSYCHOL SCI, V4, P835, DOI 10.1177/2167702615622383; Matuschek H, 2017, J MEM LANG, V94, P305, DOI 10.1016/j.jml.2017.01.001; McVay JC, 2012, J EXP PSYCHOL LEARN, V38, P525, DOI 10.1037/a0025896; Mills C, 2018, CONSCIOUS COGN, V58, P20, DOI 10.1016/j.concog.2017.10.003; Mittner M, 2016, TRENDS COGN SCI, V20, P570, DOI 10.1016/j.tics.2016.06.004; Mittner M, 2014, J NEUROSCI, V34, P16286, DOI 10.1523/JNEUROSCI.2062-14.2014; Mooneyham BW, 2013, CAN J EXP PSYCHOL, V67, P11, DOI 10.1037/a0031569; Morad Y, 2000, CURR EYE RES, V21, P535, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT535; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Ottaviani C, 2013, BIOL PSYCHOL, V94, P38, DOI 10.1016/j.biopsycho.2013.05.003; Ottaviani C, 2011, PSYCHOPHYSIOLOGY, V48, P453, DOI 10.1111/j.1469-8986.2010.01122.x; Papies E, 2007, J EXP SOC PSYCHOL, V43, P810, DOI 10.1016/j.jesp.2006.08.001; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schwarz N., 2007, SCI REAL TIME DATA C, P11; Scollon CN., 2003, J HAPPINESS STUD, V4, P5, DOI [10.1023/A:1023605205115, DOI 10.1023/A:1023605205115]; Seli P, 2013, J EXP PSYCHOL HUMAN, V39, P1, DOI 10.1037/a0030954; Siegle GJ, 2003, COGNITIVE THER RES, V27, P365, DOI 10.1023/A:1023974602357; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Unsworth N, 2014, PSYCHON B REV, P757; Unsworth N, 2016, COGN AFFECT BEHAV NE, V16, P601, DOI 10.3758/s13415-016-0417-4; van den Brink RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165274; van Rij J., 2017, INTERPRETING TIME SE; van Rij J, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519832483; van Vugt MK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00732; Verkuil B., 2010, J EXP PSYCHOPATHOL, V1, DOI DOI 10.5127/JEP.009110; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; Weinstein Y, 2018, BEHAV RES METHODS, V50, P642, DOI 10.3758/s13428-017-0891-9; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Wood SN, 2015, J R STAT SOC C-APPL, V64, P139, DOI 10.1111/rssc.12068; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2017, MGCV MIXED GAM COMPU	87	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243532	10.1371/journal.pone.0243532	http://dx.doi.org/10.1371/journal.pone.0243532			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296415	gold, Green Published			2022-12-26	WOS:000598626100058
J	Lin, KS; Schulte, CR; Marr, LC				Lin, Kaisen; Schulte, Chase R.; Marr, Linsey C.			Survival of MS2 and phi 6 viruses in droplets as a function of relative humidity, pH, and salt, protein, and surfactant concentrations	PLOS ONE			English	Article							INFLUENZA-VIRUS; ANIMAL VIRUSES; EBOLA-VIRUS; INACTIVATION; TEMPERATURE; PERSISTENCE; AGGREGATION; INFECTIVITY; SUITABILITY; ROTAVIRUS	The survival of viruses in droplets is known to depend on droplets' chemical composition, which may vary in respiratory fluid between individuals and over the course of disease. This relationship is also important for understanding the persistence of viruses in droplets generated from wastewater, freshwater, and seawater. We investigated the effects of salt (0, 1, and 35 g/L), protein (0, 100, and 1000 mu g/mL), surfactant (0, 1, and 10 mu g/mL), and droplet pH (4.0, 7.0, and 10.0) on the viability of viruses in 1-mu L droplets pipetted onto polystyrene surfaces and exposed to 20%, 50%, and 80% relative humidity (RH) using a culture-based approach. Results showed that viability of MS2, a non-enveloped virus, was generally higher than that of phi 6, an enveloped virus, in droplets after 1 hour. The chemical composition of droplets greatly influenced virus viability. Specifically, the survival of MS2 was similar in droplets at different pH values, but the viability of phi 6 was significantly reduced in acidic and basic droplets compared to neutral ones. The presence of bovine serum albumin protected both MS2 and phi 6 from inactivation in droplets. The effects of sodium chloride and the surfactant sodium dodecyl sulfate varied by virus type and RH. Meanwhile, RH affected the viability of viruses as shown previously: viability was lowest at intermediate to high RH. The results demonstrate that the viability of viruses is determined by the chemical composition of carrier droplets, especially pH and protein content, and environmental factors. These findings emphasize the importance of understanding the chemical composition of carrier droplets in order to predict the persistence of viruses contained in them.	[Lin, Kaisen; Schulte, Chase R.; Marr, Linsey C.] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Lin, KS (corresponding author), Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA.	ksnlin@ucdavis.edu		Lin, Kaisen/0000-0003-4022-1505	National Institute of Health Director's New Innovator Award [1-DP2A1112243]; National Science Foundation [CBET1438103, ECCS-1542100]	National Institute of Health Director's New Innovator Award; National Science Foundation(National Science Foundation (NSF))	L.C.M. received National Institute of Health Director's New Innovator Award (1-DP2A1112243) https://www.nih.gov/and funding support from National Science Foundation (CBET1438103 and ECCS-1542100) https://www.nsf.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; [Anonymous], 2005, J PEDIAT GASTROENTER, V41, pS39; [Anonymous], 2017, MEDICINE, V96, pe6504; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P245, DOI 10.1021/acs.estlett.5b00193; Biryukov J, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00441-20; Brorson K, 2003, BIOTECHNOL BIOENG, V82, P321, DOI 10.1002/bit.10574; Chattopadhyay D, 2002, ENVIRON SCI TECHNOL, V36, P4017, DOI 10.1021/es0114097; Cochran RE, 2017, CHEM-US, V2, P655, DOI 10.1016/j.chempr.2017.03.007; Costello DA, 2015, J VIROL, V89, P350, DOI 10.1128/JVI.01927-14; Dawson DJ, 2005, J APPL MICROBIOL, V98, P203, DOI 10.1111/j.1365-2672.2004.02439.x; de Carvalho NA, 2017, ENVIRON SCI TECHNOL, V51, P8692, DOI 10.1021/acs.est.7b01296; DIMMOCK NJ, 1967, VIROLOGY, V31, P338, DOI 10.1016/0042-6822(67)90179-1; Ding J, 2019, ATMOS CHEM PHYS, V19, P7939, DOI 10.5194/acp-19-7939-2019; DONALDSON AI, 1976, VET MICROBIOL, V1, P413, DOI 10.1016/0378-1135(76)90056-0; DUNKLIN EW, 1948, J EXP MED, V87, P87, DOI 10.1084/jem.87.2.87; EHRLICH R, 1970, APPL MICROBIOL, V19, P245, DOI 10.1128/AEM.19.2.245-249.1970; Expert Panel on Gastrointestinal Imaging, 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; FAIX RG, 1985, J PEDIATR-US, V106, P649, DOI 10.1016/S0022-3476(85)80096-2; Feng YY, 2003, J IND MICROBIOL BIOT, V30, P549, DOI 10.1007/s10295-003-0080-y; Feng Z, 2016, COLLOID SURFACE B, V148, P622, DOI 10.1016/j.colsurfb.2016.09.025; Firquet S, 2015, MICROBES ENVIRON, V30, P140, DOI 10.1264/jsme2.ME14145; Freedman MA, 2019, J PHYS CHEM A, V123, P1275, DOI 10.1021/acs.jpca.8b10676; Gamble, 2020, EFFECT OF TEMPERATUR, DOI [10.1101/2020.10.16.341883, DOI 10.1101/2020.10.16.341883]; Gassilloud B, 2005, APPL ENVIRON MICROB, V71, P912, DOI 10.1128/AEM.71.2.912-920.2005; Gerba CP, 2017, ENVIRON SCI TECHNOL, V51, P7318, DOI 10.1021/acs.est.6b05835; GRANT SB, 1994, ENVIRON SCI TECHNOL, V28, P928, DOI 10.1021/es00054a026; Gutierrez L, 2012, ENVIRON SCI TECHNOL, V46, P8705, DOI 10.1021/es301336u; JENSEN MM, 1964, APPL MICROBIOL, V12, P418, DOI 10.1128/AEM.12.5.418-420.1964; Kadoi K, 2001, MICROBIOLOGICA, V24, P17; Kampf G, 2020, J HOSP INFECT, V105, P587, DOI [10.1016/j.jhin.2020.01.022, 10.1016/j.jhin.2020.06.001]; Kesimer M, 2017, NEW ENGL J MED, V377, P911, DOI 10.1056/NEJMoa1701632; Kormuth KA, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00552-19; Kormuth KA, 2018, J INFECT DIS, V218, P739, DOI 10.1093/infdis/jiy221; Kotwal G, 2014, CURR OPIN VIROL, V4, P37, DOI 10.1016/j.coviro.2013.12.003; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; LESTER W, 1948, J EXP MED, V88, P361, DOI 10.1084/jem.88.3.361; Lin K, 2019, HUMIDITY DEPENDENT D, DOI [10.1021/acs.est.9b04959, DOI 10.1021/ACS.EST.9B04959]; Lin K, 2017, ENVIRON SCI TECHNOL, V51, P2669, DOI 10.1021/acs.est.6b04846; Loh TP, 2011, EPIDEMIOL INFECT, V139, P1884, DOI 10.1017/S0950268810002955; MAHL MC, 1975, CAN J MICROBIOL, V21, P819, DOI 10.1139/m75-121; McEachran AD, 2015, ENVIRON HEALTH PERSP, V123, P337, DOI 10.1289/ehp.1408555; Michaud JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04409-z; PACHT ER, 1991, CHEST, V100, P1397, DOI 10.1378/chest.100.5.1397; PANCORBO OC, 1987, APPL ENVIRON MICROB, V53, P1803, DOI 10.1128/AEM.53.8.1803-1811.1987; Pinto F, 2010, AM J INFECT CONTROL, V38, P393, DOI 10.1016/j.ajic.2009.08.012; Prevost B, 2016, WATER RES, V91, P68, DOI 10.1016/j.watres.2015.12.049; Prussin AJ, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00551-18; Ratjen F, 1996, EUR RESPIR J, V9, P328, DOI 10.1183/09031936.96.09020328; REYNOLDS HY, 1984, DM-DIS MON, V30, P1, DOI 10.1016/0011-5029(84)90008-7; SALO RJ, 1976, ARCH VIROL, V52, P269, DOI 10.1007/BF01315616; Schuit M, 2020, J INFECT DIS, V221, P372, DOI 10.1093/infdis/jiz582; Schultz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00532-5; Seo K, 2012, J FOOD PROTECT, V75, P533, DOI 10.4315/0362-028X.JFP-11-199; SONGER JR, 1967, APPL MICROBIOL, V15, P35, DOI 10.1128/AEM.15.1.35-42.1967; Soulie V, 2015, PHYS CHEM CHEM PHYS, V17, P22296, DOI 10.1039/c5cp02444g; Tang JW, 2010, EPIDEMIOL INFECT, V138, P226, DOI 10.1017/S0950268809990410; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; Thompson SS, 1999, APPL ENVIRON MICROB, V65, P1186; Tong YY, 1998, FEMS MICROBIOL ECOL, V26, P311, DOI 10.1111/j.1574-6941.1998.tb00515.x; TROUWBORST T, 1973, APPL MICROBIOL, V26, P252, DOI 10.1128/AEM.26.3.252-257.1973; TROUWBORST T, 1974, J GEN VIROL, V24, P155, DOI 10.1099/0022-1317-24-1-155; Tseng CC, 2005, AEROSOL SCI TECH, V39, P1136, DOI 10.1080/02786820500428575; Tung-Thompson G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134277; Turgeon N, 2014, APPL ENVIRON MICROB, V80, P4242, DOI 10.1128/AEM.00767-14; Vejerano EP, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0939; Veldhuizen EJA, 2000, BBA-BIOMEMBRANES, V1467, P255, DOI 10.1016/S0005-2736(00)00256-X; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Vollenbroich D, 1997, BIOLOGICALS, V25, P289, DOI 10.1006/biol.1997.0099; WARE GW, 1993, REV ENV CONTAMINATIO; Wei HR, 2018, P NATL ACAD SCI USA, V115, P7272, DOI 10.1073/pnas.1720488115; WON WD, 1966, APPL MICROBIOL, V14, P742, DOI 10.1128/AEM.14.5.742-745.1966; World Health Organization Geneva, 2018, GLOB HLTH EST 2016 D; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]; Ye YY, 2018, ENVIRON SCI TECHNOL, V52, P7698, DOI 10.1021/acs.est.8b00824; Zuo ZL, 2014, APPL ENVIRON MICROB, V80, P2796, DOI 10.1128/AEM.00056-14	76	29	28	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243505	10.1371/journal.pone.0243505	http://dx.doi.org/10.1371/journal.pone.0243505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290421	Green Published, gold			2022-12-26	WOS:000598620100004
J	Morais, S; Oliveira, J; Lau, C; Pereira, M; Goncalves, M; Monteiro, C; Goncalves, AR; Matos, R; Sampaio, M; Cruz, E; Freitas, I; Santos, R; Lima, M				Morais, Sara; Oliveira, Jorge; Lau, Catarina; Pereira, Monica; Goncalves, Marta; Monteiro, Catarina; Goncalves, Ana Rita; Matos, Rui; Sampaio, Marco; Cruz, Eugenia; Freitas, Ines; Santos, Rosario; Lima, Margarida			alpha IIb beta 3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; INTEGRIN ALPHA-IIB-BETA-3; PROPLATELET FORMATION; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; FLOW-CYTOMETRY; OUTSIDE-IN; PLATELET; ACTIVATION; RECEPTOR	Background Rare pathogenic variants in either the ITGA2B or ITGB3 genes have been linked to autosomal dominant macrothrombocytopenia associated with abnormal platelet production and function, deserving the designation of Glanzmann Thrombasthenia-Like Syndrome (GTLS) or ITGA2B/ITGB3-related thrombocytopenia. Objectives To describe a series of patients with familial macrothrombocytopenia and decreased expression of alpha IIb beta 3 integrin due to defects in the ITGA2B or ITGB3 genes. Methods We reviewed the clinical and laboratory records of 10 Portuguese families with GTLS (33 patients and 11 unaffected relatives), including the functional and genetic defects. Results Patients had absent to moderate bleeding, macrothrombocytopenia, low alpha IIb beta 3 expression, impaired platelet aggregation/ATP release to physiological agonists and low expression of activation-induced binding sites on alpha IIb beta 3 (PAC-1) and receptor-induced binding sites on its ligand (bound fibrinogen), upon stimulation with TRAP-6 and ADP. Evidence for constitutive alpha IIb beta 3 activation, occurred in 2 out of 9 patients from 8 families studied, but also in 2 out of 12 healthy controls. We identified 7 missense variants: 3 in ITGA2B (5 families), and 4 in ITGB3 (5 families). Three variants (alpha IIb: p.Arg1026Trp and p.Arg1026Gln and beta 3: p.Asp749His) were previously reported. The remaining (alpha IIb: p.Gly1007Val and beta 3: p.Thr746Pro, p.His748Pro and p.Arg760Cys) are new, expanding the alpha IIb beta 3 defects associated with GTLS. The integration of the clinical and laboratory data allowed the identification of two GTLS subgroups, with distinct disease severity. Conclusions Previously reported ITGA2B and ITGB3 variants related to thrombocytopenia were clustered in a confined region of the membrane-proximal cytoplasmic domains, the inner membrane clasp. For the first time, variants are reported at the outer membrane clasp, at the transmembrane domain of alpha IIb, and at the membrane distal cytoplasmic domains of beta 3. This is the largest single-center series of inherited macrothrombocytopenia associated with alpha IIb beta 3 variants published to date.	[Morais, Sara; Pereira, Monica; Matos, Rui; Sampaio, Marco; Cruz, Eugenia] Ctr Hosp Univ Porto CHUP, Hosp Santo Antonio HSA, Serv Hematol Clin, Setor Trombose & Hemostase, Porto, Portugal; [Morais, Sara; Oliveira, Jorge; Lau, Catarina; Pereira, Monica; Goncalves, Marta; Monteiro, Catarina; Goncalves, Ana Rita; Sampaio, Marco; Freitas, Ines; Santos, Rosario; Lima, Margarida] Univ Porto UMIB ICBAS, Inst Ciencias Biomed, Unidade Multidisciplinar Invest Biomed, Porto, Portugal; [Oliveira, Jorge; Monteiro, Catarina; Goncalves, Ana Rita; Santos, Rosario] Ctr Hosp Univ Porto CHUP, Ctr Genet Med Doutor Jacinto Magalhaes CGMJM, Unidade Genet Mol, Porto, Portugal; [Lau, Catarina; Goncalves, Marta; Lima, Margarida] Ctr Hosp Univ Porto CHUP, Hosp Santo Antonio HSA, Serv Hematol Clin, Lab Citometria,Unidade Diagnost Hematol, Porto, Portugal; [Freitas, Ines] Ctr Hosp Univ Porto CHUP, Hosp Santo Antonio HSA, Serv Hematol Lab, Porto, Portugal	Universidade do Porto	Morais, S (corresponding author), Ctr Hosp Univ Porto CHUP, Hosp Santo Antonio HSA, Serv Hematol Clin, Setor Trombose & Hemostase, Porto, Portugal.; Morais, S (corresponding author), Univ Porto UMIB ICBAS, Inst Ciencias Biomed, Unidade Multidisciplinar Invest Biomed, Porto, Portugal.	saratsmorais@hotmail.com	Santos, Rosário/AAZ-7103-2020; Oliveira, Jorge/O-4421-2019; Santos, Rosário/AAC-4883-2020; Lima, Margarida/S-7466-2016	Santos, Rosário/0000-0002-8594-6377; Oliveira, Jorge/0000-0003-3924-6385; Goncalves, Ana/0000-0002-3917-2323; Morais, Sara/0000-0003-4266-4457; Sampaio, Marco/0000-0001-9171-003X; Cruz, Eugenia/0000-0002-4801-5047; Lima, Margarida/0000-0001-9702-5260; Pereira, Monica/0000-0002-3346-0543; Monteiro, Catarina/0000-0002-6659-4951	Centro Hospitalar Universitario do Porto (CHUP); Forum Hematologico do Norte (FHN)	Centro Hospitalar Universitario do Porto (CHUP); Forum Hematologico do Norte (FHN)	This study was supported by the Centro Hospitalar Universitario do Porto (CHUP) and by the Forum Hematologico do Norte (FHN). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CS, 1990, BLOOD, V75, P128; [Anonymous], 2006, ICES CM 2006 OCC, V12, P1; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Balduini CL, 2017, PLATELETS, V28, P3, DOI 10.3109/09537104.2016.1171835; Bastida JM, 2018, HAEMATOLOGICA, V103, P148, DOI 10.3324/haematol.2017.171132; Buitrago L, 2015, P NATL ACAD SCI USA, V112, pE1898, DOI 10.1073/pnas.1422238112; Bury L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034449; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Durrant TN, 2017, BLOOD, V130, P1607, DOI [10.1182/blood-2017-03773614, 10.1182/blood-2017-03-773614]; Elbatarny M, 2014, HAEMOPHILIA, V20, P831, DOI 10.1111/hae.12503; Favier M, 2018, AM J HEMATOL, V93, P195, DOI 10.1002/ajh.24958; Fogerty AE, 2018, TRANSFUS MED REV, V32, P225, DOI 10.1016/j.tmrv.2018.08.004; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; Geddis AE, 2010, SEMIN HEMATOL, V47, P212, DOI 10.1053/j.seminhematol.2010.03.001; Ghevaert C, 2008, BLOOD, V111, P3407, DOI 10.1182/blood-2007-09-112615; GINSBERG MH, 1990, BLOOD, V76, P2017; GRALNICK HR, 1992, BRIT J HAEMATOL, V80, P347, DOI 10.1111/j.1365-2141.1992.tb08144.x; Gresele P, 2016, SEMIN THROMB HEMOST, V42, P292, DOI 10.1055/s-0035-1570078; Gresele P, 2009, HAEMATOL-HEMATOL J, V94, P663, DOI 10.3324/haematol.2008.002246; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; HARDISTY R, 1992, BLOOD, V80, P696; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Huskens D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192079; Jayo A, 2010, HAEMATOL-HEMATOL J, V95, P1158, DOI 10.3324/haematol.2009.018572; Johnson B, 2016, HAEMATOLOGICA, V101, P1170, DOI 10.3324/haematol.2016.146316; Kashiwagi H, 2013, MOL GENET GENOM MED, V1, P77, DOI 10.1002/mgg3.9; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Michelson AD, 1996, BLOOD, V87, P4925, DOI 10.1182/blood.V87.12.4925.bloodjournal87124925; Miyashita N, 2018, ANN HEMATOL, V97, P629, DOI 10.1007/s00277-017-3214-4; Morkis Iuri Vicente Camargo, 2016, Rev. Bras. Hematol. Hemoter., V38, P310, DOI 10.1016/j.bjhh.2016.07.001; Nurden AT, 2015, HUM MUTAT, V36, P548, DOI 10.1002/humu.22776; Nurden AT, 2013, SEMIN THROMB HEMOST, V39, P642, DOI 10.1055/s-0033-1353393; Nurden AT, 2011, SEMIN THROMB HEMOST, V37, P698, DOI 10.1055/s-0031-1291380; Nurden P, 2017, BLOOD ADV, V1, P494, DOI 10.1182/bloodadvances.2016002808; Pedersen OH, 2018, PLATELETS, V29, P199, DOI 10.1080/09537104.2017.1353684; Peyruchaud O, 1998, BLOOD, V92, P4178, DOI 10.1182/blood.V92.11.4178.423k08_4178_4187; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodeghiero F, 2010, J THROMB HAEMOST, V8, P2063, DOI 10.1111/j.1538-7836.2010.03975.x; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Thon JN, 2010, SEMIN HEMATOL, V47, P220, DOI 10.1053/j.seminhematol.2010.03.005; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Ulmer TS, 2010, CELL ADHES MIGR, V4, P243, DOI 10.4161/cam.4.2.10592; van Asten I, 2018, J THROMB HAEMOST, V16, P689, DOI 10.1111/jth.13952; van Asten I, 2018, SEMIN THROMB HEMOST, V44, P197, DOI 10.1055/s-0038-1636901; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2011, J THROMB HAEMOST, V9, P20, DOI 10.1111/j.1538-7836.2011.04355.x; ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41	60	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0235136	10.1371/journal.pone.0235136	http://dx.doi.org/10.1371/journal.pone.0235136			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33276370	gold, Green Published			2022-12-26	WOS:000597150200042
J	Alzakerin, HM; Halkiadakis, Y; Morgan, KD				Alzakerin, Helia Mahzoun; Halkiadakis, Yannis; Morgan, Kristin D.			Characterizing gait pattern dynamics during symmetric and asymmetric walking using autoregressive modeling	PLOS ONE			English	Article							GROUND REACTION FORCES; VARIABILITY; TREADMILL	Gait asymmetry is often observed in populations with varying degrees of neuromuscular control. While changes in vertical ground reaction force (vGRF) peak magnitude are associated with altered limb loading that can be observed during asymmetric gait, the challenge is identifying techniques with the sensitivity to detect these altered movement patterns. Autoregressive (AR) modeling has successfully delineated between healthy and pathological gait during running; but has been little explored in walking. Thus, AR modeling was implemented to assess differences in vGRF pattern dynamics during symmetric and asymmetric walking. We hypothesized that the AR model coefficients would better detect differences amongst the symmetric and asymmetric walking conditions than the vGRF peak magnitude mean. Seventeen healthy individuals performed a protocol that involved walking on a split-belt instrumented treadmill at different symmetric (0.75m/s, 1.0 m/s, 1.5 m/s) and asymmetric (Side 1: 0.75m/s-Side 2:1.0 m/s; Side 1:1.0m/s-Side 2:1.5 m/s) gait conditions. Vertical ground reaction force peaks extracted during the weight-acceptance and propulsive phase of each step were used to construct a vGRF peak time series. Then, a second order AR model was fit to the vGRF peak waveform data to determine the AR model coefficients. The resulting AR coefficients were plotted on a stationarity triangle and their distance from the triangle centroid was computed. Significant differences in vGRF patterns were detected amongst the symmetric and asymmetric conditions using the AR modeling coefficients (p = 0.01); however, no differences were found when comparing vGRF peak magnitude means. These findings suggest that AR modeling has the sensitivity to identify differences in gait asymmetry that could aid in monitoring rehabilitation progression.	[Alzakerin, Helia Mahzoun; Halkiadakis, Yannis; Morgan, Kristin D.] Univ Connecticut, Biomed Engn, Sch Engn, Storrs, CT 06269 USA	University of Connecticut	Morgan, KD (corresponding author), Univ Connecticut, Biomed Engn, Sch Engn, Storrs, CT 06269 USA.	Kristin.2.morgan@uconn.edu		Morgan, Kristin/0000-0002-5803-2107				Alzakerin HM, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1545-6; [Anonymous], 2007, RUNA, V26, P289; [Anonymous], 1999, MS MAGAZINE APR, V9, P50; Balasubramanian CK, 2007, ARCH PHYS MED REHAB, V88, P43, DOI 10.1016/j.apmr.2006.10.004; Box GEP, 1976, TIME SERIES ANAL HOL; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Gardinier ES, 2012, MED SCI SPORT EXER, V44, P1490, DOI 10.1249/MSS.0b013e31824d2783; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hsiang SM, 2002, SAFETY SCI, V40, P639, DOI 10.1016/S0925-7535(01)00064-9; Koontz AM, 2001, MED ENG PHYS, V23, P285, DOI 10.1016/S1350-4533(00)00082-5; Masani K, 2002, J APPL PHYSIOL, V92, P1885, DOI 10.1152/japplphysiol.00969.2000; McCrory JL, 2001, GAIT POSTURE, V14, P104, DOI 10.1016/S0966-6362(01)00140-0; Montgomery D. C., 2015, INTRO TIME SERIES AN; Morgan KD, 2019, J APPL BIOMECH, V35, P388, DOI 10.1123/jab.2018-0414; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Pietrosimone B, 2019, MED SCI SPORT EXER, V51, P246, DOI 10.1249/MSS.0000000000001776; Pietrosimone B, 2018, J ORTHOP RES, V36, P2932, DOI 10.1002/jor.24056; Pietrosimone B, 2016, AM J SPORT MED, V44, P425, DOI 10.1177/0363546515618380; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Roper JA, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115627611; Winter SL, 2017, HUM MOVEMENT SCI, V51, P153, DOI 10.1016/j.humov.2016.12.003	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243221	10.1371/journal.pone.0243221	http://dx.doi.org/10.1371/journal.pone.0243221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270770	Green Published, gold			2022-12-26	WOS:000597149100102
J	Bouzid, D; Mullaert, J; Le Hingrat, Q; Laurent, O; Duval, X; Lescure, X; Timsit, JF; Descamps, D; Montravers, P; Choquet, C; Lucet, JC; Casalino, E; Visseaux, B				Bouzid, Donia; Mullaert, Jimmy; Le Hingrat, Quentin; Laurent, Odile; Duval, Xavier; Lescure, Xavier; Timsit, Jean-Francois; Descamps, Diane; Montravers, Philippe; Choquet, Christophe; Lucet, Jean-Christophe; Casalino, Enrique; Visseaux, Benoit		ED Influenza Study Grp	Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department	PLOS ONE			English	Article							SYNCYTIAL VIRUS	Background Rapid identification of patients with high suspicion of COVID-19 will become a challenge with the co-circulation of multiple respiratory viruses (RVs). We have identified clinical or biological characteristics to help distinguish SARS-CoV-2 from other RVs. Methods We used a prospective cohort including all consecutive patients admitted through the emergency department's (ED) and presenting respiratory symptoms from November 2019 to April 2020. Patients were tested for RV using multiplex polymerase chain reaction (mPCR) and SARS-CoV-2 RT-PCR. Results 203/508 patients were positive for an RV during the non-SARS-CoV-2 epidemic period (November to February), and 268/596 patients were SARS-CoV-2 positive during the SARS-CoV-2 epidemic (March to April). Younger age, male gender, fever, absence of expectoration and absence of chronic lung disease were statistically associated with SARS-CoV-2 detection. Combining these variables allowed for the distinguishing of SARS-CoV-2 infections with 83, 65, 75 and 76% sensitivity, specificity, PPV and NPV, respectively. Conclusion Patients' characteristics associated with a positive PCR are common between SARS-CoV-2 and other RVs, but a simple discrimination of strong SARS-CoV-2 suspicion with a limited set of clinical features seems possible. Such scoring could be useful but has to be prospectively evaluated and will not eliminate the need for rapid PCR assays.	[Bouzid, Donia; Mullaert, Jimmy; Le Hingrat, Quentin; Duval, Xavier; Lescure, Xavier; Timsit, Jean-Francois; Descamps, Diane; Lucet, Jean-Christophe; Casalino, Enrique; Visseaux, Benoit] Univ Paris, IAME, INSERM, Paris, France; [Bouzid, Donia; Laurent, Odile; Choquet, Christophe; Casalino, Enrique] Bichat Claude Bernard Univ Hosp, AP HP Nord, Emergency Dept, Paris, France; [Mullaert, Jimmy] Bichat Claude Bernard Univ Hosp, AP HP Nord, Dept Epidemiol Biostat & Clin Res, Paris, France; [Le Hingrat, Quentin; Duval, Xavier; Descamps, Diane; Visseaux, Benoit] Bichat Claude Bernard Univ Hosp, AP HP Nord, Virol Dept, Paris, France; [Lescure, Xavier] Bichat Claude Bernard Univ Hosp, AP HP Nord, Infect Dis Dept, Paris, France; [Timsit, Jean-Francois] Bichat Claude Bernard Univ Hosp, AP HP Nord, Med & Infect Dis Intens Care Unit, Paris, France; [Montravers, Philippe] Bichat Claude Bernard Univ Hosp, AP HP Nord, Dept Anesthesiol & Crit Care Med, Paris, France; [Lucet, Jean-Christophe] Bichat Claude Bernard Univ Hosp, AP HP Nord, Infect Control Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Bouzid, D (corresponding author), Univ Paris, IAME, INSERM, Paris, France.; Bouzid, D (corresponding author), Bichat Claude Bernard Univ Hosp, AP HP Nord, Emergency Dept, Paris, France.	donia.bouzid@aphp.fr	Casalino, Enrique/GYU-1974-2022; Le Hingrat, Quentin/AAC-7439-2021; Bouzid, Donia/AAC-9054-2022	Casalino, Enrique/0000-0002-4352-6729; Le Hingrat, Quentin/0000-0001-9017-4941; Bouzid, Donia/0000-0002-7538-3320	AP-HP (Assistance Publique -Hopitaux de Paris); Qiagen	AP-HP (Assistance Publique -Hopitaux de Paris); Qiagen	This study was funded by the AP-HP (Assistance Publique -Hopitaux de Paris). This study was supported by Qiagen in the form of a grant funding the data management of the RespiFast2 study targeting to assess the impact of respiratory viruses and of discounted equipment and consumables in the context of the COVID-19 outbreak. Qiagen had no role in the study conception, design, conduct, data analysis or manuscript preparation.	[Anonymous], 2020, COVID 19 SITUATION U; Babady NE, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01658-17; COMMISSION IMPLEMENTING DECISION (EU), 2018945 COMM IMPL DE, P74; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266; Leber AL, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01945-17, 10.1128/jcm.01945-17]; Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li Y, 2019, LANCET GLOB HEALTH, V7, pE1031, DOI 10.1016/S2214-109X(19)30264-5; Loubet P, 2017, CLIN MICROBIOL INFEC, V23, P253, DOI 10.1016/j.cmi.2016.11.014; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Sberna G, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104470; Solomon DA, 2020, JAMA-J AM MED ASSOC, V324, P1342, DOI 10.1001/jama.2020.14661; Souty C, 2019, CLIN MICROBIOL INFEC, V25, P1147, DOI 10.1016/j.cmi.2019.01.014; Visseaux B, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104520; Visseaux B, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00630-20; Zayet S, 2020, MICROBES INFECT, V22, P481, DOI 10.1016/j.micinf.2020.05.016	18	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243261	10.1371/journal.pone.0243261	http://dx.doi.org/10.1371/journal.pone.0243261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270790	Green Published, Green Submitted, gold			2022-12-26	WOS:000597149100018
J	Liu, T; Liu, MJ; Hu, XH; Xie, BS				Liu, Ting; Liu, Meijuan; Hu, Xiaohan; Xie, Bangsheng			The effect of environmental regulations on innovation in heavy-polluting and resource-based enterprises: Quasi-natural experimental evidence from China	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; PRODUCTIVITY GROWTH; COMPETITIVENESS; PERFORMANCE; COST	Environmental protection regulations adopted by governments affect the microeconomic behavior of enterprises. The Chinese government began piloting the outgoing leading officials' accountability audit of natural resources assets (OANRA) in some regions in 2014. Based on this quasi-natural experimental setting, this paper chose heavy-polluting and resource-based enterprises in pilot regions of China from 2011 to 2016 as examples for studying the impact of the OANRA on enterprise innovation and further examines the role of government subsidies in this process. The study finds that the OANRA has no significant impact on enterprise innovation. However, with support from government subsidies, the OANRA dramatically accelerates enterprise innovation investment. The results are still seen after applying propensity matching analysis (PSM), balancing panel data and deleting special provinces. Further analysis shows that this effect is more obvious among small-scale, state-owned enterprises that are located in areas with high degrees of marketization and high bank credit constraints. This study advances the research of the OANRA's effects on the microeconomic behavior of enterprises. Moreover, the adjustment effect of government subsidies also provides great reference value to making rational use of policy to cooperate with the OANRA.	[Liu, Ting; Liu, Meijuan; Hu, Xiaohan; Xie, Bangsheng] Fujian A&F Univ, Sch Management, Fuzhou, Fujian, Peoples R China		Liu, MJ; Hu, XH; Xie, BS (corresponding author), Fujian A&F Univ, Sch Management, Fuzhou, Fujian, Peoples R China.	19950005@zafu.edu.cn; xiaohan.hu@helsinki.fi; xbs2002@163.com			National Social Science Foundation of China [17BGL127]; Zhejiang Provincial Natural Science Foundation of China; Fujian Provincial Social Science Research Base Major Project [FJ2018JDZ064]; Provincial Platform Research Project of School of Management of Fujian Agriculture and Forestry University [KXJD1804A]	National Social Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Fujian Provincial Social Science Research Base Major Project; Provincial Platform Research Project of School of Management of Fujian Agriculture and Forestry University	This research was supported by National Social Science Foundation of China (No.17BGL127, Meijuan Liu, http://fz.people.com.cn/skygb/sk/index.php/index/index).And it was also supported by Zhejiang Provincial Natural Science Foundation of China (Grant No.LY18G030015,Meijuan Liu, http://www.zjnsf.gov.cn/), Fujian Provincial Social Science Research Base Major Project (FJ2018JDZ064, Bangsheng Xie, http://www.fjskl.org.cn/channels/483.html), and Provincial Platform Research Project of School of Management of Fujian Agriculture and Forestry University (KXJD1804A, Bangsheng Xie, http://glxy.fafu.edu.cn/).	Acharya VV, 2014, REV FINANC STUD, V27, P301, DOI 10.1093/rfs/hht009; Ambec S., 2005, ENERGY STUDIES REV, V14, P42, DOI DOI 10.15173/esr.v14i2.493; [Anonymous], 2014, J NURS REGUL, V5, pS3; [Anonymous], 1996, EUR J POLIT ECON; [Anonymous], 2016, CHINA PROVINCIAL MAR; [Anonymous], 2018, MONOGRAFIAS CON PERS, V1, P13; [Anonymous], 2015, OECUSSE POST JAN, V1, P15; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Arque-Castells P, 2013, REV IND ORGAN, V43, P193, DOI 10.1007/s11151-013-9381-0; Baranchuk N, 2014, J FINANC ECON, V111, P578, DOI 10.1016/j.jfineco.2013.11.010; Callon JD, 1995, COMPETITIVE ADVANTAG; Chen SM, 2011, J CORP FINANC, V17, P259, DOI 10.1016/j.jcorpfin.2010.08.004; Dabiq, 2014, DABIQ, V6, P3; Dang L., 2015, CHINA IND EC, V07, P146, DOI DOI 10.19581/J.CNKI.CIEJOURNAL.2015.07.010; Denison E.F, 2010, ACCOUNTING SLOWER EC; Domazlicky BR, 2004, ENVIRON RESOUR ECON, V28, P301, DOI 10.1023/B:EARE.0000031056.93333.3a; Flammer C, 2015, STRATEGIC MANAGE J, V36, P1469, DOI 10.1002/smj.2307; Gan CH., 2015, CHINA IND EC, V3, P44, DOI [10.19581/j.cnki.ciejournal.2015.03.004, DOI 10.19581/J.CNKI.CIEJOURNAL.2015.03.004]; GOLLOP FM, 1983, J POLIT ECON, V91, P654, DOI 10.1086/261170; GRAY WB, 1987, AM ECON REV, V77, P998; Hall BH, 2012, HBK ECON, V1, P609, DOI 10.1016/S0169-7218(10)01014-2; Hamamoto M, 2006, RESOUR ENERGY ECON, V28, P299, DOI 10.1016/j.reseneeco.2005.11.001; Hewitt-Dundas N, 2010, EUR PLAN STUD, V18, P107, DOI 10.1080/09654310903343559; Hsu PH, 2014, J FINANC ECON, V112, P116, DOI 10.1016/j.jfineco.2013.12.002; JAFFE AB, 1995, J ECON LIT, V33, P132; Jaffe AB, 2015, IMPACT R D SUBSIDY I; Jones BF, 2005, Q J ECON, V120, P835, DOI 10.1162/003355305774268165; Kleer R, 2010, RES POLICY, V39, P1361, DOI 10.1016/j.respol.2010.08.001; Li B., 2016, AUDITING RES, V5, P32; Ma H, 2019, J SHANGHAI U FINANC, V2, P30; Mehta M. N., 2014, National Journal of Community Medicine, V5, P10; National Council of State Boards of Nursing, 2014, J NURSING REGULATION, V5, P3; Nini G, 2009, J FINANC ECON, V92, P400, DOI 10.1016/j.jfineco.2008.04.008; PALMER K, 1995, J ECON PERSPECT, V9, P119, DOI 10.1257/jep.9.4.119; PORTER ME, 1995, J ECON PERSPECT, V9, P97, DOI 10.1257/jep.9.4.97; Quan J, 2018, AUDITING RES, V2, P46; Ramanathan R, 2010, MANAGE DECIS, V48, P1493, DOI 10.1108/00251741011090298; Scharfstein DS, 2000, J FINANC, V55, P2537, DOI 10.1111/0022-1082.00299; Takalo T, 2010, J TECHNOL TRANSFER, V35, P16, DOI 10.1007/s10961-009-9112-8; The Times, 2015, TIMES, V02, P24; Thong R, 2018, J ACCOUNT ECON, V66, P67, DOI 10.1016/j.jacceco.2018.02.001; Tian X, 2014, REV FINANC STUD, V27, P211, DOI 10.1093/rfs/hhr130; Wagner M, 2008, ECOL ECON, V66, P392, DOI 10.1016/j.ecolecon.2007.10.001; Yang CH, 2012, RESOUR ENERGY ECON, V34, P514, DOI 10.1016/j.reseneeco.2012.05.001; Yang WX, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9060912; Yin Z.C., 2020, MANAG WORLD, V36, P59; Zhang H., 2015, AUDITING RES, V2, P14; Zhao J, 2016, CHINA IND EC, V9, P109; Zhou LA., 2007, EC RES J, V7, P36, DOI DOI 10.4236/JSS.2016.45008	49	4	4	13	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0239549	10.1371/journal.pone.0239549	http://dx.doi.org/10.1371/journal.pone.0239549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270678	gold, Green Published			2022-12-26	WOS:000597149100063
J	Mitsikas, DA; Glykos, NM				Mitsikas, Dimitrios A.; Glykos, Nicholas M.			A molecular dynamics simulation study on the propensity of Asn-Gly-containing heptapeptides towards beta-turn structures: Comparison with ab initio quantum mechanical calculations	PLOS ONE			English	Article							MINNESOTA DENSITY FUNCTIONALS; LONDON-DISPERSION; HAIRPIN PEPTIDE; FORCE-FIELDS; NONCOVALENT INTERACTIONS; PROTEIN STRUCTURES; AQUEOUS-SOLUTION; STABILITY; NMR; CONFORMATION	Both molecular mechanical and quantum mechanical calculations play an important role in describing the behavior and structure of molecules. In this work, we compare for the same peptide systems the results obtained from folding molecular dynamics simulations with previously reported results from quantum mechanical calculations. More specifically, three molecular dynamics simulations of 5 mu s each in explicit water solvent were carried out for three Asn-Gly-containing heptapeptides, in order to study their folding and dynamics. Previous data, based on quantum mechanical calculations within the DFT framework have shown that these peptides adopt beta-turn structures in aqueous solution, with type I' beta-turn being the most preferred motif. The results from our analyses indicate that at least for the given systems, force field and simulation protocol, the two methods diverge in their predictions. The possibility of a force field-dependent deficiency is examined as a possible source of the observed discrepancy.	[Mitsikas, Dimitrios A.; Glykos, Nicholas M.] Democritus Univ Thrace, Dept Mol Biol & Genet, Univ Campus, Alexandroupolis, Greece		Glykos, NM (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Univ Campus, Alexandroupolis, Greece.	glykos@mbg.duth.gr		Mitsikas, Dimitrios/0000-0002-2417-0309; Glykos, Nicholas/0000-0003-3782-206X				Altis A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945165; Altis A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2746330; Aravinda S, 2002, ANGEW CHEM INT EDIT, V41, P3863, DOI 10.1002/1521-3773(20021018)41:20<3863::AID-ANIE3863>3.0.CO;2-A; Baltzis AS, 2016, PROTEIN SCI, V25, P587, DOI 10.1002/pro.2850; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; CHOU PY, 1977, J MOL BIOL, V115, P135, DOI 10.1016/0022-2836(77)90094-8; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Brevern AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33191; deAlba E, 1997, J AM CHEM SOC, V119, P175, DOI 10.1021/ja962325e; Duddy WJ, 2004, PROTEIN SCI, V13, P3051, DOI 10.1110/ps.04920904; Espinosa JF, 2000, ANGEW CHEM INT EDIT, V39, P2330, DOI 10.1002/1521-3773(20000703)39:13<2330::AID-ANIE2330>3.0.CO;2-C; Espinosa JF, 2002, PROTEIN SCI, V11, P1492, DOI 10.1110/ps.4140102; Espinosa JF, 2001, J MOL BIOL, V306, P397, DOI 10.1006/jmbi.2000.4349; Gellman SH, 1998, CURR OPIN CHEM BIOL, V2, P717, DOI 10.1016/S1367-5931(98)80109-9; Georgoulia PS, 2019, ARCH BIOCHEM BIOPHYS, V664, P76, DOI 10.1016/j.abb.2019.01.033; Georgoulia PS, 2018, ACS OMEGA, V3, P14746, DOI 10.1021/acsomega.8b01579; Georgoulia PS, 2013, J PHYS CHEM B, V117, P5522, DOI 10.1021/jp401239v; Georgoulia PS, 2011, J PHYS CHEM B, V115, P15221, DOI 10.1021/jp209597e; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Goerigk L, 2015, J PHYS CHEM LETT, V6, P3891, DOI 10.1021/acs.jpclett.5b01591; Goerigk L, 2014, J PHYS CHEM B, V118, P14612, DOI 10.1021/jp510148h; Goerigk L, 2013, J CHEM THEORY COMPUT, V9, P3240, DOI 10.1021/ct400321m; Griffiths-Jones SR, 1998, CHEM COMMUN, P789, DOI 10.1039/a800749g; Griffiths-Jones SR, 1999, J MOL BIOL, V292, P1051, DOI 10.1006/jmbi.1999.3119; Gunasekaran K, 1997, PROTEIN ENG, V10, P1131, DOI 10.1093/protein/10.10.1131; Gunasekaran K, 1998, J MOL BIOL, V284, P1505, DOI 10.1006/jmbi.1998.2154; Haque TS, 1996, J AM CHEM SOC, V118, P6975, DOI 10.1021/ja960429j; Haque TS, 1997, J AM CHEM SOC, V119, P2303, DOI 10.1021/ja963653h; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Izaguirre JA, 1999, J CHEM PHYS, V110, P9853, DOI 10.1063/1.478995; Jiang F, 2014, J PHYS CHEM B, V118, P6983, DOI 10.1021/jp5017449; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kang YK, 2016, BIOPOLYMERS, V105, P653, DOI 10.1002/bip.22863; Kang YK, 2010, J COMPUT CHEM, V31, P2915, DOI 10.1002/jcc.21587; Koukos PI, 2014, J PHYS CHEM B, V118, P10076, DOI 10.1021/jp5046113; Koukos PI, 2014, J CHEM INF MODEL, V54, P209, DOI 10.1021/ci4005817; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4; LEWIS PN, 1971, P NATL ACAD SCI USA, V68, P2293, DOI 10.1073/pnas.68.9.2293; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mardirossian N, 2016, J CHEM THEORY COMPUT, V12, P4303, DOI 10.1021/acs.jctc.6b00637; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; MATTOS C, 1994, J MOL BIOL, V238, P733, DOI 10.1006/jmbi.1994.1332; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Patapati KK, 2011, BIOPHYS J, V101, P1766, DOI 10.1016/j.bpj.2011.08.044; Patapati KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015290; Patmanidis I, 2013, J MOL GRAPH MODEL, V41, P68, DOI 10.1016/j.jmgm.2013.02.004; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plumley JA, 2011, J COMPUT CHEM, V32, P1519, DOI 10.1002/jcc.21729; Popp A, 2014, J PHYS CHEM B, V118, P14234, DOI 10.1021/jp506658x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RamirezAlvarado M, 1997, J MOL BIOL, V273, P898, DOI 10.1006/jmbi.1997.1347; Razavi AM, 2015, J CHEM THEORY COMPUT, V11, P2801, DOI 10.1021/acs.jctc.5b00088; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SAWYER L, 1978, J MOL BIOL, V118, P137, DOI 10.1016/0022-2836(78)90412-6; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Serafeim AP, 2016, J CHEM INF MODEL, V56, P2035, DOI 10.1021/acs.jcim.6b00493; Sharadadevi A, 2018, J BIOMOL STRUCT DYN, V36, P3916, DOI 10.1080/07391102.2017.1403958; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; Stanger HE, 1998, J AM CHEM SOC, V120, P4236, DOI 10.1021/ja973704q; Syud FA, 1999, J AM CHEM SOC, V121, P11577, DOI 10.1021/ja992733t; Syud FA, 2001, J AM CHEM SOC, V123, P8667, DOI 10.1021/ja0109803; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Zhang C, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3435332; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zhao Y, 2011, CHEM PHYS LETT, V502, P1, DOI 10.1016/j.cplett.2010.11.060; Zhou CY, 2015, J PHYS CHEM B, V119, P1035, DOI 10.1021/jp5064676	78	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243429	10.1371/journal.pone.0243429	http://dx.doi.org/10.1371/journal.pone.0243429			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270807	Green Published, Green Submitted, gold			2022-12-26	WOS:000597149100047
J	Maly, S; Janousek, L; Bortel, R; Sebek, J; Hospodka, J; Skapa, J; Fronek, J				Maly, Stepan; Janousek, Libor; Bortel, Radoslav; Sebek, Jan; Hospodka, Jiri; Skapa, Jiri; Fronek, Jiri			NIRS-based monitoring of kidney graft perfusion	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; ANATOMICAL RELATIONSHIPS; PIG-KIDNEY; TRANSPLANTATION; PROBE	Introduction Acute early vascular complications are rare, but serious complications after kidney transplantation. They often result in graft loss. For this reason, shortening the diagnostic process is crucial. Currently, it is standard procedure to monitor renal graft perfusion using Doppler ultrasound (DU). With respect to acute vascular complications, the main disadvantage of this type of examination is its periodicity. It would be of great benefit if graft blood perfusion could be monitored continuously during the early postoperative period. It appears evident that a well-designed near infrared spectroscopy (NIRS) monitoring system could prove very useful during the early post-transplantation period. Its role in the immediate diagnosis of vascular complications could result in a significant increase in graft salvage, thus improving the patient's overall quality of life and lowering morbidity and mortality for renal graft recipients. The aim of this study was to design, construct and test such a monitoring system. Materials and methods We designed a rough NIRS-based system prototype and prepared a two-stage laboratory experiment based on a laboratory pig model. In the first stage, a total of 10 animals were used to verify and optimize the technical aspects and functionality of the prototype sensor by testing it on the animal kidneys in-vivo. As a result of these tests, a more specific prototype was designed. During the second stage, we prepared a unique laboratory model of a pig kidney autotransplantation and tested the system for long-term functionality on a group of 20 animals. Overall sensitivity and specificity were calculated, and a final prototype was prepared and completed with its own analytic software and chassis. Results We designed and constructed a NIRS-based system for kidney graft perfusion monitoring. The measurement system provided reliable performance and 100% sensitivity when detecting acute diminished blood perfusion of the transplanted kidneys in laboratory conditions. Conclusion The system appears to be a useful tool for diagnosing diminished blood perfusion of kidney transplants during the early postoperative period. However, further testing is still required. We believe that applying our method in current human transplantation medicine is feasible, and we are confident that our prototype is ready for human testing.	[Maly, Stepan; Janousek, Libor; Fronek, Jiri] Inst Clin & Expt Med, Transplant Surg Dept, Prague, Czech Republic; [Maly, Stepan; Janousek, Libor] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Bortel, Radoslav; Sebek, Jan; Hospodka, Jiri; Skapa, Jiri] Czech Tech Univ, Fac Elect Engn, Prague, Czech Republic; [Fronek, Jiri] Charles Univ Prague, Fac Med 2, Dept Anat, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Czech Technical University Prague; Charles University Prague	Maly, S (corresponding author), Inst Clin & Expt Med, Transplant Surg Dept, Prague, Czech Republic.; Maly, S (corresponding author), Charles Univ Prague, Fac Med 1, Prague, Czech Republic.	stepanmaly@seznam.cz			Ministry of Health of Czech Republic - AZV CR; Czech Health Research council [16-34134A]	Ministry of Health of Czech Republic - AZV CR; Czech Health Research council	The project was funded entirely by a grant: Ministry of Health of Czech Republic - AZV CR; Czech Health Research council (http://www.azvcr.cz/), Grant 16-34134A, 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl TJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.087005; Amdisen C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178301; Bagetti HJS, 2008, J UROLOGY, V179, P1627, DOI 10.1016/j.juro.2007.11.040; Benoit G, 2011, B ACAD NATL MED, V195, P351; Benoit G, 2011, B ACAD NAT MED PARIS, V195, P351, DOI 10.1016/S0001-4079(19)32093-X; Carvalho JA, 2019, TRANSPL P, V51, P1590, DOI 10.1016/j.transproceed.2019.05.001; Crane J, 2011, EXP CLIN TRANSPLANT, V9, P118; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Grosenick D, 2015, BIOMED OPT EXPRESS, V6, P309, DOI 10.1364/BOE.6.000309; Hakim DN, 2016, EXP CLIN TRANSPLANT, V14, P454, DOI 10.6002/ect.2014.0135; Kirk AD, 2003, IMMUNOL REV, V196, P176, DOI 10.1046/j.1600-065X.2003.00081.x; Malakasioti G, 2018, NEPHROL DIAL TRANSPL, V33, P1863, DOI 10.1093/ndt/gfy116; Pereira-Sampaio MA, 2004, J UROLOGY, V172, P2077, DOI 10.1097/01.ju.0000138085.19352.b5; Civantos DVP, 2019, TRANSPL P, V51, P328, DOI [10.1016/j.transoroceed.2018.12.011, 10.1016/j.transproceed.2018.12.011]; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Rodgers SK, 2014, RADIOL CLIN N AM, V52, P1307, DOI 10.1016/j.rcl.2014.07.009; Sharfuddin A, 2014, CLIN J AM SOC NEPHRO, V9, P416, DOI 10.2215/CJN.02960313; Tarzamni MK, 2007, TRANSPL P, V39, P1098, DOI 10.1016/j.transproceed.2007.02.004; Vaughan DL, 1995, INT J ANGIOL, V4, P25; Vidal E, 2014, PEDIATR NEPHROL, V29, P909, DOI 10.1007/s00467-013-2698-y; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; 2014, REG ANESTH PAIN MED, V9, P339	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243154	10.1371/journal.pone.0243154	http://dx.doi.org/10.1371/journal.pone.0243154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264371	Green Published, gold			2022-12-26	WOS:000596569200030
J	Gardner, AM; Gardner, PR				Gardner, Anne M.; Gardner, Paul R.			Allostery in the nitric oxide dioxygenase mechanism of flavohemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED HEMOGLOBIN-N; MYCOBACTERIUM-TUBERCULOSIS HEMOGLOBIN; ESCHERICHIA-COLI; ENZYMATIC FUNCTION; LIGAND MIGRATION; HUMAN CYTOGLOBIN; MYOGLOBIN; DETOXIFICATION; NANOSECOND; OXIDATION	The substrates O-2 and NO cooperatively activate the NO dioxygenase function of Escherichia coli flavohemoglobin. Steady-state and transient kinetic measurements support a structure-based mechanistic model in which O-2 and NO movements and conserved amino acids at the E11, G8, E2, E7, B10, and F7 positions within the globin domain control activation. In the cooperative and allosteric mechanism, O-2 migrates to the catalytic heme site via a long hydrophobic tunnel and displaces LeuE11 away from the ferric iron, which forces open a short tunnel to the catalytic site gated by the ValG8/ IleE15 pair and LeuE11. NO permeates this tunnel and leverages upon the gating side chains triggering the CD loop to furl, which moves the E and F-helices and switches an electron transfer gate formed by LysF7, GlnE7, and water. This allows FADH(2) to reduce the ferric iron, which forms the stable ferric-superoxide-TyrB10/GlnE7 complex. This complex reacts with internalized NO with a bimolecular rate constant of 1010 M-1 s(-1) forming nitrate, which migrates to the CD loop and unfurls the spring-like structure. To restart the cycle, LeuE11 toggles back to the ferric iron. Actuating electron transfer with O-2 and NO movements averts irreversible NO poisoning and reductive inactivation of the enzyme. Together, structure snapshots and kinetic constants provide glimpses of intermediate conformational states, time scales for motion, and associated energies.	[Gardner, Anne M.; Gardner, Paul R.] Miami Valley Biotech, Res & Dev Div, Dayton, OH 45409 USA; [Gardner, Anne M.; Gardner, Paul R.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Gardner, Paul R.] Univ Dayton, Chem & Biochem Dept, Dayton, OH 45469 USA; [Gardner, Anne M.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA	Cincinnati Children's Hospital Medical Center; University of Dayton; University System of Ohio; Ohio State University	Gardner, PR (corresponding author), Miami Valley Biotech, Res & Dev Div, Dayton, OH 45409 USA.; Gardner, PR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA.; Gardner, PR (corresponding author), Univ Dayton, Chem & Biochem Dept, Dayton, OH 45469 USA.	paul.gardner@mvbiotech.com		Gardner, Paul/0000-0001-8189-0903; Gardner, Anne/0000-0001-7095-772X	American Heart Association [9730193N]; National Institutes of Health [GM65090]; Cincinnati Children's Hospital Research Foundation	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital Research Foundation	This work was initiated with funding from the Cincinnati Children's Hospital Research Foundation Trustees, American Heart Association Scientist Development Grant 9730193N, and the National Institutes of Health grant GM65090. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Blomberg LM, 2004, J BIOL INORG CHEM, V9, P923, DOI 10.1007/s00775-004-0585-5; Boron Ignacio, 2015, F1000Res, V4, P22, DOI 10.12688/f1000research.5921.2; Bourgeois D, 2003, P NATL ACAD SCI USA, V100, P8704, DOI 10.1073/pnas.1430900100; Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333; Bustamante JP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004701; Cazade PA, 2012, CHEMPHYSCHEM, V13, P4276, DOI 10.1002/cphc.201200608; COOPER CE, 1994, BIOCHEM SOC T, V22, P709, DOI 10.1042/bst0220709; Corti P, 2016, P NATL ACAD SCI USA, V113, P8538, DOI 10.1073/pnas.1522670113; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; Daigle R, 2009, BIOPHYS J, V97, P2967, DOI 10.1016/j.bpj.2009.09.006; Das AK, 2018, ANGEW CHEM INT EDIT, V57, P3509, DOI 10.1002/anie.201711445; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Hammi E, 2012, FEBS J, V279, P4565, DOI 10.1111/febs.12043; El Hammi E, 2012, PHYS CHEM CHEM PHYS, V14, P13872, DOI 10.1039/c2cp41261f; El Hammi E, 2011, BIOCHEMISTRY-US, V50, P1255, DOI 10.1021/bi101650q; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; Ferreiro DN, 2013, J INORG BIOCHEM, V119, P75, DOI 10.1016/j.jinorgbio.2012.10.015; Ferreiro DU, 2014, Q REV BIOPHYS, V47, P285, DOI 10.1017/S0033583514000092; Forrester MT, 2012, FREE RADICAL BIO MED, V53, P1211, DOI 10.1016/j.freeradbiomed.2012.06.038; Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Gabba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049770; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/683729; Gardner PR, 2015, J BIOL CHEM, V290, P27204, DOI 10.1074/jbc.M115.679621; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; Giordano D, 2020, COMPUT STRUCT BIOTEC, V18, P2132, DOI 10.1016/j.csbj.2020.08.007; Goldstein S, 2004, J AM CHEM SOC, V126, P15694, DOI 10.1021/ja046186+; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 2012, FREE RADICAL BIO MED, V53, P1209, DOI 10.1016/j.freeradbiomed.2012.06.033; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; Koebke KJ, 2016, BIOCHEMISTRY-US, V55, P686, DOI 10.1021/acs.biochem.5b01145; KUKI A, 1987, SCIENCE, V236, P1647, DOI 10.1126/science.3603005; Lechauve C, 2018, J CLIN INVEST, V128, P5073, DOI 10.1172/JCI99933; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Miranda JJL, 2005, J BIOL CHEM, V280, P36754, DOI 10.1074/jbc.M505918200; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; NOBLE RW, 1987, EUR J BIOCHEM, V168, P563, DOI 10.1111/j.1432-1033.1987.tb13454.x; Oliveira A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049291; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pesce A, 2016, FEBS J, V283, P305, DOI 10.1111/febs.13571; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Poole R. K., 2020, F1000RES; Rheault JF, 2015, BIOCHEMISTRY-US, V54, P2073, DOI 10.1021/bi5010624; Segel IH, 1975, ENZYME KINETICS BEHA; Singh S, 2014, J BIOL CHEM, V289, P21573, DOI 10.1074/jbc.M114.578187; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Teng CL, 2004, BIOPHYS J, V86, P1713, DOI 10.1016/S0006-3495(04)74240-X; Terrell JR, 2018, BIOCHEM BIOPH RES CO, V495, P1858, DOI 10.1016/j.bbrc.2017.12.038; VONBODMAN SB, 1986, P NATL ACAD SCI USA, V83, P9443; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yukl ET, 2009, J AM CHEM SOC, V131, P7234, DOI 10.1021/ja9026924	72	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100186	10.1074/jbc.RA120.016637	http://dx.doi.org/10.1074/jbc.RA120.016637			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33310705	Green Published, gold			2022-12-26	WOS:000672866400164
J	Kim, JE; Vali, SW; Nguyen, TQ; Dancis, A; Lindahl, PA				Kim, Joshua E.; Vali, Shaik Waseem; Nguyen, Trang Q.; Dancis, Andrew; Lindahl, Paul A.			Mossbauer and LC-ICP-MS investigation of iron trafficking between vacuoles and mitochondria in vma2 Delta Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; COPPER DETOXIFICATION; INTACT MITOCHONDRIA; PH HOMEOSTASIS; YEAST; PROTON; CELLS; EPR; POLYPHOSPHATE; ACIDIFICATION	Vacuoles are acidic organelles that store Fe-III polyphosphate, participate in iron homeostasis, and have been proposed to deliver iron to mitochondria for iron-sulfur cluster (ISC) and heme biosynthesis. Vma2. cells have dysfunctional V-ATPases, rendering their vacuoles nonacidic. These cells have mitochondria that are iron-dysregulated, suggesting disruption of a putative vacuole-to-mitochondria iron trafficking pathway. To investigate this potential pathway, we examined the iron content of a vma2. mutant derived from W303 cells using Mossbauer and EPR spectroscopies and liquid chromatography interfaced with inductively-coupled-plasma mass spectrometry. Relative to WT cells, vma2 Delta cells contained WT concentrations of iron but nonheme Fe-II dominated the iron content of fermenting and respiring vma2 Delta cells, indicating that the vacuolar Fe-III ions present in WT cells had been reduced. However, vma2 Delta cells synthesized WT levels of ISCs/hemes and had normal aconitase activity. The iron content of vma2 Delta mitochondria was similar to WT, all suggesting that iron delivery to mitochondria was not disrupted. Chromatograms of cytosolic flow-through solutions exhibited iron species with apparent masses of 600 and 800 Da for WT and vma2 Delta, respectively. Mutant cells contained high copper concentrations and high concentrations of a species assigned to metallothionein, indicating copper dysregulation. vma2. cells from previously studied strain BY4741 exhibited iron-associated properties more consistent with prior studies, suggesting subtle strain differences. Vacuoles with functional V-ATPases appear unnecessary in W303 cells for iron to enter mitochondria and be used in ISC/heme biosynthesis; thus, there appears to be no direct or dedicated vacuole-to-mitochondria iron trafficking pathway. The vma2 Delta phenotype may arise from alterations in trafficking of iron directly from cytosol to mitochondria.	[Kim, Joshua E.; Nguyen, Trang Q.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Vali, Shaik Waseem; Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Dancis, Andrew] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Dancis, Andrew] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Lindahl, PA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu			National Institutes of Health [GM127021, GM107542]; National Science Foundation [MCB-1817389]; T3 grant from Texas AM University; Robert A. Welch Foundation [A1170]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); T3 grant from Texas AM University; Robert A. Welch Foundation(The Welch Foundation)	This work was supported by the National Institutes of Health (GM127021 to P. A. L. and GM107542 to A. D.), the National Science Foundation (MCB-1817389), a T3 grant from Texas A&M University, and the Robert A. Welch Foundation (A1170). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the National Science Foundation, or the Welch Foundation.	Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Cockrell A, 2014, BIOCHEMISTRY-US, V53, P2926, DOI 10.1021/bi500002n; Cockrell AL, 2011, BIOCHEMISTRY-US, V50, P10275, DOI 10.1021/bi2014954; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Diab HI, 2013, J BIOL CHEM, V288, P11366, DOI 10.1074/jbc.M112.419259; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Eskes E, 2018, CURR GENET, V64, P155, DOI 10.1007/s00294-017-0743-2; Fansler B., 1969, METHODS ENZYMOL, V13, P26; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Holmes-Hampton GP, 2013, BIOCHEMISTRY-US, V52, P105, DOI 10.1021/bi3015339; Horie T, 2017, J BIOL CHEM, V292, P8533, DOI 10.1074/jbc.M116.762963; Hudder BN, 2007, J BIOL INORG CHEM, V12, P1029, DOI 10.1007/s00775-007-0275-1; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hughes CE, 2020, CELL, V180, P296, DOI 10.1016/j.cell.2019.12.035; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2016, ADV EXP MED BIOL, V892, P33, DOI 10.1007/978-3-319-25304-6_3; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lindahl PA, 2009, METHOD ENZYMOL, V456, P267, DOI 10.1016/S0076-6879(08)04415-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Moore MJ, 2018, BIOCHEMISTRY-US, V57, P672, DOI 10.1021/acs.biochem.7b01034; Morales JG, 2010, BIOCHEMISTRY-US, V49, P5436, DOI 10.1021/bi100558z; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nguyen TQ, 2020, METALLOMICS, V12, P1094, DOI 10.1039/c9mt00312f; Nguyen TQ, 2019, METALLOMICS, V11, P1298, DOI 10.1039/c9mt00104b; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Park J, 2014, BIOCHEMISTRY-US, V53, P3940, DOI 10.1021/bi500148y; Petrezselyova S, 2010, FUNGAL BIOL-UK, V114, P144, DOI 10.1016/j.funbio.2009.11.002; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; SUPEK F, 1994, J BIOL CHEM, V269, P26479; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Martinez-Pastor MT, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2215-8; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tomaschevsky AA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1052, DOI 10.1134/S0006297910080158; Trilisenko L., 2019, CELLS-BASEL, V8, P1; Trilisenko L, 2013, FOLIA MICROBIOL, V58, P437, DOI 10.1007/s12223-013-0226-x; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Winter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113869; Wofford JD, 2019, BMC SYST BIOL, V13, DOI 10.1186/s12918-019-0702-2; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787; Zadrag-Tecza R, 2009, BIOGERONTOLOGY, V10, P481, DOI 10.1007/s10522-008-9192-0	56	4	4	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100141	10.1074/jbc.RA120.015907	http://dx.doi.org/10.1074/jbc.RA120.015907			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268384	Green Published, gold			2022-12-26	WOS:000672866400120
J	Whiteley, AM; Prado, MA; de Poot, SAH; Paulo, JA; Ashton, M; Dominguez, S; Weber, M; Ngu, H; Szpyt, J; Jedrychowski, MP; Easton, A; Gygi, SP; Kurz, T; Monteiro, MJ; Brown, EJ; Finley, D				Whiteley, Alexandra M.; Prado, Miguel A.; de Poot, Stefanie A. H.; Paulo, Joao A.; Ashton, Marissa; Dominguez, Sara; Weber, Martin; Hai Ngu; Szpyt, John; Jedrychowski, Mark P.; Easton, Amy; Gygi, Steven P.; Kurz, Thimo; Monteiro, Mervyn J.; Brown, Eric J.; Finley, Daniel			Global proteomics of Ubqln2-based murine models of ALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR ANTIVIRAL RESPONSE; UBIQUITIN-ASSOCIATED DOMAIN; I INTERFERON INDUCTION; PROTEIN AGGREGATION; UBIQUITYLATED PROTEINS; MAMMALIAN GENE; GAG PROTEIN; UBA DOMAIN; TRIM32; MUTATIONS	Familial neurodegenerative diseases commonly involve mutations that result in either aberrant proteins or dysfunctional components of the proteolytic machinery that act on aberrant proteins. UBQLN2 is a ubiquitin receptor of the UBL/UBA family that binds the proteasome through its ubiquitin-like domain and is thought to deliver ubiquitinated proteins to proteasomes for degradation. UBQLN2 mutations result in familial amyotrophic lateral sclerosis (ALS)/frontotemporal dementia in humans through an unknown mechanism. Quantitative multiplexed proteomics was used to provide for the first time an unbiased and global analysis of the role of Ubqln2 in controlling the composition of the proteome. We studied several murine models of Ubqln2-linked ALS and also generated Ubqln2 null mutant mice. We identified impacts of Ubqln2 on diverse physiological pathways, most notably serotonergic signaling. Interestingly, we observed an upregulation of proteasome subunits, suggesting a compensatory response to diminished proteasome output. Among the specific proteins whose abundance is linked to UBQLN2 function, the strongest hits were the ubiquitin ligase TRIM32 and two retroelement-derived proteins, PEG10 and CXX1B. Cycloheximide chase studies using induced human neurons and HEK293 cells suggested that PEG10 and TRIM32 are direct clients. Although UBQLN2 directs the degradation of multiple proteins via the proteasome, it surprisingly conferred strong protection from degradation on the Gag-like protein CXX1B, which is expressed from the same family of retroelement genes as PEG10. In summary, this study charts the proteomic landscape of ALS-related Ubqln2 mutants and identifies candidate client proteins that are altered in vivo in disease models and whose degradation is promoted by UBQLN2.	[Whiteley, Alexandra M.; Prado, Miguel A.; de Poot, Stefanie A. H.; Paulo, Joao A.; Ashton, Marissa; Szpyt, John; Jedrychowski, Mark P.; Gygi, Steven P.; Finley, Daniel] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Dominguez, Sara; Weber, Martin; Easton, Amy] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Hai Ngu] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Kurz, Thimo] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Glasgow, Lanark, Scotland; [Monteiro, Mervyn J.] Univ Maryland, Med Sch, Dept Anat & Neurobiol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Brown, Eric J.] Genentech Inc, Dept Immunol & Infect Dis, San Francisco, CA 94080 USA; [Whiteley, Alexandra M.] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA	Harvard University; Harvard Medical School; Roche Holding; Genentech; Roche Holding; Genentech; University of Glasgow; University System of Maryland; University of Maryland Baltimore; Roche Holding; Genentech; University of Colorado System; University of Colorado Boulder	Finley, D (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	Daniel_finley@hms.harvard.edu	Prado, Miguel A/P-3922-2017; Weber, Martin/GPW-6095-2022	Prado, Miguel A/0000-0002-4914-1619; Weber, Martin/0000-0001-5039-5010	National Institutes of Health [R01 GM043601]; Harvard Brain Science Initiative Seed grant; Target ALS; Harvard Medical School Hearst Fund; Cancer Research Institute Irvington Postdoctoral Fellowship; Goldberg Fellowship Award; National Institutes of Health/National Institute of General Medical Sciences [R01 GM132129, GM97645]; Motor-Neurone Disease Scotland (MNDS)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Brain Science Initiative Seed grant; Target ALS; Harvard Medical School Hearst Fund; Cancer Research Institute Irvington Postdoctoral Fellowship; Goldberg Fellowship Award; National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Motor-Neurone Disease Scotland (MNDS)	This work was supported by a grant to D. F. from the National Institutes of Health (R01 GM043601), by a Harvard Brain Science Initiative Seed grant to D. F., and by Target ALS. A. M. W. was supported by a grant from the Harvard Medical School Hearst Fund and the Cancer Research Institute Irvington Postdoctoral Fellowship. M. A. P. was supported by the Goldberg Fellowship Award. J. A. P. was supported by National Institutes of Health/National Institute of General Medical Sciences grant R01 GM132129 and S. P. G. GM97645. T. K. was supported by Motor-Neurone Disease Scotland (MNDS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abed M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214110; Akamatsu S, 2015, CELL REP, V12, P922, DOI 10.1016/j.celrep.2015.07.012; Alexander EJ, 2018, P NATL ACAD SCI USA, V115, pE11485, DOI 10.1073/pnas.1811997115; Ashley J, 2018, CELL, V172, P262, DOI 10.1016/j.cell.2017.12.022; Assereto S, 2016, LAB INVEST, V96, P862, DOI 10.1038/labinvest.2016.63; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blaise S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030917; Blokhuis AM, 2016, ACTA NEUROPATHOL, V132, P175, DOI 10.1007/s00401-016-1575-8; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; Chang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130162; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen X, 2019, J MOL BIOL, V431, P939, DOI 10.1016/j.jmb.2019.01.021; Chen X, 2016, STRUCTURE, V24, P1257, DOI 10.1016/j.str.2016.05.018; Chen YC, 2014, EMBO J, V33, P1548, DOI 10.15252/embj.201487943; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Dao TP, 2018, MOL CELL, V69, P965, DOI 10.1016/j.molcel.2018.02.004; Daoud H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.03.015; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fletcher AJ, 2018, CELL HOST MICROBE, V24, P761, DOI 10.1016/j.chom.2018.10.007; Foldi CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018152; Ford DL, 2006, BIOCHEM J, V399, P397, DOI 10.1042/BJ20060441; Fritsch J, 2017, BBA-MOL CELL RES, V1864, P2138, DOI 10.1016/j.bbamcr.2017.07.017; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gerson JE, 2020, HUM MOL GENET, V29, P2596, DOI 10.1093/hmg/ddaa152; Gilpin KM, 2015, HUM MOL GENET, V24, P2565, DOI 10.1093/hmg/ddv020; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Grumati P, 2018, J BIOL CHEM, V293, P5404, DOI 10.1074/jbc.TM117.000117; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787; Halloran M, 2020, CELL MOL LIFE SCI, V77, P3859, DOI 10.1007/s00018-019-03394-w; Harman CA, 2019, BBA-GEN SUBJECTS, V1863, P1568, DOI 10.1016/j.bbagen.2019.06.002; Hirayama S, 2018, P NATL ACAD SCI USA, V115, pE4199, DOI 10.1073/pnas.1711017115; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Inoue M, 2005, FEBS LETT, V579, P604, DOI 10.1016/j.febslet.2004.12.030; Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Kallop DY, 2014, J NEUROSCI, V34, P6425, DOI 10.1523/JNEUROSCI.4963-13.2014; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kurlawala Z, 2021, J CELL BIOCHEM, V122, P43, DOI 10.1002/jcb.29830; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Le NTT, 2016, P NATL ACAD SCI USA, V113, pE7580, DOI 10.1073/pnas.1608432113; Le Pichon CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062342; Lee DY, 2013, EMBO REP, V14, P373, DOI 10.1038/embor.2013.22; Lee YC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0479-4; Liu C, 2019, J IMMUNOL, V202, P2957, DOI 10.4049/jimmunol.1800656; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Liu YH, 2017, NEUROCHEM RES, V42, P1084, DOI 10.1007/s11064-016-2142-3; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Lomash RM, 2015, CELL REP, V12, P743, DOI 10.1016/j.celrep.2015.06.064; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lux H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008686; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Maminska A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0848; Marin I, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-63; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; N'Diaye EN, 2008, MOL BIOL CELL, V19, P1252, DOI 10.1091/mbc.E07-08-0775; N'Diaye EN, 2009, AUTOPHAGY, V5, P573, DOI 10.4161/auto.5.4.8312; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Navarrete-Perea J, 2018, J PROTEOME RES, V17, P2226, DOI 10.1021/acs.jproteome.8b00217; Okreglak V, 2014, P NATL ACAD SCI USA, V111, P8019, DOI 10.1073/pnas.1405755111; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024; Paulo JA, 2016, J AM SOC MASS SPECTR, V27, P1620, DOI 10.1007/s13361-016-1434-9; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piper R. C., 2014, COLD SPRING HARB PER, V6; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Rose CM, 2016, CELL SYST, V3, P395, DOI 10.1016/j.cels.2016.08.009; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Sato T, 2011, J CELL SCI, V124, P3492, DOI 10.1242/jcs.088799; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schweppe DK, 2018, J PROTEOME RES, V17, P722, DOI 10.1021/acs.jproteome.7b00572; Senturk M, 2019, NAT CELL BIOL, V21, P384, DOI 10.1038/s41556-019-0281-x; Sharkey LM, 2020, NEUROBIOL DIS, V143, DOI 10.1016/j.nbd.2020.105016; Sharkey LM, 2018, P NATL ACAD SCI USA, V115, pE10495, DOI 10.1073/pnas.1810522115; Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Shin EJ, 2012, EMBO REP, V13, P339, DOI 10.1038/embor.2012.3; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suzuki R, 2016, EMBO REP, V17, P842, DOI 10.15252/embr.201541402; Synofzik M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.002; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Teyssou E, 2017, NEUROBIOL AGING, V58, DOI 10.1016/j.neurobiolaging.2017.06.018; Tsuchiya H, 2017, MOL CELL, V66, P488, DOI 10.1016/j.molcel.2017.04.024; Vermeiren Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00185; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Weber M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0047-15.2015; Whiteley AM, 2017, ELIFE, V6, DOI 10.7554/eLife.26435; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Williams KL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.008; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Wu JJ, 2020, P NATL ACAD SCI USA, V117, P15230, DOI 10.1073/pnas.1917371117; Wu QX, 2015, ACTA NEUROPATHOL, V129, P417, DOI 10.1007/s00401-014-1367-y; Yan J, 2014, J MOL CELL BIOL, V6, P154, DOI 10.1093/jmcb/mju005; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang L, 2013, MOL CELL, V51, P559, DOI 10.1016/j.molcel.2013.07.014; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	134	5	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100153	10.1074/jbc.RA120.015960	http://dx.doi.org/10.1074/jbc.RA120.015960			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33277362	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400131
J	Zheng, LF; Xie, CB; Zheng, J; Dong, QR; Si, TX; Zhang, J; Hou, ST				Zheng, Lifeng; Xie, Chengbin; Zheng, Ju; Dong, Qiangrui; Si, Tengxiao; Zhang, Jing; Hou, Sheng-Tao			An imbalanced ratio between PC(16:0/16:0) and LPC(16:0) revealed by lipidomics supports the role of the Lands cycle in ischemic brain injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; STROKE; METABOLISM; ACTIVATION; MECHANISMS; MICROGLIA; RELEASE; CELLS; LYSOPHOSPHOLIPIDS; APOPTOSIS	Promoting brain recovery after stroke is challenging as a plethora of inhibitory molecules are produced in the brain preventing it from full healing. Moreover, the full scope of inhibitory molecules produced is not well understood. Here, using a high-sensitivity UPLC-MS-based shotgun lipidomics strategy, we semiquantitively measured the differential lipid contents in the mouse cerebral cortex recovering from a transient middle cerebral artery occlusion (MCAO). The lipidomic data were interrogated using the soft independent modeling of class analogy (SIMCA) method involving principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA). Statistics of the 578 confirmed lipids revealed 84 species were differentially changed during MCAO/reperfusion. The most dynamic changes in lipids occurred between 1 and 7 days post-MCAO, whereas concentrations had subsided to the Sham group level at 14 and 28 days post-MCAO. Quantitative analyses revealed a strong monotonic relationship between the reduction in phosphatidylcholine (PC)(16:0/16:0) and the increase in lysophosphatidylcholine (LPC)(16:0) levels (Spearman's Rs = -0.86) during the 1 to 7 days reperfusion period. Inhibition of cPLA2 prevented changes in the ratio between PC(16:0/16:0) and LPC(16:0), indicating altered Land's cycle of PC. A series of in vitro studies showed that LPC(16:0), but not PC(16:0/16:0), was detrimental to the integrity of neuronal growth cones and neuronal viability through evoking intracellular calcium influx. In contrast, PC(16:0/16:0) significantly suppressed microglial secretion of IL-1 beta and TNF-alpha, limiting neuroinflammation pathways. Together, these data support the role of the imbalanced ratio between PC(16:0/16:0) and LPC(16:0), maintained by Lands' cycle, in neuronal damage and microglia-mediated inflammatory response during ischemic recovery.	[Zheng, Lifeng; Xie, Chengbin; Zheng, Ju; Dong, Qiangrui; Si, Tengxiao; Zhang, Jing; Hou, Sheng-Tao] Southern Univ Sci & Technol, Brain Res Ctr, Shenzhen, Guangdong, Peoples R China; [Zheng, Lifeng; Xie, Chengbin; Zheng, Ju; Dong, Qiangrui; Si, Tengxiao; Zhang, Jing; Hou, Sheng-Tao] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Hou, Sheng-Tao] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Southern University of Science & Technology; Southern University of Science & Technology; University of Ottawa	Hou, ST (corresponding author), Southern Univ Sci & Technol, Brain Res Ctr, Shenzhen, Guangdong, Peoples R China.; Hou, ST (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen, Guangdong, Peoples R China.; Hou, ST (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	hou.st@sustech.edu.cn		Xie, Chengbin/0000-0002-5986-6816; Hou, Sheng Tao/0000-0001-9736-342X	National Natural Science Foundation of China [81871026]; Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions [2019SHIBS0002]; Shenzhen Science and Technology Innovation Committee Research Grants [JCYJ20180504165806229, KQJSCX20180322151111754]; Shenzhen Sanming Project (Baoan Hospital) [2018.06]; SUSTech Brain Research Centre Fund; Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases and SUSTechUQ Joint Center for Neuroscience and Neural Engineering (CNNE)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions; Shenzhen Science and Technology Innovation Committee Research Grants; Shenzhen Sanming Project (Baoan Hospital); SUSTech Brain Research Centre Fund; Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases and SUSTechUQ Joint Center for Neuroscience and Neural Engineering (CNNE)	Financial supports to Dr Sheng-Tao Hou were from grants from the National Natural Science Foundation of China (81871026); Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions (2019SHIBS0002); Shenzhen Science and Technology Innovation Committee Research Grants (JCYJ20180504165806229; KQJSCX20180322151111754); Shenzhen Sanming Project (Baoan Hospital, 2018.06), and SUSTech Brain Research Centre Fund. STH is also supported by the Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases and SUSTechUQ Joint Center for Neuroscience and Neural Engineering (CNNE).	Berchtold D, 2020, BRAIN PATHOL, V30, P1209, DOI 10.1111/bpa.12911; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Campbell BCV, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0118-8; Faezi M, 2015, CURR NEUROVASC RES, V12, P353, DOI 10.2174/1567202612666150819100746; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; Hou ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep01350; Hou ST, 2016, J BIOL CHEM, V291, P27007, DOI 10.1074/jbc.M116.756429; Hou ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep07890; Hou ST, 2020, NEUROCHEM INT, V139, DOI 10.1016/j.neuint.2020.104795; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2002, INT REV CYTOL, V221, P93; Inose Y, 2015, NEUROPATHOLOGY, V35, P209, DOI 10.1111/neup.12182; Jackson SK, 2008, J LEUKOCYTE BIOL, V84, P86, DOI 10.1189/jlb.0907601; Jia Z., 2019, FRONT PHARMACOL, V10, P1; Jiang SX, 2012, J NEUROCHEM, V122, P764, DOI 10.1111/j.1471-4159.2012.07823.x; Jiang SX, 2010, BIOCHEM BIOPH RES CO, V401, P435, DOI 10.1016/j.bbrc.2010.09.074; Jiang SX, 2010, J BIOL CHEM, V285, P9908, DOI 10.1074/jbc.M109.080689; Jove M, 2015, NEUROLOGY, V84, P36, DOI 10.1212/WNL.0000000000001093; Khan M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0311-y; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KINOUCHI H, 1990, MOL CHEM NEUROPATHOL, V12, P215, DOI 10.1007/BF03159946; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Liu H, 2017, BIOSCI TRENDS, V11, P439, DOI 10.5582/bst.2017.01046; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Sabogal-Guaqueta AM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00989; Mavroudakis L, 2021, ANAL BIOANAL CHEM, V413, P2735, DOI 10.1007/s00216-020-02987-w; Mills JK, 2005, BBA-BIOMEMBRANES, V1716, P77, DOI 10.1016/j.bbamem.2005.08.007; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Ronaldson PT, 2020, J CEREBR BLOOD F MET, V40, pS6, DOI 10.1177/0271678X20951995; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Roza C, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00138; Sarafian MH, 2014, ANAL CHEM, V86, P5766, DOI 10.1021/ac500317c; Savitz SI, 2016, STEM CELLS, V34, P537, DOI 10.1002/stem.2253; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SHOLL DA, 1953, J ANAT, V87, P387; Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560; SUN GY, 1984, J NEUROCHEM, V43, P1081, DOI 10.1111/j.1471-4159.1984.tb12847.x; Sun L., 2019, NAT MED, V25; Sun YJ, 2009, BBA-MOL CELL BIOL L, V1791, P61, DOI 10.1016/j.bbalip.2008.09.007; Takenouchi T, 2007, J NEUROCHEM, V102, P1518, DOI 10.1111/j.1471-4159.2007.04570.x; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang B, 2019, ANNU REV PHYSIOL, V81, P165, DOI 10.1146/annurev-physiol-020518-114444; Wang HYJ, 2012, ANAL BIOANAL CHEM, V404, P113, DOI 10.1007/s00216-012-6077-5; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Yun DH, 2006, EXP MOL MED, V38, P375, DOI 10.1038/emm.2006.44; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Zheng LF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16826-0	53	8	8	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100151	10.1074/jbc.RA120.016565	http://dx.doi.org/10.1074/jbc.RA120.016565			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33288676	Green Published, gold			2022-12-26	WOS:000672866400129
J	Kosaka, Y; Aoki, W; Mori, M; Aburaya, S; Ohtani, Y; Minakuchi, H; Ueda, M				Kosaka, Yuishin; Aoki, Wataru; Mori, Megumi; Aburaya, Shunsuke; Ohtani, Yuta; Minakuchi, Hiroyoshi; Ueda, Mitsuyoshi			Selected reaction monitoring for the quantification of Escherichia coli ribosomal proteins	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; ORTHOGONAL TRANSLATION; MASS-SPECTROMETRY; GENETIC-CODE; COMPLETE SET; ACTIVE-SITE; RNA; PROTEOMICS; RECONSTITUTION; BIOGENESIS	Ribosomes are the sophisticated machinery that is responsible for protein synthesis in a cell. Recently, quantitative mass spectrometry (qMS) have been successfully applied for understanding the dynamics of protein complexes. Here, we developed a highly specific and reproducible method to quantify all ribosomal proteins (r-proteins) by combining selected reaction monitoring (SRM) and isotope labeling. We optimized the SRM methods using purified ribosomes and Escherichia coli lysates and verified this approach as detecting 41 of the 54 r-proteins separately synthesized in E. coli S30 extracts. The SRM methods will enable us to utilize qMS as a highly specific analytical tool in the research of E. coli ribosomes, and this methodology have potential to accelerate the understanding of ribosome biogenesis, function, and the development of engineered ribosomes with additional functions.	[Kosaka, Yuishin; Aoki, Wataru; Mori, Megumi; Aburaya, Shunsuke; Ohtani, Yuta; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Aoki, Wataru; Ueda, Mitsuyoshi] Kyoto Integrated Sci & Technol Bioanal Ctr, Kyoto, Japan; [Minakuchi, Hiroyoshi] Kyoto Monotech, Kyoto, Japan	Kyoto University	Aoki, W (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan.; Aoki, W (corresponding author), Kyoto Integrated Sci & Technol Bioanal Ctr, Kyoto, Japan.	aoki.wataru.6a@kyoto-u.ac.jp		Aburaya, Shunsuke/0000-0001-6194-9664; Aoki, Wataru/0000-0002-3118-9390	Japan Society for the Promotion of Science [19K16109, 26830139]; Sugiyama Chemical & Industrial Laboratory; JGC-S Scholarship Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sugiyama Chemical & Industrial Laboratory; JGC-S Scholarship Foundation	W.A. was supported by the Japan Society for the Promotion of Science (grant No. 19K16109 and 26830139; https://www.jsps.go.jp/english/), Sugiyama Chemical & Industrial Laboratory (http://www.sugiyama-c-i-l.or.jp/), and the JGC-S Scholarship Foundation (https://www.jgcs.or.jp/en/).Kyoto-monotech provided a monolithic column and support in the form of salaries for HM. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Al-Majdoub ZM, 2014, J PROTEOME RES, V13, P1211, DOI 10.1021/pr400667h; Aleksashin NA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15756-1; Aleksashin NA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08892-w; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bernardo A. S., 2005, F PETRARCH LETT OLD, VI, p[10, 159]; Bourmaud A, 2016, PROTEOMICS, V16, P2146, DOI 10.1002/pmic.201500543; Brown CW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3676-8; Carlson ED, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11427-y; Caschera F, 2018, ACS SYNTH BIOL, V7, P2481, DOI 10.1021/acssynbio.8b00276; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; Chen SS, 2012, MOL BIOSYST, V8, P3325, DOI 10.1039/c2mb25310k; Chubiz LM, 2008, NUCLEIC ACIDS RES, V36, P4038, DOI 10.1093/nar/gkn354; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; d'Aquino AE, 2020, NUCLEIC ACIDS RES, V48, P2777, DOI 10.1093/nar/gkaa001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davydov II, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2373; Fried SD, 2015, ANGEW CHEM INT EDIT, V54, P12791, DOI 10.1002/anie.201506311; Fritz BR, 2015, NUCLEIC ACIDS RES, V43, P4774, DOI 10.1093/nar/gkv329; Fritz BR, 2014, NUCLEIC ACIDS RES, V42, P6774, DOI 10.1093/nar/gku307; Giansanti P, 2016, NAT PROTOC, V11, P993, DOI 10.1038/nprot.2016.057; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Ishizuka N, 2000, ANAL CHEM, V72, P1275, DOI 10.1021/ac990942q; Jewett MC, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.31; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Levy M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6020; Li J, 2017, ACS SYNTH BIOL, V6, P1327, DOI 10.1021/acssynbio.6b00342; Liu Y, 2015, ACS SYNTH BIOL, V4, P454, DOI 10.1021/sb5002467; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maki JA, 2002, MOL CELL, V10, P129, DOI 10.1016/S1097-2765(02)00562-2; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Murase Y, 2018, ACS SYNTH BIOL, V7, P576, DOI 10.1021/acssynbio.7b00333; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pei HR, 2017, FEBS LETT, V591, P3421, DOI 10.1002/1873-3468.12840; Picotti P, 2013, NAT METHODS, V10, P24, DOI 10.1038/nmeth.2291; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Pronobis MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160509; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; Schmied WH, 2018, NATURE, V564, P444, DOI 10.1038/s41586-018-0773-z; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Shilling PJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0939-8; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimojo M, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0874-8; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Tamaru D, 2018, RNA, V24, P1512, DOI 10.1261/rna.065615.118; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wang KH, 2012, ANGEW CHEM INT EDIT, V51, P2288, DOI 10.1002/anie.201105016; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8	59	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0236850	10.1371/journal.pone.0236850	http://dx.doi.org/10.1371/journal.pone.0236850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315868	Green Published, gold, Green Submitted			2022-12-26	WOS:000600186100040
J	Dagnew, GW; Asresie, MB				Dagnew, Gizachew Worku; Asresie, Melash Belachew			Factors associated with chronic energy malnutrition among reproductive-age women in Ethiopia: An analysis of the 2016 Ethiopia demographic and health survey data	PLOS ONE			English	Article							CHILD UNDERNUTRITION; RISK-FACTORS; NUTRITION; BURDEN; UNDERWEIGHT; PREVALENCE; OVERWEIGHT; COUNTRIES; OBESITY; BIRTH	Background Women with chronic-energy malnutrition persists in many developing countries, including Ethiopia. To avert this problem identifying the predictor variables for a high magnitude of underweight is paramount. Consequently, this study aimed to assess the factors associated with chronic energy malnutrition among reproductive-age women in Ethiopia. Methods We used the 2016 Ethiopia demographic health survey data. The survey was a community-based cross-sectional study conducted from January 18 to June 27, 2016. A two-stage stratified cluster sampling technique was employed to select Participants. A total of 13,451 reproductive-age group women (age 15-49 years and who were not pregnant and < 2 months of postpartum) were included in the analysis. Both descriptive and analytical analyses were performed. A P-value of less than 0.05 was used to declare statistical significance. Results About 22.6% (95%CI: 21.5%-23.6%) of reproductive-age women were underweight. The magnitude of underweight is highest in the Afar region (39.6%) and lowest in Addis Ababa city administration (13.5%). Women who lived in the rural area (AOR = 1.59; 95%CI: 1.19-2.12), those who did not attend formal education (AOR = 1.23; 95%CI: 1.01-1.50), unemployed women (AOR = 1.28; 95%CI:1.13-1.44), women who belong to the poorest household wealth index (AOR = 1.42; 95%CI:1.04-1.94), women who were not married (AOR = 1.41; 95%CI: 1.18-2.69), women who lived in Tigray and the pastoral regions have higher odds of underweight. On the other hand, women who lived in southern nations nationalities and people's region, and women whose age group 25-34 years had lower odds of underweight. Conclusions Chronic-energy malnutrition among reproductive-age women is high in Ethiopia. Improving the food security of rural, never married, and unemployed women would reduce the magnitude of underweight. Moreover, strengthening girls' education, creating employment opportunities for women, and enhancing household income can further reduce the problem of chronic energy malnutrition.	[Dagnew, Gizachew Worku; Asresie, Melash Belachew] Bahir Dar Univ, Coll & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia	Bahir Dar University	Dagnew, GW (corresponding author), Bahir Dar Univ, Coll & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	giz.work12@gmail.com	Dagnew, Gizachew Worku/ABE-7194-2021	Dagnew, Gizachew Worku/0000-0003-2043-3041; Asresie, Melash Belachew/0000-0002-4173-0646				Abdullah A, 2015, CURR OBES REP, V4, P337, DOI 10.1007/s13679-015-0170-y; Abraham Saba., 2015, BMC NUTR, V1, P12, DOI [10.1186/s40795-015-0005-y, DOI 10.1186/S40795-015-0005-Y]; Abrha S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3315-3; Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Al Kibria GM, 2019, GLOBAL HLTH RES POLI, V4, P1; Anne Bossuyt, 2019, Agriculture for improved nutrition: seizing the momentum, P165, DOI 10.1079/9781786399311.0165; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2000, WHO TECHN REP SER; Birhane T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-680; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Chaparro C, 2011, HLTH LIFE COURSE PAN, P12; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; Desyibelew HD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221712; Devgun P, 2014, SCI INT J RES HLTH, V2, P527; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Engidaw MT., 2019, J FAMILY MED HLTH CA, V5, P1, DOI [10.11648/j.jfmhc.20190501.11, DOI 10.11648/J.JFMHC.20190501.11, 10.11648/j. jfmhc.20190501.11]; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J, 2018, 2018 GLOBAL NUTR REP; Ferede A, 2017, PUBLIC HEALTH, V152, P1, DOI 10.1016/j.puhe.2017.06.011; Franklin B, 2012, J COMMUN HEALTH, V37, P253, DOI 10.1007/s10900-011-9420-4; Hashan MR, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034321; Hoddinott J, 2013, ROAD TO GOOD NUTRITION: A GLOBAL PERSPECTIVE, P64; Hong SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194454; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Julla BW., 2018, WORLD SCI RES, V5, P13, DOI [10.20448/journal.510.2018.51.13.23, DOI 10.20448/JOURNAL.510.2018.51.13.23]; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Kumera Gemechu, 2018, Matern Health Neonatol Perinatol, V4, P18, DOI 10.1186/s40748-018-0087-z; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Lopez-Arana S, 2013, OBES REV, V14, P806, DOI 10.1111/obr.12051; Mbagaya G, 2014, PROTEIN ENERGY MALNU; Mtumwa AH, 2016, S AFR J CLIN NUTR, V29, P75, DOI 10.1080/16070658.2016.1216509; Napoli M., 2011, MASTER HUMAN DEV FOO, P1; Praskova DM, 2018, AUC GEOGR, V53, P193, DOI 10.14712/23361980.2018.19; Rashid S, 2018, GLOB FOOD SECUR-AGR, V19, P31, DOI 10.1016/j.gfs.2018.09.002; Razak F, 2013, LANCET, V381, P626, DOI 10.1016/S0140-6736(13)60344-X; Regassa N, 2012, J BIOSOC SCI, V44, P537, DOI 10.1017/S002193201200017X; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; Tebekaw Y, 2011, DEMOGRAPHIC TRANSITION AND DEVELOPMENT IN AFRICA: THE UNIQUE CASE OF ETHIOPIA, P105, DOI 10.1007/978-90-481-8918-2_6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, ACC NUTR IMPR ANI MA; World Health Organization, 2016, ACC NUTR IMPR ANI MA	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243148	10.1371/journal.pone.0243148	http://dx.doi.org/10.1371/journal.pone.0243148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306693	Green Published, gold			2022-12-26	WOS:000600144200003
J	Sellers, RA; Robertson, DL; Tassabehji, M				Sellers, Robert A.; Robertson, David L.; Tassabehji, May			Ancestry of the AUTS2 family-A novel group of polycomb-complex proteins involved in human neurological disease	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTOCEREBRAL BRIDGE; GENETIC-VARIATION; PREDICTION; EXPRESSION; DROSOPHILA; IDENTIFICATION; DUPLICATION; PROTEOME; YEAST	Autism susceptibility candidate 2 (AUTS2) is a neurodevelopmental regulator associated with an autosomal dominant intellectual disability syndrome, AUTS2 syndrome, and is implicated as an important gene in human-specific evolution. AUTS2 exists as part of a tripartite gene family, the AUTS2 family, which includes two relatively undefined proteins, Fibrosin (FBRS) and Fibrosin-like protein 1 (FBRSL1). Evolutionary ancestors of AUTS2 have not been formally identified outside of the Animalia clade. A Drosophila melanogaster protein, Tay bridge, with a role in neurodevelopment, has been shown to display limited similarity to the C-terminal of AUTS2, suggesting that evolutionary ancestors of the AUTS2 family may exist within other Protostome lineages. Here we present an evolutionary analysis of the AUTS2 family, which highlights ancestral homologs of AUTS2 in multiple Protostome species, implicates AUTS2 as the closest human relative to the progenitor of the AUTS2 family, and demonstrates that Tay bridge is a divergent ortholog of the ancestral AUTS2 progenitor gene. We also define regions of high relative sequence identity, with potential functional significance, shared by the extended AUTS2 protein family. Using structural predictions coupled with sequence conservation and human variant data from 15,708 individuals, a putative domain structure for AUTS2 was produced that can be used to aid interpretation of the consequences of nucleotide variation on protein structure and function in human disease. To assess the role of AUTS2 in human-specific evolution, we recalculated allele frequencies at previously identified human derived sites using large population genome data, and show a high prevalence of ancestral alleles, suggesting that AUTS2 may not be a rapidly evolving gene, as previously thought.	[Sellers, Robert A.; Tassabehji, May] Univ Manchester, Evolut & Genom Sci, Sch Biol Sci, Manchester, Lancs, England; [Robertson, David L.] MRC Univ Glasgow, Ctr Virus Res, Garscube Campus, Glasgow, Lanark, Scotland	University of Manchester; University of Glasgow	Tassabehji, M (corresponding author), Univ Manchester, Evolut & Genom Sci, Sch Biol Sci, Manchester, Lancs, England.	m.Tassabehji@manchester.ac.uk						Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Banerjee S, 2017, DNA RES, V24, P435, DOI 10.1093/dnares/dsx015; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Beunders G, 2016, J MED GENET, V53, P523, DOI 10.1136/jmedgenet-2015-103601; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dickerson JE, 2012, MOL BIOL EVOL, V29, P61, DOI 10.1093/molbev/msr111; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Ebina T, 2009, BIOPOLYMERS, V92, P1, DOI 10.1002/bip.21105; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Hori K, 2014, CELL REP, V9, P2166, DOI 10.1016/j.celrep.2014.11.045; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kondrychyn I, 2017, G3-GENES GENOM GENET, V7, P2577, DOI 10.1534/g3.117.042622; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin CY, 2013, CELL REP, V3, P1739, DOI 10.1016/j.celrep.2013.04.022; Makino T, 2012, GENOME RES, V22, P2427, DOI 10.1101/gr.131953.111; McLysaght A, 2014, P NATL ACAD SCI USA, V111, P361, DOI 10.1073/pnas.1309324111; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Molnar C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003982; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oksenberg N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.78; Oksenberg N, 2013, TRENDS GENET, V29, P600, DOI 10.1016/j.tig.2013.08.001; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; OP026, 2016, J CROHNS COLITIS, V10, pS21; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; Polyakova V, 2011, INT J CARDIOL, V151, P18, DOI 10.1016/j.ijcard.2010.04.053; Prakash S, 2007, EXP MOL PATHOL, V82, P42, DOI 10.1016/j.yexmp.2006.06.008; Singh PP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004394; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Xie T, 2016, MOL BIOL EVOL, V33, P2368, DOI 10.1093/molbev/msw108; Yeates DK, 2005, EVOLUTIONARY BIOL FL; Zhu YS, 2016, NEUROSCIENCE, V333, P35, DOI 10.1016/j.neuroscience.2016.07.007	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0232101	10.1371/journal.pone.0232101	http://dx.doi.org/10.1371/journal.pone.0232101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306672	Green Published, Green Accepted, gold			2022-12-26	WOS:000600144200036
J	Chae, SM; Choi, J; Lim, S; Choi, HJ; Park, J; Hong, SH; Park, CS; Choi, JH; Chae, MS				Chae, Sumin; Choi, Junghee; Lim, Sujin; Choi, Ho Joong; Park, Jaesik; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Chae, Min Suk			Stress burden related to postreperfusion syndrome may aggravate hyperglycemia with insulin resistance during living donor liver transplantation: A propensity score-matching analysis	PLOS ONE			English	Article							C-PEPTIDE; BLOOD-GLUCOSE; ACTIVATION	Background We investigated the impact of postreperfusion syndrome (PRS) on hyperglycemia occurrence and connecting (C) peptide release, which acts as a surrogate marker for insulin resistance, during the intraoperative period after graft reperfusion in patients undergoing living donor liver transplantation (LDLT) using propensity score (PS)-matching analysis. Patients and methods Medical records from 324 adult patients who underwent elective LDLT were retrospectively reviewed, and their data were analyzed according to PRS occurrence (PRS vs. non-PRS groups) using the PS-matching method. Intraoperative levels of blood glucose and C-peptide were measured through the arterial or venous line at each surgical phase. Hyperglycemia was defined as a peak glucose level >200 mg/dL, and normal plasma concentrations of C-peptide in the fasting state were taken to range between 0.5 and 2.0 ng/mL. Results After PS matching, there were no significant differences in pre- and intra-operative recipient findings and donor-graft findings between groups. Although glucose and C-peptide levels continuously increased through the surgical phases in both groups, glucose and C-peptide levels during the neohepatic phase were significantly higher in the PRS group than in the non-PRS group, and larger changes in levels were observed between the preanhepatic and neohepatic phases. There were higher incidences of C-peptide levels >2.0 ng/mL and peak glucose levels >200 mg/dL in the neohepatic phase in patients with PRS than in those without. PRS adjusted for PS with or without exogenous insulin infusion was significantly associated with hyperglycemia occurrence during the neohepatic phase. Conclusions Elucidating the association between PRS and hyperglycemia occurrence will help with establishing a standard protocol for intraoperative glycemic control in patients undergoing LDLT.	[Chae, Sumin] United Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Choi, Junghee; Lim, Sujin; Park, Jaesik; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Chae, Min Suk] Catholic Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Seoul St Marys Hosp, Seoul, South Korea; [Choi, Ho Joong] Catholic Univ Korea, Coll Med, Dept Surg, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Chae, MS (corresponding author), Catholic Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Seoul St Marys Hosp, Seoul, South Korea.	shscms@gmail.com		Chae, Min Suk/0000-0002-1426-4651				Banu S, 2011, CNS NEUROL DISORD-DR, V10, P921, DOI 10.2174/187152711799219271; Bezinover D, 2011, LIVER TRANSPLANT, V17, P324, DOI 10.1002/lt.22227; Bo S, 2012, EUR J ENDOCRINOL, V167, P173, DOI 10.1530/EJE-12-0085; Carli F, 2015, CAN J ANESTH, V62, P110, DOI 10.1007/s12630-014-0264-0; Chae MS, 2018, ANN TRANSPL, V23, DOI 10.12659/AOT.908787; Chae MS, 2018, LIVER TRANSPLANT, V24, P623, DOI 10.1002/lt.25022; Chung HS, 2015, TRANSPL P, V47, P1877, DOI 10.1016/j.transproceed.2015.03.052; Chung HS, 2015, ANN TRANSPL, V20, P303, DOI 10.12659/AOT.893648; Chung IS, 2012, CLIN TRANSPLANT, V26, P539, DOI 10.1111/j.1399-0012.2011.01568.x; Cines DB, 1998, BLOOD, V91, P3527; Erice E, 2012, AM J PHYSIOL-GASTR L, V302, pG1458, DOI 10.1152/ajpgi.00389.2011; Fiegel M, 2012, SEMIN CARDIOTHORAC V, V16, P106, DOI 10.1177/1089253212444791; Garcia-Compean D, 2009, ANN HEPATOL, V8, P13, DOI 10.1016/S1665-2681(19)31805-8; Girn Hardev Ramandeep Singh, 2007, Vasc Endovascular Surg, V41, P277; Gresele P, 2003, J AM COLL CARDIOL, V41, P1013, DOI 10.1016/S0735-1097(02)02972-8; Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381; Jeong SM, 2015, KOREAN J ANESTHESIOL, V68, P527, DOI 10.4097/kjae.2015.68.6.527; Konrad T, 2001, TRANSPLANT P, V33, P2576, DOI 10.1016/S0041-1345(01)02102-9; Leighton E, 2017, DIABETES THER, V8, P475, DOI 10.1007/s13300-017-0265-4; Marchetti P, 2005, LIVER TRANSPLANT, V11, P612, DOI 10.1002/lt.20439; Marvin MR, 2013, DIABETES TECHNOL THE, V15, P246, DOI 10.1089/dia.2012.0277; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nanashima A, 2001, J Hepatobiliary Pancreat Surg, V8, P557, DOI 10.1007/s005340100025; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Palermo NE, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0721-y; Park CS, 2015, WORLD J GASTROENTERO, V21, P6835, DOI 10.3748/wjg.v21.i22.6835; Park J, 2020, BMC SURG, V20, DOI 10.1186/s12893-019-0658-6; Park J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215603; Patel N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003152; Ryu HG, 2012, LIVER TRANSPLANT, V18, P1430, DOI 10.1002/lt.23511; Turton JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194987; VILSTRUP H, 1986, EUR J CLIN INVEST, V16, P193, DOI 10.1111/j.1365-2362.1986.tb01328.x; Xu ZD, 2012, HEPATOB PANCREAT DIS, V11, P34, DOI 10.1016/S1499-3872(11)60123-9; Yan YK, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0913-2; Yaribeygi H, 2019, LIFE SCI, V237, DOI 10.1016/j.lfs.2019.116950	36	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243873	10.1371/journal.pone.0243873	http://dx.doi.org/10.1371/journal.pone.0243873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301501	Green Published, gold			2022-12-26	WOS:000600143100021
J	Kern, A; Shanahan, D; Buesen, R; Geiger, D				Kern, Andreas; Shanahan, Diane; Buesen, Roland; Geiger, Dominik			Safety evaluation of a beta-mannanase enzyme preparation produced with Thermothelomyces thermophilus expressing a protein-engineered beta-mannanase gene	PLOS ONE			English	Article							MYCELIOPHTHORA; DIETS	Mannanase 19287 enzyme is an engineered beta-mannanase that can be added to diets for animals raised for human consumption to hydrolyze beta-mannans. Established toxicological analyses were conducted with the enzyme preparation to ensure the safety of this product for the intended use. The mannanase 19287 preparation was produced with Thermothelomyces thermophilus strain DSM 33149. In vitro toxicity studies presented here used dosages of the mannanase 19287 test articles up to 5000 mu g/plate. For in vivo toxicity studies in Wistar rats, test articles were administered at 5.1 mg/L for inhalation toxicity and up to 15,000 mg/kg rat feed for oral toxicity, based on the Total Organic Solids (TOS) content in each test article. No treatment related adverse effects were reported in any study. The No Observed Adverse Effect Levels in the high dose group of the subchronic oral toxicity study were calculated as 1117-1298 mg TOS/kg bw/day in rats. Comparing these values to an Estimated Daily Intake for poultry demonstrated safety factors larger than 5000. Our results confirm that T. thermophilus fulfills the recognized safety criteria for the manufacture of food enzyme preparations and represent the first peer-reviewed safety evaluation of an enzyme preparation by T. thermophilus. The results of the toxicity studies presented herein attest to the safety of the mannanase 19287 enzyme for its intended use.	[Kern, Andreas; Shanahan, Diane] BASF Corp, San Diego, CA 92121 USA; [Buesen, Roland] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany; [Geiger, Dominik] BASF SE, Global Serv Cluster Safety, Ludwigshafen, Germany	BASF; BASF; BASF	Kern, A (corresponding author), BASF Corp, San Diego, CA 92121 USA.	andreas.a.kern@basf.com			BASF Corp., San Diego, CA; BASF SE, Ludwigshafen, Germany	BASF Corp., San Diego, CA(BASF); BASF SE, Ludwigshafen, Germany(BASF)	BASF Corp., San Diego, CA, and BASF SE, Ludwigshafen, Germany, the study sponsor, financially supported this project including the writing of this manuscript and paying third party costs. BASF SE, Experimental Toxicology and Ecology, an inspection body accredited by the national accreditation body of Germany, was paid to execute the toxicology studies, collect, analyze, and interpret data. The funders provided support in the form of salaries for authors [AK, DS, RB, DG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AISE, 2017, GUID SAF HANDL ENZ D; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; AMFEP, 2013, GUID SAF HANDL IND E; [Anonymous], 2015, BMJ, V2015, ph1887; Aunstrup K, 1979, APPL BIOCHEM BIOENG, P28; Aunstrup K, 1979, MICROBIAL TECHNOLOGY, P281; Barry M. A., 2006, Morbidity and Mortality Weekly Report, V55, P563; Brinch DS, 2002, REGUL TOXICOL PHARM, V35, P296, DOI 10.1006/rtph.2002.1538; Bukhtojarov FE, 2004, BIOCHEMISTRY-MOSCOW+, V69, P542, DOI 10.1023/B:BIRY.0000029853.34093.13; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; COUCH J. R., 1967, BRIT POULTRY SCI, V8, P243, DOI 10.1080/00071666708415675; Dyadic International (USA) Inc, 2009, GRAS NOT 292 CELL EN; Enzyme Technical Association, 2018, WORK SAF ENZ; FAO WHO, 2004, 61 M JOINT FAO WHO E, V922; FAO/WHO, 2006, COMP FOOD ADD SPEC, P63; FAO/WHO, 2009, FOOD DER MOD BIOT, VSecond; FDA, 2003, TOX PRINC SAF ASS FO; FDA Center for Food Safety and Applied Nutrition (CFSAN), 2009, AG RESP LETT GRAS NO; GREEN MHL, 1976, MUTAT RES, V38, P3, DOI 10.1016/0165-1161(76)90076-5; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Henrissat B, 2020, GLYCOSYL HYDROLASE F; HYNES MJ, 1983, MOL CELL BIOL, V3, P1430, DOI 10.1128/MCB.3.8.1430; International Food Biotechnology Council, 1990, REGUL TOXICOL PHARM, V12, pS114; Lee JT, 2003, POULTRY SCI, V82, P1925, DOI 10.1093/ps/82.12.1925; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mann-Felix Y, 2015, MYCOLOGIA, V107, P619, DOI [10.3852/14-288, 10.3852/14-228]; Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB), 2019, ENZ NOM; Nourrisson C, 2017, CLIN MICROBIOL INFEC, V23, P338, DOI 10.1016/j.cmi.2016.10.025; Pariza MW, 2010, REGUL TOXICOL PHARM, V56, P332, DOI 10.1016/j.yrtph.2009.10.005; PARIZA MW, 1983, J FOOD PROTECT, V46, P453, DOI 10.4315/0362-028X-46.5.453; Pariza MW, 2001, REGUL TOXICOL PHARM, V33, P173, DOI 10.1006/rtph.2001.1466; Ross, 2020, ROSS 708 BROIL PERF; Srivastava PK, 2017, BIOTECHNOL ADV, V35, P1, DOI 10.1016/j.biotechadv.2016.11.001; U.S.Pharmacopeial Convention, 2018, FOOD CHEM COD, P413; van den Brink J, 2012, FUNGAL DIVERS, V52, P197, DOI 10.1007/s13225-011-0107-z; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; VERMA SVS, 1982, BRIT POULTRY SCI, V23, P95, DOI 10.1080/00071688208447935; Visser H., 2011, IND BIOTECHNOL, V7, P214, DOI [10.1089/ind.2011.7.214, DOI 10.1089/IND.2011.7.214]; Wu G, 2005, POULTRY SCI, V84, P894, DOI 10.1093/ps/84.6.894; Yoon SY, 2010, J ANIM SCI, V88, P181, DOI 10.2527/jas.2008-1741	40	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243647	10.1371/journal.pone.0243647	http://dx.doi.org/10.1371/journal.pone.0243647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301505	Green Published, gold			2022-12-26	WOS:000600143100059
J	Shim, YS; Lim, KI; Lee, HS; Hwang, JS				Shim, Young Suk; Lim, Kyung In; Lee, Hae Sang; Hwang, Jin Soon			Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty	PLOS ONE			English	Article							FINAL HEIGHT; ADULT HEIGHT; SUPPRESSIVE THERAPY; GIRLS; PATTERN; AGE	Objective Gonadotropin-releasing hormone agonist (GnRHa) treatment improves the potential for gaining height in patients with central precocious puberty (CPP). However, most studies have focused on girls because CPP in boys is relatively rare. Therefore, we aimed to determine the effect of GnRHa treatment on auxological outcomes in boys with CPP. Methods Eighty-five boys with CPP were treated with leuprolide or triptorelin acetate 3.75 mg over 2 years. Anthropometry, bone age, sexual maturity rating, and predicted adult height (PAH) were assessed every 6 months. Furthermore, 20 boys were followed up after treatment discontinuation until achievement of the final adult height (FAH). Results The mean chronological age (CA) and bone age (BA) of the patients with CPP at treatment initiation were 9.5 +/- 0.5 years and 11.7 +/- 0.9 years, respectively. The mean duration of treatment was 2.87 +/- 0.63 years. The PAH at treatment initiation was 172.1 cm (-0.23 +/- 1.05 PAH standard deviation score). The PAH at treatment discontinuation (176.2 +/- 6.6 cm) was significantly higher than the pretreatment PAH. In addition, the mean final adult height in the 20 boys who were followed up after discontinuation of treatment was 173.4 +/- 5.8 cm, which was significantly higher than the initial PAH (170.1 +/- 4.5 cm; p = 0.006). In multivariate analysis, the height gain (the difference between the FAH and PAH at treatment initiation) significantly correlated with the target height. Conclusion Long-term GnRHa treatment significantly improved the growth potential and FAH in boys with CPP.	[Shim, Young Suk] Hallym Univ, Med Ctr, Sch Med, Dept Pediat, Seoul, South Korea; [Lim, Kyung In] Gachon Univ, Gil Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea; [Lee, Hae Sang; Hwang, Jin Soon] Ajou Univ, Ajou Univ Hosp, Dept Pediat, Sch Med, Suwon, South Korea	Hallym University; Gachon University; Ajou University; Ajou University Hospital	Lee, HS (corresponding author), Ajou Univ, Ajou Univ Hosp, Dept Pediat, Sch Med, Suwon, South Korea.	seaon98@naver.com	Shim, Young Suk/AFX-0329-2022; lee, Hae Sang/AFL-6833-2022; lee, haesang/AAG-6951-2022	Shim, Young Suk/0000-0002-0850-5279; lee, Hae Sang/0000-0002-9684-4042; 	Ajou University School of Medicine [M2016-C0460-00033]	Ajou University School of Medicine	HS Lee received the new faculty research grant from Ajou University School of Medicine, URL: http://medicine.ajou.ac.kr/, Grant number M2016-C0460-00033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2002, MORB MORTAL WKLY REP, V58, P1; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Bertelloni S, 2008, ASIAN J ANDROL, V10, P525, DOI 10.1111/j.1745-7262.2008.00409.x; Bhatia S, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e30; BLANCOGARCIA M, 1983, ARCH FR PEDIATR, V40, P637; Brito VN, 2008, J CLIN ENDOCR METAB, V93, P2662, DOI 10.1210/jc.2007-2183; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Drop SLS, 1998, ENDOCR REV, V19, P540, DOI 10.1210/er.19.5.540; Durand A, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0130-x; Galluzzi F, 1998, ACTA PAEDIATR, V87, P521, DOI 10.1080/08035259850158227; Greulich WW, 1959, RADIOLOGIC ATLAS SKE, V2nd; Houk CP, 2008, J PEDIATR ENDOCR MET, V21, P1113; Kaplowitz PB, 2009, CURR OPIN ENDOCRINOL, V16, P31, DOI 10.1097/MED.0b013e328320a650; Klein K, 2016, J PEDIATR ENDOCR MET, V29, P1241, DOI 10.1515/jpem-2015-0376; Klein KO, 2018, J PEDIATR ENDOCR MET, V31, P655, DOI 10.1515/jpem-2017-0523; Klein KO, 2001, J CLIN ENDOCR METAB, V86, P4711, DOI 10.1210/jc.86.10.4711; Lazar L, 2001, J CLIN ENDOCR METAB, V86, P4127, DOI 10.1210/jc.86.9.4127; Lazar L, 2007, J CLIN ENDOCR METAB, V92, P3483, DOI 10.1210/jc.2007-0321; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; OERTER KE, 1991, J CLIN ENDOCR METAB, V73, P1235, DOI 10.1210/jcem-73-6-1235; Oostdijk W, 1996, ARCH DIS CHILD, V75, P292, DOI 10.1136/adc.75.4.292; Partsch CJ, 2002, CLIN ENDOCRINOL, V56, P129, DOI 10.1046/j.0300-0664.2001.01490.x; Partsch CJ, 2000, J PEDIATR ENDOCR MET, V13, P747; PAUL D, 1995, J CLIN ENDOCR METAB, V80, P546, DOI 10.1210/jc.80.2.546; Prader A, 1966, Triangle, V7, P240; Rizzo V, 2000, J PEDIATR ENDOCR MET, V13, P781; SIGURJONSDOTTIR TJ, 1968, AM J DIS CHILD, V115, P309, DOI 10.1001/archpedi.1968.02100010311003; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; Wilson AC, 2007, EXPERT OPIN INV DRUG, V16, P1851, DOI 10.1517/13543784.16.11.1851; XhrouetHeinrichs D, 1997, ACTA PAEDIATR, V86, P808; Yoon JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195209; 문진수, 2008, Clinical and Experimental Pediatrics, V51, P1	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243212	10.1371/journal.pone.0243212	http://dx.doi.org/10.1371/journal.pone.0243212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301485	Green Published, gold			2022-12-26	WOS:000600143100070
J	Guo, SJ; Xie, Y; Dai, QL; Li, HH; Yang, JZ				Guo, Shuangjian; Xie, Yuan; Dai, Qionglin; Li, Haihong; Yang, Junzhong			Dynamics in the Sakaguchi-Kuramoto model with bimodal frequency distribution	PLOS ONE			English	Article							SYNCHRONIZATION	In this work, we study the Sakaguchi-Kuramoto model with natural frequency following a bimodal distribution. By using Ott-Antonsen ansatz, we reduce the globally coupled phase oscillators to low dimensional coupled ordinary differential equations. For symmetrical bimodal frequency distribution, we analyze the stabilities of the incoherent state and different partial synchronous states. Different types of bifurcations are identified and the effect of the phase lag on the dynamics is investigated. For asymmetrical bimodal frequency distribution, we observe the revival of the incoherent state, and then the conditions for the revival are specified.	[Guo, Shuangjian; Dai, Qionglin; Li, Haihong; Yang, Junzhong] Beijing Univ Posts & Telecommun, Sch Sci, Beijing, Peoples R China; [Xie, Yuan] Xian Aeronaut Univ, Fac Sci, Xian, Peoples R China	Beijing University of Posts & Telecommunications; Xi'an Aeronautical University	Yang, JZ (corresponding author), Beijing Univ Posts & Telecommun, Sch Sci, Beijing, Peoples R China.	jzyang@bupt.edu.cn	yang, junzhong J/G-3046-2011	yang, junzhong J/0000-0002-9290-1927; Guo, Shuangjian/0000-0001-8062-1541				AAH A., 2019, BR J ANAESTH, V122, pe136; Abrams DM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.084103; Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Acebron JA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016218; Acebron JA, 1998, PHYS REV E, V57, P5287, DOI 10.1103/PhysRevE.57.5287; [Anonymous], 2011, AM J GASTROENTEROLOG, V106, pS76; [Anonymous], 2017, BR J ANAESTH, V119, pe31; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2016, NEWS CE DRY REFORMIN, V94, P30; [Anonymous], 2012, P NATL ACAD SCI US, V109, pE1377; Bick C, 2018, CHAOS, V28, DOI 10.1063/1.5041444; BONILLA LL, 1992, J STAT PHYS, V67, P313, DOI 10.1007/BF01049037; BUCK J, 1976, SCI AM, V234, P74; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; By CC, 2014, PEDIAT DERMATOL, V31, pe152; Cheng HY, 2017, NONLINEAR DYNAM, V89, P2273, DOI 10.1007/s11071-017-3585-z; Eckhardt B, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021110; Hong H, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046202; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Lee WS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.044101; Liu ZJ, 2020, COMMUN NONLINEAR SCI, V81, DOI 10.1016/j.cnsns.2019.104997; Martens EA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026204; Martens EA, 2016, CHAOS, V26, DOI 10.1063/1.4958930; Montbrio E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056125; Montbrio E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056201; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Ott E, 2008, CHAOS, V18, DOI 10.1063/1.2930766; Pazo D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046215; Pietras B, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.062219; Pietras B, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052211; Pikovsky A., 2002, AAPT, V70, P655, DOI DOI 10.1119/1.1475332; SAKAGUCHI H, 1986, PROG THEOR PHYS, V76, P576, DOI 10.1143/PTP.76.576; Skardal PS, 2019, EUR PHYS J B, V92, DOI 10.1140/epjb/e2019-90543-x; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tsimring LS, 2005, PHYS REV LETT, V95, P1; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Yuan D, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012910; Zhang XY, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.038701	40	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243196	10.1371/journal.pone.0243196	http://dx.doi.org/10.1371/journal.pone.0243196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296390	gold, Green Published			2022-12-26	WOS:000598626100025
J	van Haastert, PJM				van Haastert, Peter J. M.			Unified control of amoeboid pseudopod extension in multiple organisms by branched F-actin in the front and parallel F-actin/myosin in the cortex	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; CELL-MIGRATION; ARP2/3 COMPLEX; LEADING-EDGE; EUKARYOTIC CHEMOTAXIS; THERMAL FLUCTUATIONS; SHALLOW GRADIENTS; BINDING PROTEIN; MOTILITY DRIVEN; RAS ACTIVATION	The trajectory of moving eukaryotic cells depends on the kinetics and direction of extending pseudopods. The direction of pseudopods has been well studied to unravel mechanisms for chemotaxis, wound healing and inflammation. However, the kinetics of pseudopod extension-when and why do pseudopods start and stop- is equally important, but is largely unknown. Here the START and STOP of about 4000 pseudopods was determined in four different species, at four conditions and in nine mutants (fast amoeboids Dictyostelium and neutrophils, slow mesenchymal stem cells, and fungus B.d. chytrid with pseudopod and a flagellum). The START of a first pseudopod is a random event with a probability that is species-specific (23%/s for neutrophils). In all species and conditions, the START of a second pseudopod is strongly inhibited by the extending first pseudopod, which depends on parallel filamentous actin/myosin in the cell cortex. Pseudopods extend at a constant rate by polymerization of branched F-actin at the pseudopod tip, which requires the Scar complex. The STOP of pseudopod extension is induced by multiple inhibitory processes that evolve during pseudopod extension and mainly depend on the increasing size of the pseudopod. Surprisingly, no differences in pseudopod kinetics are detectable between polarized, unpolarized or chemotactic cells, and also not between different species except for small differences in numerical values. This suggests that the analysis has uncovered the fundament of cell movement with distinct roles for stimulatory branched F-actin in the protrusion and inhibitory parallel F-actin in the contractile cortex.	[van Haastert, Peter J. M.] Univ Groningen, Dept Cell Biochem, Groningen, Netherlands	University of Groningen	van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Groningen, Netherlands.	p.j.m.van.haastert@rug.nl						Ajjath AH, 2019, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2019)030; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; [Anonymous], 2015, BOCKLER IMPULS, V4, P4; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; Barbazan J, 2019, CURR OPIN CELL BIOL, V56, P71, DOI 10.1016/j.ceb.2018.09.002; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Blagg SL, 2004, BIOCHEM SOC T, V32, P1113, DOI 10.1042/BST0321113; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Bolourani P, 2008, J BIOL CHEM, V283, P10232, DOI 10.1074/jbc.M707459200; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bosgraaf L, 2008, J CELL SCI, V121, P3589, DOI 10.1242/jcs.031781; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; Bosgraaf L, 2010, CELL ADHES MIGR, V4, P46, DOI 10.4161/cam.4.1.9953; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Caccavo D, 2017, CARBOHYD POLYM, V167, P136, DOI 10.1016/j.carbpol.2017.03.027; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chugh P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.186254; Chugh P, 2017, NAT CELL BIOL, V19, P689, DOI 10.1038/ncb3525; Clark AG, 2013, BIOPHYS J, V105, P570, DOI 10.1016/j.bpj.2013.05.057; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Danuser G, 2013, ANNU REV CELL DEV BI, V29, P501, DOI 10.1146/annurev-cellbio-101512-122308; Davidson AJ, 2016, TRENDS CELL BIOL, V26, P569, DOI 10.1016/j.tcb.2016.04.001; Davidson Andrew J., 2013, Communicative & Integrative Biology, V6, pe27033, DOI 10.4161/cib.27033; Devreotes P, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a005959; Devreotes PN, 2017, ANNU REV CELL DEV BI, V33, P103, DOI 10.1146/annurev-cellbio-100616-060739; Diz-Munoz A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002474; Dusenbery D. B., 2009, LIVING MICRO SCALE U; Dvorak KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195278; Faix Jan, 2013, Small GTPases, V4, P110, DOI 10.4161/sgtp.23476; Fritz-Laylin LK, 2017, ELIFE, V6, DOI 10.7554/eLife.26990; Fritz-Laylin LK, 2017, J CELL BIOL, V216, P1673, DOI 10.1083/jcb.201701074; Fukushima S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224121; Gao RC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0562; Gebbie L, 2004, MOL BIOL CELL, V15, P3915, DOI 10.1091/mbc.E03-12-0908; Genuth MA, 2018, DEV BIOL, V444, pS252, DOI 10.1016/j.ydbio.2018.02.016; Gerhardt M, 2014, J CELL SCI, V127, P4507, DOI 10.1242/jcs.156000; Gerisch G, 2016, METHODS MOL BIOL, V1407, P79, DOI 10.1007/978-1-4939-3480-5_6; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Golla SSV, 2017, EJNMMI PHYS, V4, DOI 10.1186/s40658-017-0197-0; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Graessl M, 2017, J CELL BIOL, V216, P4271, DOI 10.1083/jcb.201706052; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Hecht I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002044; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P5613, DOI 10.1073/pnas.78.9.5613; Hohmann T, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040362; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2018, CELL ADHES MIGR, V12, P401, DOI 10.1080/19336918.2018.1448352; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jegou A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2888; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; Kamp M, 2019, THESIS; Kataria R, 2013, P NATL ACAD SCI USA, V110, P6424, DOI 10.1073/pnas.1301851110; KILLICH T, 1994, BIOSYSTEMS, V33, P75, DOI 10.1016/0303-2647(94)90048-5; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kortholt A, 2013, J CELL SCI, V126, P4502, DOI 10.1242/jcs.132340; Kortholt A, 2006, J BIOL CHEM, V281, P23367, DOI 10.1074/jbc.M600804200; Kortholt A, 2010, MOL BIOL CELL, V21, P936, DOI 10.1091/mbc.E09-03-0177; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Kumar R, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.07.011; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Litschko C, 2019, P NATL ACAD SCI USA, V116, P3594, DOI 10.1073/pnas.1821638116; Liu CI, 2005, DEV BIOL, V285, P238, DOI 10.1016/j.ydbio.2005.05.045; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lomakin AJ, 2015, NAT CELL BIOL, V17, P1435, DOI 10.1038/ncb3246; LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864; Makarava N, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042703; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Miao YC, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188585; Miao YC, 2017, NAT CELL BIOL, V19, P329, DOI 10.1038/ncb3495; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mueller J, 2017, CELL, V171, P188, DOI 10.1016/j.cell.2017.07.051; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Ngo KX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35449; Nishikawa M, 2017, ELIFE, V6, DOI [10.7554/eLife.19595.001, 10.7554/eLife.19595, 10.7554/eLife.30537]; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Plak K, 2014, MOL BIOL CELL, V25, P4195, DOI 10.1091/mbc.E14-08-1285; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prahl LS, 2018, ADV EXP MED BIOL, V1092, P159, DOI 10.1007/978-3-319-95294-9_9; Ramalingam N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9496; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rottner K, 2017, J CELL SCI, V130, P3427, DOI 10.1242/jcs.206433; Sackmann E, 2015, BBA-MOL CELL RES, V1853, P3132, DOI 10.1016/j.bbamcr.2015.06.012; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Skoge M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154491; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Tanabe Y, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214775; Tsai TYC, 2019, DEV CELL, V49, P189, DOI 10.1016/j.devcel.2019.03.025; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Ura S, 2012, CURR BIOL, V22, P553, DOI 10.1016/j.cub.2012.02.020; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; van Haastert PJM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208892; van Haastert PJM, 2017, MOL BIOL CELL, V28, P922, DOI 10.1091/mbc.E16-10-0733; Van Haastert PJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027532; Van Haastert PJM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001708; Van Haastert PJM, 2010, BIOPHYS J, V99, P3345, DOI 10.1016/j.bpj.2010.09.042; Van Haastert PJM, 2010, J CELL SCI, V123, P3031, DOI 10.1242/jcs.071118; Van Haastert PJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006814; Van Haastert PJM, 2009, HFSP J, V3, P282, DOI 10.2976/1.3185725; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; VANHAASTERT PJM, 1986, J BIOL CHEM, V261, P6904; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2014, J CELL BIOL, V204, P497, DOI 10.1083/jcb.201309081; Vicker MG, 2002, FEBS LETT, V510, P5, DOI 10.1016/S0014-5793(01)03207-0; Yamashiro S, 2018, MOL BIOL CELL, V29, P1941, DOI 10.1091/mbc.E18-01-0061; Yang CS, 2011, NAT CELL BIOL, V13, P1012, DOI 10.1038/ncb2321; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Ydenberg CA, 2011, CYTOSKELETON, V68, P596, DOI 10.1002/cm.20543; Yu M, 2018, NANO LETT, V18, P5239, DOI 10.1021/acs.nanolett.8b02211; Zhao M, 2002, J CELL BIOL, V157, P921, DOI 10.1083/jcb.200112070; Zimmerman SP, 2017, J CELL SCI, V130, P2971, DOI 10.1242/jcs.205948	126	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243442	10.1371/journal.pone.0243442	http://dx.doi.org/10.1371/journal.pone.0243442			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296414	gold, Green Published			2022-12-26	WOS:000598626100051
J	Alter, BJ; Aung, MS; Strigo, IA; Fields, HL				Alter, Benedict J.; Aung, Mya Sandi; Strigo, Irina A.; Fields, Howard L.			Onset hyperalgesia and offset analgesia: Transient increases or decreases of noxious thermal stimulus intensity robustly modulate subsequent perceived pain intensity	PLOS ONE			English	Article							NOCICEPTIVE INFORMATION; PLACEBO; MECHANISMS; NEUROSCIENCE; ACTIVATION	Reported pain intensity depends not only on stimulus intensity but also on previously experienced pain. A painfully hot temperature applied to the skin evokes a lower subjective pain intensity if immediately preceded by a higher temperature, a phenomenon called offset analgesia. Previous work indicated that prior pain experience can also increase subsequent perceived pain intensity. Therefore, we examined whether a given noxious stimulus is experienced as more intense when it is preceded by an increase from a lower temperature. Using healthy volunteer subjects, we observed a disproportionate increase in pain intensity at a given stimulus intensity when this intensity is preceded by a rise from a lower intensity. This disproportionate increase is similar in magnitude to that of offset analgesia. We call this effect onset hyperalgesia. Control stimuli, in which a noxious temperature is held constant, demonstrate that onset hyperalgesia is distinct from receptor or central sensitization. The absolute magnitudes of offset analgesia and onset hyperalgesia correlate with each other but not with the noxious stimulus temperature. Finally, the magnitude of both offset analgesia and onset hyperalgesia depends on preceding temperature changes. Overall, this study demonstrates that the perceptual effect of a noxious thermal stimulus is influenced in a bidirectional manner depending upon both the intensity and direction of change of the immediately preceding thermal stimulus.	[Alter, Benedict J.; Aung, Mya Sandi] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Alter, Benedict J.] Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA 15260 USA; [Strigo, Irina A.] Univ Calif San Francisco, San Francisco VA Hlth Care Syst, San Francisco, CA USA; [Strigo, Irina A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alter, BJ (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.; Alter, BJ (corresponding author), Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA 15260 USA.	alterbj@upmc.edu	Alter, Benedict/ABD-8516-2021; Strigo, Irina/L-9882-2016	Alter, Benedict/0000-0002-0171-3411; Strigo, Irina/0000-0002-8799-716X; Aung, Mya Sandi/0000-0002-4244-3235	Foundation for Anesthesia Education and Research; UCSF Department of Anesthesia and Perioperative Care; National Institute of General Medical Sciences [T32GM075770]; United States Department of Veterans Affairs Clinical Sciences Research and Development Service [I01CX-000816, I01-CX-001652]; National Institute Of Arthritis And Musculoskeletal And Skin Diseases [U19AR076737, UH2AR076724]	Foundation for Anesthesia Education and Research; UCSF Department of Anesthesia and Perioperative Care; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Veterans Affairs Clinical Sciences Research and Development Service; National Institute Of Arthritis And Musculoskeletal And Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the Foundation for Anesthesia Education and Research (https://www.asahq.org/faer/researchfunding/researchfellowshipgrant) in the form of a Research Fellowship Grant awarded to BJA, the UCSF Department of Anesthesia and Perioperative Care (https://anesthesia.ucsf.edu/research-scholars) in the form of Research Scholar Funds awarded to BJA, the National Institute of General Medical Sciences (https://www.nigms.nih.gov/) in the form of a grant awarded to BJA (T32GM075770), the United States Department of Veterans Affairs Clinical Sciences Research and Development Service (https://www.research.va.gov/services/csrd/) in the form of grants awarded to IAS (I01CX-000816, I01-CX-001652), and the National Institute Of Arthritis And Musculoskeletal And Skin Diseases (https://www.niams.nih.gov/) in the form of grants awarded to IAS (U19AR076737, UH2AR076724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, J CANC RES THER, V14, pS622; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Barratt W, 2006, BARRATT SIMPLIFIED M; Beck B, 2019, J NEUROPHYSIOL, V121, P1778, DOI 10.1152/jn.00335.2018; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Campbell CM, 2010, J PAIN, V11, P443, DOI 10.1016/j.jpain.2009.08.009; Derbyshire SWG, 2008, EUR J PAIN, V12, P980, DOI 10.1016/j.ejpain.2008.01.008; Derbyshire SWG, 2009, NEUROIMAGE, V47, P1002, DOI 10.1016/j.neuroimage.2009.04.032; Feenstra Tjerk, 2015, SCI SIGNAL, V8, P12; Fields HL., 2006, P 11 WORLD C PAIN, P449; Fields HL, 2018, PAIN, V159, pS3, DOI 10.1097/j.pain.0000000000001272; GAUDRY E, 1975, MULTIVAR BEHAV RES, V10, P331, DOI 10.1207/s15327906mbr1003_6; Geuter S, 2017, ANNU REV NEUROSCI, V40, P167, DOI 10.1146/annurev-neuro-072116-031132; Grill JD, 2002, J NEUROPHYSIOL, V87, P2205, DOI 10.1152/jn.00730.2001; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoffman GA, 2005, PERSPECT BIOL MED, V48, P248, DOI 10.1353/pbm.2005.0054; Honigman L, 2013, EXP BRAIN RES, V228, P493, DOI 10.1007/s00221-013-3580-7; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kobinata H, 2017, PAIN, V158, P1951, DOI 10.1097/j.pain.0000000000000989; Ligato D, 2018, EUR J PAIN, V22, P142, DOI 10.1002/ejp.1110; Margari F, 2014, NEUROPSYCH DIS TREAT, V10, P1613, DOI 10.2147/NDT.S66209; Marino EN, 2013, ADDICT BEHAV, V38, P2154, DOI 10.1016/j.addbeh.2013.01.020; Martucci KT, 2012, PAIN, V153, P1232, DOI 10.1016/j.pain.2012.02.035; Martucci KT, 2012, PAIN, V153, P463, DOI 10.1016/j.pain.2011.11.010; Morch CD, 2015, PAIN, V156, P1906, DOI 10.1097/j.pain.0000000000000250; Nahman-Averbuch H, 2014, PAIN, V155, P2491, DOI 10.1016/j.pain.2014.07.008; Naugle KM, 2017, J PAIN, V18, P1496, DOI 10.1016/j.jpain.2017.08.003; Naugle KM, 2013, PAIN, V154, P2381, DOI 10.1016/j.pain.2013.07.015; Niesters M, 2011, ANESTHESIOLOGY, V115, P1063, DOI 10.1097/ALN.0b013e31822fd03a; Oudejans LCJ, 2015, PAIN, V156, P2521, DOI 10.1097/j.pain.0000000000000321; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Petre B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04009-9; Price DD, 1988, PSYCHOL NEURAL MECH; Sprenger C, 2018, NEUROIMAGE, V183, P788, DOI 10.1016/j.neuroimage.2018.09.003; Starr CJ, 2010, J PAIN, V11, P1394, DOI 10.1016/j.jpain.2010.03.014; Staud R, 2006, J PAIN, V7, P575, DOI 10.1016/j.jpain.2006.02.005; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Szikszay TM, 2019, CLIN J PAIN, V35, P189, DOI 10.1097/AJP.0000000000000657; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Yelle MD, 2008, PAIN, V134, P174, DOI 10.1016/j.pain.2007.04.014; Yelle MD, 2009, J NEUROSCI, V29, P10264, DOI 10.1523/JNEUROSCI.4648-08.2009	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0231124	10.1371/journal.pone.0231124	http://dx.doi.org/10.1371/journal.pone.0231124			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8OF	33290407	gold, Green Published			2022-12-26	WOS:000598620100013
J	Higgins, BE; Taylor, DJ; Bi, W; Binns, AM; Crabb, DP				Higgins, Bethany E.; Taylor, Deanna J.; Bi, Wei; Binns, Alison M.; Crabb, David P.			Novel computer-based assessments of everyday visual function in people with age-related macular degeneration	PLOS ONE			English	Article							CRASH INVOLVEMENT; FIELD DEFECTS; EYE-MOVEMENTS; OLDER DRIVERS; RISK-FACTORS; SEARCH; CLASSIFICATION; PERFORMANCE; POPULATION; IMPAIRMENT	Purpose To test the hypothesis that the performance in novel computer-based tasks of everyday visual function worsens with disease severity in people with non-neovascular age-related macular degeneration. Methods Participants with and without non-neovascular age-related macular degeneration (>= 60 years, minimum logMAR binocular visual acuity 0.7) performed a series of standard visual function tests and two novel computer-based tasks. In a visual search task, participants had to locate an image of a single real-world object within an array of 49 distractor images. Next, in a series of simulated dynamic driving scenes, participants were asked to identify one or two approaching real-world road signs and then select these road signs from four options. Outcome measures were median response times and total correct responses. Results Forty-nine participants had no macular disease (n = 11), early/intermediate age-related macular degeneration (n = 16) or geographic atrophy (n = 22). Groups were age-similar with median (interquartile range) logMAR visual acuity of 0.00 (-0.08,0.12), 0.13 (-0.08,0.70) and 0.32 (0.12,0.70) respectively. Median (interquartile range) visual search response times were 1.9 (1.0,2.4), 1.8 (1.1,3.7) and 2.4 (1.2,6.0) seconds respectively. Median (interquartile range) road sign response times (single road signs) were 1.2 (0.4,1.7), 1.5 (0.9,2.8) and 1.8 (1.0,5.5) seconds respectively. Median (interquartile range) road sign response times (double road signs) were 1.7 (0.7,2.4), 2.3 (1.2,3.1) and 2.5 (1.7,6) seconds respectively. Participants with geographic atrophy recorded slower response times in all tasks and over 50% performed outside the normative limit for task performance. There were no significant differences between groups in total correct responses across all tasks. Conclusions In a novel computer-based assessment, people with increasing severity of age-related macular degeneration take longer to perform visual search of everyday objects and take longer to identify road signs than those with no age-related macular degeneration. These novel assessments could be useful as patient-relevant, secondary outcomes for clinical trials.	[Higgins, Bethany E.; Taylor, Deanna J.; Bi, Wei; Binns, Alison M.; Crabb, David P.] Univ London, Sch Hlth Sci, Optometry & Visual Sci, London, England	University of London	Crabb, DP (corresponding author), Univ London, Sch Hlth Sci, Optometry & Visual Sci, London, England.	David.Crabb.1@city.ac.uk		Higgins, Bethany/0000-0002-4530-6156; Crabb, David/0000-0001-8754-3902	Roche Products Ltd, UK	Roche Products Ltd, UK	This study was funded as part of an unrestricted investigator-initiated research grant from Roche Products Ltd, UK, (https://www.roche.co.uk/) awarded to DPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DRIV EYES RUL; Aspinall PA, 2014, BRIT J OPHTHALMOL, V98, P1393, DOI 10.1136/bjophthalmol-2014-305032; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Coeckelbergh TRM, 2002, VISION RES, V42, P669, DOI 10.1016/S0042-6989(01)00297-8; Denniss J, 2017, INVEST OPHTH VIS SCI, V58, P2652, DOI 10.1167/iovs.16-21086; Driving Standards Agency-Great Britain, 2007, OFF HIGHW COD; ELLIOTT DB, 1990, OPHTHAL PHYSL OPT, V10, P323, DOI 10.1111/j.1475-1313.1990.tb00877.x; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORD A, 1959, J OPT SOC AM, V49, P287, DOI 10.1364/JOSA.49.000287; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Friedman SM, 1999, INVEST OPHTH VIS SCI, V40, P858; Geringswald F, 2013, J VISION, V13, DOI 10.1167/13.3.28; Haegerstrom-Portnoy G, 2000, OPTOMETRY VISION SCI, V77, P653, DOI 10.1097/00006324-200012000-00012; Hassell JB, 2006, BRIT J OPHTHALMOL, V90, P593, DOI 10.1136/bjo.2005.086595; Jacko J. A., 2002, Universal Access in the Information Society, V1, P197, DOI 10.1007/s102090100015; Jones PR, 2020, OPHTHAL PHYSL OPT, V40, P35, DOI 10.1111/opo.12658; Kuyk TK, 2005, VISION RES, V45, P3224, DOI 10.1016/j.visres.2005.07.019; Lovie-Kitchin JE, 1986, OPTOMETRY VISION SCI, DOI [10.1097/00006324-198605000-00008, DOI 10.1097/00006324-198605000-00008]; MacKeben M, 2011, INVEST OPHTH VIS SCI, V52, P7603, DOI 10.1167/iovs.10-6728; McGwin G, 2000, ACCIDENT ANAL PREV, V32, P735, DOI 10.1016/S0001-4575(99)00123-2; McGwin G, 1998, ACCIDENT ANAL PREV, V30, P781, DOI 10.1016/S0001-4575(98)00031-1; McGwin G, 2013, BRIT J OPHTHALMOL, V97, P1173, DOI 10.1136/bjophthalmol-2013-303601; Minassian DC, 2011, BRIT J OPHTHALMOL, V95, P1433, DOI 10.1136/bjo.2010.195370; Mones J, 2005, EYE, V19, P1142, DOI 10.1038/sj.eye.6701717; MURPHY KS, 1988, OPHTHAL PHYSL OPT, V8, P345, DOI 10.1111/j.1475-1313.1988.tb01065.x; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Patnaik JL, 2019, OPHTHALMOL RETINA, V3, P336, DOI 10.1016/j.oret.2018.11.004; Quartilho A, 2016, EYE, V30, P602, DOI 10.1038/eye.2015.288; R Core Team, 2020, R LANG ENV STAT COMP; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; RUBIN GS, 1994, OPTOMETRY VISION SCI, V71, P750, DOI 10.1097/00006324-199412000-00005; Schoonjans F, 2011, EPIDEMIOLOGY, V22, P750, DOI 10.1097/EDE.0b013e318225c1de; SZLYK JP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1033, DOI 10.1001/archopht.1995.01100080085033; Taylor DJ, 2018, GRAEF ARCH CLIN EXP, V256, P815, DOI 10.1007/s00417-017-3879-3; Taylor DJ, 2017, INVEST OPHTH VIS SCI, V58, P1887, DOI 10.1167/iovs.16-21122; Taylor DJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011504; Thibaut M, 2016, J FR OPHTALMOL, V39, P82, DOI 10.1016/j.jfo.2015.08.010; Thibaut M, 2018, CLIN EXP OPTOM, V101, P372, DOI 10.1111/cxo.12644; Van der Stigchel S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00579; Wiecek E, 2012, INVEST OPHTH VIS SCI, V53, P6600, DOI 10.1167/iovs.12-10012; Wood JM, 2018, INVEST OPHTH VIS SCI, V59, P273, DOI 10.1167/iovs.17-22751	45	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243578	10.1371/journal.pone.0243578	http://dx.doi.org/10.1371/journal.pone.0243578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284855	gold, Green Published, Green Accepted			2022-12-26	WOS:000597930500048
J	Lau, H; Corrales, N; Rodriguez, S; Luong, C; Mohammadi, M; Khosrawipour, V; Li, SR; Alexander, M; de Vos, P; Lakey, JRT				Lau, Hien; Corrales, Nicole; Rodriguez, Samuel; Luong, Colleen; Mohammadi, Mohammadreza; Khosrawipour, Veria; Li, Shiri; Alexander, Michael; de Vos, Paul; Lakey, Jonathan R. T.			Dose-dependent effects of necrostatin-1 supplementation to tissue culture media of young porcine islets	PLOS ONE			English	Article							IN-VITRO; CELL-DEATH; TRANSPLANTATION; XENOTRANSPLANTATION; CYTOKINES; HYPOXIA; VIVO	Previous studies have shown that necrostatin-1 (Nec-1) supplementation improved the viability of murine islets following exposure to nitric oxide, increased the survival of human islets during hypoxic culture, and augmented the maturation of pre-weaned porcine islets (PPIs) after 7 days of tissue culture. A limitation of these studies is that only one concentration of Nec-1 was used, and no studies have determined the optimal dose of Nec-1 for PPIs. Thus, the present study examined the effects of Nec-1 on PPIs at four different doses-0, 25, 50, 100, and 200 mu M-after 7 days of tissue culture when supplemented on day 3. PPIs were isolated from pancreata of pre-weaned Yorkshire piglets (8-15 days old) and cultured in a specific islet maturation media added with Nec-1 on day 3 of tissue culture at 4 different doses-0, 25, 50, 100, and 200 mu M (n = 6 for each dose). After 7 days of tissue culture, islets were assessed for recovery, viability, endocrine cellular content, GLUT2 expression in beta cells, and insulin secretion after glucose challenge. Nec-1 did not affect the viability of both intact islets and dissociated islets cells during tissue culture regardless of doses. Islets cultured in media supplemented with Nec-1 at 100 mu M, but not 25, 50, or 200 mu M, had a significantly higher recovery, composition of endocrine cells, GLUT2 expression in beta cells, and insulin secretion capacity than control islets cultured in media without Nec-1 supplementation. Moreover, culturing islets in 200 mu M Nec-1 supplemented media not only failed to improve the insulin release but resulted in a lower glucose-induced insulin stimulation index compared to islets cultured in media added with 100 mu M Nec-1. Xenotransplantation using porcine islets continues to demonstrate scientific advances to justify this area of research. Our findings indicate that Nec-1 supplementation at 100 mu M was most effective to enhance the in vitro maturation of PPIs during tissue culture.	[Lau, Hien; Corrales, Nicole; Rodriguez, Samuel; Luong, Colleen; Khosrawipour, Veria; Li, Shiri; Alexander, Michael; Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA; [Mohammadi, Mohammadreza] Univ Calif Irvine, Dept Mat Sci & Engn, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Mohammadi, Mohammadreza; Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA; [de Vos, Paul] Univ Groningen, Dept Pathol & Med Biol, Immunoendocrinol, Groningen, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Groningen	Lakey, JRT (corresponding author), Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.; Lakey, JRT (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	jlakey@hs.uci.edu		Lakey, Jonathan/0000-0001-8553-4287; de vos, paul/0000-0001-9618-2408	Juvenile Diabetes Research Foundation [3-SRA-2016-255-S-B]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	JL received funding from Juvenile Diabetes Research Foundation (http://www.jdrf.org), grant #3-SRA-2016-255-S-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; Aronson R, 2012, DIABETES TECHNOL THE, V14, P741, DOI 10.1089/dia.2012.0038; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bottino Rita, 2015, World J Transplant, V5, P243, DOI 10.5500/wjt.v5.i4.243; Bru-Tari E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45853-1; Bruni A, 2014, DIABETES METAB SYNDR, V7, P211, DOI 10.2147/DMSO.S50789; Bruni A, 2018, CELL TRANSPLANT, V27, P890, DOI 10.1177/0963689718766323; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Contreras JL, 2003, DIABETES, V52, P2935, DOI 10.2337/diabetes.52.12.2935; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ekser B, 2017, CURR OPIN ORGAN TRAN, V22, P513, DOI 10.1097/MOT.0000000000000463; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Ellis C, 2016, CELL TRANSPLANT, V25, P539, DOI 10.3727/096368915X689451; Foster ED, 2018, DIABETES CARE, V41, P1001, DOI 10.2337/dc17-1779; Giovagnoli S, 2005, J CONTROL RELEASE, V107, P65, DOI 10.1016/j.jconrel.2005.05.021; Hassouna T, 2018, TRANSPLANTATION, V102, pE413, DOI 10.1097/TP.0000000000002354; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Iqbal A, 2018, DIABETES METAB J, V42, P3, DOI 10.4093/dmj.2018.42.1.3; Jimenez-Vera E, 2015, XENOTRANSPLANTATION, V22, P114, DOI 10.1111/xen.12151; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; Lamb M, 2014, CELL TRANSPLANT, V23, P263, DOI 10.3727/096368912X662372; Lau H, 2020, ISLETS, V12, P41, DOI 10.1080/19382014.2020.1750933; Lau H, 2020, XENOTRANSPLANTATION, V27, DOI 10.1111/xen.12555; Li WC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26404-6; Lund T, 2008, TRANSPL INT, V21, P669, DOI 10.1111/j.1432-2277.2008.00664.x; Matsumoto S, 2016, EBIOMEDICINE, V12, P255, DOI 10.1016/j.ebiom.2016.08.034; Matsumoto S, 2010, J DIABETES, V2, P16, DOI 10.1111/j.1753-0407.2009.00048.x; Miki A, 2014, PANCREAS, V43, P1317, DOI 10.1097/MPA.0000000000000184; Mita A, 2008, TRANSPLANTATION, V86, P46, DOI 10.1097/TP.0b013e31817c79c0; Mohanasundaram D, 2011, GEN COMP ENDOCR, V174, P71, DOI 10.1016/j.ygcen.2011.07.004; Nagaraju S, 2015, XENOTRANSPLANTATION, V22, P7, DOI 10.1111/xen.12130; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Pan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093944; Paredes-Juarez GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14623; Park CG, 2015, INT J SURG, V23, P261, DOI 10.1016/j.ijsu.2015.07.703; Rickels MR, 2019, ENDOCR REV, V40, P631, DOI 10.1210/er.2018-00154; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; RUTTENBE.MA, 1972, SCIENCE, V177, P623, DOI 10.1126/science.177.4049.623; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stelly C., 2018, INT J AFRICANA STUDI, V19, P77; Sun JJ, 2019, J CLIN ENDOCR METAB, V104, P83, DOI 10.1210/jc.2018-00968; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tamura Y, 2011, FEBS LETT, V585, P3058, DOI 10.1016/j.febslet.2011.08.028; Vanderschelden R, 2019, CELL TRANSPLANT, V28, P967, DOI 10.1177/0963689719847460; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wu JR, 2015, NEURAL REGEN RES, V10, P1120, DOI 10.4103/1673-5374.160108; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zheng HW, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.177	56	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243506	10.1371/journal.pone.0243506	http://dx.doi.org/10.1371/journal.pone.0243506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284818	gold, Green Published			2022-12-26	WOS:000597930500032
J	Kurita, H; Nihonyanagi, H; Watanabe, Y; Sugano, K; Shinozaki, R; Kishikawa, K; Numano, R; Takashima, K				Kurita, Hirofumi; Nihonyanagi, Hirohito; Watanabe, Yuki; Sugano, Kenta; Shinozaki, Ryuto; Kishikawa, Kenta; Numano, Rika; Takashima, Kazunori			Mechanistic studies of gene delivery into mammalian cells by electrical short-circuiting via an aqueous droplet in dielectric oil	PLOS ONE			English	Article							ELECTROPORATION DEVICE; IN-VITRO; ELECTROTRANSFER; INVOLVEMENT	We have developed a novel methodology for the delivery of cell-impermeable molecules, based on electrical short-circuiting via a water droplet in dielectric oil. When a cell suspension droplet is placed between a pair of electrodes with an intense DC electric field, droplet bouncing and droplet deformation, which results in an instantaneous short-circuit, can be induced, depending on the electric field strength. We have demonstrated successful transfection of various mammalian cells using the short-circuiting; however, the molecular mechanism remains to be elucidated. In this study, flow cytometric assays were performed with Jurkat cells. An aqueous droplet containing Jurkat cells and plasmids carrying fluorescent proteins was treated with droplet bouncing or short-circuiting. The short-circuiting resulted in sufficient cell viability and fluorescent protein expression after 24 hours' incubation. In contrast, droplet bouncing did not result in successful gene transfection. Transient membrane pore formation was investigated by uptake of a cell-impermeable fluorescence dye YO-PRO-1 and the influx of calcium ions. As a result, short-circuiting increased YO-PRO-1 fluorescence intensity and intracellular calcium ion concentration, but droplet bouncing did not. We also investigated the contribution of endocytosis to the transfection. The pre-treatment of cells with endocytosis inhibitors decreased the efficiency of gene transfection in a concentration-dependent manner. Besides, the use of pH-sensitive dye conjugates indicated the formation of an acidic environment in the endosomes after the short-circuiting. Endocytosis is a possible mechanism for the intracellular delivery of exogenous DNA.	[Kurita, Hirofumi; Nihonyanagi, Hirohito; Watanabe, Yuki; Sugano, Kenta; Shinozaki, Ryuto; Kishikawa, Kenta; Numano, Rika; Takashima, Kazunori] Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Kurita, H (corresponding author), Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Toyohashi, Aichi, Japan.	kurita@chem.tut.ac.jp	Kurita, Hirofumi/K-6757-2012	Kurita, Hirofumi/0000-0002-2538-6590	Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST) [AS2915129U]; Cooperative Project for Innovative Research from Toyohashi Univ. of Tech	Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST); Cooperative Project for Innovative Research from Toyohashi Univ. of Tech	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) (AS2915129U to HK and RN) from Japan Science and Technology Agency (JST) and Cooperative Project for Innovative Research from Toyohashi Univ. of Tech. (to HK and RN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2013, ANAL CHEM, V85, P1637, DOI 10.1021/ac302887a; Altman A, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P1; Asada A, 2013, IEEE T IND APPL, V49, P311, DOI 10.1109/TIA.2012.2229452; Cao YH, 2019, P NATL ACAD SCI USA, V116, P7899, DOI 10.1073/pnas.1818553116; Cervia LD, 2018, MOL PHARMACEUT, V15, P3617, DOI 10.1021/acs.molpharmaceut.8b00207; Cervia LD, 2018, MOL THER-NUCL ACIDS, V11, P263, DOI 10.1016/j.omtn.2018.02.009; Chang AY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63172-8; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demiryurek Y, 2015, BBA-BIOMEMBRANES, V1848, P1706, DOI 10.1016/j.bbamem.2015.04.007; Escoffre JM, 2012, CURR GENE THER, V12, P417, DOI 10.2174/156652312802762554; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Guignet EG, 2008, NAT METHODS, V5, P393, DOI 10.1038/NMETH.1201; He ZL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63732-y; Huang D, 2017, SENSOR ACTUAT B-CHEM, V250, P703, DOI 10.1016/j.snb.2017.04.085; Im DJ, 2017, BIOCHEM ENG J, V122, P133, DOI 10.1016/j.bej.2017.03.010; Im DJ, 2015, ANAL CHEM, V87, P6592, DOI 10.1021/acs.analchem.5b00725; Ishino T, 2020, J VET MED SCI, V82, P14, DOI 10.1292/jvms.19-0475; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Jinno M, 2017, PLASMA SOURCES SCI T, V26, DOI 10.1088/1361-6595/aa70de; Kim YH, 2019, BIOELECTROCHEMISTRY, V126, P29, DOI 10.1016/j.bioelechem.2018.11.010; Kurita Hirofumi, 2016, Biochem Biophys Rep, V8, P81, DOI 10.1016/j.bbrep.2016.08.001; Kurita H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144254; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao M, 2017, MOL THER, V25, P803, DOI 10.1016/j.ymthe.2016.12.009; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Napotnik TB, 2018, BIOELECTROCHEMISTRY, V120, P166, DOI 10.1016/j.bioelechem.2017.12.005; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Robertson MJ, 2014, NAT PROTOC, V9, P1592, DOI 10.1038/nprot.2014.106; Rosazza C, 2016, CURR GENE THER, V16, P98, DOI 10.2174/1566523216666160331130040; Rosazza C, 2013, MOL THER, V21, P2217, DOI 10.1038/mt.2013.182; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; Wu MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020923; Yoo BS, 2018, ANALYST, V143, P5785, DOI 10.1039/c8an01259h; Zhao DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18469	41	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243361	10.1371/journal.pone.0243361	http://dx.doi.org/10.1371/journal.pone.0243361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275626	gold, Green Published			2022-12-26	WOS:000597150200010
J	Alameda, L; Levier, A; Gholam-Rezaee, M; Golay, P; Vandenberghe, F; Delacretaz, A; Baumann, P; Glatard, A; Dubath, C; Herane-Vives, A; Rodriguez, V; Solida, A; Do, KQ; Eap, CB; Conus, P				Alameda, Luis; Levier, Axel; Gholam-Rezaee, Mehdi; Golay, Philippe; Vandenberghe, Frederik; Delacretaz, Aurelie; Baumann, Philipp; Glatard, Anais; Dubath, Celine; Herane-Vives, Andres; Rodriguez, Victoria; Solida, Alessandra; Do, Kim Q.; Eap, Chin B.; Conus, Philippe			Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication	PLOS ONE			English	Article							BODY-MASS INDEX; ANTIPSYCHOTIC-NAIVE PATIENTS; C-REACTIVE PROTEIN; CHILDHOOD MALTREATMENT; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; ABDOMINAL OBESITY; WEIGHT-GAIN; FAT MASS; SCHIZOPHRENIA	Background It has been suggested that exposure to Childhood Trauma [CT] may play a role in the risk of obesity in Early Psychosis [EP] patients; however, whether this is independently of age at exposure to CT and the medication profile has yet to be investigated. Methods 113 EP-patients aged 18-35 were recruited from the Treatment and Early Intervention in Psychosis Program [TIPP-Lausanne]. Body Mass Index [BMI], Weight Gain [WG] and Waist Circumference [WC] were measured prospectively at baseline and after 1, 2, 3, 6 and 12 months of weight gain inducing psychotropic treatment. Patients were classified as Early-Trauma and Late-Trauma if the exposure had occurred before age 12 or between ages 12 and 16 respectively. Generalized Linear Mixed-Models were adjusted for age, sex, socioeconomic status, baseline BMI, medication and for diagnosis of depression. Results Late-Trauma patients, when compared to Non-Trauma patients showed greater WCs during the follow-up [p = 0.013]. No differences were found in any of the other follow-up measures. Conclusions Exposition to CT during adolescence in EP-patients treated with psychotropic medication is associated with greater WC during the early phase of the disease. Further investigation exploring mechanisms underlying the interactions between peripubertal stress, corticoids responsiveness and a subsequent increase of abdominal adiposity is warranted.	[Alameda, Luis; Rodriguez, Victoria] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England; [Alameda, Luis; Golay, Philippe; Solida, Alessandra; Conus, Philippe] Lausanne Univ Hosp CHUV, Serv Gen Psychiat Treatment & Early Intervent Psy, Program TIPP Lausanne, Lausanne, Switzerland; [Alameda, Luis] Univ Seville, Hosp Univ Virgen Rocio, Dept Psychiat, Seville, Spain; [Alameda, Luis] IBiS, Inst Invest Sanitaria Sevilla, Seville, Spain; [Levier, Axel; Vandenberghe, Frederik; Delacretaz, Aurelie; Glatard, Anais; Dubath, Celine; Eap, Chin B.] Lausanne Univ Hosp, Hosp Cery, Ctr Psychiat Neurosci, Dept Psychiat,Unit Pharmacogenet & Clin Psychopha, Prilly, Switzerland; [Gholam-Rezaee, Mehdi] Lausanne Univ Hosp CHUV, Ctr Psychiat Epidemiol & Psychopathol, Dept Psychiat, Lausanne, Switzerland; [Golay, Philippe] Lausanne Univ Hosp, Dept Psychiat, Community Psychiat Serv, Consultat Chauderon, Lausanne, Switzerland; [Golay, Philippe] Univ Lausanne, Lausanne, Switzerland; [Golay, Philippe] Univ Lausanne, Fac Social & Polit Sci, Inst Psychol, Lausanne, Switzerland; [Baumann, Philipp; Do, Kim Q.] Lausanne Univ Hosp CHUV, Ctr Psychiat Neurosci, Dept Psychiat, Unit Res Schizophrenia, Lausanne, Switzerland; [Herane-Vives, Andres] Kings Coll London, Ctr Affect Disorders, Inst Psychiat Psychol & Neurosci, Dept Psychol Med,Affect Disorders Res Grp, London, England; [Herane-Vives, Andres] Univ Catolica Norte, Fac Med, Dept Clin, Coquimbo, Chile; [Eap, Chin B.] Univ Geneva, Sch Pharm, Dept Pharmaceut Sci, Geneva, Switzerland; [Alameda, Luis] Inst Psychiat Psychol & Neurosci, London, England; [Levier, Axel] Ctr Neurosci Psychiat, Lausanne, Switzerland	University of London; King's College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Sevilla; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; King's College London; Universidad Catolica del Norte; University of Geneva	Alameda, L (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England.; Alameda, L (corresponding author), Lausanne Univ Hosp CHUV, Serv Gen Psychiat Treatment & Early Intervent Psy, Program TIPP Lausanne, Lausanne, Switzerland.; Alameda, L (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Dept Psychiat, Seville, Spain.; Alameda, L (corresponding author), IBiS, Inst Invest Sanitaria Sevilla, Seville, Spain.; Alameda, L (corresponding author), Inst Psychiat Psychol & Neurosci, London, England.	laluisalameda@gmail.com	Do, Kim Q./G-6694-2016; Golay, Philippe/GMX-4576-2022	Do, Kim Q./0000-0003-1968-1646; Golay, Philippe/0000-0002-2273-6241; Alameda, Luis/0000-0002-8621-2885; Conus, Philippe/0000-0002-5832-1910; Vandenberghe, Frederik/0000-0002-8964-2047	Swiss National Science Foundation [320030_135736/1, 320030-120686, 324730-144064, 320030-173211, 171804]; National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases" from the Swiss National Science Foundation [51NF40-158776]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases" from the Swiss National Science Foundation	This work represents an independent research part supported by the The Swiss National Science Foundation (no. 320030_135736/1 to P.C. and K.Q.D., no 320030-120686, 324730-144064 and 320030-173211 to C.B.E and PC and no 171804 to LA), the National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases" from the Swiss National Science Foundation (n omicron 51NF40-158776) The Damm-Etienne and Alamaya Foundation were supporting the recruitment as well as the phenotyping (including psychopathology, neurocognition and neurobiological biomarkers) of our early psychosis patients cohort). The views expressed are those of the author(s) and not necessarily those of the The Swiss National Science Foundation, the Damm-Etienne or Alamaya Foundations.	Aas M, 2017, BRAIN BEHAV IMMUN, V65, P342, DOI 10.1016/j.bbi.2017.06.005; Alameda L, 2015, PSYCHOL MED, V45, P2727, DOI 10.1017/S0033291715000690; Alameda L, 2017, SCHIZOPHRENIA BULL, V43, P1027, DOI 10.1093/schbul/sbw163; Alameda L, 2016, J CLIN PSYCHIAT, V77, pE612, DOI 10.4088/JCP.15m09947; Alameda L, 2016, PSYCHIAT RES, V239, P212, DOI 10.1016/j.psychres.2016.03.010; Anjum S, 2018, DIABETES METAB SYND, V12, P135, DOI 10.1016/j.dsx.2017.11.006; [Anonymous], 2014, FRONTIERS ARCHITECTU, V3, P1, DOI DOI 10.1520/C1557-03R13.2; Ashworth M, 2017, BRIT J GEN PRACT, V67, P436, DOI 10.3399/bjgp17X692621; Association AAP, 1994, DIAGN STAT MAN MENT; Attux C, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-60; Bahr SM, 2015, EBIOMEDICINE, V2, P1725, DOI 10.1016/j.ebiom.2015.10.018; Barrett E, 2004, OBES RES, V12, P362; Baumann PS, 2013, EARLY INTERV PSYCHIA, V7, P322, DOI 10.1111/eip.12037; Bioque M, 2018, SCHIZOPHR RES, V193, P188, DOI 10.1016/j.schres.2017.06.032; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Chen DC, 2016, PSYCHOL MED, V46, P3219, DOI 10.1017/S0033291716001902; Choong E, 2008, Rev Med Suisse, V4, P1994; Choong E, 2013, JAMA PSYCHIAT, V70, P1011, DOI 10.1001/jamapsychiatry.2013.187; Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54; Delacretaz A, 2018, J CLIN LIPIDOL, V12, P219, DOI 10.1016/j.jacl.2017.10.002; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fisher HL, 2010, PSYCHOL MED, V40, P1967, DOI 10.1017/S0033291710000231; Gonzalez-Blanco L, 2016, SCHIZOPHR RES, V174, P156, DOI 10.1016/j.schres.2016.03.018; Greenhalgh AM, 2017, SCHIZOPHR RES, V179, P57, DOI 10.1016/j.schres.2016.09.026; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hepgul N, 2012, PSYCHOL MED, V42, P1893, DOI 10.1017/S0033291711002947; Herane-Vives A, 2018, ACTA PSYCHIAT SCAND, V137, P216, DOI 10.1111/acps.12852; HOWARD LM, 1993, AM J PSYCHIAT, V150, P839; Kuhlman KR, 2015, PSYCHONEUROENDOCRINO, V54, P103, DOI 10.1016/j.psyneuen.2015.01.020; Lasserre AM, 2017, MOL PSYCHIATR, V22, P1026, DOI 10.1038/mp.2016.178; Lasserre AM, 2014, JAMA PSYCHIAT, V71, P880, DOI 10.1001/jamapsychiatry.2014.411; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Morgan C, 2020, BRIT J PSYCHIAT, V217, P575, DOI 10.1192/bjp.2020.133; Morgan C, 2016, WORLD PSYCHIATRY, V15, P93, DOI 10.1002/wps.20330; Opel N, 2015, PSYCHONEUROENDOCRINO, V51, P219, DOI 10.1016/j.psyneuen.2014.10.001; Pariante CM, 2017, EUR NEUROPSYCHOPHARM, V27, P554, DOI 10.1016/j.euroneuro.2017.04.001; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Sinclair D, 2014, PSYCHOPHARMACOLOGY, V231, P1581, DOI 10.1007/s00213-013-3415-z; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Steptoe A, 2004, INT J OBESITY, V28, P1168, DOI 10.1038/sj.ijo.0802715; Team RC, 2014, R LANG ENV STAT COMP; Thornberry TP, 2001, DEV PSYCHOPATHOL, V13, P957, DOI 10.1017/S0954579401004114; Vandenberghe F, 2016, PHARMACOGENET GENOM, V26, P547, DOI 10.1097/FPC.0000000000000249; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vicennati V, 2000, J CLIN ENDOCR METAB, V85, P4093, DOI 10.1210/jc.85.11.4093; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x	48	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242569	10.1371/journal.pone.0242569	http://dx.doi.org/10.1371/journal.pone.0242569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270646	gold, Green Published			2022-12-26	WOS:000597149100071
J	Chen, Y; Ma, CN; Luo, L; Yin, JY; Gao, Z; Yu, ZL; Wan, ZX				Chen, Yao; Ma, Chen'Xi' Nan; Luo, Lan; Yin, Jieyun; Gao, Zhan; Yu, Zengli; Wan, Zhongxiao			The cross-sectional association between mean corpuscular volume level and cognitive function in Chinese over 45 years old: Evidence from the China Health and Retirement Longitudinal Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; EPISODIC MEMORY; SEX-DIFFERENCES; PERFORMANCE; ANEMIA; DEMENTIA; HEMOGLOBIN; PREVALENCE; BIOMARKERS; DECLINE	Fewer studies have focused on the independent association between mean corpuscular volume (MCV) and cognitive performance. This study was designed to characterize the cross-sectional association between MCV and cognitive performance in a large sample of Chinese residents (age >= 45 years) from the China Health and Retirement Longitudinal Study (CHARLS). A total of 4023 male and 4173 female adults with MCV >= 80 fl were included for analysis. By multivariable linear regression analysis, for the total subjects, MCV level was significantly negatively associated with global cognitive function and episodic memory. When adjusted by sex, only in male subjects, higher MCV level was associated with reduced scores for global cognitive function, episodic memory and mental status. Via binary logistic regression analysis, the higher MCV level (MCV>100 fl) was associated with poor global cognitive function (OR = 1.601; 95% CI = 1.198-2.139; p = 0.001), episodic memory (OR = 1.679; 95% CI = 1.281-2.201; p<0.001), and mental status (OR = 1.422; 95% CI = 1.032-1.959; p = 0.031) for the whole participants. When testing this association by sex, the significant relationship between higher MCV level with worse episodic memory was observed both in male (OR = 1.690; 95% CI = 1.211-2.358; p = 0.002) and female (OR = 1.729; 95% CI = 1.079-2.770; p = 0.023) subjects; while the association between higher MCV level and poor global cognitive function (OR = 1.885; 95% CI = 1.329, 2.675; p<0.001) and mental status (OR = 1.544; 95% CI = 1.034, 2.306; p = 0.034) only existed in male subjects. Further studies are warranted to clarify the association between MCV level and cognitive performance by considering sex into consideration both cross-sectionally and longitudinally.	[Chen, Yao; Yu, Zengli; Wan, Zhongxiao] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Ma, Chen'Xi' Nan; Luo, Lan; Yin, Jieyun; Wan, Zhongxiao] Soochow Univ, Sch Publ Hlth, Med Coll, Suzhou, Peoples R China; [Gao, Zhan] Zhengzhou Univ, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Soochow University - China; Zhengzhou University	Yu, ZL; Wan, ZX (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China.; Wan, ZX (corresponding author), Soochow Univ, Sch Publ Hlth, Med Coll, Suzhou, Peoples R China.	zly@zzu.edu.cn; zhxwan@suda.edu.cn		Wan, Zhongxiao/0000-0002-6297-5933; Ma, Chenxinan/0000-0001-5239-8530	National Natural Science Foundation of China [81872609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant NO. 81872609).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedictus MR, 2017, EUR RADIOL, V27, P1169, DOI 10.1007/s00330-016-4450-z; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen HH, 2012, PSYCHIAT CLIN NEUROS, V66, P367, DOI 10.1111/j.1440-1819.2012.02347.x; Curtis Alexander E, 2016, Aorta (Stamford), V4, P124, DOI 10.12945/j.aorta.2016.16.014; DANON D, 1992, EXP GERONTOL, V27, P275, DOI 10.1016/0531-5565(92)90055-5; Deal JA, 2009, J AM GERIATR SOC, V57, P1604, DOI 10.1111/j.1532-5415.2009.02400.x; Finucane TE, 2010, J AM GERIATR SOC, V58, P994, DOI 10.1111/j.1532-5415.2010.02828.x; Gamaldo AA, 2013, J AM GERIATR SOC, V61, P84, DOI 10.1111/jgs.12066; Guidelines CJCftRoADP, 2017, CHIN J HLTH MANAGE, V11, P937; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; International WHOaAsD, 2012, DEM PUBL HLTH PRIOR; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jeong SM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0322-2; Jia JP, 2018, ALZHEIMERS DEMENT, V14, P483, DOI 10.1016/j.jalz.2017.12.006; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P1, DOI 10.1016/j.jalz.2013.01.012; Kiani A, 2016, WORLD J GASTROENTERO, V22, P4926, DOI 10.3748/wjg.v22.i20.4926; Tamura M, 2010, J GERONTOL A-BIOL, V65, P1380, DOI 10.1093/gerona/glq126; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li JX, 2017, J AM GERIATR SOC, V65, P373, DOI 10.1111/jgs.14368; Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114; Luo Y, 2019, J GERONTOL B-PSYCHOL, V74, pE60, DOI 10.1093/geronb/gbz016; Maitland SB, 2004, MEM COGNITION, V32, P1160, DOI 10.3758/BF03196889; Maner B.S., 2020, MEAN CORPUSCULAR VOL; Mohanty JG, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-11; Nagao T, 2017, J GEN FAM MED, V18, P200, DOI 10.1002/jgf2.31; Pan X, 2020, AGING MENT HEALTH, V24, P1046, DOI 10.1080/13607863.2019.1597015; Qin TT, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1308-7; Santos IS, 2012, INT PSYCHOGERIATR, V24, P74, DOI 10.1017/S1041610211001724; Sha TT, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0355-1; Shah RC, 2009, NEUROEPIDEMIOLOGY, V32, P40, DOI 10.1159/000170905; Stevenson A, 2017, J ALZHEIMERS DIS, V60, P845, DOI 10.3233/JAD-170363; Valladao JBR, 2020, J NEUROPSYCH CLIN N, V32, P227, DOI 10.1176/appi.neuropsych.19040088; Wang T, 2017, J ALZHEIMERS DIS, V58, P79, DOI [10.3233/JAD-161243, 10.3233/jad-161243]; Winchester LM, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0556-z; Wolters FJ, 2019, NEUROLOGY, V93, pE917, DOI 10.1212/WNL.0000000000008003; Wu YT, 2018, INT J EPIDEMIOL, V47, P709, DOI 10.1093/ije/dyy007; Zamboni V, 2006, INT J GERIATR PSYCH, V21, P529, DOI 10.1002/gps.1520; Zhang Y, 2020, ADV MATER INTERFACES, V7, DOI 10.1002/admi.201902011; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203	41	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243227	10.1371/journal.pone.0243227	http://dx.doi.org/10.1371/journal.pone.0243227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270788	Green Published			2022-12-26	WOS:000597149100094
J	Fernandez-Fontelo, A; Morina, D; Cabana, A; Arratia, A; Puig, P				Fernandez-Fontelo, Amanda; Morina, David; Cabana, Alejandra; Arratia, Argimiro; Puig, Pere			Estimating the real burden of disease under a pandemic situation: The SARS-CoV2 case	PLOS ONE			English	Article							TIME-SERIES MODELS; COUNT DATA	The present paper introduces a new model used to study and analyse the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) epidemic-reported-data from Spain. This is a Hidden Markov Model whose hidden layer is a regeneration process with Poisson immigration, Po-INAR(1), together with a mechanism that allows the estimation of the under-reporting in non-stationary count time series. A novelty of the model is that the expectation of the unobserved process's innovations is a time-dependent function defined in such a way that information about the spread of an epidemic, as modelled through a Susceptible-Infectious-Removed dynamical system, is incorporated into the model. In addition, the parameter controlling the intensity of the under-reporting is also made to vary with time to adjust to possible seasonality or trend in the data. Maximum likelihood methods are used to estimate the parameters of the model.	[Fernandez-Fontelo, Amanda] Humboldt Univ, Sch Business & Econ, Chair Stat, Berlin, Germany; [Morina, David; Cabana, Alejandra; Puig, Pere] Univ Autonoma Barcelona, Barcelona Grad Sch Math BGSMath, Dept Matemat, Barcelona, Spain; [Morina, David] Univ Barcelona, Riskctr IREA, Dept Econometr Stat & Appl Econ, Barcelona, Spain; [Morina, David] Ctr Recerca Matemat CRM, Barcelona, Spain; [Arratia, Argimiro] Univ Politecn Cataluna, Dept Comp Sci, Barcelona, Spain	Humboldt University of Berlin; Autonomous University of Barcelona; University of Barcelona; Centre de Recerca Matematica (CRM); Universitat Politecnica de Catalunya	Fernandez-Fontelo, A (corresponding author), Humboldt Univ, Sch Business & Econ, Chair Stat, Berlin, Germany.	fernanda@hu-berlin.de	Cabaña, Alejandra/H-1519-2015; Moriña, David/AAX-8427-2021; Arratia, Argimiro A/Q-2397-2018; Fernández-Fontelo, Amanda/GRY-0348-2022; FERNANDEZ-FONTELO, AMANDA/ABB-2023-2020	Cabaña, Alejandra/0000-0002-1289-967X; Moriña, David/0000-0001-5949-7443; Arratia, Argimiro A/0000-0003-1551-420X; Fernández-Fontelo, Amanda/0000-0002-0822-6915; FERNANDEZ-FONTELO, AMANDA/0000-0002-0822-6915	Instituto de Salud Carlos III [COV20/00115]; Spanish Ministry of Economy and Competitiveness [RTI2018-096072-B-I00]; German Research Foundation (D.F.G.); Spanish Ministry of Economy and Competitiveness, through the Mara de Maeztu Programme for Units of Excellence in RD [MDM-2014-0445]; Fundacion Santander Universidades; MINECO (Ministerio de Economa, Industria y Competitividad) [TIN2017-89244-R]; AGAUR (Generalitat de Catalunya) [2017SGR-856]; frame CY Initiative of Excellence (grant\Investissements d'Avenir") [ANR-16-IDEX-0008]; Project \EcoDep" [PSI-AAP2020-0000000013]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); German Research Foundation (D.F.G.)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness, through the Mara de Maeztu Programme for Units of Excellence in RD; Fundacion Santander Universidades; MINECO (Ministerio de Economa, Industria y Competitividad); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); frame CY Initiative of Excellence (grant\Investissements d'Avenir")(French National Research Agency (ANR)); Project \EcoDep"	This work was co-funded by Instituto de Salud Carlos III (COV20/00115), and the Spanish Ministry of Economy and Competitiveness (RTI2018-096072-B-I00). A.Ferna ' ndez-Fontelo acknowledges financial support from the German Research Foundation (D.F.G.). D. Morina acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the Mara de Maeztu Programme for Units of Excellence in R&D (MDM-2014-0445) and Fundacion Santander Universidades. A. Arratia acknowledges support by grant TIN2017-89244-R from MINECO (Ministerio de Economa, Industria y Competitividad) and the recognition 2017SGR-856 (MACDA) from AGAUR (Generalitat de Catalunya). This work was also processed in the Yframe CY Initiative of Excellence (grant\Investissements d'Avenir"ANR-16-IDEX-0008), Project \EcoDep" PSI-AAP2020-0000000013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Osh M. A., 1987, J TIME SER ANAL, V8, P261, DOI DOI 10.1111/J.1467-9892.1987.TB00438.X; Alfonso JH, 2015, CONTACT DERMATITIS, V72, P409, DOI 10.1111/cod.12355; ANDERSON R M, 1991; Arnold C, 2020, WHAT WELL NEED FIND; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Birrell PJ, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21580; Cardinal M, 1999, STAT MED, V18, P2025, DOI 10.1002/(SICI)1097-0258(19990815)18:15<2025::AID-SIM163>3.3.CO;2-4; Cohen J, 2020, UNDERREPORTING COVID; Davis RA, 2015, HDB MODERN STAT METH, V1; Ducrot A, 2020, MATH MED BIOL, V37, P243, DOI 10.1093/imammb/dqz013; Fan CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051679; Fernandez-Fontelo A, 2019, STAT MED, V38, P4404, DOI 10.1002/sim.8306; Fernandez-Fontelo A, 2016, STAT MED, V35, P4875, DOI 10.1002/sim.7026; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Hao X, RECONSTRUCTION FULL, V584, P420; Hill EM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007096; Hossmann S., 2020, ROLE ASYMPTOMATIC SA; Jazi MA, 2012, JIRSS-J IRAN STAT SO, V11, P173; Jazi MA, 2012, J TIME SER ANAL, V33, P954, DOI 10.1111/j.1467-9892.2012.00809.x; MCKENZIE E, 1985, WATER RESOUR BULL, V21, P645; McKenzie E, 2003, HANDB STAT, V21, P573, DOI 10.1016/S0169-7161(03)21018-X; Moreno E, 1998, J STAT PLAN INFER, V66, P147, DOI 10.1016/S0378-3758(97)00073-6; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Romero JM, 2020, AGUJERO DONDE SE COL; Stoner O, 2019, J AM STAT ASSOC, V114, P1481, DOI 10.1080/01621459.2019.1573732; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Weaver M, 2020, UK CORONAVIRUS DEATH; Weiss CH, 2008, ASTA-ADV STAT ANAL, V92, P319, DOI 10.1007/s10182-008-0072-3; Winkelmann R., 1996, EMPIR ECON, V21, P575, DOI [10.1007/BF01180702, DOI 10.1007/BF01180702]; Zhu R, 2003, STOCH MODELS, V19, P235, DOI 10.1081/STM-120020388; Zhu R, 2010, J STAT PLAN INFER, V140, P1874, DOI 10.1016/j.jspi.2010.01.031; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	34	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242956	10.1371/journal.pone.0242956	http://dx.doi.org/10.1371/journal.pone.0242956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270713	Green Published, Green Submitted, gold			2022-12-26	WOS:000597149100086
J	Liu, XW; Wang, F; Xu, CW; Chen, XR; Hou, X; Li, Q; Li, PS; Xie, Z; Liu, YD; Chang, LP; Guan, YF; Zhang, XC; Yang, L; Wang, H; Yi, X; Zhang, JJ; Xia, XF; Moran, C; Chen, LK				Liu, Xuewen; Wang, Fang; Xu, Chunwei; Chen, Xinru; Hou, Xue; Li, Qian; Li, Pansong; Xie, Zhi; Liu, Yongdong; Chang, Lianpeng; Guan, Yanfang; Zhang, Xuchao; Yang, Ling; Wang, Hui; Yi, Xin; Zhang, Jianjun; Xia, Xuefeng; Moran, Cesar; Chen, Likun			Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma	ONCOGENE			English	Article							MOLECULAR CHARACTERIZATION; POOR-PROGNOSIS; KRAS MUTATION; LUNG; EGFR; IDENTIFICATION; AMPLIFICATION	Pulmonary sarcomatoid carcinoma (PSC) contains carcinomatous component (CaC) and sarcomatous component (SaC). Herein, we explored the genomic origin and intratumor heterogeneity (ITH) of PSC. We collected 31 resected PSC tumors and obtained CaC and SaC by laser capture microdissection for next-generation sequencing. The majority of PSCs (97%) had component-shared alterations. Driver mutations in EGFR, KRAS, MET, PIK3CA, and EML4-ALK fusion were mostly component-shared. Twenty-seven (87%) PSCs had component-private alterations. Compared with pure lung adenocarcinoma (LUAD), adenocarcinoma component of PSC showed lower EGFR incidence. Compared with other typical sarcomas, numerous genes of SaC exhibited significant differences. CaC and SaC had equivalent and proportional tumor mutation burden (TMB), as well as PD-L1 level. Compared with LUAD, SaC had significant higher TMB and more patients with high PD-L1 expression (tumor proportion score >= 50%). PSC with lower proportion of component-shared alterations (trunk-ratio) had a prolonged disease-free survival (DFS), regardless of the influence of clinical factors. We conclude that most PSCs originate from a monoclone accompanied by genomic ITH which is a potential independent prognostic factor, and more proportion of PSCs may be beneficial from immune checkpoint inhibitors.	[Liu, Xuewen] Cent South Univ, Xiangya Hosp 3, Dept Oncol, Changsha 410013, Hunan, Peoples R China; [Wang, Fang] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Mol Diagnost,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Xu, Chunwei] Nanjing Univ Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210002, Jiangsu, Peoples R China; [Chen, Xinru; Hou, Xue; Chen, Likun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Li, Qian; Li, Pansong; Chang, Lianpeng; Guan, Yanfang; Yang, Ling; Yi, Xin; Xia, Xuefeng] Geneplus Beijing, Beijing 102206, Peoples R China; [Xie, Zhi; Zhang, Xuchao] Guangdong Gen Hosp GGH, Guangdong Prov Key Lab Translat Med Lung Canc, Guangdong Lung Canc Inst, Guangzhou 510080, Guangdong, Peoples R China; [Xie, Zhi; Zhang, Xuchao] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Yongdong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Hui] Cent South Univ, Hunan Canc Hosp, Dept Radiat Oncol, Changsha 410013, Hunan, Peoples R China; [Wang, Hui] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China; [Wang, Hui] Hunan Prov Key Lab Translat Radiat Oncol, Changsha 410013, Hunan, Peoples R China; [Zhang, Jianjun] Univ Texas MD Anderson Canc Ctr, Dept Genom Med & Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Moran, Cesar] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Central South University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University; Central South University; Central South University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, LK (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.; Moran, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	cesarmoran@mdanderson.org; chenlk@sysucc.org.cn	zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022	Li, Qian/0000-0001-9413-1877	National Natural Science Foundation of China [81572270]; Nature Science Foundation of Hunan Province [2017JJ3188]; Foundation of Hunan Health Committee Research Plan [A2017005]; Foundation of Wisdom Gathering and Talent Cultivating Program from the Third Xiangya Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Foundation of Hunan Health Committee Research Plan; Foundation of Wisdom Gathering and Talent Cultivating Program from the Third Xiangya Hospital	This study was supported by the National Natural Science Foundation of China (81572270), Nature Science Foundation of Hunan Province (2017JJ3188), Foundation of Hunan Health Committee Research Plan (A2017005) and Foundation of Wisdom Gathering and Talent Cultivating Program from the Third Xiangya Hospital.	Babacan NA, 2020, CLIN LUNG CANCER, V21, pE456, DOI 10.1016/j.cllc.2020.02.022; Bevilacqua C, 2018, MOL ASPECTS MED, V59, P5, DOI 10.1016/j.mam.2017.09.003; Blaukovitsch M, 2006, VIRCHOWS ARCH, V449, P455, DOI 10.1007/s00428-006-0256-8; Chan TA, 2019, ANN ONCOL, V30, P44, DOI 10.1093/annonc/mdy495; Chang YL, 2011, ANN SURG ONCOL, V18, P2952, DOI 10.1245/s10434-011-1621-7; Chen FM, 2019, ONCOTARGETS THER, V12, P3321, DOI 10.2147/OTT.S196751; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cimpeanu E, 2020, WORLD J CLIN CASES, V8, P97, DOI 10.12998/wjcc.v8.i1.97; D'Angelo SP, 2011, J CLIN ONCOL, V29, P2066, DOI 10.1200/JCO.2010.32.6181; Fallet V, 2015, ANN ONCOL, V26, P1748, DOI 10.1093/annonc/mdv232; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Goto T, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3059-1; Italiano A, 2009, INT J CANCER, V125, P2479, DOI 10.1002/ijc.24610; Kaira K, 2010, J THORAC ONCOL, V5, P460, DOI 10.1097/JTO.0b013e3181ce3e3c; Kim S, 2015, EUR J CANCER, V51, P2698, DOI 10.1016/j.ejca.2015.08.013; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Leone A, 2011, INT J CANCER, V128, P732, DOI 10.1002/ijc.25335; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li Y, 2018, LUNG CANCER, V122, P113, DOI 10.1016/j.lungcan.2018.06.001; Liang XH, 2019, INT J CLIN ONCOL, V24, P1061, DOI 10.1007/s10147-019-01454-6; Lin G, 2020, ANN ONCOL, V31, P517, DOI 10.1016/j.annonc.2020.01.014; Lin YB, 2016, AM J CLIN ONCOL-CANC, V39, P215, DOI 10.1097/COC.0000000000000101; Liu XW, 2016, J CLIN ONCOL, V34, P794, DOI 10.1200/JCO.2015.62.0674; Lococo F, 2016, J THORAC ONCOL, V11, P1282, DOI 10.1016/j.jtho.2016.04.020; Manzotti G, 2019, CLIN CANCER RES, V25, P2348, DOI 10.1158/1078-0432.CCR-18-2364; Martin LW, 2007, ANN THORAC SURG, V84, P973, DOI 10.1016/j.athoracsur.2007.03.099; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Mehrad M, 2018, HISTOPATHOLOGY, V73, P207, DOI 10.1111/his.13505; Nakagomi Takahiro, 2018, Oncotarget, V9, P10635, DOI 10.18632/oncotarget.24365; Nong JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05327-w; Pelosi G, 2012, LUNG CANCER, V77, P507, DOI 10.1016/j.lungcan.2012.05.093; Pelosi G, 2010, INT J SURG PATHOL, V18, P103, DOI 10.1177/1066896908330049; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Schrock AB, 2017, J THORAC ONCOL, V12, P932, DOI 10.1016/j.jtho.2017.03.005; Sim JK, 2018, KOREAN J INTERN MED, V33, P737, DOI 10.3904/kjim.2017.245; Terra SBSP, 2016, MODERN PATHOL, V29, P824, DOI 10.1038/modpathol.2016.89; Tong JH, 2016, CLIN CANCER RES, V22, P3048, DOI 10.1158/1078-0432.CCR-15-2061; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Vieira T, 2013, J THORAC ONCOL, V8, P1574, DOI 10.1097/01.JTO.0000437008.00554.90; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weissferdt A, 2017, HUM PATHOL, V63, P14, DOI 10.1016/j.humpath.2016.12.010; Yendamuri S, 2012, SURGERY, V152, P397, DOI 10.1016/j.surg.2012.05.007; Yu YF, 2019, J CANCER RES THER, V15, P909, DOI 10.4103/jcrt.JCRT_591_18	47	11	11	2	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2021	40	4					821	832		10.1038/s41388-020-01573-9	http://dx.doi.org/10.1038/s41388-020-01573-9		DEC 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QA4GO	33273725				2022-12-26	WOS:000599064900001
J	Abe, M; Katano, H; Nagi, M; Higashi, Y; Sato, Y; Kikuchi, K; Hasegawa, H; Miyazaki, Y				Abe, Masahiro; Katano, Harutaka; Nagi, Minoru; Higashi, Yoshitsugu; Sato, Yuko; Kikuchi, Ken; Hasegawa, Hideki; Miyazaki, Yoshitsugu			Potency of gastrointestinal colonization and virulence of Candida auris in a murine endogenous candidiasis	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; BIOFILM FORMATION; CLONAL STRAIN; MOUSE MODEL; EPIDEMIOLOGY; HOSPITALS; ALBICANS	BackgroundCandida auris infections have recently emerged worldwide, and this species is highly capable of colonization and is associated with high levels of mortality. However, strain-dependent differences in colonization capabilities and virulence have not yet been reported. Objectives In the present study, we aimed to clarify the differences between clinically isolated invasive and non-invasive strains of C. auris. Methods We evaluated colonization, dissemination, and survival rates in wild C57BL/6J mice inoculated with invasive or non-invasive strains of C. auris under cortisone acetate immunosuppression, comparing with those of Candida albicans and Candida glabrata infections. We also evaluated the potency of biofilm formation. Results Stool fungal burdens were significantly higher in mice inoculated with the invasive strains than in those infected with the non-invasive strain. Along with intestinal colonization, liver and kidney fungal burdens were also significantly higher in mice inoculated with the invasive strains. In addition, histopathological findings revealed greater dissemination and colonization of the invasive strains. Regarding biofilm-forming capability, the invasive strain of C. auris exhibited a significantly higher capacity of producing biofilms. Moreover, inoculation with the invasive strains resulted in significantly greater loss of body weight than that noted following infection with the non-invasive strain. Conclusions Invasive strains showed higher colonization capability and rates of dissemination from gastrointestinal tracts under cortisone acetate immunosuppression than non-invasive strains, although the mortality rates caused by C. auris were lower than those caused by C. albicans.	[Abe, Masahiro; Nagi, Minoru; Higashi, Yoshitsugu; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Katano, Harutaka; Sato, Yuko; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kikuchi, Ken] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan; [Hasegawa, Hideki] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Tokyo Women's Medical University; National Institute of Infectious Diseases (NIID)	Miyazaki, Y (corresponding author), Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan.	ym46@niid.go.jp	Hasegawa, Hideki/C-7978-2014; Abe, Masahiro/AAJ-3032-2021	Abe, Masahiro/0000-0002-6355-716X; miyazaki, yoshitsugu/0000-0001-8942-0869	Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED) [JP19fk0108045, JP19fk0108049, JP19fk0108094, JP19fk0108104]; JSPS KAKENHI [JP19fk0108045, JP19fk0108049, JP19fk0108094, JP19fk0108104, JP17K10040]	Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED) under Grant Number (JP19fk0108045, JP19fk0108049, JP19fk0108094, and JP19fk0108104), and by JSPS KAKENHI Grant Number JP17K10040. JP19fk0108045, JP19fk0108049, JP19fk0108094, and JP17K10040 were given to YM. JP19fk0108104 was given to HK and HH. URL of AMED is https://www.amed.go.jp/en/index.html URL of JSPS KAKENHI is https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2019, J ANTIMICROB CHEMOTH, V74, P1327, DOI 10.1093/jac/dkz020; [Anonymous], 2004, NEW HIBERNIA REV, V8.1, P9; Ben-Ami R, 2017, EMERG INFECT DIS, V23, P195, DOI 10.3201/eid2302.161486; Blumberg HM, 2001, CLIN INFECT DIS, V33, P177, DOI 10.1086/321811; Bouza E, 2008, INT J ANTIMICROB AG, V32, pS87, DOI 10.1016/S0924-8579(08)70006-2; Chandra J, 2007, INFECT IMMUN, V75, P2612, DOI 10.1128/IAI.01841-06; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2013, EMERG INFECT DIS, V19, P1670, DOI 10.3201/eid1910.130393; Fakhim H, 2018, MYCOSES, V61, P377, DOI 10.1111/myc.12754; Fridkin SK, 1996, CLIN MICROBIOL REV, V9, P499, DOI 10.1128/CMR.9.4.499; Hirschfeld J, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.26102; Jabra-Rizk MA, 2004, EMERG INFECT DIS, V10, P14, DOI 10.3201/eid1001.030119; Jeffery-Smith A, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00029-17; Johnson CJ, 2018, MBIO, V9, DOI [10.1128/mBio.01403-18, 10.1128/mbio.01403-18]; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; Kumar D, 2015, J INFECT DEV COUNTR, V9, P435, DOI 10.3855/jidc.4582; Lee WG, 2011, J CLIN MICROBIOL, V49, P3139, DOI 10.1128/JCM.00319-11; Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691; Magobo RE, 2014, EMERG INFECT DIS, V20, P1250, DOI 10.3201/eid2007.131765; Munoz JF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07779-6; Nucci M, 2001, CLIN INFECT DIS, V33, P1959, DOI 10.1086/323759; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Poissy J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2766-1; Rajendran R, 2016, CLIN MICROBIOL INFEC, V22, P87, DOI 10.1016/j.cmi.2015.09.018; Sarma S, 2013, INDIAN J MED MICROBI, V31, P90, DOI 10.4103/0255-0857.108746; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Sekizuka T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223433; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; The Lancet Public H, 2018, LANCET PUBLIC HEALTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Tian SF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0131-0; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; VERFAILLIE C, 1991, BONE MARROW TRANSPL, V8, P177; Welsh RM, 2017, J CLIN MICROBIOL, V55, P2996, DOI [10.1128/jcm.00921-17, 10.1128/JCM.00921-17]; Williams DW, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22434; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xin H, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00339-19; Yue HZ, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0187-x	38	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243223	10.1371/journal.pone.0243223	http://dx.doi.org/10.1371/journal.pone.0243223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264362	Green Published, gold			2022-12-26	WOS:000596569200001
J	Gong, SZ; Kirmizialtin, S; Chang, A; Mayfield, JE; Zhang, YJ; Johnson, KA				Gong, Shanzhong; Kirmizialtin, Serdal; Chang, Adrienne; Mayfield, Joshua E.; Zhang, Yan Jessie; Johnson, Kenneth A.			Kinetic and thermodynamic analysis defines roles for two metal ions in DNA polymerase specificity and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; PYROPHOSPHATE RELEASE; ACTIVE-SITE; WATER EXCHANGE; MECHANISM; MAGNESIUM; PROTEIN; SELECTIVITY; DYNAMICS; DISCRIMINATION	Magnesium ions play a critical role in catalysis by many enzymes and contribute to the fidelity of DNA polymerases through a two-metal ion mechanism. However, specificity is a kinetic phenomenon and the roles of Mg2+ ions in each step in the catalysis have not been resolved. We first examined the roles of Mg2+ by kinetic analysis of single nucleotide incorporation catalyzed by HIV reverse transcriptase. We show that Mg.dNTP binding induces an enzyme conformational change at a rate that is independent of free Mg2+ concentration. Subsequently, the second Mg2+ binds to the closed state of the enzyme-DNA-Mg.dNTP complex (K-d = 3.7 mM) to facilitate catalysis. Weak binding of the catalytic Mg2+ contributes to fidelity by sampling the correctly aligned substrate without perturbing the equilibrium for nucleotide binding at physiological Mg2+ concentrations. An increase of the Mg2+ concentration from 0.25 to 10 mM increases nucleotide specificity (k(cat)/K-m) 12-fold largely by increasing the rate of the chemistry relative to the rate of nucleotide release. Mg2+ binds very weakly (K-d = 37 mM) to the open state of the enzyme. Analysis of published crystal structures showed that HIV reverse transcriptase binds only two metal ions prior to incorporation of a correct base pair. Molecular dynamics simulations support the two-metal ion mechanism and the kinetic data indicating weak binding of the catalytic Mg2+. Molecular dynamics simulations also revealed the importance of the divalent cation cloud surrounding exposed phosphates on the DNA. These results enlighten the roles of the two metal ions in the specificity of DNA polymerases.	[Gong, Shanzhong; Mayfield, Joshua E.; Zhang, Yan Jessie; Johnson, Kenneth A.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Kirmizialtin, Serdal; Chang, Adrienne] New York Univ Abu Dhabi, Sci Div, Chem Program, Abu Dhabi, U Arab Emirates	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	kajohnson@utexas.edu		Zhang, Yan/0000-0002-9360-5388; Zhang, Yan/0000-0002-1130-0012; Johnson, Kenneth/0000-0002-6575-2823; Chang, Adrienne/0000-0003-3497-1561	Welch Foundation [F-1604]; National Institutes of Health [R01GM114223, R01AI110577, R01GM104896, R01GM125882, AD181]	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grants from the Welch Foundation (F-1604 to K. A. J.), The National Institutes of Health (R01GM114223 and R01AI110577 to K. A. J.; and R01GM104896 and R01GM125882 to Y. J. Z.), and AD181 faculty research grant (to S. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ADAMS JA, 1993, PROTEIN SCI, V2, P2177, DOI 10.1002/pro.5560021217; Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Atis M, 2017, J PHYS CHEM B, V121, P9557, DOI 10.1021/acs.jpcb.7b08320; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bleuzen A, 1997, MAGN RESON CHEM, V35, P765, DOI 10.1002/(SICI)1097-458X(199711)35:11<765::AID-OMR169>3.0.CO;2-F; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cowan JA, 2000, J BIOL INORG CHEM, V5, P67, DOI 10.1007/s007750050009; Cristofaro JV, 2002, BIOCHEMISTRY-US, V41, P10968, DOI 10.1021/bi025871v; Delva P, 2004, J MEMBRANE BIOL, V199, P163, DOI 10.1007/s00232-004-0686-7; Delva P, 1998, LIFE SCI, V62, P2231, DOI 10.1016/S0024-3205(98)00201-X; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Faradjian AK, 2004, J CHEM PHYS, V120, P10880, DOI 10.1063/1.1738640; Fenstermacher KJ, 2011, J BIOL CHEM, V286, P40433, DOI 10.1074/jbc.M111.289850; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Kirmizialtin S, 2012, BIOPHYS J, V102, P829, DOI 10.1016/j.bpj.2011.12.055; Kirmizialtin S, 2011, J PHYS CHEM A, V115, P6137, DOI 10.1021/jp111093c; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Lee Y, 2017, J AM CHEM SOC, V139, P12334, DOI 10.1021/jacs.7b04198; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; MANNING GS, 1984, J PHYS CHEM-US, V88, P6654, DOI 10.1021/j150670a030; Martell L., 1964, STABILITY CONSTANTS; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; NOAT G, 1970, EUR J BIOCHEM, V13, P347, DOI 10.1111/j.1432-1033.1970.tb00937.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Stevens DR, 2018, J AM CHEM SOC, V140, P8965, DOI 10.1021/jacs.8b05177; STORER AC, 1976, BIOCHEM J, V159, P1; Tashiro M, 1997, BIOPHYS J, V73, P3358, DOI 10.1016/S0006-3495(97)78360-7; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tsai MD, 2019, PROTEIN SCI, V28, P288, DOI 10.1002/pro.3542; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; VALBERG LS, 1965, J CLIN INVEST, V44, P379, DOI 10.1172/JCI105151; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Walser M, 1967, Ergeb Physiol, V59, P185; Wennberg CL, 2013, J CHEM THEORY COMPUT, V9, P3527, DOI 10.1021/ct400140n; West AMA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2716389; Yang LJ, 2004, J AM CHEM SOC, V126, P8441, DOI 10.1021/ja049412o; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Yang W, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0118-2	59	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100184	10.1074/jbc.RA120.016489	http://dx.doi.org/10.1074/jbc.RA120.016489			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33310704	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400162
J	Petrozziello, T; Dios, AM; Mueller, KA; Vaine, CA; Hendriks, WT; Glajch, KE; Mills, AN; Mangkalaphiban, K; Penney, EB; Ito, N; Fernandez-Cerado, C; Legarda, GPA; Velasco-Andrada, MS; Acuna, PJ; Ang, MA; Munoz, EL; Diesta, CCE; Macalintal-Canlas, R; Acuna, G; Sharma, N; Ozelius, LJ; Bragg, DC; Sadri-Vakili, G				Petrozziello, Tiziana; Dios, Amanda M.; Mueller, Kaly A.; Vaine, Christine A.; Hendriks, William T.; Glajch, Kelly E.; Mills, Alexandra N.; Mangkalaphiban, Kotchaphorn; Penney, Ellen B.; Ito, Naoto; Fernandez-Cerado, Cara; Legarda, Gierold Paul A.; Velasco-Andrada, M. Salvie; Acuna, Patrick J.; Ang, Mark A.; Munoz, Edwin L.; Diesta, Cid Czarina E.; Macalintal-Canlas, Regina; Acuna, Geraldine; Sharma, Nutan; Ozelius, Laurie J.; Bragg, D. Cristopher; Sadri-Vakili, Ghazaleh			SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; ACETYLTRANSFERASE ACTIVITY; SODIUM PHENYLBUTYRATE; TAF(II)250; GENOME; CELLS; RETROTRANSPOSONS; DEACETYLATION; DYSREGULATION; ACTIVATION	X-linked Dystonia-Parkinsonism (XDP) is a neurodegenerative disease linked to an insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon within an intron of TAF1. This SVA insertion induces aberrant TAF1 splicing and partial intron retention, thereby decreasing levels of the full-length transcript. Here we sought to determine if these altered transcriptional dynamics caused by the SVA are also accompanied by local changes in histone acetylation, given that these modifications influence gene expression. Because TAF1 protein may itself exhibit histone acetyltransferase activity, we also examined whether decreased TAF1 expression in XDP cell lines and post-mortem brain affects global levels of acetylated histone H3 (AcH3). The results demonstrate that total AcH3 are not altered in XDP post-mortem prefrontal cortex or cell lines. We also did not detect local differences in AcH3 associated with TAF1 exons or intronic sites flanking the SVA insertion. There was, however, a decrease in AcH3 association with the exon immediately proximal to the intronic SVA, and this decrease was normalized by CRISPR/Cas-excision of the SVA. Collectively, these data suggest that the SVA insertion alters histone status in this region, which may contribute to the dysregulation of TAF1 expression.	[Petrozziello, Tiziana; Dios, Amanda M.; Mueller, Kaly A.; Glajch, Kelly E.; Mills, Alexandra N.; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Healey Ctr ALS Mass Gen, NeuroEpigenet Lab, Boston, MA 02114 USA; [Vaine, Christine A.; Hendriks, William T.; Mangkalaphiban, Kotchaphorn; Penney, Ellen B.; Ito, Naoto; Acuna, Patrick J.; Acuna, Geraldine; Sharma, Nutan; Ozelius, Laurie J.; Bragg, D. Cristopher] Massachusetts Gen Hosp, Dept Neurol, Collaborat Ctr X Linked Dystonia Parkinsonism, Boston, MA 02114 USA; [Fernandez-Cerado, Cara; Legarda, Gierold Paul A.; Velasco-Andrada, M. Salvie] Sunshine Care Fdn, Roxas City, Capiz, Philippines; [Ang, Mark A.; Munoz, Edwin L.] Univ Philippines, Dept Pathol, Coll Med, Manila, Philippines; [Diesta, Cid Czarina E.; Macalintal-Canlas, Regina] Makati Med Ctr, Dept Neurosci, Makati, Philippines	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of the Philippines System; University of the Philippines Manila; Makati Medical Center	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, Healey Ctr ALS Mass Gen, NeuroEpigenet Lab, Boston, MA 02114 USA.	gsadrivakili@mgh.harvard.edu	Petrozziello, Tiziana/GNM-6238-2022; Bragg, D. Cristopher/AGT-6759-2022	Mangkalaphiban, Kotchaphorn/0000-0002-5341-9329; Petrozziello, Tiziana/0000-0002-5487-1667	 [2015S002822]		GSV was founded by the MGH Collaborative Center for X-linked Dystonia Parkinsonism, https://www.massgeneral.org/neurology/xdp-center (2015S002822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneichyk T, 2018, CELL, V172, P897, DOI 10.1016/j.cell.2018.02.011; [Anonymous], 2011, J DIAGN MED SONOG, V27, P14, DOI 10.1177/8756479310393510; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2018, J EUROPEAN COMPETITI, V9, P579, DOI [10.1093/jeclap/lpy066, DOI 10.1093/JECLAP/LPY066]; Atluri VSR, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00342; Benoy V, 2017, NEUROTHERAPEUTICS, V14, P417, DOI 10.1007/s13311-016-0501-z; Bragg DC, 2019, CURR OPIN NEUROL, V32, P604, DOI 10.1097/WCO.0000000000000708; Bragg DC, 2017, P NATL ACAD SCI USA, V114, pE11020, DOI 10.1073/pnas.1712526114; Brunmeir R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000927; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9; Dios AM, 2019, MUSCLE NERVE, V60, P443, DOI 10.1002/mus.26620; Domingo A, 2015, EUR J HUM GENET, V23, P1334, DOI 10.1038/ejhg.2014.292; Dunphy EL, 2000, MOL CELL BIOL, V20, P1134, DOI 10.1128/MCB.20.4.1134-1139.2000; Fan J, 2016, METHOD ENZYMOL, V574, P125, DOI 10.1016/bs.mie.2016.01.007; Ferrari R, 2020, MOL CELL, V77, P475, DOI 10.1016/j.molcel.2019.10.020; Ganesan A, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0776-0; Gianfrancesco O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235977; Gianfrancesco O, 2017, NEUROPEPTIDES, V64, P3, DOI 10.1016/j.npep.2016.09.006; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Goto S, 2005, ANN NEUROL, V58, P7, DOI 10.1002/ana.20513; Guedes-Dias P, 2015, BBA-MOL BASIS DIS, V1852, P2484, DOI 10.1016/j.bbadis.2015.08.012; Gupta R, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2020.117278; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Herzfeld T, 2007, MAMM GENOME, V18, P787, DOI 10.1007/s00335-007-9063-z; Hilton TL, 2005, MOL CELL BIOL, V25, P4321, DOI 10.1128/MCB.25.10.4321-4332.2005; Hogarth P, 2007, MOVEMENT DISORD, V22, P1962, DOI 10.1002/mds.21632; Ito N, 2016, DIS MODEL MECH, V9, P451, DOI 10.1242/dmm.022590; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kim DS, 2010, INT J MOL MED, V26, P151, DOI 10.3892/ijmm_00000447; Kouzarides T, 2007, CELL, V128, P802, DOI 10.1016/j.cell.2007.02.018; Krosschell KJ, 2018, MUSCLE NERVE, V57, P193, DOI 10.1002/mus.25776; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kwon Yun-Jeong, 2013, Genomics & Informatics, V11, P142, DOI 10.5808/GI.2013.11.3.142; Leaf healthcare, 2015, CISC VIS NETW IND GL, P1; Lee CY, 2019, TOXICOEPIGENETICS: CORE PRINCIPLES AND APPLICATIONS, P3, DOI 10.1016/B978-0-12-812433-8.00001-0; Lee L V, 1976, Adv Neurol, V14, P137; Lee Lillian V, 2011, Int J Neurosci, V121 Suppl 1, P3, DOI 10.3109/00207454.2010.526728; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Valor LM, 2017, ONCOTARGET, V8, P5660, DOI 10.18632/oncotarget.13924; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Park G, 2016, J BIOL CHEM, V291, P3531, DOI 10.1074/jbc.M115.675488; Percharde M, 2018, CELL, V174, P391, DOI 10.1016/j.cell.2018.05.043; Pirooznia SK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00030; Rakovic A, 2018, MOVEMENT DISORD, V33, P1108, DOI 10.1002/mds.27441; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; Robbez-Masson L, 2018, GENOME RES, V28, P836, DOI 10.1101/gr.228171.117; Rossaert E, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0750-2; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Saleh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00894; Savage AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090833; Savage AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-101; Sharma S, 2015, PHARMACOL RES, V100, P157, DOI 10.1016/j.phrs.2015.08.002; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Vaine CA, 2017, NEUROBIOL DIS, V100, P108, DOI 10.1016/j.nbd.2016.12.016; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Wang H, 2014, CELL RES, V24, P1433, DOI 10.1038/cr.2014.148; Wassarman DA, 2001, J CELL SCI, V114, P2895; Westenberger A, 2019, ANN NEUROL, V85, P812, DOI 10.1002/ana.25488; Wood Jason G., 2013, Frontiers in Genetics, V4, P274, DOI 10.3389/fgene.2013.00274; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028	76	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243655	10.1371/journal.pone.0243655	http://dx.doi.org/10.1371/journal.pone.0243655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315879	Green Published, gold			2022-12-26	WOS:000600186100021
J	Zimmermann, GG; Jasper, SP; Kmiecik, LL; Neto, LS; da Silva, TX; Oiole, YA				Zimmermann, Gabriel Ganancini; Jasper, Samir Paulo; Kmiecik, Leonardo Leonidas; Neto, Lauro Strapasson; da Silva, Thiago Xavier; Oiole, Yasser Alabi			Development of test bench to determine the distribution of granular fertilizers in planting rows using spiral roller, two spiral rollers and fluted roller	PLOS ONE			English	Article							SYSTEM	The success of the application of granular fertilizers (GFs) in planting rows depends on the uniformity and performance of product dispensing systems, which are influenced by external factors. The objective of this study was to determine the outflow rates of two GF formulations (GF(1) 04-14-08 and GF(2) 04-30-10) using three types of fertilizer spreader-with one spiral roller (A), two spiral rollers (B), or a fluted roller (C)-and three operating speeds (1,11, 1.94, and 2.77 m s(-1)). The following parameters were determined in GFs: density, angle of repose, water content, and segregation (particle size). In the designed test bench, GFs were transferred from a reservoir to a spreader, and ultimately to a container, where they were weighed, and data were transmitted to the data acquisition system (DAS). A total of 7,560 outflow data points were collected (g s(-1)) and subjected to descriptive analysis of measures of central tendency, dispersion, asymmetry, and kurtosis, and Shewhart control charts were generated. Particle density and segregation were significantly different between the GFs, whereas the angle of repose and water content were not significantly different. The bench design and the DAS allowed measuring the outflow of GFs in different spreaders and demonstrated that this parameter was influenced by particle segregation. The segregation of GF(1) was higher than that of GF(2). The outflow variability at the speed of 1.11 m s(-1) was lower, and the spreader with a fluted roller had the highest uniformity and was the most suitable for application with variable rates.	[Zimmermann, Gabriel Ganancini; Jasper, Samir Paulo; Kmiecik, Leonardo Leonidas; Oiole, Yasser Alabi] Univ Fed Parana, Soil & Engn Dept Agr, Grad Program Soil Sci, Agr Sci Sect, Curitiba, Parana, Brazil; [Neto, Lauro Strapasson; da Silva, Thiago Xavier] Univ Fed Parana, Agron, Gearing Farm Tractor Lab, Agr Sci Sect, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Zimmermann, GG (corresponding author), Univ Fed Parana, Soil & Engn Dept Agr, Grad Program Soil Sci, Agr Sci Sect, Curitiba, Parana, Brazil.	gabrielganancini@gmail.com		Zimmermann, Gabriel/0000-0002-9709-4458				Dalacort R, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113991; Noronha RHD, 2011, BRAGANTIA, V70, P931, DOI 10.1590/S0006-87052011000400028; Franck CJ, 2015, REV BRAS ENG AGR AMB, V19, P512, DOI 10.1590/1807-1929/agriambi.v19n5p512-518; Ministerio da Agricultura, 2017, MAP MAN MET AN OF FE; Osaki M, 2014, AGR SYST, V127, P178, DOI 10.1016/j.agsy.2014.02.002; Roy ED, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.43, 10.1038/nplants.2016.43]; Su N, 2015, INT J AGR BIOL ENG, V8, P19, DOI 10.3965/j.ijabe.20150804.1644; Wijekularathna DK, 2022, COMMUN STAT-SIMUL C, V51, P757, DOI 10.1080/03610918.2019.1658780	8	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243799	10.1371/journal.pone.0243799	http://dx.doi.org/10.1371/journal.pone.0243799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315901	gold, Green Published			2022-12-26	WOS:000600186100001
J	Braun, RG; Kittner, SJ; Ryan, KA; Cole, JW				Braun, Robynne G.; Kittner, Steven J.; Ryan, Kathleen A.; Cole, John W.			Effects of the BDNF Val66Met polymorphism on functional status and disability in young stroke patients	PLOS ONE			English	Article							ISCHEMIC-STROKE; SEX	Background and purpose The preponderance of evidence from recent studies in human subjects supports a negative effect of the BDNF Val66Met polymorphism on motor outcomes and motor recovery. However prior studies have generally reported the effect of the Met allele in older stroke patients, while potential effects in younger stroke patients have remained essentially unexamined. The lack of research in younger patients is significant since aging effects on CNS repair and functional recovery after stroke are known to interact with the effects of genetic polymorphisms. Here we present a study of first-ever ischemic stroke patients aged 15-49 years that examines the effect of Met carrier status on functional disability. Methods 829 patients with a first ischemic stroke (Average age = 41.4 years, SD = 6.9) were recruited from the Baltimore-Washington region. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research (CIDR). Data cleaning and harmonization were done at the GEI-funded GENEVA Coordinating Center at the University of Washington. Our sample contained 165 Met carriers and 664 non-Met carriers. Modified Rankin scores as recorded at discharge were obtained from the hospital records by study personnel blinded to genotype, and binarized into "Good" versus "Poor" outcomes (mRS 0-2 vs. 3+), with mRS scores 3+ reflecting a degree of disability that causes loss of independence. Results Our analysis showed that the Met allele conveyed a proportionally greater risk for poor outcomes and disability-related loss of independence with mRS scores 3+ (adjusted OR 1.73, 95% CI 1.13-2.64, p = 0.01). Conclusions The BDNF Val66Met polymorphism was negatively associated with functional outcomes at discharge in our sample of 829 young stroke patients. This finding stands in contrast to what would be predicted under the tenets of the resource modulation hypothesis (i.e. that younger patients would be spared from the negative effect of the Met allele on recovery since it is posited to arise as a manifestation of age-related decline in physiologic resources).	[Braun, Robynne G.; Kittner, Steven J.; Cole, John W.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Kittner, Steven J.; Ryan, Kathleen A.; Cole, John W.] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Braun, RG (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	robynne.braun@umm.edu	Braun, Robynne/AAD-5391-2021	Braun, Robynne/0000-0002-3579-6665	NIH National Center for Medical Rehabilitation Research [K12HD093427]; NIH National Institute of Neurological Disorders and Stroke [R01NS45012, R01NS105150]; American Heart Association [17IBDG33700328]; Bayer Pharmaceuticals [17IBDG33700328]	NIH National Center for Medical Rehabilitation Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Bayer Pharmaceuticals(Bayer AG)	RGB: Grant #K12HD093427, NIH National Center for Medical Rehabilitation Research (https://www.nichd.nih.gov/about/org/ncmrr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJK: Grant #R01NS45012 and Grant #R01NS105150, NIH National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JWC: Grant #17IBDG33700328, American Heart Association and Bayer Pharmaceuticals. (https://www.heart.org/en/professional/institute/grants/aha-bayer-innovation-and-discovery-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJK, JWC and KAR: This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System, Baltimore, Maryland. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Balkaya M, 2019, NEUROBIOL DIS, V126, P36, DOI 10.1016/j.nbd.2018.08.009; Begliuomini S, 2007, HUM REPROD, V22, P995, DOI 10.1093/humrep/del479; Charalambous CC, 2018, J PHYSIOL-LONDON, V596, P1999, DOI 10.1113/JP275881; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; French MA, 2018, TOP STROKE REHABIL, V25, P276, DOI 10.1080/10749357.2018.1437938; Fridriksson J, 2018, BRAIN STIMUL, V11, P1276, DOI 10.1016/j.brs.2018.08.009; Helm EE, 2016, EXP BRAIN RES, V234, P341, DOI 10.1007/s00221-015-4465-8; Kennedy KM, 2015, BRAIN RES, V1612, P104, DOI 10.1016/j.brainres.2014.09.044; Kim DY, 2016, PHYS THER, V96, P533, DOI 10.2522/ptj.20150135; Kim EJ, 2016, EUR J NEUROL, V23, P76, DOI 10.1111/ene.12791; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Mirowsha-Guzel D, 2014, TOP STROKE REHABIL, V21, pS33, DOI 10.1310/tsr21S1-S33; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Shiner CT, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00069; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Spencer-Segal JL, 2011, J NEUROSCI, V31, P6780, DOI 10.1523/JNEUROSCI.0910-11.2011; Tsai SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00156; van der Vliet R, 2017, BRAIN STIMUL, V10, P882, DOI 10.1016/j.brs.2017.07.004	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0237033	10.1371/journal.pone.0237033	http://dx.doi.org/10.1371/journal.pone.0237033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306691	gold, Green Published			2022-12-26	WOS:000600144200035
J	Chiu, TJ; Chen, YJ; Kuo, FY; Chen, YY				Chiu, Tai-Jan; Chen, Yi-Ju; Kuo, Fang-Ying; Chen, Yen-Yang			Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma	PLOS ONE			English	Article							HEPATIC RESECTION; CARCINOMA; PROGNOSIS; INFLAMMATION; FEATURES; CANCER; RECURRENCE; PATTERNS; SYSTEM; IMPACT	Objectives Although elevated neutrophil-to-lymphocyte ratio (NLR) has been associated with survival in some liver cancers, its prognostic relevance has not been studied in the context of combined hepatocellular cholangiocarcinoma CHCC-CC, a rare primary liver cancer. We investigated whether elevated NLR and a predominance of cholangiocarcinoma might predict poor prognosis in patients with resectable CHCC-CC. Methods We retrospectively reviewed the clinicopathologic data of forty-two patients with CHCC-CC receiving hepatectomies at our hospital. We used Kaplan-Meier and Cox regression to analyze survival. Results Two-year disease-free survival and five-year overall survival rates were 43.2% and 32.9%, respectively. Univariate analyses showed that patients with NLR >= 3 had significantly worse 2-year DFS and 5-year OS rates. Univariant Kaplan-Meier survival analysis also associated these rates with a predominance in intrahepatic cholangiocarcinoma, AJCC tumor stage, pathological T stage and lymph-vascular invasion. However, our multivariate analysis found NLR >= 3 to be the only independent predictor of disease recurrence and poorer survival. Conclusions Neutrophil-to-lymphocyte ratio was the most important independent predictor of poorer survival in patients with resectable CHCC-CC. Predominance of intrahepatic cholangiocarcinoma, advanced AJCC tumor stage and pathological T stage, and lymph-vascular invasion also may affect poor prognosis in patients receiving complete tumor resections.	[Chiu, Tai-Jan; Chen, Yen-Yang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Chiu, Tai-Jan; Chen, Yen-Yang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chiu, Tai-Jan; Chen, Yen-Yang] Kaohsiung Chang Gung Mem Hosp, Canc Ctr, Kaohsiung Chang Gung Cholangiocarcinoma & Pancrea, Kaohsiung, Taiwan; [Chiu, Tai-Jan] Chang Gung Univ, Inst Clin Med Sci, Kaohsiung, Taiwan; [Chen, Yi-Ju] I Shou Univ, E Da Hosp, Dept Anat Pathol, Kaohsiung, Taiwan; [Kuo, Fang-Ying] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung University	Chen, YY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan.; Chen, YY (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chen, YY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Canc Ctr, Kaohsiung Chang Gung Cholangiocarcinoma & Pancrea, Kaohsiung, Taiwan.	chen.y9964@gmail.com			Kaohsiung Chang Gung Memorial Hospital Taiwan [CMRPG8E0811/0812/0813, CMRPG8C0531, CMRPG8D0801]	Kaohsiung Chang Gung Memorial Hospital Taiwan	This study was funded by grant obtained by Dr. Yen-Yang Chen from Kaohsiung Chang Gung Memorial Hospital Taiwan (Grant nos. CMRPG8E0881, CMRPG8F1771/1772). This study was also funded by grants obtained by Dr. Tai-Jan Chiu from Kaohsiung Chang Gung Memorial Hospital Taiwan (Grant CMRPG8E0811/0812/0813, CMRPG8C0531 and CMRPG8D0801).	ALLEN RA, 1949, AM J PATHOL, V25, P647; [Anonymous], 2007, REV GERMANIQUE INT, VVI, P161; [Anonymous], 1998, CONTINUITY CHANGE, V13, P34; ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO;2-T; Ariizumi S, 2012, ANN SURG ONCOL, V19, P1628, DOI 10.1245/s10434-011-2150-0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Borsig L, 2014, ONCOGENE, V33, P3217, DOI 10.1038/onc.2013.272; Brunt E, 2018, HEPATOLOGY, V68, P113, DOI 10.1002/hep.29789; Chen Q, 2015, TUMOR BIOL, V36, P5283, DOI 10.1007/s13277-015-3188-6; Chok KSH, 2009, WORLD J SURG, V33, P1916, DOI 10.1007/s00268-009-0112-5; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; De Lu C, 2016, J GASTROEN HEPATOL, V31, P1330, DOI 10.1111/jgh.13309; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Feng F, 2017, ONCOTARGET, V8, P5281, DOI 10.18632/oncotarget.14136; Gomez D, 2008, J SURG ONCOL, V97, P513, DOI 10.1002/jso.21001; GOODMAN ZD, 1985, CANCER-AM CANCER SOC, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z; He CB, 2018, ONCOL LETT, V15, P4262, DOI 10.3892/ol.2018.7882; Ikai I, 2004, CANCER-AM CANCER SOC, V101, P796, DOI 10.1002/cncr.20426; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jaiswal M, 2000, CANCER RES, V60, P184; Jarnagin WR, 2002, CANCER-AM CANCER SOC, V94, P2040, DOI 10.1002/cncr.10392; Kassahun WT, 2008, INT J CLIN PRACT, V62, P1271, DOI 10.1111/j.1742-1241.2007.01694.x; Lee JH, 2011, J CLIN GASTROENTEROL, V45, P69, DOI 10.1097/MCG.0b013e3181ce5dfa; Lee SD, 2014, HEPATOB PANCREAT DIS, V13, P594, DOI 10.1016/S1499-3872(14)60275-7; Lee WS, 2006, SURG TODAY, V36, P892, DOI 10.1007/s00595-006-3276-8; Li SH, 2017, WORLD J GASTROENTERO, V23, P3122, DOI 10.3748/wjg.v23.i17.3122; Liu CL, 2003, ARCH SURG-CHICAGO, V138, P86, DOI 10.1001/archsurg.138.1.86; Liver Cancer Study Group of Japan, 1990, Ann Surg, V211, P277; Ma MC, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4146-7; MAEDA T, 1995, HUM PATHOL, V26, P956, DOI 10.1016/0046-8177(95)90084-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Omichi K, 2017, SURGERY, V162, P752, DOI 10.1016/j.surg.2017.05.015; Sanada Y, 2005, HEPATOL RES, V32, P185, DOI 10.1016/j.hepres.2005.04.003; Shin CI, 2007, J COMPUT ASSIST TOMO, V31, P109, DOI 10.1097/01.rct.0000235072.34808.9b; Taguchi J, 1996, J GASTROEN HEPATOL, V11, P758, DOI 10.1111/j.1440-1746.1996.tb00327.x; Tang D, 2006, J GASTROINTEST SURG, V10, P987, DOI 10.1016/j.gassur.2006.01.018; Wang YJ, 2018, INT J SURG, V55, P73, DOI 10.1016/j.ijsu.2018.05.022; Yano Y, 2003, JPN J CLIN ONCOL, V33, P283, DOI 10.1093/jjco/hyg056; Yin X, 2012, ANN SURG ONCOL, V19, P2869, DOI 10.1245/s10434-012-2328-0	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240791	10.1371/journal.pone.0240791	http://dx.doi.org/10.1371/journal.pone.0240791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306714	Green Published, gold			2022-12-26	WOS:000600144200001
J	Shi, Y; Gong, WH; Gong, XR; Wang, P; Zhao, X				Shi, Ying; Gong, Weihua; Gong, Xiangrong; Wang, Ping; Zhao, Xin			Genome-wide DNA methylation analysis of breast cancer MCF-7 / Taxol cells with MeDIP-Seq	PLOS ONE			English	Article							IMMUNOPRECIPITATION MEDIP; MIGRATION	Breast cancer (BC) is the most frequently diagnosed tumor in women worldwide. Although the combination of surgery and Taxol chemotherapy can achieve a certain therapeutic effect, patients often develop drug-resistance, resulting in a poor prognosis. Therefore, it is significative to seek the molecular mechanism of chemotherapy resistance. Recent studies have found that abnormal epigenetic regulation in breast cells changes the expression of key genes, which can lead to the occurrence, development, and maintenance of cancer, even related to the development of drug-resistance. Therefore, in this study, we performed methylated DNA immunoprecipitation-sequencing (MeDIP-seq) to reveal the difference in methylation between breast cancer drug-resistant cells and sensitive cells. A total of 55076 differentially methylated genes (DMGs) were detected, including 21061 hypermethylated DMGs and 34015 hypomethylated DMGs. Moreover, Gene Ontology (GO) analysis and KEGG pathway analysis reveal the function and pathway of screening genes. These results indicate that DNA methylation may be involved in regulating the occurrence and development of breast cancer.	[Shi, Ying; Gong, Weihua; Wang, Ping] Zhengzhou Univ, Clin Lab, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Gong, Xiangrong] Zhengzhou Univ, Internal Med Dept, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhao, Xin] Zhengzhou Univ, Dept Radiol, Affiliated Hosp 3, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhao, X (corresponding author), Zhengzhou Univ, Dept Radiol, Affiliated Hosp 3, Zhengzhou, Peoples R China.	zdsfyzx@zzu.edu.cn			key scientific research project plan of colleges and universities in Henan Province [19A320055]	key scientific research project plan of colleges and universities in Henan Province	This work is supported by the key scientific research project plan of colleges and universities in Henan Province. The project number is: 19A320055. The project name is: The mechanism of pyroptosis in drug resistance of breast tumor cells.	Al Emran A, 2019, TRENDS IMMUNOL, V40, P328, DOI 10.1016/j.it.2019.02.004; [Anonymous], 2001, PALESTINE ISRAEL J, VViii, P115; [Anonymous], 2019, CIRCULATION, V2019; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Castroviejo-Bermejo M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809172; Chen JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126403; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Du Q, 2009, ONCOL REP, V22, P659, DOI 10.3892/or_00000486; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gomez-Miragaya J, 2019, MOL CANCER RES, V17, P2063, DOI 10.1158/1541-7786.MCR-19-0040; Gonzalez N, 2017, CELL SIGNAL, V30, P154, DOI 10.1016/j.cellsig.2016.12.002; Gradishar WJ, 2016, J NATL COMPR CANC NE, V14, P324, DOI 10.6004/jnccn.2016.0037; Gusyatiner O, 2018, SEMIN CANCER BIOL, V51, P50, DOI 10.1016/j.semcancer.2017.11.010; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Kanwal R, 2015, METHODS MOL BIOL, V1238, P3, DOI 10.1007/978-1-4939-1804-1_1; Li QJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15308-7; Liu XY, 2018, THERANOSTICS, V8, P6386, DOI 10.7150/thno.29164; Lo PK, 2008, PHARMACOGENOMICS, V9, P1879, DOI 10.2217/14622416.9.12.1879; Luo XG, 2014, CANCER LETT, V344, P129, DOI 10.1016/j.canlet.2013.10.026; Matveev I, 2017, SOCIOL OBOZR, V16, P29, DOI 10.17323/1728-192X-2017-2-29-53; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Olova N, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1408-2; Paul MR, 2020, J CLIN INVEST, V130, P4252, DOI 10.1172/JCI129941; Pettitt SJ, 2019, CURR OPIN GENET DEV, V54, P55, DOI 10.1016/j.gde.2019.03.001; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Scarano MI, 2005, J CELL PHYSIOL, V204, P21, DOI 10.1002/jcp.20280; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Turnham DJ, 2020, CARCINOGENESIS, V41, P1432, DOI 10.1093/carcin/bgaa005; Wang B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4711-0; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weng YI, 2009, METHODS MOL BIOL, V590, P165, DOI 10.1007/978-1-60327-378-7_10; Yotani T, 2018, CANCER SCI, V109, P1690, DOI 10.1111/cas.13566; Yu J, 2018, J CLIN INVEST, V128, P2376, DOI 10.1172/JCI97924; Yu PA, 2019, ACTA PHARMACOL SIN, V40, P1237, DOI 10.1038/s41401-019-0222-z; Zhang F, 2019, ONCOL LETT, V18, P1287, DOI 10.3892/ol.2019.10405; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong P, 2020, MOL PHARMACEUT, V17, P1114, DOI 10.1021/acs.molpharmaceut.9b01148	43	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0241515	10.1371/journal.pone.0241515	http://dx.doi.org/10.1371/journal.pone.0241515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306680	gold, Green Published			2022-12-26	WOS:000600144200009
J	Drozd, D; Wolf, H; Stemme, T				Drozd, Denise; Wolf, Harald; Stemme, Torben			Structure of the pecten neuropil pathway and its innervation by bimodal peg afferents in two scorpion species	PLOS ONE			English	Article							SPIDER CUPIENNIUS-SALEI; CENTRAL-NERVOUS-SYSTEM; ELAPHUS POCOCK ARACHNIDA; CENTRAL PROJECTIONS; OLFACTORY SYSTEMS; SENSORY NEURONS; FORELEGS WHIPS; ANTENNAL LOBE; MECHANOSENSORY NEURONS; CONTACT CHEMORECEPTION	The pectines of scorpions are comb-like structures, located ventrally behind the fourth walking legs and consisting of variable numbers of teeth, or pegs, which contain thousands of bimodal peg sensillae. The associated neuropils are situated ventrally in the synganglion, extending between the second and fourth walking leg neuromeres. While the general morphology is consistent among scorpions, taxon-specific differences in pecten and neuropil structure remain elusive but are crucial for a better understanding of chemosensory processing. We analysed two scorpion species (Mesobuthus eupeus and Heterometrus petersii) regarding their pecten neuropil anatomy and the respective peg afferent innervation with anterograde and lipophilic tracing experiments, combined with immunohistochemistry and confocal laser-scanning microscopy. The pecten neuropils consisted of three subcompartments: a posterior pecten neuropil, an anterior pecten neuropil and a hitherto unknown accessory pecten neuropil. These subregions exhibited taxon-specific variations with regard to compartmentalisation and structure. Most notable were structural differences in the anterior pecten neuropils that ranged from ovoid shape and strong fragmentation in Heterometrus petersii to elongated shape with little compartmentalisation in Mesobuthus eupeus. Labelling the afferents of distinct pegs revealed a topographic organisation of the bimodal projections along a medio-lateral axis. At the same time, all subregions along the posterior-anterior axis were innervated by a single peg's afferents. The somatotopic projection pattern of bimodal sensillae appears to be common among arachnids, including scorpions. This includes the structure and organisation of the respective neuropils and the somatotopic projection patterns of chemosensory afferents. Nonetheless, the scorpion pecten pathway exhibits unique features, e.g. glomerular compartmentalisation superimposed on somatotopy, that are assumed to allow high resolution of substrate-borne chemical gradients.	[Drozd, Denise; Wolf, Harald; Stemme, Torben] Univ Ulm, Inst Neurobiol, Ulm, Germany	Ulm University	Drozd, D; Wolf, H; Stemme, T (corresponding author), Univ Ulm, Inst Neurobiol, Ulm, Germany.	denise.drozd@uni-ulm.de; harald.wolf@uni-ulm.de; torben.stemme@uni-ulm.de		Drozd, Denise/0000-0002-0607-1665	German Science Foundation, Deutsche Forschungsgemeinschaft [STE2826-1-1]	German Science Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	TS and HW were funded by the German Science Foundation, Deutsche Forschungsgemeinschaft, grant STE2826-1-1 (https://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Ai H, 2007, J COMP NEUROL, V502, P1030, DOI 10.1002/cne.21341; AKKERHUIS G J O, 1985, Experimental and Applied Acarology, V1, P235, DOI 10.1007/BF01198521; [Anonymous], 1999, VIERTELJAHRSHEFTE ZE, V47, P401; ANTON S, 1994, CELL TISSUE RES, V278, P399; ANTON S, 1993, ZOOMORPHOLOGY, V113, P21, DOI 10.1007/BF00430974; Babu K. S., 1965, Zoologische Jahrbuecher (Anatomie), V82, P1; Babu K.S., 1985, P3; BABU KS, 1993, J BIOSCIENCES, V18, P247, DOI 10.1007/BF02703122; BABU KS, 1989, CELL TISSUE RES, V258, P69, DOI 10.1007/BF00223146; Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; Barth FG, 2002, SPIDERS WORLD; BAUCHHENSS E, 1983, INT J INSECT MORPHOL, V12, P129, DOI 10.1016/0020-7322(83)90005-3; BROWNELL P, 1988, CHEM SENSES, V13, P677; BROWNELL PH, 1974, TISSUE CELL, V6, P471, DOI 10.1016/0040-8166(74)90039-1; Brownell PH, 1998, ANN NY ACAD SCI, V855, P502, DOI 10.1111/j.1749-6632.1998.tb10614.x; CARTHY JD, 1966, EXPERIENTIA, V22, P89, DOI 10.1007/BF01900166; CLOUDSLEY-THOMPSON J. L., 1955, ANN AND MAG NAT HIST, V8, P556; Cushing PE, 2012, J ARACHNOL, V40, P123, DOI 10.1636/B11-71.1; Derby CD, 2016, CHEM SENSES, V41, P381, DOI 10.1093/chemse/bjw057; Dethier VG, 1947, REV ENTOMOL, V1, P181; Drozd D., 2019, TOPOGRAPHIC ORG PECT; DUYJACQUEMIN MN, 1991, INT J INSECT MORPHOL, V20, P205, DOI 10.1016/0020-7322(91)90010-7; EDGECOMB RS, 1992, J COMP NEUROL, V315, P431, DOI 10.1002/cne.903150406; Eisenbeis G, 1987, ATLAS BIOL SOIL, DOI [10.1007/978-3-642-72634-7, DOI 10.1007/978-3-642-72634-7]; Eisthen HL, 2002, BRAIN BEHAV EVOLUT, V59, P273, DOI 10.1159/000063564; Fabian-Fine R, 1999, CELL TISSUE RES, V295, P13, DOI 10.1007/s004410051208; Borges LMF, 2016, REV BRAS PARASITOL V, V25, P217, DOI 10.1590/S1984-29612016039; Fet V, 1998, J ARID ENVIRON, V39, P609, DOI 10.1006/jare.1997.0386; Fet Victor, 2006, Boletin de la SEA, P269; Foelix R., 1983, Bulletin of the British Arachnological Society, V6, P68; Foelix R.F., 1985, P118; Foelix R.F., 1983, Bulletin of the British Arachnological Society, V6, P53; Foelix Rainer, 2001, Andrias, V15, P129; FOELIX RF, 1970, J EXP ZOOL, V175, P99, DOI 10.1002/jez.1401750106; Gaffin D, 2001, SCORPION BIOLOGY AND RESEARCH, P184; Gaffin DD, 2002, MICROSC RES TECHNIQ, V58, P325, DOI 10.1002/jemt.10140; Gaffin DD, 1997, J COMP PHYSIOL A, V181, P291, DOI 10.1007/s003590050115; GAFFIN DD, 1992, ETHOLOGY, V91, P59; Gaffin DD., 1994, THESIS; Gaffin DD, 2017, J ARACHNOL, V45, P265, DOI 10.1636/JoA-S-16-070.1; Gaffin DD, 2012, ANIM BEHAV, V83, P429, DOI 10.1016/j.anbehav.2011.11.014; Gainett G, 2017, ARTHROPOD STRUCT DEV, V46, P178, DOI 10.1016/j.asd.2016.12.005; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Galizia CG, 2000, CURR OPIN NEUROBIOL, V10, P504, DOI 10.1016/S0959-4388(00)00109-4; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GORB SN, 1993, J MORPHOL, V217, P129, DOI 10.1002/jmor.1052170202; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; Hallberg E, 1999, MICROSC RES TECHNIQ, V47, P428, DOI 10.1002/(SICI)1097-0029(19991215)47:6<428::AID-JEMT6>3.0.CO;2-P; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hansson Bill S., 1999, P125; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Harzsch S, 2018, PROG NEUROBIOL, V161, P23, DOI 10.1016/j.pneurobio.2017.11.005; Harzsch S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-58; HAUPT J, 1982, ROUX ARCH DEV BIOL, V191, P137, DOI 10.1007/BF00848452; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Hughes KL, 2019, INVERTEBR NEUROSCI, V19, DOI 10.1007/s10158-019-0228-8; Hummel NA, 2007, EXP APPL ACAROL, V43, P265, DOI 10.1007/s10493-007-9120-z; IGELMUND P, 1987, J MORPHOL, V193, P75, DOI 10.1002/jmor.1051930108; IGELMUND P, 1991, J COMP PHYSIOL A, V168, P63, DOI 10.1007/BF00217104; IGELMUND P, 1991, J COMP PHYSIOL A, V168, P75, DOI 10.1007/BF00217105; Ignell R, 2001, BRAIN BEHAV EVOLUT, V57, P1, DOI 10.1159/000047222; Ivanov V., 1979, FAUNA ECOLOGY ARACHN, P73; Jackson G. J., 1974, Acarologia, V16, P583; Jedrzejowska I, 2016, ARTHROPOD STRUCT DEV, V45, P488, DOI 10.1016/j.asd.2016.09.001; KENT KS, 1988, J COMP NEUROL, V271, P559, DOI 10.1002/cne.902710407; Kladt N, 2007, J COMP PHYSIOL A, V193, P1033, DOI 10.1007/s00359-007-0254-6; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Klann AE, 2008, ARTHROPOD STRUCT DEV, V37, P3, DOI 10.1016/j.asd.2007.04.001; Knowlton ED, 2011, J COMP PHYSIOL A, V197, P895, DOI 10.1007/s00359-011-0650-9; KRAPF D, 1986, ZOOL ANZ, V217, P119; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Krieger J, 2015, PEERJ, V3, DOI 10.7717/peerj.1433; Kvello P, 2010, J NEUROPHYSIOL, V103, P2965, DOI 10.1152/jn.00985.2009; LEVINE RB, 1985, J COMP PHYSIOL A, V157, P1; Loesel Rudolf, 2013, P299; MAHSBERG D, 1990, Acta Zoologica Fennica, P267; Matsubayashi Y, 2008, J NEUROSCI METH, V174, P71, DOI 10.1016/j.jneumeth.2008.07.003; Maurer M, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0151-1; Mellon D, 2012, J EXP BIOL, V215, P2163, DOI 10.1242/jeb.069492; Melville J.M., 2000, DISSERTATION; Melville JM, 2003, J INSECT BEHAV, V16, P97, DOI 10.1023/A:1022853413104; Mineo MF, 2006, ACTA ETHOL, V9, P79, DOI 10.1007/s10211-006-0021-7; MORO SD, 1985, MONIT ZOOL ITAL, V19, P207; Musaelian A., 2020, BIORXIV, DOI [10.1101/2020.06.17.156612, DOI 10.1101/2020.06.17.156612]; NEWLAND PL, 1991, J COMP NEUROL, V312, P493, DOI 10.1002/cne.903120402; Newland PL, 2000, J COMP NEUROL, V425, P82; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; OBENCHAIN FD, 1974, J MORPHOL, V142, P205, DOI 10.1002/jmor.1051420207; PETERSON BA, 1988, J COMP NEUROL, V275, P128, DOI 10.1002/cne.902750111; PFLUGER HJ, 1988, PHILOS T R SOC B, V321, P1, DOI 10.1098/rstb.1988.0090; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; Prevost ED, 2020, ANIM COGN, V23, P1215, DOI 10.1007/s10071-020-01386-z; Punzo Fred, 1998, Bulletin of the British Arachnological Society, V11, P111; Rogers SM, 2003, ADV INSECT PHYSIOL, V31, P141, DOI 10.1016/S0065-2806(03)31003-3; Ruano F, 2000, BEHAV ECOL, V11, P396, DOI 10.1093/beheco/11.4.396; Ruhlemann H, 1908, Z WISS ZOOL ABT A, V91, P599; Runia E, 2006, HIST THEORY, V45, P1, DOI 10.1111/j.1468-2303.2006.00346.x; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; SCHMIDT M, 1992, J COMP NEUROL, V318, P277, DOI 10.1002/cne.903180305; Sharma PP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2953; SHULTZ JW, 1989, ZOOL J LINN SOC-LOND, V97, P1, DOI 10.1111/j.1096-3642.1989.tb00552.x; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; Sombke A, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0137-z; Sombke A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-1; Sombke A, 2011, CHEM SENSES, V36, P43, DOI 10.1093/chemse/bjq096; Stegner MEJ, 2011, ARTHROPOD STRUCT DEV, V40, P221, DOI 10.1016/j.asd.2011.04.001; Steinbrecht R.A., 1987, P353; Steinmetz Steffany B., 2004, Euscorpius, V12-17, P1; Stemme T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-119; Stemme T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-168; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Strausfeld N, 2009, ANN NY ACAD SCI, V1170, P487, DOI 10.1111/j.1749-6632.2009.04020.x; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; TICHY H, 1992, MICROSC RES TECHNIQ, V22, P372, DOI 10.1002/jemt.1070220406; Tuchina O, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00094; van Wijk M, 2006, EXP APPL ACAROL, V40, P217, DOI 10.1007/s10493-006-9038-x; Vj R, 2014, J CLIN DIAGN RES, V8, P25; Weygoldt P., 2000, THEIR BIOL MORPHOLOG; Willemart RH, 2007, ENTOMOL EXP APPL, V123, P73, DOI 10.1111/j.1570-7458.2007.00527.x; Willemart RH, 2009, ACTA ZOOL-STOCKHOLM, V90, P209, DOI 10.1111/j.1463-6395.2008.00341.x; Wlllemart RH, 2004, ZOOL ANZ, V242, P353, DOI 10.1078/0044-5231-00109; Wolf H, 2008, ARTHROPOD STRUCT DEV, V37, P67, DOI 10.1016/j.asd.2007.05.003; Wolf H, 2017, ARTHROPOD STRUCT DEV, V46, P753, DOI 10.1016/j.asd.2017.10.002; Wolf H, 2012, ZOOLOGY, V115, P151, DOI 10.1016/j.zool.2011.10.002; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331	127	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243753	10.1371/journal.pone.0243753	http://dx.doi.org/10.1371/journal.pone.0243753			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301509	Green Published, gold			2022-12-26	WOS:000600143100023
J	Lucidarme, J; Zhu, BQ; Xu, L; Bai, XL; Gao, Y; Gonzalez-Lopez, JJ; Mulhall, R; Scott, KJ; Smith, A; Stefanelli, P; Stenmark, B; Torpiano, P; Tzanakaki, G; Borrow, R; Shao, ZJ				Lucidarme, Jay; Zhu, Bingqing; Xu, Li; Bai, Xilian; Gao, Yuan; Jose Gonzalez-Lopez, Juan; Mulhall, Robert; Scott, Kevin J.; Smith, Andrew; Stefanelli, Paola; Stenmark, Bianca; Torpiano, Paul; Tzanakaki, Georgina; Borrow, Ray; Shao, Zhujun			Genomic analysis of the meningococcal ST-4821 complex-Western clade, potential sexual transmission and predicted antibiotic susceptibility and vaccine coverage	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; SEROGROUP-B; CIPROFLOXACIN-RESISTANT; CHINA; EMERGENCE; CARRIAGE; STRAINS; PROTEIN	Introduction The ST-4821 complex (cc4821) is a leading cause of serogroup C and serogroup B invasive meningococcal disease in China where diverse strains in two phylogenetic groups (groups 1 and 2) have acquired fluoroquinolone resistance. cc4821 was recently prevalent among carriage isolates in men who have sex with men in New York City (USA). Genome-level population studies have thus far been limited to Chinese isolates. The aim of the present study was to build upon these with an extended panel of international cc4821 isolates. Methods Genomes of isolates from Asia (1972 to 2017), Europe (2011 to 2018), North America (2007), and South America (2014) were sequenced or obtained from the PubMLST Neisseria database. Core genome comparisons were performed in PubMLST. Results Four lineages were identified. Western isolates formed a distinct, mainly serogroup B sublineage with alleles associated with fluoroquinolone susceptibility (MIC <0.03 mg/L) and reduced penicillin susceptibility (MIC 0.094 to 1 mg/L). A third of these were from anogenital sites in men who have sex with men and had unique denitrification gene alleles. Generally 4CMenB vaccine strain coverage was reliant on strain-specific NHBA peptides. Discussion The previously identified cc4821 group 2 was resolved into three separate lineages. Clustering of western isolates was surprising given the overall diversity of cc4821. Possible association of this cluster with the anogenital niche is worthy of monitoring given concerns surrounding antibiotic resistance and potential subcapsular vaccine escape.	[Lucidarme, Jay; Bai, Xilian; Borrow, Ray] Manchester Royal Infirm, Meningococcal Reference Unit, Publ Hlth England, Manchester, Lancs, England; [Zhu, Bingqing; Xu, Li; Gao, Yuan; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Jose Gonzalez-Lopez, Juan] Hosp Univ Vail dHebron, Dept Clin Microbiol, Barcelona, Spain; [Mulhall, Robert] Childrens Hlth Ireland, Irish Meningitis & Sepsis Reference Lab, Temple St, Dublin, Ireland; [Scott, Kevin J.; Smith, Andrew] Glasgow Royal Infirm, Bacterial Resp Infect Serv, Scottish Microbiol Reference Lab, Glasgow, Lanark, Scotland; [Smith, Andrew] Univ Glasgow, Glasgow Dent Hosp & Sch, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Stefanelli, Paola] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Stenmark, Bianca] Orebro Univ, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Torpiano, Paul] Mater Dei Hosp, Dept Child & Adolescent Hlth, Msida, Malta; [Tzanakaki, Georgina] Univ West Attica, Sch Publ Hlth, Dept Publ Hlth Policy, Natl Meningitis Reference Lab, Athens, Greece	Public Health England; University of Manchester; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Glasgow; University of Glasgow; Istituto Superiore di Sanita (ISS); Orebro University; University of West Attica	Lucidarme, J (corresponding author), Manchester Royal Infirm, Meningococcal Reference Unit, Publ Hlth England, Manchester, Lancs, England.; Shao, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	jay.lucidarme@phe.gov.uk; shaozhujun@icdc.cn	STEFANELLI, PAOLA/B-8729-2016; Stenmark, Bianca/HHZ-7971-2022; González-López, Juanjo/C-5366-2014; Tzanakaki, Georgina/AAZ-6598-2021	STEFANELLI, PAOLA/0000-0003-1620-4385; Stenmark, Bianca/0000-0003-4637-8626; González-López, Juanjo/0000-0003-2419-5909; Scott, Kevin/0000-0003-3338-9967	National Key Program for Infectious Disease of China [2013ZX10004221, 2018ZX10714002-001]	National Key Program for Infectious Disease of China	This work was supported by grants (ZS) from the National Key Program for Infectious Disease of China (contract no. 2013ZX10004221 and 2018ZX10714002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, HIST NEWS, V74, P22; [Anonymous], 2012, CLIN EXP RHEUMAT S70, V30, pS77; Belkacem N, 2016, ANTIMICROB AGENTS CH, V60, P4023, DOI 10.1128/AAC.00378-16; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Brooks A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.15.2000375; Chiou CS, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-25; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Guo QL, 2018, EMERG INFECT DIS, V24, P683, DOI 10.3201/eid2404.171744; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrison LH, 2015, J INFECT DIS, V211, P1761, DOI 10.1093/infdis/jiu679; Harrison OB, 2017, SEX TRANSM INFECT, V93, P445, DOI 10.1136/sextrans-2016-052781; He BH, 2014, INT J INFECT DIS, V29, P113, DOI 10.1016/j.ijid.2014.08.022; Hong E, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00831-18, 10.1128/aac.00831-18]; Hong E, 2013, ANTIMICROB AGENTS CH, V57, P1961, DOI 10.1128/AAC.02184-12; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395; Lucidarme J, 2017, J INFECTION, V75, P95, DOI 10.1016/j.jinf.2017.05.015; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P1002, DOI 10.1128/CVI.00055-11; Ma KC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17980-1; McNamara LA, 2020, MMWR-MORBID MORTAL W, V69, P735, DOI 10.15585/mmwr.mm6924a2; McNeil LK, 2018, MBIO, V9, DOI 10.1128/mBio.00036-18; Muzzi A, 2019, VACCINE, V37, P991, DOI 10.1016/j.vaccine.2018.12.061; Ngai S, 2020, SEX TRANSM DIS, V47, P541, DOI 10.1097/OLQ.0000000000001205; Retchless AC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4560-x; Shao ZJ, 2006, LANCET, V367, P419, DOI 10.1016/S0140-6736(06)68141-5; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Moura ARSS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185038; Taha MK, 2007, ANTIMICROB AGENTS CH, V51, P2784, DOI 10.1128/AAC.00412-07; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Tsang RSW, 2017, CAN J MICROBIOL, V63, P265, DOI 10.1139/cjm-2016-0716; Tzanakaki G, 2020, EUR J CLIN MICROBIOL, V39, P2467, DOI 10.1007/s10096-020-03965-x; Tzeng YL, 2017, P NATL ACAD SCI USA, V114, P4237, DOI 10.1073/pnas.1620971114; Vacca P, 2019, J GLOB ANTIMICROB RE, V18, P177, DOI 10.1016/j.jgar.2019.07.010; Wang X, 2011, VACCINE, V29, P4739, DOI 10.1016/j.vaccine.2011.04.092; Zhang XB, 2007, J MED MICROBIOL, V56, P1224, DOI 10.1099/jmm.0.47263-0; Zhao P, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01751-5; Zhou HJ, 2015, J INFECTION, V70, P37, DOI 10.1016/j.jinf.2014.07.022; Zhu BQ, 2015, EMERG INFECT DIS, V21, P925, DOI 10.3201/eid2106.140687; ZHU PX, 1995, J CLIN MICROBIOL, V33, P458, DOI 10.1128/JCM.33.2.458-462.1995	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243426	10.1371/journal.pone.0243426	http://dx.doi.org/10.1371/journal.pone.0243426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301524	gold, Green Accepted, Green Published			2022-12-26	WOS:000600143100009
J	Mhiri, W; Ceylan, M; Turgut-Kara, N; Nalbantoglu, B; Cakir, O				Mhiri, Wissem; Ceylan, Merve; Turgut-Kara, Neslihan; Nalbantoglu, Barbaros; Cakir, Ozgur			Transcriptomic analysis reveals responses to Cycloastragenol in Arabidopsis thaliana	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; IRON	Cycloastragenol (CAG), a molecule isolated from 'Astragalus membranaceus', stimulates the telomerase activity and cell proliferation significantly. It has been proven that CAG has the ability to prevent some diseases in humans. In this study, we aimed to figure out the CAG effects on the different signaling mechanisms in plants and to broadly analyze the genome-wide transcriptional responses in order to demonstrate CAG as a new key molecule that can potentially help plants to overcome different environmental stresses. RNA-seq strategy was employed to assess the transcriptional profiles in A. thaliana calli. Our work primarily focused on an overall study on the transcriptomic responses of A. thaliana to CAG. A total of 22593 unigenes have been detected, among which 1045 unigenes associated with 213 GO terms were differentially expressed and were assigned to 118 KEGG pathways. The up-regulated genes are principally involved in cellular and metabolic processes in addition to the response to a stimulus. The data analysis revealed genes associated with defense signaling pathways such as cytochrome P450s transporter, antioxidant system genes, and stress-responsive protein families were significantly upregulated. The obtained results can potentially help in better understanding biotic and/or abiotic tolerance mechanisms in response to CAG.	[Mhiri, Wissem; Nalbantoglu, Barbaros] Yildiz Tech Univ, Fac Art & Sci, Chem Dept, Istanbul, Turkey; [Ceylan, Merve] Istanbul Univ, Inst Sci, Program Mol Biol & Genet, Istanbul, Turkey; [Turgut-Kara, Neslihan; Cakir, Ozgur] Istanbul Univ, Fac Sci, Dept Mol Biol & Genet, Istanbul, Turkey	Yildiz Technical University; Istanbul University; Istanbul University	Mhiri, W (corresponding author), Yildiz Tech Univ, Fac Art & Sci, Chem Dept, Istanbul, Turkey.; Cakir, O (corresponding author), Istanbul Univ, Fac Sci, Dept Mol Biol & Genet, Istanbul, Turkey.	mh.wissem@gmail.com; ozgurckr@istanbul.edu.tr	Kara, Neslihan Turgut/B-4846-2015; Çakır, Özgür/A-8998-2018; Çakır, Özgür/AAX-1485-2021	Kara, Neslihan Turgut/0000-0001-5355-4937; Çakır, Özgür/0000-0003-3075-683X; Çakır, Özgür/0000-0003-3075-683X	Research Fund of Yildiz Technical University (BAP Project) [3489]	Research Fund of Yildiz Technical University (BAP Project)(Yildiz Technical University)	This work was supported by the Research Fund of Yildiz Technical University (BAP Project No: 3489). The funders had no role in study design, data collection and analysis, and decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2014, REPROD HEALTH MATTER, V22, P52; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barickman TC, 2013, SELENIUM INFLUENCES; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Cartieaux F, 2003, PLANT J, V36, P177, DOI 10.1046/j.1365-313X.2003.01867.x; Chen YX, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix120; Fellenberg C, 2009, PHYTOCHEMISTRY, V70, P1392, DOI 10.1016/j.phytochem.2009.08.010; Golisz A, 2011, PLANTA, V233, P231, DOI 10.1007/s00425-010-1294-7; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Haq S, HEAT SHOCK PROTEINS, P1; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kohorn BD, 2009, PLANT J, V60, P974, DOI 10.1111/j.1365-313X.2009.04016.x; Kumar Gupta P, RES REV J MICROBIOLO, V4.; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Marco HW, 2007, IRON W CIENCY MEDIAT, P897, DOI [10.1007/s00425-007-0535-x, DOI 10.1007/S00425-007-0535-X]; McLoughlin F, 2016, PLANT PHYSIOL, V172, P1221, DOI 10.1104/pp.16.00536; Mendonca EG, 2012, BRAZ ARCH BIOL TECHN, V55, P887, DOI 10.1590/S1516-89132012000600012; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Pauliina H, TRANSCRIPTIONAL EFFE, DOI [10.1111/tpj.14121, DOI 10.1111/TPJ.14121]; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Rodriguez-Celma J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00276; Shen XY, 2014, PLANT MOL BIOL, V86, P303, DOI 10.1007/s11103-014-0230-9; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wang J, 2018, BIOMED PHARMACOTHER, V107, P1074, DOI 10.1016/j.biopha.2018.08.016; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber M, 2006, PLANT CELL ENVIRON, V29, P950, DOI 10.1111/j.1365-3040.2005.01479.x; Yu YJ, 2018, EXP THER MED, V16, P2175, DOI 10.3892/etm.2018.6501; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zhai ZY, 2014, PLANT CELL, V26, P2249, DOI 10.1105/tpc.114.123737	36	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242986	10.1371/journal.pone.0242986	http://dx.doi.org/10.1371/journal.pone.0242986			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301486	Green Published, gold			2022-12-26	WOS:000600143100029
J	Whang, YH; Kim, SK; Yoon, H; Choi, SK; Baik, YO; Lee, C; Lee, I				Whang, Yoon Hee; Kim, Soo Kyung; Yoon, Hyeseon; Choi, Seuk Keun; Baik, Yeong Ok; Lee, Chankyu; Lee, Inhwan			Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							PNEUMONIAE VIRULENCE FACTORS; PROTEIN-CONJUGATE; COLONIZATION; VALIDATION; PATHOGENS	Glycoconjugate vaccines are vaccines in which a bacterial polysaccharide antigen is conjugated to a carrier protein to enhance immunogenicity by promoting T cell-dependent immune response. However, the free (unreacted) polysaccharides remaining after the conjugation process can inhibit the immunogenicity of a conjugate vaccine. Thus, we aimed to reduce the unbound free polysaccharides in the polysaccharide-protein conjugation process for the development of a new 15-valent pneumococcal conjugate vaccine (PCV15) by varying some factors that may affect the conjugation results such as polysaccharide/protein ratio, polysaccharide size, and concentration of a coupling agent in a conjugation reaction mixture. Concentrations of a coupling agent, carbodiimide (EDAC), and a carrier protein (CRM197) used in PCV15 production, during the conjugation process, had little effect on the content of free polysaccharides. However, the size of the polysaccharide was identified as the critical factor to control the free polysaccharide content, with an inverse relationship observed between the molecular weight of the polysaccharide and the residual free polysaccharide content after conjugation. Based on these results, a new PCV15 with low free polysaccharide contamination was produced and tested for immunogenicity using a rabbit model to show that it induces similar level of immune responses in rabbits compared to a comparator vaccine Prevnar13(R).	[Whang, Yoon Hee; Kim, Soo Kyung; Yoon, Hyeseon; Choi, Seuk Keun; Baik, Yeong Ok; Lee, Chankyu; Lee, Inhwan] EuBiol Co Ltd, R&D Ctr, Chunchon, South Korea		Lee, C; Lee, I (corresponding author), EuBiol Co Ltd, R&D Ctr, Chunchon, South Korea.	cklee@eubiologics.com; inhwan@eubiologics.com			Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2711]	Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grand number: HI14C2711). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors Yoon Hee Whang, Soo Kyung Kim, Hyeseon Yoon, Seuk Keun Choi, Yeong Ok Baik, Chankyu Lee, and Inhwan Lee are employees of Eubiologics. Eubiologics provided support in the form of salaries for authors YH Whang, SK Kim, H Yoon, SK Choi, YO Baik, C Lee, and I Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 1994, LESBIAN FEMINIST FLY, V20, P1; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; Chalmers JD, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0242-0; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; Concepcion NF, 2001, CLIN DIAGN LAB IMMUN, V8, P266, DOI 10.1128/CDLI.8.2.266-272.2001; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Dransfield MT, 2009, AM J RESP CRIT CARE, V180, P499, DOI 10.1164/rccm.200903-0488OC; Geno KA, 2017, J CLIN MICROBIOL, V55, P1416, DOI 10.1128/JCM.00054-17; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Hessling M, 2017, BIOSCI BIOTECH RES C, V10, P1; JONSSON S, 1985, J INFECT DIS, V152, P4, DOI 10.1093/infdis/152.1.4; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KOEHLER LH, 1952, ANAL CHEM, V24, P1576, DOI 10.1021/ac60070a014; Kumar R, 2005, ANAL BIOCHEM, V336, P132, DOI 10.1016/j.ab.2004.09.038; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Malenovic A., 2005, Farmaco (Lausanne), V60, P157, DOI 10.1016/j.farmac.2004.11.004; McElligott M, 2014, VACCINE, V32, P3495, DOI 10.1016/j.vaccine.2014.04.047; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; PEETERS CCAM, 1992, VACCINE, V10, P833, DOI 10.1016/0264-410X(92)90046-M; Siegel SJ, 2015, ANNU REV MICROBIOL, V69, P425, DOI 10.1146/annurev-micro-091014-104209; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Yoo SH, 2002, CARBOHYD POLYM, V49, P307, DOI 10.1016/S0144-8617(01)00339-3	26	2	2	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243909	10.1371/journal.pone.0243909	http://dx.doi.org/10.1371/journal.pone.0243909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301525	gold, Green Published			2022-12-26	WOS:000600143100049
J	Diriba, G; Kebede, A; Tola, HH; Yenew, B; Moga, S; Addise, D; Alemu, A; Mohammed, Z; Getahun, M; Fantahun, M; Tadesse, M; Dagne, B; Amare, M; Assefa, G; Abera, D; Desta, K				Diriba, Getu; Kebede, Abebaw; Tola, Habteyes Hailu; Yenew, Bazezew; Moga, Shewki; Addise, Desalegn; Alemu, Ayinalem; Mohammed, Zemedu; Getahun, Muluwork; Fantahun, Mengistu; Tadesse, Mengistu; Dagne, Biniyam; Amare, Misikir; Assefa, Gebeyehu; Abera, Dessie; Desta, Kassu			Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; DIAGNOSIS	Background Molecular characterization of Mycobacterium tuberculosis (MTB) is important to understand the pathogenesis, diagnosis, treatment, and prevention of tuberculosis (TB). However, there is limited information on molecular characteristics and drug-resistant patterns of MTB in patients with extra-pulmonary tuberculosis (EPTB) in Ethiopia. Thus, this study aimed to determine the molecular characteristics and drug resistance patterns of MTB in patients with EPTB in Addis Ababa, Ethiopia. Methods This study was conducted on frozen stored isolates of EPTB survey conducted in Addis Ababa, Ethiopia. A drug susceptibility test was performed using BACTEC-MGIT 960. Species and strain identification were performed using the Geno-Type MTBC and spoligotyping technique, respectively. Data were entered into the MIRU-VNTRplus database to assess the spoligotype patterns of MTB. Analysis was performed using SPSS version 23, and participants' characteristics were presented by numbers and proportions. Results Of 151 MTB isolates, 29 (19.2%) were resistant to at least one drug. The highest proportion of isolates was resistant to Isoniazid (14.6%) and Pyrazinamide (14.6%). Nine percent of isolates had multidrug-resistant TB (MDR-TB), and 21.4% of them had pre-extensively drug-resistant TB (pre-XDR-TB). Among the 151 MTB isolates characterized by spoligotyping, 142 (94.6%) had known patterns, while 9 (6.0%) isolates were not matched with the MIRU-VNTRplus spoligotype database. Of the isolates which had known patterns, 2% was M.bovis while 98% M. tuberculosis. Forty-one different spoligotype patterns were identified. The most frequently identified SpolDB4 (SIT) wereSIT149 (21.2%), SIT53 (14.6%) and SIT26 (9.6%). The predominant genotypes identified were T (53.6%), Central Asia Strain (19.2%) and Haarlem (9.9%). Conclusion The present study showed a high proportion of MDR-TB and pre-XDR-TB among EPTB patients. The strains were mostly grouped into SIT149, SIT53, and SIT26. The T family lineage was the most prevalent genotype. MDR-TB and pre-XDR-TB prevention is required to combat these strains in EPTB. A large scale study is required to describe the molecular characteristics and drug resistance patterns of MTB isolates in EPTB patients.	[Diriba, Getu; Kebede, Abebaw; Tola, Habteyes Hailu; Yenew, Bazezew; Moga, Shewki; Addise, Desalegn; Alemu, Ayinalem; Mohammed, Zemedu; Getahun, Muluwork; Tadesse, Mengistu; Dagne, Biniyam; Amare, Misikir] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Diriba, Getu; Abera, Dessie; Desta, Kassu] Addis Ababa Univ, Dept Med Lab Sci, Coll Hlth Sci, Addis Ababa, Ethiopia; [Kebede, Abebaw] Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Coll Nat & Computat Sci, Addis Ababa, Ethiopia; [Fantahun, Mengistu] Millennium Med Coll, St Pauls Hosp, Addis Ababa, Ethiopia; [Assefa, Gebeyehu] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Diriba, G (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.; Diriba, G (corresponding author), Addis Ababa Univ, Dept Med Lab Sci, Coll Hlth Sci, Addis Ababa, Ethiopia.	getud2020@gmail.com	Tessema, Bazezew Yenew/AAO-4148-2020	Alemu Shitie, Ayinalem/0000-0001-5307-8774; Diriba, Getu/0000-0002-0166-682X; Dagne, Biniyam/0000-0002-5930-2690; Kebede, Abebaw/0000-0002-6154-7275; Mitku, Gebeyehu Assefa/0000-0003-1308-7566	FIC NIH HHS [D43 TW009127] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 2016, TREATM GUID DRUGR TU; [Anonymous], 2018, TECHN DET MUT ASS DR; Aung WW, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01984-17; Biadglegne F, 2014, INDIAN J MED RES, V140, P116; Boonsarngsuk V, 2018, CLIN RESPIR J, V12, P2101, DOI 10.1111/crj.12779; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; Desai U, 2019, LUNG INDIA, V36, P3, DOI 10.4103/lungindia.lungindia_192_18; Dusthackeer A, 2015, INDIAN J MED RES, V142, P568, DOI 10.4103/0971-5916.171284; Fantahun M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222402; Garedew L, 2013, SCAND J INFECT DIS, V45, P512, DOI 10.3109/00365548.2013.773068; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kandhakumari G, 2015, INDIAN J MED MICROBI, V33, P267, DOI 10.4103/0255-0857.154871; Khan MT, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3764-2; Korma W, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1177-4; Kulchavenya E, 2014, THER ADV INFECT DIS, V2, P61, DOI 10.1177/2049936114528173; Kumar R, 2018, INT J LIFE SCI SCI R, V4, P1707; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Lee HY, 2015, KOREAN J INTERN MED, V30, P325, DOI 10.3904/kjim.2015.30.3.325; Lee JY, 2015, TUBERC RESPIR DIS, V78, P47, DOI 10.4046/trd.2015.78.2.47; Maningi NE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2898-3; Maurya AK, 2012, J POSTGRAD MED, V58, P185, DOI 10.4103/0022-3859.101379; Mehta PK, 2012, FEMS IMMUNOL MED MIC, V66, P20, DOI 10.1111/j.1574-695X.2012.00987.x; Mok J, 2019, INT J TUBERC LUNG D, V23, P151, DOI 10.5588/ijtld.18.0109; Neonakis IK, 2007, EUR J CLIN MICROBIOL, V26, P151, DOI 10.1007/s10096-007-0255-y; Pang Y, 2019, EMERG INFECT DIS, V25, P457, DOI 10.3201/eid2503.180572; Purohit M, 2015, J CLIN DIAGN RES, V9, pEE1, DOI 10.7860/JCDR/2015/12422.5792; Rahman A, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00511-17; Rasolofo-Razanamparany V, 1999, INT J TUBERC LUNG D, V3, P632; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Seung KJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017863; Sharma SK, 2017, INT J TUBERC LUNG D, V21, P1112, DOI 10.5588/ijtld.16.0939; Sharma S, 2018, BIOMED BIOTECH RES J, V2, P132, DOI 10.4103/bbrj.bbrj_48_18; Shibabaw A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229040; Suzana S, 2017, TROP MED INT HEALTH, V22, P703, DOI 10.1111/tmi.12875; Tahseen S, 2019, INT J TUBERC LUNG D, V23, P900, DOI 10.5588/ijtld.18.0531; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Viegas SO, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0603-5; Worku T, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-017-0235-7; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0; Zhao P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099659	45	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243493	10.1371/journal.pone.0243493	http://dx.doi.org/10.1371/journal.pone.0243493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284842	gold, Green Published			2022-12-26	WOS:000597930500051
J	Ogino, Y; Schmidt, AJ				Ogino, Yumiko; Schmidt, Axel Jeremias			Impact of class-level labelling change on prescriptions of antidepressants for adolescents: An interrupted time-series study using a health insurance claims database in Japan, 2005-2013	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; SUICIDALITY; REGRESSION; CHILDREN; RISK; DEPRESSION; CARE	Background In October 2007, the Japanese Health Authority directed that precautions be added to antidepressants (ADs) labelling regarding suicide risk among young people. This study evaluates the impact of the labelling change on AD prescriptions and Japanese adolescent suicide rates. Methods We compared AD prescription rates per 100,000 population as a primary outcome. The intervention group comprised adolescents (10-24 years), while the control group comprised adults (25-64 years). We defined the pre-intervention period as January 2005 to October 2007 and post-intervention as November 2007 to February 2013. Monthly prescription rate data from a commercial claims database were triangulated with annual suicide rates in Japan. We performed segmented regression analysis for the prescription rates, using a quasi-Poisson model, and tested for level and trend changes. Results The commercial claims database included 152,686 adolescents and 195,251 adults during the pre-intervention period and 846,367 adolescents and 1,352,453 adults during post-intervention. Post-intervention, the overall AD prescription rates decreased only in adult males (-95.8 prescription per 100,000) but increased in all other groups. The mean annual suicide rate increased in adolescent males (+1.5 suicides per 100,000) but decreased in all other groups. Overall, the upward trend became moderate or inverse in all groups post-intervention but with a large difference between males and females. The suicide rates rose slightly in adolescents but began declining in adults a year post-intervention. In females, changes in level, trend, and suicide rates were very small in both adolescents and adults. Conclusions Contrary to expectations, the mean prescription rates only decreased in adult males, but not in adolescents, regardless of gender. Downward level and trend change were clearly observed in adult males but not in adolescents, the original target of the updated warning. There were no clear temporal associations between suicide rates and the labelling change in either group.	[Ogino, Yumiko] Univ London, London Sch Hyg & Trop Med, Int Programme, MSc Publ Hlth Programme, London, England; [Schmidt, Axel Jeremias] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ogino, Y (corresponding author), Univ London, London Sch Hyg & Trop Med, Int Programme, MSc Publ Hlth Programme, London, England.	yumiko.ogino@osakafu-u.net		Ogino, Yumiko/0000-0002-7874-4144				Akaike H., 1973, 2 INT S INF THEOR; Ando S, 2013, PSYCHIAT CLIN NEUROS, V67, P471, DOI 10.1111/pcn.12086; [Anonymous], 2017, WHO AD HLTH DEV; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Courtet P, 2017, WORLD PSYCHIATRY, V16, P317, DOI 10.1002/wps.20460; Dean AJ, 2007, PHARMACOEPIDEM DR S, V16, P1048, DOI 10.1002/pds.1396; European Medicines Agency, 2017, GUID GOOD PHARM PRAC; European Medicines Agency Press Office, 2005, EUR MED AG FIN REV A; Food and Drug Administration Center for Drug Evaluation and Research, 2007, INF DRUG CLASS ANT C; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hernandez JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045515; Japanese Society of Mood Disorders, 2016, TREATM GUID MAJ DEPR; JMDC, CLAIMS DAT PHARM IND; Kawakami N, 2016, REPORT WORLD MENTAL; Lam D, 2013, PEDIATR DRUGS, V15, P319, DOI 10.1007/s40272-013-0014-8; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Ministry of Health Labour and Welfare, 2009, PHARM MED DEV SAF IN; Ministry of Health Labour and Welfare, 2007, PERS TRAIN WORK GROU, P13; Ministry of Health Labour and Welfare, 2016, AN SUIC WHIT PAP SUI; Ministry of Health Labour and Welfare, 2015, SUIC YOUNG GEN WHIT; Muller-Oerlinghausen B, 1999, J CLIN PSYCHIAT, V60, P94; Okumura Yasuyuki, 2014, Seishin Shinkeigaku Zasshi, V116, P921; Olfson M, 2008, ARCH GEN PSYCHIAT, V65, P94, DOI 10.1001/archgenpsychiatry.2007.5; Ooba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066116; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Pharmaceuticals and Medical Devices Agency, 2011, REP PIL RES PRESCR E; Pharmaceuticals and Medical Devices Agency, 2013, REV PREC; Tanaka S, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0016-5; The National Statistics Center Japan, E STAT PORT SIT OFF; ucer BH, 2004, ANADOLU U J SCI TECH, V5, P259; Usami M, 2011, JAPANESE J CHILD ADO, V52, P21; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007; Volkers AC, 2007, PHARMACOEPIDEM DR S, V16, P1054, DOI 10.1002/pds.1430; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wheeler BW, 2008, BMJ-BRIT MED J, V336, P542, DOI 10.1136/bmj.39462.375613.BE; World Health Organisation, 2017, FACT SHEETS DEPR; World Health Organization, 2019, FACT SHEETS SUIC	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243424	10.1371/journal.pone.0243424	http://dx.doi.org/10.1371/journal.pone.0243424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284822	Green Published, gold			2022-12-26	WOS:000597930500004
J	Lim, JH; Han, YS; Lee, SJ; Nam, KY				Lim, Jun Hyun; Han, Yong Seop; Lee, Sang Joon; Nam, Ki Yup			Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration	PLOS ONE			English	Article							PNEUMATIC DISPLACEMENT; SUBRETINAL HEMORRHAGE; MANAGEMENT; SECONDARY; VITRECTOMY; THERAPY	Purpose We investigated risk factors for breakthrough vitreous hemorrhage (VH) after an intravitreal tissue plasminogen activator (tPA) and gas injection in patients with submacular hemorrhage (SMH) associated with age-related macular degeneration (AMD). Methods The medical records of patients diagnosed with SMH associated with AMD who received an intravitreal tPA (50 mu g/0.05 mL) and perfluoropropane gas (0.3 mL) injection were reviewed retrospectively. We analyzed the associations of breakthrough VH with age, sex, best-corrected visual acuity, intraocular pressure, AMD subtype, accompanying sub-retinal pigment epithelium (RPE) hemorrhage, history of cataract surgery, history of hypertension and diabetes mellitus, history of drinking and smoking, and history of antiplatelet or anticoagulant medication. We also examined the relationships between various parameters, including the area ratio of the SMH to the optic disc (AHD) and the height of the SMH obtained from optical coherence tomography. Results In total, 52 eyes from 52 patients were enrolled in this study; 16 eyes (30%) showed breakthrough VH. The proportions of patients with a current smoking history were 75.0% in the VH group and 22.2% in the non-VH group (p = 0.010). Other factors did not differ significantly between the two groups. The proportion of cases with accompanying sub-RPE hemorrhage was 50.0% and 58.3% in the VH and non-VH groups, respectively (p = 0.763). The AHD (p = 0.001) and SMH height (p < 0.001) were significantly greater in the VH group. In a receiver operating characteristic curve analysis, the cut-off values of AHD and SMH height were 20.1 and 1208 mu m, respectively. According to logistic regression analysis, when the AHD and SMH height were greater than the individual cut-off values, the odds ratio of VH increased by 10.286 fold (95% confidence interval [CI], 2.452-43.148; p = 0.001) and 75.400 fold (95% CI, 7.991-711.441; p < 0.001), respectively, with respect to their respective reference groups (less than the cut-off value). Among the significant factors associated with VH occurrence, including current smoking, AHD, and SMH height, only current smoking and SMH height were found to be significant in multiple regression analysis (p = 0.040, 0.016). Conclusions The incidence of breakthrough VH was significantly higher in those with current smoking status and for SMH with a larger AHD and greater height. The height of the SMH was more predictable of the possibility of VH than AHD.	[Lim, Jun Hyun; Lee, Sang Joon] Kosin Univ Hosp, Dept Ophthalmol, Busan, South Korea; [Han, Yong Seop] Gyeonsang Natl Univ, Coll Med, Dept Ophthalmol, Jinju, South Korea; [Han, Yong Seop; Nam, Ki Yup] Gyeonsang Natl Univ, Dept Ophthalmol, Changwon Hosp, Chang Won, South Korea; [Lee, Sang Joon] Kosin Univ, Coll Med, Dept Ophthalmol, Busan, South Korea; [Nam, Ki Yup] Chungnnam Natl Univ, Coll Med, Dept Ophthalmol, Daejeon, South Korea	Gyeongsang National University; Gyeongsang National University	Nam, KY (corresponding author), Gyeonsang Natl Univ, Dept Ophthalmol, Changwon Hosp, Chang Won, South Korea.; Nam, KY (corresponding author), Chungnnam Natl Univ, Coll Med, Dept Ophthalmol, Daejeon, South Korea.	oksnam1231@daum.net		Nam, Ki Yup/0000-0002-3602-8422				BENNETT SR, 1990, AM J OPHTHALMOL, V109, P33, DOI 10.1016/S0002-9394(14)75575-8; Chang W, 2014, AM J OPHTHALMOL, V157, P1250, DOI 10.1016/j.ajo.2014.02.007; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Cho HJ, 2013, AM J OPHTHALMOL, V156, P524, DOI 10.1016/j.ajo.2013.04.029; GILLIES A, 1983, ANN OPHTHALMOL, V15, P1068; Gopalakrishan M, 2007, RETINA-J RET VIT DIS, V27, P329, DOI 10.1097/01.iae.0000231544.43093.40; Guthoff R, 2011, RETINA-J RET VIT DIS, V31, P36, DOI 10.1097/IAE.0b013e3181e37884; Hattenbach LO, 2001, OPHTHALMOLOGY, V108, P1485, DOI 10.1016/S0161-6420(01)00648-0; Hochman MA, 1997, SURV OPHTHALMOL, V42, P195, DOI 10.1016/S0039-6257(97)00089-1; Kadonosono K, 2015, OPHTHALMOLOGY, V122, P123, DOI 10.1016/j.ophtha.2014.07.027; Kapran Z, 2013, OSLI RETINA, V44, P471, DOI 10.3928/23258160-20130909-09; Krepler K, 2000, RETINA-J RET VIT DIS, V20, P251, DOI 10.1097/00006982-200005000-00004; Kunavisarut P, 2018, ASIA-PAC J OPHTHALMO, V7, P109, DOI 10.22608/APO.2017389; Kung YH, 2010, J OCUL PHARMACOL TH, V26, P469, DOI 10.1089/jop.2010.0066; Malik Farhan F, 2014, Int Ophthalmol Clin, V54, P51, DOI 10.1097/IIO.0000000000000018; Martel JN, 2013, JAMA OPHTHALMOL, V131, P1632, DOI 10.1001/jamaophthalmol.2013.5464; Moschos MM, 2016, OXID MED CELL LONGEV; Papavasileiou E, 2013, RETINA-J RET VIT DIS, V33, P846, DOI 10.1097/IAE.0b013e318271f278; PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P575; Sandhu SS, 2010, CLIN OPHTHALMOL, V4, P637; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; Shienbaum G, 2013, AM J OPHTHALMOL, V155, P1009, DOI 10.1016/j.ajo.2013.01.012; Shin YI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28938-1; Stifter E, 2007, AM J OPHTHALMOL, V144, P886, DOI 10.1016/j.ajo.2007.07.034; Wu TT, 2011, RETINA-J RET VIT DIS, V31, P2071, DOI 10.1097/IAE.0b013e31822528c8; Wu TT, 2005, J OCUL PHARMACOL TH, V21, P62, DOI 10.1089/jop.2005.21.62	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243201	10.1371/journal.pone.0243201	http://dx.doi.org/10.1371/journal.pone.0243201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270725	Green Published, gold			2022-12-26	WOS:000597149100123
J	Rek, J; Musiime, A; Zedi, M; Otto, G; Kyagamba, P; Rwatooro, JA; Arinaitwe, E; Nankabirwa, J; Staedke, SG; Drakeley, C; Rosenthal, PJ; Kamya, M; Dorsey, G; Krezanoski, PJ				Rek, John; Musiime, Alex; Zedi, Maato; Otto, Geoffrey; Kyagamba, Patrick; Rwatooro, Jackson Asiimwe; Arinaitwe, Emmanuel; Nankabirwa, Joaniter; Staedke, Sarah G.; Drakeley, Chris; Rosenthal, Philip J.; Kamya, Moses; Dorsey, Grant; Krezanoski, Paul J.			Non-adherence to long-lasting insecticide treated bednet use following successful malaria control in Tororo, Uganda	PLOS ONE			English	Article							MOSQUITO NETS; TRANSMISSION; AREA	Indoor residual spraying (IRS) and long-lasting insecticide-treated bednets (LLINs) are common tools for reducing malaria transmission. We studied a cohort in Uganda with universal access to LLINs after 5 years of sustained IRS to explore LLIN adherence when malaria transmission has been greatly reduced. Eighty households and 526 individuals in Nagongera, Uganda were followed from October 2017 -October 2019. Every two weeks, mosquitoes were collected from sleeping rooms and LLIN adherence the prior night assessed. Episodes of malaria were diagnosed using passive surveillance. Risk factors for LLIN non-adherence were evaluated using multi-level mixed logistic regression. An age-matched case-control design was used to measure the association between LLIN non-adherence and malaria. Across all time periods, and particularly in the last 6 months, non-adherence was higher among both children <5 years (OR 3.31, 95% CI: 2.30-4.75; p<0.001) and school-aged children 5-17 years (OR 6.88, 95% CI: 5.01-9.45; p<0.001) compared to adults. In the first 18 months, collection of fewer mosquitoes was associated with non-adherence (OR 3.25, 95% CI: 2.92-3.63; p<0.001), and, in the last 6 months, residents of poorer households were less adherent (OR 5.1, 95% CI: 1.17-22.2; p = 0.03). Any reported non-adherence over the prior two months was associated with a 15-fold increase in the odds of having malaria (OR 15.0, 95% CI: 1.95 to 114.9; p = 0.009). Knowledge about LLIN use was high, and the most frequently reported barriers to use included heat and low perceived risk of malaria. Children, particularly school-aged, participants exposed to fewer mosquitoes, and those from poorer households, were less likely to use LLINs. Non-adherence to LLINs was associated with an increased risk of malaria. Strategies, such as behavior change communications, should be prioritized to ensure consistent LLIN use even when malaria transmission has been greatly reduced.	[Rek, John; Musiime, Alex; Zedi, Maato; Otto, Geoffrey; Kyagamba, Patrick; Rwatooro, Jackson Asiimwe; Arinaitwe, Emmanuel; Nankabirwa, Joaniter; Kamya, Moses] Infect Dis Res Collaborat, Kampala, Uganda; [Arinaitwe, Emmanuel; Staedke, Sarah G.; Drakeley, Chris] London Sch Hyg & Trop Med, London, England; [Nankabirwa, Joaniter; Kamya, Moses] Makerere Univ Coll Hlth Sci, Kampala, Uganda; [Rosenthal, Philip J.; Dorsey, Grant; Krezanoski, Paul J.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of London; London School of Hygiene & Tropical Medicine; Makerere University; University of California System; University of California San Francisco	Krezanoski, PJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	paul.krezanoski@ucsf.edu	Musiime, Alex K/AHC-2477-2022		National Institutes of Health [U19AI089674]; National Institute of Allergy and Infectious Disease Career Mentored Award [K23AI139364]; Fogarty International Center [K43TW010365]; Fogarty International Center of the National Institutes of Health [D43TW010526]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease Career Mentored Award; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674) and supported by a National Institute of Allergy and Infectious Disease Career Mentored Award (PJK; K23AI139364). JIN is supported by the Fogarty International Center (Emerging Global Leader Award grant number K43TW010365). EA is supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW010526. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, CANC DISCOV, V4, pOF5; [Anonymous], 2007, INS TREAT MOSQ NETS; Buchwald AG, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1178-9; Chase C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-132; Choi L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012688.pub2; Clark S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154808; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Fernando SD, 2009, T ROY SOC TROP MED H, V103, P1204, DOI 10.1016/j.trstmh.2008.10.018; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Goesch JN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-60; Gonahasa S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2571-3; Harvey SA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1918-5; Kamau A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2822-x; Leake D W Jr, 1994, Asia Pac J Public Health, V7, P92; Malede A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7692-2; Nankabirwa JI, 2020, AM J TROP MED HYG, V103, P1525, DOI 10.4269/ajtmh.20-0250; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Parker W, 2018, MALAWI MED J, V30, P99, DOI 10.4314/mmj.v30i2.9; Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2; Protopopoff N, 2018, LANCET, V391, P1577, DOI [10.1016/S0140-6736(18)30427-6, 10.1016/s0140-6736(18)30427-6]; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Raouf S, 2017, CLIN INFECT DIS, V65, P453, DOI 10.1093/cid/cix251; Staedke SG, 2020, LANCET, V395, P1292, DOI 10.1016/S0140-6736(20)30214-2; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; WHO, 2019, WORLD MALARIA REPORT	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243303	10.1371/journal.pone.0243303	http://dx.doi.org/10.1371/journal.pone.0243303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270743	Green Published, gold			2022-12-26	WOS:000597149100011
J	Akerlund, CA; Donnelly, J; Zeiler, FA; Helbok, R; Holst, A; Cabeleira, M; Guiza, F; Meyfroidt, G; Czosnyka, M; Smielewski, P; Stocchetti, N; Ercole, A; Nelson, DW				AI Akerlund, Cecilia; Donnelly, Joseph; Zeiler, Frederick A.; Helbok, Raimund; Holst, Anders; Cabeleira, Manuel; Guiza, Fabian; Meyfroidt, Geert; Czosnyka, Marek; Smielewski, Peter; Stocchetti, Nino; Ercole, Ari; Nelson, David W.		CENTER TBI High	Impact of duration and magnitude of raised intracranial pressure on outcome after severe traumatic brain injury: A CENTER-TBI high-resolution group study	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; THRESHOLDS; HYPERTENSION; REACTIVITY; BURDEN; CARE	Magnitude of intracranial pressure (ICP) elevations and their duration have been associated with worse outcomes in patients with traumatic brain injuries (TBI), however published thresholds for injury vary and uncertainty about these levels has received relatively little attention. In this study, we have analyzed high-resolution ICP monitoring data in 227 adult patients in the CENTER-TBI dataset. Our aim was to identify thresholds of ICP intensity and duration associated with worse outcome, and to evaluate the uncertainty in any such thresholds. We present ICP intensity and duration plots to visualize the relationship between ICP events and outcome. We also introduced a novel bootstrap technique to evaluate uncertainty of the equipoise line. We found that an intensity threshold of 18 +/- 4 mmHg (2 standard deviations) was associated with worse outcomes in this cohort. In contrast, the uncertainty in what duration is associated with harm was larger, and safe durations were found to be population dependent. The pressure and time dose (PTD) was also calculated as area under the curve above thresholds of ICP. A relationship between PTD and mortality could be established, as well as for unfavourable outcome. This relationship remained valid for mortality but not unfavourable outcome after adjusting for IMPACT core variables and maximum therapy intensity level. Importantly, during periods of impaired autoregulation (defined as pressure reactivity index (PRx)>0.3) ICP events were associated with worse outcomes for nearly all durations and ICP levels in this cohort and there was a stronger relationship between outcome and PTD. Whilst caution should be exercised in ascribing causation in observational analyses, these results suggest intracranial hypertension is poorly tolerated in the presence of impaired autoregulation. ICP level guidelines may need to be revised in the future taking into account cerebrovascular autoregulation status considered jointly with ICP levels.	[AI Akerlund, Cecilia; Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [AI Akerlund, Cecilia; Holst, Anders] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden; [Donnelly, Joseph; Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Sect Neurosurg, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Anat & Cell Sci, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Ercole, Ari] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Helbok, Raimund] Med Univ Innsbruck, Neurol Intens Care Unit, Dept Neurol, Innsbruck, Austria; [Guiza, Fabian; Meyfroidt, Geert] Univ Hosp Leuven, Dept & Lab Intens Care Med, Leuven, Belgium; [Guiza, Fabian; Meyfroidt, Geert] Katholieke Univ Leuven, Leuven, Belgium; [Czosnyka, Marek] Warsaw Univ Technolol, Inst Elect Syst, Warsaw, Poland; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy	Karolinska Institutet; Royal Institute of Technology; University of Cambridge; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Cambridge; Medical University of Innsbruck; KU Leuven; University Hospital Leuven; KU Leuven; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Akerlund, CA (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden.; Akerlund, CA (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden.	cecilia.akerlund@sll.se	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Nelson, David/0000-0003-2530-8207; Meyfroidt, Geert/0000-0003-4259-3935; Zeiler, Frederick/0000-0003-1737-0510; Smielewski, Peter/0000-0001-5096-3938	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR); Canadian Foundation for Innovation (CFI); University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Stockholm City Council; Integra LifeSciences	European Union 7th Framework program (EC); Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Stockholm City Council; Integra LifeSciences	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). FAZ receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the University of Manitoba Centre on Aging, the University of Manitoba VPRI Research Investment Fund (RIF), and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. DN has also been funded by the Regional Research Agreement (ALF) with Stockholm City Council. Integra LifeSciences provided financial support in respect to data curation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; [Anonymous], 2019, PRESSURE REACTIVITY; Carney N, 2016, NEUROSURGERY, DOI [10.1227/NEU.0000000000001432, DOI 10.1227/NEU.0000000000001432]; CENTER-TBI, CTR TBI ETH APPR; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2020, BRIT J ANAESTHESIA; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Hemphill JC, 2005, PHYSIOL MEAS, V26, P373, DOI 10.1088/0967-3334/26/4/004; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Magni F, 2015, STROKE, V46, P2464, DOI 10.1161/STROKEAHA.115.010219; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; R Core Team, 2018, R LANG ENV STAT COMP; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Smith M, 2019, INTENS CARE MED, V45, P1819, DOI 10.1007/s00134-019-05818-4; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PREDICTING OUTCOME T; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	36	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243427	10.1371/journal.pone.0243427	http://dx.doi.org/10.1371/journal.pone.0243427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315872	Green Submitted, gold, Green Published			2022-12-26	WOS:000600186100002
J	Luong, XG; Stevens, SK; Jekle, A; Lin, TI; Gupta, K; Misner, D; Chanda, S; Mukherjee, S; Williams, C; Stoycheva, A; Blatt, LM; Beigelman, LN; Symons, JA; Raboisson, P; McGowan, D; Vandyck, K; Deval, J				Luong, Xuan G.; Stevens, Sarah K.; Jekle, Andreas; Lin, Tse-, I; Gupta, Kusum; Misner, Dinah; Chanda, Sushmita; Mukherjee, Sucheta; Williams, Caroline; Stoycheva, Antitsa; Blatt, Lawrence M.; Beigelman, Leonid N.; Symons, Julian A.; Raboisson, Pierre; McGowan, David; Vandyck, Koen; Deval, Jerome			Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MALIC ENZYME; IN-VITRO; EXPRESSION; ACID; MODELS; EPIDEMIOLOGY; DEIODINASE; MECHANISMS; MGL-3196	Thyroid hormones are important modulators of metabolic activity in mammals and alter cholesterol and fatty acid levels through activation of the nuclear thyroid hormone receptor (THR). Currently, there are several THR beta agonists in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) that have demonstrated the potential to reduce liver fat and restore liver function. In this study, we tested three THR beta-agonism-based NASH treatment candidates, GC-1 (sobetirome), MGL-3196 (resmetirom), and VK2809, and compared their selectivity for THR beta and their ability to modulate the expression of genes specific to cholesterol and fatty acid biosynthesis and metabolism in vitro using human hepatic cells and in vivo using a rat model. Treatment with GC-1 upregulated the transcription of CPT1A in the human hepatocyte-derived Huh-7 cell line with a dose-response comparable to that of the native THR ligand, triiodothyronine (T3). VK2809A (active parent of VK2809), MGL-3196, and VK2809 were approximately 30-fold, 1,000-fold, and 2,000-fold less potent than T3, respectively. Additionally, these relative potencies were confirmed by quantification of other direct gene targets of THR, namely, ANGPTL4 and DIO1. In primary human hepatocytes, potencies were conserved for every compound except for VK2809, which showed significantly increased potency that was comparable to that of its active counterpart, VK2809A. In high-fat diet fed rats, a single dose of T3 significantly reduced total cholesterol levels and concurrently increased liver Dio1 and Me1 RNA expression. MGL-3196 treatment resulted in concentration-dependent decreases in total and low-density lipoprotein cholesterol with corresponding increases in liver gene expression, but the compound was significantly less potent than T3. In conclusion, we have implemented a strategy to rank the efficacy of THR beta agonists by quantifying changes in the transcription of genes that lead to metabolic alterations, an effect that is directly downstream of THR binding and activation.	[Luong, Xuan G.; Stevens, Sarah K.; Jekle, Andreas; Gupta, Kusum; Misner, Dinah; Chanda, Sushmita; Mukherjee, Sucheta; Williams, Caroline; Stoycheva, Antitsa; Blatt, Lawrence M.; Beigelman, Leonid N.; Symons, Julian A.; Deval, Jerome] Aligos Therapeut Inc, San Francisco, CA 94080 USA; [Lin, Tse-, I; Raboisson, Pierre; McGowan, David; Vandyck, Koen] Aligos Belgium BV, Leuven, Belgium		Luong, XG; Deval, J (corresponding author), Aligos Therapeut Inc, San Francisco, CA 94080 USA.	xluong@aligos.com; jdeval@aligos.com		Luong, Xuan/0000-0003-0600-8778	Aligos Therapeutics, Inc.	Aligos Therapeutics, Inc.	Aligos Therapeutics, Inc. provided funding for this study. The funder provided support in the form of salaries for XGL, SKS, AJ, KG, D. Misner, SC, SM, CW, AS, LMB, LNB, JAS, JD, TL, PR, D. McGowan, and KV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson GW, 2009, MOL CELL ENDOCRINOL, V302, P99, DOI 10.1016/j.mce.2009.01.005; [Anonymous], 2000, ARCH IBADAN MED ONCO, V1, P9; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Attia SL, 2021, CTS-CLIN TRANSL SCI, V14, P11, DOI 10.1111/cts.12839; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Boyer SH, 2008, J MED CHEM, V51, P7075, DOI 10.1021/jm800824d; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chavez-Tapia NC, 2011, CURR MED CHEM, V18, P1079; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chiellini G, 1998, CHEM BIOL, V5, P299, DOI 10.1016/S1074-5521(98)90168-5; Columbano Amedeo, 2017, Gene Expression-The Journal of Liver Research, V17, P265, DOI 10.3727/105221617X14968563796227; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Eshraghian A, 2017, WORLD J GASTROENTERO, V23, P7495, DOI 10.3748/wjg.v23.i42.7495; GOODRIDGE AG, 1976, J BIOL CHEM, V251, P3027; Haning H, 2005, BIOORG MED CHEM LETT, V15, P1835, DOI 10.1016/j.bmcl.2005.02.028; Harrison SA, 2019, LANCET, V394, P2012, DOI 10.1016/S0140-6736(19)32517-6; IRITANI N, 1992, EUR J BIOCHEM, V205, P433, DOI 10.1111/j.1432-1033.1992.tb16797.x; Jakobsson T, 2017, DRUGS, V77, P1613, DOI 10.1007/s40265-017-0791-4; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Kelly MJ, 2014, J MED CHEM, V57, P3912, DOI 10.1021/jm4019299; Kim KH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00485; Kirschberg TA, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127465; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Lian B, 2016, J AM COLL CARDIOL, V67, P1932, DOI 10.1016/S0735-1097(16)31933-7; Loomba R, 2019, J HEPATOL, V70, pE150, DOI 10.1016/S0618-8278(19)30266-X; MAIA AL, 1995, ENDOCRINOLOGY, V136, P4842, DOI 10.1210/en.136.11.4842; Matos SL, 2005, BRAZ ARCH BIOL TECHN, V48, P203, DOI 10.1590/S1516-89132005000200006; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mengeling BJ, 2008, MOL CELL ENDOCRINOL, V280, P47, DOI 10.1016/j.mce.2007.09.011; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Pedrelli M, 2010, WORLD J GASTROENTERO, V16, P5958, DOI 10.3748/wjg.v16.i47.5958; Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Saponaro F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00331; Scanlan TS, 2010, HEART FAIL REV, V15, P177, DOI 10.1007/s10741-008-9122-x; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Sinha RA, 2018, NAT REV ENDOCRINOL, V14, P259, DOI 10.1038/nrendo.2018.10; Taub R, 2013, ATHEROSCLEROSIS, V230, P373, DOI 10.1016/j.atherosclerosis.2013.07.056; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; TOWLE HC, 1980, BIOCHEMISTRY-US, V19, P579, DOI 10.1021/bi00544a029; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Williams GR, 2000, MOL CELL BIOL, V20, P8329, DOI 10.1128/MCB.20.22.8329-8342.2000; Wu J, 2013, HEPATOLOGY, V58, P617, DOI 10.1002/hep.26272; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; Zhou J, 2019, THYROID, V29, P1158, DOI 10.1089/thy.2019.0007	53	9	9	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0240338	10.1371/journal.pone.0240338	http://dx.doi.org/10.1371/journal.pone.0240338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306682	gold, Green Published, Green Submitted			2022-12-26	WOS:000600144200072
J	Owusu, M; Sylverken, AA; Ankrah, ST; El-Duah, P; Ayisi-Boateng, NK; Yeboah, R; Gorman, R; Asamoah, J; Binger, T; Acheampong, G; Bekoe, FA; Ohene, SA; Larsen-Reindorf, R; Awuah, AAA; Amuasi, J; Owusu-Dabo, E; Adu-Sarkodie, Y; Phillips, RO				Owusu, Michael; Sylverken, Augustina Angelina; Ankrah, Sampson Twumasi; El-Duah, Philip; Ayisi-Boateng, Nana Kwame; Yeboah, Richmond; Gorman, Richmond; Asamoah, Jesse; Binger, Tabea; Acheampong, Godfred; Bekoe, Franklin Asiedu; Ohene, Sally-Ann; Larsen-Reindorf, Rita; Awuah, Anthony Afum-Adjei; Amuasi, John; Owusu-Dabo, Ellis; Adu-Sarkodie, Yaw; Phillips, Richard Odame			Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study	PLOS ONE			English	Article							CORONAVIRUS	Background Global cases of COVID-19 continue to rise, causing havoc to several economies. So far, Ghana has recorded 48,643 confirmed cases with 320 associated deaths. Although summaries of data are usually provided by the Ministry of Health, detailed epidemiological profile of cases are limited. This study sought to describe the socio-demographic features, pattern of COVID-19 spread and the viral load dynamics among subjects residing in northern, middle and part of the southern belt of Ghana. Methods This was a cross-sectional retrospective study that reviewed records of samples collected from February to July, 2020. Respiratory specimens such as sputum, deep-cough saliva and nasopharyngeal swabs were collected from suspected COVID-19 subjects in 12 regions of Ghana for laboratory analysis and confirmation by real-time reverse transcription polymerase chain reaction (RT-PCR). Results A total of 72,434 samples were collected during the review period, with majority of the sampled individuals being females (37,464; 51.9%). The prevalence of SARS-CoV-2 identified in the study population was 13.2% [95%CI: 12.9, 13.4). Males were mostly infected (4,897; 51.5%) compared to females. Individuals between the ages 21-30 years recorded the highest number of infections (3,144, 33.4%). Symptomatic subjects had higher viral loads (1479.7 copies/mu l; IQR = 40.6-178919) than asymptomatic subjects (49.9; IQR = 5.5-3641.6). There was significant association between gender or age and infection with SARS-CoV-2 (p<0.05). Among all the suspected clinical presentations, anosmia was the strongest predictor of SARS-CoV-2 infection (Adj. OR (95%CI): 24.39 (20.18, 29.49). We observed an average reproductive number of 1.36 with a minimum of 1.28 and maximum of 1.43. The virus trajectory shows a gradual reduction of the virus reproductive number. Conclusion This study has described the epidemiological profile of COVID-19 cases in northern, middle and part of the southern belt of Ghana, with males and younger individuals at greater risk of contracting the disease. Health professionals should be conscious of individuals presenting with anosmia since this was seen as the strongest predictor of virus infection.	[Owusu, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana; [Owusu, Michael; Sylverken, Augustina Angelina; El-Duah, Philip; Yeboah, Richmond; Gorman, Richmond; Asamoah, Jesse; Binger, Tabea; Awuah, Anthony Afum-Adjei; Amuasi, John; Phillips, Richard Odame] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Sylverken, Augustina Angelina] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [Ankrah, Sampson Twumasi] Kwame Nkrumah Univ Sci & Technol, Dept Stat & Actuarial Sci, Kumasi, Ghana; [El-Duah, Philip] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Ayisi-Boateng, Nana Kwame; Phillips, Richard Odame] Kwame Nkrumah Univ Sci & Technol, Dept Med, Kumasi, Ghana; [Acheampong, Godfred] Ctr Hlth Syst Strengthening, Kumasi, Ghana; [Bekoe, Franklin Asiedu] Ghana Hlth Serv, Dis Surveillance Unit, Accra, Ghana; [Ohene, Sally-Ann] World Hlth Org Off, Accra, Ghana; [Larsen-Reindorf, Rita] Ghana Hlth Serv, Ashanti Reg Hlth Directorate, Accra, Ghana; [Awuah, Anthony Afum-Adjei] Kwame Nkrumah Univ Sci & Technol, Dept Mol Med, Kumasi, Ghana; [Amuasi, John; Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Dept Global & Int Hlth, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kwame Nkrumah University Science & Technology; Ghana Health Service; Ghana Health Service; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Owusu, M (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana.; Owusu, M (corresponding author), Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana.	michaelowusu80@gmail.com	El-Duah, Philip/AAN-7425-2021; Phillips, Richard Odame/ABD-5394-2021	El-Duah, Philip/0000-0003-1671-0755; Phillips, Richard Odame/0000-0001-8992-0222; YEBOAH, RICHMOND/0000-0002-2765-6179; Acheampong, Godfred/0000-0003-2495-9235; Gorman, Richmond/0000-0002-6831-3375	MRC [MR/J01477X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anjorin AA, 2021, TROP MED INT HEALTH, V26, P2, DOI 10.1111/tmi.13504; Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896; Chen WJ, 2006, CLIN INFECT DIS, V42, P1561, DOI 10.1086/503843; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Cummings Matthew J, 2020, medRxiv, DOI [10.1016/S0140-6736(20)31189-2, 10.1101/2020.04.15.20067157]; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Di Gennaro F, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5030141; Foundation QDTOOSG, 2009, QGIS GEOGR INF SYST; Genot L, 2020, BRAZIL COVID 19 HITT; Gerna G, 2006, J MED VIROL, V78, P938, DOI 10.1002/jmv.20645; GHS, 2020, GHAN HLTH SERV COVID; GHS, 2020, IMM REL GHAN CONF 2, V2020, P1; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Heidari F, 2020, RHINOLOGY, V58, P302, DOI 10.4193/Rhin20.140; Hogan AB, 2020, LANCET GLOB HEALTH, V8, pE1132, DOI 10.1016/S2214-109X(20)30288-6; Hopkins C, 2020, LOSS SENSE SMELL MAR, V26, P2020; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Li MY, 2020, NUTR METAB CARDIOVAS, V30, P1061, DOI 10.1016/j.numecd.2020.04.013; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marchese-Ragona R., 2020, SUDDEN HYPOSMIA PREV, DOI [DOI 10.1101/2020.04.06.20045393, 10.1101/2020.04.06.20045393]; Meng XM, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102581; Moeser A, 2020, COVID 19 AFFECTS MEN; Mwiine AmonAshaba., 2020, CHIK WORLDW OV; NYC-Health, 2020, COR DIS 2019 COVID 1; Sahu KK, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2793; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Soler ZM, 2020, INT FORUM ALLERGY RH, V10, P814, DOI 10.1002/alr.22578; Statista, 2020, FEDERALISM COVID 19; WHO/Europe, 2020, SUPP OLD PEOPL COVID; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization,, 2020, TAIL MAL INT COVID 1; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Yu FT, 2020, CLIN INFECT DIS, V71, P793, DOI 10.1093/cid/ciaa345; Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243711	10.1371/journal.pone.0243711	http://dx.doi.org/10.1371/journal.pone.0243711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301533	Green Published, gold			2022-12-26	WOS:000600143100026
J	Wang, G; Wang, QB; Bai, J; Li, G; Tao, KX; Wang, GB; Xia, ZF				Wang, Geng; Wang, Qingbo; Bai, Jie; Li, Gang; Tao, Kaixiong; Wang, Guobin; Xia, Zefeng			RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BARIATRIC SURGERY; NONALCOHOLIC STEATOHEPATITIS; SLEEVE GASTRECTOMY; BYPASS-SURGERY; WEIGHT-LOSS; RAT MODEL; OBESITY; IDENTIFICATION; PREVALENCE	Background Roux-en-Y gastric bypass (RYGB) could reduce nonalcoholic fatty liver disease (NAFLD) ahead of the weight-loss effects. But the detailed mechanisms remain unclear. Material and methods A high-fat diet (HFD) was fed to induce obesity. RYGB was then performed. Gastric nesfatin-1 was measured by enzyme-linked immunosorbent assay (ELISA) in portal vein and polymerase chain reaction (PCR) in gastric tissues. Modified surgeries including vagus-preserved bypass and vagectomy were performed and postprandial gastric nesfatin-1 were analyzed. The effects of nesfatin-1 on hepatocytes were studied by PCR and immunohistochemistry. Both intraperitoneal and intracerebroventricular injection (ICV) were performed to analyze the in vivo effects on liver lipid metabolism. Results Increased postprandial portal vein nesfatin-1 was observed in RYGB but not in control groups. This increase is mainly due to induction of gastric nesfatin-1. A modified RYGB in which the gastric vagus is preserved is conducted and, in this case, this nesfatin-1 induction effect is diminished. Mere vagectomy could also induce a similar nesfatin-1 increase pattern. The infusion of nesfatin-1 in the brain could inhibit the expression of gastric nesfatin-1, and the effects are diminished after gastric vagectomy. In vivo and in vitro nesfatin-1 stimulation in the liver resulted in improvements in lipid metabolism. Conclusions Severing the gastric vagus during RYGB could cut off the negative control from the central nervous system (CNS) and result in increased postprandial gastric nesfatin-1 post surgery, which in turn, improves NAFLD.	[Wang, Geng; Bai, Jie; Li, Gang; Tao, Kaixiong; Wang, Guobin; Xia, Zefeng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China; [Wang, Qingbo] Wuhan Univ, Dept Gastrointestinal Surg 2, Renmin Hosp, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Xia, ZF (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China.	xiazefe0521@sina.com			National Key Basic Research Program of China [2015CB5540007]; National Natural Science Foundation of China [81472740, 81200276, 81700488]; Natural Science Foundation of Hubei Province of China [2014CFA060]; Natural Science Foundation of Huazhong University of Science and Technology [5001530030]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Natural Science Foundation of Huazhong University of Science and Technology	Guobin Wang, the National Key Basic Research Program of China (No.2015CB5540007); National Natural Science Foundation of China (No.81472740);Natural Science Foundation of Hubei Province of China (No.2014CFA060);Natural Science Foundation of Huazhong University of Science and Technology (No.5001530030). Zefeng Xia, National Natural Science Foundation of China (No. 81200276). Geng Wang, National Natural Science Foundation of China (No. 81700488).	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Alizai PH, 2015, OBES SURG, V25, P2047, DOI 10.1007/s11695-015-1664-0; [Anonymous], 2012, AM J PHYSIOL-ENDOC M, V303, pE410; [Anonymous], 2011, J CLIN ENDOCR METAB, V96, pE304; Arterburn DE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3961; Barker KB, 2006, AM J GASTROENTEROL, V101, P368, DOI 10.1111/j.1572-0241.2006.00419.x; Basar O, 2012, SCAND J CLIN LAB INV, V72, P479, DOI 10.3109/00365513.2012.699097; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bueter M, 2012, JOVE-J VIS EXP, DOI 10.3791/3940; Caiazzo R, 2014, ANN SURG, V260, P893, DOI 10.1097/SLA.0000000000000945; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen X, 2015, NEUROPEPTIDES, V53, P45, DOI 10.1016/j.npep.2015.07.004; Chen Z, 2018, CELL MOL NEUROBIOL, V38, P627, DOI 10.1007/s10571-017-0509-x; Choi YK, 2001, J CLIN MICROBIOL, V39, P3311, DOI 10.1128/JCM.39.9.3311-3315.2001; Dore R, 2017, J ENDOCRINOL, V232, pR45, DOI 10.1530/JOE-16-0361; Du JP, 2018, OBES SURG, V28, P3851, DOI 10.1007/s11695-018-3351-4; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Froylich D, 2016, SURG OBES RELAT DIS, V12, P127, DOI 10.1016/j.soard.2015.04.004; Guo FF, 2015, J NEUROCHEM, V132, P266, DOI 10.1111/jnc.12973; Hankir MK, 2017, CELL METAB, V25, P335, DOI 10.1016/j.cmet.2016.12.006; Huang B, 2017, 2017 INTERNATIONAL CONFERENCE ON MECHANICAL, SYSTEM AND CONTROL ENGINEERING (ICMSC), P333, DOI 10.1109/ICMSC.2017.7959496; Lassailly G, 2015, GASTROENTEROLOGY, V149, P379, DOI 10.1053/j.gastro.2015.04.014; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Malek N, 2016, PHARMACOL RES, V111, P251, DOI 10.1016/j.phrs.2016.06.012; Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330; Mortazavi S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00022; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Salgado W, 2016, OBES SURG, V26, P2718, DOI 10.1007/s11695-016-2176-2; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; SCHOLTENS E, 1983, EXPERIENTIA, V39, P1176, DOI 10.1007/BF01943169; Shao YK, 2017, OBES SURG, V27, P295, DOI 10.1007/s11695-016-2297-7; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Stengel A, 2013, HISTOCHEM CELL BIOL, V139, P909, DOI 10.1007/s00418-013-1087-8; Tang CH, 2012, PEPTIDES, V36, P39, DOI 10.1016/j.peptides.2012.04.014; van Dammen L, 2018, OBES REV, V19, P1679, DOI 10.1111/obr.12752; Verbeek J, 2015, GUT, V64, P673, DOI 10.1136/gutjnl-2014-306748; Wang H, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-967, 10.1186/1471-2407-12-528]; Wang QB, 2019, OBES SURG, V29, P1681, DOI 10.1007/s11695-019-03789-5; Wolfe BM, 2016, CIRC RES, V118, P1844, DOI 10.1161/CIRCRESAHA.116.307591; Xia ZF, 2015, CURR PHARM DESIGN, V21, P1464, DOI 10.2174/1381612821666141219125527; Yin Y, 2015, MOL CELL ENDOCRINOL, V417, P20, DOI 10.1016/j.mce.2015.09.006; Yuan FH, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0190-y; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039	43	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243640	10.1371/journal.pone.0243640	http://dx.doi.org/10.1371/journal.pone.0243640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301513	Green Published, gold			2022-12-26	WOS:000600143100067
J	Pittner, S; Bugelli, V; Benbow, ME; Ehrenfellner, B; Zissler, A; Campobasso, CP; Oostra, RJ; Aalders, MCG; Zehner, R; Lutz, L; Monticelli, FC; Staufer, C; Helm, K; Pinchi, V; Receveur, JP; Geissenberger, J; Steinbacher, P; Amendt, J				Pittner, Stefan; Bugelli, Valentina; Benbow, M. Eric; Ehrenfellner, Bianca; Zissler, Angela; Campobasso, Carlo P.; Oostra, Roelof-Jan; Aalders, Maurice C. G.; Zehner, Richard; Lutz, Lena; Monticelli, Fabio C.; Staufer, Christian; Helm, Katharina; Pinchi, Vilma; Receveur, Joseph P.; Geissenberger, Janine; Steinbacher, Peter; Amendt, Jens			The applicability of forensic time since death estimation methods for buried bodies in advanced decomposition stages	PLOS ONE			English	Article							SKELETAL-MUSCLE PROTEINS; POSTMORTEM INTERVAL; DEGRADATION; RELIABILITY; SUCCESSION; DIVERSITY	Estimation of the postmortem interval in advanced postmortem stages is a challenging task. Although there are several approaches available for addressing postmortem changes of a (human) body or its environment (ecologically and/or biochemically), most are restricted to specific timeframes and/or individual and environmental conditions. It is well known, for instance, that buried bodies decompose in a remarkably different manner than on the ground surface. However, data on how established methods for PMI estimation perform under these conditions are scarce. It is important to understand whether and how postmortem changes are affected under burial conditions, if corrective factors could be conceived, or if methods have to be excluded for respective cases. We present the first multi-methodological assessment of human postmortem decomposition carried out on buried body donors in Europe, at the Amsterdam Research Initiative for Sub-surface Taphonomy and Anthropology (ARISTA) in the Netherlands. We used a multidisciplinary approach to investigate postmortem changes of morphology, skeletal muscle protein decomposition, presence of insects and other necrophilous animals as well as microbial communities (i.e., microbiomes) from August to November 2018 associated with two complete body exhumations and eight partial exhumations. Our results clearly display the current possibilities and limitations of methods for PMI estimation in buried remains and provide a baseline for future research and application.	[Pittner, Stefan; Monticelli, Fabio C.; Staufer, Christian; Helm, Katharina] Univ Salzburg, Dept Forens Med, Salzburg, Austria; [Bugelli, Valentina; Pinchi, Vilma] Univ Florence, Dept Med & Hlth Sci, Florence, Italy; [Benbow, M. Eric; Receveur, Joseph P.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Benbow, M. Eric] Michigan State Univ, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [Benbow, M. Eric] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; [Ehrenfellner, Bianca; Zissler, Angela; Geissenberger, Janine; Steinbacher, Peter] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Campobasso, Carlo P.] Univ L Vanvitelli Campania, Dept Expt Med, Naples, Italy; [Oostra, Roelof-Jan] Univ Amsterdam, Dept Med Biol, Amsterdam UMC Locat AMC, Amsterdam, Netherlands; [Aalders, Maurice C. G.] Univ Amsterdam, Dept Biomed Engn & Phys, Amsterdam UMC Locat AMC, Amsterdam, Netherlands; [Zehner, Richard; Lutz, Lena; Amendt, Jens] Goethe Univ Frankfurt, Inst Legal Med, Frankfurt, Germany	Salzburg University; University of Florence; Michigan State University; Michigan State University; Michigan State University; Salzburg University; Universita della Campania Vanvitelli; University of Amsterdam; University of Amsterdam; Goethe University Frankfurt	Pittner, S (corresponding author), Univ Salzburg, Dept Forens Med, Salzburg, Austria.	stefan.pittner@sbg.ac.at	z, r/ABA-2962-2021; Pinchi, Vilma/ABA-7212-2021	Pinchi, Vilma/0000-0002-6124-3298; Oostra, Roelof-Jan/0000-0002-2452-8307; Aalders, Maurice/0000-0001-8083-9209; Pittner, Stefan/0000-0002-9862-9135	Austrian Science Fund (FWF) [P31490]; Foundation "Forensisches Forum"; Tu-Ba Foundation for Legal Medicine	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Foundation "Forensisches Forum"; Tu-Ba Foundation for Legal Medicine	This work was supported by the Austrian Science Fund (FWF), grant P31490, received by Peter Steinbacher, the Foundation "Forensisches Forum", received by Jens Amendt and the Tu-Ba Foundation for Legal Medicine, received by Stefan Pittner.	[Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Benbow ME, 2013, J MED ENTOMOL, V50, P440, DOI 10.1603/ME12194; Benbow ME, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1331; Boehme P, 2010, INT J LEGAL MED, V124, P577, DOI 10.1007/s00414-010-0429-5; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolton SN, 2015, J FORENSIC SCI, V60, P1061, DOI 10.1111/1556-4029.12764; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bourel B, 2004, INT J LEGAL MED, V118, P215, DOI 10.1007/s00414-004-0449-0; Bugelli V, 2018, FOREN SCI RES, V3, P94, DOI 10.1080/20961790.2017.1418622; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Camelena F, 2016, ANAEROBE, V40, P15, DOI 10.1016/j.anaerobe.2016.04.015; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Choi KM, 2019, INT J LEGAL MED, V133, P899, DOI 10.1007/s00414-019-02011-6; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cockle DL, 2015, FORENSIC SCI INT, V253, DOI 10.1016/j.forsciint.2015.05.018; Connor M, 2018, J FORENSIC SCI, V63, P1350, DOI 10.1111/1556-4029.13727; da Fonseca CAR, 2019, LEGAL MED-TOKYO, V36, P67, DOI 10.1016/j.legalmed.2018.11.003; Dabbs GR, 2016, J FORENSIC SCI, V61, P445, DOI 10.1111/1556-4029.12962; Dautartas A, 2018, J FORENSIC SCI, V63, P1673, DOI 10.1111/1556-4029.13784; De Donno A, 2014, SCI JUSTICE, V54, P439, DOI 10.1016/j.scijus.2014.10.003; DeBruyn JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3437; Disney RHL, 2008, ANNU REV ENTOMOL, V53, P39, DOI 10.1146/annurev.ento.53.103106.093415; Disney RHL, 1989, SCUTTLE FLIES DIPTER, P10; Ehrenfellner B, 2017, INT J LEGAL MED, V131, P1615, DOI 10.1007/s00414-017-1643-1; El-Noor MMA, 2016, AM J FOREN MED PATH, V37, P40, DOI 10.1097/PAF.0000000000000214; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Fiedler S, 2003, NATURWISSENSCHAFTEN, V90, P291, DOI 10.1007/s00114-003-0437-0; Finley SJ, 2016, MICROB ECOL, V71, P524, DOI 10.1007/s00248-015-0725-1; Fisher R, 1973, GUIDELINES APPL PATH, V4th; Foditsch EE, 2016, INT J LEGAL MED, V130, P433, DOI 10.1007/s00414-015-1204-4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaudry E, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P273, DOI 10.1007/978-1-4020-9684-6_13; Gelderman HT, 2018, INT J LEGAL MED, V132, P863, DOI 10.1007/s00414-017-1700-9; Griffiths BS, 1999, SOIL PDU SOIL MICROB; Heaton V, 2010, J FORENSIC SCI, V55, P302, DOI 10.1111/j.1556-4029.2009.01291.x; Henssge C, 2004, FORENSIC SCI INT, V144, P167, DOI 10.1016/j.forsciint.2004.04.051; Holmes B, 1992, GENERA FLAVOBACTERIU, P3620, DOI [10.1007/0-387-30747-8_19, DOI 10.1007/0-387-30747-8_19]; Hyde ER, 2015, INT J LEGAL MED, V129, P661, DOI 10.1007/s00414-014-1128-4; Hyde ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077733; Kassambara A., 2017, GGPUBR GGPLOT2 BASED; Kaszubinski SF, 2020, J FORENSIC SCI, V65, P1210, DOI 10.1111/1556-4029.14303; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim Hye Jeong, 2014, Korean J Pathol, V48, P193, DOI 10.4132/KoreanJPathol.2014.48.3.193; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Langley N., 2019, FORENSIC ANTHR, V2, P152, DOI [10.5744/fa.2019.1011, DOI 10.5744/FA.2019.1011]; Liu RN, 2020, ENVIRON MICROBIOL, V22, P2273, DOI 10.1111/1462-2920.15000; Marhoff SJ, 2016, AUST J FORENSIC SCI, V48, P24, DOI 10.1080/00450618.2015.1021378; Marhoff-Beard SJ, 2018, FORENSIC SCI INT, V291, P158, DOI 10.1016/j.forsciint.2018.08.022; Matuszewski S, 2020, INT J LEGAL MED, V134, P793, DOI 10.1007/s00414-019-02074-5; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Megyesi MS, 2005, J FORENSIC SCI, V50, P618; Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646; Moffatt C, 2016, J FORENSIC SCI, V61, pS201, DOI 10.1111/1556-4029.12931; Myburgh J, 2013, FORENSIC SCI INT, V229, DOI 10.1016/j.forsciint.2013.03.037; Nawrocka M, 2016, J FORENSIC SCI, V61, P798, DOI 10.1111/1556-4029.13105; Oksanen J., 2015, VEGAN COMMUNITY ECOL; Oostra RJ, 2020, FORENSIC SCI INT, V317, DOI 10.1016/j.forsciint.2020.110483; Pechal JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23989-w; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Pittner S, 2020, INT J LEGAL MED, V134, P1361, DOI 10.1007/s00414-020-02278-0; Pittner S, 2016, INT J LEGAL MED, V130, P1547, DOI 10.1007/s00414-016-1349-9; Pittner S, 2016, INT J LEGAL MED, V130, P421, DOI 10.1007/s00414-015-1210-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prieto-Bonete G, 2019, J PROTEOMICS, V192, P54, DOI 10.1016/j.jprot.2018.08.008; Procopio N, 2019, FORENSIC SCI INT-GEN, V39, P73, DOI 10.1016/j.fsigen.2018.12.002; Receveur JP, 2020, HYDROBIOLOGIA, V847, P331, DOI 10.1007/s10750-019-04097-w; Rhine S, 1998, FORENSIC OSTEOLOGY A, V2nd, P145; Ribereau-Gayon A, 2018, SCI JUSTICE, V58, P167, DOI 10.1016/j.scijus.2017.12.001; RODRIGUEZ WC, 1985, J FORENSIC SCI, V30, P836; Ryan MP, 2018, VIRULENCE, V9, P480, DOI 10.1080/21505594.2017.1419116; Sambrook J., 2001, MOL CLONING LAB MANU; Sampaio-Silva F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056507, 10.1371/annotation/cb8b37ac-cbe2-45e3-b9fe-d62e7ced4b25]; Schlaghamersky J, 2015, DOES CARCASS DECOMPO, P87; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith KGV, 1986, MANUAL FORENSIC ENTO; Sorg M. H., 1997, FORENSIC TAPHONOMY P; STANDEN V, 1978, J ANIM ECOL, V47, P25, DOI 10.2307/3920; Suckling JK, 2016, J FORENSIC SCI, V61, P19, DOI 10.1111/1556-4029.12892; Sutherland A, 2013, FORENSIC SCI INT, V231, P257, DOI 10.1016/j.forsciint.2013.05.035; Tozzo P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103540; Van Elsas JD., 2006, MODERN SOIL MICROBIO, DOI [10.1201/9781420015201, DOI 10.1201/9781420015201]; Vass AA, 2011, FORENSIC SCI INT, V204, P34, DOI 10.1016/j.forsciint.2010.04.052; Wescott DJ, 2018, FOREN SCI RES, V3, P278, DOI 10.1080/20961790.2018.1488571; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams A, 2019, FORENSIC SCI INT, V296, P74, DOI 10.1016/j.forsciint.2019.01.010; Wilson AS, 2007, FORENSIC SCI INT, V169, P6, DOI 10.1016/j.forsciint.2006.07.023; Wood P.L., 2013, METABOLOMICS, V3, P3, DOI [DOI 10.4172/2153-0769.1000127, 10.4172/2153-0769.1000127]; Zhang Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213829	92	12	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243395	10.1371/journal.pone.0243395	http://dx.doi.org/10.1371/journal.pone.0243395			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296399	Green Published, gold			2022-12-26	WOS:000598626100026
J	Slowinski, J; Surmik, D; Duda, P; Zaton, M				Slowinski, Jakub; Surmik, Dawid; Duda, Piotr; Zaton, Michal			Assessment of serpulid-hydroid association through the Jurassic: A case study from the Polish Basin	PLOS ONE			English	Article							KRAKOW-SILESIA HOMOCLINE; ORE-BEARING CLAYS; PALEOENVIRONMENTAL RECONSTRUCTION; CZESTOCHOWA AREA; 1ST RECORD; MIDDLE; BRYOZOANS; GNASZYN; POLAND; ULTRASTRUCTURE	The coexistence of sessile, tube-dwelling polychaetes (serpulids) and hydroids, has been investigated. Serpulid tubes bearing traces after hydroids are derived from different stratigraphic intervals spanning the Middle and Upper Jurassic, the rocks of which represent the diverse paleoenvironments of the Polish Basin. Although fossil colonial hydroids classified under the species Protulophila gestroi are a commonly occurring symbiont of these polychaetes during the Late Cretaceous and Cenozoic, they seem to be significantly less frequent during the Jurassic and limited to specific paleoenvironments. The hydroids described here are represented by traces after a thin stolonal network with elongated polyp chambers that open to the outer polychaete tube's surface with small, more or less subcircular apertures. Small chimney-like bulges around openings are an effect of the incorporation of the organism by in vivo embedment (bioclaustration) within the outer layers of the calcareous tube of the serpulid host. Considering the rich collection of well-preserved serpulid tubes (>3000 specimens), the frequency of bioclaustrated hydroids is very low, with an infestation percentage of only 0.6% (20 cases). It has been noticed that only specimens of the genus Propomatoceros from the Upper Bajocian, Lower Bathonian, Middle Bathonian, and Callovian have been found infested. However, the majority of bioclaustrated hydroids (17 cases) have been recorded in the Middle Bathonian serpulid species Propomatoceros lumbricalis coming from a single sampled site. Representatives of other genera are not affected, which is congruent with previous reports indicating that Protulophila gestroi was strongly selective in the choice of its host. A presumably commensal relationship is compared with the recent symbiosis between the hydroids of the genus Proboscidactyla and certain genera of sabellid polychaetes.	[Slowinski, Jakub; Surmik, Dawid; Zaton, Michal] Univ Silesia Katowice, Inst Earth Sci, Sosnowiec, Poland; [Duda, Piotr] Univ Silesia Katowice, Fac Comp Sci & Mat Sci, Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Slowinski, J (corresponding author), Univ Silesia Katowice, Inst Earth Sci, Sosnowiec, Poland.	jakub.slowinski@us.edu.pl	Słowiński, Jakub/CAJ-2424-2022	Surmik, Dawid/0000-0003-0121-9592; Slowinski, Jakub/0000-0001-9633-5929; Zaton, Michal/0000-0001-5136-5286	University of Silesia in Katowice, Institute of Earth Sciences	University of Silesia in Katowice, Institute of Earth Sciences	The research is supported by the University of Silesia in Katowice, Institute of Earth Sciences. There was no additional external funding received for this study.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; [Anonymous], 2014, C37314A ASTM, V88, P1; [Anonymous], 2015, JMIR MED INFORM, V3, pe22; Ballard L, 1997, J MAR BIOL ASSOC UK, V77, P999, DOI 10.1017/S0025315400038583; Barski Marcin, 2004, Tomy Jurajskie, V2, P61; Baumiller Tomasz K., 2002, Paleontological Society Papers, V8, P195; Bertling M, 2006, LETHAIA, V39, P265, DOI 10.1080/00241160600787890; Brandt JF, 1834, ACAD IMP SCI; CANCINO JM, 1987, J EXP MAR BIOL ECOL, V113, P105, DOI 10.1016/0022-0981(87)90158-4; Carboni MG, 1982, ATTI SOC TOSCANA S A, VA88, P51; Dayczak-Calikow ska K., 1988, GEOL Q, V32, P117; Dolakova N, 2014, NEUES JAHRB GEOL P-A, V271, P169, DOI 10.1127/0077-7749/2014/0383; DONALDSON S, 1974, BIOL BULL, V147, P573, DOI 10.2307/1540741; Drishti Limaye A., 2012, P SOC PHOTO-OPT INS, V8506; Evans S, 1997, LETHAIA, V30, P185; Gedl P, 2012, ACTA GEOL POL, V62, P463; Gedl P, 2012, ACTA GEOL POL, V62, P267, DOI 10.2478/v10263-012-0014-y; GIZEJEWSKA M, 1976, B POL ACAD SCI-EARTH, V24, P167; HAND C, 1950, BIOL BULL, V99, P74, DOI 10.2307/1538753; HUGHES RG, 1983, J MAR BIOL ASSOC UK, V63, P467, DOI 10.1017/S0025315400070806; Ippolitov AP, 2007, PALEONTOL J+, V41, P429, DOI 10.1134/S0031030107040090; Ippolitov Alexei P., 2014, Memoirs of Museum Victoria, V71, P123; Ippolitov AP., 2010, EARTH SCI FRONTIERS, V17, P207; Jager M., 1993, Contributions to Tertiary and Quaternary Geology, V29, P73; Jager M., 2001, STUTTGARTER BEITRA B, V308, P1; Jager M., 2011, ANN NATURH MUS WIEN, V113, P675; Joger, 1983, GEOL JB A, V68, P3; Joger M., 2008, GEOLOGIE PALAONTOLOG, V71, P47; Kamali Sarvestani H, 2015, GEOSCIENCES, V25, P421; Kawamura M, 2008, J MAR BIOL ASSOC UK, V88, P1601, DOI 10.1017/S0025315408002944; Kutek J, 1992, OXF KIMM JOINT WORK, P30; Kutek Jan, 1994, Acta Geologica Polonica, V44, P167; Kuziomko-Szewczuk M, 2010, THESIS; Leonowicz P, 2015, FACIES, V61, DOI 10.1007/s10347-015-0438-4; Leonowicz P, 2015, GEOL Q, V59, P325, DOI 10.7306/gq.1221; Leonowicz P, 2013, GEOL Q, V57, P243, DOI 10.7306/gq.1092; Leonowicz P, 2012, ACTA GEOL POL, V62, P281, DOI 10.2478/v10263-012-0015-x; Machalski M, 1998, ACTA PALAEONTOL POL, V43, P609; Majewski W., 2000, ACTA GEOL POL, V50, P431; Mangold Charles, 1996, Revue de Paleobiologie, V15, P55; Marynowski L, 2007, APPL GEOCHEM, V22, P2456, DOI 10.1016/j.apgeochem.2007.06.015; Matyja Bronislaw Andrzej, 2000, Acta Geologica Polonica, V50, P191; Matyszkiewicz J, 2012, SEDIMENT GEOL, V263, P109, DOI 10.1016/j.sedgeo.2011.08.005; McCormick JM, 1969, THESIS; McKinney F, 2009, ICHNOS, V16, P193, DOI 10.1080/10420940802686160; Mokady O, 2001, MOL BIOL EVOL, V18, P975, DOI 10.1093/oxfordjournals.molbev.a003898; Montano S, 2014, MAR BIODIVERS, V44, P581, DOI 10.1007/s12526-014-0207-6; Montano S, 2015, ZOOL SCR, V44, P92, DOI 10.1111/zsc.12081; Nawrocki J, 2005, ACTA GEOL POL, V55, P229; Niebuhr B, 2005, NEUES JAHRB GEOL P-M, P219; PALMER TJ, 1988, PALAEONTOLOGY, V31, P939; Poulsen Niels E., 1998, Acta Geologica Polonica, V48, P237; Puce S, 2005, MAR ECOL-EVOL PERSP, V26, P73, DOI 10.1111/j.1439-0485.2005.00050.x; Puce S, 2007, SYMBIOSIS, V44, P137; Radwanska U, 2004, ACTA GEOL POL, V54, P35; Radwanska Urszula, 1996, Acta Geologica Polonica, V46, P61; Ronowicz M, 2013, POLAR BIOL, V36, P705, DOI 10.1007/s00300-013-1297-5; Rovereto G., 1901, Palaeontographia Italica, Vvii, P219; Roycki SZ, 1953, PRZEGLD I GEOL, V17, P1; Sadlok G, 2020, PALAEOBIO PALAEOENV, V100, P757, DOI 10.1007/s12549-019-00410-6; Savazzi Enrico, 2001, Paleontological Research, V5, P55; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; SCRUTTON C T, 1975, Palaeontology (Oxford), V18, P255; Sowerby JDC, 1829, MINERAL CONCHOLOGY G, P1829, DOI [10.1038/s41598-017-04695-5, DOI 10.1038/S41598-017-04695-5]; Sowiski J., 2019, THESIS; SPENCER AN, 1975, BIOL BULL, V149, P236, DOI 10.2307/1540493; STRICKLAND DL, 1971, PAC SCI, V25, P88; Szczepanik P, 2007, GEOL Q, V51, P57; Szewczuk A, 2010, THESIS; Tapanila Leif, 2007, P345, DOI 10.1016/B978-044452949-7/50145-5; Tapanila Leif, 2008, Paleontological Society Papers, V14, P271; Tarkowski R, 1994, GEBIOS, V27, P461, DOI [10.1016/S0016-6995(94)80167-3, DOI 10.1016/S0016-6995(94)80167-3]; Taylor Paul D., 2008, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V110A, P17; TAYLOR PD, 1990, PALAEONTOLOGY, V33, P1; Taylor PD, 2003, EARTH-SCI REV, V62, P1, DOI 10.1016/S0012-8252(02)00131-9; Taylor PD, 2002, PALAIOS, V17, P522, DOI 10.1669/0883-1351(2002)017<0522:ANTFMO>2.0.CO;2; The Working Group on Diabetes and Cardiovascular Diseases of the European Society of Cardiology and the European Association for the Study of Diabetes, 2007, RATIONAL PHARMACOTHE, V4, P71; Topper TP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06704; Uchida T., 1941, J FS HOKKAIDO IMPERI, V7, P431; Vinn O, 2008, PALAEONTOLOGY, V51, P295, DOI 10.1111/j.1475-4983.2008.00763.x; Vinn O, 2017, PALAIOS, V32, P231, DOI 10.2110/palo.2016.092; Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x; WALKER S E, 1992, Palaios, V7, P236, DOI 10.2307/3514934; Walter B., 1965, COMPTE RENDU SOMMAIR, P286; WRIGLEY ARTHUR, 1951, PROC GEOL ASSOC LONDON, V62, P177; Zagorsek K, 2009, B GEOSCI, V84, P631, DOI 10.3140/bull.geosci.1079; Zapalski MK, 2011, PALAEOGEOGR PALAEOCL, V302, P484, DOI 10.1016/j.palaeo.2011.01.013; Zaton M, 2004, GEOL Q, V48, P339; Zaton M., 2006, PRZ GEOL, V54, P131; Zaton M, 2013, PALAIOS, V28, P839, DOI 10.2110/palo.2013.025; Zaton M, 2012, PALAIOS, V27, P550, DOI 10.2110/palo.2012.p12-013r; Zaton M, 2012, FACIES, V58, P57, DOI 10.1007/s10347-011-0273-1; Zaton M, 2011, PALAEOGEOGR PALAEOCL, V307, P232, DOI 10.1016/j.palaeo.2011.05.022; Zaton M, 2011, FACIES, V57, P275, DOI 10.1007/s10347-010-0244-y; Zaton M, 2009, B GEOSCI, V84, P653, DOI 10.3140/bull.geosci.1167; Zaton M, 2009, ACTA PALAEONTOL POL, V54, P267, DOI 10.4202/app.2008.0088	96	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242924	10.1371/journal.pone.0242924	http://dx.doi.org/10.1371/journal.pone.0242924			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296393	gold, Green Published			2022-12-26	WOS:000598626100012
J	Margraf, J; Brailovskaia, J; Schneider, S				Margraf, Jurgen; Brailovskaia, Julia; Schneider, Silvia			Behavioral measures to fight COVID-19: An 8-country study of perceived usefulness, adherence and their predictors	PLOS ONE			English	Article							POSITIVE MENTAL-HEALTH; DISORDERS	Behavioral measures, such as the wearing of facemasks and maintaining of distance to other people, have been central in fighting the COVID-19 pandemic and will continue to be important in curbing its spread. We therefore investigated their perceived usefulness, adherence and their predictors in representative online samples in eight countries (France, Germany, Poland, Russia, Spain, Sweden, U.K., U.S.). Of the 7,658 participants, 77.4% rated governmental measures (highest: Germany, lowest: France) as useful and 91.7% reported adherence to them. Adherence was lowest in Russia and Poland, where people felt particularly left alone and not well supported, and in the U.S. and Sweden, where governments showed ambivalent attitudes towards the measures. The highest adherence was reported in countries with very high mortality (U.K., Spain, France) or very positively perceived government communication (Germany). Female gender, higher age, belonging to a risk group, being affected physically and mentally, perception of governmental communication as guided by the interests of people, feeling of being well informed and the level of positive mental health positively predicted both outcomes, while being affected economically negatively predicted both outcomes. Country-specific results are considered in the light of the protection motivation theory and the theory of planned behavior together with potential ways to improve active participation of the population. Overall, we recommend the governments and authorities to stress that each individual can contribute to the control of the COVID-19 situation by adherence to the measures in the public communication. Moreover, they should emphasize the risk of unconscious infection of older individuals by younger people, as well as the importance of physical activity for the protection of mental and physical health especially during the pandemic.	[Margraf, Jurgen; Brailovskaia, Julia] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Psychol & Psychotherapy, Bochum, Germany; [Schneider, Silvia] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Child & Adolescent Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Brailovskaia, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Psychol & Psychotherapy, Bochum, Germany.	julia.brailovskaia@rub.de	Brailovskaia, Julia/AAN-7333-2021; Margraf, Jürgen/A-6873-2008; Schneider, Silvia/C-5229-2015	Brailovskaia, Julia/0000-0001-7607-1305; Margraf, Jürgen/0000-0001-5207-7016; Schneider, Silvia/0000-0003-0698-8411	Open Access Publication Funds of the Ruhr-Universitat Bochum	Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the Open Access Publication Funds of the Ruhr-Universitat Bochum to Jurgen Margraf (JM) to pay the publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2020, GUARDIAN 1026; Beltekian D, 2020, COVID 19 DATA; Bieda A, 2017, PSYCHOL ASSESSMENT, V29, P408, DOI 10.1037/pas0000353; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bock P, 2020, EURONEWS; Brailovskaia J, INT J CLIN HLTH PSYC, DOI [10.1016/j.ijchp.2020.06.002, DOI 10.1016/J.IJCHP.2020.06.00232837518]; Brailovskaia J, 2022, CURR PSYCHOL, V41, P6543, DOI 10.1007/s12144-020-01152-x; Brailovskaia J, 2020, COMPUT HUM BEHAV, V113, DOI 10.1016/j.chb.2020.106511; Brailovskaia J, 2020, CYBERPSYCH BEH SOC N, V23, P346, DOI 10.1089/cyber.2019.0563; Brailovskaia J, 2020, CRISIS, V41, P383, DOI 10.1027/0227-5910/a000652; Brailovskaia J, 2019, J BEHAV ADDICT, V8, P703, DOI 10.1556/2006.8.2019.63; Brailovskaia J, 2018, DRUG ALCOHOL DEPEN, V192, P324, DOI 10.1016/j.drugalcdep.2018.08.027; Carter H, 2015, HEALTH SECUR, V13, P45, DOI 10.1089/hs.2014.0061; Cismaru M, 2011, SOC MARK Q, V17, P62, DOI 10.1080/15245004.2011.595539; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Corona-Regeln N, 2020, SUEDDEUTSCHE ZEITUNG, V2020, P29; Die Bundesregierung, 2020, COR DEUTSCHL HILF KU; Dmitrieva I, 2020, COVID 19 RUSSIAN GOV; Drury J., 2009, INT J MASS EMERGENCI, V27, P66, DOI DOI 10.1007/S13398-014-0173-7.2; Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929; Eurostat, 2007, TASK FORC COR SOC VA; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; GaIatzer-Levy IR, 2018, CLIN PSYCHOL REV, V63, P41, DOI 10.1016/j.cpr.2018.05.008; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Garcia L.B., El Gobierno Obliga a Quedarse en Casa a los Trabajadores de Servicios no Esenciales del 30 de Marzo al 9 de Abril; Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y; Gershman J., 2020, WALL STR J, V8; Gouvernement, 2020, COR COVID 19; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Hoffmeyer-Zlotnik JHP, 2012, HARMONISIERUNG DEMOG; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011; Lazarus JV, 2020, NAT MED, P1, DOI [10.1038/s41591-019-0740-8, DOI 10.1038/S41591-019-0740-831932805]; Lukat J, 2017, CLIN PSYCHOL PSYCHOT, V24, P322, DOI 10.1002/cpp.2026; Lukat Justina, 2016, BMC Psychol, V4, P8, DOI 10.1186/s40359-016-0111-x; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mayr S, 2007, TUTOR QUANT METHODS, V3, P51, DOI 10.20982/tqmp.03.2.p051; McKibbin W., 2020, EC TIME COVID 19, P45, DOI DOI 10.2139/SSRN.3547729; McMurtry A., 2020, SPAIN FIGHTS 73 COVI; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Mondor L, 2012, EMERG INFECT DIS, V18, P1184, DOI 10.3201/eid1807.120249; Patchen M, 2006, PUBLIC ATTITUDES BEH; Richards J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1391-4; Robert Koch Institute, 2020, TAGL LAG RKI COR KRA; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; Scholten S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194642; Scholten S, 2017, SSM-POPUL HLTH, V3, P639, DOI 10.1016/j.ssmph.2017.07.010; Secon Holly, 2020, BUSINESS INSIDER; Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; STEVENS JP, 1980, PSYCHOL BULL, V88, P728, DOI 10.1037/0033-2909.88.3.728; Szrek H, 2012, JUDGM DECIS MAK, V7, P716; Teasdale E, 2012, BRIT J HEALTH PSYCH, V17, P44, DOI 10.1111/j.2044-8287.2011.02017.x; Teismann T, 2019, INT J CLIN HLTH PSYC, V19, P165, DOI 10.1016/j.ijchp.2019.02.003; Teismann T, 2018, BEHAV RES THER, V108, P40, DOI 10.1016/j.brat.2018.06.006; Teismann T, 2018, INT J CLIN HLTH PSYC, V18, P1, DOI 10.1016/j.ijchp.2017.08.001; The Euroqol Group, 2013, EQ 5D 3L USER GUIDE; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Thiessen T, 2020, FRANCE HERE ARE DETA; Truskauskaite-Kuneviciene I, 2022, CURR PSYCHOL, V41, P1951, DOI 10.1007/s12144-020-00714-3; TVN24, 2020, NOW OGR PRZEM SI BD; Urban D., 2006, REGRESSIONSANALYSE T; WHO, 2020, WEEKLY EPIDEMIOLOGIC; Wiest B., 2020, FORBES; Williams L, 2015, PSYCHOL HEALTH MED, V20, P832, DOI 10.1080/13548506.2015.1028946; World Health Organization, 2003, HLTH DEV PHYS ACT SP; World Health Organization, 2020, CONS ADJ PUBL HLTH S; Zuckerman M., 2014, SENSATION SEEKING PS; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	71	52	52	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243523	10.1371/journal.pone.0243523	http://dx.doi.org/10.1371/journal.pone.0243523			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284865	gold, Green Published			2022-12-26	WOS:000597930500037
J	Rutledge, CA; Chiba, T; Redding, K; Dezfulian, C; Sims-Lucas, S; Kaufman, BA				Rutledge, Cody A.; Chiba, Takuto; Redding, Kevin; Dezfulian, Cameron; Sims-Lucas, Sunder; Kaufman, Brett A.			A novel ultrasound-guided mouse model of sudden cardiac arrest	PLOS ONE			English	Article							ANIMAL-MODELS; CARDIOPULMONARY-RESUSCITATION; RENAL DYSFUNCTION; OUTCOMES; HYPOTHERMIA; ISCHEMIA; SURVIVAL; KIDNEY	Aim Mouse models of sudden cardiac arrest are limited by challenges with surgical technique and obtaining reliable venous access. To overcome this limitation, we sought to develop a simplified method in the mouse that uses ultrasound-guided injection of potassium chloride directly into the heart. Methods Potassium chloride was delivered directly into the left ventricular cavity under ultrasound guidance in intubated mice, resulting in immediate asystole. Mice were resuscitated with injection of epinephrine and manual chest compressions and evaluated for survival, body temperature, cardiac function, kidney damage, and diffuse tissue injury. Results The direct injection sudden cardiac arrest model causes rapid asystole with high surgical survival rates and short surgical duration. Sudden cardiac arrest mice with 8-min of asystole have significant cardiac dysfunction at 24 hours and high lethality within the first seven days, where after cardiac function begins to improve. Sudden cardiac arrest mice have secondary organ damage, including significant kidney injury but no significant change to neurologic function. Conclusions Ultrasound-guided direct injection of potassium chloride allows for rapid and reliable cardiac arrest in the mouse that mirrors human pathology without the need for intravenous access. This technique will improve investigators' ability to study the mechanisms underlying post-arrest changes in a mouse model.	[Rutledge, Cody A.; Redding, Kevin; Kaufman, Brett A.] Univ Pittsburgh, Cardiovasc Inst, Div Cardiol, Pittsburgh, PA 15260 USA; [Chiba, Takuto; Sims-Lucas, Sunder] Univ Pittsburgh, Childrens Hosp Pittsburgh, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Chiba, Takuto; Sims-Lucas, Sunder] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA; [Dezfulian, Cameron] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Dezfulian, Cameron] Univ Pittsburgh, Crit Care Med Dept, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaufman, BA (corresponding author), Univ Pittsburgh, Cardiovasc Inst, Div Cardiol, Pittsburgh, PA 15260 USA.	bkauf@pitt.edu		Kaufman, Brett/0000-0003-4767-4937	American Heart Association Transformation Project Award [18TPA34230048]; NIH Instrument Grant for Advanced HighResolution Rodent Ultrasound Imaging System [1S10OD023684-01A1]; NIH Training Program in Imaging Sciences in Translational Cardiovascular Research [5T32HL129964-02]	American Heart Association Transformation Project Award(American Heart Association); NIH Instrument Grant for Advanced HighResolution Rodent Ultrasound Imaging System(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Program in Imaging Sciences in Translational Cardiovascular Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this manuscript was supported by: American Heart Association Transformation Project Award 18TPA34230048 (to BK), NIH Instrument Grant for Advanced HighResolution Rodent Ultrasound Imaging System 1S10OD023684-01A1 (to Dr. Kang Kim, University of Pittsburgh), NIH Training Program in Imaging Sciences in Translational Cardiovascular Research 5T32HL129964-02 (to CR), and Richard K. Mellon Institute Award for postdoctoral trainees (to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Andersen CA, 2019, ANN FAM MED, V17, P61, DOI 10.1370/afm.2330; [Anonymous], 2020, NAT ENERGY, V5, P1, DOI 10.1038/s41560-020-0552-6; Barouxis D, 2012, J MATERN-FETAL NEO M, V25, P44, DOI 10.3109/14767058.2012.714633; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Biasucci DG, 2015, INTENS CARE MED, V41, P731, DOI 10.1007/s00134-015-3728-y; Burne-Taney MJ, 2003, AM J PHYSIOL-RENAL, V285, pF87, DOI 10.1152/ajprenal.00026.2003; Chen MH, 2007, RESUSCITATION, V75, P372, DOI 10.1016/j.resuscitation.2007.04.007; Chiba S, 2019, PROCEEDINGS OF THE 18TH ACM SIGPLAN INTERNATIONAL CONFERENCE ON GENERATIVE PROGRAMMING: CONCEPTS AND EXPERIENCES (GPCE '19), P1, DOI 10.1145/3357765.3359521; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; GLAUMANN B, 1975, VIRCHOWS ARCH B, V19, P281; Heyman SN, 2009, EXPERT OPIN DRUG DIS, V4, P629, DOI 10.1517/17460440902946389; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchens MP, 2011, JOVE-J VIS EXP, DOI 10.3791/3116; Ikeda K, 2015, NITRIC OXIDE-BIOL CH, V49, P90, DOI 10.1016/j.niox.2015.05.001; Kofler J, 2004, J NEUROSCI METH, V136, P33, DOI 10.1016/j.jneumeth.2003.12.024; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Liu HQ, 2018, AGING DIS, V9, P31, DOI 10.14336/AD.2017.0221; Matsushita K, KIDNEY INT, P10; Nolan JP, 2017, INTENS CARE MED, V43, P1282, DOI 10.1007/s00134-017-4739-7; Papadimitriou D, 2008, LAB ANIM-UK, V42, P265, DOI 10.1258/la.2007.006035; Piao L, 2020, CRIT CARE MED, V48, pE133, DOI 10.1097/CCM.0000000000004095; Reynolds JC, 2014, CIRCULATION, V128, P2488; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; Ruiz-Bailen M, 2005, RESUSCITATION, V66, P175, DOI 10.1016/j.resuscitation.2005.01.012; Sandroni C, 2013, RESUSCITATION, V84, P1324, DOI 10.1016/j.resuscitation.2013.06.020; Schmidt GA, 2014, INTENS CARE MED, P14; SHANLEY PF, 1986, AM J PATHOL, V122, P462; Tsukamoto A, 2015, EXP ANIM TOKYO, V64, P139, DOI 10.1538/expanim.14-0073; Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301; Vognsen M, 2017, RESUSCITATION, V113, P115, DOI 10.1016/j.resuscitation.2017.01.024; Yanta J, 2013, RESUSCITATION, V84, P1371, DOI 10.1016/j.resuscitation.2013.03.037; Yong Y, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116821; 2016, J PEASANT STUDIES, V43, P1	37	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0237292	10.1371/journal.pone.0237292	http://dx.doi.org/10.1371/journal.pone.0237292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275630	Green Submitted, Green Published, gold			2022-12-26	WOS:000597150200030
J	Brauner, R; Bignon-Topalovic, J; Bashamboo, A; McElreavey, K				Brauner, Raja; Bignon-Topalovic, Joelle; Bashamboo, Anu; McElreavey, Ken			Pituitary stalk interruption syndrome is characterized by genetic heterogeneity	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; MAGNETIC-RESONANCE; SHORT STATURE; MUTATIONS; HYPOPITUITARISM; HYPOPLASIA; DISORDERS; VARIABILITY; REPRESSOR; INTERACTS	Pituitary stalk interruption syndrome is a rare disorder characterized by an absent or ectopic posterior pituitary, interrupted pituitary stalk and anterior pituitary hypoplasia, as well as in some cases, a range of heterogeneous somatic anomalies. A genetic cause is identified in only around 5% of all cases. Here, we define the genetic variants associated with PSIS followed by the same pediatric endocrinologist. Exome sequencing was performed in 52 (33 boys and 19 girls), including 2 familial cases single center pediatric cases, among them associated 36 (69.2%) had associated symptoms or syndromes. We identified rare and novel variants in genes (37 families with 39 individuals) known to be involved in one or more of the following-midline development and/or pituitary development or function (BMP4, CDON, GLI2, GLI3, HESX1, KIAA0556, LHX9, NKX2-1, PROP1, PTCH1, SHH, TBX19, TGIF1), syndromic and non-syndromic forms of hypogonadotropic hypogonadism (CCDC141, CHD7, FANCA, FANCC, FANCD2, FANCE, FANCG, IL17RD, KISS1R, NSMF, PMM2, SEMA3E, WDR11), syndromic forms of short stature (FGFR3, NBAS, PRMT7, RAF1, SLX4, SMARCA2, SOX11), cerebellum atrophy with optic anomalies (DNMT1, NBAS), axonal migration (ROBO1, SLIT2), and agenesis of the corpus callosum (ARID1B, CC2D2A, CEP120, CSPP1, DHCR7, INPP5E, VPS13B, ZNF423). Pituitary stalk interruption syndrome is characterized by a complex genetic heterogeneity, that reflects a complex phenotypic heterogeneity. Seizures, intellectual disability, micropenis or cryptorchidism, seen at presentation are usually considered as secondary to the pituitary deficiencies. However, this study shows that they are due to specific gene mutations. PSIS should therefore be considered as part of the phenotypic spectrum of other known genetic syndromes rather than as specific clinical entity.	[Brauner, Raja] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Brauner, Raja] Univ Paris 05, Paris, France; [Bignon-Topalovic, Joelle; Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France	Fondation Adolphe de Rothschild; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McElreavey, K (corresponding author), Inst Pasteur, Human Dev Genet Unit, Paris, France.	kenmce@pasteur.fr		Brauner, Raja/0000-0002-4456-4508	Fondation Ophtalmologique Adolphe de Rothschild and Laboratoire Lilly France	Fondation Ophtalmologique Adolphe de Rothschild and Laboratoire Lilly France	This study was supported by Fondation Ophtalmologique Adolphe de Rothschild and Laboratoire Lilly France in the form of funding awarded to RB.	Accornero S, 2010, J CLIN ENDOCR METAB, V95, P3595, DOI 10.1210/jc.2010-0621; Akawi N, 2015, NAT GENET, V47, P1363, DOI 10.1038/ng.3410; [Anonymous], 2011, J CLIN ENDOCRINOL ME, V96, pE304; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Baban A, 2008, AM J MED GENET A, V146A, P384, DOI 10.1002/ajmg.a.32111; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Balicza P, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00335; Bar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142354; Bashamboo A, 2016, J CLIN ENDOCR METAB, V101, P12, DOI 10.1210/jc.2015-2995; Bashamboo A, 2017, J CLIN ENDOCR METAB, V102, P2401, DOI 10.1210/jc.2016-1095; Blockus H, 2014, CURR OPIN NEUROBIOL, V27, P82, DOI 10.1016/j.conb.2014.03.003; Castinetti F, 2008, J CLIN ENDOCR METAB, V93, P2790, DOI 10.1210/jc.2007-2389; Corvest V, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00304; De Rienzo F, 2015, CLIN ENDOCRINOL, V83, P849, DOI 10.1111/cen.12849; Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dupuis-Girod S, 2001, J PEDIATR-US, V138, P129, DOI 10.1067/mpd.2001.109200; El Chehadeh-Djebbar S, 2011, EUR J MED GENET, V54, P369, DOI 10.1016/j.ejmg.2011.03.001; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009; Hauer NN, 2018, GENET MED, V20, P630, DOI 10.1038/gim.2017.159; Hempel A, 2016, J MED GENET, V53, P152, DOI 10.1136/jmedgenet-2015-103393; Karaca E, 2015, J CLIN ENDOCR METAB, V100, pE140, DOI 10.1210/jc.2014-1984; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Liu ZQ, 2020, J CLIN RES PEDIATR E, V12, P212, DOI 10.4274/jcrpe.galenos.2019.2018.0309; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; Maksimova N, 2010, J MED GENET, V47, P538, DOI 10.1136/jmg.2009.074815; Matthijs G, 1999, MOL GENET METAB, V68, P220, DOI 10.1006/mgme.1999.2914; McCormack SE, 2017, J CLIN ENDOCR METAB, V102, P2501, DOI 10.1210/jc.2017-00332; Mcnay DEG, 2007, J CLIN ENDOCR METAB, V92, P691, DOI 10.1210/jc.2006-1609; Melo ME, 2007, CLIN ENDOCRINOL, V66, P95, DOI 10.1111/j.1365-2265.2006.02692.x; Murphy MW, 2015, NAT STRUCT MOL BIOL, V22, P442, DOI 10.1038/nsmb.3032; Neirijnck Y, 2018, KIDNEY INT, V93, P1142, DOI 10.1016/j.kint.2017.11.026; Petryk A, 2015, J CLIN ENDOCR METAB, V100, P803, DOI 10.1210/jc.2014-4357; Pham LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053189; Reynaud R, 2011, EUR J ENDOCRINOL, V164, P457, DOI 10.1530/EJE-10-0892; Reynaud R, 2012, J CLIN ENDOCR METAB, V97, pE1068, DOI 10.1210/jc.2011-3056; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sajedi E, 2008, BBA-MOL CELL RES, V1783, P131, DOI 10.1016/j.bbamcr.2007.08.010; Scala M, 2019, J PEDIATR ENDOCR MET, V32, P95, DOI 10.1515/jpem-2018-0272; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Simon D, 2006, CLIN ENDOCRINOL, V64, P416, DOI 10.1111/j.1365-2265.2006.02484.x; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Tatsi C, 2013, J CLIN ENDOCR METAB, V98, pE779, DOI 10.1210/jc.2012-3982; Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; Zwaveling-Soonawala N, 2018, J CLIN ENDOCR METAB, V103, P415, DOI 10.1210/jc.2017-01660	53	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242358	10.1371/journal.pone.0242358	http://dx.doi.org/10.1371/journal.pone.0242358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270637	gold, Green Published			2022-12-26	WOS:000597149100139
J	Hong, SW; Kang, JH; Kim, JS; Gong, HS				Hong, Seok Woo; Kang, Jeong-Hyun; Kim, Jong Seop; Gong, Hyun Sik			Association between forearm cortical bone properties and handgrip strength in women with distal radius fractures: A cross-sectional study	PLOS ONE			English	Article							MINERAL DENSITY; GRIP STRENGTH; THICKNESS; GEOMETRY	Objectives Mechanical and biochemical bone properties are influenced by muscles. However, the muscle-bone interaction has not been fully elucidated regarding the upper extremities. The objective of the present study was to evaluate the mechanical muscle-bone interaction at the forearm by evaluating the relationship between the properties of three-dimensional (3D) forearm cortical bone models derived from conventional computed tomography (CT) images and handgrip strength (HGS). Methods A total of 108 women (mean age, 75.2 +/- 9.4 years; range, 62-101 years) with a distal radius fracture who took conventional CT scans for the assessment of the fracture were included in this study. Distal radius 3D models were reconstructed and the average cortical bone density (Cd) and thickness (Ct) of the region of interest (ROI), which might be affected by the forearm flexor muscles, were calculated using a 3D modeling software. Clinical parameters including HGS, lumbar and hip bone mineral densities (BMDs), and other demographic factors were also obtained. A multivariate linear regression analysis was performed to identify relevant factors associated with HGS. Results HGS was found to be independently associated with height and Cd, but no significant difference was found between HGS and Ct, age, weight, as well as lumber and hip BMDs. Conclusions Cortical bone density might be associated with HGS, which is generated by the forearm flexor muscles. Hence, the mechanical muscle-bone interaction in the upper extremities could be supported by the present study.	[Hong, Seok Woo] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Orthoped Surg, Sch Med, Seoul, South Korea; [Kang, Jeong-Hyun] Ajou Univ, Inst Oral Hlth Sci, Clin Oral Med & Orofacial Pain, Sch Med, Suwon, Gyeonggi Do, South Korea; [Kim, Jong Seop; Gong, Hyun Sik] Seoul Natl Univ, Coll Med, Dept Orthoped Surg, Bundang Hosp, Coll, Seongnam, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Ajou University; Seoul National University (SNU)	Gong, HS (corresponding author), Seoul Natl Univ, Coll Med, Dept Orthoped Surg, Bundang Hosp, Coll, Seongnam, Gyeonggi Do, South Korea.	hsgong@snu.ac.kr		HONG, SEOK WOO/0000-0003-4059-1557	National Research Foundation of Korea (NRF) - Korea government [2018R1C1B6007671, 2020R1A2C1005778]; Seoul National University Bundang Hospital [14-2019-034]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); Seoul National University Bundang Hospital	This study was supported by the National Research Foundation of Korea (NRF) granted by the Korea government (Grant number: 2018R1C1B6007671 (Jeong Hyun Kang), 2020R1A2C1005778 (Hyun Sik Gong)) and by the SNUBH research fund granted by the Seoul National University Bundang Hospital (Grant number 14-2019-034 (Hyun Sik Gong)). The funders hand no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 2018, J BONE JOINT SURG AM, V100, P2073, DOI 10.2106/JBJS.17.01376; [Anonymous], 2016, MEDICINE, V95, pe3187; [Anonymous], 2014, J EARLY MODERN CULTU, V14, P187, DOI [10.1353/jem.2014.0039, DOI 10.1353/JEM.2014.0039]; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; BECHTOL CO, 1954, J BONE JOINT SURG AM, V36-A, P820, DOI 10.2106/00004623-195436040-00013; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Caetano Edie Benedito, 2017, Rev. bras. ortop., V52, P731, DOI 10.1016/j.rboe.2017.10.004; Cianferotti L, 2014, ENDOCRINE, V45, P165, DOI 10.1007/s12020-013-0026-8; D'Eliaa G, 2009, CLIN CASES MINER BON, V6, P234; Dennison EM, 2014, BONE, V64, P13, DOI 10.1016/j.bone.2014.03.040; Despres P, 2017, PHYS MEDICA, V42, P76, DOI 10.1016/j.ejmp.2017.07.024; Fat DL, 2012, SKELETAL RADIOL, V41, P557, DOI 10.1007/s00256-011-1255-7; Genisa M, 2018, P I MECH ENG H, V232, P1168, DOI 10.1177/0954411918806333; Hart NH, 2017, J MUSCULOSKEL NEURON, V17, P114; Hasegawa Y, 2001, J BIOMECH, V34, P497, DOI 10.1016/S0021-9290(00)00211-6; Hong SW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60554-w; Kaufmann Robert A, 2007, Am J Orthop (Belle Mead NJ), V36, pE128; Kaya A, 2005, ARCH MED RES, V36, P603, DOI 10.1016/j.arcmed.2005.03.026; Kim CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214612; Laurent MR, 2016, MOL CELL ENDOCRINOL, V432, P24, DOI 10.1016/j.mce.2015.10.017; Lee Seung Hoo, 2020, J Bone Metab, V27, P85, DOI 10.11005/jbm.2020.27.2.85; Lenchik L, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0784-7; Leversedge FJ, 2008, HAND CLIN, V24, P219, DOI 10.1016/j.hcl.2008.03.010; Lorentzon M, 2015, J INTERN MED, V277, P650, DOI 10.1111/joim.12369; MacIntyre NJ, 2012, PHYSIOTHER CAN, V64, P284, DOI 10.3138/ptc.2011-22BH; Martinez H, 2001, CLIN ORAL IMPLAN RES, V12, P423, DOI 10.1034/j.1600-0501.2001.120501.x; Mather J, 2013, J SHOULDER ELB SURG, V22, P732, DOI 10.1016/j.jse.2012.08.018; Methot Jennifer, 2010, Can J Plast Surg, V18, pe10; Nakamura M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29061-x; PETERSEN P, 1989, AM J OCCUP THER, V43, P444, DOI 10.5014/ajot.43.7.444; Soucek O, 2011, CLIN ENDOCRINOL, V74, P445, DOI 10.1111/j.1365-2265.2010.03955.x; Sousa-Santos AR, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0625-y; SPADARO JA, 1994, J ORTHOPAED RES, V12, P211, DOI 10.1002/jor.1100120210; TURNER CH, 1994, J BONE MINER RES, V9, P87; Wagner SC, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.15.01244; Webber T, 2015, J HAND SURG-AM, V40, P493, DOI 10.1016/j.jhsa.2014.12.015; Zammit AR, 2019, J GERONTOL A-BIOL, V74, P519, DOI 10.1093/gerona/gly046	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243294	10.1371/journal.pone.0243294	http://dx.doi.org/10.1371/journal.pone.0243294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270744	gold, Green Published			2022-12-26	WOS:000597149100154
J	Spudic, D; Smajla, D; Sarabon, N				Spudic, Darjan; Smajla, Darjan; Sarabon, Nejc			Intra-session reliability of electromyographic measurements in flywheel squats	PLOS ONE			English	Article							MUSCLE ACTIVATION	Although the popularity of flywheel (FW) devices in sports research is increasing, to date, no study has been designed to test the reliability of electromyographic (EMG) variables during FW squats as a basic lower-body FW resistance exercise. At the primary level, our study was conducted to determine the minimum number of the consecutive flywheel (FW) squat repetitions that need to be averaged in a single set to obtain excellent reliability of peak, mean and three position-specific EMG variables. At the secondary level, comprehensive analysis for peak and mean EMG variables was done. Intra-set reliability was investigated using the minimum number of repetitions determined from the primary level of the study. Twenty-six participants performed five sets of seven squats with three FW loads (0.05, 0.125, 0.225 kg center dot m(2)). EMG signals were collected from eight leg muscles. By averaging twelve consecutive repetitions, we obtained ICC2.k > 0.95 for mean and peak EMG(RMS) regardless of the muscle, load or phase of the squat (concentric vs. eccentric). Due to the heterogeneity of the results at the primary level, position-specific variables were excluded from the inter-set reliability analysis at the secondary level. Trustworthy mean and peak EMG variables from the primary level showed good to excellent inter-set reliability. We suggest averaging twelve consecutive squat repetitions to achieve good to excellent intra-session reliability of EMG variables. By following the proposed protocol, activation of leg muscles can be confidently studied in intra-session repeated-measures study designs.	[Spudic, Darjan] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Smajla, Darjan; Sarabon, Nejc] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Smajla, Darjan; Sarabon, Nejc] InnoRenew CoE, Izola, Slovenia; [Sarabon, Nejc] Sci Practice Ltd, Lab Motor Control & Motor Behav, S2P, Ljubljana, Slovenia; [Sarabon, Nejc] Univ Primorska, Andrej Marusic Inst, Koper, Slovenia	University of Ljubljana; University of Primorska; University of Primorska	Sarabon, N (corresponding author), Univ Primorska, Fac Hlth Sci, Izola, Slovenia.; Sarabon, N (corresponding author), InnoRenew CoE, Izola, Slovenia.; Sarabon, N (corresponding author), Sci Practice Ltd, Lab Motor Control & Motor Behav, S2P, Ljubljana, Slovenia.; Sarabon, N (corresponding author), Univ Primorska, Andrej Marusic Inst, Koper, Slovenia.	nejc.sarabon@fvz.upr.si		Smajla, Darjan/0000-0001-5441-8988; Sarabon, Nejc/0000-0003-0747-3735	Slovenian Research Agency [L5-1845]; project "Kinesiology of monostructural, polystructural and conventional sports" [P5-0147]; S2P, Science to Practice, Ltd.	Slovenian Research Agency(Slovenian Research Agency - Slovenia); project "Kinesiology of monostructural, polystructural and conventional sports"; S2P, Science to Practice, Ltd.	This study was supported by the Slovenian Research Agency in the form of salaries for NS. and DSM, within the framework of the project "Body asymmetries as a risk factor in musculoskeletal injury development: studying etiological mechanisms and designing corrective interventions for primary and tertiary preventive care" (L5-1845) and a Research Program Fund within the framework of the project "Kinesiology of monostructural, polystructural and conventional sports"(P5-0147). S2P, Science to Practice, Ltd. also provided support in the form of a salary for NS.. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkner BA, 2004, ACTA PHYSIOL SCAND, V181, P345, DOI 10.1111/j.1365-201X.2004.01293.x; Alkner BA, 2019, AEROSP MED HUM PERF, V90, P506, DOI 10.3357/AMHP.5097.2019; [Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1, DOI DOI 10.1109/ARRAY.2016.7832589; [Anonymous], 2008, GI QUALITY PRACTICE; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Carroll KM, 2019, SPORT BIOMECH, V18, P390, DOI 10.1080/14763141.2018.1433715; Duchateau J, 2014, J APPL PHYSIOL, V116, P1418, DOI 10.1152/japplphysiol.00002.2013; EuroSurg Collaborative, 2020, BRIT J SURG, V107, pE161, DOI [10.1002/bjs.11326, 10.1002/bjs.11482]; Fonda B, 2011, J ELECTROMYOGR KINES, V21, P854, DOI 10.1016/j.jelekin.2011.05.010; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Herzog W, 2018, J SPORT HEALTH SCI, V7, P255, DOI 10.1016/j.jshs.2018.05.005; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Luera MJ, 2014, J STRENGTH COND RES, V28, P328, DOI 10.1519/JSC.0b013e3182a1f434; Maffiuletti NA, 2016, EUR J APPL PHYSIOL, V116, P1091, DOI 10.1007/s00421-016-3346-6; Micklewright D, 2017, SPORTS MED, V47, P2375, DOI 10.1007/s40279-017-0711-5; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; Naczk M, 2016, J STRENGTH COND RES, V30, P2107, DOI 10.1097/JSC.0000000000000217; Norrbrand L, 2011, AVIAT SPACE ENVIR MD, V82, P13, DOI 10.3357/ASEM.2867.2011; Norrbrand L, 2010, EUR J APPL PHYSIOL, V110, P997, DOI 10.1007/s00421-010-1575-7; Oliveira AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00335; Onambele GL, 2008, J BIOMECH, V41, P3133, DOI 10.1016/j.jbiomech.2008.09.004; Pozzo M, 2006, MUSCLE NERVE, V34, P169, DOI 10.1002/mus.20574; Reaz MBI, 2006, BIOL PROCED ONLINE, V8, P11, DOI [10.1251/bpo115, 10.1251/bpo124]; Rhea M.R., 2016, HUMAN MOVEMENT, V17, P43, DOI [10.1515/humo-2016-0006, DOI 10.1515/HUMO-2016-0006]; Sabido R, 2018, INT J SPORT PHYSIOL, V13, P482, DOI 10.1123/ijspp.2017-0282; Trindade TB, 2020, ISOKINET EXERC SCI, V28, P1, DOI 10.3233/IES-193142; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	28	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243090	10.1371/journal.pone.0243090	http://dx.doi.org/10.1371/journal.pone.0243090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270677	gold, Green Published			2022-12-26	WOS:000597149100085
J	Stockbridge, EL; Loethen, AD; Annan, E; Miller, TL				Stockbridge, Erica L.; Loethen, Abiah D.; Annan, Esther; Miller, Thaddeus L.			Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data	PLOS ONE			English	Article							ADHERENCE; PREVENTION; CARE; NONADHERENCE; ELIMINATION; MEDICATION; DIAGNOSIS; BELIEFS; DISEASE; CASCADE	Background Risk-targeted testing and treatment of latent tuberculosis infection (LTBI) is a critical component of the United States' (US) tuberculosis (TB) elimination strategy, but relatively low treatment completion rates remain a challenge. Both treatment persistence and completion may be facilitated by diagnosing LTBI using interferon gamma release assays (IGRA) rather than tuberculin skin tests (TST). Methods We used a national sample of administrative claims data to explore associations diagnostic test choice (TST, IGRA, TST with subsequent IGRA) and treatment persistence and completion in persons initiating a daily dose isoniazid LTBI treatment regimen in the US private healthcare sector between July 2011 and March 2014. Associations were analyzed with a generalized ordered logit model (completion) and a negative binomial regression model (persistence). Results Of 662 persons initiating treatment, 327 (49.4%) completed at least the 6-month regimen and 173 (26.1%) completed the 9-month regimen; 129 (19.5%) persisted in treatment one month or less. Six-month completion was least likely in persons receiving a TST (42.2%) relative to persons receiving an IGRA (55.0%) or TST then IGRA (67.2%; p = 0.001). Those receiving an IGRA or a TST followed by an IGRA had higher odds of completion compared to those receiving a TST (aOR = 1.59 and 2.50; p = 0.017 and 0.001, respectively). Receiving an IGRA or a TST and subsequent IGRA was associated with increased treatment persistence relative to TST (aIRR = 1.14 and 1.25; p = 0.027 and 0.009, respectively). Conclusions IGRA use is significantly associated with both higher levels of LTBI treatment completion and treatment persistence. These differences are apparent both when IGRAs alone were administered and when IGRAs were administered subsequent to a TST. Our results suggest that IGRAs contribute to more effective LTBI treatment and consequently individual and population protections against TB.	[Stockbridge, Erica L.; Loethen, Abiah D.] Magellan Hlth Inc, Dept Adv Hlth Analyt & Solut, Scottsdale, AZ 85251 USA; [Stockbridge, Erica L.; Miller, Thaddeus L.] Univ North Texas, Sch Publ Hlth, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA; [Annan, Esther] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat & Epidemiol, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Stockbridge, EL (corresponding author), Magellan Hlth Inc, Dept Adv Hlth Analyt & Solut, Scottsdale, AZ 85251 USA.; Stockbridge, EL (corresponding author), Univ North Texas, Sch Publ Hlth, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA.	estockbridge@magellanhealth.com						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; Balaban V, 2015, PUBLIC HEALTH REP, V130, P349, DOI 10.1177/003335491513000413; Barss L, 2020, INT J TUBERC LUNG D, V24, P100, DOI 10.5588/ijtld.19.0185; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Byrne M, 2005, J PSYCHOSOM RES, V58, P403, DOI 10.1016/j.jpsychores.2004.11.010; Centers for Disease Control and Prevention, 2020, LAT TUB INF GUID PRI; Centers for Disease Control and Prevention, 2014, NCHS URB CLASS SCHEM; Centers for Disease Control and Prevention, 2016, TREATM REG LAT TB IN; Centers for Disease Control and Prevention, 2016, TUB TB TEST BCG VACC; Centers for Disease Control and Prevention, 2013, REP TUB US 2012; Clatworthy J, 2007, BIPOLAR DISORD, V9, P656, DOI 10.1111/j.1399-5618.2007.00434.x; Collins JM, 2019, AM J PUBLIC HEALTH, V109, P1028, DOI 10.2105/AJPH.2019.305069; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Crossa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138349; Eastment MC, 2017, J AM BOARD FAM MED, V30, P520, DOI 10.3122/jabfm.2017.04.170070; Government Publishing Office, 2010, PAT PROT AFF CAR ACT; Grinsdale JA, 2011, INT J TUBERC LUNG D, V15, P1614, DOI 10.5588/ijtld.11.0102; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2015, INT J TUBERC LUNG D, V19, P31, DOI 10.5588/ijtld.14.0373; Hofmann BM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h705; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; *I MED COMM EL TUB, 2000, END NEGL EL TUB US; Iqbal SA, 2021, J PUBLIC HEALTH MAN, V27, pE151, DOI 10.1097/PHH.0000000000001077; Jiang XY, 2010, CRIT CARE, V14, pR66; Kertes J, 2008, ISR MED ASSOC J, V10, P207; Lambert Lauren A, 2018, Microbiol Insights, V11, p1178636118811311, DOI 10.1177/1178636118811311; Lemstra M, 2012, CAN J CARDIOL, V28, P567, DOI 10.1016/j.cjca.2012.03.018; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; LoBue PA, 2017, LANCET INFECT DIS, V17, pE327, DOI 10.1016/S1473-3099(17)30248-7; Macaraig MM, 2018, INT J TUBERC LUNG D, V22, P1344, DOI 10.5588/ijtld.18.0035; Mancuso JD, 2016, AM J RESP CRIT CARE, V194, P501, DOI 10.1164/rccm.201508-1683OC; McClintock AH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2245-8; Menzies NA, 2018, AM J EPIDEMIOL, V187, P2011, DOI 10.1093/aje/kwy094; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; Offord S, 2013, ADV THER, V30, P286, DOI 10.1007/s12325-013-0016-5; Optum, 2014, CLINF DAT MART 2014; Owusu-Edusei K, 2017, INT J TUBERC LUNG D, V21, P684, DOI 10.5588/ijtld.16.0617; Parsyan AE, 2007, J INFECTION, V54, P262, DOI 10.1016/j.jinf.2006.04.010; Roy A, 2016, ASIAN J PHARM CLIN R, V9, P19; Sandgren A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1550-y; Scholman T, 2015, AM J TRANSPLANT, V15, P2616, DOI 10.1111/ajt.13330; Schwartz NG, 2020, MMWR-MORBID MORTAL W, V69, P286, DOI 10.15585/mmwr.mm6911a3; Serna MC, 2010, EUR PSYCHIAT, V25, P206, DOI 10.1016/j.eurpsy.2009.07.012; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036551; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Sterling Timothy R, 2020, MMWR Recomm Rep, V69, P1, DOI 10.15585/mmwr.rr6901a1; Stockbridge EL, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5578-3; Stockbridge EL, 2018, J PUBLIC HEALTH MAN, V24, pE25, DOI [10.1097/phh.0000000000000628, 10.1097/PHH.0000000000000628]; Stockbridge EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193432; Stuurman AL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1549-4; Swieczkowski D, 2016, CARDIOL J, V23, P483, DOI 10.5603/CJ.a2016.0048; Tavast E, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/381929; U.S. Census Bureau, 2015, AM COMM SURV ACS; Virnig BA, 2001, ANNU REV PUBL HEALTH, V22, P213, DOI 10.1146/annurev.publhealth.22.1.213; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Health Organization, GLOB HLTH OBS DAT RE	61	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243102	10.1371/journal.pone.0243102	http://dx.doi.org/10.1371/journal.pone.0243102			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270737	Green Published, gold			2022-12-26	WOS:000597149100088
J	Wang, Y; Zhang, K; Georgiev, P; Wells, S; Xu, HY; Lacey, BM; Xu, ZW; Laskey, J; Mcleod, R; Methot, JL; Bittinger, M; Pasternak, A; Ranganath, S				Wang, Yun; Zhang, Kelvin; Georgiev, Peter; Wells, Steven; Xu, Haiyan; Lacey, Brian M.; Xu, Zangwei; Laskey, Jason; Mcleod, Robbie; Methot, Joey L.; Bittinger, Mark; Pasternak, Alexander; Ranganath, Sheila			Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function	PLOS ONE			English	Article							CANCER; HPK1; ACTIVATION; PHOSPHORYLATION; MECHANISMS; EFFICACY; UBIQUITINATION; PROTEINS; DRUGS; CAMP	Hematopoietic progenitor kinase 1 (HPK1), a hematopoietic cell-specific Ste20-related serine/threonine kinase, is a negative regulator of signal transduction in immune cells, including T cells, B cells, and dendritic cells (DCs). In mice, HPK1 deficiency subverts inhibition of the anti-tumor immune response and is associated with functional augmentation of anti-tumor T cells. We have used a potent, small molecule HPK1 inhibitor, Compound 1, to investigate the effects of pharmacological intervention of HPK1 kinase activity in immune cells. Compound 1 enhanced Th1 cytokine production in T cells and fully reverted immune suppression imposed by the prostaglandin E-2 (PGE(2)) and adenosine pathways in human T cells. Moreover, the combination of Compound 1 with pembrolizumab, a humanized monoclonal antibody against the programmed cell death protein 1 (PD-1), demonstrated a synergistic effect, resulting in enhanced interferon (IFN)-gamma production. Collectively, our results suggest that blocking HPK1 kinase activity with small molecule inhibitors alone or in combination with checkpoint blockade may be an attractive approach for the immunotherapy of cancer.	[Wang, Yun; Georgiev, Peter; Wells, Steven; Bittinger, Mark; Ranganath, Sheila] Merck & Co Inc, Dept Oncol Early Discovery, Boston, MA 02115 USA; [Zhang, Kelvin] Merck & Co Inc, Dept Genet & Pharmacogen, Boston, MA USA; [Xu, Haiyan; Lacey, Brian M.; Xu, Zangwei; Laskey, Jason; Mcleod, Robbie] Merck & Co Inc, Dept Quantitat Biosci, Boston, MA USA; [Methot, Joey L.; Pasternak, Alexander] Merck & Co Inc, Dept Discovery Chem, Boston, MA 02115 USA; [Zhang, Kelvin] Codiak BioSci, Cambridge, MA USA; [Wells, Steven] Columbia Univ, New York, NY USA; [Bittinger, Mark] Sai Life Sci Inc, Cambridge, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Columbia University	Ranganath, S (corresponding author), Merck & Co Inc, Dept Oncol Early Discovery, Boston, MA 02115 USA.; Pasternak, A (corresponding author), Merck & Co Inc, Dept Discovery Chem, Boston, MA 02115 USA.	alexander_pasternak@merck.com; sheila_ranganath@merck.com		Wells, Steven/0000-0001-5428-0683; Georgiev, Peter/0000-0002-4613-1255; wang, yun/0000-0002-4346-0096	Merck Sharp Dohme Corp.	Merck Sharp Dohme Corp.(Merck & Company)	This work was supported by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America. All authors are employees and stockholders in Merck & Co., Inc., Kenilworth, NJ, United States of America, during the period this study was conducted. The funder provided support in the form of salaries for all authors [YW, KZ, PG, SW, HX, BL, ZX, JL, RM, JM, MB, AP, SR] and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alzabin S, 2010, CANCER IMMUNOL IMMUN, V59, P419, DOI 10.1007/s00262-009-0761-0; Alzabin S, 2009, J IMMUNOL, V182, P6187, DOI 10.4049/jimmunol.0802631; [Anonymous], 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3210; [Anonymous], 2007, EFSA SCI REPORT, V121, P1; Arab S, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e23; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; Chan B., 2018, Patent, Patent No. [2018183964A1, 2018183964, WO 2018183964 A1]; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Ciciola P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030675; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diab A, 2020, CANCER DISCOV, V10, P1158, DOI 10.1158/2159-8290.CD-19-1510; Georgiev Peter, 2019, Immunohorizons, V3, P294, DOI 10.4049/immunohorizons.1900037; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hernandez S, 2018, CELL REP, V25, P80, DOI 10.1016/j.celrep.2018.09.012; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kashmiry A, 2018, BBA-MOL CELL BIOL L, V1863, P1297, DOI 10.1016/j.bbalip.2018.07.003; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Khushalani NI, 2020, FUTURE ONCOL, V16, P2165, DOI 10.2217/fon-2020-0351; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kumar S, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13010009; Lacey BM, 2021, SLAS DISCOV, V26, P88, DOI 10.1177/2472555220952071; Lee HT, 2019, MOLECULES, V24, DOI 10.3390/molecules24061190; Leone RD, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0360-8; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liu JQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212670; Majumder M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041019; Ni L, 2018, CANCER MED-US, V7, P4509, DOI 10.1002/cam4.1700; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Pluhar GE, 2015, CRIT REV IMMUNOL, V35, P153, DOI 10.1615/CritRevImmunol.2015013607; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; Rotte A, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1259-z; Sawasdikosol S, 2007, J BIOL CHEM, V282, P34693, DOI 10.1074/jbc.M707425200; Sawasdikosol S, 2019, STRUCTURE, V27, P1, DOI 10.1016/j.str.2018.12.009; Sawasdikosol S, 2012, IMMUNOL RES, V54, P262, DOI 10.1007/s12026-012-8319-1; Sciaraffia E, 2014, J LEUKOCYTE BIOL, V96, P113, DOI 10.1189/jlb.3A0513-302RR; Seidel JA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00086; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Sitkovsky MV, 2020, CURR OPIN PHARMACOL, V53, P98, DOI 10.1016/j.coph.2020.07.011; Sitkovsky MV, 2020, CANCER DISCOV, V10, P16, DOI 10.1158/2159-8290.CD-19-1280; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Vigano S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00925; Wang XH, 2012, J BIOL CHEM, V287, P34091, DOI 10.1074/jbc.M112.371062; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang Q, 2017, MOL MED REP, V16, P6472, DOI 10.3892/mmr.2017.7494	52	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243145	10.1371/journal.pone.0243145	http://dx.doi.org/10.1371/journal.pone.0243145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270695	Green Published, gold			2022-12-26	WOS:000597149100023
J	Zou, YY; Fineberg, S; Pearlman, A; Feinman, RD; Fine, EJ				Zou, Yiyu; Fineberg, Susan; Pearlman, Alexander; Feinman, Richard D.; Fine, Eugene J.			The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer	PLOS ONE			English	Article							METABOLIC THERAPY; FEASIBILITY; CHEMOTHERAPY; INHIBITION; RADIATION; ONCOLOGY; CACHEXIA; OBESITY; TUMORS	Background The effects of diet in cancer, in general, and breast cancer in particular, are not well understood. Insulin inhibition in ketogenic, high fat diets, modulate downstream signaling molecules and are postulated to have therapeutic benefits. Obesity and diabetes have been associated with higher incidence of breast cancer. Addition of anti-cancer drugs together with diet is also not well studied. Methods Two diets, one ketogenic, the other standard mouse chow, were tested in a spontaneous breast cancer model in 34 mice. Subgroups of 3-9 mice were assigned, in which the diet were implemented either with or without added rapamycin, an mTOR inhibitor and potential anti-cancer drug. Results Blood glucose and insulin concentrations in mice ingesting the ketogenic diet (KD) were significantly lower, whereas beta hydroxybutyrate (BHB) levels were significantly higher, respectively, than in mice on the standard diet (SD). Growth of primary breast tumors and lung metastases were inhibited, and lifespans were longer in the KD mice compared to mice on the SD (p<0.005). Rapamycin improved survival in both mouse diet groups, but when combined with the KD was more effective than when combined with the SD. Conclusions The study provides proof of principle that a ketogenic diet a) results in serum insulin reduction and ketosis in a spontaneous breast cancer mouse model; b) can serve as a therapeutic anti-cancer agent; and c) can enhance the effects of rapamycin, an anti-cancer drug, permitting dose reduction for comparable effect. Further, the ketogenic diet in this model produces superior cancer control than standard mouse chow whether with or without added rapamycin.	[Zou, Yiyu; Pearlman, Alexander; Fine, Eugene J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Fineberg, Susan; Fine, Eugene J.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Feinman, Richard D.] SUNY Downstate Hlth Sci Ctr, Brooklyn, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Fine, EJ (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.; Fine, EJ (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	eugene.fine@einsteinmed.org			CTSA Grant from National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1TR002556]; ST Balchug	CTSA Grant from National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH); ST Balchug	Generous funding for this project was provided by ST Balchug, a commercial company which operates in the real estate sector. In addition, the study was supported in part by the CTSA Grant UL1TR002556 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; [Anonymous], 1995, NUTRIENT REQUIREMENT; [Anonymous], 2014, AM J PHYSIOL-RENAL, V307, pF891; Basho RK, 2018, ONCOLOGIST, V23, P1300, DOI 10.1634/theoncologist.2017-0498; BECK SA, 1989, CANCER RES, V49, P3800; Boone E, VALIDITY RELIABILITY; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; Fine EJ, 2012, NUTRITION, V28, P1028, DOI 10.1016/j.nut.2012.05.001; Goodwin PJ, 2015, BREAST, V24, pS56, DOI 10.1016/j.breast.2015.07.014; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hopkins BD, 2018, NATURE, V560, P499, DOI 10.1038/s41586-018-0343-4; Hsieh MH, 2019, CELL REP, V28, P1860, DOI 10.1016/j.celrep.2019.07.027; Iyikesici MS, 2019, INT J HYPERTHER, V36, P446, DOI 10.1080/02656736.2019.1589584; Jain V, 2017, MATURITAS, V104, P80, DOI 10.1016/j.maturitas.2017.08.006; Kabat GC, 2017, CANCER EPIDEM BIOMAR, V26, P1730, DOI 10.1158/1055-9965.EPI-17-0495; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Khodabakhshi A, 2020, NUTR CANCER, V72, P627, DOI 10.1080/01635581.2019.1650942; Kim HS, 2012, BJU INT, V110, P1062, DOI 10.1111/j.1464-410X.2012.10971.x; Klement RJ, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-1337-2; Klement RJ, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0991-5; Klement RJ, 2018, COMPLEMENT MED RES, V25, P102, DOI 10.1159/000484045; Nagini S, 2019, SEMIN CANCER BIOL, V56, P25, DOI 10.1016/j.semcancer.2017.12.010; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Niraula S, 2012, BREAST CANCER RES TR, V135, P821, DOI 10.1007/s10549-012-2223-1; Pimentel I, 2019, BREAST, V48, P17, DOI 10.1016/j.breast.2019.08.003; Radogna F, 2015, BIOCHEM PHARMACOL, V94, P1, DOI 10.1016/j.bcp.2014.12.018; Senapati P, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0290-9; Seyfried TN, 2015, CANCER LETT, V356, P289, DOI 10.1016/j.canlet.2014.07.015; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shishido SN, 2014, INT J CANCER, V134, P1474, DOI 10.1002/ijc.28461; Thakur B, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152652; TISDALE MJ, 1987, BRIT J CANCER, V56, P39, DOI 10.1038/bjc.1987.149; Venkateswaran V, 2007, J NATL CANCER I, V99, P1793, DOI 10.1093/jnci/djm231; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Woodhouse C, 2019, CURR ONCOL, V26, pE433, DOI 10.3747/co.26.4889; Zahra A, 2017, RADIAT RES, V187, P743, DOI [10.1667/RR14668.1, 10.1667/rr14668.1]; Zou YY, 1998, J NATL CANCER I, V90, P1130, DOI 10.1093/jnci/90.15.1130	40	13	14	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0233662	10.1371/journal.pone.0233662	http://dx.doi.org/10.1371/journal.pone.0233662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270630	gold, Green Published, Green Submitted			2022-12-26	WOS:000597149100106
J	Cappel, C; Gonzalez, AC; Damme, M				Cappel, Cedric; Gonzalez, Adriana Carolina; Damme, Markus			Quantification and characterization of the 5 ' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC LEUKOENCEPHALOPATHY; ALZHEIMERS-DISEASE; DNASE-II; EXPRESSION; RESISTANCE; VARIANTS; RNASET2; ENZYMES; GENE; T2	Phospholipase D3 (PLD3) and phospholipase D4 (PLD4), the most recently described lysosomal nucleases, are associated with Alzheimer's disease, spinocerebellar ataxia, and systemic lupus erythematosus. They exhibit 5' exonuclease activity on single-stranded DNA, hydrolyzing it at the acidic pH associated with the lysosome. However, their full cellular function is inadequately understood. To examine these enzymes, we developed a robust and automatable cell-based assay based on fluorophore- and fluorescence-quencher-coupled oligonucleotides for the quantitative determination of acidic 5' exonuclease activity. We validated the assay under knockout and PLD-overexpression conditions and then applied it to characterize PLD3 and PLD4 biochemically. Our experiments revealed PLD3 as the principal acid 5' exonuclease in HeLa cells, where it showed a markedly higher specific activity compared with PLD4. We further used our newly developed assay to determine the substrate specificity and inhibitory profile of PLD3 and found that proteolytic processing of PLD3 is dispensable for its hydrolytic activity. We followed the expression, proteolytic processing, and intracellular distribution of genetic PLD3 variants previously associated with Alzheimer's disease and investigated each variant's effect on the 5' nuclease activity of PLD3, finding that some variants lead to reduced activity, but others not. The development of a PLD3/4-specific biochemical assay will be instrumental in understanding better both nucleases and their incompletely understood roles in vitro and in vivo.	[Cappel, Cedric; Gonzalez, Adriana Carolina; Damme, Markus] Christian Albrechts Univ Kiel, Biochem Inst, Kiel, Germany	University of Kiel	Damme, M (corresponding author), Christian Albrechts Univ Kiel, Biochem Inst, Kiel, Germany.	mdamme@biochem.uni-kiel.de		Damme, Markus/0000-0002-9699-9351; Cappel, Cedric Curt/0000-0002-3333-3528	Alzheimer Forschung Initiative e.V.; Hans & Ilse-Breuer Stiftung	Alzheimer Forschung Initiative e.V.; Hans & Ilse-Breuer Stiftung	Funding for the project was provided by the Alzheimer Forschung Initiative e.V. (M. D.) and the Hans & Ilse-Breuer Stiftung (A. C. G.).	Akizuki S, 2019, ANN RHEUM DIS, V78, P509, DOI 10.1136/annrheumdis-2018-214116; BERNARDI A, 1968, BIOCHIM BIOPHYS ACTA, V155, P360, DOI 10.1016/0005-2787(68)90180-9; Bernardi A., 1971, SPLEEN ACID EXONUCLE, V4; Bernardi A., 1971, ENZYMES, V4, P329; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; DESREUX V, 1962, J GEN PHYSIOL, V45, P93, DOI 10.1085/jgp.45.4.93; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Engelman CD, 2018, NEUROBIOL AGING, V66, DOI 10.1016/j.neurobiolaging.2017.12.025; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Fazzari P, 2017, NATURE, V541, pE1, DOI 10.1038/nature21030; Gavin AL, 2018, NAT IMMUNOL, V19, P942, DOI 10.1038/s41590-018-0179-y; Gonzalez AC, 2018, BRAIN, V141, DOI 10.1093/brain/awy258; Gonzalez AC, 2018, CELL REP, V22, P1040, DOI 10.1016/j.celrep.2017.12.100; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Heilmann S, 2015, NATURE, V520, pE3, DOI 10.1038/nature14039; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; HOBBS J, 1972, BIOCHEMISTRY-US, V11, P4336, DOI 10.1021/bi00773a021; Hooli BV, 2015, NATURE, V520, pE7, DOI 10.1038/nature14040; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Jung S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-623; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; LACKEY D, 1977, J BACTERIOL, V131, P583, DOI 10.1128/JB.131.2.583-588.1977; Lambert JC, 2015, NATURE, V520, pE1, DOI 10.1038/nature14036; Marques ARA, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221739; Miyake K, 2017, J LEUKOCYTE BIOL, V101, P135, DOI 10.1189/jlb.4MR0316-108R; Monia BP, 1996, J BIOL CHEM, V271, P14533, DOI 10.1074/jbc.271.24.14533; Nibbeling EAR, 2017, BRAIN, V140, P2860, DOI 10.1093/brain/awx251; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Nygaard HB, 2019, J GERONTOL A-BIOL, V74, P1386, DOI 10.1093/gerona/gly098; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Otani Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027544; Pedersen KM, 1998, J BIOL CHEM, V273, P31494, DOI 10.1074/jbc.273.47.31494; Platt FM, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0025-4; Tan MS, 2018, J ALZHEIMERS DIS, V65, P871, DOI 10.3233/JAD-180431; van der Lee SJ, 2015, NATURE, V520, pE2, DOI 10.1038/nature14038; Yoshikawa F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013932; Zhang DF, 2016, MOL NEUROBIOL, V53, P4034, DOI 10.1007/s12035-015-9353-5	42	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100152	10.1074/jbc.RA120.015867	http://dx.doi.org/10.1074/jbc.RA120.015867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33288674	gold, Green Published			2022-12-26	WOS:000672866400130
J	Kartje, ZJ; Janis, HI; Mukhopadhyay, S; Gagnon, KT				Kartje, Zachary J.; Janis, Helen, I; Mukhopadhyay, Shaoni; Gagnon, Keith T.			Revisiting T7 RNA polymerase transcription in vitro with the Broccoli RNA aptamer as a simplified real-time fluorescent reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; T4 DNA; EXPRESSION; BINDING; PROTEIN; MIMICS; RECOGNITION; FLUOROPHORE; INITIATION; SELECTION	Methods for rapid and high-throughput screening of transcription in vitro to examine reaction conditions, enzyme mutants, promoter variants, and small molecule modulators can be extremely valuable tools. However, these techniques may be difficult to establish or inaccessible to many researchers. To develop a straightforward and cost-effective platform for assessing transcription in vitro, we used the "Broccoli" RNA aptamer as a direct, real-time fluorescent transcript readout. To demonstrate the utility of our approach, we screened the effect of common reaction conditions and components on bacteriophage T7 RNA polymerase (RNAP) activity using a common quantitative PCR instrument for fluorescence detection. Several essential conditions for in vitro transcription by T7 RNAP were confirmed with this assay, including the importance of enzyme and substrate concentrations, covariation of magnesium and nucleoside triphosphates, and the effects of several typical additives. When we used this method to assess all possible point mutants of a canonical T7 RNAP promoter, our results coincided well with previous reports. This approach should translate well to a broad variety of bacteriophage in vitro transcription systems and provides a platform for developing fluorescence-based readouts of more complex transcription systems in vitro.	[Kartje, Zachary J.; Janis, Helen, I; Gagnon, Keith T.] Southern Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA; [Mukhopadhyay, Shaoni; Gagnon, Keith T.] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Kartje, Zachary J.] Univ Massachusetts, Med Sch, RNA Therapeut Inst, Worcester, MA 01605 USA; [Janis, Helen, I] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Massachusetts System; University of Massachusetts Worcester; University of Arizona	Gagnon, KT (corresponding author), Southern Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA.; Gagnon, KT (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	ktgagnon@siu.edu			SIU Dissertation Research Award; SIU REACH Award	SIU Dissertation Research Award; SIU REACH Award	This work was supported by faculty startup funds to K. T. G., an SIU Dissertation Research Award to Z. J. K., and an SIU REACH Award to H. I. J.	Ageely EA, 2016, ACS CHEM BIOL, V11, P2398, DOI 10.1021/acschembio.6b00047; Autour A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02993-8; Bergbrede T, 2017, SLAS DISCOV, V22, P378, DOI 10.1177/2472555217690326; Bouhedda F, 2020, NAT CHEM BIOL, V16, P69, DOI 10.1038/s41589-019-0381-8; Brunelle JL, 2013, METHOD ENZYMOL, V530, P101, DOI 10.1016/B978-0-12-420037-1.00005-1; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; CHAMBERL.M, 1973, J BIOL CHEM, V248, P2235; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen XJ, 2019, NAT BIOTECHNOL, V37, P1287, DOI 10.1038/s41587-019-0249-1; Chen ZQ, 2005, BIOCHEM BIOPH RES CO, V333, P664, DOI 10.1016/j.bbrc.2005.05.166; Contreras-Llano LE, 2018, SYN BIOL, V3, DOI 10.1093/synbio/ysy012; D'Arienzo V, 2021, J GEN VIROL, V102, DOI 10.1099/jgv.0.001373; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; Dolgosheina EV, 2014, ACS CHEM BIOL, V9, P2412, DOI 10.1021/cb500499x; Fields C, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3219; Filonov GS, 2015, CHEM BIOL, V22, P649, DOI 10.1016/j.chembiol.2015.04.018; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; FRUGIER M, 1994, NUCLEIC ACIDS RES, V22, P2784, DOI 10.1093/nar/22.14.2784; Garcia-Martinez LF, 2002, ANAL BIOCHEM, V301, P103, DOI 10.1006/abio.2001.5472; Gholamalipour Y, 2018, NUCLEIC ACIDS RES, V46, P9253, DOI 10.1093/nar/gky796; GREEN MH, 1964, P NATL ACAD SCI USA, V52, P1388, DOI 10.1073/pnas.52.6.1388; Hofer K, 2013, J AM CHEM SOC, V135, P13692, DOI 10.1021/ja407142f; Huang H, 2014, NAT CHEM BIOL, V10, P686, DOI [10.1038/NCHEMBIO.1561, 10.1038/nchembio.1561]; Ichetovkin IE, 1997, J BIOL CHEM, V272, P33009, DOI 10.1074/jbc.272.52.33009; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Kanodia P, 2020, RNA, V26, P888, DOI 10.1261/rna.074963.120; Kartje ZJ, 2018, BIOCHEMISTRY-US, V57, P3027, DOI 10.1021/acs.biochem.8b00107; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Komura R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196905; Kramer NJ, 2016, SCIENCE, V353, P708, DOI 10.1126/science.aaf7791; Lukavsky PJ, 2004, RNA, V10, P889, DOI 10.1261/rna.5264804; MARMUR J, 1963, SCIENCE, V142, P387, DOI 10.1126/science.142.3590.387; MASLAK M, 1994, BIOCHEMISTRY-US, V33, P6918, DOI 10.1021/bi00188a022; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; NIEUWLANDT DT, 1990, J BACTERIOL, V172, P7104, DOI 10.1128/jb.172.12.7104-7110.1990; NUSS DL, 1975, ARCH BIOCHEM BIOPHYS, V169, P513, DOI 10.1016/0003-9861(75)90194-0; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Paudel BP, 2018, P NATL ACAD SCI USA, V115, P11917, DOI 10.1073/pnas.1806685115; Paudel BP, 2014, J AM CHEM SOC, V136, P16700, DOI 10.1021/ja5073146; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; ROBERTS JW, 1969, NATURE, V223, P480, DOI 10.1038/223480a0; ROHDE W, 1981, BIOSCIENCE REP, V1, P327, DOI 10.1007/BF01114872; Rohilla KJ, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0468-y; Rong M, 1998, J BIOL CHEM, V273, P10253, DOI 10.1074/jbc.273.17.10253; Rong MQ, 1998, P NATL ACAD SCI USA, V95, P515, DOI 10.1073/pnas.95.2.515; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Siboni RB, 2015, CELL REP, V13, P2386, DOI 10.1016/j.celrep.2015.11.028; Takahashi S, 2019, BIOCHEMISTRY-US, V58, P1081, DOI 10.1021/acs.biochem.8b01204; Trachman RJ, 2017, NAT CHEM BIOL, V13, P807, DOI 10.1038/nchembio.2392; UHLENBECK OC, 1983, J BIOMOL STRUCT DYN, V1, P539, DOI 10.1080/07391102.1983.10507460; Voss C, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-7; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865; Yim SS, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20198875; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682	59	7	7	12	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100175	10.1074/jbc.RA120.014553	http://dx.doi.org/10.1074/jbc.RA120.014553			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303627	Green Published, gold			2022-12-26	WOS:000672866400153
J	Shen, Z; Zhang, YH; Zhang, L; Li, Y; Sun, YD; Li, ZY				Shen, Zhan; Zhang, Yan-hua; Zhang, Lei; Li, Yuan; Sun, Ya-dong; Li, Zu-yao			Changes in the distribution of endogenous hormones in Phyllostachys edulis 'Pachyloen' during bamboo shooting	PLOS ONE			English	Article							ABA; STRESS; COLD	In this study, we investigated the changes in the distribution and regulation of endogenous hormones in Phyllostachys edulis 'Pachyloen' during bamboo shooting. Enzyme-linked immunosorbent assay was used to measure the mass fractions of indole-3-acetic acid (IAA), gibberellic acid (GA), zeatin riboside (ZR), and abscisic acid (ABA) in rhizomes, shoots, and maternal bamboo organs during shoot sprouting, shoot growth, and new-bamboo formation. Measurements were compared among bamboo parts and developmental periods. The overall mass fractions of IAA and ABA were significantly higher than those of ZR and GA, driven by differences among bamboo parts and developmental periods. The abundance of each endogenous hormone varied among bamboo parts and developmental periods. During bamboo shooting, ABA had the highest mass fraction in all bamboo parts sampled, followed by IAA, GA, and ZR. Among bamboo parts, rhizomes had more IAA, ZR, and GA than the other parts, but significantly less ABA. Winter shoots had higher ZR: IAA and GA: IAA ratios than rhizomes and maternal bamboo organs. During shoot growth, ABA was the most abundant hormone in rhizomes and maternal bamboo organs, followed by IAA, ZR, and GA. In contrast, IAA was the most abundant hormone in spring shoots, followed by ABA, ZR, and GA. Maternal bamboo organs had a significantly higher ZR: GA ratio, and significantly lower IAA: ABA, ZR: ABA, and GA: ABA ratios than rhizomes. Spring shoots had significantly higher IAA: ABA, ZR: ABA, and GA: ABA ratios than rhizomes and maternal bamboo organs; significantly higher ZR mass fractions, and ZR: GA and ZR: IAA ratios and significantly lower ABA mass fractions than rhizomes; and significantly higher GA: IAA ratio than maternal bamboo organs. During new-bamboo formation, ABA was the most abundant hormone in rhizomes, winter shoots, and maternal bamboo organs, followed by IAA, ZR, and GA. Maternal bamboo organs had significantly lower IAA mass fractions and significantly higher ABA mass fractions than rhizomes and new bamboo tissue. IAA and ABA abundances exhibited an inverse relationship in rhizomes and maternal bamboo organs. GA: ABA and GA: IAA ratios decreased gradually and other hormone ratios exhibited parabolic trends over the bamboo-shooting period, with the highest ratios observed in new bamboo tissues. Overall, the coordination or antagonism among endogenous hormones plays a key regulatory role in bamboo shoot growth. The formation of thick walls in P. edulis 'Pachyloen', one of its major traits, may be partially attributed to the relatively high IAA and ZR and low GA mass fractions.	[Shen, Zhan; Li, Yuan; Sun, Ya-dong; Li, Zu-yao] Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China; [Shen, Zhan; Li, Zu-yao] Jiangxi Prov Key Lab Bamboo Germplasm Resources &, Nanchang, Jiangxi, Peoples R China; [Zhang, Yan-hua; Zhang, Lei] Nanjing Forestry Univ, Coll Forestry, Nanjing, Jiangsu, Peoples R China	Jiangxi Agricultural University; Nanjing Forestry University	Li, ZY (corresponding author), Jiangxi Agr Univ, Coll Forestry, Nanchang, Jiangxi, Peoples R China.; Li, ZY (corresponding author), Jiangxi Prov Key Lab Bamboo Germplasm Resources &, Nanchang, Jiangxi, Peoples R China.	jxlizuyao@126.com			Key Technologies Research and Development Program of China [2015BAD04B01]	Key Technologies Research and Development Program of China(National Key Technology R&D Program)	The study was financially supported by the Key Technologies Research and Development Program of China (2015BAD04B01).	[Anonymous], 2013, RIGAKU J, V29, P26; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; [陈建华 CHEN Jianhua], 2011, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V31, P70; Chen Ting, 2015, Journal of Zhejiang A&F University, V32, P181; Du H, 2013, PLANT MOL BIOL, V83, P475, DOI 10.1007/s11103-013-0103-7; Durbak A, 2012, CURR OPIN PLANT BIOL, V15, P92, DOI 10.1016/j.pbi.2011.12.004; Fang Kai, 2012, Acta Agriculturae Universitatis Jiangxiensis, V34, P54; Fang Kai, 2011, Acta Agriculturae Universitatis Jiangxiensis, V33, P1107; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; Ghanem ME, 2011, J PLANT GROWTH REGUL, V30, P144, DOI 10.1007/s00344-010-9178-4; [何奇江 HE Qijiang], 2006, [科技通报, Bulletin of Science and Technology], V22, P477; Huang JianQin, 2002, Scientia Silvae Sinicae, V38, P38; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kof EM, 2006, RUSS J PLANT PHYSL+, V53, P359, DOI 10.1134/S1021443706030113; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Li Jian, 2011, Acta Agriculturae Universitatis Jiangxiensis, V33, P537; Li Y, 2017, NONWOOD FOREST RES, V35, P147; Li Ying-chun, 2009, Forest Research, V22, P608; Li ZY, 2013, NONWOOD FOREST RES, V31, P167; Liu XH, 2013, SPECTROSC SPECT ANAL, V33, P2512, DOI 10.3964/j.issn.1000-0593(2013)09-2512-07; Lou GH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0289-z; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Roldan V G, 2008, NATURE, V455, P189; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Shi JianMin, 2009, Forest Research, Beijing, V22, P872; Sunayana MR, 2005, BIOTECHNOL LETT, V27, P1897, DOI 10.1007/s10529-005-3900-5; Wang Bo, 2015, Journal of Zhejiang Forestry Science and Technology, V35, P13; Wang CR, 2008, J INTEGR PLANT BIOL, V50, P427, DOI 10.1111/j.1774-7909.2008.00638.x; Wu XingBo, 2016, Journal of Zhejiang A&F University, V33, P209; Yang G., 1997, J JIANGXI AGR U, V19, P97; Yang RongChao, 2012, Acta Agrestia Sinica, V20, P1; Yu ShuHong, 2016, Journal of Zhejiang A&F University, V33, P807; Zheng YS, 1998, SCI SILVAE SINICAE, V34, P100	34	4	4	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0241806	10.1371/journal.pone.0241806	http://dx.doi.org/10.1371/journal.pone.0241806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306692	gold, Green Published			2022-12-26	WOS:000600144200033
J	Peters, BL; Deng, JX; Ferguson, AL				Peters, Brandon L.; Deng, Jinxia; Ferguson, Andrew L.			Free energy calculations of the functional selectivity of 5-HT2B G protein-coupled receptor	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; BINDING; ACTIVATION; AGONIST; GPCRS; STATE	G Protein-Coupled Receptors (GPCRs) mediate intracellular signaling in response to extracellular ligand binding and are the target of one-third of approved drugs. Ligand binding modulates the GPCR molecular free energy landscape by preferentially stabilizing active or inactive conformations that dictate intracellular protein recruitment and downstream signaling. We perform enhanced sampling molecular dynamics simulations to recover the free energy surfaces of a thermostable mutant of the GPCR serotonin receptor 5-HT2B in the unliganded form and bound to a lysergic acid diethylamide (LSD) agonist and lisuride antagonist. LSD binding imparts a similar to 110 kJ/mol driving force for conformational rearrangement into an active state. The lisuride-bound form is structurally similar to the apo form and only similar to 24 kJ/mol more stable. This work quantifies ligand-induced conformational specificity and functional selectivity of 5-HT2B and presents a platform for high-throughput virtual screening of ligands and rational engineering of the ligand-bound molecular free energy landscape.	[Peters, Brandon L.; Ferguson, Andrew L.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Deng, Jinxia] Zoetis Inc, Kalamazoo, MI USA	University of Chicago; Zoetis	Ferguson, AL (corresponding author), Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA.	andrewferguson@uchicago.edu		Ferguson, Andrew/0000-0002-8829-9726	External Innovation Department of Zoetis Inc.; National Science Foundation [DMR-1828629]	External Innovation Department of Zoetis Inc.; National Science Foundation(National Science Foundation (NSF))	This work was supported by the External Innovation Department of Zoetis Inc. The funder provided support in the form of salaries for authors B.L.P., J.D., and A.L.F., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was completed in part with resources provided by the University of Chicago Research Computing Center. We gratefully acknowledge compute time on the University of Chicago high-performance GPU-based cyberinfrastructure acquired under National Science Foundation Grant No. DMR-1828629.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Allen M. P., 2017, COMPUTER SIMULATION; Allen RJ, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/46/463102; [Anonymous], MOL OPERATING ENV; [Anonymous], ACD STRUCT EL; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Chen QY, 2017, CELL, V168, P339, DOI 10.1016/j.cell.2017.01.012; Chen W, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5092521; Chen W, 2018, J COMPUT CHEM, V39, P2079, DOI 10.1002/jcc.25520; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Escobedo FA, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/333101; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Filizola M, 2014, G PROTEIN COUPLED RE; Fleetwood O, 2020, BIOCHEMISTRY-US, V59, P880, DOI 10.1021/acs.biochem.9b00842; Ghahremanpour MM, 2014, BIOINFORMATICS, V30, P439, DOI 10.1093/bioinformatics/btt680; Golovin A, 2005, PROTEINS, V58, P190, DOI 10.1002/prot.20288; Gonzalez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023815; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Heifetz A, 2018, COMPUTATIONAL METHOD; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hockney R.W., 1998, COMPUTER SIMULATION; Hofmann C, 2006, CLIN NEUROPHARMACOL, V29, P80, DOI 10.1097/00002826-200603000-00005; Hollingsworth SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11062-7; Ibrahim P, 2019, CURR OPIN STRUC BIOL, V55, P129, DOI 10.1016/j.sbi.2019.04.002; Johnston JM, 2014, ADV EXP MED BIOL, V796, P95, DOI 10.1007/978-94-007-7423-0_6; Kohlhoff KJ, 2014, NAT CHEM, V6, P15, DOI [10.1038/NCHEM.1821, 10.1038/nchem.1821]; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Li JN, 2013, J AM CHEM SOC, V135, P8749, DOI 10.1021/ja404391q; Long AW, 2018, MOL SYST DES ENG, V3, P49, DOI 10.1039/c7me00077d; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Maroteaux L, 2017, PHARMACOL THERAPEUT, V170, P14, DOI 10.1016/j.pharmthera.2016.10.008; McCorvy JD, 2018, NAT STRUCT MOL BIOL, V25, P787, DOI 10.1038/s41594-018-0116-7; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Meral D, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5060960; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; Provasi D, 2010, BIOPHYS J, V98, P2347, DOI 10.1016/j.bpj.2010.01.047; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rodriguez-Espigares I, 2020, NAT METHODS, V17, P777, DOI 10.1038/s41592-020-0884-y; Saleh N, 2017, J CHEM INF MODEL, V57, P1210, DOI 10.1021/acs.jcim.6b00772; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schneider Sebastian, 2015, Methods Mol Biol, V1335, P277, DOI 10.1007/978-1-4939-2914-6_18; Sutto L, 2012, WIRES COMPUT MOL SCI, V2, P771, DOI 10.1002/wcms.1103; Taylor BC, 2019, P NATL ACAD SCI USA, V116, P8131, DOI 10.1073/pnas.1814131116; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Velgy N, 2018, METHODS MOL BIOL, V1705, P133, DOI 10.1007/978-1-4939-7465-8_6; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733; Zia SR, 2016, J CHEM THEORY COMPUT, V12, P6049, DOI 10.1021/acs.jctc.6b00475	68	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243313	10.1371/journal.pone.0243313	http://dx.doi.org/10.1371/journal.pone.0243313			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296400	Green Published, gold			2022-12-26	WOS:000598626100019
J	Barros, AD; Lima, AP; Fachin-Espinar, MT; Nunez, CV				Barros, Andre de Lima; Lima, Albertina Pimentel; Fachin-Espinar, Maria Teresa; Nunez, Cecilia Veronica			Evaluation of benzocaine-based anesthetic gel in anuran skins extracts: A case study using the frog Lithodytes lineatus (Anura: Leptodactylidae)	PLOS ONE			English	Article							POISON FROGS; TRICAINE METHANESULFONATE; ANTIMICROBIAL ACTIVITY; TREE FROG; ALKALOIDS; PEPTIDES; SECRETIONS; ARTHROPOD; EUGENOL; MS-222	Extracts made from the skin of dead Lithodytes lineatus frog individuals with the application of the benzocaine-based anesthetic gel, introduced into the oral cavity, were analyzed by H-1 Nuclear Magnetic Resonance to investigate whether the application of this product (oral) can make studies that use extracts from the skins of these animals unfeasible. For comparison, we used skins of another species of anuran following the same death protocol. No trace of the benzocaine substance was found in the H-1-NMR spectra of the skin extracts from any of the tested anuran species. Still, using the hierarchical clustering model, it was possible to observe the formation of well-defined groups between the skin extracts of anurans and the anesthetic used to kill these animals. Our results suggest that the lethal dose of benzocaine in gel used inside the mouth of frogs may have no influence on potential results regarding the chemical composition or even bioassays using extracts made from the skin of these animals killed under this protocol since there was no detection of this substance for the analyzed samples.	[Barros, Andre de Lima; Lima, Albertina Pimentel] Inst Nacl Pesquisas Amazonia INPA, Dept Ecol, Manaus, Amazonas, Brazil; [Barros, Andre de Lima; Fachin-Espinar, Maria Teresa; Nunez, Cecilia Veronica] Inst Nacl Pesquisas Amazonia INPA, Lab Bioprospeccao & Biotecnol LABB, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Barros, AD (corresponding author), Inst Nacl Pesquisas Amazonia INPA, Dept Ecol, Manaus, Amazonas, Brazil.; Barros, AD (corresponding author), Inst Nacl Pesquisas Amazonia INPA, Lab Bioprospeccao & Biotecnol LABB, Manaus, Amazonas, Brazil.	andrelima1701@gmail.com	Nunez, Cecilia V/I-9681-2016	Nunez, Cecilia V/0000-0003-3400-9508; Barros, Andre/0000-0002-9804-4188	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [Pro-Amazonia/CAPES 23038.000738/2013-78]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [CT-Amazonia/CNPq - 405804/2013-0, 309654/2016-5, 305177/2019-2]; FAPEAM	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAM	YES -Specify the role(s) played. The authors thanks to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) granted the doctoral scholarship to ALB and financial support (Pro-Amazonia/CAPES 23038.000738/2013-78) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provide financial support (CT-Amazonia/CNPq -405804/2013-0) and CVN fellowships (309654/2016-5 and 305177/2019-2) and to FAPEAM for financial support.	Amezquita A, 2017, EVOLUTION, V71, P1039, DOI 10.1111/evo.13170; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2004, ASIAN AFFAIRS, VXXXV, P3; AVMA, 2020, GUID EUTH AN; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Cecala Kristen K., 2007, Herpetological Review, V38, P63; Chen Megan H., 1999, Herpetological Review, V30, P34; Clark VC, 2010, ENVIRON RES ADV, P1; Crook AC, 2006, AM MIDL NAT, V155, P417, DOI 10.1674/0003-0031(2006)155[417:AEOMAB]2.0.CO;2; DALY JW, 1995, P NATL ACAD SCI USA, V92, P9, DOI 10.1073/pnas.92.1.9; DALY JW, 1994, J CHEM ECOL, V20, P943, DOI 10.1007/BF02059589; Darst CR, 2005, AM NAT, V165, P56, DOI 10.1086/426599; Goraya J, 2000, EUR J BIOCHEM, V267, P894, DOI 10.1046/j.1432-1327.2000.01074.x; Goulet F, 2010, J AM ASSOC LAB ANIM, V49, P460; Guenette S. A., 2006, Journal of Herpetological Medicine and Surgery, V16, P38; Guenette SA, 2007, VET ANAESTH ANALG, V34, P164, DOI 10.1111/j.1467-2995.2006.00316.x; Guenette SA, 2013, EXP ANIM TOKYO, V62, P87; Jeckel AM, 2019, CHEMOECOLOGY, V29, P225, DOI 10.1007/s00049-019-00291-3; Kaiser Hinrich, 2001, Herpetological Review, V32, P93; Kawasaki H, 2003, BIOCHEM BIOPH RES CO, V312, P1082, DOI 10.1016/j.bbrc.2003.11.052; Lafortune M., 2001, Journal of Herpetological Medicine and Surgery, V11, P13; LETCHER J, 1992, ZOO BIOL, V11, P243, DOI 10.1002/zoo.1430110404; Lillywhite HB, 2017, BIOSCIENCE, V67, P52, DOI 10.1093/biosci/biw143; Mebs D, 2018, TOXICON, V152, P103, DOI 10.1016/j.toxicon.2018.07.027; Mitchell MA, 2009, J EXOT PET MED, V18, P40, DOI 10.1053/j.jepm.2008.11.006; Nascimento ACC, 2003, PROTEIN PEPTIDE LETT, V10, P227, DOI 10.2174/0929866033478933; Saporito RA, 2018, EVOLUTION, V72, P1009, DOI 10.1111/evo.13468; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; Saporito RA, 2009, HETEROCYCLES, V79, P277, DOI 10.3987/REV-08-SR(D)11; Shen W, 2016, GENE, V576, P136, DOI 10.1016/j.gene.2015.09.086; Shine R, 2015, BIOLOGY AND EVOLUTION OF CROCODYLIANS, P1; Smith BP, 2002, J NAT PROD, V65, P439, DOI 10.1021/np010506a	32	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243654	10.1371/journal.pone.0243654	http://dx.doi.org/10.1371/journal.pone.0243654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290419	Green Published, gold			2022-12-26	WOS:000598620100024
J	Rasoamanana, H; Ravelomanantsoa, S; Yahiaoui, N; Dianzinga, N; Rebert, E; Gauche, MM; Pecrix, Y; Costet, L; Rieux, A; Prior, P; Robene, I; Cellier, G; Guerin, F; Poussier, S				Rasoamanana, Hasina; Ravelomanantsoa, Santatra; Yahiaoui, Noura; Dianzinga, Niry; Rebert, Emeline; Gauche, Miharisoa-Mirana; Pecrix, Yann; Costet, Laurent; Rieux, Adrien; Prior, Philippe; Robene, Isabelle; Cellier, Gilles; Guerin, Fabien; Poussier, Stephane			Contrasting genetic diversity and structure among Malagasy Ralstonia pseudosolanacearum phylotype I populations inferred from an optimized Multilocus Variable Number of Tandem Repeat Analysis scheme	PLOS ONE			English	Article							SOLANACEARUM SPECIES COMPLEX; BACTERIAL WILT; GENOME SEQUENCE; 1ST REPORT; STRAINS; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; INFECTION; PROGRAM	The Ralstonia solanacearum species complex (RSSC), composed of three species and four phylotypes, are globally distributed soil-borne bacteria with a very broad host range. In 2009, a devastating potato bacterial wilt outbreak was declared in the central highlands of Madagascar, which reduced the production of vegetable crops including potato, eggplant, tomato and pepper. A molecular epidemiology study of Malagasy RSSC strains carried out between 2013 and 2017 identified R. pseudosolanacearum (phylotypes I and III) and R. solanacearum (phylotype II). A previously published population biology analysis of phylotypes II and III using two MultiLocus Variable Number of Tandem Repeats Analysis (MLVA) schemes revealed an emergent epidemic phylotype II (sequevar 1) group and endemic phylotype III isolates. We developed an optimized MLVA scheme (RS1-MLVA14) to characterize phylotype I strains in Madagascar to understand their genetic diversity and structure. The collection included isolates from 16 fields of different Solanaceae species sampled in Analamanga and Itasy regions (highlands) in 2013 (123 strains) and in Atsinanana region (lowlands) in 2006 (25 strains). Thirty-one haplotypes were identified, two of them being particularly prevalent: MT007 (30.14%) and MT004 (16.44%) (sequevar 18). Genetic diversity analysis revealed a significant contrasting level of diversity according to elevation and sampling region. More diverse at low altitude than at high altitude, the Malagasy phylotype I isolates were structured in two clusters, probably resulting from different historical introductions. Interestingly, the most prevalent Malagasy phylotype I isolates were genetically distant from regional and worldwide isolates. In this work, we demonstrated that the RS1-MLVA14 scheme can resolve differences from regional to field scales and is thus suited for deciphering the epidemiology of phylotype I populations.	[Rasoamanana, Hasina; Yahiaoui, Noura; Dianzinga, Niry; Rebert, Emeline; Gauche, Miharisoa-Mirana; Guerin, Fabien; Poussier, Stephane] Univ La Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France; [Ravelomanantsoa, Santatra] Ctr Natl Rech Appl Dev Rural FOFIFA, Antananarivo, Madagascar; [Pecrix, Yann; Costet, Laurent; Rieux, Adrien; Robene, Isabelle] Ctr Cooperat Int Rech Agron Dev, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France; [Prior, Philippe] Inst Natl Rech Agr Alimentat & Environm, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France; [Cellier, Gilles] Anses Plant Hlth Lab, Trop Pests & Dis Unit, St Pierre, Reunion, France	University of La Reunion; CIRAD; INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Poussier, S (corresponding author), Univ La Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France.	stephane.poussier@univ-reunion.fr		Dianzinga, Niry T./0000-0002-3159-5866; Pecrix, Yann/0000-0002-6537-3145; Poussier, Stephane/0000-0003-0273-3518	Agropolis Fondation [1403-011, ANR-10-LABX-0001-01]; European Union: European regional development fund (ERDF, programme INTERREG V); Conseil Regional de La Reunion; Centre de Cooperation Internationale en Recherche agronomique pour le Developpement (CIRAD); ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail); CIRAD	Agropolis Fondation; European Union: European regional development fund (ERDF, programme INTERREG V); Conseil Regional de La Reunion; Centre de Cooperation Internationale en Recherche agronomique pour le Developpement (CIRAD); ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail)(French National Research Agency (ANR)); CIRAD	This project was supported by Agropolis Fondation under the reference ID 1403-011 through the "Investissements d'avenir" program (Labex Agro: ANR-10-LABX-0001-01). This work was funded by the European Union: European regional development fund (ERDF, programme INTERREG V), by the Conseil Regional de La Reunion and by the Centre de Cooperation Internationale en Recherche agronomique pour le Developpement (CIRAD). HR and SR received doctoral fellowships from the Conseil Regional de La Reunion. NY was supported by a doctoral fellowship from ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail) and CIRAD. The authors greatly acknowledge the Plant Protection Platform (3P, IBISA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman A, 2017, PLANT PATHOL, V66, P826, DOI 10.1111/ppa.12661; Abdurahman A, 2019, PHYTOPATHOLOGY, V109, P1922, DOI 10.1094/PHYTO-12-18-0476-R; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergsma-Vlami M, 2018, PLANT DIS, V102, P2258, DOI 10.1094/PDIS-09-17-1345-RE; Blomme G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01290; Borg I, 2010, MODERN MULTIDIMENSIO; BOURIQUET G., 1946, Encyclopedie mycologique, V12; BOURIQUET G., 1934, ANN CRYPTOGAMIE EXOT, V7, P97; BOURIQUET G., 1934, International Bulletin of Plant Protection, V8, P99; Buhlmann A, 2014, ENVIRON MICROBIOL, V16, P2112, DOI 10.1111/1462-2920.12289; Carstensen GD, 2017, PLANT PATHOL, V66, P393, DOI 10.1111/ppa.12577; Cellier G, 2010, PHYTOPATHOLOGY, V100, P1250, DOI 10.1094/PHYTO-02-10-0059; Chesneau T, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02209; CIAMPI L, 1980, AM POTATO J, V57, P377, DOI 10.1007/BF02854329; Coupat B, 2008, FEMS MICROBIOL ECOL, V66, P14, DOI 10.1111/j.1574-6941.2008.00552.x; Dadant R, 1960, LISTE MALADIES PLANT, V17, P94; Deberdt P, 2014, PHYTOPATHOLOGY, V104, P586, DOI 10.1094/PHYTO-09-13-0264-R; Elphinstone J. G., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P9; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Ferreira MASV, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00489; FERT, 2012, ET FIL LEG HAUT TERR, P88; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco CS, 2017, PHYTOPATHOLOGY, V107, P395, DOI 10.1094/PHYTO-08-16-0300-R; Gironde S, 2012, APPL ENVIRON MICROB, V78, P3266, DOI 10.1128/AEM.06655-11; Guinard J, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01415-15; Guinard J, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.03095-16, 10.1128/AEM.03095-16]; HAYWARD AC, 1994, BACTERIAL WILT, P9; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Janse J. D., 1996, Bulletin OEPP, V26, P679, DOI 10.1111/j.1365-2338.1996.tb01512.x; Jiang GF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01549; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Kim S. H., 2003, Plant Disease, V87, P450, DOI 10.1094/PDIS.2003.87.4.450C; Kyaw HWW, 2017, J GEN PLANT PATHOL, V83, P216, DOI 10.1007/s10327-017-0720-0; LALLMAHOMED G M, 1988, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V36, P54; Li ZF, 2011, J BACTERIOL, V193, P6088, DOI 10.1128/JB.06009-11; Lin CH, 2014, PLANT PATHOL, V63, P1395, DOI 10.1111/ppa.12209; Liu Y, 2017, EUR J PLANT PATHOL, V147, P541, DOI 10.1007/s10658-016-1023-6; Lopez-Soriano P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163729; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mascheretti S, 2008, MOL ECOL, V17, P2755, DOI 10.1111/j.1365-294X.2008.03773.x; Mayer C, 2007, PHOBOS TANDEM REPEAT; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Milgroom, 2017, POPULATION BIOL PLAN; Milling A, 2009, PHYTOPATHOLOGY, V99, P1127, DOI 10.1094/PHYTO-99-10-1127; Monteil M, 2007, MICROBIOL-SGM, V153, P1141, DOI 10.1099/mic.0.2006/001164-0; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; N'Guessan CA, 2012, PHYTOPATHOLOGY, V102, P733, DOI 10.1094/PHYTO-11-11-0300; N'Guessan CA, 2013, J MICROBIOL METH, V92, P366, DOI 10.1016/j.mimet.2013.01.012; Nakato GV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215090; Ngoc LBT, 2009, APPL ENVIRON MICROB, V75, P1173, DOI 10.1128/AEM.02245-08; Parkinson N, 2013, APPL ENVIRON MICROB, V79, P6016, DOI 10.1128/AEM.01219-13; Pastou D, 2020, PLANT DIS, V104, P278, DOI 10.1094/PDIS-05-19-1068-PDN; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Poulin L, 2015, APPL ENVIRON MICROB, V81, P688, DOI 10.1128/AEM.02768-14; Pourcel C, 2011, STRAIN TYPING USING; Pradhanang PM, 2000, PLANT PATHOL, V49, P403, DOI 10.1046/j.1365-3059.2000.00480.x; Prior P, 2005, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.2005.695.14; Prior P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2413-z; Pruvost O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098129; Rache L, 2019, PHYTOPATHOLOGY, V109, P859, DOI 10.1094/PHYTO-06-18-0210-R; Rakotofiringa FMD, 2019, CARACTERISATION CLIM; Rakotondramanana Rabakoarihanta A, 1984, POTATO DEV TRANSFER; Ramsubhag A, 2012, PLANT PATHOL, V61, P844, DOI 10.1111/j.1365-3059.2011.02572.x; Ravelomanantsoa S, 2016, BIOL POPULATIONS COM; Ravelomanantsoa S, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02258; Ravelomanantsoa S, 2016, PEERJ, V4, DOI 10.7717/peerj.1949; Safni I, 2014, INT J SYST EVOL MICR, V64, P3087, DOI 10.1099/ijs.0.066712-0; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Samad HM, 2008, ANAL FILIERE TOMATE; Santiago TR, 2020, PLANT DIS, V104, P1019, DOI 10.1094/PDIS-09-19-1929-RE; Tjou-Tam-Sin NNA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01895; Tusiime G, 1998, ELPHINSTONE J BACTER; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Belkum A, 2007, FEMS IMMUNOL MED MIC, V49, P22, DOI 10.1111/j.1574-695X.2006.00173.x; Vergnaud G, 2009, METHODS MOL BIOL, V551, P141, DOI 10.1007/978-1-60327-999-4_12; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; Yahiaoui N, 2016, PLANT DIS, V100, P2522, DOI 10.1094/PDIS-06-16-0811-PDN; Yahiaoui N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02139; Zaluga J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-126; Zhao S, 2012, PHYTOPATHOLOGY, V102, P948, DOI 10.1094/PHYTO-04-12-0078-R	90	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0242846	10.1371/journal.pone.0242846	http://dx.doi.org/10.1371/journal.pone.0242846			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290390	Green Published, gold			2022-12-26	WOS:000598620100017
J	Rendon, P; Steinhoff-Knopp, B; Saggau, P; Burkhard, B				Rendon, Paula; Steinhoff-Knopp, Bastian; Saggau, Philipp; Burkhard, Benjamin			Assessment of the relationships between agroecosystem condition and the ecosystem service soil erosion regulation in Northern Germany	PLOS ONE			English	Article							EUROPEAN AGRICULTURAL SOILS; BIODIVERSITY; FRAMEWORK; HEALTH; CONSERVATION; INDICATORS; TRADEOFFS; QUALITY; WATER	Ecosystems provide multiple services that are necessary to maintain human life. Agroecosystems are very productive suppliers of biomass-related provisioning ecosystem services, e.g. food, fibre, and energy. At the same time, they are highly dependent on good ecosystem condition and regulating ecosystem services such as soil fertility, water supply or soil erosion regulation. Assessments of this interplay of ecosystem condition and services are needed to understand the relationships in highly managed systems. Therefore, the aim of this study is twofold: First, to test the concept and indicators proposed by the European Union Working Group on Mapping and Assessment of Ecosystems and their Services (MAES) for assessing agroecosystem condition at a regional level. Second, to identify the relationships between ecosystem condition and the delivery of ecosystem services. For this purpose, we applied an operational framework for integrated mapping and assessment of ecosystems and their services. We used the proposed indicators to assess the condition of agroecosystems in Northern Germany and regulating ecosystem service control of erosion rates. We used existing data from official databases to calculate the different indicators and created maps of environmental pressures, ecosystem condition and ecosystem service indicators for the Federal State of Lower Saxony. Furthermore, we identified areas within the state where pressures are high, conditions are unfavourable, and more sustainable management practices are needed. Despite the limitations of the indicators and data availability, our results show positive, negative, and no significant correlations between the different pressures and condition indicators, and the control of erosion rates. The idea behind the MAES framework is to indicate the general condition of an ecosystem. However, we observed that not all proposed indicators can explain to what extent ecosystems can provide specific ecosystem services. Further research on other ecosystem services provided by agroecosystems would help to identify synergies and trade-offs. Moreover, the definition of a reference condition, although complicated for anthropogenically highly modified agroecosystems, would provide a benchmark to compare information on the condition of the ecosystems, leading to better land use policy and management decisions.	[Rendon, Paula; Steinhoff-Knopp, Bastian; Burkhard, Benjamin] Leibniz Univ Hannover, Inst Phys Geog & Landscape Ecol, Hannover, Germany; [Saggau, Philipp] Univ Kiel, Inst Geog, Kiel, Germany; [Burkhard, Benjamin] Leibniz Ctr Agr Landscape Res ZALF, Muncheberg, Germany	Leibniz University Hannover; University of Kiel; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Rendon, P (corresponding author), Leibniz Univ Hannover, Inst Phys Geog & Landscape Ecol, Hannover, Germany.	rendon@phygeo.uni-hannover.de	Burkhard, Benjamin/ABF-1090-2021; Steinhoff-Knopp, Bastian/J-2842-2019; Rendon, Paula/ABG-8156-2021; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Rendon, Paula/AAD-4651-2022	Burkhard, Benjamin/0000-0001-8636-9009; Steinhoff-Knopp, Bastian/0000-0002-9926-8028; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Rendon, Paula/0000-0002-0277-1365; Saggau, Philipp/0000-0002-4648-1650	Leibniz Universitat Hannover	Leibniz Universitat Hannover	The publication of this article was funded by the Open Access Publishing Fund of Leibniz Universitat Hannover.	Akaike H, 1976, MATH SCI, V14, P5; Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; [Anonymous], 2017, BODENSCHUTZ, DOI DOI 10.37307/J.1868-7741.2017.04.04; [Anonymous], 2016, CIRE ANTILLES GUYANE; [Anonymous], 2019, MAPP ASS EC THEIR SE; [Anonymous], 2012, CORINE LAND COV CLC; Auerswald K, 2013, BODENSCHUTZ, V4, P109; Ballabio C, 2016, GEODERMA, V261, P110, DOI 10.1016/j.geoderma.2015.07.006; Bastian O, 2013, ECOL INDIC, V24, P12, DOI 10.1016/j.ecolind.2012.05.016; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; Batista PVG, 2019, EARTH-SCI REV, V197, DOI 10.1016/j.earscirev.2019.102898; BISE, 2020, BIODIVERSITY INFORM; Boardman J, 2007, SOIL EROSION EUROPE, P480; Bordt M, 2015, SUMMARY REV APPROACH, V0, 2.a.2; Brunsdon C, 2016, PROG HUM GEOG, V40, P687, DOI 10.1177/0309132515599625; Burkhard B., 2018, One Ecosystem, V3, pe22831, DOI 10.3897/oneeco.3.e22831; Burkhard B, 2018, LANDSCAPE 2018 FRONT, P126; Craglia M., 2007, RES THEORY ADV SPATI, P93; Deutscher Wetterdienst, 2018, CLIM DAT CTR CDC OPE; EC (European Commission), 2006, COM2006231FIN; EC European Community, 2013, OFFICIAL J EUROPEAN, V226, P17; ESDAC, 2014, PAN EUR SOC STOCK AG; ESDAC, 2016, TOPS PHYS PROP EUR B; European Commission, 2011, OUR LIF INS OUR NAT; European Commission, 2015, FOOD FARM FOC LAND; European Environment Agency, 2019, LAND COV CHANG LCC 2; Garcia-Feced C, 2015, AGRON SUSTAIN DEV, V35, P273, DOI 10.1007/s13593-014-0238-1; German Environment Agency, 2018, ENV AGR; Gocht A, 2014, THUNEN ATLAS LANDWIR; Guerra CA, 2014, ECOSYSTEMS, V17, P878, DOI 10.1007/s10021-014-9766-4; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Helmholtz Zentrum Geesthacht North German Climate Monitor Helmholtz-Zentrum Geesthacht, 2019, N GERM CLIM MON; Henle K., 2014, ADV BOOKS, V1, pe1169, DOI [10.3897/ab.e1169, DOI 10.3897/AB.E1169]; Hou Y, 2013, J ENVIRON MANAGE, V127, pS117, DOI 10.1016/j.jenvman.2012.12.002; Huber S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003302; Inter-Agency and Expert Group on SDG Indicators (IAEG-SDGs), 2016, MONITORING ACTION SO; Istanbulluoglu E, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004113; Jeffrey S., 2013, ECOL PROCESS, V2, P32, DOI DOI 10.1186/2192-1709-2-32; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; Kibblewhite MG, 2008, JRC SCI TECHNICAL RE; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lal R, 2015, SUSTAINABILITY-BASEL, V7, P5875, DOI 10.3390/su7055875; Lower Saxonian Ministry of Food Agriculture and Consumer Protection, 2019, AGR NUMM 1; Lugato E, 2016, GLOBAL CHANGE BIOL, V22, P1976, DOI 10.1111/gcb.13198; Lugato E, 2014, GLOBAL CHANGE BIOL, V20, P313, DOI 10.1111/gcb.12292; Maes J., 2018, MAPPING ASSESSMENT E; Maes J., 2013, MAPPING ASSESSMENT E, DOI DOI 10.2779/12398; Malinga R, 2015, ECOSYST SERV, V13, P57, DOI 10.1016/j.ecoser.2015.01.006; Martonne DE, 1925, TRAITE GEOGRAPHIE PH; Maseyk FJF, 2017, CONSERV LETT, V10, P211, DOI 10.1111/conl.12242; Morgan, 1996, SOIL EROSION CONSERV, P320; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nielsen DC, 2011, ACSESS PUBL, P287, DOI 10.2136/2011.soilmanagement.c19; OECD, 2008, HDB CONSTRUCTING COM, DOI [10.1787/9789264043466-en, DOI 10.1787/9789264043466-EN]; Palm C, 2014, AGR ECOSYST ENVIRON, V187, P87, DOI 10.1016/j.agee.2013.10.010; Panagos P, 2015, ENVIRON SCI POLICY, V54, P438, DOI 10.1016/j.envsci.2015.08.012; Peterson EE, 2017, ECOL INDIC, V79, P265, DOI 10.1016/j.ecolind.2017.04.002; Pissourios IA, 2013, ECOL INDIC, V34, P420, DOI 10.1016/j.ecolind.2013.06.008; Pledger CL, 2016, J NEUROSURG, V125, P323; Potschin-Young M, 2016, OPENNESS GLOSSARY; Power AG., 2016, ROUTLEDGE HDB ECOSYS, P491, DOI [10.4324/9781315775302-43, DOI 10.4324/9781315775302-43]; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Reid W., 2006, BRIDGING SCALES KNOW; Rendon P, 2019, ECOSYST PEOPLE, V15, P156, DOI 10.1080/26395916.2019.1609581; Rinot O, 2019, SCI TOTAL ENVIRON, V648, P1484, DOI 10.1016/j.scitotenv.2018.08.259; Saggau P, 2019, SOIL SYST, V3, DOI 10.3390/soilsystems3030051; Santos-Martin F., 2019, ONE ECOSYST, V4, DOI [10.3897/oneeco.4.e35904., DOI 10.3897/ONEECO.4.E35904, 10.3897/oneeco.4.e35904]; Schneiders A, 2012, ECOL INDIC, V21, P123, DOI 10.1016/j.ecolind.2011.06.021; SLA (Servicezentrum Landentwicklung und Agrarforderung), 2019, SCHLAEG 2019 HAUPTZ; SLA-LEA, 2019, LAND AGR NIED LEA PO; Smith AC, 2017, ECOSYST SERV, V26, P111, DOI 10.1016/j.ecoser.2017.06.006; Solte J, 2016, SOIL THREATS EUROPE; Spulerova J, 2018, LAND-BASEL, V7, DOI 10.3390/land7020074; Steinhoff-Knopp B, 2018, CATENA, V165, P299, DOI 10.1016/j.catena.2018.02.017; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Thomsen M, 2012, ECOL INDIC, V16, P67, DOI 10.1016/j.ecolind.2011.05.012; Virto I, 2015, SUSTAINABILITY-BASEL, V7, P313, DOI 10.3390/su7010313; Wiggering H, 2016, LANDSCAPE ONLINE, V49, P1, DOI DOI 10.3097/LO.201649; Willemen L, 2020, ECOSYST SERV, V44, DOI 10.1016/j.ecoser.2020.101125; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	83	5	5	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0234288	10.1371/journal.pone.0234288	http://dx.doi.org/10.1371/journal.pone.0234288			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284810	Green Published, gold, Green Submitted			2022-12-26	WOS:000597930500034
J	Chamorro-Flores, A; Tiessen-Favier, A; Gregorio-Jorge, J; Villalobos-Lopez, MA; Guevara-Garcia, AA; Lopez-Meyer, M; Arroyo-Becerra, A				Chamorro-Flores, Alejandra; Tiessen-Favier, Axel; Gregorio-Jorge, Josefat; Villalobos-Lopez, Miguel Angel; Guevara-Garcia, Angel Arturo; Lopez-Meyer, Melina; Arroyo-Becerra, Analilia			High levels of glucose alter Physcomitrella patens metabolism and trigger a differential proteomic response	PLOS ONE			English	Article							SUGAR SIGNAL-TRANSDUCTION; MASS-SPECTROMETRY; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; GENE-EXPRESSION; ASCORBATE PEROXIDASE; SOLUBLE SUGARS; PLANT-GROWTH; MOSS; MECHANISMS	Sugars act not only as substrates for plant metabolism, but also have a pivotal role in signaling pathways. Glucose signaling has been widely studied in the vascular plant Arabidopsis thaliana, but it has remained unexplored in non-vascular species such as Physcomitrella patens. To investigate P. patens response to high glucose treatment, we explored the dynamic changes in metabolism and protein population by applying a metabolomic fingerprint analysis (DIESI-MS), carbohydrate and chlorophyll quantification, Fv/Fm determination and label-free untargeted proteomics. Glucose feeding causes specific changes in P. patens metabolomic fingerprint, carbohydrate contents and protein accumulation, which is clearly different from those of osmotically induced responses. The maximal rate of PSII was not affected although chlorophyll decreased in both treatments. The biological process, cellular component, and molecular function gene ontology (GO) classifications of the differentially expressed proteins indicate the translation process is the most represented category in response to glucose, followed by photosynthesis, cellular response to oxidative stress and protein refolding. Importantly, although several proteins have high fold changes, these proteins have no predicted identity. The most significant discovery of our study at the proteome level is that high glucose increase abundance of proteins related to the translation process, which was not previously evidenced in non-vascular plants, indicating that regulation by glucose at the translational level is a partially conserved response in both plant lineages. To our knowledge, this is the first time that metabolome fingerprint and proteomic analyses are performed after a high sugar treatment in non-vascular plants. These findings unravel evolutionarily shared and differential responses between vascular and non-vascular plants.	[Chamorro-Flores, Alejandra; Villalobos-Lopez, Miguel Angel; Arroyo-Becerra, Analilia] Inst Politecn Nacl CIBA IPN, Ctr Invest Biotecnol Aplicada, Lab Genom Func & Biotecnol Plantas, Tepetitla De Lardizabal, Tlaxcala, Mexico; [Tiessen-Favier, Axel] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Unidad Irapuato, Irapuato, Guanajuato, Mexico; [Gregorio-Jorge, Josefat] Inst Politecn Nacl, Ctr Incest Biotecnol Aplicada CIBA IPN, CONICET, Ciudad De Mexico, Mexico; [Guevara-Garcia, Angel Arturo] Univ Nacl Autonoma Mexico IBT UNAM, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca, Morelos, Mexico; [Lopez-Meyer, Melina] Inst Politecn Nacl CIIDIR IPN, Ctr Interdisciplinario Invest Desarrollo Integral, Dept Biotecnol Agr, Unidad Sinaloa, Guasave, Sinaloa, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Arroyo-Becerra, A (corresponding author), Inst Politecn Nacl CIBA IPN, Ctr Invest Biotecnol Aplicada, Lab Genom Func & Biotecnol Plantas, Tepetitla De Lardizabal, Tlaxcala, Mexico.	alarroyo@ipn.mx	Arroyo-Becerra, Analilia/AAI-1369-2021; Villalobos-López, Miguel Angel/P-2492-2017	Arroyo-Becerra, Analilia/0000-0002-3055-7518; Villalobos-López, Miguel Angel/0000-0002-8640-342X; Gregorio Jorge, Josefat/0000-0003-4606-8935	Consejo Nacional de Ciencia y Tecnologia [241651, CB2009-131860, CB2015-251848]; Instituto Politecnico Nacional-Secretaria de Investigacion y Posgrado [20131464, 20162122, 20171740, 20181767, 20196365]; Instituto Politecnico Nacional-Secretaria de Investigacion y Posgrado-Beca de Estimulo Institucional de Formacion de Investigadores (BEIFI)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional-Secretaria de Investigacion y Posgrado; Instituto Politecnico Nacional-Secretaria de Investigacion y Posgrado-Beca de Estimulo Institucional de Formacion de Investigadores (BEIFI)	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.mx/) CB2009-131860 (AAB) & CB2015-251848 (AAGG), as well as Instituto Politecnico Nacional-Secretaria de Investigacion y Posgrado (http://www.sappi.ipn.mx/) 20131464 (AAB), 20162122 (AAB), 20171740 (AAB), 20181767 (AAB) and 20196365 (AAB) that are gratefully acknowledged. ACF received a doctoral fellowship from Consejo Nacional de Ciencia y Tecnologia (241651) and Instituto Politecnico Nacional-Secretaria de Investigacion y Posgrado-Beca de Estimulo Institucional de Formacion de Investigadores (BEIFI) (http://pifi.ipn.mx/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal T, 2017, PLANTA, V245, P101, DOI 10.1007/s00425-016-2596-1; Anjum NA, 2014, PROTOPLASMA, V251, P1265, DOI 10.1007/s00709-014-0636-x; [Anonymous], 2015, NAT METHODS, V12, P1; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2008, TUPRAS, V4, P1; [Anonymous], 2012, RIV STUDI MILITARI, V1, P49, DOI DOI 10.1016/J.MIO.2012.07.002; [Anonymous], 2015, RIV STORICA ITAL, V6, P1, DOI DOI 10.3389/fpls.2015.00951; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azzabi G, 2012, PLANT CELL PHYSIOL, V53, P1815, DOI 10.1093/pcp/pcs124; Bai YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14582; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Benito B, 2003, PLANT J, V36, P382, DOI 10.1046/j.1365-313X.2003.01883.x; BERUTER J, 1995, J PLANT PHYSIOL, V146, P95, DOI 10.1016/S0176-1617(11)81973-5; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Broz AK, 2014, MITOCHONDRION, V19, P144, DOI 10.1016/j.mito.2014.05.003; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Casteel J, 2011, PLANT PHYSIOL BIOCH, V49, P1355, DOI 10.1016/j.plaphy.2011.07.001; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cho S.H., 2018, ANN PLANT REV ONLINE, P282, DOI [10.1002/9781119312994.apr0394, DOI 10.1002/9781119312994.APR0394]; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Choudhury SR, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23000, 10.4161/psb.23681]; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conklin PL, 2000, GENETICS, V154, P847; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; de Carvalho RC, 2014, PLANT CELL ENVIRON, V37, P1499, DOI 10.1111/pce.12266; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Doerr A, 2011, NAT METHODS, V8, P43, DOI 10.1038/NMETH.F.329; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2016, PLANT CELL ENVIRON, V39, P951, DOI 10.1111/pce.12621; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Gallie DR, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/795964; Garcia-Flores M, 2015, J AGR FOOD CHEM, V63, P1042, DOI 10.1021/jf504853w; Garcia-Flores M, 2012, MOL BIOSYST, V8, P1658, DOI 10.1039/c2mb25056j; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003; Han L, 2015, GENET MOL RES, V14, P4784, DOI 10.4238/2015.May.11.11; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kojima H, 2007, PLANT J, V49, P1053, DOI 10.1111/j.1365-313X.2006.03016.x; KRAPP A, 1993, PLANT J, V3, P817, DOI 10.1111/j.1365-313X.1993.00817.x; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Levin Y, 2010, METHODS MOL BIOL, V658, P217, DOI 10.1007/978-1-60761-780-8_13; Li L, 2016, CURR OPIN PLANT BIOL, V33, P116, DOI 10.1016/j.pbi.2016.06.018; Lo Bianco R, 2002, J AM SOC HORTIC SCI, V127, P115, DOI 10.21273/JASHS.127.1.115; Maekawa S, 2018, PLANT SIGNAL BEHAV, V13, DOI 10.1080/15592324.2018.1442975; Maekawa S, 2018, PLANT CELL, V30, P209, DOI 10.1105/tpc.17.00778; Medina-Navarro R, 2003, CLIN CHIM ACTA, V337, P183, DOI 10.1016/j.cccn.2003.07.005; Merchante C, 2017, PLANT J, V90, P628, DOI 10.1111/tpj.13520; Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163; Ndimba BK, 2005, PROTEOMICS, V5, P4185, DOI 10.1002/pmic.200401282; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Olsson T, 2003, J BIOL CHEM, V278, P44439, DOI 10.1074/jbc.M306265200; Ozyigit II, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00301; Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029; Aguilera-Alvarado GP, 2017, PLANT CELL PHYSIOL, V58, P1151, DOI 10.1093/pcp/pcx062; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2014, BIOCHEMISTRY-US, V53, P7693, DOI 10.1021/bi5013222; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Polyakov NB, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1470, DOI 10.1134/S0006297910120084; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Ramon Matthew, 2008, Arabidopsis Book, V6, pe0117, DOI 10.1199/tab.0117; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2020, PLANT CELL, V32, P1361, DOI 10.1105/tpc.19.00828; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sakr S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092506; Sami F, 2016, PLANT PHYSIOL BIOCH, V109, P54, DOI 10.1016/j.plaphy.2016.09.005; Sano S, 2005, BIOSCI BIOTECH BIOCH, V69, P762, DOI 10.1271/bbb.69.762; Sarnighausen E, 2004, PHYTOCHEMISTRY, V65, P1589, DOI 10.1016/j.phytochem.2004.04.028; Schaefer DG, 2001, PLANT PHYSIOL, V127, P1430, DOI 10.1104/pp.010786; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sheen J, 2014, J PLANT BIOL, V57, P67, DOI 10.1007/s12374-014-0902-7; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stare T, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5030014; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Sytykiewicz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094847; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takagi D, 2014, PLANT CELL PHYSIOL, V55, P333, DOI 10.1093/pcp/pcu007; Teixeira FK, 2004, J MOL EVOL, V59, P761, DOI 10.1007/s00239-004-2666-z; Thelander M, 2005, J EXP BOT, V56, P653, DOI 10.1093/jxb/eri040; Tholen D, 2007, PLANT PHYSIOL, V144, P1305, DOI 10.1104/pp.107.099762; Thum KE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r10; Tiessen A., 2017, American Journal of Plant Sciences, V8, P502, DOI 10.4236/ajps.2017.83035; Van den Ende W, 2009, J EXP BOT, V60, P9, DOI 10.1093/jxb/ern297; Vargas-Ortiz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067879; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; Wang XQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-192; Wang XQ, 2009, PROTEOMICS, V9, P4529, DOI 10.1002/pmic.200900062; Watson W., 2011, CLIN IMMUNOL S1, V7, pS7; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wobus U, 1999, BIOL CHEM, V380, P937, DOI 10.1515/BC.1999.116; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Xiong Y, 2015, CURR OPIN PLANT BIOL, V28, P83, DOI 10.1016/j.pbi.2015.09.006; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Xu P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-217; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294	122	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0242919	10.1371/journal.pone.0242919	http://dx.doi.org/10.1371/journal.pone.0242919			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275616	gold, Green Published			2022-12-26	WOS:000597150200036
J	Gomes, JH; Mendes, RR; Franca, CS; Da Silva-Grigoletto, ME; da Silva, DRP; Antoniolli, AR; Silva, AMDE; Quintans, LJ				Gomes, Joao Henrique; Mendes, Renata Rebello; Franca, Crystianne Santana; Da Silva-Grigoletto, Marzo Edir; Pereira da Silva, Danilo Rodrigues; Antoniolli, Angelo Roberto; de Oliveira e Silva, Ana Mara; Quintans-Junior, Lucindo Jose			Acute leucocyte, muscle damage, and stress marker responses to high-intensity functional training	PLOS ONE			English	Article							RESISTANCE EXERCISE; PHYSICAL-ACTIVITY; IMMUNE-SYSTEM; SHORT REST; CROSSFIT; MEN; PERFORMANCE; RECOVERY; FITNESS	Background High-intensity functional training (HIFT) has become more popular, and the number of practitioners has increased; however, it remains unclear whether perturbations in the immune parameters occur, even after one single bout. Our aim was to examine acute leucocyte, muscle damage, and stress marker responses following a single 'Cindy' workout session, and compare the results between novice and experienced participants. Material and methods Twenty-three HIFT practitioners (age 31.0 +/- 1.0 years) completed the 'Cindy' workout. They were categorized as novice (3-8 months of experience; n = 10) and experienced (>= 18 months; n = 13). White blood cell (WBC) count, plasma creatine kinase (CK) activity, blood cortisol level, and lactate concentration were measured. Blood analysis was performed before (pre-ex), immediately after (post-ex), 30 min after (post-30 min), and 24 h after (post-24 h) a single 'Cindy' workout session. Results WBC count was higher post-ex (6.8 to 11.8x10(3)/mu L) and returned to baseline values within post-30 min (p<0.01). Neutrophil (3.3 to 4.5x10(3)/mu L) and lymphocyte levels (2.8 to 5.9x10(3)/mu L) were higher post-ex and returned to baseline values after post-24 h, yet lymphocytopoenia (2.2x10(3)/mu L) was observed at post-30 min (p<0.01). CK increased post-ex (174.9 to 226.7 U.L-1) and remained elevated post-24 h. Cortisol (14.7 to 17.0 mu g/dL) and lactate (1.9 to 13.5 mmol.l(-1)) responses increased post-ex, but only the lactate level was reduced at post-30 min (p<0.01). The experienced participants had higher WBC, lymphocyte, and cortisol concentrations post-ex than the novice ones (p<0.01). Conclusions A single HIFT session elicited significant acute perturbations in WBC count, stress markers, and muscle tissue, which is like other similar regimens. Importantly, the experienced participants showed greater lymphocyte and cortisol responses than the novice ones.	[Gomes, Joao Henrique; Antoniolli, Angelo Roberto; de Oliveira e Silva, Ana Mara; Quintans-Junior, Lucindo Jose] Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil; [Mendes, Renata Rebello; Franca, Crystianne Santana; de Oliveira e Silva, Ana Mara] Univ Fed Sergipe, Nutr Dept, Sao Cristovao, Sergipe, Brazil; [Da Silva-Grigoletto, Marzo Edir; Pereira da Silva, Danilo Rodrigues] Univ Fed Sergipe, Dept Phys Educ, Sao Cristovao, Sergipe, Brazil; [Antoniolli, Angelo Roberto; Quintans-Junior, Lucindo Jose] Univ Fed Sergipe, Lab Neurosci & Pharmacol Assays, Sao Cristovao, Sergipe, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe	Gomes, JH (corresponding author), Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil.	profjhgomes@gmail.com	da Silva, Danilo Rodrigues Pereira/E-3747-2018; Quintans, Lucindo/A-2434-2012	da Silva, Danilo Rodrigues Pereira/0000-0003-3995-4795; Quintans, Lucindo/0000-0001-5155-938X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil [CAPES -Finance Code 001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES -Finance Code 001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Bangsbo J., 2006, J EXERC SCI FIT; Bellar D, 2015, BIOL SPORT, V32, P315, DOI 10.5604/20831862.1174771; Bishop A, 2014, J STRENGTH COND RES, V28, P1820, DOI 10.1519/JSC.0000000000000315; Butcher S, 2015, J FIT RES; Butcher SJ, 2015, OPEN ACCESS J SPORTS, V6, P241, DOI 10.2147/OAJSM.S88265; Cadegiani FA, 2019, J SPORT SCI, V37, P1296, DOI 10.1080/02640414.2018.1555912; Cerqueira E, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01550; Feito Y, 2018, SPORTS, V6, DOI 10.3390/sports6030076; Forget Patrice, 2017, BMC Res Notes, V10, P12, DOI 10.1186/s13104-016-2335-5; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Friedman RA, 2012, APPL PHYSIOL NUTR ME, V37, P241, DOI [10.1139/h11-156, 10.1139/H11-156]; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gleeson M., 2013, EXERCISE IMMUNOLOGY, V1st Edn, DOI DOI 10.1186/1471-2172-14-29; Grammer R, 2018, J ORAL MAXIL SURG, V76, P1424, DOI 10.1016/j.joms.2018.01.016; Heavens KR, 2014, J STRENGTH COND RES, V28, P1041, DOI 10.1097/JSC.0000000000000236; Hennigar SR, 2017, FASEB J, V31, P3719, DOI [10.1096/fj.201700080R, 10.1096/fj.201700080r]; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kerksick CM, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0242-y; Kliszczewicz B., 2014, J SPORT HUMAN PERF, V2, P1, DOI [10.12922/jshp.0038.2014, DOI 10.12922/JSHP.V2I2.38]; Kliszczewicz B, 2015, J HUM KINET, V47, P81, DOI 10.1515/hukin-2015-0064; Mate-Munoz JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181855; Mangine GT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0223548; Mate-Munoz JL, 2018, J SPORT SCI MED, V17, P668; Meyer J, 2017, WORKPLACE HEALTH SAF, V65, P612, DOI 10.1177/2165079916685568; Navalta JW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/694801; Navalta JW, 2010, EUR J APPL PHYSIOL, V110, P325, DOI 10.1007/s00421-010-1504-9; Neto JHF, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00919; Nieman DC, 2019, J SPORT HEALTH SCI, V8, P201, DOI 10.1016/j.jshs.2018.09.009; Opitz D, 2015, CAN J PHYSIOL PHARM, V93, P413, DOI 10.1139/cjpp-2014-0467; Peake JM, 2017, J APPL PHYSIOL, V122, P1077, DOI 10.1152/japplphysiol.00622.2016; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Poderoso R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142577; Posnakidis G, 2022, J STRENGTH COND RES, V36, P615, DOI 10.1519/JSC.0000000000003516; Rawson ES, 2017, SPORTS MED, V47, pS33, DOI 10.1007/s40279-017-0689-z; Schoenfeld BJ, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0054-7; Slattery K, 2015, SPORTS MED, V45, P453, DOI 10.1007/s40279-014-0282-7; Szivak TK, 2013, J STRENGTH COND RES, V27, P748, DOI 10.1519/JSC.0b013e318259e009; Thompson WR, 2018, ACSMS HEALTH FIT J, V22, P10, DOI 10.1249/FIT.0000000000000438; Tibana R. A., 2016, FRONT PHYSIOL, V7, P1; Tibana Ramires Alsamir, 2018, J Funct Morphol Kinesiol, V3, DOI 10.3390/jfmk3040060; Tibana Ramires Alsamir, 2019, Int J Exerc Sci, V12, P904; Tibana RA, 2019, SPORTS, V7, DOI 10.3390/sports7070161; Tibana RA, 2019, SPORTS, V7, DOI 10.3390/sports7020035; Timon R, 2019, BIOL SPORT, V36, P283, DOI 10.5114/biolsport.2019.85458; Tremblay MS, 2007, APPL PHYSIOL NUTR ME, V32, pS218, DOI 10.1139/H07-125; Morano AEV, 2020, J CELL PHYSIOL, V235, P3169, DOI 10.1002/jcp.29228; Weisenthal BM, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114531177; Wilke J, 2019, SCAND J MED SCI SPOR, V29, P144, DOI 10.1111/sms.13313	50	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243276	10.1371/journal.pone.0243276	http://dx.doi.org/10.1371/journal.pone.0243276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270727	gold, Green Published			2022-12-26	WOS:000597149100042
J	Ogata, T; Ishizaki, T; Fujita, M; Fujita, Y				Ogata, Takuya; Ishizaki, Takuma; Fujita, Miki; Fujita, Yasunari			CRISPR/Cas9-targeted mutagenesis of OsERA1 confers enhanced responses to abscisic acid and drought stress and increased primary root growth under nonstressed conditions in rice	PLOS ONE			English	Article							PROTEIN FARNESYLATION; PLANT-RESPONSES; GENE; FARNESYLTRANSFERASE; BIOSYNTHESIS; ERA1; TRANSCRIPTION; TOLERANCE	Abscisic acid (ABA) signaling components play an important role in the drought stress response in plants. Arabidopsis thaliana ENHANCED RESPONSE TO ABA1 (ERA1) encodes the beta-subunit of farnesyltransferase and regulates ABA signaling and the dehydration response. Therefore, ERA1 is an important candidate gene for enhancing drought tolerance in numerous crops. However, a rice (Oryza sativa) ERA1 homolog has not been characterized previously. Here, we show that rice osera1 mutant lines, harboring CRISPR/Cas9-induced frameshift mutations, exhibit similar leaf growth as control plants but increased primary root growth. The osera1 mutant lines also display increased sensitivity to ABA and an enhanced response to drought stress through stomatal regulation. These results illustrate that OsERA1 is a negative regulator of primary root growth under nonstressed conditions and also of responses to ABA and drought stress in rice. These findings improve our understanding of the role of ABA signaling in the drought stress response in rice and suggest a strategy to genetically improve rice.	[Ogata, Takuya; Fujita, Yasunari] Japan Int Res Ctr Agr Sci JIRCAS, Biol Resources & Postharvest Div, Tsukuba, Ibaraki, Japan; [Ishizaki, Takuma] Japan Int Res Ctr Agr Sci JIRCAS, Trop Agr Res Front TARF, Ishigaki, Okinawa, Japan; [Fujita, Miki] RIKEN, Ctr Sustainable Resource Sci, Tsukuba, Ibaraki, Japan; [Fujita, Yasunari] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Japan International Research Center for Agricultural Sciences; RIKEN; University of Tsukuba	Fujita, Y (corresponding author), Japan Int Res Ctr Agr Sci JIRCAS, Biol Resources & Postharvest Div, Tsukuba, Ibaraki, Japan.; Fujita, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yasuf@affrc.go.jp	Fujita, Miki/H-3351-2014; Fujita, Yasunari/P-9861-2018	Fujita, Miki/0000-0003-4201-4876; Fujita, Yasunari/0000-0002-5036-8319; Ogata, Takuya/0000-0003-3361-6234	Japan Society for the Promotion of Science (JSPS) of Japan [JP16K07412]; Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan; JSPS	Japan Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Japan Society for the Promotion of Science (JSPS) of Japan (Grants-in-Aid for Scientific Research (C) JP16K07412 to Y.F.) and the Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of each funder website: JSPS: https://www.jsps.go.jp/english/egrants/MAFF: https://www.maff.go.jp/e/index.html	Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; Barghetti A, 2017, GENE DEV, V31, P2282, DOI 10.1101/gad.301242.117; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Castorina G, 2020, PLANT PHYSIOL, V184, P266, DOI 10.1104/pp.20.00322; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Cui FQ, 2019, J EXP BOT, V70, P5971, DOI 10.1093/jxb/erz345; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Daszkowska-Golec A, 2018, ENVIRON EXP BOT, V148, P12, DOI 10.1016/j.envexpbot.2018.01.003; Dutilleul C, 2016, PLANT CELL ENVIRON, V39, P185, DOI 10.1111/pce.12605; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Galichet A, 2003, CURR OPIN PLANT BIOL, V6, P530, DOI 10.1016/j.pbi.2003.09.005; Galichet A, 2008, PLANT PHYSIOL, V146, P1155, DOI 10.1104/pp.107.107425; Galichet A, 2006, PLANT PHYSIOL, V142, P1412, DOI 10.1104/pp.106.088344; Goritschnig S, 2018, PLANT PHYSIOL, V148, P348; Gupta A, 2020, SCIENCE, V368, P266, DOI 10.1126/science.aaz7614; Ishizaki T, 2008, PLANT CELL REP, V27, P319, DOI 10.1007/s00299-007-0465-x; Jalakas P, 2017, PLANT PHYSIOL, V174, P665, DOI 10.1104/pp.17.00220; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li ZF, 2011, PLANT J, V68, P88, DOI 10.1111/j.1365-313X.2011.04670.x; Manmathan H, 2013, J EXP BOT, V64, P1381, DOI 10.1093/jxb/ert003; Nagatoshi Y, 2018, PLANT SIGNAL BEHAV, V13, DOI 10.1080/15592324.2018.1525998; Nagatoshi Y, 2019, PLANT CELL PHYSIOL, V60, P77, DOI 10.1093/pcp/pcy189; Northey JGB, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.114, 10.1038/nplants.2016.114]; Ogata T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175650; PANDEY S, 2009, DROUGHT FRONTIERS RI, P3; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; R Core Team, 2020, R LANG ENV STAT COMP; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Sedeek KEM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00114; Serraj R, 2009, ADV AGRON, V103, P41, DOI 10.1016/S0065-2113(09)03002-8; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Singh B, 2017, RICE SCI, V24, P322, DOI 10.1016/j.rsci.2017.10.001; Swain P, 2017, FIELD CROP RES, V209, P168, DOI 10.1016/j.fcr.2017.05.007; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Wang Y, 2005, PLANT J, V43, P413, DOI 10.1111/j.1365-313X.2005.02463.x; Wu JR, 2019, PLANTA, V250, P1449, DOI 10.1007/s00425-019-03239-7; Wu JR, 2017, NEW PHYTOL, V213, P1181, DOI 10.1111/nph.14212; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yalovsky S, 2000, PLANT CELL, V12, P1267, DOI 10.1105/tpc.12.8.1267; Yoshida T, 2019, TRENDS PLANT SCI, V24, P625, DOI 10.1016/j.tplants.2019.04.008; Zhang HM, 2010, PLANT J, V64, P764, DOI 10.1111/j.1365-313X.2010.04367.x; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397	46	19	19	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243376	10.1371/journal.pone.0243376	http://dx.doi.org/10.1371/journal.pone.0243376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270810	gold, Green Published			2022-12-26	WOS:000597149100084
J	Skarzynska, M; Leekitcharoenphon, P; Hendriksen, RS; Aarestrup, FM; Wasyl, D				Skarzynska, Magdalena; Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.; Aarestrup, Frank M.; Wasyl, Dariusz			A metagenomic glimpse into the gut of wild and domestic animals: Quantification of antimicrobial resistance and more	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; ENTEROCOCCUS-FAECIUM; BETA-LACTAMASE; GENE CFR(C); SALMONELLA; FARMS; PIG; RESISTOME	Antimicrobial resistance (AMR) in bacteria is a complex subject, why one need to look at this phenomenon from a wider and holistic perspective. The extensive use of the same antimicrobial classes in human and veterinary medicine as well as horticulture is one of the main drivers for the AMR selection. Here, we applied shotgun metagenomics to investigate the AMR epidemiology in several animal species including farm animals, which are often exposed to antimicrobial treatment opposed to an unique set of wild animals that seems not to be subjected to antimicrobial pressure. The comparison of the domestic and wild animals allowed to investigate the possible anthropogenic impact on AMR spread. Inclusion of animals with different feeding behaviors (carnivores, omnivores) enabled to further assess which AMR genes that thrives within the food chain. We tested fecal samples not only of intensively produced chickens, turkeys, and pigs, but also of wild animals such as wild boars, red foxes, and rodents. A multi-directional approach mapping obtained sequences to several databases provided insight into the occurrence of the different AMR genes. The method applied enabled also analysis of other factors that may influence AMR of intestinal microbiome such as diet. Our findings confirmed higher levels of AMR in farm animals than in wildlife. The results also revealed the potential of wildlife in the AMR dissemination. Particularly in red foxes, we found evidence of several AMR genes conferring resistance to critically important antimicrobials like quinolones and cephalosporins. In contrast, the lowest abundance of AMR was observed in rodents originating from natural environment with presumed limited exposure to antimicrobials. Shotgun metagenomics enabled us to demonstrate that discrepancies between AMR profiles found in the intestinal microbiome of various animals probably resulted from the different antimicrobial exposure, habitats, and behavior of the tested animal species.	[Skarzynska, Magdalena; Wasyl, Dariusz] Natl Vet Res Inst, Dept Microbiol, Pulawy, Poland; [Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.; Aarestrup, Frank M.] Tech Univ Denmark, WHO Collaborating Ctr Antimicrobial Resistance Fo, Natl Food Inst, Food & Agr Org,Reference Lab Antimicrobial Resist, Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.; Aarestrup, Frank M.] Tech Univ Denmark, European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark; [Wasyl, Dariusz] Natl Vet Res Inst, Dept Omics Anal, Pulawy, Poland	National Veterinary Institute - National Research Institute; Technical University of Denmark; Technical University of Denmark; National Veterinary Institute - National Research Institute	Skarzynska, M (corresponding author), Natl Vet Res Inst, Dept Microbiol, Pulawy, Poland.	magdalena.skarzynska@piwet.pulawy.pl	Leekitcharoenphon, Pimlapas/AAB-5487-2021; Wasyl, Dariusz/H-4229-2011; Skarżyńska, Magdalena/AAO-6196-2021	Wasyl, Dariusz/0000-0002-1068-8414; Skarżyńska, Magdalena/0000-0001-5666-9510; Hendriksen, Rene S./0000-0003-2934-8214; Aarestrup, Frank/0000-0002-7116-2723; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142	Novo Nordisk Foundation [NNF16OC0021856]; KNOW [05-1/KNOW2/2015]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); KNOW	This work was funded by the KNOW No. 05-1/KNOW2/2015 (Leading National Research Centre of Scientific Consortium "Healthy Animal Safe Food", granted on the basis of the decision of the Minister of Science and Higher Education) and partly supported by The Novo Nordisk Foundation (NNF16OC0021856) - Global Surveillance of Antimicrobial Resistance.	Aarestrup FM, 2000, J CLIN MICROBIOL, V38, P2774, DOI 10.1128/JCM.38.7.2774-2777.2000; Abd El-Hack ME, 2018, WORLD POULTRY SCI J, V74, P541, DOI 10.1017/S0043933918000296; Ahlbom A, 2009, ASSESSMENT ANTIBIOTI; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2009, EJHP PRACT, V15, P15; [Anonymous], 2007, CLELJ, V13, P151; [Anonymous], 2018, J GASTRIC CANC; Arnold KE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0137; Arredondo-Alonso S, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000128; Bager F, 1997, PREV VET MED, V31, P95, DOI 10.1016/S0167-5877(96)01119-1; Bengtsson-Palme J, 2018, FEMS MICROBIOL REV, V42, P68, DOI 10.1093/femsre/fux053; Brugger D, 2015, ANIM NUTR, V1, P113, DOI 10.1016/j.aninu.2015.08.005; Bushnell B, 2018, BBDUK VERSION 39 92; Candela T, 2017, INT J ANTIMICROB AG, V50, P496, DOI 10.1016/j.ijantimicag.2017.03.013; Carroll D, 2015, ZOONOSES PUBLIC HLTH, V62, P534, DOI 10.1111/zph.12182; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention, 2019, CTR DIS CONTROL PREV; Channaiah LH, 2010, FEMS MICROBIOL ECOL, V74, P464, DOI 10.1111/j.1574-6941.2010.00949.x; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Connelly S, 2018, ANAEROBE, V53, P82, DOI 10.1016/j.anaerobe.2018.04.012; European Commission, 1997, OFF J EUR COMMUN, V1997; European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5598; European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5182; European Medicines Agency, 2019, EMA2946742019; Garcia N, 2008, J ANTIMICROB CHEMOTH, V62, P942, DOI 10.1093/jac/dkn347; Guenther S, 2010, VET MICROBIOL, V144, P219, DOI 10.1016/j.vetmic.2009.12.016; Hendriksen RS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08853-3; Ho PL, 2015, J MED MICROBIOL, V64, P185, DOI 10.1099/jmm.0.000001-0; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Joyce A, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000272; Knudsen BE, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00095-16; Kumar H, 2020, GENOMICS, V112, P1988, DOI 10.1016/j.ygeno.2019.11.011; Lalak A, 2016, VET MICROBIOL, V194, P69, DOI 10.1016/j.vetmic.2016.01.023; Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lozano C, 2016, MICROB ECOL, V72, P813, DOI 10.1007/s00248-015-0648-x; Ma LP, 2016, ENVIRON SCI TECHNOL, V50, P420, DOI 10.1021/acs.est.5b03522; Munk P, 2018, NAT MICROBIOL, V3, P898, DOI 10.1038/s41564-018-0192-9; Nhung NT, 2015, APPL ENVIRON MICROB, V81, P812, DOI 10.1128/AEM.03366-14; Ogunleye AO, 2015, INT RES J MICROBIOL, V6, P37; Orlek A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00182; Perez F, 2013, ANTIMICROB AGENTS CH, V57, P4602, DOI 10.1128/AAC.00725-13; Petersen TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176469; Petersen TN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11444; Prado Marinésia Aparecida, 2006, Braz J Infect Dis, V10, P26, DOI 10.1590/S1413-86702006000100006; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Radhouani H, 2013, ANAEROBE, V23, P82, DOI 10.1016/j.anaerobe.2013.06.013; Radhouani H, 2011, J WILDLIFE DIS, V47, P769, DOI 10.7589/0090-3558-47.3.769; Ranjbar R, 2016, J INFECT PUBLIC HEAL, V9, P499, DOI 10.1016/j.jiph.2015.12.012; Rozwandowicz M, 2018, J ANTIMICROB CHEMOTH, V73, P1121, DOI 10.1093/jac/dkx488; Sarrazin S, 2019, J ANTIMICROB CHEMOTH, V74, P807, DOI 10.1093/jac/dky503; Schathauser BH, 2018, ENVIRON POLLUT, V238, P440, DOI 10.1016/j.envpol.2018.03.052; Scientific Advisory Group on Antimicrobials of the Committee for Medicinal Products for Veterinary Use, 2018, EMACVMPAWP7211182014; Senghor B., 2018, HUM MICROBIOME J, V7-8, P1, DOI [DOI 10.1016/J.HUMIC.2018.01.001, 10.1016/j.humic.2018.01.001]; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Silva N, 2010, SCI TOTAL ENVIRON, V408, P4871, DOI 10.1016/j.scitotenv.2010.06.046; Skarzynska M, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9090771; Skarzynska M, 2017, J VET RES, V61, P173, DOI 10.1515/jvetres-2017-0022; Smalla K, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0038-2014; Soki J, 2000, J MED MICROBIOL, V49, P427, DOI 10.1099/0022-1317-49-5-427; Sun J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00580; Tang YZ, 2017, J ANTIMICROB CHEMOTH, V72, P1581, DOI 10.1093/jac/dkx023; Wall BA, 2016, DRIVERS DYNAMICS EPI; Wang YC, 2011, J FOOD PROTECT, V74, P1012, DOI 10.4315/0362-028X.JFP-10-394; Wasyl D, 2018, MICROB DRUG RESIST, V24, P807, DOI 10.1089/mdr.2017.0148; Wasyl D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00221; Williams SH, 2018, MBIO, V9, DOI [10.1128/mBio.00624-18, 10.1128/mbio.00624-18]; Wong MHY, 2013, ANTIMICROB AGENTS CH, V57, P658, DOI 10.1128/AAC.01144-12; World Health Organization, 2014, ANT RES GLOB REP SUR; Yuan L, 2018, J MED MICROBIOL, V67, P733, DOI 10.1099/jmm.0.000736; Zajac M, 2013, VET MICROBIOL, V166, P686, DOI 10.1016/j.vetmic.2013.07.023; Zangenah S, 2017, EUR J CLIN MICROBIOL, V36, P657, DOI 10.1007/s10096-016-2842-2; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zeng JX, 2019, ENVIRON INT, V126, P346, DOI 10.1016/j.envint.2019.02.052	78	16	16	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242987	10.1371/journal.pone.0242987	http://dx.doi.org/10.1371/journal.pone.0242987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270717	Green Published, gold			2022-12-26	WOS:000597149100033
J	Uechi, L; Jalali, M; Wilbur, JD; French, JL; Jumbe, NL; Meaney, MJ; Gluckman, PD; Karnani, N; Sakhanenko, NA; Galas, DJ				Uechi, Lisa; Jalali, Mahjoubeh; Wilbur, Jayson D.; French, Jonathan L.; Jumbe, N. L.; Meaney, Michael J.; Gluckman, Peter D.; Karnani, Neerja; Sakhanenko, Nikita A.; Galas, David J.		GUSTO Study Grp	Complex genetic dependencies among growth and neurological phenotypes in healthy children: Towards deciphering developmental mechanisms	PLOS ONE			English	Article							EXPRESSION ANALYSIS; MYOSIN PHOSPHATASE; SUSCEPTIBILITY; IDENTIFICATION; RISK; ASSOCIATION; MODIFIERS; ALLELES; MUSCLE; MYPT2	The genetic mechanisms of childhood development in its many facets remain largely undeciphered. In the population of healthy infants studied in the Growing Up in Singapore Towards Healthy Outcomes (GUSTO) program, we have identified a range of dependencies among the observed phenotypes of fetal and early childhood growth, neurological development, and a number of genetic variants. We have quantified these dependencies using our information theory-based methods. The genetic variants show dependencies with single phenotypes as well as pleiotropic effects on more than one phenotype and thereby point to a large number of brain-specific and brain-expressed gene candidates. These dependencies provide a basis for connecting a range of variants with a spectrum of phenotypes (pleiotropy) as well as with each other. A broad survey of known regulatory expression characteristics, and other function-related information from the literature for these sets of candidate genes allowed us to assemble an integrated body of evidence, including a partial regulatory network, that points towards the biological basis of these general dependencies. Notable among the implicated loci are RAB11FIP4 (next to NF1), MTMR7 and PLD5, all highly expressed in the brain; DNMT1 (DNA methyl transferase), highly expressed in the placenta; and PPP1R12B and DMD (dystrophin), known to be important growth and development genes. While we cannot specify and decipher the mechanisms responsible for the phenotypes in this study, a number of connections for further investigation of fetal and early childhood growth and neurological development are indicated. These results and this approach open the door to new explorations of early human development.	[Uechi, Lisa; Jalali, Mahjoubeh; Sakhanenko, Nikita A.; Galas, David J.] Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA; [Wilbur, Jayson D.; French, Jonathan L.] Metrum Res Grp, Tariffville, CT USA; [Jumbe, N. L.] Pharmactuarials LLC, Mountain View, CA USA; [Meaney, Michael J.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Meaney, Michael J.] Canadian Inst Adv Res CIFAR Inst, Child & Brain Dev Program, Toronto, ON, Canada; [Gluckman, Peter D.] Univ Auckland, Ctr Human Evolut Adaptat & Dis, Auckland, New Zealand; [Karnani, Neerja] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Karnani, Neerja] Natl Univ Singapore, Brenner Ctr Mol Med, Singapore, Singapore	McGill University; University of Auckland; National University of Singapore; National University of Singapore	Sakhanenko, NA; Galas, DJ (corresponding author), Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA.	nsakhanenko@pnri.org; dgalas@pnri.org		French, Jonathan/0000-0001-9649-169X; Galas, David/0000-0001-8248-8617; Sakhanenko, Nikita/0000-0001-6256-4643; Karnani, Neerja/0000-0002-5301-409X	Healthy Birth, Growth, and Development (HBGD) program of the Bill and Melinda Gates Foundation; GUSTO Project of Singapore; Pacific Northwest Research Institute; Metrum Research Group; Pharmactuarials LLC	Healthy Birth, Growth, and Development (HBGD) program of the Bill and Melinda Gates Foundation; GUSTO Project of Singapore; Pacific Northwest Research Institute; Metrum Research Group; Pharmactuarials LLC	This work was partially funded by: the Healthy Birth, Growth, and Development (HBGD) program of the Bill and Melinda Gates Foundation, by the GUSTO Project of Singapore, and the Pacific Northwest Research Institute. Metrum Research Group provided support in the form of a salary to JDW and JLF. Pharmactuarials LLC also provided support in the form of a salary to NLJ. The funders played no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Afshari Parisa, 2015, Mol Neuropsychiatry, V1, P125, DOI 10.1159/000433599; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Amare AT, 2020, MOL PSYCHIATR, V25, P1420, DOI 10.1038/s41380-018-0336-6; Amlie-Wolf A, 2018, NUCLEIC ACIDS RES, V46, P8740, DOI 10.1093/nar/gky686; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; [Anonymous], 2014, ANN EMERG MED, V64, P218; Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Baeza-Richer C, 2013, DIS MARKERS, V34, P121, DOI [10.1155/2013/519419, 10.3233/DMA-120951]; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Bartelt-Kirbach B, 2009, NEUROGENETICS, V10, P79, DOI 10.1007/s10048-008-0154-0; Bi X, 2017, HUM BRAIN MAPP, V38, P4088, DOI 10.1002/hbm.23650; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Branco MR, 2016, DEV CELL, V36, P152, DOI 10.1016/j.devcel.2015.12.027; Checkley W, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002408; Chen CM, 2010, DEV DYNAM, V239, P1797, DOI 10.1002/dvdy.22293; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; CHURCHILL GA, 1994, GENETICS, V138, P963; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Desai BS, 2014, SCIENCE, V343, P1256, DOI 10.1126/science.1247761; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Freidin MB, 2013, J GENET, V92, P93, DOI 10.1007/s12041-013-0210-x; Furnari MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061321; Galas DJ, 2014, J COMPUT BIOL, V21, P118, DOI 10.1089/cmb.2013.0039; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Guttsches AK, 2015, HISTOCHEM CELL BIOL, V143, P443, DOI 10.1007/s00418-014-1299-6; Hill-Burns EM, 2016, HUM MOL GENET, V25, P3849, DOI 10.1093/hmg/ddw206; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hong S, 2018, ENVIRON TOXICOL PHAR, V59, P138, DOI 10.1016/j.etap.2018.03.014; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Hui KY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aai7795; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kessler R, 2001, MOL BRAIN RES, V87, P190, DOI 10.1016/S0169-328X(01)00014-6; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kunlde BW, 2016, ALZHEIMERS DEMENT, V12, P2, DOI 10.1016/j.jalz.2015.05.020; Li R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002746; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Lv Z., 2008, PLOS ONE, V3, pe3933; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McGill WJ., 1954, PSYCHOMETRIKA, V19, P97, DOI 10.1007/BF02289159; Mi Y, 2015, BMB REP, V48, P413, DOI 10.5483/BMBRep.2015.48.7.036; Minden Audrey, 2012, Cell Logist, V2, P95; Mohammadi P, 2017, GENOME RES, V27, P1872, DOI 10.1101/gr.216747.116; Monten C, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0190-1; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Mukhopadhyay A, 2016, PLACENTA, V48, P119, DOI 10.1016/j.placenta.2016.09.013; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Ning ZF, 2015, HUM MOL GENET, V24, P5126, DOI 10.1093/hmg/ddv231; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Oldridge DA, 2015, NATURE, V528, P418, DOI 10.1038/nature15540; Ostensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070174; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Perez-Belmonte LM, 2017, INT J MED SCI, V14, P891, DOI 10.7150/ijms.19854; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2001, MIXED EFFECTS MODELS; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Sakamoto S, 2016, J HUM GENET, V61, P329, DOI 10.1038/jhg.2015.153; Sakhanenko NA, 2017, J COMPUT BIOL, V24, P1153, DOI 10.1089/cmb.2017.0143; Sakhanenko NA, 2015, J COMPUT BIOL, V22, P1005, DOI 10.1089/cmb.2015.0051; Sanchez-Juan P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.011; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schwartz F, 1997, GENE, V194, P57, DOI 10.1016/S0378-1119(97)00149-2; Shen J, 2016, AM J PATHOL, V186, P419, DOI 10.1016/j.ajpath.2015.10.011; Simon MJ, 2018, J NEUROSCI RES, V96, P180, DOI 10.1002/jnr.24082; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Suguitan Jr AL, 2011, PLOS ONE, V6; Ta-Shma A, 2017, AM J HUM GENET, V100, P666, DOI 10.1016/j.ajhg.2017.02.007; Tarullo AR, 2017, DEV COGN NEUROS-NETH, V26, P1, DOI 10.1016/j.dcn.2017.03.007; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wallen ZD, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000271; Watanabe K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0174-2; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; WATANABE S, 1960, IBM J RES DEV, V4, P66, DOI 10.1147/rd.41.0066; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	106	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242684	10.1371/journal.pone.0242684	http://dx.doi.org/10.1371/journal.pone.0242684			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270668	gold, Green Published			2022-12-26	WOS:000597149100082
J	Mehta, SC; Furey, IM; Pemberton, OA; Boragine, DM; Chen, Y; Palzkill, T				Mehta, Shrenik C.; Furey, Ian M.; Pemberton, Orville A.; Boragine, David M.; Chen, Yu; Palzkill, Timothy			KPC-2 beta-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-A CARBAPENEMASE; CATALYZED HYDROLYSIS; SUBSTRATE PROFILE; MOLECULAR-BASIS; ACTIVE-SITE; ENZYME; INHIBITION; KINETICS; REQUIREMENTS; SPECIFICITY	Serine active-site beta-lactamases hydrolyze beta-lactam antibiotics through the formation of a covalent acyl-enzyme intermediate followed by deacylation via an activated water molecule. Carbapenem antibiotics are poorly hydrolyzed by most beta-lactamases owing to slow hydrolysis of the acyl-enzyme intermediate. However, the emergence of the KPC-2 carbapenemase has resulted in widespread resistance to these drugs, suggesting it operates more efficiently. Here, we investigated the unusual features of KPC-2 that enable this resistance. We show that KPC-2 has a 20,000-fold increased deacylation rate compared with the common TEM-1 beta-lactamase. Furthermore, kinetic analysis of active site alanine mutants indicates that carbapenem hydrolysis is a concerted effort involving multiple residues. Substitution of Asn170 greatly decreases the deacylation rate, but this residue is conserved in both KPC-2 and non-carbapenemase beta-lactamases, suggesting it promotes carbapenem hydrolysis only in the context of KPC-2. X-ray structure determination of the N170A enzyme in complex with hydrolyzed imipenem suggests Asn170 may prevent the inactivation of the deacylating water by the 6 alpha-hydroxyethyl substituent of carbapenems. In addition, the Thr235 residue, which interacts with the C3 carboxylate of carbapenems, also contributes strongly to the deacylation reaction. In contrast, mutation of the Arg220 and Thr237 residues decreases the acylation rate and, paradoxically, improves binding affinity for carbapenems. Thus, the role of these residues may be ground state destabilization of the enzyme-substrate complex or, alternatively, to ensure proper alignment of the substrate with key catalytic residues to facilitate acylation. These findings suggest modifications of the carbapenem scaffold to avoid hydrolysis by KPC-2 beta-lactamase.	[Mehta, Shrenik C.; Furey, Ian M.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Boragine, David M.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Pemberton, Orville A.; Chen, Yu] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA	Baylor College of Medicine; Baylor College of Medicine; State University System of Florida; University of South Florida	Palzkill, T (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.	timothyp@bcm.edu		Mehta, Shrenik/0000-0003-3302-7069	NIH [T32AI055449, R01 AI32956, R21 AI147654, T32GM008280]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R01 AI32956 to T. P. and R21 AI147654 to Y. C. D. M. B. was supported by NIH training grant T32GM008280. I. M. F. was supported by NIH training grant T32AI055449. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamski CJ, 2015, BIOCHEMISTRY-US, V54, P447, DOI 10.1021/bi501195g; Akhtar A, 2020, ACS INFECT DIS, V6, P261, DOI 10.1021/acsinfecdis.9b00304; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Andrews LD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001599; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; BIRNBAUM J, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90097-X; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Cortina GA, 2018, ACS CATAL, V8, P2741, DOI 10.1021/acscatal.7b03832; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Fonseca F, 2007, ANTIMICROB AGENTS CH, V51, P4512, DOI 10.1128/AAC.00491-07; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Frere JM, 2014, CURR OPIN PHARMACOL, V18, P112, DOI 10.1016/j.coph.2014.09.012; Galleni Moreno, 2007, P195; Henriques I, 2004, ANTIMICROB AGENTS CH, V48, P2321, DOI 10.1128/AAC.48.6.2321-2324.2004; Hidalgo-Grass C, 2012, ANTIMICROB AGENTS CH, V56, P6057, DOI 10.1128/AAC.01156-12; HOLLAWAY MR, 1969, FEBS LETT, V4, P299, DOI 10.1016/0014-5793(69)80261-9; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Kalp M, 2008, BIOCHEMISTRY-US, V47, P11830, DOI 10.1021/bi800833u; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; KEZDY FJ, 1962, BIOCHEMISTRY-US, V1, P1097, DOI 10.1021/bi00912a021; KOERBER SC, 1987, ANAL BIOCHEM, V165, P75, DOI 10.1016/0003-2697(87)90203-X; Lamoureaux TL, 2012, ANTIMICROB AGENTS CH, V56, P6006, DOI 10.1128/AAC.01338-12; Lascols C, 2012, J CLIN MICROBIOL, V50, P1632, DOI 10.1128/JCM.06115-11; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Majiduddin FK, 2005, ANTIMICROB AGENTS CH, V49, P3421, DOI 10.1128/AAC.49.8.3421-3427.2005; Majiduddin FK, 2003, ANTIMICROB AGENTS CH, V47, P1062, DOI 10.1128/AAC.47.3.1062-1067.2003; MariotteBoyer S, 1996, FEMS MICROBIOL LETT, V143, P29, DOI 10.1016/0378-1097(96)00288-1; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehta SC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004949; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; MONKS J, 1988, BIOCHEM J, V253, P323, DOI 10.1042/bj2530323; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; NAAS T, 1994, ANTIMICROB AGENTS CH, V38, P1262, DOI 10.1128/AAC.38.6.1262; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; Palzkill T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00016; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Patel MP, 2017, BIOCHEMISTRY-US, V56, P3443, DOI 10.1021/acs.biochem.7b00176; Pemberton OA, 2017, J MED CHEM, V60, P3525, DOI 10.1021/acs.jmedchem.7b00158; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; TAIBI P, 1995, J AM CHEM SOC, V117, P7600, DOI 10.1021/ja00134a003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Tremblay LW, 2010, BIOCHEMISTRY-US, V49, P3766, DOI 10.1021/bi100232q; Wilson APR, 2017, J ANTIMICROB CHEMOTH, V72, P2410, DOI 10.1093/jac/dkx181; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; ZAFARALLA G, 1992, J AM CHEM SOC, V114, P1505, DOI 10.1021/ja00030a070	65	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100155	10.1074/jbc.RA120.015050	http://dx.doi.org/10.1074/jbc.RA120.015050			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273017	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400133
J	Rivard, RS; Morris, JM; Youngman, MJ				Rivard, Rebecca S.; Morris, Julia M.; Youngman, Matthew J.			The PP2A/4/6 subfamily of phosphoprotein phosphatases regulates DAF-16 and confers resistance to environmental stress in postreproductive adult C. elegans	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-4; AKT PHOSPHORYLATION; DNA-DAMAGE; 2A; KINASE; COMPLEX; MECHANISM; SPECIFICITY; ACTIVATION; INTERACTS	Insulin and insulin-like growth factors are longevity determinants that negatively regulate Forkhead box class O (FoxO) transcription factors. In C. elegans mutations that constitutively activate DAF-16, the ortholog of mammalian FoxO3a, extend lifespan by two-fold. While environmental insults induce DAF-16 activity in younger animals, it also becomes activated in an age-dependent manner in the absence of stress, modulating gene expression well into late adulthood. The mechanism by which DAF-16 activity is regulated during aging has not been defined. Since phosphorylation of DAF-16 generally leads to its inhibition, we asked whether phosphatases might be necessary for its increased transcriptional activity in adult C. elegans. We focused on the PP2A/4/6 subfamily of phosphoprotein phosphatases, members of which had been implicated to regulate DAF-16 under low insulin signaling conditions but had not been investigated during aging in wildtype animals. Using reverse genetics, we functionally characterized all C. elegans orthologs of human catalytic, regulatory, and scaffolding subunits of PP2A/4/6 holoenzymes in postreproductive adults. We found that PP2A complex constituents PAA-1 and PPTR-1 regulate DAF-16 transcriptional activity during aging and that they cooperate with the catalytic subunit LET-92 to protect adult animals from ultraviolet radiation. PP4 complex members PPH-4.1/4.2, and SMK-1 also appear to regulate DAF-16 in an age-dependent manner, and together with PPFR-2 they contribute to innate immunity. Interestingly, SUR-6 but no other subunit of the PP2A complex was necessary for the survival of pathogen-infected animals. Finally, we found that PP6 complex constituents PPH-6 and SAPS-1 contribute to host defense during aging, apparently without affecting DAF-16 transcriptional activity. Our studies indicate that a set of PP2A/4/6 complexes protect adult C. elegans from environmental stress, thus preserving healthspan. Therefore, along with their functions in cell division and development, the PP2A/4/6 phosphatases also appear to play critical roles later in life.	[Rivard, Rebecca S.; Morris, Julia M.; Youngman, Matthew J.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Villanova University	Youngman, MJ (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	matthew.youngman@villanova.edu		Youngman, Matthew/0000-0002-9889-3323				Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Afshar K, 2010, DEVELOPMENT, V137, P237, DOI 10.1242/dev.042754; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Andreeva AV, 2001, MOL BIOL EVOL, V18, P448, DOI 10.1093/oxfordjournals.molbev.a003823; Bansal Ankita, 2014, Longev Healthspan, V3, P5, DOI 10.1186/2046-2395-3-5; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; BRENNER S, 1974, GENETICS, V77, P71; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Dues DJ, 2016, AGING-US, V8, P777, DOI 10.18632/aging.100939; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frenk S, 2018, BIOGERONTOLOGY, V19, P547, DOI 10.1007/s10522-018-9750-z; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Haccard O, 2011, RESULTS PROBL CELL D, V53, P219, DOI 10.1007/978-3-642-19065-0_11; Hall ET, 2017, BIOL OPEN, V6, P1165, DOI 10.1242/bio.025221; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hervera A, 2019, EMBO J, V38, DOI 10.15252/embj.2018101032; Hunt Tim, 2013, Adv Biol Regul, V53, P173, DOI 10.1016/j.jbior.2013.04.001; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jia SJ, 2012, DEV CELL, V22, P1065, DOI 10.1016/j.devcel.2012.03.001; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamoun M, 2013, BIOCHEM BIOPH RES CO, V440, P306, DOI 10.1016/j.bbrc.2013.09.068; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Kato H, 2015, CANCER LETT, V365, P223, DOI 10.1016/j.canlet.2015.05.022; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim SH, 2007, J CELL BIOL, V179, P41, DOI 10.1083/jcb.200705182; Kotak S, 2016, J CELL SCI, V129, P3015, DOI 10.1242/jcs.184416; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li ST, 2019, AGING CELL, V18, DOI 10.1111/acel.12896; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Lyu J, 2013, CELL REP, V5, P593, DOI 10.1016/j.celrep.2013.09.034; McHugh DR, 2020, G3-GENES GENOM GENET, V10, P1521, DOI 10.1534/g3.120.401166; Mendoza MC, 2005, MOL CELL BIOL, V25, P7839, DOI 10.1128/MCB.25.17.7839-7853.2005; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Nematullah M, 2018, MOL NEUROBIOL, V55, P1750, DOI 10.1007/s12035-017-0444-3; Ogoh H, 2016, MECH DEVELOP, V139, P1, DOI 10.1016/j.mod.2016.02.001; Okamura H, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030023; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Podshivalova K, 2017, CELL REP, V19, P441, DOI 10.1016/j.celrep.2017.03.062; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Prasanth MI, 2016, AGE, V38, DOI 10.1007/s11357-016-9889-y; Reynhout S, 2019, BBA-MOL CELL RES, V1866, P31, DOI 10.1016/j.bbamcr.2018.07.010; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Rusin SF, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3138; Sato-Carlton A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004638; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; Shen Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.126; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; VANHOOF C, 1994, EUR J BIOCHEM, V226, P899; Wengrod J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0899; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu CG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.27; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yadav L, 2017, CELL SYST, V4, P430, DOI 10.1016/j.cels.2017.02.011; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	76	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0229812	10.1371/journal.pone.0229812	http://dx.doi.org/10.1371/journal.pone.0229812			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315870	Green Published, gold, Green Submitted			2022-12-26	WOS:000600186100017
J	Shioi, R; Karaki, F; Yoshioka, H; Noguchi-Yachide, T; Ishikawa, M; Dodo, K; Hashimoto, Y; Sodeoka, M; Ohgane, K				Shioi, Ryuta; Karaki, Fumika; Yoshioka, Hiromasa; Noguchi-Yachide, Tomomi; Ishikawa, Minoru; Dodo, Kosuke; Hashimoto, Yuichi; Sodeoka, Mikiko; Ohgane, Kenji			Image-based screen capturing misfolding status of Niemann-Pick type C1 identifies potential candidates for chaperone drugs	PLOS ONE			English	Article							DISEASE TYPE-C; RETICULUM-ASSOCIATED DEGRADATION; SIZE-EXCLUSION CHROMATOGRAPHY; PURIFIED NPC1 PROTEIN; PHARMACOLOGICAL CHAPERONES; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ALPHA-GALACTOSIDASE; CHOLESTEROL EXPORT; QUALITY-CONTROL; STEROL-BINDING	Niemann-Pick disease type C is a rare, fatal neurodegenerative disorder characterized by massive intracellular accumulation of cholesterol. In most cases, loss-of-function mutations in the NPC1 gene that encodes lysosomal cholesterol transporter NPC1 are responsible for the disease, and more than half of the mutations are considered to interfere with the biogenesis or folding of the protein. We previously identified a series of oxysterol derivatives and phenanthridine-6-one derivatives as pharmacological chaperones, i.e., small molecules that can rescue folding-defective phenotypes of mutated NPC1, opening up an avenue to develop chaperone therapy for Niemann-Pick disease type C. Here, we present an improved image-based screen for NPC1 chaperones and we describe its application for drug-repurposing screening. We identified some azole antifungals, including itraconazole and posaconazole, and a kinase inhibitor, lapatinib, as probable pharmacological chaperones. A photo-crosslinking study confirmed direct binding of itraconazole to a representative folding-defective mutant protein, NPC1-I1061T. Competitive photo-crosslinking experiments suggested that oxysterol-based chaperones and itraconazole share the same or adjacent binding site(s), and the sensitivity of the crosslinking to P691S mutation in the sterol-sensing domain supports the hypothesis that their binding sites are located near this domain. Although the azoles were less effective in reducing cholesterol accumulation than the oxysterol-derived chaperones or an HDAC inhibitor, LBH-589, our findings should offer new starting points for medicinal chemistry efforts to develop better pharmacological chaperones for NPC1.	[Shioi, Ryuta; Karaki, Fumika; Yoshioka, Hiromasa; Noguchi-Yachide, Tomomi; Hashimoto, Yuichi; Ohgane, Kenji] Univ Tokyo, Inst Quantitat Biosci, Bunkyo Ku, Tokyo, Japan; [Ishikawa, Minoru] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan; [Dodo, Kosuke; Sodeoka, Mikiko; Ohgane, Kenji] RIKEN, Synthet Organ Chem Lab, Cluster Pioneering Res, Wako, Saitama, Japan; [Karaki, Fumika] Kitasato Univ, Sch Pharm, Lab Med Chem, Minato Ku, Tokyo, Japan; [Ohgane, Kenji] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biosci, Noda, Chiba, Japan	University of Tokyo; Tohoku University; RIKEN; Kitasato University; Tokyo University of Science	Ohgane, K (corresponding author), Univ Tokyo, Inst Quantitat Biosci, Bunkyo Ku, Tokyo, Japan.; Ohgane, K (corresponding author), RIKEN, Synthet Organ Chem Lab, Cluster Pioneering Res, Wako, Saitama, Japan.; Ohgane, K (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biosci, Noda, Chiba, Japan.	ohgane@rs.tus.ac.jp	Ohgane, Kenji/Q-9964-2019; Dodo, Kosuke/G-2264-2012; Yoshioka, Hiromasa/AIF-1555-2022; Sodeoka, Mikiko/A-9952-2008; Yoshioka, Hiromasa/AGV-3971-2022	Ohgane, Kenji/0000-0003-0565-6503; Dodo, Kosuke/0000-0001-6008-2915; Yoshioka, Hiromasa/0000-0002-9281-9982; Sodeoka, Mikiko/0000-0002-1344-364X; Yoshioka, Hiromasa/0000-0002-9281-9982; Karaki, Fumika/0000-0002-3815-713X; Ishikawa, Minoru/0000-0002-3937-2261	RIKEN; JSPS (JSPS KAKENHI Grant) [17K15487]; JSPS (JSPS KAKENHI Grant) from Japan Society for the Promotion of Science [JP17H03996]	RIKEN; JSPS (JSPS KAKENHI Grant); JSPS (JSPS KAKENHI Grant) from Japan Society for the Promotion of Science	The work described in this article was supported in part by Incentive Research Grant (2014) for K.O. from RIKEN (https://www.riken.jp/en/), JSPS Grant-in-Aid for Young Scientists B for K.O. (JSPS KAKENHI Grant number 17K15487) and JSPS Grants-in-Aid for Scientific Research B for Y.H. (JSPS KAKENHI Grant number JP17H03996) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chiba T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116162; Coma I, 2009, METHODS MOL BIOL, V565, P69, DOI 10.1007/978-1-60327-258-2_4; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fukuda H, 2017, BIOORG MED CHEM LETT, V27, P2781, DOI 10.1016/j.bmcl.2017.04.062; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Head SA, 2017, ACS CHEM BIOL, V12, P174, DOI 10.1021/acschembio.6b00849; Herner A, 2016, J AM CHEM SOC, V138, P14609, DOI 10.1021/jacs.6b06645; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Hosoya T, 2005, BIOORG MED CHEM LETT, V15, P1289, DOI 10.1016/j.bmcl.2005.01.041; Huang EY, 2018, MOL BIOL CELL, V29, P1021, DOI 10.1091/mbc.E17-08-0514; Ihara M, 2011, ANAL BIOCHEM, V412, P217, DOI 10.1016/j.ab.2011.01.038; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; ISHII S, 1993, BIOCHEM BIOPH RES CO, V197, P1585, DOI 10.1006/bbrc.1993.2659; Karaki F, 2014, THESIS, DOI [10.15083/00007033, DOI 10.15083/00007033]; Karaki F, 2014, BIOORGAN MED CHEM, V22, P3587, DOI 10.1016/j.bmc.2014.05.022; Karaki F, 2013, BIOORGAN MED CHEM, V21, P5297, DOI 10.1016/j.bmc.2013.06.022; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Long T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13917-5; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Lord SJ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001064; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Mackinnon Andrew L, 2009, Curr Protoc Chem Biol, V1, P55; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Nakasone N, 2014, J BIOL CHEM, V289, P19714, DOI 10.1074/jbc.M114.549915; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ohgane K, 2019, QUANTIFICATION GEL B, DOI [10.17504/protocols.io.7vghn3w, DOI 10.17504/PROTOCOLS.IO.7VGHN3W]; Ohgane K, Japan patent Application, Patent No. [JP-2017-105738A, JP-2015-242513A, 2017105738]; Ohgane K, 2014, BIOORG MED CHEM LETT, V24, P3480, DOI 10.1016/j.bmcl.2014.05.064; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Pugach EK, 2018, HUM MOL GENET, V27, P2101, DOI 10.1093/hmg/ddy117; Rudolf AF, 2019, NAT CHEM BIOL, V15, P975, DOI 10.1038/s41589-019-0370-y; Saha P, 2020, ELIFE, V9, DOI 10.7554/eLife.57089; Saliba RS, 2002, J CELL SCI, V115, P2907; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Schultz ML, 2016, BRAIN RES, V1649, P181, DOI 10.1016/j.brainres.2016.03.035; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shammas H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41707-y; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; Suzuki N, 2018, ANAL BIOCHEM, V548, P7, DOI 10.1016/j.ab.2018.02.007; Takada T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010329; Tanio M, 2012, ANAL BIOCHEM, V431, P106, DOI 10.1016/j.ab.2012.09.012; Trinh MN, 2017, P NATL ACAD SCI USA, V114, P89, DOI 10.1073/pnas.1619571114; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vanier MT, 2015, METHOD CELL BIOL, V126, P357, DOI 10.1016/bs.mcb.2014.10.028; Wang C, 2020, HUM MOL GENET, V29, P1, DOI 10.1093/hmg/ddz215; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; WARD CL, 1994, J BIOL CHEM, V269, P25710; Winkler MBL, 2019, CELL, V179, P485, DOI 10.1016/j.cell.2019.08.038; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 2004, BRAIN DEV-JPN, V26, P245, DOI 10.1016/S0387-7604(03)00162-1; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145; Zhang DL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00176; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YX, 2018, CELL, V175, P1352, DOI 10.1016/j.cell.2018.10.026	79	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243746	10.1371/journal.pone.0243746	http://dx.doi.org/10.1371/journal.pone.0243746			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315900	Green Published, gold			2022-12-26	WOS:000600186100058
J	Naghibi, L; Yazdani, M; Momtazi-Borojeni, AA; Razazan, A; Shariat, S; Mansourian, M; Arab, A; Barati, N; Arabsalmani, M; Abbasi, A; Saberi, Z; Badiee, A; Jalali, SA; Jaafari, MR				Naghibi, Laleh; Yazdani, Mona; Momtazi-Borojeni, Amir Abbas; Razazan, Atefeh; Shariat, Sheida; Mansourian, Mercedeh; Arab, Atefeh; Barati, Nastaran; Arabsalmani, Mahdieh; Abbasi, Azam; Saberi, Zahra; Badiee, Ali; Jalali, Seyed Amir; Jaafari, Mahmoud Reza			Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer	PLOS ONE			English	Article							PH-SENSITIVE LIPOSOMES; ESTABLISHED TUMORS; ANTITUMOR IMMUNITY; EFFICACY; CELLS; FORMULATION; ADJUVANT; PROTEIN; INDUCTION; MECHANISM	HER2/neu is an immunogenic protein inducing both humoral and cell-mediated immune responses. The antigen-specific cytotoxic T lymphocytes (CTLs) are the main effector immune cells in the anti-tumor immunity. To induce an effective CTL specific response against P5+435 single peptide derived from rat HER2/neu oncogene, we used a liposome delivery vehicle. In vivo enhancement of liposome stability and intracytoplasmic delivery of peptides are the main strategies which elevate the liposome-mediated drug delivery. Liposomes containing high transition temperature phospholipids, such as DSPC, are stable with prolonged in vivo circulation and more accessibility to the immune system. Incorporation of DOPE phospholipid results in the effective delivery of peptide into the cytoplasm via the endocytotic pathway. To this end, the P5+435 peptide was linked to Maleimide-PEG2000-DSPE and coupled on the surface of nanoliposomes containing DSPC: DSPG: Cholesterol with/without DOPE. We observed that mice vaccinated with Lip-DOPE-P5+435 formulation had the highest number of IFN-gamma- producing CTLs with the highest cytotoxic activity that consequently led to significantly smallest tumor size and prolonged survival rate in the TUBO mice model. In conclusion, our study indicated that the liposomal form of P5+435 peptide containing DOPE can be regarded as a promising prophylactic anti-cancer vaccine to generate potent antigen-specific immunity.	[Naghibi, Laleh; Yazdani, Mona; Shariat, Sheida; Mansourian, Mercedeh; Arab, Atefeh; Arabsalmani, Mahdieh; Abbasi, Azam; Saberi, Zahra; Badiee, Ali; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Nanotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Naghibi, Laleh; Mansourian, Mercedeh; Arab, Atefeh; Badiee, Ali; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut Nanotechnol, Mashhad, Razavi Khorasan, Iran; [Momtazi-Borojeni, Amir Abbas] Mashhad Univ Med Sci, Fac Med, Dept Med Biotechnol, Mashhad, Razavi Khorasan, Iran; [Razazan, Atefeh] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Mol Med, Tehran, Iran; [Arab, Atefeh; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Barati, Nastaran] Hamadan Univ Med Sci, Res & Technol, Hamadan, Iran; [Jalali, Seyed Amir] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran	Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Tehran University of Medical Sciences; Mashhad University Medical Science; Shahid Beheshti University Medical Sciences	Badiee, A; Jaafari, MR (corresponding author), Mashhad Univ Med Sci, Nanotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran.; Badiee, A; Jaafari, MR (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut Nanotechnol, Mashhad, Razavi Khorasan, Iran.; Jaafari, MR (corresponding author), Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran.; Jalali, SA (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran.	Badieea@mums.ac.ir; Jalalia@sbmu.ac.ir; Jafarimr@mums.ac.ir	Barati, Nastaran/GQQ-5548-2022; Yazdani, Mona/AAG-3444-2021		Biotechnology and Nanotechnology Research Center, Mashhad University of Medical Sciences [910445]	Biotechnology and Nanotechnology Research Center, Mashhad University of Medical Sciences	This study was supported financially by Biotechnology and Nanotechnology Research Center, Mashhad University of Medical Sciences (Grant Number 910445). Mashhad University of Medical Sciences also provided facilities and equipment for this research.	Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2815; Arabi L, 2015, J CONTROL RELEASE, V220, P275, DOI 10.1016/j.jconrel.2015.10.044; Babai I, 2001, VACCINE, V20, P505, DOI 10.1016/S0264-410X(01)00326-7; Badiee A, 2009, COLLOID SURFACE B, V74, P37, DOI 10.1016/j.colsurfb.2009.06.025; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Bretscher PA, 2014, SCAND J IMMUNOL, V79, P361, DOI 10.1111/sji.12175; Chang JS, 2001, VACCINE, V19, P3608, DOI 10.1016/S0264-410X(01)00104-9; CONNOR J, 1984, P NATL ACAD SCI-BIOL, V81, P1715, DOI 10.1073/pnas.81.6.1715; Farzad N, 2019, ARTIF CELL NANOMED B, V47, P665, DOI 10.1080/21691401.2019.1576702; Gameiro S.R., 2008, PULMONARY DELIVERY L, P32; Ghaffari-Nazari H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142563; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Huang ZH, 2009, ANGEW CHEM INT EDIT, V48, P4146, DOI 10.1002/anie.200900111; Jalali SA, 2012, NANOMED-NANOTECHNOL, V8, P692, DOI 10.1016/j.nano.2011.09.010; Jalali Seyed Amir, 2011, Recent Pat Biotechnol, V5, P108; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Krieg AM, 2001, CURR OPIN MOL THER, V3, P15; Krishnan L, 2000, J IMMUNOL, V165, P5177, DOI 10.4049/jimmunol.165.9.5177; LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D; Mansourian M, 2014, IMMUNOL LETT, V162, P87, DOI 10.1016/j.imlet.2014.07.008; Matsui K, 2003, INT IMMUNOL, V15, P797, DOI 10.1093/intimm/dxg078; Mazumdar T, 2005, J PARASITOL, V91, P269, DOI 10.1645/GE-356R1; Milani A, 2013, ANN ONCOL, V24, P1740, DOI 10.1093/annonc/mdt133; MOGHIMI SM, 1988, FEBS LETT, V233, P143, DOI 10.1016/0014-5793(88)81372-3; Nikpoor AR, 2017, NANOMED-NANOTECHNOL, V13, P2671, DOI 10.1016/j.nano.2017.08.010; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Rastakhiz S, 2019, J CELL BIOCHEM, V120, P1294, DOI 10.1002/jcb.27090; REDDY R, 1991, J IMMUNOL METHODS, V141, P157, DOI 10.1016/0022-1759(91)90142-3; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schluep T, 2006, CLIN CANCER RES, V12, P1606, DOI 10.1158/1078-0432.CCR-05-1566; Schmidt ST, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8010007; Shariat S, 2014, CANCER LETT, V355, P54, DOI 10.1016/j.canlet.2014.09.016; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; Talesh GA, 2016, IMMUNOL LETT, V176, P57, DOI 10.1016/j.imlet.2016.05.016; Wang RF, 1999, IMMUNOL REV, V170, P85, DOI 10.1111/j.1600-065X.1999.tb01331.x; Watabe S, 2001, VACCINE, V19, P4434, DOI 10.1016/S0264-410X(01)00194-3; Watson DS, 2012, VACCINE, V30, P2256, DOI 10.1016/j.vaccine.2012.01.070; Yanasarn N, 2011, MOL PHARMACEUT, V8, P1174, DOI 10.1021/mp200016d; Yazdani M, 2017, CURR DRUG DELIV, V14, P492, DOI 10.2174/1567201813666160712164149; Yoshikawa T, 2008, BIOCHEM BIOPH RES CO, V366, P408, DOI 10.1016/j.bbrc.2007.11.153; Zamani P N.J., 2019, J CONTROL RELEASE; Zamani P, 2018, J CELL PHYSIOL, V233, P5189, DOI 10.1002/jcp.26361; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	44	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243550	10.1371/journal.pone.0243550	http://dx.doi.org/10.1371/journal.pone.0243550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301467	gold, Green Published			2022-12-26	WOS:000600143100037
J	Fiedler, S; Wunnemann, H; Hofmann, I; Theobalt, N; Feuchtinger, A; Walch, A; Schwaiger, J; Wanke, R; Blutke, A				Fiedler, Sonja; Wuennemann, Hannah; Hofmann, Isabel; Theobalt, Natalie; Feuchtinger, Annette; Walch, Axel; Schwaiger, Julia; Wanke, Ruediger; Blutke, Andreas			A practical guide to unbiased quantitative morphological analyses of the gills of rainbow trout (Oncorhynchus mykiss) in ecotoxicological studies	PLOS ONE			English	Article							DESIGN-BASED STEREOLOGY; SURFACE-AREA; FISH GILL; HISTOPATHOLOGICAL ALTERATIONS; ARBITRARY PARTICLES; SALMO-GAIRDNERI; PATHOLOGICAL RESEARCH; MEMBRANE THICKNESS; PROLONGED EXPOSURE; BRACHYDANIO-RERIO	Rainbow trout (Oncorhynchus mykiss) are frequently used as experimental animals in ecotoxicological studies, in which they are experimentally exposed to defined concentrations of test substances, such as heavy metals, pesticides, or pharmaceuticals. Following exposure to a broad variety of aquatic pollutants, early morphologically detectable toxic effects often manifest in alterations of the gills. Suitable methods for an accurate and unbiased quantitative characterization of the type and the extent of morphological gill alterations are therefore essential prerequisites for recognition, objective evaluation and comparison of the severity of gill lesions. The aim of the present guidelines is to provide practicable, standardized and detailed protocols for the application of unbiased quantitative stereological analyses of relevant morphological parameters of the gills of rainbow trout. These gill parameters inter alia include the total volume of the primary and secondary gill lamellae, the surface area of the secondary gill lamellae epithelium (i.e., the respiratory surface) and the thickness of the diffusion barrier. The featured protocols are adapted to fish of frequently used body size classes (300-2000 g). They include well-established, conventional sampling methods, probes and test systems for unbiased quantitative stereological analyses of light- and electron microscopic 2-D gill sections, as well as the application of modern 3-D light sheet fluorescence microscopy (LSFM) of optically cleared gill samples as an innovative, fast and efficient quantitative morphological analysis approach. The methods shown here provide a basis for standardized and representative state-of-the-art quantitative morphological analyses of trout gills, ensuring the unbiasedness and reproducibility, as well as the intra- and inter-study comparability of analyses results. Their broad implementation will therefore significantly contribute to the reliable identification of no observed effect concentration (NOEC) limits in ecotoxicological studies and, moreover, to limit the number of experimental animals by reduction of unnecessary repetition of experiments.	[Fiedler, Sonja; Hofmann, Isabel; Theobalt, Natalie; Wanke, Ruediger] Ludwig Maximilians Univ Munchen, Inst Vet Pathol, Ctr Clin Vet Med, Munich, Germany; [Wuennemann, Hannah; Schwaiger, Julia] Bavarian Environm Agcy, Unit 73 Aquat Ecotoxicol, Microbial Ecol, Wielenbach, Germany; [Feuchtinger, Annette; Walch, Axel; Blutke, Andreas] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Blutke, A (corresponding author), Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany.	andreas.parzefall@helmholtz-muenchen.de	Walch, Axel/B-4554-2012	Walch, Axel/0000-0001-5578-4023	Hanns-Seidel-Stiftung e.V., German Federal Ministry of Education and Research (BMBF)	Hanns-Seidel-Stiftung e.V., German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	SF, IH, and NT received a PhD scholarship from the Hanns-Seidel-Stiftung e.V., using funds of the German Federal Ministry of Education and Research (BMBF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie S, 2018, SKIN RES TECHNOL, V24, P294, DOI 10.1111/srt.12429; Adams ET, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P149, DOI 10.1016/B978-0-12-415759-0.00006-6; Al-Bairuty GA, 2013, AQUAT TOXICOL, V126, P104, DOI 10.1016/j.aquatox.2012.10.005; Albl B, 2016, TOXICOL PATHOL, V44, P414, DOI 10.1177/0192623316631023; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2014, OECD SERIES TESTING, V177; [Anonymous], 1979, STEREOLOGICAL METHOD; Asmonaite G, 2018, ENVIRON SCI TECHNOL, V52, P14392, DOI 10.1021/acs.est.8b04848; BAATRUP E, 1987, ECOTOX ENVIRON SAFE, V14, P129, DOI 10.1016/0147-6513(87)90055-8; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Barisic J, 2015, ECOTOX ENVIRON SAFE, V118, P158, DOI 10.1016/j.ecoenv.2015.04.027; Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P704, DOI 10.1101/pdb.top076539; BELL CE, 1993, ECOTOX ENVIRON SAFE, V26, P280, DOI 10.1006/eesa.1993.1056; Birzle C., 2015, THESIS; Blutke A, 2014, MOL CELL ENDOCRINOL, V394, P88, DOI 10.1016/j.mce.2014.07.002; Blutke A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71465-1; Blutke A, 2018, JOVE-J VIS EXP, DOI 10.3791/57276; Blutke A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12709; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; BRAUNBECK T, 1990, ARCH ENVIRON CON TOX, V19, P405, DOI 10.1007/BF01054986; Brede C, 2012, J CLIN INVEST, V122, P4439, DOI 10.1172/JCI65100; Brown DL, 2017, J TOXICOL PATHOL, V30, P183, DOI 10.1293/tox.2017-0013; Bucholtz RH, 2013, FISH RES, V145, P100, DOI 10.1016/j.fishres.2013.02.003; Burkhardt-Holm P, 1997, HISTOCHEM J, V29, P893, DOI 10.1023/A:1026450109620; Candeo A, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.5.056001; Chance RJ, 2018, J FISH BIOL, V93, P1069, DOI 10.1111/jfb.13803; Choi E, 2018, AQUAT TOXICOL, V198, P20, DOI 10.1016/j.aquatox.2018.02.007; Corsetti S, 2019, J NEUROSCI METH, V319, P16, DOI 10.1016/j.jneumeth.2018.07.011; Cressey D, 2014, NATURE, V506, P419, DOI 10.1038/506419a; Cruz AL, 2009, BRAZ J BIOL, V69, P385, DOI 10.1590/S1519-69842009000200022; Da Costa OTF, 2007, J MICROSC-OXFORD, V225, P1, DOI 10.1111/j.1365-2818.2007.01710.x; Dalum AS, 2016, FISH SHELLFISH IMMUN, V58, P153, DOI 10.1016/j.fsi.2016.09.013; de Moraes MFPG, 2005, PHYSIOL BIOCHEM ZOOL, V78, P546, DOI 10.1086/430686; Deebani A, 2019, J AM ASSOC LAB ANIM, V58, P390, DOI 10.30802/AALAS-JAALAS-18-000069; Delesse A., 1847, CR HEBD ACAD SCI, V25, P544; Dobosz M, 2014, NEOPLASIA, V16, P1, DOI 10.1593/neo.131848; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Evans D, 2006, NOBODY KNOWS WHERE THE BLUES COME FROM: LYRICS AND HISTORY, P3; EVANS DH, 1987, ENVIRON HEALTH PERSP, V71, P47, DOI 10.2307/3430412; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fernandes MN, 2012, MICRON, V43, P961, DOI 10.1016/j.micron.2012.03.018; Feuchtinger A, 2016, HISTOCHEM CELL BIOL, V146, P781, DOI 10.1007/s00418-016-1495-7; Fonseca AR, 2017, SCI TOTAL ENVIRON, V599, P217, DOI 10.1016/j.scitotenv.2017.04.196; Gage GJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3564; Genina EA, 2010, EXPERT REV MED DEVIC, V7, P825, DOI 10.1586/ERD.10.50; Gernhofer M., 2001, Journal of Aquatic Ecosystem Stress and Recovery, V8, P241, DOI 10.1023/A:1012958804442; Gundersen HJG, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P215, DOI 10.1016/B978-0-12-415759-0.00008-X; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; HAMPTON JA, 1989, AM J ANAT, V185, P58, DOI 10.1002/aja.1001850107; HARDY RW, 1987, FISH PHYSIOL BIOCHEM, V3, P133, DOI 10.1007/BF02180415; Harrison L, 2019, INT J OBESITY, V43, P1305, DOI 10.1038/s41366-018-0221-z; HELANDER KG, 1983, J MICROSC-OXFORD, V132, P223, DOI 10.1111/j.1365-2818.1983.tb04276.x; Herbach N, 2009, AM J PHYSIOL-RENAL, V296, pF819, DOI 10.1152/ajprenal.90665.2008; HERMANNS W, 1981, HISTOCHEMISTRY, V73, P439, DOI 10.1007/BF00495658; HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82; Hoeflich A, 2002, FASEB J, V16, P1721, DOI 10.1096/fj.02-0349com; Hofmann I, 2020, GROWTH HORM IGF RES, V51, P6, DOI 10.1016/j.ghir.2019.12.006; Hong SM, 2019, ADV ANAT PATHOL, V26, P31, DOI 10.1097/PAP.0000000000000215; Howard CV, 2005, UNBIASED STEREOLOGY; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; HUGHES GM, 1976, J EXP BIOL, V64, P447; HUGHES GM, 1984, J MAR BIOL ASSOC UK, V64, P637, DOI 10.1017/S0025315400030319; HUGHES GM, 1979, WATER RES, V13, P665, DOI 10.1016/0043-1354(79)90017-4; HUGHES GM, 1972, RESP PHYSIOL, V14, P1, DOI 10.1016/0034-5687(72)90014-X; JENSEN EB, 1979, J MICROSC-OXFORD, V115, P19, DOI 10.1111/j.1365-2818.1979.tb00149.x; KARLSSONNORRGREN L, 1985, J FISH BIOL, V27, P81, DOI 10.1111/j.1095-8649.1985.tb04011.x; Kayser K, 2015, DIAGNOSTIC PATHOLOGY; Kennel P, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.8.086002; Klingberg A, 2017, J AM SOC NEPHROL, V28, P452, DOI 10.1681/ASN.2016020232; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Koppang EO, 2010, J ANAT, V217, P728, DOI 10.1111/j.1469-7580.2010.01305.x; Kriz W, 1998, J AM SOC NEPHROL, V9, P381; Lang G., 2013, HISTOTECHNIK PRAXISL, V2; LAURENT P, 1989, CAN J ZOOL, V67, P3055, DOI 10.1139/z89-429; Lavado R, 2011, AQUAT TOXICOL, V101, P57, DOI 10.1016/j.aquatox.2010.09.002; Phuong LM, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.168658; Phuong LM, 2017, COMP BIOCHEM PHYS A, V203, P288, DOI 10.1016/j.cbpa.2016.10.006; Lugo-Hernandez E, 2017, J CEREBR BLOOD F MET, V37, P3355, DOI 10.1177/0271678X17698970; Madsen KM, 1999, J AM SOC NEPHROL, V10, P1124; MALLATT J, 1985, CAN J FISH AQUAT SCI, V42, P630, DOI 10.1139/f85-083; Matenaers C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192879; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; MATTFELDT T, 1985, J MICROSC-OXFORD, V139, P279, DOI 10.1111/j.1365-2818.1985.tb02644.x; Mazon AD, 1998, J FISH BIOL, V52, P50, DOI 10.1006/jfbi.1997.0558; Mehinto AC, 2010, ENVIRON SCI TECHNOL, V44, P2176, DOI 10.1021/es903702m; Memmert U, 2013, ENVIRON TOXICOL CHEM, V32, P442, DOI 10.1002/etc.2085; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Monteiro SM, 2009, ECOTOX ENVIRON SAFE, V72, P213, DOI 10.1016/j.ecoenv.2008.02.008; Nero V, 2006, ECOTOX ENVIRON SAFE, V65, P252, DOI 10.1016/j.ecoenv.2005.07.009; NOWAK B, 1992, AQUAT TOXICOL, V23, P65, DOI 10.1016/0166-445X(92)90012-C; Nunes B, 2015, ARCH ENVIRON CON TOX, V68, P371, DOI 10.1007/s00244-014-0101-z; Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; OLSON KR, 1985, J ELECTRON MICR TECH, V2, P217, DOI 10.1002/jemt.1060020307; Ostrander GK., 2000, LAB FISH; OULMI Y, 1995, ECOTOX ENVIRON SAFE, V32, P39, DOI 10.1006/eesa.1995.1083; Pakkenberg B, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00042; Ramage IJ, 2002, KIDNEY INT, V62, P895, DOI 10.1046/j.1523-1755.2002.00527.x; Raskovic B, 2019, MICROSC RES TECHNIQ, V82, P861, DOI 10.1002/jemt.23228; Readman GD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06917-2; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rieger A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158977; Rodrigues S, 2017, ENVIRON TOXICOL PHAR, V53, P164, DOI 10.1016/j.etap.2017.05.012; SCHERLE W, 1970, Mikroskopie, V26, P57; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schneider JP, 2014, AM J PHYSIOL-LUNG C, V306, pL341, DOI 10.1152/ajplung.00329.2013; Schwaiger J, 2004, AQUAT TOXICOL, V68, P141, DOI 10.1016/j.aquatox.2004.03.014; Schwaiger J, 2002, AQUAT TOXICOL, V59, P177, DOI 10.1016/S0166-445X(01)00248-X; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tanaka N, 2017, NAT BIOMED ENG, V1, P796, DOI 10.1038/s41551-017-0139-0; Thophon S, 2003, ENVIRON POLLUT, V121, P307, DOI 10.1016/S0269-7491(02)00270-1; Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011; Ueda HR, 2020, NAT REV NEUROSCI, V21, P61, DOI 10.1038/s41583-019-0250-1; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Wanke R, 2001, VERH DEUT G, V85, P250; Waser WP, 2005, FISH PHYSIOL BIOCHEM, V31, P73, DOI 10.1007/s10695-006-0002-9; Wilson JM, 2002, J EXP ZOOL, V293, P192, DOI 10.1002/jez.10124; Wolf JC, 2014, AQUAT TOXICOL, V146, P127, DOI 10.1016/j.aquatox.2013.10.033; Yang L, 2019, ACS NANO, V13, P1029, DOI 10.1021/acsnano.8b07524; Zagato E, 2018, MICROSC RES TECHNIQ, V81, P941, DOI 10.1002/jemt.22981; Zhao S, 2020, CELL, V180, P796, DOI 10.1016/j.cell.2020.01.030	133	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243462	10.1371/journal.pone.0243462	http://dx.doi.org/10.1371/journal.pone.0243462			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296424	Green Published, gold			2022-12-26	WOS:000598626100010
J	Uda, M; Yoshihara, T; Ichinoseki-Sekine, N; Baba, T; Yoshioka, T				Uda, Munehiro; Yoshihara, Toshinori; Ichinoseki-Sekine, Noriko; Baba, Takeshi; Yoshioka, Toshitada			Potential roles of neuronal nitric oxide synthase and the PTEN-induced kinase 1 (PINK1)/Parkin pathway for mitochondrial protein degradation in disuse-induced soleus muscle atrophy in adult rats	PLOS ONE			English	Article							HUMAN CU,ZN-SUPEROXIDE DISMUTASE; SINGLE TRYPTOPHAN RESIDUE; SKELETAL-MUSCLE; SUPEROXIDE GENERATION; OXIDATIVE STRESS; PARKIN; EXPRESSION; NOS; PEROXYNITRITE; CALPAIN	Excessive nitric oxide (NO) production and mitochondrial dysfunction can activate protein degradation in disuse-induced skeletal muscle atrophy. However, the increase in NO production in atrophied muscles remains controversial. In addition, although several studies have investigated the PTEN-induced kinase 1 (PINK1)/Parkin pathway, a mitophagy pathway, in atrophied muscle, the involvement of this pathway in soleus muscle atrophy is unclear. In this study, we investigated the involvement of neuronal nitric oxide synthase (nNOS) and the PINK1/Parkin pathway in soleus muscle atrophy induced by 14 days of hindlimb unloading (HU) in adult rats. HU lowered the weight of the soleus muscles. nNOS expression showed an increase in atrophied soleus muscles. Although HU increased malondialdehyde as oxidative modification of the protein, it decreased 6-nitrotryptophan, a marker of protein nitration. Additionally, the nitrosocysteine content and S-nitrosylated Parkin were not altered, suggesting the absence of excessive nitrosative stress after HU. The expression of PINK1 and Parkin was also unchanged, whereas the expression of heat shock protein 70 (HSP70), which is required for Parkin activity, was reduced in atrophied soleus muscles. Moreover, we observed accumulation and reduced ubiquitination of high molecular weight mitofusin 2, which is a target of Parkin, in atrophied soleus muscles. These results indicate that excessive NO is not produced in atrophied soleus muscles despite nNOS accumulation, suggesting that excessive NO dose not mediate in soleus muscle atrophy at least after 14 days of HU. Furthermore, the PINK1/Parkin pathway may not play a role in mitophagy at this time point. In contrast, the activity of Parkin may be downregulated because of reduced HSP70 expression, which may contribute to attenuated degradation of target proteins in the atrophied soleus muscles after 14 days of HU. The present study provides new insights into the roles of nNOS and a protein degradation pathway in soleus muscle atrophy.	[Uda, Munehiro; Yoshioka, Toshitada] Hirosaki Gakuin Univ, Sch Nursing, Hirosaki, Aomori, Japan; [Yoshihara, Toshinori; Ichinoseki-Sekine, Noriko] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Ichinoseki-Sekine, Noriko] Open Univ Japan, Fac Liberal Arts, Chiba, Japan; [Baba, Takeshi] Juntendo Univ, Sch Med, Chiba, Japan	Juntendo University; Juntendo University	Uda, M (corresponding author), Hirosaki Gakuin Univ, Sch Nursing, Hirosaki, Aomori, Japan.	uda@hirogaku-u.ac.jp		Uda, Munehiro/0000-0001-7945-7035; Ichinoseki-Sekine, Noriko/0000-0002-0467-3312	JSPS KAKENHI [JP26560402, JP19K11554]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP26560402, JP19K11554 to MU.	Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x; Baehr LM, 2017, J APPL PHYSIOL, V122, P1336, DOI 10.1152/japplphysiol.00703.2016; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Chen YZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179978; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Deval C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103691; Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665; Escobar-Henriques M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00517; Hafen PS, 2019, J APPL PHYSIOL, V127, P47, DOI 10.1152/japplphysiol.01098.2018; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Horowitz JM, 1999, NEUROREPORT, V10, P3393, DOI 10.1097/00001756-199911080-00025; Ichinoseki-Sekine N, 2014, J APPL PHYSIOL, V117, P518, DOI 10.1152/japplphysiol.00170.2014; Ihara H, 2006, NITRIC OXIDE-BIOL CH, V15, P13, DOI 10.1016/j.niox.2005.11.011; Iizumi K, 2018, J CLIN BIOCHEM NUTR, V63, P197, DOI 10.3164/jcbn.18-53; Ikeda K, 2007, NITRIC OXIDE-BIOL CH, V16, P18, DOI 10.1016/j.niox.2006.04.263; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; Kang C, 2016, ACTA PHYSIOL, V218, P188, DOI 10.1111/apha.12690; Kasamatsu S, 2014, BIOCHEM J, V459, P251, DOI 10.1042/BJ20131262; Kawasaki H, 2014, FREE RADICAL BIO MED, V73, P75, DOI 10.1016/j.freeradbiomed.2014.04.034; Kellogg DL, 2017, FREE RADICAL BIO MED, V110, P261, DOI 10.1016/j.freeradbiomed.2017.06.018; Kuczmarski JM, 2018, EXP PHYSIOL, V103, P545, DOI 10.1113/EP086649; Terradas ALI, 2018, J PATHOL, V246, P433, DOI 10.1002/path.5149; Leermakers PA, 2019, MUSCLE NERVE, V60, P769, DOI 10.1002/mus.26702; Liu J, 2012, IUBMB LIFE, V64, P901, DOI 10.1002/iub.1087; Lomonosova YN, 2011, BIOCHEMISTRY-MOSCOW+, V76, P571, DOI 10.1134/S0006297911050075; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mata-Greenwood E, 2006, AM J PHYSIOL-LUNG C, V290, pL232, DOI 10.1152/ajplung.00393.2004; Matsuda N, 2020, NEUROSCI RES, V159, P16, DOI 10.1016/j.neures.2020.03.009; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Oishi Y, 2008, ACTA PHYSIOL, V192, P381, DOI 10.1111/j.1748-1716.2007.01747.x; Ozawa K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02202; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Powers SK, 2016, FREE RADICAL BIO MED, V98, P208, DOI 10.1016/j.freeradbiomed.2016.02.021; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rosa-Caldwell ME, 2020, APPL PHYSIOL NUTR ME, V45, P264, DOI 10.1139/apnm-2019-0218; Rudnick J, 2004, FASEB J, V18, P1228, DOI 10.1096/fj.03-0792fje; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Shenkman BS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00298; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Song Y, 2002, BIOCHEMISTRY-US, V41, P10616, DOI 10.1021/bi026060u; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819; Staron RS, 1999, HISTOCHEM CELL BIOL, V111, P117, DOI 10.1007/s004180050341; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Talbert EE, 2013, J APPL PHYSIOL, V114, P1482, DOI 10.1152/japplphysiol.00925.2012; Tamura Y, 2015, J PHYSIOL-LONDON, V593, P2707, DOI 10.1113/JP270093; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Uda M, 2015, MOL CELL BIOCHEM, V409, P59, DOI 10.1007/s11010-015-2512-1; Uda M, 2012, BIOSCIENCE REP, V32, P521, DOI 10.1042/BSR20120032; Van Gammeren D, 2007, J APPL PHYSIOL, V102, P157, DOI 10.1152/japplphysiol.00043.2006; Vitadello M, 2014, ANTIOXID REDOX SIGN, V20, P2479, DOI 10.1089/ars.2012.4794; Yamakura F, 2005, J BIOCHEM, V138, P57, DOI 10.1093/jb/mvi095; Yamakura F, 2001, BBA-PROTEIN STRUCT M, V1548, P38, DOI 10.1016/S0167-4838(01)00212-6; Yoshihara T, 2019, J PHYSIOL SCI, V69, P235, DOI 10.1007/s12576-018-0640-6; Yoshihara T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12597; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	75	2	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243660	10.1371/journal.pone.0243660	http://dx.doi.org/10.1371/journal.pone.0243660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296434	gold, Green Published			2022-12-26	WOS:000598626100009
J	Bhatia, R; Klausner, J				Bhatia, Rajiv; Klausner, Jeffrey			Estimating individual risks of COVID-19-associated hospitalization and death using publicly available data	PLOS ONE			English	Article								We describe a method to estimate individual risks of hospitalization and death attributable to non-household and household transmission of SARS-CoV-2 using available public data on confirmed-case incidence data along with estimates of the clinical fraction, timing of transmission, isolation adherence, secondary infection risks, contact rates, and case-hospitalization and case-fatality ratios. Using the method, we estimate that risks for a 90-day period at the median daily summertime U.S. county confirmed COVID-19 case incidence of 10.8 per 100,000 and pre-pandemic contact rates range from 0.4 to 8.9 per 100,000 for the four deciles of age between 20 and 60 years. The corresponding 90-day period risk of hospitalization ranges from 13.7 to 69.2 per 100,000. Assuming a non-household secondary infection risk of 4% and pre-pandemic contact rates, the share of transmissions attributable to household settings ranges from 73% to 78%. These estimates are sensitive to the parameter assumptions; nevertheless, they are comparable to the COVID-19 hospitalization and fatality rates observed over the time period. We conclude that individual risk of hospitalization and death from SARS-CoV-2 infection is calculable from publicly available data sources. Access to publicly reported infection incidence data by setting and other exposure characteristics along with setting specific estimates of secondary infection risk would allow for more precise individual risk estimation.	[Bhatia, Rajiv] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Klausner, Jeffrey] Univ Calif Los Angeles, Dept Med & Publ Hlth, Los Angeles, CA USA	Stanford University; University of California System; University of California Los Angeles	Bhatia, R (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	drajiv@stanford.edu		Bhatia, Rajiv/0000-0002-3371-4101				Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Bodas M, 2020, HEALTH AFFAIR, V39, P936, DOI 10.1377/hlthaff.2020.00382; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Casey M, 2020, ESTIMATING PRESYMPTO, DOI 10.1101/2020.05.08.20094870; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; de Bruin WB, 2020, AM J PREV MED, V59, P157, DOI 10.1016/j.amepre.2020.05.001; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Havers FP, 2020, JAMA INTERN MED, DOI [10.1001/jamainternmed.2020.4130, DOI 10.1001/JAMAINTERNMED.2020.413032692365]; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Kim S, 2022, CLIN INFECT DIS, V74, P1594, DOI 10.1093/cid/ciab668; Koh WC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240205; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Leclerc Quentin J, 2020, Wellcome Open Res, V5, P83, DOI [10.12688/wellcomeopenres.15889.1, 10.12688/wellcomeopenres.15889.2]; Lei H, 2020, J INFECTION, V81, P993, DOI 10.1016/j.jinf.2020.08.033; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Madewell Zachary J, 2020, medRxiv, DOI 10.1101/2020.07.29.20164590; Marshall K, 2020, MMWR-MORBID MORTAL W, V69, P847, DOI 10.15585/mmwr.mm6926e4; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Niepel C, 2020, BRIT J HEALTH PSYCH, V25, P883, DOI 10.1111/bjhp.12438; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Poletti P., 2020, PROBABILITY SYMPTOMS; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P841, DOI 10.15585/mmwr.mm6926e3; Thompson Derek, 2020, ATLANTIC; Webster RK, 2020, PUBLIC HEALTH, V182, P163, DOI 10.1016/j.puhe.2020.03.007; WHO, 2019, REP WHO CHIN JOINT M	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243026	10.1371/journal.pone.0243026	http://dx.doi.org/10.1371/journal.pone.0243026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284861	Green Published, gold, Green Submitted			2022-12-26	WOS:000597930500001
J	Alam, JJ; Krakovsky, M; Germann, U; Levy, A				Alam, John J.; Krakovsky, Michael; Germann, Ursula; Levy, Aharon			Continuous administration of a p38 alpha inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; P38 MAPK INHIBITOR; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; KINASE INHIBITOR; GENE-EXPRESSION; MOUSE MODEL; INJURY; REPERFUSION; IL-1-BETA	There is unmet need for effective stroke therapies. Numerous neuroprotection attempts for acute cerebral ischemia have failed and as a result there is growing interest in developing therapies to promote functional recovery through increasing synaptic plasticity. For this research study, we hypothesized that in addition to its previously reported role in mediating cell death during the acute phase, the alpha isoform of p38 mitogen-activated protein kinase, p38 alpha, may also contribute to interleukin-1 beta-mediated impairment of functional recovery during the subacute phase after acute ischemic stroke. Accordingly, an oral, brain-penetrant, small molecule p38 alpha inhibitor, neflamapimod, was evaluated as a subacute phase stroke treatment to promote functional recovery. Neflamapimod administration to rats after transient middle cerebral artery occlusion at two dose levels was initiated outside of the previously characterized therapeutic window for neuroprotection of less than 24 hours for p38 alpha inhibitors. Six-week administration of neflamapimod, starting at 48 hours after reperfusion, significantly improved behavioral outcomes assessed by the modified neurological severity score at Week 4 and at Week 6 post stroke in a dose-dependent manner. Neflamapimod demonstrated beneficial effects on additional measures of sensory and motor function. It also resulted in a dose-related increase in brain-derived neurotrophic factor (BDNF) protein levels, a previously reported potential marker of synaptic plasticity that was measured in brain homogenates at sacrifice. Taken together with literature evidence on the role of p38 alpha-dependent suppression by interleukin-1 beta of BDNF-mediated synaptic plasticity and BDNF production, our findings support a mechanistic model in which inhibition of p38 alpha promotes functional recovery after ischemic stroke by blocking the deleterious effects of interleukin-1 beta on synaptic plasticity. The dose-related in vivo efficacy of neflamapimod offers the possibility of having a therapy for stroke that could be initiated outside the short time window for neuroprotection and for improving recovery after a completed stroke.	[Alam, John J.; Germann, Ursula] EIP Pharma Inc, Boston, MA 02210 USA; [Krakovsky, Michael; Levy, Aharon] Pharmaseed Ltd, Ness Ziona, Israel		Alam, JJ (corresponding author), EIP Pharma Inc, Boston, MA 02210 USA.	jalam@eippharma.com		Alam, John/0000-0002-1285-1115				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alam J, 2017, JPAD-J PREV ALZHEIM, V4, P273, DOI 10.14283/jpad.2017.41; Alam JJ, 2015, J ALZHEIMERS DIS, V48, P219, DOI 10.3233/JAD-150277; [Anonymous], 2001, J WUHAN UNIV TECHNOL, V23, P1; [Anonymous], 2012, INT J BIOL PHARM APP, V1, P195; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2010, AACN BOLD VOICES, V2, P13; Aspey BS, 1998, NEUROPATH APPL NEURO, V24, P487; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Berretta A, 2014, EXPERT REV NEUROTHER, V14, P1335, DOI 10.1586/14737175.2014.969242; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Cai Y, 2018, J BIOMED NANOTECHNOL, V14, P585, DOI 10.1166/jbn.2018.2522; Cassidy JM, 2017, TRANSL STROKE RES, V8, P33, DOI 10.1007/s12975-016-0467-5; Chang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16951; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng CY, 2020, J ETHNOPHARMACOL, V252, DOI 10.1016/j.jep.2020.112612; Cheng CY, 2017, AM J CHINESE MED, V45, P1683, DOI 10.1142/S0192415X17500914; Cheng CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155748; Cheng CY, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0752-y; Cho DY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1011-1; Chollet F., 2013, NEUROSCIENCE, V15, P67, DOI DOI 10.31887/DCNS.2013.15.1/FCH0LLET; Choudhury GR, 2014, BRAIN RES, V1551, P45, DOI 10.1016/j.brainres.2014.01.013; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Colie S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45306; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Cramer SC, 2018, J STROKE, V20, P57, DOI 10.5853/jos.2017.02796; Crozier J, 2018, NEUROREHAB NEURAL RE, V32, P543, DOI 10.1177/1545968318766663; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Duffy JP, 2011, ACS MED CHEM LETT, V2, P758, DOI 10.1021/ml2001455; Ferrer I, 2003, ACTA NEUROPATHOL, V105, P425, DOI 10.1007/s00401-002-0661-2; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Hacke W, 2008, NAT CLIN PRACT NEURO, V4, P474, DOI 10.1038/ncpneuro0867; Han D, 2015, MOL CELL ENDOCRINOL, V400, P21, DOI 10.1016/j.mce.2014.11.010; Hayakawa M, 2017, J BIOL CHEM, V292, P1762, DOI 10.1074/jbc.M116.764548; Henninger N, 2006, STROKE, V37, P1283, DOI 10.1161/01.STR.0000217223.72193.98; Huang YY, 2011, J NEUROSCI, V31, P18048, DOI 10.1523/JNEUROSCI.4067-11.2011; Iadecolar C, 2020, J CLIN INVEST, V130, P2777, DOI 10.1172/JCI135530; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Karsy M, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.1.FOCUS16522; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; King M, 2019, NEUROL RES, V41, P354, DOI 10.1080/01616412.2018.1564451; Krupinski J, 2003, NEUROPATH APPL NEURO, V29, P144, DOI 10.1046/j.1365-2990.2003.00454.x; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; Lambertsen KL, 2019, ACTA NEUROPATHOL, V137, P693, DOI 10.1007/s00401-018-1930-z; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Legos JJ, 2002, EUR J PHARMACOL, V447, P37, DOI 10.1016/S0014-2999(02)01890-3; Legos JJ, 2001, BRAIN RES, V892, P70, DOI 10.1016/S0006-8993(00)03228-5; Lennmyr F, 2003, ACTA NEUROL SCAND, V108, P339, DOI 10.1034/j.1600-0404.2003.00129.x; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Lin Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.284; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lynch MA, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.006.2009; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Mang CS, 2013, PHYS THER, V93, P1707, DOI 10.2522/ptj.20130053; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Morris MW, 2015, ORGAN BEHAV HUM DEC, V129, P1, DOI 10.1016/j.obhdp.2015.03.001; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; O'Donoghue ML, 2016, JAMA-J AM MED ASSOC, V315, P1591, DOI 10.1001/jama.2016.3609; Patterson SL, 2015, NEUROPHARMACOLOGY, V96, P11, DOI 10.1016/j.neuropharm.2014.12.020; Pfeilschifter W, 2010, NEUROCHEM RES, V35, P1391, DOI 10.1007/s11064-010-0197-0; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Piao CS, 2002, MOL BRAIN RES, V107, P137, DOI 10.1016/S0169-328X(02)00456-4; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Pozzi D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00111; Prieto GA, 2015, P NATL ACAD SCI USA, V112, pE5078, DOI 10.1073/pnas.1514486112; Rajsic S, 2019, EUR J HEALTH ECON, V20, P107, DOI 10.1007/s10198-018-0984-0; Ridker PM, 2018, EUR HEART J, V39, P3518, DOI 10.1093/eurheartj/ehy360; Risco A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00065; Salmeron KE, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1599-9; Savitz SI, 2013, STROKE, V44, pS107, DOI 10.1161/STROKEAHA.112.679605; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Scheltens P, 2018, ANN CLIN TRANSL NEUR, V5, P464, DOI 10.1002/acn3.549; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Shehadah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054083; Small SL, 2013, NAT REV NEUROL, V9, P698, DOI 10.1038/nrneurol.2013.222; Smith CJ, 2018, STROKE, V49, P1210, DOI 10.1161/STROKEAHA.118.020750; Smith DE, 2009, IMMUNITY, V30, P817, DOI 10.1016/j.immuni.2009.03.020; Sobowale OA, 2016, STROKE, V47, P2160, DOI 10.1161/STROKEAHA.115.010001; Sommer CJ, 2017, ACTA NEUROPATHOL, V133, P245, DOI 10.1007/s00401-017-1667-0; Song C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-59; Tanaka N, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0009-18.2018; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Umezawa H, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00072; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Venkat P, 2018, NEUROPHARMACOLOGY, V134, P310, DOI 10.1016/j.neuropharm.2017.08.036; Verkaar F, 2011, CHEM BIOL, V18, P485, DOI 10.1016/j.chembiol.2011.01.015; WANG XK, 1994, MOL CHEM NEUROPATHOL, V23, P103, DOI 10.1007/BF02815404; Xiong XY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00249; Zhao LR, 2018, PROG NEUROBIOL, V163, P5, DOI 10.1016/j.pneurobio.2018.01.004; Zou CL, 2017, RES J BIOTECHNOL, V12, P25; 2010, INT J COMPUTER APPL, V3, P12	103	4	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0233073	10.1371/journal.pone.0233073	http://dx.doi.org/10.1371/journal.pone.0233073			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275615	gold, Green Published			2022-12-26	WOS:000597150200040
J	Bae, CR; Zhang, HY; Kwon, YG				Bae, Cho-Rong; Zhang, Haiying; Kwon, Young-Guen			The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice	PLOS ONE			English	Article							VASCULAR-LEAKAGE-BLOCKER; HEPATIC-FIBROSIS; KUPFFER CELLS; LIVER-INJURY; CAPILLARIZATION; DEFENESTRATION; STEATOSIS; SINUSOIDS; SAC-1004; MODEL	Non-alcoholic steatohepatitis (NASH) is a severe, advanced form of non-alcoholic fatty liver disease (NAFLD) that is associated with features of metabolic syndrome and characterized by hepatic steatosis, inflammation, and fibrosis. In addition, NASH is associated with endothelial dysfunction within the hepatic vasculature. Treatment with CU06-1004 (previously called Sac-1004) ameliorates endothelial dysfunction by inhibiting hyperpermeability and inflammation. In this study, we investigated the protective effects of CU06-1004 in a choline-deficient L-amino acid (CDAA)-induced mouse model of NASH for 3 or 6 weeks. Specifically, we evaluated the effects of CU06-1004 on lipid accumulation, inflammation, hepatic fibrosis, and liver sinusoidal endothelial cell (LSEC) capillarization through biochemical analysis, immunohistochemistry, and real-time PCR. We found that the administration of CU06-1004 to mice improved liver triglyceride (TG) and serum alanine aminotransferase (ALT) in this CDAA-induced model of NASH for 6 weeks. In groups of NASH induced mice for both 3 and 6 weeks, CU06-1004 significantly reduced the hepatic expression of genes related to lipogenesis, inflammation, and cell adhesion. However, expression of genes related to hepatic fibrosis and vascular endothelial changes were only decreased in animals with mild NASH. These results suggest that the administration of CU06-1004 suppresses hepatic steatosis, inflammation, fibrosis, and LSEC capillarization in a CDAA-induced mouse model of NASH. This suggests that CU06-1004 has therapeutic potential for the treatment of mild NASH.	[Bae, Cho-Rong; Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea; [Zhang, Haiying] CURACLE Co Ltd, Seongnam Si, Gyeonggi Do, South Korea	Yonsei University	Kwon, YG (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea.	ygkwon@yonsei.ac.kr			CURACLE Co, Ltd.; National Research Foundation of Korea (NRF)	CURACLE Co, Ltd.; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	CURACLE Co, Ltd., provided support for the study in the form of salary for HZ, and provided the CU06-1004 sample. The specific roles of this author are articulated in the `author contributions' section. Funding was received from National Research Foundation of Korea (NRF) for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batbold D, 2016, J UROLOGY, V195, P1936, DOI 10.1016/j.juro.2015.12.103; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; DeLeve LD, 2008, AM J PATHOL, V173, P993, DOI 10.2353/ajpath.2008.070720; DeLeve LD, 2017, SEMIN LIVER DIS, V37, P377, DOI 10.1055/s-0037-1617455; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; Enomoto Katsuhiko, 2004, Medical Electron Microscopy, V37, P208, DOI 10.1007/s00795-004-0261-4; ESSANI NA, 1995, BIOCHEM BIOPH RES CO, V211, P74, DOI 10.1006/bbrc.1995.1780; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Fassio E, 2004, HEPATOLOGY, V40, P820, DOI 10.1002/hep.20410; Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666; Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4; Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012; HORN T, 1987, HEPATOLOGY, V7, P77, DOI 10.1002/hep.1840070117; Gonzalez-Paredes FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156650; Kohjima M, 2007, INT J MOL MED, V20, P351; Kruger-Genge A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184411; Lee K, 2014, BIOCHEM BIOPH RES CO, V450, P1320, DOI 10.1016/j.bbrc.2014.06.139; Lefere S, 2019, JHEP REP, V1, P30, DOI 10.1016/j.jhepr.2019.02.004; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Liao JK, 2013, J CLIN INVEST, V123, P540, DOI 10.1172/JCI66843; Liu WL, 2016, P NATL ACAD SCI USA, V113, P2288, DOI 10.1073/pnas.1525093113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maharjan S, 2013, BIOCHEM BIOPH RES CO, V435, P420, DOI 10.1016/j.bbrc.2013.04.104; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; Maurice J, 2018, CLIN MED, V18, P245, DOI 10.7861/clinmedicine.18-3-245; Miller AM, 2010, ALCOHOL CLIN EXP RES, V34, P719, DOI 10.1111/j.1530-0277.2009.01141.x; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Ou Q, 2018, DIGEST DIS SCI, V63, P3398, DOI 10.1007/s10620-018-5268-0; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239; Senturk O, 2008, INTERN MED J, V38, P183, DOI 10.1111/j.1445-5994.2007.01481.x; Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012; Vaishaali N, 2020, BIORXIV PREPRINT, DOI [10.1101/2020.01.27.921353, DOI 10.1101/2020.01.27.921353]; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Wattacheril J, 2018, ANNU REV PHARMACOL, V58, P649, DOI 10.1146/annurev-pharmtox-010617-052545; Wu Y, 2019, DRUG DES DEV THER, V13, P2667, DOI 10.2147/DDDT.S210797; Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017; Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6; Yang YM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00378; Zhang H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0897-3; Zhang Q, 2014, J MOL ENDOCRINOL, V53, P281, DOI 10.1530/JME-14-0049	46	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243497	10.1371/journal.pone.0243497	http://dx.doi.org/10.1371/journal.pone.0243497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275637	Green Published, gold			2022-12-26	WOS:000597150200035
J	Cunha, AOB; Bezerra, JDP; Oliveira, TGL; Barbier, E; Bernard, E; Machado, AR; Souza-Motta, CM				Cunha, Aline O. B.; Bezerra, Jadson D. P.; Oliveira, Thays G. L.; Barbier, Eder; Bernard, Enrico; Machado, Alexandre R.; Souza-Motta, Cristina M.			Living in the dark: Bat caves as hotspots of fungal diversity	PLOS ONE			English	Article							FILAMENTOUS FUNGI; AIRBORNE FUNGI; CAATINGA; GUANO; HARMANECKA; MYCOBIOTA; COMMUNITY; THREATS; BRAZIL; AREAS	Bat caves are very special roosts that harbour thousands of bats of one or more species. Such sites may hold an incredible "dark fungal diversity" which is still underestimated. We explored the culturable fungal richness in the air, on bats, and in the guano in a bat cave in Brazil's Caatinga dry forest. Fungal abundance was 683 colony-forming units (CFU) in the guano, 673 CFU in the air, and 105 CFU on the bats. Based on morphological and phylogenetic analysis of ITS, LSU, and TUB2 sequences, fungal isolates of 59 taxa belonging to 37 genera in the phyla Ascomycota (28 genera, including Aspergillus, Penicillium, Cladosporium, and Talaromyces), Basidiomycota (eight genera, including Rhodotorula and Schizophyllum), and Mucoromycota (only Rhizopus) were identified. The fungal richness in the air was 23 taxa (especially Aspergillus taxa), mainly found at 15 m and 45 m from the cave entrance; on the bodies of bats it was 36 taxa (mainly Aspergillus taxa), especially on their wing membranes (21 taxa, nine of which were exclusively found in this microhabitat); and in guano 10 fungal taxa (especially Aspergillus and Penicillium) were found. The fungal richness associated with guano (fresh and non-fresh) was similar from bats with different eating habits (insectivorous, frugivorous, and haematophagous). Sampling effort was not sufficient to reveal the total fungal taxa richness estimated. Eight (21.6%) of the 37 genera and 17 (53.1%) of the 32 identified fungal species are reported for the first time in caves. Our results highlight bat caves in Brazil as hotspots of fungal diversity, emphasizing the need to protect such special roosts.	[Cunha, Aline O. B.; Oliveira, Thays G. L.; Machado, Alexandre R.; Souza-Motta, Cristina M.] Univ Fed Pernambuco, Ctr Biociencias, Dept Micol Prof Chaves Batista, Recife, PE, Brazil; [Bezerra, Jadson D. P.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Biociencias & Tecnol, Setor Micol, Goiania, Go, Brazil; [Barbier, Eder; Bernard, Enrico] Univ Fed Pernambuco, Ctr Biociencias, Dept Zool, Lab Ciencia Aplicada Conservacao Biodiversidade, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Goias; Universidade Federal de Pernambuco	Souza-Motta, CM (corresponding author), Univ Fed Pernambuco, Ctr Biociencias, Dept Micol Prof Chaves Batista, Recife, PE, Brazil.; Bezerra, JDP (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Biociencias & Tecnol, Setor Micol, Goiania, Go, Brazil.	jadsondpb@gmail.com; cristina.motta@ufbe.br	Bezerra, Jadson DP/A-5846-2019; Barbier, Eder/C-3515-2012	Bezerra, Jadson DP/0000-0002-7782-8602; Barbier, Eder/0000-0001-5068-7048; Souza-Motta, Cristina/0000-0002-0964-8271	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE) [APQ-0143-2.12/15, APQ-0350-2.12/19]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001, 88887.311891/2018-00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Grupo Boticario de Protecao a Natureza; Anglo American; CAPES; FACEPE [88887.353052/201900, 88882.306290/2018-01]; CNPq	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Grupo Boticario de Protecao a Natureza; Anglo American; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE - Finance codes APQ-0143-2.12/15 and APQ-0350-2.12/19) - http://www.facepe.br/, the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Finance code 001; CAPES-PRInt process number 88887.311891/2018-00) -https://www.capes.gov.br/, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - http://cnpq.br/.Funding for fieldwork was also partially provided by the Fundacao Grupo Boticario de Protecao a Natureza http://www.fundacaogrupoboticario.org.br and the Anglo American - https://brasil.angloamerican.com/pt-pt.E.Barbier and J. Bezerra were supported by a postdoctoral grant from CAPES and FACEPE (Process numbers - 88887.353052/201900 and 88882.306290/2018-01, respectively). C.M. Souza-Motta and E. Bernard have a fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, BIOD BRAS AV ID AR A; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Azevedo IS., 2015, REV BRASIKESLEIRA ES, V1, P1; Barbosa RD, 2020, ACTA BOT BRAS, V34, P409, DOI 10.1590/0102-33062019abb0411; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Bezerra JDP, 2017, MYCOL PROG, V16, DOI 10.1007/s11557-016-1254-0; Borda DR, 2014, J CAVE KARST STUD, V76, P114, DOI 10.4311/2013MB0116; Bystriakova N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53104-6; CABI, 2020, CABI INV SPEC COMP; CASIRILLON A L, 1976, Acta Amazonica, V6, P487; CECAV, 2014, CECAV CTR NAC PESQ C; Chagas A, 2018, ZOOKEYS, P13, DOI 10.3897/zookeys.737.20307; Chen YY, 2017, MYCOSPHERE, V8, P103, DOI 10.5943/mycosphere/8/1/9; Crous PW, 2018, PERSOONIA, V41, P238, DOI [10.3767/persoonia.2018.41.12, 10.3767/persoonia.2018.40.10]; da Silva J.M.C., 2017, CAATINGA LARGEST TRO, P359; de Oliveira HFM, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030049; De Paula CCP, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920180583; Delgado-Jaramillo M, 2018, ORYX, V52, P579, DOI 10.1017/S0030605316001186; Fernandez-Cortes A, 2011, ENVIRON SCI POLLUT R, V18, P1037, DOI 10.1007/s11356-011-0513-5; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gonzalez-Martinez S, 2019, EXTREMOPHILES, V23, P557, DOI 10.1007/s00792-019-01107-6; Guimaraes M.M., 2014, VER BRAS ESP, V4, P1; Harris JA, 1971, THESIS; Held BW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234208; Heshmatnia J, 2017, J CLIN IMMUNOL, V37, P342, DOI 10.1007/s10875-017-0395-5; Holz PH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204282; Iskali G, 2015, J CAVE KARST STUD, V77, P28, DOI 10.4311/2013LSC0128; Jiang Jia-Rui, 2017, Mycology-An International Journal On Fungal Biology, V8, P164, DOI 10.1080/21501203.2017.1366370; Johnson LJAN, 2013, APPL ENVIRON MICROB, V79, P5465, DOI 10.1128/AEM.01429-13; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kokurewicz T, 2016, MICROB ECOL, V72, P36, DOI 10.1007/s00248-016-0763-3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ladle RJ, 2012, CONSERV BIOL, V26, P978, DOI 10.1111/j.1523-1739.2012.01936.x; Lewinsohn TM, 2005, CONSERV BIOL, V19, P619, DOI 10.1111/j.1523-1739.2005.00680.x; Lorch JM, 2018, PERSOONIA, V41, P56, DOI 10.3767/persoonia.2018.41.04; Lorch JM, 2013, MYCOLOGIA, V105, P237, DOI 10.3852/12-207; Maia LC, 2014, FUNGOS PARQUE NACL C; Mammola S, 2019, BIOSCIENCE, V69, P641, DOI 10.1093/biosci/biz064; Miller M.A., 2010, P GAT COMP ENV WORKS; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Monro AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190801; Moulds T. A., 2006, THESIS; Nascimento MC., 2020, SOC BRASILEIRA ESTUD; Nieves-Rivera AM, 2009, INT J SPELEOL, V38, P61, DOI 10.5038/1827-806X.38.1.7; Novakova Alena, 2018, Czech Mycology, V70, P101; Novakova A, 2010, MYCOL PROG, V9, P253, DOI 10.1007/s11557-009-0634-0; Nylander JA, 2004, PROGRAM DISTRIBUTED; Ogorek R, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10081337; Ogorek R, 2016, J CAVE KARST STUD, V78, P41, DOI 10.4311/2015MB0108; Ogorek R, 2016, MICROB ECOL, V71, P87, DOI 10.1007/s00248-015-0686-4; Oliveira U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08707-2; Otalora-Ardila A, 2019, ACTA CHIROPTEROL, V21, P411, DOI 10.3161/15081109ACC2019.21.2.016; de Paula CCP, 2016, J CAVE KARST STUD, V78, P208, DOI 10.4311/2016MB0100; Pohl CH, 2007, S AFR J SCI, V103, P277; Poulson TL, 2000, ECOSY WORLD, V30, P231; Prado D.E., 2003, ECOLOGIA CONSERVACA; Rito KF, 2017, J ECOL, V105, P828, DOI 10.1111/1365-2745.12712; Rocha-Silva F, 2014, MED MYCOL CASE REP, V4, P1, DOI 10.1016/j.mmcr.2013.12.002; Sabernasab M, 2019, FOREST SCI, V65, P743, DOI 10.1093/forsci/fxz045; Samson RA, 2009, PERSOONIA, V22, P14, DOI 10.3767/003158509X418925; Sharma L, 2019, 868331 BIORXIV, DOI [10.1101/868331, DOI 10.1101/868331V1]; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Silva J. M. C., 2017, CAATINGA LARGEST TRO, P3, DOI [10.1007/978-3-319-68339-3, DOI 10.1007/978-3-319-68339-3]; Taylor ELS, 2013, INT J SPELEOL, V42, P267, DOI 10.5038/1827-806X.42.3.10; Siqueira Filho JA, 2012, FLORA CAATINGAS RIO; Specht MJ, 2019, J ENVIRON MANAGE, V232, P607, DOI 10.1016/j.jenvman.2018.11.101; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Taboada SG, 1979, MURCIELAGOS CUBA; Tanney JB, 2017, STUD MYCOL, P237, DOI 10.1016/j.simyco.2017.11.001; Taylor ELS, 2014, AMBIENT SCI, V1, P16, DOI 10.21276/ambi.2014.01.1.ra02; da Silva UBT, 2018, BIOL CONSERV, V221, P312, DOI 10.1016/j.biocon.2018.03.028; Vanderwolf KJ, 2013, INT J SPELEOL, V42, P77, DOI 10.5038/1827-806X.42.1.9; Vanderwolf KJ, 2013, NORTHEAST NAT, V20, P115, DOI 10.1656/045.020.0109; Vaughan MJ, 2015, MICROB ECOL, V70, P175, DOI 10.1007/s00248-014-0560-9; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; VILGALYS R, 1994, P NATL ACAD SCI USA, V91, P4599, DOI 10.1073/pnas.91.10.4599; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhang JF, 2017, MYCOSPHERE, V8, P550, DOI 10.5943/mycosphere/8/4/4; Zhang ZF, 2017, PERSOONIA, V39, P1, DOI 10.3767/persoonia.2017.39.01; Zhang ZF, 2021, FUNGAL DIVERS, V106, P29, DOI 10.1007/s13225-020-00453-7; Zhang ZF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01407	81	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243494	10.1371/journal.pone.0243494	http://dx.doi.org/10.1371/journal.pone.0243494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275627	gold, Green Published			2022-12-26	WOS:000597150200032
J	Leonard, CE; Baydyuk, M; Stepler, MA; Burton, DA; Donoghue, MJ				Leonard, Carrie E.; Baydyuk, Maryna; Stepler, Marissa A.; Burton, Denver A.; Donoghue, Maria J.			EphA7 isoforms differentially regulate cortical dendrite development	PLOS ONE			English	Article							TRUNCATED TRKB RECEPTORS; SIGNALING MECHANISMS; TUBEROUS SCLEROSIS; CEREBRAL-CORTEX; VISUAL-CORTEX; EPHRIN-AS; NEURONS; LIGANDS; PROTEIN; MODEL	The shape of a neuron facilitates its functionality within neural circuits. Dendrites integrate incoming signals from axons, receiving excitatory input onto small protrusions called dendritic spines. Therefore, understanding dendritic growth and development is fundamental for discerning neural function. We previously demonstrated that EphA7 receptor signaling during cortical development impacts dendrites in two ways: EphA7 restricts dendritic growth early and promotes dendritic spine formation later. Here, the molecular basis for this shift in EphA7 function is defined. Expression analyses reveal that EphA7 full-length (EphA7-FL) and truncated (EphA7-T1; lacking kinase domain) isoforms are dynamically expressed in the developing cortex. Peak expression of EphA7-FL overlaps with dendritic elaboration around birth, while highest expression of EphA7-T1 coincides with dendritic spine formation in early postnatal life. Overexpression studies in cultured neurons demonstrate that EphA7-FL inhibits both dendritic growth and spine formation, while EphA7-T1 increases spine density. Furthermore, signaling downstream of EphA7 shifts during development, such that in vivo inhibition of mTOR by rapamycin in EphA7-mutant neurons ameliorates dendritic branching, but not dendritic spine phenotypes. Finally, direct interaction between EphA7-FL and EphA7-T1 is demonstrated in cultured cells, which results in reduction of EphA7-FL phosphorylation. In cortex, both isoforms are colocalized to synaptic fractions and both transcripts are expressed together within individual neurons, supporting a model where EphA7-T1 modulates EphA7-FL repulsive signaling during development. Thus, the divergent functions of EphA7 during cortical dendrite development are explained by the presence of two variants of the receptor.	[Leonard, Carrie E.; Baydyuk, Maryna; Stepler, Marissa A.; Burton, Denver A.; Donoghue, Maria J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Leonard, Carrie E.; Donoghue, Maria J.] Georgetown Univ, Interdisciplinary Program Neurosci, Washington, DC 20057 USA; [Leonard, Carrie E.] Univ Maryland, Dept Anim Sci, College Pk, MD 20742 USA; [Stepler, Marissa A.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Burton, Denver A.] MedStar Georgetown Univ Hosp, Dept Orthopaed, Washington, DC USA; [Donoghue, Maria J.] Coll William & Mary, Off Dean Fac Arts & Sci, Williamsburg, VA 23185 USA	Georgetown University; Georgetown University; University System of Maryland; University of Maryland College Park; Jefferson University; Georgetown University; William & Mary	Donoghue, MJ (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.; Donoghue, MJ (corresponding author), Georgetown Univ, Interdisciplinary Program Neurosci, Washington, DC 20057 USA.; Donoghue, MJ (corresponding author), Coll William & Mary, Off Dean Fac Arts & Sci, Williamsburg, VA 23185 USA.	mdvelleca@wm.edu		kraft, denver/0000-0003-1745-997X; Leonard, Carrie/0000-0002-2199-8637				Anderl S, 2011, HUM MOL GENET, V20, P4597, DOI 10.1093/hmg/ddr393; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 1996, SINGAPORE LAW REV, V17, P9; Anton ES, 1996, J NEUROSCI, V16, P2283; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Berry E, 2013, RELIG COMPASS, V7, P454, DOI 10.1111/rec3.12065; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; CIOSSEK T, 1995, ONCOGENE, V10, P97; Ciossek T, 1999, MOL BRAIN RES, V74, P231, DOI 10.1016/S0169-328X(99)00285-5; Clifford MA, 2014, P NATL ACAD SCI USA, V111, P4994, DOI 10.1073/pnas.1323793111; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Eide FF, 1996, J NEUROSCI, V16, P3123; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Glausier JR, 2012, NEUROSCIENCE, DOI [10.1016/n.neuroscience.2012.04.0, DOI 10.1016/N.NEUROSCIENCE.2012.04.0]; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guan M, 2009, INT J CANCER, V124, P88, DOI 10.1002/ijc.23890; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Jordheim H, 2011, CONTRIB HIST CONCEPT, V6, P21, DOI 10.3167/choc.2011.060202; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KOESTER SE, 1992, J NEUROSCI, V12, P1382; Ledda F, 2017, CELL MOL LIFE SCI; Leech JD, 2015, MOL CANCER RES, V13, P548, DOI 10.1158/1541-7786.MCR-14-0178; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Miller K, 2006, J COMP NEUROL, V496, P627, DOI 10.1002/cne.20926; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MORI T, 1995, MOL BRAIN RES, V34, P154, DOI 10.1016/0169-328X(95)00154-K; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; North H a, 2013, CEREB CORTEX; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Phillips M, 2015, NEUROSCI LETT, V601, P30, DOI 10.1016/j.neulet.2015.01.011; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rakic P, 1974, SCIENCE 85, V183; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Rogers JH, 1999, MOL BRAIN RES, V74, P225, DOI 10.1016/S0169-328X(99)00284-3; Sala C, 2008, ACTA NEUROBIOL EXP, V68, P289; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; SHOLL DA, 1953, J ANAT, V87, P387; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; Son AI, 2016, J COMP NEUROL, V524, P2080, DOI 10.1002/cne.23933; Soskis MJ, 2012, NAT NEUROSCI, V15, P1645, DOI 10.1038/nn.3249; Suguitan Jr AL, 2011, PLOS ONE, V6; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Traylor RN, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-17; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Tsai PT, 2018, CELL REP, V25, P357, DOI 10.1016/j.celrep.2018.09.039; Ucuncu M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090464; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; VERCELLI A, 1992, EXP BRAIN RES, V90, P346; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-79; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932	66	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0231561	10.1371/journal.pone.0231561	http://dx.doi.org/10.1371/journal.pone.0231561			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275600	Green Published, gold, Green Submitted			2022-12-26	WOS:000597150200021
J	Hauk, C; Schafermann, S; Martus, P; Muzafarova, N; Babaley, M; Waning, B; Heide, L				Hauk, Cathrin; Schafermann, Simon; Martus, Peter; Muzafarova, Nigorsulton; Babaley, Magali; Waning, Brenda; Heide, Lutz			Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MEDICINES; MARKET; HEALTH	Background Quality-assured medicines are a principal means of achieving health-related Sustainable Development Goals. An example of quality assurance/quality control (QA/QC) procedures in drug procurement is provided by the operation of the Global Drug Facility (GDF) of the Stop TB Partnership, the largest provider of tuberculosis (TB) medicines to the public sector worldwide. Methods Procedures and results of GDF's quality assurance/quality control (QA/QC) over the five-year period 2013-2017 were analysed retrospectively. 13,999 batches of 51 different medicines had been procured and reviewed within this period. 1,388 of these batches had been analysed in the laboratories of GDF's external quality control agent (QCA). Assay and dissolution results determined by the manufacturers and by the external QCA were compared using Bland-Altman analysis. Results All investigated batches of medicines were in specifications at the time of shipment. The costs for QA/QC were 0.8% of purchase costs. The median time required for chemical analysis was 10 working days. Comparison of the medicine quality analysis results showed for the poorly water-soluble compound rifampicin a bias of 4.4%, with the manufacturers reporting higher values than the external QCA, most likely due to different methods employed for the analysis. Overall 95% limits of agreement (LOAs) were -6.7 to +8.0% for assay, and -10.1 to +11.8% for dissolution. In case of kanamycin injections, 95% LOAs for assay reached -14.5 to +13.2%, largely attributable to samples from one manufacturer who had used a microbiological assay while the external QCA had used an HPLC assay. Conclusions GDF's procedures represent a useful benchmark when evaluating QA/QC procedures of other medicine procurement operations. Inter-laboratory comparison using Bland-Altman plots allows to investigate bias and variability in medicine quality control and should be considered as a routine procedure by drug procurement agencies, to identify priorities for further improvements.	[Hauk, Cathrin; Schafermann, Simon; Heide, Lutz] Eberhard Karls Univ Tubingen, Pharmaceut Inst, Tubingen, Germany; [Martus, Peter] Eberhard Karls Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Muzafarova, Nigorsulton; Babaley, Magali; Waning, Brenda] Stop TB Partnership, Global Drug Facil, Geneva, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Heide, L (corresponding author), Eberhard Karls Univ Tubingen, Pharmaceut Inst, Tubingen, Germany.	heide@uni-tuebingen.de			Stop TB Partnership/UNOPS [STBP/USAID/GSA/92954/2017-40]	Stop TB Partnership/UNOPS	This work was supported by Stop TB Partnership/UNOPS grant number STBP/USAID/GSA/92954/2017-40 (to LH, Eberhard Karls University Tubingen). The principal design of this study was part of the grant support agreement.	Abdo-Rabbo A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-28; Ammar HO, 1996, PHARMAZIE, V51, P165; Arinaminpathy N, 2015, B WORLD HEALTH ORGAN, V93, P237, DOI 10.2471/BLT.14.147256; Arinaminpathy N, 2013, LANCET, V382, P1373, DOI 10.1016/S0140-6736(13)60896-X; Becker C, 2009, J PHARM SCI-US, V98, P2252, DOI 10.1002/jps.21624; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Global Drug Facility, 2017, PROCUREMENT NOTICES; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Kaur H, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000409; Kaur H, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0544; Kaur H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125577; Lunte K, 2015, B WORLD HEALTH ORGAN, V93, P279, DOI 10.2471/BLT.14.145920; Management Sciences for Health, 2012, MDS 3 MAN ACC MED HL; Matiru R, 2007, B WORLD HEALTH ORGAN, V85, P348, DOI 10.2471/BLT.06.035402; Moore T, 2012, ASSURING QUALITY ESS; Nwokike J, 2018, B WORLD HEALTH ORGAN, V96, P135, DOI 10.2471/BLT.17.199562; Panchagnula R, 2008, DRUG DEV IND PHARM, V34, P642, DOI [10.1080/03639040701842451, 10.1080/03639040701842451 ]; 't Hoen EF, 2019, B WORLD HEALTH ORGAN, V97, P311; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; van Valen M, 2018, LANCET GLOB HEALTH, V6, pE609, DOI 10.1016/S2214-109X(18)30190-6; Waning B, 2018, UN C PRES GLOB DRUG; WHO, 2017, GLOB TUB REP 2017; WHO Expert Committee on Specifications for Pharmaceutical Preparations, 2014, WHO TECHN REP SER, V986; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO	27	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243428	10.1371/journal.pone.0243428	http://dx.doi.org/10.1371/journal.pone.0243428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270800	gold, Green Published			2022-12-26	WOS:000597149100015
J	Wang, YY; Hussain, SM; Wluka, AE; Lim, YZ; Urquhart, DM; Mishra, GD; Teede, H; Doust, J; Brown, WJ; Cicuttini, FM				Wang, Yuanyuan; Hussain, Sultana Monira; Wluka, Anita E.; Lim, Yuan Z.; Urquhart, Donna M.; Mishra, Gita D.; Teede, Helena; Doust, Jenny; Brown, Wendy J.; Cicuttini, Flavia M.			Rates, costs and determinants of lumbar spine imaging in population-based women born in 1973-1978: Data from the Australian Longitudinal Study on Women's Health	PLOS ONE			English	Article							LOW-BACK-PAIN; PRIMARY-CARE; AMERICAN-COLLEGE; PREVALENCE; MANAGEMENT; PHYSICIANS; ADULTS	Objective There are concerns that lumbar spine imaging represents low value care. Our aim was to examine the use of lumbar spine imaging [radiography, computed tomography (CT), magnetic resonance imaging (MRI)] over 20 years, and costs and person-level characteristics of imaging in a large cohort of Australian women. Methods The Australian Longitudinal Study on Women's Health (ALSWH) is a longitudinal population-based survey of women randomly selected from national health insurance scheme (Medicare) database. This study examined 13458 women born in 1973-1978 who consented to link their ALSWH and Medical Benefits Scheme records. Self-reported data on demographics, body mass index, depression, physical and mental health, and back pain were collected in each survey performed in 1996, 2000, 2003, 2006, 2009, 2012, and 2015. Data on lumbar spine imaging from 1996 to 2015 were obtained from the Medical Benefits Scheme database. Results 38.9% of women underwent some form of lumbar spine imaging over 20 years. While radiography increased from 1996 to 2011 and decreased thereafter, CT and MRI continued to increase from 1996 to 2015. In women with self-reported back pain, depression and poorer physical health were associated with imaging, with no significant differences in types of imaging. Based on imaging rates in ALSWH, the estimated costs for Australian women aged 30-39 years were AU$51,735,649 over 2011-2015. Conclusions Lumbar spine imaging was common in population-based Australian women, with rates increasing over 20 years. Depression and poor physical health were associated with lumbar spine imaging. Raising awareness of this in clinicians is likely to result in significant cost savings if clinical guidelines are followed, with the potential of freeing resources for high value care and health outcomes.	[Wang, Yuanyuan; Hussain, Sultana Monira; Wluka, Anita E.; Lim, Yuan Z.; Urquhart, Donna M.; Cicuttini, Flavia M.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Teede, Helena] Monash Univ, Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Teede, Helena] Monash Hlth, Diabet & Vasc Med Unit, Clayton, Vic, Australia; [Doust, Jenny] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Brown, Wendy J.] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia	Monash University; University of Queensland; Monash University; Bond University; University of Queensland	Cicuttini, FM (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	flavia.cicuttini@monash.edu	Brown, Wendy J/A-1553-2016; Wluka, Anita E/H-5349-2011; Doust, Jenny/AGI-8773-2022	Brown, Wendy J/0000-0001-9093-4509; Wluka, Anita E/0000-0001-8024-9049; Doust, Jenny/0000-0002-4024-9308; Wang, Yuanyuan/0000-0002-7629-4178	Australian Government Department of Health and Ageing; Alfred Foundation; Medical Research Future Fund; National Health and Medical Research Council (NHMRC) [APP1168185, APP1150102]; NHMRC [APP1142198, APP1133903, APP1142809, APP1121844, APP1942516]; Royal Australasian College of Physicians Woolcock Scholarship; Australian Rheumatology Association Top-Up Scholarship; Monash University Postgraduate Excellence Award	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Alfred Foundation; Medical Research Future Fund(Medical Research Future Fund (MRFF)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians Woolcock Scholarship; Australian Rheumatology Association Top-Up Scholarship; Monash University Postgraduate Excellence Award	The Australian Longitudinal Study on Women's Health is funded by the Australian Government Department of Health and Ageing (https://www.health.gov.au/) (GDM). The current linkage study is further supported by the Alfred Foundation (https://www.alfredhealth.org.au/the-alfred-foundation) (FMC, SMH) and Medical Research Future Fund (https://www.health.gov.au/initiatives-and-programs/medical-research-futurefund) (DMU, FMC, HT, GDM). YW and AEW are the recipients of National Health and Medical Research Council (NHMRC, https://www.nhmrc.gov.au/) Translating Research into Practice Fellowship (APP1168185 and APP1150102, respectively). SMH is the recipient of NHMRC Early Career Fellowship (APP1142198). YZL is the recipient of NHMRC Clinical Postgraduate Scholarship (APP1133903), Royal Australasian College of Physicians Woolcock Scholarship, Australian Rheumatology Association Top-Up Scholarship and Monash University Postgraduate ExcellencYe Award. DMU is the recipient of NHMRC Career Development Fellowship (Clinical Level 2, APP1142809). GDM is the recipient of NHMRC Principal Research Fellowship (APP1121844). HT is the recipient of NHMRC Practitioner Fellowship (APP1942516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Clinical Innovation, 2016, MOD CAR MAN PEOPL AC; Aguilar I, 2011, ARCH INTERN MED, V171, P1385, DOI 10.1001/archinternmed.2011.231; [Anonymous], 2013, FIN BUDG 2013 14 BUD; Australian Government Department of Health, 2021, NAT RUR GEN PATHW; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bardin LD, 2017, MED J AUSTRALIA, V206, P268, DOI 10.5694/mja16.00828; Brady SRE, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003368; Brilleman SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-71; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Buchbinder R, 2009, SPINE, V34, P1218, DOI 10.1097/BRS.0b013e318195d688; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Chou L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204885; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2012, RADIOL CLIN N AM, V50, P569, DOI 10.1016/j.rcl.2012.04.005; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Davis Patricia C, 2009, J Am Coll Radiol, V6, P401, DOI 10.1016/j.jacr.2009.02.008; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Downie A, 2019, BRIT J SPORT MED, DOI [10.1136/bjsports-2018-100087, DOI 10.1136/BJSP0RTS-2018-100087]; Enthoven WTM, 2016, PHYS THER, V96, P305, DOI 10.2522/ptj.20140525; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hockey R, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-3; Hoffmann TC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-7; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jenkins HJ, 2016, EUR J PAIN, V20, P573, DOI 10.1002/ejp.764; Jenkins HJ, 2015, CAN MED ASSOC J, V187, P401, DOI 10.1503/cmaj.141183; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; National Institute for Health and Care Excellence (NICE), 2016, LOW BACK PAIN SCIAT; RANZCR Choosing Wisely, 2015, RANZCR CHOOSING WISE; Schneider S, 2006, CLIN J PAIN, V22, P738, DOI 10.1097/01.ajp.0000210920.03289.93; Slade SC, 2016, CLIN J PAIN, V32, P800, DOI 10.1097/AJP.0000000000000324; Tan AL, 2016, J GEN INTERN MED, V31, P156, DOI 10.1007/s11606-015-3475-3; Toward Optimized Practice Low Back Pain Working Group, 2015, EV INF PRIM CAR MAN; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P327, DOI 10.1016/j.jmpt.2004.04.006; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Wisely Choosing . American College of Physicians, 5 THINGS PHYS PAT SH	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243282	10.1371/journal.pone.0243282	http://dx.doi.org/10.1371/journal.pone.0243282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270739	Green Published, gold			2022-12-26	WOS:000597149100138
J	Stefanski, KM; Russell, CM; Westerfield, JM; Lamichhane, R; Barrera, FN				Stefanski, Katherine M.; Russell, Charles M.; Westerfield, Justin M.; Lamichhane, Rajan; Barrera, Francisco N.			PIP2 promotes conformation-specific dimerization of the EphA2 membrane region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; TRYPTOPHAN FLUORESCENCE; EXPRESSION; PROTEINS; BINDING; LIGAND; OVEREXPRESSION; ACTIVATION; STABILITY; EPHRINS	The impact of the EphA2 receptor on cancer malignancy hinges on the two different ways it can be activated. EphA2 induces antioncogenic signaling after ligand binding, but ligand-independent activation of EphA2 is pro-oncogenic. It is believed that the transmembrane (TM) domain of EphA2 adopts two alternate conformations in the ligand-dependent and the ligand-independent states. However, it is poorly understood how the difference in TM helical crossing angles found in the two conformations impacts the activity and regulation of EphA2. We devised a method that uses hydrophobic matching to stabilize two conformations of a peptide comprising the EphA2 TM domain and a portion of the intracellular juxtamembrane (JM) segment. The two conformations exhibit different TM crossing angles, resembling the ligand-dependent and ligand-independent states. We developed a single-molecule technique using styrene maleic acid lipid particles to measure dimerization in membranes. We observed that the signaling lipid PIP2 promotes TM dimerization, but only in the small crossing angle state, which we propose corresponds to the ligand-independent conformation. In this state the two TMs are almost parallel, and the positively charged JM segments are expected to be close to each other, causing electrostatic repulsion. The mechanism PIP2 uses to promote dimerization might involve alleviating this repulsion due to its high density of negative charges. Our data reveal a conformational coupling between the TM and JM regions and suggest that PIP2 might directly exert a regulatory effect on EphA2 activation in cells that is specific to the ligand-independent conformation of the receptor.	[Stefanski, Katherine M.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN USA; [Russell, Charles M.; Westerfield, Justin M.; Lamichhane, Rajan; Barrera, Francisco N.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Lamichhane, R; Barrera, FN (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	rajan@utk.edu; fbarrera@utk.edu			NIH [R01GM120642]; College of Arts and Sciences, University of Tennessee, Knoxville	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Arts and Sciences, University of Tennessee, Knoxville	This work was supported by NIH grant R01GM120642 (F. N. B.) and start-up funds from the College of Arts and Sciences, University of Tennessee, Knoxville (R. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Alves DS, 2018, ELIFE, V7, DOI 10.7554/eLife.36645; Barquilla A, 2016, MOL BIOL CELL, V27, P2757, DOI 10.1091/mbc.E16-01-0048; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; Boettcher JM, 2011, BIOCHEMISTRY-US, V50, P2264, DOI 10.1021/bi1013694; Borthakur S, 2014, J BIOL CHEM, V289, P19694, DOI 10.1074/jbc.M114.567602; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Burck J, 2016, ACCOUNTS CHEM RES, V49, P184, DOI 10.1021/acs.accounts.5b00346; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Chavent M, 2018, STRUCTURE, V26, P1025, DOI 10.1016/j.str.2018.05.003; Chavent M, 2016, STRUCTURE, V24, P337, DOI 10.1016/j.str.2015.11.008; Chen J., 2020, J VIROL, V94; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Gulamhussein AA, 2019, EUR POLYM J, V112, P120, DOI 10.1016/j.eurpolymj.2018.12.008; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; Hedger G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09198; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q; Kucerka N, 2009, BIOPHYS J, V97, P1926, DOI 10.1016/j.bpj.2009.06.050; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lamichhane R, 2010, METHODS, V52, P192, DOI 10.1016/j.ymeth.2010.06.010; Lee HJ, 2012, STRUCTURE, V20, P41, DOI 10.1016/j.str.2011.11.013; Lin YG, 2007, CANCER, V109, P332, DOI 10.1002/cncr.22415; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Nguyen VP, 2019, BIOPHYS J, V117, P659, DOI 10.1016/j.bpj.2019.07.023; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Paraiso KHT, 2015, CANCER DISCOV, V5, P264, DOI 10.1158/2159-8290.CD-14-0293; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Risley M, 2009, MECH DEVELOP, V126, P230, DOI 10.1016/j.mod.2008.10.009; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sharonov GV, 2014, J BIOL CHEM, V289, P14955, DOI 10.1074/jbc.M114.558783; Shi XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45084; Singh DR, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0017-7; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Slochower DR, 2013, J PHYS CHEM B, V117, P8322, DOI 10.1021/jp401414y; Tamagaki H, 2014, BIOCHEMISTRY-US, V53, P5000, DOI 10.1021/bi500327q; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Tinnefeld P, 2011, NATURE, V473, P461, DOI 10.1038/473461a; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Ulmschneider MB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5863; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vargas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092309; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wang ZC, 2019, J PHYS CHEM B, V123, P10709, DOI 10.1021/acs.jpcb.9b09352; Westerfield JM, 2020, J BIOL CHEM, V295, P1792, DOI 10.1074/jbc.REV119.009457; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yokoyama S., 2015, NAT COMMUN, V6, P1; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5; Zhao J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29845-1	66	8	8	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100149	10.1074/jbc.RA120.016423	http://dx.doi.org/10.1074/jbc.RA120.016423			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33277361	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400127
J	Wang, YT; Hou, LM; Ardehali, MB; Kingston, RE; Dynlacht, BD				Wang, Yating; Hou, Liming; Ardehali, M. Behfar; Kingston, Robert E.; Dynlacht, Brian D.			Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ELONGIN; ELONGATION-FACTOR; IDENTIFICATION; DEGRADATION; ACTIVATION; PROTEIN; REPEAT	Elongin is an RNA polymerase II (RNAPII)-associated factor that has been shown to stimulate transcriptional elongation in vitro. The Elongin complex is thought to be required for transcriptional induction in response to cellular stimuli and to ubiquitinate RNAPII in response to DNA damage. Yet, the impact of the Elongin complex on transcription in vivo has not been well studied. Here, we performed comprehensive studies of the role of Elongin A, the largest subunit of the Elongin complex, on RNAPII transcription genome-wide. Our results suggest that Elongin A localizes to actively transcribed regions and potential enhancers, and the level of recruitment correlated with transcription levels. We also identified a large group of factors involved in transcription as Elongin A-associated factors. In addition, we found that loss of Elongin A leads to dramatically reduced levels of serine2-phosphorylated, but not total, RNAPII, and cells depleted of Elongin A show stronger promoter RNAPII pausing, suggesting that Elongin A may be involved in the release of paused RNAPII. Our RNA-seq studies suggest that loss of Elongin A did not alter global transcription, and unlike prior in vitro studies, we did not observe a dramatic impact on RNAPII elongation rates in our cell-based nascent RNA-seq experiments upon Elongin A depletion. Taken together, our studies provide the first comprehensive analysis of the role of Elongin A in regulating transcription in vivo. Our studies also revealed that unlike prior in vitro findings, depletion of Elongin A has little impact on global transcription profiles and transcription elongation in vivo.	[Wang, Yating; Hou, Liming; Dynlacht, Brian D.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ardehali, M. Behfar; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ardehali, M. Behfar; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hou, Liming] Nanjing Agr Univ, Dept Anim Genet Breeding & Reprod, Coll Anim Sci & Technol, Nanjing 210000, Jiangsu, Peoples R China	New York University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanjing Agricultural University	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	Brian.Dvnlacht@nyulangone.org		Ardehali, Behfar/0000-0002-4648-275X; Hou, Liming/0000-0001-9717-125X; Wang, Yating/0000-0002-2030-6176	NIH [5R01GM122395, R01GM043901, R37GM048405, R35GM131743]; Nanjing Agricultural University [060804008]; NYU Grossman School of Medicine; Laura and Isaac Perlmutter Cancer Center Support grant from the National Cancer Institute [P30CA016087]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nanjing Agricultural University; NYU Grossman School of Medicine; Laura and Isaac Perlmutter Cancer Center Support grant from the National Cancer Institute	This work was supported by the NIH grant 5R01GM122395 to B. D. D., NIH grants R01GM043901, R37GM048405, and R35GM131743 to R. E. K. and Nanjing Agricultural University Research Start-up Funding 060804008 to L. H. The mass spectrometric work is supported in part by NYU Grossman School of Medicine and the Laura and Isaac Perlmutter Cancer Center Support grant P30CA016087 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardehali M. B., 2021, J BIOL CHEM, V296; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aso T, 2000, J BIOL CHEM, V275, P6546, DOI 10.1074/jbc.275.9.6546; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fitz J, 2018, EMBO J, V37, DOI 10.15252/embj.201797965; Fong N, 2017, MOL CELL, V66, P546, DOI 10.1016/j.molcel.2017.04.016; Fong N, 2014, GENE DEV, V28, P2663, DOI 10.1101/gad.252106.114; Harlen KM, 2017, NAT REV MOL CELL BIO, V18, P263, DOI 10.1038/nrm.2017.10; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hou LM, 2019, P NATL ACAD SCI USA, V116, P14583, DOI 10.1073/pnas.1904324116; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mayer A, 2017, CURR OPIN CELL BIOL, V46, P72, DOI 10.1016/j.ceb.2017.03.002; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; Yang Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005794; Yasukawa T, 2012, CELL REP, V2, P1129, DOI 10.1016/j.celrep.2012.09.031; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249	35	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100170	10.1074/jbc.RA120.015876	http://dx.doi.org/10.1074/jbc.RA120.015876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33298525	Green Published, gold			2022-12-26	WOS:000672866400148
J	Iqbal, J; Al-Awadhi, M; Ahmad, S				Iqbal, Jamshaid; Al-Awadhi, Mohammad; Ahmad, Suhail			Decreasing trend of imported malaria cases but increasing influx of mixed P. falciparum and P. vivax infections in malaria-free Kuwait	PLOS ONE			English	Article							REGION; INDIA	Malaria still continues to be the most important parasitic disease worldwide, affecting 228 million people and causing 405,000 deaths each year. In this retrospective study during 2013 to 2018, we documented the incidence of imported malaria infection and evaluated the impact of malaria preventive measures in Kuwait, a non-endemic country. The epidemiologic and demographic data of all malaria cases was collected from the Infectious Diseases Hospital, Kuwait where all suspected cases of malaria are referred for confirmation and therapeutic intervention. The diagnosis of malaria infection was done by microscopy of Giemsa stained blood films. Selected samples were retested with BinaxNOW(R) Malaria rapid test and molecular assay to reconfirm the Plasmodium spp. or mixed infection. Overall, 1913 (25.9%) malaria cases were detected, 81.5% of which were among male subjects. Male subjects had higher incidence of P. vivax malaria (113; 91.1%) and mixed infection with P. falciparum and P. vivax (1245; 90.0%) compared to females who had higher rate of P. falciparum infection (52.4%). An overwhelming majority of malaria cases (1895; 99.1%) were detected among expatriates from malaria-endemic countries; India (1012; 52.9%), Pakistan (390; 20.4%), Afghanistan (94; 4.9%) and African countries (313; 16.3%). Only 18 cases involved Kuwaiti nationals, all with a history of travel to African countries. The majority of malaria cases were detected during the summer and fall months (May-October). Our data showed that the incidence rate of imported malaria cases was stable during 2013 to 2018, however, the incidence of total malaria cases showed a declining trend over the years. This study confirms that the preventive program has been successful in reducing the incidence of imported malaria infections in Kuwait. The most striking finding of this study was high incidence of mixed infection with P. falciparum and P. vivax, with almost all (97%) cases among workers from India.	[Iqbal, Jamshaid; Al-Awadhi, Mohammad; Ahmad, Suhail] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait	Kuwait University	Iqbal, J (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait.	jamshaid.rafique@ku.edu.kw	Ahmad, Suhail/AAJ-5456-2021		Research Sector and College of Graduate Studies, Kuwait University, Kuwait [YM 06/14]	Research Sector and College of Graduate Studies, Kuwait University, Kuwait	The financial support for this study was provided by the Research Sector and College of Graduate Studies, Kuwait University, Kuwait under the Research Project YM 06/14. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2018, PATHOG GLOB HEALTH, V112, P57, DOI 10.1080/20477724.2017.1399234; Ahmad S, 2018, EXPERT REV ANTI-INFE, V16, P709, DOI 10.1080/14787210.2018.1519393; Al-Awadhi M, 2020, MED PRIN PRACT, V29, P347, DOI 10.1159/000504625; Al-Kuwari MG, 2009, J TRAVEL MED, V16, P119, DOI 10.1111/j.1708-8305.2008.00285.x; Al-Rumhi A, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05111-6; Alshahrani A M, 2019, Malar Control Elimin, V5, P144, DOI 10.4172/2470-6965/1000144; Alshahrani AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1581-2; Ashley EA, 2019, J INFECT DIS, V220, P100, DOI 10.1093/infdis/jiz052; Bashawri LA, 2001, SAUDI MED J, V22, P133; Bin Dajem SM, 2015, SAUDI MED J, V36, P248, DOI 10.15537/smj.2015.2.10874; Coleman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105980; Dayanand KK, 2019, AM J TROP MED HYG, V100, P275, DOI 10.4269/ajtmh.18-0005; El Hassan IM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0858-1; Farag E, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.050; Guerin PJ, 2019, J VECTOR DIS, V56, P41, DOI 10.4103/0972-9062.257773; Guerra CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10339-1; Gupta B, 2010, TROP MED INT HEALTH, V15, P819, DOI 10.1111/j.1365-3156.2010.02549.x; Haanshuus CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158816; Soliman RH, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2438-7; Hawash Y, 2019, KOREAN J PARASITOL, V57, P233, DOI 10.3347/kjp.2019.57.3.233; Iqbal J, 2003, J TRAVEL MED, V10, P324, DOI 10.2310/7060.2003.9291; Ismaeel AY, 2004, J TRAVEL MED, V11, P97, DOI 10.2310/7060.2004.17059; Lee RA, 2020, P NATL ACAD SCI USA, V117, P25722, DOI 10.1073/pnas.2010196117; Loutan L, 2003, INT J ANTIMICROB AG, V21, P158, DOI 10.1016/S0924-8579(02)00367-9; Ramirez AM, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03326-1; Mischlinger J, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00104-19; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; National Vector Borne Disease Control Program/Ministry of Health and Family Welfare Government of India, 2020, MAL REP 2020; Nilles EJ, 2014, J TRAVEL MED, V21, P201, DOI 10.1111/jtm.12110; Norman FF, 2020, FUTURE MICROBIOL, V15, P213, DOI 10.2217/fmb-2019-0212; Ota-Sullivan K, 2013, J CLIN MICROBIOL, V51, P1567, DOI 10.1128/JCM.00293-13; Punnath K, 2020, PARASITOL RES, V119, P1043, DOI 10.1007/s00436-019-06540-2; Simon B, 2017, PARASITE, V24, DOI 10.1051/parasite/2017028; Siwal N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193046; Snow RW, 2013, ADV PARASIT, V82, P205, DOI 10.1016/B978-0-12-407706-5.00003-4; Swan H, 2005, AM J TROP MED HYG, V73, P850, DOI 10.4269/ajtmh.2005.73.850; The Public Authority for Civil Information, 2019, 2019 STAT REP; World Health Organization, 2003, WORLD MALARIA REPORT	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243617	10.1371/journal.pone.0243617	http://dx.doi.org/10.1371/journal.pone.0243617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306727	gold, Green Published			2022-12-26	WOS:000600144200011
J	El-Menyar, A; Mekkodathil, A; Asim, M; Consunji, R; Strandvik, G; Peralta, R; Rizoli, S; Abdelrahman, H; Mollazehi, M; Parchani, A; Al-Thani, H				El-Menyar, Ayman; Mekkodathil, Ahammad; Asim, Mohammad; Consunji, Rafael; Strandvik, Gustav; Peralta, Ruben; Rizoli, Sandro; Abdelrahman, Husham; Mollazehi, Monira; Parchani, Ashok; Al-Thani, Hassan			Maturation process and international accreditation of trauma system in a rapidly developing country	PLOS ONE			English	Article							OUTCOMES	Background As trauma systems mature, they are expected to improve patient care, reduce in-hospital complications and optimize outcomes. Qatar has a single trauma center, at the Hamad General Hospital, which serves as the hub for the trauma system that was verified as a level 1 trauma system by the Accreditation Canada International Distinction program in 2014. We hypothesized that this international accreditation was a major step, in the maturation process of the Qatar trauma system, that has positively impacted patient care, reduced complications and improved outcomes of trauma patients in such a rapidly developing country. Methods A retrospective analysis of data was conducted for all trauma patients who were admitted between 2010 and 2018. Data were obtained from the level 1 trauma center registry at Hamad Medical Corporation. Patients were divided into Group 1- pre-accreditation (admitted from January 2010 to October 2014) and Group 2- post-accreditation (admitted from November 2014 to December 2018). Patients' characteristics and in-hospital outcomes were analyzed and compared. Data included patients' demographics; injury types, mechanism and injury severity scores, interventions, hospital stay, complications and mortality (pre-hospital and in-hospital). Time series analysis for mortality was performed using expert modeler. Results Data from a total of 15,864 patients was collected and analyzed. Group 2 patients had more severe injuries in comparison to Group 1 (p<0.05). However, Group 2, had a lower complication rate (ventilator associated pneumonia (VAP)) and a shorter mean hospital length of stay (p<0.05). The overall mortality was 8%. In Group 2; the pre-hospital mortality was higher (52% vs. 41%, p = 0.001), while in-hospital mortality was lower (48% vs. 59%) compared to Group 1 (p = 0.001). Conclusions The international recognition and accreditation of the trauma center in 2014 was the key factor in the maturation of the trauma system that improved the in-hospital outcomes. Accreditation also brought other benefits including a reduction in VAP and hospital length of stay. However, further studies are required to explore the maturation process of all individual components of the trauma system including the prehospital setting.	[El-Menyar, Ayman] Weill Cornell Med Coll, Clin Med, Doha, Qatar; [El-Menyar, Ayman; Mekkodathil, Ahammad; Asim, Mohammad] Hamad Gen Hosp, Trauma Surg, Clin Res, Doha, Qatar; [Consunji, Rafael] Hamad Gen Hosp, Trauma Surg, Injury Prevent Program, Doha, Qatar; [Strandvik, Gustav; Peralta, Ruben; Rizoli, Sandro; Abdelrahman, Husham; Parchani, Ashok; Al-Thani, Hassan] Hamad Gen Hosp, Trauma Surg, Doha, Qatar; [Mollazehi, Monira] Hamad Gen Hosp, Qatar Trauma Registry, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Hamad General Hospital; Hamad Medical Corporation; Hamad General Hospital; Hamad Medical Corporation; Hamad General Hospital; Hamad Medical Corporation; Hamad General Hospital	El-Menyar, A (corresponding author), Weill Cornell Med Coll, Clin Med, Doha, Qatar.; El-Menyar, A (corresponding author), Hamad Gen Hosp, Trauma Surg, Clin Res, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Peralta, Ruben/0000-0003-2817-0194				Accreditation Canada Trauma Distinction Information Package, 2014, TRAUM DIST INF PACK; Al-Thani H, 2019, J EMERG TRAUMA SHOCK, V12, P209, DOI 10.4103/JETS.JETS_56_19; Al-Thani Hassan, 2017, Air Med J, V36, P188, DOI 10.1016/j.amj.2017.03.003; [Anonymous], QAT MDPS; [Anonymous], QAT NUMB REG MOT VEH; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Arbabi S, 2003, ARCH SURG-CHICAGO, V138, P47, DOI 10.1001/archsurg.138.1.47; Barquist E, 2000, J TRAUMA, V49, P63, DOI 10.1097/00005373-200007000-00009; Committee on Trauma American College of Surgeons, 2014, RESOURCES OPTIMAL CA; Harmsen AMK, 2017, EUR J TRAUMA EMERG S, V43, P685, DOI 10.1007/s00068-016-0722-1; Kinney E. P., 2015, J HOSP ADM, V4, P1, DOI [10.5430/jha.v4n5p1, DOI 10.5430/JHA.V4N5P1]; Lansink KWW, 2013, WORLD J SURG, V37, P2353, DOI 10.1007/s00268-013-2103-9; Lanzarotti S, 2003, AM SURGEON, V69, P766; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Peitzman AB, 1999, ANN SURG, V230, P87, DOI 10.1097/00000658-199907000-00013; Pigneri DA, 2017, SURG CLIN N AM, V97, P947, DOI 10.1016/j.suc.2017.06.011; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Raeeszadeh M, 2018, ARCH TRAUMA RES, V7, P102, DOI 10.4103/atr.atr_48_18; WHO, PROJ MORT CAUS DEATH	19	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243658	10.1371/journal.pone.0243658	http://dx.doi.org/10.1371/journal.pone.0243658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301481	gold, Green Published			2022-12-26	WOS:000600143100076
J	Fraeulin, L; Holzgreve, F; Brinkbaumer, M; Dziuba, A; Friebe, D; Klemz, S; Schmitt, M; Theis, AAL; Tenberg, S; van Mark, A; Maurer-Grubinger, C; Ohlendorf, D				Fraeulin, Laura; Holzgreve, Fabian; Brinkbaeumer, Mark; Dziuba, Anna; Friebe, David; Klemz, Stefanie; Schmitt, Marco; Theis, Anna-Lena A.; Tenberg, Sarah; van Mark, Anke; Maurer-Grubinger, Christian; Ohlendorf, Daniela			Intra- and inter-rater reliability of joint range of motion tests using tape measure, digital inclinometer and inertial motion capturing	PLOS ONE			English	Article							LUMBAR SPINE; CLINICAL MEASUREMENT; CONCURRENT VALIDITY; SHOULDER; HIP; MOBILITY; REPRODUCIBILITY; FLEXIBILITY; SYSTEM; RESPONSIVENESS	Background In clinical practice range of motion (RoM) is usually assessed with low-cost devices such as a tape measure (TM) or a digital inclinometer (DI). However, the intra- and inter-rater reliability of typical RoM tests differ, which impairs the evaluation of therapy progress. More objective and reliable kinematic data can be obtained with the inertial motion capture system (IMC) by Xsens. The aim of this study was to obtain the intra- and inter-rater reliability of the TM, DI and IMC methods in five RoM tests: modified Thomas test (DI), shoulder test modified after Janda (DI), retroflexion of the trunk modified after Janda (DI), lateral inclination (TM) and fingertip-to-floor test (TM). Methods Two raters executed the RoM tests (TM or DI) in a randomized order on 22 healthy individuals while, simultaneously, the IMC data (Xsens MVN) was collected. After 15 warm-up repetitions, each rater recorded five measurements. Findings Intra-rater reliabilities were (almost) perfect for tests in all three devices (ICCs 0.886-0.996). Inter-rater reliability was substantial to (almost) perfect in the DI (ICCs 0.71-0.87) and the IMC methods (ICCs 0.61-0.993) and (almost) perfect in the TM methods (ICCs 0.923-0.961). The measurement error (ME) for the tests measured in degree (degrees) was 0.9-3.3 degrees for the DI methods and 0.5-1.2 degrees for the IMC approaches. In the tests measured in centimeters the ME was 0.5-1.3cm for the TM methods and 0.6-2.7cm for the IMC methods. Pearson correlations between the results of the DI or the TM respectively with the IMC results were significant in all tests except for the shoulder test on the right body side (r = 0.41-0.81). Interpretation Measurement repetitions of either one or multiple trained raters can be considered reliable in all three devices.	[Fraeulin, Laura; Holzgreve, Fabian; van Mark, Anke; Maurer-Grubinger, Christian; Ohlendorf, Daniela] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Brinkbaeumer, Mark; Dziuba, Anna; Friebe, David; Klemz, Stefanie; Schmitt, Marco; Theis, Anna-Lena A.; Tenberg, Sarah] Goethe Univ Frankfurt, Inst Sports Sci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Fraeulin, L (corresponding author), Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.	fraeulin@med.uni-frankfurt.de	Maurer, Christian/AAS-9688-2020; Holzgreve, Fabian/ABA-7388-2020	Maurer, Christian/0000-0002-8426-813X; Holzgreve, Fabian/0000-0002-1115-131X; Maltry, Laura/0000-0001-5214-5963; Dziuba, Anna/0000-0002-8151-4622				Al-Amri M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030719; ALARANTA H, 1994, SCAND J REHABIL MED, V26, P147; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2000, NAT BIOTECHNOL, V18, pIT18; Bierma-Zeinstra SMA, 1998, CLIN REHABIL, V12, P497, DOI 10.1191/026921598677459668; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bland JM, 1996, BRIT MED J, V313, P744; BOONE DC, 1978, PHYS THER, V58, P1355, DOI 10.1093/ptj/58.11.1355; Boyce David, 2008, Physiotherapy Theory and Practice, V24, P113, DOI 10.1080/09593980701378298; BURDETT RG, 1986, PHYS THER, V66, P677, DOI 10.1093/ptj/66.5.677; Chen SPC, 1997, J OCCUP ENVIRON MED, V39, P217, DOI 10.1097/00043764-199703000-00011; Clapis Phyllis A., 2008, Physiotherapy Theory and Practice, V24, P135, DOI 10.1080/09593980701378256; Clarkson HM, 2005, JOINT MOTION FUNCTIO; Cloete T, 2010, IEEE ENG MED BIO, P5125, DOI 10.1109/IEMBS.2010.5626196; de Winter AF, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-18; Dogan M, 2019, GAIT POSTURE, V70, P141, DOI 10.1016/j.gaitpost.2019.02.024; Ekedahl H, 2012, ARCH PHYS MED REHAB, V93, P2210, DOI 10.1016/j.apmr.2012.04.020; Evans JD., 1996, STRAIGHTFORWARD STAT; FITZGERALD GK, 1983, PHYS THER, V63, P1776, DOI 10.1093/ptj/63.11.1776; FROST M, 1982, PHYS THER, V62, P1431, DOI 10.1093/ptj/62.10.1431; GAUVIN MG, 1990, PHYS THER, V70, P443, DOI 10.1093/ptj/70.7.443; GILL K, 1988, SPINE, V13, P50, DOI 10.1097/00007632-198801000-00012; Grabe M., 2014, MEASUREMENT UNCERTAI, DOI 10.1007/978-3-319-04888-8; Green S, 1998, ARTHRIT CARE RES, V11, P43, DOI 10.1002/art.1790110108; Hatano G, 2019, J SPORT REHABIL, V28, P325, DOI 10.1123/jsr.2017-0203; Heikkila S, 2000, J RHEUMATOL, V27, P1251; Holzgreve F, 2018, J OCCUP MED TOXICOL, V13, DOI 10.1186/s12995-018-0220-y; Hoving JL, 2002, ANN RHEUM DIS, V61, P612, DOI 10.1136/ard.61.7.612; HYYTIAINEN K, 1991, SCAND J REHABIL MED, V23, P3; Inokuchi H, 2015, EUR SPINE J, V24, P2807, DOI 10.1007/s00586-015-3913-2; JONSSON E, 1990, UPSALA J MED SCI, V95, P75, DOI 10.3109/03009739009178578; Karatsidis A, 2019, MED ENG PHYS, V65, P68, DOI 10.1016/j.medengphy.2018.12.021; Keogh JWL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215806; KIPPERS V, 1987, PHYS THER, V67, P1680, DOI 10.1093/ptj/67.11.1680; Kolber Morey J., 2009, Physiotherapy Theory and Practice, V25, P572, DOI 10.3109/09593980802667995; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mavor MP, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20154280; MELLIN G, 1991, SPINE, V16, P1108, DOI 10.1097/00007632-199109000-00016; MERRITT JL, 1986, MAYO CLIN PROC, V61, P192, DOI 10.1016/S0025-6196(12)61848-5; Mundt M, 2019, J BIOMECH, V84, P81, DOI 10.1016/j.jbiomech.2018.12.023; Ng JKF, 2001, SPINE, V26, P53, DOI 10.1097/00007632-200101010-00011; Nguyen, 1999, HDB TIME SERIES ANAL; Nuesch C, 2017, J BIOMECH, V57, P32, DOI 10.1016/j.jbiomech.2017.03.015; Perret C, 2001, ARCH PHYS MED REHAB, V82, P1566, DOI 10.1053/apmr.2001.26064; PETHERICK M, 1988, PHYS THER, V68, P966, DOI 10.1093/ptj/68.6.966; PORTEK I, 1983, BRIT J RHEUMATOL, V22, P197; Rigoni M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081781; Roach S, 2013, INT J SPORTS PHYS TH, V8, P680; Roach SM, 2015, INT J SPORTS PHYS TH, V10, P13; Robert-Lachaine X, 2017, MED BIOL ENG COMPUT, V55, P609, DOI 10.1007/s11517-016-1537-2; s NA, 2018, LANCET INFECT DIS, V18, pe228; Saur PMM, 1996, SPINE, V21, P1332, DOI 10.1097/00007632-199606010-00011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smolenski U, 2016, JANDA MANUELLE MUSKE; Strand LI, 2011, PHYS THER, V91, P404, DOI 10.2522/ptj.20100016; Uswr PT, 2015, RELIABILITY BUBBLE I; Valentine RE, 2006, ARCH PHYS MED REHAB, V87, P1242, DOI 10.1016/j.apmr.2006.05.008; van der Straaten R, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010141; Vigotsky AD, 2016, PEERJ, V4, DOI 10.7717/peerj.2325; Zhang JT, 2013, PHYSIOL MEAS, V34, pN63, DOI 10.1088/0967-3334/34/8/N63	60	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243646	10.1371/journal.pone.0243646	http://dx.doi.org/10.1371/journal.pone.0243646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301541	Green Published, gold			2022-12-26	WOS:000600143100057
J	Tineo, D; Bustamante, DE; Calderon, MS; Mendoza, JE; Huaman, E; Oliva, M				Tineo, Daniel; Bustamante, Danilo E.; Calderon, Martha S.; Mendoza, Jani E.; Huaman, Eyner; Oliva, Manuel			An integrative approach reveals five new species of highland papayas (Caricaceae, Vasconcellea) from northern Peru	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; PHYLOGENETIC ANALYSIS; DELIMITATION; DIVERSITY; CHLOROPLAST; RHODOPHYTA; RELATIVES; PATTERNS; TAXONOMY; CLADE	The assignment of accurate species names is crucial, especially for those with confirmed agronomic potential such as highland papayas. The use of additional methodologies and data sets is recommended to establish well-supported boundaries among species of Vasconcellea. Accordingly, six chloroplast (trnL-trnF, rpl20-rps12, psbA-trnH intergenic spacers, matK and rbcL genes) and nuclear (ITS) markers were used to delimit species in the genus Vasconcellea using phylogeny and four DNA-based methods. Our results demonstrated congruence among different methodologies applied in this integrative study (i.e., morphology, multilocus phylogeny, genetic distance, coalescence methods). Genetic distance (ABGD, SPN), a coalescence method (BPP), and the multilocus phylogeny supported 22-25 different species of Vasconcellea, including the following five new species from northern Peru: V. badilloi sp. nov., V. carvalhoae sp. nov., V. chachapoyensis sp. nov., V. pentalobis sp. nov., and V. peruviensis sp. nov. Genetic markers that gave better resolution for distinguishing species were ITS and trnL-trnF. Phylogenetic diversity and DNA-species delimitation methods could be used to discover taxa within traditionally defined species.	[Tineo, Daniel; Bustamante, Danilo E.; Calderon, Martha S.; Mendoza, Jani E.; Huaman, Eyner; Oliva, Manuel] Univ Nacl Toribio Rodriguez Mendoza, Inst Invest Desarrollo Sustentable Ceja Selva IND, Chachapoyas, Amazonas, Brazil		Bustamante, DE (corresponding author), Univ Nacl Toribio Rodriguez Mendoza, Inst Invest Desarrollo Sustentable Ceja Selva IND, Chachapoyas, Amazonas, Brazil.	danilo.bustamante@untrm.edu.pe	Bustamante, Danilo E./A-8619-2012; Huaman, Eyner/AAH-1259-2021	Bustamante, Danilo E./0000-0002-5979-6993; Huaman, Eyner/0000-0002-3772-5334; Tineo Flores, Daniel/0000-0001-5263-6316; OLIVA CRUZ, SEGUNDO MANUEL/0000-0002-9670-0970; Mendoza Merino, Jani Elisabet/0000-0001-8324-039X	INDES-CES/UNTRM throughout Project SNIP [312252, 352431]	INDES-CES/UNTRM throughout Project SNIP	This research was funded by INDES-CES/UNTRM throughout Project SNIP No 312252 "FISIOVEG" and Project SNIP No 352431 "PROCICEA". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Aradhya MK, 1999, GENET RESOUR CROP EV, V46, P579, DOI 10.1023/A:1008786531609; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BADILLO V M, 1967, Agronomia Tropical (Maracay), V17, P245; Badillo V. M., 1993, REV FAC AGRON UCV, V43, P1; Badillo Victor M., 2000, Ernstia, V10, P74; Badillo VM, 1971, MONOGRAFIA FAMILIA C; Bustamante DE, 2020, MITOCHONDRIAL DNA B, V5, P1327, DOI 10.1080/23802359.2020.1734494; Bustamante DE, 2019, MYCOKEYS, P47, DOI 10.3897/mycokeys.58.35764; Carrasco B, 2009, GENET RESOUR CROP EV, V56, P331, DOI 10.1007/s10722-008-9367-1; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carvalho FA, 2015, MOL PHYLOGENY BIOGEO; Carvalho FA, 2013, E MONOGRAPH CARICACE; Carvalho FA, 2012, MOL PHYLOGENET EVOL, V65, P46, DOI 10.1016/j.ympev.2012.05.019; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; d'Eeckenbrugge GC, 2014, PLANT GENETICS GENOM, P47, DOI DOI 10.1007/978-1-4614-8087-7_; de Candolle A.L.P.P., 1864, PRODROMUS SYSTEMATIS, V16; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Goldstein PZ, 2000, CONSERV BIOL, V14, P120, DOI 10.1046/j.1523-1739.2000.98122.x; Gonzalez SL, 2015, ARNALDOA, V20, P315; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; JobinDecor MP, 1997, GENET RESOUR CROP EV, V44, P471, DOI 10.1023/A:1008644901727; Kyndt T, 2006, GENOME, V49, P786, DOI 10.1139/G06-035; Kyndt T, 2005, MOL PHYLOGENET EVOL, V37, P442, DOI 10.1016/j.ympev.2005.06.017; Kyndt T, 2005, AM J BOT, V92, P1033, DOI 10.3732/ajb.92.6.1033; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Liu F, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0649-5; Liu SL, 2015, EUR J PHYCOL, V50, P439, DOI 10.1080/09670262.2015.1076892; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Luo A, 2018, SYST BIOL, V67, P830, DOI 10.1093/sysbio/syy011; Olson ME, 2002, INT J PLANT SCI, V163, P51, DOI 10.1086/324046; Pavan AC, 2016, MOL PHYLOGENET EVOL, V103, P184, DOI 10.1016/j.ympev.2016.07.011; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pentinsaari M, 2017, MOL ECOL RESOUR, V17, P393, DOI 10.1111/1755-0998.12557; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rannala B, 2003, GENETICS, V164, P1645; Renner MAM, 2017, MOL PHYLOGENET EVOL, V107, P576, DOI 10.1016/j.ympev.2016.12.018; Restrepo M. T., 2005, Proceedings of the Interamerican Society for Tropical Horticulture, V48, P119; Scheldeman X, 2007, BIODIVERS CONSERV, V16, P1867, DOI 10.1007/s10531-006-9086-x; Scheldeman X, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - TROPICAL AND SUBTROPICAL FRUITS, P213, DOI 10.1007/978-3-642-20447-0_11; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stevison L, 2008, NAT ED, V1, P111; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Sun P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21695; Surveswaran S, 2018, MOL PHYLOGENET EVOL, V124, P106, DOI 10.1016/j.ympev.2018.02.025; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiers B, 2020, INDEX HERBARIORUM GL; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulloa CU, 2004, 10 ANOS ADICIONES FL; Van Droogenbroeck B, 2002, THEOR APPL GENET, V105, P289, DOI 10.1007/s00122-002-0983-4; Van Droogenbroeck B, 2006, ANN BOT-LONDON, V97, P793, DOI 10.1093/aob/mcl038; WCSP, 2019, WORLD CHECKL SEL PLA; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071; 2019, CAN J KIDNEY HLTH DI, V6, P1	59	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242469	10.1371/journal.pone.0242469	http://dx.doi.org/10.1371/journal.pone.0242469			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301452	Green Published, gold			2022-12-26	WOS:000600143100034
J	Jacobs, ML; Martill, DM				Jacobs, Megan L.; Martill, David M.			A new ophthalmosaurid ichthyosaur from the Upper Jurassic (Early Tithonian) Kimmeridge Clay of Dorset, UK, with implications for Late Jurassic ichthyosaur diversity	PLOS ONE			English	Article							CAYPULLISAURUS ICHTHYOSAURIA; NEUQUEN BASIN; GENUS; STRATIGRAPHY; BOREHOLES; POSITION; FOREFIN; REMAINS; BANDS	A new ophthalmosaurid ichthyosaur, Thalassodraco etchesi gen. et sp. nov., from the Upper Jurassic Kimmeridge Clay Formation of Dorset, UK is described. The specimen, a partial, articulated skull and anterior thorax in the Etches Collection of Kimmeridge, Dorset, is exceptionally well preserved on a slab of laminated coccolith limestone and has been expertly prepared. It comprises a near complete skull in articulation with associated anterior vertebral column and dorsal ribs, complete pectoral girdle, fully exposed left forelimb, and some elements of the right forelimb. Other elements present, including an ischiopubis are preserved on separate slabs. Presumed rapid burial of the anterior portion of the specimen in the coccolith substrate has preserved a number of ossified ligaments lying across the vertebral column and associated ribs as well as stomach contents and decayed internal organs. Aspects of the dentition, skull roof bones and the forelimb configuration distinguishes the new specimen from previously described Late Jurassic ichthyosaurs. Autopmorphies for T. etchesi include a large rounded protuberance on the supratemporal bone; a thin L-shaped lachrymal, with a steeply curved posterior border; similar to 70 teeth on the upper tooth row, and deep anterior dorsal ribs. A well resolved phylogenetic analysis shows T. etchesi as a member of a basal clade within Ophthalmosauridae comprising Nannopterygius, Gengasaurus, Paraophthalmosaurus and Thalassodraco. The new specimen adds to the diversity of the Ichthyopterygia of the Kimmeridge Clay Formation and emphasises the important contribution of amateur collectors in palaeontology.	[Jacobs, Megan L.; Martill, David M.] Univ Portsmouth, Sch Environm Geog & Geosci, Portsmouth, Hants, England; [Jacobs, Megan L.] Baylor Univ, Dept Geosci, Waco, TX 76798 USA	University of Portsmouth; Baylor University	Jacobs, ML (corresponding author), Univ Portsmouth, Sch Environm Geog & Geosci, Portsmouth, Hants, England.; Jacobs, ML (corresponding author), Baylor Univ, Dept Geosci, Waco, TX 76798 USA.	meganj673@hotmail.co.uk		Martill, David/0000-0002-3208-5702; Jacobs, Megan/0000-0003-2674-9477	University of Portsmouth	University of Portsmouth	We thank Sandra Chapman and Susie Maidment for access to the NHM collections, Etches Collection staff for access to the collections in their care. We thank Dr Steve Etches for the offer to study the specimen, and his help and discussion throughout the project. I would also like to thank twoanonymous reviewers and Nikolay Zverkov for their comments which improved the manuscript significantly. We also thank the University of Portsmouth for supporting this study.	Andrews C.W, 1910, DESCRIPTIVE CATALOGU; Andrews C. W., 1913, DESCRIPTIVE CATALO 2; [Anonymous], 1996, UK GEOL SOC LOND SPE, DOI DOI 10.1144/GSL.SP.1996.103.01.06; [Anonymous], 1997, COOK REP INTERNET PR, V6, P1; APPLEBY R. M., 1956, PROC ZOOL SOC LONDON, V126, P403; Arkhangelsky MS, 2008, PALEONTOL J+, V42, P287, DOI 10.1134/S0031030108030106; Arkhangelsky MS, 2018, PALEONTOL J+, V52, P49, DOI 10.1134/S0031030118010033; Arkhangelsky MS, 2020, PALAEOBIO PALAEOENV, V100, P197, DOI 10.1007/s12549-019-00397-0; Arkhangelsky MS., 2001, PALEONTOL J, V35, P629; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1992, TERRA NOVA, V4, P649, DOI 10.1111/j.1365-3121.1992.tb00614.x; Baur G., 1887, American Naturalist, Vxxi, P837; Benton M.J., 1995, FOSSIL REPTILES GREA; Boulenger, 1904, P ZOOL SOC LOND, V1, P424; Broili Ferdinand, 1907, Palaeontographica Stuttgart, V54; Buchy MC, 2010, J PALEONTOL, V84, P149; Cope JCW, 2015, P GEOLOGIST ASSOC, V126, P100, DOI 10.1016/j.pgeola.2014.10.008; Cox B.M., 1981, I GEOLOGICAL SCI REP, P1; DAMBORENEA SE, 1979, PALAEOGEOGR PALAEOCL, V27, P85, DOI 10.1016/0031-0182(79)90095-6; De Blainville H.D., 1835, NOUV ANN MUS HIST NA, V4, P233; de la Beche HT., 1821, T GEOLOGICAL SOC LON, V1, P559, DOI [10.1144/transgsla.5.559, DOI 10.1144/TRANSGSLA.5.559]; Delsett LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169971; Druckenmiller PS, 2012, NORW J GEOL, V92, P311; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Efimov, 1999, PALEONTOL J, V33, P174; Etches S, 1999, S ETCHES KIMMERIDGE; Etches S, 2010, LIFE JURASSIC SEAS A; Etches S, 2009, LETHAIA, V42, P204, DOI 10.1111/j.1502-3931.2008.00133.x; Fernandez M, 2007, J PALEONTOL, V81, P368, DOI 10.1666/0022-3360(2007)81[368:RAPPOC]2.0.CO;2; Fernandez MS, 2012, GEOBIOS-LYON, V45, P535, DOI 10.1016/j.geobios.2012.02.001; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fernandez MS, 2001, J VERTEBR PALEONTOL, V21, P515, DOI 10.1671/0272-4634(2001)021[0515:DOVHOT]2.0.CO;2; Fischer V, 2011, CRETACEOUS RES, V32, P155, DOI 10.1016/j.cretres.2010.11.005; Fischer V, 2016, PEERJ, V4, DOI 10.7717/peerj.2604; Fischer V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10825; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Foffa D, 2018, ACTA PALAEONTOL POL, V63, P287, DOI 10.4202/app.00455.2018; Gale A, 2019, P GEOLOGIST ASSOC, V130, P355, DOI 10.1016/j.pgeola.2018.01.005; Gallois R, 2000, P GEOLOGIST ASSOC, V111, P265, DOI 10.1016/S0016-7878(00)80019-X; Gallois R, 2001, P GEOLOGIST ASSOC, V112, P169, DOI 10.1016/S0016-7878(01)80025-0; GALLOIS RW, 1979, GEOL MAG, V116, P247, DOI 10.1017/S0016756800043740; Gasparini Z., 1992, World and Regional Geology, V3, P361; Gasparini Z, 2006, NEUES JAHRB GEOL P-A, V240, P343; Gasparini Zulma, 1993, Ameghiniana, V30, P245; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gutarra S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2786; HALLAM A, 1985, J GEOL SOC LONDON, V142, P433, DOI 10.1144/gsjgs.142.3.0433; Hallam A, 1965, GEOLOGY SCOTLAND, V2, DOI [10.1016/0022-3956(65)90012-9, DOI 10.1016/0022-3956(65)90012-914302767]; Hallam A., 1987, MARINE PETROLEUM SOU, V26, P251; Hallam A, 1992, GEOLOGY ENGLAND WALE, P325; Home E, 1832, PHILOS T ROY SOC LON, P571; Huene F, 1927, GEOLOGIE PALAONTOLOG, P22; Huene F, ICHTHYOSAURIER LIAS; Hulke JW, 1870, Q J GEOLOGICAL SOC, V26, P172; Hulke JW, 1870, Q J GEOLOGICAL SOC, V27, P440; Iaonnides NS, 1976, MICROPALEONTOLOGY, V22, P443; Kuhn O., 1946, Ber naturf Ges Ramburg, V29, P69; Leanza H., 1990, Facies, V22, P169, DOI 10.1007/BF02536951; Lee S, 2018, INT SOC DESIGN CONF, P80, DOI 10.1109/ISOCC.2018.8649902; Lees JA, 2004, MAR MICROPALEONTOL, V52, P29, DOI 10.1016/j.marmicro.2004.04.005; Maddison W.P., 2019, MESQUITE MODULAR SYS; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch Michael W., 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V7, P425; Martill D. M., 1993, KAUPIA DARMSTADTER B, V2, P11; Martill D.M., 2006, ACTAS 3 JORNADAS INT, P35; Martill DM, 2013, ACTA PALAEONTOL POL, V58, P285, DOI 10.4202/app.2011.0071; MARTILL DM, 1987, PALAEONTOLOGY, V30, P543; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 2005, Paludicola, V5, P20; Massare Judy A., 2006, Paludicola, V5, P242; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2016, PAP PALAEONTOL, V2, P59, DOI 10.1002/spp2.1030; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; McCoy F, 1867, T P ROYAL SOC VICTOR, V8, P41; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; McGowan C, 2003, HDB PALEOHERPETOLOGY, V8, P175; Moon BC, 2019, J SYST PALAEONTOL, V17, P129, DOI 10.1080/14772019.2017.1394922; Moon Benjamin C., 2016, Monograph of the Palaeontographical Society, V170, P1; Morgans-Bell HS, 2001, GEOL MAG, V138, P511, DOI 10.1017/S0016756801005738; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani R, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0241; Motani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088640; Nace RL, 1939, AM J SCI, V237, P673, DOI 10.2475/ajs.237.9.673; Paparella I, 2017, GEOL MAG, V154, P837, DOI 10.1017/S0016756816000455; Pardo-Perez Judith, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P287, DOI 10.1007/s12549-012-0074-8; Pearson SJ, 2004, J GEOL SOC LONDON, V161, P675, DOI 10.1144/0016-764903-089; Pollard J. E., 1968, Palaeontology, V11, P376; Roberts AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103152; Russell D.A., 1993, GEOLOGICAL SURVEY CA, P195; Saelen G, 1998, GEOLOGY, V26, P747, DOI 10.1130/0091-7613(1998)026<0747:EOROIL>2.3.CO;2; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Seeley H.G., 1874, Q J GEOL SOC, V30, P696, DOI DOI 10.1144/GSL.JGS.1874.030.01-04.64; SELLWOOD BW, 1993, PHILOS T R SOC B, V341, P225, DOI 10.1098/rstb.1993.0107; TYSON RV, 1979, NATURE, V277, P377, DOI 10.1038/277377a0; VALDES P, 1993, PHILOS T ROY SOC B, V341, P317, DOI 10.1098/rstb.1993.0117; von HILLEBRANDT A., 1992, JURASSIC CIRCUM PACI, P247; Wignall P.B., 1990, Proceedings of the Yorkshire Geological Society, V48, P197; WIGNALL P B, 1991, Palaios, V6, P264, DOI 10.2307/3514906; WIGNALL PB, 1993, J GEOL SOC LONDON, V150, P323, DOI 10.1144/gsjgs.150.2.0323; WIGNALL PB, 1989, J GEOL SOC LONDON, V146, P273, DOI 10.1144/gsjgs.146.2.0273; WIGNALL PB, 1991, GEOL SOC SPEC PUBL, P291, DOI 10.1144/GSL.SP.1991.058.01.19; Zakharov VA, 2003, STRATIGR GEO CORREL+, V11, P152; Zverkov N.G., 2015, [Труды Зоологического института РАН, Trudy Zoologicheskogo instituta RAN], V319, P558; Zverkov N. G., 2015, Trudy Zoologicheskogo Instituta, V319, P81; Zverkov NG, 2020, ZOOLOGICAL J LINNEAN, DOI [10.1093/zoolinnean/zlaa028, DOI 10.1093/Z00LINNEAN/ZLAA02832780030]; Zverkov NG, 2019, J SYST PALAEONTOL, V17, P963, DOI 10.1080/14772019.2018.1515793; Zverkov NG, 2019, PEERJ, V7, DOI 10.7717/peerj.6799	109	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0241700	10.1371/journal.pone.0241700	http://dx.doi.org/10.1371/journal.pone.0241700			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296370	Green Published, gold			2022-12-26	WOS:000598626100042
J	Karagyozov, L; Grozdanov, PN; Bohmer, FD				Karagyozov, Luchezar; Grozdanov, Petar N.; Boehmer, Frank-D.			The translation attenuating arginine-rich sequence in the extended signal peptide of the protein-tyrosine phosphatase PTPRJ/DEP1 is conserved in mammals	PLOS ONE			English	Article							CD148; EXPRESSION; RECEPTOR; DEP-1	The signal peptides, present at the N-terminus of many proteins, guide the proteins into cell membranes. In some proteins, the signal peptide is with an extended N-terminal region. Previously, it was demonstrated that the N-terminally extended signal peptide of the human PTPRJ contains a cluster of arginine residues, which attenuates translation. The analysis of the mammalian orthologous sequences revealed that this sequence is highly conserved. The PTPRJ transcripts in placentals, marsupials, and monotremes encode a stretch of 10-14 arginine residues, positioned 11-12 codons downstream of the initiating AUG. The remarkable conservation of the repeated arginine residues in the PTPRJ signal peptides points to their key role. Further, the presence of an arginine cluster in the extended signal peptides of other proteins (E3 ubiquitin-protein ligase, NOTCH3) is noted and indicates a more general importance of this cis-acting mechanism of translational suppression.	[Karagyozov, Luchezar; Boehmer, Frank-D.] Jena Univ Hosp, Inst Mol Cell Biol, CMB, Jena, Germany; [Grozdanov, Petar N.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Friedrich Schiller University of Jena; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Karagyozov, L; Bohmer, FD (corresponding author), Jena Univ Hosp, Inst Mol Cell Biol, CMB, Jena, Germany.	lucho3ka@yahoo.com; i5frbo@uni-jena.de						Andersen JN, 2005, METHODS, V35, P90, DOI 10.1016/j.ymeth.2004.07.012; [Anonymous], 2013, TREAT GUIDEL MED LET, V11, pe1; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Fournier P, 2016, CANCER RES, V76, P5080, DOI 10.1158/0008-5472.CAN-16-1071; Hiss JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002767; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Karagyozov L, 2008, NUCLEIC ACIDS RES, V36, P4443, DOI 10.1093/nar/gkn391; Katsumoto TR, 2013, J CLIN INVEST, V123, P2037, DOI 10.1172/JCI66397; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kruger J, 2015, MOL METAB, V4, P325, DOI 10.1016/j.molmet.2015.02.001; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Meyer C, 2018, INT J MED MICROBIOL, V308, P3, DOI 10.1016/j.ijmm.2017.07.003; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Nagy Z, 2020, BLOOD, V135, P1574, DOI 10.1182/blood.2019002848; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sabi R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S5; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Shintani T, 2017, SCI REP, V7, P1; Shintani T, 2015, J BIOCHEM, V158, P235, DOI 10.1093/jb/mvv045; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Wilson DN, 2016, CURR OPIN STRUC BIOL, V37, P123, DOI 10.1016/j.sbi.2016.01.008	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0240498	10.1371/journal.pone.0240498	http://dx.doi.org/10.1371/journal.pone.0240498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296397	gold, Green Submitted, Green Published			2022-12-26	WOS:000598626100048
J	Vergni, D; Gaudio, R; Santoni, D				Vergni, Davide; Gaudio, Rosanna; Santoni, Daniele			The farther the better: Investigating how distance from human self affects the propensity of a peptide to be presented on cell surface by MHC class I molecules, the case of Trypanosoma cruzi	PLOS ONE			English	Article							REVERSE VACCINOLOGY; NEURAL-NETWORKS; EPITOPES; IDENTIFICATION; PREDICTIONS; AFFINITIES	More than twenty years ago the reverse vaccinology paradigm came to light trying to design new vaccines based on the analysis of genomic information in order to select those pathogen peptides able to trigger an immune response. In this context, focusing on the proteome of Trypanosoma cruzi, we investigated the link between the probabilities for pathogen peptides to be presented on a cell surface and their distance from human self. We found a reasonable but, as far as we know, undiscovered property: the farther the distance between a peptide and the human-self the higher the probability for that peptide to be presented on a cell surface. We also found that the most distant peptides from human self bind, on average, a broader collection of HLAs than expected, implying a potential immunological role in a large portion of individuals. Finally, introducing a novel quantitative indicator for a peptide to measure its potential immunological role, we proposed a pool of peptides that could be potential epitopes and that can be suitable for experimental testing. The software to compute peptide classes according to the distance from human self is free available at .	[Vergni, Davide] CNR, Ist Applicaz Calcolo Mauro Picone, Rome, Italy; [Gaudio, Rosanna] Univ Tor Vergata, Dept Biol, Rome, Italy; [Santoni, Daniele] CNR, Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Santoni, D (corresponding author), CNR, Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy.	daniele.santoni@iasi.cnr.it						Abbas AK, 1994, ELSEVIER HLTH SCI; Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; Alileche A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3514-z; Alileche A, 2012, PEPTIDES, V38, P302, DOI 10.1016/j.peptides.2012.09.015; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Aparicio-Burgos JE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001050; Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; Burroughs NJ, 2004, IMMUNOGENETICS, V56, P311, DOI 10.1007/s00251-004-0691-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunha-Neto E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00640; Dumonteil E, 2012, EXPERT REV VACCINES, V11, P1043, DOI [10.1586/erv.12.85, 10.1586/ERV.12.85]; Dumonteil E, 2009, INFECT GENET EVOL, V9, P1075, DOI 10.1016/j.meegid.2009.02.009; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; Goswami J, 2013, J FORENSIC LEG MED, V20, P513, DOI 10.1016/j.jflm.2013.02.003; Gupta S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000797; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; He YQ, 2010, J BIOMED BIOTECHNOL, P1, DOI [10.1155/2010/218590, 10.1155/2010/297505]; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Molinaro AM., 2010, STAT BIOINFORMATICS; Nakayasu ES, 2012, J PROTEOME RES, V11, P237, DOI 10.1021/pr200806s; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Sanchez-Burgos G, 2010, VIRUS RES, V153, P113, DOI 10.1016/j.virusres.2010.07.014; Santoni D, 2020, J IMMUNOL METHODS, V481, DOI 10.1016/j.jim.2020.112787; Santoni D, 2018, J IMMUNOL METHODS, V459, P35, DOI 10.1016/j.jim.2018.05.009; Schirle M, 2001, J IMMUNOL METHODS, V257, P1, DOI 10.1016/S0022-1759(01)00459-8; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Silva RM, 2015, BIOINFORMATICS, V31, P2421, DOI 10.1093/bioinformatics/btv189; Teh-Poot C, 2015, J INFECT DIS, V211, P258, DOI 10.1093/infdis/jiu418; Vergni D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164540; Zheng JZ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050112	41	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243285	10.1371/journal.pone.0243285	http://dx.doi.org/10.1371/journal.pone.0243285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284846	gold, Green Published			2022-12-26	WOS:000597930500044
J	Matray, T; Singh, S; Sherif, H; Farber, K; Kwang, E; VanBrunt, M; Matsui, E; Yada, H				Matray, Tracy; Singh, Sharat; Sherif, Hesham; Farber, Kenneth; Kwang, Erin; VanBrunt, Michael; Matsui, Eriko; Yada, Hiroaki			A novel class of polymeric fluorescent dyes assembled using a DNA synthesizer	PLOS ONE			English	Article							LABELS	In the pursuit of a novel class of fluorescent dyes we have developed a programmable polymer system that enables the rational design and control of macromolecular constructs through simple control of polymer primary sequence. These polymers are assembled using standard phosphoramidite chemistry on a DNA synthesizer which allows for extremely rapid prototyping and enables many permutations due to the large selection of phosphoramidite monomers presently available on the market. This programmability to some extent allows us to control the interactions/spacing of payload molecules distributed along the designed polymeric backbone. Control of molecular architecture using this technology has allowed us to address the long-standing technical issue of contact quenching between fluorescent dyes offering new possibilities in the life sciences arena. Much like peptidic sequences coding for enzymes, cofactors, and receptors (all needing control of tertiary structure for proper function via primary sequence) our programmable system approaches a similar endpoint using a phosphate based polymeric backbone assembled in a completely automated fashion. Using this novel technology, we have efficiently synthesized several types of fluorescent dyes and demonstrated the programmability in molecule design, including the increases in brightness of the fluorescence emission.	[Matray, Tracy; Sherif, Hesham; Farber, Kenneth; Kwang, Erin; VanBrunt, Michael] Sony Biotechnol, R&D Dept, Bothell, WA 98021 USA; [Singh, Sharat] Sony Biotechnol, Bothell, WA USA; [Matsui, Eriko; Yada, Hiroaki] Sony Imaging Prod & Solut Inc, Med Business Grp, Atsugi, Kanagawa, Japan		Matray, T (corresponding author), Sony Biotechnol, R&D Dept, Bothell, WA 98021 USA.	Tracy.Matray@sony.com		Matray, Tracy/0000-0002-2026-8683	Sony Corporation; Sony Imaging Products Solutions Inc.	Sony Corporation; Sony Imaging Products Solutions Inc.	All work funded by Sony Corporation and Sony Imaging Products & Solutions Inc. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2010, MOL PROBES HDB A GUI, P664; BEAUCAGE SL, 1993, TETRAHEDRON, V49, P1925, DOI 10.1016/S0040-4020(01)86295-5; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; Chattopadhyay PK, 2012, CYTOM PART A, V81A, P456, DOI 10.1002/cyto.a.22043; Cuppoletti A, 2005, BIOCONJUGATE CHEM, V16, P528, DOI 10.1021/bc0497766; Dubrovsky T, 2009, INT J NANOSCI, V8, P163, DOI 10.1142/S0219581X09005657; Luo Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-24; Paris PL, 1998, NUCLEIC ACIDS RES, V26, P3789, DOI 10.1093/nar/26.16.3789; Teo YN, 2009, J AM CHEM SOC, V131, P3923, DOI 10.1021/ja805502k; Tram K, 2011, NUCLEOS NUCLEOT NUCL, V30, P1, DOI 10.1080/15257770.2010.536798; Wilson JN, 2007, TETRAHEDRON, V63, P3427, DOI 10.1016/j.tet.2006.07.113	11	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243218	10.1371/journal.pone.0243218	http://dx.doi.org/10.1371/journal.pone.0243218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275644	gold, Green Published			2022-12-26	WOS:000597150200029
J	Takikawa, T; Ohashi, K; Ogawa, H; Otaka, N; Kawanishi, H; Fang, LX; Ozaki, Y; Eguchi, S; Tatsumi, M; Takefuji, M; Murohara, T; Ouchi, N				Takikawa, Tomonobu; Ohashi, Koji; Ogawa, Hayato; Otaka, Naoya; Kawanishi, Hiroshi; Fang, Lixin; Ozaki, Yuta; Eguchi, Shunsuke; Tatsumi, Minako; Takefuji, Mikito; Murohara, Toyoaki; Ouchi, Noriyuki			Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction	PLOS ONE			English	Article							HEART-FAILURE; ISCHEMIA-REPERFUSION; NATIONAL-REGISTRY; OBESITY; INJURY; ADIPOKINE; PATHWAYS; OUTCOMES; LEPTIN; RISK	Background Myocardial infarction (MI) is a leading cause of death worldwide. We previously identified adipolin, also known as C1q/Tnf-related protein 12, as an anti-inflammatory adipokine with protective features against metabolic and vascular disorders. Here, we investigated the effect of adipolin on myocardial remodeling in a mouse model of MI. Methods Male adipolin-knockout (APL-KO) and wild-type (WT) mice were subjected to the permanent ligation of the left anterior descending coronary artery to create MI. Results APL-KO mice exhibited increased ratios of heart weight/body weight and lung weight/body weight after MI compared with WT mice. APL-KO mice showed increased left ventricular diastolic diameter and decreased fractional shortening after MI compared with WT mice. APL-KO mice exhibited increased expression of pro-inflammatory mediators and enhanced cardiomyocyte apoptosis in the post-MI hearts compared with WT mice. Systemic administration of adenoviral vectors expressing adipolin to WT mice after MI surgery improved left ventricular contractile dysfunction and reduced cardiac expression of pro-inflammatory genes. Treatment of cultured cardiomyocytes with adipolin protein reduced lipopolysaccharide-induced expression of pro-inflammatory mediators and hypoxia-induced apoptosis. Treatment with adipolin protein increased Akt phosphorylation in cardiomyocytes. Inhibition of PI3 kinase/Akt signaling reversed the anti-inflammatory and anti-apoptotic effects of adipolin in cardiomyocytes. Conclusion Our data indicate that adipolin ameliorates pathological remodeling of myocardium after MI, at least in part, by its ability to reduce myocardial inflammatory response and apoptosis.	[Takikawa, Tomonobu; Ogawa, Hayato; Otaka, Naoya; Kawanishi, Hiroshi; Fang, Lixin; Ozaki, Yuta; Eguchi, Shunsuke; Takefuji, Mikito; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi, Japan; [Ohashi, Koji; Tatsumi, Minako; Ouchi, Noriyuki] Nagoya Univ, Dept Mol Med & Cardiol, Grad Sch Med, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Ohashi, K; Ouchi, N (corresponding author), Nagoya Univ, Dept Mol Med & Cardiol, Grad Sch Med, Nagoya, Aichi, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Takefuji, Mikito/GXG-5982-2022	Ohashi, Koji/0000-0002-9666-026X	Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid for Scientific Research and grants from Takeda Science Foundation to N.O. K. O was supported with Grant-in-Aid for Scientific Research.	Abbate A, 2006, INT J BIOCHEM CELL B, V38, P1834, DOI 10.1016/j.biocel.2006.04.010; Ahl S, 2015, J CLIN ENDOCR METAB, V100, P4172, DOI 10.1210/jc.2015-2765; Aires V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45600-6; Alpert MA, 2018, PROG CARDIOVASC DIS, V61, P114, DOI 10.1016/j.pcad.2018.07.012; Barron HV, 2001, J AM COLL CARDIOL, V38, P1654, DOI 10.1016/S0735-1097(01)01613-8; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Berry MF, 2004, J HEART LUNG TRANSPL, V23, P1061, DOI 10.1016/j.healun.2004.06.021; Chandrashekhar Y, 2005, Curr Heart Fail Rep, V2, P18, DOI 10.1007/s11897-005-0003-5; Enomoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083183; Enomoto T, 2012, BIOCHEM BIOPH RES CO, V428, P155, DOI 10.1016/j.bbrc.2012.10.031; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Fadaei R, 2019, CYTOKINE, V113, P326, DOI 10.1016/j.cyto.2018.09.019; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Gu Y, 2019, MED SCI MONITOR, V25, P5426, DOI 10.12659/MSM.915108; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Joki Y, 2015, CIRC-HEART FAIL, V8, P342, DOI 10.1161/CIRCHEARTFAILURE.114.001647; Joki Y, 2015, BIOCHEM BIOPH RES CO, V459, P124, DOI 10.1016/j.bbrc.2015.02.081; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Ogawa H, 2020, CARDIOVASC RES, V116, P237, DOI 10.1093/cvr/cvz074; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Otaka N, 2018, CIRC RES, V123, P1326, DOI 10.1161/CIRCRESAHA.118.313777; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Packer M, 2018, CIRCULATION, V137, P1614, DOI 10.1161/CIRCULATIONAHA.117.032474; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Ramani R, 2004, AM J PHYSIOL-HEART C, V287, pH1369, DOI 10.1152/ajpheart.00641.2003; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spencer FA, 2002, CIRCULATION, V105, P2605, DOI 10.1161/01.CIR.0000017861.00991.2F; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P1870, DOI 10.1016/j.jacc.2011.06.057; Wei ZK, 2012, J BIOL CHEM, V287, P35804, DOI 10.1074/jbc.M112.365965; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3; Yuasa D, 2016, FASEB J, V30, P1065, DOI 10.1096/fj.15-279885	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243483	10.1371/journal.pone.0243483	http://dx.doi.org/10.1371/journal.pone.0243483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275602	Green Published, gold			2022-12-26	WOS:000597150200012
J	Cassmann, ED; Mammadova, N; Greenlee, JJ				Cassmann, Eric D.; Mammadova, Najiba; Greenlee, Justin J.			Autoclave treatment of the classical scrapie agent US No. 13-7 and experimental inoculation to susceptible VRQ/ARQ sheep via the oral route results in decreased transmission efficiency	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; SPONGIFORM-ENCEPHALOPATHY; CREUTZFELDT-JAKOB; INACTIVATION; PRIONS; DEER; ACCUMULATION; INFECTIVITY; DIAGNOSIS; STRAINS	Scrapie, a prion disease of sheep, is highly resistant to conventional deactivation. Numerous methods to deactivate scrapie have been tested in laboratory animal models, and adequate autoclave treatment can reduce or remove the infectivity of some classical scrapie strains depending on the heating parameters used. In this study, we autoclaved brain homogenate from a sheep with US scrapie strain 13-7 for 30 minutes at 121 degrees C. Genetically susceptible VRQ/ARQ sheep were orally inoculated with 3 grams of the autoclaved brain homogenate. For comparison, a second group of sheep was inoculated with a non-autoclaved brain homogenate. Rectal biopsies were used to assess antemortem scrapie disease progression throughout the study. Five out of ten (5/10) sheep that received autoclaved inoculum ultimately developed scrapie after an experimental endpoint of 72 months. These sheep had a mean incubation period of 26.99 months. Two out of five (2/5) positive sheep had detectable PrPSc in antemortem rectal biopsies, and two (2/5) other sheep had PrPSc in postmortem rectal tissue. A single sheep (1/5) was positive for scrapie in the CNS, small intestine, and retropharyngeal lymph node but had negative rectal tissue. All of the sheep (10/10) that received non-autoclaved inoculum developed scrapie with a mean incubation period of 20.2 months and had positive rectal biopsies at the earliest timepoint (14.7 months post-inoculation). These results demonstrate that sheep are orally susceptible to US derived classical scrapie strain 13-7 after autoclave treatment at 121 degrees C for 30 minutes. Differences in incubation periods and time interval to first positive rectal biopsies indicate a partial reduction in infectivity titers for the autoclaved inoculum group.	[Cassmann, Eric D.; Mammadova, Najiba; Greenlee, Justin J.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Greenlee, JJ (corresponding author), ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	justin.greenlee@usda.gov		Cassmann, Eric/0000-0002-7130-2650; Greenlee, Justin/0000-0003-2202-3054	U.S. Department of Energy (DOE); U.S. Department of Agriculture (USDA); ORAU under DOE [SC0014664]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); ORAU under DOE	This research was supported in part by an appointment (N. Mammadova) to the Agricultural Research Service (ARS) Research Participation Program administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). ORISE is managed by ORAU under DOE contract number DE-SC0014664. All opinions expressed in this paper are the author's and do not necessarily reflect the policies and views of USDA, ARS, DOE, or ORAU/ORISE. This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agricultural Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	[Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Cassmann ED, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00430; CHO HJ, 1983, CAN J COMP MED, V47, P494; DEES C, 1985, J GEN VIROL, V66, P845, DOI 10.1099/0022-1317-66-4-845; Dennis MM, 2009, AM J VET RES, V70, P63, DOI 10.2460/ajvr.70.1.63; DICKINSON AG, 1978, NEW ENGL J MED, V299, P1413, DOI 10.1056/NEJM197812212992512; ERNST DR, 1993, J VIROL METHODS, V41, P193, DOI 10.1016/0166-0934(93)90126-C; Fernie K, 2007, BIOTECHNOL APPL BIOC, V47, P175, DOI 10.1042/BA20060249; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; Giles K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023499; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; Gonzalez L, 2005, VET REC, V156, P846, DOI 10.1136/vr.156.26.846-b; Greenlee JJ, 2006, VET PATHOL, V43, P733, DOI 10.1354/vp.43-5-733; Greenlee JJ, 2016, RES VET SCI, V105, P188, DOI 10.1016/j.rvsc.2016.02.016; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P1087, DOI 10.1177/1040638712461249; HAIG DA, 1969, J GEN VIROL 3, V5, P455; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hamir AN, 2009, VET PATHOL, V46, P39, DOI 10.1354/vp.46-1-39; HOPE J, 1988, NATURE, V336, P390, DOI 10.1038/336390a0; Hughson AG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005914; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; KIMBERLIN RH, 1983, J NEUROL SCI, V59, P355, DOI 10.1016/0022-510X(83)90021-7; LATARJET R, 1970, NATURE, V227, P1341, DOI 10.1038/2271341a0; Machin D., 2006, SURVIVAL ANAL PRACTI; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Millson G. C., 1979, Slow transmissible diseases of the nervous system. Volume 2., P409; PRUSINER SB, 1981, P NATL ACAD SCI-BIOL, V78, P4606, DOI 10.1073/pnas.78.7.4606; PRUSINER SB, 1984, METHOD VIROL, V8, P293; Sakudo A, 2011, INT J MOL MED, V27, P483, DOI 10.3892/ijmm.2011.605; SOMERVILLE RA, 1983, J GEN VIROL, V64, P2045, DOI 10.1099/0022-1317-64-9-2045; Spiropoulos J, 2019, TRANSBOUND EMERG DIS, V66, P1993, DOI 10.1111/tbed.13247; Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Taylor DM, 1997, VET MICROBIOL, V58, P87, DOI 10.1016/S0378-1135(97)00103-X; USDA-APHIS-VS, 2019, SCRAP PROGR STAND, V1; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	40	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243009	10.1371/journal.pone.0243009	http://dx.doi.org/10.1371/journal.pone.0243009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270721	Green Published, gold			2022-12-26	WOS:000597149100053
J	Green, EH; Kikis, EA				Green, Emily H.; Kikis, Elise A.			Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; APOLIPOPROTEIN-E; AMYLOID-BETA; DISEASE; AGGREGATION; THRESHOLD; COLLAPSE; BINDING	The proteostasis network comprises the biochemical pathways that together maintain and regulate proper protein synthesis, transport, folding, and degradation. Many neurodegenerative diseases are characterized by a failure of the proteostasis network to sustain the health of the proteome, resulting in protein misfolding, aggregation, and, often, neurotoxicity. Although important advances have been made in recent years to identify genetic risk factors for neurodegenerative diseases, we still know relatively little about environmental risk factors such as air pollution. Exposure to nano-sized particulate air pollution, referred to herein as nanoparticulate matter (nPM), has been shown to trigger the accumulation of misfolded and oligomerized amyloid beta in mice. This suggests that the ability to maintain proteostasis is likely compromised in Alzheimer 's disease (AD) pathogenesis upon exposure to nPM. We aim to determine whether this aspect of the environment interacts with proteostasis network machinery to trigger protein misfolding. This could at least partially explain how air pollution exacerbates the symptoms of neurodegenerative diseases of aging, such as AD. We hypothesize that nPM challenges the buffering capacity of the proteostasis network by reducing the efficiency of folding for metastable proteins, thereby disrupting what has proven to be a very delicate proteostasis balance. We will test this hypothesis using C. elegans as our model system. Specifically, we will determine the impact of particulate air pollution on the aggregation and toxicity of disease-associated reporters of proteostasis and on transcriptional responses to stress.	[Green, Emily H.; Kikis, Elise A.] Univ South, Biol Dept, Sewanee, TN 37375 USA	Sewanee: University of the South	Kikis, EA (corresponding author), Univ South, Biol Dept, Sewanee, TN 37375 USA.	eakikis@sewanee.edu			University of the South; Appalachian Colleges Association Faculty Fellowship [19 60002]	University of the South; Appalachian Colleges Association Faculty Fellowship	Funding for this work includes Faculty Development Grants provided by the University of the South to EAK and Appalachian Colleges Association Faculty Fellowship #19 60002 to EAK. The funders have not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Floyd J, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0750-5; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; Bertram L, 2019, NAT REV NEUROL, V15, P191, DOI 10.1038/s41582-019-0158-4; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Cacciottolo M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.280; Cacciottolo M, 2020, FREE RADICAL BIO MED, V147, P242, DOI 10.1016/j.freeradbiomed.2019.12.023; Cheng H, 2016, ENVIRON HEALTH PERSP, V124, P1537, DOI 10.1289/EHP134; Crimins JL, 2013, AGEING RES REV, V12, P757, DOI 10.1016/j.arr.2013.03.002; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Haghani A, 2019, J GERONTOL A-BIOL, V74, P1189, DOI 10.1093/gerona/glz063; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Lee AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173644; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; McColl G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-57; Mohri-Shiomi A, 2008, J BIOL CHEM, V283, P194, DOI 10.1074/jbc.M707956200; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Pomatto LCD, 2018, FREE RADICAL BIO MED, V121, P86, DOI 10.1016/j.freeradbiomed.2018.04.574; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977	30	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243419	10.1371/journal.pone.0243419	http://dx.doi.org/10.1371/journal.pone.0243419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270781	gold, Green Published			2022-12-26	WOS:000597149100026
J	Hsu, HMC; Yao, ZF; Hwang, K; Hsieh, SL				Hsu, Howard Muchen; Yao, Zai-Fu; Hwang, Kai; Hsieh, Shulan			Between-module functional connectivity of the salient ventral attention network and dorsal attention network is associated with motor inhibition	PLOS ONE			English	Article							STOP-SIGNAL; REGIONAL HOMOGENEITY; RESPONSE-INHIBITION; FMRI; ABILITY; CORTEX; AGE	The ability to inhibit motor response is crucial for daily activities. However, whether brain networks connecting spatially distinct brain regions can explain individual differences in motor inhibition is not known. Therefore, we took a graph-theoretic perspective to examine the relationship between the properties of topological organization in functional brain networks and motor inhibition. We analyzed data from 141 healthy adults aged 20 to 78, who underwent resting-state functional magnetic resonance imaging and performed a stop-signal task along with neuropsychological assessments outside the scanner. The graph-theoretic properties of 17 functional brain networks were estimated, including within-network connectivity and between-network connectivity. We employed multiple linear regression to examine how these graph-theoretical properties were associated with motor inhibition. The results showed that between-network connectivity of the salient ventral attention network and dorsal attention network explained the highest and second highest variance of individual differences in motor inhibition. In addition, we also found those two networks span over brain regions in the frontal-cingulate-parietal network, suggesting that these network interactions are also important to motor inhibition.	[Hsu, Howard Muchen; Hsieh, Shulan] Natl Cheng Kung Univ, Dept Psychol, Tainan, Taiwan; [Yao, Zai-Fu] Univ Amsterdam, Dept Psychol Brain & Cognit, Amsterdam, Netherlands; [Hwang, Kai] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Hwang, Kai] Univ Iowa, Iowa Neurosci Inst, Iowa City, IA USA; [Hsieh, Shulan] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan; [Hsieh, Shulan] Natl Cheng Kung Univ, Dept & Inst Publ Hlth, Tainan, Taiwan	National Cheng Kung University; University of Amsterdam; University of Iowa; University of Iowa; National Cheng Kung University; National Cheng Kung University	Hsieh, SL (corresponding author), Natl Cheng Kung Univ, Dept Psychol, Tainan, Taiwan.; Hsieh, SL (corresponding author), Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan.; Hsieh, SL (corresponding author), Natl Cheng Kung Univ, Dept & Inst Publ Hlth, Tainan, Taiwan.		Yao, Zai-Fu/AAG-3463-2021; Yao, Zai-Fu/GSE-2501-2022	Yao, Zai-Fu/0000-0002-9823-9110; Hsieh, Shulan/0000-0001-6247-244X; Hwang, Kai/0000-0002-1064-7815	Ministry of Science and Technology (MOST), Taiwan [104-2410-H-006-021-MY2, 106-2410-H-006-031-MY2, 108-2321-B-006-022-MY2, 108-2410-H-006 -038 -MY3]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan)	The Ministry of Science and Technology (MOST), Taiwan, for financially supporting this research [Contract No. 104-2410-H-006-021-MY2, 106-2410-H-006-031-MY2, 108-2321-B-006-022-MY2, 108-2410-H-006 -038 -MY3].	[Anonymous], 2007, COMMON KNOWL, V13, P214; [Anonymous], 2016, MICROSC MICROANAL, V22, P486; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boekel W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205718; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Cai WD, 2016, CEREB CORTEX, V26, P2140, DOI 10.1093/cercor/bhv046; Cai WD, 2014, J NEUROSCI, V34, P14652, DOI 10.1523/JNEUROSCI.3048-14.2014; Cohen J.E., 1988, STAT POWER ANAL BEHA; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Geerligs L, 2017, HUM BRAIN MAPP, V38, P4125, DOI 10.1002/hbm.23653; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Hsieh S, 2017, COGN AFFECT BEHAV NE, V17, P348, DOI 10.3758/s13415-016-0483-7; Hsieh S, 2017, ACTA PSYCHOL, V173, P122, DOI 10.1016/j.actpsy.2016.12.011; Hsu WT, 2018, SOC COGN AFFECT NEUR, V13, P224, DOI 10.1093/scan/nsy002; Hu SE, 2019, BRAIN IMAGING BEHAV, V13, P1526, DOI 10.1007/s11682-019-00103-w; Hu S, 2014, BRAIN STRUCT FUNCT, V219, P983, DOI 10.1007/s00429-013-0548-0; Hu S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00004; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; Jaekel J, 2016, J PEDIATR-US, V169, P87, DOI 10.1016/j.jpeds.2015.10.029; Jeffreys H., 1961, THEORY PROBABILITY; Kumar S, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1346; Lee HH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00766; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Ly A, 2016, J MATH PSYCHOL, V72, P43, DOI 10.1016/j.jmp.2016.01.003; Manza P, 2016, HUM BRAIN MAPP, V37, P648, DOI 10.1002/hbm.23056; Manza P, 2015, NEUROIMAGE, V107, P311, DOI 10.1016/j.neuroimage.2014.12.016; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schakel AH, 2017, COMP TERRIT POLIT, P1, DOI 10.1057/978-1-137-51787-6_1; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Tian LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066572; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Vaessen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090068; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Verbruggen F, 2008, BEHAV RES METHODS, V40, P479, DOI 10.3758/BRM.40.2.479; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang W, 2018, DRUG ALCOHOL DEPEN, V192, P137, DOI 10.1016/j.drugalcdep.2018.07.037; Wetzels R, 2012, PSYCHON B REV, V19, P1057, DOI 10.3758/s13423-012-0295-x; Xiao T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00209; Yang MH, 2019, HUM BRAIN MAPP, V40, P2639, DOI 10.1002/hbm.24550; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang S, 2017, NICOTINE TOB RES, V19, P452, DOI 10.1093/ntr/ntw209; Zhang YH, 2018, NEUROIMAGE-CLIN, V18, P793, DOI 10.1016/j.nicl.2018.03.016	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242985	10.1371/journal.pone.0242985	http://dx.doi.org/10.1371/journal.pone.0242985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270664	gold, Green Published			2022-12-26	WOS:000597149100032
J	Li, JJ; Islam, F; Huang, Q; Wang, J; Zhou, WJ; Xu, L; Yang, C				Li, Juanjuan; Islam, Faisal; Huang, Qian; Wang, Jian; Zhou, Weijun; Xu, Ling; Yang, Chong			Genome-wide characterization of WRKY gene family in Helianthus annuus L. and their expression profiles under biotic and abiotic stresses	PLOS ONE			English	Article							ENHANCES DISEASE RESISTANCE; TRANSCRIPTION FACTOR; ARABIDOPSIS; DROUGHT; PROTEIN; TOLERANCE; ACID; OVEREXPRESSION; TOBACCO; KINASE	WRKY transcription factors play important roles in various physiological processes and stress responses in flowering plants. Sunflower (Helianthus annuus L.) is one of the important vegetable oil supplies in the world. However, the information about WRKY genes in sunflower is limited. In this study, ninety HaWRKY genes were identified and renamed according to their locations on chromosomes. Further phylogenetic analyses classified them into four main groups including a species-specific WKKY group. Besides, HaWRKY genes within the same group or subgroup generally showed similar exon-intron structures and motif compositions. The gene duplication analysis showed that five pairs of HaWRKY genes (HaWRKY8/9, HaWRKY53/54, HaWRKY65/66, HaWRKY66/67 and HaWRKY71/72) are tandem duplicated and four HaWRKY gene pairs (HaWRKY15/82, HaWRKY25/65, HaWRKY28/55 and HaWRKY50/53) are also identified as segmental duplication events, indicating that these duplication genes were contribute to the diversity and expansion of HaWRKY gene families. The dN/dS ratio of these duplicated gene pairs were also calculated to understand the evolutionary constraints. In addition, synteny analyses of sunflower WRKY genes provided deep insight to the evolution of HaWRKY genes. Transcriptomic and qRT-PCR analyses of HaWRKY genes displayed distinct expression patterns in different plant tissues, as well as under various abiotic and biotic stresses, which provide a foundation for further functional analyses of these genes. Those functional genes related to stress tolerance and quality improvement could be applied in marker assisted breeding of the crop.	[Li, Juanjuan; Xu, Ling] Zhejiang Sci Tech Univ, Coll Life Sci & Med, Zhejiang Key Lab Plant Secondary Metab & Regulat, Hangzhou, Peoples R China; [Islam, Faisal; Huang, Qian; Wang, Jian; Zhou, Weijun] Zhejiang Univ, Inst Crop Sci, Minist Agr & Rural Affairs, Lab Spect Sensing, Hangzhou, Peoples R China; [Yang, Chong] Guangdong Acad Sci, Inst Bioengn, Bioengn Res Lab, Guangzhou, Peoples R China	Zhejiang Sci-Tech University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University; Guangdong Academy of Sciences; Institute of Biological & Medical Engineering, Guangdong Academy of Sciences	Xu, L (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci & Med, Zhejiang Key Lab Plant Secondary Metab & Regulat, Hangzhou, Peoples R China.; Yang, C (corresponding author), Guangdong Acad Sci, Inst Bioengn, Bioengn Res Lab, Guangzhou, Peoples R China.	lxu@zstu.edu.cn; parker815@163.com	Islam, Faisal/F-9159-2014		National Natural Science Foundation of China [31701333]; GDAS' Project of Science and Technology Development [2020GDASYL-20200103062]; Zhejiang Provincial Natural Science Foundation [LGN18C130007]; Inner Mongolia Science & Technology Plan [201802072]; Jiangsu Collaborative Innovation Center for Modern Crop Production	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); GDAS' Project of Science and Technology Development; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Inner Mongolia Science & Technology Plan; Jiangsu Collaborative Innovation Center for Modern Crop Production	This work was supported by the National Natural Science Foundation of China (31701333), GDAS' Project of Science and Technology Development (2020GDASYL-20200103062), Zhejiang Provincial Natural Science Foundation (LGN18C130007), the Jiangsu Collaborative Innovation Center for Modern Crop Production, and Inner Mongolia Science & Technology Plan (201802072). The funders had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Badouin H, 2017, NATURE, V546, P148, DOI 10.1038/nature22380; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Chen F, 2017, CRIT REV PLANT SCI, V36, P311, DOI 10.1080/07352689.2018.1441103; Chen JN, 2017, PLANT CELL, V29, P1425, DOI 10.1105/tpc.17.00364; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Giacomelli JI, 2010, PLANT SCI, V178, P398, DOI 10.1016/j.plantsci.2010.02.008; Guo HY, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100393; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaya MD, 2006, EUR J AGRON, V24, P291, DOI 10.1016/j.eja.2005.08.001; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li F, 2012, NUMER LINEAR ALGEBR, V19, P153, DOI 10.1002/nla.750; Li JJ, 2020, IND CROP PROD, V143, DOI 10.1016/j.indcrop.2019.111924; Li W, 2016, MOL PLANT, V9, P1492, DOI 10.1016/j.molp.2016.08.003; Li W, 2015, PLANT SCI, V236, P205, DOI 10.1016/j.plantsci.2015.04.004; Liu AK, 2020, IND CROP PROD, V148, DOI 10.1016/j.indcrop.2020.112268; Liu XN, 2003, CROP SCI, V43, P678; Lu K, 2016, J EXP BOT, V67, P5009, DOI 10.1093/jxb/erw266; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Song H, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1467-2; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Vanderauwera S, 2012, P NATL ACAD SCI USA, V109, P20113, DOI 10.1073/pnas.1217516109; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0076-3; Xu L, 2019, ENVIRON EXP BOT, V162, P144, DOI 10.1016/j.envexpbot.2019.02.016; Yang C, 2020, PLANT SOIL, V450, P303, DOI 10.1007/s11104-020-04495-3; Yang C, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700009; Yu YC, 2016, PLANT J, V85, P96, DOI 10.1111/tpj.13092; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	45	7	8	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0241965	10.1371/journal.pone.0241965	http://dx.doi.org/10.1371/journal.pone.0241965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270651	Green Submitted, gold, Green Published			2022-12-26	WOS:000597149100096
J	Lin, YP; Schmeller, DS; Ding, TS; Wang, YC; Lien, WY; Henle, K; Klenke, RA				Lin, Yu-Pin; Schmeller, Dirk S.; Ding, Tzung-Su; Wang, Yung Chieh; Lien, Wan-Yu; Henle, Klaus; Klenke, Reinhard A.			A GIS-based policy support tool to determine national responsibilities and priorities for biodiversity conservation	PLOS ONE			English	Article							SPECIES CONSERVATION; RED LISTS; MAP; ECOREGIONS; WORLD; FRAMEWORK; HABITATS; HOTSPOTS; REGIONS; SCALES	Efficient biodiversity conservation requires that limited resources be allocated in accordance with national responsibilities and priorities. Without appropriate computational tools, the process of determining these national responsibilities and conservation priorities is time intensive when considering many species across geographic scales. Here, we have developed a computational tool as a module for the ArcGIS geographic information system. The ArcGIS National Responsibility Assessment Tool (NRA-Tool) can be used to create hierarchical lists of national responsibilities and priorities for global species conservation. Our tool will allow conservationists to prioritize conservation efforts and to focus limited resources on relevant species and regions. We showcase our tool with data on 258 bird species and various biophysical regions, including Environmental Zones in 58 Asian countries and regions. Our tool provides a decision support system for conservation policy with attractive and easily interpretable visual outputs illustrating national responsibilities and priorities for species conservation. The graphical output allows for smooth integration into assessment reports, such as the European Article 17 report, the Living Planet Index report, or similar regional and global reports.	[Lin, Yu-Pin; Lien, Wan-Yu] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei, Taiwan; [Schmeller, Dirk S.] Univ Toulouse, UPS, ECOLAB, INPT,CNRS, Toulouse, France; [Ding, Tzung-Su] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan; [Wang, Yung Chieh] Natl Chung Hsing Univ, Dept Soil & Water Conservat, Taichung, Taiwan; [Henle, Klaus; Klenke, Reinhard A.] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Klenke, Reinhard A.] German Ctr Integrat Biodivers Res iDiv, sDiv Synth Ctr iDiv, Leipzig, Germany	National Taiwan University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); National Taiwan University; National Chung Hsing University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Klenke, RA (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	reinhard.klenke@ufz.de	DING, Tzung-Su/AAG-7712-2019; Schmeller, Dirk S/F-4324-2010; Schmeller, Dirk S./S-6431-2019	Schmeller, Dirk S/0000-0002-3860-9933; Schmeller, Dirk S./0000-0002-3860-9933	National Science Council of Taiwan [NSC101-2923-I-002-001-MY2]; project SCALES: Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales, under the European Union's Framework Program 7 [226852]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); project SCALES: Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales, under the European Union's Framework Program 7	Y-P L, T-S D, Y-Ch W, W-Y L were mainly funded by the National Science Council of Taiwan under grant NSC101-2923-I-002-001-MY2. In 2014 the NSC was renamed in Ministry of Science and Technology (MOST, http://www.most.gov.tw/? l=en) K H, D S S, R A K were funded by the project SCALES: Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales, under the European Union's Framework Program 7 (grant 226852; https://cordis.europa.eu/project/id/226852, www.scalesproject.net).	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; [Anonymous], 2016, RUL PROC IUCN RED LI; [Anonymous], 2020, INTERACTIVE REPRESEN; [Anonymous], 2020, INTERNET REPRESENTAT; [Anonymous], 2020, MICROSOFT C DOCUMENT; [Anonymous], 2020, MICROSOFT VISUAL STU; ArcGIS-NRA, 2020, ARCGIS NRA TOOL DESC; ArcGIS-NRA, 2020, ARCGIS NRA TOOL PROJ; Arponen A, 2012, BIODIVERS CONSERV, V21, P875, DOI 10.1007/s10531-012-0242-1; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cadotte MW, 2018, BIOL CONSERV, V225, P128, DOI 10.1016/j.biocon.2018.06.014; Campagnaro T, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041189; Carvalho F, 2020, ENVIRON CONSERV, V47, P113, DOI 10.1017/S0376892920000090; Delavenne J, 2012, ICES J MAR SCI, V69, P75, DOI 10.1093/icesjms/fsr180; Eaton MA, 2005, CONSERV BIOL, V19, P1557, DOI 10.1111/j.1523-1739.2005.00213.x; ESRI, 2020, ESRI ARCOBJECTS SDK; ESRI, 2020, ESRI ARCGIS RUNTIME; ESRI, 2013, PROJ TYP ARCGIS MAN; EuroGeographics, 2020, GISCO GEOGR INF MAPS; Gardenfors U, 2001, TRENDS ECOL EVOL, V16, P511, DOI 10.1016/S0169-5347(01)02214-5; Gardenfors U, 2001, CONSERV BIOL, V15, P1206, DOI 10.1046/j.1523-1739.2001.00112.x; Gardenfors Ulf, 2000, Ecological Bulletins, V48, P181; Gauthier P, 2010, BIOL CONSERV, V143, P1501, DOI 10.1016/j.biocon.2010.03.032; Helldin JO, 2015, NAT CONSERV-BULGARIA, P143, DOI 10.3897/natureconservation.11.4433; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN (International Union for Conservation of Nature and Natural Resources), 2020, RED LIST DAT; IUCN (International Union for Conservation of Nature and Natural Resources), 2020, SPAT DAT MAPP RES SP; IUCN (International Union for Conservation of Nature and Natural Resources), 2020, TERR MAMM CROC SIC S; Jenkins Jr R, 1988, BIODIVERSITY; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Keller V, 2004, CONSERV BIOL, V18, P1636, DOI 10.1111/j.1523-1739.2004.00464.x; Kosman E, 2019, DIVERS DISTRIB, V25, P1156, DOI 10.1111/ddi.12923; Kujala H, 2018, METHODS ECOL EVOL, V9, P1121, DOI 10.1111/2041-210X.12939; Leathwick JR, 2010, BIOL CONSERV, V143, P984, DOI 10.1016/j.biocon.2010.01.012; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; McGowan J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14554-z; Mehlman DW, 2004, BIOL CONSERV, V120, P383, DOI 10.1016/j.biocon.2004.03.013; Meller L, 2014, DIVERS DISTRIB, V20, P309, DOI 10.1111/ddi.12162; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Metzger MJ, 2018, GLOBAL ENV STRATIFIC, DOI [10.7488/ds/2354, DOI 10.7488/DS/2354]; Microsoft, 2020, MICROSOFT NET FRAMEW; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Moilanen A, 2009, SPATIAL CONSERVATION; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Natural Earth, 2020, 1 10M CROSS BLEND HY; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ottewell KM, 2016, DIVERS DISTRIB, V22, P174, DOI 10.1111/ddi.12387; Pert PL, 2013, LANDSCAPE URBAN PLAN, V114, P80, DOI 10.1016/j.landurbplan.2013.02.010; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; QGIS Development Team, 2018, QGIS GEOGR INF SYST; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Schatz B, 2014, J NAT CONSERV, V22, P75, DOI 10.1016/j.jnc.2013.09.003; Schmeller D, 2008, BIODIVERS CONSERV, V17, P3623, DOI 10.1007/s10531-008-9446-9; Schmeller D, 2008, BIODIVERS CONSERV, V17, P3607, DOI 10.1007/s10531-008-9439-8; Schmeller DS, 2008, CONSERV BIOL, V22, P593, DOI 10.1111/j.1523-1739.2008.00961.x; Schmeller DS, 2015, J NAT CONSERV, V25, P51, DOI 10.1016/j.jnc.2015.03.003; Schmeller DS, 2014, J NAT CONSERV, V22, P349, DOI 10.1016/j.jnc.2014.03.002; Schmeller DS, 2012, NAT CONSERV-BULGARIA, P21, DOI 10.3897/natureconservation.3.3710; Schnittler M, 1999, BIODIVERS CONSERV, V8, P891, DOI 10.1023/A:1008828704456; Schnittler M, 2004, NATURSCHUTZ BIOL VIE, V8, P39; Schnittler Martin, 1994, Natur und Landschaft, V69, P451; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Thomassen HA, 2011, EVOL APPL, V4, P397, DOI 10.1111/j.1752-4571.2010.00172.x; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; Vasudev D, 2015, BIOL CONSERV, V181, P124, DOI 10.1016/j.biocon.2014.11.021; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Watts ME, 2017, LEARNING LANDSCAPE E, DOI [10.1007/978-1-4939-6374-4, DOI 10.1007/978-1-4939-6374-4]; Zhang L, 2014, J NAT CONSERV, V22, P326, DOI 10.1016/j.jnc.2014.02.007	71	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243135	10.1371/journal.pone.0243135	http://dx.doi.org/10.1371/journal.pone.0243135			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270722	Green Published, gold			2022-12-26	WOS:000597149100065
J	Basnet, TB; Srijana, GC; Basnet, R; Neupane, B				Basnet, Til Bahadur; Srijana, G. C.; Basnet, Rajesh; Neupane, Bidusha			Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; FATTY-ACIDS; VITAMIN-A; RISK; MORTALITY; INFLAMMATION; METAANALYSIS; CONSUMPTION	Dietary nutrients have significant effects on the risk of cardiovascular diseases. However, the results were not uniform across different countries. The study aims to determine the relative importance of dietary nutrients associated with coronary artery disease (CAD) among the Nepalese population. A hospital-based matched case-control study was carried out at Shahid Gangalal National Heart Center in Nepal. In the present study, patients with more than seventy percent stenosis in any main coronary artery branch in angiography were defined as cases, while those presenting normal coronary angiography or negative for stressed exercise test were considered controls. Dietary intakes of 612 respondents over the past 12 months were evaluated using a semi-quantitative customized food frequency questionnaire. In conditional regression model, the daily average dietary intake of beta-carotene (OR: 0.54; 95%CI: 0.34, 0.87), and vitamin C (OR: 0.96; 95%CI: 0.93, 0.99) were inversely, whereas dietary carbohydrate (OR: 1.16; 95%CI: 1.1, 1.24), total fat/oil (OR: 1.47; 95%CI: 1.27, 1.69), saturated fatty acid (SFA) (OR: 1.2; 95%CI: 1.11, 1.3), cholesterol (OR: 1.01; 95%CI: 1.001, 1.014), and iron intakes (OR: 1.11; 95%CI: 1.03, 1.19) were positively linked with CAD. Moreover, in random forest analysis, the daily average dietary intakes of SFA, vitamin A, total fat/oil, beta-carotene, and cholesterol were among the top five nutrients (out of 12 nutrients variables) of relative importance associated with CAD. The nutrients of relative importance imply a reasonable preventive measure in public health nutrients specific intervention to prevent CAD in a resource-poor country like Nepal. The findings are at best suggestive of a possible relationship between these nutrients and the development of CAD, but prospective cohort studies and randomized control trials will need to be performed in the Nepalese population.	[Basnet, Til Bahadur] Prubanchal Univ, Little Buddha Coll Hlth Sci, Kathmandu, Nepal; [Srijana, G. C.] Tribhuvan Univ, Maharajgunj Nursing Campus, Kathmandu, Nepal; [Basnet, Rajesh; Neupane, Bidusha] Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Tribhuvan University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Basnet, TB (corresponding author), Prubanchal Univ, Little Buddha Coll Hlth Sci, Kathmandu, Nepal.	ddst19asnet@hotmail.com	Basnet, Til Bahadur/ABG-7507-2020	Basnet, Til Bahadur/0000-0003-4638-4874; BASNET, RAJESH/0000-0002-0128-8590; Neupane, Bidusha/0000-0003-2569-4937				Aidinoff E, 2017, SPINAL CORD, V55, P321, DOI 10.1038/sc.2016.109; Al-Attas O, 2014, CLIN MED INSIGHTS-EN, V7, P1, DOI 10.4137/CMED.S13573; Alissa EM, 2005, ASIA PAC J CLIN NUTR, V14, P137; Anderson JJB, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003815; [Anonymous], 2011, J AM DIET ASSOC, V111, P762, DOI 10.1016/j.jada.2011.03.022; [Anonymous], 2000, OB PREV MAN GLOB EP; [Anonymous], 2012, GLOB REP MORT ATTR T; [Anonymous], 2012, REGEN MED S3, V7, pS14; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berger S, 2015, AM J CLIN NUTR, V102, P276, DOI 10.3945/ajcn.114.100305; Beunza JJ, 2019, J BIOMED INFORM, V97, DOI 10.1016/j.jbi.2019.103257; Brenna JT, 2009, ANN NUTR METAB, V55, P97, DOI 10.1159/000228998; Campbell RK, 2015, ECOL FOOD NUTR, V54, P314, DOI 10.1080/03670244.2014.990635; Chagas P, 2017, CLIN NUTR, V36, P1036, DOI 10.1016/j.clnu.2016.06.017; Choi Y, 2015, AM J CARDIOL, V116, P520, DOI 10.1016/j.amjcard.2015.05.005; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Clar C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004467.pub3; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Desai K, 2005, PLOS MED, V2, pe142; Doi-Kanno Mana, 2016, J Med Dent Sci, V63, P37; Eshak ES, 2018, J NUTR BIOCHEM, V56, P126, DOI 10.1016/j.jnutbio.2018.02.008; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Gautham A, 2013, INT RES J PHARM, V4, P16, DOI [10.7897/2230-8407.04505, DOI 10.7897/2230-8407.04505]; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Guasch-Ferre M, 2015, AM J CLIN NUTR, V102, P1563, DOI 10.3945/ajcn.115.116046; Hooper L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011834, 10.1002/14651858.CD002137.pub2]; Hu T, 2014, NUTR METAB CARDIOVAS, V24, P337, DOI 10.1016/j.numecd.2013.12.008; Hu T, 2019, BRIT J NUTR, V121, P461, DOI [10.1017/s0007114518003513, 10.1017/S0007114518003513]; Hunnicutt J, 2014, J NUTR, V144, P359, DOI 10.3945/jn.113.185124; Ishihara J, 2008, J AM COLL NUTR, V27, P127, DOI 10.1080/07315724.2008.10719684; Iyengar SS, 2017, INDIAN HEART J, V69, P211, DOI 10.1016/j.ihj.2016.09.009; Jang Y, 2001, ARTERIOSCL THROM VAS, V21, P2065, DOI 10.1161/hq1201.100258; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Koju R, 2014, Kathmandu Univ Med J (KUMJ), V12, P137; Kong SH, 2017, AM J CLIN NUTR, V106, P27, DOI 10.3945/ajcn.116.148171; La Torre G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193360; Loewen OK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102529; Marventano S, 2015, INT J FOOD SCI NUTR, V66, P611, DOI 10.3109/09637486.2015.1077790; Matos A, 2018, NUTR HOSP, V35, P1215, DOI 10.20960/nh.1804; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115; Nettleton JA, 2013, ANN NUTR METAB, V63, P96, DOI 10.1159/000353207; North CJ, 2009, EUR J CLIN NUTR, V63, P921, DOI 10.1038/ejcn.2009.8; Oikonomou E, 2018, ANGIOLOGY, V69, P339, DOI 10.1177/0003319717721603; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Shrestha A, 2017, INT J FOOD SCI NUTR, V68, P605, DOI 10.1080/09637486.2016.1268099; Sun Q, 2011, AM J CLIN NUTR, V94, P534, DOI 10.3945/ajcn.110.008763; Superko HR, 2017, J CLIN LIPIDOL, V11, P1309, DOI 10.1016/j.jacl.2017.08.005; Virtanen JK, 2016, AM J CLIN NUTR, V103, P895, DOI 10.3945/ajcn.115.122317; Virtanen JK, 2014, ARTERIOSCL THROM VAS, V34, P2679, DOI 10.1161/ATVBAHA.114.304082; Worknop C, 2017, GLOB HLTH GOV, V11, P7; World Health Organization, 2017, FACT SHEET; World Health Organization, 2017, NONC DIS PROGR MON; World Health Organization (WHO), 2005, STEPS SURV MAN WHO S; Wu YH, 2015, CLIN NUTR, V34, P603, DOI 10.1016/j.clnu.2014.05.009; Zang JJ, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0454-2; Zhang X, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.01.08; Zhao LG, 2017, J EPIDEMIOL, V27, P89, DOI 10.1016/j.je.2016.10.002; Zock PL, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0793-y; Zong G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5796	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243063	10.1371/journal.pone.0243063	http://dx.doi.org/10.1371/journal.pone.0243063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301496	Green Published, gold			2022-12-26	WOS:000600143100013
J	Grandjean, D; Sarkis, R; Lecoq-Julien, C; Benard, A; Roger, V; Levesque, E; Bernes-Luciani, E; Maestracci, B; Morvan, P; Gully, E; Berceau-Falancourt, D; Haufstater, P; Herin, G; Cabrera, J; Muzzin, Q; Gallet, C; Bacque, H; Broc, JM; Thomas, L; Lichaa, A; Moujaes, G; Saliba, M; Kuhn, A; Galey, M; Berthail, B; Lapeyre, L; Capelli, A; Renault, S; Bachir, K; Kovinger, A; Comas, E; Stainmesse, A; Etienne, E; Voeltzel, S; Mansouri, S; Berceau-Falancourt, M; Dami, A; Charlet, L; Ruau, E; Issa, M; Grenet, C; Billy, C; Tourtier, JP; Desquilbet, L				Grandjean, Dominique; Sarkis, Riad; Lecoq-Julien, Clothilde; Benard, Aymeric; Roger, Vinciane; Levesque, Eric; Bernes-Luciani, Eric; Maestracci, Bruno; Morvan, Pascal; Gully, Eric; Berceau-Falancourt, David; Haufstater, Pierre; Herin, Gregory; Cabrera, Joaquin; Muzzin, Quentin; Gallet, Capucine; Bacque, Helene; Broc, Jean-Marie; Thomas, Leo; Lichaa, Anthony; Moujaes, Georges; Saliba, Michele; Kuhn, Aurore; Galey, Mathilde; Berthail, Benoit; Lapeyre, Lucien; Capelli, Anthoni; Renault, Steevens; Bachir, Karim; Kovinger, Anthony; Comas, Eric; Stainmesse, Aymeric; Etienne, Erwan; Voeltzel, Sebastien; Mansouri, Sofiane; Berceau-Falancourt, Marlene; Dami, Aime; Charlet, Lary; Ruau, Eric; Issa, Mario; Grenet, Carine; Billy, Christophe; Tourtier, Jean-Pierre; Desquilbet, Loic			Can the detection dog alert on COVID-19 positive persons by sniffing axillary sweat samples? A proof-of-concept study	PLOS ONE			English	Article							CANINE OLFACTORY DETECTION; PROSTATE-CANCER; SCENT-DETECTION; BLADDER-CANCER; LUNG; IDENTIFICATION; DIAGNOSIS; IDENTIFY; URINE; SPECTROMETRY	The aim of this proof-of-concept study was to evaluate if trained dogs could discriminate between sweat samples from symptomatic COVID-19 positive individuals (SARS-CoV-2 PCR positive) and those from asymptomatic COVID-19 negative individuals. The study was conducted at 2 sites (Paris, France, and Beirut, Lebanon), followed the same training and testing protocols, and involved six detection dogs (three explosive detection dogs, one search and rescue dog, and two colon cancer detection dogs). A total of 177 individuals were recruited for the study (95 symptomatic COVID-19 positive and 82 asymptomatic COVID-19 negative individuals) from five hospitals, and one underarm sweat sample per individual was collected. The dog training sessions lasted between one and three weeks. Once trained, the dog had to mark the COVID-19 positive sample randomly placed behind one of three or four olfactory cones (the other cones contained at least one COVID-19 negative sample and between zero and two mocks). During the testing session, a COVID-19 positive sample could be used up to a maximum of three times for one dog. The dog and its handler were both blinded to the COVID-positive sample location. The success rate per dog (i.e., the number of correct indications divided by the number of trials) ranged from 76% to 100%. The lower bound of the 95% confidence interval of the estimated success rate was most of the time higher than the success rate obtained by chance after removing the number of mocks from calculations. These results provide some evidence that detection dogs may be able to discriminate between sweat samples from symptomatic COVID-19 individuals and those from asymptomatic COVID-19 negative individuals. However, due to the limitations of this proof-of-concept study (including using some COVID-19 samples more than once and potential confounding biases), these results must be confirmed in validation studies.	[Grandjean, Dominique; Lecoq-Julien, Clothilde; Roger, Vinciane; Cabrera, Joaquin; Muzzin, Quentin; Gallet, Capucine; Bacque, Helene; Desquilbet, Loic] Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France; [Sarkis, Riad; Lichaa, Anthony; Moujaes, Georges; Saliba, Michele; Issa, Mario] Univ Franco Libanaise St Joseph, Fac Med, Beirout, Lebanon; [Benard, Aymeric; Bernes-Luciani, Eric; Maestracci, Bruno; Dami, Aime] Serv Incendie & Secours Corse Sud, Ajaccio, France; [Levesque, Eric; Lapeyre, Lucien; Tourtier, Jean-Pierre] Univ Paris Est Creteil, Ctr Hosp Univ Henri Mondor, Maisons Alfort, France; [Morvan, Pascal; Capelli, Anthoni; Renault, Steevens; Bachir, Karim; Kovinger, Anthony] DiagNose, Neuvy, France; [Gully, Eric; Comas, Eric; Stainmesse, Aymeric; Etienne, Erwan; Voeltzel, Sebastien; Mansouri, Sofiane; Charlet, Lary; Ruau, Eric] Serv Dept Incendie & Secours Seine & Marne, Melun, France; [Berceau-Falancourt, David] Compagnie Cynophile Prefecture Police, Paris, France; [Haufstater, Pierre] Hop Univ Pitie Salpetriere, Paris, France; [Herin, Gregory] Biodes SAS, Strasbourg, France; [Broc, Jean-Marie; Thomas, Leo; Kuhn, Aurore; Galey, Mathilde; Berthail, Benoit] Hop Instruct Armees Begin, St Mande, France; [Berceau-Falancourt, Marlene] Cynopro Dectect Dogs, Paris, France; [Grenet, Carine] Grand Hop Est Francilien, Jossigny, France; [Billy, Christophe] Ctr Hosp Francois Quesnay, Mantes La Jolie, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Grandjean, D (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France.	dominique.grandjean@vet-alfort.fr	Mjaess, Georges/AAB-3350-2021	Mjaess, Georges/0000-0002-8703-4611; Lichaa, Anthony/0000-0002-3582-4187; GRANDJEAN, Dominique/0000-0002-8408-8358				Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Angle C, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00047; Angle TC, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2015.00079; [Anonymous], 2005, J PEDIAT GASTROENTER, V41, pS39; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bijland LR, 2013, NETH J MED, V71, P300; Bjartell AS, 2011, EUR UROL, V59, P202, DOI 10.1016/j.eururo.2010.10.033; Boedeker E, 2012, INTERACT CARDIOV TH, V14, P511, DOI 10.1093/icvts/ivr070; Bomers MK, 2014, J INFECTION, V69, P456, DOI 10.1016/j.jinf.2014.05.017; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Buszewski B, 2012, ANAL BIOANAL CHEM, V404, P141, DOI 10.1007/s00216-012-6102-8; Campbell Leon Frederick, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-008566; Centers for Disease Control and Prevention, 2020, COVID 19 AN; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Concha A, 2014, CHEM SENSES, V39, P749, DOI 10.1093/chemse/bju045; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Edwards TL, 2017, J VET BEHAV, V20, P59, DOI 10.1016/j.jveb.2017.05.002; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Elliker KR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-22; Grabowska-Polanowska B, 2017, BIOANALYSIS, V9, P1465, DOI 10.4155/bio-2017-0128; Guest C, 2019, LANCET INFECT DIS, V19, P578, DOI 10.1016/S1473-3099(19)30220-8; Hasegawa Y, 2004, CHEM BIODIVERS, V1, P2042, DOI 10.1002/cbdv.200490157; Hasell J., 2020, TESTING EARLY TESTIN; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Jendrny P, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05281-3; Johnen D, 2017, APPL ANIM BEHAV SCI, V189, P1, DOI 10.1016/j.applanim.2017.01.001; Kirton A, 2008, EPILEPSY BEHAV, V13, P499, DOI 10.1016/j.yebeh.2008.05.011; Kitiyakara T, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa7b8e; Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786; Lippi G, 2012, CLIN CHEM LAB MED, V50, P435, DOI 10.1515/CCLM.2011.672; Maurer M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw051; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Mitro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038110; Murota H, 2015, J DERMATOL SCI, V77, P3, DOI 10.1016/j.jdermsci.2014.08.011; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Pirrone F, 2017, J VET BEHAV, V19, P105, DOI 10.1016/j.jveb.2017.03.004; Propper RE, 2020, EXP BIOL MED, V245, P997, DOI 10.1177/1535370220935409; Ren SY, 2020, WORLD J CLIN CASES, V8, P1391, DOI 10.12998/wjcc.v8.i8.1391; Richards KM, 2008, J VET BEHAV, V3, P25, DOI 10.1016/j.jveb.2007.10.006; Rooney NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210092; Rooney NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069921; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437; Taverna G, 2015, J UROLOGY, V193, P1382, DOI 10.1016/j.juro.2014.09.099; Taylor NAS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-4; Temmam S., 2020, NAT COMMUN, V10, P100164, DOI [10.1016/j.onehlt.2020.100164, DOI 10.1016/J.ONEHLT.2020.100164]; Troccaz M, 2004, CHEM BIODIVERS, V1, P1022, DOI 10.1002/cbdv.200490077; Venter M, 2020, J CLIN PATHOL, V73, P370, DOI 10.1136/jclinpath-2020-206685; Walczak M, 2012, J VET BEHAV, V7, P283, DOI 10.1016/j.jveb.2012.01.001; WALLNER WE, 1976, ENVIRON ENTOMOL, V5, P183, DOI 10.1093/ee/5.1.183; WILLIAMS H, 1989, LANCET, V1, P734; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Willis CM, 2010, CANCER BIOMARK, V8, P145, DOI 10.3233/CBM-2011-0208; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Wilson C, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00091; Woidtke L, 2018, FORENSIC SCI INT, V282, P111, DOI 10.1016/j.forsciint.2017.11.021; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777; Zeng XN, 1996, J CHEM ECOL, V22, P237, DOI 10.1007/BF02055096	61	32	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243122	10.1371/journal.pone.0243122	http://dx.doi.org/10.1371/journal.pone.0243122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301539	Green Published, gold, Green Submitted			2022-12-26	WOS:000600143100066
J	Kuang, LS; Liu, YZ; Wei, W; Song, XQ; Li, XQ; Liu, QQ; Hong, WM; Liu, Q; Li, JW; Chen, ZW; Fang, Y; Xia, SJ				Kuang, Lishan; Liu, Yizhuo; Wei, Wei; Song, Xueqing; Li, Xiaoqian; Liu, Qiqi; Hong, Weimin; Liu, Qian; Li, Jingwei; Chen, Zhongwei; Fang, Yu; Xia, Sujian			Non-prescription sale of antibiotics and service quality in community pharmacies in Guangzhou, China: A simulated client method	PLOS ONE			English	Article							REASONS	Objective To measure the situation of the non-prescription sale of antibiotics and the service quality of community pharmacies in Guangzhou, China. Methods A simulated client method was conducted to estimate the non-prescription sale of antibiotics and service quality based on scenarios about adult acute upper respiratory tract infection in 2019. A total of 595 community pharmacies from 11 districts were investigated in Guangzhou, China. We used binary logistic regression to evaluate the factors associated with the non-prescription sale of antibiotics. Results The proportion of non-prescription dispensing of antibiotics was 63.1% in Guangzhou, China, with a higher incidence of antibiotic dispensing without prescription in outer districts (69.3%). Cephalosporin (44.1%) and Amoxicillin (39.0%) were sold more often than other antibiotics. Chain pharmacies had better performance on the prescription sale of antibiotics and service quality. Traditional Chinese medicine was commonly recommended by pharmacy staff. Conclusion Since the non-prescription sale of antibiotics is prevalent in Guangzhou, effective solutions should be determined. Strengthened public awareness and regulatory system innovation are needed.	[Kuang, Lishan; Wei, Wei; Xia, Sujian] Jinan Univ, Sch Med, Dept Hlth Stat, Guangzhou, Guangdong, Peoples R China; [Liu, Yizhuo; Song, Xueqing; Li, Xiaoqian; Liu, Qiqi; Hong, Weimin; Liu, Qian; Li, Jingwei; Chen, Zhongwei] Jinan Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China; [Fang, Yu] Xi An Jiao Tong Univ, Sch Pharm, Xian, Shaanxi, Peoples R China	Jinan University; Jinan University; Xi'an Jiaotong University	Xia, SJ (corresponding author), Jinan Univ, Sch Med, Dept Hlth Stat, Guangzhou, Guangdong, Peoples R China.; Fang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Xian, Shaanxi, Peoples R China.	yufang@mail.xjtu.edu.cn; xiasujian@163.com			Committee of the Communist Youth League of Jinan University	Committee of the Communist Youth League of Jinan University	Committee of the Communist Youth League of Jinan University; https://tw.jnu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhomoud F, 2017, INT J INFECT DIS, V57, P3, DOI 10.1016/j.ijid.2017.01.014; Alrasheedy AA, 2020, EXPERT REV ANTI-INFE, V18, P87, DOI 10.1080/14787210.2020.1705156; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; [Anonymous], 2017, LANCET HIV, V2, pe115; Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001; Badger-Emeka LI, 2018, INT J HEALTH SCI-IJH, V12, P11; Bhanwra S, 2013, J PHARMACOL PHARMACO, V4, P62, DOI 10.4103/0976-500X.107687; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chang J, 2019, LANCET INFECT DIS, V19, P1345, DOI 10.1016/S1473-3099(19)30324-X; Chang J, 2018, EXPERT REV ANTI-INFE, V16, P163, DOI 10.1080/14787210.2018.1425616; [陈晶 Chen Jing], 2015, [中国药学杂志, Chinese Pharmaceutical Journal], V50, P1643; Chen YK, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224454; Chinese National Medical Prosucts Asministration, 2019, REG PROF QUAL SYST L; Cicero TJ, 2012, J MED INTERNET RES, V14, P347, DOI 10.2196/jmir.2236; Farkas M, 2019, MICROB DRUG RESIST, V25, P1430, DOI 10.1089/mdr.2018.0424; Guangzhou Statistics Bureau, 2019, POP SIZ DISTR GUANGZ; Horumpende PG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207465; Hoxha I, 2018, J GLOB ANTIMICROB RE, V13, P240, DOI 10.1016/j.jgar.2018.01.019; Hu XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181780; [黄瀚 Huang Han], 2014, [中国药房, China Pharmacy], V25, P2398; Jacobs TG, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4359-8; Kalungia AC, 2016, EXPERT REV ANTI-INFE, V14, P1215, DOI 10.1080/14787210.2016.1227702; Khan TM, 2013, EUR J HOSP PHARM-S P, V20, P26, DOI 10.1136/ejhpharm-2012-000161; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Koji EM, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0571-x; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Li Z, 2019, CHINA PHARM, V7, P1320; Liu JX, 2020, LANCET INFECT DIS, V20, P169, DOI 10.1016/S1473-3099(19)30744-3; Lombardo S, 2016, INTERACT J MED RES, V5, P24, DOI 10.2196/ijmr.5231; Machowska A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010027; Matuz M, 2007, PHARM WORLD SCI, V29, P695, DOI 10.1007/s11096-007-9132-0; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; [孟令全 Meng Lingquan], 2012, [中国药房, China Pharmacy], V23, P1245; Ministry of Health of the People's Republic of China, 2006, PRESCR MAN; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; National Bureau of Statistics, 2019, CHIN STAT YB; National Health and Family Plan Commission of China National Development and Reform Commission of China Ministry of Education of China, 2016, NAT ACT PLAN CONT AN; National Medical Products Administration, 2003, SUP ANT DRUG SAL COM; Ocan M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2109-3; Ong DSY, 2008, J ANTIMICROB CHEMOTH, V62, P587, DOI 10.1093/jac/dkn230; Pang B, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019102; Sakeena MHF, 2018, INT J ANTIMICROB AG, V52, P771, DOI 10.1016/j.ijantimicag.2018.09.022; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Viola M, 2005, Eur Ann Allergy Clin Immunol, V37, P223; Wirtz VJ, 2013, TROP MED INT HEALTH, V18, P665, DOI 10.1111/tmi.12096; Wu H-X, 2011, CHINA PHARM, V22, P862; Yu Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019142; Zapata-Cachafeiro M, 2019, J ANTIMICROB CHEMOTH, V74, P511, DOI 10.1093/jac/dky440; Zhen K, 2019, CHINA FOOD DRUG ADM, V4, P102; Zhongyan L, 2011, RES REGIONAL COMPREH	51	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243555	10.1371/journal.pone.0243555	http://dx.doi.org/10.1371/journal.pone.0243555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301450	Green Published, gold			2022-12-26	WOS:000600143100022
J	Lebek, S; Hegner, P; Schach, C; Reuthner, K; Tafelmeier, M; Maier, LS; Arzt, M; Wagner, S				Lebek, Simon; Hegner, Philipp; Schach, Christian; Reuthner, Kathrin; Tafelmeier, Maria; Maier, Lars Siegfried; Arzt, Michael; Wagner, Stefan			A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROTEIN-KINASE-II; ANIMAL-MODEL; BLOOD-PRESSURE; UPPER AIRWAY; CA2+ LEAK; RAT MODEL; HEART; HYPERTENSION; EXPRESSION	Aims Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroethylene (PTFE) injection into the tongue induces spontaneous obstructive apneas. Methods and results PTFE (100 mu l) was injected into the tongue of 31 male C57BL/6 mice and 28 mice were used as control. Spontaneous apneas and inspiratory flow limitations were recorded by whole-body plethysmography and mRNA expression of the hypoxia marker KDM6A was quantified by qPCR. Left ventricular function was assessed by echocardiography and ventricular CaMKII expression was measured by Western blotting. After PTFE injection, mice showed features of OSA such as significantly increased tongue diameters that were associated with significantly and sustained increased frequencies of inspiratory flow limitations and apneas. Decreased KDM6A mRNA levels indicated chronic hypoxemia. 8 weeks after surgery, PTFE-treated mice showed a significantly reduced left ventricular ejection fraction. Moreover, the severity of diastolic dysfunction (measured as E/e') correlated significantly with the frequency of apneas. Accordingly, CaMKII expression was significantly increased in PTFE mice and correlated significantly with the frequency of apneas. Conclusions We describe here the first mouse model of spontaneous inspiratory flow limitations, obstructive apneas, and hypoxia by tongue enlargement due to PTFE injection. These mice develop systolic and diastolic dysfunction and increased CaMKII expression. This mouse model offers great opportunities to investigate the effects of obstructive apneas.	[Lebek, Simon; Hegner, Philipp; Schach, Christian; Reuthner, Kathrin; Tafelmeier, Maria; Maier, Lars Siegfried; Arzt, Michael; Wagner, Stefan] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany	University of Regensburg	Wagner, S (corresponding author), Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany.	stefan.wagner@ukr.de	Wagner, Stefan/AAE-3721-2021; Maier, Lars/AAQ-8313-2021	Wagner, Stefan/0000-0002-9471-1166; Maier, Lars/0000-0001-9915-4429; Lebek, Simon/0000-0003-4525-797X; Hegner, Philipp/0000-0003-1776-777X	Max Weber scholarship; DFG [WA 2539/4-1, WA 2539/5-1, WA 2539/7-1, WA 2539/8-1, MA 1982/5-1, MA 1982/7-1, SFB 1350, 387509280]; ReForM C program of the faculty	Max Weber scholarship; DFG(German Research Foundation (DFG)); ReForM C program of the faculty	SL was funded by the Max Weber scholarship. SW was funded by DFG grants WA 2539/4-1, 5-1, 7-1, and 8-1. LSM was funded by DFG grants MA 1982/5-1 and 7-1. SW and LSM were also funded by the DFG SFB 1350 grant (Project Number 387509280, TPA6), and were supported by the ReForM C program of the faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MA, 2005, CIRCULATION, V112, P375, DOI 10.1161/CIRCULATIONAHA.104.501841; Baum DM, 2018, AM J RESP CRIT CARE, V198, P1336, DOI 10.1164/rccm.201801-0162LE; Belaidi E, 2009, J AM COLL CARDIOL, V53, P1309, DOI 10.1016/j.jacc.2008.12.050; Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5; Brennick MJ, 2009, AM J RESP CRIT CARE, V179, P158, DOI 10.1164/rccm.200809-1435OC; Brooks D, 1997, J CLIN INVEST, V99, P106, DOI 10.1172/JCI119120; Buchner S, 2015, EUR RESPIR J, V45, P680, DOI 10.1183/09031936.00057014; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chami HA, 2011, CIRCULATION, V123, P1280, DOI 10.1161/CIRCULATIONAHA.110.974022; Chopra S, 2016, AM J RESP CELL MOL, V54, P299, DOI 10.1165/rcmb.2015-0218TR; Cowie MR, 2015, NEW ENGL J MED, V373, P1095, DOI 10.1056/NEJMoa1506459; Crossland RF, 2013, AM J PHYSIOL-REG I, V305, pR334, DOI 10.1152/ajpregu.00244.2013; Curado TF, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy089; Dematteis M, 2009, ILAR J, V50, P262, DOI 10.1093/ilar.50.3.262; Diamond DA, 2012, NEW ENGL J MED, V366, P1218, DOI 10.1056/NEJMct1108922; Dybkova N, 2014, CARDIOVASC RES, V103, P168, DOI 10.1093/cvr/cvu120; Farre R, 2007, SLEEP, V30, P930, DOI 10.1093/sleep/30.7.930; Farre R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01556; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Hamano G, 2019, J CARDIOVASC PHARM, V73, P282, DOI 10.1097/FJC.0000000000000662; Joyeux-Faure M, 2005, J APPL PHYSIOL, V98, P1691, DOI 10.1152/japplphysiol.01146.2004; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Korcarz CE, 2016, SLEEP, V39, P1187, DOI 10.5665/sleep.5828; Lebek S, 2020, CIRC RES, V126, P603, DOI 10.1161/CIRCRESAHA.119.315755; Linz D, 2013, HYPERTENSION, V62, P767, DOI 10.1161/HYPERTENSIONAHA.113.01728; Liu YY, 2019, MED SCI MONITOR, V25, P1806, DOI 10.12659/MSM.913056; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HY, 2015, EUR J ORTHODONT, V37, P284, DOI 10.1093/ejo/cju041; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Naghshin J, 2009, J APPL PHYSIOL, V107, P787, DOI 10.1152/japplphysiol.91256.2008; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; ODonnell CP, 1996, J APPL PHYSIOL, V80, P773, DOI 10.1152/jappl.1996.80.3.773; Ortlepp JR, 2000, EUR J CLIN INVEST, V30, P195; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; Philip P, 2005, NEUROBIOL DIS, V20, P428, DOI 10.1016/j.nbd.2005.03.024; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rossi VA, 2013, EUR RESPIR J, V41, P1439, DOI 10.1183/09031936.00128412; Rubies C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47813-1; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Shim CY, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01774-2017; Simeone KA, 2018, EPILEPSIA, V59, P345, DOI 10.1111/epi.13971; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Tietjens JR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010440; Toischer K, 2010, CIRCULATION, V122, P993, DOI 10.1161/CIRCULATIONAHA.110.943431; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; WHITE SG, 1995, J APPL PHYSIOL, V79, P324, DOI 10.1152/jappl.1995.79.1.324; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243844	10.1371/journal.pone.0243844	http://dx.doi.org/10.1371/journal.pone.0243844			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301470	Green Published, gold			2022-12-26	WOS:000600143100058
J	Martin, AJ; Stearns, D; Whitten, MJ; Hage, MM; Page, M; Basu, A				Martin, Anthony J.; Stearns, Dorothy; Whitten, Meredith J.; Hage, Melissa M.; Page, Michael; Basu, Arya			First known trace fossil of a nesting iguana (Pleistocene), The Bahamas	PLOS ONE			English	Article							SAN-SALVADOR ISLAND; CARDISOMA-GUANHUMI; ROCK IGUANA; LAND CRAB; CYCLURA; ICHNOGENUS; AGGREGATION; REPTILIA; DINOSAUR; HABITAT	Most species of modern iguanas (Iguania, Iguanidae) dig burrows for dwelling and nesting, yet neither type of burrow has been interpreted as trace fossils in the geologic record. Here we describe and diagnose the first known fossil example of an iguana nesting burrow, preserved in the Grotto Beach Formation (Early Late Pleistocene, similar to 115 kya) on San Salvador Island, The Bahamas. The trace fossil, located directly below a protosol, is exposed in a vertical section of a cross-bedded oolitic eolianite. Abundant root traces, a probable land-crab burrow, and lack of ghost-crab burrows further indicate a vegetated inland dune as the paleoenvironmental setting. The trace fossil matches dimensions and overall forms of burrows made by modern iguanas, and internal structures indicate active backfilling consistent with modern iguana nesting burrows. The trace fossil is also located on an island with a modern native species of rock iguana (Cyclura riyeli riyeli), suggesting a presence of iguanas on San Salvador since the Late Pleistocene. This nesting burrow may provide a search image for more fossil iguana burrows in The Bahamas and other places with long-established iguana species and favorable geological conditions for preserving their burrows.	[Martin, Anthony J.; Page, Michael] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Stearns, Dorothy] Univ Colorado, Sch Med, Aurora, CO USA; [Whitten, Meredith J.] North Carolina Div Marine Fisheries, Morehead City, NC USA; [Hage, Melissa M.] Emory Univ, Dept Environm Sci, Oxford Coll, Oxford, GA USA; [Page, Michael; Basu, Arya] Emory Univ, Ctr Digital Scholarship, Atlanta, GA 30322 USA	Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; Emory University; Emory University	Martin, AJ (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.	geoam@emory.edu		Basu, Aryabrata/0000-0003-4862-3701				Alberts A.C., 2004, IGUANA, V11, P213; [Anonymous], 2006, REV BRAS ALERG IMMUN, V29, P1; Aplasca AC, 2016, PEERJ, V4, DOI 10.7717/peerj.1793; Benshemesh J, 2014, J MAMMAL, V95, P1054, DOI 10.1644/14-MAMM-A-051; Bishop Gale A., 2011, Anthropological Papers of the American Museum of Natural History, V94, P247; BOCK BC, 1989, COPEIA, P978, DOI 10.2307/1445983; Brannen NA, 1993, GEOMORPHOLOGY FACIES, V13, P30; Bright DB, 1972, CONTRIBUTIONS SCI, V220, P1; Brooke M., 1990, THE MANX SHEARWATER; BURGER J, 1991, J HERPETOL, V25, P430, DOI 10.2307/1564765; Burghardt G, 1982, IGUANAS WORLD THEIR; Carew J.L, 1985, PLEISTOCENE HOLOCENE, P11; CAREW JL, 1995, QUATERNARY SCI REV, V14, P145, DOI 10.1016/0277-3791(94)00108-N; Carew JL, 1989, FIELD TRIP GUIDEBOOK, P7; CHRISTIAN K, 1986, Caribbean Journal of Science, V22, P159; Conrad JL, 2007, J PALEONTOL, V81, P1365, DOI 10.1666/06-005R.1; Conrad JL, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3584[1:ACLCIS]2.0.CO;2; CURRAN H A, 1991, Palaios, V6, P498, DOI 10.2307/3514987; Curran H.A., 2008, P 13 S GEOL BAH OTH, P183; CURRAN HA, 1984, J PALEONTOL, V58, P312; Curran HA, 1997, GUIDE BAHAMIAN ICHNO, P31; Daza JD, 2012, J HERPETOL, V46, P104, DOI 10.1670/10-112; ESTES R, 1973, SCIENCE, V180, P748, DOI 10.1126/science.180.4087.748; ETHERIDGE RICHARD, 1965, QUART J FLORIDA ACAD SCI, V28, P83; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Foos A.M., 1995, GEOL SOC AM SPEC PAP, V300, P223, DOI [10.1130/0-8137-2300-0.223, DOI 10.1130/0-8137-2300-0.223]; Franz Richard, 1995, Caribbean Journal of Science, V31, P149; Franz Richard, 2009, Bulletin of the Florida Museum of Natural History, V49, P1; FREY RW, 1984, J PALEONTOL, V58, P333; GAO KQ, 1995, J VERTEBR PALEONTOL, V15, P57; Genise JF, 2016, ICHNOENTOMOLOGY INSE; GICCA D, 1980, Caribbean Journal of Science, V16, P9; Glumac B, 2016, GEOLOGICAL SOC AM AB, V48, DOI [10.1130/abs/2016AM-282135, DOI 10.1130/ABS/2016AM-282135]; Goodman RM, 2005, ANIM CONSERV, V8, P397, DOI 10.1017/S1367943005002404; HARRIS JG, 1995, CARBONATE EVAPORITE, V10, P215, DOI 10.1007/BF03175406; HARRIS MP, 1969, IBIS, V111, P139, DOI 10.1111/j.1474-919X.1969.tb02523.x; Hastings AK, 2014, J HERPETOL, V48, P380, DOI 10.1670/13-091R1; Hayes W., 2016, HERPETOLOGICAL CONSE, V11, P90; Hayes William K., 2003, Bahamas Journal of Science, V11, P2; Hayes William K., 2004, P232; Hearty PJ, 2008, PALAEOGEOGR PALAEOCL, V267, P41, DOI 10.1016/j.palaeo.2008.06.003; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hearty PJ, 2011, PALAIOS, V26, P394, DOI 10.2110/palo.2010.p10-132r; HERREID CF, 1963, ECOLOGY, V44, P773; Hillbrand PA, 2011, IRCF REPTILES AMPHIB, V19, P155; Iverson JB, 2004, HERPETOL MONOGR, V18, P1, DOI 10.1655/0733-1347(2004)018[0001:TNEOTA]2.0.CO;2; JAMES PC, 1986, ETHOLOGY, V71, P287; Kehlmaier C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2235; KEIGHLEY DG, 1994, PALAEONTOLOGY, V37, P305; Kindler P, 2011, GEOLOGY, V39, P523, DOI 10.1130/G32011.1; Knapp CR, 2006, CAN J ZOOL, V84, P1566, DOI 10.1139/Z06-157; Krumenacker LJ, 2019, PALAEOGEOGR PALAEOCL, V530, P300, DOI 10.1016/j.palaeo.2019.05.047; Leib E, 2004, J CLIN DENSITOM, V7, P7; Lemm JM, 2012, CYCLURA: NATURAL HISTORY, HUSBANDRY, AND CONSERVATION OF WEST INDIAN ROCK IGUANAS, P1; Loope DB, 2006, PALAIOS, V21, P132, DOI 10.2110/palo.2005.p05-55; Malone CL, 2000, MOL PHYLOGENET EVOL, V17, P269, DOI 10.1006/mpev.2000.0836; Malone CL, 2003, CONSERV GENET, V4, P1, DOI 10.1023/A:1021885323539; Martin A.J., 2017, EVOLUTION UNDERGROUN; Martin A.J., 2013, LIFE TRACES GEORGIA; Martin AJ, 2006, TRACES FOSSILS SAN S; Martin AJ, 2011, GEOARCHAEOLOGY ST CA, V94, P114; Mattheus CR, 2018, J COASTAL RES, V34, P1328, DOI 10.2112/JCOASTRES-D-17-00170.1; MORA JM, 1989, HERPETOLOGICA, V45, P293; Moretti M., 2007, SEDIMENT GEOL, V135, P167; Morgan G.S., 2013, B FLORIDA MUSEUM NAT, V52, P161, DOI DOI 10.1206/3916.1; MYLROIE JE, 1995, CARBONATE EVAPORITE, V10, P193, DOI 10.1007/BF03175404; Mylroie JE, 2008, FIELD GUIDE GEOLOGY; Mylroie JE, 2008, QUATERN INT, V183, P61, DOI 10.1016/j.quaint.2007.06.030; Olson L., 1982, SMITHSONIAN CONTRIBU, P48; Olson S.L., 1990, SMITHSONIAN CONTRIBU, V508, P1, DOI DOI 10.5479/si.00810282.508; Perez-Buitrago N., 2016, HERPETOLOGICAL CONSE, V11, P197; PINDER AW, 1993, PHYSIOL ZOOL, V66, P216, DOI 10.1086/physzool.66.2.30163687; PREGILL GK, 1981, ANNU REV ECOL SYST, V12, P75, DOI 10.1146/annurev.es.12.110181.000451; RAND AS, 1983, COPEIA, P705, DOI 10.2307/1444336; RAND AS, 1968, COPEIA, P552, DOI 10.2307/1442024; Rodiguez-Schettino L., 1999, IGUANID LIZARDS CUBA; Ruckdeschel C., 2006, SEA TURTLES ATLANTIC; SHINN E A, 1968, Journal of Paleontology, V42, P879; Simoes TR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9149; Smith JJ, 2008, J PALEONTOL, V82, P267, DOI 10.1666/06-023.1; Smith KT, 2009, B PEABODY MUS NAT HI, V50, P219, DOI 10.3374/014.050.0201; Steadman DW, 2007, P NATL ACAD SCI USA, V104, P19897, DOI 10.1073/pnas.0709572104; Steadman DW, 2015, P NATL ACAD SCI USA, V112, pE5963, DOI 10.1073/pnas.1516490112; Stromback A, 2005, GEOL SOC SPEC PUBL, V252, P163, DOI 10.1144/GSL.SP.2005.252.01.08; Targarona R.R., 2010, CROCODILES STATUS SU, P114; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Trimm Jr. NA, 2005, P 10 S NAT HIST BAH, P137; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Walkowiak K, 2014, OPT SWITCH NETW, V13, P63, DOI 10.1016/j.osn.2014.02.002; White, 1995, GEOL SOC AM SPEC PAP, V300, P63, DOI 10.1130/0-8137-2300-0.63; WHITE B, 1988, SEDIMENT GEOL, V55, P163, DOI 10.1016/0037-0738(88)90095-4; Wiewandt T. A., 1977, THESIS	92	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242935	10.1371/journal.pone.0242935	http://dx.doi.org/10.1371/journal.pone.0242935			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296401	gold, Green Published			2022-12-26	WOS:000598626100029
J	Fajemila, OT; Sariaslan, N; Langer, MR				Fajemila, Olugbenga T.; Sariaslan, Nisan; Langer, Martin R.			Spatial distribution of benthic foraminifera in the Lagos Lagoon (Nigeria): Tracing the impact of environmental perturbations	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; LARGER FORAMINIFERA; ASSEMBLAGES; POLLUTION; SEDIMENTS; REEF; CALCIFICATION; THECAMOEBIANS; COMMUNITIES; INDICATORS	Lagos Lagoon is among Africa's largest estuarine ecosystems, bordered by one of the fastest growing megacities in the world and the ultimate repository of contaminants carried in industrial, municipal and agricultural wastes. The high levels of pollutants have progressively deteriorated the water quality, adversely affected lagoon ecosystems, impacted the livelihood of the coastal population and pose serious risks to human health. Benthic foraminifera are excellent proxies and sensitive bioindicators of environmental disturbances but comprehensive studies on the structure, distribution, diversity and impact of pollution upon foraminiferal communities have not yet been conducted in the Lagos Lagoon. To demonstrate the potential of foraminifera as proxies of environmental perturbations, benthic foraminifera were investigated on a lagoon-wide basis. Lagos Lagoon comprises areas that range from low levels of direct impact to those of severely affected by various forms of anthropogenic disturbance. The goals of this study are to analyze patterns of distribution and species richness, to document foraminiferal community structures, and to identify taxa that track documented records of pollution in Lagos Lagoon sediments. Heat maps were generated from abundance records for selected species to illustrate environmental preferences and relative resistance levels to individual forms of anthropogenic disturbance. Sediments were analyzed for a range of physicochemical properties, via a multi-parameter sensor probe-device, including temperature, pH, depth and total dissolved solids (TDS). Quantitative analysis of 24 sediment samples yielded a total 3872 individuals of benthic foraminifera that belong to 42 species and 25 genera. They comprise 10 porcellaneous, 22 hyaline perforate and 10 agglutinated species. Ammobaculites exiguus, Ammotium salsum, Ammonia aoteana, Ammonia convexa and Trochammina sp. 1 have been found to be the most abundant species. For the first time, the complete present-day foraminifera fauna is illustrated here via scanning electron microscopy. The features recorded allow to assess the spatial effects of pollution upon foraminiferal assemblages on a lagoon-wide basis. The data generated may ultimately form the basis to assess the progressive deterioration of Lagos Lagoon ecosystems from cores by using benthic foraminifera as bioindicators of environmental perturbation.	[Fajemila, Olugbenga T.] Osun State Univ, Dept Geol Sci, Osogbo, Nigeria; [Sariaslan, Nisan; Langer, Martin R.] Rhein Friedrich Wilhelm Univ Bonn, Inst Geowissensch, Palaontol, Bonn, Germany	University of Bonn	Langer, MR (corresponding author), Rhein Friedrich Wilhelm Univ Bonn, Inst Geowissensch, Palaontol, Bonn, Germany.	martin.langer@uni-bonn.de	Fajemila, Olugbenga T./AAT-7453-2021	Fajemila, Olugbenga T./0000-0002-9949-0091	Tertiary Education Tax Fund Nigeria [TETFund/16b/0014]; German Science Foundation (DFG) [LA 884/10-1, LA 884/5-1]	Tertiary Education Tax Fund Nigeria; German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from Tertiary Education Tax Fund Nigeria (www.tetfund.gov.ng) to OTF (TETFund/16b/0014), and the German Science Foundation (DFG; www.dfg.de) to ML (LA 884/10-1, LA 884/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekunbi FO, 2018, J GEOSCI ENV PROT, V6, P112, DOI [10.4236/gep.2018.62008, DOI 10.4236/GEP.2018.62008]; AJAO EA, 1990, OIL CHEM POLLUT, V7, P85, DOI 10.1016/S0269-8579(05)80017-6; Alani R, 2017, AM J BIOL ENV STAT, V3, P49, DOI [10.11648/j.ajbes.20170304.11, DOI 10.11648/J.AJBES.20170304.11]; Alo B., 2014, LAND OCEAN INTERACTI, P65, DOI [DOI 10.1007/978-3-319-06388-1_6, 10.1007/978-3-319-06388-1_6]; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; Amaeze N. H., 2015, Journal of Applied Sciences and Environmental Management, V19, P503, DOI 10.4314/jasem.v19i3.21; Amaeze N. H., 2012, INT J ENV PROTECTION, V2, P8; Aniyikaiye TE, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071235; [Anonymous], 2019, LANCET GLOB HEALTH, V7, pE1, DOI 10.1016/S2214-109X(18)30536-9; [Anonymous], 1999, MODERN FORAMINIFERA; [Anonymous], 2010, EUR J SCI RES; [Anonymous], 1989, RANDA, V25, P183; [Anonymous], 2008, EEARTH DISCUSSIONS; ASSEEZ LO, 1974, PALAEOGEOGR PALAEOCL, V16, P243, DOI 10.1016/0031-0182(74)90021-2; Benson NU, 2020, REG STUD MAR SCI, V37, DOI 10.1016/j.rsma.2020.101335; Benson NU, 2014, ENVIRON MONIT ASSESS, V186, P5519, DOI 10.1007/s10661-014-3800-z; Boudreau REA, 2001, J FORAMIN RES, V31, P108, DOI 10.2113/0310108; Brunner CA, 2013, ENVIRON SCI TECHNOL, V47, P9115, DOI 10.1021/es401943y; Cherchi A, 2012, BIOGEOSCIENCES, V9, P4607, DOI 10.5194/bg-9-4607-2012; CITA MB, 1978, OCEANOL ACTA, V1, P445; Coopriyanovskiy V. P., 2017, INT J OPEN INFORM TE, V5, P56; CULVER S J, 1990, Palaios, V5, P34, DOI 10.2307/3514995; Debenay Jean-Pierre, 1997, Revue de Micropaleontologie, V40, P15, DOI 10.1016/S0035-1598(97)90087-8; Debenay Jean-Pierre, 1993, Revue de Paleobiologie, V12, P265; DEBENAY JP, 1990, J FORAMIN RES, V20, P267, DOI 10.2113/gsjfr.20.3.267; DEBENAY JP, 1989, HYDROBIOLOGIA, V174, P161, DOI 10.1007/BF00014063; Doherty VF, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5576-9; Don-Pedro K.N., 2004, WEST AFR J APPL ECOL, V5, P103, DOI DOI 10.4314/WAJAE.V5I1.45601; du Chatelet EA, 2011, NEUES JAHRB GEOL P-A, V262, P91, DOI 10.1127/0077-7749/2011/0187; Eichler PPB, 2006, J COASTAL RES, P1144; Elijah F. B., 2015, POUTLRY FISHERIES WI, V3, P131, DOI [10.4172/2375-446X.1000131, DOI 10.4172/2375-446X.1000131]; Emmanuel B. E., 2010, African Journal of Environmental Science and Technology, V4, P480; Fajemila OT, 2017, NEUES JAHRB GEOL P-A, V285, P337, DOI 10.1127/njgpa/2017/0686; Fajemila Olugbenga T., 2016, Revue de Micropaleontologie, V59, P397, DOI 10.1016/j.revmic.2016.09.002; Frontalini Fabrizio, 2011, Revue de Micropaleontologie, V54, P115, DOI 10.1016/j.revmic.2011.03.001; Glenn-Sullivan EC, 2001, PALAIOS, V16, P399, DOI 10.2307/3515579; Habura A, 2006, J EUKARYOT MICROBIOL, V53, P204, DOI 10.1111/j.1550-7408.2006.00096.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayward BW, 2004, PALAEOGEOGR PALAEOCL, V211, P59, DOI 10.1016/j.palaeo.2004.04.007; Hayward BW, MICROPALEONTOLOGY; HILL MB, 1958, PHILOS T ROY SOC B, V241, P319, DOI 10.1098/rstb.1958.0006; INGLE JAMES C., 1967, BULL AMER PALEONTOL, V52, P217; Jorissen FJ, 2009, DEEP-SEA RES PT II, V56, P2270, DOI 10.1016/j.dsr2.2009.04.009; Langer MR, 2006, MICROPALEONTOLOGY, V52, P343, DOI 10.2113/gsmicropal.52.4.343; Langer MR, 2016, NEUES JAHRB GEOL P-A, V281, P327, DOI 10.1127/njgpa/2016/0602; Langer MR, 2016, MICROPALEONTOLOGY, V62, P69; Langer MR, 2013, NEUES JAHRB GEOL P-A, V267, P155, DOI 10.1127/0077-7749/2013/0302; Langer MR, 2003, CORAL REEFS, V22, P143, DOI 10.1007/s00338-003-0298-1; Lawson E., 2011, ADV BIOL RES, V5, P8; Le Cadre V, 2003, J FORAMIN RES, V33, P1, DOI 10.2113/0330001; LEA DW, 1995, J FORAMIN RES, V25, P14, DOI 10.2113/gsjfr.25.1.14; Lipps JH, 1999, MICROPALEONTOLOGY, V45, P278, DOI 10.2307/1486137; Magno MC, 2012, MAR GEOL, V315, P143, DOI 10.1016/j.margeo.2012.04.002; Martins V, 2010, ESTUAR COAST SHELF S, V87, P293, DOI 10.1016/j.ecss.2010.01.011; Mekuleyi GO, 2019, INT J ECOTOXICOL ECO, V4, P93, DOI [10.11648/j.ijee.20190404.13, DOI 10.11648/J.IJEE.20190404.13]; Mennillo E, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.108986; Mikhalevich VI, 1983, BOTTOM FORAMINIFERA; Mojtahid M, 2006, MAR MICROPALEONTOL, V61, P58, DOI 10.1016/j.marmicro.2006.05.004; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Obi CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01213; Okewole O, 2007, POLLUTION INDICATING; Olayinka OO, 2018, J HEALTH POLLUT, V8, DOI 10.5696/2156-9614-8.20.181210; Omezuruike OI, 2008, AFR J BIOTECHNOL, V7, P617; Phillips O.A., 2012, J MINING GEOLOGY, V48, P71; Phillips OA, 2020, ASIAN J EARTH SCI, V13, P45; PHLEGER F B, 1978, Journal of Foraminiferal Research, V8, P127; Roni T, 2017, MAR POLLUT BULL, V117, P50, DOI 10.1016/j.marpolbul.2016.12.045; Schott W, 1955, DTSCH SUDPOLAR EXPED, V6, P411; SCOTT DB, 1990, NATO ADV SCI I C-MAT, V327, P717; Sogbanmu TO, 2016, ENVIRON SCI POLLUT R, V23, P14489, DOI 10.1007/s11356-016-6490-y; Suokhrie T., 2017, MICROPALEONTOLOGY IT, P265; Thissen JM, 2017, PALAEONTOGR ABT A, V308, P1, DOI 10.1127/pala/308/2017/1; Uzoma E. C., 2015, African Journal of Biotechnology, V14, P2114; Vilela CG, 2011, MAR POLLUT BULL, V62, P2055, DOI 10.1016/j.marpolbul.2011.07.023; Weinmann Anna E., 2017, Revue de Micropaleontologie, V60, P511, DOI 10.1016/j.revmic.2017.09.002; Yordanova EK, 2002, FACIES, V46, P169, DOI 10.1007/BF02668080; 2019, CAN J KIDNEY HLTH DI, V6, P1	77	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243481	10.1371/journal.pone.0243481	http://dx.doi.org/10.1371/journal.pone.0243481			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284843	Green Published, gold			2022-12-26	WOS:000597930500042
J	Ngarambe, J; Nganyiyimana, J; Kim, I; Santamouris, M; Yun, GY				Ngarambe, Jack; Nganyiyimana, Jacques; Kim, Inhan; Santamouris, Mat; Yun, Geun Young			Synergies between urban heat island and heat waves in Seoul: The role of wind speed and land use characteristics	PLOS ONE			English	Article							ANTHROPOGENIC HEAT; CLIMATE ZONES; SOUTH-KOREA; COOL ROOFS; TEMPERATURE; MORTALITY; IMPACT; VULNERABILITY; MITIGATION; SUMMER	The effects of heat waves (HW) are more pronounced in urban areas than in rural areas due to the additive effect of the urban heat island (UHI) phenomenon. However, the synergies between UHI and HW are still an open scientific question and have only been quantified for a few metropolitan cities. In the current study, we explore the synergies between UHI and HW in Seoul city. We consider summertime data from two non-consecutive years (i.e., 2012 and 2016) and ten automatic weather stations. Our results show that UHI is more intense during HW periods than non-heat wave (NHW) periods (i.e., normal summer background conditions), with a maximum UHI difference of 3.30 degrees C and 4.50 degrees C, between HW and NHW periods, in 2012 and 2016 respectively. Our results also show substantial variations in the synergies between UHI and HW due to land use characteristics and synoptic weather conditions; the synergies were relatively more intense in densely built areas and under low wind speed conditions. Our results contribute to our understanding of thermal risks posed by HW in urban areas and, subsequently, the health risks on urban populations. Moreover, they are of significant importance to emergency relief providers as a resource allocation guideline, for instance, regarding which areas and time of the day to prioritize during HW periods in Seoul.	[Ngarambe, Jack; Nganyiyimana, Jacques; Santamouris, Mat; Yun, Geun Young] Kyung Hee Univ, Dept Architectural Engn, Yongin, Gyeongi Do, South Korea; [Kim, Inhan] Kyung Hee Univ, Dept Architecture, Yongin, Gyeongi Do, South Korea; [Santamouris, Mat] Univ New South Wales, Fac Built Environm, Sydney, NSW, Australia	Kyung Hee University; Kyung Hee University; University of New South Wales Sydney	Yun, GY (corresponding author), Kyung Hee Univ, Dept Architectural Engn, Yongin, Gyeongi Do, South Korea.	gyyun@khu.ac.kr	Mat, Santamouris/AAP-2836-2021; Yun, Geun Young/C-3843-2012	Yun, Geun Young/0000-0002-9868-8776	Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korean government (MOTIE) [20192020101170]; Architecture & Urban Development Research Program - Ministry of Land, Infrastructure and Transport of the Korean government [20AUDP-B127891-04]	Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korean government (MOTIE); Architecture & Urban Development Research Program - Ministry of Land, Infrastructure and Transport of the Korean government	This work was supported by Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korean government (MOTIE) (20192020101170, Development of Energy-Recovery Ventilators Equipped with Air Filters for Fine Dust Removal). This research was supported by a grant (20AUDP-B127891-04) from the Architecture & Urban Development Research Program funded by the Ministry of Land, Infrastructure and Transport of the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamaas B, 2017, ATMOS CHEM PHYS, V17, P10795, DOI 10.5194/acp-17-10795-2017; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2020, CLIN J SPORT MED, V29, pe111; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Bokaie M, 2016, SUSTAIN CITIES SOC, V23, P94, DOI 10.1016/j.scs.2016.03.009; Chen Y, 2009, THEOR APPL CLIMATOL, V97, P123, DOI 10.1007/s00704-008-0054-0; Cheung PK, 2019, BUILD ENVIRON, V164, DOI 10.1016/j.buildenv.2019.106362; Choi N, 2019, ASIA-PAC J ATMOS SCI, V55, P101, DOI 10.1007/s13143-018-00101-w; Deilami K, 2018, INT J APPL EARTH OBS, V67, P30, DOI 10.1016/j.jag.2017.12.009; Estevez J, 2011, J HYDROL, V402, P144, DOI 10.1016/j.jhydrol.2011.02.031; Founda D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11407-6; Gaffin SR, 2008, THEOR APPL CLIMATOL, V94, P1, DOI 10.1007/s00704-007-0368-3; Gao K, 2019, BUILD ENVIRON, V164, DOI 10.1016/j.buildenv.2019.106346; Guo AD, 2020, SUSTAIN CITIES SOC, V53, DOI 10.1016/j.scs.2019.101972; He BJ, 2020, SUSTAIN CITIES SOC, V55, DOI 10.1016/j.scs.2020.102028; He BJ, 2018, URBAN CLIM, V24, P26, DOI 10.1016/j.uclim.2018.01.004; Heaviside C, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0100-9; Ichinose T, 1999, ATMOS ENVIRON, V33, P3897, DOI 10.1016/S1352-2310(99)00132-6; Imran HM, 2019, WEATHER CLIM EXTREME, V25, DOI 10.1016/j.wace.2019.100217; Imran HM, 2018, J CLEAN PROD, V197, P393, DOI 10.1016/j.jclepro.2018.06.179; Kang M-G, 1998, DEV SOC, V27, P99; Khan HS, 2020, ENERGIES, V13, DOI 10.3390/en13020470; Kim DW, 2017, NAT HAZARDS, V89, P35, DOI 10.1007/s11069-017-2951-y; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kotharkar R, 2018, URBAN CLIM, V24, P1011, DOI 10.1016/j.uclim.2017.12.006; Kuglitsch FG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041841; Kysely J, 2009, CLIM RES, V38, P105, DOI 10.3354/cr00775; Lee D, 2018, URBAN CLIM, V24, P503, DOI 10.1016/j.uclim.2017.06.005; Lee WS, 2016, INT J CLIMATOL, V36, P4815, DOI 10.1002/joc.4671; Lee YY, 2016, ENERG BUILDINGS, V110, P353, DOI 10.1016/j.enbuild.2015.11.013; Li D, 2013, J APPL METEOROL CLIM, V52, P2051, DOI 10.1175/JAMC-D-13-02.1; Macintyre HL, 2019, ENVIRON INT, V127, P430, DOI 10.1016/j.envint.2019.02.065; McHugh TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13767; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mohajerani A, 2017, J ENVIRON MANAGE, V197, P522, DOI 10.1016/j.jenvman.2017.03.095; Morris CJG, 2001, J APPL METEOROL, V40, P169, DOI 10.1175/1520-0450(2001)040<0169:QOTIOW>2.0.CO;2; Ngarambe J, 2021, J HAZARD MATER, V403, DOI 10.1016/j.jhazmat.2020.123615; Noor MN, 2014, KEY ENG MATER, V594-595, P889, DOI 10.4028/www.scientific.net/KEM.594-595.889; Noor Norazian Mohamed, 2015, Materials Science Forum, V803, P278, DOI 10.4028/www.scientific.net/MSF.803.278; Oh JW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60632-z; Park S, 2019, QUATERN INT, V519, P74, DOI 10.1016/j.quaint.2019.04.004; Perkins SE, 2013, J CLIMATE, V26, P4500, DOI 10.1175/JCLI-D-12-00383.1; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Pyrgou A, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109102; Reid CE, 2009, ENVIRON HEALTH PERSP, V117, P1730, DOI 10.1289/ehp.0900683; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Robinson PJ, 2001, J APPL METEOROLOGY, V40, P14; Rydman RJ, CHICAGO HEAT DISASTE, V16; Santamouris M, 2020, ENERG BUILDINGS, V217, DOI 10.1016/j.enbuild.2020.110002; Santamouris M, 2020, ENERG BUILDINGS, V207, DOI 10.1016/j.enbuild.2019.109482; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; Stewart ID, 2012, B AM METEOROL SOC, V93, P1879, DOI 10.1175/BAMS-D-11-00019.1; Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x; Tsekeri E, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.139843; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Working Party on Thrombolysis in the Management of Limb Ischemia, 2003, J VASC INTERV RADIOL, V7, pS337; Yang JC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay3452; Yang J, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101487; Yang J, 2019, URBAN CLIM, V28, DOI 10.1016/j.uclim.2019.100458; Yang J, 2019, SCI TOTAL ENVIRON, V649, P695, DOI 10.1016/j.scitotenv.2018.08.332; Yoo JM, 2011, ASIA-PAC J ATMOS SCI, V47, P439, DOI 10.1007/s13143-011-0029-4; Yun GY, 2020, SCI TOTAL ENVIRON, V709, DOI 10.1016/j.scitotenv.2019.136068; Yun GY., 2007, P CISBAT INT C LAUS; Zhao ZQ, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11080776	65	19	19	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243571	10.1371/journal.pone.0243571	http://dx.doi.org/10.1371/journal.pone.0243571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284850	Green Published, gold			2022-12-26	WOS:000597930500053
J	Soomers, VLMN; van der Graaf, WTA; Zaidi, S; Kaal, SEJ; Hayes, AJ; Schreuder, BHWB; Jones, RL; Desar, IME; Husson, O				Soomers, Vicky L. M. N.; van der Graaf, Winette T. A.; Zaidi, Shane; Kaal, Suzanne E. J.; Hayes, Andrew J.; Schreuder, Bart H. W. B.; Jones, Robin L.; Desar, Ingrid M. E.; Husson, Olga			The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United Kingdom	PLOS ONE			English	Article							CANCER-DIAGNOSIS; OVARIAN-CANCER; DELAY; EXPERIENCES; MODEL; CARE	Introduction Sarcomas are rare tumours. Early diagnosis is challenging, but important for local control and potentially survival and quality of life(QoL). We investigated (1)the route to diagnosis (RtD) experienced by sarcoma patients, including factors contributing to the length of the RtD from patients' perspective; (2)the impact of the RtD on QoL and care satisfaction; and (3)differences in aims 1-2 between English and Dutch patients. Methods Fifteen sarcoma patients from The Royal Marsden Hospital, United Kingdom, and Radboud University Medical Centre, The Netherlands, were interviewed, exploring RtD experiences. Interviews were analysed according to qualitative content analysis. Results The main themes were: patient interval, diagnostic interval, reflection on the RtD and recommendations for improvement. Patient interval was long if symptoms were attributed as benign, did not interfere with daily life or were expected to cease. An incorrect working diagnosis, ineffective process of additional investigations, long referral times and lack of a lead clinician lengthened the diagnostic interval. Long waiting times, false reassurance and inadequate information provision led to dissatisfaction and a high emotional burden. Factors for improvement included increasing awareness of patients and healthcare providers, empowering patients, and having a lead clinician. Conclusion The RtD of sarcoma patients is complex. Increasing awareness of patients and healthcare providers may contribute to shorten the RtD.	[Soomers, Vicky L. M. N.; van der Graaf, Winette T. A.; Kaal, Suzanne E. J.; Schreuder, Bart H. W. B.; Desar, Ingrid M. E.] Radboudumc, Nijmegen, Netherlands; [van der Graaf, Winette T. A.; Husson, Olga] Antoni van Leeuwenhoekziekenhuis, Amsterdam, Netherlands; [van der Graaf, Winette T. A.; Zaidi, Shane; Hayes, Andrew J.; Jones, Robin L.] Royal Marsden Hosp NHS Fdn Trust, London, England; [Schreuder, Bart H. W. B.] Prinses Maxima Ctr, Utrecht, Netherlands; [Husson, Olga] Inst Canc Res, London, England	Radboud University Nijmegen; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Husson, O (corresponding author), Antoni van Leeuwenhoekziekenhuis, Amsterdam, Netherlands.; Husson, O (corresponding author), Inst Canc Res, London, England.	Olga.Husson@icr.ac.uk	Husson, Olga/L-1339-2015; Husson, Olga/ABI-4686-2020; Schreuder, H.W.B./L-4638-2015	Husson, Olga/0000-0002-1387-8686; Husson, Olga/0000-0002-1387-8686; Hayes, Andrew/0000-0002-9832-4219; Jones, Robin/0000-0003-4173-3844				Black G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135027; Blay JY, 2016, LANCET ONCOL, V17, pE62, DOI 10.1016/S1470-2045(15)00388-5; Brousselle A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2390-1; Chiu S, 2015, CAN FAM PHYSICIAN, V61, pE509; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P261, DOI 10.3322/caac.21400; Evans J, 2007, FAM PRACT, V24, P48, DOI 10.1093/fampra/cml063; Fern LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6493; Gibson F, 2013, PSYCHO-ONCOLOGY, V22, P2585, DOI 10.1002/pon.3325; Harrison WD, 2016, J SURG ONCOL, V113, P361, DOI 10.1002/jso.24149; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Larsen MB, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572409; McPhail S, 2015, BRIT J CANCER, V112, pS108, DOI 10.1038/bjc.2015.49; Mesko NW, 2014, J SURG ONCOL, V110, P919, DOI 10.1002/jso.23770; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; Mossialos E, 2016, COMMONWALTH FUND 201; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; Risberg T, 1996, ANTICANCER RES, V16, P995; Robinson KM, 2012, QUAL LIFE RES, V21, P1519, DOI 10.1007/s11136-011-0077-3; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Soomers V, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2019-000592; Stiller CA, 2013, EUR J CANCER, V49, P684, DOI 10.1016/j.ejca.2012.09.011; UK S, 2020, DEL COST LIV CALL PO; Walming S, 2018, COLORECTAL DIS, V20, P126, DOI 10.1111/codi.13836; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Wilson R, 2019, CLIN SARCOMA RES, V9, DOI 10.1186/s13569-019-0121-6	27	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243439	10.1371/journal.pone.0243439	http://dx.doi.org/10.1371/journal.pone.0243439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284856	gold, Green Published			2022-12-26	WOS:000597930500019
J	Wonfor, RE; Creevey, CJ; Natoli, M; Hegarty, M; Nash, DM; Rose, MT				Wonfor, Ruth E.; Creevey, Christopher J.; Natoli, Manuela; Hegarty, Matthew; Nash, Deborah M.; Rose, Michael T.			Interaction of preimplantation factor with the global bovine endometrial transcriptome	PLOS ONE			English	Article							INTERFERON REGULATORY FACTORS; TUMOR-NECROSIS-FACTOR; EARLY-PREGNANCY; ESTROUS-CYCLE; EXPRESSION; IMMUNITY; RECEPTOR; INFLAMMATION; ADHESION; CD40	Preimplantation factor (PIF) is an embryo derived peptide which exerts an immune modulatory effect on human endometrium, promoting immune tolerance to the embryo whilst maintaining the immune response to invading pathogens. While bovine embryos secrete PIF, the effect on the bovine endometrium is unknown. Maternal recognition of pregnancy is driven by an embryo-maternal cross talk, however the process differs between humans and cattle. As many embryos are lost during the early part of pregnancy in cattle, a greater knowledge of factors affecting the embryo-maternal crosstalk, such as PIF, is needed to improve fertility. Therefore, for the first time, we demonstrate the effect of synthetic PIF (sPIF) on the bovine transcriptome in an ex vivo bovine endometrial tissue culture model. Explants were cultured for 30h with sPIF (100nM) or in control media. Total RNA was analysed via RNA-sequencing. As a result of sPIF treatment, 102 genes were differentially expressed compared to the control (Padj<0.1), although none by more than 2-fold. The majority of genes (78) were downregulated. Pathway analysis revealed targeting of several immune based pathways. Genes for the TNF, NF-kappa B, IL-17, MAPK and TLR signalling pathways were down-regulated by sPIF. However, some immune genes were demonstrated to be upregulated following sPIF treatment, including C3. Steroid biosynthesis was the only over-represented pathway with all genes upregulated. We demonstrate that sPIF can modulate the bovine endometrial transcriptome in an immune modulatory manner, like that in the human endometrium, however, the regulation of genes was much weaker than in previous human work.	[Wonfor, Ruth E.; Creevey, Christopher J.; Natoli, Manuela; Hegarty, Matthew; Nash, Deborah M.; Rose, Michael T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Ceredigion, Wales; [Creevey, Christopher J.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Natoli, Manuela] Canc Res UK, Cambridge, England; [Rose, Michael T.] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Queens University Belfast; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Tasmania	Wonfor, RE (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Ceredigion, Wales.	rec21@aber.ac.uk	Rose, Michael/AAI-6335-2021; Creevey, Christopher James/A-1836-2013	Creevey, Christopher James/0000-0001-7183-1555; Nash, Deborah Mary/0000-0001-5834-770X; Wonfor, Ruth/0000-0002-7732-9483; Hegarty, Matthew/0000-0001-6547-3800; Rose, Michael/0000-0001-6058-1319	Aberystwyth University through the Doctoral Career Development Scheme	Aberystwyth University through the Doctoral Career Development Scheme	R. Wonfor was funded by Aberystwyth University through the Doctoral Career Development Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Alminana C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033625; [Anonymous], 2012, PHILOSOPHY, V87, P6; Ara A, 2018, IMMUNOTARGETS THER, V7, P55, DOI 10.2147/ITT.S163614; Arosh JA, 2002, BIOL REPROD, V67, P161, DOI 10.1095/biolreprod67.1.161; Balyura M, 2018, HORM METAB RES, V50, P168, DOI 10.1055/s-0043-120064; Barnea ER, 2004, AM J REPROD IMMUNOL, V51, P319, DOI 10.1111/j.1600-0897.2004.00159.x; Barnea ER, 2016, IMMUNOBIOLOGY, V221, P778, DOI 10.1016/j.imbio.2016.02.004; Barnea ER, 2015, IMMUNOBIOLOGY, V220, P865, DOI 10.1016/j.imbio.2015.01.010; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Bauersachs S, 2017, BIOL REPROD, V97, P413, DOI 10.1093/biolre/iox095; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Beguin EP, 2019, J PROTEOMICS, V192, P89, DOI 10.1016/j.jprot.2018.08.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122874; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borges AM, 2012, AM J REPROD IMMUNOL, V67, P526, DOI 10.1111/j.1600-0897.2012.01106.x; Buska K, 2017, REPROD BIOL, V17, P89, DOI 10.1016/j.repbio.2017.01.003; Chandel HS, 2014, CLIN EXP IMMUNOL, V176, P283, DOI 10.1111/cei.12264; Choi HJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113428; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Correia-Alvarez E, 2015, THERIOGENOLOGY, V83, P1028, DOI 10.1016/j.theriogenology.2014.12.007; Cotechini T, 2015, PLACENTA, V36, P960, DOI 10.1016/j.placenta.2015.05.016; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Denny KJ, 2013, AM J REPROD IMMUNOL, V69, P3, DOI 10.1111/aji.12000; Duzyj CM, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-36; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Ealy AD, 2009, AM J REPROD IMMUNOL, V61, P95, DOI 10.1111/j.1600-0897.2008.00673.x; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; FURIE MB, 1995, AM J PATHOL, V146, P1287; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gilbert RO, 2005, THERIOGENOLOGY, V64, P1879, DOI 10.1016/j.theriogenology.2005.04.022; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Greene JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144133; Groebner AE, 2011, REPROD FERT DEVELOP, V23, P619, DOI 10.1071/RD10230; Guggeri D, 2018, REPROD DOMEST ANIM, V53, P930, DOI 10.1111/rda.13190; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Haneda S, 2017, J REPROD DEVELOP, V63, P127, DOI 10.1262/jrd.2016-096; Immler RT, 2015, 94 ANN M GERM PHYS S; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khatib H, 2019, J DAIRY SCI, V102, P3744, DOI 10.3168/jds.2018-15252; King AE, 2001, MOL HUM REPROD, V7, P175, DOI 10.1093/molehr/7.2.175; King AE, 2001, J CLIN ENDOCR METAB, V86, P405, DOI 10.1210/jc.86.1.405; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Kotowicz K, 2000, IMMUNOLOGY, V100, P441, DOI 10.1046/j.1365-2567.2000.00061.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis GS, 2004, ANIM REPROD SCI, V82-3, P281, DOI 10.1016/j.anireprosci.2004.04.026; Lewis GS, 2003, J ANIM SCI, V81, P285; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madoz LV, 2013, J DAIRY SCI, V96, P4333, DOI 10.3168/jds.2012-6269; Mamo S, 2011, BIOL REPROD, V85, P1143, DOI 10.1095/biolreprod.111.092643; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Marth CD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2139-3; Mathew DJ, 2019, BIOL REPROD, V100, P365, DOI 10.1093/biolre/ioy199; Matsubara K, 2016, HYPERTENS RES, V39, P407, DOI 10.1038/hr.2015.160; McCabe M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-193; Mentorou C, 2010, J REPROD IMMUNOL; Moindjie H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119156; Monastra G, 2018, EUR REV MED PHARMACO, V22, P2502, DOI 10.26355/eurrev_201804_14845; Moore SG, 2017, BIOL REPROD, V97, P18, DOI 10.1093/biolre/iox059; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Moraes JGN, 2018, P NATL ACAD SCI USA, V115, pE1749, DOI 10.1073/pnas.1721191115; Moretti S, 2015, EXPERT OPIN BIOL TH, V15, pS51, DOI 10.1517/14712598.2015.1044895; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Munoz M, 2012, J PROTEOME RES, V11, P751, DOI 10.1021/pr200969a; Nash DM, 2018, VET MED SCI, V4, P351, DOI 10.1002/vms3.126; Ostuni MA, 2014, BIOL OPEN, V3, P1173, DOI 10.1242/bio.20149845; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; Romani L, 2012, ANN NY ACAD SCI, V1269, P1, DOI 10.1111/j.1749-6632.2012.06716.x; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Saut JPE, 2014, REPRODUCTION, V148, P593, DOI 10.1530/REP-14-0230; Soto P, 2003, AM J REPROD IMMUNOL, V50, P380, DOI 10.1034/j.1600-0897.2003.00101.x; Spencer TE, 1998, BIOL REPROD, V58, P1154, DOI 10.1095/biolreprod58.5.1154; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stewart DM, 2001, ENDOCRINOLOGY, V142, P98, DOI 10.1210/en.142.1.98; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thatcher WW, 2001, THERIOGENOLOGY, V56, P1435, DOI 10.1016/S0093-691X(01)00645-8; Valour D, 2013, REPROD DOMEST ANIM, V48, P484, DOI 10.1111/rda.12113; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Wiltbank MC, 2016, THERIOGENOLOGY, V86, P239, DOI 10.1016/j.theriogenology.2016.04.037; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; Wonfor RE, 2017, THERIOGENOLOGY, V102, P174, DOI 10.1016/j.theriogenology.2017.08.001; Wu DD, 2016, SHOCK, V46, P329, DOI 10.1097/SHK.0000000000000595; Zhao G, 2018, THERIOGENOLOGY, V105, P51, DOI 10.1016/j.theriogenology.2017.09.004; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030	101	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0242874	10.1371/journal.pone.0242874	http://dx.doi.org/10.1371/journal.pone.0242874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284816	Green Published, gold, Green Accepted			2022-12-26	WOS:000597930500043
J	Chen, YA; Park, J; Natsume-Kitatani, Y; Kawashima, H; Mohsen, A; Hosomi, K; Tanisawa, K; Ohno, H; Konishi, K; Murakami, H; Miyachi, M; Kunisawa, J; Mizuguchi, K				Chen, Yi-An; Park, Jonguk; Natsume-Kitatani, Yayoi; Kawashima, Hitoshi; Mohsen, Attayeb; Hosomi, Koji; Tanisawa, Kumpei; Ohno, Harumi; Konishi, Kana; Murakami, Haruka; Miyachi, Motohiko; Kunisawa, Jun; Mizuguchi, Kenji			MANTA, an integrative database and analysis platform that relates microbiome and phenotypic data	PLOS ONE			English	Article							INDEXES; SILVA	With an ever-increasing interest in understanding the relationships between the microbiota and the host, more tools to map, analyze and interpret these relationships have been developed. Most of these tools, however, focus on taxonomic profiling and comparative analysis among groups, with very few analytical tools designed to correlate microbiota and the host phenotypic data. We have developed a software program for creating a web-based integrative database and analysis platform called MANTA (Microbiota And pheNoType correlation Analysis platform). In addition to storing the data, MANTA is equipped with an intuitive user interface that can be used to correlate the microbial composition with phenotypic parameters. Using a case study, we demonstrated that MANTA was able to quickly identify the significant correlations between microbial abundances and phenotypes that are supported by previous studies. Moreover, MANTA enabled the users to quick access locally stored data that can help interpret microbiota-phenotype relations. MANTA is available at https://mizuguchilab.org/manta/ for download and the source code can be found at https://github.com/chenyian-nibio/manta.	[Chen, Yi-An; Park, Jonguk; Natsume-Kitatani, Yayoi; Kawashima, Hitoshi; Mohsen, Attayeb; Mizuguchi, Kenji] Natl Inst Biomed Innovat Hlth & Nutr, Artificial Intelligence Ctr Hlth & Biomed Res, Lab Bioinformat, Ibaraki, Osaka, Japan; [Hosomi, Koji; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Vaccine Mat, Ctr Vaccine & Adjuvant Res, Ibaraki, Osaka, Japan; [Hosomi, Koji; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Gut Environm Syst, Ibaraki, Osaka, Japan; [Tanisawa, Kumpei; Ohno, Harumi; Konishi, Kana; Murakami, Haruka; Miyachi, Motohiko] Natl Inst Biomed Innovat Hlth & Nutr, Dept Phys Act Res, Shinjuku Ku, Tokyo, Japan		Chen, YA; Mizuguchi, K (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Artificial Intelligence Ctr Hlth & Biomed Res, Lab Bioinformat, Ibaraki, Osaka, Japan.	chenyian@nibiohn.go.jp; kenji@niobiohn.gp.jp	Mizuguchi, Kenji/GVS-5857-2022; Miyachi, Motohiko/AAW-3403-2020; Mohsen, Attayeb/I-6728-2018	Mizuguchi, Kenji/0000-0003-3021-7078; Miyachi, Motohiko/0000-0002-1146-0905; Mohsen, Attayeb/0000-0003-0690-8012; Kawashima, Hitoshi/0000-0003-3612-4294; Tanisawa, Kumpei/0000-0002-9334-7104; Chen, Yi-An/0000-0003-4936-8060	Japan Society for the Promotion of Science [17K07268, 18H02150, 18H02674, 17K09604, 18K17997]; Japan Agency for Medical Research and Development (AMED) [17fk0108223h0002, 17ek0410032s0102, 17fk0108207h0002, 17ek0210078h0002, 17ak0101068h0001, 17gm1010006s0101, 18ck0106243h0003]; Ministry of Health, Labour and Welfare of Japan [15654110]; ONO Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ONO Medical Research Foundation	This work was supported by the Japan Society for the Promotion of Science under grant numbers 17K07268 (K.M.), 18H02150 (J.K.), 18H02674 (J.K.), 17K09604 (J.K.), and 18K17997 (K.H.); the Japan Agency for Medical Research and Development (AMED) under grant numbers 17fk0108223h0002 (J.K.), 17ek0410032s0102 (J. K.), 17fk0108207h0002 (J.K.), 17ek0210078h0002 (J.K.), 17ak0101068h0001 (J.K.), 17gm1010006s0101 (J.K.), and 18ck0106243h0003 (J.K.); the Ministry of Health, Labour and Welfare of Japan under grant number 15654110 (M.M.); the ONO Medical Research Foundation (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaband C, 2019, CLIN GASTROENTEROL H, V17, P218, DOI 10.1016/j.cgh.2018.09.017; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bougeard S, 2018, J STAT SOFTW, V86, P1, DOI 10.18637/jss.v086.i01; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chen YA, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw009; Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331; Croux C, 2010, STAT METHOD APPL-GER, V19, P497, DOI 10.1007/s10260-010-0142-z; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hosomi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04511-0; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Jin BT, 2018, MIAN INTERACTIVE WEB, P416073, DOI [10.1101/416073, DOI 10.1101/416073]; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McMurdie PJ, 2015, BIOINFORMATICS, V31, P282, DOI 10.1093/bioinformatics/btu616; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mohsen A, 2018, ZENODO; Mohsen A, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3187-5; Morgenthaler S, 2007, STAT METHOD APPL, V16, P171, DOI 10.1007/s10260-007-0057-5; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Or Nick H. K., 2017, POLICY STUD J, V45, pS67; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243609	10.1371/journal.pone.0243609	http://dx.doi.org/10.1371/journal.pone.0243609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275647	Green Published, gold			2022-12-26	WOS:000597150200041
J	Ihme, H; Schwarting, RKW; Melo-Thomas, L				Ihme, Hannah; Schwarting, Rainer K. W.; Melo-Thomas, Liana			Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats	PLOS ONE			English	Article							PARKINSONS-DISEASE; PARADOXICAL KINESIA; GLUTAMATERGIC NEUROTRANSMISSION; ELECTRICAL-STIMULATION; DOPAMINE RELEASE; ANIMAL-MODEL; DISORDERS; RECEPTORS	Deep brain stimulation (DBS) of the colliculus inferior (IC) improves haloperidol-induced catalepsy and induces paradoxal kinesia in rats. Since the IC is part of the brain aversive system, DBS of this structure has long been related to aversive behavior in rats limiting its clinical use. This study aimed to improve intracollicular DBS parameters in order to avoid anxiogenic side effects while preserving motor improvements in rats. Catalepsy was induced by systemic haloperidol (0.5mg/kg) and after 60 min the bar test was performed during which a given rat received continuous (5 min, with or without pre-stimulation) or intermittent (5 x 1 min) DBS (30Hz, 200-600 mu A, pulse width 100 mu s). Only continuous DBS with pre-stimulation reduced catalepsy time. The rats were also submitted to the elevated plus maze (EPM) test and received either continuous stimulation with or without pre-stimulation, or sham treatment. Only rats receiving continuous DBS with pre-stimulation increased the time spent and the number of entries into the open arms of the EPM suggesting an anxiolytic effect. The present intracollicular DBS parameters induced motor improvements without any evidence of aversive behavior, pointing to the IC as an alternative DBS target to induce paradoxical kinesia improving motor deficits in parkinsonian patients.	[Ihme, Hannah; Schwarting, Rainer K. W.; Melo-Thomas, Liana] Philipps Univ Marburg, Behav Neurosci Expt & Biol Psychol, Marburg, Germany; [Schwarting, Rainer K. W.; Melo-Thomas, Liana] Ctr Mind Brain & Behav CMBB, Marburg, Germany; [Melo-Thomas, Liana] Behav Neurosci Inst INeC, Sao Paulo, Brazil	Philipps University Marburg	Melo-Thomas, L (corresponding author), Philipps Univ Marburg, Behav Neurosci Expt & Biol Psychol, Marburg, Germany.; Melo-Thomas, L (corresponding author), Ctr Mind Brain & Behav CMBB, Marburg, Germany.; Melo-Thomas, L (corresponding author), Behav Neurosci Inst INeC, Sao Paulo, Brazil.	melothom@staff.uni-marburg.de	Schwarting, RAINER/AAJ-1516-2021	Ihme, Hannah/0000-0003-2879-3084; Melo-Thomas, Liana/0000-0003-0313-3055; Schwarting, Rainer/0000-0002-4686-3974	German Research Foundation (Deutsche Forschungsgemeinschaft: DFG) [ME4197/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft: DFG)(German Research Foundation (DFG))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by a grant from the German Research Foundation to L.M.T. (Deutsche Forschungsgemeinschaft: DFG; ME4197/2-1).	Anzak A, 2011, EUR J NEUROSCI, V34, P124, DOI 10.1111/j.1460-9568.2011.07735.x; Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Bejjani BP, 1998, MOVEMENT DISORD, V13, P969, DOI 10.1002/mds.870130618; Bonanni L, 2010, NEUROL SCI, V31, P751, DOI 10.1007/s10072-010-0403-5; BRANDAO ML, 1993, BEHAV BRAIN RES, V58, P49, DOI 10.1016/0166-4328(93)90089-9; Casseday JH, 1996, BRAIN BEHAV EVOLUT, V47, P311, DOI 10.1159/000113249; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Cuadra G, 2000, BRAIN RES BULL, V52, P413, DOI 10.1016/S0361-9230(00)00278-1; Engelhardt KA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19990-y; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Hojlund A, 2017, COMPUT STRUCT BIOTEC, V15, P68, DOI 10.1016/j.csbj.2016.11.003; KEEFE KA, 1989, ARCH NEUROL-CHICAGO, V46, P1070, DOI 10.1001/archneur.1989.00520460046012; Khoo HM, 2014, MOVEMENT DISORD, V29, P270, DOI 10.1002/mds.25810; Kuncel AM, 2006, MOVEMENT DISORD, V21, P1920, DOI 10.1002/mds.21087; Machado A, 2006, MOVEMENT DISORD, V21, pS247, DOI 10.1002/mds.20959; MARSDEN CD, 1977, LANCET, V1, P345; Medeiros P, 2014, BEHAV BRAIN RES, V268, P8, DOI 10.1016/j.bbr.2014.03.027; Melo LL, 2010, BRAIN RES, V1349, P41, DOI 10.1016/j.brainres.2010.06.020; MELO LL, 1995, PHARMACOL BIOCHEM BE, V51, P317, DOI 10.1016/0091-3057(94)00387-X; Melo-Thomas L, 2015, BEHAV BRAIN RES, V279, P1, DOI 10.1016/j.bbr.2014.10.035; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; Murrow RW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00213; Okun MS, 2005, ARCH NEUROL-CHICAGO, V62, P1250, DOI 10.1001/archneur.62.8.noc40425; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Pontone GM, 2009, MOVEMENT DISORD, V24, P1333, DOI 10.1002/mds.22611; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Sesia T, 2008, EXP NEUROL, V214, P135, DOI 10.1016/j.expneurol.2008.07.015; Simsek H, 2015, NEUROSURGERY, V77, pN12, DOI 10.1227/NEU.0000000000000827; Souques M.A, 1921, REV NEUROL, V37, P534; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Thevathasan W, 2018, MOVEMENT DISORD, V33, P10, DOI 10.1002/mds.27098; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Tonelli LC, 2018, BEHAV BRAIN RES, V337, P204, DOI 10.1016/j.bbr.2017.09.021; Tostes JG, 2013, NEUROSCIENCE, V255, P212, DOI 10.1016/j.neuroscience.2013.09.064; Zheng Z, 2010, STEREOT FUNCT NEUROS, V88, P29, DOI 10.1159/000260077	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243438	10.1371/journal.pone.0243438	http://dx.doi.org/10.1371/journal.pone.0243438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275614	gold, Green Published			2022-12-26	WOS:000597150200028
J	Chen, YH; Karimi, M; Rutten-van Molken, MPMH				Chen, Yi Hsuan; Karimi, Milad; Rutten-van Molken, Maureen P. M. H.			The disease burden of multimorbidity and its interaction with educational level	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; QUALITY-OF-LIFE; PREVALENCE; DISABILITY; MORTALITY; ILLNESS; INDEX; COSTS	Introduction Policies to adequately respond to the rise in multimorbidity have top-priority. To understand the actual burden of multimorbidity, this study aimed to: 1) estimate the trend in prevalence of multimorbidity in the Netherlands, 2) study the association between multimorbidity and physical and mental health outcomes and healthcare cost, and 3) investigate how the association between multimorbidity and health outcomes interacts with socio-economic status (SES). Methods Prevalence estimates were obtained from a nationally representative pharmacy database over 2007-2016. Impact on costs was estimated in a fixed effect regression model on claims data over 2009-2015. Data on physical and mental health and SES were obtained from the National Health Survey in 2017, in which the Katz-10 was used to measure limitations in activities of daily living (ADL) and the Mental Health Inventory (MHI) to measure mental health. SES was approximated by the level of education. Generalized linear models (2-part models for ADL) were used to analyze the health data. In all models an indicator variable for the presence or absence of multimorbidity was included or a categorical variable for the number of chronic conditions. Interactions terms of multimorbidity and educational level were added into the previously mentioned models. Results Over the past ten years, there was an increase of 1.6%-point in the percentage of people with multimorbidity. The percentage of people with three or more conditions increased with +2.1%-point. People with multimorbidity had considerably worse physical and mental health outcomes than people without multimorbidity. For the ADL, the impact of multimorbidity was three times greater in the lowest educational level than in the highest educational level. For the MHI, the impact of multimorbidity was two times greater in the lowest than in the highest educational level. Each additional chronic condition was associated with a greater worsening in health outcomes. Similarly, for costs, where there was no evidence of a diminishing impact of additional conditions either. In patients with multimorbidity total healthcare costs were on average euro874 higher than in patients with a single morbidity. Conclusion The impact of multimorbidity on health and costs seems to be greater in the sicker and lower educated population.	[Chen, Yi Hsuan; Karimi, Milad; Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam	Chen, YH (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.	chen@esphm.eur.nl	; Rutten-van Molken, Maureen/G-8481-2014	Chen, Yi Hsuan/0000-0002-5119-1527; Rutten-van Molken, Maureen/0000-0001-8706-3159				Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Afshar S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2008-7; Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; Allison P.D, 2005, CAUSAL INFERENCE PAN; Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; [Anonymous], 2019, GOMMER RED VOLKSGEZO; Arik G, 2015, ARCH GERONTOL GERIAT, V61, P344, DOI 10.1016/j.archger.2015.08.019; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Bahler C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0698-2; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boeckxstaens P, 2015, EUR J GEN PRACT, V21, P39, DOI 10.3109/13814788.2014.914167; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; Cortaredona S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0978-2; Cuijpers P, 2009, PSYCHIAT RES, V168, P250, DOI 10.1016/j.psychres.2008.05.012; Ferretti-Rebustini RED, 2015, REV ESC ENFERM USP, V49, P944, DOI 10.1590/S0080-623420150000600010; Drewes YM, 2011, AGE AGEING, V40, P352, DOI 10.1093/ageing/afr010; EMANUEL EJ, 1994, NEW ENGL J MED, V330, P540, DOI 10.1056/NEJM199402243300806; FLANDERS WD, 1992, AM J EPIDEMIOL, V135, P926, DOI 10.1093/oxfordjournals.aje.a116388; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Hopman P, 2015, EUR J INTERN MED, V26, P190, DOI 10.1016/j.ejim.2015.02.006; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Laan W, 2013, MATURITAS, V75, P276, DOI 10.1016/j.maturitas.2013.04.005; Lamers LM, 2004, HEALTH POLICY, V68, P113, DOI 10.1016/j.healthpol.2003.09.001; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Netherlands Statistics, STATLINE POP DYN; Netherlands Statistics, TRENDS NETH 2018; Netherlands Statistics, 2016, STATLINE HEALTHC EXP; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Pache B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1515-x; Park B, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1016-6; Rijken M., 2013, Eurohealth, V19, P29; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Rizzuto D, 2017, J AM GERIATR SOC, V65, P1056, DOI 10.1111/jgs.14868; Lopez S, 2017, J BIOSOC SCI, V49, P597, DOI 10.1017/S0021932016000651; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Skinner HG, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1304-y; Tetzlaff J, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0815-z; Ubalde-Lopez M, 2017, J OCCUP REHABIL, V27, P210, DOI 10.1007/s10926-016-9647-0; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van der Zee-Neuen A, 2016, ARTHRIT CARE RES, V68, P1823, DOI 10.1002/acr.22913; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Wade D T, 1988, Int Disabil Stud, V10, P64; Wang LL, 2018, APPL HEALTH ECON HEA, V16, P15, DOI 10.1007/s40258-017-0346-6; WHO Collaborating Centre for Drug Statistics Methodology, 2019, GUID ATC CLASS DDD A; Williams JS, 2016, AM J MED SCI, V352, P45, DOI 10.1016/j.amjms.2016.03.004; Wooldridge JM, 2005, REV ECON STAT, V87, P385, DOI 10.1162/0034653053970320; World Health Organization, 2016, MULT; Xu XL, 2019, J AFFECT DISORDERS, V246, P394, DOI 10.1016/j.jad.2018.12.106	54	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243275	10.1371/journal.pone.0243275	http://dx.doi.org/10.1371/journal.pone.0243275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270760	Green Published			2022-12-26	WOS:000597149100041
J	Ohtsuki, T; Matsuoka, K; Fuji, Y; Nishizaki, Y; Masumoto, N; Sugimoto, N; Sato, K; Matsufuji, H				Ohtsuki, Takashi; Matsuoka, Kiyoaki; Fuji, Yushiro; Nishizaki, Yuzo; Masumoto, Naoko; Sugimoto, Naoki; Sato, Kyoko; Matsufuji, Hiroshi			Development of an HPLC method with relative molar sensitivity based on H-1-qNMR to determine acteoside and pedaliin in dried sesame leaf powders and processed foods	PLOS ONE			English	Article							POLYPHENOLS; STANDARD	A high-performance liquid chromatography (HPLC) method with relative molar sensitivity (RMS) based on H-1 quantitative NMR spectroscopy (H-1-qNMR) has been developed for food ingredients such as acteoside (verbascoside) and pedaliin (pedalitin-6-O-glucoside) without requiring authentic and identical standards as the reliable analytical methods. This method is used methyl 4-hydroxybenzoate (MHB) as an alternative reference standard. Each RMS is also calculated from the ratio of each analyte's molar absorption coefficient to that of MHB after correcting the purities of the analytes and reference standard by H-1-qNMR. Therefore, this method can quantify several analytes with metrological traceability to the International System of Units (SI) using the RMS and one alternative reference standard. In this study, the content of acteoside and pedaliin in several samples, such as dried sesame leaf powders and commercially processed foods, can be determined by the proposed RMS method and demonstrated in good agreement that obtained by a conventional method. Moreover, the proposed method yields analytical data with SI-traceability without the need for an authentic and identical analyte standard. Thus, the proposed RMS method is a useful and practical tool for determining acteoside and pedaliin in terms of the accuracy of quantitative values, the routine analysis, and the cost of reagents.	[Ohtsuki, Takashi; Matsuoka, Kiyoaki; Fuji, Yushiro; Matsufuji, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Nishizaki, Yuzo; Masumoto, Naoko; Sugimoto, Naoki; Sato, Kyoko] Natl Inst Hlth Sci, Div Food Additives, Kawasaki Ku, Kawasaki, Kanagawa, Japan	Nihon University; National Institute of Health Sciences - Japan	Ohtsuki, T (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan.	ohtsuki.takashi@nihon-u.ac.jp			JSPS KAKENHI [17K07822]; Nihon University Fund for Supporting Education and Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nihon University Fund for Supporting Education and Research	Takashi Ohtsuki (TO) was funded by JSPS KAKENHI (http://www.jsps.go.jp/english/egrants/index.html) [17K07822]. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. This research was also financially supported by the Nihon University Fund for Supporting Education and Research (TO). The funder provided support in the form of salaries for TO but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Fernandez L, 2005, PHARM BIOL, V43, P226, DOI 10.1080/13880200590928799; Fuji Y, 2018, ACS OMEGA, V3, P17287, DOI 10.1021/acsomega.8b02798; Fuji Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194449; Kitamaki Y, 2017, ANAL CHEM, V89, P6963, DOI 10.1021/acs.analchem.6b05074; Korshavn KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17842; Liao X, 2020, J PHARM ANAL; Masumoto N, 2019, J NAT MED-TOKYO, V73, P566, DOI 10.1007/s11418-019-01306-7; Matsufuji H, 2011, J JPN SOC FOOD SCI, V58, P88, DOI 10.3136/nskkk.58.88; Nishizaki Y, 2019, FOOD ADDIT CONTAM A, V36, P203, DOI 10.1080/19440049.2018.1556817; Nishizaki Y, 2018, FOOD ADDIT CONTAM A, V35, P838, DOI 10.1080/19440049.2018.1440642; Nishizaki Y, 2015, FOOD HYG SAFE SCI, V56, P185, DOI 10.3358/shokueishi.56.185; Ohtsuki T, 2015, TALANTA, V131, P712, DOI 10.1016/j.talanta.2014.08.002; Quinn TJ, 1997, METROLOGIA, V34, P61, DOI 10.1088/0026-1394/34/1/9; Rehecho S, 2011, LWT-FOOD SCI TECHNOL, V44, P875, DOI 10.1016/j.lwt.2010.11.035; Seo ES, 2013, MOL CELLS, V35, P348, DOI 10.1007/s10059-013-0021-1; Shiao YJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040895; Tahara M, 2014, ENV SCI, V27, P142; Takahashi M, 2018, SEP SCI PLUS, V1, P498, DOI 10.1002/sscp.201800081; Takahashi M, 2018, J CHROMATOGR A, V1555, P45, DOI 10.1016/j.chroma.2018.04.029; Wang J, 2015, TOXICOL APPL PHARM, V285, P128, DOI 10.1016/j.taap.2015.04.004; Wang SQ, 2010, BIOORG MED CHEM LETT, V20, P6411, DOI 10.1016/j.bmcl.2010.09.086; Wells RJ, 2004, ACCREDIT QUAL ASSUR, V9, P450, DOI 10.1007/s00769-004-0779-0; Wu YT, 2007, J CHROMATOGR B, V853, P281, DOI 10.1016/j.jchromb.2007.03.033; Wu YT, 2006, J CHROMATOGR B, V844, P89, DOI 10.1016/j.jchromb.2006.07.011; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580; Yuan JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162696	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243175	10.1371/journal.pone.0243175	http://dx.doi.org/10.1371/journal.pone.0243175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270771	gold, Green Published			2022-12-26	WOS:000597149100160
J	Pedergnana, A; Calandra, I; Evans, AA; Bob, K; Hildebrandt, A; Olle, A				Pedergnana, Antonella; Calandra, Ivan; Evans, Adrian A.; Bob, Konstantin; Hildebrandt, Andreas; Olle, Andreu			Polish is quantitatively different on quartzite flakes used on different worked materials	PLOS ONE			English	Article							SCANNING CONFOCAL MICROSCOPY; FOCUS VARIATION MICROSCOPY; STONE TOOL RESEARCH; USE-WEAR ANALYSIS; LASER PROFILOMETRY; DENTAL MICROWEAR; SURFACE WEAR; QUANTIFICATION; LSCM; DISCRIMINATION	Metrology has been successfully used in the last decade to quantify use-wear on stone tools. Such techniques have been mostly applied to fine-grained rocks (chert), while studies on coarse-grained raw materials have been relatively infrequent. In this study, confocal microscopy was employed to investigate polished surfaces on a coarse-grained lithology, quartzite. Wear originating from contact with five different worked materials were classified in a data-driven approach using machine learning. Two different classifiers, a decision tree and a support-vector machine, were used to assign the different textures to a worked material based on a selected number of parameters (Mean density of furrows, Mean depth of furrows, Core material volume-Vmc). The method proved successful, presenting high scores for bone and hide (100%). The obtained classification rates are satisfactory for the other worked materials, with the only exception of cane, which shows overlaps with other materials. Although the results presented here are preliminary, they can be used to develop future studies on quartzite including enlarged sample sizes.	[Pedergnana, Antonella; Calandra, Ivan] RGZM, Lab Traceol & Controlled Expt, MONREPOS Archaeol Res Ctr & Museum Human Behav Ev, TraCEr, Neuwied, Germany; [Evans, Adrian A.] Univ Bradford, Sch Life Sci, Bradford, W Yorkshire, England; [Bob, Konstantin; Hildebrandt, Andreas] Johannes Gutenberg Univ Mainz, Inst Comp Sci, Sci Comp & Bioinformat, Mainz, Germany; [Olle, Andreu] IPHES, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Olle, Andreu] Univ Rovira & Virgili, Dept Hist & Hist Art, Tarragona, Spain	Leibniz-Forschungsinstitut fur Archaologie (RGZM); University of Bradford; Johannes Gutenberg University of Mainz; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili	Pedergnana, A (corresponding author), RGZM, Lab Traceol & Controlled Expt, MONREPOS Archaeol Res Ctr & Museum Human Behav Ev, TraCEr, Neuwied, Germany.	pedergnana@rgzm.de	Pedergnana, Antonella/AAR-4764-2020; Ollé, Andreu/D-6837-2013	Pedergnana, Antonella/0000-0002-2055-2019; Ollé, Andreu/0000-0002-8643-5536; Calandra, Ivan/0000-0003-3816-6359; Bob, Konstantin/0000-0002-1929-9829	Romisch-Germanisches Zentralmuseum - Leibniz Research Institute for Archaeology by German Federal and Rhineland Palatinate funding (Sondertatbestand "Spurenlabor"); Spanish MICINU-FEDER project [PGC2018-093925-B-C32]; Catalan AGAUR project [2017-SGR-1040]; URV project [2019-PFR-URV-91]; Fragmented Heritage Project [AH/L00688X/1]; AHRC [AH/L00688X/1] Funding Source: UKRI	Romisch-Germanisches Zentralmuseum - Leibniz Research Institute for Archaeology by German Federal and Rhineland Palatinate funding (Sondertatbestand "Spurenlabor"); Spanish MICINU-FEDER project; Catalan AGAUR project(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); URV project; Fragmented Heritage Project; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research has been supported within the Romisch-Germanisches Zentralmuseum - Leibniz Research Institute for Archaeology by German Federal and Rhineland Palatinate funding (Sondertatbestand "Spurenlabor"), the Spanish MICINU-FEDER project PGC2018-093925-B-C32, the Catalan AGAUR project 2017-SGR-1040, the URV project 2019-PFR-URV-91 and the Fragmented Heritage Project (AH/L00688X/1).	Anderson PC, 2006, J ARCHAEOL SCI, V33, P1559, DOI 10.1016/j.jas.2006.02.011; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2012, 2517822012 ISO; [Anonymous], 1996, 42881996 ISO; [Anonymous], 1986, TEXTUS, V13, P31; [Anonymous], 2020, J GYNECOL ONCOL, V31, pe69; Arman SD, 2016, SURF TOPOGR-METROL, V4, DOI 10.1088/2051-672X/4/2/024007; Arroyo A, 2016, J ARCHAEOLOGICAL SCI; BAMFORTH DB, 1990, J ARCHAEOL SCI, V17, P413, DOI 10.1016/0305-4403(90)90006-Q; BAMFORTH DB, 1988, J ARCHAEOL SCI, V15, P11, DOI 10.1016/0305-4403(88)90015-5; Bello-Alonso P, 2019, QUATERN INT, V526, P169, DOI 10.1016/j.quaint.2019.09.025; Blateyron F., 2013, CHARACTERISATION ARE, P45, DOI [10.1007/978-3-642-36458-7_3, DOI 10.1007/978-3-642-36458-7_3]; Calandra I, 2019, J ARCHAEOL SCI, V110, DOI 10.1016/j.jas.2019.105012; Calandra I, 2019, ARCHAEOL ANTHROP SCI, V11, P5937, DOI 10.1007/s12520-019-00801-y; Caux S, 2018, J ARCHAEOL SCI-REP, V20, P210, DOI 10.1016/j.jasrep.2018.04.027; Chen PY, 2009, ACTA BIOMATER, V5, P693, DOI 10.1016/j.actbio.2008.09.011; Clemente-Conte I., 2009, BAR INT SERIES, V1939, p93e98; de Lombera-Hermida A, 2020, J HUM EVOL, V145, DOI 10.1016/j.jhevol.2020.102812; Evans AA, 2014, J ARCHAEOL SCI, V48, P1, DOI 10.1016/j.jas.2014.03.002; Evans AA, 2011, SCANNING, V33, P294, DOI 10.1002/sca.20272; Evans AA, 2008, J ARCHAEOL SCI, V35, P2223, DOI 10.1016/j.jas.2008.02.006; Evans AA, 2014, MICRON, V65, P69, DOI 10.1016/j.micron.2014.04.006; Henshilwood CS, 2018, NATURE, V562, P115, DOI 10.1038/s41586-018-0514-3; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hurcombe L, 1992, FORMATION USE WEAR T; Ibanez JJ, 2019, J ARCHAEOL METHOD TH, V26, P1176, DOI 10.1007/s10816-018-9408-9; Ibanez JJ, 2014, J ARCHAEOL SCI, V48, P96, DOI 10.1016/j.jas.2013.10.012; Ibanez JJ, 2016, CEREAL CULTIVATION D; ISO 4287, 1997, 4287 ISO; Keeley L.H., 1980, EXPT DETERMINATION S; Kelleher JD, 2015, FUNDAMENTALS OF MACHINE LEARNING FOR PREDICTIVE DATA ANALYTICS: ALGORITHMS, WORKED EXAMPLES, AND CASE STUDIES, P1; Key AJM, 2015, J ARCHAEOL METHOD TH, V22, P1193, DOI 10.1007/s10816-014-9224-9; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Leach R., 2014, CHARACTERISATION ARE; LEAKEY M D, 1971, P306; Leipus M, 2007, BUENOS AIRES SOC ARG, P179; Lemorini C, 2014, J HUM EVOL, V72, P10, DOI 10.1016/j.jhevol.2014.03.002; Lerner H, 2007, J ARCHAEOL SCI, V34, P711, DOI 10.1016/j.jas.2006.07.009; Levi Sala I., 1996, BRIT ARCHAEOLOGICAL; Macdonald D.A., 2014, MICROSCOPY TODAY, V22, P22; Macdonald DA, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.05.026; Macdonald DA, 2014, J ARCHAEOL SCI, V48, P26, DOI 10.1016/j.jas.2013.10.003; Marreiros J, 2020, J PALEOLITH ARCHAEOL, V3, P475, DOI 10.1007/s41982-020-00058-1; Martin C, 2020, CMARTIN GGCONVEXHULL; Martisius NL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206078; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Moloney NL, 1996, NONFLINT STONE TOOLS; Moncel MH, 2008, OCCUPATIONS HUMAINES; Mosquera M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190889; Olle A, 2014, J ARCHAEOL SCI, V48, P60, DOI 10.1016/j.jas.2013.10.028; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Pedergnana A, 2019, EXPT DEV METHOD; Pedergnana A., 2017, EXPT DEV METHOD ITS; Pedergnana A, 2020, J ARCHAEOL SCI-REP, V30, DOI 10.1016/j.jasrep.2020.102237; Pedergnana A, 2020, QUATERN INT, V569, P181, DOI 10.1016/j.quaint.2019.11.015; Pedergnana A, 2018, ARCHAEOL ANTHROP SCI, V10, P369, DOI 10.1007/s12520-016-0368-2; Pedergnana A, 2017, QUATERN INT, V433, P163, DOI 10.1016/j.quaint.2015.06.031; Pedergnana A, 2017, QUATERN INT, V427, P35, DOI 10.1016/j.quaint.2016.01.053; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Philpotts A., 2009, PRINCIPLES IGNEOUS M, DOI [10.1017/CBO9780511813429, DOI 10.1017/CBO9780511813429]; R Core Team, 2021, R LANGUAGE ENV STAT; Ramdarshan A., 2017, PALAEONTOL ELECTRON, V20, P1, DOI DOI 10.26879/762; Rosso DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177298; Rstudio T, 2020, RSTUDIO INT DEV R; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Stemp WJ, 2018, ARCHAEOMETRY, V60, P660, DOI 10.1111/arcm.12335; Stemp WJ, 2009, ARCHAEOMETRY, V51, P366, DOI 10.1111/j.1475-4754.2008.00404.x; Stemp WJ, 2019, J ARCHAEOL SCI-REP, V24, P513, DOI 10.1016/j.jasrep.2019.02.010; Stemp WJ, 2015, ARCHAEOL ANTHROP SCI, V7, P423, DOI 10.1007/s12520-014-0204-5; Stemp WJ, 2015, SURF TOPOGR-METROL, V3, DOI 10.1088/2051-672X/3/3/034006; Stemp WJ, 2014, J ARCHAEOL SCI, V48, P15, DOI 10.1016/j.jas.2013.04.027; Stemp WJ, 2013, SCANNING, V35, P28, DOI 10.1002/sca.21032; Stemp WJ, 2011, SCANNING, V33, P279, DOI 10.1002/sca.20250; Stemp WJ, 2001, J ARCHAEOL SCI, V28, P81, DOI 10.1006/jasc.2000.0547; Stevens NE, 2010, J ARCHAEOL SCI, V37, P2671, DOI 10.1016/j.jas.2010.06.004; Sussman C, 1988, OXFORD BAR INT SERIE, V395; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Tucker M.E., 2001, SEDIMENTARY PETROLOG, VThird; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vaughan P.C., 1985, USE WEAR ANAL FLAKED; Werner JJ, 2018, J ARCHAEOL SCI-REP, V17, P597, DOI 10.1016/j.jasrep.2017.12.008; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Xie LY, 2019, J ARCHAEOL SCI-REP, V25, P351, DOI 10.1016/j.jasrep.2019.04.017; Xie Y., 2014, IMPLEMENTING REPRODU; Xie Y, 2020, KNITR GEN PURPOSE PA; Xie Y., 2018, R MARKDOWN DEFINITIV; Xie Y., 2015, DYNAMIC DOCUMENTS R, V2nd; Xu Zhijing, 2019, Epidemics, V27, P19, DOI 10.1016/j.epidem.2018.12.003; YAMADA S, 1993, TGEST RETROUVESRACES, V50, P2	91	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243295	10.1371/journal.pone.0243295	http://dx.doi.org/10.1371/journal.pone.0243295			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270795	Green Published, gold			2022-12-26	WOS:000597149100158
J	Woitok, M; Grieger, E; Akinrinmade, OA; Bethke, S; Pham, AT; Stein, C; Fendel, R; Fischer, R; Barth, S; Niesen, J				Woitok, Mira; Grieger, Elena; Akinrinmade, Olusiji A.; Bethke, Susanne; Anh Tuan Pham; Stein, Christoph; Fendel, Rolf; Fischer, Rainer; Barth, Stefan; Niesen, Judith			Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes	PLOS ONE			English	Article							EX-VIVO BINDING; IN-VITRO; FUSION PROTEINS; ANTIBODY FRAGMENTS; SURFACE; EXPRESSION; RECEPTOR; PHOSPHATIDYLSERINE; ELIMINATION; IMMUNOTOXIN	In vitro and ex vivo development of novel therapeutic agents requires reliable and accurate analyses of the cell conditions they were preclinical tested for, such as apoptosis. The detection of apoptotic cells by annexin V (AV) coupled to fluorophores has often shown limitations in the choice of the dye due to interference with other fluorescent-labeled cell markers. The SNAP-tag technology is an easy, rapid and versatile method for functionalization of proteins and was therefore used for labeling AV with various fluorophores. We generated the fusion protein AV-SNAP and analyzed its capacity for the specific display of apoptotic cells in various assays with therapeutic agents. AV-SNAP showed an efficient coupling reaction with five different fluorescent dyes. Two selected fluorophores were tested with suspension, adherent and peripheral blood cells, treated by heat-shock or apoptosis-inducing therapeutic agents. Flow cytometry analysis of apoptotic cells revealed a strong visualization using AV-SNAP coupled to these two fluorophores exemplary, which was comparable to a commercial AV-Assay-kit. The combination of the apoptosis-specific binding protein AV with the SNAP-tag provides a novel solid method to facilitate protein labeling using several, easy to change, fluorescent dyes at once. It avoids high costs and allows an ordinary exchange of dyes and easier use of other fluorescent-labeled cell markers, which is of high interest for the preclinical testing of therapeutic agents in e.g. cancer research.	[Woitok, Mira; Grieger, Elena; Bethke, Susanne; Anh Tuan Pham; Stein, Christoph; Fendel, Rolf; Fischer, Rainer; Barth, Stefan; Niesen, Judith] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Woitok, Mira; Bethke, Susanne; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol Biol 7, Aachen, Germany; [Akinrinmade, Olusiji A.; Barth, Stefan] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Integrat Biomed Sci, Cape Town, South Africa; [Fendel, Rolf] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Niesen, Judith] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Niesen, Judith] Univ Med Ctr Hamburg Eppendorf, Mildred Scheel Canc Career Ctr HaTriCS4, Hamburg, Germany; [Niesen, Judith] Res Inst Childrens Canc Ctr, Hamburg, Germany	Fraunhofer Gesellschaft; RWTH Aachen University; University of Cape Town; Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Niesen, J (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.; Niesen, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany.; Niesen, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Mildred Scheel Canc Career Ctr HaTriCS4, Hamburg, Germany.; Niesen, J (corresponding author), Res Inst Childrens Canc Ctr, Hamburg, Germany.	j.niesen@uke.de	Fendel, Rolf/K-3985-2013; Barth, Stefan/F-7301-2012	Fendel, Rolf/0000-0003-4716-0311; Barth, Stefan/0000-0001-9589-653X; Niesen, Judith/0000-0003-1050-2859	RWTH Aachen University scholarship of Young Researchers at the RWTH Aachen University (RFwN); Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Erich and Gertrud Roggenbuck Stiftung; German Cancer Aid (Mildred Scheel Cancer Career Center)	RWTH Aachen University scholarship of Young Researchers at the RWTH Aachen University (RFwN); Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Erich and Gertrud Roggenbuck Stiftung; German Cancer Aid (Mildred Scheel Cancer Career Center)	Mira Woitok was supported by the RWTH Aachen University scholarship of Young Researchers at the RWTH Aachen University (RFwN). This work was supported by the Fordergemeinschaft Kinderkrebs-Zentrum Hamburg, the Erich and Gertrud Roggenbuck Stiftung and the German Cancer Aid (via the Mildred Scheel Cancer Career Center).	Ahn JH, 2011, ASSAY DRUG DEV TECHN, V9, P236, DOI 10.1089/adt.2010.0327; Amoury M, 2013, CURR PHARM DESIGN, V19, P5429, DOI 10.2174/13816128113199990405; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; [Anonymous], 2013, CANC DISCOV, V3, pOF14; Biswas S, 2013, EUR J PHARM BIOPHARM, V84, P517, DOI 10.1016/j.ejpb.2012.12.021; Brehm H, 2015, CANCER LETT, V365, P149, DOI 10.1016/j.canlet.2015.04.004; Bruell D, 2003, INT J ONCOL, V23, P1179; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Cole Nelson B, 2013, Curr Protoc Protein Sci, V73, DOI 10.1002/0471140864.ps3001s73; Colombo M, 2012, SMALL, V8, P1492, DOI 10.1002/smll.201102284; Cremer C, 2015, J IMMUNOTHER, V38, P85, DOI 10.1097/CJI.0000000000000053; Donahue CJ, 2001, CYTOMETRY, V45, P225, DOI 10.1002/1097-0320(20011101)45:3<225::AID-CYTO1166>3.0.CO;2-4; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Engin S, 2013, CURR PHARM DESIGN, V19, P5443, DOI 10.2174/1381612811319300015; FADOK VA, 1992, J IMMUNOL, V148, P2207; Hristodorov D, 2015, MABS-AUSTIN, V7, P853, DOI 10.1080/19420862.2015.1066950; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Hussain AF, 2019, NAT PROTOC, V14, P3101, DOI 10.1038/s41596-019-0214-y; Hussain AF, 2011, BIOCONJUGATE CHEM, V22, P2487, DOI 10.1021/bc200304k; Ishiyama T, 1996, CLIN EXP IMMUNOL, V106, P351, DOI 10.1046/j.1365-2249.1996.d01-829.x; Johnson N, 1997, LEUKEMIA RES, V21, P961, DOI 10.1016/S0145-2126(97)00077-5; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Kampmeier F, 2010, EUR J NUCL MED MOL I, V37, P1926, DOI 10.1007/s00259-010-1482-5; Kampmeier F, 2009, BIOCONJUGATE CHEM, V20, P1010, DOI 10.1021/bc9000257; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Koff JL, 2015, INT J MOL SCI, V16, P2942, DOI 10.3390/ijms16022942; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Liu XM, 2006, J DERMATOL SCI, V42, P262, DOI 10.1016/j.jdermsci.2006.02.003; Lukinavicius Grazvydas, 2015, Methods Mol Biol, V1266, P107, DOI 10.1007/978-1-4939-2272-7_7; Macias-Contreras M, 2018, BIOCONJUGATE CHEM, V29, P4104, DOI 10.1021/acs.bioconjchem.8b00703; Mattes MJ, 2007, BRIT J CANCER, V96, P928, DOI 10.1038/sj.bjc.6603663; Mladenov R, 2015, INT J CANCER, V137, P2729, DOI 10.1002/ijc.29628; Niesen J, 2016, BIOCONJUGATE CHEM, V27, P1931, DOI 10.1021/acs.bioconjchem.6b00315; Niesen J, 2016, CANCER LETT, V374, P229, DOI 10.1016/j.canlet.2016.02.020; Niesen J, 2015, J CANCER RES CLIN, V141, P2079, DOI 10.1007/s00432-015-1975-5; Niesen J, 2015, J CANCER RES CLIN, V141, P1049, DOI 10.1007/s00432-014-1884-z; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Schwemmlein M, 2006, BRIT J HAEMATOL, V133, P141, DOI 10.1111/j.1365-2141.2005.05869.x; Stein C, 2013, CURR PHARM DESIGN, V19, P5449, DOI 10.2174/1381612811319300016; Stocker M, 2008, PROTEIN EXPRES PURIF, V58, P325, DOI 10.1016/j.pep.2007.12.009; Tur MK, 2011, INT J CANCER, V129, P1277, DOI 10.1002/ijc.25766; Wlodkowic D., 2012, Experimental Oncology, V34, P255; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Woitok M, 2016, CANCER LETT, V381, P323, DOI 10.1016/j.canlet.2016.08.003; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	47	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243286	10.1371/journal.pone.0243286	http://dx.doi.org/10.1371/journal.pone.0243286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270761	gold, Green Published			2022-12-26	WOS:000597149100142
J	Li, C; Liu, Y; Tian, J; Zhu, YS; Fan, JJ				Li, Cong; Liu, Yu; Tian, Jing; Zhu, Yanshu; Fan, Jinjuan			Changes in sucrose metabolism in maize varieties with different cadmium sensitivities under cadmium stress	PLOS ONE			English	Article							GENE-EXPRESSION; ACCUMULATION; TOLERANCE; TRANSPORTERS; ENZYMES; SYSTEMS; PLANTS; ROLES; CULTIVARS; DROUGHT	Sucrose metabolism contributes to the growth and development of plants and helps plants cope with abiotic stresses, including stress from Cd. Many of these processes are not well-defined, including the mechanism underlying the response of sucrose metabolism to Cd stress. In this study, we investigated how sucrose metabolism in maize varieties with low (FY9) and high (SY33) sensitivities to Cd changed in response to different levels of Cd (0 (control), 5, 10, and 20 mg L-1 Cd). The results showed that photosynthesis was impaired, and the biomass decreased, in both varieties of maize at different Cd concentrations. Cd inhibited the activities of sucrose phosphate synthase (SPS) and sucrose synthase (SS) (sucrose synthesis), and stimulated the activities of acid invertase (AI) and SS (sucrose hydrolysis). The total soluble sugar contents were higher in the Cd-treated seedlings than in the control. Also, Cd concentrations in the shoots were higher in SY33 than in FY9, and in the roots were lower in SY33 than in FY9. The decreases in the photosynthetic rate, synthesis of photosynthetic products, enzyme activity in sucrose synthesis direction, and increases in activity in hydrolysis direction were more obvious in SY33 (the sensitive variety) than in FY9 (the tolerant variety), and more photosynthetic products were converted into soluble sugar in SY33 than in FY9 as the Cd stress increased. The transcript levels of the sugar transporter genes also differed between the two varieties at different concentrations of Cd. These results suggest that sucrose metabolism may be a secondary response to Cd additions, and that the Cd-sensitive variety used more carbohydrates to defend against Cd stress rather than to support growth than the Cd-tolerant variety.	[Li, Cong; Liu, Yu; Tian, Jing; Zhu, Yanshu; Fan, Jinjuan] Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China; [Li, Cong; Tian, Jing; Zhu, Yanshu; Fan, Jinjuan] Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Fan, JJ (corresponding author), Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China.; Fan, JJ (corresponding author), Shenyang Key Lab Maize Genom Select Breeding, Shenyang, Liaoning, Peoples R China.	jinjuanf@hotmail.com			scientific research projects of Liaoning Provincial Department of Education, China [LSNZD201608, LSNYB201607]	scientific research projects of Liaoning Provincial Department of Education, China	This research was financially supported by the scientific research projects of Liaoning Provincial Department of Education, China (No. LSNZD201608 and LSNYB201607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElgawad H, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113705; [Anonymous], 2012, SESTRINSTVO, V32, P4; [Anonymous], 2015, REINFORCED PLASTIC, V59, P171; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Bonfig KB, 2010, MOL PLANT, V3, P1037, DOI 10.1093/mp/ssq053; Chaoui A, 2005, CR BIOL, V328, P23, DOI 10.1016/j.crvi.2004.10.001; Chardon F, 2013, CURR BIOL, V23, P697, DOI 10.1016/j.cub.2013.03.021; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Durand M, 2016, PLANT PHYSIOL, V170, P1460, DOI 10.1104/pp.15.01926; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Faller P, 2005, BBA-BIOENERGETICS, V1706, P158, DOI 10.1016/j.bbabio.2004.10.005; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Guo JJ, 2019, ECOTOX ENVIRON SAFE, V172, P380, DOI 10.1016/j.ecoenv.2019.01.069; Guo Q, 2014, BIOL PLANTARUM, V58, P174, DOI 10.1007/s10535-013-0359-4; Guo Q, 2017, ECOTOX ENVIRON SAFE, V139, P50, DOI 10.1016/j.ecoenv.2016.12.013; Hanikenne M, 2011, CURR OPIN PLANT BIOL, V14, P252, DOI 10.1016/j.pbi.2011.04.003; Hir R, 2015, MOL PLANT, V8, P1687, DOI DOI 10.1016/J.MOLP.2015.08.007; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kamnev AA, 2000, BIOSCIENCE REP, V20, P239, DOI 10.1023/A:1026436806319; Khan KY, 2020, ECOTOX ENVIRON SAFE, V200, DOI 10.1016/j.ecoenv.2020.110748; Liu JG, 2007, J HAZARD MATER, V143, P443, DOI 10.1016/j.jhazmat.2006.09.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCREADY RM, 1950, ANAL CHEM, V22, P1156, DOI 10.1021/ac60045a016; MOYA JL, 1993, PHOTOSYNTH RES, V36, P75, DOI 10.1007/BF00016271; Nagele T, 2012, PLANT J, V72, P102, DOI 10.1111/j.1365-313X.2012.05064.x; OBENLAND DM, 1993, PLANT PHYSIOL, V101, P1331, DOI 10.1104/pp.101.4.1331; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Ranwala AP, 1998, PHYSIOL PLANTARUM, V103, P541, DOI 10.1034/j.1399-3054.1998.1030413.x; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Saher S, 2005, PLANT PHYSIOL BIOCH, V43, P573, DOI 10.1016/j.plaphy.2005.05.006; Sanchez-Linares L, 2012, J EXP BOT, V63, P4513, DOI 10.1093/jxb/ers130; Sfaxi-Bousbih A, 2010, ECOTOX ENVIRON SAFE, V73, P1123, DOI 10.1016/j.ecoenv.2010.01.005; Shah K, 1998, ACTA PHYSIOL PLANT, V20, P189, DOI 10.1007/s11738-998-0013-5; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Vatehova Z, 2016, PLANT PHYSIOL BIOCH, V108, P90, DOI 10.1016/j.plaphy.2016.06.035; Verma S, 2001, BIOL PLANTARUM, V44, P117, DOI 10.1023/A:1017938809311; WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3; Wang M, 2007, BIORESOURCE TECHNOL, V98, P82, DOI 10.1016/j.biortech.2005.11.028; Wang ZF, 2017, ECOTOX ENVIRON SAFE, V135, P75, DOI 10.1016/j.ecoenv.2016.09.013; Woolhouse HW, 1983, ENCY PLANT PHYSL C, V12C, P245, DOI DOI 10.1007/978-3-642-68153-0_; Wu ZC, 2015, CHEMOSPHERE, V138, P526, DOI 10.1016/j.chemosphere.2015.06.080; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; XU DP, 1989, PLANT PHYSIOL, V89, P1106, DOI 10.1104/pp.89.4.1106; Xu XH, 2014, B ENVIRON CONTAM TOX, V93, P618, DOI 10.1007/s00128-014-1361-z; Yang LM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00190; Yuan HM, 2016, PLANT CELL ENVIRON, V39, P120, DOI 10.1111/pce.12597; Zhang FQ, 2009, J HAZARD MATER, V168, P76, DOI 10.1016/j.jhazmat.2009.02.002; [张宇 Zhang Yu], 2015, [海洋湖沼通报, Transactions of Oceanology and Limnology], P50; Zhao XW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4395-x	54	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243835	10.1371/journal.pone.0243835	http://dx.doi.org/10.1371/journal.pone.0243835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306745	gold, Green Published			2022-12-26	WOS:000600144200026
J	Ma, TL; Matsuoka, S; Drummond-Barbosa, D				Ma, Tianlu; Matsuoka, Shinya; Drummond-Barbosa, Daniela			RNAi-based screens uncover a potential new role for the orphan neuropeptide receptor Moody in Drosophila female germline stem cell maintenance	PLOS ONE			English	Article							EGG-LAYING RHYTHM; EXPRESSION; NEURONS; MORPHOGENESIS; REPRODUCTION; TEMPERATURE; MELATONIN; DEFENSE; PATHWAY; INSULIN	Reproduction is highly sensitive to changes in physiology and the external environment. Neuropeptides are evolutionarily conserved signaling molecules that regulate multiple physiological processes. However, the potential reproductive roles of many neuropeptide signaling pathways remain underexplored. Here, we describe the results of RNAi-based screens in Drosophila melanogaster to identify neuropeptides/neuropeptide receptors with potential roles in oogenesis. The screen read-outs were either the number of eggs laid per female per day over time or fluorescence microscopy analysis of dissected ovaries. We found that the orphan neuropeptide receptor encoded by moody (homologous to mammalian melatonin receptors) is likely required in somatic cells for normal egg production and proper germline stem cell maintenance. However, the egg laying screens had low signal-to-noise ratio and did not lead to the identification of additional candidates. Thus, although egg count assays might be useful for large-scale screens to identify oogenesis regulators that result in dramatic changes in oogenesis, more labor-intensive microscopy-based screen are better applicable for identifying new physiological regulators of oogenesis with more subtle phenotypes.	[Ma, Tianlu; Matsuoka, Shinya; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Matsuoka, Shinya] AstraZeneca KK, Osaka, Japan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; AstraZeneca	Drummond-Barbosa, D (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	dbarbosa@jhu.edu			National Institutes of Health (NIH) [R01 GM069875, R01 GM125121, T32 CA009110]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants R01 GM069875 (D.D.-B) and R01 GM125121 (D.D.-B.). T.M. was supported by NIH training grant T32 CA009110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rodriguez A, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12590; Agapite J, 2020, NUCLEIC ACIDS RES, V48, pD650, DOI 10.1093/nar/gkz813; Ameku T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005004; Ameku T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006123; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Armstrong AR, 2018, DEV BIOL, V440, P31, DOI 10.1016/j.ydbio.2018.04.028; Armstrong AR, 2014, DEVELOPMENT, V141, P4479, DOI 10.1242/dev.116467; Azizi V, 2021, INT J NEUROSCI, V131, P780, DOI 10.1080/00207454.2020.1758085; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Barson JR, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.02.006; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Burbach JPH, 2011, METHODS MOL BIOL, V789, P1, DOI 10.1007/978-1-61779-310-3_1; Comeras LB, 2019, ANN NY ACAD SCI, V1455, P59, DOI 10.1111/nyas.14179; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Drummond-Barbosa D, 2019, GENETICS, V213, P9, DOI 10.1534/genetics.119.300234; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ekmekcioglu C, 2006, BIOMED PHARMACOTHER, V60, P97, DOI 10.1016/j.biopha.2006.01.002; Evangelou A, 2019, G3-GENES GENOM GENET, V9, P3877, DOI 10.1534/g3.119.400715; Fergani C, 2018, ELIFE, V7, DOI 10.7554/eLife.40476; Gizowski C, 2017, BEST PRACT RES CL EN, V31, P535, DOI 10.1016/j.beem.2017.11.001; Goda T, 2018, GENE DEV, V32, P140, DOI 10.1101/gad.307884.117; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; Guobis Z, 2012, J ORAL MAXILLOFAC RE, V3, pe2; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Harter CJL, 2018, J ENDOCRINOL, V238, pR173, DOI 10.1530/JOE-18-0108; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Hegazi S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092363; Holtzman S, 2010, FLY, V4, P349, DOI 10.4161/fly.4.4.13304; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Hoxha V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003217; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hu XY, 2019, ECOTOX ENVIRON SAFE, V171, P871, DOI 10.1016/j.ecoenv.2019.01.029; Hussain A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002455; Jasienska G, 2017, LANCET, V390, P510, DOI [10.1016/S0140-6736(17)30573-1, 10.1016/s0140-6736(17)30573-1]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jevitt A, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000538; Kaprara A, 2018, METABOLISM, V86, P3, DOI 10.1016/j.metabol.2017.11.018; Kim WJ, 2013, NEURON, V80, P1190, DOI 10.1016/j.neuron.2013.09.034; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lainez NM, 2019, ENDOCRINOLOGY, V160, P2719, DOI 10.1210/en.2019-00487; LaJeunesse Dennis R., 2010, BMC Physiology, V10, P14, DOI 10.1186/1472-6793-10-14; Leader DP, 2018, NUCLEIC ACIDS RES, V46, pD809, DOI 10.1093/nar/gkx976; Lee KM, 2015, CURR BIOL, V25, P790, DOI 10.1016/j.cub.2015.01.050; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li C, 2010, ADV EXP MED BIOL, V692, P98; Limmer S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00365; LIN HF, 1994, DEVELOPMENT, V120, P947; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Manjunatha T, 2008, J GENET, V87, P495, DOI 10.1007/s12041-008-0072-9; Martelli C, 2017, CELL REP, V20, P464, DOI 10.1016/j.celrep.2017.06.043; Matsuoka S, 2017, GENETICS, V206, P953, DOI 10.1534/genetics.117.201921; Mazzalupo S, 2006, CELL DEATH DIFFER, V13, P1950, DOI 10.1038/sj.cdd.4401892; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meiselman M, 2017, P NATL ACAD SCI USA, V114, pE3849, DOI 10.1073/pnas.1620760114; Nassel DR, 2019, PROG NEUROBIOL, V179, DOI 10.1016/j.pneurobio.2019.02.003; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Russo AF, 2017, HEADACHE, V57, P37, DOI 10.1111/head.13084; Saedi S, 2018, J CHEM NEUROANAT, V92, P71, DOI 10.1016/j.jchemneu.2018.07.001; Sakamoto K, 2012, J REPROD DEVELOP, V58, P700, DOI 10.1262/jrd.2011-038; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Sun TC, 2020, CRYOBIOLOGY, V95, P1, DOI 10.1016/j.cryobiol.2020.01.018; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vimal D, 2019, CHEMOSPHERE, V225, P247, DOI 10.1016/j.chemosphere.2019.02.134; Vissers JHA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10368; Weaver LN, 2020, G3-GENES GENOM GENET, V10, P4147, DOI 10.1534/g3.120.401676; Weaver LN, 2019, DEV BIOL, V456, P179, DOI 10.1016/j.ydbio.2019.08.015; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zer-Krispil S, 2018, CURR BIOL, V28, P1445, DOI 10.1016/j.cub.2018.03.039	78	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243756	10.1371/journal.pone.0243756	http://dx.doi.org/10.1371/journal.pone.0243756			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33307547	Green Published, gold			2022-12-26	WOS:000600144200024
J	Narita, D; Sato, I; Ogawada, D; Matsumura, A				Narita, Daiju; Sato, Ichiro; Ogawada, Daikichi; Matsumura, Akiko			Integrating economic measures of adaptation effectiveness into climate change interventions: A case study of irrigation development in Mwea, Kenya	PLOS ONE			English	Article							AFRICA; CONSTRAINTS; IMPACTS; RISKS	As climate change adaptation is becoming a recognized policy issue, the need is growing for quantitative economic evaluation of adaptation-related public investment, particularly in the context of climate finance. Funds are meant to be allocated not to any types of beneficial investments with or without climate change but to projects regarded as effective for climate change adaptation based on some metrics. But attempts at such project-specific evaluation of adaptation effects are few, in part because such assessments require an integration of various types of simulation analyses. Against this background, we conduct a case study of a Kenyan irrigation development project using a combination of downscaled climate data, runoff simulations, yield forecasting, and local socioeconomic projections to examine the effects of interventions specifically attributable to climate change adaptation, i.e., how much irrigation development can reduce the negative effects of climate change in the future. The results show that despite the uncertainties in precipitation trends, increased temperatures due to climate change have a general tendency to reduce rice yields, and that irrigation development will mitigate income impacts from the yield loss-for example, for the median scenario, the household income loss of 6% in 2050 due to climate change without irrigation development is flipped to become positive with the project. This means that the irrigation development project will likely be effective as a means for climate change adaptation.	[Narita, Daiju] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Narita, Daiju] JICA Ogata Res Inst, Tokyo, Japan; [Narita, Daiju] Kiel Inst World Econ, Kiel, Germany; [Sato, Ichiro] Japan Int Cooperat Agcy JICA, Sendai, Miyagi, Japan; [Ogawada, Daikichi; Matsumura, Akiko] Nippon Koei Co Ltd, Tsukuba, Ibaraki, Japan	University of Tokyo; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); Nippon Koei Co., Ltd.	Narita, D (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.; Narita, D (corresponding author), JICA Ogata Res Inst, Tokyo, Japan.; Narita, D (corresponding author), Kiel Inst World Econ, Kiel, Germany.	daiju.narita@global.c.u-tokyo.ac.jp	Sato, Ichiro/HGU-7251-2022; Narita, Daiju/G-7125-2016	Sato, Ichiro/0000-0001-7253-2178; Narita, Daiju/0000-0001-5695-9913	JICA; JICA Ogata Research Institute (JICA-RI); JSPS Kakenhi [17KT0066, 17K00677]	JICA; JICA Ogata Research Institute (JICA-RI); JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by JICA and the JICA Ogata Research Institute (JICA-RI), which also provided various logistical support. Daiju Narita acknowledges financial support from JSPS Kakenhi (Grant Numbers: 17KT0066 and 17K00677) for his research activities. Besides logistical support, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawala S., 2008, EC ASPECTS ADAPTATIO; Amaru S, 2013, APPL GEOGR, V39, P128, DOI 10.1016/j.apgeog.2012.12.006; [Anonymous], 2015, ENERGY STORAGE SCI T, V4, P110; [Anonymous], 2014, JPN J MED ULTRASON, V41, P405; Atera E. A., 2018, Journal of Development and Agricultural Economics, V10, P64, DOI 10.5897/jdae2017.0881; Burke M, 2015, REV ECON STAT, V97, P461, DOI 10.1162/REST_a_00478; Da Cunha DA, 2015, ENVIRON DEV ECON, V20, P57, DOI 10.1017/S1355770X14000102; Doorenbos J., 1977, FAO Irrigation and Drainage Paper; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; Finger R, 2010, AGR SYST, V103, P666, DOI 10.1016/j.agsy.2010.08.005; Hallegatte S., 2012, Policy Research Working Paper - World Bank; Herath S., 1990, P 5 INT C URB STORM, P111; JICA, 2017, TERM EV REP RIC BAS; JICA and Nippon Koei, 2018, EC EV AD MEAS CLIM C; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Kenya Ministry of Agriculture Livestock and Fisheries, 2014, NAT RIC DEV STRAT 20; Lempert R., 2013, 6465 WORLD BANK, DOI [10.1596/18139450-6465, DOI 10.1596/1813-9450-6465]; Lobell DB, 2014, GLOB FOOD SECUR-AGR, V3, P72, DOI 10.1016/j.gfs.2014.05.002; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Mendelsohn R, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S2010007812500066; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nyang'au WO, 2014, INT J AGRON, V2014, DOI 10.1155/2014/849496; Organization for Economic Co-operation and Development (OECD), 2015, EC CONS CLIM CHANG; Prudhomme C, 2010, J HYDROL, V390, P198, DOI 10.1016/j.jhydrol.2010.06.043; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Samejima H, 2020, PLANT PROD SCI, V23, P297, DOI 10.1080/1343943X.2020.1727752; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Seo SN, 2009, ENVIRON RESOUR ECON, V43, P313, DOI 10.1007/s10640-009-9270-z; Short C., 2012, TECHNICAL NOTES SERI; UNEP-DTU, 2016, AD FIN GAP REP 2016; van Ittersum MK, 2016, P NATL ACAD SCI USA, V113, P14964, DOI 10.1073/pnas.1610359113; van Oort PAJ, 2018, GLOBAL CHANGE BIOL, V24, P1029, DOI 10.1111/gcb.13967; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Weedon GP, 2014, WATER RESOUR RES, V50, P7505, DOI 10.1002/2014WR015638; You LZ, 2014, FOOD POLICY, V47, P34, DOI 10.1016/j.foodpol.2014.04.006; You LZ, 2011, FOOD POLICY, V36, P770, DOI 10.1016/j.foodpol.2011.09.001	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243779	10.1371/journal.pone.0243779	http://dx.doi.org/10.1371/journal.pone.0243779			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306704	gold, Green Published			2022-12-26	WOS:000600144200055
J	Van de Walle, P; Munoz-Jimenez, C; Askjaer, P; Schoofs, L; Temmerman, L				Van de Walle, Pieter; Munoz-Jimenez, Celia; Askjaer, Peter; Schoofs, Liliane; Temmerman, Liesbet			DamID identifies targets of CEH-60/PBX that are associated with neuron development and muscle structure in Caenorhabditis elegans	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; C-ELEGANS; TRANSCRIPTION FACTOR; NUCLEAR-ORGANIZATION; HOMEODOMAIN PROTEIN; HOX GENES; TGF-BETA; PBX; EXPRESSION; HOMOLOG	Transcription factors govern many of the time- and tissue-specific gene expression events in living organisms. CEH-60, a homolog of the TALE transcription factor PBX in vertebrates, was recently characterized as a new regulator of intestinal lipid mobilization in Caenorhabditis elegans. Because CEH-60's orthologs and paralogs exhibit several other functions, notably in neuron and muscle development, and because ceh-60 expression is not limited to the C. elegans intestine, we sought to identify additional functions of CEH-60 through DNA adenine methyltransferase identification (DamID). DamID identifies protein-genome interaction sites through GATC-specific methylation. We here report 872 putative CEH-60 gene targets in young adult animals, and 587 in L2 larvae, many of which are associated with neuron development or muscle structure. In light of this, we investigate morphology and function of ceh-60 expressing AWC neurons, and contraction of pharyngeal muscles. We find no clear functional consequences of loss of ceh-60 in these assays, suggesting that in AWC neurons and pharyngeal muscle, CEH-60 function is likely more subtle or redundant with other factors.	[Van de Walle, Pieter; Schoofs, Liliane; Temmerman, Liesbet] Univ Leuven, Anim Physiol & Neurobiol, KU Leuven, Leuven, Belgium; [Munoz-Jimenez, Celia; Askjaer, Peter] CSIC JA Univ Pablo Olavide, Andalusian Ctr Dev Biol CABD, Seville, Spain	KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Temmerman, L (corresponding author), Univ Leuven, Anim Physiol & Neurobiol, KU Leuven, Leuven, Belgium.	Liesbet.Temmerman@kuleuven.be	Van de Walle, Pieter/AAH-4563-2021; Askjaer, Peter/I-3316-2012	Van de Walle, Pieter/0000-0002-6020-7885; Temmerman, Liesbet/0000-0002-1249-3995; Askjaer, Peter/0000-0003-3192-4428	FWO Flanders [G095915, 1S00617N]; KU Leuven [C16/19/003]; Spanish Ministry of Science and Innovation [PID2019-105069GB-I00, MDM-2016-0687]; Spanish Research Council [2019AEP142]; Genie COST action [BM1408]	FWO Flanders(FWO); KU Leuven(KU Leuven); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Research Council; Genie COST action	PVdW is an n SB PhD fellow of the FWO Flanders (1S00617N, https://www.fwo.be).The authors are grateful to the FWO Flanders (G095915) and KU Leuven (https://www.kuleuven.be, C16/19/003), the Spanish Ministry of Science and Innovation (PID2019-105069GB-I00 and MDM-2016-0687 to PA) and the Spanish Research Council (2019AEP142 to PA) for financial support. We are especially grateful to the Genie COST action (BM1408) for supporting this research.	Altun Z.F., 2009, WORMATLAS; Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Benian GM, 2010, ENCY MOV DISORD, V132, P171, DOI [10.1016/B978-0-12-374105-9.00223-9, DOI 10.1016/B978-0-12-374105-9.00223-9]; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bryantsev AL, 2012, DEV CELL, V23, P664, DOI 10.1016/j.devcel.2012.08.004; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Cheetham SW, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.170209; Cho OH, 2015, DEV DYNAM, V244, P43, DOI 10.1002/dvdy.24217; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Dowen RH, 2019, DEV CELL, V49, P235, DOI 10.1016/j.devcel.2019.03.002; Erickson T, 2011, GENESIS, V49, P725, DOI 10.1002/dvg.20781; Fernandez-Aranda F, 2016, ENDOCRINE, V51, P256, DOI 10.1007/s12020-015-0684-9; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Gomez-Saldivar G, 2016, METHODS MOL BIOL, V1411, P341, DOI 10.1007/978-1-4939-3530-7_22; Goszczynski B, 2016, DEV BIOL, V413, P112, DOI 10.1016/j.ydbio.2016.02.031; Guan G, 2019, BIORXIV; Gutierrez-Triana JA, 2016, DEVELOPMENT, V143, P4272, DOI 10.1242/dev.139261; Hall DH., 2011, WORMATLAS; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hristova M, 2005, MOL CELL BIOL, V25, P11059, DOI 10.1128/MCB.25.24.11059-11072.2005; Hughes S, 2013, BIOL OPEN, V2, P718, DOI 10.1242/bio.20134549; Jia LY, 2006, GENETICS, V173, P1241, DOI 10.1534/genetics.106.057000; Jiang Y, 2008, MECH DEVELOP, V125, P451, DOI 10.1016/j.mod.2008.01.009; Jiang Y, 2009, DEV BIOL, V334, P535, DOI 10.1016/j.ydbio.2009.07.034; KAGAWA H, 1989, J MOL BIOL, V207, P311, DOI 10.1016/0022-2836(89)90257-X; Katidou M, 2013, DEV BIOL, V373, P184, DOI 10.1016/j.ydbio.2012.10.027; Kauffman A, 2011, JOVE-J VIS EXP, DOI 10.3791/2490; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Liu HR, 2006, DEVELOPMENT, V133, P641, DOI 10.1242/dev.02234; Liu J, 2000, DEVELOPMENT, V127, P5179; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Matsunaga Y, 2017, MOL BIOL CELL, V28, P1591, DOI 10.1091/mbc.E16-10-0707; Matsuo Kanae, 2019, MicroPubl Biol, V2019, DOI 10.17912/micropub.biology.000110; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McKeown CR, 2006, DEV DYNAM, V235, P530, DOI 10.1002/dvdy.20633; Mercer KB, 2007, MOL BIOL CELL, V18, P976, DOI [10.1091/mbc.e06-09-0813, DOI 10.1091/MBC.E06-09-0813]; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; MOERMAN DG, 1982, CELL, V29, P773, DOI 10.1016/0092-8674(82)90439-1; Mosbech MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070087; Munoz-Jimenez C, 2017, GENETICS, V206, P1763, DOI 10.1534/genetics.117.201012; Mutlu AS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15296-8; Nash B, 2000, GENE DEV, V14, P2486, DOI 10.1101/gad.831500; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Remesal L, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186841; Ruksana R, 2005, GENES CELLS, V10, P261, DOI 10.1111/j.1365-2443.2005.00829.x; Rushforth AM, 1998, GENETICS, V150, P1067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schultz RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101929; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Sen SQ, 2019, ELIFE, V8, DOI 10.7554/eLife.44036; Sharma R, 2016, GENESIS, V54, P151, DOI 10.1002/dvg.22925; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Small TM, 2004, J MOL BIOL, V342, P91, DOI 10.1016/j.jmb.2004.07.006; Sparacio AP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233059; Spooner PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040182; Thiebaud N, 2014, J NEUROSCI, V34, P6970, DOI 10.1523/JNEUROSCI.3366-13.2014; Tosti L, 2018, GENOME RES, V28, P592, DOI 10.1101/gr.227124.117; Trojanowski NF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22940; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Nostrand EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003325; Van Rompay L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16381; Van Sinay E, 2017, P NATL ACAD SCI USA, V114, pE4065, DOI 10.1073/pnas.1617392114; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Vissers JHA, 2018, CELL REP, V25, P1561, DOI 10.1016/j.celrep.2018.10.038; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang XL, 2005, DEV BIOL, V284, P273, DOI 10.1016/j.ydbio.2005.05.020; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yao ZZ, 2013, BIOL OPEN, V2, P546, DOI 10.1242/bio.20133921; Zhang XD, 2012, P NATL ACAD SCI USA, V109, P17081, DOI 10.1073/pnas.1205982109; Zheng CG, 2015, CELL REP, V13, P1343, DOI 10.1016/j.celrep.2015.10.044; Zheng CG, 2015, NEURON, V88, P514, DOI 10.1016/j.neuron.2015.09.049	85	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242939	10.1371/journal.pone.0242939	http://dx.doi.org/10.1371/journal.pone.0242939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306687	gold, Green Published			2022-12-26	WOS:000600144200032
J	Boyd, SH; Niemiller, KDK; Dooley, KE; Nix, J; Niemiller, ML				Boyd, Spencer H.; Niemiller, K. Denise Kendall; Dooley, Katherine E.; Nix, Jennifer; Niemiller, Matthew L.			Using environmental DNA methods to survey for rare groundwater fauna: Detection of an endangered endemic cave crayfish in northern Alabama	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBGENUS AVITICAMBARUS; DECAPODA CAMBARIDAE; DEGRADATION; EDNA; PHYLOGEOGRAPHY; CONSERVATION; BIODIVERSITY; TEMPERATURE; DIVERSITY	The conservation and management of subterranean biodiversity is hindered by a lack of knowledge on the true distributions for many species, e.g., the Wallacean shortfall. In recent years, several studies have demonstrated the potential of environmental DNA (eDNA) as an effective approach to detect and monitor biodiversity, including rare, threatened, and endangered taxa. However, there are few eDNA studies of groundwater fauna. Here we report the results of the development and implementation of an eDNA assay targeting a short fragment of the mitochondrial CO1 locus of a critically imperiled cave crayfish, the Sweet Home Alabama Cave Crayfish (Cambarus speleocoopi), known from just four cave systems in the Interior Plateau karst region of northern Alabama. We detected C. speleocoopi DNA from water samples collected at 5 of 16 sites sampled (caves and springs), including two historical sites as well as three additional and potentially new sites in Marshall County, Alabama. All three of these sites were within 2 km of historical sites. Our study is the first to detect a groundwater crustacean in the Interior Plateau karst region. Additionally, our study contributes to the growing literature that eDNA is a viable complementary tool for detection and monitoring of a fauna that is difficult to survey and study using traditional approaches.	[Boyd, Spencer H.; Niemiller, K. Denise Kendall; Dooley, Katherine E.; Nix, Jennifer; Niemiller, Matthew L.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	University of Alabama System; University of Alabama Huntsville	Niemiller, ML (corresponding author), Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA.	matthew.niemiller@uah.edu	; Niemiller, Matthew/B-2454-2012	Dooley, Katherine/0000-0002-4198-4304; Niemiller, Matthew/0000-0001-6353-8797	Cave Conservancy Foundation [7959]; University of Alabama in Huntsville New Faculty Research Award [251353]; Integrated DNA Technologies Sustainability Award	Cave Conservancy Foundation; University of Alabama in Huntsville New Faculty Research Award; Integrated DNA Technologies Sustainability Award	This study was supported by funding from the Cave Conservancy Foundation (contract no. 7959) to MLN, The University of Alabama in Huntsville New Faculty Research Award (no. 251353) to MLN, and the Integrated DNA Technologies Sustainability Award to MLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185043; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Beng KC, 2020, BIODIVERS CONSERV, V29, P2089, DOI 10.1007/s10531-020-01980-0; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Buhay J, 2010, CAMBARUS SPELEOCOOPI, DOI [10.2305/IUCN.UK.2010-3.RLTS.T164915A5938003.en, DOI 10.2305/IUCN.UK.2010-3.RLTS.T164915A5938003.EN]; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P121, DOI 10.1651/08-3089.1; Buxton AS, 2017, SCI REP-UK, V7, DOI 10.1038/srep46294; DiStefano RJ, 2020, FRESHW CRAYFISH, V25, P47, DOI 10.5869/fc.2020.v25-1.047; Dorazio RM, 2018, MOL ECOL RESOUR, V18, P368, DOI 10.1111/1755-0998.12735; Dunn N, 2017, ECOL EVOL, V7, P7777, DOI 10.1002/ece3.3316; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Eme D, 2014, J BIOGEOGR, V41, P687, DOI 10.1111/jbi.12237; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2019, CONSERV BIOL, V33, P214, DOI 10.1111/cobi.13179; Fiser C, 2014, BIOSCIENCE, V64, P971, DOI 10.1093/biosci/biu148; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; GIBERT J, 1994, GROUNDWATER ECOLOGY; Goldberg CS, 2018, SCI TOTAL ENVIRON, V633, P695, DOI 10.1016/j.scitotenv.2018.02.295; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goricki S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45054; Goricki Spela, 2016, Natura Sloveniae, V18, P57; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Harrison JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1409; Harvey MS, 2011, INVERTEBR SYST, V25, P1, DOI 10.1071/IS11011; Hobbs H.H. Jr., 1977, Smithsonian Contributions to Zoology, VNo. 244, P1; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; Huryn A, 2017, ALABAMA WILDLIFE, P113; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Korbel K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40702; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Lyons KM, 2019, THESIS U TEXAS AUSTI; Machler E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195529; Mammola S, 2019, BIOSCIENCE, V69, P641, DOI 10.1093/biosci/biz064; Mouser J, 2019, THESIS OKLAHOMA STAT; NatureServe, 2020, NATURESERVE EXPL; Niemiller ML, 2018, CONSERV GENET RESOUR, V10, P247, DOI 10.1007/s12686-017-0785-2; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Niemiller ML, 2018, ECOLOGICAL STUDIES C, P451, DOI [10.1002/ar.24044, DOI 10.1002/AR.24044]; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Stoeckle BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189119; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Voros J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170945; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White NE, 2020, HYDROBIOLOGIA, V847, P3201, DOI 10.1007/s10750-020-04304-z; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200; Zigler KS, 2020, J CAVE KARST STUD, V82, P125, DOI 10.4311/2019LSC0125; Zulkefli NS, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183339	59	9	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242741	10.1371/journal.pone.0242741	http://dx.doi.org/10.1371/journal.pone.0242741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301442	gold, Green Published			2022-12-26	WOS:000600143100038
J	Izano, MA; Cushing, LJ; Lin, J; Eick, SM; Goin, DE; Epel, E; Woodruff, TJ; Morello-Frosch, R				Izano, Monika A.; Cushing, Lara J.; Lin, Jue; Eick, Stephanie M.; Goin, Dana E.; Epel, Elissa; Woodruff, Tracey J.; Morello-Frosch, Rachel			The association of maternal psychosocial stress with newborn telomere length	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CAUSAL INFERENCE; SOCIAL-STATUS; RISK; PREGNANCY; HEALTH; STRAIN	Background Telomere length in early life predicts later length, and shortened telomere length among adults and children has been linked to increased risk of chronic disease and mortality. Maternal stress during pregnancy may impact telomere length of the newborn. Methods In a diverse cohort of 355 pregnant women receiving prenatal and delivery care services at two hospitals in San Francisco, California, we investigated the relationship between self-reported maternal psychosocial stressors during the 2(nd) trimester of pregnancy and telomere length (T/S ratio) in newborn umbilical cord blood leukocytes. We examined financial strain, food insecurity, high job strain, poor neighborhood quality, low standing in one's community, experience of stressful/traumatic life events, caregiving for a dependent family member, perceived stress, and unplanned pregnancy. We used linear regression and Targeted Minimum Loss-Based Estimation (TMLE) to evaluate the change in the T/S ratio associated with exposure to each stressor controlling for maternal age, education, parity, race/ethnicity, and delivery hospital. Results In TMLE analyses, low community standing (-0.09; 95% confidence interval [CI]-0.19 to 0.00) and perceived stress (-0.07; 95% CI -0.15 to 0.021 was marginally associated with shorter newborn telomere length, but the associations were not significant after adjusting for multiple comparisons. All linear regression estimates were not statistically significant. Our results also suggest that the association between some maternal stressors and newborn telomere length varies by race/ethnicity and infant sex. Conclusions This study is the first to examine the joint effect of multiple stressors during pregnancy on newborn TL using a flexible modeling approach.	[Izano, Monika A.; Eick, Stephanie M.; Goin, Dana E.; Woodruff, Tracey J.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Program Reprod Hlth & Environm, San Francisco, CA USA; [Cushing, Lara J.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA; [Lin, Jue] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Morello-Frosch, Rachel] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Morello-Frosch, Rachel] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Morello-Frosch, R (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Morello-Frosch, R (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	rmf@berkeley.edu		Eick, Stephanie/0000-0001-6695-3291	United States Environmental Protection Agency [RD83543301]; National Institute of Environmental Health Sciences [P01-ES022841]; National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) Program [UG3 OD023272, UH3 OD023272]	United States Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) Program	This work was supported by grants RD83543301 from the United States Environmental Protection Agency, P01-ES022841 from the National Institute of Environmental Health Sciences, National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) Program UG3 OD023272, UH3 OD023272.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Anderson SA, 1990, J NUTR; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickel G., 2000, MEASURING FOOD SECUR; Blumberg SJ, 1999, AM J PUBLIC HLTH; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, PERCEIVED STRESS PRO; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; der Laan MJ, 2003, UNIFIED METHODS CENS; der Laan MJ, 2007, STAT APPL GENET MOL, P6; der Laan MJ, 2011, TARGETED LEARNING CA; Dohrenwend BP, 2006, PSYCHOL BULL, V132, P477, DOI 10.1037/0033-2909.132.3.477; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gruber S., 2011, TMLE R PACKAGE TARGE; Hall KS, 2014, SOC SCI MED, V100, P62, DOI 10.1016/j.socscimed.2013.10.037; Hall KS, 2013, CONTRACEPTION, V88, P641, DOI 10.1016/j.contraception.2013.06.003; Hoxha M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-41; Kahn JR, 2006, J HEALTH SOC BEHAV, V47, P17, DOI 10.1177/002214650604700102; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kaufmann RB, 1997, AM J EPIDEMIOL, V145, P810; Marchetto NM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.177; Martens DS, 2017, JAMA PEDIATR, V171, P1160, DOI 10.1001/jamapediatrics.2017.3024; Morin AM, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0370-2; NEWTON RW, 1984, BRIT MED J, V288, P1191, DOI 10.1136/bmj.288.6425.1191; Operario D, 2004, PSYCHOL HLTH; Parker EA, 2001, HEALTH EDUC BEHAV, V28, P462, DOI 10.1177/109019810102800407; Polley EC., 2011, TARGETED LEARNING CA, P43; RCore Team, 2020, R LANG ENV STAT COMP; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Salihu HM, 2016, SOUTH MED J, V109, P767, DOI 10.14423/SMJ.0000000000000567; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schuler MS, 2017, AM J EPIDEMIOL, V185, P65, DOI 10.1093/aje/kww165; Schulz AJ, 2005, ENVIRON HEALTH PERSP, V113, P1817, DOI 10.1289/ehp.7913; Schulz AJ, 2005, METHODS COMMUNITY BA, P107; Send TS, 2017, NEUROPSYCHOPHARMACOL, V42, P2407, DOI 10.1038/npp.2017.73; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Van der laan MJ, 2003, UNIFIED CROSS VALIDA; vander Laan M. J., 2006, INT J BIOSTAT, V2	45	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242064	10.1371/journal.pone.0242064	http://dx.doi.org/10.1371/journal.pone.0242064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301453	Green Published, gold			2022-12-26	WOS:000600143100024
J	Mugnier, A; Morin, A; Cellard, F; Devaux, L; Delmas, M; Adib-Lesaux, A; Flanagan, J; Laxalde, J; Chastant, S; Grellet, A				Mugnier, Amelie; Morin, Anthony; Cellard, Fanny; Devaux, Loic; Delmas, Magalie; Adib-Lesaux, Achraf; Flanagan, John; Laxalde, Jeremy; Chastant, Sylvie; Grellet, Aurelien			Association between birth weight and risk of overweight at adulthood in Labrador dogs	PLOS ONE			English	Article							VETERINARY PRACTICES; DEVELOPMENTAL ORIGINS; OBESITY; PREVALENCE; QUALITY; MUSCLE; MEN; FAT	Several studies in humans indicate that low birth weight predisposes individuals to obesity in later life. Despite the constant increase in prevalence of obesity in the canine population and the major health consequences of this affection, few investigations have been carried out on the association between birth weight and the development of overweight in dogs. The purpose of the current study was to examine the association between birth weight and some other neonatal characteristics and overweight at adulthood in a population of purebred Labrador dogs. Information was collected about the sex, age, neuter status, birth weight, and growth rates (between 0-2 days and 2-15 days of age) in 93 Labrador dogs raised under similar environmental conditions until two months old. The body condition scores (BCS, scale of 1-9) of these dogs at adulthood were recorded, with BCS equal to or greater than 6 classified as overweight. Dogs were split into two groups based on the median birth weight in the population: lower than the median (LTM) and higher than the median (HTM). A logistic regression model was applied to analyse associations between the general characteristics of the dogs (sex, age, neuter status), early life parameters (birth weight, growth rates) and overweight at adulthood. Birth weight was the only early-life parameter found to be associated with overweight (p value = 0.032) with a prevalence of overweight of 70% among the dogs with LTM birth weight vs. 47% in dogs born with HTM birth weight. Overweight was also associated with age and neuter status (p value = 0.029 and 0.005 respectively). Our results suggest that, as in humans, dogs with the lowest birth weights are more likely to become overweight at adulthood. More studies are needed to further examine this relationship and to explore the underlying mechanisms. A subsequent objective could be to identify preventive strategies such as an adapted early nutrition programme for at-risk individuals.	[Mugnier, Amelie; Cellard, Fanny; Devaux, Loic; Chastant, Sylvie; Grellet, Aurelien] Univ Toulouse, ENVT, NeoCare, Toulouse, France; [Morin, Anthony] CESECAH, Lieu Dit Monsable, Lezoux, France; [Delmas, Magalie] Ecole Chiens Guides Aveugles Grand Sud Ouest, Toulouse, France; [Adib-Lesaux, Achraf; Flanagan, John; Laxalde, Jeremy] Royal Canin, Aimargues, France	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Mugnier, A (corresponding author), Univ Toulouse, ENVT, NeoCare, Toulouse, France.	amelie.mugnier@envt.fr	CHASTANT, Sylvie/ABG-2003-2020; Mugnier, Amélie/AAQ-2305-2020	CHASTANT, Sylvie/0000-0003-0790-6377; Mugnier, Amélie/0000-0001-9711-1679	Royal Canin SAS (Aimargues, France)	Royal Canin SAS (Aimargues, France)	This study was partially funded by Royal Canin SAS (Aimargues, France). The funder provided support in the form of salaries for AM. Moreover, AAL, JL and JF participated in the analyses of the data and in the reviewing of the paper. There was no additional external funding received for this study.	[Anonymous], 2021, LANG ENV STAT COMP; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 1998, MOTHERS BABIES HLTH; Beauchamp B, 2015, INT J OBESITY, V39, P702, DOI 10.1038/ijo.2014.120; Bland IM, 2010, PREV VET MED, V94, P310, DOI 10.1016/j.prevetmed.2010.01.013; Colliard L, 2006, J NUTR, V136, p1951S, DOI 10.1093/jn/136.7.1951S; Corbee RJ, 2013, J ANIM PHYSIOL AN N, V97, P904, DOI 10.1111/j.1439-0396.2012.01336.x; Courcier EA, 2011, PREV VET MED, V102, P66, DOI 10.1016/j.prevetmed.2011.06.010; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2013, CURR DIABETES REP, V13, P27, DOI 10.1007/s11892-012-0344-x; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; German AJ, 2012, VET J, V192, P428, DOI 10.1016/j.tvjl.2011.09.015; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Jeusette I, 2004, J ANIM PHYSIOL AN N, V88, P117, DOI 10.1111/j.1439-0396.2003.00467.x; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Jornayvaz FR, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0389-2; Laflamme D, 1997, CANINE PRACT, V22, P10; Laflamme DP, 2005, VET CLIN N AM-SMALL, V35, P713, DOI 10.1016/j.cvsm.2004.12.011; Le Gal A, 2016, P 8 INT S CAN FEL RE, P157; Leclerc L, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0994-7; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Lung T, 2019, INT J OBESITY, V43, P782, DOI 10.1038/s41366-018-0210-2; Mao JF, 2013, PREV VET MED, V112, P438, DOI 10.1016/j.prevetmed.2013.08.012; Mawby DI, 2004, J AM ANIM HOSP ASSOC, V40, P109, DOI 10.5326/0400109; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Poore KR, 2004, J PHYSIOL-LONDON, V558, P295, DOI 10.1113/jphysiol.2004.061390; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Sarr O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098433; SONNENSCHEIN EG, 1991, AM J EPIDEMIOL, V133, P694, DOI 10.1093/oxfordjournals.aje.a115944	37	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243820	10.1371/journal.pone.0243820	http://dx.doi.org/10.1371/journal.pone.0243820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301504	Green Published, gold			2022-12-26	WOS:000600143100004
J	Gasteiger, S; Primavesi, F; Werkl, P; Dostal, L; Gehwolf, P; Braunwarth, E; Maglione, M; Sopper, S; Ofner, D; Stattner, S				Gasteiger, Silvia; Primavesi, Florian; Werkl, Peter; Dostal, Lucie; Gehwolf, Philipp; Braunwarth, Eva; Maglione, Manuel; Sopper, Sieghart; Oefner, Dietmar; Staettner, Stefan			The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study	PLOS ONE			English	Article							INTERNATIONAL STUDY-GROUP; SURGICAL COMPLICATIONS; CLAVIEN-DINDO; CLASSIFICATION; SURGERY; PANCREATICODUODENECTOMY; DEFINITION; MANAGEMENT	Background Presepsin is involved in binding lipopolysaccharides and previous studies have confirmed its value as a marker for early diagnosis and prediction of severity in sepsis. Comparable studies assessing the predictive potential regarding postoperative complications and mortality following pancreatic resection are lacking. Methods This prospective study included 70 patients undergoing pancreatic resection from December 2017 until May 2019. Presepsin was measured preoperatively, on postoperative day 1, 3 and 8 (POD1/3/8) and correlated with the clinical course and mortality. Results Severe complications (Clavien-Dindo >= 3a) occurred in 28 patients (40%), postoperative pancreatic fistula (POPF) grade B/C occurred in 20 patients (28.6%), infectious complications in 28 (40%), and four patients (5.7%) died during hospital stay. Presepsin levels at any timepoint did not correlate with further development of postoperative complications or in-hospital mortality whereas CRP levels on postoperative day (POD) 3 were significantly associated with clinically relevant POPF (AUC 0.664, 95%CI 0.528-0.800; p = 0.033). Preoperative Presepsin levels as well as Presepsin on POD1 were significantly elevated in patients with malignant compared to benign underlying disease (299pg/ml vs. 174pg/ml and 693.5pg/ml vs. 294pg/ml; p = 0.009 and 0.013, respectively). Conclusion In our cohort, Presepsin was not eligible to predict the postoperative course following pancreatic resection. However, Presepsin levels were significantly elevated in patients with malignant disease, this finding warrants further investigation.	[Gasteiger, Silvia; Werkl, Peter; Gehwolf, Philipp; Braunwarth, Eva; Maglione, Manuel; Oefner, Dietmar; Staettner, Stefan] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria; [Primavesi, Florian; Staettner, Stefan] Salzkammergut Klinikum, Dept Surg, Vocklabruck, Austria; [Dostal, Lucie] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Sopper, Sieghart] Med Univ Innsbruck, Dept Haematol & Oncol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Stattner, S (corresponding author), Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria.; Stattner, S (corresponding author), Salzkammergut Klinikum, Dept Surg, Vocklabruck, Austria.	s.staettner@icloud.com		Stattner, Stefan/0000-0002-5226-7597; Maglione, Manuel/0000-0003-1479-6129				[Anonymous], 2015, MEDICINE, V94, pe1435; Arai Y, 2015, J INFECT CHEMOTHER, V21, P564, DOI 10.1016/j.jiac.2015.04.011; Aykut B, 2019, NATURE, V574, P264, DOI 10.1038/s41586-019-1608-2; Babic A, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0008-5; Bassi C, 2001, DIGEST SURG, V18, P453, DOI 10.1159/000050193; Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Berberat PO, 1999, DIGEST SURG, V16, P327, DOI 10.1159/000018743; Bolliger M, 2018, EUR SURG, V50, P256, DOI 10.1007/s10353-018-0551-z; Bosch F, 2019, SHOCK; Buchler MW, 2003, ARCH SURG-CHICAGO, V138, P1310, DOI 10.1001/archsurg.138.12.1310; Cameron JL, 2015, J AM COLL SURGEONS, V220, P530, DOI 10.1016/j.jamcollsurg.2014.12.031; Cardini B, 2019, EUR SURG, V51, P81, DOI 10.1007/s10353-019-0585-x; Carter JV, 2016, SURGERY, V159, P1638, DOI 10.1016/j.surg.2015.12.029; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Clementi A, 2019, BLOOD PURIFICAT, V47, P140, DOI 10.1159/000494207; Dickson I, 2018, NAT REV GASTRO HEPAT, V15, P328, DOI 10.1038/s41575-018-0013-x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Gervais DA, 2001, RADIOGRAPHICS, V21, P673, DOI 10.1148/radiographics.21.3.g01ma16673; Halloran CM, 2002, DIGEST SURG, V19, P138, DOI 10.1159/000052029; Kang CM, 2015, WORLD J GASTROENTERO, V21, P5794, DOI 10.3748/wjg.v21.i19.5794; Kang J, 2019, SHOCK, V52, P362, DOI 10.1097/SHK.0000000000001269; Larsen FF, 2017, EUR J INTERN MED, V45, P46, DOI 10.1016/j.ejim.2017.09.030; Liu QY, 2014, WORLD J GASTROENTERO, V20, P17491, DOI 10.3748/wjg.v20.i46.17491; Lu B, 2018, AM J EMERG MED, V36, P1341, DOI 10.1016/j.ajem.2017.12.038; Mitsuhashi K, 2015, ONCOTARGET, V6, P7209, DOI 10.18632/oncotarget.3109; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Schindl M, 2018, BRIT J SURG, V105, P811, DOI 10.1002/bjs.10840; Shirakawa K, 2011, CLIN CHEM LAB MED, V49, P937, DOI 10.1515/CCLM.2011.145; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Stojadinovic A, 2003, J AM COLL SURGEONS, V196, P954, DOI 10.1016/S1072-7515(03)00010-3; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; 2018, INT J COMMUN SYST, V31	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243510	10.1371/journal.pone.0243510	http://dx.doi.org/10.1371/journal.pone.0243510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296435	Green Published, gold			2022-12-26	WOS:000598626100018
J	Miller, J; Vienneau-Hathaway, J; Dendev, E; Lan, MA; Ayoub, NA				Miller, Jeremy; Vienneau-Hathaway, Jannelle; Dendev, Enkhbileg; Lan, Merrina; Ayoub, Nadia A.			The common house spider, Parasteatoda tepidariorum, maintains silk gene expression on sub-optimal diet	PLOS ONE			English	Article							PREY-WRAPPING SILK; MECHANICAL-PROPERTIES; DRAGLINE SILK; BLACK-WIDOW; COB WEAVER; PROTEINS; NEPHILA; FIBROIN; DIVERSITY; SEQUENCE	Cobweb weaving spiders and their relatives spin multiple task-specific fiber types. The unique material properties of each silk type result from differences in amino acid sequence and structure of their component proteins, primarily spidroins (spider fibrous proteins). Amino acid content and gene expression measurements of spider silks suggest some spiders change expression patterns of individual protein components in response to environmental cues. We quantified mRNA abundance of three spidroin encoding genes involved in prey capture in the common house spider, Parasteatoda tepidariorum (Theridiidae), fed different diets. After 10 days of acclimation to the lab on a diet of mealworms, spiders were split into three groups: (1) individuals were immediately dissected, (2) spiders were fed high-energy crickets, or (3) spiders were fed low-energy flies, for 1 month. All spiders gained mass during the acclimation period and cricket-fed spiders continued to gain mass, while fly-fed spiders either maintained or lost mass. Using quantitative PCR, we found no significant differences in the absolute or relative abundance of dragline gene transcripts, major ampullate spidroin 1 (MaSp1) and major ampullate spidroin 2 (MaSp2), among groups. In contrast, prey-wrapping minor ampullate spidroin (MiSp) gene transcripts were significantly less abundant in fly-fed than lab-acclimated spiders. However, when measured relative to Actin, cricket-fed spiders showed the lowest expression of MiSp. Our results suggest that house spiders are able to maintain silk production, even in the face of a low-quality diet.	[Miller, Jeremy; Vienneau-Hathaway, Jannelle; Dendev, Enkhbileg; Lan, Merrina; Ayoub, Nadia A.] Washington & Lee Univ, Dept Biol, Lexington, VA 24450 USA; [Miller, Jeremy] Univ Kentucky, Coll Med, Lexington, KY USA	Washington & Lee University; University of Kentucky	Ayoub, NA (corresponding author), Washington & Lee Univ, Dept Biol, Lexington, VA 24450 USA.	ayoubn@wlu.edu			Howard Hughes Medical Institute [52007570]; National Science Foundation, Biology Directorate [1755142]; Washington and Lee Unviersity	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation, Biology Directorate(National Science Foundation (NSF)); Washington and Lee Unviersity	Funding for this work was provided by the Howard Hughes Medical Institute (52007570) to support the salary of JM, the National Science Foundation, Biology Directorate (1755142) to NAA, and Washington and Lee Unviersity through Summer Lenfest Research Support to NAA, and through the Summer Research Scholars Program to support the salaries of JV-H, ED, and ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Ayoub NA, 2013, MOL BIOL EVOL, V30, P589, DOI 10.1093/molbev/mss254; Babb PL, 2017, NAT GENET, V49, P895, DOI 10.1038/ng.3852; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00782; Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730; Blamires SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192005; Blamires SJ, 2017, ANNU REV ENTOMOL, V62, P443, DOI 10.1146/annurev-ento-031616-035615; Blamires SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26383; Blamires SJ, 2015, BIOMACROMOLECULES, V16, P1218, DOI 10.1021/acs.biomac.5b00006; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Casem ML, 2010, J ARACHNOL, V38, P99, DOI 10.1636/Sh09-20.1; Clarke TH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07388-1; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9; Craig HC, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0471; Craig HC, 2019, CHEM COMMUN, V55, P4687, DOI 10.1039/c9cc01045a; Finke MD, 2013, ZOO BIOL, V32, P27, DOI 10.1002/zoo.21012; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; Foelix R. F, 2011, BIOL SPIDERS; Garb JE, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0496-1; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Guinea GV, 2012, BIOMACROMOLECULES, V13, P2087, DOI 10.1021/bm3004644; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland GP, 2008, CHEM COMMUN, P5568, DOI 10.1039/b812928b; Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208; Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e; Kono N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44775-2; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; Stellwagen SD, 2019, G3-GENES GENOM GENET, V9, P1909, DOI 10.1534/g3.119.400065; Townley Mark A., 2013, P283; Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437; Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200; Vasanthavada K, 2012, J BIOL CHEM, V287, P35986, DOI 10.1074/jbc.M112.399816; Vienneau-Hathaway JM, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0927-x; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zschokke Samuel, 1993, Bulletin of the British Arachnological Society, V9, P169	42	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0237286	10.1371/journal.pone.0237286	http://dx.doi.org/10.1371/journal.pone.0237286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296374	gold, Green Submitted, Green Published			2022-12-26	WOS:000598626100055
J	Na, YJ; Hall, A; Choi, KM; Hu, L; Rose, J; Coover, RA; Miller, A; Hennigan, RF; Dombi, E; Kim, MO; Subramanian, S; Ratner, N; Wu, JQ				Na, Youjin; Hall, Ashley; Choi, Kwangmin; Hu, Liang; Rose, Jonathan; Coover, Robert A.; Miller, Adam; Hennigan, Robert F.; Dombi, Eva; Kim, Mi-Ok; Subramanian, Subbaya; Ratner, Nancy; Wu, Jianqiang			MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK	ONCOGENE			English	Article							IN-VIVO; SCHWANN-CELLS; MOUSE MODEL; MIR-155; CANCER; DIFFERENTIATION; INHIBITION; ACTIVATION; TYPE-1; ROLES	MicroRNAs (miRs) are small non-coding RNAs that can have large impacts on oncogenic pathways. Possible functions of dysregulated miRs have not been studied in neurofibromatosis type 1 (NF1) plexiform neurofibromas (PNFs). In PNFs, Schwann cells (SCs) have biallelic NF1 mutations necessary for tumorigenesis. We analyzed a miR microarray comparing with normal and PNF SCs and identified differences in miR expression, and we validated in mouse PNFs versus normal mouse SCs by qRT-PCR. Among these, miR-155 was a top overexpressed miR, and its expression was regulated by RAS/MAPK signaling. Overexpression of miR-155 increased mature Nf1(-/-) mouse SC proliferation. In SC precursors, which model tumor-initiating cells, pharmacological and genetic inhibition of miR-155 decreased PNF-derived sphere numbers in vitro, and we identified Maf as a miR-155 target. In vivo, global deletion of miR-155 significantly decreased tumor number and volume, increasing mouse survival. Fluorescent nanoparticles entered PNFs, suggesting that an anti-miR might have therapeutic potential. However, treatment of established PNFs using anti-miR-155 peptide nucleic acid-loaded nanoparticles marginally decreased tumor numbers and did not reduce tumor growth. These results suggest that miR-155 plays a functional role in PNF growth and/or SC proliferation, and that targeting neurofibroma miRs is feasible, and might provide novel therapeutic opportunities.	[Na, Youjin; Hall, Ashley; Choi, Kwangmin; Hu, Liang; Rose, Jonathan; Coover, Robert A.; Miller, Adam; Hennigan, Robert F.; Ratner, Nancy; Wu, Jianqiang] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Dombi, Eva] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Kim, Mi-Ok] UCSF, Dept Epidemiol & Biostat, Box 0128,1450 3rd St,Suite 285, San Francisco, CA 94143 USA; [Subramanian, Subbaya] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Ratner, Nancy; Wu, Jianqiang] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Coover, Robert A.] High Point Univ, Fred Wilson Sch Pharm, Pharmaceut Sci, One Univ Pkwy, High Point, NC 27268 USA	Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati	Wu, JQ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Wu, JQ (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA.	Jianqiang.wu@cchmc.org		Coover, Robert/0000-0001-8153-6912; RATNER, NANCY/0000-0001-5030-9354; Rose, Jonathan/0000-0002-6262-2433	NIH [R01 NS097233, NIH R0 NS28840, R37 NS096356]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Mark Saltzman and Christopher J. Cheng (Yale School of Engineering and Applied Science) for providing fluorescence-conjugated nanoparticles to fulfill part of the in vivo experiments. This work was supported by NIH R01 NS097233 to J.W. NIH R0 NS28840 and R37 NS096356 to N.R.	Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Baulcombe D, 2002, SCIENCE, V297, P2002, DOI 10.1126/science.1077906; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Boyd KP, 2009, J AM ACAD DERMATOL, V61, P1, DOI 10.1016/j.jaad.2008.12.051; Brundage ME, 2014, ONCOGENE, V33, P5626, DOI 10.1038/onc.2013.506; Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x; Chen ZG, 2019, CANCER DISCOV, V9, P114, DOI 10.1158/2159-8290.CD-18-0151; Chene CJ, 2011, BIOMATERIALS, V32, P6194, DOI 10.1016/j.biomaterials.2011.04.053; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160; Ganguly S, 2008, OLIGONUCLEOTIDES, V18, P277, DOI 10.1089/oli.2008.0140; Gong M, 2012, NEURO-ONCOLOGY, V14, P1007, DOI 10.1093/neuonc/nos124; Gordon JEA, 2013, BRIT J HAEMATOL, V162, P162, DOI 10.1111/bjh.12364; Gross AM, 2020, NEW ENGL J MED, V382, P1430, DOI 10.1056/NEJMoa1912735; Hall A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8389; Higgs Gadareth, 2013, J Clin Bioinforma, V3, P17, DOI 10.1186/2043-9113-3-17; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jousma E, 2015, PEDIATR BLOOD CANCER, V62, P1709, DOI 10.1002/pbc.25546; Kim M, 2018, GENE DEV, V32, P645, DOI 10.1101/gad.310490.117; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kraniak JM, 2010, MOL CELL BIOCHEM, V344, P267, DOI 10.1007/s11010-010-0551-1; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Liu M, 2020, J CLIN INVEST, V130, P2081, DOI 10.1172/JCI131335; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Martin Elizabeth C, 2014, Genes Cancer, V5, P353; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Presneau N, 2013, BRIT J CANCER, V108, P964, DOI 10.1038/bjc.2012.518; Radomska KJ, 2019, CANCER DISCOV, V9, P130, DOI 10.1158/2159-8290.CD-18-0156; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Rice FL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216527; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sherman LS, 2001, METHOD ENZYMOL, V333, P348; Solomon J, 2004, COMPUT MED IMAG GRAP, V28, P257, DOI 10.1016/j.compmedimag.2004.03.002; Su W, 2014, J IMMUNOL, V192, P358, DOI 10.4049/jimmunol.1301397; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trotta R, 2013, BLOOD, V121, P3126, DOI 10.1182/blood-2012-12-467597; Varan A, 2016, CLIN GENET, V89, P341, DOI 10.1111/cge.12625; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Wu JQ, 2016, CELL REP, V14, P1979, DOI 10.1016/j.celrep.2016.01.074; Wu JQ, 2012, PEDIATR BLOOD CANCER, V58, P173, DOI 10.1002/pbc.23015; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhang C, 2015, DIABETES-METAB RES, V31, P773, DOI 10.1002/dmrr.2676; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhou Y, 2019, CLIN NEUROL NEUROSUR, V176, P103, DOI 10.1016/j.clineuro.2018.12.005; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	60	4	4	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					951	963		10.1038/s41388-020-01581-9	http://dx.doi.org/10.1038/s41388-020-01581-9		DEC 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33293695	Green Accepted			2022-12-26	WOS:000599053400002
J	Seid, M; Beyene, G; Alemu, Y; Workalemahu, B; Delbo, M; Taddesse, D; Biresaw, G; Manilal, A				Seid, Mohammed; Beyene, Getnet; Alemu, Yared; Workalemahu, Bereket; Delbo, Mulugeta; Taddesse, Dagimawie; Biresaw, Gelila; Manilal, Aseer			Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; STREPTOCOCCUS-PNEUMONIAE; INFECTED ADULTS; NASOPHARYNGEAL CARRIAGE; ANTIBIOTIC-RESISTANCE; COTE-DIVOIRE; COLONIZATION; PREVALENCE; IMPACT	Background Infections caused by antibiotic-resistant bacteria results in high rates of morbidity and mortality. Although the prolonged cotrimoxazole (CTX) prophylaxis is arguably associated with the risk of increasing drug resistance in the common pathogens, information regarding its impact on Streptococci pneumoniae / pneumococcus is very limited. Objective This study was conducted to investigate the effect of cotrimoxazole prophylaxis on nasopharyngeal colonization rate and antimicrobial resistance using Streptococci pneumoniae (pneumococcus) as an indicator organism among HIV patients in Arba Minch, Ethiopia. Materials and methods A comparative cross-sectional study was designed and conducted among HIV patients attending the Anti-Retroviral Treatment (ART) clinic of Arba Minch General Hospital (AMGH) from April 01 to August 31, 2018. A total of 252 participants were systematically selected and clustered into two study groups based on their CTX prophylaxis status, one taking CTX prophylaxis, and the second one, the control group (without prophylaxis). A structured questionnaire was used to collect socio-demographic and clinical data from patients. A nasopharyngeal swab was collected and cultured for pneumococcal isolation and identification in accordance with standard microbiological techniques. An antibiotics sensitivity test was performed according to the CLSI guidelines. Data were analyzed using the Statistical package for social science (SPSS) version 20. The primary outcome was determined using logistic regression analysis. Results Of the 252 enrolled HIV patients (mean age (37.38 +/- 9.03 years), 144 (57.14%) were males. The overall, nasopharyngeal colonization rate of S. pneumoniae was 13.5% (95% CI: 8.4-15.6). Asymptomatic pneumococcal carriage rates among patients on CTX prophylaxis and the control group were 16.3%, and 10.3% respectively (p-value = 0.03). Regarding the risk factors analyzed, CTX prophylaxis (AOR: 2.2; 95% CI: 1.05-4.9) and gender (AOR: 2.5; 95% CI: 1.09-5.93) were significantly associated with pneumococcal colonization, showing a male preponderance. Cotrimoxazole-resistant pneumococci were 85.7% vs. 47.4% in the prophylaxis group and the control group respectively and it was statistically significant (AOR: 6.7; 95% CI: 1.3-36). Percentages of multi-drug resistant isolates in these two groups were 38.09 and 15.38 respectively (p-value = 0.04). Among the CTX resistant pneumococci isolates, 85% were also found to be co-resistant towards penicillin and was statistically significant. Conclusion The percentage prevalence of nasopharyngeal pneumococci colonization was higher in patients taking CTX prophylaxis. It was noted that CTX prophylaxis eventually results in the selection of cotrimoxazole resistance and multi-drug resistance in pneumococci. There is evidence of existing cross-resistance between cotrimoxazole and penicillin antibiotics. Therefore, CTX prophylaxis must be administered judiciously. Surveillance for antimicrobial susceptibility is warranted where the prophylaxis is common.	[Seid, Mohammed; Taddesse, Dagimawie; Biresaw, Gelila; Manilal, Aseer] Arba Minch Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Beyene, Getnet; Alemu, Yared] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Workalemahu, Bereket; Delbo, Mulugeta] Arba Minch Coll Hlth Sci, Dept Med Lab Sci, Arba Minch, Ethiopia	Arba Minch University; Jimma University	Seid, M; Manilal, A (corresponding author), Arba Minch Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Arba Minch, Ethiopia.	mohamedseid2005@gmail.com; aseermanilal@gmail.com	Manilal, Aseer/AAM-1726-2020; Manilal, Aseer/GRR-8490-2022; Manilal, Aseer/GPX-1261-2022	Manilal, Aseer/0000-0002-1146-8093; Manilal, Aseer/0000-0002-1146-8093; Manilal, Aseer/0000-0002-1146-8093; Abate, Dagimawie/0000-0002-3770-1957; Workalemahu, Bereket/0000-0002-8221-0604; Alemu, Yared/0000-0001-8752-8809				Abdel-Haq N, 1999, PEDIATR INFECT DIS J, V18, P647, DOI 10.1097/00006454-199907000-00017; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2018, GLOB BURD HIV AIDS; [Anonymous], 2018, M100 PERFORMANCE STA; Blossom DB, 2006, INT J INFECT DIS, V10, P458, DOI 10.1016/j.ijid.2006.05.010; Bradshaw JL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007911; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Conklin LM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-015-1312-2; Egwuatu C C, 2016, Afr J Infect Dis, V10, P156, DOI 10.21010/ajid.v10i2.12; El Moujaber G, 2017, J MED MICROBIOL, V66, P847, DOI 10.1099/jmm.0.000503; Feola TD, 2016, HUM VACC IMMUNOTHER, V12, P2441, DOI 10.1080/21645515.2016.1172758; GEDDES AM, 1979, J ANTIMICROB CHEMOTH, V5, P221, DOI 10.1093/jac/5.Supplement_B.221; Gill CJ, 2008, J INFECT DIS, V197, P1000, DOI 10.1086/528806; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Gill CJ, 2004, B WORLD HEALTH ORGAN, V82, P290; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Harimurti K, 2016, J INFECT PUBLIC HEAL, V9, P633, DOI 10.1016/j.jiph.2016.01.004; Heinsbroek E, 2015, AIDS, V29, P1837, DOI 10.1097/QAD.0000000000000755; Iloliev A, 2008, CENT ASIAN SURV, V27, P59, DOI 10.1080/02634930802213924; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Kibret GD, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0594-9; Marwa KJ, 2015, AIDS RES TREAT, V2015, DOI 10.1155/2015/103874; Mwambete KD, 2013, CLIN MICROBIOL, V3, P134; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; Nicoletti C, 2007, DIAGN MICR INFEC DIS, V57, P259, DOI 10.1016/j.diagmicrobio.2006.08.021; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Onwubiko C, 2008, J CLIN MICROBIOL, V46, P3621, DOI 10.1128/JCM.01245-08; Pemba L, 2008, J INFECTION, V56, P171, DOI 10.1016/j.jinf.2007.12.003; RodriguezBarradas MC, 1997, J INFECT DIS, V175, P590, DOI 10.1093/infdis/175.3.590; Sibanda EL, 2011, CLIN INFECT DIS, V52, P1184, DOI 10.1093/cid/cir067; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; UNAIDS/WHO, 2000, PROV WHO UNAIDS SECR; Wasihun AG, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1056-x; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; William Buwembo, 2012, Int J Microbiol, V2012, P916129, DOI 10.1155/2012/916129; World Health Organization, 2003, MANUAL LAB IDENTIFIC; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243054	10.1371/journal.pone.0243054	http://dx.doi.org/10.1371/journal.pone.0243054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284828	gold, Green Published			2022-12-26	WOS:000597930500052
J	Inthaphatha, S; Yamamoto, E; Louangpradith, V; Takahashi, Y; Phengsavanh, A; Kariya, T; Saw, YM; Hamajima, N				Inthaphatha, Souphalak; Yamamoto, Eiko; Louangpradith, Viengsakhone; Takahashi, Yuki; Phengsavanh, Alongkone; Kariya, Tetsuyoshi; Saw, Yu Mon; Hamajima, Nobuyuki			Factors associated with postpartum depression among women in Vientiane Capital, Lao People's Democratic Republic: A cross-sectional study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MATERNAL DEPRESSION; THAI WOMEN; PREGNANCY; PREVALENCE; SATISFACTION; TRANSITION; ANXIETY; INCOME; CARE	Postpartum depression is a worldwide public health concern. The prevalence of postpartum depression is reported to be greater in developing countries than in developed countries. However, to the best of our knowledge, no papers on postpartum depression in the Lao People's Democratic Republic have been published. In order to strengthen maternal and child health, the current situation of postpartum depression should be understood. This study aims to determine the prevalence of postpartum depression and identify factors associated with postpartum depression in Vientiane Capital, Lao People's Democratic Republic. Study participants were 428 women 6-8 weeks postpartum who visited four central hospitals in Vientiane Capital for postnatal care from July to August 2019. Structured questionnaires were used to collect socio-demographic, obstetrical and infant, and psychiatric data about the women and their partners. The Edinburgh Postnatal Depression Scale (EPDS) was used to identify suspected cases of postpartum depression with the cut-off score of 9/10. Multivariable logistic regression was used to examine independent factors that were associated with suspected postpartum depression (EPDS >= 10). The mean age of the 428 women was 28.1 years, and the prevalence of suspected postpartum depression was 31.8%. Multivariable logistic regression using variables that were statistically significant on bivariate analyses indicated that three variables were associated with suspected postpartum depression: unintended pregnancy (AOR = 1.66, 95% CI 1.00-2.73, P = 0.049), low birth satisfaction (AOR = 1.85, 95% CI 1.00-3.43, P = 0.049), and depression during pregnancy (AOR = 3.99, 95% CI 2.35-6.77, P <0.001). In this study, unintended pregnancy, low birth satisfaction, and depression during pregnancy were independent risk factors for postpartum depression. These results suggest that the mental health of pregnant women should be monitored, and that health care services, especially family planning and supportive birth care, should be strengthened to prevent postpartum depression.	[Inthaphatha, Souphalak; Yamamoto, Eiko; Louangpradith, Viengsakhone; Kariya, Tetsuyoshi; Saw, Yu Mon; Hamajima, Nobuyuki] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi, Japan; [Louangpradith, Viengsakhone] Minist Hlth, Dept Healthcare & Rehabil, Vientiane Capital, Laos; [Takahashi, Yuki] Nagoya Univ, Dept Integrated Hlth Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Phengsavanh, Alongkone] Univ Hlth Sci, Fac Med, Vientiane Capital, Laos	Nagoya University; Nagoya University	Yamamoto, E (corresponding author), Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi, Japan.	yamaeiko@med.nagoya-u.ac.jp	KARIYA, TETSUYOSHI/L-4750-2017	KARIYA, TETSUYOSHI/0000-0002-7757-4251; Yamamoto, Eiko/0000-0002-0517-5091; Saw, Yu Mon/0000-0002-5038-0043				American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; [Anonymous], 2019, Cancer Discov, V9, pOF3, DOI 10.1158/2159-8290.CD-NB2018-158; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; Bell AF, 2016, MIDWIFERY, V39, P112, DOI 10.1016/j.midw.2016.04.014; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bergink V, 2011, BRIT J PSYCHIAT, V198, P264, DOI 10.1192/bjp.bp.110.082990; Britton JR, 2012, J PSYCHOSOM OBST GYN, V33, P37, DOI 10.3109/0167482X.2012.658464; Chi XL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01668; Cleland K, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1104373; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; ECCIL, 2017, LAO SOC IND SURV 2 2; Fan QP, 2020, ASIAN J PSYCHIATR, V47, DOI 10.1016/j.ajp.2019.101855; Feinberg ME, 2016, PREV SCI, V17, P751, DOI 10.1007/s11121-016-0674-z; Feldman R, 2009, J AM ACAD CHILD PSY, V48, P919, DOI 10.1097/CHI.0b013e3181b21651; Figueiredo B, 2018, J AFFECT DISORDERS, V238, P204, DOI 10.1016/j.jad.2018.05.064; Figueiredo B, 2011, J AFFECT DISORDERS, V132, P146, DOI 10.1016/j.jad.2011.02.007; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gan YX, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2188-2; Garthus-Niegel S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01728; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Hildingsson I, 2015, WOMEN BIRTH, V28, pE7, DOI 10.1016/j.wombi.2015.01.011; Joshi D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214992; Lao Statistics Bureau, 2015, PROV REP 4 LAO POP H; Lawrence E, 2008, J FAM PSYCHOL, V22, P41, DOI 10.1037/0893-3200.22.1.41; Le Strat Y, 2011, J AFFECT DISORDERS, V135, P128, DOI 10.1016/j.jad.2011.07.004; Limlomwongse N, 2006, ARCH WOMEN MENT HLTH, V9, P131, DOI 10.1007/s00737-005-0115-7; Mercier RJ, 2013, BJOG-INT J OBSTET GY, V120, P1116, DOI 10.1111/1471-0528.12255; Ministry of Health of Lao PDR, 2018, REP PSYCH SERV DEL 2; Ministry of Health of Lao PDR, 2012, MENT HLTH STRAT YEAR; Ministry of Health of Lao PDR, 2015, NAT STRAT ACT PLAN I; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Panyayong Benjaporn, 2013, Journal of the Medical Association of Thailand, V96, P761; Ryan D, 2005, CAN FAM PHYSICIAN, V51, P1087; Saisto T, 2001, ACTA OBSTET GYN SCAN, V80, P39, DOI 10.1080/791201832; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; The World Bank, 2019, GDP CAP CURR US LAO; Trop J, 2018, MIDWIFERY, V65, P18, DOI 10.1016/j.midw.2018.06.020; Yokoyama S, 2001, 1 MIN HLTH JICA; Zaidi F, 2017, J CLIN DIAGN RES, V11, pQC13, DOI 10.7860/JCDR/2017/25480.10479	40	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243463	10.1371/journal.pone.0243463	http://dx.doi.org/10.1371/journal.pone.0243463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AS	33275620	gold, Green Published			2022-12-26	WOS:000597150200015
J	Murray, AT				Murray, Alan T.			Planning for classroom physical distancing to minimize the threat of COVID-19 disease spread	PLOS ONE			English	Article							SPATIAL OPTIMIZATION; UNCERTAINTY; DISPERSION	The coronavirus disease 2019 is a respiratory illness spread between people. A primary weapon for reducing or eliminating this disease involves physical distancing to thwart transmission. Efforts to keep the economy moving include enacting physical distancing strategies that will increase the safety of workplaces, schools, businesses, etc. Given that education is a critical economic sector that impacts essentially all other sectors in some way, this paper details a planning approach for classroom physical distancing supported by spatial optimization. Devising a configuration of desks and/or workspaces that are physically distant is a type of dispersion problem that can be formalized mathematically and solved. Planning efforts for a university campus serve to illustrate how spatial optimization can support safety enhancements.	[Murray, Alan T.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Murray, AT (corresponding author), Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA.	amurray@ucsb.edu						[Anonymous], 2012, AM J TRANSPLANT, V12, P1, DOI 10.1111/j.1600-6143.2011.03886.x; Anoruo N., 2020, ABC NEWS; Church R. L., 2018, LOCATION COVERING MO; Church RL, 2015, INT SER OPER RES MAN, V232, P155, DOI 10.1007/978-3-319-20282-2_6; Downs JA, 2008, ECOL MODEL, V214, P284, DOI 10.1016/j.ecolmodel.2008.02.006; ERKUT E, 1990, EUR J OPER RES, V46, P48, DOI 10.1016/0377-2217(90)90297-O; Grubesic T. H., 2008, APPL SPAT ANAL POLIC, V1, P175, DOI DOI 10.1007/S12061-008-9013-5; KUBY MJ, 1987, GEOGR ANAL, V19, P315; MOON ID, 1984, MANAGE SCI, V30, P290, DOI 10.1287/mnsc.30.3.290; Murray A. T., 2003, Computers, Environment and Urban Systems, V27, P205, DOI 10.1016/S0198-9715(02)00016-9; Murray AT, 2019, J GEOGR SYST, V21, P319, DOI 10.1007/s10109-019-00302-5; Murray AT, 1997, EUR J OPER RES, V101, P598, DOI 10.1016/S0377-2217(96)00175-0; Niblett MR, 2015, EUR J OPER RES, V247, P764, DOI 10.1016/j.ejor.2015.06.054; Padberg M. W., 1973, Mathematical Programming, V5, P199, DOI 10.1007/BF01580121; THOMPSON EF, 1973, FOREST CHRON, V49, P247, DOI 10.5558/tfc49247-6; Tong DQ, 2012, ANN ASSOC AM GEOGR, V102, P1290, DOI 10.1080/00045608.2012.685044; UC Santa Barbara, 2020, INSTR SPAC REV REC; Virginia Tech, 2020, FALL 2020 CLASSR SET; Wei R, 2012, INT J GEOGR INF SCI, V26, P1231, DOI 10.1080/13658816.2011.633918	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243345	10.1371/journal.pone.0243345	http://dx.doi.org/10.1371/journal.pone.0243345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AS	33275618	gold, Green Published			2022-12-26	WOS:000597150200003
J	Achiha, T; Kijima, N; Kodama, Y; Kagawa, N; Kinoshita, M; Fujimoto, Y; Nonaka, M; Fukai, J; Inoue, A; Nishida, N; Yamanaka, T; Harada, A; Mori, K; Tsuyuguchi, N; Uda, T; Ishibashi, K; Tomogane, Y; Sakamoto, D; Shofuda, T; Yoshioka, E; Kanematsu, D; Mano, M; Luu, B; Taylor, MD; Kanemura, Y; Kishima, H				Achiha, Takamune; Kijima, Noriyuki; Kodama, Yoshinori; Kagawa, Naoki; Kinoshita, Manabu; Fujimoto, Yasunori; Nonaka, Masahiro; Fukai, Junya; Inoue, Akihiro; Nishida, Namiko; Yamanaka, Takumi; Harada, Atsuko; Mori, Kanji; Tsuyuguchi, Naohiro; Uda, Takehiro; Ishibashi, Kenichi; Tomogane, Yusuke; Sakamoto, Daisuke; Shofuda, Tomoko; Yoshioka, Ema; Kanematsu, Daisuke; Mano, Masayuki; Luu, Betty; Taylor, Michael D.; Kanemura, Yonehiro; Kishima, Haruhiko			Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion	PLOS ONE			English	Article							CHILDHOOD MEDULLOBLASTOMA; CANCER; ALCAM; ALCAM/CD166; STRATIFICATION; CARCINOMA; SURVIVAL; MARKER	Cluster of differentiation (CD) 166 or activated leukocyte cell adhesion molecule (ALCAM) is a transmembrane molecule known to be an intercellular adhesion factor. The expression and function of ALCAM in medulloblastoma (MB), a pediatric brain tumor with highly advanced molecular genetics, remains unclear. Therefore, this study aimed to clarify the significance and functional role of ALCAM expression in MB. ALCAM expression in 45 patients with MB was evaluated by immunohistochemical analysis of formalin-fixed paraffin-embedded clinical specimens and the relationship between ALCAM expression and pathological type/molecular subgroup, such as WNT, SHH, Group 3, and Group 4, was examined. Eight ALCAM positive (18%), seven partially positive (16%), and 30 negative (67%) cases were detected. All seven cases of the WNT molecular subgroup were ALCAM positive and ALCAM expression strongly correlated with this subgroup (P < 0.0001). In addition, functional studies using MB cell lines revealed ALCAM expression affected proliferation and migration as a positive regulator in vitro. However, ALCAM silencing did not affect survival or the formation of leptomeningeal dissemination in an orthotopic mouse model, but did induce a malignant phenotype with increased tumor cell invasion at the dissemination sites (P = 0.0029). In conclusion, our results revealed that ALCAM exhibited highly specific expression in the WNT subgroup of MB. Furthermore, we demonstrated that the cell kinetics of MB cell lines can be altered by the expression of ALCAM.	[Achiha, Takamune; Kijima, Noriyuki; Kagawa, Naoki; Kinoshita, Manabu; Fujimoto, Yasunori; Kishima, Haruhiko] Osaka Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan; [Achiha, Takamune; Kijima, Noriyuki; Kodama, Yoshinori; Kagawa, Naoki; Kinoshita, Manabu; Fujimoto, Yasunori; Nonaka, Masahiro; Fukai, Junya; Inoue, Akihiro; Nishida, Namiko; Yamanaka, Takumi; Harada, Atsuko; Mori, Kanji; Tsuyuguchi, Naohiro; Uda, Takehiro; Ishibashi, Kenichi; Tomogane, Yusuke; Sakamoto, Daisuke; Shofuda, Tomoko; Yoshioka, Ema; Kanematsu, Daisuke; Mano, Masayuki; Kanemura, Yonehiro] Kansai Mol Diag Network Cent Nervous Syst Tumors, Osaka, Japan; [Kijima, Noriyuki; Nonaka, Masahiro; Kanemura, Yonehiro] Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, Osaka, Japan; [Kodama, Yoshinori] Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Kyoto, Japan; [Kodama, Yoshinori; Mano, Masayuki] Natl Hosp Org, Osaka Natl Hosp, Dept Cent Lab & Surg Pathol, Osaka, Japan; [Nonaka, Masahiro] Kansai Med Univ, Dept Neurosurg, Hirakata, Osaka, Japan; [Fukai, Junya] Wakayama Med Univ, Dept Neurol Surg, Sch Med, Wakayama, Japan; [Inoue, Akihiro] Ehime Univ, Dept Neurosurg, Sch Med, Matsuyama, Ehime, Japan; [Nishida, Namiko] Tazuke Kofukai Fdn, Kitano Hosp, Med Res Inst, Dept Neurosurg, Osaka, Japan; [Yamanaka, Takumi] Kyoto Prefectural Univ Med, Dept Neurosurg, Kyoto, Japan; [Harada, Atsuko] Takatsuki Gen Hosp, Dept Pediat Neurosurg, Osaka, Japan; [Mori, Kanji] Kansai Rosai Hosp, Dept Neurosurg, Amagasaki, Hyogo, Japan; [Tsuyuguchi, Naohiro] Kindai Univ, Dept Neurosurg, Fac Med, Sayama, Osaka, Japan; [Uda, Takehiro] Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan; [Ishibashi, Kenichi] Osaka City Gen Hosp, Dept Neurosurg, Osaka, Japan; [Tomogane, Yusuke; Sakamoto, Daisuke; Kanemura, Yonehiro] Hyogo Coll Med, Dept Neurosurg, Nishinomiya, Hyogo, Japan; [Shofuda, Tomoko; Yoshioka, Ema; Kanematsu, Daisuke] Natl Hosp Org, Osaka Natl Hosp, Inst Clin Res, Dept Biomed Res & Innovat Res, Osaka, Japan; [Luu, Betty; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Luu, Betty; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Dept Surg, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Osaka University; Osaka National Hospital; Kyoto Prefectural University of Medicine; Osaka National Hospital; Kansai Medical University; Wakayama Medical University; Ehime University; Kitano Hospital; Kyoto Prefectural University of Medicine; Kansai Rosai Hospital; Osaka Metropolitan University; Osaka City General Hospital; Hyogo College of Medicine; Osaka National Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Kijima, N (corresponding author), Osaka Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.; Kijima, N (corresponding author), Kansai Mol Diag Network Cent Nervous Syst Tumors, Osaka, Japan.; Kijima, N (corresponding author), Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, Osaka, Japan.	n-kijima@nsurg.med.osaka-u.ac.jp	Uda, Takehiro/ABD-7340-2021	Kijima, Noriyuki/0000-0003-2103-1909	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K10755]; Japan Agency for Medical Research and Development (AMED) [JP18ck0106330, JP18gm0810011]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	YF Japan Society for the Promotion of Science (JSPS) KAKENHI https://www.jsps.go.jp/english/Grant Number JP16K10755 YK Japan Agency for Medical Research and Development (AMED) https://www.amed.go.jp/en/Grant Number JP18ck0106330 and JP18gm0810011.	Allmendinger O, 2012, HUM PATHOL, V43, P1289, DOI 10.1016/j.humpath.2011.10.007; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Cizelsky W, 2014, DEVELOPMENT, V141, P2064, DOI 10.1242/dev.107938; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Devis Laura, 2018, Oncotarget, V9, P16648, DOI 10.18632/oncotarget.24625; Devis L, 2017, J PATHOL, V241, P475, DOI 10.1002/path.4851; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Fujita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090304; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Goschzik T, 2015, NEUROPATH APPL NEURO, V41, P135, DOI 10.1111/nan.12161; Guadagno E, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0562-9; Ishiguro F, 2012, J THORAC ONCOL, V7, P890, DOI 10.1097/JTO.0b013e31824af2db; Ivanov DP, 2016, J BIOTECHNOL, V236, P10, DOI 10.1016/j.jbiotec.2016.07.028; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kijima N, 2012, NEURO-ONCOLOGY, V14, P1254, DOI 10.1093/neuonc/nor202; King JA, 2004, BREAST CANCER RES, V6, pR478, DOI 10.1186/bcr815; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Northcott PA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0063-6; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Ramaswamy V, 2016, ACTA NEUROPATHOL, V131, P821, DOI 10.1007/s00401-016-1569-6; Sasaki T, 2018, J NEURO-ONCOL, V140, P329, DOI 10.1007/s11060-018-2957-7; Seigfried FA, 2017, DEV BIOL, V426, P69, DOI 10.1016/j.ydbio.2017.04.004; Sekine S, 2002, AM J PATHOL, V161, P1997, DOI 10.1016/S0002-9440(10)64477-X; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; van Kempen LCLT, 2004, J INVEST DERMATOL, V122, P1293, DOI 10.1111/j.0022-202X.2004.22531.x; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231	32	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243272	10.1371/journal.pone.0243272	http://dx.doi.org/10.1371/journal.pone.0243272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270750	gold, Green Published			2022-12-26	WOS:000597149100037
J	McClanahan, A; Moench, M; Fu, QS				McClanahan, Alexander; Moench, Matthew; Fu, Qiushi			Dimensionality analysis of forearm muscle activation for myoelectric control in transradial amputees	PLOS ONE			English	Article							PATTERN-RECOGNITION; UPPER EXTREMITY; PROSTHESIS USE; SURFACE EMG; SYNERGIES; HAND; MOTOR; REORGANIZATION; ALGORITHMS; REGRESSION	Establishing a natural communication interface between the user and the terminal device is one of the central challenges of hand neuroprosthetics research. Surface electromyography (EMG) is the most common source of neural signals for interpreting a user's intent in these interfaces. However, how the capacity of EMG generation is affected by various clinical parameters remains largely unknown. In this study, we examined the EMG activity of forearm muscles recorded from 11 transradially amputated subjects who performed a wide range of movements. EMG recordings from 40 able-bodied subjects were also analyzed to provide comparative benchmarks. By using non-negative matrix factorization, we extracted the synergistic EMG patterns for each subject to estimate the dimensionality of muscle control, under the framework of motor synergies. We found that amputees exhibited less than four synergies (with substantial variability related to the length of remaining limb and age), whereas able-bodied subjects commonly demonstrate five or more synergies. The results of this study provide novel insight into the muscle synergy framework and the design of natural myoelectric control interfaces.	[McClanahan, Alexander; Moench, Matthew] Univ Cent Florida, Coll Med, Orlando, FL USA; [Fu, Qiushi] Univ Cent Florida, NeuroMech Syst Lab, Mech & Aerosp Engn, Orlando, FL 32816 USA; [Fu, Qiushi] Univ Cent Florida, Biionix Bion Mat Implants & Interfaces Cluster, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Fu, QS (corresponding author), Univ Cent Florida, NeuroMech Syst Lab, Mech & Aerosp Engn, Orlando, FL 32816 USA.; Fu, QS (corresponding author), Univ Cent Florida, Biionix Bion Mat Implants & Interfaces Cluster, Orlando, FL 32816 USA.	Qiushi.Fu@ucf.edu		Fu, Qiushi/0000-0002-4421-0742	VPR AECR award, University of Central Florida	VPR AECR award, University of Central Florida	QF: VPR AECR award, University of Central Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri A, 2014, IEEE T NEUR SYS REH, V22, P1198, DOI 10.1109/TNSRE.2014.2323576; Amsuess S, 2015, IEEE T NEUR SYS REH, V23, P827, DOI 10.1109/TNSRE.2014.2361478; Antuvan CW, 2019, IEEE T NEUR SYS REH, V27, P552, DOI 10.1109/TNSRE.2018.2873839; Atzori M, 2016, FRONT NEUROROBOTICS, V10, DOI 10.3389/fnbot.2016.00009; Atzori M, 2016, J REHABIL RES DEV, V53, P345, DOI 10.1682/JRRD.2014.09.0218; Atzori M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.53; Atzori M, 2015, IEEE ENG MED BIO, P3456, DOI 10.1109/EMBC.2015.7319136; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Cipriani C, 2011, IEEE T NEUR SYS REH, V19, P260, DOI 10.1109/TNSRE.2011.2108667; Crouch DL, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa61bc; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; Farina D, 2014, IEEE T NEUR SYS REH, V22, P797, DOI 10.1109/TNSRE.2014.2305111; Godfrey S B, 2013, IEEE Int Conf Rehabil Robot, V2013, P6650377, DOI 10.1109/ICORR.2013.6650377; Godfrey SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205653; Guo XL, 2017, IEEE T NEUR SYS REH, V25, P2046, DOI 10.1109/TNSRE.2017.2702117; Hahne JM, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat3630; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hargrove LJ, 2010, IEEE T NEUR SYS REH, V18, P49, DOI 10.1109/TNSRE.2009.2039590; Hermansson LM, 2005, J REHABIL MED, V37, P166, DOI 10.1080/16501970410024280; Hunter JP, 2008, NEUROSCIENCE, V156, P939, DOI 10.1016/j.neuroscience.2008.07.053; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Ison M, 2016, IEEE T NEUR SYS REH, V24, P424, DOI 10.1109/TNSRE.2015.2417775; Ison M, 2015, IEEE T ROBOT, V31, P259, DOI 10.1109/TRO.2015.2395731; Ison M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/051001; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P501, DOI 10.1109/TNSRE.2013.2278411; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Kaufman L., 2009, FINDING GROUPS DATA; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Lopes J, 2018, CLIN NUTR, V37, P914, DOI 10.1016/j.clnu.2017.03.018; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Manickaraj N, 2017, J NEUROPHYSIOL, V118, P2132, DOI 10.1152/jn.00210.2017; Marchessault JA, 2011, J HAND SURG-AM, V36A, P1718, DOI 10.1016/j.jhsa.2011.07.025; Matrone GC, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-40; Montagnani F, 2015, IEEE T NEUR SYS REH, V23, P600, DOI 10.1109/TNSRE.2015.2398112; Montoya P, 1998, EUR J NEUROSCI, V10, P1095, DOI 10.1046/j.1460-9568.1998.00122.x; Nielsen JLG, 2011, IEEE T BIO-MED ENG, V58, P681, DOI 10.1109/TBME.2010.2068298; Palermo F, 2017, INT C REHAB ROBOT, P1154, DOI 10.1109/ICORR.2017.8009405; Pierrie SN, 2018, J HAND SURG-AM, V43, P657, DOI 10.1016/j.jhsa.2018.03.053; Rehbaum H, 2012, IEEE ENG MED BIO, P1346, DOI 10.1109/EMBC.2012.6346187; Roche AD, 2014, CURR SURG REP, V2, DOI 10.1007/s40137-013-0044-8; Roh J, 2013, J NEUROPHYSIOL, V109, P768, DOI 10.1152/jn.00670.2012; Roh J, 2012, J NEUROPHYSIOL, V107, P2123, DOI 10.1152/jn.00173.2011; Rohde RS, 2010, J HAND SURG-AM, V35A, P1858, DOI 10.1016/j.jhsa.2010.08.030; Rossi M, 2017, INT C REHAB ROBOT, P1356, DOI 10.1109/ICORR.2017.8009437; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Shenoy P, 2008, IEEE T BIO-MED ENG, V55, P1128, DOI 10.1109/TBME.2007.909536; Shibata D, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/fnhum.2014.01050, 10.3389/fnhum.2014.00564]; Simon AM, 2011, IEEE ENG MED BIO, P3354, DOI 10.1109/IEMBS.2011.6090909; Smith LH, 2016, IEEE T BIO-MED ENG, V63, P737, DOI 10.1109/TBME.2015.2469741; Stango A, 2015, IEEE T NEUR SYS REH, V23, P189, DOI 10.1109/TNSRE.2014.2366752; Sun JS, 2016, CHINESE PHYS B, V25, DOI 10.1088/1674-1056/25/6/063301; Taborri J, 2018, APPL BIONICS BIOMECH; Tintle SM, 2010, J BONE JOINT SURG AM, V92A, P2934, DOI [10.2106/JBJSJ.00258, 10.2106/JBJS.J.00258]; Torres-Oviedo G, 2010, J NEUROPHYSIOL, V103, P3084, DOI 10.1152/jn.00960.2009; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; Vujaklija I, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00007; Wallner C, 2019, J RADIAT RES, V60, P825, DOI 10.1093/jrr/rrz067; Weiss EJ, 2004, J NEUROPHYSIOL, V92, P523, DOI 10.1152/jn.01265.2003; Wurth SM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-91; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293; Zariffa J, 2012, J SPINAL CORD MED, V35, P310, DOI 10.1179/2045772312Y.0000000037; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	70	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242921	10.1371/journal.pone.0242921	http://dx.doi.org/10.1371/journal.pone.0242921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270686	Green Published, gold			2022-12-26	WOS:000597149100153
J	Ohsawa, Y; Tsubokura, M				Ohsawa, Yukio; Tsubokura, Masaharu			Stay with your community: Bridges between clusters trigger expansion of COVID-19	PLOS ONE			English	Article							MODEL	In this study, the spread of virus infection was simulated using artificial human networks. Here, real-space urban life was modeled as a modified scale-free network with constraints. To date, the scale-free network has been adopted for modeling online communities in several studies. However, in the present study, it has been modified to represent the social behaviors of people where the generated communities are restricted and reflect spatiotemporal constraints in real life. Furthermore, the networks have been extended by introducing multiple cliques in the initial step of network construction and enabling people to contact hidden (zero-degree) as well as popular (large-degree) people. Consequently, four findings and a policy proposal were obtained. First, "second waves" were observed in some cases of the simulations even without external influence or constraints on people's social contacts or the releasing of the constraints. These waves tend to be lower than the first wave and occur in "fresh" clusters, that is, via the infection of people who are connected in the network but have not been infected previously. This implies that the bridge between infected and fresh clusters may trigger a new spread of the virus. Second, if the network changes its structure on the way of infection spread or after its suppression, a second wave larger than the first can occur. Third, the peak height in the time series of the number of infected cases depends on the difference between the upper bound of the number of people each member actually meets and the number of people they choose to meet during the period of infection spread. This tendency is observed for the two kinds of artificial networks introduced here and implies the impact of bridges between communities on the virus spreading. Fourth, the release of a previously imposed constraint may trigger a second wave higher than the peak of the time series without introducing any constraint so far previously, if the release is introduced at a time close to the peak. Thus, overall, both the government and individuals should be careful in returning to society where people enjoy free inter-community contact.	[Ohsawa, Yukio] Univ Tokyo, Sch Engn, Dept Syst Innovat, Tokyo, Japan; [Tsubokura, Masaharu] Fukushima Med Univ, Dept Radiat Hlth Management, Sch Med, Fukushima, Japan	University of Tokyo; Fukushima Medical University	Ohsawa, Y (corresponding author), Univ Tokyo, Sch Engn, Dept Syst Innovat, Tokyo, Japan.	ohsawa@sys.t.u-tokyo.ac.jp	Tsubokura, Masaharu/AAV-4364-2021	Tsubokura, Masaharu/0000-0001-8027-202X	JSPS Kakenhi [19H05577, 16H01836]; Japan Society for the Promotion of Science	JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grant JSPS Kakenhi 19H05577 (in progress) and Kakenhi 16H01836 (funded till March 2020) by Japan Society for the Promotion of Science https://www.jsps.go.jp/english/.There was no additional internal or external funding received for this study.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berger D, 2020, 202025 SSRNS ELIBRAR, DOI [10.2139/ssrn.3561142, DOI 10.2139/SSRN.3561142]; Chapman JA, 2006, ANN ALLERG ASTHMA IM, V96, pS1, DOI 10.1016/S1081-1206(10)60926-X; Cremonini M, 2020, SSRN LIB, DOI [10.2139/ssrn.3584368, DOI 10.2139/SSRN.3584368]; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Durrett R, 2004, RANDOM GRAPH DYNAMIC; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Hassan K, 2014, ARXIV14113444; Hassan MK, 2017, PHYSICA A, V469, P23, DOI 10.1016/j.physa.2016.11.001; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Karaivanov A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240878; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kurahashi Setsuya, 2013, SICE Journal of Control, Measurement, and System Integration, V6, P76; Kurahashi S, 2020, ESTIMATING EFFECTIVE; Liu F, 2020, MATH THEORIES CORONA; Liu FZ, 2020, IEEE T CONTROL NETW, V7, P1115, DOI 10.1109/TCNS.2019.2963488; Masuda Naoki, 2013, F1000Prime Rep, V5, P6, DOI 10.12703/P5-6; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Ministry of Health Labor and Welfare, 2020, NEW COR INF DIS CONT; Morris M., 2020, CANT I PLEASE JUST V; Ohsawa Y, 2014, PROCEDIA COMPUT SCI, V35, P946, DOI 10.1016/j.procs.2014.08.172; Pal D., 2020, MATH ANAL COVID 19 E, V30, DOI [10.1101/2020.04.25.20079111, DOI 10.1101/2020.04.25.20079111]; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Surano FV, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.042306; TUDOR DW, 1985, MATH BIOSCI, V73, P131, DOI 10.1016/0025-5564(85)90081-1; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Xue D, 2019, IEEE T SIGNAL PROCES, V67, P1163, DOI 10.1109/TSP.2018.2887211; Ziff A. L., 2020, FRACTAL KINETICS COV	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242766	10.1371/journal.pone.0242766	http://dx.doi.org/10.1371/journal.pone.0242766			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270662	Green Submitted, gold, Green Published			2022-12-26	WOS:000597149100156
J	Pooam, M; Jourdan, N; El Esawi, M; Sherrard, RM; Ahmad, M				Pooam, Marootpong; Jourdan, Nathalie; El Esawi, Mohamed; Sherrard, Rachel M.; Ahmad, Margaret			HEK293 cell response to static magnetic fields via the radical pair mechanism may explain therapeutic effects of pulsed electromagnetic fields	PLOS ONE			English	Article							PATHWAY MARKERS; ENHANCEMENT; BIOLOGY	PEMF (Pulsed Electromagnetic Field) stimulation has been used for therapeutic purposes for over 50 years including in the treatment of memory loss, depression, alleviation of pain, bone and wound healing, and treatment of certain cancers. However, the underlying cellular mechanisms mediating these effects have remained poorly understood. In particular, because magnetic field pulses will induce electric currents in the stimulated tissue, it is unclear whether the observed effects are due to the magnetic or electric component of the stimulation. Recently, it has been shown that PEMFs stimulate the formation of ROS (reactive oxygen species) in human cell cultures by a mechanism that requires cryptochrome, a putative magnetosensor. Here we show by qPCR analysis of ROS-regulated gene expression that simply removing cell cultures from the Earth's geomagnetic field by placing them in a Low-Level Field condition induces similar effects on ROS signaling as does exposure of cells to PEMF. This effect can be explained by the so-called Radical Pair mechanism, which provides a quantum physical means by which the rates and product yields (e.g. ROS) of biochemical redox reactions may be modulated by magnetic fields. Since transient cancelling of the Earth's magnetic field can in principle be achieved by PEMF exposure, we propose that the therapeutic effects of PEMFs may be explained by the ensuing modulation of ROS synthesis. Our results could lead to significant improvements in the design and therapeutic applications of PEMF devices.	[Pooam, Marootpong; Jourdan, Nathalie; El Esawi, Mohamed; Sherrard, Rachel M.; Ahmad, Margaret] Sorbonne Univ, UMR8256, IBPS, CNRS, Paris, France; [Pooam, Marootpong] Naresuan Univ, Fac Sci, Dept Biol, Phitsanulok, Thailand; [El Esawi, Mohamed] Tanta Univ, Fac Sci, Bot Dept, Tanta, Egypt; [Ahmad, Margaret] Xavier Univ, Cincinnati, OH 45207 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Naresuan University; Egyptian Knowledge Bank (EKB); Tanta University; Xavier University	Ahmad, M (corresponding author), Sorbonne Univ, UMR8256, IBPS, CNRS, Paris, France.; Ahmad, M (corresponding author), Xavier Univ, Cincinnati, OH 45207 USA.	margaret.ahmad@upmc.fr	El-Esawi, Mohamed A./F-1953-2017	El-Esawi, Mohamed A./0000-0002-8871-5689; Sherrard, Rachel/0000-0002-6595-3545; Ahmad, Margaret/0000-0003-4524-5813; POOAM, Marootpong/0000-0001-6351-0778	National Science Foundation USA [1658640, FA9550-14-0-0409, ANR-19-CE37-0021]	National Science Foundation USA(National Science Foundation (NSF))	National Science Foundation USA (#1658640) to MA Air Force Office of Scientific Research USA (FA9550-14-0-0409) to MA Novo Nordisk Foundation (Denmark) to MA Agence Nationale de Recherche, France grant no: ANR-19-CE37-0021 to RS.	[Anonymous], 2017, CANC DISCOVERY, V7, pOF12, DOI DOI 10.1158/2159-8290.CD-RW2016-234; BASSETT CAL, 1989, CRIT REV BIOMED ENG, V17, P451; Bassett CAL, 1994, BIOL EFFECTS ELECT M, P13; Bloise N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199046; Castello PR, 2014, BIOELECTROMAGNETICS, V35, P598, DOI 10.1002/bem.21858; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Cook JJ, 2015, CLIN PODIATR MED SUR, V32, P45, DOI 10.1016/j.cpm.2014.09.003; Dufor T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9847; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Ganesan K, 2009, INDIAN J EXP BIOL, V47, P939; Guo LF, 2011, ELECTROMAGN BIOL MED, V30, P21, DOI 10.3109/15368378.2011.566775; Hammad M, 2020, PHOTOCH PHOTOBIO SCI, V19, P341, DOI 10.1039/c9pp00469f; HONG FT, 1995, BIOSYSTEMS, V36, P187, DOI 10.1016/0303-2647(95)01555-Y; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Khamaganova IV, 1995, TERAPEVT ARKH, V67, P84; Kubat NJ, 2015, J INFLAMM RES, V8, P59, DOI 10.2147/JIR.S78631; Lefevre CT, 2013, MICROBIOL MOL BIOL R, V77, P497, DOI 10.1128/MMBR.00021-13; Liboff AR, 2004, BIOELECTROMAGNETIC M, P17; Lu CX, 2016, INT J BIOCHEM CELL B, V78, P206, DOI 10.1016/j.biocel.2016.06.010; Markov M, 2015, ELECTROMAGN BIOL MED, V34, P190, DOI 10.3109/15368378.2015.1077338; Martino CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022753; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P296, DOI 10.1002/bem.20565; Maziarz A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0312-5; Paolucci T, 2020, J PAIN RES, V13, P1385, DOI 10.2147/JPR.S231778; Pooam M, 2019, PLANTA, V249, P319, DOI 10.1007/s00425-018-3002-y; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Ross CL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00266; Ross CL, 2013, J INFLAMM RES, V6, P45, DOI 10.2147/JIR.S40269; Saliev T, 2014, CELL PROLIFERAT, V47, P485, DOI 10.1111/cpr.12142; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sherrard RM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006229; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Strauch B, 2009, AESTHET SURG J, V29, P135, DOI 10.1016/j.asj.2009.02.001; Usselman RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38543; Usselman RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093065; Varcaccio-Garofalo G., 1995, Clinical and Experimental Obstetrics and Gynecology, V22, P350; WILTSCHKO R, 1995, ZOOPHYSIOL, V33, P1; Yuan J, 2018, CELL PHYSIOL BIOCHEM, V46, P1581, DOI 10.1159/000489206	40	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243038	10.1371/journal.pone.0243038	http://dx.doi.org/10.1371/journal.pone.0243038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270696	Green Published, gold			2022-12-26	WOS:000597149100030
J	Li, N; Kong, H; Zheng, XZ; Li, XY; Ma, J; Zhang, H; Wang, DX; Li, HC; Liu, XM				Li, Nan; Kong, Hao; Zheng, Xi-Zi; Li, Xue-Ying; Ma, Jing; Zhang, Hong; Wang, Dong-Xin; Li, Hai-Chao; Liu, Xin-Min			Early predictive factors of progression from severe type to critical ill type in patients with Coronavirus Disease 2019: A retrospective cohort study	PLOS ONE			English	Article								Background The current worldwide pandemic of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, and the mortality rate of critical ill patients remains high. The purpose of this study was to identify factors that early predict the progression of COVID-19 from severe to critical illness. Methods This retrospective cohort study included adult patients with severe or critical ill COVID-19 who were consecutively admitted to the Zhongfaxincheng campus of Tongji Hospital (Wuhan, China) from February 8 to 18, 2020. Baseline variables, data at hospital admission and during hospital stay, as well as clinical outcomes were collected from electronic medical records system. The primary endpoint was the development of critical illness. A multivariable logistic regression model was used to identify independent factors that were associated with the progression from severe to critical illness. Results A total of 138 patients were included in the analysis; of them 119 were diagnosed as severe cases and 16 as critical ill cases at hospital admission. During hospital stay, 19 more severe cases progressed to critical illness. For all enrolled patients, longer duration from diagnosis to admission (odds ratio [OR] 1.108, 95% CI 1.022-1.202; P = 0.013), pulse oxygen saturation at admission <93% (OR 5.775, 95% CI 1.257-26.535; P = 0.024), higher neutrophil count (OR 1.495, 95% CI 1.177-1.899; P = 0.001) and higher creatine kinase-MB level at admission (OR 2.449, 95% CI 1.089-5.511; P = 0.030) were associated with a higher risk, whereas higher lymphocyte count at admission (OR 0.149, 95% CI 0.026-0.852; P = 0.032) was associated with a lower risk of critical illness development. For the subgroup of severe cases at hospital admission, the above factors except creatine kinase-MB level were also found to have similar correlation with critical illness development. Conclusions Higher neutrophil count and lower lymphocyte count at admission were early independent predictors of progression to critical illness in severe COVID-19 patients.	[Li, Nan; Kong, Hao; Wang, Dong-Xin] Peking Univ First Hosp, Dept Anesthesiol & Crit Care Med, Beijing, Peoples R China; [Zheng, Xi-Zi] Peking Univ First Hosp, Dept Nephrol, Beijing, Peoples R China; [Li, Xue-Ying] Peking Univ First Hosp, Dept Biostat, Beijing, Peoples R China; [Ma, Jing; Zhang, Hong; Li, Hai-Chao] Peking Univ First Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Liu, Xin-Min] Peking Univ First Hosp, Dept Geriatr, Beijing, Peoples R China	Peking University; Peking University	Wang, DX (corresponding author), Peking Univ First Hosp, Dept Anesthesiol & Crit Care Med, Beijing, Peoples R China.; Li, HC (corresponding author), Peking Univ First Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China.	dxwang65@bjmu.edu.cn; lhch91767@sina.com						[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, LANCET, V395, P1054; [Anonymous], BRIEF PNEUM EP SIT; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Chan KW, 2020, AM J CHINESE MED, V48, P737, DOI 10.1142/S0192415X20500378; Gao L, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01352-w; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Han H, 2020, J MED VIROL, V92, P819, DOI 10.1002/jmv.25809; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1733, DOI 10.1002/jmv.25819; Lu Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230979; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; Powell AGMT, 2020, BJS OPEN, V4, P416, DOI 10.1002/bjs5.50277; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wang K, 2020, CLIN RADIOL, V75, P341, DOI 10.1016/j.crad.2020.03.004; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang GM, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01338-8; Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243195	10.1371/journal.pone.0243195	http://dx.doi.org/10.1371/journal.pone.0243195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264366	Green Submitted, gold, Green Published			2022-12-26	WOS:000596569200023
J	Swain, SM; Liddle, RA				Swain, Sandip M.; Liddle, Rodger A.			Piezo1 acts upstream of TRPV4 to induce pathological changes in endothelial cells due to shear stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; CATION CHANNEL TRPV4; INDUCED LUNG INJURY; ION-CHANNEL; PHOSPHOLIPASE A(2); CA2+ INFLUX; EXPRESSION; ACID; VISCOSITY; PRESSURE	The ion channels Piezo1 and TRPV4 have both, independently, been implicated in high venous pressure- and fluid shear stress-induced vascular hyperpermeability in endothelial cells. However, the mechanism by which Piezo1 and TRPV4 channels execute the same function is poorly understood. Here we demonstrate that Piezo1 regulates TRPV4 channel activation in endothelial cells and that Piezo1-mediated TRPV4 channel opening is a function of the strength and duration of fluid shear stress. We first confirmed that either fluid shear stress or the Piezo1 agonist, Yoda1, led to an elevation in intracellular calcium ([Ca2+](i)) and that application of the Piezo1 antagonist, GsMTx4, completely blocked this change. We discovered that high and prolonged shear stress caused sustained [Ca2+] i elevation that was blocked by inhibition of TRPV4 channel opening. Moreover, Piezo1 stimulated TRPV4 opening through activation of phospholipase A2. TRPV4-dependent sustained [Ca2+] i elevation was responsible for fluid shear stress-mediated and Piezo1-mediated disruption of adherens junctions and actin remodeling. Blockade of TRPV4 channels with the selective TRPV4 blocker, HC067047, prevented the loss of endothelial cell integrity and actin disruption induced by Yoda1 or shear stress and prevented Piezo1-induced monocyte adhesion to endothelial cell monolayers. These findings demonstrate that Piezo1 activation by fluid shear stress initiates a calcium signal that causes TRPV4 opening, which in turn is responsible for the sustained phase calcium elevation that triggers pathological events in endothelial cells. Thus, deleterious effects of shear stress are initiated by Piezo1 but require TRPV4.	[Swain, Sandip M.; Liddle, Rodger A.] Duke Univ, Dept Med, Durham, NC 27706 USA; [Liddle, Rodger A.] Dept Vet Affairs Hlth Care Syst, Durham, NC 27705 USA	Duke University	Liddle, RA (corresponding author), Duke Univ, Dept Med, Durham, NC 27706 USA.; Liddle, RA (corresponding author), Dept Vet Affairs Hlth Care Syst, Durham, NC 27705 USA.	rodger.liddle@duke.edu		Swain, Sandip M./0000-0002-2404-8186	NIH [R01 DK120555, R01 DK125308, R01 DK124474]; Department of Veterans Affairs [BX002230]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants R01 DK120555, R01 DK125308, R01 DK124474, and the Department of Veterans Affairs BX002230. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albarran-Juarez J, 2018, J EXP MED, V215, P2655, DOI 10.1084/jem.20180483; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Baeyens N, 2018, BIOCHEM PHARMACOL, V158, P185, DOI 10.1016/j.bcp.2018.10.023; Ballermann BJ, 1998, KIDNEY INT, V54, pS100, DOI 10.1046/j.1523-1755.1998.06720.x; Beech DJ, 2019, ARTERIOSCL THROM VAS, V39, P2228, DOI 10.1161/ATVBAHA.119.313348; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Cao S, 2018, J BIOL CHEM, V293, P5307, DOI 10.1074/jbc.M117.811075; Choi S, 2019, NITRIC OXIDE-BIOL CH, V83, P51, DOI 10.1016/j.niox.2018.12.007; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Dalal PJ, 2020, AM J PATHOL, V190, P535, DOI 10.1016/j.ajpath.2019.11.004; Dalghi MG, 2019, AM J PHYSIOL-RENAL, V317, pF303, DOI 10.1152/ajprenal.00214.2019; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dubin AE, 2017, NEURON, V94, P266, DOI 10.1016/j.neuron.2017.03.039; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Friedrich EE, 2019, P NATL ACAD SCI USA, V116, P12980, DOI 10.1073/pnas.1902165116; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamaguchi K, 2003, BBA-MOL CELL BIOL L, V1635, P37, DOI 10.1016/j.bbalip.2003.10.004; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Heathcote HR, 2019, BRIT J PHARMACOL, V176, P3297, DOI 10.1111/bph.14762; Hong D, 2006, AM J PHYSIOL-HEART C, V290, pH2498, DOI 10.1152/ajpheart.00828.2005; Hoyer J, 1998, FASEB J, V12, P359, DOI 10.1096/fasebj.12.3.359; Hu KZ, 2017, BIOMED PHARMACOTHER, V91, P841, DOI 10.1016/j.biopha.2017.04.094; Inglebert M, 2020, BIOMICROFLUIDICS, V14, DOI 10.1063/1.5143391; Jian MY, 2008, AM J RESP CELL MOL, V38, P386, DOI 10.1165/rcmb.2007-0192OC; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Loufrani L, 2008, MED BIOL ENG COMPUT, V46, P451, DOI 10.1007/s11517-008-0306-2; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nigro P, 2011, ANTIOXID REDOX SIGN, V15, P1405, DOI 10.1089/ars.2010.3679; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Phuong TTT, 2017, J PHYSIOL-LONDON, V595, P6869, DOI 10.1113/JP275052; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; RING CP, 1976, BRIT J OPHTHALMOL, V60, P397, DOI 10.1136/bjo.60.6.397; Romac JMJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04194-9; Ryskamp DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30583; Schmitz B, 2013, ATHEROSCLEROSIS, V230, P185, DOI 10.1016/j.atherosclerosis.2013.07.039; Siddiqui MR, 2019, AM J RESP CELL MOL, V61, P257, DOI 10.1165/rcmb.2018-0235OC; Sloop GD, 2020, CUREUS, V12, DOI 10.7759/cureus.7090; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Souilhol C, 2020, NAT REV CARDIOL, V17, P52, DOI 10.1038/s41569-019-0239-5; Stolwijk JA, 2016, J BIOL CHEM, V291, P22894, DOI 10.1074/jbc.M116.756114; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Swain SM, 2020, J CLIN INVEST, V130, P2527, DOI 10.1172/JCI134111; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Vergnolle N, 2010, BRIT J PHARMACOL, V159, P1161, DOI 10.1111/j.1476-5381.2009.00590.x; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wilson C, 2019, HYPERTENSION, V74, P1200, DOI 10.1161/HYPERTENSIONAHA.119.13791; Xu SW, 2016, ONCOTARGET, V7, P37622, DOI 10.18632/oncotarget.9376; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422; Zumbansen Markus, 2009, J RNAi Gene Silencing, V6, P354	71	32	35	13	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100171	10.1074/jbc.RA120.015059	http://dx.doi.org/10.1074/jbc.RA120.015059			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33298523	gold, Green Published			2022-12-26	WOS:000672866400149
J	Tadele, DS; Robertson, J; Crispin, R; Herrera, MC; Chlubnova, M; Piechaczyk, L; Ayuda-Duran, P; Singh, SK; Gedde-Dahl, T; Floisand, Y; Skavland, J; Wesche, J; Gjertsen, BT; Enserink, JM				Tadele, Dagim Shiferaw; Robertson, Joseph; Crispin, Richard; Herrera, Maria C.; Chlubnova, Marketa; Piechaczyk, Laure; Ayuda-Duran, Pilar; Singh, Sachin Kumar; Gedde-Dahl, Tobias; Floisand, Yngvar; Skavland, Jorn; Wesche, Jorgen; Gjertsen, Bjorn-Tore; Enserink, Jorrit M.			A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; DNA-DAMAGE; STEM-CELLS; GENE; EXPRESSION; IMATINIB; LYMPHOMA; PHOSPHORYLATION	Breakpoint Cluster Region-Abelson kinase (BCR-Abl) is a driver oncogene that causes chronic myeloid leukemia and a subset of acute lymphoid leukemias. Although tyrosine kinase inhibitors provide an effective treatment for these diseases, they generally do not kill leukemic stem cells (LSCs), the cancer-initiating cells that compete with normal hematopoietic stem cells for the bone marrow niche. New strategies to target cancers driven by BCR-Abl are therefore urgently needed. We performed a small molecule screen based on competition between isogenic untransformed cells and BCR-Abl-transformed cells and identified several compounds that selectively impair the fitness of BCR-Abl-transformed cells. Interestingly, systems-level analysis of one of these novel compounds, DJ34, revealed that it induced depletion of c-Myc and activation of p53. DJ34-mediated c-Myc depletion occurred in a wide range of tumor cell types, including lymphoma, lung, glioblastoma, breast cancer, and several forms of leukemia, with primary LSCs being particularly sensitive to DJ34. Further analyses revealed that DJ34 interferes with c-Myc synthesis at the level of transcription, and we provide data showing that DJ34 is a DNA intercalator and topoisomerase II inhibitor. Physiologically, DJ34 induced apoptosis, cell cycle arrest, and cell differentiation. Taken together, we have identified a novel compound that dually targets c-Myc and p53 in a wide variety of cancers, and with particularly strong activity against LSCs.	[Tadele, Dagim Shiferaw; Robertson, Joseph; Crispin, Richard; Chlubnova, Marketa; Piechaczyk, Laure; Ayuda-Duran, Pilar; Enserink, Jorrit M.] Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Herrera, Maria C.] Univ Oslo, Fac Math & Nat Sci, Sect Biochem & Mol Biol, Oslo, Norway; [Singh, Sachin Kumar; Wesche, Jorgen] Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Gedde-Dahl, Tobias; Floisand, Yngvar] Oslo Univ Hosp, Dept Hematol, Oslo, Norway; [Skavland, Jorn; Gjertsen, Bjorn-Tore] Univ Bergen, Dept Clin Sci, Precis Oncol Res Grp, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen	Enserink, JM (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway.	jorrit.enserink@ibv.uio.no	Ayuda-Durán, Pilar/AAR-6755-2021; Gjertsen, Bjorn T/O-1542-2015	Ayuda-Durán, Pilar/0000-0002-9799-3680; Gjertsen, Bjorn T/0000-0001-9358-9704; Herrera, MCarmen/0000-0002-1004-0570; Piechaczyk, Laure/0000-0002-9165-0337; Floisand, Yngvar/0000-0001-7267-1944	European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) [609020]; Norwegian Cancer Society [3311782, 4487303, 144176, 6786517, 182524]; Norwegian Health Authority South-East [2014014, 2012012]; Norwegian Research Council [267454]; Research Council of Norway through its Centers of Excellence funding scheme [262652]; South-Eastern Norway Regional Health Authority; Research Council of Norway INFRASTRUKTUR-program [295910]	European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND); Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Health Authority South-East; Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Council of Norway through its Centers of Excellence funding scheme; South-Eastern Norway Regional Health Authority; Research Council of Norway INFRASTRUKTUR-program(Research Council of Norway)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under grant agreement no. 609020-Scientia Fellows. This work was further supported by grants from the Norwegian Cancer Society (project numbers: 3311782, 4487303, 144176, 6786517, and 182524), the Norwegian Health Authority South-East (2014014 and 2012012), and the Norwegian Research Council (267454). This work was partly supported by the Research Council of Norway through its Centers of Excellence funding scheme, project number 262652. Mass spectrometry-based proteomic analyses were performed by the Proteomics Core Facility, Department of Immunology, University of Oslo/Oslo University Hospital, which is supported by the Core Facilities program of the South-Eastern Norway Regional Health Authority. This core facility is also a member of the National Network of Advanced Proteomics Infrastructure (NAPI), which is funded by the Research Council of Norway INFRASTRUKTUR-program (project number: 295910).	Abraham SA, 2016, NATURE, V534, P341, DOI 10.1038/nature18288; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Arango D, 2001, CANCER RES, V61, P4910; Asmussen J, 2014, CANCER DISCOV, V4, P200, DOI 10.1158/2159-8290.CD-13-0235; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Baker PR, 2014, MOL CELL PROTEOMICS, V13, P1392, DOI 10.1074/mcp.O113.037200; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; BOGESO KP, 1991, J MED CHEM, V34, P2023; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; BUNCH RT, 1994, BIOCHEM PHARMACOL, V47, P317, DOI 10.1016/0006-2952(94)90023-X; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; Chymkowitch P, 2015, GENOME RES, V25, P897, DOI 10.1101/gr.185793.114; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dutta D, 2018, NUCLEIC ACIDS RES, V46, P5355, DOI 10.1093/nar/gky385; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fajardo AM, 2014, CANCERS, V6, P436, DOI 10.3390/cancers6010436; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Fielding AK, 2014, BLOOD, V123, P843, DOI 10.1182/blood-2013-09-529008; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Heo JH, 2016, SEMIN CANCER BIOL, V36, P33, DOI 10.1016/j.semcancer.2015.09.015; Herrera MC, 2018, NUCLEIC ACIDS RES, V46, P11698, DOI 10.1093/nar/gky846; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Makinoshima H, 2015, J BIOL CHEM, V290, P17495, DOI 10.1074/jbc.M115.660498; Malyukova A, 2007, CANCER RES, V67, P5611, DOI 10.1158/0008-5472.CAN-06-4381; Modi H, 2007, BLOOD, V109, P5411, DOI 10.1182/blood-2006-06-032490; Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Pan XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105381; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; Rowley JD, 2013, SCIENCE, V340, P1412, DOI 10.1126/science.1241318; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vaseva AV, 2018, CANCER CELL, V34, P807, DOI 10.1016/j.ccell.2018.10.001; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072846; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zheng H, 2008, COLD SH Q B, V73, P427, DOI 10.1101/sqb.2008.73.047	57	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100179	10.1074/jbc.RA120.015285	http://dx.doi.org/10.1074/jbc.RA120.015285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303632	Green Published, gold			2022-12-26	WOS:000672866400157
J	Lin, ZB; Song, JY; Li, AC; Chen, C; Huang, XX; Xu, BH				Lin, Zhuang-Bin; Song, Jian-Yuan; Li, An-Chuan; Chen, Cheng; Huang, Xiao-Xue; Xu, Ben-Hua			The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis	PLOS ONE			English	Article							CURATIVE RESECTION; CHEMOTHERAPY; ADENOCARCINOMA; RADIATION; EPIDEMIOLOGY; SURVEILLANCE; CHEMORADIOTHERAPY; GEMCITABINE; OUTCOMES; SURGERY	Background The survival time of patients with early pancreatic cancer (PC) is still disappointing, even after surgical resection. PC has an extremely poor prognosis. Herein, we aimed to investigate the survival effect of postoperative radiotherapy (PORT) on resected stage I to II PC. Material and methods A large eligible sample of patients was identified from 2010 to 2015 from the Surveillance, Epidemiology, and End Results (SEER) registry. Survival analysis was conducted to evaluate the efficiency of PORT. Propensity score matching (PSM) analysis was used to reduce selection bias and to make the groups comparable. Results A total of 3219 patients with resected stage I to II PC was included after rigid screening. The median overall survival (OS) was 26 months with PORT (n = 1055) versus 21 months with non-PORT (n = 2164) before matching (p<0.001). By multivariable analysis, PORT remained a favorable prognostic predictor for OS. In PSM analysis, receiving PORT was associated with improved OS (median, 26 months vs. 23 months; at 2 years, 51.7% vs. 46.7%; at 5 years, 23.3% vs. 17.4% (P = 0.006). After further meticulous exploration, only the stage IIB subgroup benefited from PORT (p<0.001). This result was due to the positive lymph node state (N+), whose mortality risk was cut by 23.4% (p<0.001) by PORT. Conclusion Addition of PORT to the treatment of patients with resected stage I to II PC conveys a survival benefit, particularly among those with N-positive or stage IIB disease.	[Lin, Zhuang-Bin; Huang, Xiao-Xue; Xu, Ben-Hua] Fujian Med Univ, Grad Sch, Fuzhou, Peoples R China; [Lin, Zhuang-Bin; Song, Jian-Yuan; Li, An-Chuan; Chen, Cheng; Huang, Xiao-Xue; Xu, Ben-Hua] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China; [Lin, Zhuang-Bin; Song, Jian-Yuan; Li, An-Chuan; Chen, Cheng; Huang, Xiao-Xue; Xu, Ben-Hua] Fujian Med Univ, Union Clin Med Coll, Fuzhou, Peoples R China; [Song, Jian-Yuan; Chen, Cheng; Xu, Ben-Hua] Fujian Med Univ, Coll Med Technol & Engn, Fuzhou, Peoples R China; [Li, An-Chuan; Xu, Ben-Hua] Fujian Med Univ, Sch Clin Med, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Xu, BH (corresponding author), Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China.; Xu, BH (corresponding author), Fujian Med Univ, Union Clin Med Coll, Fuzhou, Peoples R China.; Xu, BH (corresponding author), Fujian Med Univ, Coll Med Technol & Engn, Fuzhou, Peoples R China.; Xu, BH (corresponding author), Fujian Med Univ, Sch Clin Med, Fuzhou, Peoples R China.	benhuaxu@sina.com		Song, Jianyuan/0000-0003-4987-4975	Joint Funds for the innovation of science and Technology, Fujian province [2017Y9061]; Natural Science Foundation of Fujian province [2019J01149]; Training project of Middle-aged and Young Core Talents in health system of Fujian Province [2019-ZQN-44]	Joint Funds for the innovation of science and Technology, Fujian province; Natural Science Foundation of Fujian province(Natural Science Foundation of Fujian Province); Training project of Middle-aged and Young Core Talents in health system of Fujian Province	Y Benhua Xu, Joint Funds for the innovation of science and Technology, Fujian province [grant number 2017Y9061]. Jianyuan Song, the Natural Science Foundation of Fujian province [grant number 2019J01149], the Training project of Middle-aged and Young Core Talents in health system of Fujian Province [grant number 2019-ZQN-44]. Benhua Xu plays a role in conception and design of the paper; Jian-Yuan Song plays a role in analysis and interpretation.	Frakes J, 2017, J GASTROINTEST ONCOL, V8, P758, DOI 10.21037/jgo.2017.08.05; Franko J, 2012, ANN SURG ONCOL, V19, P26, DOI 10.1245/s10434-011-1898-6; GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6; Hazard L, 2007, CANCER, V110, P2191, DOI 10.1002/cncr.23047; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Kantor O, 2016, SURGERY, V160, P1466, DOI 10.1016/j.surg.2016.07.033; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Kooby DA, 2013, ANN SURG ONCOL, V20, P3634, DOI 10.1245/s10434-013-3047-x; Lim YJ, 2015, J GASTROINTEST SURG, V19, P2183, DOI 10.1007/s11605-015-2941-x; McDade TP, 2010, CANCER-AM CANCER SOC, V116, P3257, DOI 10.1002/cncr.25069; McDonald Andrew M, 2015, J Gastrointest Cancer, V46, P149, DOI 10.1007/s12029-015-9702-7; Mellon EA, 2014, CANCER-AM CANCER SOC, V120, P1171, DOI 10.1002/cncr.28543; Moody JS, 2009, J GASTROENTEROL, V44, P84, DOI 10.1007/s00535-008-2280-8; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; NITECKI SS, 1995, ANN SURG, V221, P59, DOI 10.1097/00000658-199501000-00007; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Opfermann KJ, 2014, AM J CLIN ONCOL-CANC, V37, P112, DOI 10.1097/COC.0b013e31826e0570; Ostapoff KT, 2017, HPB, V19, P587, DOI 10.1016/j.hpb.2017.03.002; Rutter CE, 2015, CANCER-AM CANCER SOC, V121, P4141, DOI 10.1002/cncr.29652; Shinde A, 2019, J GASTROINTEST ONCOL, V10, P462, DOI 10.21037/jgo.2019.01.19; Showalter TN, 2011, INT J RADIAT ONCOL, V81, P1328, DOI 10.1016/j.ijrobp.2010.07.1993; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simons JP, 2010, CANCER-AM CANCER SOC, V116, P1681, DOI 10.1002/cncr.24918; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Sugawara A, 2014, J SURG ONCOL, V110, P960, DOI 10.1002/jso.23752; Tempero M, 2019, J NATL COMPR CANC NE, V17, P1, DOI 10.6004/jnccn.2019.0003; Van Laethem JL, 2010, J CLIN ONCOL, V28, P4450, DOI 10.1200/JCO.2010.30.3446	27	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243170	10.1371/journal.pone.0243170	http://dx.doi.org/10.1371/journal.pone.0243170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315874	gold, Green Published			2022-12-26	WOS:000600186100085
J	Perez-Gracia, J; Avila, FJ; Ares, J; Valles, JA; Remon, L				Perez-Gracia, Jesus; Avila, Francisco J.; Ares, Jorge; Valles, Juan A.; Remon, Laura			Misalignment and tilt effect on aspheric intraocular lens designs after a corneal refractive surgery	PLOS ONE			English	Article							SPHERICAL-ABERRATION; IMAGE QUALITY; PUPIL SIZE; DECENTRATION; MODEL; OPTICS; IMPACT	Purpose To numerically evaluate and compare the tolerance to misalignment and tilt of aspheric intraocular lenses (10Ls) designed for three eyes: with standard cornea and with simulated corneas after myopic and hyperopic laser ablation surgery. Methods Three aspheric 10Ls of +20.00 diopter (D) with different spherical aberration (SA) (4) values have been designed using a theoretical model eye. Drastic changes on the theoretical eye anterior corneal asphericity have been performed to simulate myopic and hyperopic refractive surgeries. The effect of IOL misalignment and tilt on the image quality has been evaluated using a commercial optical software design for the three eye models. Image quality was assessed from the modulation transfer function (MTF), root mean square (RMS) values of defocus, astigmatism, coma and spherical aberration (4), and retinal images obtained from a visual simulator using an aleatory optotype of 0.00 LogMar visual acuity (VA). Results IOL misalignment and tilt reduced MTF values in general, and increased wavefront aberrations errors. Aberration-freel0Ls maintained best the MTF values when misalignments were applied, together with good on -axis optical quality.I0Ls with negative SA (4) correction decreased the MTF value under 0.43 for misalignments values higher than 0.50 mm with the three corneas. The effect of misalignment on RMS astigmatism and coma was correlated with the IOL SA (4) and with the three corneas. Conclusions This theoretical study shows that the largest degradation in image quality arises for the IOL with the highest amount of spherical aberration (4). Moreover, it has been found that the aspherical design has a more influential role in misalignment tolerance than in tilt tolerance.	[Perez-Gracia, Jesus; Avila, Francisco J.; Ares, Jorge; Valles, Juan A.; Remon, Laura] Univ Zaragoza, Dept Fis Aplicada, Zaragoza, Spain	University of Zaragoza	Remon, L (corresponding author), Univ Zaragoza, Dept Fis Aplicada, Zaragoza, Spain.	lauremar@unizar.es	Avila, Francisco/AAD-7785-2021; REMON MARTIN, LAURA/L-7922-2017	Avila, Francisco/0000-0002-9068-7728; Perez-Gracia, Jesus/0000-0002-1959-6559; REMON MARTIN, LAURA/0000-0002-3979-4528	Spanish Ministry of Economy and Competitiveness [DI-16-08888, DPI2017-84047-R]; Department of Industry and Innovation (Government of Aragon) [E24-17R]; Feder 2014-2020: Construyendo Europa desde Aragon	Spanish Ministry of Economy and Competitiveness(Spanish Government); Department of Industry and Innovation (Government of Aragon); Feder 2014-2020: Construyendo Europa desde Aragon	This study was supported by the Spanish Ministry of Economy and Competitiveness (Grant DPI2017-84047-R) and the Department of Industry and Innovation (Government of Aragon) through the research group Grant E24-17R (cofinanciando con Feder 2014-2020: Construyendo Europa desde Aragon). J. Perez-Gracia was supported by the Spanish Ministry of Economy and Competitiveness, DI-16-08888.	Ahn Hyun Seok, 2013, Korean J Ophthalmol, V27, P81, DOI 10.3341/kjo.2013.27.2.81; Al-Sayyari TM, 2014, SAUDI J OPHTHALMOL, V28, P274, DOI 10.1016/j.sjopt.2014.06.005; Anera RG, 2003, J CATARACT REFR SURG, V29, P762, DOI 10.1016/S0886-3350(02)01895-3; ANSI, 2017, Z80282017 ANSI; Artal P, 2001, J VISION, V1, DOI 10.1167/1.1.1; Barbero S, 2011, OPT EXPRESS, V19, P6215, DOI 10.1364/OE.19.006215; Baumeister M, 2009, J CATARACT REFR SURG, V35, P1006, DOI 10.1016/j.jcrs.2009.01.023; Beiko GHH, 2007, J CATARACT REFR SURG, V33, P1455, DOI 10.1016/j.jcrs.2007.04.019; Bottos KM, 2011, J CATARACT REFR SURG, V37, P1109, DOI 10.1016/j.jcrs.2010.12.058; Bozukova D, 2013, J CATARACT REFR SURG, V39, P1404, DOI 10.1016/j.jcrs.2013.01.050; Cabeza-Gil I, 2020, ANN BIOMED ENG, V48, P1127, DOI 10.1007/s10439-019-02432-9; Calvo R, 2010, AM J OPHTHALMOL, V149, P785, DOI 10.1016/j.ajo.2009.12.023; Chang PY, 2017, J FORMOS MED ASSOC, V116, P177, DOI 10.1016/j.jfma.2016.04.003; Chassagne B, 2020, BIOMED OPT EXPRESS, V11, P850, DOI 10.1364/BOE.382162; Du W, 2019, INT J OPHTHALMOL-CHI, V12, P1788, DOI 10.18240/ijo.2019.11.19; Eppig T, 2009, J CATARACT REFR SURG, V35, P1091, DOI 10.1016/j.jcrs.2009.01.034; Forbes GW, 2007, OPT EXPRESS, V15, P5218, DOI 10.1364/OE.15.005218; Holladay JT, 2002, J REFRACT SURG, V18, P683; International Organization for Standardization, 2014, 119792 ISO; Ivarsen A, 2012, INVEST OPHTH VIS SCI, V53, P6011, DOI 10.1167/iovs.12-10208; Iwama Y, 2020, JPN J OPHTHALMOL, V64, P359, DOI 10.1007/s10384-020-00737-0; Jia LX, 2014, INT J OPHTHALMOL-CHI, V7, P816, DOI 10.3980/j.issn.2222-3959.2014.05.14; Kohnen T, 2009, OPHTHALMOLOGY, V116, P1697, DOI 10.1016/j.ophtha.2009.03.052; Langenbucher A, 2017, Z MED PHYS, V27, P255, DOI 10.1016/j.zemedi.2017.03.003; Lawu T, 2019, J CATARACT REFR SURG, V45, P662, DOI 10.1016/j.jcrs.2018.10.049; Lee H, 2018, J CATARACT REFR SURG, V44, P725, DOI 10.1016/j.jcrs.2018.03.028; Leisser C, 2020, OPHTHALMOLOGICA, V243, P37, DOI [10.1159/000498898, 10.1159/000499116]; Li MY, 2019, ACTA OPHTHALMOL, V97, pE373, DOI 10.1111/aos.14017; Lim SJ, 1998, J CATARACT REFR SURG, V24, P397, DOI 10.1016/S0886-3350(98)80330-1; Madrid-Costa D, 2012, J CATARACT REFR SURG, V38, P774, DOI 10.1016/j.jcrs.2011.11.036; McKelvie J, 2011, OPHTHALMOLOGY, V118, P1724, DOI 10.1016/j.ophtha.2011.02.025; Munoz G, 2010, J CATARACT REFR SURG, V36, P1934, DOI 10.1016/j.jcrs.2010.06.062; NAVARRO R, 1985, J OPT SOC AM A, V2, P1273, DOI 10.1364/JOSAA.2.001273; Ortiz S, 2013, BIOMED OPT EXPRESS, V4, P387, DOI 10.1364/BOE.4.000387; Perches S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150204; Perez-Gracia J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232546; Perez-Merino P, 2018, J CATARACT REFR SURG, V44, P889, DOI 10.1016/j.jcrs.2018.02.025; Perez-Vives C, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/2687385; Piers PA, 2007, J REFRACT SURG, V23, P374; Remon L, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.3.035003; RIDLEY H, 1952, LANCET, V262, P118; Singh K, 2017, INDIAN J OPHTHALMOL, V65, P1281, DOI 10.4103/ijo.IJO_863_17; Solomon JD, 2010, J REFRACT SURG, V26, P863, DOI 10.3928/1081597X-20100129-01; Taketani F, 2004, J CATARACT REFR SURG, V30, P2158, DOI 10.1016/j.jcrs.2004.02.072; Tandogan T, 2017, J REFRACT SURG, V33, P808, DOI 10.3928/1081597X-20171004-02; Uzel MM, 2018, SEMIN OPHTHALMOL, V33, P766, DOI 10.1080/08820538.2018.1443146; Vega-Estrada A, 2020, EUR J OPHTHALMOL, V30, P446, DOI 10.1177/1120672119834478; Wang J, 2012, OPT EXPRESS, V20, P11652, DOI 10.1364/OE.20.011652; Wang L, 2019, J CATARACT REFR SURG, V45, P35, DOI 10.1016/j.jcrs.2018.08.025; Zvornicanin J, 2018, J CURR OPHTHALMOL, V30, P287, DOI 10.1016/j.joco.2018.04.003	50	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243740	10.1371/journal.pone.0243740	http://dx.doi.org/10.1371/journal.pone.0243740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315894	Green Published, gold			2022-12-26	WOS:000600186100052
J	Yuan, Y; Naito, H; Kitamori, K; Hashimoto, S; Asano, T; Nakajima, T				Yuan, Yuan; Naito, Hisao; Kitamori, Kazuya; Hashimoto, Sayuki; Asano, Tomomi; Nakajima, Tamie			The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension	PLOS ONE			English	Article							FATTY LIVER; TISSUE INHIBITOR; DISEASE; METALLOPROTEINASE-1; SERUM; EXPRESSION; STEATOSIS; INJURY	Hypertension is an important risk factor for nonalcoholic steatohepatitis. We have previously demonstrated that hypertensive rats fed a high fat and cholesterol (HFC) diet incurred a more severe hepatic inflammatory response and fibrosis. Here we investigated the role of hypertension in NASH by comparing HFC-induced hepatic fibrogenesis between spontaneously hypertensive rats (SHRs) and their normotensive Wistar Kyoto counterpart. Compared to the counterpart, the HFC diet led to stronger aggregation of CD68-positive macrophages in SHRs. HFC feeding also resulted in significantly higher upregulation of the fibrosis-related gene alpha-smooth muscle actin in SHR. The HFC diet induced higher overexpression of serum tissue inhibitor of metalloproteinase-1 (TIMP1) and greater suppression of matrix metalloproteinase-2 (MMP2):TIMP1, MMP8:TIMP1, and MMP9:TIMP1 ratios, as a proxy of the activities of these MMPs in SHR. Administration of the antihypertensive agent hydralazine to SHRs significantly ameliorated HFC-induced liver fibrosis; it suppressed the aggregation of CD68-positive macrophages and the upregulation of platelet-derived growth factor receptor beta, and collagen, type 1, alpha-1 chain. In conclusion, a hypertensive environment exacerbated the hepatic fibrogenetic effects of the HFC diet; while the effects were partially reversed by the antihypertensive agent hydralazine. Our data suggest that antihypertensive drugs hold promise for treating NASH exacerbated by hypertension.	[Yuan, Yuan; Nakajima, Tamie] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi, Japan; [Naito, Hisao] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan; [Naito, Hisao; Kitamori, Kazuya; Hashimoto, Sayuki; Asano, Tomomi] Kinjo Gakuin Univ, Coll Human Life & Environm, Nagoya, Aichi, Japan; [Yuan, Yuan] Shenzhen Univ, Sch Med, Dept Pathol, Shenzhen, Guangdong, Peoples R China; [Hashimoto, Sayuki] Kobe Shoin Womens Univ, Fac Human Sci, Kobe, Hyogo, Japan	Chubu University; Fujita Health University; Shenzhen University	Nakajima, T (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi, Japan.	tnasu23@med.nagoya-u.ac.jp		Nakajima, Tamie/0000-0002-0474-7019	 [B15H04788];  [C16K00877];  [C18K10033];  [C19K10583]	; ; ; 	The work has been supported by Grants-in-Aid for Scientific Research (B15H04788, C16K00877, C18K10033, and C19K10583).	[Anonymous], 2016, LANCET HIV, V3, pE191, DOI 10.1016/S2352-3018(16)30020-0; Arata M, 2014, WORLD J DIABETES, V5, P917, DOI 10.4239/wjd.v5.i6.917; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Duarte N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/984578; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Feng M, 2018, INT J BIOL SCI, V14, P1033, DOI 10.7150/ijbs.25589; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001; Ghadir MR, 2010, HEPAT MON, V10, P285; Ikuta T, 2012, HEPATOL RES, V42, P310, DOI 10.1111/j.1872-034X.2011.00920.x; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kasahara A, 1997, J HEPATOL, V26, P574, DOI 10.1016/S0168-8278(97)80423-0; Kitamori Kazuya, 2012, Environmental Health and Preventive Medicine, V17, P173, DOI 10.1007/s12199-011-0235-9; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Kozono M, 2016, MOL MED REP, V14, P5385, DOI 10.3892/mmr.2016.5875; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Murawaki Y, 1997, J HEPATOL, V26, P1213, DOI 10.1016/S0168-8278(97)80454-0; Naito H, 2016, ENVIRON HEALTH PREV, V21, P368, DOI 10.1007/s12199-016-0539-x; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Prystupa A, 2015, ANN AGR ENV MED, V22, P325, DOI 10.5604/12321966.1152088; Robitaille J, 2004, J HUM GENET, V49, P482, DOI 10.1007/s10038-004-0177-9; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Toyoda H, 2013, BIOMARKERS, V18, P82, DOI 10.3109/1354750X.2012.738249; Wang YH, 2016, HEPATOL RES, V46, P1304, DOI 10.1111/hepr.12688; Ying HZ, 2017, MOL MED REP, V16, P7879, DOI 10.3892/mmr.2017.7641; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Yuan Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091018	34	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243846	10.1371/journal.pone.0243846	http://dx.doi.org/10.1371/journal.pone.0243846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315911	Green Published, gold			2022-12-26	WOS:000600186100073
J	Chaniad, P; Tewtrakul, S; Sudsai, T; Langyanai, S; Kaewdana, K				Chaniad, Prapaporn; Tewtrakul, Supinya; Sudsai, Teeratad; Langyanai, Supat; Kaewdana, Kantarakorn			Anti-inflammatory, wound healing and antioxidant potential of compounds from Dioscorea bulbifera L. bulbils	PLOS ONE			English	Article							FLAVONOIDS; EXTRACT; INTEGRASE	Background Dioscorea bulbifera L. (Dioscoreaceae) has been traditionally used in Thai folk medicine as a diuretic and anthelmintic, for longevity preparations, and for wound and inflammation treatment. This plant is also commonly used in traditional Indian and Chinese medicines in the treatment of sore throat, gastric cancer, rectal carcinoma and goiters. However, the wound healing effects of the active compounds in this plant have not been investigated. Objective This study aimed to identify compounds responsible for the wound healing activity of D. bulbifera and determine their potential anti-inflammatory and antioxidant activities. Methods Crude extracts of D. bulbifera bulbils, their derived fractions and eleven purified compounds were tested for anti-inflammatory activity against LPS-induced NO production in RAW264.7 macrophages. The wound healing effects were evaluated via cell proliferation and migration assays using human dermal fibroblasts (HDFs), and the antioxidant effects were determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radical ((OH)-O-center dot) scavenging activity assays. Results 15,16-Epoxy-6 alpha-O-acetyl-8 beta-hydroxy-19-nor-clero-13(16),14-diene-17,12;18,2-diolide (2), (+)-catechin (5), quercetin (6) and myricetin (11) exhibited significantly potent wound healing effects and promoted marked cell proliferation, resulting in % viabilities of 107.4-137.6, 121.1-151.9, 98.0-131.9, 90.9-115.9, respectively. Among them, (+)-catechin produced the highest % cell migration, resulting in 100.0% wound closure sooner (at day 2) than the other compounds. In addition, 1 mu g/ml (+)-catechin significantly increased fibroblast migration by 2.4-fold compared to that in the control after 24 h. Regarding anti-inflammatory properties, kaempferol (7) and quercetin (6) decreased (p < 0.005) NO production, with IC50 values of 46.6 and 56.2 mu M, respectively. In addition, the crude extracts, solvent fractions and flavonoid compounds were also found to possess marked antioxidant activity in both DPPH and (OH)-O-center dot radical scavenging assays. Conclusions These findings provide more evidence to support the traditional use of D. bulbifera for the treatment of wounds and inflammation.	[Chaniad, Prapaporn; Kaewdana, Kantarakorn] Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand; [Tewtrakul, Supinya; Sudsai, Teeratad; Langyanai, Supat] Prince Songkla Univ, Fac Pharmaceut Sci, Hat Yai, Songkhla, Thailand	Walailak University; Prince of Songkla University	Chaniad, P (corresponding author), Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand.	prapaporn.ch@wu.ac.th			Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand [WU-IRG-62-049]	Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand	This work was supported by a grant from the Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand (Grant No. WU-IRG-62-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Zabeer, 2009, Diabetologia Croatica, V38, P63; Alsawalha M, 2019, PHARMACOGN MAG, V15, P483, DOI 10.4103/pm.pm_81_19; Ambiga S, 2007, ANC SCI LIFE, V26, P45; Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098; Chaniad P., 2016, Songklanakarin Journal of Science and Technology, V38, P229; Chaniad P, 2016, PHARM BIOL, V54, P1077, DOI 10.3109/13880209.2015.1103272; Dey P, 2016, PHARM BIOL, V54, P1474, DOI 10.3109/13880209.2015.1104702; Dioscorea bulbifera L, 2010, DIOSC BULB L; Dunnill C, 2015, INT WOUND J, P14; Fu R, 2013, J ETHNOPHARMACOL, V147, P517, DOI 10.1016/j.jep.2013.03.058; Gadkari PV, 2015, FOOD BIOPROD PROCESS, V93, P122, DOI 10.1016/j.fbp.2013.12.004; Garcia-Aranda MI, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115427; Ghosh S, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/929051; Gopalakrishnan A, 2016, INDIAN J EXP BIOL, V54, P187; Harper D, 2014, SURGERY OXFORD, V32, P445, DOI DOI 10.1016/j.mpsur.2014.06.010; Hwang KA, 2019, J CHIN MED ASSOC, V82, P251, DOI 10.1097/JCMA.0000000000000051; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Jing LL, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0820-3; Kim HH, 2013, ARCH PHARM RES, V36, P1533, DOI 10.1007/s12272-013-0147-x; Lim JS, 2018, J MED FOOD, V21, P1204, DOI 10.1089/jmf.2018.4187; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Mandal S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep072; Mbiantcha M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/912935; Muzolf-Panek M, 2012, EUR FOOD RES TECHNOL, V235, P1001, DOI 10.1007/s00217-012-1826-4; Nagaraja S, 2014, J IMMUNOL, V192, P1824, DOI 10.4049/jimmunol.1302481; Okigbo R, 2009, INT J INTEGR BIOL, P6; Panduraju T., 2010, Journal of Pharmacy Research, V3, P3138; Schmidt CA, 2010, J NAT PROD, V73, P2035, DOI 10.1021/np100523s; Sharifi R, 2013, PHARM BIOL, V51, P298, DOI 10.3109/13880209.2012.721789; Sinno Hani, 2013, Plast Surg Int, V2013, P146764, DOI 10.1155/2013/146764; Sorg H, 2017, EUR SURG RES, V58, P81, DOI 10.1159/000454919; Sudsai T, 2013, J ETHNOPHARMACOL, V150, P223, DOI 10.1016/j.jep.2013.08.038; Takano-Ishikawa Y, 2006, PHYTOMEDICINE, V13, P310, DOI 10.1016/j.phymed.2005.01.016; Thiruvoth FM, 2015, PLAST AESTHET RES, V2, P250, DOI [10.4103/2347-9264.158851, DOI 10.4103/2347-9264.158851]; Treml J, 2016, COMPR REV FOOD SCI F, V15, P720, DOI 10.1111/1541-4337.12204; Wild T, 2010, NUTRITION, V26, P862, DOI 10.1016/j.nut.2010.05.008	36	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243632	10.1371/journal.pone.0243632	http://dx.doi.org/10.1371/journal.pone.0243632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306733	Green Published, gold			2022-12-26	WOS:000600144200019
J	Megersa, BS; Bussmann, H; Barnighausen, T; Muche, AA; Alemu, K; Deckert, A				Megersa, Bikila Soboka; Bussmann, Hermann; Baernighausen, Till; Muche, Achenef Asmamaw; Alemu, Kassahun; Deckert, Andreas			Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study	PLOS ONE			English	Article							COST-EFFECTIVENESS; WOMEN; PREVENTION; RISK; FACILITATORS; POPULATION; COLLECTION; SPECIMENS; COUNTRIES; ATTITUDES	Objective To explore the barriers to successful home-based human papillomavirus (HPV) self-sampling in North Gondar, Ethiopia. Methods The study participants were women who had previously participated in a community-wide home-based HPV self-sampling pilot study, community health workers, women's development army leaders, and the sample collectors of the home-based HPV self-sampling pilot study. A community based qualitative descriptive study was conducted. We applied purposive and convenience sampling. In total, 47 women participated in the study (in-depth interviews n = 22, four focus group discussions n = 25, 6-7 participants each). The study employed thematic analysis for clustering the emerged themes. Results Husband disapproval was identified as the main barrier to the acceptance of home-based HPV self-sampling. Social influence, lack of knowledge about cervical cancer and screening, lack of health education on cervical cancer and HPV-based screening, feeling healthy, and religious influence were identified as additional barriers. Fear of using Evalyn brush (R) for self-sampling was found to be the main barrier to the provision of a quality sample. The inability of the sample collectors to check the proper utilization of Evalyn brush (R) and the difficulty in understanding the instructions did also contribute to the low-quality. Providing health education concerning cervical cancer and HPV self-sapling to women, male involvement in the screening program, and linking the screening service to existing local health facilities were suggested to guarantee the success of home-based HPV self-sampling. Conclusions Educating women regarding cervical cancer and HPV testing, providing clear instructions on how to collect self-sample, and male involvement in the screening program are prerequisites for a successful implementation of home-based HPV testing. Women empowerment should also be focused to overcome the identified sociocultural barriers. Furthermore, the screening program should guarantee the timely provision of the test results and offering women follow-up examinations and treatment for abnormal findings.	[Megersa, Bikila Soboka; Baernighausen, Till; Deckert, Andreas] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Bussmann, Hermann] Heidelberg Univ, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany; [Muche, Achenef Asmamaw; Alemu, Kassahun] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Gondar	Megersa, BS (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.	bikila070@gmail.com		Soboka, Bikila/0000-0002-7227-9560; Muche, Achenef/0000-0001-7971-3537	Open Society Foundation; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Open Society Foundation; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	The project was funded by the Open Society Foundation as part of the Civil Society Leadership Award for a master thesis to BSM. In addition, we acknowledge financial support by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate S. M., 2015, GYNECOLOGY OBSTET TR, DOI [10.4172/2161-0932.S3, DOI 10.4172/2161-0932.S3]; Abiodun OA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-814; Allen-Leigh B, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3723-5; Anaman-Torgbor JA, 2017, EUR J ONCOL NURS, V31, P22, DOI 10.1016/j.ejon.2017.09.005; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Austad K, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00228; Aweke YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181415; Ayres L, 2007, J WOUND OSTOMY CONT, V34, P131, DOI 10.1097/01.WON.0000264823.57743.5f; Bayu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149908; BERHANE Y, 2006, ETHIOP J HLTH DEV, V0020, P00135; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; Boyce CNP., 2006, PATHFINDER INT TOOL; Brandt T, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7354-4; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Broquet C, 2015, AFR HEALTH SCI, V15, P755, DOI 10.4314/ahs.v15i3.8; Bruni L, 2019, HUMAN PAPILLIMAVIRUS; Bruni L AG, 2018, HUMAN PAPILLOMAVIRUS, P17; Burger EA, 2017, CANCER EPIDEM BIOMAR, V26, P95, DOI 10.1158/1055-9965.EPI-16-0350; Campos NG, 2017, HEALTH POLICY PLANN, V32, P956, DOI 10.1093/heapol/czw182; Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Dareng EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141679; Defo VF, 2020, AMA J ETHICS, V22, P116; Domgue JF, 2020, INT J CANCER, V147, P128, DOI 10.1002/ijc.32746; Domgue JF, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00048; Duggleby W, 2005, QUAL HEALTH RES, V15, P832, DOI 10.1177/1049732304273916; Duke P, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0206-1; Ethiopian Federal Ministry of Health, 2015, NAT CANC CONTR PLAN; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Fall NS, 2019, AM J TROP MED HYG, V100, P1552, DOI 10.4269/ajtmh.19-0045; Olaza-Maguina AF, 2019, ECANCERMEDICALSCIENC, V13, DOI 10.3332/ecancer.2019.901; Fitzpatrick MB, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6810-5; Garrett JJ, 2013, CULT HEALTH SEX, V15, P637, DOI 10.1080/13691058.2012.760206; Gelibo T, 2017, J ONCOL RES TREAT, V2, P115; Geremew AB, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0471-1; Getachew S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216522; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Gizaw M, 2019, CANCER PREV RES, V12, P609, DOI 10.1158/1940-6207.CAPR-19-0156; Glanz K., 2008, HLTH BEHAV HLTH ED T; Gravitt PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013711; Guvenc G, 2011, J ADV NURS, V67, P428, DOI 10.1111/j.1365-2648.2010.05450.x; Habtu Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4203-2; Hernández- Márquez Clara I, 2014, Rev. salud pública, V16, P697, DOI 10.15446/rsap.v16n5.30071; Huynh J, 2010, J LOW GENIT TRACT DI, V14, P356, DOI 10.1097/LGT.0b013e3181dc115b; Jede F, 2020, PAPILLOMAVIRUS RES, V9, DOI 10.1016/j.pvr.2020.100198; Johnson CE, 2008, J LOW GENIT TRACT DI, V12, P232, DOI 10.1097/LGT.0b013e31815d8d88; Kabalika Chiluba, 2018, Int J MCH AIDS, V7, P17, DOI 10.21106/ijma.223; Lazcano-Ponce E, 2011, LANCET, V378, P1868, DOI 10.1016/S0140-6736(11)61522-5; Legard R., 2003, QUALITATIVE RES PRAC, P138, DOI DOI 10.1080/09687637.2016.1189876; Lehmann U, 2007, STATE EVIDENCE PROGR, P1; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Maes K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5159-5; Malone C, 2020, PREV MED, V132, DOI 10.1016/j.ypmed.2019.105953; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Mbachu C, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0399-6; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Mesafint Z, 2018, ETHIOP J HEALTH SCI, V28, P111, DOI 10.4314/ejhs.v28i2.2; Mezei AK, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020484; Mezei AK, 2017, INT J CANCER, V141, P437, DOI 10.1002/ijc.30695; Mitchell S, 2011, INT J GYNECOL OBSTET, V114, P111, DOI 10.1016/j.ijgo.2011.01.028; Mitiku I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163136; Modibbo F, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0123-z; Modibbo FI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008533; Morse JM, 2000, DETERMINING SAMPLE S; Ndikom CM, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-11; Nega AD, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0579-z; Ngugi CW, 2012, HEALTH CARE WOMEN IN, V33, P595, DOI 10.1080/07399332.2011.646367; Olaniran A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1272223; Penaranda E, 2015, J LOW GENIT TRACT DI, V19, P323, DOI 10.1097/LGT.0000000000000134; Racey CS, 2016, J RURAL HEALTH, V32, P136, DOI 10.1111/jrh.12136; Ritchie J., 2013, QUALITATIVE RES PRAC; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sankaranarayanan R, 2014, ANN GLOB HEALTH, V80, P412, DOI 10.1016/j.aogh.2014.09.014; Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790; Sudenga SL, 2013, INT J GYNECOL CANCER, V23, P895, DOI 10.1097/IGC.0b013e31828e425c; Tamalet C, 2013, CLIN MICROBIOL INFEC, V19, pE44, DOI 10.1111/1469-0691.12063; WHO, 2013, WHO GUID SCREEN TREA; World Health Organization Africa, 2018, ETH LAUNCH HUM PAP V; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Yang H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026413; Yitbarek K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025937	84	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243036	10.1371/journal.pone.0243036	http://dx.doi.org/10.1371/journal.pone.0243036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WM	33306681	gold, Green Published			2022-12-26	WOS:000600144200013
J	Shearer, TR; Hwang, TS; Steinkamp, PN; Azuma, M				Shearer, Thomas R.; Hwang, Thomas S.; Steinkamp, Peter N.; Azuma, Mitsuyoshi			Segmenting OCT for detecting drug efficacy in CRAO	PLOS ONE			English	Article							RETINAL ARTERY-OCCLUSION; NERVE-FIBER LAYER; INDUCED PROTEOLYSIS; THICKNESS	Purpose Thinning of the inner layers of the retina occurs in patients with central retinal artery occlusion (CRAO). The mechanism for such thinning may be partially due to proteolysis by a calcium-activated protease called calpain. Calpain inhibitor SNJ-1945 ameliorated the proteolysis in a past series of model experiments. The purposes of the present retrospective study were to: 1) use segmentation analysis of optical coherence tomography (OCT) images to mathematically model the loss of specific retinal layers in CRAO patients, and 2) predict the number of patients and days of observation needed for clinical trials of inhibitors against CRAO. Methods A retrospective case control study was conducted by computer-aided search for CRAO (ICD10 H43.1) with at least one OCT procedure (CPT: 92134) in the OHSU Epic patient data base. Results After initial swelling, thinning of the inner retinal layers, especially the ganglion cell (GCL) layer followed exponential decay curves. Using sample size statistics and GCL thickness as a marker in a 30-day clinical trial, 19 eyes/group could theoretically detect a 20% beneficial effect of an inhibitor against CRAO. Other markers, such as the whole retinal thickness and combined inner layers could also be used as less-specific markers. Conclusions Using thickness changes in the GCL layer to monitor the efficacy of potential inhibitors against CRAO is practical in human trials requiring a reasonable number of patients and relatively short trial period. Translational relevance Measurement of GCL thickness would be a useful indicator of CRAO progression in a clinical trial of putative inhibitors.	[Shearer, Thomas R.] Oregon Hlth & Sci Univ, Dept Integrat Biomed & Diagnost Sci, Portland, OR 97201 USA; [Hwang, Thomas S.; Steinkamp, Peter N.] OHSU, Dept Ophthalmol, Portland, OR USA; [Azuma, Mitsuyoshi] Senju Lab Ocular Sci, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Shearer, TR (corresponding author), Oregon Hlth & Sci Univ, Dept Integrat Biomed & Diagnost Sci, Portland, OR 97201 USA.	shearert@ohsu.edu		Shearer, Thomas/0000-0002-1123-0878	Senju Pharmaceutical Co. [GSODO0069A]	Senju Pharmaceutical Co.	This research was supported in part by contract #GSODO0069A from Senju Pharmaceutical Co. to TRS. TRS, TSH and PNS are paid consultants for Senju Pharmaceutical Co., Ltd. Additionally, funding for this study is provided by Senju Pharmaceutical Co., Ltd in the form of salary for MA. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahn SJ, 2015, AM J OPHTHALMOL, V159, P667, DOI 10.1016/j.ajo.2015.01.001; Azuma M, 2014, CURR EYE RES, V39, P421, DOI 10.3109/02713683.2013.845225; Chen HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09269; Ding SLS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081406; Farris W, CENTRAL RETINAL ARTE; Fraser SG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001989.pub2; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hayreh SS, 2005, AM J OPHTHALMOL, V140, P376, DOI 10.1016/j.ajo.2005.03.038; Hirata M, 2015, INVEST OPHTH VIS SCI, V56, P6049, DOI 10.1167/iovs.15-17360; Ikeda F, 2010, JPN J OPHTHALMOL, V54, P423, DOI 10.1007/s10384-010-0841-x; Invernizzi A, 2018, OPHTHALMOL RETINA, V2, P808, DOI 10.1016/j.oret.2017.12.012; Nieves-Moreno M, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.1.20; Oka T, 2006, J NEUROSCI RES, V83, P1342, DOI 10.1002/jnr.20827; Paquet-Durand F, 2007, J NEUROSCI RES, V85, P693, DOI 10.1002/jnr.21151; Sakamoto Y, 2000, CURR EYE RES, V21, P571, DOI 10.1076/0271-3683(200007)21:1;1-Z;FT571; Shin HJ, 2014, INVEST OPHTH VIS SCI, V55, P2403, DOI 10.1167/iovs.13-13769; Shinoda K, 2008, GRAEF ARCH CLIN EXP, V246, P949, DOI 10.1007/s00417-008-0791-x; Sim S, DIAGNOSIS MANAGEMENT; Varma DD, 2013, EYE, V27, P688, DOI 10.1038/eye.2013.25; Zar JH, 1974, BIOSTATISTICAL ANAL, V5th, P147	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242920	10.1371/journal.pone.0242920	http://dx.doi.org/10.1371/journal.pone.0242920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306701	gold, Green Published, Green Submitted			2022-12-26	WOS:000600144200057
J	Morales-Burruezo, I; Gandia-Franco, JL; Cobo, J; Vela-Hernandez, A; Bellot-Arcis, C				Morales-Burruezo, Ignacio; Gandia-Franco, Jose-Luis; Cobo, Juan; Vela-Hernandez, Arturo; Bellot-Arcis, Carlos			Arch expansion with the Invisalign system: Efficacy and predictability	PLOS ONE			English	Article							TOOTH MOVEMENT; APPLIANCES	Background In adult patients, treatment of skeletal crossbite requires combined treatment by fixed or removable appliances and orthognathic surgery. In cases of dentoalveolar crossbite, expansion can be achieved with fixed multibrackets and removable transparent aligners. Various researchers have already assessed the Invisalign system's predictability for arch expansion. However, most of this research was conducted using older appliances, making it necessary to assess the characteristics of the updated system SmartTrack. Material and methods A sample of 114 patients with transverse malocclusion were treated with SmartTrack. The predictability of the system's software (Clincheck) was assessed by comparing planned measurements (width of canines, premolars and molars rotations and inclinations) with the real measurements achieved at the end of the first treatment phase. Measurements were imported to Clincheck software to create three data sets; T1: initial measurements at start of treatment; T2: Clincheck predicted measurements at end of first treatment phase; T3: measurements taken at start of the second treatment phase. Results Widths underwent significant advances as a result of treatment. For all widths, virtual planning obtained prognoses of greater expansion than actually achieved: a mean of 0.63 mm more expansion at the canine level (p<0.001), 0.77 mm at first premolar (p<0.001), 0.81 at second premolar (p<0.001), 0.69 mm at first molar (p<0.001), and 0.25 mm at second molar (p = 0.183). All the treatment plan's estimations, with the exception of the second molar, were significantly higher than the actual outcomes. Conclusions Aligners are an effective tool for producing arch expansion, being more effective in premolar area and less effective in canine and second molar area. Predictability was reasonable for expansion movement. Overcorrection should be considered at the virtual planning stage in order to obtain the expected outcomes.	[Morales-Burruezo, Ignacio; Vela-Hernandez, Arturo; Bellot-Arcis, Carlos] Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain; [Gandia-Franco, Jose-Luis] Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia, Spain; [Cobo, Juan] Univ Oviedo, Orthodont Med & Dent Sch, Inst Asturiano Odontol, Dept Surg & Med Surg Specialties, Oviedo, Spain	University of Valencia; University of Valencia; University of Oviedo	Morales-Burruezo, I (corresponding author), Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain.	nachomoralesburruezo@hotmail.com	BELLOT-ARCIS, CARLOS/AGP-0731-2022	BELLOT-ARCIS, CARLOS/0000-0003-4363-2713				Almerich-Silla JM, 2014, MED ORAL PATOL ORAL, V19, pE15, DOI 10.4317/medoral.19096; Bellot-Arcis C, 2012, MED ORAL PATOL ORAL, V17, pE638, DOI 10.4317/medoral.17722; Boyd R.L., 2001, SEMIN ORTHOD, V7, P274; Castaner-Peiro Amparo, 2006, Med Oral Patol Oral Cir Bucal, V11, pE210; Celikoglu M, 2010, MED ORAL PATOL ORAL, V15, pE791, DOI 10.4317/medoral.15.e791; Clements KM, 2003, AM J ORTHOD DENTOFAC, V124, P502, DOI 10.1016/S0889-5406(03)00577-8; Djeu G, 2005, AM J ORTHOD DENTOFAC, V128, P292, DOI 10.1016/j.ajodo.2005.06.002; Grunheid T, 2017, ANGLE ORTHOD, V87, P809, DOI 10.2319/022717-147.1; Gu JF, 2017, AM J ORTHOD DENTOFAC, V151, P259, DOI 10.1016/j.ajodo.2016.06.041; Gungor AY, 2012, MED ORAL PATOL ORAL, V17, pE311, DOI 10.4317/medoral.17389; Houle JP, 2017, ANGLE ORTHOD, V87, P19, DOI 10.2319/122115-875.1; Kassas W, 2013, J WORLD FED ORTHOD, V2, pE61, DOI 10.1016/j.ejwf.2013.03.003; Ke YY, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-018-0695-z; Kravitz ND, 2009, AM J ORTHOD DENTOFAC, V135, P27, DOI 10.1016/j.ajodo.2007.05.018; Kuncio D, 2007, ANGLE ORTHOD, V77, P864, DOI 10.2319/100106-398.1; Madhavi R., 2011, INTERNAT J COMPUTER, V2, P23; Papadimitriou A, 2018, PROG ORTHOD, V19, DOI 10.1186/s40510-018-0235-z; Ramis M.R., 2018, J ALIGNER ORTHO, V2, P13; Rossini G, 2015, ANGLE ORTHOD, V85, P881, DOI 10.2319/061614-436.1; Solano-Mendoza B, 2017, CLIN ORAL INVEST, V21, P1475, DOI 10.1007/s00784-016-1908-y	20	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242979	10.1371/journal.pone.0242979	http://dx.doi.org/10.1371/journal.pone.0242979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301484	Green Published, gold			2022-12-26	WOS:000600143100047
J	Petrovskaya, A; Kirillov, B; Asmolova, A; Galli, G; Feurra, M; Medvedeva, A				Petrovskaya, Aleksandra; Kirillov, Bogdan; Asmolova, Anastasiya; Galli, Giulia; Feurra, Matteo; Medvedeva, Angela			Examining the effects of transcranial direct current stimulation on human episodic memory with machine learning	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; NONINVASIVE BRAIN-STIMULATION; SEMANTIC ELABORATION; TDCS; ITEM; REPRODUCIBILITY; RETRIEVAL; HEALTHY	We aimed to replicate a published effect of transcranial direct-current stimulation (tDCS)-induced recognition enhancement over the human ventrolateral prefrontal cortex (VLPFC) and analyse the data with machine learning. We investigated effects over an adjacent region, the dorsolateral prefrontal cortex (DLPFC). In total, we analyzed data from 97 participants after exclusions. We found weak or absent effects over the VLPFC and DLPFC. We conducted machine learning studies to examine the effects of semantic and phonetic features on memorization, which revealed no effect of VLPFC tDCS on the original dataset or the current data. The highest contributing factor to memory performance was individual differences in memory not explained by word features, tDCS group, or sample size, while semantic, phonetic, and orthographic word characteristics did not contribute significantly. To our knowledge, this is the first tDCS study to investigate cognitive effects with machine learning, and future studies may benefit from studying physiological as well as cognitive effects with data-driven approaches and computational models.	[Petrovskaya, Aleksandra; Asmolova, Anastasiya; Feurra, Matteo] Natl Res Univ Higher Sch Econ, Psychol Dept, Moscow, Russia; [Petrovskaya, Aleksandra; Asmolova, Anastasiya; Feurra, Matteo] Natl Res Univ Higher Sch Econ, Inst Cognit Neurosci, Moscow, Russia; [Kirillov, Bogdan] Skolkovo Inst Sci & Technol, Ctr Life Sci, Skolkovo, Russia; [Galli, Giulia] Kingston Univ, Dept Psychol, Kingston Upon Thames, Surrey, England; [Medvedeva, Angela] Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX USA; [Petrovskaya, Aleksandra] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	HSE University (National Research University Higher School of Economics); HSE University (National Research University Higher School of Economics); Skolkovo Institute of Science & Technology; Kingston University; University of Texas System; University of Texas Health Science Center Houston; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Kirillov, B (corresponding author), Skolkovo Inst Sci & Technol, Ctr Life Sci, Skolkovo, Russia.	Bogdan.Kirillov@skoltech.ru	Feurra, Matteo/K-1524-2019; Petrovskaya, Alexandra/B-6122-2017; Asmolova, Anastasiya/AAV-2471-2021	Feurra, Matteo/0000-0003-0934-6764; Asmolova, Anastasiya/0000-0003-1789-754X; Petrovskaia, Aleksandra/0000-0001-9202-0727; Kirillov, Bogdan/0000-0002-7104-8613; Galli, Giulia/0000-0001-9894-3514	Russian Academic Excellence Project '5-100'	Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The article was prepared within the framework of the HSE University Basic Research Program and funded by the Russian Academic Excellence Project '5-100'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2011, METHODS MODELS PSYCH, V2, P45; Balzarotti S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159555; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2014, NEUROPSYCHOLOGIA, V53, P197, DOI 10.1016/j.neuropsychologia.2013.11.021; Blumenfeld RS, 2013, CEREB CORTEX, V23, P2457, DOI 10.1093/cercor/bhs223; Blumenfeld RS, 2011, J COGNITIVE NEUROSCI, V23, P257, DOI 10.1162/jocn.2010.21459; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Bojanowski Piotr, 2017, T ASSOC COMPUT LING, V5, P135, DOI 10.1162/tacl_a_00051; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Cesario J, 2014, PERSPECT PSYCHOL SCI, V9, P40, DOI 10.1177/1745691613513470; de Lara Gabriel A, 2017, Front Neurosci, V11, P452, DOI 10.3389/fnins.2017.00452; Dedoncker J, 2016, J NEURAL TRANSM, V123, P1159, DOI 10.1007/s00702-016-1558-x; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; EINSTEIN GO, 1980, J EXP PSYCHOL-HUM L, V6, P588, DOI 10.1037/0278-7393.6.5.588; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Galli G, 2019, BRAIN STIMUL, V12, P231, DOI 10.1016/j.brs.2018.11.008; Giordano J, 2017, DOSE-RESPONSE, V15, DOI 10.1177/1559325816685467; Gray SJ, 2015, CORTEX, V73, P188, DOI 10.1016/j.cortex.2015.09.003; Habich A, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00542; Hammer A, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-72; Hawco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073789; Heroux ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175635; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Javadi AH, 2013, BRAIN STIMUL, V6, P668, DOI 10.1016/j.brs.2012.10.007; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; Jones KT, 2014, EXP BRAIN RES, V232, P4043, DOI 10.1007/s00221-014-4090-y; Joulin A, 2018, ARXIV180407745; Lafontaine MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081721; Lu Y, 2015, CURR BIOL, V25, P780, DOI 10.1016/j.cub.2015.01.055; Lyashevskaya O., 2009, FREQUENCY DICT MODER; Manenti R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00049; Manenti R, 2012, BRAIN STIMUL, V5, P103, DOI 10.1016/j.brs.2012.03.004; Matzen LE, 2015, BRAIN RES, V1624, P286, DOI 10.1016/j.brainres.2015.07.036; Medvedeva A, 2019, CEREB CORTEX, V29, P657, DOI 10.1093/cercor/bhx347; Meinzer M, 2014, CORTEX, V50, P137, DOI 10.1016/j.cortex.2013.07.013; Mendoza H, 2019, SPRING SER CHALLENGE, P135, DOI 10.1007/978-3-030-05318-5_7; Minarik T, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3399/fnhum.2016.00453, 10.3389/fnhum.2016.00453]; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Olsen RK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00146; Olson RS, 2019, SPRING SER CHALLENGE, P151, DOI 10.1007/978-3-030-05318-5_8; Paquette C, 2011, J CEREBR BLOOD F MET, V31, P2086, DOI 10.1038/jcbfm.2011.72; Paszke A., 2017, 31 C NEUR INF PROC S; Pergolizzi D, 2016, BRAIN COGNITION, V108, P56, DOI 10.1016/j.bandc.2016.06.009; Peterchev AV, 2017, ELIFE, V6, DOI 10.7554/eLife.25812; Pisoni A, 2015, NEUROPSYCHOLOGIA, V66, P267, DOI 10.1016/j.neuropsychologia.2014.11.025; Polania R, 2018, NAT NEUROSCI, V21, P174, DOI 10.1038/s41593-017-0054-4; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P2261, DOI 10.1016/j.neuropsychologia.2008.10.024; Sandrini M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00289; Smirni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144838; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stagg CJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01465; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Staresina BP, 2009, CEREB CORTEX, V19, P1198, DOI 10.1093/cercor/bhn165; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Takahashi E, 2007, NEUROIMAGE, V34, P827, DOI 10.1016/j.neuroimage.2006.10.009; Vannorsdall TD, 2016, COGN BEHAV NEUROL, V29, P11, DOI 10.1097/WNN.0000000000000086; Zhang Dongxu, 2018, ARXIV180408166; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	63	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0235179	10.1371/journal.pone.0235179	http://dx.doi.org/10.1371/journal.pone.0235179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296363	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000598626100032
J	Peramuna, A; Bae, H; Lopez, CQ; Fromberg, A; Petersen, B; Simonsen, HT				Peramuna, Anantha; Bae, Hansol; Quinonero Lopez, Carmen; Fromberg, Arvid; Petersen, Bent; Simonsen, Henrik Toft			Connecting moss lipid droplets to patchoulol biosynthesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OIL BODIES; PROTEINS; EXPRESSION; OLEOSIN; GROWTH; UNIQUE; SEIPIN; YEAST	Plant-derived terpenoids are extensively used in perfume, food, cosmetic and pharmaceutical industries, and several attempts are being made to produce terpenes in heterologous hosts. Native hosts have evolved to accumulate large quantities of terpenes in specialized cells. However, heterologous cells lack the capacity needed to produce and store high amounts of non-native terpenes, leading to reduced growth and loss of volatile terpenes by evaporation. Here, we describe how to direct the sesquiterpene patchoulol production into cytoplasmic lipid droplets (LDs) in Physcomitrium patens (syn. Physcomitrella patens), by attaching patchoulol synthase (PTS) to proteins linked to plant LD biogenesis. Three different LD-proteins: Oleosin (PpOLE1), Lipid Droplet Associated Protein (AtLDAP1) and Seipin (PpSeipin325) were tested as anchors. Ectopic expression of PTS increased the number and size of LDs, implying an unknown mechanism between heterologous terpene production and LD biogenesis. The expression of PTS physically linked to Seipin increased the LD size and the retention of patchoulol in the cell. Overall, the expression of PTS was lower in the anchored mutants than in the control, but when normalized to the expression the production of patchoulol was higher in the seipin-linked mutants.	[Peramuna, Anantha; Bae, Hansol; Quinonero Lopez, Carmen; Simonsen, Henrik Toft] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Bae, Hansol; Simonsen, Henrik Toft] Mosspirat Biotech, Horsholm, Denmark; [Fromberg, Arvid] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Petersen, Bent] Univ Copenhagen, GLOBE Inst, Copenhagen, Denmark; [Petersen, Bent] AIMST Univ, Ctr Excellence Omics Driven Computat Biodiscovery, Bedong, Kedah, Malaysia	Technical University of Denmark; Technical University of Denmark; University of Copenhagen; AIMST University	Simonsen, HT (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.; Simonsen, HT (corresponding author), Mosspirat Biotech, Horsholm, Denmark.	hets@dtu.dk	Simonsen, Henrik Toft/I-4263-2016	Simonsen, Henrik Toft/0000-0003-3070-807X; Petersen, Bent/0000-0002-2472-8317; Fromberg, Arvid/0000-0001-6524-4979	Danish Council for Independent Research [4005-00158B]; People Program (Marie Curie Actions) of the European 517 Union's Seventh Framework Program FP7/2007-2013/under REA grant [607011]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); People Program (Marie Curie Actions) of the European 517 Union's Seventh Framework Program FP7/2007-2013/under REA grant	AP, HB, and HTS were supported by The Danish Council for Independent Research (#4005-00158B). CQ was supported by funding from the People Program (Marie Curie Actions) of the European 517 Union's Seventh Framework Program FP7/2007-2013/under REA grant agreement no [607011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mosspiration Biotech provided support in the form of part of the salaries for authors [HB and HTS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ackermann J, 2013, FOUND TRENDS COMPUT, V9, P149, DOI 10.1561/0600000065; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Andersen T.B., 2015, CHROMATOGRAPHY, V2, P277, DOI DOI 10.3390/CHROMATOGRAPHY2020277; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Araujo C, 2003, J FOOD PROTECT, V66, P625, DOI 10.4315/0362-028X-66.4.625; Bach SS, 2014, METHODS MOL BIOL, V1153, P257, DOI 10.1007/978-1-4939-0606-2_19; Batth R, 2020, BIOPROTOCOL; Berthelot K, 2014, BBA-BIOMEMBRANES, V1838, P287, DOI 10.1016/j.bbamem.2013.08.025; Berthelot K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048065; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brocard L, 2017, FRONT PLANT SCI, P8, DOI [10.3389/fpls.2017.00008, DOI 10.3389/FPLS.2017.00008]; Cai YQ, 2015, PLANT CELL, V27, P2616, DOI 10.1105/tpc.15.00588; Chapman KD, 2013, PLANT SCI, V207, P128, DOI 10.1016/j.plantsci.2013.03.003; Coleman RA, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158762; Coulon D, 2020, BIOCHIMIE, V169, P29, DOI 10.1016/j.biochi.2019.09.018; Daviet L, 2010, FLAVOUR FRAG J, V25, P123, DOI 10.1002/ffj.1981; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He XL, 2013, CRIT REV PLANT SCI, V32, P293, DOI 10.1080/07352689.2013.765765; Huang AHC, 2018, PLANT PHYSIOL, V176, P1894, DOI 10.1104/pp.17.01677; Huang CY, 2017, PLANT PHYSIOL, V174, P2248, DOI 10.1104/pp.17.00366; Huang CY, 2009, PLANT PHYSIOL, V150, P1192, DOI 10.1104/pp.109.138123; Ikram NKK, 2019, MOLECULES, V24, DOI 10.3390/molecules24213822; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Kamatou GPP, 2007, S AFR J BOT, V73, P102, DOI 10.1016/j.sajb.2006.08.001; Kim EY, 2016, PLANT PHYSIOL, V170, P2494, DOI 10.1104/pp.16.00165; King BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25030; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauersen KJ, 2016, METAB ENG, V38, P331, DOI 10.1016/j.ymben.2016.07.013; Park KY, 2018, BIOCHEM BIOPH RES CO, V495, P1885, DOI 10.1016/j.bbrc.2017.12.068; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sadre R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08515-4; Salminen TA, 2018, PLANTS-BASEL, V7, DOI 10.3390/plants7010006; Salminen TA, 2016, PLANTA, V244, P971, DOI 10.1007/s00425-016-2585-4; Schempp FM, 2018, J AGR FOOD CHEM, V66, P2247, DOI 10.1021/acs.jafc.7b00473; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Sun H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174804; Sun H, 2012, PLANT CELL REP, V31, P1877, DOI 10.1007/s00299-012-1301-5; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tanaka M, 2016, PHYTOCHEMISTRY, V130, P77, DOI 10.1016/j.phytochem.2016.06.008; Troncoso-Ponce MA, 2013, PLANT SCI, V205, P13, DOI 10.1016/j.plantsci.2013.01.004; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Zhan X, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00636; Zhao C, 2018, ACS SYNTH BIOL, V7, P774, DOI 10.1021/acssynbio.7b00368	50	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243620	10.1371/journal.pone.0243620	http://dx.doi.org/10.1371/journal.pone.0243620			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284858	gold, Green Published			2022-12-26	WOS:000597930500002
J	Rommens, PM; Herteleer, M; Handrich, K; Boudissa, M; Wagner, D; Hopf, JC				Rommens, Pol Maria; Herteleer, Michiel; Handrich, Kristin; Boudissa, Mehdi; Wagner, Daniel; Hopf, Johannes Christof			Medial buttressing of the quadrilateral surface in acetabular and periprosthetic acetabular fractures	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; QUALITY-OF-LIFE; INTERNAL-FIXATION; ELDERLY-PATIENTS; OPEN REDUCTION; CLASSIFICATION; POPULATION; MANAGEMENT	Background In geriatric acetabular fractures, the quadrilateral plate is often involved in the fracture pattern and medially displaced. Open reduction and internal fixation (ORIF) includes reduction of the quadrilateral plate and securing its position. In this study, the concept of medial buttressing in acute and periprosthetic acetabular fractures is evaluated. Materials and methods Patients, who sustained an acetabular fracture between 2012 and 2018, in whom ORIF with a specific implant for medial buttressing was performed, were included in the study. Patients were divided in two groups; acute acetabular fractures (group 1) and periprosthetic acetabular fractures (group 2). Demographics, type of fracture, surgical approach, type of implant for medial buttressing, comorbidities, general and surgical in-hospital complications and length of hospital stay were recorded retrospectively. The following data were collected from the surviving patients by telephone interview: EQ-5D-5L, SF-8 physical and SF-8 mental before trauma and at follow-up, UCLA activity scale, Parker Mobility Score and Numeric Rating Scale. Results Forty-six patients were included in this study, 30 males (65.2%) and 16 females (34.8%). Forty patients were included group 1 and six patients in group 2. The median age of patients of group 1 was 78 years. Among them, 82.5% presented with comorbidities. Their median length of in-hospital stay was 20.5 days. 57.5% of patients suffered from in-hospital complications. The concept of medial buttressing was successful in all but one patient. ORIF together with primary total hip arthroplasty (THA) was carried out as a single stage procedure in 3 patients. Secondary THA was performed in 5 additional patients (5/37 = 13.5%) within the observation period. Among surviving patients, 79.2% were evaluated after 3 years of follow-up. Quality of life, activity level and mobility dropped importantly and were lower than the values of a German reference population. SF-8 mental did not change. The median age of patients of group 2 was 79.5 years, all of them presented with one or several comorbidities. The median length of in-hospital stay was 18.5 days. 50% of patients suffered from in-hospital complications. The concept of medial buttressing was successful in all patients. 5 of 6 patients (83.3%) could be evaluated after a median of 136 weeks. In none of these patients, secondary surgery was necessary. Quality of life, activity level and mobility importantly dropped as well in this group. SF-8 mental remained unchanged. Conclusion In geriatric acetabular fractures with involvement and medial displacement of the quadrilateral plate, medial buttressing as part of ORIF proved to be reliable. Only 13.5% of patients of group 1 needed a secondary THA within 3 years of follow-up, which is lower than in comparable studies. Despite successful surgery, quality of life, activity level and mobility dropped importantly in all patients. The loss of independence did however not influence SF-8 mental values.	[Rommens, Pol Maria; Herteleer, Michiel; Handrich, Kristin; Boudissa, Mehdi; Wagner, Daniel; Hopf, Johannes Christof] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthopaed & Traumatol, Mainz, Germany	Johannes Gutenberg University of Mainz	Rommens, PM (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthopaed & Traumatol, Mainz, Germany.	pol.rommens@unimedizin-mainz.de	; Wagner, Daniel/G-1308-2015	Rommens, Pol/0000-0002-5175-3876; Herteleer, Michiel/0000-0002-0010-4446; Wagner, Daniel/0000-0003-4455-1018				Anglen JO, 2003, J ORTHOP TRAUMA, V17, P625, DOI 10.1097/00005131-200310000-00005; Beierlein V, 2012, DIAGNOSTICA, V58, P145, DOI 10.1026/0012-1924/a000068; Borg T, 2019, BONE JOINT J, V101B, P478, DOI 10.1302/0301-620X.101B4.BJJ-2018-1027.R2; Boudissa M, 2020, AGING CLIN EXP RES, V32, P571, DOI 10.1007/s40520-019-01231-5; Brooks L, 1996, HLTH POLICY, V1, P53; Butterwick D, 2015, J BONE JOINT SURG AM, V97A, P758, DOI 10.2106/JBJS.N.01037; Carroll EA, 2010, J ORTHOP TRAUMA, V24, P637, DOI 10.1097/BOT.0b013e3181ceb685; Chen KF, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.19.01027; COLE JD, 1994, CLIN ORTHOP RELAT R, P112; Gillispie GJ, 2017, J ORTHOP TRAUMA, V31, P570, DOI 10.1097/BOT.0000000000000963; Giunta JC, 2019, INT ORTHOP, V43, P2383, DOI 10.1007/s00264-018-4204-4; Grochtdreis T, 2019, EUR J HEALTH ECON, V20, P933, DOI 10.1007/s10198-019-01054-1; Herath SC, 2019, J ORTHOP TRAUMA, V33, pS8, DOI 10.1097/BOT.0000000000001406; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; Jeffcoat DM, 2012, J ORTHOP TRAUMA, V26, P284, DOI 10.1097/BOT.0b013e31821e10a2; JUDET R, 1962, Mem Acad Chir (Paris), V88, P369; JUDET R, 1964, J BONE JOINT SURG AM, V46, P1615, DOI 10.2106/00004623-196446080-00001; Keel MJB, 2012, J BONE JOINT SURG BR, V94B, P405, DOI 10.1302/0301-620X.94B3.27801; Kim JW, 2015, INT ORTHOP, V39, P1175, DOI 10.1007/s00264-015-2711-0; LETOURNEL E, 1993, CLIN ORTHOP RELAT R, P62; Letournel E, 1993, ENTIRELY REVISED ENL; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; May C, 2018, J BONE JOINT SURG AM, V100, P1047, DOI 10.2106/JBJS.17.00295; Melhem E, 2020, ORTHOP TRAUMATOL-SUR, V106, P831, DOI 10.1016/j.otsr.2019.11.019; Morley D C Jr, 1986, Orthop Rev, V15, P135; Naal FD, 2009, CLIN ORTHOP RELAT R, V467, P958, DOI 10.1007/s11999-008-0358-5; PARKER MJ, 1993, J BONE JOINT SURG BR, V75, P797, DOI 10.1302/0301-620X.75B5.8376443; RAGNARSSON B, 1992, ACTA ORTHOP SCAND, V63, P511, DOI 10.3109/17453679209154725; Resch H, 2017, ARCH ORTHOP TRAUM SU, V137, P549, DOI 10.1007/s00402-017-2649-3; Rickman M, 2012, EUR J TRAUMA EMERG S, V38, P511, DOI 10.1007/s00068-012-0231-9; Rinne PP, 2017, INJURY, V48, P2157, DOI 10.1016/j.injury.2017.08.003; Rodriguez C S, 2001, Pain Manag Nurs, V2, P38, DOI 10.1053/jpmn.2001.23746; Rommens PM, 2020, INT ORTHOP, V44, P2123, DOI 10.1007/s00264-020-04672-0; Rommens PM, 2013, INJURY, V44, P1733, DOI 10.1016/j.injury.2013.06.023; ROMNESS DW, 1990, J BONE JOINT SURG BR, V72, P761, DOI 10.1302/0301-620X.72B5.2211750; Ryan SP, 2017, J ORTHOP TRAUMA, V31, P644, DOI 10.1097/BOT.0000000000000990; Salama W, 2017, INT ORTHOP, V41, P181, DOI 10.1007/s00264-016-3175-6; Sermon A, 2008, INJURY, V39, P914, DOI 10.1016/j.injury.2007.12.004; Tosounidis TH, 2015, INT ORTHOP, V39, P2219, DOI 10.1007/s00264-015-2883-7; Walley Kempland C, 2017, Eur J Orthop Surg Traumatol, V27, P689, DOI 10.1007/s00590-017-1949-1; White G, 2013, INJURY, V44, P159, DOI 10.1016/j.injury.2012.10.010; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	42	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243592	10.1371/journal.pone.0243592	http://dx.doi.org/10.1371/journal.pone.0243592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284841	Green Published, gold			2022-12-26	WOS:000597930500023
J	Bissmeyer, SRS; Hossain, S; Goldsworthy, RL				Bissmeyer, Susan R. S.; Hossain, Shaikat; Goldsworthy, Raymond L.			Perceptual learning of pitch provided by cochlear implant stimulation rate	PLOS ONE			English	Article							PULSE-RATE DISCRIMINATION; AUDITORY-NERVE FIBERS; TEMPORAL PITCH; FINE-STRUCTURE; ELECTRICAL-STIMULATION; SPEECH RECOGNITION; CODING STRATEGY; ELECTRODE CONFIGURATION; MULTIPULSE INTEGRATION; STIMULUS LEVEL	Cochlear implant users hear pitch evoked by stimulation rate, but discrimination diminishes for rates above 300 Hz. This upper limit on rate pitch is surprising given the remarkable and specialized ability of the auditory nerve to respond synchronously to stimulation rates at least as high as 3 kHz and arguably as high as 10 kHz. Sensitivity to stimulation rate as a pitch cue varies widely across cochlear implant users and can be improved with training. The present study examines individual differences and perceptual learning of stimulation rate as a cue for pitch ranking. Adult cochlear implant users participated in electrode psychophysics that involved testing once per week for three weeks. Stimulation pulse rate discrimination was measured in bipolar and monopolar configurations for apical and basal electrodes. Base stimulation rates between 100 and 800 Hz were examined. Individual differences were quantified using psychophysically derived metrics of spatial tuning and temporal integration. This study examined distribution of measures across subjects, predictive power of psychophysically derived metrics of spatial tuning and temporal integration, and the effect of training on rate discrimination thresholds. Psychophysical metrics of spatial tuning and temporal integration were not predictive of stimulation rate discrimination, but discrimination thresholds improved at lower frequencies with training. Since most clinical devices do not use variable stimulation rates, it is unknown to what extent recipients may learn to use stimulation rate cues if provided in a clear and consistent manner.	[Bissmeyer, Susan R. S.; Goldsworthy, Raymond L.] Univ Southern Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90007 USA; [Bissmeyer, Susan R. S.; Hossain, Shaikat; Goldsworthy, Raymond L.] Univ Southern Calif, Keck Sch Med, Auditory Res Ctr, Caruso Dept Otolaryngol, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Bissmeyer, SRS (corresponding author), Univ Southern Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90007 USA.; Bissmeyer, SRS (corresponding author), Univ Southern Calif, Keck Sch Med, Auditory Res Ctr, Caruso Dept Otolaryngol, Los Angeles, CA 90007 USA.	ssubrahm@usc.edu	Bissmeyer, Susan/GSD-6978-2022	Goldsworthy, Ray/0000-0003-3781-5468; Bissmeyer, Susan/0000-0001-6169-4323	USC Tina and Rick Caruso Department of Otolaryngology; NIH NIDCD [T32 DC009975-10, R01 DC018701]	USC Tina and Rick Caruso Department of Otolaryngology; NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the USC Tina and Rick Caruso Department of Otolaryngology (RLG and SRSB), NIH NIDCD Grant T32 DC009975-10 (SRSB and SH) and NIH NIDCD Grant R01 DC018701 (RLG and SRSB) (https://keck.usc.edu/otolaryngology/; https://dornsife.usc.edu/hcn/; https://www.nidcd.nih.gov/;).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argstatter H, 2016, NORD J MUSIC THER, V25, P9, DOI 10.1080/08098131.2016.1179879; Arnoldner C, 2007, ACTA OTO-LARYNGOL, V127, P1298, DOI 10.1080/00016480701275261; Bahmer Andreas, 2013, Cochlear Implants Int, V14, P142, DOI 10.1179/1754762812Y.0000000011; Baumann U, 2004, HEARING RES, V196, P49, DOI 10.1016/j.heares.2004.06.008; Bianchi F, 2019, JARO-J ASSOC RES OTO, V20, P263, DOI 10.1007/s10162-018-00710-2; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; Carlyon RP, 2010, J ACOUST SOC AM, V127, P1469, DOI 10.1121/1.3291981; Cosentino S, 2016, JARO-J ASSOC RES OTO, V17, P371, DOI 10.1007/s10162-016-0569-5; Drennan WR, 2003, J ACOUST SOC AM, V114, P2178, DOI 10.1121/1.1609994; Dreyer A, 2006, J NEUROPHYSIOL, V96, P2327, DOI 10.1152/jn.00326.2006; DYNES SBC, 1992, HEARING RES, V58, P79, DOI 10.1016/0378-5955(92)90011-B; Fallon JB, 2014, HEARING RES, V315, P1, DOI 10.1016/j.heares.2014.06.001; Fu Qian-Jie, 2007, Trends Amplif, V11, P193, DOI 10.1177/1084713807301379; Golding NL, 2012, J PHYSIOL-LONDON, V590, P5563, DOI 10.1113/jphysiol.2012.229328; Goldsworthy RL, 2014, J ACOUST SOC AM, V135, P334, DOI 10.1121/1.4835735; Gordon KA, 2007, CLIN NEUROPHYSIOL, V118, P1671, DOI 10.1016/j.clinph.2007.04.030; Heinz MG, 2001, NEURAL COMPUT, V13, P2273, DOI 10.1162/089976601750541804; Heng J, 2011, HEARING RES, V280, P192, DOI 10.1016/j.heares.2011.05.017; HILL KG, 1989, HEARING RES, V39, P63, DOI 10.1016/0378-5955(89)90082-8; Hughes ML, 2014, HEARING RES, V316, P44, DOI 10.1016/j.heares.2014.07.007; Hughes ML, 2012, HEARING RES, V285, P46, DOI 10.1016/j.heares.2012.01.010; Hutter E, 2015, Cochlear Implants Int, V16 Suppl 3, pS13, DOI 10.1179/1467010015Z.000000000261; Irvine DRF, 2018, HEARING RES, V362, P61, DOI 10.1016/j.heares.2017.10.011; Jesteadt W, 2005, J ACOUST SOC AM, V118, P325, DOI 10.1121/1.1928709; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kong YY, 2010, J ACOUST SOC AM, V127, P3114, DOI 10.1121/1.3372713; Kong YY, 2009, J ACOUST SOC AM, V125, P1649, DOI 10.1121/1.3068457; LEHNHARDT E, 1992, ORL J OTO-RHINO-LARY, V54, P308, DOI 10.1159/000276320; Macherey O, 2011, JARO-J ASSOC RES OTO, V12, P233, DOI 10.1007/s10162-010-0248-x; McDermott HJ, 1997, J ACOUST SOC AM, V101, P1622, DOI 10.1121/1.418177; McKay C. M., 2000, Acoustics Research Letters Online, V1, P25, DOI 10.1121/1.1318742; McKay CM, 1999, HEARING RES, V136, P159, DOI 10.1016/S0378-5955(99)00121-5; McKay CM, 2012, J ACOUST SOC AM, V131, P2209, DOI 10.1121/1.3683248; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Middlebrooks JC, 2007, EXPERT REV MED DEVIC, V4, P428, DOI 10.1007/s10162-007-0070-2; Middlebrooks JC, 2010, J NEUROSCI, V30, P1937, DOI 10.1523/JNEUROSCI.4949-09.2010; Moore BCJ, 2005, SPR HDB AUD, V24, P234; Morris DJ, 2000, JARO, V1, P211, DOI 10.1007/s101620010022; Muller J, 2012, ORL J OTO-RHINO-LARY, V74, P185, DOI 10.1159/000337089; Muniak MA, 2016, SPRINGER HANDB AUDIT, V52, P157, DOI 10.1007/978-1-4939-3031-9_6; Nelson DA, 2002, J ACOUST SOC AM, V112, P2932, DOI 10.1121/1.1514935; Nelson DA, 2011, J ACOUST SOC AM, V129, P3916, DOI 10.1121/1.3583503; PFINGST BE, 1994, HEARING RES, V78, P197, DOI 10.1016/0378-5955(94)90026-4; Pfingst BE, 2001, JARO-J ASSOC RES OTO, V2, P87, DOI 10.1007/s101620010065; Pfingst BE, 1997, HEARING RES, V112, P247, DOI 10.1016/S0378-5955(97)00122-6; Reiss LAJ, 2014, NEUROSCIENCE, V256, P43, DOI 10.1016/j.neuroscience.2013.10.024; Rosskothen-Kuhl N, 2018, BIORXIV, DOI [10.1101/498105, DOI 10.1101/498105]; Shafiro V, 2015, J SPEECH LANG HEAR R, V58, P509, DOI 10.1044/2015_JSLHR-H-14-0312; Shannon RV, 2015, HEARING RES, V322, P57, DOI 10.1016/j.heares.2014.11.003; SHANNON RV, 1990, J ACOUST SOC AM, V87, P905, DOI 10.1121/1.398902; SHANNON RV, 1983, HEARING RES, V12, P1, DOI 10.1016/0378-5955(83)90115-6; Shannon RV, 2004, SPR HDB AUD, V20, P334; Shepherd RK, 1997, HEARING RES, V108, P112, DOI 10.1016/S0378-5955(97)00046-4; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Stahl P, 2016, J ACOUST SOC AM, V139, P1578, DOI 10.1121/1.4944564; TONG YC, 1982, J ACOUST SOC AM, V71, P153, DOI 10.1121/1.387342; TONG YC, 1985, J ACOUST SOC AM, V77, P1881, DOI 10.1121/1.391939; TOWNSHEND B, 1987, J ACOUST SOC AM, V82, P106, DOI 10.1121/1.395554; Vandali AE, 2005, J ACOUST SOC AM, V117, P3126, DOI 10.1121/1.1874632; Vandali A, 2015, EAR HEARING, V36, pE1, DOI 10.1097/AUD.0000000000000109; Vandali AE, 2012, J ACOUST SOC AM, V132, P392, DOI 10.1121/1.4718452; Vandali AE, 2011, J ACOUST SOC AM, V129, P4023, DOI 10.1121/1.3573988; VANDENHONERT C, 1987, HEARING RES, V29, P207, DOI 10.1016/0378-5955(87)90168-7; vanHoesel RJM, 1997, J ACOUST SOC AM, V102, P495, DOI 10.1121/1.419611; Venter PJ, 2014, JARO-J ASSOC RES OTO, V15, P849, DOI 10.1007/s10162-014-0468-6; Vermeire K, 2010, ORL-J OTO-RHIN-LARYN, V72, P305, DOI 10.1159/000319748; Verschooten E, 2019, HEARING RES, V377, P109, DOI 10.1016/j.heares.2019.03.011; Vollmer M, 2011, J NEUROPHYSIOL, V106, P2423, DOI 10.1152/jn.00565.2011; Wilson BS, 2004, INT CONGR SER, V1273, P3, DOI 10.1016/j.ics.2004.08.018; Wouters J, 2015, IEEE SIGNAL PROC MAG, V32, P67, DOI 10.1109/MSP.2014.2371671; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Zeng FG, 2002, HEARING RES, V174, P101, DOI 10.1016/S0378-5955(02)00644-5; Zhou N, 2019, HEARING RES, V371, P1, DOI 10.1016/j.heares.2018.10.018; Zhou N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165476; Zhou N, 2016, J ACOUST SOC AM, V140, P1537, DOI 10.1121/1.4962230; Zhou N, 2016, J ACOUST SOC AM, V139, pEL70, DOI 10.1121/1.4943783; Zhou N, 2014, J ACOUST SOC AM, V136, P1257, DOI 10.1121/1.4890640; Zwolan TA, 1996, AM J OTOL, V17, P717	79	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242842	10.1371/journal.pone.0242842	http://dx.doi.org/10.1371/journal.pone.0242842			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270735	gold, Green Published			2022-12-26	WOS:000597149100077
J	Kiran, A; Butt, WH; Shaukat, A; Farooq, MU; Fatima, U; Azam, F; Anwar, Z				Kiran, Ayesha; Butt, Wasi Haider; Shaukat, Arslan; Farooq, Muhammad Umar; Fatima, Urooj; Azam, Farooque; Anwar, Zeeshan			Multi-objective regression test suite optimization using three variants of adaptive neuro fuzzy inference system	PLOS ONE			English	Article							HARMONY SEARCH; SELECTION; ALGORITHM; PRIORITIZATION; REDUCTION; NETWORK	In the process of software development, regression testing is one of the major activities that is done after making modifications in the current system or whenever a software system evolves. But, the test suite size increases with the addition of new test cases and it becomes in-efficient because of the occurrence of redundant, broken, and obsolete test cases. For that reason, it results in additional time and budget to run all these test cases. Many researchers have proposed computational intelligence and conventional approaches for dealing with this problem and they have achieved an optimized test suite by selecting, minimizing or reducing, and prioritizing test cases. Currently, most of these optimization approaches are single objective and static in nature. But, it is mandatory to use multi-objective dynamic approaches for optimization due to the advancements in information technology and associated market challenges. Therefore, we have proposed three variants of self-tunable Adaptive Neuro-fuzzy Inference System i.e. TLBO-ANFIS, FA-ANFIS, and HS-ANFIS, for multi-objective regression test suites optimization. Two benchmark test suites are used for evaluating the proposed ANFIS variants. The performance of proposed ANFIS variants is measured using Standard Deviation and Root Mean Square Error. A comparison of experimental results is also done with six existing methods i.e. GA-ANFIS, PSO-ANFIS, MOGA, NSGA-II, MOPSO, and TOPSIS and it is concluded that the proposed method effectively reduces the size of regression test suite without a reduction in the fault detection rate.	[Kiran, Ayesha; Butt, Wasi Haider; Shaukat, Arslan; Farooq, Muhammad Umar; Fatima, Urooj; Azam, Farooque] Natl Univ Sci & Technol NUST, Coll Elect & Mech Engn, Dept Comp & Software Engn, Islamabad, Pakistan; [Anwar, Zeeshan] Natl Univ Sci & Technol NUST, Mil Coll Signals, Dept Comp & Software Engn, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan	Butt, WH (corresponding author), Natl Univ Sci & Technol NUST, Coll Elect & Mech Engn, Dept Comp & Software Engn, Islamabad, Pakistan.	wasi@ceme.nust.edu.pk	Azam, Farooque/AAB-4035-2021; Kiran, Ayesha/AAC-2660-2020	Azam, Farooque/0000-0002-7421-7400; Butt, Wasi Haider/0000-0002-1347-3662; Kiran, Ayesha/0000-0002-7687-8333				Aggarwal KK, 2001, BOOK SOFTWARE ENG; [Anonymous], 2016, EUR J PREV CARDIOL, V23, pNP1; Anwar Z., 2014, INT J SOFTWARE ENG I, V1, P41; Anwar Z, 2019, NEURAL COMPUT APPL, V31, P7287, DOI 10.1007/s00521-018-3560-8; Anwar Z, 2013, 2013 16TH INTERNATIONAL MULTI TOPIC CONFERENCE (INMIC), P95, DOI 10.1109/INMIC.2013.6731331; Aouf A, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/3145436; Apostolopoulos T., 2011, INT J COMBINATORICS, V2011; Augustsson A, FRAMEWORK EVALUATING; Azar AT, 2010, ADAPTIVE NEUROFUZZY; Choudhary A, 2018, PROCEEDINGS 2018 IEEE/ACM 11TH INTERNATIONAL WORKSHOP ON SEARCH-BASED SOFTWARE TESTING (SBST), P13, DOI 10.1145/3194718.3194722; Eghbali S, 2016, IEEE T SOFTWARE ENG, V42, P1178, DOI 10.1109/TSE.2016.2550441; Eren Y., 2017, OPTIM RENEW ENERGY S, P27, DOI DOI 10.1016/B978-0-08-101041-9.00002-8; Esfandyari S, 2018, INFORM SOFTWARE TECH, V94, P165, DOI 10.1016/j.infsof.2017.10.007; Garousi V, 2018, INFORM SOFTWARE TECH, V103, P40, DOI 10.1016/j.infsof.2018.06.007; Haider A.A., 2012, P 2012 INT C EM TECH, P1; Haider AA, 2014, J INTELL FUZZY SYST, V27, P863, DOI 10.3233/IFS-131045; Hutchins M., 1994, ICSE-16. 16th International Conference on Software Engineering (Cat. No.94CH3409-0), P191, DOI 10.1109/ICSE.1994.296778; Jabbarvand R., 2016, P 25 INT S SOFTWARE, P425, DOI DOI 10.1145/2931037.2931067; Jang J., 1997, NEUROFUZZY SOFT COMP, V7458, P23; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Karaboga D, 2019, ARTIF INTELL REV, V52, P2263, DOI 10.1007/s10462-017-9610-2; Khan R, 2016, 2016 SECOND INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE & COMMUNICATION TECHNOLOGY (CICT), P32, DOI 10.1109/CICT.2016.16; Khan SUR, 2018, IEEE ACCESS, V6, P11816, DOI 10.1109/ACCESS.2018.2809600; Kim JH, 2016, PROCEDIA ENGINEER, V154, P1401, DOI 10.1016/j.proeng.2016.07.510; Kiran A, 2019, IEEE ACCESS, V7, P89093, DOI 10.1109/ACCESS.2019.2926384; Kothari SC, 2016, 2016 IEEE/ACM 3RD INTERNATIONAL WORKSHOP ON SOFTWARE ENGINEERING RESEARCH AND INDUSTRIAL PRACTICE (SER&IP), P3, DOI 10.1145/2897022.2897032; Kumar S, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2016.0101; Lin CT, 2017, SCI COMPUT PROGRAM, V150, P1, DOI 10.1016/j.scico.2017.05.004; Liu P, 2013, MATH PROBLEMS ENG; Marchetto A, 2019, IEEE T SOFTWARE ENG, V45, P363, DOI 10.1109/TSE.2017.2777831; Metwally AS, 2016, PROC INT SYMP SOFTW, P59, DOI 10.1109/ISSRE.2016.20; Miranda B, 2017, J SYST SOFTWARE, V131, P528, DOI 10.1016/j.jss.2016.06.058; Miskony B, 2018, APPL SOFT COMPUT, V72, P579, DOI 10.1016/j.asoc.2018.04.039; Mohanty Subhasish, 2020, Progress in Computing, Analytics and Networking. Proceedings of ICCAN 2019. Advances in Intelligent Systems and Computing (AISC 1119), P55, DOI 10.1007/978-981-15-2414-1_6; Petrovic G, 2019, FACTA UNIV-SER MECH, V17, P455, DOI 10.22190/FUME190420039P; Precup RE, 2016, IEEE INT FUZZY SYST, P72, DOI 10.1109/FUZZ-IEEE.2016.7737670; Rao RV, 2011, COMPUT AIDED DESIGN, V43, P303, DOI 10.1016/j.cad.2010.12.015; Rao RV, 2013, SCI IRAN, V20, P967, DOI 10.1016/j.scient.2013.01.002; Shi A, 2018, ISSTA'18: PROCEEDINGS OF THE 27TH ACM SIGSOFT INTERNATIONAL SYMPOSIUM ON SOFTWARE TESTING AND ANALYSIS, P84, DOI 10.1145/3213846.3213875; Singh S, 2017, PURE APPL GEOPHYS, V174, P2793, DOI 10.1007/s00024-017-1556-4; Singh Shilpi, 2016, CSI Transactions on ICT, V4, P73, DOI 10.1007/s40012-016-0098-8; Smuc NR, 2012, GEODERMA, V183, P1, DOI 10.1016/j.geoderma.2012.03.009; Sugave SR, 2018, IET SOFTW, V12, P271, DOI 10.1049/iet-sen.2017.0130; Sugave SR, 2017, 2017 INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND CONTROL SYSTEMS (ICICCS), P701; Turner AJ, 2016, LECT NOTES COMPUT SC, V9962, P244, DOI 10.1007/978-3-319-47106-8_19; Vilela M., 2019, DECISION MAKING APPL, V2, P1; Waghmare G, 2013, INFORM SCIENCES, V229, P159, DOI 10.1016/j.ins.2012.11.009; Wang KC, 2018, COMPUTING, V100, P787, DOI 10.1007/s00607-018-0610-0; Wang XY, 2017, SCI CHINA INFORM SCI, V60, DOI 10.1007/s11432-016-9057-8; Xu ZW, 2005, PROCEEDINGS OF THE 2005 IEEE INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION, P120; Yang X.S., 2013, IJSI, V1, P36, DOI [10.1504/IJSI.2013.055801, DOI 10.1504/IJSI.2013.055801]; Yang XS, 2009, STUD COMPUT INTELL, V191, P1, DOI 10.1109/MILCOM.2009.5379772; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang YY, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2017.0615	54	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242708	10.1371/journal.pone.0242708	http://dx.doi.org/10.1371/journal.pone.0242708			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270654	gold, Green Published			2022-12-26	WOS:000597149100062
J	Sharma, V; Jobrack, J; Cerenzia, W; Tilles, S; Ryan, R; Sih-Meynier, R; Zeitler, S; Manning, M				Sharma, Vibha; Jobrack, Jennifer; Cerenzia, Wendy; Tilles, Stephen; Ryan, Robert; Sih-Meynier, Regina; Zeitler, Stefan; Manning, Michael			A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy	PLOS ONE			English	Article							FOOD ALLERGY; BSACI GUIDELINE; NATURAL-HISTORY; IMMUNOTHERAPY; EPIDEMIOLOGY	Rationale Food allergy is documented to result in considerable morbidity, negative impact on quality of life, and substantial medical care costs. Although anecdotal data suggest widely varying practices in the diagnosis and management of food allergies, the diversity and relative frequency of these practices have not been documented. Methods A questionnaire was developed evaluating allergists' management approaches of individuals with peanut allergy (PA) in Germany (DE), France (FR), and the United Kingdom (UK). Results Here, we report the survey results from a total of 109 allergists from DE, FR and the UK. They reported to confirm PA at initial diagnosis using skin prick test (>= 60%), while allergists from DE and FR reported using allergen-specific IgE testing more (>86%) compared to the UK (<50%). At initial diagnosis, oral food challenge was used less in DE (13%) and FR (14%) and very rarely in the UK (3%) to confirm diagnosis. Recognition of acute reactions, use of adrenaline auto-injectors and allergen avoidance were reported to be discussed with the patient/caregiver at the initial office visit by most allergists (>75%). Half of the responders reported assessing the patient's quality of life. 63% allergists reported retesting for PA resolution at a later date, with 45% allergists indicated to recommend ingestion of a normal serving of peanut regularly upon resolution. Lack of effective PA treatment was reported to be a 'very significant' barrier for optimal PA treatment, with allergists being less than 'moderately familiar' with data from clinical trials testing new treatments options for PA. Lastly, allergists stated that the severity of patient's PA ranked as the most important factor in their decision to recommend oral immunotherapy for PA treatment. Conclusions This survey provides essential insights into the practice of allergists and highlights some areas that would inform strategies for education and improving PA healthcare.	[Sharma, Vibha] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester, Lancs, England; [Sharma, Vibha] Royal Manchester Childrens Hosp NHS Fdn Trust, Manchester, Lancs, England; [Jobrack, Jennifer] Food Allergy Pros LLC, Chicago, IL USA; [Cerenzia, Wendy] CE Outcomes, Birmingham, AL USA; [Tilles, Stephen; Sih-Meynier, Regina] Aimmune Therapeut, Med Affairs, Brisbane, CA USA; [Tilles, Stephen] Univ Washington, Seattle, WA 98195 USA; [Ryan, Robert] Aimmune Therapeut, London, England; [Zeitler, Stefan] Aimmune Therapeut Germany GmbH, Munich, Germany; [Manning, Michael] Med Res Arizona, Scottsdale, AZ USA	University of Manchester; Royal Manchester Children's Hospital; University of Washington; University of Washington Seattle	Zeitler, S (corresponding author), Aimmune Therapeut Germany GmbH, Munich, Germany.	szeitler@aimmune.com		Manning, Michael/0000-0003-4455-7356	Aimmune Therapeutics Inc.; CE Outcomes LLC; Food Allergy Pros LLC; Aimmune Therapeutics	Aimmune Therapeutics Inc.; CE Outcomes LLC; Food Allergy Pros LLC; Aimmune Therapeutics	This study was supported by Aimmune Therapeutics Inc. in the form of salaries for SZ, RR, ST and RSM, CE Outcomes LLC in the form of a salary for WC, and Food Allergy Pros LLC in the form of a salary for JJ. The specific roles of these authors are articulated in the `author contributions' section. Editorial support was provided by infill healthcare communication and supported by Aimmune Therapeutics Inc. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was sponsored by Aimmune Therapeutics. The authors would like to thank Sylvie Stacy, Andrea Vereda, and Ian Hitchcock for valuable input into the study design, Lee Baylis for critical review of the manuscript, and Brandon Coleman for providing analytical support for this study. Editorial assistance and medical writing support were offered by infill healthcare communications and funded by Aimmune Therapeutics.	Al-Ahmed Nasser, 2008, Allergy Asthma Clin Immunol, V4, P139, DOI 10.1186/1710-1492-4-4-139; Al-Muhsen S, 2003, CAN MED ASSOC J, V168, P1279; Anagnostou A, 2020, J ALLER CL IMM-PRACT, V8, P46, DOI 10.1016/j.jaip.2019.09.004; Blaiss MS, 2019, ANN ALLERG ASTHMA IM, V122, P463, DOI 10.1016/j.anai.2018.08.019; Calvani M, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100651; Chinthrajah RS, 2015, PEDIATR CLIN N AM, V62, P1393, DOI 10.1016/j.pcl.2015.07.009; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; DunnGalvin A, 2020, ALLERGY, V75, P2899, DOI 10.1111/all.14363; Ewan P, 2016, CLIN EXP ALLERGY, V46, P1258, DOI 10.1111/cea.12788; Ezendam J, 2012, EUROPEAN J NUTR FOOD, P46; Feeney M, 2016, J ALLERGY CLIN IMMUN, V138, P1108, DOI 10.1016/j.jaci.2016.04.016; Fineman S, 2013, ANN ALLERG ASTHMA IM, V111, P529, DOI 10.1016/j.anai.2013.09.026; Gernez Y, 2017, J ALLER CL IMM-PRACT, V5, P250, DOI 10.1016/j.jaip.2016.12.004; Gomes-Belo J, 2018, CURR PEDIATR REV, V14, P139, DOI 10.2174/1573396314666180423105842; Grabenhenrich L, 2020, ALLERGY, V75, P2294, DOI 10.1111/all.14290; Grzeskowiak LE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56961-3; Koplin JJ, 2019, J ALLER CL IMM-PRACT, V7, P375, DOI 10.1016/j.jaip.2018.11.010; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Lai M, 2019, ANN ALLERG ASTHMA IM, V122, P647, DOI 10.1016/j.anai.2019.03.034; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Patrawala M, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00908-6; Pouessel G, 2019, ALLERGY, V74, P1193, DOI 10.1111/all.13717; Roberts G, 2019, LANCET, V393, P2180, DOI 10.1016/S0140-6736(19)30767-6; Ryan D, 2017, ALLERGY, V72, P1123, DOI 10.1111/all.13134; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Savage J, 2016, J ALLER CL IMM-PRACT, V4, P196, DOI 10.1016/j.jaip.2015.11.024; Shaker M, 2019, ALLERGY ASTHMA PROC, V40, P290, DOI 10.2500/aap.2019.40.4240; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Stiefel G, 2017, CLIN EXP ALLERGY, V47, P719, DOI 10.1111/cea.12957; Vander Leek TK, 2000, J PEDIATR-US, V137, P749, DOI 10.1067/mpd.2000.109376; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Worm M, 2015, ALLERGO J, V24, P16, DOI 10.1007/s15007-015-0812-0; Yu W, 2016, NAT REV IMMUNOL, V16, P751, DOI 10.1038/nri.2016.111	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0241648	10.1371/journal.pone.0241648	http://dx.doi.org/10.1371/journal.pone.0241648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270629	Green Published, gold			2022-12-26	WOS:000597149100046
J	Caulkins, J; Grass, D; Feichtinger, G; Hartl, R; Kort, PM; Prskawetz, A; Seidl, A; Wrzaczek, S				Caulkins, Jonathan; Grass, Dieter; Feichtinger, Gustav; Hartl, Richard; Kort, Peter M.; Prskawetz, Alexia; Seidl, Andrea; Wrzaczek, Stefan			How long should the COVID-19 lockdown continue?	PLOS ONE			English	Article								Nations struggled to decide when and how to end COVID-19 inspired lockdowns, with sharply divergent views between those arguing for a resumption of economic activity and those arguing for continuing the lockdown in some form. We examine the choice between continuing or ending a full lockdown within a simple optimal control model that encompasses both health and economic outcomes, and pays particular attention to when need for care exceeds hospital capacity. The model shows that very different strategies can perform similarly well and even both be optimal for the same relative valuation on work and life because of the presence of a so-called Skiba threshold. Qualitatively the alternate strategies correspond to trying essentially to eradicate the virus or merely to flatten the curve so fewer people urgently need healthcare when hospitals are already filled to capacity.	[Caulkins, Jonathan] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Grass, Dieter] Int Inst Appl Syst Anal IIASA, Laxenburg, Austria; [Feichtinger, Gustav] Vienna Univ Technol, Inst Stat & Math Methods Econ, Res Unit Operat Res & Control Syst ORCOS, Vienna, Austria; [Feichtinger, Gustav; Prskawetz, Alexia; Wrzaczek, Stefan] Univ Vienna, IIASA, VID OAW, Wittgenstein Ctr Demog & Global Human Capital, Vienna, Austria; [Hartl, Richard; Seidl, Andrea] Univ Vienna, Dept Business Decis & Analyt, Vienna, Austria; [Kort, Peter M.] Tilburg Univ, Tilburg Sch Econ & Management, Tilburg, Netherlands; [Kort, Peter M.] Univ Antwerp, Dept Econ, Antwerp, Belgium; [Prskawetz, Alexia] Vienna Univ Technol, Inst Stat & Math Methods Econ, Res Unit Econ ECON, Vienna, Austria	Carnegie Mellon University; International Institute for Applied Systems Analysis (IIASA); Technische Universitat Wien; International Institute for Applied Systems Analysis (IIASA); University of Vienna; University of Vienna; Tilburg University; University of Antwerp; Technische Universitat Wien	Caulkins, J (corresponding author), Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA.	caulkins@andrew.cmu.edu	Hartl, Richard F./C-7043-2017	Hartl, Richard F./0000-0002-0461-0979; Wrzaczek, Stefan/0000-0002-3891-5471; Caulkins, Jonathan/0000-0002-7748-9989; Kort, Peter/0000-0001-5973-1981				Abel Brodeur, 2020, 13411 IZA; Alvarez Fernando E, 2020, 26981 WP NAT BUR EC; Baker Scott R, 2020, REV ASSET PRICING ST; Bloom David E, 2020, J EC LIT; CDC, 2020, COVID 19 PAND PLANN; Daron Acemoglu, 2009, INTRO MODERN EC GROW; Daron Acemoglu, 2020, 27102 WP NAT BUR EC; Delius Gustav W, 2020, MORE PREVALENT LESS; Dirk Krueger, 2020, 27047 WP NAT BUR EC; Eichenbaum Martin S, 2020, 26882 WP NAT BUR EC; Eran Bendavid, 2020, JAY COVID 19 ANTIBOD; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Grass D., 2008, OPTIMAL CONTROL NONL; Hammit James K., 2020, SSRN; Hens N, 2020, EUR HEART J-ACUTE CA, V9, P204, DOI 10.1177/2048872620924922; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HEALTH, V5, pe86; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kniesner TJ, 2012, REV ECON STAT, V94, P74, DOI 10.1162/REST_a_00229; Liyan Shi, 2020, EIEF WORKING PAPERS, V2004; Martin Gonzalez-Eiras, 2020, 14612 CEPR; Nick Huberts, 2020, OPTIMAL TIMING INTER; Richard Layard, 2020, 13186 IZA; Safiya Richardson, 2020, NORTHWELL COVID 19 R; TOMIYAMA K, 1989, J ECON DYN CONTROL, V13, P319, DOI 10.1016/0165-1889(89)90027-4; Tsai Thomas C, 2020, AM HOSP CAPACITY PRO; Willem Lander, 2020, NIEL IMPACT CONTACT	26	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0243413	10.1371/journal.pone.0243413	http://dx.doi.org/10.1371/journal.pone.0243413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264368	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000596569200069
J	Patel, KR; Benavente, MCR; Lorenz, WW; Mace, EM; Barb, AW				Patel, Kashyap R.; Benavente, Maria C. Rodriguez; Lorenz, W. Walter; Mace, Emily M.; Barb, Adam W.			Fc gamma receptor IIIa/CD16a processing correlates with the expression of glycan-related genes in human natural killer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NK CELLS; GLYCOFORMS; AFFINITY; REVEALS; IGG1; SITE	Many therapeutic monoclonal antibodies require binding to Fc. receptors (Fc.Rs) for full effect and increasing the binding affinity increases efficacy. Preeminent among the five activating human Fc gamma Rs is Fc gamma RIIIa/CD16a expressed by natural killer (NK) cells. CD16a is heavily processed, and recent reports indicate that the composition of the five CD16a asparagine(N)linked carbohydrates (glycans) impacts affinity. These observations indicate that specific manipulation of CD16a N-glycan composition in CD16a-expressing effector cells including NK cells may improve treatment efficacy. However, it is unclear if modifying the expression of select genes that encode processing enzymes in CD16a-expressing effector cells is sufficient to affect N-glycan composition. We identified substantial processing differences using a glycoproteomics approach by comparing CD16a isolated from two NK cell lines, NK92 and YTS, with CD16a expressed by HEK293F cells and previous reports of CD16a from primary NK cells. Gene expression profiling by RNA-Seq and qRT-PCR revealed expression levels for glycan-modifying genes that correlated with CD16a glycan composition. These results identified a high degree of variability between the processing of the same human protein by different human cell types. N-glycan processing correlated with the expression of glycan-modifying genes and thus explained the substantial differences in CD16a processing by NK cells of different origins.	[Patel, Kashyap R.; Barb, Adam W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Benavente, Maria C. Rodriguez; Barb, Adam W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Lorenz, W. Walter] Univ Georgia, Georgia Genom & Bioinformat Core, Athens, GA 30602 USA; [Lorenz, W. Walter] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Mace, Emily M.] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA; [Barb, Adam W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Barb, Adam W.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Iowa State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Columbia University; NewYork-Presbyterian Hospital; University System of Georgia; University of Georgia; Harvard University; Brigham & Women's Hospital	Barb, AW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.; Barb, AW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Barb, AW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.; Barb, AW (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	abarb@uga.edu		Barb, Adam/0000-0003-3290-8649; Mace, Emily/0000-0003-0226-7393; Lorenz, W. Walter/0000-0002-0933-2007; Rodriguez Benavente, Maria/0000-0001-8484-251X	National Institutes of Health [R01 GM115489, R21 AI142122]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding to A. W. B. by the National Institutes of Health under Awards No. R01 GM115489 (NIGMS) and R21 AI142122 (NIAID). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01869; Alessandri L, 2012, MABS-AUSTIN, V4, P509, DOI 10.4161/mabs.20450; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2017, ESSENTIALS GLYCOBIOL, V3rd; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Chiesa S, 2005, MOL IMMUNOL, V42, P477, DOI 10.1016/j.molimm.2004.07.030; Clemenceau B, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/482089; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Falconer DJ, 2018, ACS CHEM BIOL, V13, P2179, DOI 10.1021/acschembio.8b00342; GONG JH, 1994, LEUKEMIA, V8, P652; Gunesch JT, 2019, MOL IMMUNOL, V115, P64, DOI 10.1016/j.molimm.2018.07.015; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Hsu HT, 2016, J CELL BIOL, V215, P875, DOI 10.1083/jcb.201604136; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; HWU P, 1995, CANCER RES, V55, P3369; HWU P, 1993, J EXP MED, V178, P361, DOI 10.1084/jem.178.1.361; Jochems C, 2016, ONCOTARGET, V7, P86359, DOI 10.18632/oncotarget.13411; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Patel KR, 2019, MOL CELL PROTEOMICS, V18, P2178, DOI 10.1074/mcp.RA119.001607; Patel KR, 2020, GLYCOBIOLOGY, V30, P427, DOI 10.1093/glycob/cwaa002; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Peruzzi G, 2013, J IMMUNOL, V191, P1883, DOI 10.4049/jimmunol.1300313; Roberts JT, 2020, MOL CELL PROTEOMICS, V19, P362, DOI 10.1074/mcp.RA119.001733; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Shibata-Koyama M, 2009, GLYCOBIOLOGY, V19, P126, DOI 10.1093/glycob/cwn110; Snyder KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02873; Subedi GP, 2018, J BIOL CHEM, V293, P16842, DOI 10.1074/jbc.RA118.004998; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Taniguchi T, 2017, J BIOL CHEM, V292, P11079, DOI 10.1074/jbc.M116.770123; Washburn N, 2019, MOL CELL PROTEOMICS, V18, P534, DOI 10.1074/mcp.RA118.001142; Yagi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21145-y; Yang JC, 2016, ADV IMMUNOL, V130, P279, DOI 10.1016/bs.ai.2015.12.006; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047; Zhu H, 2020, BLOOD, V135, P399, DOI 10.1182/blood.2019000621	49	5	5	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100183	10.1074/jbc.RA120.015516	http://dx.doi.org/10.1074/jbc.RA120.015516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33310702	gold, Green Published			2022-12-26	WOS:000672866400161
J	Hindriks, R				Hindriks, Rikkert			Lag-invariant detection of interactions in spatially-extended systems using linear inverse modeling	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; MEG; EEG; REGULARIZATION; COMMUNICATION; NETWORKS	Measurements on physical systems result from the systems' activity being converted into sensor measurements by a forward model. In a number of cases, inversion of the forward model is extremely sensitive to perturbations such as sensor noise or numerical errors in the forward model. Regularization is then required, which introduces bias in the reconstruction of the systems' activity. One domain in which this is particularly problematic is the reconstruction of interactions in spatially-extended complex systems such as the human brain. Brain interactions can be reconstructed from non-invasive measurements such as electroencephalography (EEG) or magnetoencephalography (MEG), whose forward models are linear and instantaneous, but have large null-spaces and high condition numbers. This leads to incomplete unmixing of the forward models and hence to spurious interactions. This motivated the development of interaction measures that are exclusively sensitive to lagged, i.e. delayed interactions. The drawback of such measures is that they only detect interactions that have sufficiently large lags and this introduces bias in reconstructed brain networks. We introduce three estimators for linear interactions in spatially-extended systems that are uniformly sensitive to all lags. We derive some basic properties of and relationships between the estimators and evaluate their performance using numerical simulations from a simple benchmark model.	[Hindriks, Rikkert] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Hindriks, R (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	r.hindriks@vu.nl		Hindriks, Rikkert/0000-0003-3575-186X	NWO-Wiskundeclusters grant [613.009.105]	NWO-Wiskundeclusters grant	R.H. Rikkert Hindriks is supported by the NWO-Wiskundeclusters grant nr. 613.009.105, made available by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) www.nwo.nl.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Basti A, 2018, NEUROIMAGE, V175, P161, DOI 10.1016/j.neuroimage.2018.03.004; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Colclough GL, 2015, NEUROIMAGE, V117, P439, DOI 10.1016/j.neuroimage.2015.03.071; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Drakesmith M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081553; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gohel B, 2017, IRBM, V38, P127, DOI 10.1016/j.irbm.2017.03.002; Gratiy SL, 2017, EUR J NEUROSCI, V45, P1013, DOI 10.1111/ejn.13534; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hansen P. C., 2010, DISCRETE INVERSE PRO; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; Hauk O., 2019, OBJECTIVE EVALUATION; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Hincapie A.-S., 2016, PARAMETERS, V2016, P12; Hindriks R, 2017, BIORXIV; Hindriks R, 2011, HUM BRAIN MAPP, V32, P1161, DOI 10.1002/hbm.21099; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Mitsuhata Y, 2004, GEOPHYS PROSPECT, V52, P213, DOI 10.1111/j.1365-2478.2004.00412.x; Nicholson C, 1975, J CLIN NEUROPHYSIOL; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051913; O'Neill GC, 2015, PHYS MED BIOL, V60, pR271, DOI 10.1088/0031-9155/60/21/R271; Ossadtchi A, 2018, NEUROIMAGE, V183, P950, DOI 10.1016/j.neuroimage.2018.08.031; Palva JM, 2018, NEUROIMAGE, V173, P632, DOI 10.1016/j.neuroimage.2018.02.032; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Pascual-marqui RD, 2017, INNOVATIONS ORTHOGON, P1; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Rizkallah J, 2019, BIORXIV, DOI [10.1101/617118, DOI 10.1101/617118]; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Shen YZ, 2012, J GEODESY, V86, P597, DOI 10.1007/s00190-012-0542-y; Pereira SS, 2017, BRAIN CONNECT, V7, P541, DOI 10.1089/brain.2017.0525; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Vallarino E, 2019, 2 STEP ESTIMATION CR, P1; Wang SH, 2018, NEUROIMAGE, V173, P610, DOI 10.1016/j.neuroimage.2018.01.056; Wens V, 2015, HUM BRAIN MAPP, V36, P4604, DOI 10.1002/hbm.22943; Wens V, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012823	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242715	10.1371/journal.pone.0242715	http://dx.doi.org/10.1371/journal.pone.0242715			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306719	gold, Green Published			2022-12-26	WOS:000600144200069
J	Kim, W; Lee, H; Chung, YD				Kim, Wooil; Lee, Hyubjin; Chung, Yon Dohn			Safe contact tracing for COVID-19: A method without privacy breach using functional encryption techniques based-on spatio-temporal trajectory data	PLOS ONE			English	Article								The COVID-19 pandemic has spread all over the globe. In the absence of a vaccine, a small number of countries have managed to control the diffusion of viruses by early detection and early quarantine. South Korea, one of the countries which have kept the epidemics well-controlled, has opened the infected patients' trajectory to the public. Such a reaction has been regarded as an effective method, however, serious privacy breach cases have been issued in South Korea. Furthermore, some suspected contacts have refused to take infection tests because they are afraid of being exposed. To solve this problem, we propose a privacy-preserving contact tracing method based on spatio-temporal trajectory which can be practically used in many quarantine systems. In addition, we develop a system to visualize the contact tracing workflow.	[Kim, Wooil; Lee, Hyubjin; Chung, Yon Dohn] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea	Korea University	Chung, YD (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.	ydchung@korea.ac.kr			MSIT (Ministry of Science and ICT), Korea, under the ICT Creative Consilience program [IITP-2020-0-01819]; National Research Foundation of Korea [NRF-2020K2A9A1A01095894]	MSIT (Ministry of Science and ICT), Korea, under the ICT Creative Consilience program; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by a grant from the MSIT (Ministry of Science and ICT), Korea, under the ICT Creative Consilience program (IITP-2020-0-01819) supervised by the IITP (Institute for Information & communications Technology Planning & Evaluation) for WK, HL and YDC, and under the framework of international cooperation program managed by the National Research Foundation of Korea (NRF-2020K2A9A1A01095894) for WK and YDC.	[Anonymous], 2020, UPD COVID 19 REP KOR; [Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, TIMES; [Anonymous], 2020, TIMES NY; Boneh D, 2011, LECT NOTES COMPUT SC, V6597, P253, DOI 10.1007/978-3-642-19571-6_16; Canetti R., 2020, ANONYMOUS COLLOCATIO; Carreno B., 2020, REUTERS 0311; Douriez M, 2016, PROCEEDINGS OF 3RD IEEE/ACM INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS, (DSAA 2016), P140, DOI 10.1109/DSAA.2016.21; goverment agency S, 2020, TRACETOGETHER; He H, 2020, EFFICIENT SUSPECTED; Information SV, 2020, SCHENG AR CRIS EU ST; Jazeera A, 2020, JAZEERA A; Journal WS, 2020, J WS; Kim S, 2018, LECT NOTES COMPUT SC, V11035, P544, DOI 10.1007/978-3-319-98113-0_29; Li Y, 2019, PROCEEDINGS OF THE 2019 ACM ASIA CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (ASIACCS '19), P134, DOI 10.1145/3321705.3329829; Troncoso C., 2020, ARXIV; Wikipedia, 2020, COVID 19 PAND; World Health Organization, 2020, MENT HLTH PSYCH CONS; Yu Y.W., 2020, ARXIV PREPRINT ARXIV	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0242758	10.1371/journal.pone.0242758	http://dx.doi.org/10.1371/journal.pone.0242758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306698	Green Submitted, gold, Green Published			2022-12-26	WOS:000600144200071
J	Bloom, K; Karunanidhi, A; Tobita, K; Hoppel, C; Thiels, E; Peet, E; Wang, YD; Basu, S; Vockley, J				Bloom, Kaitlyn; Karunanidhi, Anuradha; Tobita, Kimimasa; Hoppel, Charles; Thiels, Edda; Peet, Eloise; Wang, Yudong; Basu, Shrabani; Vockley, Jerry			ACAD10 protein expression and Neurobehavioral assessment of Acad10-deficient mice	PLOS ONE			English	Article							GAIT DYNAMICS	Acyl-CoA dehydrogenase 10 (Acad10)-deficient mice develop impaired glucose tolerance, peripheral insulin resistance, and abnormal weight gain. In addition, they exhibit biochemical features of deficiencies of fatty acid oxidation, such as accumulation of metabolites consistent with abnormal mitochondrial energy metabolism and fasting induced rhabdomyolysis. ACAD10 has significant expression in mouse brain, unlike other acyl-CoA dehydrogenases (ACADs) involved in fatty acid oxidation. The presence of ACAD10 in human tissues was determined using immunohistochemical staining. To characterize the effect of ACAD10 deficiency on the brain, micro-MRI and neurobehavioral evaluations were performed. Acad10-deficient mouse behavior was examined using open field testing and DigiGait analysis for changes in general activity as well as indices of gait, respectively. ACAD10 protein was shown to colocalize to mitochondria and peroxisomes in lung, muscle, kidney, and pancreas human tissue. Acad10-deficient mice demonstrated subtle behavioral abnormalities, which included reduced activity and increased time in the arena perimeter in the open field test. Mutant animals exhibited brake and propulsion metrics similar to those of control animals, which indicates normal balance, stability of gait, and the absence of significant motor impairment. The lack of evidence for motor impairment combined with avoidance of the center of an open field arena and reduced vertical and horizontal exploration are consistent with a phenotype characterized by elevated anxiety. These results implicate ACAD10 function in normal mouse behavior, which suggests a novel role for ACAD10 in brain metabolism.	[Bloom, Kaitlyn; Karunanidhi, Anuradha; Tobita, Kimimasa; Wang, Yudong; Basu, Shrabani; Vockley, Jerry] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Hoppel, Charles] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Thiels, Edda; Peet, Eloise] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Thiels, Edda; Peet, Eloise] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Vockley, Jerry] UPMC Childrens Hosp Pittsburgh, Ctr Rare Dis Therapy, Pittsburgh, PA 15224 USA; [Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vockley, J (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA.; Vockley, J (corresponding author), UPMC Childrens Hosp Pittsburgh, Ctr Rare Dis Therapy, Pittsburgh, PA 15224 USA.; Vockley, J (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA.	gerard.vockley@chp.edu	Wang, Yudong/ABG-1086-2021; Vockley, Jerry/B-5210-2016	Wang, Yudong/0000-0003-3224-4555; Basu, Shrabani/0000-0001-5096-5490; Vockley, Jerry/0000-0002-8180-6457; Bloom, Kaitlyn/0000-0002-3218-5842	NIH [R01 DK109907]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by NIH grant R01 DK109907. JV received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berryman ER, 2009, J MUSCULOSKEL NEURON, V9, P89; Bian L, 2010, DIABETOLOGIA, V53, P1349, DOI 10.1007/s00125-010-1695-y; Bloom K, 2018, J INHERIT METAB DIS, V41, P49, DOI 10.1007/s10545-017-0013-y; Chen JT, 2015, MOL GENET GENOMICS, V290, P699, DOI 10.1007/s00438-014-0954-x; Gould S, 2009, IEEE I CONF COMP VIS, P1, DOI 10.1109/ICCV.2009.5459211; Hallak JA, 2019, JAMA OPHTHALMOL, V137, P738, DOI 10.1001/jamaophthalmol.2019.0868; Hampton TG, 2004, PHYSIOL BEHAV, V82, P381, DOI 10.1016/j.physbeh.2004.04.006; He MA, 2011, MOL GENET METAB, V102, P418, DOI 10.1016/j.ymgme.2010.12.005; Hong MG, 2013, HUM MUTAT, V34, P515, DOI 10.1002/humu.22267; Lamprea MR, 2008, BRAZ J MED BIOL RES, V41, P135, DOI 10.1590/S0100-879X2008000200010; Lehninger N, 1982, PRINCIPLES BIOCH, V2nd; Minkler PE, 2015, MOL GENET METAB, V116, P231, DOI 10.1016/j.ymgme.2015.10.002; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Swigonova Z, 2009, J MOL EVOL, V69, P176, DOI 10.1007/s00239-009-9263-0; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Vockley J., 2016, ONLINE METABOLIC MOL; Vockley J, ACAD10 11 GRANT RENE; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Wu JW, 2019, J CELL BIOCHEM, V120, P1773, DOI 10.1002/jcb.27481; Ye X, 2004, MOL BIOL REP, V31, P191, DOI 10.1023/B:MOLE.0000043622.57408.6b	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242445	10.1371/journal.pone.0242445	http://dx.doi.org/10.1371/journal.pone.0242445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301490	Green Published, gold			2022-12-26	WOS:000600143100080
J	Okawara, M; Nagata, T; Nagata, M; Otani, M; Mori, K; Fujino, Y				Okawara, Makoto; Nagata, Tomohisa; Nagata, Masako; Otani, Makoto; Mori, Koji; Fujino, Yoshihisa			Association between the course of hypnotics treatment for insomnia and work functioning impairment in Japanese workers	PLOS ONE			English	Article							HEALTH; PRODUCTIVITY; COST	Study objectives This cross-sectional study analyzed the effect of treatment with hypnotics for sleep disorders, particularly insomnia, on daytime work functioning by phase of treatment in Japanese workers. Methods Subjects were respondents (n = 36,375) to a questionnaire survey conducted in 2015 to assess work functioning impairment in 15 companies in Japan. The questionnaire results were analyzed together with the respondents' healthcare data extracted from public health insurance claims. Work functioning impairment was measured using the Work Functioning Impairment Scale (WFun). The status of treatment for insomnia was determined using data on diseases and prescribed drugs extracted from health insurance claims from the past 16 months. The odds ratio of severe work functioning impairment according to on-treatment duration and off-treatment duration was estimated using logistic regression analysis. Results The risk of severe work functioning impairment was significantly higher in subjects with insomnia who were being treated with hypnotics for 1 month or longer compared to non-insomnia subjects. This increased risk tended to be reduced with longer on-treatment duration. For subjects who had previously received hypnotics treatment for insomnia, the risk of severe work functioning impairment was significantly increased in all subgroups stratified by time from discontinuation of the prescription. This increased risk tended to be reduced with longer off-treatment duration. Conclusions Workers who are or were receiving hypnotics to treat insomnia may have a higher risk of daytime functioning impairment. Those with protracted insomnia require careful assessment of the risks and benefits of prescription hypnotics.	[Okawara, Makoto; Fujino, Yoshihisa] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan; [Nagata, Tomohisa; Nagata, Masako; Mori, Koji] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Occupat Hlth Practice & Management, Kitakyushu, Fukuoka, Japan; [Otani, Makoto] Univ Occupat & Environm Hlth, Data Sci Ctr Occupat Hlth, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Okawara, M (corresponding author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan.	makotouoeh@med.uoeh-u.ac.jp	Okawara, Makoto/AAG-2516-2022; Okawara, Makoto/ACJ-5728-2022	Okawara, Makoto/0000-0002-2777-743X; Okawara, Makoto/0000-0002-2777-743X	JSPS KAKENHI [JP 18K10079]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 18K10079. This grant was awarded to Yoshihisa Fujino. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K10079/The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2000, J EPIDEMIOL, V10, P79; DiBonaventura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137117; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fujino Y, 2015, J OCCUP HEALTH, V57, P521, DOI 10.1539/joh.15-0135-OA; Goetzel RZ, 2004, J OCCUP ENVIRON MED, V46, P398, DOI 10.1097/01.jom.0000121151.40413.bd; Ishak Waguih W, 2012, Innov Clin Neurosci, V9, P13; Kim K, 2000, SLEEP, V23, P41; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; Mishima Kazuo, 2015, Nihon Rinsho, V73, P1036; Nagata T, 2018, J OCCUP ENVIRON MED, V60, pE273, DOI 10.1097/JOM.0000000000001291; Nagata T, 2017, J OCCUP ENVIRON MED, V59, P557, DOI 10.1097/JOM.0000000000001025; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rosekind MR, 2010, J OCCUP ENVIRON MED, V52, P91, DOI 10.1097/JOM.0b013e3181c78c30; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Staner L, 2005, PSYCHOPHARMACOLOGY, V181, P790, DOI 10.1007/s00213-005-0082-8; Takemura S, 2007, GERIATR MED, V45, P679; Takeshima N, 2016, PSYCHIAT RES, V237, P201, DOI 10.1016/j.psychres.2016.01.040; 2005, EVANGELIKUS ELET, V43, P3	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243635	10.1371/journal.pone.0243635	http://dx.doi.org/10.1371/journal.pone.0243635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301520	gold, Green Published			2022-12-26	WOS:000600143100028
J	Oluoch-Aridi, J; Adam, MB; Wafula, F; K'okwaro, G				Oluoch-Aridi, Jackline; Adam, Mary B.; Wafula, Francis; K'okwaro, Gilbert			Eliciting women's preferences for place of child birth at a peri-urban setting in Nairobi, Kenya: A discrete choice experiment	PLOS ONE			English	Article							MATERNAL HEALTH-SERVICES; DELIVERY; CARE	Objective Maternal and newborn mortality rates are high in peri-urban areas in cities in Kenya, yet little is known about what drives women's decisions on where to deliver. This study aimed at understanding women's preferences on place of childbirth and how sociodemographic factors shape these preferences. Methods This study used a Discrete Choice Experiment (DCE) to quantify the relative importance of attributes on women's choice of place of childbirth within a peri-urban setting in Nairobi, Kenya. Participants were women aged 18-49 years, who had delivered at six health facilities. The DCE consisted of six attributes: cleanliness, availability of medical equipment and drug supplies, attitude of healthcare worker, cost of delivery services, the quality of clinical services, distance and an opt-out alternative. Each woman received eight questions. A conditional logit model established the relative strength of preferences. A mixed logit model was used to assess how women's preferences for selected attributes changed based on their sociodemographic characteristics. Results 411 women participated in the Discrete Choice Experiment, a response rate of 97.6% and completed 20,080 choice tasks. Health facility cleanliness was found to have the strongest association with choice of health facility (beta = 1.488 p<0.001) followed respectively by medical equipment and supplies availability (beta = 1.435 p<0.001). The opt-out alternative (beta = 1.424 p<0.001) came third. The attitude of the health care workers (beta = 1.347, p<0.001), quality of clinical services (beta = 0.385, p<0.001), distance (beta = 0.339, p<0.001) and cost (beta = 0.0002 p<0.001) were ranked 4(th) to 7(th) respectively. Women who were younger and were the main income earners having a stronger preference for clean health facilities. Older married women had stronger preference for availability of medical equipment and kind healthcare workers. Conclusions Women preferred both technical and process indicators of quality of care. DCE's can lead to the development of person-centered strategies that take into account the preferences of women to improve maternal and newborn health outcomes.	[Oluoch-Aridi, Jackline; Adam, Mary B.; Wafula, Francis; K'okwaro, Gilbert] Strathmore Univ, Inst Healthcare Management, Nairobi, Kenya; [Oluoch-Aridi, Jackline] Univ Notre Dame, Ford Family Program Human Dev Studies & Solidar, Kellogg Inst Int Studies, Notre Dame, IN 46556 USA; [Adam, Mary B.] AIC Hosp, Maternal Newborn Community Hlth, Kijabe, Kenya	Strathmore University; University of Notre Dame	Oluoch-Aridi, J (corresponding author), Strathmore Univ, Inst Healthcare Management, Nairobi, Kenya.; Oluoch-Aridi, J (corresponding author), Univ Notre Dame, Ford Family Program Human Dev Studies & Solidar, Kellogg Inst Int Studies, Notre Dame, IN 46556 USA.	Jackline.A.Oluoch-Aridi1@nd.edu	Oluoch-Aridi, Jackline/AFV-3364-2022	Oluoch-Aridi, Jackline/0000-0002-8456-6735; Wafula, Francis/0000-0002-5761-6151; Adam, Mary/0000-0002-0791-4791	Kellogg Institute of International	Kellogg Institute of International	This study was funded by the Kellogg Institute of International studies by a grant to the corresponding author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123606; African Population and Health Research Center (APHRC), 2014, POP HLTH DYN NAIR IN, P1; Afulani PA, 2019, LANCET, V394, P1692, DOI 10.1016/S0140-6736(19)32258-5; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2016, AM J HLTH SYST PH S2; [Anonymous], 2014, INT J AMBIENT SYST A, V2, P11, DOI DOI 10.5121/IJASA.2014.2402; [Anonymous], 2016, J GERIATR CARDIOL; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; Banke-Thomas A, 2017, SEX REPROD HEALTHC, V12, P37, DOI 10.1016/j.srhc.2017.02.004; Bazant ES, 2009, INT J QUAL HEALTH C, V21, P79, DOI 10.1093/intqhc/mzn058; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Bourbonnais N, 2013, KENYA NATL COMM HUM, P3; Calhoun LM, 2018, MATERN CHILD HLTH J, V22, P409, DOI 10.1007/s10995-017-2408-7; Chen A, 2014, ASSESSING QUALITY PR; Echoka Elizabeth, 2014, Pan Afr Med J, V17 Suppl 1, P4, DOI 10.11694/pamj.supp.2014.17.1.3042; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Fotso JC, 2009, MATERN CHILD HLTH J, V13, P130, DOI 10.1007/s10995-008-0326-4; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gitimu A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0442-2; Hanson K, 2005, HEALTH ECON, V14, P687, DOI 10.1002/hec.959; Hensher DA, 2015, APPLIED CHOICE ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9781316136232; Honda A, 2015, HEALTH POLICY PLANN, V30, P600, DOI 10.1093/heapol/czu038; Huber J, 1996, J MARKETING RES, V33, P307, DOI 10.2307/3152127; Izugbara CO, 2009, PUBLIC HEALTH REP, V124, P585, DOI 10.1177/003335490912400416; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Jewkes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122001; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Lang'at E, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0048-1; Larson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135621; Leslie HH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002464; Louviere JJ, 2011, J CHOICE MODEL, V4, P1; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; McFadden D, 1973, FRONTIERS ECONOMETRI; Ministry of Security and Public Administration, 2014, KEN QUAL MOD HLTH EM, P1; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; National Bureau of Statistics Nairobi Kenya, 2015, KEN DEM HLTH SURV 20; Oluoch-Aridi J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-036966; Orme B, 2010, GETTING STARTED CONJ; Owili PO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177756; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sharma J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171236; Tama E, 2018, INT J HEALTH POLICY, V7, P603, DOI 10.15171/ijhpm.2017.135; Tomedi A, 2013, INT J GYNECOL OBSTET, V120, P152, DOI 10.1016/j.ijgo.2012.09.013; United Nations, 2015, 2030 AG SUST DEV; Wamalwa EW, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.375.6708; Warren CE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1288-6; World Health Organization department of reproductive health and research, 2004, MAK PREGN SAF CRIT R, P1; Ziraba A. K., 2009, REPROD HLTH, V6, P1	53	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0242149	10.1371/journal.pone.0242149	http://dx.doi.org/10.1371/journal.pone.0242149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0WB	33301447	Green Published, gold			2022-12-26	WOS:000600143100035
J	Wang, Y; Yalcin, A; VandeWeerd, C				Wang, Yan; Yalcin, Ali; VandeWeerd, Carla			An entropy-based approach to the study of human mobility and behavior in private homes	PLOS ONE			English	Article								Understanding human mobility in outdoor environments is critical for many applications including traffic modeling, urban planning, and epidemic modeling. Using data collected from mobile devices, researchers have studied human mobility in outdoor environments and found that human mobility is highly regular and predictable. In this study, we focus on human mobility in private homes. Understanding this type of human mobility is essential as smart-homes and their assistive applications become ubiquitous. We model the movement of a resident using ambient motion sensor data and construct a chronological symbol sequence that represents the resident's movement trajectory. Entropy rate is used to quantify the regularity of the resident's mobility patterns, and an upper bound of predictability is estimated. However, the presence of visitors and malfunctioning sensors result in data that is not representative of the resident's mobility patterns. We apply a change-point detection algorithm based on penalized contrast function to detect these changes, and to identify the time periods when the data do not completely reflect the resident's activities. Experimental results using the data collected from 10 private homes over periods of 178 to 713 days show that human mobility at home is also highly predictable in the range of 70% independent of variations in floor plans and individual daily routines.	[Wang, Yan] Citibank NA, Tampa, FL USA; [Yalcin, Ali; VandeWeerd, Carla] Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33620 USA; [VandeWeerd, Carla] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL USA; [Wang, Yan] 3800 Citibank Ctr, Tampa, FL USA; [Yalcin, Ali; VandeWeerd, Carla] 4202 E Fowler Ave, Tampa, FL 33620 USA; [VandeWeerd, Carla] 2004 Mowry Rd, Gainesville, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Yalcin, A (corresponding author), Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33620 USA.; Yalcin, A (corresponding author), 4202 E Fowler Ave, Tampa, FL 33620 USA.	ayalcin@usf.edu		Wang, Yan/0000-0002-4999-3686				Abowd G, 2002, WS0202 AAAI; Agoulmine N., 2011, IEEE Nanotechnology Magazine, V5, P6, DOI 10.1109/MNANO.2011.941951; Alam MR, 2012, IEEE T SYST MAN CY C, V42, P1190, DOI 10.1109/TSMCC.2012.2189204; [Anonymous], 2000, Contracept Technol Update, V21, P33; [Anonymous], 2013, POLAR GEOPOLITICS NE, V3, P1, DOI DOI 10.4236/NJGC.2013.31001; [Anonymous], 2010, SCIENCE, V327, P1018; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; [Anonymous], 2005, GENOME BIOL, V6, P1; Austin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090256; Barbosa H, 2018, PHYS REP, V734, P1, DOI 10.1016/j.physrep.2018.01.001; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Cai HX, 2004, IEEE T INFORM THEORY, V50, P1551, DOI 10.1109/TIT.2004.830771; Calenge C, 2011, ANAL ANIMAL MOVEMENT; Chan M, 2009, IFMBE PROC, V23, P1014; CHAN M, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN AND CYBERNETICS, VOLS 1-5, P1586, DOI 10.1109/ICSMC.1995.537998; Cover TM, 1991, ELEMENTS INFORM THEO, P63; Cuttone A, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-017-0129-1; Das S. K., 2014, P 2 INT C SMART HOM, P3; Das SK, 2002, IEEE WIREL COMMUN, V9, P77, DOI 10.1109/MWC.2002.1160085; Deen MJ, 2015, PERS UBIQUIT COMPUT, V19, P573, DOI 10.1007/s00779-015-0856-x; Feuz KD, 2015, IEEE T HUM-MACH SYST, V45, P575, DOI 10.1109/THMS.2014.2362529; Gazeaux J, 2013, J GEOPHYS RES-SOL EA, V118, P2397, DOI 10.1002/jgrb.50152; Ge Y., 2010, PROC 16 ACM SIGKDD I, P899, DOI [10.1145/1835804.1835918, DOI 10.1145/1835804.1835918]; Goulet-Langlois G, 2018, IEEE T INTELL TRANSP, V19, P1583, DOI 10.1109/TITS.2017.2728704; Guande Qi, 2011, 2011 IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops 2011). PerCom-Workshops 2011: 2011 IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops 2011), P384, DOI 10.1109/PERCOMW.2011.5766912; Hao JG, 2016, INT CONF INTEL ENVIR, P103, DOI 10.1109/IE.2016.24; Helal S, 2005, COMPUTER, V38, P50, DOI 10.1109/MC.2005.107; Ikanovic EL, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0107-7; Intille SS, 2006, LECT NOTES COMPUT SC, V3968, P349; Jacobs PG, 2015, J AM ACAD AUDIOL, V26, P777, DOI 10.3766/jaaa.15010; Kaibin Bao, 2011, 2011 Eighth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2011), P1335, DOI 10.1109/FSKD.2011.6019758; Kim J, 2010, P IEEE INT S WORLD W, P14; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Lee D, 2015, IEEE T HUM-MACH SYST, V45, P624, DOI 10.1109/THMS.2015.2443712; Lee S, 2013, IEEE T HUM-MACH SYST, V43, P535, DOI 10.1109/THMS.2013.2285921; Lu CH, 2018, IEEE T HUM-MACH SYST, V48, P380, DOI 10.1109/THMS.2018.2844119; Majumder S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010130; McInerney J, 2013, PERVASIVE MOB COMPUT, V9, P808, DOI 10.1016/j.pmcj.2013.07.016; Mozer M. C., 1998, Intelligent Environments. Papers from the 1998 AAAI Symposium, P110; Niu YS, 2016, STAT SCI, V31, P611, DOI 10.1214/16-STS587; Rantz MJ, 2009, IEEE ENG MED BIO, P6159, DOI 10.1109/IEMBS.2009.5334587; Rao S. P., 2004, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V13, P81, DOI 10.1142/S0218213004001533; Remagnino P, 2005, IEEE T SYST MAN CY A, V35, P1, DOI 10.1109/TSMCA.2004.838456; Romig S., 2017, IEEE INFOCOM 2017 IE, P1, DOI DOI 10.1109/INFOCOM.2017.8057234; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Strang G., 1991, CALCULUS; Stute M, 2017, PROCEEDINGS OF THE 20TH ACM INTERNATIONAL CONFERENCE ON MODELLING, ANALYSIS AND SIMULATION OF WIRELESS AND MOBILE SYSTEMS (MSWIM'17), P219, DOI 10.1145/3127540.3127542; Sur M, 2014, ECOL INFORM, V20, P47, DOI 10.1016/j.ecoinf.2014.01.007; Truong C, 2020, SIGNAL PROCESS, V167, DOI 10.1016/j.sigpro.2019.107299; VandeWeerd C, 2020, HEALTH TECHNOL-GER, V10, P1291, DOI 10.1007/s12553-019-00404-6; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Williams JA, 2017, TECHNOL HEALTH CARE, V25, P89, DOI 10.3233/THC-161255; YAO YC, 1988, STAT PROBABIL LETT, V6, P181, DOI 10.1016/0167-7152(88)90118-6; Zhang SM, 2017, IEEE T HUM-MACH SYST, V47, P814, DOI 10.1109/THMS.2017.2693238; Zhao Z, 2018, TRANSPORT RES B-METH, V112, P73, DOI 10.1016/j.trb.2018.03.017; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677	59	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243503	10.1371/journal.pone.0243503	http://dx.doi.org/10.1371/journal.pone.0243503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301515	gold, Green Published			2022-12-26	WOS:000600143100007
J	Loughney, L; McCaffrey, N; Timon, CM; Grundy, J; McCarren, A; Cahill, R; Moyna, N; Mulsow, J				Loughney, Lisa; McCaffrey, Noel; Timon, Claire M.; Grundy, Joshua; McCarren, Andrew; Cahill, Ronan; Moyna, Niall; Mulsow, Jurgen			Physical, psychological and nutritional outcomes in a cohort of Irish patients with metastatic peritoneal malignancy scheduled for cytoreductive surgery (CRS) and heated intrapertioneal chemotherapy (HIPEC): An exploratory pilot study	PLOS ONE			English	Article							HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; QUALITY-OF-LIFE; COLORECTAL-CANCER; GASTRIC-CANCER; CARCINOMATOSIS; MORBIDITY; EXPERIENCE; MANAGEMENT; STRENGTH; GRIP	Background Treatment for peritoneal malignancy (PM) can include cytoreductive surgery (CRS) and heated intrapertioneal chemotherapy (HIPEC) and is associated with morbidity and mortality. Physical, psychological and nutritional outcomes are important pre-operatively. The aim of this pilot study was to investigate these outcomes in patients with PM before and after CRS-HIPEC. Methods Between June 2018 and November 2019, participants were recruited to a single-centre study. Primary outcome was cardiopulmonary exercise testing (CPET) variables oxygen uptake (VO2) at anaerobic threshold (AT) and at peak. Secondary outcome measures were upper and lower body strength, health related quality of life (HRQoL) and the surgical fear questionnaire. Exploratory outcomes included body mass index, nutrient intake and post-operative outcome. All participants were asked to undertake assessments pre CRS-HIPEC and 12 weeks following the procedure. Results Thirty-nine patients were screened, 38 were eligible and 16 were recruited. Ten female and 6 male, median (IQR) age 53 (42-63) years. Of the 16 patients recruited, 14 proceeded with CRS-HIPEC and 10 competed the follow up assessment at week 12. Pre-operative VO2 at AT and peak was 16.8 (13.7-18) ml.kg(-1).min(-1) and 22.2 (19.3-25.3) ml.kg(-1).min(-1), upper body strength was 25.9 (20.3-41.5) kg, lower body strength was 14 (10.4-20.3) sec, HRQoL (overall health status) was 72.5 (46.3-80) % whilst overall surgical fear was 39 (30.5-51). The VO2 at AT decreased significantly (p = 0.05) and HRQoL improved (p = 0.04) between pre and post- CRS-HIPEC. There were no significant differences for any of the other outcome measures. Conclusion This pilot study showed a significant decrease in VO2 at AT and an improvement in overall HRQoL at the 12 week follow up. The findings will inform a larger study design to investigate a prehabilitation and rehabilitation cancer survivorship programme.	[Loughney, Lisa; McCaffrey, Noel] ExWell Med, Dublin, Ireland; [Loughney, Lisa; McCaffrey, Noel; Moyna, Niall] Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland; [Loughney, Lisa] Royal Coll Surgeons Ireland, Dublin, Ireland; [Timon, Claire M.] Dublin City Univ, Sch Nursing Psychotherapy & Community Hlth, Dublin, Ireland; [Grundy, Joshua; Mulsow, Jurgen] Mater Misericordiae Univ Hosp Dublin, Natl Ctr Peritoneal Malignancy, Dublin, Ireland; [McCarren, Andrew] Dublin City Univ, Dept Comp, Dublin, Ireland; [Cahill, Ronan] Mater Misericordiae Univ Hosp, Dept Colorectal Surg, Dublin, Ireland	Dublin City University; Royal College of Surgeons - Ireland; Dublin City University; Mater Misericordiae University Hospital; University College Dublin; Dublin City University; Mater Misericordiae University Hospital; University College Dublin	Loughney, L (corresponding author), ExWell Med, Dublin, Ireland.; Loughney, L (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland.; Loughney, L (corresponding author), Royal Coll Surgeons Ireland, Dublin, Ireland.	lisa.loughney@gmail.com	Timon, Claire/AAW-1695-2021; McCarren, Andrew/AAE-2724-2021	Cahill, Ronan/0000-0002-1270-4000; McCarren, Andrew/0000-0002-7297-0984; Timon, Claire M/0000-0002-5778-6003				Albertsmeier M, 2014, DIGEST SURG, V31, P334, DOI 10.1159/000369259; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015; Ashvin R, 2016, INDIA J SURG ONCOL, V7, P208, DOI 10.1007/s13193-016-0514-4; Baratti D, 2016, CRIT REV ONCOL HEMAT, V100, P209, DOI 10.1016/j.critrevonc.2016.01.017; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bohannon Richard W, 2019, J Phys Ther Sci, V31, P75, DOI 10.1589/jpts.31.75; Chen CH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-98; Chua TC, 2009, ANN SURG, V249, P900, DOI 10.1097/SLA.0b013e3181a45d86; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cortes-Guiral D, 2021, EJSO-EUR J SURG ONC, V47, P60, DOI 10.1016/j.ejso.2020.01.032; Cushen SJ, 2015, TOP CLIN NUTR, V30, P103, DOI 10.1097/TIN.0000000000000023; Davies SJ, 2004, BRIT J ANAESTH, V93, P121, DOI 10.1093/bja/aeh164; Custodio IDD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157113; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Feingold PL, 2016, J GASTROINTEST ONCOL, V7, P87, DOI 10.3978/j.issn.2078-6891.2015.098; Gillis C, 2015, ANESTHESIOLOGY, V123, P1455, DOI 10.1097/ALN.0000000000000795; Glehen O, 2004, J CLIN ONCOL, V22, P3284, DOI 10.1200/JCO.2004.10.012; Grocott MPW, 2007, J CLIN EPIDEMIOL, V60, P919, DOI 10.1016/j.jclinepi.2006.12.003; Guazzi M, 2017, J AM COLL CARDIOL, V70, P1618, DOI 10.1016/j.jacc.2017.08.012; Hompes D, 2012, ANN SURG ONCOL, V19, P2186, DOI 10.1245/s10434-012-2264-z; Hopkinson J, 2018, ASIA-PAC J ONCOL NUR, V5, P358, DOI 10.4103/apjon.apjon_12_18; Huber M, 2020, EUROPEAN J SURG ONCO, DOI [10.1016/j.ejso.2020.07.041, DOI 10.1016/J.EJS0.2020.07.041]; Institute of Medicine, 2010, DIETARY REFERENCE IN; Institute of Medicine, 2006, ESSENTIAL GUIDE NUTR, DOI [10.17226/11537, DOI 10.17226/11537, DOI 10.17226/11537.HTTPS://WWW.NAL.USDA.GOV/SITES/DEFAULT/FILES/FNIC_UPLOADS/DRIESSENTIALGUIDENUTREQ.PDF]; Lee L, 2014, SURGERY, V155, P211, DOI 10.1016/j.surg.2013.10.002; Leimkuhler M, 2020, ANN SURG ONCOL, V27, P3973, DOI 10.1245/s10434-020-08379-9; Levett DZH, 2019, ANAESTHESIA, V74, P36, DOI 10.1111/anae.14507; Levine EA, 2007, J AM COLL SURGEONS, V204, P943, DOI 10.1016/j.jamcollsurg.2006.12.048; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Moran J, 2016, BRIT J ANAESTH, V116, P177, DOI 10.1093/bja/aev454; Ozalevli S, 2007, RESP MED, V101, P286, DOI 10.1016/j.rmed.2006.05.007; Paap D, 2014, EXPERT REV CARDIOVAS, V12, P1439, DOI 10.1586/14779072.2014.985657; Pamela K, 2018, J GASTROINTEST SURG, V22, P884, DOI 10.1007/s11605-017-3661-1; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sato T, 2016, GASTRIC CANCER, V19, P1008, DOI 10.1007/s10120-015-0554-4; Schwedhelm C, 2016, NUTR REV, V74, P737, DOI 10.1093/nutrit/nuw045; Theunissen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162737; Timon CM, 2016, NUTR RES REV, V29, P268, DOI 10.1017/S0954422416000172; Trepanier M, 2019, ANN SURG, V270, P493, DOI 10.1097/SLA.0000000000003465; Tsilimparis N, 2013, ANN SURG ONCOL, V20, P226, DOI 10.1245/s10434-012-2579-9; van Rooijen SJ, 2019, AM J PHYS MED REHAB, V98, P888, DOI 10.1097/PHM.0000000000001221; Vashi PG, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-118; Vrinten C, 2017, PSYCHO-ONCOLOGY, V26, P1070, DOI 10.1002/pon.4287; Wasserman K, 2005, PRINCIPLES EXERCISE, P1; Weber T, 2012, CLIN COLORECTAL CANC, V11, P167, DOI 10.1016/j.clcc.2012.01.001; Weimann A, 2017, CLIN NUTR, V36, P623, DOI 10.1016/j.clnu.2017.02.013	48	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242816	10.1371/journal.pone.0242816	http://dx.doi.org/10.1371/journal.pone.0242816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296392	gold, Green Accepted, Green Published			2022-12-26	WOS:000598626100028
J	Mattila, HR; Otis, GW; Nguyen, LTP; Pham, HD; Knight, OM; Phan, NT				Mattila, Heather R.; Otis, Gard W.; Nguyen, Lien T. P.; Pham, Hanh D.; Knight, Olivia M.; Phan, Ngoc T.			Honey bees (Apis cerana) use animal feces as a tool to defend colonies against group attack by giant hornets (Vespa soror)	PLOS ONE			English	Article							MELLIFERA-CYPRIA; SHIELD DEFENSE; MASS ATTACK; HOST-PLANT; HYMENOPTERA; BEHAVIOR; VELUTINA; VESPIDAE; EVOLUTION; BEETLE	Honey bees (genus Apis) are well known for the impressive suite of nest defenses they have evolved to protect their abundant stockpiles of food and the large colonies they sustain. In Asia, honey bees have evolved under tremendous predatory pressure from social wasps in the genus Vespa, the most formidable of which are the giant hornets that attack colonies in groups, kill adult defenders, and prey on brood. We document for the first time an extraordinary collective defense used by Apis cerana against the giant hornet Vespa soror. In response to attack by V. soror, A. cerana workers foraged for and applied spots of animal feces around their nest entrances. Fecal spotting increased after colonies were exposed either to naturally occurring attacks or to chemicals that scout hornets use to target colonies for mass attack. Spotting continued for days after attacks ceased and occurred in response to V. soror, which frequently landed at and chewed on entrances to breach nests, but not Vespa velutina, a smaller hornet that rarely landed at entrances. Moderate to heavy fecal spotting suppressed attempts by V. soror to penetrate nests by lowering the incidence of multiple-hornet attacks and substantially reducing the likelihood of them approaching and chewing on entrances. We argue that A. cerana forages for animal feces because it has properties that repel this deadly predator from nest entrances, providing the first report of tool use by honey bees and the first evidence that they forage for solids that are not derived from plants. Our study describes a remarkable weapon in the already sophisticated portfolio of defenses that honey bees have evolved in response to the predatory threats they face. It also highlights the strong selective pressure honey bees will encounter if giant hornets, recently detected in western North America, become established.	[Mattila, Heather R.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Otis, Gard W.; Knight, Olivia M.] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Nguyen, Lien T. P.] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Insect Ecol Dept, Hanoi, Vietnam; [Pham, Hanh D.] Natl Inst Anim Sci, Bee Res Ctr, Hanoi, Vietnam; [Phan, Ngoc T.] Vietnam Natl Univ Agr, Res Ctr Trop Bees & Beekeeping, Hanoi, Vietnam; [Knight, Olivia M.] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal; [Phan, Ngoc T.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Wellesley College; University of Guelph; Vietnam Academy of Science & Technology (VAST); Vietnam National University of Agriculture (VNUA); Fundacao Champalimaud; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mattila, HR (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	hmattila@wellesley.edu		Phan, Ngoc/0000-0001-6003-6265	National Geographic Society Committee for Research and Exploration [9338-13]; Vietnam Academy of Science and Technology [KHCBSS.01/18-20]; Wellesley College (Knafel Chair in the Natural Sciences); Wellesley College (Science Center Summer Research Program); Wellesley College (Faculty Award for open-access publication)	National Geographic Society Committee for Research and Exploration(National Geographic Society); Vietnam Academy of Science and Technology; Wellesley College (Knafel Chair in the Natural Sciences); Wellesley College (Science Center Summer Research Program); Wellesley College (Faculty Award for open-access publication)	Funding for this study was provided by the National Geographic Society Committee for Research and Exploration (grant number 9338-13; to GWO, HRM, LTPN, HDP), the Vietnam Academy of Science and Technology (grant number KHCBSS.01/18-20; to LTPN), and Wellesley College (Knafel Chair in the Natural Sciences, the Science Center Summer Research Program, and a Faculty Award for open-access publication; to HRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol DP, 2012, CURR SCI INDIA, V102, P1350; Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; ALCOCK J, 1972, EVOLUTION, V26, P464, DOI 10.1111/j.1558-5646.1972.tb01950.x; Amoroso CR, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-019-2769-6; [Anonymous], 2009, QUADERNO CCP, V1, P18; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Arca M, 2014, BEHAV PROCESS, V106, P122, DOI 10.1016/j.beproc.2014.05.002; ARCHER ME, 1993, ENTOMOL SCAND, V24, P469; Archer Michael E., 1995, Entomologist's Monthly Magazine, V131, P47; BAUMGARTNER DL, 1989, J KANSAS ENTOMOL SOC, V62, P11; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Bentley-Condit VK, 2010, BEHAVIOUR, V147, P185, DOI 10.1163/000579509X12512865686555; Bernays EA, 2000, J INSECT PHYSIOL, V46, P825, DOI 10.1016/S0022-1910(99)00172-9; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Britton NF, 2007, B MATH BIOL, V69, P957, DOI 10.1007/s11538-006-9178-5; Brodmann J, 2009, CURR BIOL, V19, P1368, DOI 10.1016/j.cub.2009.06.067; Butler CG, 1940, J EXP BIOL, V17, P253; Byers JA, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1288-1; Carpenter James M., 1997, Natural History Bulletin of Ibaraki University, V1, P51; Cobey S, 2020, ASIAN GIANT HORNET V; Conti B, 2012, PARASITOL RES, V110, P2013, DOI 10.1007/s00436-011-2730-8; Couto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115943; Crain B. J., 2013, INT J COMP PSYCHOL, V26, P281, DOI DOI 10.5811/WESTJEM.2011.5.6700; Curtis VA, 2014, TRENDS IMMUNOL, V35, P457, DOI 10.1016/j.it.2014.08.006; Dainat B, 2020, APIDOLOGIE, V51, P422, DOI 10.1007/s13592-019-00728-2; DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; DYER FC, 1991, ECOLOGY, V72, P156, DOI 10.2307/1938911; FUCHS S, 1974, Apidologie, V5, P271, DOI 10.1051/apido:19740304; Fuchs S, 2011, HONEYBEES OF ASIA, P369, DOI 10.1007/978-3-642-16422-4_17; Fujiwara A, 2018, ENTOMOL SCI, V21, P93, DOI 10.1111/ens.12285; Fujiwara A, 2016, APIDOLOGIE, V47, P789, DOI 10.1007/s13592-016-0432-z; Gomez NE, 1999, J CHEM ECOL, V25, P1007, DOI 10.1023/A:1020821507014; Graczyk TK, 2005, CLIN MICROBIOL REV, V18, P128, DOI 10.1128/CMR.18.1.128-132.2005; Gruter C, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0200; Hansell M, 2008, TRENDS ECOL EVOL, V23, P73, DOI 10.1016/j.tree.2007.10.006; HERRERA CM, 1990, BEE WORLD, V71, P67, DOI 10.1080/0005772X.1990.11099039; Kandemir I, 2012, J APICULT RES, V51, P169, DOI 10.3896/IBRA.1.51.2.04; Kastberger G, 2003, BEHAV RES METH INS C, V35, P429, DOI 10.3758/BF03195520; Kastberger G, 2014, NATURWISSENSCHAFTEN, V101, P861, DOI 10.1007/s00114-014-1220-0; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Keefover-Ring K, 2013, CHEMOECOLOGY, V23, P1, DOI 10.1007/s00049-012-0117-7; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; Kirchner WH, 1999, INSECT SOC, V46, P239, DOI 10.1007/s000400050140; Kishi S, 2017, APPL ENTOMOL ZOOL, V52, P361, DOI 10.1007/s13355-017-0506-z; KOENIGER N, 1975, Zeitschrift fuer Tierpsychologie, V37, P99; Koeniger N, 1996, APIDOLOGIE, V27, P341, DOI 10.1051/apido:19960502; Kozak P, 2020, BEE CULTURE, V148, P85; Lau PW, 2016, J EXP BIOL, V219, P790, DOI 10.1242/jeb.132019; Levey DJ, 2004, NATURE, V431, P39, DOI 10.1038/431039a; Lien NTP, 2002, J NEW YORK ENTOMOL S, V110, P199, DOI 10.1664/0028-7199(2002)110[0199:VOVIHV]2.0.CO;2; Lorenzon M. C. A., 2005, Braz. J. Biol., V65, P291, DOI 10.1590/S1519-69842005000200013; Makino S, 2010, SOCIOBIOLOGY, V56, P283; MARTIN SJ, 1992, INSECT SOC, V39, P99, DOI 10.1007/BF01240534; MATHEW KP, 1990, BEE WORLD, V71, P61, DOI 10.1080/0005772X.1990.11099038; MATSUURA M, 1988, APPL ENTOMOL ZOOL, V23, P428, DOI 10.1303/aez.23.428; MATSUURA M, 1973, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V19, P125; Matsuura M., 1984, B FAC AGR MEIJI U, V69, P1; McClenaghan B, 2019, J APICULT RES, V58, P141, DOI 10.1080/00218839.2018.1494917; Mhatre N, 2018, ETHOLOGY, V124, P691, DOI 10.1111/eth.12773; Monceau K, 2013, APIDOLOGIE, V44, P209, DOI 10.1007/s13592-012-0172-7; Morton TC, 1998, J CHEM ECOL, V24, P765, DOI 10.1023/A:1022382931766; Ngamo TLS, 2007, AFR J AGRIC RES, V2, P164; Nguyen LTP, 2006, ZOOL SCI, V23, P95, DOI 10.2108/zsj.23.95; Nogueira-de-Sa F, 2005, J TROP ECOL, V21, P189, DOI 10.1017/S0266467404002147; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; ONO M, 1987, EXPERIENTIA, V43, P1031, DOI 10.1007/BF01952231; Papachristoforou A, 2008, APIDOLOGIE, V39, P468, DOI 10.1051/apido:2008027; Papachristoforou A, 2007, CURR BIOL, V17, pR795, DOI 10.1016/j.cub.2007.07.033; Perrard A, 2013, J HYMENOPT RES, V32, P1, DOI 10.3897/JHR.32.4685; PIERCE JD, 1986, FLA ENTOMOL, V69, P95, DOI 10.2307/3494748; Pirk CWW, 2011, J COMP PHYSIOL B, V181, P353, DOI 10.1007/s00360-010-0530-6; Pusceddu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180278; Radloff SE, 2010, APIDOLOGIE, V41, P589, DOI 10.1051/apido/2010008; Robinson WS, 2013, J APICULT RES, V52, P160, DOI 10.3896/IBRA.1.52.3.08; Sakagami S. F., 1960, Acta Hymenopterologica, V1, P171; SCHNEIDER P, 1971, Zeitschrift fuer Tierpsychologie, V29, P337; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Sen Sarma M, 2002, ZOOLOGY, V105, P215, DOI 10.1078/0944-2006-00064; SHAH FA, 1991, BEE WORLD, V72, P161, DOI 10.1080/0005772X.1991.11099099; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Smith-Pardo AH, 2020, INSECT SYST DIVER, V4, DOI 10.1093/isd/ixaa006; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Sub An Goon, 2010, UNDERSTANDING SENSOR, V22, P281; Sugahara M, 2009, NATURWISSENSCHAFTEN, V96, P1133, DOI 10.1007/s00114-009-0575-0; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002423; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; van Lawick-Goodall J., 1970, Adv. Stud. Behav., V3, P195; Vencl FV, 1998, CHEMOECOLOGY, V8, P25, DOI 10.1007/PL00001800; Vencl FV, 2009, J CHEM ECOL, V35, P281, DOI 10.1007/s10886-008-9577-1; Vencl FV, 1999, J CHEM ECOL, V25, P549, DOI 10.1023/A:1020905920952; Wang ZW, 2014, INSECT SOC, V61, P67, DOI 10.1007/s00040-013-0326-2; WILLE A, 1983, ANNU REV ENTOMOL, V28, P41, DOI 10.1146/annurev.en.28.010183.000353; Wille A., 1973, Revista Biol trop, V21, P1; Wilson TM, 2020, ANN ENTOMOL SOC AM, V113, P468, DOI 10.1093/aesa/saaa024; Winston M.L., 1991, BIOL HONEY BEE; Zhu GP, 2020, P NATL ACAD SCI USA, V117, P24646, DOI 10.1073/pnas.2011441117	98	10	10	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242668	10.1371/journal.pone.0242668	http://dx.doi.org/10.1371/journal.pone.0242668			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296376	gold, Green Published			2022-12-26	WOS:000598626100024
J	Milojevic-Dupont, N; Hans, N; Kaack, LH; Zumwald, M; Andrieux, F; Soares, DD; Lohrey, S; Pichler, PP; Creutzig, F				Milojevic-Dupont, Nikola; Hans, Nicolai; Kaack, Lynn H.; Zumwald, Marius; Andrieux, Francois; de Barros Soares, Daniel; Lohrey, Steffen; Pichler, Peter-Paul; Creutzig, Felix			Learning from urban form to predict building heights	PLOS ONE			English	Article							3D CITY MODELS; ENERGY USE; DENSITY; FRAMEWORK	Understanding cities as complex systems, sustainable urban planning depends on reliable high-resolution data, for example of the building stock to upscale region-wide retrofit policies. For some cities and regions, these data exist in detailed 3D models based on real-world measurements. However, they are still expensive to build and maintain, a significant challenge, especially for small and medium-sized cities that are home to the majority of the European population. New methods are needed to estimate relevant building stock characteristics reliably and cost-effectively. Here, we present a machine learning based method for predicting building heights, which is based only on open-access geospatial data on urban form, such as building footprints and street networks. The method allows to predict building heights for regions where no dedicated 3D models exist currently. We train our model using building data from four European countries (France, Italy, the Netherlands, and Germany) and find that the morphology of the urban fabric surrounding a given building is highly predictive of the height of the building. A test on the German state of Brandenburg shows that our model predicts building heights with an average error well below the typical floor height (about 2.5 m), without having access to training data from Germany. Furthermore, we show that even a small amount of local height data obtained by citizens substantially improves the prediction accuracy. Our results illustrate the possibility of predicting missing data on urban infrastructure; they also underline the value of open government data and volunteered geographic information for scientific applications, such as contextual but scalable strategies to mitigate climate change.	[Milojevic-Dupont, Nikola; Creutzig, Felix] Tech Univ Berlin, Chair Sustainabil Econ, Sch Planning Bldg & Environm, Berlin, Germany; [Milojevic-Dupont, Nikola; Lohrey, Steffen; Creutzig, Felix] Mercator Res Inst Global Commons & Climate Change, Working Grp Land Use Infrastruct & Transport, Berlin, Germany; [Hans, Nicolai] Humboldt Univ, Appl Stat, Sch Business & Econ, Berlin, Germany; [Kaack, Lynn H.] Swiss Fed Inst Technol, Dept Humanities, Energy Polit Grp, Social & Polit Sci, Zurich, Switzerland; [Zumwald, Marius] Swiss Fed Inst Technol, Dept Environm Syst Sci, Weather & Climate Risk Grp, Zurich, Switzerland; [Zumwald, Marius] Swiss Fed Inst Technol, Dept Environm Syst Sci, Climate Phys Grp, Zurich, Switzerland; [Andrieux, Francois; de Barros Soares, Daniel] Nam R, Paris, France; [Pichler, Peter-Paul] Potsdam Inst Climate Impact Res PIK, FutureLab Social Metab & Impacts, Potsdam, Germany	Technical University of Berlin; Humboldt University of Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Potsdam Institut fur Klimafolgenforschung	Milojevic-Dupont, N (corresponding author), Tech Univ Berlin, Chair Sustainabil Econ, Sch Planning Bldg & Environm, Berlin, Germany.; Milojevic-Dupont, N (corresponding author), Mercator Res Inst Global Commons & Climate Change, Working Grp Land Use Infrastruct & Transport, Berlin, Germany.	milojevic@mcc-berlin.net	Creutzig, Felix/B-8691-2016; Lohrey, Steffen/AAB-1656-2021	Creutzig, Felix/0000-0002-5710-3348; Lohrey, Steffen/0000-0001-7881-9102; Milojevic-Dupont, Nikola/0000-0001-6641-1978; Pichler, Peter-Paul/0000-0001-6708-5748	German Research Foundation; TU Berlin	German Research Foundation(German Research Foundation (DFG)); TU Berlin	We acknowledge support by the German Research Foundation and the Open Access Publication Fund of TU Berlin. The authors D.d.B.S and F.A are employed by a commercial company Nam.R, but they did not receive specific funding for their work within this study.	Bai XM, 2018, NATURE, V555, P19, DOI 10.1038/d41586-018-02409-z; Barrington-Leigh C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180698; Behnisch M, 2019, LANDSCAPE URBAN PLAN, V191, DOI 10.1016/j.landurbplan.2019.103631; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Berlin Senate Department for Urban Development, 2014, 3D GEBAUD BERL; Biljecki F., 2017, ISPRS ANN PHOTOGRAMM, VIV-4/W5, P17, DOI [10.5194/isprs-annals-IV-4-W5-17-2017, DOI 10.5194/ISPRS-ANNALS-IV-4-W5-17-2017]; Biljecki F, 2017, COMPUT ENVIRON URBAN, V64, P1, DOI 10.1016/j.compenvurbsys.2017.01.001; Biljecki F, 2015, ISPRS INT GEO-INF, V4, P2842, DOI 10.3390/ijgi4042842; Boeing G, 2020, ENVIRON PLAN B-URBAN, V47, P590, DOI 10.1177/2399808318784595; Boeing G, 2017, COMPUT ENVIRON URBAN, V65, P126, DOI 10.1016/j.compenvurbsys.2017.05.004; Bordeaux Metropole (France), 2020, MOD AGGL 3D; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brest Metropole (France), 2020, MOD TERR 3D; Brovelli MA, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7080289; Bruyns GJB, 2021, URBAN STUD, V58, P922, DOI 10.1177/0042098020936970; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Creutzig F., 2019, Global Sustainability, V2, pe1, DOI 10.1017/sus.2018.15; Creutzig F, 2020, TRANSPORT REV, V40, P711, DOI 10.1080/01441647.2020.1762795; Creutzig F, 2016, NAT CLIM CHANGE, V6, P1054, DOI 10.1038/nclimate3169; Dukai BB, 2018, 3D REGISTRATION BUIL; Dutch State, 2018, WIJ BOUWB; Fan HC, 2014, INT J GEOGR INF SCI, V28, P700, DOI 10.1080/13658816.2013.867495; Fleischmann M., 2019, J OPEN SOURCE SOFTWA, V4, P1807, DOI 10.21105/joss.01807; French State, 2019, COD CONSTR HAB ART R; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Froemelt A, 2020, J IND ECOL, V24, P639, DOI 10.1111/jiec.12969; Guneralp B, 2017, P NATL ACAD SCI USA, V114, P8945, DOI 10.1073/pnas.1606035114; Klemmer K, 2019, ARXIV190509796; Klemmer K, 2020, ARXIV200610461; Kontokosta CE, 2017, APPL ENERG, V197, P303, DOI 10.1016/j.apenergy.2017.04.005; Land Schleswig-Holstein (Germany), 2009, LAND LAND SCHLESW HO; Landesvermessung und Geobasisinformation Brandenburg, 2020, 3D GEB BRAND; Lobo J., 2020, SSRN ELECT J, DOI DOI 10.2139/SSRN.3526992; Louf R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0924; Marz A, 2019, ARXIV190703178; Masson V, 2020, URBAN CLIM, V31, DOI 10.1016/j.uclim.2019.100536; Metropole de Lyon (France), 2020, MAQ 3D TEXT COMM ARR; Meyer H, 2021, METHODS ECOL EVOL, V12, P1620, DOI 10.1111/2041-210X.13650; Meyer H, 2019, ECOL MODEL, V411, DOI 10.1016/j.ecolmodel.2019.108815; Ministero della della sanita (Italy), 1975, DECR MIN 5 LUGL 1975; Montpellier Mediterranee Metropole (France), 2020, PHOT 3D URB VILL MON; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Publieke Dienstverlening Op de Kaart (Netherlands), 2020, BAS KAD BRK; Reinhart CF, 2016, BUILD ENVIRON, V97, P196, DOI 10.1016/j.buildenv.2015.12.001; Rey S. J., 2010, HDB APPL SPATIAL ANA, P175, DOI [10.1007/978-3-642-03647-7_11, DOI 10.1007/978-3-642-03647-7_11]; Rolnick D., 2019, CORR; Schroter K, 2018, ENVIRON MODELL SOFTW, V105, P118, DOI 10.1016/j.envsoft.2018.03.032; Sikder SK, 2018, URBAN CLIM, V26, P10, DOI 10.1016/j.uclim.2018.08.004; Silva M, 2018, SUSTAIN CITIES SOC, V40, P372, DOI 10.1016/j.scs.2018.01.028; Silva M, 2017, J PLAN LIT, V32, P346, DOI 10.1177/0885412217706900; Silva MC, 2017, APPL ENERG, V202, P386, DOI 10.1016/j.apenergy.2017.05.113; Sturrock HJW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204399; Ville et eurometropole de Strasbourg (France), 2020, MAQ 3D NUM SEM TERR; Zeppelzauer M, 2018, ICMR '18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA RETRIEVAL, P126, DOI 10.1145/3206025.3206060; Zhou Q, 2018, INT J GEOGR INF SCI, V32, P257, DOI 10.1080/13658816.2017.1395883; Zhu D, 2020, INT J GEOGR INF SCI, V34, P735, DOI 10.1080/13658816.2019.1599122; Zhu Z, 2019, REMOTE SENS ENVIRON, V228, P164, DOI 10.1016/j.rse.2019.04.020	58	14	14	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242010	10.1371/journal.pone.0242010	http://dx.doi.org/10.1371/journal.pone.0242010			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296369	Green Published, gold			2022-12-26	WOS:000598626100003
J	Jimenez-Toro, I; Rodriguez, CA; Zuluaga, AF; Otalvaro, JD; Vesga, O				Jimenez-Toro, Ivone; Rodriguez, Carlos A.; Zuluaga, Andres F.; Otalvaro, Julian D.; Vesga, Omar			A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone	PLOS ONE			English	Article							EXPERIMENTAL ENDOCARDITIS; INFECTIVE ENDOCARDITIS; ANTIMICROBIAL THERAPY; FAECALIS; GENTAMICIN; EFFICACY; RESISTANT; PHARMACOKINETICS; MANAGEMENT; IMPACT	The combination of ampicillin (AMP) and ceftriaxone (CRO) is considered synergistic against Enterococcus faecalis based on in vitro tests and the rabbit endocarditis model, however, in vitro assays are limited by the use of fixed antibiotic concentrations and the rabbit model by poor bacterial growth, high variability, and the use of point dose-effect estimations, that may lead to inaccurate assessment of antibiotic combinations and hinder optimal translation. Here, we tested AMP+CRO against two strains of E. faecalis and one of E. faecium in an optimized mouse thigh infection model that yields high bacterial growth and allows to define the complete dose-response relationship. By fitting Hill's sigmoid model and estimating the parameters maximal effect (E-max) and effective dose 50 (ED50), the following interactions were defined: synergism (E-max increase >= 2 log(10) CFU/g), antagonism (E-max reduction >= 1 log(10) CFU/g) and potentiation (ED50 reduction >= 50% without changes in E-max). AMP monotherapy was effective against the three strains, yielding valid dose-response curves in terms of dose and the index fT(>MIC). CRO monotherapy showed no effect. The combination AMP+CRO against E. faecalis led to potentiation (59-81% ED50 reduction) and not synergism (no changes in E-max). Against E. faecium, the combination was indifferent. The optimized mouse infection model allowed to obtain the complete dose-response curve of AMP+CRO and to define its interaction based on pharmacodynamic parameter changes. Integrating these results with the pharmacokinetics will allow to derive the PK/PD index bound to the activity of the combination, essential for proper translation to the clinic.	[Jimenez-Toro, Ivone; Rodriguez, Carlos A.; Zuluaga, Andres F.; Vesga, Omar] Univ Antioquia, Sch Med, GRIPE, Medellin, Colombia; [Jimenez-Toro, Ivone; Rodriguez, Carlos A.; Zuluaga, Andres F.; Otalvaro, Julian D.] Univ Antioquia, Sch Med, Integrated Lab Specialized Med LIME, Medellin, Colombia; [Vesga, Omar] Hosp Univ San Vicente FDN, Infect Dis Unit, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Rodriguez, CA (corresponding author), Univ Antioquia, Sch Med, GRIPE, Medellin, Colombia.; Rodriguez, CA (corresponding author), Univ Antioquia, Sch Med, Integrated Lab Specialized Med LIME, Medellin, Colombia.	andres.rodriguez@udea.edu.co	Zuluaga, Andres F./K-7366-2016; Rodriguez, Carlos A./P-8324-2019	Zuluaga, Andres F./0000-0001-5656-4153; Rodriguez, Carlos A./0000-0002-4042-4313; Vesga, Omar/0000-0002-4308-7930; Otalvaro, Julian David/0000-0001-5202-1645	Minciencias (Colombian Ministry of Science and Technology) [111571149738]; 785 National PhD Scholarship 2017; University of Antioquia	Minciencias (Colombian Ministry of Science and Technology); 785 National PhD Scholarship 2017; University of Antioquia	This project was funded by Minciencias (Colombian Ministry of Science and Technology), grant 111571149738 (AFZ, CAR) and 785 National PhD Scholarship 2017 (IJT), and by the University of Antioquia. www.minciencias.gov.co www.udea.edu.co The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose PG, 2007, CLIN INFECT DIS, V44, P79, DOI 10.1086/510079; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Beganovic M, 2018, CLIN INFECT DIS, V67, P303, DOI 10.1093/cid/ciy064; Bhagunde P, 2012, ANTIMICROB AGENTS CH, V56, P2237, DOI 10.1128/AAC.06113-11; CARBON C, 1993, J ANTIMICROB CHEMOTH, V31, P71, DOI 10.1093/jac/31.suppl_D.71; CARON F, 1991, J INFECT DIS, V164, P888, DOI 10.1093/infdis/164.5.888; CDC. U. S. Department of Health and Human Services Centers for Disease Control and Prevention, 2013, ANNUAL REPORT TO CON, P65; Clinical and Laboratory Standards Institute, 1999, METHODS DETERMINING; CLSI, 2020, M100 PERF STAND ANT, V30th; Crass RL, 2019, PHARMACOTHERAPY, V39, P182, DOI 10.1002/phar.2210; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Fernandez-Hidalgo N, 2013, CLIN INFECT DIS, V56, P1261, DOI 10.1093/cid/cit052; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Gavalda J, 1999, ANTIMICROB AGENTS CH, V43, P639, DOI 10.1128/AAC.43.3.639; Gavalda J, 2003, J ANTIMICROB CHEMOTH, V52, P514, DOI 10.1093/jac/dkg360; Gilmore MS, 2003, SCIENCE, V299, P1999, DOI 10.1126/science.1083534; Jimenez-Toro I, 2018, ASM MICROBE; Jimenez-Toro I, 2019, REV CHIL INFECTOL, V36, P551, DOI [10.4067/S0716-10182019000500551, DOI 10.4067/S0716-10182019000500551]; Kak V, 2000, ANTIMICROB AGENTS CH, V44, P2545, DOI 10.1128/AAC.44.9.2545-2546.2000; Leone S, 2016, INFECTION, V44, P273, DOI 10.1007/s15010-015-0836-0; Lorenzo MP, 2019, J ANTIMICROB CHEMOTH, V74, P2269, DOI 10.1093/jac/dkz173; MAINARDI JL, 1995, ANTIMICROB AGENTS CH, V39, P1984, DOI 10.1128/AAC.39.9.1984; Miro JM, 2013, CIRCULATION, V127, P1763, DOI 10.1161/CIRCULATIONAHA.113.002431; Neely MN, 2012, THER DRUG MONIT, V34, P467, DOI 10.1097/FTD.0b013e31825c4ba6; Pasticci Maria Bruna, 2008, Open Microbiol J, V2, P79, DOI 10.2174/1874285800802010079; Pericas JM, 2017, J ANTIMICROB CHEMOTH, V72, P1714, DOI 10.1093/jac/dkx016; Pillai SK, 2005, ANTIBIOTICS LAB MED, V5, P365; Rodriguez CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155806; Rodriguez CA, 2017, INT J ANTIMICROB AG, V49, P189, DOI 10.1016/j.ijantimicag.2016.10.011; Rodriguez CA, 2015, ANTIMICROB AGENTS CH, V59, P233, DOI 10.1128/AAC.02352-13; Soto E, 2014, BRIT J CLIN PHARMACO, V77, P509, DOI 10.1111/bcp.12232; VANOGTROP ML, 1992, ANTIMICROB AGENTS CH, V36, P2375, DOI 10.1128/AAC.36.11.2375; Winterton G., 1998, FEDERAL LAW REV, V26, P1, DOI 10.22145/flr.26.1.1; Zuluaga A, 2004, THERAPEUTIC EQUIVALE; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55; Zuluaga AF, 2014, CLIN INFECT DIS, V59, P459, DOI 10.1093/cid/ciu306; Zuluaga AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010744	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243365	10.1371/journal.pone.0243365	http://dx.doi.org/10.1371/journal.pone.0243365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290425	Green Published, gold			2022-12-26	WOS:000598620100011
J	Liu, B; Davies, K; Hall, A				Liu, Bo; Davies, Keith; Hall, Avice			Silicon builds resilience in strawberry plants against both strawberry powdery mildew Podosphaera aphanis and two-spotted spider mites Tetranychus urticae	PLOS ONE			English	Article							POTASSIUM SILICATE; BIOCONTROL AGENTS; RESISTANCE; TRANSPORT; ACARI; GROWTH	Silicon is found in all plants and the accumulation of silicon can improve plant tolerance to biotic stress. Strawberry powdery mildew (Podosphaera aphanis) and two-spotted spider mite (Tetranychus urticae) are both detrimental to strawberry production worldwide. Two field trials were done on a UK commercial strawberry farm in 2014 and 2015, to assess the effects of silicon nutrient applied via the fertigation system on P. aphanis and T. urticae. The silicon treatments decreased the severity of both P. aphanis and T. urticae in two consecutive years on different cultivars. The percentage leaf area infected with P. aphanis mycelium from silicon treated plants were 2.19 (in 2014) and 0.41 (in 2015) compared with 3.08 (in 2014) and 0.57 (in 2015) from the untreated plants. The etiology of the pathogen as measured by the Area Under the Disease Progress Curve from silicon (with and without fungicides) treatments was 152.7 compared with 217.5 from non-silicon (with and without fungicides) treatments for the overall period of 2014-2015. The average numbers of T. urticae recorded on strawberry leaves were 1.43 (in 2014) and 1.83 (in 2015) in plants treated with silicon compared with 8.82 (in 2014) and 6.69 (in 2015) in untreated plants. The silicon contents of the leaves from the silicon alone treatment were 26.8 mu g mg(-1) (in 2014) and 22.2 mu g mg(-1) (in 2015) compared with 19.7 mu g mg(-1) (in 2014) and 21.4 mu g mg(-1) (in 2015) from the untreated. The silicon nutrient root application contributed to improved plant resilience against P. aphanis and T. urticae. Silicon could play an important role in broad spectrum control of pests and diseases in commercial strawberry production.	[Liu, Bo; Davies, Keith; Hall, Avice] Univ Hertfordshire, Sch Life & Med Sci, Dept Clin Pharmaceut & Biol Sci, Hatfield, Herts, England; [Davies, Keith] Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway	University of Hertfordshire; Norwegian Institute of Bioeconomy Research	Liu, B (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Dept Clin Pharmaceut & Biol Sci, Hatfield, Herts, England.	b.liu7@herts.ac.uk		Davies, Keith/0000-0001-6060-2394; LIU, BO/0000-0001-5896-9074	Orion Future Technology Ltd	Orion Future Technology Ltd	The author B.L.'s PhD study was mainly self-funded, with an additional funding (no more than 15 percent of the overall funding) provided by Orion Future Technology Ltd (http://orionft.com).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ali S, 2013, ECOTOX ENVIRON SAFE, V89, P66, DOI 10.1016/j.ecoenv.2012.11.015; [Anonymous], 2004, 50 UBC, V50, P11; Dagli F, 2001, PEST MANAG SCI, V57, P609, DOI 10.1002/ps.334; Dallagnol LJ, 2012, PLANT PATHOL, V61, P323, DOI 10.1111/j.1365-3059.2011.02518.x; Dallagnol LJ, 2014, TROP PLANT PATHOL, V39, P56, DOI [10.1590/S1982-56762014005000003, http://dx.doi.org/10.1590/s1982-56762014005000003]; de Camacaro MEP, 2002, J AM SOC HORTIC SCI, V127, P901, DOI 10.21273/JASHS.127.6.901; Debona D, 2017, ANNU REV PHYTOPATHOL, V55, P85, DOI 10.1146/annurev-phyto-080516-035312; Dodgson JLA, 2007, THESIS; ELLIOTT CL, 1991, J AGR FOOD CHEM, V39, P1118, DOI 10.1021/jf00006a024; Epstein E, 2009, ANN APPL BIOL, V155, P155, DOI 10.1111/j.1744-7348.2009.00343.x; Fasulo Thomas R., 2009, 2 SPOTTED SPIDER MIT; Fatema K., 2014, THESIS; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Fountain MT, 2010, CROP PROT, V29, P1286, DOI 10.1016/j.cropro.2010.06.016; Green JR, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P66; Hall AM, 2016, SF62; Jin X., 2016, THESIS; Jin XiaoLei, 2013, Aspects of Applied Biology, P151; Kanto Takeshi, 2006, Journal of General Plant Pathology, V72, P137, DOI 10.1007/s10327-005-0270-8; Klingen I, 2007, BIOL CONTROL, V43, P222, DOI 10.1016/j.biocontrol.2007.07.013; Korndorfer AP, 2011, NEOTROP ENTOMOL, V40, P387, DOI 10.1590/S1519-566X2011000300013; Livinali E, 2014, ELECTRON J BIOTECHN, V17, P193, DOI 10.1016/j.ejbt.2014.06.002; Lovelidge B, 2010, HORTICULTURE WE 0312; Lucas J.A., 1998, PLANT PATHOLOGY PLAN; Lv C, 2009, FIFTH INTERNATIONAL CONFERENCE ON INFORMATION ASSURANCE AND SECURITY, VOL 2, PROCEEDINGS, P19, DOI 10.1109/IAS.2009.49; Ma JF, 2008, CELL MOL LIFE SCI, V65, P3049, DOI 10.1007/s00018-008-7580-x; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Ma JF, 2015, TRENDS PLANT SCI, V20, P435, DOI 10.1016/j.tplants.2015.04.007; Ma JF, 2011, P JPN ACAD B-PHYS, V87, P377, DOI 10.2183/pjab.87.377; Ma JF, 2010, ADV EXP MED BIOL, V679, P99; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Pertot I, 2008, CROP PROT, V27, P622, DOI 10.1016/j.cropro.2007.09.004; Pozza Edson Ampélio, 2015, Rev. Ceres, V62, P323, DOI 10.1590/0034-737X201562030013; Prischmann DA, 2005, BIOL CONTROL, V33, P324, DOI 10.1016/j.biocontrol.2005.03.008; Ranger CM, 2009, ENVIRON ENTOMOL, V38, P129, DOI 10.1603/022.038.0116; Sakr N., 2016, Hellenic Plant Protection Journal, V9, P1, DOI 10.1515/hppj-2016-0001; Tesfagiorgis HB, 2014, BIOL CONTROL, V73, P8, DOI 10.1016/j.biocontrol.2014.03.010; Tubaa BS, 2015, SILICON PLANT DIS, P7, DOI [DOI 10.1007/978-3-319-22930-0_2, 10.1007/978-3-319-22930-0_2]; Wang M, 2017, FRONT PLANT SCI, P8, DOI [10.3389/fpls.2017.00008, DOI 10.3389/FPLS.2017.00008]	40	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0241151	10.1371/journal.pone.0241151	http://dx.doi.org/10.1371/journal.pone.0241151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290389	Green Published, gold			2022-12-26	WOS:000598620100025
J	Bi, RJ; Zhou, C; Jiao, Y				Bi, Rujia; Zhou, Can; Jiao, Yan			Detection of fish movement patterns across management unit boundaries using age-structured Bayesian hierarchical models with tag-recovery data	PLOS ONE			English	Article							YELLOW PERCH; STOCK ASSESSMENT; LAKE-ERIE; POPULATION-DYNAMICS; SPATIALLY EXPLICIT; CROSS-VALIDATION; MORTALITY-RATES; SHEDDING RATES; SAMPLE-SIZES; RECAPTURE	Tagging studies have been widely conducted to investigate the movement pattern of wild fish populations. In this study, we present a set of length-based, age-structured Bayesian hierarchical models to explore variabilities and uncertainties in modeling tag-recovery data. These models fully incorporate uncertainties in age classifications of tagged fish based on length and uncertainties in estimated population structure. Results of a tagging experiment conducted by the Ontario Ministry of Natural Resources and Forestry (OMNRF) on yellow perch in Lake Erie was analyzed as a case study. A total of 13,694 yellow perch were tagged with PIT tags from 2009 to 2015; 322 of these were recaptured in the Ontario commercial gillnet fishery and recorded by OMNRF personnel. Different movement configurations modeling the tag-recovery data were compared, and all configurations revealed that yellow perch individuals in the western basin (MU1) exhibited relatively strong site fidelity, and individuals from the central basin (MU2 and MU3) moved within this basin, but their movements to the western basin (MU1) appeared small. Model with random effects of year and age on movement had the best performance, indicating variations in movement of yellow perch across the lake among years and age classes. This kind of model is applicable to other tagging studies to explore temporal and age-class variations while incorporating uncertainties in age classification.	[Bi, Rujia; Zhou, Can; Jiao, Yan] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Bi, RJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	rbi@vt.edu		Bi, Rujia/0000-0002-1954-6797; Zhou, Can/0000-0003-4533-5333	 [458000]		This work was supported by a grant #458000 awarded to YJ by Ontario Commercial Fisheries' Association (https://www.ocfa.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin N.A., 2009, COMMERCIAL FISH PROD; Barrowman NJ, 1996, BIOMETRICS, V52, P1410, DOI 10.2307/2532854; BERKES F, 1987, T AM FISH SOC, V116, P494, DOI 10.1577/1548-8659(1987)116<494:QMAPP>2.0.CO;2; Beverton R.J.H., 1957, FISH INVEST LONDON S, V19; Bi RJ, 2019, CAN J FISH AQUAT SCI, V76, P217, DOI 10.1139/cjfas-2017-0526; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Brownie C., 1985, RESOURCE PUBLICATION, V156; Coggins LG, 2013, T AM FISH SOC, V142, P832, DOI 10.1080/00028487.2013.768550; Denwood MJ, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i09; Dieckmann U, 1999, TRENDS ECOL EVOL, V14, P88, DOI 10.1016/S0169-5347(98)01571-7; Eveson JP, 2009, ENVIRON ECOL STAT SE, V3, P987, DOI 10.1007/978-0-387-78151-8_45; Farmer TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8724; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; Fridriksson A., 1934, RAPPORTS PROCES VERB, V86, P1; Gelman A., 1992, BAYESIAN STAT, V4, P625; Gelman A., 2014, BAYESIAN DATA ANAL, VThird; Gillanders BM, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P457, DOI 10.1007/978-90-481-2406-0_13; GLERL (Great Lakes Environmental Research Laboratory), DAT WAT LEV IC COV S; Goethel DR, 2017, CAN J FISH AQUAT SCI, V74, P1878, DOI 10.1139/cjfas-2016-0290; Goethel DR, 2015, ICES J MAR SCI, V72, P164, DOI 10.1093/icesjms/fsu014; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; Hampton J, 2001, MAR FRESHWATER RES, V52, P937, DOI 10.1071/MF01049; Harrison Susan, 1994, P111; Hestbeck JB, 1995, J APPL STAT, V22, P737, DOI 10.1080/02664769524586; Hightower JE, 2013, AM FISH S S, V80, P249; HILBORN R, 1990, CAN J FISH AQUAT SCI, V47, P635, DOI 10.1139/f90-071; Hulson PJF, 2017, FISH B-NOAA, V115, P326, DOI 10.7755/FB.115.3.4; Imbrock F, 1996, J FISH BIOL, V49, P1; Joe M, 2002, J APPL STAT, V29, P373, DOI 10.1080/02664760120108836; Kaemingk MA, 2011, N AM J FISH MANAGE, V31, P726, DOI 10.1080/02755947.2011.611863; Kendall WL, 2009, ENVIRON ECOL STAT SE, V3, P765, DOI 10.1007/978-0-387-78151-8_35; KIRKWOOD GP, 1984, AUST J MAR FRESH RES, V35, P601; Latour R.J., 2005, MANAGEMENT TECHNIQUE, P45; Li Y, 2018, THESIS; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Maunder MN, 1998, THESIS; NCAR (National Center for Atmospheric Research), 2019, CLIM DAT GUID HURR N; Palkovacs EP, 2014, EVOL APPL, V7, P212, DOI 10.1111/eva.12111; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pine WE, 2012, FISHERIES TECHNIQUES, THIRD EDITION, P521; Plummer M., 2003, P 3 INT WORKSHOP DIS; Polacheck T, 2006, CAN J FISH AQUAT SCI, V63, P534, DOI 10.1139/f05-232; POLLOCK KH, 1991, AM FISH S S, V12, P423; Punt AE, 2000, MAR FRESHWATER RES, V51, P205, DOI 10.1071/MF99124; R Core Team, 2021, R LANGUAGE ENV STAT; REGIER HA, 1973, SCIENCE, V180, P1248, DOI 10.1126/science.180.4092.1248; Royle J. A., 2008, HIERARCHICAL MODELIN; Ryan PA, 2003, SPECIAL PUBLICATIONS, V03-02; Sepulveda-Villet OJ, 2011, CAN J FISH AQUAT SCI, V68, P1435, DOI 10.1139/F2011-077; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Thorsteinsson V, 2002, CT961394 FAIR CT MAR; Tzadik OE, 2015, PEERJ, V3, DOI 10.7717/peerj.1010; Vandergoot CS, 2014, T AM FISH SOC, V143, P188, DOI 10.1080/00028487.2013.837095; Vehtari A., 2016, LOO EFFICIENT LEAVE; Vehtari A., 2015, PARETO SMOOTHED IMPO; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; WHITESIDE MC, 1985, ENVIRON BIOL FISH, V12, P47, DOI 10.1007/BF00007709; Wilberg MJ, 2005, N AM J FISH MANAGE, V25, P1130, DOI 10.1577/M04-193.1; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; YPTG, 2016, REPORT LAKE ERIE YEL; YPTG, 2015, REPORT LAKE ERIE YEL; Yu H, 2011, T AM FISH SOC, V140, P905, DOI 10.1080/00028487.2011.599258	65	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243423	10.1371/journal.pone.0243423	http://dx.doi.org/10.1371/journal.pone.0243423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284798	Green Published, gold			2022-12-26	WOS:000597930500003
J	Sauvat, L; Hamid, AIA; Blavignac, C; Josse, J; Lesens, O; Gueirard, P				Sauvat, Leo; Hamid, Aizat Iman Abdul; Blavignac, Christelle; Josse, Jerome; Lesens, Olivier; Gueirard, Pascale			Biofilm-coated microbeads and the mouse ear skin: An innovative model for analysing anti-biofilm immune response in vivo	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BIOFILMS	Owing to its ability to form biofilms, Staphylococcus aureus is responsible for an increasing number of infections on implantable medical devices. The aim of this study was to develop a mouse model using microbeads coated with S. aureus biofilm to simulate such infections and to analyse the dynamics of anti-biofilm inflammatory responses by intravital imaging. Scanning electron microscopy and flow cytometry were used in vitro to study the ability of an mCherry fluorescent strain of S. aureus to coat silica microbeads. Biofilm-coated microbeads were then inoculated intradermally into the ear tissue of LysM-EGFP transgenic mice (EGFP fluorescent immune cells). General and specific real-time inflammatory responses were studied in ear tissue by confocal microscopy at early (4-6h) and late time points (after 24h) after injection. The displacement properties of immune cells were analysed. The responses were compared with those obtained in control mice injected with only microbeads. In vitro, our protocol was capable of generating reproducible inocula of biofilm-coated microbeads verified by labelling matrix components, observing biofilm ultrastructure and confirmed in vivo and in situ with a matrix specific fluorescent probe. In vivo, a major inflammatory response was observed in the mouse ear pinna at both time points. Real-time observations of cell recruitment at injection sites showed that immune cells had difficulty in accessing biofilm bacteria and highlighted areas of direct interaction. The average speed of cells was lower in infected mice compared to control mice and in tissue areas where direct contact between immune cells and bacteria was observed, the average cell velocity and linearity were decreased in comparison to cells in areas where no bacteria were visible. This model provides an innovative way to analyse specific immune responses against biofilm infections on medical devices. It paves the way for live evaluation of the effectiveness of immunomodulatory therapies combined with antibiotics.	[Sauvat, Leo; Hamid, Aizat Iman Abdul; Lesens, Olivier; Gueirard, Pascale] Univ Clermont Auvergne, Lab Microorganismes Genome & Environm, UMR CNRS 6023, Clermont Ferrand, France; [Sauvat, Leo; Lesens, Olivier] CHU Clermont Ferrand, Infect & Trop Dis Dept, CRMVT, CRIOA, Clermont Ferrand, France; [Blavignac, Christelle] Univ Clermont Auvergne, Ctr Imagerie Cellulaire Sante, Clermont Ferrand, France; [Josse, Jerome] Univ Claude Bernard Lyon 1, Univ Lyon, CIRI Ctr Int Rech Infectiol, Inserm,U1111,CNRS,UMR5308,Ecole Normale Super Lyo, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gueirard, P (corresponding author), Univ Clermont Auvergne, Lab Microorganismes Genome & Environm, UMR CNRS 6023, Clermont Ferrand, France.	pascale.gueirard@uca.fr			(Auvergne Rhones Alpes Region)	(Auvergne Rhones Alpes Region)	PG Pack research Ambition 2017-IMMUNOFILM-Staph project (Auvergne Rhones Alpes Region) https://aaprecherche.auvergnerhonealpes.fr/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino R, 2007, NAT PROTOC, V2, P1705, DOI 10.1038/nprot.2007.120; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2017, REV LATINO AM ENTERM, V25, pe2847, DOI 10.1590/1518-8345.1610.2847; [Anonymous], 2019, NAT SURV PREV NOS IN; Arciola CR, 2018, NAT REV MICROBIOL, V16, P397, DOI 10.1038/s41579-018-0019-y; Chan WT, 2017, INT J NANOMED, V12, P3421, DOI 10.2147/IJN.S126823; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crabbe A, 2008, ENVIRON MICROBIOL, V10, P2098, DOI 10.1111/j.1462-2920.2008.01631.x; Dakheel KH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4708425; de Vor L, 2020, FEBS LETT, V594, P2556, DOI 10.1002/1873-3468.13767; Dorhoi A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01895; Forestier C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02309; Hamid AIA, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-019-1635-z; Heim CE, 2014, J IMMUNOL, V192, P3778, DOI 10.4049/jimmunol.1303408; Jamal M, 2018, J CHIN MED ASSOC, V81, P7, DOI 10.1016/j.jcma.2017.07.012; Jauregui RG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01082; Josse J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01602; Kobayashi SD, 2015, AM J PATHOL, V185, P1518, DOI 10.1016/j.ajpath.2014.11.030; Konrat K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157663; Le KY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00359; Lindeque B, 2014, ORTHOPEDICS, V37, P257, DOI 10.3928/01477447-20140401-08; Del Pozo JL, 2018, EXPERT REV ANTI-INFE, V16, P51, DOI 10.1080/14787210.2018.1417036; Mac-Daniel L, 2016, JOVE-J VIS EXP, DOI 10.3791/53796; Nishitani K, 2015, J ORTHOP RES, V33, P1311, DOI 10.1002/jor.22907; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Oliveira WF, 2018, J HOSP INFECT, V98, P111, DOI 10.1016/j.jhin.2017.11.008; Peel TN, 2013, CLIN MICROBIOL INFEC, V19, P181, DOI 10.1111/j.1469-0691.2011.03758.x; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Scherr TD, 2015, MBIO, V6, DOI 10.1128/mBio.01021-15; Sultan AR, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00352-18; Suresh MK, 2019, INT J MED MICROBIOL, V309, P1, DOI 10.1016/j.ijmm.2018.11.002; Svensson CM, 2018, CYTOM PART A, V93A, P357, DOI 10.1002/cyto.a.23249; Tasse J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31437-y; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; van Gennip M, 2012, INFECT IMMUN, V80, P2601, DOI 10.1128/IAI.06215-11; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65	40	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243500	10.1371/journal.pone.0243500	http://dx.doi.org/10.1371/journal.pone.0243500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275636	Green Published, gold			2022-12-26	WOS:000597150200005
J	Slattery, M; Attard, H; Stewart, V; Roennfeldt, H; Wheeler, AJ				Slattery, Maddy; Attard, Hayley; Stewart, Victoria; Roennfeldt, Helena; Wheeler, Amanda J.			Participation in creative workshops supports mental health consumers to share their stories of recovery: A one-year qualitative follow-up study	PLOS ONE			English	Article							ART; PEOPLE; EXPERIENCES	Participation in creative activities has been linked with positive outcomes for people with mental illness. This longitudinal qualitative study is a one-year follow-up of eight mental health consumers who participated in a series of creative workshops in Brisbane, Australia that aimed to increase participants' capacity and skills in sharing their stories of recovery with others. It also sought to understand successful factors of the creative workshops to inform future workshops. Semi-structured interviews gathered information regarding participants' memories of the workshops and how they had shared their stories with others over the preceding 12 months. Interpretative phenomenological analysis identified that participants' enjoyed being engaged in a range of creative mediums in a group setting; that peer mentor support was highly valued; and that participants' recovery stories had become more positive and were shared more often and openly with others. Overall, participation in the creative workshops had long-lasting benefits for participants with respect to improved confidence and understanding about their illness. Future creative workshops should consider the inclusion of peer mentors with lived experience as a support for participants to reauthor their recovery story.	[Slattery, Maddy; Attard, Hayley; Stewart, Victoria; Roennfeldt, Helena; Wheeler, Amanda J.] Griffith Univ, Sch Human Serv & Social Work, Brisbane, Qld, Australia; [Wheeler, Amanda J.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	Griffith University; University of Auckland	Stewart, V (corresponding author), Griffith Univ, Sch Human Serv & Social Work, Brisbane, Qld, Australia.	v.stewart@griffith.edu.au	Stewart, Victoria/P-2505-2018; Slattery, Maddy/ABF-5364-2021	Stewart, Victoria/0000-0003-2892-2288; Slattery, Maddy/0000-0001-5888-2534; Roennfeldt, Helena/0000-0002-4569-1226				[Anonymous], 2014, NAT PHOTONICS, V8, P1, DOI 10.1038/nphoton.2013.359; Bos Arjan E R, 2009, Issues Ment Health Nurs, V30, P509, DOI 10.1080/01612840802601382; Caddy L, 2012, J PSYCHIATR MENT HLT, V19, P327, DOI 10.1111/j.1365-2850.2011.01785.x; Cooper P, 2013, BRIT J OCCUP THER, V76, P186, DOI 10.4276/030802213X13651610908452; Dolling S., 2013, MENTAL HLTH PRACTICE, V16, P36, DOI [https://doi.org/10.7748/mhp2013.05.16.8.36.e855, DOI 10.7748/MHP2013.05.16.8.36.E855, DOI 10.7748/mhp2013.05.16.8.36.e855]; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Fade S, 2004, P NUTR SOC, V63, P647, DOI 10.1079/PNS2004398; Hacking S, 2008, HEALTH SOC CARE COMM, V16, P638, DOI 10.1111/j.1365-2524.2008.00789.x; Hilse C., 2007, BRIT J OCCUPATIONAL, V20, P431, DOI [10.1177/030802260707001004, DOI 10.1177/030802260707001004]; King R, 2013, INT J MENT HEALTH NU, V22, P444, DOI 10.1111/j.1447-0349.2012.00891.x; Lawson J, 2014, J HEALTH PSYCHOL, V19, P765, DOI 10.1177/1359105313479627; Makin S, 2012, CHRONIC ILLN, V8, P64, DOI 10.1177/1742395311422613; Marino C, 2016, PSYCHIATR REHABIL J, V39, P154, DOI 10.1037/prj0000171; Menard S., 2012, QUANTITATIVE APPL SO; Mizock L, 2015, PSYCHIATR REHABIL J, V38, P279, DOI 10.1037/prj0000111; Oster G. D., 2004, USING DRAWINGS ASSES; Qualitative Solution and Research, 2017, NVIV VERS 11; Roe D, 2005, Med Humanit, V31, P89, DOI 10.1136/jmh.2005.000214; Smith JA, 2009, QUAL RES PSYCHOL; Spandler H, 2007, J PSYCHIATR MENT HLT, V14, P791, DOI 10.1111/j.1365-2850.2007.01174.x; Stewart V, 2019, MENT HEALTH SOC INCL, V23, P16, DOI 10.1108/MHSI-08-2018-0029; Stickley T, 2007, J PSYCHIATR MENT HLT, V14, P783, DOI 10.1111/j.1365-2850.2007.01173.x; Stickley T, 2012, PUBLIC HEALTH, V126, DOI 10.1016/j.puhe.2012.04.002; Stickley T, 2018, J MENT HEALTH, V27, P367, DOI 10.1080/09638237.2018.1437609; Swan P, 2013, MENT HEALTH SOC INCL, V17, P19, DOI 10.1108/20428301311305278; Van Lith T, 2013, DISABIL REHABIL, V35, P1309, DOI 10.3109/09638288.2012.732188; Van Lith T, 2009, ADV MENT HEALTH, V8, P183, DOI 10.5172/jamh.8.2.183; Van Lith T, 2011, DISABIL REHABIL, V33, P652, DOI 10.3109/09638288.2010.505998; Whitley R, 2012, COMMUNITY MENT HLT J, V48, P547, DOI 10.1007/s10597-011-9427-4; Wilson C, 2017, INT J MENT HEALTH PR, V19, P268, DOI 10.1080/14623730.2017.1345688	30	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243284	10.1371/journal.pone.0243284	http://dx.doi.org/10.1371/journal.pone.0243284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33270738	Green Published, gold			2022-12-26	WOS:000597149100141
J	Yawata, A; Tsujimura, T; Takeishi, R; Magara, J; Yu, L; Inoue, M				Yawata, Akiko; Tsujimura, Takanori; Takeishi, Ryosuke; Magara, Jin; Yu, Li; Inoue, Makoto			Comparison of physical properties of voluntary coughing, huffing and swallowing in healthy subjects	PLOS ONE			English	Article							FORCED EXPIRATION TECHNIQUE; HAND GRIP STRENGTH; MUSCLE STRENGTH; ASPIRATION; COORDINATION; STIMULATION; PNEUMONIA; LARYNGEAL; DYNAMICS; FLOW	Coughing, huffing and swallowing protect the airway from aspiration. This study was conducted to compare the physical properties of voluntary coughing, huffing and swallowing in healthy subjects. Ten healthy men were asked to huff, cough and swallow repeatedly. Electromyograms (EMGs) were recorded from the left side of the external oblique (EO), sternocleidomastoid, suprahyoid (SH) and thyrohyoid muscles. Airflow was recorded using a face mask with two-way non-rebreathing valves. The expiratory velocity of huffing and coughing and the SH EMG of all actions presented high intraclass correlation coefficients (> 0.8). The inspiratory and expiratory velocities did not differ significantly between coughing and huffing. The expiratory acceleration of coughing was significantly higher than that of huffing, whereas the expiratory volume of coughing was significantly smaller than that of huffing. The EO EMG of coughing and huffing were significantly larger than that of swallowing. The EO EMG activity during the expiratory phase was significantly higher than that of the other phases of both coughing and huffing. The SH EMG of coughing and huffing were significantly smaller than that of swallowing. Correlation analysis revealed that the expiratory velocity of coughing was strongly positively correlated with that of huffing. The expiratory volume of huffing was significantly positively correlated with hand grip strength. These results suggest that EO and SH muscle activities during huffing or coughing differ those during swallowing, and huffing and coughing may work similarly in expiratory function.	[Yawata, Akiko; Tsujimura, Takanori; Takeishi, Ryosuke; Magara, Jin; Inoue, Makoto] Niigata Univ, Div Dysphagia Rehabil, Grad Sch Med & Dent Sci, Chuo Ku, Niigata, Japan; [Yu, Li] Tongji Univ, Tongji Hosp, Dept Resp & Crit Care Med, Sch Med, Shanghai, Peoples R China	Niigata University; Tongji University	Tsujimura, T (corresponding author), Niigata Univ, Div Dysphagia Rehabil, Grad Sch Med & Dent Sci, Chuo Ku, Niigata, Japan.	tsujimura@dent.niigata-u.ac.jp	Magara, Jin/AAN-2019-2021; Tsujimura, Takanori/AAK-7420-2021	Tsujimura, Takanori/0000-0003-4552-8813; Inoue, Makoto/0000-0002-6503-2973	JSPS KAKENHI [JP20K10069]; Yamazaki Spice Promotion Foundation [218]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamazaki Spice Promotion Foundation	This study was funded in part by a grant from JSPS KAKENHI (Grant Number JP20K10069) to TT, a grant from Yamazaki Spice Promotion Foundation (Grant Number 218) to TT. There was no additional external funding received for this study.	[Anonymous], 2017, PUBLIC CULTURE, V29, P191; [Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Antonella L, 2019, J ELECTROMYOGR KINES, V49, DOI 10.1016/j.jelekin.2019.102359; Ashiga H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42422-4; Bahat G, 2014, AGING MALE, V17, P136, DOI 10.3109/13685538.2014.936001; Chang AB, 2006, PAEDIATR RESPIR REV, V7, P2, DOI 10.1016/j.prrv.2005.11.009; Fini NA, 2019, ARCH PHYS MED REHAB, V100, P883, DOI 10.1016/j.apmr.2018.10.006; Fontana GA, 1997, EUR RESPIR J, V10, P983, DOI 10.1183/09031936.97.10050983; HASANI A, 1994, THORAX, V49, P557, DOI 10.1136/thx.49.6.557; HASANI A, 1994, CHEST, V105, P1420, DOI 10.1378/chest.105.5.1420; Hegland KW, 2012, J APPL PHYSIOL, V113, P39, DOI 10.1152/japplphysiol.01299.2011; Huff A, 2018, LUNG, V196, P601, DOI 10.1007/s00408-018-0133-7; Kijima M, 1999, AM J RESP CRIT CARE, V159, P1898, DOI 10.1164/ajrccm.159.6.9811092; Kulnik ST, 2016, THORAX, V71, P474, DOI 10.1136/thoraxjnl-2015-207810; Landi F, 2020, J CACHEXIA SARCOPENI, V11, P38, DOI 10.1002/jcsm.12485; Lasserson D, 2006, THORAX, V61, P699, DOI 10.1136/thx.2005.057901; Lavietes MH, 1998, EUR RESPIR J, V11, P156, DOI 10.1183/09031936.98.11010156; Mandell LA, 2019, NEW ENGL J MED, V380, P651, DOI 10.1056/NEJMra1714562; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; McCool FD, 2006, CHEST, V129, p48S, DOI 10.1378/chest.129.1_suppl.48S; Miyashita N, 2018, JPN CLIN MED, V9, DOI 10.1177/1179670717751433; Netter FH, 2014, ATLAS HUMAN ANATOMY; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Park JS, 2017, GERODONTOLOGY, V34, P121, DOI 10.1111/ger.12234; Ratnovsky A, 2003, J BIOMECH, V36, P1771, DOI 10.1016/S0021-9290(03)00232-X; Ratnovsky A, 2008, RESP PHYSIOL NEUROBI, V163, P82, DOI 10.1016/j.resp.2008.04.019; Recently Released Market Study, 2011, CPER, V26, P183; SHAKER R, 1990, GASTROENTEROLOGY, V98, P1478, DOI 10.1016/0016-5085(90)91078-K; Shaker R, 2013, PRINCIPLES DEGLUTITI, DOI [10.1007/978-1-4614-3794-9_14, DOI 10.1007/978-1-4614-3794-9_14]; Smith JA, 2012, J PHYSIOL-LONDON, V590, P563, DOI 10.1113/jphysiol.2011.213157; Smith MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194560; Sohn D, 2018, ARCH PHYS MED REHAB, V99, P2532, DOI 10.1016/j.apmr.2018.06.015; SUTTON PP, 1983, EUR J RESPIR DIS, V64, P62; Takahashi K, 2018, J APPL PHYSIOL, V124, P10, DOI 10.1152/japplphysiol.00512.2017; Takei E, 2020, PHYSIOL BEHAV, V225, DOI 10.1016/j.physbeh.2020.113102; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Torres-Tamayo N, 2018, J ANAT, V232, P227, DOI 10.1111/joa.12743; Tsujimura T, 2019, J PHYSIOL-LONDON, V597, P2949, DOI 10.1113/JP277895; Tsujimura T, 2018, J APPL PHYSIOL, V124, P1148, DOI 10.1152/japplphysiol.00944.2017; Tsujimura T, 2013, J PHYSIOL-LONDON, V591, P4667, DOI 10.1113/jphysiol.2013.256024; Wakasugi Y, 2008, DYSPHAGIA, V23, P364, DOI 10.1007/s00455-008-9150-7	41	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242810	10.1371/journal.pone.0242810	http://dx.doi.org/10.1371/journal.pone.0242810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270679	gold, Green Published			2022-12-26	WOS:000597149100098
J	Malcolm, TR; Belousoff, MJ; Venugopal, H; Borg, NA; Drinkwater, N; Atkinson, SC; McGowan, S				Malcolm, Tess R.; Belousoff, Matthew J.; Venugopal, Hariprasad; Borg, Natalie A.; Drinkwater, Nyssa; Atkinson, Sarah C.; McGowan, Sheena			Active site metals mediate an oligomeric equilibrium in Plasmodium M17 aminopeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LEUCINE AMINOPEPTIDASE; SIZE-DISTRIBUTION ANALYSIS; LEUCYL AMINOPEPTIDASE; FALCIPARUM M1; BOVINE LENS; HELICOBACTER-PYLORI; STRUCTURAL BASIS; BINDING; INHIBITORS; MECHANISM	M17 leucyl aminopeptidases are metal-dependent exopeptidases that rely on oligomerization to diversify their functional roles. The M17 aminopeptidases from Plasmodium falciparum (PfA-M17) and Plasmodium vivax (Pv-M17) function as catalytically active hexamers to generate free amino acids from human hemoglobin and are drug targets for the design of novel antimalarial agents. However, the molecular basis for oligomeric assembly is not fully understood. In this study, we found that the active site metal ions essential for catalytic activity have a secondary structural role mediating the formation of active hexamers. We found that PfA-M17 and Pv-M17 exist in a metal-dependent dynamic equilibrium between active hexameric species and smaller inactive species that can be controlled by manipulating the identity and concentration of metals available. Mutation of residues involved in metal ion binding impaired catalytic activity and the formation of active hexamers. Structural resolution of Pv-M17 by cryoelectron microscopy and X-ray crystallography together with solution studies revealed that PfA-M17 and Pv-M17 bind metal ions and substrates in a conserved fashion, although Pv-M17 forms the active hexamer more readily and processes substrates faster than PfA-M17. On the basis of these studies, we propose a dynamic equilibrium between monomer <-> dimer <-> tetramer <-> hexamer, which becomes directional toward the large oligomeric states with the addition of metal ions. This sophisticated metal-dependent dynamic equilibrium may apply to other M17 aminopeptidases and underpin the moonlighting capabilities of this enzyme family.	[Malcolm, Tess R.; Belousoff, Matthew J.; Borg, Natalie A.; Drinkwater, Nyssa; Atkinson, Sarah C.; McGowan, Sheena] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Malcolm, Tess R.; Belousoff, Matthew J.; Drinkwater, Nyssa; McGowan, Sheena] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [Venugopal, Hariprasad] Monash Univ, Ramacciotti Ctr Cryoelectron Microscopy, Clayton, Vic, Australia; [Borg, Natalie A.; Atkinson, Sarah C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Borg, Natalie A.; Atkinson, Sarah C.] RMIT Univ, Sch Hlth & Biomed Sci, Immun & Immune Evas Lab, Chron Infect & Inflammatory Dis Res, Bundoora, Vic, Australia	Monash University; Monash University; Monash University; Monash University; Royal Melbourne Institute of Technology (RMIT)	McGowan, S (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; McGowan, S (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic, Australia.	sheena.mcgowan@monash.edu	; McGowan, Sheena/C-4797-2014; Belousoff, Matthew/N-4066-2017	Borg, Natalie/0000-0002-8677-9056; Venugopal, Hariprasad/0000-0001-5230-2973; McGowan, Sheena/0000-0001-6863-1106; Malcolm, Tess/0000-0001-8581-9039; Belousoff, Matthew/0000-0002-3229-474X	National Health and Medical Research Council (Synergy Grant) [1185354]; Australian Research Council [DECRA DE190100304]; RTP scholarship from Australian Department of Education, Skills and Employment; Monash Graduate Completion Award	National Health and Medical Research Council (Synergy Grant); Australian Research Council(Australian Research Council); RTP scholarship from Australian Department of Education, Skills and Employment; Monash Graduate Completion Award	This work was supported by the National Health and Medical Research Council (Synergy Grant 1185354 to S. M.) and Australian Research Council (DECRA DE190100304 to S. A.). T. R. M. is supported by RTP scholarship from Australian Department of Education, Skills and Employment and by the Monash Graduate Completion Award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLEN MP, 1983, BIOCHEMISTRY-US, V22, P3778, DOI 10.1021/bi00285a010; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Ayo B, 2017, GLOBAL CHANGE BIOL, V23, P4084, DOI 10.1111/gcb.13779; Bhosale M, 2010, BIOCHEM BIOPH RES CO, V395, P76, DOI 10.1016/j.bbrc.2010.03.142; BURLEY SK, 1990, P NATL ACAD SCI USA, V87, P6878, DOI 10.1073/pnas.87.17.6878; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; CARPENTER FH, 1973, J BIOL CHEM, V248, P294; Carroll RK, 2013, BIOL CHEM, V394, P791, DOI 10.1515/hsz-2012-0308; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu LR, 2008, J BIOL CHEM, V283, P19351, DOI 10.1074/jbc.M801034200; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dong L, 2005, MICROBIOL-SGM, V151, P2017, DOI 10.1099/mic.0.27767-0; Drinkwater N, 2016, EUR J MED CHEM, V110, P43, DOI 10.1016/j.ejmech.2016.01.015; DuPrez K, 2014, FASEB J, V28; Duprez K, 2014, ACTA CRYSTALLOGR D, V70, P1649, DOI 10.1107/S1399004714006245; Dutoit R, 2019, J BIOL CHEM, V294, P17777, DOI 10.1074/jbc.RA119.009281; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Izawa N, 1997, J AGR FOOD CHEM, V45, P4897, DOI 10.1021/jf970453w; Jaffe EK, 2012, ARCH BIOCHEM BIOPHYS, V519, P144, DOI 10.1016/j.abb.2011.10.010; Jia HL, 2010, MOL BIOCHEM PARASIT, V170, P1, DOI 10.1016/j.molbiopara.2009.11.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaushik JK, 2006, BIOCHEMISTRY-US, V45, P7100, DOI 10.1021/bi052610n; KIM HD, 1993, P NATL ACAD SCI USA, V90, P5006, DOI 10.1073/pnas.90.11.5006; Kumar S, 2015, BIOCHEM J, V468, P73, DOI 10.1042/BJ20141154; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JY, 2010, MOL BIOCHEM PARASIT, V170, P45, DOI 10.1016/j.molbiopara.2009.11.003; Lin SJ, 2008, EUR FOOD RES TECHNOL, V227, P159, DOI 10.1007/s00217-007-0705-x; Macek P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601601; Maric S, 2009, BIOCHEMISTRY-US, V48, P5435, DOI 10.1021/bi9003638; Marvin RG, 2012, CHEM BIOL, V19, P731, DOI 10.1016/j.chembiol.2012.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mistry SN, 2014, J MED CHEM, V57, P9168, DOI 10.1021/jm501323a; Modak JK, 2016, BIOCHIMIE, V121, P60, DOI 10.1016/j.biochi.2015.11.021; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poreba M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031938; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rosenbaum E, 2011, BBA-PROTEINS PROTEOM, V1814, P1289, DOI 10.1016/j.bbapap.2010.11.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Skinner-Adams TS, 2007, J MED CHEM, V50, P6024, DOI 10.1021/jm070733v; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Strater N, 1999, EMBO J, V18, P4513, DOI 10.1093/emboj/18.16.4513; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; THOMPSON GA, 1976, J BIOL CHEM, V251, P1618; Tu CJ, 2003, PLANT PHYSIOL, V132, P243, DOI 10.1104/pp.102.013854; VANWART HE, 1981, BIOCHEMISTRY-US, V20, P5682, DOI 10.1021/bi00523a007; VANWART HE, 1981, FED PROC, V40, P1788; Vinh NB, 2019, J MED CHEM, V62, P622, DOI 10.1021/acs.jmedchem.8b01310; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	64	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100173	10.1074/jbc.RA120.016313	http://dx.doi.org/10.1074/jbc.RA120.016313			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303633	Green Published, gold			2022-12-26	WOS:000672866400151
J	Khayyeri, H; Hammerman, M; Turunen, MJ; Blomgran, P; Notermans, T; Guizar-Sicairos, M; Eliasson, P; Aspenberg, P; Isaksson, H				Khayyeri, Hanifeh; Hammerman, Malin; Turunen, Mikael J.; Blomgran, Parmis; Notermans, Thomas; Guizar-Sicairos, Manuel; Eliasson, Pernilla; Aspenberg, Per; Isaksson, Hanna			Diminishing effects of mechanical loading over time during rat Achilles tendon healing	PLOS ONE			English	Article							MECHANOBIOLOGY; PARATENON; MATRIX; CELLS	Mechanical loading affects tendon healing and recovery. However, our understanding about how physical loading affects recovery of viscoelastic functions, collagen production and tissue organisation is limited. The objective of this study was to investigate how different magnitudes of loading affects biomechanical and collagen properties of healing Achilles tendons over time. Achilles tendon from female Sprague Dawley rats were cut transversely and divided into two groups; normal loading (control) and reduced loading by Botox (unloading). The rats were sacrificed at 1, 2- and 4-weeks post-injury and mechanical testing (creep test and load to failure), small angle x-ray scattering (SAXS) and histological analysis were performed. The effect of unloading was primarily seen at the early time points, with inferior mechanical and collagen properties (SAXS), and reduced histological maturation of the tissue in unloaded compared to loaded tendons. However, by 4 weeks no differences remained. SAXS and histology revealed heterogeneous tissue maturation with more mature tissue at the peripheral region compared to the center of the callus. Thus, mechanical loading advances Achilles tendon biomechanical and collagen properties earlier compared to unloaded tendons, and the spatial variation in tissue maturation and collagen organization across the callus suggests important regional (mechano-) biological activities that require more investigation.	[Khayyeri, Hanifeh; Hammerman, Malin; Notermans, Thomas; Isaksson, Hanna] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Hammerman, Malin; Blomgran, Parmis; Eliasson, Pernilla; Aspenberg, Per] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Turunen, Mikael J.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Guizar-Sicairos, Manuel] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland	Lund University; Linkoping University; University of Eastern Finland; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Isaksson, H (corresponding author), Lund Univ, Dept Biomed Engn, Lund, Sweden.	Hanna.Isaksson@bme.lth.se	Isaksson, Hanna/L-1340-2015; Guizar-Sicairos, Manuel/AAB-3793-2019	Isaksson, Hanna/0000-0002-9690-8907; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Turunen, Mikael/0000-0003-1093-1178; Eliasson, Pernilla/0000-0001-6718-034X; Blomgran, Parmis/0000-0002-2654-1361	European Community's Seventh Framework Program (FP7/2007-2013) [262348]; Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2012-626941]; Knut and Alice Wallenberg Foundation [2017.0221]	European Community's Seventh Framework Program (FP7/2007-2013); Marie Curie Intra-European Fellowship for Career Development; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The authors would like to thank the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 262348 (ESMI, European Soft Matter Infrastructure Network) that enabled beamtime at the cSAXS beamline of the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. The authors are grateful for the financial support by the Marie Curie Intra-European Fellowship for Career Development (PIEF-GA-2012-626941) (HK) and the Knut and Alice Wallenberg Foundation (Wallenberg Academy Fellows 2017.0221, HI).	ABRAHAMS M, 1967, MED BIOL ENG, V5, P433, DOI 10.1007/BF02479137; Angele P, 2004, BIORHEOLOGY, V41, P335; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Aubry S, 2015, RADIOLOGY, V274, P821, DOI 10.1148/radiol.14140434; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; CICHON JV, 1995, LARYNGOSCOPE, V105, P144, DOI 10.1288/00005537-199502000-00006; COHEN RE, 1976, J BIOMECH, V9, P175, DOI 10.1016/0021-9290(76)90002-6; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Eliasson P, 2007, J APPL PHYSIOL, V103, P459, DOI 10.1152/japplphysiol.01333.2006; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Freedman BR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29060-y; Freedman BR, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0880; Hammerman M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201211; Hammerman M, 2015, J APPL PHYSIOL, V119, P534, DOI 10.1152/japplphysiol.00239.2015; Hillin CD, 2019, J ORTHOP RES, V37, P562, DOI 10.1002/jor.24241; Huegel J, 2019, J BIOMECH, V88, P194, DOI 10.1016/j.jbiomech.2019.03.029; Julkunen P, 2010, OSTEOARTHR CARTILAGE, V18, P406, DOI 10.1016/j.joca.2009.11.007; Khayyeri H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13107-7; Killian ML, 2012, J SHOULDER ELB SURG, V21, P228, DOI 10.1016/j.jse.2011.11.002; Kukreti U, 2000, J BIOMECH, V33, P1569, DOI 10.1016/S0021-9290(00)00150-0; Lavagnino M, 2015, J ORTHOP RES, V33, P813, DOI 10.1002/jor.22871; Lyras DN, 2016, ARCH BONE JT SURG-AB, V4, P156; Miller KS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006340; Momose T, 2002, CLIN ANAT, V15, P199, DOI 10.1002/ca.10009; Muller SA, 2018, AM J SPORT MED, V46, P1214, DOI 10.1177/0363546518756093; RIGBY BJ, 1959, J GEN PHYSIOL, V43, P265, DOI 10.1085/jgp.43.2.265; Sasaki K, 2012, J ELECTRON MICROSC, V61, P327, DOI 10.1093/jmicro/dfs057; Svensson RB, 2019, TRANSL SPORTS MED, V2, P316, DOI 10.1002/tsm2.103; Turunen MJ, 2017, J STRUCT BIOL, V199, P209, DOI 10.1016/j.jsb.2017.07.009; Turunen MJ, 2012, J ORTHOP RES, V30, P435, DOI 10.1002/jor.21538; Wall ME, 2016, ADV EXP MED BIOL, V920, P79, DOI 10.1007/978-3-319-33943-6_7; Wren TAL, 2000, J REHABIL RES DEV, V37, P135	33	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0236681	10.1371/journal.pone.0236681	http://dx.doi.org/10.1371/journal.pone.0236681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315857	Green Published, gold, Green Submitted			2022-12-26	WOS:000600186100028
J	Morris, E; Hippman, C; Albert, A; Slomp, C; Inglis, A; Carrion, P; Batallones, R; Andrighetti, H; Ross, C; Dyer, R; Honer, W; Austin, J				Morris, Emily; Hippman, Catriona; Albert, Arianne; Slomp, Caitlin; Inglis, Angela; Carrion, Prescilla; Batallones, Rolan; Andrighetti, Heather; Ross, Colin; Dyer, Roger; Honer, William; Austin, Jehannine			A prospective study to explore the relationship between MTHFR C677T genotype, physiological folate levels, and postpartum psychopathology in at-risk women	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTION; NEGATIVE SYNDROME SCALE; METHYLENETETRAHYDROFOLATE-REDUCTASE; BIPOLAR DISORDER; 2 POLYMORPHISMS; MTHFR GENE; DEPRESSION; SCHIZOPHRENIA; HOMOCYSTEINE; PREGNANCY	Background The etiology of postpartum psychopathologies are not well understood, but folate metabolism pathways are of potential interest. Demands for folate increase dramatically during pregnancy, low folate level has been associated with psychiatric disorders, and supplementation may improve symptomatology. The MTHFR C677T variant influences folate metabolism and has been implicated in depression during pregnancy. Objective To conduct a prospective longitudinal study to explore the relationship between MTHFR C677T genotype, folate levels, and postpartum psychopathology in at-risk women. Hypothesis In the first three months postpartum, folate will moderate a relationship between MTHFR genotype and depression, with TT homozygous women having more symptoms than CC homozygous women. Methods We recruited 365 pregnant women with a history of mood or psychotic disorder, and at 3 postpartum timepoints, administered the Edinburgh Postnatal Depression Scale (EPDS); Clinician-Administered Rating Scale for Mania (CARS-M) and the Positive and Negative Symptom Scale (PANSS) and drew blood for genotype/folate level analysis. We used robust linear regression to investigate interactions between genotype and folate level on the highest EPDS and CARS-M scores, and logistic regression to explore interactions with PANSS psychosis scores above/below cut-off. Results There was no significant interaction effect between MTHFR genotype and folate level on highest EPDS (p = 0.36), but there was a significant interaction between genotype, folate level and log(CARS-M) (p = 0.02); post-hoc analyses revealed differences in the effect of folate level between CC/CT, and TT genotypes, with folate level in CC and CT having an inverse relationship with symptoms of mania, while there was no relationship in participants with TT genotype. There was no significant interaction between MTHFR genotype and folate level on the likelihood of meeting positive symptom criteria for psychosis on the PANSS (p = 0.86). Discussion These data suggest that perhaps there is a relationship between MTHFR C677T, folate level and some symptoms of postpartum psychopathology.	[Morris, Emily; Inglis, Angela; Austin, Jehannine] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Morris, Emily; Hippman, Catriona; Slomp, Caitlin; Inglis, Angela; Carrion, Prescilla; Batallones, Rolan; Andrighetti, Heather; Honer, William; Austin, Jehannine] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Albert, Arianne] Womens Hlth Res Inst, Vancouver, BC, Canada; [Ross, Colin] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Ross, Colin] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Dyer, Roger] BC Childrens Hosp, Res Inst, Analyt Core Metabol & Nutr ACMaN, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia	Austin, J (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.; Austin, J (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	jehannine.austin@ubc.ca	Hippman, Catriona/AAW-5828-2020	Hippman, Catriona/0000-0002-1676-5548; Dyer, Roger/0000-0003-2009-1563; Slomp, Caitlin/0000-0003-4063-2937; Albert, Arianne/0000-0002-3050-0888; Carrion, Prescilla/0000-0003-4965-9175; Austin, Jehannine/0000-0003-0338-7055	Canadian Institutes of Health Research (CIHR); BC Mental Health and Substance Use Services; Canada Research Chairs Program; Michael Smith Foundation for Health Research; CIHR; Canadian Institutes of Health Research [CIHR MOP 82750]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Mental Health and Substance Use Services; Canada Research Chairs Program(Canada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was made possible through funding from the Canadian Institutes of Health Research (CIHR), JA was supported by BC Mental Health and Substance Use Services, the Canada Research Chairs Program, the Michael Smith Foundation for Health Research, and CIHR. JA received funding from the Canadian Institutes of Health Research (https://cihrirsc.gc.ca/e/193.html) to conduct this work (CIHR MOP 82750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2005, NEUROBIOL AGING, V26, P251, DOI 10.1016/j.neurobiolaging.2004.03.007; ALTMAN EG, 1994, BIOL PSYCHIAT, V36, P124, DOI 10.1016/0006-3223(94)91193-2; Arinami T, 1997, AM J MED GENET, V74, P526, DOI 10.1002/(SICI)1096-8628(19970919)74:5<526::AID-AJMG14>3.0.CO;2-E; Assary E, 2018, SEMIN CELL DEV BIOL, V77, P133, DOI 10.1016/j.semcdb.2017.10.016; Bakker RC, 1997, PHARM WORLD SCI, V19, P126, DOI 10.1023/A:1008634632501; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Bosanac P, 2003, AUST NZ J PSYCHIAT, V37, P24, DOI 10.1046/j.1440-1614.2003.01104.x; Bray Nicholas J, 2019, Brain Neurosci Adv, V2, DOI 10.1177/2398212818799271; Couto TCE, 2015, WORLD J PSYCHIATR, V5, P103, DOI 10.5498/wjp.v5.i1.103; Chen EYH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4024; Chong MFF, 2014, J PSYCHIATR RES, V55, P110, DOI 10.1016/j.jpsychires.2014.04.006; Comasco E, 2011, PSYCHIAT GENET, V21, P19, DOI 10.1097/YPG.0b013e328341a3c1; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Coyle N, 2000, LANCET, V356, P1490, DOI 10.1016/S0140-6736(00)02877-4; DAVIES A, 1995, SCHIZOPHR RES, V16, P25, DOI 10.1016/0920-9964(94)00062-D; Dawson JF, 2014, J BUS PSYCHOL, V29, P1, DOI 10.1007/s10869-013-9308-7; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; First M. B., 1997, STRUCTURED CLIN INTE; Fox J., 2016, APPL REGRESSION ANAL, V3rd; Freeman MP, 2002, AM J PSYCHIAT, V159, P1609, DOI 10.1176/appi.ajp.159.9.1609; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howard L, 2005, POSTNATAL DEPRESSION, V72; Hui CLM, 2013, SCHIZOPHR RES, V150, P297, DOI 10.1016/j.schres.2013.08.010; Jones I, 2000, AM J MED GENET, V96, P850, DOI 10.1002/1096-8628(20001204)96:6<850::AID-AJMG31>3.0.CO;2-1; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kempisty B, 2006, NEUROSCI LETT, V400, P267, DOI 10.1016/j.neulet.2006.02.055; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Lewis SJ, 2012, EUR J CLIN NUTR, V66, P97, DOI 10.1038/ejcn.2011.136; Lewis SJ, 2006, MOL PSYCHIATR, V11, P352, DOI 10.1038/sj.mp.4001790; Lewis SJ, 2005, AM J MED GENET B, V135B, P2, DOI 10.1002/ajmg.b.30170; Maechler Martin, 2020, ROBUSTBASE BASIC ROB; MARKS MN, 1992, J AFFECT DISORDERS, V24, P253, DOI 10.1016/0165-0327(92)90110-R; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; Middle F, 2000, PSYCHIATR GENET, V10, P195, DOI 10.1097/00041444-200010040-00008; Mighton CE, 2016, ARCH WOMEN MENT HLTH, V19, P253, DOI 10.1007/s00737-015-0561-9; Monji A, 2005, J CLIN PSYCHOPHARM, V25, P3, DOI 10.1097/01.jcp.0000150225.76748.73; Muntjewerff JW, 2005, AM J MED GENET B, V135B, P69, DOI 10.1002/ajmg.b.30179; Muntjewerff JW, 2006, MOL PSYCHIATR, V11, P143, DOI 10.1038/sj.mp.4001746; Nishio K, 2008, J EPIDEMIOL, V18, P125, DOI 10.2188/jea.JE2007417; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robertson E, 2003, ACTA PSYCHIAT SCAND, V108, P387, DOI 10.1034/j.1600-0447.2003.00167.x; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; THORNTON WE, 1977, AM J OBSTET GYNECOL, V129, P222, DOI 10.1016/0002-9378(77)90752-9; Viguera AC, 2002, AM J PSYCHIAT, V159, P2102, DOI 10.1176/appi.ajp.159.12.2102; Wan L, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0276-6; Wisner KL, 2004, BIOL PSYCHIAT, V56, P592, DOI 10.1016/j.biopsych.2004.07.022; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Yang FZ, 2015, J AFFECT DISORDERS, V183, P339, DOI 10.1016/j.jad.2015.05.033; Yaremco E, 2013, BIRTH DEFECTS RES A, V97, P416, DOI 10.1002/bdra.23144; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Yonkers KA, 2001, AM J PSYCHIAT, V158, P1856, DOI 10.1176/appi.ajp.158.11.1856; Zhang XL, 2014, J AFFECT DISORDERS, V165, P208, DOI 10.1016/j.jad.2014.04.049	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243936	10.1371/journal.pone.0243936	http://dx.doi.org/10.1371/journal.pone.0243936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH1MP	33315905	gold, Green Published			2022-12-26	WOS:000600186100039
J	Ndiaye, A; Niang, EA; Diene, AN; Nourdine, MA; Sarr, PC; Konate, L; Faye, O; Gaye, O; Sy, O				Ndiaye, Assane; Niang, El Hadji Amadou; Diene, Aminata Niang; Nourdine, Mohamed Abderemane; Sarr, Pape Cheikh; Konate, Lassana; Faye, Ousmane; Gaye, Oumar; Sy, Ousmane			Mapping the breeding sites of Anopheles gambiae s. l. in areas of residual malaria transmission in central western Senegal	PLOS ONE			English	Article								Despite the deployment of several effective control interventions in central-western Senegal, residual malaria transmission is still occurring in some hotspots. To better tailor targeted control actions, it is critical to unravel the underlying environmental and geographical factors that cause the persistence infection in hotspot villages. "Hotspots villages" were defined in our study as those reporting more than six indigenous malaria cases during the previous year. A total of ten villages, including seven hotspots and three non-hotspots, were surveyed. All potential mosquito breeding sites identified in and around the ten study villages were regularly monitored between 2013 and 2017. Monitoring comprised the detection of anopheline larvae and the collection of epidemiological, hydrogeological, topographical, and biogeographical data. The number of larval breeding sites described and monitored during the study period ranged from 50 to 62. Breeding sites were more numerous in hotspot sites in each year of monitoring, with 90.3% (56/62) in 2013, 90.9% (50/55) in 2014, 90.3% (56/62) in 2015 and 86% (43/50) in 2017 (Fisher exact test; p = 1). In the non-hotspot areas, the data for the same years were, respectively, 9.7% (6/62), 9.1% (5/55), 9.7% (6/62) and 14% (7/50) (p = 1). The Hotspot villages were characterized mostly by saline or moderately saline hydro-morphic and halomorphic soils allowing water retention and a potential larval breeding sites. By contrast, non-hotspot villages were characterized mainly by a high proportion of extremely permeable sandy-textured soils, which due to their porosity had low water retention. The annual number of confirmed malaria cases was correlated with the frequency and extent of breeding sites. Malaria cases were significantly more frequent in the hamlets located near breeding sites of An. gambiae s.l., gradually decreasing with increasing remoteness. This study shows that the characteristics of larval breeding sites, as measured by their longevity, stability, proximity to human habitation, and their positivity in Anopheles larvae are likely determining factors in the persistence of malaria hotspots in central-western Senegal. The results of this study shed more light on the environmental factors underlying the residual transmission and should make it possible to better target vector control interventions for malaria elimination in west-central Senegal.	[Ndiaye, Assane; Diene, Aminata Niang] Univ Cheikh Anta Diop Dakar, Fac Lettres & Sci Humaines, Dept Geog, Dakar, Senegal; [Niang, El Hadji Amadou; Nourdine, Mohamed Abderemane; Sarr, Pape Cheikh; Konate, Lassana; Faye, Ousmane; Sy, Ousmane] Univ Cheikh Anta Diop, Fac Sci & Tech, Lab Ecol Vectorielle & Parasitaire, Dakar, Senegal; [Nourdine, Mohamed Abderemane; Sarr, Pape Cheikh; Gaye, Oumar; Sy, Ousmane] Univ Cheikh Anta Diop, Fac Med, Lab Parasitol Med Pharm & Odontostomatol, Dakar, Senegal	University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar	Sy, O (corresponding author), Univ Cheikh Anta Diop, Fac Sci & Tech, Lab Ecol Vectorielle & Parasitaire, Dakar, Senegal.; Sy, O (corresponding author), Univ Cheikh Anta Diop, Fac Med, Lab Parasitol Med Pharm & Odontostomatol, Dakar, Senegal.	syousmane7@gmail.com		Sarr, Pape Cheikh/0000-0003-3570-9901	DELTAS Africa Initiative [DEL-15-010]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [WT: 107741/A/15/Z]; UK government	DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This work was supported through the DELTAS Africa Initiative [MARCAD Grant Number: DEL-15-010]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [WT: 107741/A/15/Z] and the UK government.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Akasso R.J, 2005, LIAISON NEWSLETTER O; [Anonymous], 1975, MANUAL PRACTICAL ENT; [Anonymous], 2006, GPSMAP 60CSX SENS MA; [Anonymous], 1987, JPSAIM; [Anonymous], 2019, REP PAL MOND; Brahmin, 2006, THESIS; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cisse B, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002175; DELMONT J, 1982, CAH ETUD AFR, V22, P117, DOI 10.3406/cea.1982.2276; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Djamouko-Djonkam L, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0597-6; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Gaudart J, 2009, ANAL CLIMATIC CHANGE; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gillies MT, 1968, ANOPHELINE AFRICA S, V54, P122; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Mlacha YP, 2017, GEOSPATIAL HEALTH, V12, P74, DOI 10.4081/gh.2017.494; Ndiaye, 2001, CLIMATIC VARIATIONS, P25; Niang EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104622; NPFAM, 2017, ANN EP REC 2017 MAL; Pierrat C, 2010, THESIS; Rabe T, 2003, THESIS; Rippstein, 2004, DEV FODDER CROPS GRO, DOI [10.1055/s-2004-822821, DOI 10.1055/S-2004-822821]; Sagna P, 2005, THESIS; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Stefani A, 2011, THESIS; Sy O., 2016, Bulletin de la Societe de Pathologie Exotique, V109, P31, DOI 10.1007/s13149-016-0469-2; Sy O, 2015, Bull Soc Pathol Exot, V108, P213, DOI 10.1007/s13149-015-0431-8; Sy O, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2212-x; Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; World Health Organization, 2018, MALARIA; Yaro AS, 2012, J INSECT PHYSIOL, V58, P1050, DOI 10.1016/j.jinsphys.2012.04.002	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0236607	10.1371/journal.pone.0236607	http://dx.doi.org/10.1371/journal.pone.0236607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306671	gold, Green Submitted, Green Published			2022-12-26	WOS:000600144200067
J	Noll, C; Nasruddin-Yekta, A; Sternisek, P; Weig, M; Gross, U; Schilling, AF; Beil, FT; Bader, O				Noll, Christine; Nasruddin-Yekta, Azadda; Sternisek, Pia; Weig, Michael; Gross, Uwe; Schilling, Arndt F.; Beil, Frank Timo; Bader, Oliver			Rapid direct detection of pathogens for diagnosis of joint infections by MALDI-TOF MS after liquid enrichment in the BacT/Alert blood culture system	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DIRECT IDENTIFICATION; PERFORMANCE; BOTTLES; BONE	Pathogen identification is a critical step during diagnosis of infectious diseases. Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry (MALDI-TOF-MS) has become the gold standard for identification of microorganisms cultured on solid media in microbiology laboratories. Direct identification of microbes from liquid specimen, circumventing the need for the additional overnight cultivation step, has been successfully established for blood culture, urine and liquor. Here, we evaluate the ability of MALDI-TOF MS for direct identification of pathogens in synovial fluid after liquid enrichment in BacT/Alert blood culture bottles. Influence of synovial specimen quality on direct species identification with the MALDI BioTyper/Sepsityper was tested with samples inoculated from pretested native synovia with concomitant inoculation of blood or pus, or highly viscous fluid. Here, we achieved >90% concordance with culture on solid medium, and only mixed-species samples posed significant problems. Performance in routine diagnostics was tested prospectively on bottles inoculated by treating physicians on ward. There, we achieved >70% concordance with culture on solid media. The major contributors to test failure were the absence of a measurable mass signal and mixed-specimen samples. The Sepsityper workflow worked well on samples derived from BacT/Alert blood culture bottles inoculated with synovial fluid, giving concordant results to identification from solid media. Host remnant material in the inoculum, such as blood or pus, had no detrimental effect on identification score values of the BioTyper system after processing with the Sepsityper workflow, and neither had the initial viscosity of the synovial sample.	[Noll, Christine; Nasruddin-Yekta, Azadda; Sternisek, Pia; Weig, Michael; Gross, Uwe; Bader, Oliver] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Schilling, Arndt F.] Univ Med Ctr Gottingen, Dept Trauma Surg Orthoped & Plast Surg, Gottingen, Germany; [Beil, Frank Timo] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany	University of Gottingen; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Noll, C (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	Christine.Noll@med.uni-goettingen.de	Bader, Oliver/C-7650-2015	Bader, Oliver/0000-0002-1534-440X	AO Trauma foundation through the AOT CPP program [FP00006675_SA002]	AO Trauma foundation through the AOT CPP program	This study was supported through a grant of the AO Trauma foundation (grant number FP00006675_SA002) through the AOT CPP program. Conceived the study: CN, UG, AS, FTB, OB Provided samples: CN, MW, AS, FTB Performed experiments: AN, PS Evaluated data: CN, AN, OB Wrote the manuscript: CN, AN, OB.	[Anonymous], 2015, BMJ, V2015, ph1887; Bogut A, 2014, J MED MICROBIOL, V63, P176, DOI 10.1099/jmm.0.066068-0; Font-Vizcarra L, 2010, CLIN ORTHOP RELAT R, V468, P2238, DOI 10.1007/s11999-010-1254-3; Harju I, 2017, J CLIN MICROBIOL, V55, P914, DOI 10.1128/JCM.01990-16; Jmir Editorial Office, 2018, JMIR Public Health Surveill, V4, pe53, DOI 10.2196/publichealth.9932; Lallemand E, 2016, EUR J CLIN MICROBIOL, V35, P857, DOI 10.1007/s10096-016-2608-x; Lallemand E, 2017, RES MICROBIOL, V168, P122, DOI 10.1016/j.resmic.2016.09.005; Larsen LH, 2012, J MED MICROBIOL, V61, P309, DOI 10.1099/jmm.0.035303-0; Leitner L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23266-w; Metsemakers WJ, 2018, INJURY, V49, P511, DOI 10.1016/j.injury.2016.09.019; Mortelmaier C, 2019, ANAL BIOANAL CHEM, V411, P7027, DOI 10.1007/s00216-019-02080-x; Parvizi J, 2010, J AM ACAD ORTHOP SUR, V18, P771, DOI 10.5435/00124635-201012000-00007; Riederer K, 2015, DIAGN MICR INFEC DIS, V82, P105, DOI 10.1016/j.diagmicrobio.2015.03.003; Ruiz-Aragon J, 2018, ENFERM INFEC MICR CL, V36, P484, DOI 10.1016/j.eimc.2017.08.012; Schafer P, 2008, CLIN INFECT DIS, V47, P1403, DOI 10.1086/592973; Schubert S, 2011, J MOL DIAGN, V13, P701, DOI 10.1016/j.jmoldx.2011.07.004; Scott JS, 2016, INFECT DIS-NOR, V48, P530, DOI 10.3109/23744235.2016.1165350; Szabados F, 2011, CLIN MICROBIOL INFEC, V17, P192, DOI 10.1111/j.1469-0691.2010.03229.x; Tsuchida S, 2018, J MICROBIOL METH, V148, P40, DOI 10.1016/j.mimet.2018.03.014	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243790	10.1371/journal.pone.0243790	http://dx.doi.org/10.1371/journal.pone.0243790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306699	gold, Green Published			2022-12-26	WOS:000600144200029
J	de Almeida, LH; Bispo, PC				de Almeida, Lucas Henrique; Bispo, Pitagoras Conceicao			Perlidae (Plecoptera) from the Paranapiacaba Mountains, Atlantic Forest, Brazil: Diversity and implications of the integrative approach and teneral specimens on taxonomy	PLOS ONE			English	Article							STONEFLIES INSECTA PLECOPTERA; SAO-PAULO STATE; ESPIRITO-SANTO STATE; ANACRONEURIA PLECOPTERA; 1ST RECORDS; SOUTHEASTERN BRAZIL; TOCANTINS STATE; AQUATIC INSECTS; DNA BARCODES; COSTA-RICA	The study of complementary sources of biological variation (e.g. morphological, molecular) has allowed a better understanding of biodiversity through the construction of an integrative taxonomy. Using this approach, specimens from the Paranapiacaba Mountains, southeastern Brazil, were studied to update the knowledge on the stonefly family Perlidae from the region, characterize the species, and make associations between nymphs and adults using a fragment of the mitochondrial cytochrome c oxidase subunit I (COI) gene. The study also discusses the implications of integrative taxonomy and teneral specimens for the study of South American Perlidae. The molecular data were analyzed using Bayesian inference, Neighbor-joining, and delimiting species methods. Our results revealed that, in general, there was a morphological and molecular congruence between species. In the Paranapiacaba Mountains, three genera and 15 species were recorded: Anacroneuria boraceiensis Froehlich 2004, A. debilis (Pictet 1841) (new record), A. fiorentini De Ribeiro and Froehlich 2007 (new record), A. flintorum Froehlich 2002, A. iporanga Bispo and Froehlich 2004, A. itajaimirim Bispo and Froehlich 2004, A. polita (Burmeister 1913), A. subcostalis Klapalek 1921, A. tupi Bispo and Froehlich 2004 (with a description of the nymph), Kempnyia auberti Froehlich 1996, K. colossica (Navas 1934), K. flava Klapalek 1916, K. neotropica (Jacobson and Bianchi 1905) (including its new junior synonym K. petersorum Froehlich 1996), Kempnyia sp., and Macrogynoplax veneranda Froehlich 1984. COI sequences were obtained for 11 species, five of which had nymphs associated with adults. Among the five associated nymphs, the nymph of A. tupi is described here. The results of this study indicate that the color of adult teneral specimens differs from that of mature specimens. Given this, the synonym of K. neotropica and K. petersorum was proposed since these species have high morphological and molecular similarities and differ only in color patterns. In addition, the previous record of A. petersi Froehlich 2002 from the Paranapiacaba Mountains was invalidated since it was considered a teneral specimen of A. flintorum. These results suggest that the development of an integrative taxonomy is essential to continue advancing the study of Perlidae diversity in South America.	[de Almeida, Lucas Henrique] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Programa Posgrad Entomol, Ribeirao Preto, SP, Brazil; [de Almeida, Lucas Henrique; Bispo, Pitagoras Conceicao] Univ Estadual Paulista, Fac Ciencias & Letras Assis, Dept Ciencias Biol, Lab Biol Aquat, Assis, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	de Almeida, LH (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Programa Posgrad Entomol, Ribeirao Preto, SP, Brazil.; de Almeida, LH (corresponding author), Univ Estadual Paulista, Fac Ciencias & Letras Assis, Dept Ciencias Biol, Lab Biol Aquat, Assis, SP, Brazil.	lucasalmeida768@yahoo.com.br	Almeida, Lucas Henrique/AAB-7432-2021	Almeida, Lucas Henrique/0000-0002-3388-4143	Sao Paulo Research Foundation (FAPESP) [15/22008-9, 04/09711-8, 12/21196-8]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq) [305275/2014-3, 303260/2018-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LHA -Sao Paulo Research Foundation (FAPESP, 15/22008-9) (http://www.fapesp.br/en/); Coordination for the Improvement of Higher Education Personnel (CAPES, no number) (https://www.capes.gov.br).PCB -Sao Paulo Research Foundation (FAPESP, 04/09711-8; 12/21196-8) (http://www.fapesp.br/en/); National Council for Scientific and Technological Development (CNPq, 305275/2014-3; 303260/2018-1) (http://www.cnpq.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avelino-Capistrano F, 2016, ZOOTAXA, V4079, P372, DOI 10.11646/zootaxa.4079.3.5; Avelino-Capistrano F, 2014, FRESHW SCI, V33, P325, DOI 10.1086/675226; Baldin C, 2013, ZOOTAXA, V3694, P391, DOI 10.11646/zootaxa.3694.4.7; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bispo PC, 2004, AQUAT INSECT, V26, P97, DOI 10.1080/01650420412331325837; Bispo PC, 2004, AQUAT INSECT, V26, P191, DOI 10.1080/01650420412331327277; Bispo PC, 2004, ZOOTAXA, P1; Bispo PC, 2008, AQUAT INSECT, V30, P61, DOI 10.1080/01650420701829641; Bispo PC, 2012, AQUAT INSECT, V34, P217, DOI 10.1080/01650424.2013.800559; Bispo PD, 2014, ZOOTAXA, V 3779, P591, DOI 10.11646/zootaxa.3779.5.9; Boumans L, 2012, ZOOTAXA, P59; Burmeister H, 1839, THEOD CHR FRIEDR END, V2, P863; Calor Adolfo Ricardo, 2012, EntomoBrasilis, V5, P164; Da Silva FAC, 2011, ZOOTAXA, P59; Chen ZT, 2020, ZOOTAXA, V4751, P345, DOI 10.11646/zootaxa.4751.2.9; Chen ZT, 2018, INT J BIOL MACROMOL, V111, P542, DOI 10.1016/j.ijbiomac.2018.01.065; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Almeida LH, 2019, ZOOTAXA, V4550, P141, DOI 10.11646/zootaxa.4550.1.9; De Almeida LH, 2018, ZOOTAXA, V4370, P409, DOI 10.11646/zootaxa.4370.4.6; De Almeida LH, 2017, ZOOTAXA, V4247, P480, DOI 10.11646/zootaxa.4247.4.9; De Menezes ET, 2020, ZOOTAXA, V4722, P463, DOI 10.11646/zootaxa.4722.5.4; De Ribeiro VR, 2007, ZOOTAXA, P53, DOI 10.11646/zootaxa.1624.1.5; DeWalt RE, 2019, INSECTS, V10, DOI 10.3390/insects10040099; Ding SM, 2019, MOL PHYLOGENET EVOL, V135, P123, DOI 10.1016/j.ympev.2019.03.005; Duarte T, 2016, ZOOTAXA, V4079, P291, DOI 10.11646/zootaxa.4079.2.10; Duarte T, 2014, ZOOTAXA, V3779, P81, DOI 10.11646/zootaxa.3779.1.9; Enderlein G xFCnther, 1909, Zoologischer Anzeiger Leipzig, V34; Fenoglio S, 2007, CARIBB J SCI, V43, P220; Ribeiro JMF, 2015, ZOOTAXA, V4057, P295, DOI 10.11646/zootaxa.4057.2.11; Ribeiro JMF, 2015, ZOOTAXA, V3948, P109, DOI 10.11646/zootaxa.3948.1.7; Ribeiro JMF, 2014, ZOOTAXA, V3881, P17, DOI 10.11646/zootaxa.3881.1.2; Ribeiro JMF, 2009, ZOOTAXA, P1; Florestal F, 2009, PLANO MANEJO PARQUE, P1100; Fochetti R, 2011, ZOOTAXA, P49; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Froehlich C.G., 1984, Annales de Limnologie, V20, P39; Froehlich C. G., 1996, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V69, P117; Froehlich C. G., 1969, Beitr Neotrop Fauna, V6, P17; FROEHLICH CG, 1988, AQUAT INSECT, V10, P153, DOI 10.1080/01650428809361324; FROEHLICH CG, 1984, AQUAT INSECT, V6, P137, DOI 10.1080/01650428409361176; Froehlich CG, 2004, AQUAT INSECT, V26, P53, DOI 10.1076/aqin.26.1.53.35377; Froehlich CG, 2003, STUD NEOTROP FAUNA E, V38, P129, DOI 10.1076/snfe.38.2.129.15929; Froehlich CG, 2002, P BIOL SOC WASH, V115, P75; Froehlich CG, 1990, SIZE VARIATION KEMPN, V1st, P347; Froehlich Claudio G., 2001, P377; Froehlich CG, 2010, ZOOTAXA, P55; Froehlich Claudio Gilberto, 2011, Illiesia, V7, P133; Froehlich Claudio Gilberto, 2010, Illiesia, V6, P118; Gamboa M, 2019, SYST BIODIVERS, DOI 10.1080/14772000.2019.1687604; Gamboa M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210269; Gattolliat JL, 2016, ZOOSYMPOSIA, V11, P135, DOI 10.11646/zoosymposia.11.1.15; Genkai-Kato M, 2000, ECOL RES, V15, P175, DOI 10.1046/j.1440-1703.2000.00336.x; Gill Brian A., 2015, Illiesia, V11, P130; Goncalves MD, 2019, ZOOSYMPOSIA, V16, P96, DOI 10.11646/zoosymposia.16.1.10; Goncalves MD, 2017, ZOOTAXA, V4273, P141, DOI 10.11646/zootaxa.4273.1.11; Gray DP, 2009, NEW ZEAL J MAR FRESH, V43, P605, DOI 10.1080/00288330909510026; Gutierrez-Fonseca PE, 2011, ZOOTAXA, P16; Haidekker A, 2008, AQUAT ECOL, V42, P463, DOI 10.1007/s10452-007-9097-z; Hamada N, 2019, ZOOTAXA, V4712, P377, DOI 10.11646/zootaxa.4712.3.4; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huemer P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206668; Jacobson GG, 1905, ORTHOPTERA PSEUDONEU; Jewett SG, 1960, ARQ MUS NAC, V50, P167; JEWETT STANLEY G., 1959, AMER MIDLAND NAT, V61, P148, DOI 10.2307/2422347; Kato Y, 2013, LIMNOLOGY, V14, P179, DOI 10.1007/s10201-012-0395-3; Klapalek F, 1914, ACTA SOC ENTOMOLOGIC, V11, P53; Klapalek F, 1921, ANN SOC ENTOMOL FR, V61, P320; Klapalek F, 1909, WIENER ENTOMOL ZEITU, V28, P215; Klapalek F, 1916, CASOPIS CESKE SPOLEN, V13, P45; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Maldonado V, 2002, AQUAT INSECT, V24, P219, DOI 10.1076/aqin.24.3.219.8119; McCulloch GA, 2016, MOL PHYLOGENET EVOL, V96, P150, DOI 10.1016/j.ympev.2015.10.028; Molina Carlos I., 2017, Ecologia en Bolivia, V52, P88; Mynott JH, 2011, INVERTEBR SYST, V25, P11, DOI 10.1071/IS10025; Navas L, 1932, PLECOPTEROS INSECTOS, P58; Navas L, 1934, REV REAL ACAD CIENCI; Novaes MC, 2016, ZOOTAXA, V4208, P94, DOI 10.11646/zootaxa.4208.1.7; Novaes MC, 2012, ZOOTAXA, P71; Novaes MC, 2014, ZOOTAXA, V3856, P433, DOI 10.11646/zootaxa.3856.3.8; Novaes MC, 2014, ZOOTAXA, V 3779, P277, DOI 10.11646/zootaxa.3779.2.8; Novaes MC, 2014, ZOOTAXA, V3765, P458, DOI 10.11646/zootaxa.3765.5.4; Paciencia Gabriel de Paula, 2011, EntomoBrasilis, V4, P114; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Pessacq P, 2019, ZOOSYMPOSIA, V16, P182, DOI 10.11646/zoosymposia.16.1.15; Pessacq P, 2015, ZOOTAXA, V4033, P270, DOI 10.11646/zootaxa.4033.2.6; Pictet FJ, 1841, HIST NATURELLE GENER, DOI [10.5962/bhl.title.124172, DOI 10.5962/BHL.TITLE.124172]; Pires AC, 2010, BIOTA NEOTROP, V10, P339, DOI 10.1590/S1676-06032010000200035; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ribeiro-Ferreira AC, 2001, AQUAT INSECT, V23, P187, DOI 10.1076/aqin.23.3.187.4890; Rico A, 2015, ENVIRON TOXICOL CHEM, V34, P1907, DOI 10.1002/etc.3008; Righi-Cavallaro KO, 2013, STUD NEOTROP FAUNA E, V48, P125, DOI 10.1080/01650521.2013.844590; Righi-Cavallaro KO, 2013, ZOOTAXA, V3635, P579, DOI 10.11646/zootaxa.3635.5.7; Rippel MLS, 2019, ZOOTAXA, V4560, P355, DOI 10.11646/zootaxa.4560.2.8; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rippel MLS, 2019, ZOOTAXA, V4700, P471, DOI 10.11646/zootaxa.4700.4.5; South EJ, 2019, ZOOKEYS, P45, DOI 10.3897/zookeys.858.33818; Stark Bill P., 2004, Monographs of the Western North American Naturalist, V2, P1, DOI 10.3398/1545-0228-2.1.1; Stark Bill P., 1995, Spixiana, V18, P211; Stark BP, 1999, P BIOL SOC WASH, V112, P70; Stark BP, 2000, AQUAT INSECT, V22, P305, DOI 10.1076/0165-0424(200010)22:4;1-Y;FT305; STARK BP, 1989, AQUAT INSECT, V11, P153, DOI 10.1080/01650428909361364; Stark BP, 1998, P BIOL SOC WASH, V111, P551; Stark BP, 2009, AQUATIC BIODIVERSITY, P154; SWEENEY BW, 1986, FRESHWATER BIOL, V16, P39, DOI 10.1111/j.1365-2427.1986.tb00946.x; Thomas MA, 2000, P NATL ACAD SCI USA, V97, P13178, DOI 10.1073/pnas.230296997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; De Figueroa JMT, 2011, ZOOTAXA, P49, DOI 10.11646/zootaxa.3000.1.3; Vanzolini PE, 1967, MANUAL COLETA PREPAR; Vilela DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223241; Vitecek S, 2017, ARTHROPOD SYST PHYLO, V75, P497; Weiss S, 2012, J ZOOL SYST EVOL RES, V50, P19, DOI 10.1111/j.1439-0469.2011.00639.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1; Zuniga Maria del C., 2002, Spixiana, V25, P209; Zuniga Maria del C., 2001, P301; ZWICK P, 1973, Annales Zoologici (Warsaw), V30, P471; ZWICK P, 1971, Revue Suisse de Zoologie, V78, P1123	119	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243393	10.1371/journal.pone.0243393	http://dx.doi.org/10.1371/journal.pone.0243393			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301489	Green Published, gold			2022-12-26	WOS:000600143100033
J	Abd El-Baky, RM; Mandour, SA; Ahmed, EF; Hashem, ZS; Sandle, T; Mohamed, DS				Abd El-Baky, Rehab Mahmoud; Mandour, Sahar A.; Ahmed, Eman Farouk; Hashem, Zeinab Shawky; Sandle, Tim; Mohamed, Doaa Safwat			Virulence profiles of some Pseudomonas aeruginosa clinical isolates and their association with the suppression of Candida growth in polymicrobial infections	PLOS ONE			English	Article							BIOFILM FORMATION; PATHOGENIC FUNGUS; ALBICANS; PYOCYANIN; 1-HYDROXYPHENAZINE; BIOSYNTHESIS; PHOSPHOLIPASE; INHIBIT; HYPHAE; GENES	Pseudomonas aeruginosa is an opportunistic pathogen that can cause a variety of diseases especially in the hospital environment. However, this pathogen also exhibits antimicrobial activity against Gram-positive bacteria and fungi. This study aimed to characterize different virulence factors, secreted metabolites and to study their role in the suppression of Candida growth. Fifteen P. aeruginosa isolates were tested for their anticandidal activity against 3 different Candida spp. by the cross-streak method. The effect on hyphae production was tested microscopically using light and scanning electron microscopy (SEM). Polymerase chain reaction was used in the detection of some virulence genes. Lipopolysaccharide profile was performed using SDS-polyacrylamide gel stained with silver. Fatty acids were analyzed by GC-MS as methyl ester derivatives. It was found that 5 P. aeruginosa isolates inhibited all tested Candida spp. (50-100% inhibition), one isolate inhibited C. glabrata only and 3 isolates showed no activity against the tested Candida spp. The P. aeruginosa isolates inhibiting all Candida spp. were positive for all virulence genes. GC-Ms analysis revealed that isolates with high anticandidal activity showed spectra for several compounds, each known for their antifungal activity in comparison to those with low or no anticandidal activity. Hence, clinical isolates of P. aeruginosa showed Candida species-specific interactions by different means, giving rise to the importance of studying microbial interaction in polymicrobial infections and their contribution to causing disease.	[Abd El-Baky, Rehab Mahmoud; Hashem, Zeinab Shawky] Menia Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt; [Abd El-Baky, Rehab Mahmoud; Mandour, Sahar A.; Ahmed, Eman Farouk; Mohamed, Doaa Safwat] Deraya Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt; [Sandle, Tim] Univ Manchester, Div Pharm & Optometry, Sch Hlth Sci, Manchester, Lancs, England	Egyptian Knowledge Bank (EKB); Minia University; Deraya University; University of Manchester	Abd El-Baky, RM (corresponding author), Menia Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt.; Abd El-Baky, RM (corresponding author), Deraya Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt.	dr_rehab010@yahoo.com	El-Baky, Rehab Mahmoud Abd/AAK-7586-2021	El-Baky, Rehab Mahmoud Abd/0000-0001-6094-5653; Mandour, Sahar/0000-0003-2500-0480; Hashem, Zeinab Shawky/0000-0003-4216-8584				Aleksic I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02454; Almarzoqi A, 2015, MOL PHENOTYPIC STUDY; Amara A. A., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V5, P556; Balewski L, 2019, MOLECULES, V24, DOI 10.3390/molecules24224070; Bandara HMHN, 2013, MOL ORAL MICROBIOL, V28, P54, DOI 10.1111/omi.12006; Bandara HMHN, 2010, J MED MICROBIOL, V59, P1225, DOI 10.1099/jmm.0.021832-0; Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125; Bandara HMHN, 2009, J MED MICROBIOL, V58, P1623, DOI 10.1099/jmm.0.012989-0; Bardin EE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28665-7; Bengen I., 1985, NENNEN ERKLINGEN ZEI, P159; Brand A, 2008, FEMS MICROBIOL LETT, V287, P48, DOI 10.1111/j.1574-6968.2008.01301.x; Briard B, 2017, ISME J, V11, P1578, DOI 10.1038/ismej.2017.32; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x; Clancy C, 1998, 36 ANN M INF DIS SOC, P317; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Dhamgaye S, 2016, CELL MICROBIOL, V18, P1716, DOI 10.1111/cmi.12674; EDMONDS P, 1972, APPL MICROBIOL, V24, P219, DOI 10.1128/AEM.24.2.219-225.1972; Faraji F, 2016, MICROB PATHOGENESIS, V99, P1, DOI 10.1016/j.micpath.2016.07.013; Fuse K, 2013, J INFECT CHEMOTHER, V19, P82, DOI 10.1007/s10156-012-0457-9; Galdino A. C. M., 2017, PATHOPHYSIOLOGICAL A, P381, DOI [10.1007/978-981-10-6141-7_16, DOI 10.1007/978-981-10-6141-7_16, 10.1007/978-981, DOI 10.1007/978-981]; Ganesan AK, 1999, J BIOL CHEM, V274, P9503, DOI 10.1074/jbc.274.14.9503; Gibson J, 2009, APPL ENVIRON MICROB, V75, P504, DOI 10.1128/AEM.01037-08; GUTTERSON N, 1990, CRIT REV BIOTECHNOL, V10, P69, DOI 10.3109/07388559009038205; Hickey C, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00357; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Jung Kyung-Hwan, 2007, Mycobiology, V35, P39, DOI 10.4489/MYCO.2007.35.1.039; Kaleli I, 2007, MYCOSES, V50, P74, DOI 10.1111/j.1439-0507.2006.01322.x; Kandela S.A., 1997, ACTA MICROBIOL POL, V46, P37; KERR JR, 1994, J CLIN MICROBIOL, V32, P525, DOI 10.1128/JCM.32.2.525-527.1994; Kerr JR, 1999, J CLIN PATHOL, V52, P385, DOI 10.1136/jcp.52.5.385; Khattab M.A., 2015, J MICROBIAL BIOCH TE, V7, P274; Kuang ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027091; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; LEISINGER T, 1979, MICROBIOL REV, V43, P422, DOI 10.1128/MMBR.43.3.422-442.1979; Liu HM, 2007, CURR MICROBIOL, V54, P302, DOI 10.1007/s00284-006-0444-4; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Morales DK, 2010, MOL MICROBIOL, V78, P1379, DOI 10.1111/j.1365-2958.2010.07414.x; Muller MM, 2011, APPL MICROBIOL BIOT, V89, P585, DOI 10.1007/s00253-010-2901-z; Nowroozi J, 2012, CELL J, V14, P7; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Ovchinnikova ES, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-281; PUGH D, 1977, SABOURAUDIA, V15, P29; Rinzan FF, 2009, PSEUDOMONAS AERUGINO; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sabina J, 2009, EUKARYOT CELL, V8, P1314, DOI 10.1128/EC.00138-09; Sandven Per, 2000, Revista Iberoamericana de Micologia, V17, P73; Shi DM, 2016, INT J CLIN PHARM TH, V54, P343, DOI 10.5414/CP202460; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; STEWARTTULL DE, 1972, J MED MICROBIOL, V5, P67, DOI 10.1099/00222615-5-1-67; Stutzman PE, 1999, P INT C CEM MICR, DOI [10.1016/s0039-6257(99)00100-9 10588441, DOI 10.1016/S0039-6257(99)00100-9]; TAYLOR GW, 1995, J CHROMATOGR B, V664, P458, DOI 10.1016/0378-4347(94)00494-P; Terada LS, 1999, INFECT IMMUN, V67, P2371, DOI 10.1128/IAI.67.5.2371-2376.1999; Thippakorn C, 2018, EXCLI J, V17, P544, DOI 10.17179/excli2018-1238; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Wilbanks B, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0952-4; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; Xu LQ, 2017, INT J MED SCI, V14, P1368, DOI 10.7150/ijms.18896; Yang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09936; Yu H, 2014, CAN J MICROBIOL, V60, P227, DOI 10.1139/cjm-2013-0667	67	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2020	15	12							e0243418	10.1371/journal.pone.0243418	http://dx.doi.org/10.1371/journal.pone.0243418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8OF	33290412	gold, Green Published			2022-12-26	WOS:000598620100019
J	Abe, K; Wakabayashi, H; Nakayama, H; Suzuki, T; Kuroda, M; Yoshida, N; Tojo, J; Kogure, A; Rai, T; Saito, H; Mukai, S; Fujita, M; Hayashi, M; Takahashi, A; Ohira, H				Abe, Kazumichi; Wakabayashi, Hiroto; Nakayama, Haruo; Suzuki, Tomohiro; Kuroda, Masahito; Yoshida, Naoe; Tojo, Jun; Kogure, Atsuko; Rai, Tsuyoshi; Saito, Hironobu; Mukai, Shinji; Fujita, Masashi; Hayashi, Manabu; Takahashi, Atsushi; Ohira, Hiromasa			Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; SUSTAINED VIROLOGICAL RESPONSE; ALBUMIN-BILIRUBIN SCORE; LIVER-CIRRHOSIS; RISK-FACTORS; INTERFERON; THERAPY; INFECTION; REGIMENS; IMPACT	The present study aimed to investigate the incidence of hepatocellular carcinoma (HCC) and factors related to HCC occurrence after direct-acting antiviral (DAA) treatment in the Fukushima Liver Academic Group (FLAG). We conducted a multicenter retrospective cohort study of 1068 patients without cirrhosis (NC) or with compensated liver cirrhosis (LC) who achieved a sustained virologic response (SVR). First, we compared the cumulative HCC incidence and survival rates in NC (n = 880) and LC (n = 188) patients without a history of HCC treatment. Second, we performed multivariate analysis of factors related to HCC occurrence after DAA treatment. Overall, the average age was 65 years, and the male/female ratio was 511/557. Thirty-nine (4%) patients developed HCC. The cumulative 4-year HCC incidence and survival rates were 3.0% and 99.8% in NC patients and 11.5% and 98.5% in LC patients, respectively. The independent factors affecting HCC occurrence identified by multivariate analysis were the serum albumin (ALB) level before SVR for NC patients and the ALBI score, platelet count, and diabetes before SVR for LC patients. The factors related to HCC occurrence differed between NC and LC patients. Careful surveillance of post-SVR patients with these risk factors is needed.	[Abe, Kazumichi; Fujita, Masashi; Hayashi, Manabu; Takahashi, Atsushi; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan; [Abe, Kazumichi] Hanawa Kosei Hosp, Dept Internal Med, Higashishirakawa, Japan; [Wakabayashi, Hiroto] Takeda Gen Hosp, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan; [Nakayama, Haruo] Iwaki City Med Ctr, Dept Gastroenterol, Iwaki, Fukushima, Japan; [Suzuki, Tomohiro] Fukushima Rosai Hosp, Dept Gastroenterol, Iwaki, Fukushima, Japan; [Kuroda, Masahito] Fukushima Red Cross Hosp, Dept Gastroenterol, Fukushima, Japan; [Yoshida, Naoe] Iwase Gen Hosp, Dept Internal Med, Sukagawa, Japan; [Tojo, Jun] Cosmos Clin, Koriyama, Fukushima, Japan; [Kogure, Atsuko] Fujita Gen Hosp, Dept Gastroenterol, Date, Japan; [Rai, Tsuyoshi; Saito, Hironobu] Rai Clin, Miharu, Japan; [Mukai, Shinji] Ohta Nishinouchi Hosp, Dept Gastroenterol, Koriyama, Fukushima, Japan	Fukushima Medical University	Abe, K (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan.; Abe, K (corresponding author), Hanawa Kosei Hosp, Dept Internal Med, Higashishirakawa, Japan.	k-abe@fmu.ac.jp		Abe, Kazumichi/0000-0001-5359-9465				Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Chayama K, 2015, HEPATOLOGY, V61, P1523, DOI 10.1002/hep.27705; Ebel F, 2020, ALIMENT PHARM THER, V51, P194, DOI 10.1111/apt.15597; Gardini AC, 2019, DIGEST LIVER DIS, V51, P681, DOI 10.1016/j.dld.2018.09.016; Hedenstierna M, 2016, CLIN INFECT DIS, V63, P723, DOI 10.1093/cid/ciw362; Hiraoka A, 2017, LIVER CANCER, V6, P204, DOI 10.1159/000452846; Huang CF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004157; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Ioannou GN, 2019, GASTROENTEROLOGY, V157, P1264, DOI 10.1053/j.gastro.2019.07.033; Ioannou GN, 2018, J HEPATOL, V69, P1088, DOI 10.1016/j.jhep.2018.07.024; Ioannou GN, 2018, J HEPATOL, V68, P25, DOI 10.1016/j.jhep.2017.08.030; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kanda T, 2019, HEPATOL INT, V13, P649, DOI 10.1007/s12072-019-09988-7; Kanwal F, 2017, GASTROENTEROLOGY, V153, P996, DOI 10.1053/j.gastro.2017.06.012; Lei Q, 2018, EXP THER MED, V15, P3074, DOI 10.3892/etm.2018.5748; Liangpunsakul S, 2003, AM J MED SCI, V326, P111, DOI 10.1097/00000441-200309000-00001; Mecci AJ, 2019, ALIMENT PHARM THER, V50, P204, DOI 10.1111/apt.15296; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Ogata F, 2017, ONCOLOGY-BASEL, V93, P92, DOI 10.1159/000470910; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Shigefuku R, 2019, HEPATOL RES, V49, P1127, DOI 10.1111/hepr.13388; Shin HP, 2017, CLIN MOL HEPATOL, V23, P316, DOI 10.3350/cmh.2016.0087; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Singer AW, 2018, ALIMENT PHARM THER, V47, P1278, DOI 10.1111/apt.14593; Suda G, 2019, J GASTROENTEROL, V54, P641, DOI 10.1007/s00535-019-01556-y; Suda G, 2019, J GASTROENTEROL, V54, P78, DOI 10.1007/s00535-018-1495-6; Tanaka A, 2007, WORLD J GASTROENTERO, V13, P5180, DOI 10.3748/wjg.v13.i39.5180; Tani J, 2020, ONCOL LETT, V19, P2205, DOI 10.3892/ol.2020.11341; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1440-1746.2005.03800.x; Toyoda H, 2016, BRIT J CANCER, V114, P744, DOI 10.1038/bjc.2016.33; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vveksler BB, 2007, ALIMENT PHARM THER, V26, P13, DOI 10.1111/j.1365-2036.2007.03512.x; Watanabe T, 2019, HEPATOL RES, V49, P136, DOI 10.1111/hepr.13278; Yoshida EM, 2015, HEPATOLOGY, V61, P41, DOI 10.1002/hep.27366; Zou DL, 2016, TURK J GASTROENTEROL, V27, P180, DOI 10.5152/tjg.2016.15502	37	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0243473	10.1371/journal.pone.0243473	http://dx.doi.org/10.1371/journal.pone.0243473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284844	gold, Green Published			2022-12-26	WOS:000597930500027
J	Cui, CH; Liu, Y; Gerloff, D; Rohde, C; Pauli, C; Kohn, M; Misiak, D; Oellerich, T; Schwartz, S; Schmidt, LH; Wiewrodt, R; Marra, A; Hillejan, L; Bartel, F; Wickenhauser, C; Huttelmaier, S; Gollner, S; Zhou, FB; Edemir, B; Muller-Tidow, C				Cui, Chunhong; Liu, Yi; Gerloff, Dennis; Rohde, Christian; Pauli, Cornelius; Koehn, Marcel; Misiak, Danny; Oellerich, Thomas; Schwartz, Schraga; Schmidt, Lars-Henning; Wiewrodt, Rainer; Marra, Alessandro; Hillejan, Ludger; Bartel, Frank; Wickenhauser, Claudia; Huettelmaier, Stefan; Goellner, Stefanie; Zhou, Fengbiao; Edemir, Bayram; Mueller-Tidow, Carsten			NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration	ONCOGENE			English	Article							NONCODING RNA; DYSKERATOSIS-CONGENITA; SELF-RENEWAL; SNORNA U50; MUTATIONS; PSEUDOURIDYLATION; RECOGNITION; MICRORNAS; PROMOTES; MODOMICS	Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide underlining the urgent need for new biomarkers and therapeutic targets for this disease. Long noncoding RNAs are critical players in NSCLC but the role of small RNA species is not well understood. In the present study, we investigated the role of H/ACA box small nucleolar RNAs (snoRNAs) and snoRNA-bound ribonucleoproteins (snoRNPs) in the tumorigenesis of NSCLC. H/ACA box snoRNPs including the NOP10 core protein were highly expressed in NSCLC. High levels of either NOP10 mRNA or protein were associated with poor prognosis in NSCLC patients. Loss of NOP10 and subsequent reduction of H/ACA box snoRNAs and rRNA pseudouridylation inhibited lung cancer cell growth, colony formation, migration, and invasion. A focused CRISPR/Cas9 snoRNA knockout screen revealed that genomic deletion of SNORA65, SNORA7A, and SNORA7B reduced proliferation of lung cancer cells. In line, high levels of SNORA65, SNORA7A, and SNORA7B were observed in primary lung cancer specimens with associated changes in rRNA pseudouridylation. Knockdown of either SNORA65 or SNORA7A/B inhibited growth and colony formation of NSCLC cell lines. Our data indicate that specific H/ACA box snoRNAs and snoRNA-associated proteins such as NOP10 have an oncogenic role in NSCLC providing new potential biomarkers and therapeutic targets for the disease.	[Cui, Chunhong; Liu, Yi; Rohde, Christian; Goellner, Stefanie; Zhou, Fengbiao; Mueller-Tidow, Carsten] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, D-69120 Heidelberg, Germany; [Gerloff, Dennis; Pauli, Cornelius; Edemir, Bayram] Martin Luther Univ Halle Wittenberg, Dept Hematol & Oncol, D-06120 Halle, Saale, Germany; [Koehn, Marcel; Misiak, Danny; Huettelmaier, Stefan; Goellner, Stefanie] Martin Luther Univ Halle Wittenberg, Inst Mol Med, D-06120 Halle, Saale, Germany; [Oellerich, Thomas] Goethe Univ, Dept Med 2, Hematol Oncol, D-60590 Frankfurt, Germany; [Oellerich, Thomas] German Canc Res Ctr, German Canc Consortium, D-69120 Heidelberg, Germany; [Oellerich, Thomas] Frankfurt Canc Inst, Dept Mol Diagnost Translat Prote, D-60596 Frankfurt, Germany; [Schwartz, Schraga] Weizmann Inst Sci, Rehovot, Israel; [Schmidt, Lars-Henning; Wiewrodt, Rainer] Univ Munster, Dept Med A, D-48149 Munster, Germany; [Marra, Alessandro] Rems Murr Kliniken, Dept Surg, Thorac Surg, D-71364 Winnenden, Germany; [Hillejan, Ludger] Niels Stensen Kliniken, Dept Thorac Surg, D-49179 Ostercappeln, Germany; [Bartel, Frank; Wickenhauser, Claudia] Martin Luther Univ Halle Wittenberg, Inst Pathol, D-06097 Halle, Saale, Germany; [Mueller-Tidow, Carsten] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Cui, Chunhong] Shanghai Univ Med & Hlth Sci, Shanghai 201318, Peoples R China; [Gerloff, Dennis] Martin Luther Univ Halle Wittenberg, Dept Dermatol & Venereol, D-06120 Halle, Saale, Germany; [Schmidt, Lars-Henning] Klinikum Ingolstadt, Klin Pneumol Beatmungsmed & Thorakale Onkol, D-85049 Ingolstadt, Germany	Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Weizmann Institute of Science; University of Munster; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Shanghai University of Medicine & Health Sciences; Martin Luther University Halle Wittenberg	Muller-Tidow, C (corresponding author), Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, D-69120 Heidelberg, Germany.; Muller-Tidow, C (corresponding author), Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany.	Carsten.Mueller-Tidow@med.uni-heidelberg.de	Misiak, Danny/AAV-9317-2020; Hüttelmaier, Stefan/AAQ-1203-2021; Zhou, Fengbiao/AAL-3221-2021	Misiak, Danny/0000-0001-5931-8425; Zhou, Fengbiao/0000-0002-9221-1096; Cui, Chunhong/0000-0002-7705-204X	German Research Foundation (DFG) [ZH831/1-1, MU1328/15-1, MU1328/18-1]; German Cancer Aid (DKH) [70112974, 70113908]; German Jose-Carreras Leukemia Foundation (DJCLS) [22R/2017]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid (DKH)(Deutsche Krebshilfe); German Jose-Carreras Leukemia Foundation (DJCLS)	We thank Katrin Nerger for excellent technical assistance and Dr. sc. agr. Volker Eckstein and Stefanie Hofmann for cell sorting. We are grateful to Annette Becker, M.A., for help with project organization. Research reported in this publication was (in part) supported by funds from the German Research Foundation (DFG; ZH831/1-1 to F. Z., MU1328/15-1 and MU1328/18-1 to C.M-T.), the German Cancer Aid (DKH; Projects 70112974 and 70113908 to C.M-T.) and the German Jose-Carreras Leukemia Foundation (DJCLS; 22R/2017 to C.M-T).	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Aubrey BJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026062; Bakin AV, 1998, METH MOL B, V77, P297; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chang LS, 2002, BIOCHEM BIOPH RES CO, V299, P196, DOI 10.1016/S0006-291X(02)02623-2; Chen JB, 2018, J CANCER, V9, P4774, DOI 10.7150/jca.25811; Chen LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08588; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fernandez-Marcelo T, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0195-9; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Kiss AM, 2002, NUCLEIC ACIDS RES, V30, P4643, DOI 10.1093/nar/gkf592; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; de Sousa VML, 2018, PATHOBIOLOGY, V85, P96, DOI 10.1159/000487440; Lekka E, 2018, FEBS LETT, V592, P2884, DOI 10.1002/1873-3468.13182; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lu QC, 2018, FASEB J, V32, P3957, DOI 10.1096/fj.201701237RR; Machnicka Magdalena A, 2013, Nucleic Acids Res, V41, pD262, DOI 10.1093/nar/gks1007; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Massenet S, 2017, RNA BIOL, V14, P680, DOI 10.1080/15476286.2016.1243646; McMahon M, 2015, WIRES RNA, V6, P173, DOI 10.1002/wrna.1266; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Okugawa Y, 2017, GUT, V66, P107, DOI 10.1136/gutjnl-2015-309359; Pao W, 2004, SEMIN CANCER BIOL, V14, P33, DOI 10.1016/j.semcancer.2003.11.005; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Penzo M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020038; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Yoshihama Maki, 2013, BMC Res Notes, V6, P426, DOI 10.1186/1756-0500-6-426; Zaringhalam M, 2016, METHODS, V107, P63, DOI 10.1016/j.ymeth.2016.03.001; Zhang Y, 2017, STEM CELLS, V35, P222, DOI 10.1002/stem.2490; Zhou FB, 2017, NAT CELL BIOL, V19, P844, DOI 10.1038/ncb3563	53	17	17	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2021	40	5					909	921		10.1038/s41388-020-01570-y	http://dx.doi.org/10.1038/s41388-020-01570-y		DEC 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QC5NB	33288886	Green Published, hybrid			2022-12-26	WOS:000599015000001
J	Han, J; Qu, HB; Han, ML; Ding, YC; Xie, MW; Hu, JG; Chen, YW; Dong, HY				Han, Jing; Qu, Hongbo; Han, Mingli; Ding, Yichao; Xie, Mingwei; Hu, Jianguo; Chen, Yuanwen; Dong, Huaying			MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer	ONCOGENE			English	Article							RNA; METASTASIS; BIOMARKERS; PROLIFERATION; EMTANSINE; LAPATINIB; HER2	Trastuzumab resistance has been becoming a major obstacle for treatment of HER-2-positive breast cancer patients. Increasing evidence suggests that mesenchymal stem cells (MSCs) play critical roles during the formation of drug resistance, however, the underlying mechanism is not well known. In this study, mass spectrometry, RNA pulldown and RNA immunoprecipitation assays were performed to verify the direct interactions among AGAP2-AS1 and other associated targets, such as human antigen R (HuR), miR-15a-5p, and carnitine palmitoyl transferase 1 (CPT1). In vitro and in vivo experimental assays were done to clarify the functional role of AGAP2-AS1 in trastuzumab resistance, stemness, and fatty acid oxidation (FAO). The results showed that MSC co-culture induced trastuzumab resistance. AGAP2-AS1 was upregulated in MSC-cultured cells, and knockdown of AGAP2-AS1 reversed the MSC-mediated trastuzumab resistance. Furthermore, MSC culture-induced AGAP2-AS1 regulates stemness and trastuzumab resistance via activating FAO. Mechanistically, AGAP2-AS1 is associated with HuR, and the AGAP2-AS1-HuR complex could directly bind to the CPT1, increasing its expression via improving RNA stability. In addition, AGAP2-AS1 could serve as ceRNA via sponging miR-15a-5p and releasing CPT1 mRNA. Clinically, increased expression of serum AGAP2-AS1 predicts poor response to trastuzumab treatment in breast cancer patients. In conclusion, MSC culture-induced AGAP2-AS1 caused stemness and trastuzumab resistance via promoting CPT1 expression and inducing FAO. Our results provide new insight of the role of MSCs in trastuzumab resistance and AGAP2-AS1 could be promising predictive biomarker and therapeutic target for HER-2+ breast cancer patients.	[Han, Jing; Ding, Yichao; Xie, Mingwei; Dong, Huaying] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Gen Surg, Haikou 570311, Hainan, Peoples R China; [Qu, Hongbo] First Peoples Hosp Chenzhou City, Dept Breast & Thyroid Surg, Chenzhou City 423000, Hunan, Peoples R China; [Han, Mingli] Zhengzhou Univ, Affiliated Hosp 1, Dept Breast Surg, Zhengzhou 450052, Peoples R China; [Hu, Jianguo] Chongqing Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Chongqing 400010, Peoples R China; [Chen, Yuanwen] Univ Chinese Acad Sci, Chongqing Renji Hosp, Dept Gen Surg, Chongqing 400062, Peoples R China	Hainan Medical University; Zhengzhou University; Chongqing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, HY (corresponding author), Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Gen Surg, Haikou 570311, Hainan, Peoples R China.	dr_dhy@163.com		Dong, Huaying/0000-0002-4905-6940	National Natural Science Foundation of China [81960475, 82072932]; "Nanhai series" talent cultivation program of Hainan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Nanhai series" talent cultivation program of Hainan Province	This study is supported by National Natural Science Foundation of China (81960475, 82072932) and The "Nanhai series" talent cultivation program of Hainan Province.	Amadori D, 2011, EUR J CANCER, V47, P2091, DOI 10.1016/j.ejca.2011.05.005; Arshi A, 2018, MOL THER-NUCL ACIDS, V12, P751, DOI 10.1016/j.omtn.2018.07.014; Bai Y, 2019, J CELL PHYSIOL, V234, P18837, DOI 10.1002/jcp.28522; Bakheet T, 2018, BBA-GENE REGUL MECH, V1861, P167, DOI 10.1016/j.bbagrm.2017.12.006; Bighin C, 2013, FUTURE ONCOL, V9, P955, DOI [10.2217/fon.13.74, 10.2217/FON.13.74]; Boero S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0680-0; Borst P, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120066; Chen RS, 2020, J CELL BIOCHEM, V121, P4043, DOI 10.1002/jcb.29573; Choi HJ, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101589; Cuiffo BG, 2014, CELL STEM CELL, V15, P762, DOI 10.1016/j.stem.2014.10.001; Di C, 2015, EXP THER MED, V9, P289, DOI 10.3892/etm.2014.2141; Dong HY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0875-3; Freudenberg JA, 2009, EXP MOL PATHOL, V87, P1, DOI 10.1016/j.yexmp.2009.05.001; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Ghoveud E, 2020, NEUROMOL MED, V22, P111, DOI 10.1007/s12017-019-08570-6; Han ML, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1145-5; He WM, 2019, ONCOGENE, V38, P4637, DOI 10.1038/s41388-019-0747-0; HUANG P, 2018, SCI REP UK, V8; Hui BQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1384-9; Kang M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0845-9; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li N, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0828-0; Li ZX, 2019, EXP THER MED, V18, P435, DOI 10.3892/etm.2019.7629; Liu ZK, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1188-x; Liu ZX, 2019, ONCOGENE, V38, P88, DOI 10.1038/s41388-018-0407-9; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luo N, 2020, J CELL BIOCHEM, V121, P4176, DOI 10.1002/jcb.29572; Montemurro F, 2014, MOL ONCOL, V8, P20, DOI 10.1016/j.molonc.2013.08.013; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; PEREZ EA, 2019, BMC CANCER, V19; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Ponde N, 2018, BREAST CANCER RES TR, V168, P631, DOI 10.1007/s10549-017-4628-3; Qian C, 2019, J CELL PHYSIOL, V234, P11620, DOI 10.1002/jcp.27819; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017; Seymour L, 2017, LANCET ONCOL, V18, pE143, DOI 10.1016/S1470-2045(17)30074-8; Shetty P, 2017, ANN CLIN BIOCHEM, V54, P463, DOI 10.1177/0004563216665867; Shi SJ, 2015, ONCOTARGET, V6, P11652, DOI 10.18632/oncotarget.3457; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song XY, 2020, J CELL MOL MED, V24, P772, DOI 10.1111/jcmm.14786; Storti CB, 2020, EXP MOL PATHOL, V112, DOI 10.1016/j.yexmp.2019.104354; Tian T, 2018, MOL THER-NUCL ACIDS, V12, P359, DOI 10.1016/j.omtn.2018.05.018; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2426-z; Yang XJ, 2020, EXP THER MED, V19, P3097, DOI 10.3892/etm.2020.8558; Zhang JW, 2017, NUCLEIC ACIDS RES, V45, P2849, DOI 10.1093/nar/gkw991; Zhang W, 2018, INT J ONCOL, V53, P527, DOI 10.3892/ijo.2018.4412; Zhu HY, 2018, BIOCHEM BIOPH RES CO, V496, P1308, DOI 10.1016/j.bbrc.2018.02.006	48	34	34	6	25	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2021	40	4					833	847		10.1038/s41388-020-01574-8	http://dx.doi.org/10.1038/s41388-020-01574-8		DEC 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QA4GO	33273726				2022-12-26	WOS:000599064900002
J	Singh, D; Sharma, NL; Singh, CK; Sarkar, SK; Singh, I; Dotaniya, ML				Singh, Deepti; Sharma, Nithi Lal; Singh, Chandan Kumar; Sarkar, Susheel Kumar; Singh, Ishwar; Dotaniya, Mohan Lal			Effect of chromium (VI) toxicity on morpho-physiological characteristics, yield, and yield components of two chickpea (Cicer arietinum L.) varieties	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; PLANT-GROWTH; OXIDATIVE STRESS; ANTIOXIDATIVE DEFENSE; LEAD TOXICITY; HEAVY-METALS; CR UPTAKE; ACID; PHOTOSYNTHESIS; TOLERANCE	The ever-increasing industrial activities over the decades have generated high toxic metal such as chromium (Cr) that hampers the crop productivity. This study evaluated the effect of Cr on two chickpea (Cicer arietinum L.) varieties, Pusa 2085 and Pusa Green 112, in hydroponic and pot-grown conditions. First, growth parameters (seed germination, seedling growth, and biomass production) and physio-biochemical parameters (oxidative stress and the content of antioxidants and proline) were measured to evaluate the performance of both varieties grown hydroponically for 21 days at concentrations of 0, 30, 60, 90 and 120 mu M Cr in the form of potassium dichromate (K2Cr2O7). In both varieties, significantly deleterious effects on germination and seedling growth parameters were observed at 90 and 120 mu M, while growth was stimulated at 30 mu M Cr. Significant increases in malondialdehyde and hydrogen peroxide content and electrolyte leakage demonstrated enhanced oxidative injury to seedlings caused by higher concentrations of Cr. Further, increasing concentrations of Cr positively correlated with increased proline content, superoxide dismutase activity, and peroxide content in leaves. There was also an increase in peroxisomal ascorbate peroxidase and catalase in the leaves of both varieties at lower Cr concentrations, whereas a steep decline was recorded at higher Cr concentrations. In the pot experiments conducted over two consecutive years, growth, yield, yield attributes, grain protein, and Cr uptake and accumulation were measured at different Cr concentrations. Pusa Green 112 showed a significant reduction in plant growth, chlorophyll content, grain protein, pod number, and grain yield per plant when compared with Pusa 2085. Overall, our results indicate that Pusa 2085 has a higher Cr tolerance than Pusa Green 112. Therefore, Pusa 2085 could be used to further elucidate the mechanisms of Cr tolerance in plants and in breeding programmes to produce Cr-resistant varieties.	[Singh, Deepti; Sharma, Nithi Lal] Meerut Univ, Dept Bot, Meerut, Uttar Pradesh, India; [Singh, Chandan Kumar] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Sarkar, Susheel Kumar] ICAR Indian Agr Stat Res Inst, Div Design Expt DE, New Delhi, India; [Singh, Ishwar] CCS Univ, Dept Bot, Meerut, Uttar Pradesh, India; [Dotaniya, Mohan Lal] ICAR Directorate Rapeseed Mustard Res Sewar, Bharatpur, India	Chaudhary Charan Singh University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Chaudhary Charan Singh University; Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Rapeseed & Mustard Research	Singh, D (corresponding author), Meerut Univ, Dept Bot, Meerut, Uttar Pradesh, India.	deep.botanydu@gmail.com		Singh, Dr. Deepti/0000-0002-9683-8363; Sarkar, Susheel/0000-0002-2406-4012; Dotaniya, M L/0000-0001-9311-088X	Head of Department of Botany, Meerut College, Meerut, Uttar Pradesh, India	Head of Department of Botany, Meerut College, Meerut, Uttar Pradesh, India	We are grateful to the Head of Department of Botany, Meerut College, Meerut, Uttar Pradesh, India, and Dr. Dharmendra Singh, Principal Scientist, Division of Genetics, IARI, New Delhi, for providing support to carry out all the research activities.	Adrees M, 2015, ECOTOX ENVIRON SAFE, V122, P1, DOI 10.1016/j.ecoenv.2015.07.003; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Afshan S, 2015, ENVIRON SCI POLLUT R, V22, P11679, DOI 10.1007/s11356-015-4396-8; Ahmad R, 2020, ENVIRON SCI POLLUT R, V27, P1101, DOI 10.1007/s11356-019-06761-z; Ahmad R, 2020, PHYSIOL PLANTARUM, V168, P289, DOI 10.1111/ppl.13001; Akinci IE, 2010, AFR J BIOTECHNOL, V9, P4589; Ali B, 2014, IND CROP PROD, V52, P617, DOI 10.1016/j.indcrop.2013.11.033; Ali S, 2013, BIOL PLANTARUM, V57, P758, DOI 10.1007/s10535-013-0336-y; Ali S, 2011, PLANT SOIL ENVIRON, V57, P153, DOI 10.17221/335/2010-PSE; Ali S, 2015, ENVIRON SCI POLLUT R, V22, P10669, DOI 10.1007/s11356-015-4193-4; Ali S, 2015, ENVIRON SCI POLLUT R, V22, P10601, DOI 10.1007/s11356-015-4271-7; Ali Z, 2015, INT J ENVIRON SCI TE, V12, P537, DOI 10.1007/s13762-013-0428-4; Anjum SA, 2017, PEDOSPHERE, V27, P262, DOI 10.1016/S1002-0160(17)60315-1; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf U, 2015, ENVIRON SCI POLLUT R, V22, P18318, DOI 10.1007/s11356-015-5463-x; Balal RM, 2017, ENVIRON EXP BOT, V140, P8, DOI 10.1016/j.envexpbot.2017.05.011; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BISHNOI NR, 1993, J PLANT PHYSIOL, V142, P25, DOI 10.1016/S0176-1617(11)80102-1; Chaturvedi S, 2014, ANN PHYTOMEDICINE, V3, P50; Chow YN, 2018, J CLEAN PROD, V202, P101, DOI 10.1016/j.jclepro.2018.07.144; Gomes MAD, 2017, ECOTOX ENVIRON SAFE, V140, P55, DOI 10.1016/j.ecoenv.2017.01.042; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Dheeba B, 2015, J TOXICOL-US, V2015, DOI 10.1155/2015/367217; Diwan H, 2010, PLANT GROWTH REGUL, V61, P97, DOI 10.1007/s10725-010-9454-0; Dotaniya ML, 2014, ENVIRON MONIT ASSESS, V186, P2957, DOI 10.1007/s10661-013-3593-5; Fahad S, 2015, CLEAN-SOIL AIR WATER, V43, P1433, DOI 10.1002/clen.201400376; Gautam V, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020164; Gill RA, 2016, ENVIRON SCI POLLUT R, V23, P20483, DOI 10.1007/s11356-016-7167-2; Gill RA, 2015, PLANT PHYSIOL BIOCH, V94, P130, DOI 10.1016/j.plaphy.2015.06.001; Gill RA, 2015, CHEMOSPHERE, V120, P154, DOI 10.1016/j.chemosphere.2014.06.029; HAHN H, 1992, IFAC WORK S, P208; Hasan SA, 2008, ENVIRON POLLUT, V151, P60, DOI 10.1016/j.envpol.2007.03.006; Hayat S, 2012, PROTOPLASMA, V249, P599, DOI 10.1007/s00709-011-0331-0; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hira Amin, 2013, American Journal of Plant Sciences, V4, P2431, DOI 10.4236/ajps.2013.412302; Hussain A, 2018, ENVIRON POLLUT, V242, P1518, DOI 10.1016/j.envpol.2018.08.036; Hussein AM, 2019, J MATERN-FETAL NEO M, V32, P3386, DOI 10.1080/14767058.2018.1463986; Islam F, 2016, PLANT PHYSIOL BIOCH, V108, P456, DOI 10.1016/j.plaphy.2016.08.014; ISWARAN V, 1980, Geobios (Jodhpur), V7, P281; Jabeen N, 2016, ARCH AGRON SOIL SCI, V62, P648, DOI 10.1080/03650340.2015.1082032; Jain Radha, 2000, Indian Journal of Plant Physiology, V5, P228; Jamshed Zaidi, 2017, African Journal of Environmental Science and Technology, V11, P255, DOI 10.5897/ajest2017.2299; JANA S, 1981, AQUAT BOT, V11, P67, DOI 10.1016/0304-3770(81)90047-4; Karthik C, 2016, J ADV RES, V7, P839, DOI 10.1016/j.jare.2016.08.007; Khaliq A, 2016, ARCH AGRON SOIL SCI, V62, P633, DOI 10.1080/03650340.2015.1073263; Kumar P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52479-w; Kumar R, 2014, SPECTROSC LETT, V47, P554, DOI 10.1080/00387010.2013.824901; Kundu D, 2018, GENES ENVIRON, V40, DOI 10.1186/s41021-018-0109-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma J, 2016, ENVIRON SCI POLLUT R, V23, P1768, DOI 10.1007/s11356-015-5439-x; METZNER H, 1965, PLANTA, V65, P186, DOI 10.1007/BF00384998; Mobin M, 2007, J PLANT PHYSIOL, V164, P601, DOI 10.1016/j.jplph.2006.03.003; Muslu A, 2013, BANGL J BOT, V42, P105; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Pourrut B., 2013, HEAVY METAL STRESS P, P121, DOI DOI 10.1007/978-3-642-38469-1_7; Rai V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934182; Rajendran M, 2019, J CENT SOUTH UNIV, V26, P489, DOI 10.1007/s11771-019-4021-y; Rodriguez E, 2012, PLANT PHYSIOL BIOCH, V53, P94, DOI 10.1016/j.plaphy.2012.01.013; Samantaray S., 2015, DISCOVERY, V27, P27; Shahid M, 2017, CHEMOSPHERE, V178, P513, DOI 10.1016/j.chemosphere.2017.03.074; Shanker AK, 2005, ENVIRON INT, V31, P739, DOI 10.1016/j.envint.2005.02.003; Sharma A, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010100; SHARMA DC, 1995, PLANT SCI, V111, P145, DOI 10.1016/0168-9452(95)04230-R; Sharma P, 2016, ENVIRON EXP BOT, V122, P1, DOI 10.1016/j.envexpbot.2015.08.005; SIMON L, 1994, J PLANT NUTR, V17, P293, DOI 10.1080/01904169409364728; Singh HP, 2013, ENVIRON CHEM LETT, V11, P229, DOI 10.1007/s10311-013-0407-5; Sinha S, 2005, CHEMOSPHERE, V58, P595, DOI 10.1016/j.chemosphere.2004.08.071; SINHA SK, 1988, B ENVIRON CONTAM TOX, V41, P419, DOI 10.1007/BF01688888; Sundaramoorthy P, 2010, CR BIOL, V333, P597, DOI 10.1016/j.crvi.2010.03.002; Tang JianMin, 2012, African Journal of Biotechnology, V11, P2248; Ten-Year Strategy to Reduce Vitamin and Mineral Deficiencies Maternal Infant and Young Child Nutrition Working Group: Formulations Subgroup, 2009, FOOD NUTR B S, V30, pS239; Valentovic P, 2006, PLANT SOIL ENVIRON, V52, P186, DOI 10.17221/3364-PSE; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; Wani PA, 2007, AUST J EXP AGR, V47, P712, DOI 10.1071/EA05369; Wani PA, 2008, BIOTECHNOL LETT, V30, P159, DOI 10.1007/s10529-007-9515-2; Yang JX, 2010, J ENVIRON SCI, V22, P696, DOI 10.1016/S1001-0742(09)60165-0; Zewail RMY, 2020, J PLANT NUTR, V43, P1268, DOI 10.1080/01904167.2020.1727504; Zhao YY, 2019, ECOTOX ENVIRON SAFE, V173, P314, DOI 10.1016/j.ecoenv.2019.01.090; Zou JH, 2009, ACTA BIOL CRACOV BOT, V51, P23	83	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243032	10.1371/journal.pone.0243032	http://dx.doi.org/10.1371/journal.pone.0243032			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270694	Green Published, gold			2022-12-26	WOS:000597149100039
J	Wang, M				Wang, Meng			Applying Internet information technology combined with deep learning to tourism collaborative recommendation system	PLOS ONE			English	Article								Recently, more personalized travel methods have emerged in the tourism industry, such as individual travel and self-guided travel. The service models of traditional tourism limit the diversity of service options and cannot fully meet the individual needs of tourists anymore. The aim is to integrate sparse tourism information on the Internet, thereby providing more convenient, faster, and more personalized tourism services. Based on the shortcomings of the traditional tourism recommendation system, a deep learning-based classification processing method of tourism product information is proposed. This method uses word embedding in the data preprocessing stage. The Convolutional Neural Network (CNN) is used to process review information of users and tourism service items. The Deep Neural Network (DNN) is used to process the necessary information of users and tourism service items. Also, factorization machine technology is used to learn the interaction between the extracted features to improve the prediction model. The results show that the proposed model can maintain an excellent precision of 64.2% when generating personalized recommendation lists for users. The sensitivity and accuracy of the recommendation list are better than other algorithms. By adding DNN, the word embedding method, and the factorization machine model, the precision is improved by 30%, 33.3%, and 40%, respectively. The model accuracy is the highest with 40 hidden factors, 100 convolutions, and a 100+50 combination hidden layer. Compared with traditional methods, the proposed algorithm can provide users with personalized travel products more accurately in personalized travel recommendations. The results have enriched and developed the theory of tourism service supply chain, providing a reference for constructing a personalized tourism service system.	[Wang, Meng] Henan Univ Engn, Sch Econ & Trade, Zhengzhou, Henan, Peoples R China	Henan University of Engineering	Wang, M (corresponding author), Henan Univ Engn, Sch Econ & Trade, Zhengzhou, Henan, Peoples R China.	wangmeng8194@outlook.com						Chang P, 2018, AM J NEURORADIOL, V39, P1201, DOI 10.3174/ajnr.A5667; Chen L, 2020, EXPERT SYST APPL, V144, DOI 10.1016/j.eswa.2019.113070; Colomo-Palacios R, 2017, PERVASIVE MOB COMPUT, V38, P505, DOI 10.1016/j.pmcj.2016.03.001; De Pessemier T, 2017, MULTIMED TOOLS APPL, V76, P2787, DOI 10.1007/s11042-016-3265-x; Flyverbom M, 2019, BUS SOC, V58, P3, DOI 10.1177/0007650317727540; Guo JP, 2018, J MANAGE INFORM SYST, V35, P1121, DOI 10.1080/07421222.2018.1523564; Hesmondhalgh D, 2018, INFORM COMMUN SOC, V21, P1555, DOI 10.1080/1369118X.2017.1340498; Huang CD, 2017, INFORM MANAGE-AMSTER, V54, P757, DOI 10.1016/j.im.2016.11.010; Lee HeeJun, 2020, [Smart Media Journal, 스마트미디어저널], V9, P45; Li J, 2018, TOURISM MANAGE, V69, P317, DOI 10.1016/j.tourman.2018.06.027; Liu M, 2017, TSINGHUA SCI TECHNOL, V22, P619, DOI 10.23919/TST.2017.8195345; Liu WB, 2017, NEUROCOMPUTING, V234, P11, DOI 10.1016/j.neucom.2016.12.038; Long Y, 2017, TOURISM MANAGE, V62, P302, DOI 10.1016/j.tourman.2017.05.002; Miah SJ, 2017, INFORM MANAGE-AMSTER, V54, P771, DOI 10.1016/j.im.2016.11.011; Perez-Morales A, 2018, J FLOOD RISK MANAG, V11, pS302, DOI 10.1111/jfr3.12207; Rinaldi A, 2019, QUAL QUANT, P1; Schmitt JB, 2018, INFORM COMMUN SOC, V21, P1151, DOI 10.1080/1369118X.2017.1305427; Sony M, 2018, PROD MANUF RES, V6, P416, DOI 10.1080/21693277.2018.1540949; Tian YH, 2019, PROC CIRP, V83, P490, DOI 10.1016/j.procir.2019.04.126; Winkler JK, 2019, JAMA DERMATOL, V155, P1135, DOI 10.1001/jamadermatol.2019.1735; Yin HZ, 2017, IEEE T KNOWL DATA EN, V29, P2537, DOI 10.1109/TKDE.2017.2741484; Zhu ZY, 2019, NEUROCOMPUTING, V323, P62, DOI 10.1016/j.neucom.2018.09.050; Zintgraf LM, 2017, ARXIV170204595, P26; Ziyadin S., 2019, INT J CIVIL ENG TECH, V10, P1055	24	8	8	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0240656	10.1371/journal.pone.0240656	http://dx.doi.org/10.1371/journal.pone.0240656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AH	33271589	Green Published, gold			2022-12-26	WOS:000597149100054
J	Dangerfield, TL; Johnson, KA				Dangerfield, Tyler L.; Johnson, Kenneth A.			Conformational dynamics during high-fidelity DNA replication and translocation defined using a DNA polymerase with a fluorescent artificial amino acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE INCORPORATION; KINETIC MECHANISM; PYROPHOSPHATE RELEASE; ESCHERICHIA-COLI; RNA-POLYMERASE; INDUCED-FIT; FREE-ENERGY; EXONUCLEASE; TEMPERATURE; SPECIFICITY	We address the role of enzyme conformational dynamics in specificity for a high-fidelity DNA polymerase responsible for genome replication. We present the complete characterization of the conformational dynamics during the correct nucleotide incorporation forward and reverse reactions using stopped-flow and rapid-quench methods with a T7 DNA polymerase variant containing a fluorescent unnatural amino acid, (7-hydroxy-4-coumarin-yl) ethylglycine, which provides a signal for enzyme conformational changes. We show that the forward conformational change (>6000 s(-1)) is much faster than chemistry (300 s(-1)) while the enzyme opening to allow release of bound nucleotide (1.7 s(-1)) is much slower than chemistry. These parameters show that the conformational change selects a correct nucleotide for incorporation through an induced-fit mechanism. We also measured conformational changes occurring after chemistry and during pyrophosphorolysis, providing new insights into processive polymerization. Pyrophosphorolysis occurs via a conformational selection mechanism as the pyrophosphate binds to a rare pretranslocation state of the enzyme-DNA complex. Global data fitting was achieved by including experiments in the forward and reverse directions to correlate conformational changes with chemical reaction steps. This analysis provided well-constrained values for nine rate constants to establish a complete free-energy profile including the rates of DNA translocation during processive synthesis. Translocation does not follow Brownian ratchet or power stroke models invoking nucleotide binding as the driving force. Rather, translocation is rapid and thermodynamically favorable after enzyme opening and pyrophosphate release, and it appears to limit the rate of processive synthesis at 4 degrees C.	[Dangerfield, Tyler L.; Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu		Dangerfield, Tyler/0000-0003-1413-2082; Johnson, Kenneth/0000-0002-6575-2823	NIH [1 R01 GM114223, R01AI110577]; Welch Foundation [F-1604]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	This work was supported by grants from NIH (1 R01 GM114223 and R01AI110577 to K. A. J.) and the Welch Foundation (F-1604 to K. A. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atis M, 2017, J PHYS CHEM B, V121, P9557, DOI 10.1021/acs.jpcb.7b08320; Bakhtina M, 2009, BIOCHEMISTRY-US, V48, P3197, DOI 10.1021/bi802119f; Balbo PB, 2011, BIOCHEMISTRY-US, V50, P9865, DOI 10.1021/bi200954r; Benkovic SJ, 1995, METHOD ENZYMOL, V262, P257; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Dahl JM, 2012, J BIOL CHEM, V287, P13407, DOI 10.1074/jbc.M111.338418; Dangerfield TL, 2020, J BIOL CHEM, V295, P17265, DOI 10.1074/jbc.RA120.015557; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fernandez-Leiro R, 2017, NAT STRUCT MOL BIOL, V24, P140, DOI 10.1038/nsmb.3348; Fiala KA, 2008, NUCLEIC ACIDS RES, V36, P1990, DOI 10.1093/nar/gkn004; Foster BM, 2019, BIOCHEMISTRY-US, V58, P4466, DOI 10.1021/acs.biochem.9b00525; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Guo Q, 2006, J MOL BIOL, V358, P241, DOI 10.1016/j.jmb.2006.02.001; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; HEINONEN J, 1974, ANAL BIOCHEM, V59, P366, DOI 10.1016/0003-2697(74)90288-7; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kirmizialtin S, 2015, J PHYS CHEM B, V119, P11513, DOI 10.1021/acs.jpcb.5b05467; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Lee HR, 2008, J BIOL CHEM, V283, P14402, DOI 10.1074/jbc.M705007200; Li A, 2017, J BIOL CHEM, V292, P6695, DOI 10.1074/jbc.M116.760827; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Lieberman KR, 2013, J AM CHEM SOC, V135, P9149, DOI 10.1021/ja403640b; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Oertell K, 2016, P NATL ACAD SCI USA, V113, pE2277, DOI 10.1073/pnas.1600279113; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Prasad BR, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1288-6; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tsai YC, 2009, ANAL BIOCHEM, V384, P136, DOI 10.1016/j.ab.2008.09.006; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Xu CL, 2014, J MOL BIOL, V426, P2901, DOI 10.1016/j.jmb.2014.06.003; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	41	6	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100143	10.1074/jbc.RA120.016617	http://dx.doi.org/10.1074/jbc.RA120.016617			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33273013	Green Published, gold			2022-12-26	WOS:000672866400121
J	LaBreck, CJ; Trebino, CE; Ferreira, CN; Morrison, JJ; DiBiasio, EC; Conti, J; Camberg, JL				LaBreck, Christopher J.; Trebino, Catherine E.; Ferreira, Colby N.; Morrison, Josiah J.; DiBiasio, Eric C.; Conti, Joseph; Camberg, Jodi L.			Degradation of MinD oscillator complexes by Escherichia coli ClpXP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION INHIBITOR MINC; TO-POLE OSCILLATION; N-TERMINAL DOMAIN; CELL-DIVISION; TOPOLOGICAL REGULATION; ASSEMBLY DYNAMICS; RAPID POLE; Z-RING; PROTEIN; ATP	MinD is a cell division ATPase in Escherichia coli that oscillates from pole to pole and regulates the spatial position of the cell division machinery. Together with MinC and MinE, the Min system restricts assembly of the FtsZ-ring to midcell, oscillating between the opposite ends of the cell and preventing FtsZ-ring misassembly at the poles. Here, we show that the ATP-dependent bacterial proteasome complex ClpXP degrades MinD in reconstituted degradation reactions in vitro and in vivo through direct recognition of the MinD N-terminal region. MinD degradation is enhanced during stationary phase, suggesting that ClpXP regulates levels of MinD in cells that are not actively dividing. ClpXP is a major regulator of growth phase-dependent proteins, and these results suggest that MinD levels are also controlled during stationary phase. In vitro, MinC and MinD are known to coassemble into linear polymers; therefore, we monitored copolymers assembled in vitro after incubation with ClpXP and observed that ClpXP promotes rapid MinCD copolymer destabilization and direct MinD degradation by ClpXP. The N terminus of MinD, including residue Arg 3, which is near the ATP-binding site in sequence, is critical for degradation by ClpXP. Together, these results demonstrate that ClpXP degradation modifies conformational assemblies of MinD in vitro and depresses Min function in vivo during periods of reduced proliferation.	[LaBreck, Christopher J.; Trebino, Catherine E.; Ferreira, Colby N.; Morrison, Josiah J.; DiBiasio, Eric C.; Conti, Joseph; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Rhode Island	Camberg, JL (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	cambergj@uri.edu		Ferreira, Colby/0000-0001-6069-6191; Morrison, Josiah/0000-0003-3294-8050	National Institute of General Medical Sciences of the National Institutes of Health [R01GM118927]; National Science Foundation EPSCoR Cooperative Agreement [OIA-1655221]; National Science Foundation EPSCoR [OIA-1655221]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation EPSCoR Cooperative Agreement(National Science Foundation (NSF)); National Science Foundation EPSCoR(National Science Foundation (NSF))	Research reported in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM118927 to J. Camberg. This material is based on work conducted at a Rhode Island National Science Foundation Established Program to Stimulate Competitive Research (EPSCoR) research facility, the Genomics and Sequencing Center, supported in part by the National Science Foundation EPSCoR Cooperative Agreement #OIA-1655221. The TEM data was acquired at the Rhode Island Consortium for Nanoscience and Nanotechnology, a University of Rhode Island College of Engineering core facility partially funded by the National Science Foundation EPSCoR, Cooperative Agreement #OIA-1655221.	Arumugam S, 2014, P NATL ACAD SCI USA, V111, pE1192, DOI 10.1073/pnas.1317764111; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Buczek MS, 2016, MICROBIOL-SGM, V162, P909, DOI 10.1099/mic.0.000278; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Camberg JL, 2012, STRUCTURE, V20, P1128, DOI 10.1016/j.str.2012.06.004; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Conti J, 2018, MOL MICROBIOL, V107, P558, DOI 10.1111/mmi.13902; Conti J, 2015, FEBS LETT, V589, P201, DOI 10.1016/j.febslet.2014.11.047; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang HY, 2018, J BIOL CHEM, V293, P7786, DOI 10.1074/jbc.RA117.001513; LaBreck CJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00374-18; LaBreck CJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00026; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Park KT, 2015, MOL MICROBIOL, V98, P895, DOI 10.1111/mmi.13164; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Szewczak-Harris A, 2019, FEBS LETT, V593, P1915, DOI 10.1002/1873-3468.13471; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Thibault G, 2012, J PHYS CHEM B, V116, P6717, DOI 10.1021/jp212024b; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113; Vecchiarelli AG, 2014, MOL MICROBIOL, V93, P453, DOI 10.1111/mmi.12669; Viola MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170505; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Yakhnin AV, 1998, PROTEIN EXPRES PURIF, V14, P382, DOI 10.1006/prep.1998.0981	52	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100162	10.1074/jbc.RA120.013866	http://dx.doi.org/10.1074/jbc.RA120.013866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33288679	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400140
J	Passaro, F; Martino, ID; Zambelli, F; Di Benedetto, G; Barbato, M; D'Erchia, AM; Manzari, C; Pesole, G; Mutarelli, M; Cacchiarelli, D; Antonini, D; Parisi, S; Russo, T				Passaro, Fabiana; Martino, Ilaria De; Zambelli, Federico; Di Benedetto, Giorgia; Barbato, Matteo; D'Erchia, Anna Maria; Manzari, Caterina; Pesole, Graziano; Mutarelli, Margherita; Cacchiarelli, Davide; Antonini, Dario; Parisi, Silvia; Russo, Tommaso			YAP contributes to DNA methylation remodeling upon mouse embryonic stem cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; SELF-RENEWAL; GENE; YAP/TAZ; DNMT3L; PLURIPOTENCY; CIRCUITRY; DYNAMICS	The Yes-associated protein (YAP), one of the major effectors of the Hippo pathway together with its related protein WW-domain-containing transcription regulator 1 (WWTR1; also known as TAZ), mediates a range of cellular processes from proliferation and death to morphogenesis. YAP and WW-domain-containing transcription regulator 1 (WWTR1; also known as TAZ) regulate a large number of target genes, acting as coactivators of DNA-binding transcription factors or as negative regulators of transcription by interacting with the nucleosome remodeling and histone deacetylase complexes. YAP is expressed in self-renewing embryonic stem cells (ESCs), although it is still debated whether it plays any crucial roles in the control of either stemness or differentiation. Here we show that the transient downregulation of YAP in mouse ESCs perturbs cellular homeostasis, leading to the inability to differentiate properly. Bisulfite genomic sequencing revealed that this transient knockdown caused a genome-wide alteration of the DNA methylation remodeling that takes place during the early steps of differentiation, suggesting that the phenotype we observed might be due to the dysregulation of some of the mechanisms involved in regulation of ESC exit from pluripotency. By gene expression analysis, we identified two molecules that could have a role in the altered genome-wide methylation profile: the long noncoding RNA ephemeron, whose rapid upregulation is crucial for the transition of ESCs into epiblast, and the methyltransferase-like protein Dnmt3l, which, during the embryo development, cooperates with Dnmt3a and Dnmt3b to contribute to the de novo DNA methylation that governs early steps of ESC differentiation. These data suggest a new role for YAP in the governance of the epigenetic dynamics of exit from pluripotency.	[Passaro, Fabiana; Martino, Ilaria De; Di Benedetto, Giorgia; Barbato, Matteo; Parisi, Silvia; Russo, Tommaso] Univ Napoli Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Zambelli, Federico] Univ Milan, Dept Biosci, Milan, Italy; [Zambelli, Federico; D'Erchia, Anna Maria; Manzari, Caterina; Pesole, Graziano] CNR, Inst Biomembranes Bioenerget & Mol Biotechno, Rome, Italy; [D'Erchia, Anna Maria; Pesole, Graziano] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Mutarelli, Margherita; Cacchiarelli, Davide] Univ Napoli Federico II, Tigem, Naples, Italy; [Mutarelli, Margherita; Cacchiarelli, Davide] Univ Napoli Federico II, Dept Translat Med, Naples, Italy; [Antonini, Dario] Univ Napoli Federico II, Dept Biol, Naples, Italy	University of Naples Federico II; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Passaro, F; Russo, T (corresponding author), Univ Napoli Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	fabiana.passaro@unina.it; tommaso.russo@unina.it	Cacchiarelli, Davide/AAC-2693-2022; RUSSO, Tommaso/K-1331-2016; Zambelli, Federico/B-8198-2017; PASSARO, Fabiana/I-5941-2012	Cacchiarelli, Davide/0000-0002-9621-6716; De Martino, Ilaria/0000-0002-8633-4479; RUSSO, Tommaso/0000-0003-4426-0106; Zambelli, Federico/0000-0003-3487-4331; Mutarelli, Margherita/0000-0002-2168-5059; PASSARO, Fabiana/0000-0003-0150-5302; D'ERCHIA, Anna Maria/0000-0002-4627-0626	Programma di Ricerca di Interesse Nazionale grants; Federico II Finanziamento Ricerca di Ateneo project; "Prodotti alimentari" project from Regione Campania; PROSCAN project from Italian Ministry of Research	Programma di Ricerca di Interesse Nazionale grants; Federico II Finanziamento Ricerca di Ateneo project; "Prodotti alimentari" project from Regione Campania; PROSCAN project from Italian Ministry of Research	This work has been supported by Programma di Ricerca di Interesse Nazionale grants to T. R. and S. P.; Federico II Finanziamento Ricerca di Ateneo project to F. P.; "Prodotti alimentari" project from Regione Campania; and PROSCAN project from Italian Ministry of Research.	Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akalin A, 2015, BIOINFORMATICS, V31, P1127, DOI 10.1093/bioinformatics/btu775; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chung H, 2016, EMBO REP, V17, P519, DOI 10.15252/embr.201540933; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Croci O, 2017, GENE DEV, V31, P2017, DOI 10.1101/gad.301184.117; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Guenatri M, 2013, DEVELOPMENT, V140, P562, DOI 10.1242/dev.089268; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Hashimoto M, 2019, DEV CELL, V50, P138, DOI 10.1016/j.devcel.2019.05.024; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Napolitano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098669; Navarra A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0246-5; Neri F, 2013, CELL, V155, P121, DOI 10.1016/j.cell.2013.08.056; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Petell CJ, 2016, NUCLEIC ACIDS RES, V44, P7605, DOI 10.1093/nar/gkw426; Pocaterra A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.230425; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sasaki H, 2017, DEV GROWTH DIFFER, V59, P12, DOI 10.1111/dgd.12335; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Testa G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63992-8; Testa G, 2011, CYTOTHERAPY, V13, P350, DOI 10.3109/14653249.2010.520311; Tu C, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12887; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Veland N, 2019, NUCLEIC ACIDS RES, V47, P152, DOI 10.1093/nar/gky947; Zhang ZM, 2018, NATURE, V554, P387, DOI 10.1038/nature25477	44	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100138	10.1074/jbc.RA120.015896	http://dx.doi.org/10.1074/jbc.RA120.015896			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33268382	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400117
J	Laplana, M; Yuguero, O; Fibla, J				Laplana, Marina; Yuguero, Oriol; Fibla, Joan			Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients	PLOS ONE			English	Article							OLD DRUG	Background The search for a SARS-CoV-2 treatment has emerged as a worldwide priority. We evaluated the role of chloroquine and its derivatives in COVID-19 in Spanish individuals. Methods We performed a survey addressed to patients regularly taking chloroquine and its derivatives for the control of their autoimmune diseases. The survey was distributed with special attention to Spanish patient associations centred on autoimmune diseases and rheumatology and to the general population. A sample of untreated subjects was matched to the treated group according to sex, age range and incidence region. COVID-19 disease prevalence was compared between treated and untreated-matched control sample. Results A total of 319 surveys of patients regularly taking chloroquine and its derivatives were recovered for further analysis. The prevalence of declared COVID-19 status in the treated group was 5.3% and the mean prevalence among the untreated-matched groups was 3.4%. A community exposition to COVID-19 was associated with a greater prevalence of COVID-19 in both, treated (17.0% vs. 3.2%; p-value<0.001) and untreated groups (13.4% vs. 1.1%; p-value = 0.027). Conclusion We did not find differences of reported COVID-19 cases between treated and untreated groups, indicating a lack of protection by regular administration of chloroquine and its derivative drugs on COVID-19 infection. Of relevance, data indicates that patients that regularly take chloroquine derivatives are exposed to SARS-CoV-2 infection and must take the same protection measures as the general population.	[Laplana, Marina] Univ Lleida, Dept Ciencia Anim, Lleida, Spain; [Yuguero, Oriol] Hosp Univ Arnau Vilanova Lleida, Lleida, Spain; [Yuguero, Oriol; Fibla, Joan] Inst Recerca Biomed Lleida, Lleida, Spain; [Fibla, Joan] Dept Ciencies Med Basiques, Unitat Genet Humana, Lleida, Spain	Universitat de Lleida; University Hospital Arnau de Vilanova; Institut de Recerca Biomedica - IRB Lleida	Fibla, J (corresponding author), Inst Recerca Biomed Lleida, Lleida, Spain.; Fibla, J (corresponding author), Dept Ciencies Med Basiques, Unitat Genet Humana, Lleida, Spain.	joan.fibla@udl.cat	Fibla, Joan/C-5561-2008; Yuguero, Oriol/AAV-3749-2021; Laplana, Marina/G-2653-2010	Fibla, Joan/0000-0002-3255-2227; Laplana, Marina/0000-0002-2548-0704				Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293; [Anonymous], 2020, ESTUDIO ENE COVID19, P1; Boulware DR, 2020, NEW ENGL J MED, pNEJMoa2016638; Centro de Coordinacion de Alertas y Emergencias Sanitarias. Secretaria General de Sanidad. Direccion general de Salud Publica Calidad e Innovacion, 2020, ACT 123 ENF COR COVI, P1; Devaux Christian A, 2020, Int J Antimicrob Agents, V55, P105938, DOI 10.1016/j.ijantimicag.2020.105938; Emmi G, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102575; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Hassani RTJ, 2020, J INFECT PUBLIC HEAL, V13, P865, DOI [10.1016/j.jiph.2020.05.005, 10.1016/j.ijph.2020.05.005]; Infante M, 2021, EXPERT REV ANTI-INFE, V19, P5, DOI 10.1080/14787210.2020.1799785; Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085; Principi N, 2020, LANCET INFECT DIS, V20, P1118, DOI 10.1016/S1473-3099(20)30296-6; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Thangaraju P, 2020, J INFECT PUBLIC HEAL, V13, P899, DOI 10.1016/j.jiph.2020.05.006; Touret F, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104762	15	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243598	10.1371/journal.pone.0243598	http://dx.doi.org/10.1371/journal.pone.0243598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	33315903	Green Submitted, Green Published, gold			2022-12-26	WOS:000600186100032
J	Muro, RP; Masoza, TS; Kasanga, G; Kayange, N; Kidenya, BR				Muro, Restituta Phabian; Masoza, Tulla Sylvester; Kasanga, Godfrey; Kayange, Neema; Kidenya, Benson R.			Predictors and outcome of first line treatment failure among under-five children with community acquired severe pneumonia at Bugando Medical Centre, Mwanza, Tanzania: A prospective cohort study	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; MORTALITY; MANAGEMENT; ETIOLOGY; RISK	Background Despite recent advances in management and preventive strategies, high rates of first line antibiotics treatment failure and case fatality for Severe Community Acquired Pneumonia (SCAP) continue to occur in children in low and middle-income countries. This study aimed to identify the predictors and outcome of first line antibiotics treatment failure among children under-five years of age with SCAP admitted at Bugando Medical Centre (BMC) in Mwanza, Tanzania. Methods The study involved under-five children admitted with SCAP, treated with first line antibiotics as recommended by WHO. Patients with treatment failure at 48 hours were shifted to second line of antibiotics treatment and followed up for 7 days. Generalized linear model was used to determine predictors of first line antibiotics treatment failure for SCAP. Results A total of 250 children with SCAP with a median age of 18 [IQR 9-36] months were enrolled, 8.4% had HIV infection and 28% had acute malnutrition. The percentage of first line antibiotics treatment failure for the children with SCAP was 50.4%. Predictors of first line treatment failure were; presentation with convulsion (RR 1.55; 95% CI [1.11-2.16]; p-value 0.009), central cyanosis (RR 1.55; 95% CI [1.16-2.07]; p-value 0.003), low oxygen saturation (RR 1.28; 95% CI [1.01-1.62]; p-value 0.04), abnormal chest X-ray (RR 1.71; 95% CI [1.28-2.29]; p-value <0.001), HIV infection (RR 1.80; 95% CI [1.42-2.27]; p-value 0.001), moderate acute malnutrition (RR 1.48; 95% CI [1.04-2.12]; p-value = 0.030) and severe acute malnutrition (RR 2.02; 95% CI [1.56-2.61]; p-value<0.001). Mortality in children who failed first line treatment was 4.8%. Conclusion Half of the children with SCAP at this tertiary center had first line antibiotics treatment failure. HIV infection, acute malnutrition, low oxygen saturation, convulsions, central cyanosis, and abnormal chest X-ray were independently predictive of first line treatment failure. We recommend consideration of second line treatment and clinical trials for patients with SCAP to reduce associated morbidity and mortality.	[Muro, Restituta Phabian; Masoza, Tulla Sylvester; Kayange, Neema] Bugando Med Ctr, Dept Pediat & Child Hlth, Mwanza, Tanzania; [Masoza, Tulla Sylvester; Kayange, Neema] Catholic Univ Hlth & Allied Sci Bugando, Dept Pediat & Child Hlth, Mwanza, Tanzania; [Kasanga, Godfrey] Bugando Med Ctr, Dept Radiol, Mwanza, Tanzania; [Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci Bugando, Dept Biochem & Mol Biol, Mwanza, Tanzania		Masoza, TS (corresponding author), Bugando Med Ctr, Dept Pediat & Child Hlth, Mwanza, Tanzania.; Masoza, TS (corresponding author), Catholic Univ Hlth & Allied Sci Bugando, Dept Pediat & Child Hlth, Mwanza, Tanzania.	sylvestertullah@gmail.com						Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Daw Mohamed A, 2017, BMC Res Notes, V10, P170, DOI [10.1186/s13104-017-2389-z, 10.1186/s13104-017-2491-2]; [Anonymous], 2013, WHO POCKET BOOK HOSP, P80; [Anonymous], 2006, PEDIATRICS, V118, pe934; Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Forsberg P, 2012, PNEUMONIA HOSPITALIZ, P1; Gray D, 2009, EXPERT REV ANTI-INFE, V7, P437, DOI [10.1586/eri.09.14, 10.1586/ERI.09.14]; Jain DL, 2013, INDIAN PEDIATR, V50, P787; Jeena P, 2006, FAILURE STANDARD ANT, V015222, P269, DOI [10.2471/blt.04.015222, DOI 10.2471/BLT.04.015222]; Korppi Matti, 2003, Paediatr Drugs, V5, P821, DOI 10.2165/00148581-200305120-00005; Light R B, 1999, Semin Respir Infect, V14, P218; Marchisio P, 2002, CLIN INFECT DIS, V35, P168, DOI 10.1086/341028; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Rudan I, 2011, WHO GLOBAL ESTIMATE, P6163; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Webb C, 2012, PEDIATR INFECT DIS J, V31, pE152, DOI 10.1097/INF.0b013e3182638012; WHO, 1990, AC RESP INF CHILDR C; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243636	10.1371/journal.pone.0243636	http://dx.doi.org/10.1371/journal.pone.0243636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306722	Green Published, gold			2022-12-26	WOS:000600144200025
J	Gunther, J; Reichensdorfer, E; Pilarski, PM; Diepold, K				Gunther, Johannes; Reichensdoerfer, Elias; Pilarski, Patrick M.; Diepold, Klaus			Interpretable PID parameter tuning for control engineering using general dynamic neural networks: An extensive comparison	PLOS ONE			English	Article							DESIGN; SYSTEM; STABILIZATION; FEEDBACK	Modern automation systems largely rely on closed loop control, wherein a controller interacts with a controlled process via actions, based on observations. These systems are increasingly complex, yet most deployed controllers are linear Proportional-Integral-Derivative (PID) controllers. PID controllers perform well on linear and near-linear systems but their simplicity is at odds with the robustness required to reliably control complex processes. Modern machine learning techniques offer a way to extend PID controllers beyond their linear control capabilities by using neural networks. However, such an extension comes at the cost of losing stability guarantees and controller interpretability. In this paper, we examine the utility of extending PID controllers with recurrent neural networks--namely, General Dynamic Neural Networks (GDNN); we show that GDNN (neural) PID controllers perform well on a range of complex control systems and highlight how they can be a scalable and interpretable option for modern control systems. To do so, we provide an extensive study using four benchmark systems that represent the most common control engineering benchmarks. All control environments are evaluated with and without noise as well as with and without disturbances. The neural PID controller performs better than standard PID control in 15 of 16 tasks and better than model-based control in 13 of 16 tasks. As a second contribution, we address the lack of interpretability that prevents neural networks from being used in real-world control processes. We use bounded-input bounded-output stability analysis to evaluate the parameters suggested by the neural network, making them understandable for engineers. This combination of rigorous evaluation paired with better interpretability is an important step towards the acceptance of neural-network-based control approaches for real-world systems. It is furthermore an important step towards interpretable and safely applied artificial intelligence.	[Gunther, Johannes; Pilarski, Patrick M.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Gunther, Johannes; Pilarski, Patrick M.] Alberta Machine Intelligence Inst, Edmonton, AB, Canada; [Reichensdoerfer, Elias; Diepold, Klaus] Tech Univ Munich, Dept Elect & Comp Engn, Munich, Bavaria, Germany	University of Alberta; Technical University of Munich	Gunther, J (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.; Gunther, J (corresponding author), Alberta Machine Intelligence Inst, Edmonton, AB, Canada.	gunther@ualberta.ca						Ang KH, 2005, IEEE T CONTR SYST T, V13, P559, DOI 10.1109/TCST.2005.847331; Astrom KJ, 2000, EUR J CONTROL, V6, P2, DOI 10.1016/S0947-3580(00)70906-X; Bergstra J, 2013, JMLR; Berkenkamp Felix, 2017, ADV NEURAL INFORM PR, P908; Boskovic DM, 2000, IEEE DECIS CONTR P, P4777, DOI 10.1109/CDC.2001.914683; Chen X, 2012, INT C MANAGE SCI ENG, P194, DOI 10.1109/ICMSE.2012.6414182; CREVELING HF, 1975, J FLUID MECH, V67, P65, DOI 10.1017/S0022112075000171; De Jesus O, 2007, IEEE T NEURAL NETWOR, V18, P14, DOI 10.1109/TNN.2006.882371; Rubio JD, 2018, APPL SOFT COMPUT, V68, P821, DOI 10.1016/j.asoc.2017.04.056; Rubio JD, 2017, NEUROCOMPUTING, V227, P113, DOI 10.1016/j.neucom.2016.09.101; Deflorian M., 2011, IFAC P VOL, V44, P13179, DOI [10.3182/20110828-6-it-1002.01502, DOI 10.3182/20110828-6-IT-1002.01502]; ElMaraghy W, 2012, CIRP ANN-MANUF TECHN, V61, P793, DOI 10.1016/j.cirp.2012.05.001; Glasmachers T., 2017, P MACHINE LEARNING R, V77, P17; Gunther J, 2018, THESIS; Jaleel JA, 2013, 2013 INTERNATIONAL CONFERENCE ON CONTROL COMMUNICATION AND COMPUTING (ICCC), P204, DOI 10.1109/ICCC.2013.6731651; Kalman B. L., 1992, IJCNN International Joint Conference on Neural Networks (Cat. No.92CH3114-6), P578, DOI 10.1109/IJCNN.1992.227257; Kim S, 2017, IEEE-ASME T MECH, V22, P2803, DOI 10.1109/TMECH.2017.2767085; Klatt KU, 2009, COMPUT CHEM ENG, V33, P536, DOI 10.1016/j.compchemeng.2008.09.002; Kui Zhang, 2010, 2010 2nd International Conference on Intelligent Human-Machine Systems and Cybernetics (IHMSC 2010), P95, DOI 10.1109/IHMSC.2010.123; Leveson N., 2003, SYSTEMS THEORETIC AP, P16; Liang H, 2020, IEEE T FUZZY SYSTEMS; Liu L, 2020, IEEE-CAA J AUTOMATIC, V7, P1335, DOI 10.1109/JAS.2020.1003213; Majstorovic M, 2008, NEUREL 2008: NINTH SYMPOSIUM ON NEURAL NETWORK APPLICATIONS IN ELECTRICAL ENGINEERING, PROCEEDINGS, P203; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mascolo S, 1999, INT J BIFURCAT CHAOS, V9, P1425, DOI 10.1142/S0218127499000973; Pan HH, 2005, CONTROL ENG PRACT, V13, P27, DOI 10.1016/j.conengprac.2003.12.019; Parmas P, 2018, PR MACH LEARN RES, V80; Pirabakaran K., 2002, IFAC P, V35, P451; Rumelhart DE., 1995, BACKPROPAGATION THEO, P1, DOI DOI 10.5555/201784.201785; Sandner C, 2017, TECHNICAL REPORT; Smith O. J., 1957, CHEMICAL ENGINEERING, V53, P217; Stojic MR, 2001, IEEE T AUTOMAT CONTR, V46, P1293, DOI 10.1109/9.940937; Takagi T, 2014, INT C ADV MECH SYST, P254, DOI 10.1109/ICAMechS.2014.6911660; Tavakoli S., 2003, P 2003 4 INT C CONTR, P942, DOI DOI 10.1109/ICCA.2003.1595161; Vazquez R, 2006, SYST CONTROL LETT, V55, P624, DOI 10.1016/j.sysconle.2005.09.019; Vazquez R, 2010, IEEE T CONTR SYST T, V18, P789, DOI 10.1109/TCST.2009.2028549; Wang CY, 2013, CHIN CONT DECIS CONF, P3259; Wang JJ, 2011, SIMUL MODEL PRACT TH, V19, P440, DOI 10.1016/j.simpat.2010.08.003; WANG YZ, 1992, J FLUID MECH, V237, P479, DOI 10.1017/S0022112092003501; Wuest T, 2016, PROD MANUF RES, V4, P23, DOI 10.1080/21693277.2016.1192517; Yang Z, 2019, ARXIV190103838; Yu A. W., 2014, P ADV NEUR INF PROC, P1350; Zhang MG, 2006, PROCEEDINGS OF 2006 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P3016	44	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243320	10.1371/journal.pone.0243320	http://dx.doi.org/10.1371/journal.pone.0243320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301494	Green Published, Green Submitted, gold			2022-12-26	WOS:000600143100065
J	Depaermentier, MLC; Kempf, M; Banffy, E; Alt, KW				Depaermentier, Margaux L. C.; Kempf, Michael; Banffy, Eszter; Alt, Kurt W.			Tracing mobility patterns through the 6th-5th millennia BC in the Carpathian Basin with strontium and oxygen stable isotope analyses	PLOS ONE			English	Article							LATE IRON-AGE; BONE PHOSPHATE; COPPER AGE; MIGRATION; RATIOS; WATER; DIFFERENTIATION; FRACTIONATION; TEMPERATURE; DELTA-O-18	The complexity of Neolithic population movements and their interpretation through material culture have been the subject of archaeological research for decades. One of the dominant narratives proposes that groups from the Starcevo-Koros-Cris complex spread from the central towards the northern Balkans in the Early Neolithic and eventually brought the Neolithic lifestyle into present-day Hungary. Broad geographical migrations were considered to shape the continuous expansion of Neolithic groups and individuals. However, recent archaeological research, aDNA, and isotope analyses challenged the synchronous appearance of specific material culture distributions and human movement dynamics through emphasizing communication networks and socio-cultural transformation processes. This paper seeks to retrace the complexity of Neolithic mobility patterns across Hungary by means of strontium and oxygen stable isotope analyses, which were performed on a total of 718 human dental enamel samples from 55 Neolithic sites spanning the period from the Starcevo to the Balaton-Lasinja culture in Transdanubia and from the Koros to the Tiszapolgar cultural groups on the Great Hungarian Plain (Alfold). This study presents the largest strontium and oxygen isotope sample size for the Neolithic Carpathian Basin and discusses human mobility patterns on various geographical scales and throughout archaeological cultures, chronological periods, and sex and gender categories in a multiproxy analysis. Based on our results, we discuss the main stages of the Neolithisation processes and particularly trace individual movement behaviour such as exogamy patterns within extensive social networks. Furthermore, this paper presents an innovative differentiation between mobility patterns on small, micro-regional, and supra-regional scales, which provides new insights into the complex organisation of Neolithic communities.	[Depaermentier, Margaux L. C.] Univ Basel, Dept Early Medieval & Roman Prov Archaeol, Basel, Switzerland; [Kempf, Michael] Masaryk Univ, Dept Archaeol & Museol, Brno, Czech Republic; [Kempf, Michael] Univ Freiburg, Inst Environm Social Sci & Geog, Freiburg, Germany; [Banffy, Eszter] Roman German Commiss, German Archaeol Inst, Frankfurt, Germany; [Alt, Kurt W.] Danube Private Univ, Ctr Nat & Cultural Human Hist, Krems Stein, Austria; [Alt, Kurt W.] Univ Basel, Integrat Prehist & Archaeol Sci, Basel, Switzerland	University of Basel; Masaryk University Brno; University of Freiburg; University of Basel	Depaermentier, MLC (corresponding author), Univ Basel, Dept Early Medieval & Roman Prov Archaeol, Basel, Switzerland.; Alt, KW (corresponding author), Danube Private Univ, Ctr Nat & Cultural Human Hist, Krems Stein, Austria.; Alt, KW (corresponding author), Univ Basel, Integrat Prehist & Archaeol Sci, Basel, Switzerland.	m.depaermentier@unibas.ch; kurt.alt@dp-uni.ac.at	Kempf, Michael/ABG-9873-2020	Kempf, Michael/0000-0002-9474-4670; Depaermentier, Margaux/0000-0002-1801-3358	German Research Foundation (DFG) [Al 287/10-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	EB received a grant from the German Research Foundation (DFG), grant number Al 287/10-1. https://www.dfg.de/KWA received a grant from the German Research Foundation (DFG), grant number Al 287/10-1. https://www.dfg.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110793; Anders A, 2012, BAR INT SERIES, V2334; [Anonymous], 2000, MACHINE LEARNING, V39, P103; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2011, SCI MANAGEMENT, V31, P49; Banffy E., 2006, DOCUMENTA PRAEHISTOR, V33, P125, DOI DOI 10.4312/DP.33.13; Banffy E, 2013, ARCHAEOLINGUA CENTRA, V7; Banffy E, 2004, 6 MILLENNIUM BC BOUN, P15, DOI [10.1016/j.arthro.2004.08.001, DOI 10.1016/J.ARTHRO.2004.08.001]; Banffy E, 2002, ACTA ARCHAEOL ACAD S, V53, P41; Banffy E., 2016, BERICHT ROMISCH GERM, V94, P283; Barna J., 2017, FORMATION LENGYEL CU; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2013, J ANTHROPOL ARCHAEOL, V32, P303, DOI 10.1016/j.jaa.2012.01.009; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Bickle P, 2013, CARDIFF STUDIES ARCH; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Brettell R, 2012, EUR J ARCHAEOL, V15, P117, DOI 10.1179/1461957112Y.0000000001; Brettell R, 2012, J ANAL ATOM SPECTROM, V27, P778, DOI 10.1039/c2ja10335d; Britton K, 2015, AM J PHYS ANTHROPOL, V157, P226, DOI 10.1002/ajpa.22704; Bronnimann D, 2018, J ARCHAEOL SCI-REP, V17, P279, DOI 10.1016/j.jasrep.2017.11.009; Chenery C, 2010, J ARCHAEOL SCI, V37, P150, DOI 10.1016/j.jas.2009.09.025; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; DANGELA D, 1990, CHEM GEOL, V86, P75, DOI 10.1016/0168-9622(90)90007-Y; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; Depaermentier MLC, J ARCHAEOLOGICAL SCI; Domboroczki L, 2003, AGRIA, V39, P5; Domboroczki L., 2009, INTERACTIONS DIFFERE, V5, P75; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Ery K., 1963, ANTHR KOZLEMENYEK, V7, P41; Evans J, 2006, J ARCHAEOL SCI, V33, P265, DOI 10.1016/j.jas.2005.07.011; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Fuzesi A, HUMAN ACTIVITIES LAT; Gerling C., 2015, PREHISTORIC MOBILITY; Gerling C, 2012, ANTIQUITY, V86, P1097, DOI 10.1017/S0003598X00048274; Giblin JI, 2013, J ARCHAEOL SCI, V40, P227, DOI 10.1016/j.jas.2012.08.024; Giblin JI, 2009, J ARCHAEOL SCI, V36, P491, DOI 10.1016/j.jas.2008.09.034; Goldman G, 1994, J ANDRAS MUZEUM EVKO, V36, P225; Gyucha A, 2015, PREHISTORIC VILLAGE; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hemer KA, 2014, J ARCHAEOL SCI, V52, P242, DOI 10.1016/j.jas.2014.08.031; IAEA/WISER, 2020, GLOB NETW IS RIV; IAEA/WMO, 2019, GLOB NETW IS PREC GN; Jakucs J., 2015, ANTAEUS, V33, P13; Jakucs J, 2018, ANTIQUITY, V92, P91, DOI 10.15184/aqy.2017.218; Jakucs J, 2016, J WORLD PREHIST, V29, P267, DOI 10.1007/s10963-016-9096-x; Kalicz N, 1983, NIEDERSACHSENS URGES, V52, P91; Kalicz N, 1977, LINIENBANDKERAMIK GR; Kalicz N., 1987, LATE NEOLITHIC TISZA, P11; Kempf M, MODELLING SCAL UNPUB; Kempf M, 2020, J ARCHAEOL SCI-REP, V34, DOI 10.1016/j.jasrep.2020.102637; Knipper C, 2012, MIGRATIONS PREHISTOR, P293; Knipper C, 2017, MULTIDISCIPLINARNYE, P84; Knipper C, 2018, J ARCHAEOL SCI-REP, V17, P735, DOI 10.1016/j.jasrep.2017.12.001; Knipper C, 2014, J ARCHAEOL SCI, V41, P818, DOI 10.1016/j.jas.2013.09.019; Kohn MJ, 2005, EARTH PLANET SC LETT, V231, P87, DOI 10.1016/j.epsl.2004.12.004; Kutzian I, 1972, EARLY COPPER AGE TIS; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Nehlich O, 2009, J ARCHAEOL SCI, V36, P1791, DOI 10.1016/j.jas.2009.04.008; Oross K, 2012, 1 NEOLITHIC SITES CE, V2334, P129; Oross K., 2019, T LACUM PELSONEM PRE, V7, P9; Oross K., 2016, BERICHT R MISCH GERM, V94, P151; Oross K, 2009, DOC PRAEHIST, V36, P175, DOI 10.4312/dp.36.11; Osztas A., 2012, DOC PRAEH, V39, P377, DOI DOI 10.4312/DP.39.27; Pellegrini M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34986; Pollard AM, 2011, AM J PHYS ANTHROPOL, V145, P499, DOI 10.1002/ajpa.21524; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Price TD, 2012, POPULATION DYNAMICS, P311; Raczky P., 2010, RGZM TAGUNGEN, V4, P147; Rank D, 2014, ACTA ZOOL BULGAR, P109; Scholtz R, 2007, REG KUT, P35; Schuh C., 2014, THESIS; Szecsenyi-Nagy A., 2014, EARLY FARMERS VIEW A, P71, DOI DOI 10.5871/BACAD/9780197265758; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Vaday A, 1999, KOMPOLT KISTER UJKKO; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; Vohberger MA, 2011, THESIS LUDWIG MAXIMI; WaterIsotopes.org, 2017, ONLINE ISOTOPE PRECI; Whittle A, 2013, 1 FARMERS CENTRAL EU, P49; Whittle A., 2002, ANTAEUS, V25, P63; Willmes M, 2018, APPL GEOCHEM, V90, P75, DOI 10.1016/j.apgeochem.2017.12.025; Wilson JC, 2016, J ARCHAEOL SCI-REP, V6, P230, DOI 10.1016/j.jasrep.2016.02.016; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; Zalai-Gaal I, 2002, SZEKSZARD SAARBRUCKE	93	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0242745	10.1371/journal.pone.0242745	http://dx.doi.org/10.1371/journal.pone.0242745			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PE8QN	33296396	gold, Green Accepted, Green Published			2022-12-26	WOS:000598626100023
J	Lopez-de-Celis, C; Perez-Bellmunt, A; Bueno-Gracia, E; Fanlo-Mazas, P; Zarate-Tejero, CA; Llurda-Almuzara, L; Arroniz, AC; Rodriguez-Rubio, PR				Lopez-de-Celis, Carlos; Perez-Bellmunt, Albert; Bueno-Gracia, Elena; Fanlo-Mazas, Pablo; Zarate-Tejero, Carlos Antonio; Llurda-Almuzara, Luis; Cadellans Arroniz, Aida; Rodriguez-Rubio, Pere Ramon			Effect of diacutaneous fibrolysis on the muscular properties of gastrocnemius muscle	PLOS ONE			English	Article							NONINVASIVE ESTIMATION; CONTRACTILE PROPERTIES; STIFFNESS; RELIABILITY; TENSIOMYOGRAPHY; REPEATABILITY; POWER; PAIN; TONE	Diacutaneous fibrolysis is a noninvasive technique that has been shown to be effective in the treatment of musculoskeletal disorders such as shoulder pain, lateral epicondylalgia, patellofemoral pain syndrome and carpal tunnel syndrome. However, while diacutaneous fibrolysis is applied to soft tissue, its effects on muscular properties are unknown. The purpose of the present study was to evaluate the effects of diacutaneous fibrolysis on muscle properties as measured by tensiomyography and myotonometry in asymptomatic subjects. An analytical descriptive study was performed. A single session of diacutaneous fibrolysis on the gastrocnemius muscle was applied to one limb (treated limb group) and the other limb was the control (control limb group). Subjects were assessed with tensiomyography and myotonometry before treatment (T0), after treatment (T1) and 30 minutes later (T2). The primary outcomes were tensiomyography and myotonometry variables. The treated limb group showed a statistically significant increase (p<0.05) in tensiomyography parameters. A decrease in rigidity and increase in relaxation was also observed on myotonometry at T1, with some of the effects being maintained at T2. Rigidity and relaxation at T1 were statistically significant between groups (p<0.05). A single session of diacutaneous fibrolysis to the gastrocnemius muscle of asymptomatic subjects produced immediate changes in muscle properties. These changes were maintained 30 minutes after the application of the technique.	[Lopez-de-Celis, Carlos; Perez-Bellmunt, Albert; Zarate-Tejero, Carlos Antonio; Llurda-Almuzara, Luis; Cadellans Arroniz, Aida; Rodriguez-Rubio, Pere Ramon] Univ Int Catalunya, Dept Fisioterapia, Barcelona, Spain; [Lopez-de-Celis, Carlos] Inst Univ Invest Atencio Primaria IDAP Jordi Gol, Barcelona, Spain; [Bueno-Gracia, Elena; Fanlo-Mazas, Pablo] Univ Zaragoza, Dept Fisiatria & Enfermeria, Zaragoza, Spain; [Bueno-Gracia, Elena] Univ Zaragoza, Dept Fisiatria & Enfermeria, Zaragoza, Spain; [Zarate-Tejero, Carlos Antonio] Univ Zaragoza, Dept Fisioterapia, Zaragoza, Spain	Universitat Internacional de Catalunya (UIC); University of Zaragoza; University of Zaragoza; University of Zaragoza	Bueno-Gracia, E (corresponding author), Univ Zaragoza, Dept Fisiatria & Enfermeria, Zaragoza, Spain.; Bueno-Gracia, E (corresponding author), Univ Zaragoza, Dept Fisiatria & Enfermeria, Zaragoza, Spain.	ebueno@unizar.es	Perez-Bellmunt, Albert/G-5647-2019; de Celis, Carlos López/AAC-7955-2019; Fanlo, Pablo/AFM-9463-2022; LLURDA-ALMUZARA, Luis/GOG-8767-2022; Rodríguez-Rubio, Pere Ramón/AGR-6503-2022	Perez-Bellmunt, Albert/0000-0002-5607-0708; de Celis, Carlos López/0000-0002-9524-4248; Rodríguez-Rubio, Pere Ramón/0000-0001-8207-2507; LLURDA ALMUZARA, LUIS/0000-0001-9372-7580; Bueno-Gracia, Elena/0000-0002-0026-9224; Zarate Tejero, Carlos Antonio/0000-0002-0206-6412	Col.legi de Fisioterapeutes de Catalunya [reg. 59292, R3]	Col.legi de Fisioterapeutes de Catalunya	This study was supported by the Col.legi de Fisioterapeutes de Catalunya. Resolution 001/2018 of 14 March 2018 (no reg. 59292 -code R3). The funding body had no role in the study design, data collection, analysis, interpretation of data, manuscript writing or submission for publication.	Agyapong-Badu S., 2013, WORK PAP HLTH SCI, V4, P1; Alvarez-Diaz P, 2016, KNEE SURG SPORT TR A, V24, P2259, DOI 10.1007/s00167-014-3298-5; Alvarez-Diaz P, 2016, KNEE SURG SPORT TR A, V24, P2264, DOI 10.1007/s00167-014-3319-4; [Anonymous], 2015, NEUMA, VVIII/1, P58; [Anonymous], 2012, KIDNEY INT, V2, P5; Baker RT, 2013, INT J ATHL THER TRAI, V18, P16, DOI 10.1123/ijatt.18.5.16; Lopez MEB, 2013, MANUAL THER, V18, P418, DOI 10.1016/j.math.2013.02.006; Barra ME, 2011, CLIN REHABIL, V25, P339, DOI 10.1177/0269215510385480; Bizzini M, 2003, CLIN BIOMECH, V18, P459, DOI 10.1016/S0268-0033(03)00042-1; Cadellans-Arroniz A, 2021, CLIN REHABIL, V35, P481, DOI 10.1177/0269215520968056; Chuang LL, 2012, ARCH PHYS MED REHAB, V93, P532, DOI 10.1016/j.apmr.2011.09.014; Dahmane R, 2001, MED BIOL ENG COMPUT, V39, P51, DOI 10.1007/BF02345266; Davidson MJ, 2017, PHYSIOTHER CAN, V69, P104, DOI 10.3138/ptc.2015-85; DAVIES CTM, 1983, J APPL PHYSIOL, V55, P191, DOI 10.1152/jappl.1983.55.1.191; Ditroilo M, 2013, J ELECTROMYOGR KINES, V23, P558, DOI 10.1016/j.jelekin.2013.01.014; Ditroilo M, 2011, PHYSIOL MEAS, V32, P1315, DOI 10.1088/0967-3334/32/8/020; Fanlo-Mazas P, 2019, J SPORT REHABIL, V28, P564, DOI 10.1123/jsr.2017-0272; Feng Y, 2018, SCI REP, V8, P1; Gervasi M, 2017, EUR J APPL PHYSIOL, V117, P1739, DOI 10.1007/s00421-017-3668-z; Jarocka E, 2012, PHYSIOL MEAS, V33, P65, DOI 10.1088/0967-3334/33/1/65; del Barrio SJ, 2018, CLIN REHABIL, V32, P1645, DOI 10.1177/0269215518787316; Kokkonen J, 1998, RES Q EXERCISE SPORT, V69, P411, DOI 10.1080/02701367.1998.10607716; Krizaj D, 2008, J ELECTROMYOGR KINES, V18, P645, DOI 10.1016/j.jelekin.2007.01.008; Levenez M, 2009, COMPUT METHOD BIOMEC, V12, P171, DOI DOI 10.1080/10255840903091429; Lohr C, 2018, EUR J APPL PHYSIOL, V118, P1349, DOI 10.1007/s00421-018-3867-2; Lopez-de-Celis C, 2018, CLIN REHABIL, V32, P644, DOI 10.1177/0269215517738114; Lorimer AV, 2016, SPORTS MED, V46, P1921, DOI 10.1007/s40279-016-0526-9; Martin RL, 2018, J ORTHOP SPORT PHYS, V48, pA1, DOI 10.2519/jospt.2018.0302; Marusiak J, MOV DISORD, V26AD, P2119, DOI 10.1002/mds.23841; Marusiak J, 2012, CLIN BIOMECH, V27, P632, DOI 10.1016/j.clinbiomech.2012.02.001; Perez-Bellmunt A, 2019, PHYS MED REHABIL J, V2, P118; Ratsep T, 2011, CLIN BIOMECH, V26, P213, DOI 10.1016/j.clinbiomech.2010.09.014; Rey E, 2012, J ELECTROMYOGR KINES, V22, P866, DOI 10.1016/j.jelekin.2012.06.003; Rusu LD, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-67; Simunic B, 2012, J ELECTROMYOGR KINES, V22, P527, DOI 10.1016/j.jelekin.2012.04.003; Tous-Fajardo J, 2010, J ELECTROMYOGR KINES, V20, P761, DOI 10.1016/j.jelekin.2010.02.008; Vain A, 2002, BIOL SPORT, V19, P329; Valencic V, 1997, ARTIF ORGANS, V21, P240, DOI 10.1111/j.1525-1594.1997.tb04658.x; VALENCIC V, 2001, BIOMEDICAL ENG, V1, P1; Veszely M., 2000, ANN KINESITHERAPIE, V2, P54; Viir R, 2006, J MECH MED BIOL, V6, P215, DOI 10.1142/S0219519406001856; World Medical Association (WMA), 2013, WMA DECL HELS 1975 E, P29	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2020	15	12							e0243225	10.1371/journal.pone.0243225	http://dx.doi.org/10.1371/journal.pone.0243225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PE8QN	33296423	Green Published, gold, Green Submitted			2022-12-26	WOS:000598626100004
J	Fadare, FT; Adefisoye, MA; Okoh, AI				Fadare, Folake Temitope; Adefisoye, Martins Ajibade; Okoh, Anthony Ifeanyi			Occurrence, identification, and antibiogram signatures of selected Enterobacteriaceae from Tsomo and Tyhume rivers in the Eastern Cape Province, Republic of South Africa	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; WASTE-WATER; MOLECULAR CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; HEALTHY HUMANS; MULTIPLEX PCR; E. COLI	The increasing occurrence of multidrug-resistant Enterobacteriaceae in clinical and environmental settings has been seen globally as a complex public health challenge, mostly in the developing nations where they significantly impact freshwater used for a variety of domestic purposes and irrigation. This paper detail the occurrence and antibiogram signatures of the Enterobacteriaceae community in Tsomo and Tyhume rivers within the Eastern Cape Province, the Republic of South Africa, using standard methods. The average distribution of the presumptive Enterobacteriaceae in the rivers ranged from 1 x 10(2) CFU/100ml to 1.95 x 10(4) CFU/100ml. We confirmed 56 (70.8%) out of 79 presumptive Enterobacteriaceae isolated being species within the family Enterobacteriaceae through the Matrix-Assisted Laser Desorption Ionization Time of Flight technique. Citrobacter-, Enterobacter-, Klebsiella species, and Escherichia coli were selected (n = 40) due to their pathogenic potentials for antibiogram profiling. The results of the antibiotic susceptibility testing gave a revelation that all the isolates were phenotypically multidrug-resistant. The resistance against ampicillin (95%), tetracycline and doxycycline (88%), and trimethoprim-sulfamethoxazole (85%) antibiotics were most prevalent. The Multiple Antibiotic Resistance indices stretched from 0.22 to 0.94, with the highest index observed in a C. freundii isolate. Molecular characterisation using the PCR technique revealed the dominance of bla(TEM) (30%; 12/40) among the eight groups of beta-lactams resistance determinants assayed. The prevalence of others was bla(CTX-M) genes including group 1, 2 and 9 (27.5%), bla(SHV) (20%), bla(OXA-1-like) (10%), bla(PER) (2.5%), and bla(VEB) (0%). The frequencies of the resistance determinants for the carbapenems were bla(KPC) (17.6%), bla(GES) (11.8%), bla(IMP) (11.8%), bla(VIM) (11.8%), and bla(OXA-48-like) (5.9%). Out of the six plasmid-mediated AmpC (pAmpC) genes investigated bla(ACC), bla(EBC), bla(FOX), bla(CIT), bla(DHA), and bla(MOX), only the first four were detected. In this category, the most dominant was bla(EBC), with 18.4% (7/38). The prevalence of the non-beta-lactamases include tetA (33.3%), tetB (30.5%), tetC (2.8%), tetD (11.1%), tetK (0%), tetM (13.9%), catI (12%), catII (68%), sulI (14.3%), sulII (22.9%) and aadA (8.3%). Notably, a C. koseri harboured 42.8% (12/28) of the genes assayed for which includes five of the ESBL genes (including the only bla(PER) detected in this study), two of the pAmpC resistance genes (bla(ACC) and bla(CIT)), and five of the non-beta-lactamase genes. This study gives the first report on C. koseri exhibiting the co-occurrence of ESBL/AmpC beta-lactamase genes from the environment to the best of our knowledge. The detection of a bla(PER) producing Citrobacter spp. in this study is remarkable. These findings provide evidence that freshwater serves as reservoirs of antimicrobial resistance determinants, which can then be easily transferred to human beings via the food chain and water.	[Fadare, Folake Temitope; Adefisoye, Martins Ajibade; Okoh, Anthony Ifeanyi] Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, Alice, South Africa; [Fadare, Folake Temitope; Adefisoye, Martins Ajibade; Okoh, Anthony Ifeanyi] Univ Ft Hare, Appl & Environm Microbiol Res Grp, Dept Biochem & Microbiol, Alice, South Africa	University of Fort Hare; University of Fort Hare	Fadare, FT (corresponding author), Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, Alice, South Africa.; Fadare, FT (corresponding author), Univ Ft Hare, Appl & Environm Microbiol Res Grp, Dept Biochem & Microbiol, Alice, South Africa.	folakefadare2002@gmail.com	Fadare, Folake/H-8283-2018	Fadare, Folake/0000-0001-5779-9798; Adefisoye, Martins/0000-0002-4957-4609	South African medical Research Council; National Research Foundation	South African medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation	This work was supported by South African medical Research Council http://www.mrc.ac.za/and the National Research Foundation, https://www.nrf.ac.za/.The funders did not play any role in the study design.	Abbott SL, KLEBSIELLA ENTEROBAC; Adefisoye MA, 2016, MICROBIOLOGYOPEN, V5, P143, DOI 10.1002/mbo3.319; Adrian S, 2012, CONF PROC BALK REG, P525; Ahlstrom CA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25474-w; Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2019, FRONTIERS PLANT SCI; Ateba CN, 2008, INT J FOOD MICROBIOL, V128, P181, DOI 10.1016/j.ijfoodmicro.2008.08.011; Berglund Bjorn, 2015, Infection Ecology & Epidemiology, V5, P28564, DOI 10.3402/iee.v5.28564; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Blaak H, 2014, INT J FOOD MICROBIOL, V168, P8, DOI 10.1016/j.ijfoodmicro.2013.10.006; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Chandra M, 2013, INT J MED MICROBIOL, V303, P210, DOI 10.1016/j.ijmm.2013.02.013; Clinical & Laboratory Standards Institute (CLSI), 2014, M100S23 CLIN LAB STA, V2; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Colombo S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01095; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; Department of Water Affairs and Forestry (DWAF), 1996, AQUATIC ECOSYSTEMS, V7; Department of Water Affairs (DWAF), 2012, 2012 GREEN DROP PROG; Dzierzanowska D, 2010, INT J ANTIMICROB AG, V35, P392, DOI 10.1016/j.ijantimicag.2009.12.010; Ebomah Kingsley Ehi, 2021, International Journal of Environmental Studies, V78, DOI 10.1080/00207233.2020.1778274; Ebomah KE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03899; Food and Agriculture Organization of the United Nations (FAO), 2015, STAT REP ANT RES; Forsythe SJ., 2015, MAN CLIN MICROBIOL, P714, DOI [10.1128/9781555817381.ch38, DOI 10.1128/9781555817381.CH38]; Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881; Galler H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030479; Girlich D, 2011, ANTIMICROB AGENTS CH, V55, P1256, DOI 10.1128/AAC.00921-10; Hamelin K, 2007, APPL ENVIRON MICROB, V73, P477, DOI 10.1128/AEM.01445-06; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hawser SP, 2010, ANTIMICROB AGENTS CH, V54, P3043, DOI 10.1128/AAC.00265-10; Henriques IS, 2006, RES MICROBIOL, V157, P938, DOI 10.1016/j.resmic.2006.09.003; Hoban DJ, 2012, DIAGN MICR INFEC DIS, V74, P62, DOI 10.1016/j.diagmicrobio.2012.05.024; Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13; Igbinosa EO, 2016, MICROB DRUG RESIST, V22, P238, DOI 10.1089/mdr.2015.0169; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; KRUMPERMAN PH, 1983, APPL ENVIRON MICROB, V46, P165, DOI 10.1128/AEM.46.1.165-170.1983; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Lamprecht C, 2014, S AFR J SCI, V110, P32, DOI 10.1590/sajs.2014/20130347; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Lupo A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00018; Machado E, 2009, J ANTIMICROB CHEMOTH, V63, P616, DOI 10.1093/jac/dkn510; Madigan M.M., 2012, BROCK BIOL MICROORTA; Maravic A, 2015, MAR POLLUT BULL, V90, P60, DOI 10.1016/j.marpolbul.2014.11.021; Maravic A, 2013, INT J FOOD MICROBIOL, V166, P301, DOI 10.1016/j.ijfoodmicro.2013.07.010; Maugeri TL, 2004, J APPL MICROBIOL, V97, P354, DOI 10.1111/j.1365-2672.2004.02303.x; Mbelle NM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58012-8; Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06; Njage PMK, 2015, MICROB BIOTECHNOL, V8, P462, DOI 10.1111/1751-7915.12234; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Olaniran AO, 2009, WORLD J MICROB BIOT, V25, P1743, DOI 10.1007/s11274-009-0071-x; Osundiya O. O., 2013, African Journal of Clinical and Experimental Microbiology, V14, P164; Pereira-Marques J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01277; Poonia Shubra, 2014, Indian J Community Med, V39, P156, DOI 10.4103/0970-0218.137152; Pote J, 2009, J ENVIRON SCI, V21, P62, DOI 10.1016/S1001-0742(09)60012-7; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rahimi S, 2019, LANCET RESP MED, V7, P208, DOI 10.1016/S2213-2600(19)30031-1; Rashid Mahmudur, 2015, Infection Ecology & Epidemiology, V5, P26712, DOI 10.3402/iee.v5.26712; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Reinthaler FF, 2010, WATER RES, V44, P1981, DOI 10.1016/j.watres.2009.11.052; Reuland EA, 2014, EUR J CLIN MICROBIOL, V33, P1843, DOI 10.1007/s10096-014-2142-7; Richter L, 2019, FOODBORNE PATHOG DIS, V16, P421, DOI 10.1089/fpd.2018.2558; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Ruano P, 2016, WE ARE INTECHOPEN WO, P2016; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Sharma A., 2015, INT J ADV RES, V3, P762; Sibanda T, 2013, ENVIRON MONIT ASSESS, V185, P6579, DOI 10.1007/s10661-012-3048-4; Standard Methods, 2005, P NATL ACAD SCI USA, V90, P3750; Standing TA, 2013, J WATER HEALTH, V11, P210, DOI 10.2166/wh.2013.164; Tacao M, 2012, APPL ENVIRON MICROB, V78, P4134, DOI 10.1128/AEM.00359-12; Tafoukt R, 2017, WATER RES, V120, P185, DOI 10.1016/j.watres.2017.04.073; Tao R, 2010, ENVIRON POLLUT, V158, P2101, DOI 10.1016/j.envpol.2010.03.004; Tarnberg M., 2012, EXTENDED SPECTRUM BE; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Teixeira P, 2020, ENVIRON POLLUT, V260, DOI 10.1016/j.envpol.2020.113913; Tesfaye H, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0588-1; Tham J, 2010, ARCH PEDIAT S4, V17; Thanner S, 2016, MBIO, V7, DOI 10.1128/mBio.02227-15; Titilawo Y, 2015, SCI TOTAL ENVIRON, V523, P82, DOI 10.1016/j.scitotenv.2015.03.095; Toroglu S, 2005, ANN MICROBIOL, V55, P229; Vinue L, 2009, CLIN MICROBIOL INFEC, V15, P954, DOI 10.1111/j.1469-0691.2009.02803.x; Walsh C., 2003, ANTIBIOTICS ACTIONS; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Wu XL, 2014, SCI TOTAL ENVIRON, V487, P399, DOI 10.1016/j.scitotenv.2014.04.015; Zahid HM, 2009, AFR J BIOTECHNOL, V8, P148; Zarfel G, 2013, ENVIRON POLLUT, V173, P192, DOI 10.1016/j.envpol.2012.09.019; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zurfluh K, 2015, APPL ENVIRON MICROB, V81, P3115, DOI 10.1128/AEM.00258-15; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	100	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0238084	10.1371/journal.pone.0238084	http://dx.doi.org/10.1371/journal.pone.0238084			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PD8LW	33284819	gold, Green Published, Green Submitted			2022-12-26	WOS:000597930500020
J	Frendl, DM; FitzGerald, G; Epstein, MM; Allison, JJ; Sokoloff, MH; Ware, JE				Frendl, Daniel M.; FitzGerald, Gordon; Epstein, Mara M.; Allison, Jeroan J.; Sokoloff, Mitchell H.; Ware, John E.			Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool	PLOS ONE			English	Article							OTHER-CAUSE MORTALITY; COMPETING RISKS; DECISION-MAKING; STRATIFICATION; VALIDATION; OUTCOMES; TRENDS; INDEX	Objective To develop a tool for estimating the 10-year risk of death from other causes in men with localized prostate cancer. Subjects and methods We identified 2,425 patients from the Surveillance Epidemiology and End Results-Medicare Health Outcomes Survey database, age <80, newly diagnosed with clinical stage T1-T3a prostate cancer from 1/1/1998-12/31/2009, with follow-up through 2/28/2013. We developed a Fine and Gray competing-risks model for 10-year other cause mortality considering age, patient-reported comorbid medical conditions, component scores and items of the SF-36 Health Survey, activities of daily living, and sociodemographic characteristics. Model discrimination and calibration were compared to predictions from Social Security life table mortality risk estimates. Results Over a median follow-up of 7.7 years, 76 men died of prostate-specific causes and 465 died of other causes. The strongest predictors of 10-year other cause mortality risk included increasing age at diagnosis, higher approximated Charlson Comorbidity Index score, worse patient-reported general health (fair or poor vs. excellent-good), smoking at diagnosis, and marital status (all other vs. married) (all p<0.05). Model discrimination improved over Social Security life tables (c-index of 0.70 vs. 0.59, respectively). Predictions were more accurate than predictions from the Social Security life tables, which overestimated risk in our population. Conclusions We provide a tool for estimating the 10-year risk of dying from other causes when making decisions about treating prostate cancer using pre-treatment patient-reported characteristics.	[Frendl, Daniel M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA; [Frendl, Daniel M.; Epstein, Mara M.; Allison, Jeroan J.; Ware, John E.] Univ Massachusetts, Dept Quantitat Hlth Sci, Med Sch, Worcester, MA 01605 USA; [FitzGerald, Gordon] Univ Massachusetts, Dept Surg, Med Sch, Ctr Outcomes Res, Worcester, MA 01605 USA; [Epstein, Mara M.] Univ Massachusetts, Dept Med, Med Sch, Worcester, MA 01605 USA; [Epstein, Mara M.] Meyers Primary Care Inst, Worcester, MA USA; [Sokoloff, Mitchell H.] Univ Massachusetts, Dept Urol, Med Sch, Worcester, MA 01605 USA; [Ware, John E.] John Ware Res Grp, Watertown, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Frendl, DM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA.; Frendl, DM (corresponding author), Univ Massachusetts, Dept Quantitat Hlth Sci, Med Sch, Worcester, MA 01605 USA.	dfrendl@mgh.harvard.edu		Frendl, Daniel/0000-0002-3571-6610	National Institute on Aging of the National Institutes of Health [F30AG047772]; British American Tobacco (Investments) Limited	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British American Tobacco (Investments) Limited	This work was supported by the National Institute on Aging of the National Institutes of Health under grant number F30AG047772, PI: DMF. https://www.nia.nih.gov/.JW received unrestricted research grants from British American Tobacco (Investments) Limited for smokingrelated quality of life research which did not fund this work. JW also discloses employment by the John Ware Research Group, a commercial company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambs A, 2008, HEALTH CARE FINANC R, V29, P5; Bratt O, 2015, EUR UROL, V68, P53, DOI 10.1016/j.eururo.2014.12.026; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Daskivich TJ, 2015, UROLOGY, V85, P92, DOI 10.1016/j.urology.2014.07.003; Daskivich TJ, 2014, CANCER-AM CANCER SOC, V120, P3642, DOI 10.1002/cncr.28926; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P2058, DOI 10.1002/cncr.25751; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frendl D., STAT CODE SUMMARY PR, DOI [10.17504/protocols.io.bft4jnqw, DOI 10.17504/PROTOCOLS.IO.BFT4JNQW]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoffman RM, 2015, J GEN INTERN MED, V30, P924, DOI 10.1007/s11606-014-3171-8; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hosmer DW, 1999, WILEY PS TX; Kazis LE, 2004, HEALTH CARE FINANC R, V25, P43; Kazis LE, VETERANS RAND 12 ITE; Kim SP, 2013, J UROLOGY, V189, P2092, DOI 10.1016/j.juro.2012.11.174; Kutikov A, 2012, PROSTATE CANCER P D, V15, P374, DOI 10.1038/pcan.2012.21; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Ndumele CD, 2019, MED CARE, V57, P8, DOI 10.1097/MLR.0000000000001000; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Ries LAG, 2007, SEER CANC STAT REV 1; Roberts CB, 2011, AM J MED, V124, P235, DOI 10.1016/j.amjmed.2010.10.016; Rogers WH, 2004, CALCULATING MEDICARE; Sammon JD, 2015, EUR UROL; Sanda MG, 2018, J UROLOGY, V199, P683, DOI 10.1016/j.juro.2017.11.095; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simone NL, 2008, J UROLOGY, V180, P2447, DOI 10.1016/j.juro.2008.08.017; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2020	15	12							e0240039	10.1371/journal.pone.0240039	http://dx.doi.org/10.1371/journal.pone.0240039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PD8LW	33284845	gold, Green Published			2022-12-26	WOS:000597930500008
J	de Castro, CP; dos Santos, GF; de Freitas, AD; dos Santos, MI; Andrade, RFS; Barreto, ML				de Castro, Caio Porto; dos Santos, Gervasio Ferreira; de Freitas, Anderson Dias; dos Santos, Maria Isabel; Silva Andrade, Roberto Fernandes; Barreto, Mauricio Lima			Socio-economic urban scaling properties: Influence of regional geographic heterogeneities in Brazil	PLOS ONE			English	Article							LIFE	The recent efforts dedicated to understanding important features and consequences of city growth have profited from the scaling approach to urban indicators. This kind of analysis can be conveniently used to investigate the impact of geo-economic transformations, like fast urbanization and industrial development, which occurred in continental size countries (e.g., India, China, and Brazil) during the past half-century. Profiting from high quality data, this work explores how scaling relationships among urban indicators are influenced by strong regional heterogeneities in Brazil. It is based on economic, infrastructure and violence related data sets for the time interval 2002-2016. Results indicate that regional specificities related to infrastructure, economic development, and geography have a larger influence on the absolute value of the urban indexes. Regional scaling similarities and differences among Brazilian regions were also uncovered. Interesting enough, the results indicate that the richest and poorest Brazilian regions share similar scaling behavior, despite all huge different local influences. By contrast, the results for the two richest regions, with similar average values of urban indexes and the same kind of local influences have rather different scaling properties. Thus, scaling analysis suggests that distinct political solutions might be necessary to improve life's quality, even for two regions with similar average values of urban indicators.	[de Castro, Caio Porto; dos Santos, Gervasio Ferreira; de Freitas, Anderson Dias; dos Santos, Maria Isabel; Silva Andrade, Roberto Fernandes; Barreto, Mauricio Lima] Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Ctr Data & Knowledge Integrat Hlth, Salvador, BA, Brazil; [Barreto, Mauricio Lima] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Silva Andrade, Roberto Fernandes] Univ Fed Bahia, Inst Phys, Salvador, BA, Brazil; [dos Santos, Gervasio Ferreira] Univ Fed Bahia, Econ Fac, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia	de Castro, CP (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Ctr Data & Knowledge Integrat Hlth, Salvador, BA, Brazil.	caioporto@ufba.br		Castro, Caio/0000-0001-5316-7515; Santos, Gervasio/0000-0002-3545-3590; Andrade, Roberto/0000-0002-9323-1400	Brazilian agency CNPq [305060/2015-5]; Wellcome Trust (UK) through the project Salud Urbana en America Latina (SALURBAL); National Institute of Science and Technology for Complex Systems (INCT-SC Brazil)	Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust (UK) through the project Salud Urbana en America Latina (SALURBAL)(Wellcome Trust); National Institute of Science and Technology for Complex Systems (INCT-SC Brazil)	This work was supported by the Brazilian agency CNPq through grant No. 305060/2015-5 (R.F.S.A.), by the Wellcome Trust (UK) through the project Salud Urbana en Ame ' rica Latina (SALURBAL) (C.P.C., G.F.S., A.D.F., M.I.S.). R.F.S. A. acknowledges the support of the National Institute of Science and Technology for Complex Systems (INCT-SC Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134862; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 2008, WORKSH VER VAL SHIP, V1, pB7; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; BATTY M, 1976, ENVIRON PLANN A, V8, P189, DOI 10.1068/a080189; Batty M., 2007, CITIES COMPLEXITY UN; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Brelsford C, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4644; DATASUS, 2019, DATASUS; Depersin J, 2018, P NATL ACAD SCI USA, V115, P2317, DOI 10.1073/pnas.1718690115; Florida R., 2004, CITIES CREATIVE CLAS, P1, DOI [10.4324/9780203997673, DOI 10.4324/9780203997673]; Glaeser EL, 1999, J POLIT ECON, V107, pS225, DOI 10.1086/250109; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Hall P., 1998, CITIES CIVILIZATION; Hanley QS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149546; Henderson JV, 1988, URBAN DEV THEORY FAC; Jacobs Jane., 1961, DEATH LIFE GREAT AM, P458; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Louf R, 2014, ENVIRON PLANN B, V41, P767, DOI 10.1068/b4105c; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Mumford L., 1961, CITY HIST ITS ORIGIN, DOI DOI 10.1016/j.jaa.2011.06.005; Newman M., 2005, STRUCTURE DYNAMICS N; NORDBECK S, 1971, GEOGR ANAL, VB 53, P54, DOI 10.2307/490887; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; Roberts M, 2012, REG SCI URBAN ECON, V42, P580, DOI 10.1016/j.regsciurbeco.2012.01.003; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Sahasranaman A, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0758; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677	36	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0242778	10.1371/journal.pone.0242778	http://dx.doi.org/10.1371/journal.pone.0242778			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PC7AS	33275604	gold, Green Published			2022-12-26	WOS:000597150200009
J	Dell, AC; Curry, MC; Yarnell, KM; Starbuck, GR; Wilson, PB				Dell, Andy C.; Curry, Mark C.; Yarnell, Kelly M.; Starbuck, Gareth R.; Wilson, Philippe B.			Mitochondrial D-loop sequence variation and maternal lineage in the endangered Cleveland Bay horse	PLOS ONE			English	Article							DNA SEQUENCE; ORIGINS	Genetic diversity and maternal ancestry line relationships amongst a sample of 96 Cleveland Bay horses were investigated using a 479bp length of mitochondrial D-loop sequence. The analysis yielded at total of 11 haplotypes with 27 variable positions, all of which have been described in previous equine mitochondrial DNA d-loop studies. Four main haplotype clusters were present in the Cleveland Bay breed describing 89% of the total sample. This suggests that only four principal maternal ancestry lines exist in the present-day global Cleveland Bay population. Comparison of these sequences with other domestic horse haplotypes (Fig 2) shows a close association of the Cleveland Bay horse with Northern European (Clade C), Iberian (Clade A) and North African (Clade B) horse breeds. This indicates that the Cleveland Bay horse may not have evolved exclusively from the now extinct Chapman horse, as previous work as suggested. The Cleveland Bay horse remains one of only five domestic horse breeds classified as Critical on the Rare Breeds Survival Trust (UK) Watchlist and our results provide important information on the origins of this breed and represent a valuable tool for conservation purposes.	[Dell, Andy C.; Curry, Mark C.] Univ Lincoln, Dept Biol Sci, Lincoln, England; [Dell, Andy C.; Wilson, Philippe B.] Rare Breeds Survival Trust, Stoneleigh, Warwick, England; [Yarnell, Kelly M.; Starbuck, Gareth R.; Wilson, Philippe B.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell, Notts, England	University of Lincoln; Nottingham Trent University	Dell, AC (corresponding author), Univ Lincoln, Dept Biol Sci, Lincoln, England.; Dell, AC; Wilson, PB (corresponding author), Rare Breeds Survival Trust, Stoneleigh, Warwick, England.; Wilson, PB (corresponding author), Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell, Notts, England.	andy.dell@btinternet.com; PhilippeWilson@rbst.org.uk	Wilson, Philippe B./N-2414-2019	Wilson, Philippe B./0000-0003-0207-2246; Dell, Andrew/0000-0002-8054-2023; Starbuck, Gareth/0000-0002-6281-9885				Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202; Cai DW, 2009, J ARCHAEOL SCI, V36, P835, DOI 10.1016/j.jas.2008.11.006; Das S, 2008, STUD COMPUT INTELL, V116, P1, DOI 10.1007/978-3-540-78297-1_1; Dell A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240410; DRUMMOND AJ, 2009, GENEIOUS V4 8; Emmerson S, 1996, CLEVELAND BAY HORSE; Emmerson S, 1984, CLEVELAND BAY HORSE; Glazewska I, 2007, GENET SEL EVOL, V39, P609, DOI 10.1051/gse:2007025; Glazewska I, 2010, LIVEST SCI, V129, P49, DOI 10.1016/j.livsci.2009.12.009; ISHIDA N, 1994, ANIM GENET, V25, P215, DOI 10.1111/j.1365-2052.1994.tb00196.x; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Kavar T, 2008, LIVEST SCI, V116, P1, DOI 10.1016/j.livsci.2008.03.002; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim KI, 1999, ANIM GENET, V30, P102, DOI 10.1046/j.1365-2052.1999.00419.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopes MS, 2005, ANIM GENET, V36, P196, DOI 10.1111/j.1365-2052.2005.01279.x; Luis C, 2006, J HERED, V97, P107, DOI 10.1093/jhered/esj020; McGahern AM, 2006, ANIM GENET, V37, P498, DOI 10.1111/j.1365-2052.2006.01506.x; Perez-Gutierrez LM, 2008, ANIM GENET, V39, P506, DOI 10.1111/j.1365-2052.2008.01762.x; Priskin K, 2010, GENETICA, V138, P211, DOI 10.1007/s10709-009-9411-x; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Xu S, 2007, GENETIC DIVERSITY IR, V34, P720; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7	25	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243247	10.1371/journal.pone.0243247	http://dx.doi.org/10.1371/journal.pone.0243247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270708	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000597149100051
J	Morgenstern-Kaplan, D; Buitano-Tang, B; Martinez-Gil, M; Pavon, AZP; Talavera, JO				Morgenstern-Kaplan, Dan; Buitano-Tang, Bruno; Martinez-Gil, Mercedes; Pavon, Andrea Zaldivar-Perez; Talavera, Juan O.			U-shaped-aggressiveness of SARS-CoV-2: Period between initial symptoms and clinical progression to COVID-19 suspicion. A population-based cohort study	PLOS ONE			English	Article								Background Early identification of different COVID-19 clinical presentations may depict distinct pathophysiological mechanisms and guide management strategies. Objective To determine the aggressiveness of SARS-CoV-2 using symptom progression in COVID-19 patients. Design Historic cohort study of Mexican patients. Data from January-April 2020 were provided by the Health Ministry. Setting Population-based. Patients registered in the Epidemiologic Surveillance System in Mexico. Participants Subjects who sought medical attention for clinical suspicion of COVID-19. All patients were subjected to RT-PCR testing for SARS-CoV-2. Measurements We measured the Period between initial symptoms and clinical progression to COVID-19 suspicion (PISYCS) and compared it to the primary outcomes (mortality and pneumonia). Results 65,500 patients were included. Reported fatalities and pneumonia were 2176 (3.32%), and 11568 (17.66%), respectively. According to the PISYCS, patients were distributed as follows: 14.89% in <24 hours, 43.25% between 1-3 days, 31.87% between 4-7 days and 9.97% >7 days. The distribution for mortality and pneumonia was 5.2% and 22.5% in <24 hours, 2.5% and 14% between 1-3 days, 3.6% and 19.5% between 4-7 days, 4.1% and 20.6% >7 days, respectively (p<0.001). Adjusted-risk of mortality was (OR [95% CI], p-value): <24 hours = 1.75 [1.55-1.98], p<0.001; 1-3 days = 1 (reference value); 4-7 days = 1.53 [1.37-1.70], p7 days = 1.67 [1.44-1.94], p<0.001. For pneumonia: <24 hours = 1.49 [1.39-1.58], p<0.001; 1-3 days = 1; 4-7 days = 1.48 [1.41-1.56], p7 days = 1.57 [1.46-1.69], pLimitations Using a database fed by large numbers of people carries the risk of data inaccuracy. However, this imprecision is expected to be random and data are consistent with previous studies. Conclusion The PISYCS shows a U-shaped SARS-CoV-2 aggressiveness pattern. Further studies are needed to corroborate the time-related pathophysiology behind these findings.	[Morgenstern-Kaplan, Dan; Buitano-Tang, Bruno; Martinez-Gil, Mercedes; Pavon, Andrea Zaldivar-Perez; Talavera, Juan O.] Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud Anahuac CICSA, Huixquilucan, Estado De Mexic, Mexico; [Talavera, Juan O.] ABC Med Ctr, Dept Med Educ & Res, Mexico City, Cdmx, Mexico	Universidad Anahuac	Talavera, JO (corresponding author), Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud Anahuac CICSA, Huixquilucan, Estado De Mexic, Mexico.; Talavera, JO (corresponding author), ABC Med Ctr, Dept Med Educ & Res, Mexico City, Cdmx, Mexico.	jotalaverap@abchospital.com	Morgenstern-Kaplan, Dan/F-8651-2018	Morgenstern-Kaplan, Dan/0000-0002-9031-2256; Martinez Gil, Mercedes/0000-0002-4022-1049; Buitano-Tang, Bruno/0000-0001-5131-4825				Azoulay E, 2020, INTENS CARE MED, V46, P1714, DOI 10.1007/s00134-020-06202-3; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Cannegieter SC, 2020, RES PRACT THROMB HAE, V4, P439, DOI 10.1002/rth2.12350; Cascella M, 2020, STATPEARLS; Centers For Disease Control, 2020, INT CLIN GUID MAN PA; Clancy CJ, 2020, CLIN INFECT DIS, V71, P2736, DOI 10.1093/cid/ciaa524; Direccion General de Epidemiologia Secretaria de Salud, 2020, DAT AB BAS HIST; Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273]; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Liang WH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00562-2020; Liu S, 2020, CLIN REV ALLERG IMMU, V59, P78, DOI 10.1007/s12016-020-08797-3; Maddaloni E, 2020, DIABETES RES CLIN PR, V169, P1, DOI [10.1016/j.diabres.2020.108454, DOI 10.1016/J.DIABRES.2020.10845432971157]; Maddaloni E, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01140-2; Nature, 2021, NATURE; Pascarella G, 2020, J INTERN MED, V288, P192, DOI 10.1111/joim.13091; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; SUN Q, 2020, ANN INTENSIVE CARE, V10, pNIL_0001, DOI DOI 10.1186/s13613-020-00650-2; Sun XJ, 2020, CYTOKINE GROWTH F R, V53, P38, DOI 10.1016/j.cytogfr.2020.04.002; TYRRELL DA, 1966, LANCET, V1, P76; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243268	10.1371/journal.pone.0243268	http://dx.doi.org/10.1371/journal.pone.0243268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270769	Green Submitted, Green Published, gold			2022-12-26	WOS:000597149100004
J	Pandey, AR; Chalise, B; Shrestha, N; Ojha, B; Maskey, J; Sharma, D; Godwin, P; Aryal, KK				Pandey, Achyut Raj; Chalise, Binaya; Shrestha, Niraj; Ojha, Biwesh; Maskey, Jasmine; Sharma, Dikshya; Godwin, Peter; Aryal, Krishna Kumar			Mortality and risk factors of disease in Nepal: Trend and projections from 1990 to 2040	PLOS ONE			English	Article							EPIDEMIOLOGIC TRANSITION; GLOBAL BURDEN; INTERVENTIONS	Background Between 1990 and 2017, Nepal experienced a shift in the burden of disease from communicable, maternal, neonatal and nutritional (CMNN) diseases to non-communicable diseases (NCDs). With an increasing ageing population and life-style changes including tobacco use, harmful alcohol consumption, unhealthy diets, and insufficient physical activity, the proportion of total deaths from NCDs will continue to increase. An analysis of current diseases pattern and projections of the trends informs planning of health interventions. This analysis aims to project the mortality and risk factor of disease until 2040, based on past trends. Methods This study uses secondary data from the Global Burden of Disease (GBD) Study which analyses historic data from 1990 to 2016 to predict key variables such as, the mortality rates, life expectancy and Years of Life Lost for different causes of death from 2017 to 2040. 'GBD Foresight Visualization', a visualisation tool publicly available in the webpage of Institute for Health Metrics and Evaluation was the source of data for this analysis. GBD forecasting uses three-component modelling process: the first component captures variations due to risk factors and interventions, the second takes into consideration the variation due to measures of development quantified as social development index and the third uses an autoregressive integrated moving average model to capture the unexplained component correlated over time. We extracted Nepal specific data from it and reported number of deaths, mortality rates (per 100,000 population) as well as causes of death for the period 1990 to 2040. Results In 1990, CMNN diseases were responsible for approximately two-thirds (63.6%) of total deaths in Nepal. The proportion of the deaths from the CMNN diseases has reduced to 26.8% in 2015 and is estimated to be about a fifth of the 1990 figure (12.47%) in 2040. Conversely, deaths from NCDs reflect an upward trend. NCDs claimed a third of total deaths (29.91%) in the country in 1990, while in 2015, were responsible for about two-thirds of the total deaths (63.31%). In 2040, it is predicted that NCDs will contribute to over two-thirds (78.64%) of total deaths in the country. Less than a tenth (6.49%) of the total deaths in Nepal in 1990 were associated with injuries which increased to 13.04% in 2015 but is projected to decrease to 8.89% in 2040. In 1990, metabolic risk factors including high systolic blood pressure, high total cholesterol, high fasting plasma glucose, high body mass index and impaired kidney functions collectively contributed to a tenth of the total deaths (10.38%) in Nepal, whereas, in 2040 more than a third (37.31%) of the total deaths in the country could be attributed to it. Conclusion A reverse of the situation in 1990, NCDs are predicted to be the leading cause of deaths and metabolic risk factors are predicted to contribute to the highest proportion of deaths in 2040. NCDs could demand a major share of resources within the health sector requiring extensive multi-sectoral prevention measures, re-allocation of resources and re-organisation of the health system to cater for long-term care.	[Pandey, Achyut Raj; Shrestha, Niraj; Ojha, Biwesh; Maskey, Jasmine; Sharma, Dikshya; Godwin, Peter; Aryal, Krishna Kumar] Abt Associates Inc, Nepal Hlth Sect Programme Monitoring Evaluat & Op, Kathmandu, Nepal; [Chalise, Binaya] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima, Japan	Hiroshima University	Pandey, AR (corresponding author), Abt Associates Inc, Nepal Hlth Sect Programme Monitoring Evaluat & Op, Kathmandu, Nepal.	achyutrajpandey2014@gmail.com		Chalise, Binaya/0000-0001-7292-1229; Pandey, Achyut Raj/0000-0002-1037-1273	UKaid	UKaid(CGIAR)	The data extraction process was completed by ARP working in the Monitoring, Evaluation and Operational Research (MEOR) project, funded through UKaid. No additional external funding was received for this study.	[Anonymous], 2017, MAJOR INFECT DIS; [Anonymous], 2019, CIRCULATION, V139, pe42; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Aryal BK., 2018, J NEPAL HLTH RES COU, V16, P149, DOI [10.3126/jnhrc.v16i2.20301, DOI 10.3126/JNHRC.V16I2.20301]; Aryal KK., 2014, NONCOMMUNICABLE DIS; Barr Victoria J, 2003, Hosp Q, V7, P73; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Buse K, 2020, HLTH POLICY PLANNING; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Institute for Health Metrics and Evaluation (IHME), 2019, GBD COMPARE; Jakovljevic M, 2019, J MED ECON, V22, P722, DOI 10.1080/13696998.2019.1600523; Jelsoe E., 2015, Journal of Transdisciplinary Environmental Studies, V14, P36; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Khetan AK, 2017, GLOB HEART, V12, P233, DOI 10.1016/j.gheart.2016.07.001; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mccracken K, 2009, EPIDEMIOLOGICAL TRAN, P571; Meij JJ, 2009, T ROY SOC TROP MED H, V103, P173, DOI 10.1016/j.trstmh.2008.09.015; Ministry of Health and Population, MULT ACT PLAN PREV C; Ministry of Health and Population Government of Nepal., 2015, NEP HLTH SECT STRAT; Ministry of Health and Population Government of Nepal Society for Local Integrated Development Nepal WHO. WHO STEPS surveillance, 2008, WHO STEPS SURV NONC; Ministry of Health-MOH/Nepal New ERA/Nepal ICF, 2017, NEP DEM HLTH SURV 20; Mishra SR, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0119-7; Monteiro C.A, 2015, DIET GUID BRAZ POP; Nepal Health Research Council Ministry of Health and Population Monitoring Evaluation and Operational Research, 2019, NEP BURD DIS 2017 CO; Nepal Health Research Council; World Health Organization, 2019, NEP DIS RISK FACT ST; Nepal Health Reserach Council World Health Organization, 2019, NEP NONC DIS RISK FA; Primary Health Care Revitalization Division, PACK ESS NONC DIS NE; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Sharma SR, 2019, GLOB HEALTH PROMOT, V26, P94, DOI 10.1177/1757975917720800; Soneji S, 2020, POPULATION LEVEL MOR; Subedi YP, 2017, ASIA PAC J CLIN NUTR, V26, P358, DOI 10.6133/apjcn.112015.10; The Nepal NCDI Poverty Commission, 2018, EQ INT ADDR NONC DIS; Upreti Senendra Raj, 2016, WHO South East Asia J Public Health, V5, P40, DOI 10.4103/2224-3151.206551; Woolf SH, 2008, AM J PREV MED, V34, P263, DOI 10.1016/j.amepre.2007.12.002	38	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0243055	10.1371/journal.pone.0243055	http://dx.doi.org/10.1371/journal.pone.0243055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270728	Green Published			2022-12-26	WOS:000597149100162
J	Raga-Carbajal, E; Diaz-Vilchis, A; Rojas-Trejo, SP; Rudino-Pinera, E; Olvera, C				Raga-Carbajal, Enrique; Diaz-Vilchis, Adelaida; Rojas-Trejo, Sonia P.; Rudino-Pinera, Enrique; Olvera, Clarita			The molecular basis of the nonprocessive elongation mechanism in levansucrases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS LEVANSUCRASE; CRYSTAL-STRUCTURE; LEVAN; PROTEIN; FRUCTOOLIGOSACCHARIDES; MUTAGENESIS; PRODUCTS; INSIGHTS; FEATURES; RN-01	Levansucrases (LSs) synthesize levan, a beta 2-6-linked fructose polymer, by successively transferring the fructosyl moiety from sucrose to a growing acceptor molecule. Elucidation of the levan polymerization mechanism is important for using LSs in the production of size-defined products for application in the food and pharmaceutical industries. For a deeper understanding of the levan synthesis reaction, we determined the crystallographic structure of Bacillus subtilis LS (SacB) in complex with a levan-type fructooligosaccharide and utilized site-directed mutagenesis to identify residues involved in substrate binding. The presence of a levanhexaose molecule in the central catalytic cavity allowed us to identify five substrate-binding subsites (-1, +1, +2, +3, and +4). Mutants affecting residues belonging to the identified acceptor subsites showed similar substrate affinity (Km) values to the wildtype (WT) Km value but had a lower turnover number and transfructosylation/hydrolysis ratio. Of importance, compared with the WT, the variants progressively yielded smaller-sized low-molecular-weight levans, as the affected subsites that were closer to the catalytic site, but without affecting their ability to synthesized high-molecular-weight levans. Furthermore, an additional oligosaccharide-binding site 20 angstrom away from the catalytic pocket was identified, and its potential participation in the elongation mechanism is discussed. Our results clarify, for the first time, the interaction of the enzyme with an acceptor/product oligosaccharide and elucidate the molecular basis of the nonprocessive levan elongation mechanism of LSs.	[Raga-Carbajal, Enrique; Olvera, Clarita] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico; [Diaz-Vilchis, Adelaida; Rojas-Trejo, Sonia P.; Rudino-Pinera, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Olvera, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico.	clarita@ibt.unam.mx		Raga-Carbajal, Enrique/0000-0002-7598-0520; Rudino-Pinera, Enrique/0000-0001-8170-6379; Diaz-Vilchis, Adelaida/0000-0001-5891-1470; Olvera-Carranza, Clarita/0000-0002-8364-5845	CONACyT [CB-219728, CONACyT-BMBF-267620]; National Autonomous University of Mexico [UNAM-PAPIIT IN216120]; National Council of Science and Technology (CONACyT) [420196/261902]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Autonomous University of Mexico(Universidad Nacional Autonoma de Mexico); National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (grants CB-219728 and CONACyT-BMBF-267620) and the National Autonomous University of Mexico (grant UNAM-PAPIIT IN216120). E. R.-C. acknowledges the National Council of Science and Technology (CONACyT) for providing the PhD grant No. 420196/261902 (CVU/Becario).	Abdel-Fattah AM, 2012, CARBOHYD POLYM, V89, P314, DOI 10.1016/j.carbpol.2012.02.041; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albenne C, 2007, PROTEINS, V66, P118, DOI 10.1002/prot.21083; Beine R, 2008, J BIOTECHNOL, V138, P33, DOI 10.1016/j.jbiotec.2008.07.1998; Byun BY, 2014, INT J FOOD SCI TECH, V49, P238, DOI 10.1111/ijfs.12304; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; Chayen NE, 2008, NAT METHODS, V5, P147, DOI 10.1038/NMETH.F.203; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Claverie M, 2019, BIOCHEMISTRY-US, V58, P2853, DOI 10.1021/acs.biochem.9b00373; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Rodriguez-Alegria ME, 2010, BIOCATAL BIOTRANSFOR, V28, P51, DOI 10.3109/10242420903388819; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Euzenat O, 1997, PROCESS BIOCHEM, V32, P237, DOI 10.1016/S0032-9592(96)00058-1; He CJ, 2018, APPL MICROBIOL BIOT, V102, P3217, DOI 10.1007/s00253-018-8854-3; HERNANDEZ L, 1995, BIOCHEM J, V309, P113, DOI 10.1042/bj3090113; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Iizuka M., 2002, Journal of Applied Glycoscience, V49, P229; Kang SA, 2004, J MICROBIOL BIOTECHN, V14, P796; Kanjanatanin P, 2019, INT J BIOL MACROMOL, V140, P1239, DOI 10.1016/j.ijbiomac.2019.08.151; Kirtel O, 2018, APPL MICROBIOL BIOT, V102, P9207, DOI 10.1007/s00253-018-9311-z; Kuttiyawong K., 2016, SONGKLA J SCI TECHNO, V38, P295; Li SY, 2011, MOL BIOL REP, V38, P2437, DOI 10.1007/s11033-010-0379-5; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mardo K, 2014, BIOTECHNOL APPL BIOC, V61, P11, DOI 10.1002/bab.1129; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendez-Lorenzo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143394; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakapong S, 2013, INT J BIOL MACROMOL, V54, P30, DOI 10.1016/j.ijbiomac.2012.11.017; Oner ET, 2016, BIOTECHNOL ADV, V34, P827, DOI 10.1016/j.biotechadv.2016.05.002; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Ortiz-Soto ME, 2020, INT J BIOL MACROMOL, V161, P898, DOI 10.1016/j.ijbiomac.2020.06.114; Ortiz-Soto ME, 2018, CHEM SCI, V9, P5312, DOI 10.1039/c8sc01244j; Ozimek LK, 2006, FEBS J, V273, P4104, DOI 10.1111/j.1742-4658.2006.05411.x; Polsinelli I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010083; Polsinelli I, 2019, INT J BIOL MACROMOL, V127, P496, DOI 10.1016/j.ijbiomac.2019.01.074; Porras-Dominguez JR, 2014, PROCESS BIOCHEM, V49, P783, DOI 10.1016/j.procbio.2014.02.005; Raga-Carbajal E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32872-7; Raga-Carbajal E, 2016, GLYCOBIOLOGY, V26, P377, DOI 10.1093/glycob/cwv112; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Santos-Moriano P, 2015, J MOL CATAL B-ENZYM, V119, P18, DOI 10.1016/j.molcatb.2015.05.011; SEDGWICK AD, 1984, BRIT J EXP PATHOL, V65, P215; SINAI Y, 1976, CANCER RES, V36, P1593; Sitthiyotha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204915; Strube CP, 2011, J BIOL CHEM, V286, P17593, DOI 10.1074/jbc.M110.203166; TANAKA T, 1980, J BIOCHEM, V87, P297, DOI 10.1093/oxfordjournals.jbchem.a132737; Van den Ende W, 2011, PLANT PHYSIOL, V155, P603, DOI 10.1104/pp.110.162222; Visnapuu T, 2009, RAPID COMMUN MASS SP, V23, P1337, DOI 10.1002/rcm.4007; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258	55	4	4	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100178	10.1074/jbc.RA120.015853	http://dx.doi.org/10.1074/jbc.RA120.015853			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33303628	gold, Green Published			2022-12-26	WOS:000672866400156
J	Reyes-Ruiz, JM; Nakajima, R; Baghallab, I; Goldschmidt, L; Sosna, J; Ho, PNM; Kumosani, T; Felgner, PL; Glabe, C				Reyes-Ruiz, Jorge Mauricio; Nakajima, Rie; Baghallab, Ibtisam; Goldschmidt, Luki; Sosna, Justyna; Phuong Nguyen Mai Ho; Kumosani, Taha; Felgner, Philip L.; Glabe, Charles			An "epitomic" analysis of the specificity of conformation-dependent, anti-A beta amyloid monoclonal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; AGGREGATION; SHEET	Antibodies against A beta amyloid are indispensable research tools and potential therapeutics for Alzheimer's disease. They display several unusual properties, such as specificity for aggregated forms of the peptide, the ability to distinguish polymorphic aggregate structures, and the ability to recognize generic aggregation-related epitopes formed by unrelated amyloid sequences. Understanding the mechanisms underlying these unusual properties and the structures of their corresponding epitopes is crucial for the understanding why antibodies display different therapeutic activities and for the development of more effective therapeutic agents. Here we employed a novel "epitomic" approach to map the fine structure of the epitopes of 28 monoclonal antibodies against amyloid-beta using immunoselection of random sequences from a phage display library, deep sequencing, and pattern analysis to define the critical sequence elements recognized by the antibodies. Although most of the antibodies map to major linear epitopes in the amino terminal 1 to 14 residues of A beta, the antibodies display differences in the target sequence residues that are critical for binding and in their individual preferences for nontarget residues, indicating that the antibodies bind to alternative conformations of the sequence by different mechanisms. Epitomic analysis also identifies discontinuous, nonoverlapping sequence A beta segments that may constitute the conformational epitopes that underlie the aggregation specificity of antibodies. Aggregation-specific antibodies recognize sequences that display a significantly higher predicted propensity for forming amyloid than antibodies that recognize the monomer, indicating that the ability of random sequences to aggregate into amyloid is a critical element of their binding mechanism.	[Reyes-Ruiz, Jorge Mauricio; Sosna, Justyna; Phuong Nguyen Mai Ho; Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Nakajima, Rie; Felgner, Philip L.] Univ Calif Irvine, Dept Physiol & Biophys, Vaccine Res & Dev Ctr, Irvine, CA 92717 USA; [Baghallab, Ibtisam; Kumosani, Taha] King Abdulaziz Univ, Fac Sci, Biochem Dept, Jeddah, Saudi Arabia; [Goldschmidt, Luki] Univ Washington, Inst Prot Design, Dept Biochem, Seattle, WA 98195 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; King Abdulaziz University; University of Washington; University of Washington Seattle	Glabe, C (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	cglabe@uci.edu		Felgner, Philip/0000-0002-4117-8505; Sosna, Justyna/0000-0002-3806-3459	NIH [AG056507, AG061857]; Cure Alzheimer Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund	This work was supported by NIH grants AG056507 and AG061857 (C. G.), and the Cure Alzheimer Fund (C. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott WM, 2014, IMMUNOLOGY, V142, P526, DOI 10.1111/imm.12284; Arnold Carrie, 2020, Nat Med, DOI 10.1038/d41591-020-00031-z; Baghallab I, 2018, J ALZHEIMERS DIS, V66, P1235, DOI 10.3233/JAD-180582; Bullain S, 2020, J NEUROCHEM, V155, P120, DOI 10.1111/jnc.15023; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Knopman DS, 2021, ALZHEIMERS DEMENT, V17, P696, DOI 10.1002/alz.12213; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McLean D, 2013, ACS CHEM NEUROSCI, V4, P613, DOI 10.1021/cn300226q; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Reineke U, 2009, METHODS MOL BIOL, V524, P145, DOI 10.1007/978-1-59745-450-6_11; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Shea D, 2019, P NATL ACAD SCI USA, V116, P8895, DOI 10.1073/pnas.1820585116; Tolar M, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00663-w; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	30	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100168	10.1074/jbc.RA120.015501	http://dx.doi.org/10.1074/jbc.RA120.015501			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33298522	Green Published, gold			2022-12-26	WOS:000672866400146
J	Bonfim, AP; Sakita, KM; Faria, DR; Arita, GS; Vendramini, FAVR; Capoci, IRG; Braga, AG; dos Santos, RS; Bruschi, ML; Becker, TCA; de Oliveira, AG; Kioshima, ES; Bonfim-Mendonca, PD; Svidzinski, TIE				Bonfim, Amanda Pohlmann; Sakita, Karina Mayumi; Faria, Daniella Renata; Arita, Glaucia Sayuri; Vilugron Rodrigues Vendramini, Franciele Abigail; Grenier Capoci, Isis Regina; Braga, Andressa Gimenes; dos Santos, Rafaela Said; Bruschi, Marcos Luciano; Alexandrino Becker, Tania Cristina; de Oliveira Junior, Admilton Goncalves; Kioshima, Erika Seki; Bonfim-Mendonca, Patricia de Souza; Estivalet Svidzinski, Terezinha Inez			Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis	PLOS ONE			English	Article							ALBICANS; PREVALENCE; RESISTANCE; PLATFORMS; EFFICACY; NITRATE	Vulvovaginal candidiasis (VVC) is a common vaginitis that affects women, especially in childbearing age, caused by Candida albicans in almost 80% of cases. Considering the limited drug arsenal available and the increasing fungal resistance profile, the search for new therapeutic sources with low toxicity and easy administration should be supported. Propolis has been used as a traditional medicine for multiple diseases, considering its particular composition and pharmaceutical properties that permits its wide applicability; it has also emerged as a potential antifungal agent. Thus, this study performed an in vitro and in vivo investigation into the efficacy of a new mucoadhesive thermoresponsive platform for propolis delivery (MTS-PRPe) in a preclinical murine model of VVC treatment caused by C. albicans. The methodologies involved chemical analysis, an assessment of the rheological and mucoadhesive properties of propolis formulations, in vitro and in vivo antifungal evaluations, histological evaluations and electron microscopy of the vaginal mucosa. The results demonstrated the antifungal activity of propolis extract and MTS-PRP against the standard strain and a fluconazole-resistant clinical isolate of C. albicans, in both in vitro and in vivo assays. These results were similar and even better, depending on the propolis concentration, when compared to nystatin. Thus, the formulation containing propolis exhibited good performance against C. albicans in a vulvovaginal candidiasis experimental model, representing a promising opportunity for the treatment of this infection.	[Bonfim, Amanda Pohlmann; Sakita, Karina Mayumi; Faria, Daniella Renata; Arita, Glaucia Sayuri; Vilugron Rodrigues Vendramini, Franciele Abigail; Grenier Capoci, Isis Regina; Braga, Andressa Gimenes; Kioshima, Erika Seki; Bonfim-Mendonca, Patricia de Souza; Estivalet Svidzinski, Terezinha Inez] Univ Estadual Maringa, Clin Anal & Biomed Dept, Med Mycol Lab, Maringa, Parana, Brazil; [dos Santos, Rafaela Said; Bruschi, Marcos Luciano] Univ Estadual Maringa, Dept Pharm, Maringa, Parana, Brazil; [Alexandrino Becker, Tania Cristina] Univ Estadual Maringa, Hlth Basic Sci Dept, Gen Pathol Lab, Maringa, Parana, Brazil; [de Oliveira Junior, Admilton Goncalves] Univ Estadual Londrina, Electron Microscopy & Microanal Lab, Londrina, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Londrina	Svidzinski, TIE (corresponding author), Univ Estadual Maringa, Clin Anal & Biomed Dept, Med Mycol Lab, Maringa, Parana, Brazil.	tiesvidzinski@uem.br	Bruschi, Marcos Luciano/J-1871-2012	Bruschi, Marcos Luciano/0000-0002-4838-5742; Arita, Glaucia Sayuri/0000-0002-0334-7566; Sakita, Karina/0000-0003-2899-2657	Laboratory of Medical Mycology and Laboratory of Research and Development of Drug Delivery Systems of Universidade Estadual de Maringa	Laboratory of Medical Mycology and Laboratory of Research and Development of Drug Delivery Systems of Universidade Estadual de Maringa	This study was supported by efforts from the Laboratory of Medical Mycology and Laboratory of Research and Development of Drug Delivery Systems of Universidade Estadual de Maringa, with own resources.	Andrews GP, 2009, EUR J PHARM BIOPHARM, V71, P505, DOI 10.1016/j.ejpb.2008.09.028; [Anonymous], 2015, AM J KIDNEY DIS, V66, pS79; [Anonymous], 2015, US PHARM CONV; Berretta AA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/641480; Bruschi ML, 2007, J PHARM SCI-US, V96, P2074, DOI 10.1002/jps.20843; Bruschi Marcos Luciano, 2006, Rev. Bras. Cienc. Farm., V42, P29, DOI 10.1590/S1516-93322006000100004; Carvalho FC, 2013, DRUG DEV IND PHARM, V39, P1750, DOI 10.3109/03639045.2012.734510; Choi HG, 1999, INT J PHARM, V190, P13, DOI 10.1016/S0378-5173(99)00225-2; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2008, M27A3 CLSI; Dalben-Dota KF, 2010, J ALTERN COMPLEM MED, V16, P285, DOI 10.1089/acm.2009.0281; Pereira RRD, 2013, J PHARM SCI-US, V102, P1222, DOI 10.1002/jps.23451; de Oliveira AG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00113; Ferreira SBD, 2016, J MECH BEHAV BIOMED, V55, P164, DOI 10.1016/j.jmbbm.2015.10.026; Fan SR, 2015, GYNECOL OBSTET INVES, V80, P113, DOI 10.1159/000371759; Fatahinia M, 2012, J MYCOL MED, V22, P237, DOI 10.1016/j.mycmed.2012.05.004; Fidel PL, 1997, ANTIMICROB AGENTS CH, V41, P1455, DOI 10.1128/AAC.41.7.1455; Foxman B, 2013, J LOW GENIT TRACT DI, V17, P340, DOI 10.1097/LGT.0b013e318273e8cf; Capoci IRG, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/287693; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; HEMPHILL T, 1993, OIL GAS J, V91, P45; Hiller E, 2011, INT J MED MICROBIOL, V301, P384, DOI 10.1016/j.ijmm.2011.04.004; Hosnuter M, 2004, BURNS, V30, P121, DOI 10.1016/j.burns.2003.09.022; HUPPERT M, 1978, J CLIN MICROBIOL, V8, P598; Ilkit M, 2011, CRIT REV MICROBIOL, V37, P250, DOI 10.3109/1040841X.2011.576332; Institute of Laboratory Animal Resources (US). Committee on Care Use of Laboratory Animals & National Institutes of Health (US). Division of Research Resources., 1985, GUIDE CARE USE LAB A; Jastrzebska-Stojko Z, 2013, MOLECULES, V18, P14397, DOI 10.3390/molecules181114397; Jones DS, 2009, INT J PHARMACEUT, V372, P49, DOI 10.1016/j.ijpharm.2009.01.006; Khosravi A R, 2014, J Mycol Med, V24, pe143, DOI 10.1016/j.mycmed.2014.05.002; Marchaim D, 2012, OBSTET GYNECOL, V120, P1407, DOI [10.1097/AOG.0b013e31827307b2, http://10.1097/AOG.0b013e31827307b2]; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nash EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147969; Olczyk P, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/290675; Oryan A, 2018, BIOMED PHARMACOTHER, V98, P469, DOI 10.1016/j.biopha.2017.12.069; Perea S, 2001, ANTIMICROB AGENTS CH, V45, P2676, DOI 10.1128/AAC.45.10.2676-2684.2001; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Rocha BA, 2012, J THERM ANAL CALORIM, V108, P87, DOI 10.1007/s10973-011-1713-4; Sobel JD, 2014, PATIENT PREFER ADHER, V8, P31, DOI 10.2147/PPA.S38984; Swiss Re Report, 2018, SIGMA, V3148; Tobaldini-Valerio FK, 2016, FUTURE MICROBIOL, V11, P1035, DOI 10.2217/fmb-2015-0016; Pessolato AGT, 2011, BURNS, V37, P1192, DOI 10.1016/j.burns.2011.05.016; Veiga FF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00779; Volpi N, 2006, J PHARMACEUT BIOMED, V42, P354, DOI 10.1016/j.jpba.2006.04.017; Xuan HZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/280120; Yano J, 2011, JOVE-J VIS EXP, DOI 10.3791/3382	45	6	6	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243197	10.1371/journal.pone.0243197	http://dx.doi.org/10.1371/journal.pone.0243197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306677	gold, Green Published			2022-12-26	WOS:000600144200030
J	Mesa-Varona, O; Kaspar, H; Grobbel, M; Tenhagen, BA				Mesa-Varona, Octavio; Kaspar, Heike; Grobbel, Mirjam; Tenhagen, Bernd-Alois			Phenotypical antimicrobial resistance data of clinical and non-clinical Escherichia coli from poultry in Germany between 2014 and 2017	PLOS ONE			English	Article							FLUOROQUINOLONE RESISTANCE; BROILER-CHICKENS; ANIMALS; GENES	Antimicrobial resistance (AMR) is a global threat in humans and animals, and antimicrobial usage (AMU) has been identified as a main trigger of AMR. The purpose of this work was to compare data on AMR in clinical and non-clinical isolates of Escherichia coli in German broilers and turkeys between 2014 and 2017. Furthermore, we investigated AMR changes over time and the association of changes in AMU with changes in AMR. Data on clinical and non-clinical isolates together with data on therapy frequency of broilers and turkeys were collected from German monitoring systems. Logistic regression analyses were performed to assess the association between the explanatory factors (AMU, year and isolate type) and the dependent variable (AMR). In broilers, the analysis showed lower resistance proportions of clinical isolates of E. coli to ampicillin and colistin (ampicillin: Odds ratio (OR) and 95% confidence interval (CI) = 0.44 (0.3-0.64), p<0.001; colistin: OR and 95% CI = 0.75 (0.73-0.76), p<0.001) but higher proportions for cefotaxime (OR and 95% CI = 4.58 (1.56-15.1), p = 0.007). Resistance to ampicillin, gentamicin and tetracycline was less frequent in clinical isolates in turkeys (ampicillin: OR and 95% CI = 0.4 (0.29-0.53), p<0.001; gentamicin: OR and 95% CI = 0.5 (0.26-0.94), p = 0.035; tetracycline: OR and 95% CI = 0.4 (0.29-0.55), p<0.001). The analysis found decreasing associations of AMU with resistance to tetracycline in turkeys and to colistin in broilers. Year was associated with a decrease in resistance to colistin in broilers and to tetracycline in turkeys. Differences in resistance found in this study between clinical and non-clinical isolates might play an important role in resistance prevalence. This study indicated that further data analyses over longer time intervals are required to clarify the differences found between clinical and non-clinical isolates and to assess the long-term effects of changes in AMU on the prevalence of AMR.	[Mesa-Varona, Octavio; Grobbel, Mirjam; Tenhagen, Bernd-Alois] German Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Kaspar, Heike] Resistance Antibiot, Dept Method Standardisat, Reference Labs, Berlin, Germany; [Kaspar, Heike] Fed Off Consumer Protect & Food Safety, Unit Monitoring Resistance Antibiot, Berlin, Germany	Federal Institute for Risk Assessment	Mesa-Varona, O (corresponding author), German Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	Octavio.Mesa-Varona@bfr.bund.de	Grobbel, Mirjam/AAP-2541-2021; Grobbel, Mirjam/B-3928-2010	Grobbel, Mirjam/0000-0002-8619-1498; Mesa-Varona, Octavio/0000-0001-7519-6931	European Union [773830]	European Union(European Commission)	Mesa-Varona O. This work was carried out within the framework of the ARDIG project, the European Joint Programme (EJP) on AMU and AMR in humans, food and animals. ARDIG project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No 773830. URL: https://ec.europa.eu/programmes/horizon2020/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasmae B, 2019, ACTA VET SCAND, V61, DOI 10.1186/s13028-019-0441-9; Agunos A, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00131; Agyare C., 2018, INTECHOPEN; ALBERT A, 1984, BIOMETRIKA, V71, P1; Amer MM, 2018, VET WORLD, V11, P1082, DOI 10.14202/vetworld.2018.1082-1088; Association of Poultry Processors and Poultry Trade in the EU Countries, 2019, AVEC VOIC EUR S POUL; Bundesamt fur Verbarucherschutz und Lebensmittelsicherheit (BVL), ZOON MON; Bundesamt fur Verbraucherschutz und Lebensmittelsicherkeit (BVL), 2018, BER GERM VET MON PRO; Burow E, 2017, MICROB DRUG RESIST, V23, P194, DOI 10.1089/mdr.2015.0318; Cameron A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0127-3; Caucci C, 2019, J ANTIMICROB CHEMOTH, V74, P2784, DOI 10.1093/jac/dkz212; Ceccarelli D, 2020, J MED MICROBIOL, V69, P537, DOI 10.1099/jmm.0.001176; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Cheng AC, 2012, EMERG INFECT DIS, V18, P1453, DOI 10.3201/eid1809.111515; DANMAP, 2017, US ANT AG OCC ANT RE; Djordjevic SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00086; EFSA, 2017, EUR UN SUMM REP ANT; El Garch F, 2016, VET MICROBIOL, V194, P11, DOI 10.1016/j.vetmic.2016.04.009; Elmofti H, 2019, ACTA SCI NUTR HLTH; Enli L, 2019, ANTIMICROBIAL USAGE; European Commission, EUR ON HLTH ACT PLAN; European Food Safety Authority (EFSA), 2020, EFSA J, DOI [10.2903/j.efsa.2020.6007, DOI 10.2903/J.EFSA.2020.600732874244]; European Food Safety Authority (EFSA), 2018, 5182 EFSA; European Food Safety Authority (EFSA), 2019, 5598 EFSA; European Food Safety Authority (EFSA), 2016, 4380 EFSA; European Food Safety Authority (EFSA), 2018, 5500 EFSA; European Medicines Agency (EMA), JIACRA REP; European Medicines Agency (EMA), 2019, EUR SURV VET ANT CON; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; French Agency for Food Environmental and Occupational Health & Safety (ANSES)-French Agency for Veterinary Medicinal Products (ANMV), 2019, SAL SURV VET MED PRO; Ibrahim RA, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1901-1; Irrgang A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02256; Irrgang A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159863; Koper LM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237459; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Luiken REC, 2019, J ANTIMICROB CHEMOTH, V74, P2596, DOI 10.1093/jac/dkz235; Manishimwe R., 2017, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V70, P13, DOI 10.19182/remvt.31392; MARAN, 2018, MON ANT RES ANT US A; Mihai FC, 2019, ELECTRONIC WASTE MANAGEMENT AND TREATMENT TECHNOLOGY, P1, DOI 10.1016/B978-0-12-816190-6.00001-7; Nhung NT, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040037; Projahn M, 2018, MICROB BIOTECHNOL, V11, P1017, DOI 10.1111/1751-7915.13040; Projahn M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02364-16; Public Health Agency of Sweden & National Veterinary Institute, 2019, SAL ANT OCC ANT RES; QS, LEIFT KONTR ANT MAST; Reygaert WC, 2018, AIMS MICROBIOL, V4, P482, DOI 10.3934/microbiol.2018.3.482; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Roth N, 2019, POULTRY SCI, V98, P1791, DOI 10.3382/ps/pey539; Schrijver R, 2018, CLIN MICROBIOL INFEC, V24, P577, DOI 10.1016/j.cmi.2017.09.013; Schulz J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41528-z; Sciberras M., 2019, Folia Veterinaria, V63, P1; SDa, 2017, US ANT AGR LIV NETH; Suzuki K, 2019, JPN J INFECT DIS, V72, P179, DOI 10.7883/yoken.JJID.2018.277; Taylor NM, 2016, AVIAN PATHOL, V45, P559, DOI 10.1080/03079457.2016.1185510; Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Varga C, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2187-z; Varga C, 2018, AVIAN DIS, V62, P291, DOI 10.1637/11834-032818-Reg.1; Varona OM, 2020, INFECT DRUG RESIST, V13, P957, DOI 10.2147/IDR.S237038; VMD, 2019, UK VET ANT RES SAL S; Williams HE, 2018, J ANIM SCI, V96, P5166, DOI 10.1093/jas/sky370; World Health Organization, GLOB ACT PLAN ANT RE	61	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2020	15	12							e0243772	10.1371/journal.pone.0243772	http://dx.doi.org/10.1371/journal.pone.0243772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WM	33306730	Green Published, gold			2022-12-26	WOS:000600144200064
J	Deng, JS; Zhang, BS; Xie, JT; Wu, HZ; Li, ZM; Qiu, GL; Wei, CH; Zhu, S				Deng, Jinsi; Zhang, Baoshan; Xie, Junting; Wu, Haizhen; Li, Zemin; Qiu, Guanglei; Wei, Chaohai; Zhu, Shuang			Diversity and functional prediction of microbial communities involved in the first aerobic bioreactor of coking wastewater treatment system	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BACTERIAL COMMUNITY; MEMBRANE BIOREACTOR; ACTIVATED-SLUDGE; AIRLIFT REACTOR; DEGRADATION; PERFORMANCE; REMOVAL; HYDROLYSIS; CYANIDE	The pre-aerobic process of coking wastewater treatment has strong capacity of decarbonization and detoxification, which contribute to the subsequent dinitrogen of non-carbon source/heterotrophic denitrification. The COD removal rate can reach > 90% in the first aerobic bioreactor of the novel O/H/O coking wastewater treatment system during long-term operation. The physico-chemical characteristics of influent and effluent coking wastewater in the first aerobic bioreactor were analyzed to examine how they correlated with bacterial communities. The diversity of the activated sludge microbial community was investigated using a culture-independent molecular approach. The microbial community functional profiling and detailed pathways were predicted from the 16S rRNA gene-sequencing data by the PICRUSt software and the KEGG database. High-throughput MiSeq sequencing results revealed a distinct microbial composition in the activated sludge of the first aerobic bioreactor of the O/H/O system. Proteobacteria, Bacteroidetes, and Chlorobi were the decarbonization and detoxification dominant phyla with the relative abundance of 84.07 +/- 5.45, 10.89 +/- 6.31, and 2.96 +/- 1.12%, respectively. Thiobacillus, Rhodoplanes, Lysobacter, and Leucobacter were the potential major genera involved in the crucial functional pathways related to the degradation of phenols, cyanide, benzoate, and naphthalene. These results indicated that the comprehensive understanding of the structure and function diversity of the microbial community in the bioreactor will be conducive to the optimal coking wastewater treatment.	[Deng, Jinsi; Zhang, Baoshan; Xie, Junting; Zhu, Shuang] Guangdong Pharmaceut Univ, Sch Biosci & Biopharmaceut, Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou, Peoples R China; [Wu, Haizhen] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou, Peoples R China; [Li, Zemin; Qiu, Guanglei; Wei, Chaohai] South China Univ Technol, Sch Environm & Energy, Guangzhou, Peoples R China	Guangdong Pharmaceutical University; South China University of Technology; South China University of Technology	Zhu, S (corresponding author), Guangdong Pharmaceut Univ, Sch Biosci & Biopharmaceut, Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou, Peoples R China.; Wei, CH (corresponding author), South China Univ Technol, Sch Environm & Energy, Guangzhou, Peoples R China.	cehwei@scut.edu.cn; 15683727@qq.com	Qiu, Guanglei/AAF-4399-2020	Qiu, Guanglei/0000-0002-1769-3494	Key Program of the National Natural Science Foundation of China [U1901218]; National Natural Science Foundation of China [51778238, 51808297]; Fundamental Research Funds for the Central Universities, China [2019ZD21]; Program for Science and Technology of Guangdong Province, China [2016A020221037, 2017A030313066, 2017A020216001, 2018A050506009]; Guangdong Pharmaceutical University [2017KCXTD020]	Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Program for Science and Technology of Guangdong Province, China; Guangdong Pharmaceutical University	This work was supported by the Key Program of the National Natural Science Foundation of China (No. U1901218), the National Natural Science Foundation of China (No. 51778238 and No. 51808297), the Fundamental Research Funds for the Central Universities, China (No. 2019ZD21), the Program for Science and Technology of Guangdong Province, China (No. 2016A020221037, 2017A030313066, 2017A020216001 and 2018A050506009), and the innovation and university promotion project of Guangdong Pharmaceutical University (No. 2017KCXTD020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Antwi P, 2019, BIORESOURCE TECHNOL, V284, P359, DOI 10.1016/j.biortech.2019.03.008; Balcom Ian N, 2016, F1000Res, V5, P1881, DOI 10.12688/f1000research.9157.1; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen B, 2019, WATER RES, V150, P120, DOI 10.1016/j.watres.2018.11.040; Chen R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215615; Cipollone R, 2007, APPL ENVIRON MICROB, V73, P390, DOI 10.1128/AEM.02143-06; Cydzik-Kwiatkowska A, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2012-9; Dyksma S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03124; Holmes B, 2015, BERGEYS MANUAL SYSTE, DOI [10.1002/9781118960608.gbm00349, DOI 10.1002/9781118960608.GBM00349]; Huang JL, 2019, SCI TOTAL ENVIRON, V682, P532, DOI 10.1016/j.scitotenv.2019.05.197; Joshi DR, 2018, J ENVIRON SCI-CHINA, V63, P105, DOI 10.1016/j.jes.2017.07.011; Joshi DR, 2017, WATER RES, V121, P338, DOI 10.1016/j.watres.2017.05.045; Joshi DR, 2016, APPL MICROBIOL BIOT, V100, P8191, DOI 10.1007/s00253-016-7591-8; Kaiser K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33696; Kim YM, 2013, BIORESOURCE TECHNOL, V134, P180, DOI 10.1016/j.biortech.2013.02.036; Kim YM, 2011, BIORESOURCE TECHNOL, V102, P913, DOI 10.1016/j.biortech.2010.09.032; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Law YY, 2019, ENVIRON SCI TECHNOL, V53, P8157, DOI 10.1021/acs.est.9b00955; Li Y, 2015, J CHEM TECHNOL BIOT, V90, P139, DOI 10.1002/jctb.4298; Luque-Almagro VM, 2018, APPL MICROBIOL BIOT, V102, P1067, DOI 10.1007/s00253-017-8678-6; Ma JD, 2019, BIORESOURCE TECHNOL, V289, DOI 10.1016/j.biortech.2019.121616; Ma Q, 2015, BIORESOURCE TECHNOL, V179, P436, DOI 10.1016/j.biortech.2014.12.041; Manavi N, 2017, CHEM ENG J, V312, P375, DOI 10.1016/j.cej.2016.11.155; Manefield M, 2005, ENVIRON MICROBIOL, V7, P715, DOI 10.1111/j.1462-2920.2004.00746.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miao YY, 2017, BIORESOURCE TECHNOL, V231, P36, DOI 10.1016/j.biortech.2017.01.045; Na CH, 2017, J HAZARD MATER, V338, P186, DOI 10.1016/j.jhazmat.2017.05.037; Ni B, 2013, APPL MICROBIOL BIOT, V97, P6031, DOI 10.1007/s00253-012-4402-8; Niu TH, 2016, WATER RES, V90, P369, DOI 10.1016/j.watres.2015.12.050; Ofman P, 2020, J HAZARD MATER, V383, DOI 10.1016/j.jhazmat.2019.121184; Pan JX, 2019, WATER RES, V150, P216, DOI 10.1016/j.watres.2018.11.070; Pumphrey GM, 2008, APPL ENVIRON MICROB, V74, P4111, DOI 10.1128/AEM.00464-08; Qiu GL, 2016, BIORESOURCE TECHNOL, V219, P298, DOI 10.1016/j.biortech.2016.07.126; Reis AC, 2018, APPL MICROBIOL BIOT, V102, P10299, DOI 10.1007/s00253-018-9411-9; Sahariah BP, 2016, DESALIN WATER TREAT, V57, P14396, DOI 10.1080/19443994.2015.1065448; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi SN, 2013, PROCESS BIOCHEM, V48, P1553, DOI 10.1016/j.procbio.2013.07.003; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Srinivas A, 2014, INT J SYST EVOL MICR, V64, P2198, DOI 10.1099/ijs.0.063347-0; Staib C, 2007, BIOCHEM ENG J, V34, P122, DOI 10.1016/j.bej.2006.11.029; Sun WM, 2010, APPL ENVIRON MICROB, V76, P956, DOI 10.1128/AEM.01364-09; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Tian HL, 2021, ENVIRON TECHNOL, V42, P459, DOI 10.1080/09593330.2019.1631890; Wang H, 2019, J IND MICROBIOL BIOT, V46, P573, DOI 10.1007/s10295-019-02137-x; Wang Q, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193775; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062901; Wang W, 2011, BIORESOURCE TECHNOL, V102, P2441, DOI 10.1016/j.biortech.2010.10.140; Wei CH, 2000, CHEM ENG TECHNOL, V23, P597, DOI 10.1002/1521-4125(200007)23:7<597::AID-CEAT597>3.3.CO;2-P; Wu HZ, 2019, CHEMOSPHERE, V228, P128, DOI 10.1016/j.chemosphere.2019.04.117; Wu LW, 2019, NAT MICROBIOL, V4, P1183, DOI 10.1038/s41564-019-0426-5; Xu WC, 2018, BIORESOURCE TECHNOL, V264, P106, DOI 10.1016/j.biortech.2018.05.064; Yang Q, 2015, BIORESOURCE TECHNOL, V196, P169, DOI 10.1016/j.biortech.2015.07.087; Zafra G, 2016, J HAZARD MATER, V318, P702, DOI 10.1016/j.jhazmat.2016.07.060; Zhang DD, 2019, WATER SCI TECHNOL, V79, P137, DOI 10.2166/wst.2019.027; Zhang T, 2012, BIORESOURCE TECHNOL, V104, P600, DOI 10.1016/j.biortech.2011.11.008; Zhang WH, 2012, CHEMOSPHERE, V88, P174, DOI 10.1016/j.chemosphere.2012.02.076; Zhang XH, 2019, CHEMOSPHERE, V217, P790, DOI 10.1016/j.chemosphere.2018.10.210; Zhao LM, 2019, BIOPROC BIOSYST ENG, V42, P941, DOI 10.1007/s00449-019-02094-w; Zhao WT, 2009, SEP PURIF TECHNOL, V66, P279, DOI 10.1016/j.seppur.2008.12.028; Zhao WT, 2018, SCI TOTAL ENVIRON, V635, P716, DOI 10.1016/j.scitotenv.2018.04.162; Zhao ZM, 2019, ENVIRON SCI POLLUT R, V26, P11988, DOI 10.1007/s11356-019-04648-7; Zhou J, 2017, BIORESOURCE TECHNOL, V245, P379, DOI 10.1016/j.biortech.2017.08.119; Zhou S, 2010, WORLD J MICROB BIOT, V26, P273, DOI 10.1007/s11274-009-0170-8; Zhu S, 2019, WATER RES, V164, DOI 10.1016/j.watres.2019.114963; Zhu S, 2016, APPL MICROBIOL BIOT, V100, P949, DOI 10.1007/s00253-015-7009-z; Zhu XB, 2013, APPL MICROBIOL BIOT, V97, P8767, DOI 10.1007/s00253-012-4558-2	68	7	7	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2020	15	12							e0243748	10.1371/journal.pone.0243748	http://dx.doi.org/10.1371/journal.pone.0243748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH0WB	33301488	gold, Green Published			2022-12-26	WOS:000600143100046
J	Han, YJ; Luo, ZJ; Zhai, WL; Zheng, Y; Liu, H; Wang, YR; Wu, ED; Xiong, F; Ma, YM				Han, Yujuan; Luo, Zujin; Zhai, Wenliang; Zheng, Yue; Liu, Huan; Wang, Yanran; Wu, Endong; Xiong, Fang; Ma, Yingmin			Comparison of the clinical manifestations between different age groups of patients with overseas imported COVID-19	PLOS ONE			English	Article							CORONAVIRUS; OUTBREAK; WUHAN	The current study investigated the clinical manifestations and outcomes of different age groups of patients with overseas imported COVID-19. In total, 53 COVID-19 patients admitted to the designated Beijing Xiaotangshan Hospital between March 16 and April 15 of 2020 were included. Based on the percentage of disease aggravation during hospital stay according to CT, the patients were divided into two groups: <= 40 years (group A; n = 41) and >40 years (group B; n = 12). The demographic data, epidemiological history, disease courses, potential complications, clinical symptoms, lab indices, chest CT outcomes, treatment protocols and turnovers of the two groups were compared. According to clinical typing, compared with group A, group B had a significantly greater proportion of the common type of COVID-19 (P<0.05) and greater comorbidity of type 2 diabetes (P<0.001). The two groups presented significantly different lab indices. Group B showed significantly more frequent CT abnormalities, with greater proportions of multiple lesions and bilateral lung involvement (P<0.05). During hospitalization, group B had a greater proportion of disease aggravation according to CT (P<0.01). Compared with group A, group B received a significantly greater proportion of antiviral therapy and presented a significantly greater occurrence of adverse drug reactions (P<0.05). The two groups did not significantly differ in time from admission to clinical symptom improvement or from disease onset to negative outcomes according to nucleic acid testing, the appearance of IgG or the appearance of IgM. They also did not significantly differ in length of stay. Older imported COVID-19 patients, particularly those with type 2 diabetes, showed a broader pulmonary extent and faster development of the disease, more severe pathogenetic conditions and a greater risk of developing a critically severe type. Increased attention should be given to this population in clinical practice.	[Han, Yujuan] Beijing Xiaotangshan Hosp, Dept Internal Med, Beijing, Peoples R China; [Luo, Zujin; Ma, Yingmin] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Engn Res Ctr Resp & Crit Care Med, Dept Resp & Crit Care Med,Beijing Inst Resp Med, Beijing, Peoples R China; [Zhai, Wenliang] Capital Med Univ, Xuanwu Hosp, Emergence Dept, Beijing, Peoples R China; [Zheng, Yue] Beijing Chao Yang Hosp, Dept Surg Intens Care Unit, Beijing, Peoples R China; [Liu, Huan] Beijing Xiaotangshan Hosp, Dept Hlth Educ, Beijing, Peoples R China; [Wang, Yanran] Childrens Hosp, Capital Inst Pediat, Dept Nephrol, Beijing, Peoples R China; [Wu, Endong] Capital Med Univ, Beijing Chest Hosp, Crit Care Med Dept, Beijing, Peoples R China; [Xiong, Fang] Capital Med Univ, Beijing Youan Hosp, Oncol Dept, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Institute of Pediatrics (CIP); Capital Medical University; Capital Medical University	Ma, YM (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Engn Res Ctr Resp & Crit Care Med, Dept Resp & Crit Care Med,Beijing Inst Resp Med, Beijing, Peoples R China.	mayingminicu@sina.com			National Key Research and Development Program of China [2019YFC0121700]; Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support [XMLX201709]; Beijing Hospitals Authority Youth Programme [QML20180303]	National Key Research and Development Program of China; Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support; Beijing Hospitals Authority Youth Programme	The study was funded by the National Key Research and Development Program of China (Dr Ma; No. 2019YFC0121700), Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (Dr Ma; No. XMLX201709), and Beijing Hospitals Authority Youth Programme (Dr Luo; No. QML20180303). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kim H, 2020, EUR RADIOL, V30, P3266, DOI 10.1007/s00330-020-06748-2; Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; National Health Commission of the People's Republic of China website, 2020, DIAGN TREATM NOV COR, DOI DOI 10.1001/jama.2015.12402; Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027; Pan YY, 2020, EUR RADIOL, V30, P3306, DOI 10.1007/s00330-020-06731-x; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; World Health Organization (WHO), 2020, NOV COR 2019 NCOV AD; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou L, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE003, DOI 10.3760/cma.j.issn.1001-0939.2020.0003	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243347	10.1371/journal.pone.0243347	http://dx.doi.org/10.1371/journal.pone.0243347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275609	Green Published, gold			2022-12-26	WOS:000597150200007
J	Sheikh, M; Masoudi, S; Bakhshandeh, R; Moayyedkazemi, A; Zamani, F; Nikfam, S; Mansouri, M; Shishavan, NG; Nikeghbalian, S; Brennan, P; Malekzadeh, R; Pourshams, A				Sheikh, Mahdi; Masoudi, Sahar; Bakhshandeh, Razieh; Moayyedkazemi, Alireza; Zamani, Farhad; Nikfam, Sepideh; Mansouri, Masoumeh; Shishavan, Neda Ghamarzad; Nikeghbalian, Saman; Brennan, Paul; Malekzadeh, Reza; Pourshams, Akram			Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study	PLOS ONE			English	Article							SYMPTOMATIC PATIENTS; PRIMARY-CARE; OPIOID USE; RISK; EPIDEMIOLOGY; STAGE	Objectives Investigating the survival features, and determinants of treatment and stage at presentation in Iran Methods 461 patients with pancreatic ductal adenocarcinoma (PC) were prospectively enrolled from Shariati hospital, Tehran, Iran, between 2011-2018. All patients underwent endoscopic ultrasonography, computed tomography scanning, and physical examination. Validated questionnaire was completed for the participants and all were actively followed on monthly basis. Results Median survival time was 6.5 months, and 1-, and 5-year survival rates were 26.2%, and 1.5%. Patients who were older (p<0.001), illiterate (p = 0.004), unmarried (p = 0.003), rural inhabitant (p = 0.013), opium user (p = 0.039), and had lower body mass index (BMI) (p = 0.002) had lower overall survival. Tumors located in the head of pancreas were more commonly diagnosed at lower stages (p<0.001). Only 10.4% of patients underwent surgery who were more commonly educated (p<0.001), married (p = 0.005), had a tumor located in the head of pancreas (p = 0.016), and were diagnosed at lower stages (p<0.001). After adjustment for potential confounders and risk factors, rural inhabitance (HR: 1.33 (95% CI: 1.01-1.74)), having more symptoms (HR for each increasing symptom: 1.06 (1.02-1.11)), using opium (HR: 1.51 (1.04-2.20)), having a tumor located in the body of pancreas (HR: 1.33 (1.02-1.75)), and having an advanced tumor stage (HR: 2.07 (1.34-3.19)) remained significantly associated with increased risk of mortality. After the adjusting for potential confounders, we did not find significant relationships between smoking, alcohol intake, and BMI with the risk of death among patients with pancreatic cancer. Conclusions Iranian patients with PC have very poor long-term survival. Besides tumor's stage and location, socioeconomic disparities could affect the probabilities of receiving treatment and/or survival in these patients. Opium use is an independent risk factor for mortality among PC patients in Iran.	[Sheikh, Mahdi; Malekzadeh, Reza; Pourshams, Akram] Univ Tehran Med Sci, Digest Oncol Res Ctr, Digest Dis Res Inst, Tehran, Iran; [Sheikh, Mahdi; Brennan, Paul] WHO, Sect Genet, Int Agcy Res Canc, Lyon, France; [Masoudi, Sahar; Bakhshandeh, Razieh; Moayyedkazemi, Alireza; Nikfam, Sepideh; Mansouri, Masoumeh; Shishavan, Neda Ghamarzad; Malekzadeh, Reza; Pourshams, Akram] Univ Tehran Med Sci, Liver & Pancreatobiliary Dis Res Ctr, Digest Dis Res Inst, Tehran, Iran; [Moayyedkazemi, Alireza] Lorestan Univ Med Sci, Dept Internal Med, Khorramabad, Iran; [Zamani, Farhad] Iran Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Tehran, Iran; [Nikeghbalian, Saman] Shiraz Univ Med Sci, Dept Hepatobiliary Surg, Shiraz, Iran; [Pourshams, Akram] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran	Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); Tehran University of Medical Sciences; Lorestan University of Medical Sciences; Iran University of Medical Sciences; Shiraz University of Medical Science	Pourshams, A (corresponding author), Univ Tehran Med Sci, Digest Oncol Res Ctr, Digest Dis Res Inst, Tehran, Iran.; Pourshams, A (corresponding author), Univ Tehran Med Sci, Liver & Pancreatobiliary Dis Res Ctr, Digest Dis Res Inst, Tehran, Iran.; Pourshams, A (corresponding author), Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran.	akrampourshams@gmail.com	Sheikh, Mahdi/E-9455-2015	Sheikh, Mahdi/0000-0003-3972-7824	National Institute for Medical Research Development [963236]; World Cancer Research Fund International [WCRF 2016/1633]; Wereld Kanker Onderzoek Fonds (WKOF), World Cancer Research Fund International grant programme [2016/1633]	National Institute for Medical Research Development; World Cancer Research Fund International(World Cancer Research Fund International (WCRF)); Wereld Kanker Onderzoek Fonds (WKOF), World Cancer Research Fund International grant programme	This project was funded by the National Institute for Medical Research Development (grant number: 963236, grant recipient: Akram Pourshams). MS was supported by the World Cancer Research Fund International (grant number: WCRF 2016/1633, grant recipient: Paul Brennan). Funding for grant 2016/1633 was obtained from Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme.	Ahmed AE, 2018, CANCER MANAG RES, V10, P4981, DOI 10.2147/CMAR.S173666; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Artinyan A, 2008, HPB, V10, P371, DOI 10.1080/13651820802291233; Bakens MJAM, 2017, HPB, V19, P443, DOI 10.1016/j.hpb.2017.01.010; Bilici A, 2014, WORLD J GASTROENTERO, V20, P10802, DOI 10.3748/wjg.v20.i31.10802; Boland JW, 2020, EUR J CLIN PHARMACOL, V76, P393, DOI 10.1007/s00228-019-02801-2; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cancer Research UK, 2015, PANCR CANC SURV STAT; Chandrasekaran S, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2502-x; Chen Q, 2015, ONCOL REP, V33, P840, DOI 10.3892/or.2014.3626; Dai WF, 2020, CANCER MED-US, V9, P215, DOI 10.1002/cam4.2704; Farrokhzad S, 2014, ARCH IRAN MED, V17, P102, DOI 014172/AIM.003; Grandhi RK, 2017, PAIN MED, V18, P140, DOI 10.1093/pm/pnw132; Greene FL, 2002, AJCC CANC STAGING MA, P157, DOI DOI 10.1007/978-1-4757-3656-4_18; Hajatdoost L, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54030048; Hidalgo M, 2015, PANCREATOLOGY, V15, P8, DOI 10.1016/j.pan.2014.10.001; Jorand R, 2016, MOL BIOL CELL, V27, P3659, DOI 10.1091/mbc.E16-06-0427; Kardosh A, 2018, PANCREAS, V47, P958, DOI 10.1097/MPA.0000000000001133; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Kirkegard J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202486; KISTNER B, 2015, J CLIN ONCOL S, V33; KRECH RL, 1991, J PAIN SYMPTOM MANAG, V6, P360, DOI 10.1016/0885-3924(91)90027-2; McGuigan A, 2018, WORLD J GASTROENTERO, V24, P4846, DOI 10.3748/wjg.v24.i43.4846; Nelson DB, 2019, PAIN, V160, P2365, DOI 10.1097/j.pain.0000000000001630; Oh TK, 2018, PANCREAS, V47, P837, DOI 10.1097/MPA.0000000000001094; Pourshams A, 2019, LANCET GASTROENTEROL, V4, P934, DOI 10.1016/S2468-1253(19)30347-4; Raju RS, 2015, CURR ONCOL, V22, pE478, DOI 10.3747/co.22.2653; Schmidt-Hansen M, 2016, PANCREAS, V45, P814, DOI 10.1097/MPA.0000000000000527; Shakeri R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003922; Shapiro M, 2016, JAMA SURG, V151, P338, DOI 10.1001/jamasurg.2015.4239; Sheikh M, 2020, LANCET GLOB HEALTH, V8, pE649, DOI 10.1016/S2214-109X(20)30059-0; Siri FH, 2020, J GASTROINTEST CANC, V51, P418, DOI 10.1007/s12029-019-00279-w; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; United European Gastroenterology, 2018, PANCR CANC EUR; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; van Roest MHG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166449; Warnakulasuriya S, 2020, LANCET ONCOL, V21, P1407, DOI 10.1016/S1470-2045(20)30611-2; Watanabe I, 2004, PANCREAS, V28, P160, DOI 10.1097/00006676-200403000-00007; Wong MCS, 2017, SCI REP, P7, DOI [10.1038/s41598-017-00035-9, DOI 10.1038/S41598-017-00035-9]; Zagon IS, 2012, EXPERT REV GASTROENT, V6, P133, DOI [10.1586/egh.11.106, 10.1586/EGH.11.106]; Zylla D, 2018, SUPPORT CARE CANCER, V26, P2259, DOI 10.1007/s00520-018-4062-z	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2020	15	12							e0243511	10.1371/journal.pone.0243511	http://dx.doi.org/10.1371/journal.pone.0243511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AS	33275621	Green Published, gold			2022-12-26	WOS:000597150200025
J	Hasan, MN; Chowdhury, MAB; Jahan, J; Jahan, S; Ahmed, NU; Uddin, MJ				Hasan, Mohammad Nayeem; Chowdhury, Muhammad Abdul Baker; Jahan, Jenifar; Jahan, Sumyea; Ahmed, Nasar U.; Uddin, Md Jamal			Cesarean delivery and early childhood diseases in Bangladesh: An analysis of Demographic and Health Survey (BDHS) and Multiple Indicator Cluster Survey (MICS)	PLOS ONE			English	Article							RISK-FACTORS; MODE	Introduction The rate of cesarean delivery (C-section) has been increasing worldwide, including Bangladesh, and it has a negative impact on the mother and child's health. Our aim was to examine the association between C-section and childhood diseases and to identify the key factors associated with childhood diseases. Methods We used four nationally representative data sets from multiple indicator cluster survey (MICS, 2012 and 2019) and Bangladesh Demographic and Health Survey (BDHS, 2011and 2014) and analyzed 25,270 mother-child pairs. We used the frequency of common childhood diseases (fever, short or rapid breaths, cough, blood in stools, and diarrhea) as our outcome variable and C-section as exposure variable. We included mother's age, place of residence, division, mother's education, wealth index, child age, child sex, and child size at birth as confounding variables. Negative binomial regression model was used to analyze the data. Results In the BDHS data, the prevalence of C-section increased from 17.95% in 2011 to 23.33% in 2014. Also, in MICS, the prevalence almost doubled over an eight-year period (17.74% in 2012 to 35.41% in 2019). We did not observe any significant effect of C-section on childhood diseases in both surveys. Only in 2014 BDHS, we found that C-section increases the risk of childhood disease by 5% [Risk Ratio (RR): 1.05, 95% CI: 0.95, 1.17, p = 0.33]. However, the risk of childhood disease differed significantly in all survey years by division, child's age, and child's size at birth after adjusting for important confounding variables. For example, children living in Chittagong division had a higher risk [(2011 BDHS RR: 1.22, 95% CI: 1.08, 1.38) and (2019 MICS RR: 1.21, 95% CI: 1.08, 1.35)] of having disease compared to Dhaka division. Maternal age, education, and wealth status showed significant differences with the outcome in some survey years. Conclusion Our study shows that C-section in Bangladesh continued to increase over time, and we did not find significant association between C-section and early childhood diseases. High C-section rate has a greater impact on maternal and child health as well as the burden on the health care system. We recommend raising public awareness of the negative impact of unnecessary C-section in Bangladesh.	[Hasan, Mohammad Nayeem; Jahan, Jenifar; Jahan, Sumyea; Uddin, Md Jamal] Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh; [Chowdhury, Muhammad Abdul Baker] Univ Florida, Coll Med, Dept Emergency Med, Gainesville, FL USA; [Ahmed, Nasar U.] Florida Int Univ, Dept Epidemiol, Miami, FL 33199 USA	Shahjalal University of Science & Technology (SUST); State University System of Florida; University of Florida; State University System of Florida; Florida International University	Uddin, MJ (corresponding author), Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh.	jamal-sta@sust.edu	Uddin, Md Jamal/AAD-6412-2021; Hasan, Mohammad Nayeem/AAC-9977-2022	Uddin, Md Jamal/0000-0002-8360-3274; Hasan, Mohammad Nayeem/0000-0002-2383-0459; Chowdhury, Muhammad Abdul Baker/0000-0002-2145-0938				Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Angeja ACE, 2006, BJOG-INT J OBSTET GY, V113, P1253, DOI 10.1111/j.1471-0528.2006.01069.x; [Anonymous], 2010, KHARKOV HISTORIOGRAP, V10, P138; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Begum T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188074; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Chen GD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017086; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; Farmer TW, 2003, J SCHOOL PSYCHOL, V41, P217, DOI 10.1016/S0022-4405(03)00046-3; Ferdous F, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0099-4; Gibbs RS, 2008, DANFORTHS OBSTET GYN, V10th; Gomes UA, 1999, INT J EPIDEMIOL, V28, P687, DOI 10.1093/ije/28.4.687; Gondwe T, 2019, J EPIDEMIOL GLOB HEA, V9, P252, DOI 10.2991/jegh.k.191017.001; Gondwe T, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1324-3; Haider MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208623; Hasan F, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2588-9; Imran MIK, 2019, PUBLIC HEALTH, V173, P112, DOI 10.1016/j.puhe.2019.05.011; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Kandala NB, 2006, APPL STOCH MODEL BUS, V22, P139, DOI 10.1002/asmb.624; Khan MN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177579; Lori JR, 2011, HEALTH CARE WOMEN IN, V32, P454, DOI 10.1080/07399332.2011.555831; Magne F, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00192; NIPORT, 2019, BANGL DEM HLTH SURV; Pathela P, 2006, ACTA PAEDIATR, V95, P430, DOI 10.1080/08035250500444875; Pathey P, 2014, BANGLADESH MULTIPLE, V2014, P2014; Shahabuddin ASM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012424; Tazinya AA, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0579-7; Ullah MB, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1738-6; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Yun Xiang-Dong, 2013, Zhongguo Gu Shang, V26, P714; Zakerihamidi Maryam, 2015, Int J Community Based Nurs Midwifery, V3, P39; Zhang TY, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10236	32	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2020	15	12							e0242864	10.1371/journal.pone.0242864	http://dx.doi.org/10.1371/journal.pone.0242864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PC7AH	33270671	Green Published, gold			2022-12-26	WOS:000597149100038
J	Jung, SK; Park, YH; Shin, DH; Kim, HS; Jung, JH; Kim, TH; Moon, SH				Jung, Su-Kyung; Park, Young-Hoon; Shin, Dong-ho; Kim, Hak-Soo; Jung, Jong-Hwi; Kim, Tae-Hyun; Moon, Sung Ho			Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea	PLOS ONE			English	Article							UVEAL MELANOMA; OCULAR MELANOMA; RISK-FACTORS; RADIOTHERAPY; ACUITY; BRACHYTHERAPY; IRRADIATION; MANAGEMENT; PROGNOSIS; SURVIVAL	We evaluate the ocular effects of proton beam therapy (PBT) in a single institution, in Korea, and identify factors contributing to decreasing visual acuity (VA) after PBT. A total of 40 patients who received PBT for choroidal melanoma (20092016) were reviewed. Dose fractionation was 6070 cobalt gray equivalents (CGEs) over five fractions. Complete ophthalmic examinations including funduscopy and ultrasonography were performed at baseline and at 3, 6, and 12 months after PBT, then annually thereafter. Only patients with at least 12 months follow-up were included. During the follow-up, consecutive best-corrected visual acuity (BCVA) changes were determined, and univariate and multivariate logistic regression analyses were performed to identify predictors for VA loss. The median follow-up duration was 32 months (range: 1282 months). The final BCVA of nine patients was > 20/40. The main cause of vision loss was intraocular bleeding, such as neovascular glaucoma or retinal hemorrhage. Vision loss was correlated with the tumor size, tumor distance to the optic disc or fovea, maculae receiving 30 CGEs, optic discs receiving 30 CGEs, and retinas receiving 30 CGEs. Approximately one-third of PBT-treated choroidal melanoma patients with good pretreatment BCVA maintained their VA. The patients who finally lost vision (VA < count fingers) usually experienced rapid declines in VA from 612 months after PBT. Tumor size, tumor distance to the optic disc or fovea, volume of the macula, and optic discs or retinas receiving 30 CGEs affected the final VA.	[Jung, Su-Kyung] Natl Canc Ctr, Dept Ophthalmol, Gyeonggi Do, South Korea; [Park, Young-Hoon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Shin, Dong-ho; Kim, Hak-Soo; Jung, Jong-Hwi; Kim, Tae-Hyun; Moon, Sung Ho] Natl Canc Ctr, Res Inst & Hosp, Proton Therapy Ctr, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); Catholic University of Korea; Seoul St. Mary's Hospital; National Cancer Center - Korea (NCC)	Moon, SH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Proton Therapy Ctr, Gyeonggi Do, South Korea.	shmoon@ncc.re.kr		Kim, Tae Hyun/0000-0001-8413-3385	National Cancer Center, Republic of Korea [1811050]	National Cancer Center, Republic of Korea	This work was supported by the research grant (No. 1811050) from the National Cancer Center, Republic of Korea.	Collaborative Ocular Melanoma Study Group, 2001, OPHTHALMOLOGY, V108, P348, DOI [10.1016/S0161-6420(00)00526-1, DOI 10.1016/S0161-6420(00)00526-1]; Daftari IK, 1997, INT J RADIAT ONCOL, V39, P997, DOI 10.1016/S0360-3016(97)00557-9; Dalvin LA, 2020, BRIT J OPHTHALMOL, V104, P697, DOI 10.1136/bjophthalmol-2019-314686; Damato B, 2005, INT J RADIAT ONCOL, V63, P392, DOI 10.1016/j.ijrobp.2005.02.059; Diener-West M, 2004, J CLIN ONCOL, V22, P2438, DOI 10.1200/jco.2004.08.194; DRZYMALA RE, 1991, INT J RADIAT ONCOL, V21, P71, DOI 10.1016/0360-3016(91)90168-4; Egger E, 2001, INT J RADIAT ONCOL, V51, P138, DOI 10.1016/S0360-3016(01)01560-7; Gragoudas E, 2002, ARCH OPHTHALMOL-CHIC, V120, P1665; Kim TW, 2018, CANCER RES TREAT, V50, P335, DOI 10.4143/crt.2017.070; KUO P K, 1982, International Ophthalmology Clinics, V22, P57, DOI 10.1097/00004397-198202230-00007; Kwon HJ, 2013, BRIT J OPHTHALMOL, V97, P653, DOI 10.1136/bjophthalmol-2012-302584; Meeralakshmi P, 2017, SOUTH ASIAN J CANCER, V6, P134, DOI 10.4103/sajc.sajc_160_16; Mishra KK, 2013, INT J RADIAT ONCOL, V87, P330, DOI 10.1016/j.ijrobp.2013.05.051; Park SJ, 2015, INVEST OPHTH VIS SCI, V56, P4719, DOI 10.1167/iovs.15-16532; Patel AV, 2016, OPHTHALMOLOGY, V123, P369, DOI 10.1016/j.ophtha.2015.09.031; Polishchuk AL, 2017, INT J RADIAT ONCOL, V97, P91, DOI 10.1016/j.ijrobp.2016.09.019; Rodrigues G, 2004, RADIOTHER ONCOL, V71, P127, DOI 10.1016/j.radonc.2004.02.015; SEDDON JM, 1987, OPHTHALMOLOGY, V94, P354; SEDDON JM, 1986, OPHTHALMOLOGY, V93, P666; Seibel I, 2016, GRAEF ARCH CLIN EXP, V254, P1787, DOI 10.1007/s00417-016-3429-4; Shields CL, 2000, ARCH OPHTHALMOL-CHIC, V118, P1219; Shields JA, 2015, OPHTHALMOLOGY, V122, P414, DOI 10.1016/j.ophtha.2014.08.046; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Thariat J, 2016, INT J RADIAT ONCOL, V95, P328, DOI 10.1016/j.ijrobp.2015.12.011; Toutee A, 2019, CANCERS, V11, DOI 10.3390/cancers11081047; Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032; Wisely CE, 2016, BRACHYTHERAPY, V15, P12, DOI 10.1016/j.brachy.2015.09.013; Wong W, 2019, SINGAP MED J, V60, P474, DOI 10.11622/smedj.2019054; Yue H, 2017, CURR EYE RES, V42, P759, DOI 10.1080/02713683.2016.1245422	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2020	15	12							e0242966	10.1371/journal.pone.0242966	http://dx.doi.org/10.1371/journal.pone.0242966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PB8MS	33264363	gold, Green Published			2022-12-26	WOS:000596569200071
J	Cvetko, F; Caldwell, ST; Higgins, M; Suzuki, T; Yamamoto, M; Prag, HA; Hartley, RC; Dinkova-Kostova, AT; Murphy, MP				Cvetko, Filip; Caldwell, Stuart T.; Higgins, Maureen; Suzuki, Takafumi; Yamamoto, Masayuki; Prag, Hiran A.; Hartley, Richard C.; Dinkova-Kostova, Albena T.; Murphy, Michael P.			Nrf2 is activated by disruption of mitochondrial thiol homeostasis but not by enhanced mitochondrial superoxide production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; KEAP1-NRF2 PATHWAY; REDOX; ANTIOXIDANT; GENES; GLUTATHIONE; CELLS; THIOREDOXIN; DEGRADATION	The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) regulates the expression of genes involved in antioxidant defenses to modulate fundamental cellular processes such as mitochondrial function and GSH metabolism. Previous reports proposed that mitochondrial reactive oxygen species production and disruption of the GSH pool activate the Nrf2 pathway, suggesting that Nrf2 senses mitochondrial redox signals and/or oxidative damage and signals to the nucleus to respond appropriately. However, until now, it has not been possible to disentangle the overlapping effects of mitochondrial superoxide/hydrogen peroxide production as a redox signal from changes to mitochondrial thiol homeostasis on Nrf2. Recently, we developed mitochondria-targeted reagents that can independently induce mitochondrial superoxide and hydrogen peroxide production mitoParaquat (MitoPQ) or selectively disrupt mitochondrial thiol homeostasis MitoChlorodinitrobenzoic acid (MitoCDNB). Using these reagents, here we have determined how enhanced generation of mitochondrial superoxide and hydrogen peroxide or disruption of mitochondrial thiol homeostasis affects activation of the Nrf2 system in cells, which was assessed by the Nrf2 protein level, nuclear translocation, and expression of its target genes. We found that selective disruption of the mitochondrial GSH pool and inhibition of its thioredoxin system by MitoCDNB led to Nrf2 activation, whereas using MitoPQ to enhance the production of mitochondrial superoxide and hydrogen peroxide alone did not. We further showed that Nrf2 activation by MitoCDNB requires cysteine sensors of Kelch-like ECH-associated protein 1 (Keap1). These findings provide important information on how disruption to mitochondrial redox homeostasis is sensed in the cytoplasm and signaled to the nucleus.	[Cvetko, Filip; Prag, Hiran A.; Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Murphy, Michael P.] Univ Cambridge, Dept Med, Cambridge, England; [Caldwell, Stuart T.; Hartley, Richard C.] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland; [Higgins, Maureen; Dinkova-Kostova, Albena T.] Univ Dundee, Jacqui Wood Canc Ctr, Sch Med, Div Cellular Med, Dundee, Miyagi, Scotland; [Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Dinkova-Kostova, Albena T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Dinkova-Kostova, Albena T.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	University of Cambridge; University of Cambridge; University of Glasgow; University of Dundee; Tohoku University; Tohoku University; Johns Hopkins University; Johns Hopkins University	Murphy, MP (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.; Murphy, MP (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.	mpm@mrc-mbu.cam.ac.uk	Hartley, Richard/E-3489-2010; Suzuki, Takafumi/ABC-6582-2020; Hartley, Richard/AAT-7834-2020; Yamamoto, Masayuki/A-4873-2010; Murphy, Michael/C-2120-2009	Hartley, Richard/0000-0003-1033-5405; Suzuki, Takafumi/0000-0002-3425-8208; Hartley, Richard/0000-0003-1033-5405; Yamamoto, Masayuki/0000-0002-9073-9436; Murphy, Michael/0000-0003-1115-9618; Prag, Hiran/0000-0002-4753-8567; Dinkova-Kostova, Albena/0000-0003-0316-9859	Medical Research Council UK [MC_U105663142]; Wellcome Trust [110159/A/15/Z, 110158/A/15/Z, RG88195]; Cancer Research UK [CRUK/A18644]; MRC [MC_U105663142] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work in the laboratory of M. P. M. was supported by the Medical Research Council UK (MC_U105663142) and by a Wellcome Trust Investigator award (110159/A/15/Z). Work in the laboratory of R. C. H. was supported by a Wellcome Trust Investigator award (110158/A/15/Z). This work was supported by a Wellcome Trust PhD program in Metabolic and Cardiovascular Diseases (RG88195) to F. C. Work in the laboratory of A. T. D.-K. was supported by Cancer Research UK (CRUK/A18644).	Agyeman AS, 2012, BREAST CANCER RES TR, V132, P175, DOI 10.1007/s10549-011-1536-9; Akerboom T P, 1981, Methods Enzymol, V77, P373; Antonucci S, 2019, FREE RADICAL BIO MED, V134, P678, DOI 10.1016/j.freeradbiomed.2019.01.034; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Booty LM, 2019, CELL CHEM BIOL, V26, P449, DOI 10.1016/j.chembiol.2018.12.002; Booty LM, 2015, FEBS LETT, V589, P621, DOI 10.1016/j.febslet.2015.01.027; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Dayalan Naidu S, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200105; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Fahey JW, 2004, METHOD ENZYMOL, V382, P243; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Go YM, 2013, CRIT REV BIOCHEM MOL, V48, P173, DOI 10.3109/10409238.2013.764840; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hinchy EC, 2018, J BIOL CHEM, V293, P17208, DOI 10.1074/jbc.RA118.002579; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kasai S, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020320; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1055, DOI 10.1167/iovs.10-5777; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; O'Mealey GB, 2017, J CELL SCI, V130, P3467, DOI 10.1242/jcs.203216; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021; Ryoo IG, 2018, TOXICOL APPL PHARM, V359, P24, DOI 10.1016/j.taap.2018.09.014; Sabouny R, 2017, ANTIOXID REDOX SIGN, V27, P1447, DOI 10.1089/ars.2016.6855; Saito R, 2016, MOL CELL BIOL, V36, P271, DOI 10.1128/MCB.00868-15; Scarlett JL, 1996, BIOCHEM PHARMACOL, V52, P1047, DOI 10.1016/0006-2952(96)99426-5; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; SPENCER SR, 1991, BIOCHEM J, V273, P711, DOI 10.1042/bj2730711; Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Wang P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08680-6; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	60	14	14	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100169	10.1074/jbc.RA120.016551	http://dx.doi.org/10.1074/jbc.RA120.016551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33461950	gold, Green Accepted, Green Published			2022-12-26	WOS:000672866400147
